data_6d5z_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6d5z _Structure_validation_residue.Date_analyzed 2019-04-19 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.503 HG22 ' O ' ' D' ' 13' ' ' ILE . 68.6 mt . . . . . 0 N--CA 1.463 0.193 0 CA-C-O 121.894 0.854 . . . . 0.0 111.668 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -95.9 -40.83 9.11 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.599 172.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 15' ' ' SER . . . . . 0.468 ' O ' ' HD2' ' D' ' 19' ' ' LYS . 79.6 p -70.98 -26.92 63.36 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.734 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 16' ' ' VAL . . . . . 0.517 HG21 ' O ' ' D' ' 91' ' ' ILE . 11.4 p -53.37 -28.91 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 121.802 0.81 . . . . 0.0 110.623 177.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 17' ' ' ASN . . . . . 0.422 ' N ' HG11 ' D' ' 16' ' ' VAL . 4.3 m120 -72.67 -43.19 63.46 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.374 -1.285 . . . . 0.0 109.668 176.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 18' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' D' ' 15' ' ' SER . 74.7 m-20 -57.97 -14.91 7.27 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -177.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.568 ' HD2' ' N ' ' D' ' 19' ' ' LYS . 0.0 OUTLIER -90.14 -41.4 11.66 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.508 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 20' ' ' LEU . . . . . 0.681 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 63.8 mt -73.87 -39.6 63.82 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 112.905 -1.952 . . . . 0.0 109.796 -176.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 21' ' ' ASN . . . . . 0.631 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 3.0 m120 -75.44 91.75 2.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.894 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 22' ' ' LYS . . . . . 0.554 ' HD3' HD11 ' D' ' 47' ' ' ILE . 28.8 mtpp -122.13 -41.77 2.41 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -176.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.9 -92.03 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 119.411 -1.375 . . . . 0.0 113.931 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . 0.717 ' HG2' ' HB3' ' D' ' 45' ' ' TYR . 58.1 tttm -48.55 -54.7 13.42 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.572 0.701 . . . . 0.0 110.152 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 25' ' ' GLY . . . . . 0.553 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -144.29 154.06 25.47 Favored Glycine 0 N--CA 1.433 -1.502 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.351 175.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 26' ' ' LYS . . . . . 0.668 ' HG3' ' HB2' ' D' ' 41' ' ' SER . 9.1 ptpt -150.94 161.37 42.85 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.482 -0.859 . . . . 0.0 111.335 -167.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 27' ' ' LEU . . . . . 0.681 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 38.3 tp -132.01 142.92 49.73 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.71 0.767 . . . . 0.0 112.185 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 28' ' ' SER . . . . . 0.752 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 48.0 m -132.77 144.91 50.58 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.423 -176.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 29' ' ' LEU . . . . . 0.54 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 0.0 OUTLIER -141.28 147.14 37.73 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 119.549 -0.861 . . . . 0.0 110.789 -177.779 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 41.3 m -149.77 176.34 10.79 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.179 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -138.23 166.13 24.95 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.105 0.479 . . . . 0.0 110.926 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 32' ' ' ASN . . . . . 0.677 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 0.7 OUTLIER -148.17 87.53 1.61 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.6 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.01 -98.87 0.66 Allowed Glycine 0 N--CA 1.455 -0.056 0 C-N-CA 119.941 -1.123 . . . . 0.0 111.011 -172.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 34' ' ' ASN . . . . . 0.648 ' O ' ' HE3' ' D' ' 85' ' ' LYS . 73.0 m-80 -116.33 31.12 6.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.048 0.452 . . . . 0.0 110.342 173.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 35' ' ' GLN . . . . . 0.677 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 70.7 tp60 -106.8 148.59 28.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.2 -178.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . 0.618 HD13 ' C ' ' D' ' 36' ' ' LEU . 2.9 tm? -118.53 136.04 54.06 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.924 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 37' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 25.5 mmmt -134.12 110.77 9.81 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.358 -171.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 38' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -118.71 146.56 44.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.163 0.506 . . . . 0.0 111.578 178.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 39' ' ' THR . . . . . 0.752 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 7.0 p -142.98 132.05 23.05 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.958 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 40' ' ' SER . . . . . 0.598 ' HA ' ' O ' ' D' ' 26' ' ' LYS . 25.2 p -107.78 129.21 55.07 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 172.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 41' ' ' SER . . . . . 0.668 ' HB2' ' HG3' ' D' ' 26' ' ' LYS . 40.6 m -95.16 146.88 24.0 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.161 -1.016 . . . . 0.0 109.687 -177.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 42' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' D' ' 41' ' ' SER . 76.1 m-20 80.2 5.46 1.78 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.995 -169.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 50.35 62.81 2.49 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 168.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.09 -11.82 7.26 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 118.672 -1.728 . . . . 0.0 115.594 170.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 45' ' ' TYR . . . . . 0.717 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 1.6 m-85 -85.36 157.46 20.52 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 117.406 0.603 . . . . 0.0 111.739 -177.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . 0.654 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -100.01 -173.93 30.36 Favored Glycine 0 C--O 1.215 -1.046 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 175.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 47' ' ' ILE . . . . . 0.708 HG12 ' HB3' ' D' ' 68' ' ' GLU . 36.1 mm -47.79 -57.86 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 CA-C-O 122.254 1.026 . . . . 0.0 110.081 177.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 48' ' ' SER . . . . . 0.586 ' HA ' ' HD3' ' D' ' 24' ' ' LYS . 78.5 p -175.63 -102.3 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 112.875 -1.966 . . . . 0.0 108.812 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.54 77.25 1.59 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.996 0.903 . . . . 0.0 110.094 166.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . 0.675 ' HB2' ' HE3' ' D' ' 52' ' ' LYS . 56.1 mt-10 -139.9 179.22 6.73 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.011 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 51' ' ' ASP . . . . . 0.644 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 2.9 p30 -124.66 140.42 52.95 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.522 0.677 . . . . 0.0 112.014 174.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 52' ' ' LYS . . . . . 0.792 ' HD3' ' HB2' ' D' ' 68' ' ' GLU . 0.3 OUTLIER -146.42 136.69 23.74 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.234 -175.457 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -109.69 129.64 55.59 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.713 -0.395 . . . . 0.0 109.962 175.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 54' ' ' TRP . . . . . 0.621 ' HZ3' ' CG2' ' D' ' 91' ' ' ILE . 1.1 m95 -124.25 165.2 18.03 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -174.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 55' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' D' ' 64' ' ' TYR . . . -155.15 170.33 33.27 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.928 174.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 56' ' ' ILE . . . . . 0.564 HG12 ' CG2' ' D' ' 91' ' ' ILE . 96.0 mt -138.28 113.7 9.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 124.917 1.287 . . . . 0.0 107.676 -177.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 57' ' ' PHE . . . . . 0.735 ' HB2' ' HB3' ' D' ' 90' ' ' GLU . 10.1 m-85 -115.59 105.89 13.29 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.934 -0.706 . . . . 0.0 112.018 -166.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.712 HG11 ' O ' ' D' ' 87' ' ' PRO . 81.8 t -82.69 101.33 7.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.227 173.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 59' ' ' ASN . . . . . 0.449 HD22 ' HG2' ' D' ' 87' ' ' PRO . 75.5 m-80 58.95 43.55 17.71 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.892 0.377 . . . . 0.0 110.287 -176.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.52 45.51 45.75 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.641 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 61' ' ' GLU . . . . . 0.621 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 86.2 mt-10 -137.05 105.69 5.84 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 177.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 62' ' ' LYS . . . . . 0.53 ' HB2' ' CE1' ' D' ' 57' ' ' PHE . 38.8 ttmt -70.83 99.49 1.75 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -178.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 32.7 m -88.41 -19.93 7.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -174.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 64' ' ' TYR . . . . . 0.51 ' HH ' ' CB ' ' D' ' 78' ' ' ASP . 16.1 t80 -148.17 140.42 24.22 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.307 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 60.7 m -119.73 118.02 29.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.35 176.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 66' ' ' PHE . . . . . 0.513 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 12.1 p90 -123.27 152.96 40.84 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 174.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 67' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' D' ' 52' ' ' LYS . 74.0 m-20 -119.87 135.83 54.73 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -177.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 68' ' ' GLU . . . . . 0.792 ' HB2' ' HD3' ' D' ' 52' ' ' LYS . 4.1 mm-40 -65.96 -8.19 21.24 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.792 0.329 . . . . 0.0 110.694 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.446 ' NZ ' ' HB3' ' D' ' 69' ' ' LYS . 5.9 mtpm? -60.48 -47.75 84.75 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 169.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 70' ' ' SER . . . . . 0.472 ' O ' HD13 ' D' ' 75' ' ' ILE . 22.8 t -66.87 131.43 45.9 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 113.385 -1.734 . . . . 0.0 107.87 168.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 71' ' ' THR . . . . . 0.418 ' O ' HG13 ' D' ' 75' ' ' ILE . 69.7 p -60.42 127.89 33.99 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.072 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 72' ' ' VAL . . . . . 0.667 HG12 ' HB2' ' D' ' 27' ' ' LEU . 0.1 OUTLIER -56.61 -11.79 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 120.902 0.382 . . . . 0.0 111.767 -178.757 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 73' ' ' GLY . . . . . 0.595 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -73.17 -58.3 4.76 Favored Glycine 0 N--CA 1.435 -1.37 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.084 168.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -61.2 -25.75 67.25 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-O 121.114 0.483 . . . . 0.0 110.489 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 75' ' ' ILE . . . . . 0.528 ' O ' HG12 ' D' ' 79' ' ' ILE . 76.8 mt -73.5 -40.31 55.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.637 177.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 76' ' ' SER . . . . . 0.635 ' HA ' HG12 ' D' ' 79' ' ' ILE . 31.0 t -74.72 -19.31 60.29 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.654 178.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 77' ' ' ASN . . . . . 0.443 ' O ' ' HD3' ' D' ' 81' ' ' LYS . 3.9 m120 -62.09 -41.07 97.81 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 166.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 78' ' ' ASP . . . . . 0.92 ' HA ' ' HE3' ' D' ' 81' ' ' LYS . 51.1 m-20 -67.57 -35.8 79.7 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.119 174.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . 0.635 HG12 ' HA ' ' D' ' 76' ' ' SER . 13.2 mm -67.46 -20.71 26.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.82 -176.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -69.78 -45.14 68.65 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.964 173.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 81' ' ' LYS . . . . . 0.92 ' HE3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -66.47 -64.61 0.82 Allowed 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.282 175.226 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 82' ' ' LEU . . . . . 0.608 HD21 ' O ' ' D' ' 78' ' ' ASP . 3.8 mm? -46.51 -31.7 2.91 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 43.93 73.18 0.16 Allowed 'General case' 0 N--CA 1.473 0.697 0 O-C-N 123.881 0.738 . . . . 0.0 110.767 176.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 84' ' ' ILE . . . . . 0.466 HG22 HD11 ' D' ' 89' ' ' ILE . 47.1 mm -72.61 99.52 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.931 -173.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 85' ' ' LYS . . . . . 0.648 ' HE3' ' O ' ' D' ' 34' ' ' ASN . 51.9 mtpt -103.04 165.11 11.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.569 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.1 178.67 0.55 Allowed Glycine 0 C--N 1.335 0.49 0 O-C-N 123.779 0.674 . . . . 0.0 113.204 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 87' ' ' PRO . . . . . 0.712 ' O ' HG11 ' D' ' 58' ' ' VAL . 32.2 Cg_endo -93.98 -179.65 9.08 Favored 'Cis proline' 0 C--N 1.327 -0.57 0 C-N-CA 123.537 -1.443 . . . . 0.0 114.19 -0.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 88' ' ' TYR . . . . . 0.708 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 0.5 OUTLIER 27.77 91.92 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.953 1.301 . . . . 0.0 112.752 178.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.51 HD13 ' O ' ' D' ' 85' ' ' LYS . 64.2 mt -110.42 119.03 58.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.536 0.684 . . . . 0.0 112.014 -177.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.735 ' HB3' ' HB2' ' D' ' 57' ' ' PHE . 16.1 tp10 -106.6 91.15 3.57 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.297 178.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 91' ' ' ILE . . . . . 0.621 ' CG2' ' HZ3' ' D' ' 54' ' ' TRP . 4.2 mt -96.68 109.76 23.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 92' ' ' LYS . . . . . 0.709 ' HE2' HG23 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -161.5 169.72 21.27 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.528 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . 0.647 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 26.2 pt20 -80.9 162.82 23.77 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.653 175.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 94' ' ' ILE . . . . . 0.709 HG23 ' HE2' ' D' ' 92' ' ' LYS . 10.6 pt . . . . . 0 C--N 1.303 -1.437 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.428 -170.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.527 ' C ' HG12 ' D' ' 16' ' ' VAL . 63.3 mt . . . . . 0 C--O 1.233 0.197 0 CA-C-O 121.744 0.783 . . . . 0.0 111.647 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -94.05 -58.79 2.13 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.322 175.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 15' ' ' SER . . . . . 0.558 ' HA ' ' OD1' ' D' ' 18' ' ' ASP . 29.5 m -67.22 -18.28 65.17 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.308 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 16' ' ' VAL . . . . . 0.527 HG12 ' C ' ' D' ' 13' ' ' ILE . 10.1 p -55.09 -28.89 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.962 0.887 . . . . 0.0 110.07 174.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 17' ' ' ASN . . . . . 0.478 ' N ' HG11 ' D' ' 16' ' ' VAL . 3.9 m120 -79.92 -32.86 40.11 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.021 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 18' ' ' ASP . . . . . 0.558 ' OD1' ' HA ' ' D' ' 15' ' ' SER . 1.4 m-20 -59.64 -15.99 23.0 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 176.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.574 ' O ' ' HG3' ' D' ' 22' ' ' LYS . 0.0 OUTLIER -91.3 -52.26 4.89 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 122.285 1.041 . . . . 0.0 108.496 175.309 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 20' ' ' LEU . . . . . 0.983 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 60.8 mt -56.08 -39.26 71.83 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 112.953 -1.93 . . . . 0.0 110.516 -179.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 21' ' ' ASN . . . . . 0.583 ' OD1' ' HB2' ' D' ' 26' ' ' LYS . 56.0 m-20 -78.82 96.29 5.6 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.68 177.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 22' ' ' LYS . . . . . 0.574 ' HG3' ' O ' ' D' ' 19' ' ' LYS . 54.6 mttp -122.46 -42.7 2.33 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -178.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 170.83 -86.39 0.08 OUTLIER Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 119.606 -1.283 . . . . 0.0 113.24 -177.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . 0.706 ' HE3' ' HD1' ' D' ' 45' ' ' TYR . 53.7 tptt -46.47 -52.66 12.74 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 25' ' ' GLY . . . . . 1.073 ' HA2' HD22 ' D' ' 42' ' ' ASN . . . -146.31 151.12 23.41 Favored Glycine 0 N--CA 1.436 -1.334 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.681 177.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 26' ' ' LYS . . . . . 0.697 ' HZ2' ' HB3' ' D' ' 26' ' ' LYS . 0.4 OUTLIER -143.95 160.04 41.52 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.054 -0.573 . . . . 0.0 112.3 -170.113 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 27' ' ' LEU . . . . . 0.983 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 49.2 tp -135.75 143.44 45.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.484 0.659 . . . . 0.0 112.231 -177.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 28' ' ' SER . . . . . 0.632 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 39.2 m -127.39 151.23 49.07 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.965 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 29' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 14.4 mt -140.4 156.77 46.28 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.925 177.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 60.2 m -159.19 -173.5 4.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.704 176.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -146.9 165.32 30.14 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 32' ' ' ASN . . . . . 0.47 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 51.4 t30 -150.14 88.81 1.54 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -177.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.31 -100.51 0.88 Allowed Glycine 0 C--O 1.228 -0.228 0 C-N-CA 120.306 -0.949 . . . . 0.0 110.949 -173.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -114.5 31.44 6.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.779 0.323 . . . . 0.0 110.145 173.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 35' ' ' GLN . . . . . 0.47 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 50.5 tt0 -109.63 159.96 16.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.906 0.384 . . . . 0.0 110.967 -176.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . 0.536 ' HB3' HD21 ' D' ' 83' ' ' ASN . 1.9 tm? -123.77 134.6 53.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.87 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 37' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 13.6 mmmm -132.88 122.86 25.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.522 -168.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 38' ' ' ALA . . . . . 0.458 ' HB1' ' OG ' ' D' ' 76' ' ' SER . . . -129.65 149.75 51.27 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.828 0.347 . . . . 0.0 110.467 173.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 39' ' ' THR . . . . . 0.632 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 1.7 p -150.47 136.98 18.87 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.807 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 40' ' ' SER . . . . . 0.617 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 40.8 p -107.75 133.7 51.77 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 173.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 41' ' ' SER . . . . . 0.671 ' HB2' ' CD ' ' D' ' 26' ' ' LYS . 35.4 m -94.19 164.81 12.9 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 174.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 42' ' ' ASN . . . . . 1.073 HD22 ' HA2' ' D' ' 25' ' ' GLY . 17.6 p30 61.73 10.12 3.23 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 124.669 1.231 . . . . 0.0 111.505 -171.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 53.3 60.5 3.69 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 167.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 44' ' ' GLY . . . . . 0.775 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 104.37 37.4 2.86 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 118.472 -1.823 . . . . 0.0 115.742 164.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 45' ' ' TYR . . . . . 0.706 ' HD1' ' HE3' ' D' ' 24' ' ' LYS . 2.5 m-85 -118.17 158.18 25.56 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 117.991 0.896 . . . . 0.0 109.53 172.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . 0.628 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -92.01 -176.34 42.37 Favored Glycine 0 C--O 1.213 -1.193 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 178.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 47' ' ' ILE . . . . . 0.823 HG12 ' HB3' ' D' ' 68' ' ' GLU . 40.2 mm -47.27 -54.92 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 CA-C-N 118.251 1.025 . . . . 0.0 110.714 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 22.8 t -178.22 -147.59 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 112.92 -1.946 . . . . 0.0 106.313 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -88.01 74.33 8.93 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 119.308 -0.957 . . . . 0.0 108.437 165.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -138.13 -171.93 3.15 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.607 -176.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 51' ' ' ASP . . . . . 0.669 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 52.2 p-10 -147.25 133.58 19.57 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.965 0.888 . . . . 0.0 112.697 177.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 52' ' ' LYS . . . . . 0.669 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 3.5 mptp? -145.49 134.41 22.51 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.164 -176.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -104.99 134.21 48.47 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 174.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 54' ' ' TRP . . . . . 0.624 ' HB2' ' O ' ' D' ' 66' ' ' PHE . 0.1 OUTLIER -125.58 158.13 35.39 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 -170.636 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -151.1 162.87 29.61 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.046 -1.073 . . . . 0.0 114.127 175.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 56' ' ' ILE . . . . . 0.439 ' CG2' HG21 ' D' ' 84' ' ' ILE . 66.8 mt -135.94 110.87 11.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 57' ' ' PHE . . . . . 0.698 ' HB2' ' HB3' ' D' ' 90' ' ' GLU . 19.4 m-85 -107.67 99.45 8.93 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 119.729 -0.789 . . . . 0.0 111.735 -165.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.643 HG13 ' O ' ' D' ' 87' ' ' PRO . 85.7 t -87.86 107.51 17.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.204 175.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 59' ' ' ASN . . . . . 0.433 HD21 ' HB2' ' D' ' 88' ' ' TYR . 3.8 m120 68.79 31.16 4.54 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.937 -178.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.5 -32.35 7.48 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.581 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 61' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 11.2 pt-20 -89.83 139.3 30.71 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.36 0.6 . . . . 0.0 111.686 -175.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 62' ' ' LYS . . . . . 0.528 ' HB2' ' CE1' ' D' ' 57' ' ' PHE . 38.1 ttpt -81.07 103.59 10.99 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.395 -177.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 28.2 m -82.25 -32.88 11.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.584 0.586 . . . . 0.0 112.584 -174.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 64' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -134.93 131.82 37.7 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.879 -0.329 . . . . 0.0 110.966 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 57.1 m -117.16 119.96 36.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.025 175.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 66' ' ' PHE . . . . . 0.624 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 16.1 p90 -126.31 146.8 49.88 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.195 0.522 . . . . 0.0 110.244 176.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -102.96 142.72 33.57 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -177.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 68' ' ' GLU . . . . . 0.823 ' HB3' HG12 ' D' ' 47' ' ' ILE . 5.6 mm-40 -75.89 -9.29 58.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.237 0.542 . . . . 0.0 109.703 175.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.561 ' HD3' ' HB2' ' D' ' 51' ' ' ASP . 9.1 mtmp? -67.93 -37.1 81.23 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 169.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 70' ' ' SER . . . . . 0.496 ' HG ' HG12 ' D' ' 75' ' ' ILE . 19.2 t -74.81 124.81 27.5 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 113.761 -1.563 . . . . 0.0 107.567 171.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 82.8 p -51.15 124.52 11.75 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.325 -176.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 72' ' ' VAL . . . . . 0.637 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -58.49 -11.49 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-O 121.151 0.5 . . . . 0.0 110.919 -175.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 73' ' ' GLY . . . . . 0.775 ' HA3' ' HA2' ' D' ' 44' ' ' GLY . . . -72.48 -61.77 3.5 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 114.948 -1.023 . . . . 0.0 112.861 170.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -57.77 -32.63 67.68 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 120.959 0.409 . . . . 0.0 109.951 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 75' ' ' ILE . . . . . 0.637 ' O ' HG13 ' D' ' 79' ' ' ILE . 23.8 mm -73.35 -42.19 57.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.317 177.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 76' ' ' SER . . . . . 0.545 ' HA ' HG13 ' D' ' 79' ' ' ILE . 30.2 t -73.79 -20.89 60.34 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.009 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -66.83 -29.92 69.97 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 167.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 78' ' ' ASP . . . . . 1.042 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 60.7 m-20 -77.77 -33.94 52.49 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.93 172.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . 0.637 HG13 ' O ' ' D' ' 75' ' ' ILE . 25.3 mt -68.54 -17.3 21.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.239 -175.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -72.74 -37.26 67.78 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.424 175.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 81' ' ' LYS . . . . . 1.042 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -80.13 -51.97 8.34 Favored 'General case' 0 CA--C 1.526 0.033 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.678 176.048 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 82' ' ' LEU . . . . . 0.581 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.9 mm? -49.02 -30.82 6.6 Favored 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 177.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 83' ' ' ASN . . . . . 0.536 HD21 ' HB3' ' D' ' 36' ' ' LEU . 0.8 OUTLIER 40.14 66.23 0.63 Allowed 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.121 0.888 . . . . 0.0 111.374 172.298 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 84' ' ' ILE . . . . . 0.465 HD11 HG22 ' D' ' 84' ' ' ILE . 40.1 mm -82.1 97.74 4.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.074 -174.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.26 94.28 3.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.715 0.769 . . . . 0.0 112.807 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 86' ' ' GLY . . . . . 0.474 ' H ' ' CD1' ' D' ' 89' ' ' ILE . . . 67.57 153.61 0.38 Allowed Glycine 0 N--CA 1.453 -0.169 0 CA-C-N 115.603 -0.726 . . . . 0.0 113.74 175.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 87' ' ' PRO . . . . . 0.643 ' O ' HG13 ' D' ' 58' ' ' VAL . 42.9 Cg_endo -90.44 179.18 14.63 Favored 'Cis proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.298 -1.542 . . . . 0.0 112.668 -0.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 88' ' ' TYR . . . . . 0.596 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 10.0 m-85 11.56 93.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.622 1.569 . . . . 0.0 113.89 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.51 HG21 HG13 ' D' ' 91' ' ' ILE . 77.7 mt -106.8 135.75 44.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.076 0.465 . . . . 0.0 111.839 -178.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.698 ' HB3' ' HB2' ' D' ' 57' ' ' PHE . 5.4 tp10 -121.52 97.23 5.41 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.035 173.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 91' ' ' ILE . . . . . 0.51 HG13 HG21 ' D' ' 89' ' ' ILE . 35.2 mt -95.21 102.36 13.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.467 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 92' ' ' LYS . . . . . 0.726 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -160.44 165.6 30.74 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 178.221 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . 0.565 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 17.9 pt20 -80.35 165.55 22.17 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.209 0.528 . . . . 0.0 111.219 177.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 94' ' ' ILE . . . . . 0.726 HG22 ' HE2' ' D' ' 92' ' ' LYS . 8.1 pt . . . . . 0 C--N 1.313 -1.004 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.394 -170.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.57 ' C ' HG12 ' D' ' 16' ' ' VAL . 36.3 mm . . . . . 0 N--CA 1.453 -0.322 0 CA-C-O 121.518 0.675 . . . . 0.0 111.409 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -95.86 -59.43 1.86 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.107 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 15' ' ' SER . . . . . 0.733 ' O ' ' HE3' ' D' ' 19' ' ' LYS . 90.3 p -67.07 -17.35 64.85 Favored 'General case' 0 C--O 1.219 -0.509 0 O-C-N 121.975 -0.453 . . . . 0.0 110.71 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 16' ' ' VAL . . . . . 0.754 HG21 HD11 ' D' ' 29' ' ' LEU . 11.2 p -52.72 -29.68 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.588 0.709 . . . . 0.0 110.227 174.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 17' ' ' ASN . . . . . 0.492 ' HB3' ' ND2' ' D' ' 21' ' ' ASN . 4.9 m120 -75.21 -41.19 58.32 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.646 177.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.23 -16.48 13.99 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.619 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.733 ' HE3' ' O ' ' D' ' 15' ' ' SER . 21.2 mmtp -85.72 -43.28 13.52 Favored 'General case' 0 CA--C 1.504 -0.827 0 CA-C-O 122.723 1.249 . . . . 0.0 108.195 -178.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 20' ' ' LEU . . . . . 0.996 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 63.0 mt -79.91 -37.76 33.99 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 111.308 -2.678 . . . . 0.0 110.591 -173.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 21' ' ' ASN . . . . . 0.55 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 54.2 m-80 -75.6 99.53 4.32 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.351 176.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 22' ' ' LYS . . . . . 0.663 ' HG3' ' O ' ' D' ' 20' ' ' LEU . 24.0 mtpp -120.43 -40.77 2.65 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 119.075 -1.05 . . . . 0.0 113.12 -166.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 157.55 -73.31 0.23 Allowed Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.327 -177.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . 0.904 ' HG2' ' HB3' ' D' ' 45' ' ' TYR . 77.5 tttt -63.82 -61.78 2.07 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 176.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 25' ' ' GLY . . . . . 0.55 ' HA2' ' ND2' ' D' ' 42' ' ' ASN . . . -127.54 163.71 21.2 Favored Glycine 0 N--CA 1.436 -1.331 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.024 174.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 26' ' ' LYS . . . . . 0.719 ' CD ' ' HB2' ' D' ' 41' ' ' SER . 9.7 ptpt -150.9 160.6 43.8 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.157 -0.522 . . . . 0.0 111.705 -170.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 27' ' ' LEU . . . . . 0.996 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 49.0 tp -137.08 148.04 46.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.073 0.463 . . . . 0.0 111.119 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 28' ' ' SER . . . . . 0.642 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 50.5 m -140.06 142.59 36.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.766 -173.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 29' ' ' LEU . . . . . 0.754 HD11 HG21 ' D' ' 16' ' ' VAL . 0.0 OUTLIER -141.5 147.74 38.31 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 119.688 -0.805 . . . . 0.0 111.656 -176.867 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 66.6 p -155.67 -172.47 4.15 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.83 176.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -137.44 166.53 23.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.864 0.364 . . . . 0.0 110.155 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 32' ' ' ASN . . . . . 0.473 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 23.4 t-20 -147.36 88.81 1.73 Allowed 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.98 -97.98 0.95 Allowed Glycine 0 N--CA 1.454 -0.113 0 C-N-CA 120.017 -1.087 . . . . 0.0 110.718 -170.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 76.0 m-80 -120.67 22.68 11.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.023 0.439 . . . . 0.0 110.034 173.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 35' ' ' GLN . . . . . 0.473 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 3.7 tp-100 -93.53 152.36 19.1 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.025 -177.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . 0.797 ' HB2' ' HG2' ' D' ' 85' ' ' LYS . 2.3 tm? -118.41 128.57 54.75 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.984 0.421 . . . . 0.0 110.218 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 37' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 13.6 mmmm -128.42 121.74 29.72 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.905 -167.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 38' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -131.98 151.61 51.63 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.183 0.516 . . . . 0.0 110.52 174.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 39' ' ' THR . . . . . 0.642 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 2.6 p -149.5 134.81 18.28 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.8 -176.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 40' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' D' ' 26' ' ' LYS . 36.1 t -107.74 128.03 54.21 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 41' ' ' SER . . . . . 0.719 ' HB2' ' CD ' ' D' ' 26' ' ' LYS . 46.7 m -95.21 158.79 15.31 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -177.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 42' ' ' ASN . . . . . 0.617 ' ND2' ' HB2' ' D' ' 45' ' ' TYR . 0.1 OUTLIER 81.67 -17.31 0.56 Allowed 'General case' 0 N--CA 1.475 0.802 0 O-C-N 124.584 1.178 . . . . 0.0 109.313 -169.158 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 43' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' D' ' 42' ' ' ASN . . . 72.99 63.44 0.1 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 173.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 44' ' ' GLY . . . . . 0.71 ' O ' ' HB ' ' D' ' 71' ' ' THR . . . 126.92 -40.43 1.78 Allowed Glycine 0 C--N 1.341 0.825 0 C-N-CA 119.317 -1.42 . . . . 0.0 116.052 169.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 45' ' ' TYR . . . . . 0.904 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 3.3 m-30 -59.82 156.03 15.01 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 118.515 1.157 . . . . 0.0 113.798 -172.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -98.25 -153.24 28.58 Favored Glycine 0 C--O 1.218 -0.893 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.566 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 47' ' ' ILE . . . . . 0.983 HG13 ' HB2' ' D' ' 68' ' ' GLU . 0.3 OUTLIER -50.92 -58.7 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-O 122.238 1.018 . . . . 0.0 110.184 -176.6 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 48' ' ' SER . . . . . 0.556 ' HA ' ' CD ' ' D' ' 24' ' ' LYS . 34.5 p 168.77 -76.06 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 111.47 -2.604 . . . . 0.0 106.158 -169.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -163.68 75.73 0.36 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.05 -1.432 . . . . 0.0 107.609 162.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . 0.703 ' O ' ' HG2' ' D' ' 69' ' ' LYS . 4.5 mm-40 -142.21 -159.31 0.95 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.004 -173.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 51' ' ' ASP . . . . . 0.623 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 35.6 t0 -146.62 125.99 13.14 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.118 176.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 52' ' ' LYS . . . . . 0.623 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 0.2 OUTLIER -141.62 100.0 3.67 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.111 -174.102 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -73.96 127.03 31.81 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.155 0.502 . . . . 0.0 110.515 177.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 54' ' ' TRP . . . . . 0.542 ' CH2' ' HA ' ' D' ' 92' ' ' LYS . 0.1 OUTLIER -118.74 155.26 31.4 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.611 -177.293 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -143.03 155.91 26.2 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 119.888 -1.149 . . . . 0.0 113.445 176.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 56' ' ' ILE . . . . . 0.504 HG23 HG22 ' D' ' 84' ' ' ILE . 61.0 mt -132.91 110.26 15.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 174.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 57' ' ' PHE . . . . . 0.754 ' HB2' ' HB2' ' D' ' 90' ' ' GLU . 9.4 m-85 -107.84 107.68 18.53 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 119.553 -0.859 . . . . 0.0 111.222 -167.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.678 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 98.1 t -96.63 110.74 25.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 173.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 64.21 37.51 8.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.797 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.03 -33.86 5.64 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.663 -0.78 . . . . 0.0 114.084 172.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 61' ' ' GLU . . . . . 0.521 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 12.1 pt-20 -90.86 156.87 17.69 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -177.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 41.5 mttm -77.32 126.32 30.74 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 13.1 p -94.63 -26.5 4.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 121.161 0.505 . . . . 0.0 109.947 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 64' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -148.98 137.56 21.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.858 175.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 40.6 m -120.61 124.56 45.56 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 176.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 66' ' ' PHE . . . . . 0.469 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 21.6 p90 -131.94 165.21 24.42 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 175.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 67' ' ' ASN . . . . . 0.755 ' OD1' ' HG3' ' D' ' 69' ' ' LYS . 21.7 t-20 -131.77 150.88 52.01 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -176.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 68' ' ' GLU . . . . . 0.983 ' HB2' HG13 ' D' ' 47' ' ' ILE . 35.5 mm-40 -71.65 -20.67 61.92 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 119.499 -0.88 . . . . 0.0 109.731 177.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.755 ' HG3' ' OD1' ' D' ' 67' ' ' ASN . 26.2 mtpp -61.99 -48.27 81.08 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 173.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 23.9 m -71.73 77.98 0.85 Allowed 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 112.162 -2.29 . . . . 0.0 108.42 174.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 71' ' ' THR . . . . . 0.71 ' HB ' ' O ' ' D' ' 44' ' ' GLY . 59.7 p -19.82 117.39 0.03 OUTLIER 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.161 1.385 . . . . 0.0 113.933 -173.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 72' ' ' VAL . . . . . 0.795 HG13 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -51.42 -14.89 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 176.896 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 73' ' ' GLY . . . . . 0.524 ' HA3' ' HA2' ' D' ' 44' ' ' GLY . . . -67.49 -65.36 2.77 Favored Glycine 0 N--CA 1.435 -1.433 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.818 174.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 74' ' ' ASN . . . . . 0.667 ' HA ' HD21 ' D' ' 77' ' ' ASN . 4.2 m120 -67.12 -23.52 65.83 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.485 -0.358 . . . . 0.0 110.675 -177.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 75' ' ' ILE . . . . . 0.597 ' O ' HG13 ' D' ' 79' ' ' ILE . 32.6 mm -75.13 -39.85 43.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.506 177.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 76' ' ' SER . . . . . 0.443 ' HA ' HG13 ' D' ' 79' ' ' ILE . 28.7 t -73.29 -19.33 61.07 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.948 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 77' ' ' ASN . . . . . 0.667 HD21 ' HA ' ' D' ' 74' ' ' ASN . 78.6 m-20 -66.78 -31.3 71.85 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 167.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 78' ' ' ASP . . . . . 0.982 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 59.3 m-20 -78.11 -32.15 50.37 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.223 174.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . 0.597 HG13 ' O ' ' D' ' 75' ' ' ILE . 18.0 mt -71.33 -16.69 19.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 C-N-CA 120.031 -0.668 . . . . 0.0 109.507 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -67.05 -31.57 72.17 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.821 173.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 81' ' ' LYS . . . . . 0.982 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -92.44 -49.48 6.11 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 177.321 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 82' ' ' LEU . . . . . 0.604 HD21 ' O ' ' D' ' 78' ' ' ASP . 3.7 mm? -51.27 -28.06 10.89 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -176.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 7.1 m120 33.21 72.7 0.08 Allowed 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 84' ' ' ILE . . . . . 0.571 ' N ' ' HG ' ' D' ' 36' ' ' LEU . 41.2 mm -91.45 98.96 8.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.884 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 85' ' ' LYS . . . . . 0.797 ' HG2' ' HB2' ' D' ' 36' ' ' LEU . 30.7 mmmt -141.18 101.48 4.03 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.35 171.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 86' ' ' GLY . . . . . 0.544 ' H ' ' CD1' ' D' ' 89' ' ' ILE . . . 73.34 149.87 1.36 Allowed Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.094 -0.957 . . . . 0.0 113.393 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 87' ' ' PRO . . . . . 0.614 ' O ' HG11 ' D' ' 58' ' ' VAL . 43.2 Cg_endo -88.46 178.31 19.16 Favored 'Cis proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.917 -1.701 . . . . 0.0 112.557 0.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 88' ' ' TYR . . . . . 0.678 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 3.6 m-85 11.71 94.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 125.3 1.44 . . . . 0.0 114.366 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.555 HG22 HG13 ' D' ' 91' ' ' ILE . 62.6 mt -110.56 142.88 21.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.3 0.571 . . . . 0.0 112.468 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.754 ' HB2' ' HB2' ' D' ' 57' ' ' PHE . 59.7 mm-40 -124.06 91.08 3.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.694 172.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 91' ' ' ILE . . . . . 0.555 HG13 HG22 ' D' ' 89' ' ' ILE . 23.2 mt -95.29 99.64 9.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 92' ' ' LYS . . . . . 0.684 ' HE2' HG21 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -161.09 166.95 27.22 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.639 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . 0.599 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 18.9 pt20 -81.5 164.46 21.97 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.274 176.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 94' ' ' ILE . . . . . 0.684 HG21 ' HE2' ' D' ' 92' ' ' LYS . 8.1 pt . . . . . 0 C--N 1.311 -1.071 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.351 -169.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.546 ' O ' HG12 ' D' ' 16' ' ' VAL . 40.2 mm . . . . . 0 N--CA 1.45 -0.448 0 CA-C-O 121.87 0.843 . . . . 0.0 110.752 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -88.35 -61.91 1.61 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.009 177.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 15' ' ' SER . . . . . 0.616 ' HA ' ' OD1' ' D' ' 18' ' ' ASP . 86.6 p -65.96 -17.14 64.47 Favored 'General case' 0 C--O 1.217 -0.607 0 O-C-N 122.005 -0.435 . . . . 0.0 110.379 176.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 16' ' ' VAL . . . . . 0.546 HG12 ' O ' ' D' ' 13' ' ' ILE . 1.2 p -58.03 -23.2 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-O 121.652 0.739 . . . . 0.0 109.248 176.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 17' ' ' ASN . . . . . 0.534 ' HB3' ' ND2' ' D' ' 21' ' ' ASN . 4.6 m120 -89.18 -26.48 21.24 Favored 'General case' 0 C--O 1.212 -0.91 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.253 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 18' ' ' ASP . . . . . 0.616 ' OD1' ' HA ' ' D' ' 15' ' ' SER . 1.2 m-20 -61.79 -15.64 43.11 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.648 174.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.881 ' N ' ' HE2' ' D' ' 19' ' ' LYS . 0.4 OUTLIER -86.69 -55.86 3.67 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 173.891 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 20' ' ' LEU . . . . . 1.064 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 64.6 mt -56.71 -40.67 76.07 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 112.253 -2.249 . . . . 0.0 111.266 -176.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 21' ' ' ASN . . . . . 0.576 ' OD1' ' HB2' ' D' ' 26' ' ' LYS . 55.8 m-80 -81.01 99.54 8.49 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.8 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 22' ' ' LYS . . . . . 0.614 ' HE3' ' O ' ' D' ' 19' ' ' LYS . 97.8 mttt -123.12 -41.99 2.29 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -175.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.39 -88.18 0.07 OUTLIER Glycine 0 N--CA 1.437 -1.292 0 C-N-CA 119.536 -1.316 . . . . 0.0 113.055 -176.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . 0.891 ' HE2' ' HA ' ' D' ' 48' ' ' SER . 32.8 ttpt -60.85 -62.03 2.16 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 25' ' ' GLY . . . . . 0.689 ' HA2' ' ND2' ' D' ' 42' ' ' ASN . . . -116.72 153.17 17.55 Favored Glycine 0 N--CA 1.432 -1.571 0 CA-C-N 115.21 -0.905 . . . . 0.0 112.494 175.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 26' ' ' LYS . . . . . 0.722 ' CD ' ' HB3' ' D' ' 41' ' ' SER . 9.0 ptpt -149.15 160.18 43.58 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.25 -0.975 . . . . 0.0 110.757 -171.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 27' ' ' LEU . . . . . 1.064 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 53.3 tp -138.11 150.33 46.76 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.525 0.679 . . . . 0.0 111.975 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 28' ' ' SER . . . . . 0.658 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 41.0 m -135.34 150.02 49.85 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.896 -177.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 29' ' ' LEU . . . . . 0.589 HD22 ' HB2' ' D' ' 38' ' ' ALA . 13.5 mt -140.12 149.9 43.61 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.269 177.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 22.7 t -160.05 -171.68 3.32 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 3.0 ppp? -141.85 166.07 25.72 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.109 0.481 . . . . 0.0 111.132 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 32' ' ' ASN . . . . . 0.453 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 26.6 t-20 -144.85 89.36 1.97 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.34 -0.845 . . . . 0.0 108.759 -178.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.94 -97.84 0.75 Allowed Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 119.887 -1.149 . . . . 0.0 111.099 -172.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -113.08 7.45 18.02 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.667 -0.313 . . . . 0.0 110.349 176.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 35' ' ' GLN . . . . . 0.453 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 7.5 tt0 -89.11 160.85 16.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.437 -172.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . 0.549 ' HB3' HD21 ' D' ' 83' ' ' ASN . 0.9 OUTLIER -120.78 131.59 54.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.809 176.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 37' ' ' LYS . . . . . 0.636 ' HB3' ' HZ2' ' D' ' 37' ' ' LYS . 1.3 mmmp? -134.9 119.03 17.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.865 -169.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 38' ' ' ALA . . . . . 0.589 ' HB2' HD22 ' D' ' 29' ' ' LEU . . . -115.41 151.03 35.46 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.018 0.437 . . . . 0.0 111.0 175.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 39' ' ' THR . . . . . 0.658 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 7.0 p -146.33 131.71 18.6 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.747 177.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 40' ' ' SER . . . . . 0.648 ' HB3' ' HA2' ' D' ' 73' ' ' GLY . 33.2 t -106.73 133.59 51.17 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 173.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 41' ' ' SER . . . . . 0.722 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 38.6 t -92.93 148.45 22.0 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 42' ' ' ASN . . . . . 0.689 ' ND2' ' HA2' ' D' ' 25' ' ' GLY . 0.5 OUTLIER 83.6 -16.85 0.52 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.762 1.625 . . . . 0.0 109.409 -166.731 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 62.28 55.77 2.31 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 44' ' ' GLY . . . . . 0.463 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 123.46 35.3 0.71 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 119.1 -1.524 . . . . 0.0 115.495 168.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 45' ' ' TYR . . . . . 0.736 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 2.5 m-85 -122.76 158.34 30.38 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 122.111 -0.64 . . . . 0.0 109.661 170.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . 0.61 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -98.46 176.61 30.25 Favored Glycine 0 C--O 1.221 -0.66 0 CA-C-O 118.972 -0.904 . . . . 0.0 110.875 177.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 47' ' ' ILE . . . . . 0.816 HG12 ' HB3' ' D' ' 68' ' ' GLU . 33.0 mm -47.26 -56.0 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 CA-C-O 121.922 0.867 . . . . 0.0 109.712 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 48' ' ' SER . . . . . 0.891 ' HA ' ' HE2' ' D' ' 24' ' ' LYS . 16.1 t 179.27 -149.01 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 113.149 -1.841 . . . . 0.0 107.393 178.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 49' ' ' TYR . . . . . 0.409 ' HD1' ' O ' ' D' ' 49' ' ' TYR . 0.1 OUTLIER -78.9 76.69 5.38 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.453 0.644 . . . . 0.0 110.416 168.32 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . 0.68 ' HB3' ' HE2' ' D' ' 52' ' ' LYS . 71.1 mm-40 -126.3 -166.17 1.54 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.28 -174.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 51' ' ' ASP . . . . . 0.677 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 7.0 t70 -161.04 119.68 2.5 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 114.503 -1.226 . . . . 0.0 111.565 171.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 52' ' ' LYS . . . . . 0.68 ' HE2' ' HB3' ' D' ' 50' ' ' GLU . 3.6 mptp? -142.99 115.85 8.76 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 114.22 -1.355 . . . . 0.0 109.822 -174.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -90.98 135.47 33.72 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 174.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 54' ' ' TRP . . . . . 0.622 ' HB2' ' O ' ' D' ' 66' ' ' PHE . 0.0 OUTLIER -126.93 158.02 37.91 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.855 -172.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -145.87 153.44 25.3 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 119.701 -1.237 . . . . 0.0 113.883 174.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 56' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' D' ' 90' ' ' GLU . 61.8 mt -127.62 113.75 32.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 174.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 57' ' ' PHE . . . . . 0.855 ' HB2' ' HB2' ' D' ' 90' ' ' GLU . 8.4 m-85 -109.5 105.85 15.35 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.304 -168.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.732 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 94.3 t -90.48 103.63 14.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.997 173.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 59' ' ' ASN . . . . . 0.487 ' OD1' ' HG2' ' D' ' 87' ' ' PRO . 6.3 m120 61.1 47.02 7.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.36 -0.837 . . . . 0.0 111.655 -177.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.65 -33.7 5.69 Favored Glycine 0 CA--C 1.509 -0.292 0 C-N-CA 120.681 -0.771 . . . . 0.0 114.365 172.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 61' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 16.6 pt-20 -92.97 146.83 23.33 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 120.931 -0.307 . . . . 0.0 111.229 -176.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -73.58 113.86 11.17 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 173.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 14.5 p -88.68 -23.41 6.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-O 121.098 0.475 . . . . 0.0 110.21 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 64' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -152.85 135.26 15.1 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.608 175.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 88.9 m -121.15 125.92 48.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.412 176.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 66' ' ' PHE . . . . . 0.622 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 10.1 p90 -132.54 154.52 49.9 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.08 0.467 . . . . 0.0 110.409 178.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 67' ' ' ASN . . . . . 0.586 ' HA ' ' O ' ' D' ' 52' ' ' LYS . 3.9 m120 -114.1 145.51 41.53 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -178.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 68' ' ' GLU . . . . . 0.816 ' HB3' HG12 ' D' ' 47' ' ' ILE . 35.7 mt-10 -75.8 -8.94 58.09 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.42 177.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.626 ' HG2' ' O ' ' D' ' 50' ' ' GLU . 45.5 mtmt -63.83 -55.43 23.0 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 168.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 49.9 m -57.56 118.24 5.01 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 112.528 -2.124 . . . . 0.0 109.374 172.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 81.9 p -48.13 117.53 1.97 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.685 -176.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 72' ' ' VAL . . . . . 0.65 HG13 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -57.77 -11.95 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-O 120.788 0.328 . . . . 0.0 111.073 -174.565 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 73' ' ' GLY . . . . . 0.648 ' HA2' ' HB3' ' D' ' 40' ' ' SER . . . -74.42 -61.01 3.3 Favored Glycine 0 N--CA 1.436 -1.303 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.582 175.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 74' ' ' ASN . . . . . 0.706 ' HA ' HD21 ' D' ' 77' ' ' ASN . 28.5 t-20 -60.91 -28.17 68.72 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 75' ' ' ILE . . . . . 0.53 ' O ' ' HB2' ' D' ' 78' ' ' ASP . 31.3 mm -74.46 -41.14 49.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.894 175.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 76' ' ' SER . . . . . 0.538 ' OG ' ' HB3' ' D' ' 38' ' ' ALA . 28.8 t -73.18 -19.81 61.02 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.116 -177.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 77' ' ' ASN . . . . . 0.706 HD21 ' HA ' ' D' ' 74' ' ' ASN . 77.0 m-20 -61.8 -43.45 98.83 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 165.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 78' ' ' ASP . . . . . 0.919 ' HA ' ' HG2' ' D' ' 81' ' ' LYS . 1.1 m-20 -64.03 -34.78 78.78 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.978 174.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . 0.518 HG13 ' O ' ' D' ' 75' ' ' ILE . 53.6 mt -72.22 -24.56 22.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 C-N-CA 119.129 -1.028 . . . . 0.0 110.46 -174.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -78.64 -16.11 57.72 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.175 171.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 81' ' ' LYS . . . . . 0.919 ' HG2' ' HA ' ' D' ' 78' ' ' ASP . 25.6 mmtt -76.06 -64.54 1.07 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 172.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 82' ' ' LEU . . . . . 0.647 HD23 ' O ' ' D' ' 78' ' ' ASP . 2.8 mm? -46.71 -31.09 2.71 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 113.114 -1.857 . . . . 0.0 112.521 -179.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 83' ' ' ASN . . . . . 0.549 HD21 ' HB3' ' D' ' 36' ' ' LEU . 0.7 OUTLIER 45.55 57.59 4.85 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.668 0.605 . . . . 0.0 110.574 174.677 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 84' ' ' ILE . . . . . 0.519 ' O ' ' HG ' ' D' ' 36' ' ' LEU . 44.9 mm -83.38 97.63 4.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.913 0.387 . . . . 0.0 111.37 -173.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 85' ' ' LYS . . . . . 0.479 ' HB2' ' HB2' ' D' ' 36' ' ' LEU . 2.7 tmtm? -139.34 92.88 2.62 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.74 152.06 1.65 Allowed Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.437 -0.801 . . . . 0.0 113.516 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 87' ' ' PRO . . . . . 0.509 ' O ' HG11 ' D' ' 58' ' ' VAL . 50.0 Cg_endo -90.12 179.47 14.7 Favored 'Cis proline' 0 CA--C 1.535 0.551 0 C-N-CA 123.304 -1.54 . . . . 0.0 113.195 0.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 88' ' ' TYR . . . . . 0.732 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 1.8 m-85 24.55 93.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.925 1.29 . . . . 0.0 113.62 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.728 HG21 HG13 ' D' ' 91' ' ' ILE . 3.5 mp -108.64 125.87 65.52 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-O 121.184 0.516 . . . . 0.0 111.665 -175.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.855 ' HB2' ' HB2' ' D' ' 57' ' ' PHE . 5.5 mm-40 -119.65 89.59 3.16 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.75 171.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 91' ' ' ILE . . . . . 0.728 HG13 HG21 ' D' ' 89' ' ' ILE . 34.8 mt -95.95 101.19 12.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.076 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 92' ' ' LYS . . . . . 0.657 ' HG2' ' O ' ' D' ' 93' ' ' GLN . 0.0 OUTLIER -162.34 170.57 18.65 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.247 179.131 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . 0.657 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 17.1 pt20 -81.15 161.94 23.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.542 0.687 . . . . 0.0 110.992 173.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 94' ' ' ILE . . . . . 0.643 HG23 ' HE3' ' D' ' 92' ' ' LYS . 7.7 pt . . . . . 0 C--N 1.309 -1.18 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.435 -173.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.507 ' O ' HG11 ' D' ' 16' ' ' VAL . 67.3 mt . . . . . 0 C--O 1.228 -0.067 0 CA-C-O 121.798 0.809 . . . . 0.0 111.279 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -94.66 -49.58 5.56 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.032 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 15' ' ' SER . . . . . 0.715 ' HA ' ' OD2' ' D' ' 18' ' ' ASP . 88.6 p -70.35 -15.95 62.93 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.965 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 16' ' ' VAL . . . . . 0.708 ' HA ' ' CE ' ' D' ' 19' ' ' LYS . 12.4 p -58.82 -34.47 52.36 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.107 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 175.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 17' ' ' ASN . . . . . 0.63 ' ND2' ' HA ' ' D' ' 28' ' ' SER . 4.5 m120 -64.79 -42.17 95.26 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.747 172.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 18' ' ' ASP . . . . . 0.715 ' OD2' ' HA ' ' D' ' 15' ' ' SER . 60.6 m-20 -57.2 -17.32 10.86 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -175.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.708 ' CE ' ' HA ' ' D' ' 16' ' ' VAL . 0.0 OUTLIER -92.04 -38.86 11.96 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 122.167 0.985 . . . . 0.0 109.202 174.523 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 20' ' ' LEU . . . . . 0.89 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 84.8 mt -78.86 -31.32 45.55 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 112.897 -1.956 . . . . 0.0 111.121 -170.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 21' ' ' ASN . . . . . 0.529 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 2.8 t-20 -99.12 95.74 7.31 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.291 -167.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 22' ' ' LYS . . . . . 0.471 ' NZ ' ' HB3' ' D' ' 22' ' ' LYS . 5.7 mtpm? -121.94 -42.91 2.37 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 118.308 -1.357 . . . . 0.0 113.926 -169.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 168.07 -80.32 0.1 Allowed Glycine 0 N--CA 1.439 -1.111 0 C-N-CA 119.912 -1.137 . . . . 0.0 112.787 -175.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . 0.801 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 23.4 tptm -47.85 -59.72 3.11 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 176.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 25' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -140.26 159.34 26.17 Favored Glycine 0 N--CA 1.431 -1.649 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.219 173.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 26' ' ' LYS . . . . . 0.678 ' CD ' ' HB3' ' D' ' 41' ' ' SER . 9.6 ptpt -149.67 160.57 43.41 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.467 -0.866 . . . . 0.0 110.771 -168.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 27' ' ' LEU . . . . . 0.89 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 41.4 tp -134.54 135.99 42.72 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.225 0.536 . . . . 0.0 111.747 178.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 28' ' ' SER . . . . . 0.63 ' HA ' ' ND2' ' D' ' 17' ' ' ASN . 50.6 m -125.27 133.29 52.72 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.709 -174.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 29' ' ' LEU . . . . . 0.432 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 0.0 OUTLIER -140.71 134.74 30.76 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.706 -174.078 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 72.6 p -146.8 174.12 11.77 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.799 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 23.2 ptm -136.42 118.84 15.76 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.496 0.665 . . . . 0.0 111.114 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -93.23 89.35 6.38 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.09 -104.78 2.61 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.499 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 76.0 m-80 -117.6 17.22 14.49 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.343 0.592 . . . . 0.0 109.651 175.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 35' ' ' GLN . . . . . 0.46 ' OE1' ' HD2' ' D' ' 37' ' ' LYS . 49.9 tt0 -94.4 142.19 27.71 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.479 -177.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . 0.576 ' HG ' ' N ' ' D' ' 84' ' ' ILE . 2.7 tm? -112.3 115.88 29.49 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.219 0.533 . . . . 0.0 111.195 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 37' ' ' LYS . . . . . 0.797 ' HA ' ' HE2' ' D' ' 37' ' ' LYS . 10.0 mmpt? -117.72 122.77 44.38 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 114.188 -1.369 . . . . 0.0 111.566 -168.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 38' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -130.5 154.76 47.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.136 0.493 . . . . 0.0 111.186 176.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 39' ' ' THR . . . . . 0.625 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 2.5 p -150.37 131.95 14.84 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.763 -177.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 40' ' ' SER . . . . . 0.6 ' HB3' ' HA2' ' D' ' 73' ' ' GLY . 40.4 t -108.17 129.77 55.16 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 172.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 41' ' ' SER . . . . . 0.678 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 32.7 t -95.87 154.47 17.21 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.432 -0.907 . . . . 0.0 109.592 -178.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 42' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' D' ' 41' ' ' SER . 77.0 m-20 78.28 6.69 2.52 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.96 -169.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 51.22 60.32 3.96 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 114.57 -1.196 . . . . 0.0 113.956 170.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 44' ' ' GLY . . . . . 0.588 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 105.99 37.01 2.61 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 119.189 -1.481 . . . . 0.0 114.357 170.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 45' ' ' TYR . . . . . 0.801 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 2.3 m-30 -113.96 153.19 29.73 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 173.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . 0.593 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -95.24 -162.86 34.45 Favored Glycine 0 C--O 1.219 -0.797 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 47' ' ' ILE . . . . . 0.798 HG12 ' HB3' ' D' ' 68' ' ' GLU . 39.0 mm -51.46 -55.72 7.55 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.706 0 CA-C-O 122.06 0.933 . . . . 0.0 109.035 174.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 62.3 p -174.77 -86.96 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 112.975 -1.92 . . . . 0.0 108.862 -176.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 49' ' ' TYR . . . . . 0.438 ' HD2' ' O ' ' D' ' 49' ' ' TYR . 0.1 OUTLIER -152.64 76.03 1.13 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.263 167.545 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . 0.724 ' O ' ' HG2' ' D' ' 69' ' ' LYS . 4.2 mm-40 -137.35 -164.93 1.67 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.443 -172.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 51' ' ' ASP . . . . . 0.616 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 8.9 t70 -138.26 127.93 25.05 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.741 173.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 52' ' ' LYS . . . . . 0.616 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 0.3 OUTLIER -143.07 121.68 12.52 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.407 -1.27 . . . . 0.0 109.482 -178.442 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -99.1 132.5 44.36 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.344 -0.542 . . . . 0.0 109.815 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 54' ' ' TRP . . . . . 0.677 ' NE1' ' HB3' ' D' ' 93' ' ' GLN . 0.9 OUTLIER -121.7 152.97 38.81 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.903 -172.465 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -137.65 156.07 23.43 Favored Glycine 0 N--CA 1.436 -1.364 0 C-N-CA 119.732 -1.223 . . . . 0.0 112.576 172.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 56' ' ' ILE . . . . . 0.585 HG12 ' CG2' ' D' ' 91' ' ' ILE . 96.2 mt -126.53 94.46 2.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 176.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 57' ' ' PHE . . . . . 0.579 ' HA ' ' O ' ' D' ' 61' ' ' GLU . 18.2 m-85 -95.39 108.35 20.54 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.668 -165.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.742 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 66.4 t -95.69 105.97 17.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.447 171.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 59' ' ' ASN . . . . . 0.525 ' ND2' ' HB2' ' D' ' 88' ' ' TYR . 4.1 m120 60.85 46.72 8.44 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.759 0.314 . . . . 0.0 111.495 -177.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.01 48.31 54.72 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.676 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 61' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 17.6 tp10 -159.61 126.15 4.46 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -73.48 109.6 7.12 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.087 176.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 34.4 m -82.91 -10.77 12.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 120.991 0.424 . . . . 0.0 110.777 176.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 64' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -158.93 137.85 11.18 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.271 174.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 71.7 m -122.81 113.5 19.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.145 177.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 66' ' ' PHE . . . . . 0.499 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 11.5 p90 -120.34 156.68 30.81 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.121 0.486 . . . . 0.0 110.061 177.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 67' ' ' ASN . . . . . 0.682 HD21 ' HB2' ' D' ' 69' ' ' LYS . 14.6 p-10 -122.96 133.91 54.36 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.317 -174.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 68' ' ' GLU . . . . . 0.798 ' HB3' HG12 ' D' ' 47' ' ' ILE . 40.6 mm-40 -68.05 -8.35 36.99 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.348 -176.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.724 ' HG2' ' O ' ' D' ' 50' ' ' GLU . 49.6 mtpt -63.5 -44.24 94.89 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 169.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 70' ' ' SER . . . . . 0.526 ' O ' HD12 ' D' ' 75' ' ' ILE . 24.2 t -64.19 125.72 25.45 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 113.667 -1.606 . . . . 0.0 107.689 167.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 71' ' ' THR . . . . . 0.504 HG22 ' O ' ' D' ' 44' ' ' GLY . 75.4 p -55.76 128.87 36.97 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 72' ' ' VAL . . . . . 0.66 HG12 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -57.09 -13.76 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-O 121.163 0.506 . . . . 0.0 110.601 -177.503 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 73' ' ' GLY . . . . . 0.6 ' HA2' ' HB3' ' D' ' 40' ' ' SER . . . -67.6 -63.45 3.71 Favored Glycine 0 N--CA 1.434 -1.433 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.568 171.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -64.79 -19.65 65.94 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.314 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 75' ' ' ILE . . . . . 0.526 HD12 ' O ' ' D' ' 70' ' ' SER . 74.7 mt -73.5 -41.06 56.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 173.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 76' ' ' SER . . . . . 0.671 ' HA ' HG12 ' D' ' 79' ' ' ILE . 41.5 t -75.26 -22.61 57.68 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.039 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -61.68 -25.22 67.26 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 167.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 78' ' ' ASP . . . . . 1.081 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 0.9 OUTLIER -90.03 -27.29 19.83 Favored 'General case' 0 C--O 1.227 -0.122 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 175.529 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . 0.671 HG12 ' HA ' ' D' ' 76' ' ' SER . 22.5 mm -68.86 -34.65 65.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.391 -176.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -66.88 -32.06 73.08 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -177.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 81' ' ' LYS . . . . . 1.081 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -77.25 -53.74 7.35 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.99 175.607 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 82' ' ' LEU . . . . . 0.536 ' H ' ' HG2' ' D' ' 81' ' ' LYS . 2.9 mm? -47.37 -32.22 4.69 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.008 0.523 . . . . 0.0 112.322 177.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 83' ' ' ASN . . . . . 0.512 ' HA ' ' HB3' ' D' ' 36' ' ' LEU . 9.3 t30 37.65 58.0 1.39 Allowed 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.45 1.094 . . . . 0.0 110.897 178.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 84' ' ' ILE . . . . . 0.576 ' N ' ' HG ' ' D' ' 36' ' ' LEU . 54.8 mt -80.32 104.47 8.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.993 0.425 . . . . 0.0 111.889 -172.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.21 92.97 2.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.771 0.796 . . . . 0.0 112.33 177.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.65 153.35 4.16 Favored Glycine 0 CA--C 1.509 -0.288 0 CA-C-N 115.128 -0.942 . . . . 0.0 114.196 173.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 87' ' ' PRO . . . . . 0.655 ' O ' HG12 ' D' ' 58' ' ' VAL . 50.8 Cg_endo -89.41 -179.6 14.29 Favored 'Cis proline' 0 CA--C 1.534 0.478 0 C-N-CA 123.221 -1.575 . . . . 0.0 113.247 0.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 88' ' ' TYR . . . . . 0.742 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 1.8 m-85 20.86 93.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.812 1.245 . . . . 0.0 113.897 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.9 mp -110.76 134.14 53.99 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.281 -177.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -128.2 96.5 4.47 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.495 169.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 91' ' ' ILE . . . . . 0.624 ' CG2' ' HZ3' ' D' ' 54' ' ' TRP . 6.0 mt -96.13 105.4 17.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 178.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 92' ' ' LYS . . . . . 0.758 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.1 OUTLIER -161.54 170.48 19.8 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 123.027 0.531 . . . . 0.0 111.624 -174.742 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . 0.677 ' HB3' ' NE1' ' D' ' 54' ' ' TRP . 3.0 pt20 -90.16 155.36 19.09 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.666 0.746 . . . . 0.0 111.638 176.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 94' ' ' ILE . . . . . 0.758 HG22 ' HE2' ' D' ' 92' ' ' LYS . 8.2 pt . . . . . 0 C--N 1.307 -1.257 0 CA-C-N 113.98 -1.464 . . . . 0.0 111.622 -171.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.512 ' C ' HG13 ' D' ' 16' ' ' VAL . 48.7 mt . . . . . 0 N--CA 1.45 -0.442 0 CA-C-O 121.744 0.783 . . . . 0.0 110.736 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -97.28 -56.93 2.39 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.597 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 50.9 m -67.84 -15.34 63.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.845 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 16' ' ' VAL . . . . . 0.7 ' HA ' ' CE ' ' D' ' 19' ' ' LYS . 14.3 p -56.22 -35.28 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 174.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 17' ' ' ASN . . . . . 0.417 ' N ' HG12 ' D' ' 16' ' ' VAL . 5.0 m120 -67.7 -40.23 84.34 Favored 'General case' 0 C--O 1.213 -0.856 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.92 176.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.57 -16.64 39.92 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -175.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.7 ' CE ' ' HA ' ' D' ' 16' ' ' VAL . 0.0 OUTLIER -89.97 -46.17 8.7 Favored 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 173.225 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 20' ' ' LEU . . . . . 0.806 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 84.1 mt -63.73 -35.84 81.9 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 113.594 -1.639 . . . . 0.0 110.479 -177.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 21' ' ' ASN . . . . . 0.466 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 2.8 m120 -72.65 95.93 1.93 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.8 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 22' ' ' LYS . . . . . 0.854 ' HE2' ' HA ' ' D' ' 22' ' ' LYS . 7.7 mmpt? -118.05 11.17 13.25 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -170.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.94 -74.28 1.7 Allowed Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.982 176.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . 0.764 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 55.2 tptt -53.27 -59.22 4.84 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 176.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -144.67 157.69 27.33 Favored Glycine 0 N--CA 1.43 -1.715 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.699 174.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 26' ' ' LYS . . . . . 0.876 ' HD2' ' HB3' ' D' ' 41' ' ' SER . 10.8 ptpt -151.04 160.68 43.76 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.379 -0.911 . . . . 0.0 111.354 -164.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 27' ' ' LEU . . . . . 0.806 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 28.4 tp -132.89 144.53 50.24 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.164 0.507 . . . . 0.0 111.397 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 28' ' ' SER . . . . . 0.655 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 52.4 m -137.74 143.61 41.27 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.983 -175.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 29' ' ' LEU . . . . . 0.504 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 0.0 OUTLIER -141.02 144.74 35.18 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.326 -178.7 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 35.5 m -145.66 170.07 17.2 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.035 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 31' ' ' MET . . . . . 0.567 ' SD ' ' HE2' ' D' ' 85' ' ' LYS . 61.2 mtt -130.95 111.17 11.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.043 0.449 . . . . 0.0 110.888 177.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -91.82 87.82 6.41 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.08 -125.41 8.21 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.168 -1.015 . . . . 0.0 111.48 -173.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -89.66 31.2 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 O-C-N 122.464 -0.433 . . . . 0.0 110.267 175.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 35' ' ' GLN . . . . . 0.441 ' O ' ' HA ' ' D' ' 31' ' ' MET . 3.8 tp-100 -116.88 154.45 30.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.37 -172.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . 0.899 ' HB2' ' HB2' ' D' ' 85' ' ' LYS . 1.8 tm? -118.74 126.66 52.37 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.741 176.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 37' ' ' LYS . . . . . 0.569 ' HB3' ' NZ ' ' D' ' 37' ' ' LYS . 1.1 mmmp? -129.63 117.84 21.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.587 -169.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 38' ' ' ALA . . . . . 0.502 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -119.42 152.79 36.25 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.539 0.685 . . . . 0.0 112.26 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 39' ' ' THR . . . . . 0.655 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 3.2 p -144.57 126.73 15.63 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.145 177.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 40' ' ' SER . . . . . 0.592 ' HA ' ' O ' ' D' ' 26' ' ' LYS . 14.9 p -108.49 128.9 55.2 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 172.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 41' ' ' SER . . . . . 0.876 ' HB3' ' HD2' ' D' ' 26' ' ' LYS . 42.5 t -102.43 155.72 18.07 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.161 -175.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 42' ' ' ASN . . . . . 0.522 ' ND2' ' HE3' ' D' ' 26' ' ' LYS . 74.0 m-80 76.67 8.55 3.1 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.711 -172.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 47.08 61.72 2.73 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 114.613 -1.176 . . . . 0.0 114.043 168.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.63 -14.41 7.21 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 119.004 -1.57 . . . . 0.0 114.93 172.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 45' ' ' TYR . . . . . 0.764 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 2.0 m-30 -76.19 156.75 33.38 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 117.347 0.573 . . . . 0.0 111.488 -176.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . 0.575 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -103.72 -157.5 24.5 Favored Glycine 0 C--O 1.214 -1.095 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 175.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 47' ' ' ILE . . . . . 0.844 HG13 ' HB3' ' D' ' 68' ' ' GLU . 0.8 OUTLIER -53.98 -57.33 5.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 122.778 1.275 . . . . 0.0 109.58 178.236 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 39.4 t 174.7 -116.05 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 111.205 -2.725 . . . . 0.0 105.89 -175.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -119.75 76.79 1.17 Allowed 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.888 -0.507 . . . . 0.0 109.818 165.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . 0.401 ' HB2' ' HE3' ' D' ' 52' ' ' LYS . 60.3 mm-40 -140.55 -169.3 2.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.38 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 51' ' ' ASP . . . . . 0.649 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 1.4 m-20 -139.97 134.09 31.02 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.935 173.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 52' ' ' LYS . . . . . 0.699 ' HD3' HG12 ' D' ' 47' ' ' ILE . 0.1 OUTLIER -144.66 150.15 36.88 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.787 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 53' ' ' ASN . . . . . 0.432 HD21 ' C ' ' D' ' 52' ' ' LYS . 2.8 m120 -118.95 138.72 52.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.76 0.314 . . . . 0.0 110.324 173.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 54' ' ' TRP . . . . . 0.64 ' HZ3' ' CG2' ' D' ' 91' ' ' ILE . 1.7 m95 -124.7 153.22 42.69 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -175.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -138.42 157.34 24.49 Favored Glycine 0 N--CA 1.432 -1.598 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.036 172.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 56' ' ' ILE . . . . . 0.566 HG12 ' CG2' ' D' ' 91' ' ' ILE . 95.8 mt -131.18 94.58 2.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 177.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 57' ' ' PHE . . . . . 0.52 ' CE1' ' HB2' ' D' ' 62' ' ' LYS . 48.3 m-85 -93.86 101.03 13.11 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.546 -167.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.726 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 94.7 t -83.25 102.64 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.955 173.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 59' ' ' ASN . . . . . 0.488 ' OD1' ' HG2' ' D' ' 87' ' ' PRO . 6.4 m120 59.6 45.67 12.92 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.493 -177.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.29 -30.5 7.63 Favored Glycine 0 CA--C 1.508 -0.399 0 C-N-CA 120.009 -1.091 . . . . 0.0 112.655 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -88.15 119.9 28.99 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.852 -0.674 . . . . 0.0 110.618 -174.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 62' ' ' LYS . . . . . 0.52 ' HB2' ' CE1' ' D' ' 57' ' ' PHE . 38.7 ttpt -70.76 98.56 1.56 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 176.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.554 HG11 ' O ' ' D' ' 56' ' ' ILE . 13.4 p -77.77 -29.01 15.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.448 -170.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 64' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -143.46 137.77 28.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.555 177.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 56.9 m -116.47 116.5 27.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.462 175.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 66' ' ' PHE . . . . . 0.475 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 18.3 p90 -122.06 154.98 36.59 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 170.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -117.64 146.89 43.36 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 68' ' ' GLU . . . . . 0.844 ' HB3' HG13 ' D' ' 47' ' ' ILE . 39.9 mm-40 -62.48 -24.96 67.75 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.214 0.531 . . . . 0.0 109.67 176.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.518 ' HD3' ' HB3' ' D' ' 51' ' ' ASP . 9.0 mtmp? -58.02 -44.16 87.15 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.495 173.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 15.4 t -76.18 92.73 3.28 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 113.798 -1.547 . . . . 0.0 107.627 172.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 73.4 p -30.84 122.85 0.21 Allowed 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.477 -1.238 . . . . 0.0 112.787 -172.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 72' ' ' VAL . . . . . 0.603 HG11 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -51.72 -17.42 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 O-C-N 123.319 0.387 . . . . 0.0 111.709 177.8 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 73' ' ' GLY . . . . . 0.571 ' HA2' ' CB ' ' D' ' 40' ' ' SER . . . -65.33 -65.41 2.93 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 115.371 -0.832 . . . . 0.0 113.193 171.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 74' ' ' ASN . . . . . 0.435 ' O ' ' HB2' ' D' ' 77' ' ' ASN . 49.7 t30 -65.49 -22.9 66.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.852 0.358 . . . . 0.0 110.705 -178.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 75' ' ' ILE . . . . . 0.516 ' O ' HG12 ' D' ' 79' ' ' ILE . 27.2 mm -76.93 -37.94 27.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.067 177.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 76' ' ' SER . . . . . 0.692 ' HA ' HG12 ' D' ' 79' ' ' ILE . 32.8 t -75.51 -19.45 59.36 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.224 -0.59 . . . . 0.0 110.284 175.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 77' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' D' ' 74' ' ' ASN . 5.1 m120 -63.14 -28.92 70.39 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 166.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 78' ' ' ASP . . . . . 1.065 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 1.0 OUTLIER -87.9 -30.03 20.42 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 115.387 -0.824 . . . . 0.0 113.166 176.114 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . 0.692 HG12 ' HA ' ' D' ' 76' ' ' SER . 24.3 mm -63.25 -28.22 44.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 O-C-N 121.379 -0.826 . . . . 0.0 110.669 -174.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -65.46 -40.45 93.21 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.509 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 81' ' ' LYS . . . . . 1.065 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -74.17 -51.83 14.33 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.605 176.82 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 82' ' ' LEU . . . . . 0.665 HD23 ' O ' ' D' ' 78' ' ' ASP . 4.0 mm? -48.99 -30.16 5.71 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 83' ' ' ASN . . . . . 0.63 HD21 ' HB3' ' D' ' 36' ' ' LEU . 0.7 OUTLIER 42.36 61.42 2.01 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 123.695 0.622 . . . . 0.0 110.979 174.693 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 84' ' ' ILE . . . . . 0.481 HD13 HG22 ' D' ' 84' ' ' ILE . 49.5 mt -90.94 98.19 8.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.773 -175.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 85' ' ' LYS . . . . . 0.899 ' HB2' ' HB2' ' D' ' 36' ' ' LEU . 10.9 tmtt? -141.33 94.93 2.75 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -175.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 86' ' ' GLY . . . . . 0.525 ' H ' ' CD1' ' D' ' 89' ' ' ILE . . . 69.17 150.97 0.4 Allowed Glycine 0 N--CA 1.453 -0.194 0 CA-C-N 115.283 -0.871 . . . . 0.0 113.495 -178.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 87' ' ' PRO . . . . . 0.551 ' O ' HG11 ' D' ' 58' ' ' VAL . 68.5 Cg_endo -90.21 -178.79 12.09 Favored 'Cis proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.405 -1.498 . . . . 0.0 112.835 -0.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 88' ' ' TYR . . . . . 0.726 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 1.5 m-85 13.53 93.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.175 1.39 . . . . 0.0 113.943 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.525 ' CD1' ' H ' ' D' ' 86' ' ' GLY . 67.9 mt -110.34 132.49 58.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.311 0.577 . . . . 0.0 112.363 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -123.25 93.92 4.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.867 173.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 91' ' ' ILE . . . . . 0.64 ' CG2' ' HZ3' ' D' ' 54' ' ' TRP . 7.3 mt -95.93 107.6 19.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 92' ' ' LYS . . . . . 0.776 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -163.08 171.27 16.67 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.54 -173.234 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . 0.639 ' HB3' ' NE1' ' D' ' 54' ' ' TRP . 3.5 pp0? -87.99 156.64 19.22 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.686 0.755 . . . . 0.0 112.787 178.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 94' ' ' ILE . . . . . 0.776 HG22 ' HE2' ' D' ' 92' ' ' LYS . 4.9 pt . . . . . 0 C--N 1.314 -0.938 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.005 -173.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.519 ' C ' HG11 ' D' ' 16' ' ' VAL . 53.8 mt . . . . . 0 N--CA 1.452 -0.359 0 CA-C-O 121.51 0.671 . . . . 0.0 111.284 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -94.43 -61.9 1.43 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.076 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 15' ' ' SER . . . . . 0.463 ' O ' ' HG3' ' D' ' 19' ' ' LYS . 89.3 p -64.69 -16.68 63.22 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 122.252 -0.28 . . . . 0.0 111.108 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 16' ' ' VAL . . . . . 0.655 ' HA ' ' HE3' ' D' ' 19' ' ' LYS . 14.2 p -58.63 -32.77 46.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-O 121.835 0.826 . . . . 0.0 110.002 178.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 17' ' ' ASN . . . . . 0.538 ' N ' HG13 ' D' ' 16' ' ' VAL . 5.2 m120 -71.55 -37.18 71.12 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.707 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.84 -15.17 58.21 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.655 ' HE3' ' HA ' ' D' ' 16' ' ' VAL . 71.3 mttt -91.03 -28.31 18.05 Favored 'General case' 0 CA--C 1.494 -1.199 0 CA-C-O 122.447 1.117 . . . . 0.0 109.229 -177.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 20' ' ' LEU . . . . . 0.873 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 76.1 mt -95.51 -41.14 9.1 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 112.223 -2.262 . . . . 0.0 109.061 -171.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 21' ' ' ASN . . . . . 0.67 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 59.9 m-20 -73.56 91.07 1.8 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.04 -1.436 . . . . 0.0 110.337 175.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 22' ' ' LYS . . . . . 0.452 ' HD3' HD12 ' D' ' 47' ' ' ILE . 28.7 mtpp -122.36 -41.38 2.41 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -170.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 171.77 -91.89 0.09 OUTLIER Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 119.63 -1.271 . . . . 0.0 113.3 -176.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . 0.573 ' HB3' ' O ' ' D' ' 46' ' ' GLY . 44.2 tptt -50.46 -53.56 28.74 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 25' ' ' GLY . . . . . 0.601 ' HA2' ' ND2' ' D' ' 42' ' ' ASN . . . -140.35 157.46 25.6 Favored Glycine 0 N--CA 1.435 -1.428 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.334 176.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 26' ' ' LYS . . . . . 0.67 ' CB ' ' HA ' ' D' ' 21' ' ' ASN . 9.3 ptpt -149.36 160.6 43.29 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.077 -0.562 . . . . 0.0 111.026 -169.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 27' ' ' LEU . . . . . 0.873 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 44.7 tp -137.08 144.69 43.25 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.34 0.59 . . . . 0.0 111.899 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 28' ' ' SER . . . . . 0.571 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 23.1 t -135.4 137.31 42.16 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.013 -178.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 29' ' ' LEU . . . . . 0.418 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 0.0 OUTLIER -140.5 114.29 8.89 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.345 -179.188 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 68.8 p -123.56 -173.08 2.65 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.975 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 31' ' ' MET . . . . . 0.443 ' SD ' ' HE2' ' D' ' 85' ' ' LYS . 23.0 ptt? -148.1 122.1 9.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.62 0.724 . . . . 0.0 110.961 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -91.92 88.42 6.6 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.43 177.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.56 -110.04 2.99 Favored Glycine 0 CA--C 1.515 0.069 0 C-N-CA 120.333 -0.937 . . . . 0.0 111.389 -172.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 73.6 m-80 -106.24 14.36 27.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.075 0.464 . . . . 0.0 110.716 175.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 35' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -89.04 155.36 19.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.603 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . 1.054 ' HB2' ' HB2' ' D' ' 85' ' ' LYS . 1.4 tm? -117.82 126.98 53.43 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 37' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 29.0 mmmt -130.65 117.79 20.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.829 -168.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 38' ' ' ALA . . . . . 0.401 ' O ' HG23 ' D' ' 39' ' ' THR . . . -121.39 148.89 43.79 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.865 175.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 39' ' ' THR . . . . . 0.571 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 16.5 p -147.89 138.94 23.37 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.516 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 40' ' ' SER . . . . . 0.463 ' HB3' ' HA2' ' D' ' 73' ' ' GLY . 36.7 t -107.69 128.19 54.34 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 169.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 41' ' ' SER . . . . . 0.575 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 35.1 t -94.67 161.63 14.11 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -177.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 42' ' ' ASN . . . . . 0.601 ' ND2' ' HA2' ' D' ' 25' ' ' GLY . 0.1 OUTLIER 83.47 -17.4 0.49 Allowed 'General case' 0 N--CA 1.477 0.879 0 O-C-N 124.706 1.254 . . . . 0.0 109.163 -167.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 71.52 62.48 0.15 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 44' ' ' GLY . . . . . 0.636 ' O ' ' HB ' ' D' ' 71' ' ' THR . . . 127.9 -40.69 1.7 Allowed Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 119.215 -1.469 . . . . 0.0 116.162 168.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 45' ' ' TYR . . . . . 0.538 ' CD2' ' HE3' ' D' ' 24' ' ' LYS . 3.2 m-30 -63.89 155.8 29.6 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.059 1.43 . . . . 0.0 112.422 -175.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . 0.573 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -91.29 -177.2 43.28 Favored Glycine 0 C--O 1.217 -0.926 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 172.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 47' ' ' ILE . . . . . 0.811 HG12 ' HB3' ' D' ' 68' ' ' GLU . 43.2 mm -45.66 -48.37 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.075 0 CA-C-N 117.903 0.852 . . . . 0.0 110.232 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 48' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' D' ' 47' ' ' ILE . 48.4 t 153.22 -142.97 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 O-C-N 126.411 2.319 . . . . 0.0 107.632 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -77.48 75.88 4.03 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.467 0.651 . . . . 0.0 111.183 173.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . 0.666 ' HB3' ' HE3' ' D' ' 52' ' ' LYS . 68.3 mm-40 -134.85 -176.39 4.22 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.481 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 51' ' ' ASP . . . . . 0.701 ' HB2' ' HD2' ' D' ' 69' ' ' LYS . 7.1 p-10 -152.89 113.39 4.05 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.559 173.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 52' ' ' LYS . . . . . 0.666 ' HE3' ' HB3' ' D' ' 50' ' ' GLU . 21.1 mmtp -129.88 139.03 51.24 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.314 -170.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 53' ' ' ASN . . . . . 0.489 HD21 ' C ' ' D' ' 52' ' ' LYS . 2.7 m120 -114.33 132.12 56.3 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.404 175.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 54' ' ' TRP . . . . . 0.677 ' HB2' ' O ' ' D' ' 66' ' ' PHE . 0.5 OUTLIER -128.27 160.97 30.49 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -170.431 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -152.7 162.45 29.99 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 114.892 -1.049 . . . . 0.0 113.56 172.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 56' ' ' ILE . . . . . 0.464 ' HA ' ' O ' ' D' ' 90' ' ' GLU . 58.6 mt -130.98 111.91 20.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 177.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 57' ' ' PHE . . . . . 0.956 ' HB2' ' HB3' ' D' ' 90' ' ' GLU . 10.3 m-85 -108.67 99.54 8.9 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 119.908 -0.717 . . . . 0.0 111.424 -165.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.736 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 84.3 t -81.57 103.89 9.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.713 173.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 6.9 m120 63.31 44.38 5.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.505 -176.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.53 -33.1 5.7 Favored Glycine 0 CA--C 1.509 -0.34 0 C-N-CA 120.49 -0.862 . . . . 0.0 114.304 172.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 61' ' ' GLU . . . . . 0.538 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 16.7 pt-20 -90.6 136.27 33.17 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.239 0.542 . . . . 0.0 111.801 -173.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 62' ' ' LYS . . . . . 0.46 ' HB2' ' CE2' ' D' ' 57' ' ' PHE . 38.0 ttpt -74.26 110.33 8.46 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.861 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.421 HG23 ' O ' ' D' ' 56' ' ' ILE . 29.5 m -93.65 -29.47 4.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -175.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 64' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -136.66 132.44 34.98 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 121.193 -0.203 . . . . 0.0 110.675 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 49.9 m -114.39 123.14 48.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.459 176.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 66' ' ' PHE . . . . . 0.677 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 14.1 p90 -131.48 148.76 52.67 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 173.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 67' ' ' ASN . . . . . 0.634 ' ND2' ' HB2' ' D' ' 69' ' ' LYS . 14.5 p-10 -117.94 130.95 56.52 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 68' ' ' GLU . . . . . 0.811 ' HB3' HG12 ' D' ' 47' ' ' ILE . 54.8 mm-40 -59.85 -18.27 42.92 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.009 0.433 . . . . 0.0 111.314 -173.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.701 ' HD2' ' HB2' ' D' ' 51' ' ' ASP . 46.5 mtpt -58.97 -51.9 68.07 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.393 172.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 69.8 m -64.92 103.05 0.67 Allowed 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 113.098 -1.864 . . . . 0.0 108.787 170.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 71' ' ' THR . . . . . 0.636 ' HB ' ' O ' ' D' ' 44' ' ' GLY . 72.1 p -32.73 119.05 0.3 Allowed 'General case' 0 C--N 1.322 -0.617 0 O-C-N 124.588 1.18 . . . . 0.0 112.689 -174.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 72' ' ' VAL . . . . . 0.609 HG11 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -53.34 -14.4 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.805 176.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 73' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' D' ' 40' ' ' SER . . . -66.66 -70.8 1.03 Allowed Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.743 172.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -62.15 -25.03 67.52 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 120.594 0.235 . . . . 0.0 111.286 -177.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 75' ' ' ILE . . . . . 0.625 ' O ' HG13 ' D' ' 79' ' ' ILE . 30.0 mm -73.87 -37.88 49.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.199 176.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 31.3 t -73.82 -23.13 59.61 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.817 176.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -62.28 -26.94 68.68 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 166.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 78' ' ' ASP . . . . . 1.096 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 57.6 m-20 -83.22 -36.87 24.28 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.031 -0.532 . . . . 0.0 112.089 174.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . 0.625 HG13 ' O ' ' D' ' 75' ' ' ILE . 39.2 mt -66.41 -22.64 30.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 O-C-N 121.805 -0.559 . . . . 0.0 110.878 -173.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -72.92 -31.67 64.78 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 176.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 81' ' ' LYS . . . . . 1.096 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -81.15 -50.37 9.69 Favored 'General case' 0 N--CA 1.457 -0.076 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.164 174.527 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 82' ' ' LEU . . . . . 0.589 HD21 ' O ' ' D' ' 78' ' ' ASP . 4.0 mm? -47.39 -32.32 4.84 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 177.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 83' ' ' ASN . . . . . 0.561 HD21 ' HB3' ' D' ' 36' ' ' LEU . 0.6 OUTLIER 43.72 61.49 2.26 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 124.062 0.851 . . . . 0.0 110.836 174.224 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 84' ' ' ILE . . . . . 0.448 ' O ' ' HG ' ' D' ' 36' ' ' LEU . 52.5 mt -93.74 98.55 8.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.045 -175.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 85' ' ' LYS . . . . . 1.054 ' HB2' ' HB2' ' D' ' 36' ' ' LEU . 9.4 tmtt? -143.01 94.91 2.69 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.86 151.87 4.38 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.67 -0.696 . . . . 0.0 113.566 176.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 87' ' ' PRO . . . . . 0.595 ' O ' HG11 ' D' ' 58' ' ' VAL . 55.9 Cg_endo -88.49 178.01 19.62 Favored 'Cis proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.83 -1.737 . . . . 0.0 112.479 -0.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 88' ' ' TYR . . . . . 0.736 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 1.7 m-85 28.7 91.19 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.626 1.17 . . . . 0.0 112.907 -177.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.6 HG22 HG13 ' D' ' 91' ' ' ILE . 3.7 mp -97.38 136.55 27.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.233 0.54 . . . . 0.0 110.834 -176.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.956 ' HB3' ' HB2' ' D' ' 57' ' ' PHE . 88.0 tt0 -134.94 87.38 2.33 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.807 173.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 91' ' ' ILE . . . . . 0.6 HG13 HG22 ' D' ' 89' ' ' ILE . 40.8 mt -96.56 99.49 9.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.649 -179.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 92' ' ' LYS . . . . . 0.749 ' HE2' HG23 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -161.76 165.96 27.24 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 121.191 -0.203 . . . . 0.0 110.519 178.33 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . 0.643 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 18.1 pt20 -78.67 165.32 23.78 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 120.191 -0.604 . . . . 0.0 110.59 175.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 94' ' ' ILE . . . . . 0.749 HG23 ' HE2' ' D' ' 92' ' ' LYS . 9.5 pt . . . . . 0 C--N 1.31 -1.118 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.656 -172.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.477 ' O ' HG13 ' D' ' 16' ' ' VAL . 58.4 mt . . . . . 0 C--O 1.199 -1.556 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -35.19 -33.25 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -175.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 15' ' ' SER . . . . . 0.425 ' O ' ' HD2' ' D' ' 19' ' ' LYS . 80.1 p -58.78 -27.51 65.08 Favored 'General case' 0 C--O 1.22 -0.453 0 O-C-N 121.771 -0.58 . . . . 0.0 109.909 176.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 16' ' ' VAL . . . . . 0.593 HG12 ' N ' ' D' ' 17' ' ' ASN . 7.5 p -45.28 -30.09 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.94 1.296 . . . . 0.0 111.185 174.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 17' ' ' ASN . . . . . 0.593 ' N ' HG12 ' D' ' 16' ' ' VAL . 5.9 m120 -86.37 -31.56 21.43 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.895 -177.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 18' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' D' ' 15' ' ' SER . 78.7 m-20 -60.71 -15.66 31.37 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 176.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.614 ' HD2' ' N ' ' D' ' 19' ' ' LYS . 0.0 OUTLIER -91.35 -46.57 7.95 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 122.03 0.919 . . . . 0.0 108.599 175.238 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 20' ' ' LEU . . . . . 0.885 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 63.8 mt -63.51 -40.49 97.19 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.192 -1.822 . . . . 0.0 110.348 -178.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 21' ' ' ASN . . . . . 0.635 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 55.6 m-20 -77.35 96.7 4.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.425 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 22' ' ' LYS . . . . . 0.765 ' HD2' HD13 ' D' ' 47' ' ' ILE . 65.3 mttm -122.83 -41.57 2.35 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -178.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 171.17 -86.22 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 119.575 -1.298 . . . . 0.0 113.663 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . 0.694 ' HE3' ' HD1' ' D' ' 45' ' ' TYR . 50.7 tptt -53.54 -44.47 69.23 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.85 0.833 . . . . 0.0 109.415 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 25' ' ' GLY . . . . . 0.591 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -150.2 148.13 19.03 Favored Glycine 0 N--CA 1.429 -1.802 0 CA-C-N 114.255 -1.338 . . . . 0.0 111.582 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 26' ' ' LYS . . . . . 0.635 ' CB ' ' HA ' ' D' ' 21' ' ' ASN . 10.8 ptpt -149.32 160.85 43.05 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 114.262 -0.969 . . . . 0.0 110.561 -168.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 27' ' ' LEU . . . . . 0.885 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 41.1 tp -135.65 143.58 45.57 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.237 0.541 . . . . 0.0 111.847 -178.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 28' ' ' SER . . . . . 0.632 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 27.9 t -128.18 152.62 47.83 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 29' ' ' LEU . . . . . . . . . . . . . 15.1 mt -140.78 138.75 34.33 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 177.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 60.6 m -147.05 179.16 7.81 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 31' ' ' MET . . . . . 0.427 ' HA ' ' O ' ' D' ' 35' ' ' GLN . 23.3 ptt? -134.9 122.32 21.8 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.441 0.639 . . . . 0.0 110.636 177.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -91.42 88.97 7.04 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.2 -114.74 4.03 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -169.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 34' ' ' ASN . . . . . 0.674 ' O ' ' HE3' ' D' ' 85' ' ' LYS . 4.2 m120 -109.63 31.74 5.57 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.095 0.474 . . . . 0.0 110.023 172.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 35' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' D' ' 31' ' ' MET . 3.8 tp-100 -105.81 161.35 14.5 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.601 -179.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . 0.519 ' HG ' ' N ' ' D' ' 84' ' ' ILE . 3.0 tm? -114.09 131.36 56.42 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.772 0.32 . . . . 0.0 110.766 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 37' ' ' LYS . . . . . 0.403 ' HE2' ' CG ' ' D' ' 35' ' ' GLN . 74.0 mmtt -138.34 109.05 6.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.082 -169.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 38' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -105.58 149.37 26.34 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.966 0.412 . . . . 0.0 111.229 176.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 39' ' ' THR . . . . . 0.632 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 18.0 p -143.65 129.57 19.47 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.698 175.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 40' ' ' SER . . . . . 0.722 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 72.3 p -109.38 131.56 54.95 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 41' ' ' SER . . . . . 0.611 ' HB2' ' CD ' ' D' ' 26' ' ' LYS . 52.3 m -96.56 152.82 18.27 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.714 -178.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 42' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' D' ' 41' ' ' SER . 75.9 m-80 80.09 6.12 1.76 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.005 -170.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 53.27 54.47 10.19 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 114.636 -1.166 . . . . 0.0 113.811 171.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 44' ' ' GLY . . . . . 0.742 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 104.78 35.81 3.15 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 119.431 -1.366 . . . . 0.0 114.749 168.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 45' ' ' TYR . . . . . 0.694 ' HD1' ' HE3' ' D' ' 24' ' ' LYS . 2.6 m-85 -112.78 153.81 27.21 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 168.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . 0.578 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -86.0 -174.0 49.54 Favored Glycine 0 CA--C 1.499 -0.945 0 C-N-CA 120.094 -1.05 . . . . 0.0 110.953 178.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 47' ' ' ILE . . . . . 0.78 HG12 ' HB3' ' D' ' 68' ' ' GLU . 45.3 mm -46.3 -51.33 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.231 0 CA-C-O 121.454 0.645 . . . . 0.0 109.987 177.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 48' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' D' ' 47' ' ' ILE . 41.3 t 159.31 -138.97 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.626 0 O-C-N 126.507 2.379 . . . . 0.0 107.564 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -88.88 76.01 7.99 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.474 0.655 . . . . 0.0 111.606 175.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . 0.782 ' HB2' ' HE2' ' D' ' 52' ' ' LYS . 48.6 mt-10 -150.32 179.04 8.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.541 176.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 51' ' ' ASP . . . . . 0.618 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 31.8 m-20 -133.39 134.29 43.49 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.746 173.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 52' ' ' LYS . . . . . 0.782 ' HE2' ' HB2' ' D' ' 50' ' ' GLU . 1.9 mptp? -138.43 137.58 37.36 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -176.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -115.07 134.08 55.49 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.413 174.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 54' ' ' TRP . . . . . 0.64 ' HZ3' ' CG2' ' D' ' 91' ' ' ILE . 1.1 m95 -125.73 160.09 30.65 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -172.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -148.05 158.07 27.56 Favored Glycine 0 N--CA 1.436 -1.312 0 CA-C-N 114.419 -1.264 . . . . 0.0 113.006 172.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 56' ' ' ILE . . . . . 0.604 HG12 ' CG2' ' D' ' 91' ' ' ILE . 98.1 mt -125.88 110.31 23.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-N 113.317 -1.442 . . . . 0.0 107.149 176.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 57' ' ' PHE . . . . . 0.77 ' HB2' ' HB2' ' D' ' 90' ' ' GLU . 14.0 m-85 -106.02 102.82 12.22 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 119.881 -0.728 . . . . 0.0 110.821 -167.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.689 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 95.2 t -95.5 108.97 21.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.502 178.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 59' ' ' ASN . . . . . 0.553 ' OD1' ' HG2' ' D' ' 87' ' ' PRO . 6.2 m120 59.68 52.35 5.64 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.989 -178.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.15 47.17 92.36 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.283 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 61' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 87.1 tt0 -151.45 116.17 5.17 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.315 -0.443 . . . . 0.0 109.866 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 62' ' ' LYS . . . . . 0.482 ' NZ ' ' HB3' ' D' ' 62' ' ' LYS . 6.1 ttpm? -70.96 99.04 1.71 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.462 HG12 ' O ' ' D' ' 56' ' ' ILE . 14.7 p -87.1 -30.99 5.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.581 -169.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 64' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -137.5 130.31 30.17 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.579 175.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 76.0 m -112.04 112.82 24.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.319 176.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 66' ' ' PHE . . . . . 0.538 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 7.6 p90 -118.67 150.5 39.62 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 173.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 67' ' ' ASN . . . . . 0.466 ' OD1' ' HB2' ' D' ' 69' ' ' LYS . 18.6 p30 -122.04 140.61 52.28 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 68' ' ' GLU . . . . . 0.78 ' HB3' HG12 ' D' ' 47' ' ' ILE . 39.2 mm-40 -68.33 -9.46 48.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.218 0.532 . . . . 0.0 110.368 -176.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.56 ' NZ ' ' HB3' ' D' ' 69' ' ' LYS . 5.3 mtpm? -62.73 -45.06 94.49 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 170.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 70' ' ' SER . . . . . 0.491 ' O ' HD13 ' D' ' 75' ' ' ILE . 31.1 t -66.29 125.65 26.27 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 113.528 -1.669 . . . . 0.0 107.571 168.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 71' ' ' THR . . . . . 0.424 ' O ' HG13 ' D' ' 75' ' ' ILE . 72.0 p -54.19 125.28 18.52 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -178.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 72' ' ' VAL . . . . . 0.671 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -55.32 -14.62 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 121.069 0.461 . . . . 0.0 110.918 -175.271 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 73' ' ' GLY . . . . . 0.742 ' HA3' ' HA2' ' D' ' 44' ' ' GLY . . . -71.05 -57.01 6.52 Favored Glycine 0 N--CA 1.437 -1.264 0 CA-C-N 115.043 -0.98 . . . . 0.0 112.627 170.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -61.76 -24.15 66.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.115 0.483 . . . . 0.0 110.342 176.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 75' ' ' ILE . . . . . 0.609 ' O ' HG13 ' D' ' 79' ' ' ILE . 66.4 mt -73.2 -41.53 58.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.359 175.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 28.4 t -76.16 -24.05 54.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.762 -0.199 . . . . 0.0 110.764 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 77' ' ' ASN . . . . . 0.564 ' O ' ' HD3' ' D' ' 81' ' ' LYS . 4.0 m120 -63.38 -19.03 64.3 Favored 'General case' 0 C--O 1.218 -0.601 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 168.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 78' ' ' ASP . . . . . 0.633 ' O ' HD22 ' D' ' 82' ' ' LEU . 72.0 m-20 -93.52 -45.41 7.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.068 174.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . 0.609 HG13 ' O ' ' D' ' 75' ' ' ILE . 43.0 mt -67.99 -33.35 60.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 O-C-N 121.743 -0.598 . . . . 0.0 111.729 -170.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -64.63 -13.49 53.85 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.191 174.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 81' ' ' LYS . . . . . 0.564 ' HD3' ' O ' ' D' ' 77' ' ' ASN . 16.0 mmmt -92.34 -57.8 2.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 122.185 0.993 . . . . 0.0 108.866 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 82' ' ' LEU . . . . . 0.633 HD22 ' O ' ' D' ' 78' ' ' ASP . 3.3 mm? -56.07 -23.63 34.93 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 113.821 -1.536 . . . . 0.0 112.913 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 83' ' ' ASN . . . . . 0.425 ' HA ' ' HB3' ' D' ' 36' ' ' LEU . 7.5 m120 32.72 70.46 0.1 Allowed 'General case' 0 N--CA 1.476 0.867 0 O-C-N 124.182 0.926 . . . . 0.0 112.978 -177.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 84' ' ' ILE . . . . . 0.591 HG22 HD11 ' D' ' 89' ' ' ILE . 47.2 mt -86.45 98.86 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-O 121.132 0.492 . . . . 0.0 110.991 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 85' ' ' LYS . . . . . 0.674 ' HE3' ' O ' ' D' ' 34' ' ' ASN . 0.0 OUTLIER -135.01 94.55 3.16 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.871 0.843 . . . . 0.0 111.947 -179.563 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 86' ' ' GLY . . . . . 0.552 ' H ' ' CD1' ' D' ' 89' ' ' ILE . . . 70.28 153.2 0.92 Allowed Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.622 -0.717 . . . . 0.0 113.032 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 87' ' ' PRO . . . . . 0.553 ' HG2' ' OD1' ' D' ' 59' ' ' ASN . 92.6 Cg_endo -91.18 -177.27 9.29 Favored 'Cis proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.705 -1.373 . . . . 0.0 112.52 -0.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 88' ' ' TYR . . . . . 0.689 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 14.4 m-85 8.24 93.18 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 125.473 1.509 . . . . 0.0 113.844 -177.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.625 HG12 HG23 ' D' ' 58' ' ' VAL . 67.8 mt -110.43 135.22 50.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.427 0.632 . . . . 0.0 111.83 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.77 ' HB2' ' HB2' ' D' ' 57' ' ' PHE . 5.5 mm-40 -122.58 89.52 3.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.991 176.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 91' ' ' ILE . . . . . 0.64 ' CG2' ' HZ3' ' D' ' 54' ' ' TRP . 4.7 mt -96.31 108.9 21.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 92' ' ' LYS . . . . . 0.781 ' HE2' HG23 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -162.95 172.73 14.62 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.361 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . 0.633 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 25.1 pt20 -81.5 163.58 22.6 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 119.749 -0.781 . . . . 0.0 111.219 175.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 94' ' ' ILE . . . . . 0.781 HG23 ' HE2' ' D' ' 92' ' ' LYS . 9.9 pt . . . . . 0 C--N 1.307 -1.246 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.139 -172.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.459 ' O ' HG23 ' D' ' 13' ' ' ILE . 41.9 mm . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 121.747 0.784 . . . . 0.0 111.451 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 75.0 m-80 -94.81 -50.59 5.07 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.001 172.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 15' ' ' SER . . . . . 0.507 ' O ' ' HD2' ' D' ' 19' ' ' LYS . 80.5 p -66.62 -30.59 70.9 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.256 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 16' ' ' VAL . . . . . 0.566 HG11 ' ND2' ' D' ' 17' ' ' ASN . 11.5 p -50.75 -28.53 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 121.981 0.896 . . . . 0.0 110.31 175.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 17' ' ' ASN . . . . . 0.566 ' ND2' HG11 ' D' ' 16' ' ' VAL . 4.4 m120 -83.51 -31.29 26.53 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.911 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.92 -15.55 43.94 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 177.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.55 ' HD2' ' N ' ' D' ' 19' ' ' LYS . 0.0 OUTLIER -90.82 -42.21 10.78 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 176.006 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 20' ' ' LEU . . . . . 0.924 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 64.9 mt -70.4 -41.06 73.48 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 113.327 -1.76 . . . . 0.0 110.398 -176.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 21' ' ' ASN . . . . . 0.682 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 59.4 m-20 -74.42 100.76 3.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.656 -1.157 . . . . 0.0 110.225 177.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 22' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -121.94 -43.46 2.34 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -171.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.96 -74.81 0.2 Allowed Glycine 0 N--CA 1.435 -1.39 0 C-N-CA 120.281 -0.961 . . . . 0.0 112.231 -174.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . 0.811 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 27.2 tptp -58.41 -68.42 0.26 Allowed 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 25' ' ' GLY . . . . . 0.765 ' HA2' ' ND2' ' D' ' 42' ' ' ASN . . . -127.77 156.93 20.84 Favored Glycine 0 N--CA 1.431 -1.656 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.631 173.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 26' ' ' LYS . . . . . 0.682 ' CB ' ' HA ' ' D' ' 21' ' ' ASN . 8.5 ptpt -148.31 159.45 43.98 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 114.828 -0.686 . . . . 0.0 111.192 -170.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 27' ' ' LEU . . . . . 0.924 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 42.0 tp -137.46 142.82 41.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.717 0.77 . . . . 0.0 111.968 -177.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 28' ' ' SER . . . . . 0.668 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 50.3 m -129.05 151.32 49.86 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.296 -178.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 29' ' ' LEU . . . . . 0.527 ' CD2' ' HB3' ' D' ' 38' ' ' ALA . 17.7 mt -140.89 135.49 31.36 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 177.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 48.5 m -136.85 -173.28 3.4 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 22.7 ptm -150.14 166.01 31.12 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.675 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.19 89.3 2.09 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.07 -101.88 1.51 Allowed Glycine 0 C--O 1.227 -0.3 0 C-N-CA 120.064 -1.065 . . . . 0.0 110.901 -173.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -111.15 27.81 9.33 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.183 0.515 . . . . 0.0 109.907 173.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 35' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -96.87 164.74 12.42 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -177.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . 0.506 ' C ' HD12 ' D' ' 36' ' ' LEU . 2.8 tm? -132.18 124.19 28.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.056 174.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 37' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -132.11 100.73 5.13 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.004 -168.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 38' ' ' ALA . . . . . 0.527 ' HB3' ' CD2' ' D' ' 29' ' ' LEU . . . -98.57 146.81 25.42 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.574 0.702 . . . . 0.0 112.105 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 39' ' ' THR . . . . . 0.668 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 18.3 p -141.65 128.83 20.96 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.242 176.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 40' ' ' SER . . . . . 0.6 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 77.7 p -107.12 129.5 54.83 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 173.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 41' ' ' SER . . . . . 0.657 ' HB3' ' HG3' ' D' ' 26' ' ' LYS . 46.2 t -93.03 146.7 23.43 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -175.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 42' ' ' ASN . . . . . 0.765 ' ND2' ' HA2' ' D' ' 25' ' ' GLY . 0.9 OUTLIER 82.12 -18.74 0.45 Allowed 'General case' 0 N--CA 1.477 0.925 0 O-C-N 125.59 1.806 . . . . 0.0 109.757 -167.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 60.85 60.33 1.89 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 175.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 44' ' ' GLY . . . . . 0.438 ' O ' HG23 ' D' ' 71' ' ' THR . . . 123.88 35.98 0.65 Allowed Glycine 0 C--N 1.338 0.689 0 C-N-CA 119.166 -1.492 . . . . 0.0 115.797 168.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 45' ' ' TYR . . . . . 0.811 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 7.0 m-30 -116.02 160.87 19.7 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 170.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . 0.588 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -107.84 -152.91 17.49 Favored Glycine 0 C--O 1.223 -0.533 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.87 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 47' ' ' ILE . . . . . 1.001 HG13 ' HB2' ' D' ' 68' ' ' GLU . 1.7 mp -51.45 -57.68 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 CA-C-O 122.484 1.135 . . . . 0.0 108.486 177.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 67.2 p 167.93 -77.67 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 111.378 -2.646 . . . . 0.0 107.273 -173.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 49' ' ' TYR . . . . . 0.469 ' HD2' ' O ' ' D' ' 49' ' ' TYR . 0.1 OUTLIER -154.64 74.55 0.95 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.61 165.496 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . 0.665 ' O ' ' HG2' ' D' ' 69' ' ' LYS . 59.2 mm-40 -141.46 -158.67 0.88 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.226 -176.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 51' ' ' ASP . . . . . 0.6 ' CB ' ' HD2' ' D' ' 69' ' ' LYS . 7.2 t70 -146.51 112.26 5.65 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.234 174.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 52' ' ' LYS . . . . . 0.745 ' HD3' HG12 ' D' ' 47' ' ' ILE . 4.5 mptp? -126.15 106.15 9.36 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.904 -172.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 53' ' ' ASN . . . . . 0.485 HD21 ' N ' ' D' ' 53' ' ' ASN . 2.1 m120 -88.74 130.44 35.34 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.06 0.457 . . . . 0.0 110.401 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 54' ' ' TRP . . . . . 0.706 ' HB2' ' O ' ' D' ' 66' ' ' PHE . 0.4 OUTLIER -119.63 166.02 13.72 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.108 -175.2 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -148.84 159.93 28.21 Favored Glycine 0 N--CA 1.439 -1.138 0 C-N-CA 120.04 -1.076 . . . . 0.0 113.689 175.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 56' ' ' ILE . . . . . 0.533 ' O ' HG11 ' D' ' 63' ' ' VAL . 82.8 mt -135.61 105.06 5.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 176.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 57' ' ' PHE . . . . . 0.518 ' CE1' ' NZ ' ' D' ' 92' ' ' LYS . 13.7 m-85 -101.28 98.21 8.62 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 119.178 -1.009 . . . . 0.0 111.076 -167.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.742 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 97.9 t -89.75 115.16 28.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.835 173.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 66.11 38.04 4.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.81 -175.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.92 -32.99 4.37 Favored Glycine 0 CA--C 1.509 -0.334 0 C-N-CA 120.959 -0.638 . . . . 0.0 113.512 176.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 61' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 16.6 pt-20 -90.76 141.55 28.68 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.322 0.582 . . . . 0.0 111.399 -174.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 62' ' ' LYS . . . . . 0.459 ' HB2' ' CE2' ' D' ' 57' ' ' PHE . 6.2 ttpm? -74.07 100.38 3.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.1 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.533 HG11 ' O ' ' D' ' 56' ' ' ILE . 14.5 p -79.37 -28.65 13.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.672 -173.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 64' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -140.32 141.62 35.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.639 0.257 . . . . 0.0 110.657 176.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 28.3 m -121.19 130.42 53.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.882 176.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 66' ' ' PHE . . . . . 0.706 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 19.5 p90 -136.98 140.13 41.95 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.758 0.79 . . . . 0.0 110.859 174.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 67' ' ' ASN . . . . . 0.755 HD21 ' HB2' ' D' ' 69' ' ' LYS . 11.2 p-10 -111.2 135.4 51.78 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.901 -178.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 68' ' ' GLU . . . . . 1.001 ' HB2' HG13 ' D' ' 47' ' ' ILE . 28.4 mt-10 -65.05 -13.2 57.37 Favored 'General case' 0 CA--C 1.521 -0.137 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.036 -175.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.755 ' HB2' HD21 ' D' ' 67' ' ' ASN . 5.6 mtpm? -59.91 -43.21 95.01 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 172.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 70' ' ' SER . . . . . 0.523 ' HG ' ' CD1' ' D' ' 75' ' ' ILE . 25.5 t -74.56 102.18 4.44 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 113.422 -1.717 . . . . 0.0 107.185 165.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 71' ' ' THR . . . . . 0.438 HG23 ' O ' ' D' ' 44' ' ' GLY . 62.4 p -38.95 130.35 1.49 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.631 -173.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 72' ' ' VAL . . . . . 0.8 HG12 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -53.32 -14.14 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 179.242 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 73' ' ' GLY . . . . . 0.6 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -71.56 -62.49 3.42 Favored Glycine 0 N--CA 1.435 -1.367 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.303 170.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -54.79 -31.09 58.52 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.247 0.546 . . . . 0.0 110.717 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 75' ' ' ILE . . . . . 0.523 ' CD1' ' HG ' ' D' ' 70' ' ' SER . 26.6 mm -80.37 -36.3 16.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.401 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 76' ' ' SER . . . . . 0.429 ' HA ' HG12 ' D' ' 79' ' ' ILE . 27.7 t -73.84 -20.28 60.48 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.965 178.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 77' ' ' ASN . . . . . 0.416 ' O ' ' HD3' ' D' ' 81' ' ' LYS . 5.7 m120 -61.38 -46.51 89.89 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 163.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 78' ' ' ASP . . . . . 0.908 ' HA ' ' HG2' ' D' ' 81' ' ' LYS . 51.5 m-20 -60.31 -36.16 77.28 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 174.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . 0.488 HG12 ' O ' ' D' ' 75' ' ' ILE . 29.8 mm -67.06 -30.6 50.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.248 -174.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -75.98 -15.87 60.08 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.332 174.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 81' ' ' LYS . . . . . 0.908 ' HG2' ' HA ' ' D' ' 78' ' ' ASP . 11.0 mmtp -77.33 -63.65 1.32 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 173.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 82' ' ' LEU . . . . . 0.664 HD22 ' O ' ' D' ' 78' ' ' ASP . 3.2 mm? -49.47 -26.25 3.22 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 113.242 -1.799 . . . . 0.0 113.56 -174.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 83' ' ' ASN . . . . . 0.56 ' O ' ' HE2' ' D' ' 85' ' ' LYS . 0.8 OUTLIER 51.82 66.67 1.13 Allowed 'General case' 0 N--CA 1.468 0.46 0 O-C-N 123.386 0.429 . . . . 0.0 110.251 177.137 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 84' ' ' ILE . . . . . 0.438 ' N ' ' HG ' ' D' ' 36' ' ' LEU . 46.5 mm -76.9 99.48 2.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.897 -173.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 85' ' ' LYS . . . . . 0.56 ' HE2' ' O ' ' D' ' 83' ' ' ASN . 0.0 OUTLIER -156.26 91.75 1.28 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 174.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 86' ' ' GLY . . . . . 0.518 ' H ' ' CD1' ' D' ' 89' ' ' ILE . . . 69.17 151.27 0.43 Allowed Glycine 0 N--CA 1.453 -0.219 0 CA-C-N 115.163 -0.926 . . . . 0.0 113.222 174.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 87' ' ' PRO . . . . . 0.588 ' O ' HG12 ' D' ' 58' ' ' VAL . 59.0 Cg_endo -90.76 179.91 13.15 Favored 'Cis proline' 0 CA--C 1.535 0.534 0 C-N-CA 123.336 -1.527 . . . . 0.0 112.784 -0.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 88' ' ' TYR . . . . . 0.742 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 0.9 OUTLIER 16.85 92.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 125.142 1.377 . . . . 0.0 113.705 178.76 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.518 ' CD1' ' H ' ' D' ' 86' ' ' GLY . 70.3 mt -111.5 142.73 23.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.516 ' O ' ' HD1' ' D' ' 57' ' ' PHE . 70.9 mt-10 -136.87 95.05 3.05 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.676 172.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 91' ' ' ILE . . . . . 0.611 ' CG2' ' HZ3' ' D' ' 54' ' ' TRP . 5.5 mt -96.87 106.53 18.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 92' ' ' LYS . . . . . 0.671 ' HE2' HG21 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -161.93 170.77 18.79 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.622 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . 0.592 ' HB3' ' NE1' ' D' ' 54' ' ' TRP . 18.9 pt20 -82.59 164.8 20.57 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.749 176.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 94' ' ' ILE . . . . . 0.671 HG21 ' HE2' ' D' ' 92' ' ' LYS . 10.4 pt . . . . . 0 C--N 1.31 -1.118 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.174 -172.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.513 ' C ' HG12 ' D' ' 16' ' ' VAL . 38.2 mm . . . . . 0 N--CA 1.453 -0.309 0 CA-C-O 121.497 0.665 . . . . 0.0 111.34 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -96.83 -56.27 2.62 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 177.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 37.2 m -69.39 -15.7 63.36 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 121.21 -0.196 . . . . 0.0 110.997 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 16' ' ' VAL . . . . . 0.729 ' HA ' ' HE2' ' D' ' 19' ' ' LYS . 14.1 p -56.84 -35.26 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 173.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -66.66 -44.01 82.99 Favored 'General case' 0 C--O 1.211 -0.955 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.349 175.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -56.77 -15.07 3.97 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -174.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.729 ' HE2' ' HA ' ' D' ' 16' ' ' VAL . 0.0 OUTLIER -91.54 -44.09 9.28 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-O 122.413 1.101 . . . . 0.0 108.895 174.261 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 20' ' ' LEU . . . . . 0.855 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 72.6 mt -69.76 -36.47 75.81 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 112.804 -1.998 . . . . 0.0 110.097 -174.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 21' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -69.82 98.76 1.27 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.589 177.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 22' ' ' LYS . . . . . 0.62 ' NZ ' ' HA ' ' D' ' 47' ' ' ILE . 8.8 mtmp? -121.36 -42.5 2.45 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -171.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.38 -71.66 0.32 Allowed Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.135 -1.031 . . . . 0.0 112.04 -175.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . 0.84 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 21.8 tptm -51.01 -67.42 0.25 Allowed 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 175.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.9 166.69 23.91 Favored Glycine 0 N--CA 1.43 -1.704 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.581 169.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 26' ' ' LYS . . . . . 0.8 ' HD2' ' HB2' ' D' ' 41' ' ' SER . 0.4 OUTLIER -148.15 156.93 43.17 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.543 -0.328 . . . . 0.0 110.486 -170.545 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 27' ' ' LEU . . . . . 0.855 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 46.2 tp -137.43 142.47 41.62 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.318 0.58 . . . . 0.0 111.285 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 28' ' ' SER . . . . . 0.694 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 49.0 m -137.03 143.18 42.57 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.013 -174.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 29' ' ' LEU . . . . . 0.574 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 0.2 OUTLIER -140.7 149.73 42.56 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.768 -179.113 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 36.1 t -155.01 174.45 15.16 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.17 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 31' ' ' MET . . . . . 0.413 ' SD ' ' N ' ' D' ' 31' ' ' MET . 0.0 OUTLIER -128.74 165.43 20.93 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.023 0.44 . . . . 0.0 109.884 176.838 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 32' ' ' ASN . . . . . 0.406 ' HB3' ' HB2' ' D' ' 35' ' ' GLN . 52.6 t30 -146.82 88.13 1.73 Allowed 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.61 -101.06 1.24 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.392 -168.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 34' ' ' ASN . . . . . 0.446 ' O ' ' HE2' ' D' ' 85' ' ' LYS . 4.4 m120 -116.4 20.99 13.89 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.691 -0.3 . . . . 0.0 110.705 173.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 35' ' ' GLN . . . . . 0.406 ' HB2' ' HB3' ' D' ' 32' ' ' ASN . 13.6 mm100 -88.91 163.09 15.76 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.576 0.703 . . . . 0.0 111.983 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . 0.551 ' HB3' ' ND2' ' D' ' 83' ' ' ASN . 2.4 tm? -129.93 124.95 34.32 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.933 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 37' ' ' LYS . . . . . 0.574 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 26.1 mmmt -130.38 116.15 17.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.605 -168.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 38' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -120.16 143.72 48.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.443 0.64 . . . . 0.0 111.338 176.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 39' ' ' THR . . . . . 0.694 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 4.9 p -138.55 130.11 27.62 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.095 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 40' ' ' SER . . . . . 0.712 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 24.7 p -120.75 129.52 53.65 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 41' ' ' SER . . . . . 0.8 ' HB2' ' HD2' ' D' ' 26' ' ' LYS . 49.3 m -100.92 159.45 15.19 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.174 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 42' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' D' ' 41' ' ' SER . 74.2 m-80 76.67 8.91 3.05 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 124.572 1.17 . . . . 0.0 110.707 -174.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 40.92 59.05 2.33 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 171.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 44' ' ' GLY . . . . . 0.454 ' O ' HG21 ' D' ' 71' ' ' THR . . . 114.22 35.24 1.5 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 119.419 -1.372 . . . . 0.0 114.175 172.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 45' ' ' TYR . . . . . 0.84 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 2.2 m-30 -113.18 145.74 40.45 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 122.477 -0.425 . . . . 0.0 110.02 172.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -91.63 -150.49 25.55 Favored Glycine 0 CA--C 1.504 -0.629 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.411 -178.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 47' ' ' ILE . . . . . 0.935 HG13 ' HB2' ' D' ' 68' ' ' GLU . 0.3 OUTLIER -53.77 -58.91 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 CA-C-O 122.079 0.942 . . . . 0.0 109.013 -178.585 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 48' ' ' SER . . . . . 0.444 ' O ' ' HD2' ' D' ' 49' ' ' TYR . 41.1 t 163.25 -107.32 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 111.216 -2.72 . . . . 0.0 105.381 -172.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 49' ' ' TYR . . . . . 0.444 ' HD2' ' O ' ' D' ' 48' ' ' SER . 2.7 m-30 -124.09 76.76 1.48 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 163.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . 0.556 ' HB2' HG23 ' D' ' 47' ' ' ILE . 63.8 mm-40 -148.56 -166.14 2.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.134 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 51' ' ' ASP . . . . . 0.727 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 2.8 p30 -148.41 138.7 22.6 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.382 168.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 52' ' ' LYS . . . . . 0.727 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 0.4 OUTLIER -143.44 144.35 31.98 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.098 -174.854 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 53' ' ' ASN . . . . . 0.458 HD21 ' C ' ' D' ' 52' ' ' LYS . 3.2 m120 -120.2 129.54 54.14 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 172.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 54' ' ' TRP . . . . . 0.644 ' HZ3' ' CG2' ' D' ' 91' ' ' ILE . 1.0 OUTLIER -120.99 162.04 20.59 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -173.109 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -152.19 152.96 24.6 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.414 172.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 56' ' ' ILE . . . . . 0.724 HG12 HG22 ' D' ' 91' ' ' ILE . 83.7 mt -117.3 116.93 53.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 173.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 57' ' ' PHE . . . . . 0.656 ' CE1' ' HG2' ' D' ' 62' ' ' LYS . 15.3 m-85 -107.47 98.96 8.51 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 119.467 -0.893 . . . . 0.0 111.389 -168.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.646 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 59.3 t -91.94 115.01 30.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.763 173.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 63.9 34.7 11.47 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.212 -176.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.72 -32.27 5.15 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.455 -0.878 . . . . 0.0 113.726 176.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 61' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 16.2 pt-20 -90.0 155.24 19.23 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.798 0.333 . . . . 0.0 110.799 -174.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 62' ' ' LYS . . . . . 0.656 ' HG2' ' CE1' ' D' ' 57' ' ' PHE . 57.8 mttp -80.49 103.03 10.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.961 0.41 . . . . 0.0 110.043 -178.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.416 HG11 ' CG2' ' D' ' 58' ' ' VAL . 14.1 p -78.7 -29.33 14.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.94 -177.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 64' ' ' TYR . . . . . 0.468 ' HH ' ' CB ' ' D' ' 78' ' ' ASP . 16.3 t80 -146.72 126.65 13.6 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.682 175.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 97.2 m -109.59 111.72 23.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.542 174.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 66' ' ' PHE . . . . . 0.487 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 15.9 p90 -116.36 160.71 20.13 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 172.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 67' ' ' ASN . . . . . 0.491 ' OD1' ' HB2' ' D' ' 69' ' ' LYS . 13.2 p30 -132.59 141.35 48.65 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 68' ' ' GLU . . . . . 0.935 ' HB2' HG13 ' D' ' 47' ' ' ILE . 31.4 mm-40 -64.21 -15.23 59.55 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -177.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.493 ' HA ' HD11 ' D' ' 47' ' ' ILE . 49.3 mtpt -56.81 -49.89 74.0 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 173.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 70' ' ' SER . . . . . 0.453 ' O ' HD13 ' D' ' 75' ' ' ILE . 23.1 t -63.8 128.37 35.53 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 113.426 -1.716 . . . . 0.0 107.51 168.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 71' ' ' THR . . . . . 0.454 HG21 ' O ' ' D' ' 44' ' ' GLY . 70.2 p -57.51 118.99 5.77 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 72' ' ' VAL . . . . . 0.828 HG13 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -53.61 -14.98 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -176.387 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 73' ' ' GLY . . . . . 0.712 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -67.96 -56.74 9.97 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.788 170.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -68.23 -19.97 64.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.988 0.423 . . . . 0.0 110.278 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 75' ' ' ILE . . . . . 0.541 ' O ' HG13 ' D' ' 79' ' ' ILE . 83.3 mt -72.59 -43.95 61.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.555 175.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 31.4 t -73.58 -19.15 60.96 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.166 -176.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 77' ' ' ASN . . . . . 0.402 ' O ' ' HD3' ' D' ' 81' ' ' LYS . 4.0 m120 -60.49 -44.47 95.91 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 165.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 78' ' ' ASP . . . . . 0.997 ' HA ' ' HG2' ' D' ' 81' ' ' LYS . 1.0 OUTLIER -69.66 -25.81 64.09 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 114.981 -1.009 . . . . 0.0 113.407 177.144 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . 0.541 HG13 ' O ' ' D' ' 75' ' ' ILE . 41.5 mt -77.72 -17.0 14.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 118.89 -1.124 . . . . 0.0 109.875 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -77.52 -26.83 51.45 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.256 169.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 81' ' ' LYS . . . . . 0.997 ' HG2' ' HA ' ' D' ' 78' ' ' ASP . 15.9 mmtt -74.01 -69.96 0.41 Allowed 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 176.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 82' ' ' LEU . . . . . 0.484 HD21 ' O ' ' D' ' 78' ' ' ASP . 3.5 mm? -47.28 -32.25 4.5 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 113.482 -1.69 . . . . 0.0 112.578 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 83' ' ' ASN . . . . . 0.551 ' ND2' ' HB3' ' D' ' 36' ' ' LEU . 0.7 OUTLIER 37.85 65.5 0.56 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.979 0.912 . . . . 0.0 111.269 175.821 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 84' ' ' ILE . . . . . 0.441 ' N ' ' HG ' ' D' ' 36' ' ' LEU . 2.8 mp -74.88 99.12 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.96 0.41 . . . . 0.0 111.372 -171.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 85' ' ' LYS . . . . . 0.446 ' HE2' ' O ' ' D' ' 34' ' ' ASN . 16.8 ptpt -125.9 92.3 3.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.988 0.423 . . . . 0.0 111.96 178.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.33 160.04 0.11 Allowed Glycine 0 CA--C 1.52 0.353 0 CA-C-N 115.328 -0.851 . . . . 0.0 114.146 173.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 87' ' ' PRO . . . . . 0.574 ' HD2' ' CG1' ' D' ' 58' ' ' VAL . 44.8 Cg_endo -93.68 -178.58 8.42 Favored 'Cis proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.795 -1.335 . . . . 0.0 112.176 -1.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 88' ' ' TYR . . . . . 0.646 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 16.0 m-85 24.57 92.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.823 1.249 . . . . 0.0 113.387 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.419 HD11 HG23 ' D' ' 89' ' ' ILE . 75.8 mt -111.67 130.78 64.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.581 ' O ' ' HD2' ' D' ' 57' ' ' PHE . 51.3 mt-10 -130.52 101.54 5.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.105 172.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 91' ' ' ILE . . . . . 0.724 HG22 HG12 ' D' ' 56' ' ' ILE . 4.1 mt -98.3 113.03 31.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -177.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 92' ' ' LYS . . . . . 0.711 ' HE2' HG23 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -162.28 170.57 18.71 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.084 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . 0.617 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 25.1 pt20 -80.97 164.81 22.28 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.803 176.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 94' ' ' ILE . . . . . 0.711 HG23 ' HE2' ' D' ' 92' ' ' LYS . 10.7 pt . . . . . 0 C--N 1.31 -1.109 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.899 -171.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.507 HG22 ' HE2' ' D' ' 31' ' ' MET . 63.9 mt . . . . . 0 N--CA 1.456 -0.149 0 CA-C-O 121.729 0.776 . . . . 0.0 111.736 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -96.19 -50.37 4.84 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.519 172.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 15' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' D' ' 18' ' ' ASP . 80.5 p -63.44 -24.94 68.05 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.328 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 16' ' ' VAL . . . . . 0.644 ' O ' ' HG ' ' D' ' 20' ' ' LEU . 9.8 p -54.16 -37.58 36.04 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-O 121.296 0.569 . . . . 0.0 109.593 176.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 17' ' ' ASN . . . . . 0.622 ' OD1' ' HA ' ' D' ' 28' ' ' SER . 78.6 m-20 -78.21 -22.3 48.72 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.461 -178.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 18' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' D' ' 15' ' ' SER . 1.0 OUTLIER -67.79 -17.14 64.43 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 176.379 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.583 ' O ' ' HE3' ' D' ' 22' ' ' LYS . 0.0 OUTLIER -91.74 -43.11 9.75 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 172.186 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 20' ' ' LEU . . . . . 1.007 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 85.4 mt -63.04 -40.95 99.24 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.009 -1.451 . . . . 0.0 110.131 -177.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 21' ' ' ASN . . . . . 0.55 ' OD1' ' HB2' ' D' ' 26' ' ' LYS . 51.6 m-80 -79.73 101.64 8.55 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.347 177.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 22' ' ' LYS . . . . . 0.923 ' HD2' HD13 ' D' ' 47' ' ' ILE . 97.4 mttt -122.18 -41.76 2.41 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -175.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 169.9 -91.13 0.1 OUTLIER Glycine 0 N--CA 1.437 -1.26 0 C-N-CA 119.604 -1.284 . . . . 0.0 112.982 -178.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . 0.657 ' HB3' ' O ' ' D' ' 46' ' ' GLY . 26.4 tptp -48.27 -52.86 19.36 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 25' ' ' GLY . . . . . 1.022 ' HA2' HD22 ' D' ' 42' ' ' ASN . . . -141.48 154.0 24.4 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.394 176.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 26' ' ' LYS . . . . . 0.812 ' HZ1' ' HB3' ' D' ' 26' ' ' LYS . 0.4 OUTLIER -144.92 161.94 38.1 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.573 -0.814 . . . . 0.0 112.248 -168.709 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 27' ' ' LEU . . . . . 1.007 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 51.5 tp -134.93 153.15 52.17 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.454 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 28' ' ' SER . . . . . 0.622 ' HA ' ' OD1' ' D' ' 17' ' ' ASN . 14.2 t -140.68 153.79 46.12 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 29' ' ' LEU . . . . . . . . . . . . . 20.2 mt -134.2 158.8 42.75 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.624 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 37.3 t -160.15 -177.13 6.07 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 31' ' ' MET . . . . . 0.507 ' HE2' HG22 ' D' ' 13' ' ' ILE . 1.3 pmm? -150.57 163.15 39.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.84 0.352 . . . . 0.0 111.007 177.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -144.25 88.48 1.95 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.1 175.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.47 -115.35 4.56 Favored Glycine 0 N--CA 1.454 -0.154 0 C-N-CA 120.205 -0.997 . . . . 0.0 110.991 -172.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -95.78 20.71 9.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.915 0.388 . . . . 0.0 110.926 174.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 35' ' ' GLN . . . . . 0.42 ' OE1' ' HA ' ' D' ' 35' ' ' GLN . 10.3 mm-40 -88.54 152.85 21.59 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 121.314 0.578 . . . . 0.0 111.989 176.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . 0.623 HD12 ' HA ' ' D' ' 83' ' ' ASN . 1.3 tm? -134.37 119.56 18.77 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.378 175.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 37' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -123.36 157.36 33.47 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.564 -169.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 38' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -148.83 152.26 36.19 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 113.216 -1.811 . . . . 0.0 111.341 176.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 39' ' ' THR . . . . . 0.578 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 20.6 p -145.54 139.03 26.46 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.198 175.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 40' ' ' SER . . . . . 0.518 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 33.8 p -106.1 128.78 54.12 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 171.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 41' ' ' SER . . . . . 0.588 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 48.0 t -92.18 162.58 14.26 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 176.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 42' ' ' ASN . . . . . 1.022 HD22 ' HA2' ' D' ' 25' ' ' GLY . 18.6 p30 64.64 3.78 2.08 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 124.605 1.19 . . . . 0.0 111.896 -169.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 52.79 63.24 2.32 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 165.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.62 -15.94 6.63 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 118.174 -1.965 . . . . 0.0 115.993 166.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 45' ' ' TYR . . . . . 0.651 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 2.2 m-30 -78.62 155.94 29.34 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 117.909 0.855 . . . . 0.0 110.683 -176.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . 0.657 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -96.79 -172.91 34.69 Favored Glycine 0 C--O 1.217 -0.968 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 172.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 47' ' ' ILE . . . . . 0.923 HD13 ' HD2' ' D' ' 22' ' ' LYS . 39.4 mm -48.41 -56.64 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.861 0 CA-C-N 117.975 0.888 . . . . 0.0 110.917 178.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 81.0 p -179.31 -147.38 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 112.574 -2.103 . . . . 0.0 108.025 -173.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -97.46 75.53 2.51 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.226 168.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . 0.413 ' OE2' ' HA ' ' D' ' 50' ' ' GLU . 36.8 mm-40 -144.0 -172.68 3.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.56 -178.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 51' ' ' ASP . . . . . 0.691 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 11.6 m-20 -134.86 120.13 18.94 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.141 173.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 52' ' ' LYS . . . . . 1.045 ' HG2' ' HB2' ' D' ' 68' ' ' GLU . 0.0 OUTLIER -139.41 130.35 26.3 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.436 -177.1 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -109.92 142.82 40.74 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 121.002 0.429 . . . . 0.0 110.967 -175.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 54' ' ' TRP . . . . . 0.69 ' NE1' ' HB3' ' D' ' 93' ' ' GLN . 0.8 OUTLIER -123.43 160.57 26.56 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.825 -176.925 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -138.56 160.85 25.68 Favored Glycine 0 N--CA 1.438 -1.233 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.95 174.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 56' ' ' ILE . . . . . 0.511 ' O ' HG13 ' D' ' 63' ' ' VAL . 97.0 mt -140.47 109.88 3.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 178.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 57' ' ' PHE . . . . . 0.638 ' HA ' ' O ' ' D' ' 61' ' ' GLU . 13.9 m-85 -107.92 101.25 10.53 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.624 -0.83 . . . . 0.0 111.7 -168.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.689 HG22 HG12 ' D' ' 89' ' ' ILE . 87.5 t -94.84 119.67 43.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.446 173.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 59' ' ' ASN . . . . . 0.42 ' OD1' HG13 ' D' ' 58' ' ' VAL . 5.5 m120 63.93 35.59 10.73 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.075 0.464 . . . . 0.0 110.776 -175.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.2 34.68 90.57 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.373 -0.83 . . . . 0.0 114.461 175.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 61' ' ' GLU . . . . . 0.638 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 16.3 pt-20 -138.69 145.33 40.23 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 171.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 62' ' ' LYS . . . . . 0.488 ' HB2' ' HZ3' ' D' ' 62' ' ' LYS . 3.8 ttmp? -75.34 99.39 4.09 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -177.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.511 HG13 ' O ' ' D' ' 56' ' ' ILE . 9.2 p -84.73 -33.54 8.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.577 -173.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 64' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -135.88 131.37 35.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.932 0.396 . . . . 0.0 110.595 174.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 65' ' ' THR . . . . . 0.438 HG23 ' O ' ' D' ' 54' ' ' TRP . 26.4 m -115.93 113.9 23.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.701 177.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 66' ' ' PHE . . . . . 0.555 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 10.8 p90 -116.81 130.91 57.01 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.355 0.597 . . . . 0.0 109.776 175.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -103.2 139.86 38.12 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -178.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 68' ' ' GLU . . . . . 1.045 ' HB2' ' HG2' ' D' ' 52' ' ' LYS . 40.2 mm-40 -70.63 -8.94 55.48 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.946 -174.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.581 ' HD3' ' HB3' ' D' ' 51' ' ' ASP . 47.0 mtmt -62.88 -39.73 95.35 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 169.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 31.7 t -71.45 119.9 16.26 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.502 -1.681 . . . . 0.0 107.07 165.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 70.1 p -54.87 130.59 41.73 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.255 -176.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 72' ' ' VAL . . . . . 0.605 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -55.68 -13.38 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 121.077 0.465 . . . . 0.0 111.813 -175.821 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 73' ' ' GLY . . . . . 0.518 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -74.07 -55.55 5.72 Favored Glycine 0 N--CA 1.437 -1.249 0 CA-C-N 115.212 -0.904 . . . . 0.0 112.445 169.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 74' ' ' ASN . . . . . 0.737 ' HA ' HD21 ' D' ' 77' ' ' ASN . 44.6 t30 -62.29 -23.59 66.81 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.814 0.34 . . . . 0.0 110.553 177.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 75' ' ' ILE . . . . . 0.613 ' O ' HG13 ' D' ' 79' ' ' ILE . 74.3 mt -73.83 -41.85 53.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.329 176.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 28.8 t -73.5 -20.41 60.68 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.554 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 77' ' ' ASN . . . . . 0.737 HD21 ' HA ' ' D' ' 74' ' ' ASN . 76.4 m-20 -65.84 -28.25 68.84 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 168.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 78' ' ' ASP . . . . . 1.064 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 1.0 OUTLIER -83.71 -32.22 25.64 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 115.528 -0.76 . . . . 0.0 113.032 174.823 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . 0.613 HG13 ' O ' ' D' ' 75' ' ' ILE . 25.1 mt -72.27 -16.55 18.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 120.034 -0.667 . . . . 0.0 110.041 -176.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -65.04 -49.81 68.66 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.729 172.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 81' ' ' LYS . . . . . 1.064 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -72.73 -57.58 4.0 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.637 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 82' ' ' LEU . . . . . 0.551 ' H ' ' HG2' ' D' ' 81' ' ' LYS . 4.1 mm? -44.98 -35.45 2.9 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 83' ' ' ASN . . . . . 0.623 ' HA ' HD12 ' D' ' 36' ' ' LEU . 22.2 t-20 29.33 70.88 0.07 Allowed 'General case' 0 N--CA 1.476 0.841 0 O-C-N 124.591 1.182 . . . . 0.0 111.811 178.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 84' ' ' ILE . . . . . 0.593 ' O ' ' HG ' ' D' ' 36' ' ' LEU . 50.1 mt -93.0 98.33 8.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.627 -176.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 85' ' ' LYS . . . . . 0.455 ' HB2' ' HB2' ' D' ' 36' ' ' LEU . 2.7 tmtm? -127.65 93.93 3.83 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -178.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 86' ' ' GLY . . . . . 0.465 ' H ' ' CD1' ' D' ' 89' ' ' ILE . . . 72.1 153.11 1.65 Allowed Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.918 -0.583 . . . . 0.0 113.165 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 87' ' ' PRO . . . . . 0.477 ' HD2' ' CG1' ' D' ' 58' ' ' VAL . 54.2 Cg_endo -91.21 -179.76 12.13 Favored 'Cis proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.395 -1.502 . . . . 0.0 112.923 -0.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 88' ' ' TYR . . . . . 0.617 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 19.3 m-85 10.99 93.87 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 125.74 1.616 . . . . 0.0 114.065 -178.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.689 HG12 HG22 ' D' ' 58' ' ' VAL . 68.5 mt -111.54 142.85 22.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.975 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.505 ' N ' HG21 ' D' ' 89' ' ' ILE . 38.3 tt0 -128.76 95.09 4.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.916 172.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 91' ' ' ILE . . . . . 0.622 ' CG2' ' HZ3' ' D' ' 54' ' ' TRP . 7.3 mt -97.18 109.15 22.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 92' ' ' LYS . . . . . 0.722 ' HE3' HG21 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -162.17 172.29 16.03 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 122.603 0.361 . . . . 0.0 110.308 -176.222 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . 0.69 ' HB3' ' NE1' ' D' ' 54' ' ' TRP . 17.4 pt20 -89.07 153.45 20.98 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.744 174.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 94' ' ' ILE . . . . . 0.722 HG21 ' HE3' ' D' ' 92' ' ' LYS . 10.6 pt . . . . . 0 C--N 1.309 -1.171 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.688 -171.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.512 HG22 ' HE2' ' D' ' 31' ' ' MET . 63.3 mt . . . . . 0 C--O 1.223 -0.309 0 CA-C-O 121.678 0.751 . . . . 0.0 111.43 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -92.0 -46.87 7.59 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.229 173.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 15' ' ' SER . . . . . 0.47 ' O ' ' HE2' ' D' ' 19' ' ' LYS . 92.2 p -70.23 -18.66 63.16 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.78 176.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 16' ' ' VAL . . . . . 0.613 ' O ' ' HG ' ' D' ' 20' ' ' LEU . 1.3 p -62.06 -27.43 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -69.62 -41.34 75.81 Favored 'General case' 0 C--O 1.206 -1.232 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.905 175.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 18' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' D' ' 15' ' ' SER . 49.7 m-20 -61.94 -14.54 35.64 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 176.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.674 ' HB3' ' CZ2' ' D' ' 54' ' ' TRP . 1.2 mppt? -87.79 -26.85 22.65 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.367 0.603 . . . . 0.0 110.185 177.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 20' ' ' LEU . . . . . 0.99 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 84.6 mt -105.6 -38.49 6.41 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 113.547 -1.66 . . . . 0.0 110.559 -168.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 21' ' ' ASN . . . . . 0.655 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 1.2 t-20 -88.12 89.05 7.84 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 113.571 -1.65 . . . . 0.0 108.314 -172.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 22' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -120.42 -42.2 2.57 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -163.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 178.53 -88.63 0.07 OUTLIER Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 119.455 -1.355 . . . . 0.0 113.032 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . 0.791 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 53.6 tptt -50.79 -63.55 1.09 Allowed 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -127.69 162.57 21.58 Favored Glycine 0 N--CA 1.431 -1.67 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.315 171.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 26' ' ' LYS . . . . . 0.698 ' CD ' ' HB3' ' D' ' 41' ' ' SER . 0.1 OUTLIER -149.7 160.61 43.39 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.832 -0.684 . . . . 0.0 110.979 -169.165 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 27' ' ' LEU . . . . . 0.99 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 55.3 tp -138.47 143.73 39.74 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.153 0.501 . . . . 0.0 111.226 -178.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 28' ' ' SER . . . . . 0.611 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 29.5 t -130.39 136.77 49.41 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -177.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 29' ' ' LEU . . . . . 0.636 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 14.5 mt -132.48 135.28 45.91 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.302 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 61.2 m -142.2 -171.96 3.49 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.039 176.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 31' ' ' MET . . . . . 0.512 ' HE2' HG22 ' D' ' 13' ' ' ILE . 1.4 pmm? -139.59 160.39 39.97 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.037 0.446 . . . . 0.0 110.236 178.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 32' ' ' ASN . . . . . 0.469 ' HB3' ' HB2' ' D' ' 35' ' ' GLN . 24.6 t-20 -139.84 88.07 2.21 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.22 -107.88 2.31 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.823 -169.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -108.4 26.87 9.95 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 122.505 -0.409 . . . . 0.0 110.521 174.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 35' ' ' GLN . . . . . 0.469 ' HB2' ' HB3' ' D' ' 32' ' ' ASN . 22.5 mt-30 -105.09 162.68 13.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.788 -178.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . 0.746 ' HB2' ' HB2' ' D' ' 85' ' ' LYS . 0.9 OUTLIER -128.82 135.04 48.59 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.312 -178.935 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 37' ' ' LYS . . . . . 0.636 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 75.2 mmtt -129.76 111.43 12.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.052 -168.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 38' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -111.47 144.19 41.08 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.855 0.36 . . . . 0.0 111.067 175.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 39' ' ' THR . . . . . 0.611 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 16.2 p -147.42 135.88 21.75 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.353 177.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 40' ' ' SER . . . . . 0.671 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 30.4 p -109.4 129.99 55.52 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 41' ' ' SER . . . . . 0.698 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 47.4 t -95.58 148.94 21.98 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.121 -1.031 . . . . 0.0 109.337 177.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 42' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' D' ' 41' ' ' SER . 75.8 m-20 80.19 -1.64 2.0 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.389 -168.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 49.38 61.88 2.91 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 169.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 44' ' ' GLY . . . . . 0.407 ' O ' HG21 ' D' ' 71' ' ' THR . . . 125.3 1.33 7.89 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 118.517 -1.801 . . . . 0.0 115.387 170.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 45' ' ' TYR . . . . . 0.791 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 1.5 m-30 -86.05 154.15 21.62 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 116.946 0.373 . . . . 0.0 110.333 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . 0.453 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -102.33 -153.34 24.93 Favored Glycine 0 C--O 1.219 -0.827 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 178.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 47' ' ' ILE . . . . . 0.989 HG13 ' HB2' ' D' ' 68' ' ' GLU . 2.7 mp -49.04 -58.42 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 CA-C-O 122.428 1.109 . . . . 0.0 108.833 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 48' ' ' SER . . . . . 0.538 ' HA ' ' HG2' ' D' ' 24' ' ' LYS . 36.3 t 152.83 -95.28 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 110.593 -3.003 . . . . 0.0 106.544 -174.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 49' ' ' TYR . . . . . 0.469 ' HD1' ' C ' ' D' ' 48' ' ' SER . 3.7 m-30 -130.21 75.57 1.66 Allowed 'General case' 0 N--CA 1.465 0.304 0 O-C-N 122.228 -0.295 . . . . 0.0 111.047 169.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . 0.553 ' HB2' HG21 ' D' ' 47' ' ' ILE . 50.4 mt-10 -156.81 -175.63 5.53 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.348 0.259 . . . . 0.0 110.491 176.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 51' ' ' ASP . . . . . 0.708 ' HB2' ' HD2' ' D' ' 69' ' ' LYS . 7.0 p-10 -130.7 141.59 50.4 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.062 172.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 52' ' ' LYS . . . . . 0.688 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 0.7 OUTLIER -145.28 136.07 24.52 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.213 -177.136 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -113.82 139.04 49.47 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.173 170.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 54' ' ' TRP . . . . . 0.674 ' CZ2' ' HB3' ' D' ' 19' ' ' LYS . 0.9 OUTLIER -126.71 157.01 40.19 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -172.176 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -143.23 158.08 27.13 Favored Glycine 0 N--CA 1.437 -1.298 0 C-N-CA 120.133 -1.032 . . . . 0.0 113.299 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 56' ' ' ILE . . . . . 0.823 HG12 HG22 ' D' ' 91' ' ' ILE . 91.7 mt -129.13 97.24 3.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 113.289 -1.456 . . . . 0.0 107.459 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 57' ' ' PHE . . . . . 0.581 ' HA ' ' O ' ' D' ' 61' ' ' GLU . 14.2 m-85 -100.15 103.25 14.73 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -171.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.916 HG13 HG12 ' D' ' 89' ' ' ILE . 3.8 m -95.55 99.95 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.648 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 57.93 62.9 1.92 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.692 -168.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.67 48.55 85.51 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 115.879 -0.6 . . . . 0.0 113.395 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 61' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 5.4 tp10 -157.49 115.2 3.09 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 62' ' ' LYS . . . . . 0.476 ' HE2' ' OG1' ' D' ' 65' ' ' THR . 5.8 ttpm? -77.6 98.68 5.49 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.534 HG12 HG21 ' D' ' 58' ' ' VAL . 35.4 m -88.45 -11.5 10.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.48 -173.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 64' ' ' TYR . . . . . 0.455 ' HH ' ' CB ' ' D' ' 78' ' ' ASP . 16.9 t80 -150.42 136.6 18.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.835 0.35 . . . . 0.0 110.397 174.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 65' ' ' THR . . . . . 0.476 ' OG1' ' HE2' ' D' ' 62' ' ' LYS . 24.5 m -119.4 113.54 20.94 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.161 176.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 66' ' ' PHE . . . . . 0.522 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 10.3 p90 -123.89 159.15 30.3 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 173.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 67' ' ' ASN . . . . . 0.44 ' O ' HD11 ' D' ' 75' ' ' ILE . 13.1 p30 -131.51 137.77 48.66 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 68' ' ' GLU . . . . . 0.989 ' HB2' HG13 ' D' ' 47' ' ' ILE . 37.5 mt-10 -62.18 -16.41 52.81 Favored 'General case' 0 C--N 1.345 0.395 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -174.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.708 ' HD2' ' HB2' ' D' ' 51' ' ' ASP . 5.6 mtpm? -57.98 -47.14 83.88 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.17 174.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 31.7 t -66.66 114.06 5.29 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 166.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 71' ' ' THR . . . . . 0.407 HG21 ' O ' ' D' ' 44' ' ' GLY . 59.2 p -53.32 124.85 15.79 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.418 -173.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 72' ' ' VAL . . . . . 0.529 HG13 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -53.2 -13.01 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.756 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 73' ' ' GLY . . . . . 0.671 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -70.36 -57.48 6.72 Favored Glycine 0 N--CA 1.436 -1.359 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.261 169.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -69.71 -18.46 63.54 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.51 -0.345 . . . . 0.0 111.016 178.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 75' ' ' ILE . . . . . 0.613 ' O ' HG13 ' D' ' 79' ' ' ILE . 73.7 mt -71.74 -42.47 70.54 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.388 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.032 173.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 76' ' ' SER . . . . . 0.457 ' OG ' ' HB2' ' D' ' 38' ' ' ALA . 40.3 t -72.9 -22.69 60.7 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.434 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -60.48 -30.1 69.48 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 167.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 78' ' ' ASP . . . . . 1.02 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 50.2 m-20 -87.52 -31.83 19.72 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.585 176.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . 0.613 HG13 ' O ' ' D' ' 75' ' ' ILE . 31.1 mt -71.88 -16.78 18.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.137 -177.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -67.64 -40.7 84.56 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.922 173.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 81' ' ' LYS . . . . . 1.02 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -81.35 -53.59 6.2 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.837 176.592 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 82' ' ' LEU . . . . . 0.506 HD22 ' O ' ' D' ' 78' ' ' ASP . 4.0 mm? -53.08 -26.58 16.66 Favored 'General case' 0 C--O 1.227 -0.098 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 83' ' ' ASN . . . . . 0.539 ' ND2' ' HB3' ' D' ' 36' ' ' LEU . 0.6 OUTLIER 39.14 67.91 0.4 Allowed 'General case' 0 N--CA 1.474 0.761 0 O-C-N 123.998 0.811 . . . . 0.0 111.236 176.331 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 84' ' ' ILE . . . . . 0.634 HG22 HG22 ' D' ' 56' ' ' ILE . 46.3 mm -84.43 98.49 5.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.835 -173.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 85' ' ' LYS . . . . . 0.746 ' HB2' ' HB2' ' D' ' 36' ' ' LEU . 10.0 tmtt? -145.39 95.42 2.66 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.354 0.597 . . . . 0.0 109.532 177.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 86' ' ' GLY . . . . . 0.549 ' H ' ' CD1' ' D' ' 89' ' ' ILE . . . 77.13 158.79 9.58 Favored Glycine 0 CA--C 1.498 -1.007 0 CA-C-N 115.473 -0.785 . . . . 0.0 114.147 178.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 87' ' ' PRO . . . . . 0.887 ' HD2' HG22 ' D' ' 58' ' ' VAL . 90.4 Cg_endo -80.66 -176.99 18.97 Favored 'Cis proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.355 -1.935 . . . . 0.0 113.3 0.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 88' ' ' TYR . . . . . 0.613 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 1.7 m-85 -11.36 96.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.943 1.297 . . . . 0.0 114.03 -175.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.916 HG12 HG13 ' D' ' 58' ' ' VAL . 41.0 mt -92.79 143.58 11.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -173.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -130.39 91.52 3.11 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.65 173.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 91' ' ' ILE . . . . . 0.823 HG22 HG12 ' D' ' 56' ' ' ILE . 2.5 mt -96.91 117.73 42.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -176.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 92' ' ' LYS . . . . . 0.66 ' HD3' ' O ' ' D' ' 93' ' ' GLN . 0.1 OUTLIER -162.91 173.37 13.77 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.464 0.306 . . . . 0.0 110.929 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . 0.66 ' O ' ' HD3' ' D' ' 92' ' ' LYS . 2.8 pt20 -87.03 156.89 19.57 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.33 173.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 94' ' ' ILE . . . . . 0.616 ' CG2' ' HE2' ' D' ' 92' ' ' LYS . 5.5 pt . . . . . 0 C--N 1.313 -1.02 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.397 -169.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.582 ' O ' HG11 ' D' ' 16' ' ' VAL . 52.0 mt . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 121.631 0.729 . . . . 0.0 110.747 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -88.08 -52.59 5.16 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.885 176.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 15' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' D' ' 18' ' ' ASP . 51.1 m -65.41 -21.61 66.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.488 174.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 16' ' ' VAL . . . . . 0.799 ' HA ' ' HE2' ' D' ' 19' ' ' LYS . 0.7 OUTLIER -59.12 -31.9 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.814 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 17' ' ' ASN . . . . . 0.6 ' OD1' ' HA ' ' D' ' 28' ' ' SER . 79.9 m-20 -85.06 -18.6 33.84 Favored 'General case' 0 C--O 1.205 -1.246 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.849 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 18' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' D' ' 15' ' ' SER . 73.7 m-20 -67.88 -16.36 64.05 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 122.304 -0.248 . . . . 0.0 111.599 176.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.799 ' HE2' ' HA ' ' D' ' 16' ' ' VAL . 0.0 OUTLIER -90.43 -39.83 12.41 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-O 121.987 0.899 . . . . 0.0 108.953 174.183 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 20' ' ' LEU . . . . . 0.904 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 78.3 mt -74.09 -40.17 62.91 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 113.628 -1.624 . . . . 0.0 110.107 -174.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 21' ' ' ASN . . . . . 0.526 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 2.8 m120 -78.14 95.7 4.99 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.688 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 22' ' ' LYS . . . . . 0.833 ' HD2' HD13 ' D' ' 47' ' ' ILE . 67.6 mttm -122.58 -41.12 2.4 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -176.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.56 -103.16 0.18 Allowed Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 119.161 -1.495 . . . . 0.0 113.351 -177.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . 0.863 ' HE2' ' HA ' ' D' ' 48' ' ' SER . 32.8 ttpt -49.5 -44.06 45.83 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.62 0.724 . . . . 0.0 110.362 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 25' ' ' GLY . . . . . 0.624 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -139.8 154.45 23.77 Favored Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 114.548 -1.205 . . . . 0.0 112.132 174.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 26' ' ' LYS . . . . . 0.735 ' HZ2' ' HB3' ' D' ' 26' ' ' LYS . 0.3 OUTLIER -150.67 160.42 43.84 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.331 -0.934 . . . . 0.0 110.518 -171.038 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 27' ' ' LEU . . . . . 0.904 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 41.6 tp -132.13 144.62 50.83 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.14 0.495 . . . . 0.0 111.392 177.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 28' ' ' SER . . . . . 0.6 ' HA ' ' OD1' ' D' ' 17' ' ' ASN . 9.1 t -131.32 136.42 48.1 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 29' ' ' LEU . . . . . 0.51 ' CD2' ' HB3' ' D' ' 38' ' ' ALA . 18.3 mt -127.19 157.94 38.43 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.384 -0.527 . . . . 0.0 110.53 -179.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 34.7 t -160.45 174.53 13.96 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 59.2 mtt -133.83 163.33 29.73 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.108 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 32' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' D' ' 35' ' ' GLN . 50.3 t30 -136.95 86.87 2.24 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.714 172.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.03 -108.26 2.51 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.553 -169.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 34' ' ' ASN . . . . . 0.429 ' O ' ' HE3' ' D' ' 85' ' ' LYS . 75.3 m-80 -107.11 31.76 5.12 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.586 0.707 . . . . 0.0 109.96 174.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 35' ' ' GLN . . . . . 0.497 ' OE1' ' HA ' ' D' ' 35' ' ' GLN . 6.5 mm-40 -99.9 164.48 11.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.823 -1.081 . . . . 0.0 113.263 -177.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . 0.638 ' C ' HD12 ' D' ' 36' ' ' LEU . 2.7 tm? -132.8 125.6 30.46 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.637 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 37' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 27.9 mmmt -131.2 103.06 6.27 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.768 -170.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 38' ' ' ALA . . . . . 0.51 ' HB3' ' CD2' ' D' ' 29' ' ' LEU . . . -108.57 146.39 33.38 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.403 0.62 . . . . 0.0 112.289 -176.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 39' ' ' THR . . . . . 0.433 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 14.3 p -146.32 130.37 17.36 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.17 175.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 40' ' ' SER . . . . . 0.783 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 69.2 p -108.3 135.06 50.25 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 176.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 41' ' ' SER . . . . . 0.638 ' HB3' ' HD2' ' D' ' 26' ' ' LYS . 39.1 t -96.28 147.89 23.31 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.169 -1.012 . . . . 0.0 109.676 -178.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 42' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' D' ' 41' ' ' SER . 73.0 m-80 80.6 2.99 1.8 Allowed 'General case' 0 N--CA 1.468 0.472 0 O-C-N 124.569 1.168 . . . . 0.0 110.161 -170.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 47.28 55.5 8.1 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 171.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 44' ' ' GLY . . . . . 0.802 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 117.62 35.88 1.04 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 119.477 -1.344 . . . . 0.0 113.845 172.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 45' ' ' TYR . . . . . 0.78 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 1.8 m-85 -119.25 149.71 41.31 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 173.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . 0.644 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -93.61 179.7 38.82 Favored Glycine 0 C--O 1.221 -0.71 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 176.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 47' ' ' ILE . . . . . 0.85 HG12 ' HB3' ' D' ' 68' ' ' GLU . 32.6 mm -46.72 -57.01 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.798 0 CA-C-N 118.026 0.913 . . . . 0.0 110.28 -178.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 48' ' ' SER . . . . . 0.863 ' HA ' ' HE2' ' D' ' 24' ' ' LYS . 67.5 p -175.67 -118.39 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 113.354 -1.748 . . . . 0.0 108.683 -177.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 49' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' D' ' 49' ' ' TYR . 0.2 OUTLIER -113.72 75.56 0.93 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 168.199 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . 0.615 ' HB3' ' HE2' ' D' ' 52' ' ' LYS . 68.3 mm-40 -131.81 -175.89 3.87 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.834 -175.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 51' ' ' ASP . . . . . 0.653 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 1.1 m-20 -140.36 128.89 22.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.487 169.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 52' ' ' LYS . . . . . 0.653 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 3.9 mptp? -141.56 136.42 31.09 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.504 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 53' ' ' ASN . . . . . 0.424 HD21 ' C ' ' D' ' 52' ' ' LYS . 3.0 m120 -112.01 126.98 55.73 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 175.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 54' ' ' TRP . . . . . 0.658 ' HZ3' ' CG2' ' D' ' 91' ' ' ILE . 1.3 m95 -115.47 161.63 18.31 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -174.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -150.07 163.45 29.45 Favored Glycine 0 N--CA 1.435 -1.412 0 CA-C-N 114.566 -1.197 . . . . 0.0 112.556 172.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 56' ' ' ILE . . . . . 0.822 HD12 HG12 ' D' ' 84' ' ' ILE . 76.6 mt -134.75 109.58 11.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 -179.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 57' ' ' PHE . . . . . 0.628 ' HB2' ' HB3' ' D' ' 90' ' ' GLU . 8.3 m-85 -111.63 105.9 14.57 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.879 -165.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.836 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 54.7 t -88.67 112.31 23.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.277 172.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 7.0 m120 51.18 50.75 18.39 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.421 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.49 48.44 78.17 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.535 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 61' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 43.1 tt0 -150.88 111.24 4.18 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 62' ' ' LYS . . . . . 0.447 ' NZ ' ' HB3' ' D' ' 62' ' ' LYS . 6.3 ttpm? -73.65 103.01 4.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.972 0.415 . . . . 0.0 110.048 -177.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 29.0 m -79.57 -25.65 12.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.303 -174.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 64' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -149.74 147.4 28.0 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.064 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 59.4 m -125.28 121.17 33.24 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.482 175.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 66' ' ' PHE . . . . . 0.607 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 19.5 p90 -127.49 149.88 49.92 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 174.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 67' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' D' ' 52' ' ' LYS . 3.5 m120 -111.47 145.3 39.25 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -178.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 68' ' ' GLU . . . . . 0.85 ' HB3' HG12 ' D' ' 47' ' ' ILE . 51.3 mm-40 -74.88 -9.3 58.41 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.612 176.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.407 ' HG2' ' HA ' ' D' ' 51' ' ' ASP . 23.5 mtpp -59.14 -54.35 48.0 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 113.538 -1.664 . . . . 0.0 108.102 165.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 39.8 m -66.79 119.58 12.08 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 112.91 -1.95 . . . . 0.0 109.088 174.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 82.8 p -47.56 121.24 3.82 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.978 -177.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 72' ' ' VAL . . . . . 0.9 HG11 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -57.27 -12.38 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 120.994 0.426 . . . . 0.0 110.872 -178.75 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 73' ' ' GLY . . . . . 0.802 ' HA3' ' HA2' ' D' ' 44' ' ' GLY . . . -69.15 -65.61 2.55 Favored Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 115.215 -0.902 . . . . 0.0 113.185 172.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 74' ' ' ASN . . . . . 0.811 ' HA ' HD21 ' D' ' 77' ' ' ASN . 76.8 m-20 -62.72 -23.74 67.32 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 120.662 0.267 . . . . 0.0 110.89 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 75' ' ' ILE . . . . . 0.525 ' O ' HG12 ' D' ' 79' ' ' ILE . 35.9 mm -77.47 -39.96 28.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.594 176.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 76' ' ' SER . . . . . 0.669 ' HA ' HG12 ' D' ' 79' ' ' ILE . 30.9 t -73.61 -19.88 60.75 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.963 178.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 77' ' ' ASN . . . . . 0.811 HD21 ' HA ' ' D' ' 74' ' ' ASN . 80.1 m-20 -65.6 -29.77 70.41 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 168.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 78' ' ' ASP . . . . . 1.042 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 1.0 OUTLIER -84.22 -28.72 27.08 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.734 174.92 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . 0.669 HG12 ' HA ' ' D' ' 76' ' ' SER . 17.5 mm -66.88 -19.84 26.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.657 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -69.17 -39.7 78.58 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.322 176.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 81' ' ' LYS . . . . . 1.042 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -80.24 -53.76 6.36 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.888 176.679 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 82' ' ' LEU . . . . . 0.646 HD21 ' O ' ' D' ' 78' ' ' ASP . 4.0 mm? -48.71 -29.24 4.23 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 83' ' ' ASN . . . . . 0.546 HD21 ' HB3' ' D' ' 36' ' ' LEU . 0.6 OUTLIER 39.54 73.61 0.11 Allowed 'General case' 0 N--CA 1.472 0.671 0 O-C-N 124.016 0.823 . . . . 0.0 111.464 172.889 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 84' ' ' ILE . . . . . 0.822 HG12 HD12 ' D' ' 56' ' ' ILE . 2.1 mp -66.84 105.19 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.33 -176.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 85' ' ' LYS . . . . . 0.429 ' HE3' ' O ' ' D' ' 34' ' ' ASN . 48.6 mtpt -108.19 178.71 4.42 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.911 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . -80.09 -178.37 51.65 Favored Glycine 0 CA--C 1.504 -0.604 0 C-N-CA 121.146 -0.549 . . . . 0.0 113.39 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 87' ' ' PRO . . . . . 0.666 ' O ' HG11 ' D' ' 58' ' ' VAL . 42.8 Cg_endo -93.67 -179.79 9.47 Favored 'Cis proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.887 -1.714 . . . . 0.0 114.101 -0.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 88' ' ' TYR . . . . . 0.836 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 1.7 m-85 43.85 91.12 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.881 0.873 . . . . 0.0 112.074 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 4.0 mp -111.27 127.26 68.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.295 0.569 . . . . 0.0 110.533 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.628 ' HB3' ' HB2' ' D' ' 57' ' ' PHE . 42.0 tt0 -126.55 92.05 3.48 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.187 177.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 91' ' ' ILE . . . . . 0.658 ' CG2' ' HZ3' ' D' ' 54' ' ' TRP . 3.2 mt -100.22 109.13 24.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 92' ' ' LYS . . . . . 0.741 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -162.25 167.53 23.83 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . 0.599 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 25.4 pt20 -82.44 160.19 22.77 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 119.125 -1.03 . . . . 0.0 110.567 175.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 94' ' ' ILE . . . . . 0.741 HG22 ' HE2' ' D' ' 92' ' ' LYS . 10.0 pt . . . . . 0 C--N 1.305 -1.338 0 CA-C-N 114.118 -1.401 . . . . 0.0 111.384 -168.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.564 ' HA ' HG11 ' D' ' 16' ' ' VAL . 36.7 mm . . . . . 0 N--CA 1.45 -0.456 0 CA-C-O 121.783 0.802 . . . . 0.0 110.991 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -95.19 -62.53 1.29 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.071 177.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 15' ' ' SER . . . . . 0.537 ' HA ' ' OD2' ' D' ' 18' ' ' ASP . 90.5 p -64.69 -21.45 66.75 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 120.971 -0.291 . . . . 0.0 110.531 -179.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 16' ' ' VAL . . . . . 0.62 ' O ' ' HG ' ' D' ' 20' ' ' LEU . 14.8 p -52.99 -35.93 23.16 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 CA-C-O 120.918 0.39 . . . . 0.0 110.251 176.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -68.51 -41.74 79.54 Favored 'General case' 0 C--O 1.21 -1.009 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.777 177.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 18' ' ' ASP . . . . . 0.537 ' OD2' ' HA ' ' D' ' 15' ' ' SER . 55.0 m-20 -58.64 -16.58 16.74 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -177.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.673 ' O ' ' HE3' ' D' ' 22' ' ' LYS . 0.0 OUTLIER -91.83 -52.64 4.64 Favored 'General case' 0 CA--C 1.488 -1.42 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 172.37 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 20' ' ' LEU . . . . . 0.955 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 75.8 mt -57.39 -34.95 69.41 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.031 -1.441 . . . . 0.0 110.78 -177.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 21' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -77.4 97.1 4.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.223 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 22' ' ' LYS . . . . . 0.731 ' HZ3' ' HG3' ' D' ' 68' ' ' GLU . 88.5 mttt -121.73 -40.91 2.5 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 -172.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.23 -88.6 0.11 Allowed Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 119.477 -1.344 . . . . 0.0 113.315 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . 0.712 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 52.1 tptt -49.84 -54.03 21.87 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 25' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -139.14 155.82 24.12 Favored Glycine 0 N--CA 1.429 -1.792 0 CA-C-N 114.264 -1.334 . . . . 0.0 110.943 174.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 26' ' ' LYS . . . . . 0.668 ' HG3' ' HB3' ' D' ' 41' ' ' SER . 9.2 ptpt -149.99 160.83 43.32 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.301 -0.95 . . . . 0.0 110.167 -169.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 27' ' ' LEU . . . . . 0.955 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 52.2 tp -135.19 147.29 49.33 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.188 0.518 . . . . 0.0 111.932 -176.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 28' ' ' SER . . . . . 0.591 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 22.9 t -139.79 153.32 47.09 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 29' ' ' LEU . . . . . 0.603 HD11 ' CD1' ' D' ' 20' ' ' LEU . 0.2 OUTLIER -141.27 133.97 28.68 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.914 177.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 54.1 p -133.54 -171.39 2.7 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.719 175.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 21.6 ptp -148.89 166.3 28.98 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.388 0.614 . . . . 0.0 111.466 -176.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 32' ' ' ASN . . . . . 0.446 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 22.8 t-20 -144.54 88.01 1.9 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.458 177.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.85 -108.7 2.57 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.216 -171.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -100.31 9.93 41.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.841 0.353 . . . . 0.0 110.873 176.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 35' ' ' GLN . . . . . 0.446 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 3.6 tp60 -90.82 158.24 16.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.832 0.349 . . . . 0.0 110.48 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . 0.602 ' C ' HD12 ' D' ' 36' ' ' LEU . 2.5 tm? -124.92 137.39 54.27 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.62 176.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 37' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 34.3 mmtp -130.94 115.34 16.39 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.93 -171.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -115.28 152.5 32.63 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.939 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 39' ' ' THR . . . . . 0.591 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 17.2 p -145.92 135.24 22.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.737 -1.119 . . . . 0.0 111.123 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 40' ' ' SER . . . . . 0.652 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 27.0 p -108.75 133.72 52.43 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 170.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 41' ' ' SER . . . . . 0.668 ' HB3' ' HG3' ' D' ' 26' ' ' LYS . 34.0 t -95.5 147.06 23.95 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 118.97 -1.092 . . . . 0.0 109.222 178.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 42' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' D' ' 41' ' ' SER . 75.1 m-80 80.45 -3.11 1.9 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.188 -168.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.66 62.8 2.28 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 168.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.17 -1.47 8.32 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 118.508 -1.806 . . . . 0.0 115.011 170.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 45' ' ' TYR . . . . . 0.712 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 1.4 m-30 -89.91 152.12 21.39 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 120.617 0.246 . . . . 0.0 110.808 -176.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . 0.602 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -95.24 -158.67 32.88 Favored Glycine 0 C--O 1.217 -0.952 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 174.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 47' ' ' ILE . . . . . 0.894 HG13 ' HB3' ' D' ' 68' ' ' GLU . 0.4 OUTLIER -55.42 -49.13 75.35 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 CA-C-O 122.597 1.189 . . . . 0.0 108.518 176.163 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 34.0 t 168.0 -119.77 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 111.305 -2.679 . . . . 0.0 105.422 -175.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -109.34 78.33 1.12 Allowed 'General case' 0 C--N 1.318 -0.775 0 O-C-N 121.771 -0.581 . . . . 0.0 109.679 163.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . 0.598 ' HB3' ' HE3' ' D' ' 52' ' ' LYS . 52.0 mt-10 -143.37 171.68 13.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.749 -177.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 51' ' ' ASP . . . . . 0.701 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 2.4 m-20 -131.42 135.68 47.37 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.534 176.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 52' ' ' LYS . . . . . 0.747 ' HD3' HG12 ' D' ' 47' ' ' ILE . 0.1 OUTLIER -144.96 157.19 44.22 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 123.035 0.534 . . . . 0.0 110.45 -178.029 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 53' ' ' ASN . . . . . 0.533 HD21 ' C ' ' D' ' 52' ' ' LYS . 2.7 m120 -120.98 134.26 55.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.301 175.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 54' ' ' TRP . . . . . 0.678 ' NE1' ' HB3' ' D' ' 93' ' ' GLN . 0.3 OUTLIER -126.43 160.62 29.98 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.205 -178.516 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -150.27 160.31 28.49 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.113 -1.041 . . . . 0.0 114.061 176.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 56' ' ' ILE . . . . . 0.49 HG12 ' CG2' ' D' ' 91' ' ' ILE . 73.0 mt -130.68 113.77 25.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 176.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 57' ' ' PHE . . . . . 0.627 ' HD2' ' O ' ' D' ' 90' ' ' GLU . 17.1 m-85 -108.39 105.1 14.63 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 119.688 -0.805 . . . . 0.0 111.248 -167.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.724 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 90.2 t -97.88 109.56 23.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.283 176.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 5.6 m120 55.84 39.92 30.65 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.253 178.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.97 -31.07 8.85 Favored Glycine 0 CA--C 1.508 -0.37 0 C-N-CA 120.159 -1.019 . . . . 0.0 112.771 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -88.76 126.18 35.22 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.162 -0.519 . . . . 0.0 111.032 -176.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -71.98 98.17 2.01 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 174.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 11.3 p -76.36 -27.37 17.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.823 -168.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 64' ' ' TYR . . . . . 0.427 ' CE2' ' HB3' ' D' ' 66' ' ' PHE . 15.4 t80 -145.75 128.56 16.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.722 177.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 31.3 m -109.82 105.21 14.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.062 176.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 66' ' ' PHE . . . . . 0.427 ' HB3' ' CE2' ' D' ' 64' ' ' TYR . 10.0 p90 -111.48 158.79 18.73 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -128.9 143.09 50.79 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -172.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 68' ' ' GLU . . . . . 0.894 ' HB3' HG13 ' D' ' 47' ' ' ILE . 53.6 mm-40 -64.2 -21.0 66.4 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 174.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.501 ' HE3' ' OD2' ' D' ' 51' ' ' ASP . 48.2 mtpt -51.17 -54.46 25.22 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.102 171.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 70' ' ' SER . . . . . 0.419 ' O ' HD12 ' D' ' 75' ' ' ILE . 18.0 m -65.44 120.14 12.3 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 112.118 -2.31 . . . . 0.0 108.4 170.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 70.3 p -52.9 122.74 9.83 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.234 -178.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 72' ' ' VAL . . . . . 0.853 HG13 ' HB2' ' D' ' 27' ' ' LEU . 0.1 OUTLIER -54.72 -12.23 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 120.924 0.392 . . . . 0.0 111.997 -175.432 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 73' ' ' GLY . . . . . 0.652 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -73.57 -56.46 5.51 Favored Glycine 0 N--CA 1.437 -1.27 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.656 170.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 74' ' ' ASN . . . . . 0.492 ' O ' ' HB2' ' D' ' 77' ' ' ASN . 29.6 t-20 -66.3 -19.68 65.88 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 75' ' ' ILE . . . . . 0.614 ' O ' HG13 ' D' ' 79' ' ' ILE . 74.4 mt -71.78 -41.21 70.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.17 173.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 30.7 t -72.8 -19.54 61.32 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.696 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 77' ' ' ASN . . . . . 0.492 ' HB2' ' O ' ' D' ' 74' ' ' ASN . 4.2 m120 -61.15 -30.9 70.67 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 168.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 78' ' ' ASP . . . . . 1.148 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 1.0 OUTLIER -86.4 -40.91 14.92 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 114.825 -1.079 . . . . 0.0 112.936 177.877 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . 0.614 HG13 ' O ' ' D' ' 75' ' ' ILE . 33.9 mt -63.53 -24.9 37.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 O-C-N 121.433 -0.792 . . . . 0.0 111.536 -171.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -71.39 -31.18 66.98 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 81' ' ' LYS . . . . . 1.148 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -81.11 -47.4 13.56 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.33 175.271 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 82' ' ' LEU . . . . . 0.603 HD23 ' O ' ' D' ' 78' ' ' ASP . 4.0 mm? -51.01 -26.93 6.74 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 50.31 71.03 0.44 Allowed 'General case' 0 N--CA 1.473 0.687 0 O-C-N 123.588 0.555 . . . . 0.0 110.636 176.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 84' ' ' ILE . . . . . 0.469 ' HB ' ' HG ' ' D' ' 36' ' ' LEU . 44.4 mm -78.23 96.36 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.97 -175.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 85' ' ' LYS . . . . . 0.568 ' HG2' ' HB2' ' D' ' 36' ' ' LEU . 28.4 mmmt -153.79 92.64 1.58 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.496 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.3 154.86 0.08 OUTLIER Glycine 0 C--N 1.331 0.287 0 N-CA-C 114.547 0.579 . . . . 0.0 114.547 174.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 87' ' ' PRO . . . . . 0.526 ' O ' HG12 ' D' ' 58' ' ' VAL . 76.5 Cg_endo -90.45 -178.26 11.17 Favored 'Cis proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.493 -1.461 . . . . 0.0 112.268 -0.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 88' ' ' TYR . . . . . 0.724 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 1.7 m-85 7.71 92.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 125.32 1.448 . . . . 0.0 113.773 -177.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.504 HG12 HG21 ' D' ' 58' ' ' VAL . 71.6 mt -110.95 136.62 46.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.211 0.529 . . . . 0.0 112.24 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.627 ' O ' ' HD2' ' D' ' 57' ' ' PHE . 39.3 tt0 -128.36 95.81 4.26 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.846 175.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 91' ' ' ILE . . . . . 0.622 ' CG2' ' HZ3' ' D' ' 54' ' ' TRP . 6.5 mt -96.37 108.82 21.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -177.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 92' ' ' LYS . . . . . 0.664 ' HE2' HG21 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -161.0 169.97 21.48 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 177.906 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . 0.678 ' HB3' ' NE1' ' D' ' 54' ' ' TRP . 17.4 pt20 -85.24 163.36 18.7 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.399 177.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 94' ' ' ILE . . . . . 0.664 HG21 ' HE2' ' D' ' 92' ' ' LYS . 9.3 pt . . . . . 0 C--N 1.31 -1.145 0 CA-C-N 114.197 -1.365 . . . . 0.0 111.311 -167.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.466 ' C ' HG13 ' D' ' 16' ' ' VAL . 64.2 mt . . . . . 0 N--CA 1.463 0.203 0 CA-C-O 122.103 0.954 . . . . 0.0 111.463 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -95.93 -45.65 6.85 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.656 -1.157 . . . . 0.0 110.053 172.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 15' ' ' SER . . . . . 0.538 ' O ' ' HB2' ' D' ' 18' ' ' ASP . 39.4 m -66.17 -25.44 66.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.794 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 16' ' ' VAL . . . . . 0.767 HG21 ' CG2' ' D' ' 91' ' ' ILE . 7.1 p -58.93 -33.72 50.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.057 0.456 . . . . 0.0 110.532 179.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 17' ' ' ASN . . . . . 0.534 ' O ' ' HB2' ' D' ' 21' ' ' ASN . 5.4 m120 -66.42 -41.46 89.18 Favored 'General case' 0 C--O 1.209 -1.043 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 176.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 18' ' ' ASP . . . . . 0.538 ' HB2' ' O ' ' D' ' 15' ' ' SER . 1.2 m-20 -59.72 -14.03 12.54 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 175.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.668 ' HE2' ' HA ' ' D' ' 16' ' ' VAL . 1.7 mppt? -90.55 -44.93 9.25 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.933 0.873 . . . . 0.0 109.881 175.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 20' ' ' LEU . . . . . 0.999 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 69.8 mt -85.89 -19.02 31.18 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 112.762 -2.017 . . . . 0.0 111.812 -169.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 21' ' ' ASN . . . . . 0.534 ' HB2' ' O ' ' D' ' 17' ' ' ASN . 1.4 t-20 -106.24 98.58 8.24 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.351 -0.84 . . . . 0.0 108.891 -169.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 22' ' ' LYS . . . . . 0.621 ' CE ' ' HA ' ' D' ' 47' ' ' ILE . 2.3 mppt? -119.94 -42.95 2.57 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 118.619 -1.232 . . . . 0.0 113.112 -168.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.19 -75.94 0.16 Allowed Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.147 -1.025 . . . . 0.0 112.598 -175.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . 0.776 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 53.0 tptt -52.13 -61.16 2.44 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 25' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -137.97 157.67 24.39 Favored Glycine 0 N--CA 1.43 -1.712 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.93 174.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 26' ' ' LYS . . . . . 0.637 ' CD ' ' HB3' ' D' ' 41' ' ' SER . 9.1 ptpt -149.25 162.13 40.63 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.378 -0.911 . . . . 0.0 110.818 -167.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 27' ' ' LEU . . . . . 0.999 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 58.3 tp -136.51 136.83 39.7 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.24 0.543 . . . . 0.0 111.448 -177.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 28' ' ' SER . . . . . 0.614 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 53.9 m -124.44 142.18 51.51 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.334 -175.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 29' ' ' LEU . . . . . 0.66 HD11 HD11 ' D' ' 20' ' ' LEU . 0.1 OUTLIER -141.49 148.11 38.9 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 119.49 -0.884 . . . . 0.0 112.097 -176.233 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 50.4 m -154.33 -173.81 4.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.968 176.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 31' ' ' MET . . . . . 0.45 ' HE2' ' HB2' ' D' ' 31' ' ' MET . 24.6 ptm -145.66 162.91 36.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.289 0.566 . . . . 0.0 111.197 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 32' ' ' ASN . . . . . 0.437 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 26.4 t-20 -141.8 88.58 2.13 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.057 178.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.59 -98.45 0.53 Allowed Glycine 0 CA--C 1.516 0.146 0 C-N-CA 120.256 -0.973 . . . . 0.0 111.853 -176.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -104.77 2.89 30.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.783 0.325 . . . . 0.0 110.346 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 35' ' ' GLN . . . . . 0.437 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 3.6 tp-100 -91.32 155.9 18.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.127 -174.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . 0.626 HD13 ' C ' ' D' ' 36' ' ' LEU . 1.9 tm? -124.38 137.65 54.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.366 173.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 37' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 12.8 mmmm -131.04 115.81 16.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.774 -169.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 38' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -123.01 155.02 37.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.156 0.503 . . . . 0.0 111.559 177.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 39' ' ' THR . . . . . 0.614 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 2.4 p -150.77 139.4 20.64 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.903 -178.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 40' ' ' SER . . . . . 0.669 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 53.3 p -109.0 133.97 52.27 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 173.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 41' ' ' SER . . . . . 0.637 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 35.4 t -96.01 148.05 23.06 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.905 -1.118 . . . . 0.0 109.199 176.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 42' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' D' ' 41' ' ' SER . 75.1 m-80 80.09 -0.57 2.04 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.95 -168.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.17 60.54 3.36 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 170.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 44' ' ' GLY . . . . . 0.686 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 110.15 35.95 2.06 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.317 -1.42 . . . . 0.0 114.706 169.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 45' ' ' TYR . . . . . 0.776 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 1.3 m-85 -112.97 152.75 29.02 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 173.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -88.77 -153.81 27.59 Favored Glycine 0 C--O 1.219 -0.782 0 C-N-CA 121.124 -0.56 . . . . 0.0 111.991 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 47' ' ' ILE . . . . . 1.026 HG13 ' HB3' ' D' ' 68' ' ' GLU . 1.0 OUTLIER -57.38 -57.08 11.56 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 CA-C-O 122.338 1.066 . . . . 0.0 108.184 -179.479 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 48' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' D' ' 47' ' ' ILE . 23.1 t 169.56 -63.47 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 111.893 -2.412 . . . . 0.0 106.836 -178.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 49' ' ' TYR . . . . . 0.442 ' O ' ' HD1' ' D' ' 49' ' ' TYR . 0.2 OUTLIER -165.07 74.74 0.24 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 113.746 -1.57 . . . . 0.0 109.667 168.569 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . 0.472 ' O ' ' HG2' ' D' ' 69' ' ' LYS . 72.3 mm-40 -139.99 -158.92 0.9 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.049 -175.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 51' ' ' ASP . . . . . 0.515 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 1.1 t70 -152.39 124.37 8.01 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.615 173.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 52' ' ' LYS . . . . . 0.553 ' HB2' ' CG ' ' D' ' 68' ' ' GLU . 0.2 OUTLIER -141.15 120.01 12.66 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.528 178.672 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -93.4 129.06 39.68 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 174.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 54' ' ' TRP . . . . . 0.694 ' NE1' ' HB3' ' D' ' 93' ' ' GLN . 0.1 OUTLIER -114.87 153.18 30.94 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -171.267 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -132.57 156.16 21.93 Favored Glycine 0 N--CA 1.431 -1.685 0 C-N-CA 120.157 -1.021 . . . . 0.0 114.524 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 56' ' ' ILE . . . . . 0.633 HD13 HG12 ' D' ' 84' ' ' ILE . 65.4 mt -146.28 108.27 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 113.66 -1.27 . . . . 0.0 107.652 177.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 57' ' ' PHE . . . . . 0.858 ' HB2' ' HB3' ' D' ' 90' ' ' GLU . 7.4 m-30 -117.72 107.92 14.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.97 -169.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.762 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 53.2 t -97.04 117.15 41.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.684 173.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 59' ' ' ASN . . . . . 0.666 HD22 ' HG2' ' D' ' 87' ' ' PRO . 3.6 m120 62.37 43.46 8.13 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.258 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.4 -33.87 4.19 Favored Glycine 0 CA--C 1.508 -0.361 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.905 173.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 61' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 23.5 pt-20 -90.99 155.84 18.41 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.247 0.546 . . . . 0.0 111.479 -175.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 62' ' ' LYS . . . . . 0.503 ' HD2' ' OG1' ' D' ' 65' ' ' THR . 6.2 ttpm? -85.55 125.2 32.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.561 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.472 HG22 ' O ' ' D' ' 56' ' ' ILE . 25.6 m -104.57 -29.79 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -177.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 64' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -153.21 147.33 25.59 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.863 0.363 . . . . 0.0 111.384 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 65' ' ' THR . . . . . 0.503 ' OG1' ' HD2' ' D' ' 62' ' ' LYS . 86.8 m -132.29 126.75 34.12 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.016 175.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 66' ' ' PHE . . . . . 0.556 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 14.0 p90 -130.44 155.08 47.01 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 175.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 67' ' ' ASN . . . . . 0.462 ' O ' ' HB3' ' D' ' 70' ' ' SER . 72.7 m-20 -117.57 138.23 52.06 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -177.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 68' ' ' GLU . . . . . 1.026 ' HB3' HG13 ' D' ' 47' ' ' ILE . 38.5 mm-40 -61.19 -22.82 65.1 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.885 0.374 . . . . 0.0 111.144 177.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.507 ' HD3' ' HB2' ' D' ' 51' ' ' ASP . 46.3 mtmt -65.02 -39.07 92.84 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 70' ' ' SER . . . . . 0.528 ' O ' HD12 ' D' ' 75' ' ' ILE . 23.2 t -64.79 121.32 14.29 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 113.744 -1.571 . . . . 0.0 106.817 166.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 71' ' ' THR . . . . . 0.41 ' C ' ' H ' ' D' ' 73' ' ' GLY . 54.0 p -52.33 120.36 5.45 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.045 -177.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 72' ' ' VAL . . . . . 0.925 HG11 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -55.3 -11.62 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.368 0 CA-C-O 120.984 0.421 . . . . 0.0 111.395 -175.279 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 73' ' ' GLY . . . . . 0.686 ' HA3' ' HA2' ' D' ' 44' ' ' GLY . . . -67.49 -64.73 3.05 Favored Glycine 0 N--CA 1.434 -1.434 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.884 169.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -65.54 -18.05 65.03 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.987 -0.285 . . . . 0.0 111.332 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 75' ' ' ILE . . . . . 0.682 ' O ' HG13 ' D' ' 79' ' ' ILE . 76.2 mt -70.02 -41.98 79.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 172.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 38.3 t -73.3 -26.16 60.96 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.086 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -59.73 -24.55 64.1 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.367 168.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 78' ' ' ASP . . . . . 0.959 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 76.8 m-20 -90.75 -38.76 12.82 Favored 'General case' 0 C--O 1.225 -0.225 0 O-C-N 123.849 0.718 . . . . 0.0 112.333 176.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . 0.682 HG13 ' O ' ' D' ' 75' ' ' ILE . 42.8 mt -64.88 -24.4 35.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 O-C-N 121.719 -0.613 . . . . 0.0 111.106 -172.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -70.77 -25.19 62.79 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 177.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 81' ' ' LYS . . . . . 0.959 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -90.32 -46.68 8.24 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 120.081 -0.648 . . . . 0.0 111.829 175.174 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 82' ' ' LEU . . . . . 0.609 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.9 mm? -51.33 -25.93 6.74 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 49.71 69.36 0.61 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.038 0.535 . . . . 0.0 110.8 175.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 84' ' ' ILE . . . . . 0.747 HG22 HD12 ' D' ' 91' ' ' ILE . 2.2 mp -74.0 107.33 4.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.007 -178.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 85' ' ' LYS . . . . . 0.547 ' O ' ' HE3' ' D' ' 85' ' ' LYS . 0.0 OUTLIER -150.44 179.23 8.32 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 178.317 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.48 168.3 4.6 Favored Glycine 0 CA--C 1.509 -0.299 0 CA-C-N 115.266 -0.879 . . . . 0.0 114.923 -173.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 87' ' ' PRO . . . . . 0.713 ' O ' HG12 ' D' ' 58' ' ' VAL . 46.7 Cg_endo -91.84 178.25 13.87 Favored 'Cis proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.736 -1.777 . . . . 0.0 114.165 0.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 88' ' ' TYR . . . . . 0.762 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 11.7 m-85 31.34 93.19 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.853 1.261 . . . . 0.0 113.121 -178.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.542 ' CG2' HG13 ' D' ' 91' ' ' ILE . 3.2 mp -110.19 117.55 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 CA-C-O 121.714 0.768 . . . . 0.0 110.896 -178.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.858 ' HB3' ' HB2' ' D' ' 57' ' ' PHE . 5.0 tp10 -100.93 87.4 3.28 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.126 174.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 91' ' ' ILE . . . . . 0.767 ' CG2' HG21 ' D' ' 16' ' ' VAL . 18.8 mt -98.68 101.76 12.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.751 177.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 92' ' ' LYS . . . . . 0.685 ' HE3' ' CG2' ' D' ' 94' ' ' ILE . 0.0 OUTLIER -161.4 168.62 23.49 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.469 -179.405 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . 0.694 ' HB3' ' NE1' ' D' ' 54' ' ' TRP . 26.3 pt20 -93.17 160.91 14.64 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 119.474 -0.89 . . . . 0.0 111.413 174.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 94' ' ' ILE . . . . . 0.685 ' CG2' ' HE3' ' D' ' 92' ' ' LYS . 4.7 pt . . . . . 0 C--N 1.314 -0.978 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.587 -172.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 60.5 mt . . . . . 0 N--CA 1.454 -0.235 0 CA-C-O 121.731 0.777 . . . . 0.0 111.341 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -95.12 -62.3 1.33 Allowed 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.897 175.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 15' ' ' SER . . . . . 0.511 ' HA ' ' OD1' ' D' ' 18' ' ' ASP . 88.6 p -68.24 -15.94 63.77 Favored 'General case' 0 C--O 1.223 -0.307 0 O-C-N 122.193 -0.317 . . . . 0.0 111.343 -178.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 16' ' ' VAL . . . . . 0.672 ' O ' ' HG ' ' D' ' 20' ' ' LEU . 7.4 p -52.49 -39.8 30.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.127 0.489 . . . . 0.0 109.711 173.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 17' ' ' ASN . . . . . 0.662 ' OD1' ' HA ' ' D' ' 28' ' ' SER . 79.9 m-20 -75.75 -25.88 56.9 Favored 'General case' 0 C--O 1.212 -0.891 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.32 -178.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 18' ' ' ASP . . . . . 0.511 ' OD1' ' HA ' ' D' ' 15' ' ' SER . 1.5 m-20 -66.74 -16.41 64.23 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 177.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.623 ' CE ' ' HA ' ' D' ' 16' ' ' VAL . 0.0 OUTLIER -92.2 -36.78 13.08 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-O 122.044 0.926 . . . . 0.0 108.742 174.087 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' D' D ' 20' ' ' LEU . . . . . 0.916 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 76.4 mt -71.93 -41.16 68.17 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 113.329 -1.76 . . . . 0.0 109.482 -175.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 21' ' ' ASN . . . . . 0.619 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 62.3 m-20 -81.24 94.69 6.75 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.026 -1.443 . . . . 0.0 111.55 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 22' ' ' LYS . . . . . 0.481 ' HB2' HG22 ' D' ' 47' ' ' ILE . 55.8 mtpt -123.01 -42.11 2.3 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -177.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . 0.531 ' O ' ' HE3' ' D' ' 26' ' ' LYS . . . 177.92 -94.03 0.09 OUTLIER Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 119.614 -1.279 . . . . 0.0 113.555 -178.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . 0.831 ' HE3' ' HA ' ' D' ' 48' ' ' SER . 25.7 ttpp -54.73 -43.31 72.51 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 122.072 0.939 . . . . 0.0 110.192 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -139.6 141.16 11.42 Favored Glycine 0 N--CA 1.427 -1.941 0 CA-C-N 114.193 -1.367 . . . . 0.0 111.98 178.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 26' ' ' LYS . . . . . 0.72 ' HA ' ' O ' ' D' ' 20' ' ' LEU . 9.7 ptpt -148.13 159.84 43.52 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 114.213 -0.994 . . . . 0.0 110.09 -170.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 27' ' ' LEU . . . . . 0.916 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 41.1 tp -139.52 148.46 42.66 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 120.864 0.364 . . . . 0.0 111.37 -177.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 28' ' ' SER . . . . . 0.662 ' HA ' ' OD1' ' D' ' 17' ' ' ASN . 21.1 t -140.47 148.47 41.18 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 29' ' ' LEU . . . . . 0.482 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 0.5 OUTLIER -141.88 144.89 34.05 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 175.61 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 50.1 m -148.07 -170.64 3.64 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.33 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -147.21 166.56 26.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.214 0.53 . . . . 0.0 112.028 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 32' ' ' ASN . . . . . 0.543 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 0.8 OUTLIER -146.96 88.74 1.76 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.788 179.839 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.75 -101.52 0.72 Allowed Glycine 0 CA--C 1.516 0.14 0 C-N-CA 120.327 -0.94 . . . . 0.0 111.568 -174.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -107.78 16.66 23.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.926 0.394 . . . . 0.0 110.615 176.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 35' ' ' GLN . . . . . 0.543 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 68.1 tp60 -99.39 156.76 16.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.627 -176.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . 0.86 ' HB2' ' HG2' ' D' ' 85' ' ' LYS . 2.3 tm? -120.62 140.12 52.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.667 174.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 37' ' ' LYS . . . . . 0.497 ' HE2' ' CG ' ' D' ' 35' ' ' GLN . 73.0 mmtt -132.02 123.76 27.94 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.169 -171.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 38' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -130.83 138.69 49.98 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.46 175.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 39' ' ' THR . . . . . 0.546 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 19.9 p -133.51 122.0 22.99 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.373 0.606 . . . . 0.0 111.36 178.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 40' ' ' SER . . . . . 0.668 ' HB2' ' HA2' ' D' ' 73' ' ' GLY . 40.7 m -109.99 129.58 55.65 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 175.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 41' ' ' SER . . . . . 0.646 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 37.2 t -95.74 154.82 17.03 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.617 -173.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 42' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' D' ' 41' ' ' SER . 73.6 m-80 80.38 11.86 1.01 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 114.053 -1.431 . . . . 0.0 110.079 -171.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 45.15 55.47 6.27 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 114.445 -1.252 . . . . 0.0 113.693 170.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 44' ' ' GLY . . . . . 0.633 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 108.79 35.54 2.38 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 119.754 -1.213 . . . . 0.0 114.126 171.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 45' ' ' TYR . . . . . 0.619 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 1.7 m-85 -116.04 157.67 24.31 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 171.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . 0.59 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -97.74 174.77 29.54 Favored Glycine 0 CA--C 1.501 -0.843 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 177.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 47' ' ' ILE . . . . . 0.679 ' CG1' ' HB3' ' D' ' 68' ' ' GLU . 46.3 mm -46.4 -60.37 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-O 121.614 0.721 . . . . 0.0 111.659 -177.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 48' ' ' SER . . . . . 0.831 ' HA ' ' HE3' ' D' ' 24' ' ' LYS . 22.1 t 172.93 -151.02 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 113.391 -1.731 . . . . 0.0 108.214 -177.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -80.69 77.0 7.57 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 120.9 0.381 . . . . 0.0 110.541 172.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . 0.571 ' HB2' ' NZ ' ' D' ' 52' ' ' LYS . 97.2 mt-10 -150.46 155.58 39.8 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.469 176.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 51' ' ' ASP . . . . . 0.629 ' HB3' ' HD3' ' D' ' 69' ' ' LYS . 18.6 m-20 -118.96 127.65 53.67 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.869 176.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 52' ' ' LYS . . . . . 0.711 ' HE2' ' CB ' ' D' ' 68' ' ' GLU . 3.5 mppt? -142.63 128.74 19.73 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.879 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -104.11 129.71 51.81 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.746 175.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 54' ' ' TRP . . . . . 0.633 ' HZ3' ' CG2' ' D' ' 91' ' ' ILE . 1.0 OUTLIER -115.69 160.8 19.58 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -174.498 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' D' D ' 55' ' ' GLY . . . . . 0.433 ' HA3' ' HE2' ' D' ' 62' ' ' LYS . . . -143.81 158.82 27.49 Favored Glycine 0 N--CA 1.434 -1.498 0 CA-C-N 114.848 -1.069 . . . . 0.0 113.371 176.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 56' ' ' ILE . . . . . 0.572 HG12 ' CG2' ' D' ' 91' ' ' ILE . 91.2 mt -140.92 115.09 5.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 N-CA-C 106.363 -1.718 . . . . 0.0 106.363 178.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 57' ' ' PHE . . . . . 0.725 ' CE1' ' HE2' ' D' ' 92' ' ' LYS . 5.6 m-85 -115.37 123.03 47.65 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 119.589 -0.844 . . . . 0.0 110.466 -171.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.642 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 85.3 t -101.01 112.59 34.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.954 173.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 59' ' ' ASN . . . . . 0.606 ' OD1' ' HG2' ' D' ' 87' ' ' PRO . 6.8 m120 60.78 35.95 19.39 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.322 -176.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.04 -33.05 6.6 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.374 -0.917 . . . . 0.0 113.998 174.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 61' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 24.5 pt-20 -90.08 148.64 22.9 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.914 0.388 . . . . 0.0 111.183 -174.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 62' ' ' LYS . . . . . 0.433 ' HE2' ' HA3' ' D' ' 55' ' ' GLY . 5.5 tppp? -65.66 126.56 28.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.766 175.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.527 HG12 ' O ' ' D' ' 56' ' ' ILE . 12.4 p -109.48 -29.44 2.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.663 178.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 64' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -151.5 135.22 16.35 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.758 175.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 70.6 m -117.06 125.66 51.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.133 175.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -126.8 161.02 29.19 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 121.153 0.501 . . . . 0.0 110.064 173.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 67' ' ' ASN . . . . . 0.552 ' O ' ' HB2' ' D' ' 70' ' ' SER . 73.1 m-20 -126.1 147.46 49.59 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -177.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 68' ' ' GLU . . . . . 0.711 ' CB ' ' HE2' ' D' ' 52' ' ' LYS . 39.0 mm-40 -80.98 -14.68 57.73 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.438 0.637 . . . . 0.0 109.592 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.629 ' HD3' ' HB3' ' D' ' 51' ' ' ASP . 47.6 mtmt -65.97 -48.96 69.55 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-N 113.808 -1.542 . . . . 0.0 107.27 169.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 70' ' ' SER . . . . . 0.552 ' HB2' ' O ' ' D' ' 67' ' ' ASN . 51.0 m -61.32 129.57 41.87 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 111.615 -2.539 . . . . 0.0 108.775 169.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 68.4 p -58.61 112.03 1.46 Allowed 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -178.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 72' ' ' VAL . . . . . 0.711 HG13 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -49.84 -24.36 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 121.06 0.457 . . . . 0.0 110.269 -176.557 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' D' D ' 73' ' ' GLY . . . . . 0.668 ' HA2' ' HB2' ' D' ' 40' ' ' SER . . . -60.77 -67.46 2.12 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.208 -0.905 . . . . 0.0 114.671 175.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -62.49 -19.48 63.61 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.057 0.456 . . . . 0.0 110.965 -177.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 75' ' ' ILE . . . . . 0.58 ' O ' HG13 ' D' ' 79' ' ' ILE . 34.8 mm -76.05 -39.48 36.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.017 174.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 76' ' ' SER . . . . . 0.49 ' HA ' HG13 ' D' ' 79' ' ' ILE . 40.4 t -75.01 -21.05 59.35 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.535 177.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -61.72 -30.67 70.91 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 168.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 78' ' ' ASP . . . . . 0.977 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 1.0 OUTLIER -83.65 -30.8 26.57 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.606 174.84 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . 0.58 HG13 ' O ' ' D' ' 75' ' ' ILE . 35.8 mt -69.81 -18.0 21.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.29 -177.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -66.41 -41.41 89.32 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.06 174.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 81' ' ' LYS . . . . . 0.977 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -80.23 -47.05 15.22 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 179.44 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' D' D ' 82' ' ' LEU . . . . . 0.656 HD21 ' O ' ' D' ' 78' ' ' ASP . 3.4 mm? -50.34 -27.81 6.86 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -178.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 83' ' ' ASN . . . . . 0.514 ' HA ' ' HB3' ' D' ' 36' ' ' LEU . 0.7 OUTLIER 46.16 62.6 2.2 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.553 0.533 . . . . 0.0 110.678 176.403 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' D' D ' 84' ' ' ILE . . . . . 0.453 ' N ' ' HG ' ' D' ' 36' ' ' LEU . 44.8 mm -86.32 97.36 5.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.535 -175.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 85' ' ' LYS . . . . . 0.86 ' HG2' ' HB2' ' D' ' 36' ' ' LEU . 28.3 mmmt -147.13 95.55 2.58 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.816 175.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 86' ' ' GLY . . . . . 0.524 ' H ' ' CD1' ' D' ' 89' ' ' ILE . . . 73.97 151.72 2.23 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.648 -0.706 . . . . 0.0 113.746 173.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 87' ' ' PRO . . . . . 0.606 ' HG2' ' OD1' ' D' ' 59' ' ' ASN . 62.5 Cg_endo -90.19 179.61 14.38 Favored 'Cis proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.17 -1.596 . . . . 0.0 112.773 -0.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 88' ' ' TYR . . . . . 0.642 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 5.8 m-85 15.54 94.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 125.43 1.492 . . . . 0.0 114.217 -178.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.524 ' CD1' ' H ' ' D' ' 86' ' ' GLY . 70.5 mt -110.52 133.31 56.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.223 0.535 . . . . 0.0 112.357 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.479 ' O ' ' HD1' ' D' ' 57' ' ' PHE . 46.3 mt-10 -118.97 96.75 5.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.536 174.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 91' ' ' ILE . . . . . 0.633 ' CG2' ' HZ3' ' D' ' 54' ' ' TRP . 4.0 mt -101.11 110.92 29.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 92' ' ' LYS . . . . . 0.88 ' HE3' HG21 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -163.55 172.76 13.93 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.023 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . 0.584 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 23.9 pt20 -81.6 169.34 17.17 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 119.091 -1.043 . . . . 0.0 111.185 175.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 94' ' ' ILE . . . . . 0.88 HG21 ' HE3' ' D' ' 92' ' ' LYS . 6.7 pt . . . . . 0 C--N 1.317 -0.837 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.971 -173.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.408 ' O ' HG12 ' D' ' 16' ' ' VAL . 12.2 tt . . . . . 0 N--CA 1.428 -1.553 0 CA-C-O 120.85 0.357 . . . . 0.0 111.932 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -82.13 -58.88 2.76 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -178.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 15' ' ' SER . . . . . 0.605 ' O ' ' HE2' ' D' ' 19' ' ' LYS . 97.9 p -69.97 -15.46 63.04 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.701 -178.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 16' ' ' VAL . . . . . 0.537 ' O ' ' HG ' ' D' ' 20' ' ' LEU . 1.7 p -61.3 -26.56 39.68 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -78.3 -38.05 43.37 Favored 'General case' 0 C--O 1.212 -0.891 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.545 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.99 -16.36 17.72 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.649 ' O ' ' HE2' ' D' ' 22' ' ' LYS . 35.0 mttm -91.12 -39.29 12.24 Favored 'General case' 0 CA--C 1.492 -1.28 0 CA-C-O 122.487 1.137 . . . . 0.0 109.397 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 20' ' ' LEU . . . . . 0.595 ' CB ' ' HB3' ' D' ' 27' ' ' LEU . 61.0 mt -82.26 -32.82 29.44 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 112.887 -1.961 . . . . 0.0 109.581 -174.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 21' ' ' ASN . . . . . 0.744 ' OD1' ' HB2' ' D' ' 26' ' ' LYS . 57.4 m-20 -71.95 92.33 1.27 Allowed 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.449 -1.25 . . . . 0.0 109.708 172.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 22' ' ' LYS . . . . . 0.649 ' HE2' ' O ' ' D' ' 19' ' ' LYS . 61.0 mttm -121.75 -41.45 2.47 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -174.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.93 -92.64 0.09 OUTLIER Glycine 0 N--CA 1.437 -1.283 0 C-N-CA 119.658 -1.258 . . . . 0.0 112.857 -177.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . 0.727 ' HG2' ' HB3' ' D' ' 45' ' ' TYR . 76.0 tttt -47.44 -55.83 8.22 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.584 0.707 . . . . 0.0 109.786 179.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 25' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -133.99 156.21 22.22 Favored Glycine 0 N--CA 1.432 -1.573 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.906 174.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 26' ' ' LYS . . . . . 0.744 ' HB2' ' OD1' ' D' ' 21' ' ' ASN . 0.1 OUTLIER -150.3 162.48 40.44 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.301 -0.949 . . . . 0.0 110.556 -168.516 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' D' D ' 27' ' ' LEU . . . . . 0.921 ' HB2' HG11 ' D' ' 72' ' ' VAL . 3.4 tm? -132.46 143.23 49.64 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.762 -171.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 28' ' ' SER . . . . . 0.675 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 50.0 m -137.05 145.64 44.25 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.924 178.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 29' ' ' LEU . . . . . 0.524 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 18.3 mt -138.75 157.91 45.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.157 0.503 . . . . 0.0 110.871 177.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 39.3 t -160.3 -175.49 5.07 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 175.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 31' ' ' MET . . . . . 0.689 ' HA ' ' O ' ' D' ' 35' ' ' GLN . 26.6 ptt? -150.28 127.1 11.03 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.659 0.743 . . . . 0.0 111.06 175.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.52 89.01 7.01 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.022 176.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.51 -104.1 2.02 Favored Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -169.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -120.71 31.78 6.28 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.164 0.507 . . . . 0.0 109.938 172.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 35' ' ' GLN . . . . . 0.689 ' O ' ' HA ' ' D' ' 31' ' ' MET . 32.9 tt0 -108.11 115.95 31.07 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.579 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . 0.623 ' HB2' ' HB2' ' D' ' 85' ' ' LYS . 1.1 tm? -77.76 134.95 37.95 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.225 0.536 . . . . 0.0 111.536 -177.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 37' ' ' LYS . . . . . 0.735 ' HZ3' ' HB3' ' D' ' 37' ' ' LYS . 0.7 OUTLIER -133.79 116.71 16.03 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.491 -169.313 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' D' D ' 38' ' ' ALA . . . . . 0.427 ' HA ' HD23 ' D' ' 29' ' ' LEU . . . -115.09 152.88 31.75 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.408 0.623 . . . . 0.0 112.401 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 39' ' ' THR . . . . . 0.675 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 5.2 p -150.87 134.49 16.43 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.53 177.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 40' ' ' SER . . . . . 0.524 ' HB3' ' HA2' ' D' ' 73' ' ' GLY . 40.1 t -108.11 136.12 48.32 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 172.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 41' ' ' SER . . . . . 0.726 ' HB3' ' HG3' ' D' ' 26' ' ' LYS . 47.6 t -96.17 151.78 19.17 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 118.963 -1.095 . . . . 0.0 109.748 -179.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 42' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' D' ' 41' ' ' SER . 77.1 m-20 80.66 6.75 1.45 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.693 -167.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 53.94 60.13 3.82 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 114.713 -1.13 . . . . 0.0 113.455 171.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 44' ' ' GLY . . . . . 0.625 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 104.72 37.92 2.67 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.122 -1.513 . . . . 0.0 114.989 168.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 45' ' ' TYR . . . . . 0.727 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 2.3 m-85 -116.11 154.4 30.04 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 117.856 0.828 . . . . 0.0 109.944 173.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . 0.652 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -93.78 -173.58 39.56 Favored Glycine 0 C--O 1.22 -0.744 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 178.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 47' ' ' ILE . . . . . 0.786 HG12 ' HB3' ' D' ' 68' ' ' GLU . 26.9 mm -48.55 -54.81 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-O 122.025 0.917 . . . . 0.0 108.775 175.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 48' ' ' SER . . . . . 0.594 ' HA ' ' HD3' ' D' ' 24' ' ' LYS . 93.4 p 178.76 -146.22 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 112.832 -1.985 . . . . 0.0 107.561 178.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -82.54 75.9 9.43 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.462 166.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . 0.68 ' HB3' ' HE2' ' D' ' 52' ' ' LYS . 95.6 mt-10 -146.84 163.37 36.28 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.646 -176.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 51' ' ' ASP . . . . . 0.681 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 1.4 m-20 -124.1 132.7 53.68 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.804 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 52' ' ' LYS . . . . . 0.681 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 3.5 mptp? -142.93 120.7 11.89 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.453 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 53' ' ' ASN . . . . . 0.599 ' HA ' ' OD1' ' D' ' 67' ' ' ASN . 3.0 m120 -90.83 131.46 36.47 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 176.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 54' ' ' TRP . . . . . 0.605 ' HB2' ' O ' ' D' ' 66' ' ' PHE . 0.1 OUTLIER -122.93 155.0 37.63 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -172.161 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -144.81 161.14 28.07 Favored Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.254 -0.974 . . . . 0.0 113.97 174.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 56' ' ' ILE . . . . . 0.684 HD12 HG12 ' D' ' 84' ' ' ILE . 74.0 mt -137.03 111.79 10.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 57' ' ' PHE . . . . . 0.876 ' HB2' ' HB3' ' D' ' 90' ' ' GLU . 15.8 m-85 -105.59 97.8 7.58 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.894 -167.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.719 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 99.4 t -98.2 120.64 47.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.475 176.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 67.64 34.98 4.25 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 123.438 0.461 . . . . 0.0 110.539 -175.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.35 42.54 97.68 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.625 -0.716 . . . . 0.0 113.54 177.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 61' ' ' GLU . . . . . 0.614 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 24.9 pt-20 -155.41 141.63 18.46 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 176.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 62' ' ' LYS . . . . . 0.484 ' HB2' ' CE2' ' D' ' 57' ' ' PHE . 27.9 ttpp -73.01 99.72 2.81 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -178.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.521 HG13 ' O ' ' D' ' 56' ' ' ILE . 9.1 p -84.29 -32.43 8.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.657 -172.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 64' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -134.39 132.0 38.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.746 0.307 . . . . 0.0 110.797 176.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 35.0 m -116.4 112.46 21.51 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.124 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 66' ' ' PHE . . . . . 0.605 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 9.3 p90 -118.66 158.51 25.37 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 173.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 67' ' ' ASN . . . . . 0.599 ' OD1' ' HA ' ' D' ' 53' ' ' ASN . 73.7 m-80 -129.81 142.09 50.74 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.349 -175.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 68' ' ' GLU . . . . . 0.786 ' HB3' HG12 ' D' ' 47' ' ' ILE . 42.1 mm-40 -69.07 -8.41 44.96 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 123.574 0.546 . . . . 0.0 110.415 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.41 ' HE2' ' CB ' ' D' ' 67' ' ' ASN . 44.1 mtmt -60.62 -46.66 89.44 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 167.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 70' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' D' ' 67' ' ' ASN . 35.1 t -69.78 129.78 40.51 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 113.179 -1.828 . . . . 0.0 108.355 168.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 71' ' ' THR . . . . . 0.473 ' O ' HG13 ' D' ' 75' ' ' ILE . 74.1 p -57.86 128.86 39.19 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 178.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 72' ' ' VAL . . . . . 0.921 HG11 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -54.57 -16.84 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-O 121.294 0.568 . . . . 0.0 110.44 -175.655 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' D' D ' 73' ' ' GLY . . . . . 0.625 ' HA3' ' HA2' ' D' ' 44' ' ' GLY . . . -72.92 -58.58 4.72 Favored Glycine 0 N--CA 1.435 -1.39 0 CA-C-N 114.911 -1.041 . . . . 0.0 112.841 173.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -64.25 -20.25 65.93 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 120.885 0.374 . . . . 0.0 110.305 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 75' ' ' ILE . . . . . 0.637 ' O ' HG13 ' D' ' 79' ' ' ILE . 74.7 mt -73.34 -41.12 57.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.462 171.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 76' ' ' SER . . . . . 0.411 ' OG ' ' HB2' ' D' ' 38' ' ' ALA . 41.5 t -71.03 -26.8 63.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.048 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -56.12 -30.92 62.78 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 167.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 78' ' ' ASP . . . . . 1.056 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 1.1 m-20 -90.35 -33.28 16.13 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 177.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . 0.637 HG13 ' O ' ' D' ' 75' ' ' ILE . 41.5 mt -68.3 -27.81 38.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 O-C-N 121.689 -0.632 . . . . 0.0 110.595 -175.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -73.92 -20.02 60.51 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 81' ' ' LYS . . . . . 1.056 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -89.92 -52.38 5.0 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.601 171.416 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' D' D ' 82' ' ' LEU . . . . . 0.536 ' H ' ' HG2' ' D' ' 81' ' ' LYS . 3.7 mm? -48.67 -31.44 6.78 Favored 'General case' 0 C--O 1.231 0.086 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 176.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 40.6 77.77 0.05 Allowed 'General case' 0 N--CA 1.469 0.506 0 O-C-N 124.639 1.212 . . . . 0.0 111.134 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 84' ' ' ILE . . . . . 0.684 HG12 HD12 ' D' ' 56' ' ' ILE . 2.6 mp -77.97 97.05 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.362 -176.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 85' ' ' LYS . . . . . 0.623 ' HB2' ' HB2' ' D' ' 36' ' ' LEU . 0.0 OUTLIER -158.28 93.07 1.2 Allowed 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 121.431 0.634 . . . . 0.0 110.505 -177.424 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' D' D ' 86' ' ' GLY . . . . . 0.501 ' H ' ' CD1' ' D' ' 89' ' ' ILE . . . 68.54 148.56 0.21 Allowed Glycine 0 N--CA 1.453 -0.193 0 CA-C-N 114.59 -1.187 . . . . 0.0 113.929 178.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 87' ' ' PRO . . . . . 0.591 ' O ' HG13 ' D' ' 58' ' ' VAL . 60.8 Cg_endo -90.6 -177.53 10.12 Favored 'Cis proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.533 -1.445 . . . . 0.0 112.508 -0.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 88' ' ' TYR . . . . . 0.719 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 13.0 m-85 4.89 94.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 125.527 1.531 . . . . 0.0 114.214 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.64 HG12 HG23 ' D' ' 58' ' ' VAL . 66.5 mt -108.35 148.81 12.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.192 0.52 . . . . 0.0 111.883 -177.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.876 ' HB3' ' HB2' ' D' ' 57' ' ' PHE . 39.7 tt0 -132.13 91.41 2.95 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.281 173.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 91' ' ' ILE . . . . . 0.592 HG13 HG21 ' D' ' 89' ' ' ILE . 37.0 mt -94.14 99.84 10.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.89 -176.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 92' ' ' LYS . . . . . 0.618 ' HG2' ' O ' ' D' ' 93' ' ' GLN . 0.0 OUTLIER -160.74 164.47 31.55 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 177.379 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . 0.618 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 24.3 pt20 -80.6 162.73 24.12 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.537 176.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 94' ' ' ILE . . . . . 0.448 HG22 ' HE2' ' D' ' 92' ' ' LYS . 10.6 pt . . . . . 0 C--N 1.305 -1.357 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.366 -171.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.458 HG22 ' O ' ' D' ' 13' ' ' ILE . 57.5 mt . . . . . 0 N--CA 1.452 -0.332 0 CA-C-O 122.0 0.905 . . . . 0.0 110.623 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -88.54 -57.36 2.94 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.334 176.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 15' ' ' SER . . . . . 0.552 ' O ' ' HE2' ' D' ' 19' ' ' LYS . 92.6 p -68.11 -17.74 64.45 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.673 -0.239 . . . . 0.0 111.457 -178.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 16' ' ' VAL . . . . . 0.606 HG12 ' ND2' ' D' ' 17' ' ' ASN . 9.6 p -59.97 -30.06 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-O 121.945 0.879 . . . . 0.0 109.562 176.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 17' ' ' ASN . . . . . 0.606 ' ND2' HG12 ' D' ' 16' ' ' VAL . 3.8 m120 -78.26 -33.96 49.29 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.256 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.31 -15.71 49.64 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.331 177.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.552 ' HE2' ' O ' ' D' ' 15' ' ' SER . 40.3 mttm -89.56 -39.52 13.22 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 122.726 1.25 . . . . 0.0 109.255 -179.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 20' ' ' LEU . . . . . 0.793 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 73.0 mt -77.19 -37.29 53.88 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 111.935 -2.393 . . . . 0.0 110.127 -176.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 21' ' ' ASN . . . . . 0.606 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 57.5 m-20 -75.33 95.92 3.29 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.678 177.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 22' ' ' LYS . . . . . 0.638 ' HD3' HG21 ' D' ' 47' ' ' ILE . 23.0 mtpp -120.89 -43.62 2.45 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 118.594 -1.242 . . . . 0.0 114.064 -168.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.27 -69.9 0.25 Allowed Glycine 0 N--CA 1.436 -1.315 0 C-N-CA 119.746 -1.216 . . . . 0.0 112.509 -174.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . 0.805 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 22.2 tptm -55.27 -67.07 0.31 Allowed 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 176.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 25' ' ' GLY . . . . . 1.071 ' HA2' HD22 ' D' ' 42' ' ' ASN . . . -139.38 156.49 24.61 Favored Glycine 0 CA--C 1.493 -1.337 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.279 172.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 26' ' ' LYS . . . . . 0.709 ' HB3' ' HZ3' ' D' ' 26' ' ' LYS . 0.4 OUTLIER -140.5 160.12 40.69 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -168.53 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 27' ' ' LEU . . . . . 0.793 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 45.1 tp -139.44 144.38 38.02 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.463 0.649 . . . . 0.0 112.392 -177.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 28' ' ' SER . . . . . 0.695 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 49.2 m -135.34 151.91 50.96 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.505 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 29' ' ' LEU . . . . . . . . . . . . . 16.4 mt -141.02 138.01 33.38 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 56.3 m -148.06 -179.04 6.62 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 31' ' ' MET . . . . . 0.821 ' HA ' ' O ' ' D' ' 35' ' ' GLN . 20.2 ptp -137.23 126.62 24.92 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.67 0.747 . . . . 0.0 111.057 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -90.84 88.34 7.02 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 175.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.64 -100.97 1.99 Allowed Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -165.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -120.16 12.5 11.86 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.999 0.428 . . . . 0.0 109.987 171.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 35' ' ' GLN . . . . . 0.821 ' O ' ' HA ' ' D' ' 31' ' ' MET . 25.6 mt-30 -88.63 125.94 35.06 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.471 -175.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . 0.576 HD13 ' C ' ' D' ' 36' ' ' LEU . 2.8 tm? -78.08 124.38 27.98 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.204 0.526 . . . . 0.0 111.436 -178.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 37' ' ' LYS . . . . . 0.605 ' HE2' ' HB3' ' D' ' 35' ' ' GLN . 74.9 mmtt -135.53 103.49 5.48 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.794 -173.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.28 152.64 18.38 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.322 0.582 . . . . 0.0 111.581 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 39' ' ' THR . . . . . 0.695 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 7.1 p -141.01 124.79 16.98 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.118 176.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 40' ' ' SER . . . . . 0.645 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 19.1 p -107.88 128.87 55.0 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 172.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 41' ' ' SER . . . . . 0.689 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 44.3 t -96.3 168.75 10.39 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 42' ' ' ASN . . . . . 1.071 HD22 ' HA2' ' D' ' 25' ' ' GLY . 21.3 p30 60.8 7.44 1.45 Allowed 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.975 1.422 . . . . 0.0 112.499 -174.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 41.41 60.29 2.14 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 168.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 44' ' ' GLY . . . . . 0.588 ' O ' HG21 ' D' ' 71' ' ' THR . . . 120.87 35.86 0.81 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 118.873 -1.632 . . . . 0.0 114.931 168.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 45' ' ' TYR . . . . . 0.805 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 0.7 OUTLIER -122.83 154.26 38.48 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 170.504 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . 0.586 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -99.81 -163.63 29.02 Favored Glycine 0 C--O 1.216 -1.013 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.414 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 47' ' ' ILE . . . . . 0.785 HG12 ' HB3' ' D' ' 68' ' ' GLU . 41.9 mm -55.04 -59.53 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 CA-C-O 122.088 0.947 . . . . 0.0 109.675 176.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 83.5 p 175.0 -164.61 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 112.327 -2.215 . . . . 0.0 108.789 -172.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -78.27 77.96 4.75 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.924 0.869 . . . . 0.0 111.632 173.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -145.56 -167.8 2.8 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.957 177.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 51' ' ' ASP . . . . . 0.692 ' C ' ' HD3' ' D' ' 52' ' ' LYS . 9.6 p-10 -136.34 135.18 38.65 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.359 168.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 52' ' ' LYS . . . . . 0.711 ' CE ' ' HB2' ' D' ' 68' ' ' GLU . 2.7 mppt? -139.79 128.1 22.64 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.263 -167.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 53' ' ' ASN . . . . . 0.444 HD21 ' C ' ' D' ' 52' ' ' LYS . 2.8 m120 -116.65 138.8 51.17 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 173.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 54' ' ' TRP . . . . . 0.622 ' HB2' ' O ' ' D' ' 66' ' ' PHE . 0.1 OUTLIER -125.76 160.38 29.93 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -173.077 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -140.43 156.2 25.07 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.042 -1.075 . . . . 0.0 113.908 175.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 56' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' D' ' 90' ' ' GLU . 62.8 mt -140.24 108.75 3.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 176.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 57' ' ' PHE . . . . . 0.729 ' CE2' ' HE2' ' D' ' 92' ' ' LYS . 7.0 m-85 -108.25 102.91 12.0 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.637 -168.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.716 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 78.2 t -91.97 110.17 22.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.814 170.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 59' ' ' ASN . . . . . 0.435 ' OD1' ' HG2' ' D' ' 87' ' ' PRO . 5.2 m120 63.74 44.51 4.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.436 -176.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.3 -33.91 4.7 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.793 -0.718 . . . . 0.0 114.511 172.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 61' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 12.5 pt-20 -94.81 154.06 17.44 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.966 -0.293 . . . . 0.0 111.072 -175.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -73.92 106.94 5.86 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 173.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 9.9 p -76.52 -27.9 17.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.522 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 64' ' ' TYR . . . . . 0.509 ' HH ' ' CB ' ' D' ' 78' ' ' ASP . 14.2 t80 -148.13 135.57 20.59 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.545 173.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 65' ' ' THR . . . . . 0.45 HG22 ' O ' ' D' ' 54' ' ' TRP . 65.3 m -119.87 123.04 42.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.514 174.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 66' ' ' PHE . . . . . 0.622 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 11.3 p90 -129.62 143.11 50.67 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 121.477 0.656 . . . . 0.0 110.679 178.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 67' ' ' ASN . . . . . 0.746 HD21 ' HB2' ' D' ' 69' ' ' LYS . 15.1 p-10 -110.31 130.28 55.58 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.271 -175.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 68' ' ' GLU . . . . . 0.785 ' HB3' HG12 ' D' ' 47' ' ' ILE . 35.1 mm-40 -67.62 -8.45 34.67 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.831 -177.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.746 ' HB2' HD21 ' D' ' 67' ' ' ASN . 53.3 mtpt -62.28 -40.79 97.4 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 169.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 70' ' ' SER . . . . . 0.547 ' O ' HD13 ' D' ' 75' ' ' ILE . 32.5 t -68.51 124.52 23.79 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 113.051 -1.886 . . . . 0.0 107.353 164.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 71' ' ' THR . . . . . 0.588 HG21 ' O ' ' D' ' 44' ' ' GLY . 67.3 p -55.17 130.98 44.17 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 72' ' ' VAL . . . . . 0.658 HG11 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -57.3 -14.99 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-O 120.722 0.296 . . . . 0.0 111.011 -178.582 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 73' ' ' GLY . . . . . 0.645 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -63.98 -65.45 3.02 Favored Glycine 0 N--CA 1.433 -1.562 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.156 168.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -62.62 -20.55 64.88 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.523 0.201 . . . . 0.0 111.428 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 75' ' ' ILE . . . . . 0.589 ' O ' HG13 ' D' ' 79' ' ' ILE . 69.7 mt -73.26 -40.61 57.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.148 174.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 35.9 t -75.83 -21.32 57.4 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.817 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 77' ' ' ASN . . . . . 0.615 ' O ' ' HD3' ' D' ' 81' ' ' LYS . 5.7 m120 -61.69 -23.97 66.46 Favored 'General case' 0 C--O 1.216 -0.66 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 166.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 78' ' ' ASP . . . . . 0.576 ' O ' HD22 ' D' ' 82' ' ' LEU . 1.0 OUTLIER -93.23 -41.56 9.83 Favored 'General case' 0 C--O 1.225 -0.237 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 175.913 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . 0.589 HG13 ' O ' ' D' ' 75' ' ' ILE . 56.0 mt -65.78 -34.35 69.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 O-C-N 121.449 -0.782 . . . . 0.0 111.645 -169.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -66.86 -14.05 62.29 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.126 176.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 81' ' ' LYS . . . . . 0.615 ' HD3' ' O ' ' D' ' 77' ' ' ASN . 0.0 OUTLIER -89.77 -57.39 2.88 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.207 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 82' ' ' LEU . . . . . 0.576 HD22 ' O ' ' D' ' 78' ' ' ASP . 3.4 mm? -53.86 -23.74 13.5 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 113.88 -1.509 . . . . 0.0 112.343 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 50.69 69.75 0.6 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.647 174.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 84' ' ' ILE . . . . . 0.515 ' HB ' ' HG ' ' D' ' 36' ' ' LEU . 2.2 mp -74.68 99.09 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.377 0.608 . . . . 0.0 111.175 -176.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 85' ' ' LYS . . . . . 0.58 ' O ' ' HE3' ' D' ' 85' ' ' LYS . 0.0 OUTLIER -131.99 179.07 6.31 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.165 174.722 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . -48.38 165.15 0.24 Allowed Glycine 0 C--N 1.334 0.463 0 O-C-N 123.696 0.623 . . . . 0.0 113.928 -174.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 87' ' ' PRO . . . . . 0.435 ' HG2' ' OD1' ' D' ' 59' ' ' ASN . 60.5 Cg_endo -93.82 -177.09 7.26 Favored 'Cis proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.898 -1.293 . . . . 0.0 114.758 -0.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 88' ' ' TYR . . . . . 0.716 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 41.5 m-85 23.04 93.06 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.504 1.521 . . . . 0.0 113.57 179.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.663 HG22 HG13 ' D' ' 91' ' ' ILE . 72.7 mt -112.36 139.27 37.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 178.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.682 ' HG2' ' HD2' ' D' ' 92' ' ' LYS . 88.9 tt0 -127.59 94.75 4.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.032 171.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 91' ' ' ILE . . . . . 0.663 HG13 HG22 ' D' ' 89' ' ' ILE . 27.4 mt -95.68 99.82 9.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.088 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 92' ' ' LYS . . . . . 0.729 ' HE2' ' CE2' ' D' ' 57' ' ' PHE . 0.0 OUTLIER -161.99 169.29 21.34 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.373 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . 0.655 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 3.0 pt20 -79.56 157.54 27.35 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.283 173.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 9.9 pt . . . . . 0 C--N 1.308 -1.236 0 CA-C-N 114.902 -1.044 . . . . 0.0 112.186 -170.559 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.549 ' O ' HG11 ' D' ' 16' ' ' VAL . 57.0 mt . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 121.666 0.746 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -88.19 -41.86 12.7 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.095 175.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 15' ' ' SER . . . . . 0.546 ' HA ' ' OD2' ' D' ' 18' ' ' ASP . 88.2 p -72.01 -23.52 61.41 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 122.045 -0.409 . . . . 0.0 109.907 175.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 16' ' ' VAL . . . . . 0.549 HG11 ' O ' ' D' ' 13' ' ' ILE . 0.5 OUTLIER -56.84 -24.05 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 121.515 0.674 . . . . 0.0 109.41 178.927 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -74.65 -43.75 53.81 Favored 'General case' 0 C--O 1.209 -1.071 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.771 176.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 18' ' ' ASP . . . . . 0.546 ' OD2' ' HA ' ' D' ' 15' ' ' SER . 51.4 m-20 -55.3 -16.2 3.19 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -177.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.58 ' HD2' ' N ' ' D' ' 19' ' ' LYS . 0.0 OUTLIER -91.18 -43.16 10.03 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-O 122.306 1.051 . . . . 0.0 108.691 175.533 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' D' D ' 20' ' ' LEU . . . . . 0.916 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 70.7 mt -69.36 -37.74 77.76 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 113.168 -1.833 . . . . 0.0 110.258 -177.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 21' ' ' ASN . . . . . 0.429 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 3.3 m120 -79.7 94.08 5.66 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.705 -178.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 22' ' ' LYS . . . . . 0.579 ' HE3' ' O ' ' D' ' 19' ' ' LYS . 95.8 mttt -122.32 -41.95 2.38 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -176.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 165.87 -84.0 0.1 Allowed Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 119.32 -1.419 . . . . 0.0 113.231 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . 0.804 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 27.2 tptp -44.89 -57.76 3.57 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 25' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -139.86 163.95 26.16 Favored Glycine 0 N--CA 1.431 -1.685 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.967 171.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 26' ' ' LYS . . . . . 0.674 ' HD2' ' HB3' ' D' ' 41' ' ' SER . 0.3 OUTLIER -149.29 159.59 44.14 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.933 -0.634 . . . . 0.0 109.986 -171.743 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' D' D ' 27' ' ' LEU . . . . . 0.916 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 39.8 tp -136.16 134.49 38.29 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.436 0.636 . . . . 0.0 111.806 -178.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 28' ' ' SER . . . . . 0.624 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 26.5 t -121.36 145.96 47.36 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 29' ' ' LEU . . . . . 0.7 HD22 ' HB3' ' D' ' 38' ' ' ALA . 20.9 mt -131.43 134.96 46.75 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.754 -0.779 . . . . 0.0 110.745 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 32.1 t -137.01 -171.04 2.84 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 31' ' ' MET . . . . . 0.496 ' HB2' ' O ' ' D' ' 35' ' ' GLN . 26.3 ptt? -150.08 166.59 29.29 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.81 0.338 . . . . 0.0 110.618 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 32' ' ' ASN . . . . . 0.65 ' O ' ' HB2' ' D' ' 35' ' ' GLN . 25.9 t-20 -141.82 87.28 2.04 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 176.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.48 -113.81 4.82 Favored Glycine 0 CA--C 1.516 0.142 0 C-N-CA 119.898 -1.144 . . . . 0.0 111.121 -172.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -95.7 31.0 2.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.776 0.798 . . . . 0.0 109.92 173.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 35' ' ' GLN . . . . . 0.65 ' HB2' ' O ' ' D' ' 32' ' ' ASN . 52.5 mm-40 -110.24 164.94 12.17 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 114.928 -1.033 . . . . 0.0 112.367 -178.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . 0.544 ' C ' HD12 ' D' ' 36' ' ' LEU . 2.7 tm? -130.72 128.95 41.88 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 175.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 37' ' ' LYS . . . . . 0.413 ' N ' HD12 ' D' ' 36' ' ' LEU . 35.7 mmtp -132.4 100.6 5.04 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.145 0.498 . . . . 0.0 110.842 -176.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 38' ' ' ALA . . . . . 0.7 ' HB3' HD22 ' D' ' 29' ' ' LEU . . . -96.72 149.95 21.24 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.856 -177.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 39' ' ' THR . . . . . 0.624 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 29.8 p -137.32 126.72 24.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.916 174.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 40' ' ' SER . . . . . 0.748 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 60.6 p -109.89 135.73 50.31 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 175.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 41' ' ' SER . . . . . 0.674 ' HB3' ' HD2' ' D' ' 26' ' ' LYS . 43.9 t -104.0 156.42 17.87 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.814 -176.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 42' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' D' ' 41' ' ' SER . 74.0 m-80 78.79 9.34 1.89 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.423 -172.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 43.74 59.02 3.27 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 114.73 -1.123 . . . . 0.0 113.648 170.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 44' ' ' GLY . . . . . 0.546 ' O ' HG21 ' D' ' 71' ' ' THR . . . 110.84 34.96 2.1 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 119.732 -1.223 . . . . 0.0 113.872 172.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 45' ' ' TYR . . . . . 0.804 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 2.8 m-30 -112.89 146.72 38.45 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 170.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . 0.617 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -93.93 -162.97 35.99 Favored Glycine 0 C--O 1.218 -0.876 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 175.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 47' ' ' ILE . . . . . 0.813 HG12 ' HB3' ' D' ' 68' ' ' GLU . 38.5 mm -56.27 -57.1 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.886 0 CA-C-O 122.14 0.971 . . . . 0.0 109.514 174.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -178.97 -123.05 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 112.796 -2.002 . . . . 0.0 108.906 -177.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -114.47 76.79 1.01 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.119 0.485 . . . . 0.0 109.916 169.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . 0.548 ' CB ' ' HD3' ' D' ' 52' ' ' LYS . 51.5 mt-10 -140.16 168.73 19.13 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.53 177.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 51' ' ' ASP . . . . . 0.678 ' HB3' ' HD2' ' D' ' 69' ' ' LYS . 1.6 m-20 -114.69 122.06 45.29 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.763 175.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 52' ' ' LYS . . . . . 0.805 ' HG3' ' HB2' ' D' ' 68' ' ' GLU . 0.0 OUTLIER -131.84 107.44 8.74 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.858 -166.354 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -94.33 129.35 41.04 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.466 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 54' ' ' TRP . . . . . 0.564 ' NE1' ' HB3' ' D' ' 93' ' ' GLN . 0.1 OUTLIER -121.93 153.78 38.03 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -174.827 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -141.06 158.78 26.45 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.153 -1.022 . . . . 0.0 113.607 175.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 56' ' ' ILE . . . . . 0.675 ' HA ' ' O ' ' D' ' 90' ' ' GLU . 62.8 mt -142.97 106.51 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 -178.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 57' ' ' PHE . . . . . 0.52 ' HD2' ' HB2' ' D' ' 90' ' ' GLU . 11.8 m-85 -108.6 106.87 17.13 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.59 -168.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.704 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 49.9 t -95.79 118.36 41.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.63 173.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 58.91 34.34 23.59 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.033 -178.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.91 -32.77 6.88 Favored Glycine 0 CA--C 1.505 -0.537 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.706 174.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 61' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 25.4 pt-20 -90.19 146.91 23.9 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.078 0.466 . . . . 0.0 110.818 -175.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -79.36 101.75 8.29 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 177.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.571 HG11 ' O ' ' D' ' 56' ' ' ILE . 10.5 p -76.87 -30.32 18.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.695 -172.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 64' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -147.16 142.57 27.45 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.757 0.313 . . . . 0.0 110.979 178.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 30.5 m -124.8 125.65 44.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.587 175.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 66' ' ' PHE . . . . . 0.553 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 17.5 p90 -133.83 157.49 45.79 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 121.441 0.639 . . . . 0.0 110.43 173.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 67' ' ' ASN . . . . . 0.562 ' HA ' ' O ' ' D' ' 52' ' ' LYS . 5.2 m120 -116.92 141.61 48.01 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 68' ' ' GLU . . . . . 0.813 ' HB3' HG12 ' D' ' 47' ' ' ILE . 55.6 mm-40 -70.83 -16.75 62.74 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 175.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.678 ' HD2' ' HB3' ' D' ' 51' ' ' ASP . 25.0 mtpp -60.21 -44.31 95.24 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 114.102 -1.408 . . . . 0.0 108.159 169.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 70' ' ' SER . . . . . 0.521 ' HG ' ' CD1' ' D' ' 75' ' ' ILE . 18.8 t -76.1 90.72 3.08 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 113.633 -1.621 . . . . 0.0 107.898 171.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 71' ' ' THR . . . . . 0.546 HG21 ' O ' ' D' ' 44' ' ' GLY . 65.6 p -24.39 120.67 0.05 Allowed 'General case' 0 C--N 1.32 -0.695 0 O-C-N 124.815 1.322 . . . . 0.0 112.811 -175.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 72' ' ' VAL . . . . . 0.878 HG13 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -50.96 -15.3 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 O-C-N 123.356 0.41 . . . . 0.0 111.922 179.615 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' D' D ' 73' ' ' GLY . . . . . 0.748 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -65.3 -66.86 2.25 Favored Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 115.805 -0.634 . . . . 0.0 113.183 171.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -62.07 -27.24 68.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.229 -0.485 . . . . 0.0 110.332 -177.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 75' ' ' ILE . . . . . 0.624 ' O ' HG13 ' D' ' 79' ' ' ILE . 29.9 mm -78.24 -41.48 26.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.217 178.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 76' ' ' SER . . . . . 0.531 ' OG ' ' HB1' ' D' ' 38' ' ' ALA . 29.3 t -72.37 -21.33 61.31 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.449 -178.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -64.89 -34.01 77.38 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 167.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 78' ' ' ASP . . . . . 1.042 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 0.9 OUTLIER -77.89 -31.99 51.57 Favored 'General case' 0 C--O 1.224 -0.272 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 175.005 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . 0.624 HG13 ' O ' ' D' ' 75' ' ' ILE . 60.2 mt -65.49 -21.21 28.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 O-C-N 121.543 -0.723 . . . . 0.0 111.294 -174.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -73.25 -43.48 61.08 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 176.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 81' ' ' LYS . . . . . 1.042 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -68.79 -44.47 73.53 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.468 177.269 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' D' D ' 82' ' ' LEU . . . . . 0.65 HD21 ' O ' ' D' ' 78' ' ' ASP . 3.8 mm? -55.53 -22.15 20.2 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 177.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 45.57 73.2 0.17 Allowed 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.778 0.674 . . . . 0.0 110.984 175.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 84' ' ' ILE . . . . . 0.546 ' CG2' HD12 ' D' ' 91' ' ' ILE . 35.0 mt -70.71 99.8 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.315 -177.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 85' ' ' LYS . . . . . 0.589 ' HD3' ' O ' ' D' ' 35' ' ' GLN . 30.5 mmmt -139.19 177.87 7.59 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.719 176.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.67 175.89 3.44 Favored Glycine 0 CA--C 1.506 -0.481 0 N-CA-C 115.008 0.763 . . . . 0.0 115.008 -174.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 87' ' ' PRO . . . . . 0.427 ' O ' HG11 ' D' ' 58' ' ' VAL . 33.0 Cg_endo -91.67 175.73 17.48 Favored 'Cis proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.158 -2.017 . . . . 0.0 114.53 0.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 88' ' ' TYR . . . . . 0.704 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 33.4 m-85 31.52 92.47 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.32 1.448 . . . . 0.0 112.614 -179.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 3.1 mp -109.5 143.1 20.28 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.402 -177.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.675 ' O ' ' HA ' ' D' ' 56' ' ' ILE . 37.3 mt-10 -129.24 89.19 2.81 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.385 172.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 91' ' ' ILE . . . . . 0.546 HD12 ' CG2' ' D' ' 84' ' ' ILE . 21.0 mt -94.44 99.8 10.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.912 178.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 92' ' ' LYS . . . . . 0.702 ' HD3' ' O ' ' D' ' 93' ' ' GLN . 0.0 OUTLIER -161.8 169.2 21.81 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.125 -177.434 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . 0.702 ' O ' ' HD3' ' D' ' 92' ' ' LYS . 2.5 pp0? -85.78 147.17 26.44 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.054 170.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 94' ' ' ILE . . . . . 0.462 HG23 ' HE3' ' D' ' 92' ' ' LYS . 8.9 pt . . . . . 0 C--N 1.304 -1.389 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.979 -169.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.442 HG22 HD12 ' D' ' 13' ' ' ILE . 55.8 mt . . . . . 0 N--CA 1.455 -0.222 0 CA-C-O 121.47 0.653 . . . . 0.0 111.672 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -95.06 -61.16 1.53 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.678 175.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 15' ' ' SER . . . . . 0.414 ' O ' ' HB2' ' D' ' 18' ' ' ASP . 88.5 p -60.45 -21.78 62.71 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 116.906 -0.134 . . . . 0.0 111.238 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 16' ' ' VAL . . . . . 0.67 ' HA ' ' CE ' ' D' ' 19' ' ' LYS . 9.7 p -54.51 -38.48 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 120.761 0.315 . . . . 0.0 110.647 177.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 17' ' ' ASN . . . . . 0.502 ' ND2' HG12 ' D' ' 16' ' ' VAL . 2.7 m120 -68.61 -35.79 77.81 Favored 'General case' 0 C--O 1.214 -0.793 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.7 178.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 18' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' D' ' 15' ' ' SER . 1.2 m-20 -64.42 -17.29 63.65 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -176.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.67 ' CE ' ' HA ' ' D' ' 16' ' ' VAL . 0.0 OUTLIER -90.78 -44.43 9.45 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-O 122.031 0.919 . . . . 0.0 108.563 173.778 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 20' ' ' LEU . . . . . 1.011 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 75.6 mt -61.76 -39.08 90.36 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 113.515 -1.675 . . . . 0.0 109.937 -178.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 21' ' ' ASN . . . . . 0.42 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 3.2 m120 -77.99 97.21 5.28 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.558 178.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 22' ' ' LYS . . . . . 0.817 ' HD2' HD13 ' D' ' 47' ' ' ILE . 67.5 mttm -123.12 -43.37 2.22 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -177.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.4 -96.22 0.1 Allowed Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 119.403 -1.379 . . . . 0.0 113.721 -176.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . 0.845 ' HE2' ' HA ' ' D' ' 48' ' ' SER . 35.0 ttpt -53.81 -47.36 70.92 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.737 0.78 . . . . 0.0 109.404 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 25' ' ' GLY . . . . . 0.507 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -135.96 153.71 21.55 Favored Glycine 0 N--CA 1.431 -1.642 0 CA-C-N 114.232 -1.349 . . . . 0.0 112.006 176.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 26' ' ' LYS . . . . . 0.708 ' CD ' ' HB2' ' D' ' 41' ' ' SER . 0.1 OUTLIER -150.44 160.48 43.73 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.05 -1.075 . . . . 0.0 110.213 -170.192 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 27' ' ' LEU . . . . . 1.011 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 41.8 tp -135.43 130.1 34.28 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.302 0.572 . . . . 0.0 112.023 -177.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 28' ' ' SER . . . . . 0.524 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 8.1 t -117.46 125.16 50.44 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 29' ' ' LEU . . . . . 0.569 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 1.0 OUTLIER -141.14 148.48 40.12 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 176.584 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 62.5 p -157.8 179.07 9.56 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.205 -179.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 31' ' ' MET . . . . . 0.416 ' SD ' ' N ' ' D' ' 31' ' ' MET . 0.0 OUTLIER -117.95 166.17 12.83 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.396 0.617 . . . . 0.0 110.608 179.795 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 32' ' ' ASN . . . . . 0.638 ' HB3' ' HB2' ' D' ' 35' ' ' GLN . 26.1 t-20 -144.16 87.13 1.87 Allowed 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 176.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.74 -98.65 0.7 Allowed Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.187 -1.006 . . . . 0.0 111.281 -171.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 34' ' ' ASN . . . . . 0.406 ' O ' ' HG2' ' D' ' 85' ' ' LYS . 4.8 m120 -110.66 10.36 22.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.029 0.442 . . . . 0.0 110.395 175.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 35' ' ' GLN . . . . . 0.638 ' HB2' ' HB3' ' D' ' 32' ' ' ASN . 3.8 mm100 -91.35 165.28 13.5 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 121.533 0.682 . . . . 0.0 112.222 -177.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . 0.512 HD13 ' C ' ' D' ' 36' ' ' LEU . 1.8 tm? -132.82 135.03 45.41 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.693 172.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 37' ' ' LYS . . . . . 0.569 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 34.9 mmtp -132.1 106.36 7.95 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.698 -171.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 38' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -118.52 148.46 42.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.857 0.361 . . . . 0.0 111.911 -177.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 39' ' ' THR . . . . . 0.524 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 57.2 p -145.43 148.5 33.37 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.265 178.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 40' ' ' SER . . . . . 0.553 ' HA ' ' O ' ' D' ' 26' ' ' LYS . 41.9 p -109.28 131.87 54.66 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 168.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 41' ' ' SER . . . . . 0.708 ' HB2' ' CD ' ' D' ' 26' ' ' LYS . 43.7 m -94.44 147.76 22.91 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 118.915 -1.114 . . . . 0.0 108.882 177.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 42' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' D' ' 41' ' ' SER . 75.1 m-80 80.67 2.5 1.79 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.942 -165.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.19 62.08 2.13 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 168.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 44' ' ' GLY . . . . . 0.504 ' O ' ' HB ' ' D' ' 71' ' ' THR . . . 119.19 -6.48 13.05 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 118.405 -1.855 . . . . 0.0 115.072 168.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 45' ' ' TYR . . . . . 0.734 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 1.3 m-85 -86.17 155.84 20.58 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.98 0.39 . . . . 0.0 111.784 -174.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . 0.635 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -94.84 178.95 36.63 Favored Glycine 0 C--O 1.222 -0.654 0 CA-C-O 118.812 -0.993 . . . . 0.0 110.642 174.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 47' ' ' ILE . . . . . 0.817 HD13 ' HD2' ' D' ' 22' ' ' LYS . 33.4 mm -47.65 -57.22 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 CA-C-N 118.109 0.955 . . . . 0.0 110.652 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 48' ' ' SER . . . . . 0.845 ' HA ' ' HE2' ' D' ' 24' ' ' LYS . 22.1 t 178.83 -135.24 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.02 -1.446 . . . . 0.0 107.923 -178.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -95.03 76.93 3.53 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 165.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . 0.833 ' HB3' ' HE3' ' D' ' 52' ' ' LYS . 50.6 mt-10 -144.58 164.63 30.36 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.95 -173.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 51' ' ' ASP . . . . . 0.69 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 10.7 p-10 -132.61 135.49 45.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.231 0.539 . . . . 0.0 111.337 177.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 52' ' ' LYS . . . . . 0.833 ' HE3' ' HB3' ' D' ' 50' ' ' GLU . 0.2 OUTLIER -146.97 142.35 27.44 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.392 -174.261 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 53' ' ' ASN . . . . . 0.459 HD21 ' C ' ' D' ' 52' ' ' LYS . 3.3 m120 -118.25 135.99 53.94 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 172.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 54' ' ' TRP . . . . . 0.635 ' HZ3' ' CG2' ' D' ' 91' ' ' ILE . 0.9 OUTLIER -126.29 162.49 25.35 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -170.89 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -148.69 163.46 29.03 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.204 174.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 56' ' ' ILE . . . . . 0.624 HG12 ' CG2' ' D' ' 91' ' ' ILE . 93.6 mt -135.97 108.99 8.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 C-N-CA 124.853 1.261 . . . . 0.0 107.689 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 57' ' ' PHE . . . . . 0.719 ' CE1' ' HE2' ' D' ' 92' ' ' LYS . 14.6 m-85 -107.63 101.55 10.86 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.898 -168.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.806 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 84.0 t -83.24 106.48 13.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.927 171.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 64.4 45.24 3.84 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.51 0.506 . . . . 0.0 110.692 -177.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.76 41.94 99.68 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.313 -178.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 61' ' ' GLU . . . . . 0.512 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 42.8 tt0 -142.97 112.64 6.9 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.264 -0.468 . . . . 0.0 110.059 178.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 62' ' ' LYS . . . . . 0.524 ' HB2' ' CE2' ' D' ' 57' ' ' PHE . 37.8 ttpt -70.36 105.65 3.1 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.446 -177.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 27.6 m -89.14 -24.48 5.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.708 -175.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 64' ' ' TYR . . . . . 0.463 ' HH ' ' CB ' ' D' ' 78' ' ' ASP . 16.4 t80 -141.36 135.45 30.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.766 0.317 . . . . 0.0 111.035 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 79.6 m -117.66 118.89 33.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.308 175.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 66' ' ' PHE . . . . . 0.456 ' CZ ' ' CE3' ' D' ' 54' ' ' TRP . 9.4 p90 -125.61 159.36 32.35 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 174.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 67' ' ' ASN . . . . . 0.711 ' ND2' ' HB2' ' D' ' 69' ' ' LYS . 16.0 p-10 -130.2 136.1 48.87 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -174.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 68' ' ' GLU . . . . . 0.754 ' HB3' HG12 ' D' ' 47' ' ' ILE . 51.9 mm-40 -68.31 -8.37 39.12 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.368 -175.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.711 ' HB2' ' ND2' ' D' ' 67' ' ' ASN . 6.0 mtpm? -64.74 -44.4 90.24 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 169.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 70' ' ' SER . . . . . 0.469 ' HB3' ' O ' ' D' ' 67' ' ' ASN . 35.0 t -64.61 125.43 24.71 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 113.32 -1.763 . . . . 0.0 107.847 168.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 71' ' ' THR . . . . . 0.504 ' HB ' ' O ' ' D' ' 44' ' ' GLY . 72.3 p -56.03 126.57 26.5 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 72' ' ' VAL . . . . . 0.819 HG13 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -57.56 -11.47 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-O 121.04 0.448 . . . . 0.0 111.341 -176.292 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 73' ' ' GLY . . . . . 0.455 ' HA3' ' HA2' ' D' ' 44' ' ' GLY . . . -73.49 -57.34 5.09 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.568 170.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -63.84 -23.84 67.51 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 177.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 75' ' ' ILE . . . . . 0.642 ' O ' HG13 ' D' ' 79' ' ' ILE . 72.0 mt -71.33 -44.8 72.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.216 174.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 76' ' ' SER . . . . . 0.493 ' HA ' HG13 ' D' ' 79' ' ' ILE . 31.8 t -71.55 -25.89 62.41 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 121.116 -0.233 . . . . 0.0 111.037 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -60.71 -26.36 67.1 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 169.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 78' ' ' ASP . . . . . 0.99 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 80.7 m-20 -86.3 -37.54 18.42 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.196 174.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . 0.642 HG13 ' O ' ' D' ' 75' ' ' ILE . 24.2 mt -64.85 -27.96 43.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 O-C-N 121.897 -0.502 . . . . 0.0 110.803 -175.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -69.11 -29.49 67.57 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.293 178.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 81' ' ' LYS . . . . . 0.99 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -85.04 -49.45 8.28 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 119.677 -0.809 . . . . 0.0 111.323 175.116 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 82' ' ' LEU . . . . . 0.632 HD22 ' O ' ' D' ' 78' ' ' ASP . 4.1 mm? -50.43 -26.57 5.18 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 52.89 66.91 1.09 Allowed 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.617 0.573 . . . . 0.0 110.153 178.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 84' ' ' ILE . . . . . 0.492 HG22 HG22 ' D' ' 56' ' ' ILE . 50.3 mm -73.66 99.94 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.601 -175.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 85' ' ' LYS . . . . . 0.543 ' C ' ' HE3' ' D' ' 85' ' ' LYS . 0.0 OUTLIER -142.39 -171.57 3.43 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 179.7 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . -61.22 168.12 11.54 Favored Glycine 0 CA--C 1.507 -0.45 0 CA-C-N 115.316 -0.856 . . . . 0.0 114.543 -174.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 87' ' ' PRO . . . . . 0.641 ' O ' HG12 ' D' ' 58' ' ' VAL . 45.2 Cg_endo -91.38 178.4 14.33 Favored 'Cis proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.868 -1.722 . . . . 0.0 114.171 0.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 88' ' ' TYR . . . . . 0.806 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 1.4 m-85 36.67 91.39 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 O-C-N 124.483 1.115 . . . . 0.0 112.435 178.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.58 HG21 HG13 ' D' ' 91' ' ' ILE . 3.5 mp -111.09 121.88 64.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.507 0.67 . . . . 0.0 111.03 -176.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.643 ' HB2' ' HB2' ' D' ' 57' ' ' PHE . 54.3 mt-10 -124.15 88.99 3.0 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.916 177.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 91' ' ' ILE . . . . . 0.635 ' CG2' ' HZ3' ' D' ' 54' ' ' TRP . 4.1 mt -100.06 111.05 28.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 92' ' ' LYS . . . . . 0.719 ' HE2' ' CE1' ' D' ' 57' ' ' PHE . 0.0 OUTLIER -162.57 172.47 15.37 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . 0.642 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 17.2 pt20 -81.33 158.45 24.72 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.807 173.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 7.6 pt . . . . . 0 C--N 1.305 -1.364 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.631 -172.394 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.519 ' O ' HG11 ' D' ' 16' ' ' VAL . 48.4 mt . . . . . 0 N--CA 1.45 -0.472 0 CA-C-O 121.841 0.829 . . . . 0.0 110.649 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -93.87 -57.07 2.66 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.604 -176.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' D' D ' 15' ' ' SER . . . . . 0.662 ' HA ' ' OD2' ' D' ' 18' ' ' ASP . 97.5 p -69.65 -16.16 63.32 Favored 'General case' 0 C--O 1.218 -0.59 0 C-N-CA 120.156 -0.618 . . . . 0.0 110.199 175.23 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 16' ' ' VAL . . . . . 0.519 HG11 ' O ' ' D' ' 13' ' ' ILE . 1.5 p -56.08 -23.9 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 121.974 0.892 . . . . 0.0 109.138 174.336 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 17' ' ' ASN . . . . . 0.617 ' HB3' ' ND2' ' D' ' 21' ' ' ASN . 5.4 m120 -84.71 -32.38 23.57 Favored 'General case' 0 C--O 1.206 -1.232 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.204 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 18' ' ' ASP . . . . . 0.662 ' OD2' ' HA ' ' D' ' 15' ' ' SER . 63.0 m-20 -61.61 -14.91 34.66 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 177.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.866 ' N ' ' HE2' ' D' ' 19' ' ' LYS . 0.3 OUTLIER -86.4 -48.54 8.36 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 174.334 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' D' D ' 20' ' ' LEU . . . . . 0.968 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 71.9 mt -64.92 -40.79 95.6 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 112.299 -2.228 . . . . 0.0 110.497 -176.122 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 21' ' ' ASN . . . . . 0.706 ' OD1' ' HB2' ' D' ' 26' ' ' LYS . 75.1 m-20 -85.33 97.74 10.14 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.434 -179.598 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 22' ' ' LYS . . . . . 0.609 ' NZ ' ' HB3' ' D' ' 22' ' ' LYS . 7.5 mtpm? -123.03 -41.67 2.32 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 118.767 -1.173 . . . . 0.0 114.125 -178.018 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 173.38 -82.52 0.08 OUTLIER Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 119.901 -1.143 . . . . 0.0 112.527 -177.473 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . 0.857 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 27.2 tptp -48.18 -60.94 2.26 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.675 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -134.73 160.14 24.15 Favored Glycine 0 N--CA 1.433 -1.542 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.451 174.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' D' D ' 26' ' ' LYS . . . . . 0.706 ' HB2' ' OD1' ' D' ' 21' ' ' ASN . 0.1 OUTLIER -149.63 159.74 44.08 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.57 -0.815 . . . . 0.0 111.099 -168.611 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' D' D ' 27' ' ' LEU . . . . . 0.968 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 44.9 tp -143.73 139.15 29.3 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.96 0.409 . . . . 0.0 111.942 -178.621 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 28' ' ' SER . . . . . 0.564 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 8.7 t -127.7 153.77 46.11 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 174.834 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 29' ' ' LEU . . . . . 0.555 HD21 ' HB2' ' D' ' 38' ' ' ALA . 18.4 mt -133.96 140.52 46.8 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.886 178.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 49.8 m -152.44 -176.28 5.64 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.731 178.065 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' D' D ' 31' ' ' MET . . . . . 0.461 ' HE2' ' HB2' ' D' ' 31' ' ' MET . 66.8 mtm -136.24 166.39 23.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.056 0.455 . . . . 0.0 110.546 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 32' ' ' ASN . . . . . 0.535 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 24.4 t-20 -146.06 88.38 1.81 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.39 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.15 -105.32 1.81 Allowed Glycine 0 N--CA 1.454 -0.144 0 C-N-CA 119.998 -1.096 . . . . 0.0 110.749 -170.344 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -114.16 29.89 7.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.177 0.513 . . . . 0.0 109.952 171.462 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' D' D ' 35' ' ' GLN . . . . . 0.535 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 65.0 tp60 -102.31 155.75 18.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.241 -178.146 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . 0.631 HD11 ' C ' ' D' ' 36' ' ' LEU . 2.5 tm? -113.43 129.16 56.61 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 175.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 37' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -136.14 99.01 4.01 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.967 -169.393 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' D' D ' 38' ' ' ALA . . . . . 0.555 ' HB2' HD21 ' D' ' 29' ' ' LEU . . . -98.21 150.76 21.16 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.017 176.115 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 39' ' ' THR . . . . . 0.564 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 74.4 p -133.67 123.01 24.26 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 174.394 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 40' ' ' SER . . . . . 0.56 ' HA ' ' O ' ' D' ' 26' ' ' LYS . 18.7 m -115.7 128.89 56.23 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.233 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 41' ' ' SER . . . . . 0.608 ' HB2' ' CD ' ' D' ' 26' ' ' LYS . 31.9 m -104.87 162.05 13.66 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.42 -173.066 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 42' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' D' ' 41' ' ' SER . 74.7 m-80 77.35 9.9 2.51 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 114.197 -1.365 . . . . 0.0 110.52 -171.68 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 49.04 60.5 3.7 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 114.799 -1.092 . . . . 0.0 113.753 169.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' D' D ' 44' ' ' GLY . . . . . 0.48 ' O ' HG22 ' D' ' 71' ' ' THR . . . 106.72 37.11 2.45 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 119.216 -1.469 . . . . 0.0 114.043 171.193 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 45' ' ' TYR . . . . . 0.857 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 3.9 m-30 -114.59 153.33 30.31 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 117.376 0.588 . . . . 0.0 110.037 176.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -97.82 -155.77 29.9 Favored Glycine 0 C--O 1.217 -0.909 0 CA-C-O 119.459 -0.634 . . . . 0.0 111.598 178.014 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 47' ' ' ILE . . . . . 0.954 HG13 ' HB3' ' D' ' 68' ' ' GLU . 0.4 OUTLIER -54.62 -56.53 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-O 122.118 0.961 . . . . 0.0 108.659 -179.994 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' D' D ' 48' ' ' SER . . . . . 0.461 ' HB2' ' O ' ' D' ' 47' ' ' ILE . 26.3 t 162.33 -60.3 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 111.922 -2.399 . . . . 0.0 106.909 -174.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -169.89 76.27 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.546 172.683 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . 0.65 ' O ' ' HG2' ' D' ' 69' ' ' LYS . 49.0 mt-10 -149.27 -177.94 6.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.881 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 51' ' ' ASP . . . . . 0.589 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 1.0 OUTLIER -129.07 130.15 46.17 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.457 0.646 . . . . 0.0 111.316 172.553 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' D' D ' 52' ' ' LYS . . . . . 0.589 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 0.4 OUTLIER -141.77 100.92 3.85 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.861 -179.833 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' D' D ' 53' ' ' ASN . . . . . 0.599 ' HA ' ' OD1' ' D' ' 67' ' ' ASN . 2.7 m120 -78.16 125.7 29.74 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 176.396 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 54' ' ' TRP . . . . . 0.56 ' HB2' ' O ' ' D' ' 66' ' ' PHE . 0.1 OUTLIER -118.21 155.86 29.78 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.385 -171.948 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -148.13 161.79 28.66 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 119.833 -1.175 . . . . 0.0 114.297 175.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' D' D ' 56' ' ' ILE . . . . . . . . . . . . . 71.9 mt -135.09 111.25 13.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' D' D ' 57' ' ' PHE . . . . . 0.615 ' HA ' ' O ' ' D' ' 61' ' ' GLU . 9.2 m-85 -111.83 114.16 26.95 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.654 -166.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.652 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 59.6 t -96.28 105.92 17.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.903 174.661 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 7.0 m120 56.42 51.74 10.99 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.155 -176.374 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.04 48.08 68.4 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.823 178.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' D' D ' 61' ' ' GLU . . . . . 0.615 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 86.9 tt0 -150.29 116.87 5.79 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 177.631 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 62' ' ' LYS . . . . . 0.456 ' HB2' ' CE1' ' D' ' 57' ' ' PHE . 27.3 ttpp -75.86 99.91 4.63 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.971 0.415 . . . . 0.0 110.282 179.086 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 30.3 m -84.96 -27.2 6.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.051 -175.205 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' D' D ' 64' ' ' TYR . . . . . 0.478 ' HH ' ' CB ' ' D' ' 78' ' ' ASP . 14.4 t80 -136.75 131.46 33.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.736 0.303 . . . . 0.0 110.373 178.367 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 19.4 m -117.98 104.6 11.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.94 177.816 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' D' D ' 66' ' ' PHE . . . . . 0.56 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 12.2 p90 -114.64 164.68 13.69 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 175.515 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 67' ' ' ASN . . . . . 0.599 ' OD1' ' HA ' ' D' ' 53' ' ' ASN . 74.8 m-20 -130.88 152.0 50.68 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.289 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 68' ' ' GLU . . . . . 0.954 ' HB3' HG13 ' D' ' 47' ' ' ILE . 84.0 mt-10 -68.78 -18.94 64.28 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.689 -0.804 . . . . 0.0 109.774 174.257 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.65 ' HG2' ' O ' ' D' ' 50' ' ' GLU . 45.4 mtmt -61.38 -42.46 98.75 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 172.61 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 70' ' ' SER . . . . . 0.423 ' O ' HD13 ' D' ' 75' ' ' ILE . 27.7 t -67.87 125.41 26.19 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 113.669 -1.605 . . . . 0.0 107.405 170.503 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 71' ' ' THR . . . . . 0.48 HG22 ' O ' ' D' ' 44' ' ' GLY . 76.6 p -58.19 116.33 3.5 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -176.539 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 72' ' ' VAL . . . . . 0.61 HG11 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -51.41 -20.56 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-O 120.674 0.273 . . . . 0.0 111.472 -173.654 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' D' D ' 73' ' ' GLY . . . . . 0.497 ' HA2' ' HB2' ' D' ' 40' ' ' SER . . . -63.39 -59.91 8.22 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.709 -0.678 . . . . 0.0 113.081 172.422 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 74' ' ' ASN . . . . . 0.772 ' HA ' HD21 ' D' ' 77' ' ' ASN . 4.3 m120 -66.61 -18.75 65.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.444 0.164 . . . . 0.0 110.902 178.62 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 75' ' ' ILE . . . . . 0.682 ' O ' HG13 ' D' ' 79' ' ' ILE . 77.7 mt -71.6 -42.39 71.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.021 173.752 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 76' ' ' SER . . . . . 0.475 ' HA ' HG13 ' D' ' 79' ' ' ILE . 47.1 t -74.1 -22.68 59.39 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.008 -177.439 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 77' ' ' ASN . . . . . 0.772 HD21 ' HA ' ' D' ' 74' ' ' ASN . 78.0 m-20 -63.93 -27.29 69.05 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 168.32 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 78' ' ' ASP . . . . . 1.014 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 51.6 m-20 -83.6 -36.14 24.13 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.943 173.187 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . 0.682 HG13 ' O ' ' D' ' 75' ' ' ILE . 22.2 mt -67.05 -16.04 20.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.266 -175.6 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -69.85 -48.83 57.37 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.108 174.127 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' D' D ' 81' ' ' LYS . . . . . 1.014 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -69.39 -47.82 63.03 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.645 178.427 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' D' D ' 82' ' ' LEU . . . . . 0.598 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.5 mm? -54.26 -23.97 16.98 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 178.195 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 83' ' ' ASN . . . . . 0.459 ' O ' ' HE2' ' D' ' 85' ' ' LYS . 0.7 OUTLIER 39.25 69.29 0.29 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.916 0.886 . . . . 0.0 111.159 176.008 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' D' D ' 84' ' ' ILE . . . . . 0.526 HG21 HD11 ' D' ' 91' ' ' ILE . 47.8 mm -75.17 99.28 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.166 -172.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 85' ' ' LYS . . . . . 0.559 ' O ' ' HE3' ' D' ' 85' ' ' LYS . 0.0 OUTLIER -158.19 91.44 1.1 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 173.972 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' D' D ' 86' ' ' GLY . . . . . 0.639 ' N ' HD11 ' D' ' 89' ' ' ILE . . . 69.63 154.51 0.97 Allowed Glycine 0 C--N 1.329 0.175 0 CA-C-N 115.127 -0.942 . . . . 0.0 114.106 173.163 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 87' ' ' PRO . . . . . 0.573 ' O ' HG12 ' D' ' 58' ' ' VAL . 68.8 Cg_endo -87.33 178.96 19.74 Favored 'Cis proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.681 -1.8 . . . . 0.0 112.09 -0.301 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 88' ' ' TYR . . . . . 0.652 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 2.3 m-85 4.67 91.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 125.253 1.421 . . . . 0.0 113.942 -175.45 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.639 HD11 ' N ' ' D' ' 86' ' ' GLY . 66.2 mt -111.38 129.19 67.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.999 -179.803 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.536 ' O ' ' HD2' ' D' ' 57' ' ' PHE . 49.2 mm-40 -112.33 100.36 8.73 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.879 175.266 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 91' ' ' ILE . . . . . 0.562 HG13 HG21 ' D' ' 89' ' ' ILE . 35.0 mt -94.38 101.19 12.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.05 -178.744 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 92' ' ' LYS . . . . . 0.774 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -160.5 163.64 32.73 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.107 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . 0.601 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 19.7 pt20 -79.53 167.4 20.81 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 119.764 -0.774 . . . . 0.0 110.807 176.818 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' D' D ' 94' ' ' ILE . . . . . 0.774 HG22 ' HE2' ' D' ' 92' ' ' LYS . 10.9 pt . . . . . 0 C--N 1.313 -1.006 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.572 -170.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.597 ' O ' HG12 ' D' ' 16' ' ' VAL . 51.6 mt . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 121.701 0.762 . . . . 0.0 110.544 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -85.25 -59.19 2.4 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.291 176.137 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' D' D ' 15' ' ' SER . . . . . 0.506 ' O ' ' HE2' ' D' ' 19' ' ' LYS . 88.7 p -68.22 -13.88 62.57 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 175.603 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 16' ' ' VAL . . . . . 0.597 HG12 ' O ' ' D' ' 13' ' ' ILE . 0.9 OUTLIER -62.18 -25.68 38.18 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.92 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' D' D ' 17' ' ' ASN . . . . . 0.431 ' ND2' ' H ' ' D' ' 29' ' ' LEU . 2.2 m120 -73.56 -42.24 61.9 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 114.383 -1.281 . . . . 0.0 108.592 177.122 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -59.25 -14.85 12.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.864 -178.387 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.506 ' HE2' ' O ' ' D' ' 15' ' ' SER . 34.9 mttm -91.1 -45.77 8.5 Favored 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 123.198 1.475 . . . . 0.0 108.803 -179.743 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 20' ' ' LEU . . . . . 0.831 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 59.1 mt -66.53 -36.53 82.92 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 111.986 -2.37 . . . . 0.0 109.795 -179.87 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 21' ' ' ASN . . . . . 0.631 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 3.0 m120 -74.91 94.4 2.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.399 178.837 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 22' ' ' LYS . . . . . 0.422 ' HD2' HD12 ' D' ' 47' ' ' ILE . 43.3 mttp -122.46 -43.29 2.3 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -176.681 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 171.68 -87.98 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 119.125 -1.512 . . . . 0.0 113.63 -177.13 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . 0.616 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 0.0 OUTLIER -48.02 -53.42 16.35 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.943 0.877 . . . . 0.0 109.172 179.166 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' D' D ' 25' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -149.32 156.11 26.64 Favored Glycine 0 N--CA 1.43 -1.761 0 CA-C-N 113.928 -1.487 . . . . 0.0 110.918 177.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 26' ' ' LYS . . . . . 0.719 ' HD2' ' HB3' ' D' ' 41' ' ' SER . 8.7 ptpt -151.15 160.4 43.88 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 114.331 -0.934 . . . . 0.0 110.52 -167.128 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 27' ' ' LEU . . . . . 1.101 ' HB2' HG13 ' D' ' 72' ' ' VAL . 49.7 tp -134.61 147.35 50.19 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.402 0.62 . . . . 0.0 111.937 -176.645 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 28' ' ' SER . . . . . 0.579 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 33.5 t -132.5 128.65 37.8 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.437 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 29' ' ' LEU . . . . . 0.549 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 9.3 mt -126.94 144.9 50.87 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.796 177.74 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 73.1 p -160.32 176.89 11.18 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.977 177.7 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' D' D ' 31' ' ' MET . . . . . 0.509 ' HA ' ' O ' ' D' ' 35' ' ' GLN . 0.0 OUTLIER -129.65 116.89 19.5 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.377 0.608 . . . . 0.0 110.417 177.076 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -90.36 89.36 7.58 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.395 -0.821 . . . . 0.0 108.97 179.329 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.68 -103.31 2.07 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.275 -0.964 . . . . 0.0 111.064 -171.083 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -120.4 31.14 6.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.381 0.61 . . . . 0.0 109.883 174.674 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' D' D ' 35' ' ' GLN . . . . . 0.509 ' O ' ' HA ' ' D' ' 31' ' ' MET . 8.1 tt0 -108.36 158.69 17.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.308 -174.674 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . 0.635 ' HB3' HD21 ' D' ' 83' ' ' ASN . 2.5 tm? -112.77 126.96 55.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.668 0.271 . . . . 0.0 110.346 178.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 37' ' ' LYS . . . . . 0.644 ' HZ3' ' HB3' ' D' ' 37' ' ' LYS . 1.6 mmmp? -132.58 115.7 15.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.973 -168.113 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 38' ' ' ALA . . . . . 0.499 ' HB1' ' CD2' ' D' ' 29' ' ' LEU . . . -119.91 142.54 48.62 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.925 174.617 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 39' ' ' THR . . . . . 0.579 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 15.1 p -145.76 132.46 19.96 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.057 177.73 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 40' ' ' SER . . . . . 0.803 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 78.8 p -112.28 145.38 40.08 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.326 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 41' ' ' SER . . . . . 0.719 ' HB3' ' HD2' ' D' ' 26' ' ' LYS . 44.3 t -104.39 149.8 25.08 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 118.949 -1.101 . . . . 0.0 109.821 177.176 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 42' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' D' ' 41' ' ' SER . 75.2 m-80 80.31 1.42 1.96 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.891 -171.731 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 44.58 57.76 4.27 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 170.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.91 35.77 0.71 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 119.419 -1.372 . . . . 0.0 113.857 173.313 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' D' D ' 45' ' ' TYR . . . . . 0.616 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 18.2 m-85 -126.31 148.37 49.55 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 172.1 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . 0.488 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -88.2 -168.94 44.74 Favored Glycine 0 CA--C 1.497 -1.062 0 N-CA-C 110.579 -1.009 . . . . 0.0 110.579 175.782 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 47' ' ' ILE . . . . . 0.796 HG12 ' HB3' ' D' ' 68' ' ' GLU . 50.4 mm -45.41 -56.71 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 CA-C-O 121.53 0.681 . . . . 0.0 110.001 178.714 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 48' ' ' SER . . . . . 0.405 ' HA ' ' CB ' ' D' ' 24' ' ' LYS . 40.8 t 173.41 -103.18 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 112.552 -2.113 . . . . 0.0 109.258 173.868 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -119.54 74.55 1.01 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.223 0.535 . . . . 0.0 111.705 175.129 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . 0.494 ' HA ' ' OE1' ' D' ' 50' ' ' GLU . 3.7 mm-40 -155.74 -170.35 3.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.946 173.12 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 51' ' ' ASP . . . . . 0.622 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 1.8 m-20 -133.45 138.98 46.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.928 175.458 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 52' ' ' LYS . . . . . 0.622 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 0.1 OUTLIER -144.24 144.12 31.36 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 177.926 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -114.6 142.77 46.01 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 176.672 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' D' D ' 54' ' ' TRP . . . . . 0.598 ' NE1' ' HB3' ' D' ' 93' ' ' GLN . 0.7 OUTLIER -126.71 153.84 44.92 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -173.919 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -142.31 159.76 27.16 Favored Glycine 0 N--CA 1.44 -1.091 0 CA-C-N 114.832 -1.076 . . . . 0.0 113.266 174.074 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' D' D ' 56' ' ' ILE . . . . . 0.461 ' HA ' ' O ' ' D' ' 90' ' ' GLU . 72.3 mt -137.85 105.78 3.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 179.461 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 57' ' ' PHE . . . . . 0.512 ' HA ' ' O ' ' D' ' 61' ' ' GLU . 8.9 m-85 -106.47 109.87 21.91 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.676 -0.809 . . . . 0.0 111.353 -170.032 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.577 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 94.7 t -88.69 110.6 21.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.957 173.837 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 59' ' ' ASN . . . . . 0.423 ' OD1' ' HG2' ' D' ' 87' ' ' PRO . 6.0 m120 53.39 53.83 11.09 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.191 -176.926 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.9 48.71 78.62 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.941 178.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' D' D ' 61' ' ' GLU . . . . . 0.512 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 89.1 tt0 -156.73 116.43 3.5 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.686 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 62' ' ' LYS . . . . . 0.496 ' HB2' ' CE2' ' D' ' 57' ' ' PHE . 5.5 ttpm? -73.67 101.46 3.65 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -177.864 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 32.5 m -85.74 -25.53 6.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.998 -175.508 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' D' D ' 64' ' ' TYR . . . . . 0.471 ' HH ' ' HB3' ' D' ' 78' ' ' ASP . 15.1 t80 -140.28 137.94 34.59 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.222 178.822 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 65' ' ' THR . . . . . 0.474 ' OG1' ' HE2' ' D' ' 62' ' ' LYS . 38.5 m -120.13 119.03 32.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.102 174.531 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 66' ' ' PHE . . . . . 0.584 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 9.3 p90 -126.75 158.91 35.28 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 170.843 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -128.51 142.24 51.14 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.505 -173.21 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' D' D ' 68' ' ' GLU . . . . . 0.796 ' HB3' HG12 ' D' ' 47' ' ' ILE . 5.0 mm-40 -67.14 -10.32 48.97 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 174.586 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.569 ' HE3' ' OD2' ' D' ' 51' ' ' ASP . 48.2 mtpt -63.19 -47.44 82.57 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 114.196 -1.365 . . . . 0.0 107.597 169.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 70' ' ' SER . . . . . 0.468 ' O ' HD12 ' D' ' 75' ' ' ILE . 23.3 t -67.3 138.04 56.54 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 113.505 -1.68 . . . . 0.0 107.961 170.249 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 71' ' ' THR . . . . . 0.46 ' O ' HG13 ' D' ' 75' ' ' ILE . 79.4 p -62.51 122.33 15.5 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.294 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 72' ' ' VAL . . . . . 1.101 HG13 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -56.57 -12.93 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 120.966 0.412 . . . . 0.0 111.243 -176.228 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' D' D ' 73' ' ' GLY . . . . . 0.803 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -69.38 -59.95 5.42 Favored Glycine 0 N--CA 1.435 -1.375 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.743 170.169 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 74' ' ' ASN . . . . . 0.668 ' HA ' HD21 ' D' ' 77' ' ' ASN . 46.7 t30 -62.72 -27.34 69.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.965 0.412 . . . . 0.0 109.97 177.74 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 75' ' ' ILE . . . . . 0.629 ' O ' HG13 ' D' ' 79' ' ' ILE . 77.7 mt -68.15 -45.28 83.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.899 176.328 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 29.1 t -75.78 -19.43 58.99 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.216 -176.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' D' D ' 77' ' ' ASN . . . . . 0.668 HD21 ' HA ' ' D' ' 74' ' ' ASN . 73.4 m-20 -64.48 -31.5 72.74 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 166.198 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 78' ' ' ASP . . . . . 1.06 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 58.4 m-20 -78.52 -39.89 36.75 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.567 175.304 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . 0.629 HG13 ' O ' ' D' ' 75' ' ' ILE . 22.2 mt -67.29 -17.15 22.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.349 -174.401 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -71.29 -42.92 68.1 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.375 175.65 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' D' D ' 81' ' ' LYS . . . . . 1.06 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -73.26 -51.9 15.96 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.161 176.914 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' D' D ' 82' ' ' LEU . . . . . 0.595 HD22 ' O ' ' D' ' 78' ' ' ASP . 3.7 mm? -48.05 -32.09 6.26 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 178.226 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 83' ' ' ASN . . . . . 0.635 HD21 ' HB3' ' D' ' 36' ' ' LEU . 0.7 OUTLIER 34.41 65.24 0.34 Allowed 'General case' 0 N--CA 1.477 0.914 0 O-C-N 124.18 0.925 . . . . 0.0 111.602 175.756 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' D' D ' 84' ' ' ILE . . . . . 0.423 ' N ' ' HG ' ' D' ' 36' ' ' LEU . 44.1 mt -92.84 99.89 10.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.003 0.43 . . . . 0.0 111.974 -172.839 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.96 94.27 3.68 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.616 0.722 . . . . 0.0 112.065 177.726 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 86' ' ' GLY . . . . . 0.536 ' H ' ' CD1' ' D' ' 89' ' ' ILE . . . 71.46 155.99 2.23 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.356 177.795 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 87' ' ' PRO . . . . . 0.498 ' HD2' ' CG1' ' D' ' 58' ' ' VAL . 60.7 Cg_endo -89.31 179.99 15.09 Favored 'Cis proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.141 -1.608 . . . . 0.0 113.045 0.112 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 88' ' ' TYR . . . . . 0.577 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 10.2 m-85 8.27 93.8 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 125.48 1.512 . . . . 0.0 113.875 -176.366 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.637 ' CG2' HG13 ' D' ' 91' ' ' ILE . 72.4 mt -108.71 137.74 39.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -177.885 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' D' ' 56' ' ' ILE . 55.2 mm-40 -113.48 93.04 4.21 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.084 170.161 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 91' ' ' ILE . . . . . 0.637 HG13 ' CG2' ' D' ' 89' ' ' ILE . 23.7 mt -93.68 100.7 11.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.563 178.155 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 92' ' ' LYS . . . . . 0.69 ' HD3' ' O ' ' D' ' 93' ' ' GLN . 0.0 OUTLIER -162.82 169.45 19.83 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.177 -178.223 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . 0.69 ' O ' ' HD3' ' D' ' 92' ' ' LYS . 25.7 pt20 -87.28 151.76 22.86 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.634 172.177 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' D' D ' 94' ' ' ILE . . . . . 0.505 ' CG2' ' HE3' ' D' ' 92' ' ' LYS . 9.1 pt . . . . . 0 C--N 1.307 -1.249 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.933 -170.539 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.496 ' C ' HG13 ' D' ' 16' ' ' VAL . 59.1 mt . . . . . 0 N--CA 1.45 -0.428 0 CA-C-O 121.625 0.726 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -94.41 -60.84 1.63 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.843 175.754 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 92.8 p -65.87 -18.51 65.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.822 -0.172 . . . . 0.0 111.152 -179.088 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' D' D ' 16' ' ' VAL . . . . . 0.772 ' HA ' ' HE2' ' D' ' 19' ' ' LYS . 14.5 p -54.77 -36.27 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 175.02 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 17' ' ' ASN . . . . . 0.591 ' OD1' ' HA ' ' D' ' 28' ' ' SER . 78.8 m-20 -76.23 -27.7 56.9 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.675 -178.682 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.92 -16.14 64.13 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 179.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.772 ' HE2' ' HA ' ' D' ' 16' ' ' VAL . 0.0 OUTLIER -90.92 -28.99 17.72 Favored 'General case' 0 CA--C 1.494 -1.199 0 CA-C-O 121.68 0.752 . . . . 0.0 109.046 173.486 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' D' D ' 20' ' ' LEU . . . . . 0.895 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 79.5 mt -82.98 -40.09 20.48 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 113.98 -1.464 . . . . 0.0 109.715 -173.14 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 21' ' ' ASN . . . . . 0.629 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 53.0 m-20 -78.3 92.25 4.5 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.032 -1.44 . . . . 0.0 110.694 178.69 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 22' ' ' LYS . . . . . 0.541 ' NZ ' ' HB3' ' D' ' 22' ' ' LYS . 7.3 mtpm? -123.96 -43.58 2.1 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -172.262 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 172.1 -71.63 0.11 Allowed Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 119.195 -1.478 . . . . 0.0 113.805 -175.209 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . 0.797 ' HB3' ' O ' ' D' ' 46' ' ' GLY . 17.4 tptp -56.99 -66.02 0.52 Allowed 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 179.449 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -137.19 172.32 22.73 Favored Glycine 0 N--CA 1.426 -1.975 0 CA-C-N 113.656 -1.611 . . . . 0.0 110.256 171.578 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' D' D ' 26' ' ' LYS . . . . . 0.629 ' CB ' ' HA ' ' D' ' 21' ' ' ASN . 10.5 ptpt -148.1 161.64 41.01 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.502 -0.349 . . . . 0.0 111.629 -170.294 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 27' ' ' LEU . . . . . 0.895 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 37.4 tp -134.84 145.48 48.36 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.152 0.501 . . . . 0.0 112.007 179.486 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 28' ' ' SER . . . . . 0.591 ' HA ' ' OD1' ' D' ' 17' ' ' ASN . 29.5 t -134.04 139.23 45.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.582 -178.503 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 29' ' ' LEU . . . . . 0.502 ' CD2' ' HB2' ' D' ' 38' ' ' ALA . 15.2 mt -130.94 130.4 43.4 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.059 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 49.3 m -134.35 174.2 10.79 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 178.789 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' D' D ' 31' ' ' MET . . . . . 0.773 ' HA ' ' O ' ' D' ' 35' ' ' GLN . 25.8 ptt? -137.72 121.94 18.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.815 0.817 . . . . 0.0 111.681 176.681 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -92.2 88.32 6.44 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.025 173.531 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.69 -102.35 1.75 Allowed Glycine 0 N--CA 1.454 -0.141 0 C-N-CA 120.155 -1.021 . . . . 0.0 110.879 -170.431 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -120.21 31.25 6.58 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.179 0.514 . . . . 0.0 109.845 174.02 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' D' D ' 35' ' ' GLN . . . . . 0.773 ' O ' ' HA ' ' D' ' 31' ' ' MET . 8.1 tt0 -111.43 118.08 34.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.598 -175.519 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . 0.575 ' C ' HD12 ' D' ' 36' ' ' LEU . 2.8 tm? -79.04 135.68 36.95 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.902 0.382 . . . . 0.0 110.655 178.62 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 37' ' ' LYS . . . . . 0.401 ' HD3' ' HG2' ' D' ' 35' ' ' GLN . 13.3 mmmm -135.01 99.65 4.34 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.24 -172.754 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 38' ' ' ALA . . . . . 0.502 ' HB2' ' CD2' ' D' ' 29' ' ' LEU . . . -97.73 141.42 30.77 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.486 0.66 . . . . 0.0 111.817 -177.701 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 39' ' ' THR . . . . . 0.55 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 11.5 p -143.93 132.36 22.13 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.645 177.897 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 40' ' ' SER . . . . . 0.582 ' HA ' ' O ' ' D' ' 26' ' ' LYS . 36.8 t -106.03 128.05 53.58 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 169.38 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 41' ' ' SER . . . . . 0.657 ' O ' ' HB3' ' D' ' 42' ' ' ASN . 46.8 t -93.09 142.9 26.78 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -177.13 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 42' ' ' ASN . . . . . 0.657 ' HB3' ' O ' ' D' ' 41' ' ' SER . 5.0 t30 80.16 -15.83 0.71 Allowed 'General case' 0 CA--C 1.537 0.477 0 O-C-N 124.116 0.885 . . . . 0.0 110.705 -167.816 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 43' ' ' ALA . . . . . 0.415 ' H ' ' C ' ' D' ' 41' ' ' SER . . . 60.91 62.24 1.49 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 165.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 44' ' ' GLY . . . . . 0.515 ' C ' ' HD2' ' D' ' 45' ' ' TYR . . . 123.74 35.21 0.7 Allowed Glycine 0 CA--C 1.507 -0.42 0 C-N-CA 118.481 -1.818 . . . . 0.0 115.142 167.365 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 45' ' ' TYR . . . . . 0.706 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 3.1 m-30 -122.23 162.67 20.97 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 172.465 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . 0.797 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -100.13 -149.31 23.63 Favored Glycine 0 C--O 1.218 -0.87 0 C-N-CA 121.421 -0.419 . . . . 0.0 113.219 -175.319 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 47' ' ' ILE . . . . . 1.039 HG13 ' HB2' ' D' ' 68' ' ' GLU . 1.3 mp -63.48 -59.57 4.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -176.144 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 31.0 m 167.83 -111.96 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 111.448 -2.615 . . . . 0.0 106.477 -178.517 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -110.99 75.99 0.95 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.458 163.424 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . 0.553 ' HB3' ' HE2' ' D' ' 52' ' ' LYS . 51.4 mt-10 -148.1 177.17 9.6 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.115 -179.122 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 51' ' ' ASP . . . . . 0.753 ' HB2' ' HD2' ' D' ' 69' ' ' LYS . 2.7 p30 -143.41 129.47 19.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.338 0.59 . . . . 0.0 111.851 176.625 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 52' ' ' LYS . . . . . 0.699 ' HD3' HG12 ' D' ' 47' ' ' ILE . 4.1 mptp? -138.73 136.05 35.37 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.203 -168.55 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 53' ' ' ASN . . . . . 0.46 HD21 ' C ' ' D' ' 52' ' ' LYS . 2.6 m120 -111.98 132.54 54.71 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 172.319 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 54' ' ' TRP . . . . . 0.71 ' HB2' ' O ' ' D' ' 66' ' ' PHE . 1.4 m95 -119.04 155.27 31.75 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -173.897 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -142.64 157.9 26.85 Favored Glycine 0 N--CA 1.436 -1.333 0 CA-C-N 114.524 -1.216 . . . . 0.0 113.034 171.536 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' D' D ' 56' ' ' ILE . . . . . 0.785 HG12 HG21 ' D' ' 91' ' ' ILE . 95.1 mt -127.11 104.63 12.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-N 113.081 -1.56 . . . . 0.0 106.96 178.826 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 57' ' ' PHE . . . . . 0.66 ' HD1' ' O ' ' D' ' 90' ' ' GLU . 16.2 m-85 -103.71 106.35 16.83 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.413 -166.123 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.596 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 77.2 t -90.44 111.47 23.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.996 174.815 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 5.3 m120 53.99 45.88 26.71 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.152 -178.323 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.23 49.06 35.04 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.868 179.152 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' D' D ' 61' ' ' GLU . . . . . 0.576 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 89.0 tt0 -154.23 119.68 5.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.659 0.266 . . . . 0.0 110.548 178.386 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -73.88 107.99 6.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.08 179.407 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 23.5 m -91.77 -30.1 4.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.031 -174.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' D' D ' 64' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -140.22 134.76 31.57 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.399 179.677 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' D' D ' 65' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' D' ' 54' ' ' TRP . 32.4 m -117.64 105.68 12.29 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.412 178.005 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 66' ' ' PHE . . . . . 0.71 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 10.8 p90 -112.94 153.08 28.57 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 174.517 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -109.86 145.13 37.3 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 176.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' D' D ' 68' ' ' GLU . . . . . 1.039 ' HB2' HG13 ' D' ' 47' ' ' ILE . 35.7 mt-10 -70.66 -17.79 62.85 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 177.746 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.753 ' HD2' ' HB2' ' D' ' 51' ' ' ASP . 5.7 mtpm? -58.84 -43.95 90.86 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.375 171.095 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 18.6 t -72.12 99.95 2.43 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.665 -1.607 . . . . 0.0 107.298 171.296 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' D' D ' 71' ' ' THR . . . . . 0.425 HG21 ' O ' ' D' ' 44' ' ' GLY . 75.9 p -31.53 121.56 0.26 Allowed 'General case' 0 C--N 1.317 -0.833 0 O-C-N 124.731 1.27 . . . . 0.0 111.95 -173.246 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 72' ' ' VAL . . . . . 0.606 HG13 ' HB2' ' D' ' 27' ' ' LEU . 0.1 OUTLIER -54.38 -11.71 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -178.816 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' D' D ' 73' ' ' GLY . . . . . 0.458 ' HA3' ' HA2' ' D' ' 44' ' ' GLY . . . -69.52 -67.0 2.06 Favored Glycine 0 N--CA 1.435 -1.374 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.689 172.193 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -62.71 -21.0 65.45 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.727 0.299 . . . . 0.0 111.131 -177.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' D' D ' 75' ' ' ILE . . . . . 0.466 ' O ' HG12 ' D' ' 79' ' ' ILE . 28.7 mm -80.46 -35.96 15.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.464 176.757 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 76' ' ' SER . . . . . 0.552 ' HA ' HG12 ' D' ' 79' ' ' ILE . 30.2 t -74.37 -21.66 59.56 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.916 177.21 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 77' ' ' ASN . . . . . 0.403 ' O ' ' HD2' ' D' ' 81' ' ' LYS . 4.8 m120 -64.09 -31.33 72.48 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 166.08 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 78' ' ' ASP . . . . . 0.976 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 79.5 m-20 -78.0 -30.52 50.12 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.177 174.252 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . 0.552 HG12 ' HA ' ' D' ' 76' ' ' SER . 28.7 mm -69.72 -19.98 23.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.006 -0.678 . . . . 0.0 109.642 179.732 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -64.66 -41.44 96.1 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.854 174.182 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' D' D ' 81' ' ' LYS . . . . . 0.976 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -81.66 -56.02 4.27 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 177.832 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' D' D ' 82' ' ' LEU . . . . . 0.604 HD21 ' O ' ' D' ' 78' ' ' ASP . 4.0 mm? -48.0 -30.63 4.51 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 83' ' ' ASN . . . . . 0.547 ' O ' ' HE2' ' D' ' 85' ' ' LYS . 0.7 OUTLIER 51.34 81.95 0.07 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.227 0.611 . . . . 0.0 111.21 173.36 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' D' D ' 84' ' ' ILE . . . . . 0.708 HG21 HD11 ' D' ' 91' ' ' ILE . 48.3 mt -77.08 99.8 2.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -176.367 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 85' ' ' LYS . . . . . 0.547 ' HE2' ' O ' ' D' ' 83' ' ' ASN . 0.0 OUTLIER -160.03 91.24 0.94 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 171.973 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.2 155.88 0.51 Allowed Glycine 0 N--CA 1.454 -0.133 0 CA-C-N 114.85 -1.068 . . . . 0.0 114.915 169.506 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' D' D ' 87' ' ' PRO . . . . . 0.498 ' O ' HG12 ' D' ' 58' ' ' VAL . 67.2 Cg_endo -86.8 177.61 23.5 Favored 'Cis proline' 0 CA--C 1.532 0.403 0 C-N-CA 122.467 -1.889 . . . . 0.0 112.364 -0.399 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 88' ' ' TYR . . . . . 0.596 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 3.8 m-85 6.67 92.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 125.369 1.468 . . . . 0.0 114.173 -176.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.646 HD11 HG22 ' D' ' 84' ' ' ILE . 70.3 mt -112.02 133.05 58.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.66 ' O ' ' HD1' ' D' ' 57' ' ' PHE . 69.7 mm-40 -119.9 101.87 8.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.084 172.26 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 91' ' ' ILE . . . . . 0.785 HG21 HG12 ' D' ' 56' ' ' ILE . 2.7 mt -98.11 110.54 25.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -178.316 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 92' ' ' LYS . . . . . 0.727 ' HE2' HG23 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -162.36 170.59 18.59 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.986 -0.446 . . . . 0.0 110.038 178.337 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . 0.599 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 21.7 pt20 -81.31 158.25 24.81 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.093 175.066 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' D' D ' 94' ' ' ILE . . . . . 0.727 HG23 ' HE2' ' D' ' 92' ' ' LYS . 8.0 pt . . . . . 0 C--N 1.311 -1.08 0 CA-C-N 114.11 -1.405 . . . . 0.0 111.451 -167.128 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.518 ' O ' HG11 ' D' ' 16' ' ' VAL . 7.1 tp . . . . . 0 N--CA 1.43 -1.431 0 CA-C-O 121.215 0.531 . . . . 0.0 112.373 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' D' D ' 14' ' ' ASN . . . . . 0.505 ' O ' ' HB2' ' D' ' 17' ' ' ASN . 3.9 m120 -95.69 -36.42 11.21 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.532 173.647 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 15' ' ' SER . . . . . 0.538 ' O ' ' HB2' ' D' ' 18' ' ' ASP . 80.3 p -75.89 -23.71 55.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.894 0.378 . . . . 0.0 110.224 178.142 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 16' ' ' VAL . . . . . 0.518 HG11 ' O ' ' D' ' 13' ' ' ILE . 5.6 p -61.27 -22.4 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 CA-C-O 122.196 0.998 . . . . 0.0 108.85 176.264 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 17' ' ' ASN . . . . . 0.505 ' HB2' ' O ' ' D' ' 14' ' ' ASN . 4.3 m120 -74.02 -39.73 63.37 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 113.578 -1.646 . . . . 0.0 109.271 176.476 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 18' ' ' ASP . . . . . 0.538 ' HB2' ' O ' ' D' ' 15' ' ' SER . 74.9 m-20 -57.34 -17.19 11.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.4 -0.818 . . . . 0.0 113.007 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.538 ' HD2' ' N ' ' D' ' 19' ' ' LYS . 0.0 OUTLIER -90.69 -40.72 11.7 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 121.957 0.884 . . . . 0.0 108.723 174.77 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' D' D ' 20' ' ' LEU . . . . . 0.701 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 81.5 mt -68.31 -34.83 76.85 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 113.327 -1.76 . . . . 0.0 110.523 -177.54 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 21' ' ' ASN . . . . . 0.663 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 63.6 m-20 -78.61 100.55 7.03 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.203 -179.356 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 22' ' ' LYS . . . . . 0.601 ' HD3' HD12 ' D' ' 47' ' ' ILE . 38.3 mtpt -122.07 -42.55 2.38 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 119.066 -1.054 . . . . 0.0 113.263 -170.398 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 158.11 -74.28 0.22 Allowed Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.144 -1.026 . . . . 0.0 112.719 -176.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . 0.831 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 21.9 tptm -53.06 -54.84 29.45 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.239 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 25' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -150.44 154.52 25.69 Favored Glycine 0 N--CA 1.429 -1.803 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.772 175.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 26' ' ' LYS . . . . . 0.725 ' CG ' ' HB3' ' D' ' 41' ' ' SER . 10.0 ptpt -149.67 159.61 44.2 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.707 -0.747 . . . . 0.0 110.897 -166.618 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 27' ' ' LEU . . . . . 0.701 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 42.7 tp -136.97 138.34 40.45 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.446 0.641 . . . . 0.0 111.904 -176.451 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 28' ' ' SER . . . . . 0.533 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 18.0 t -128.41 153.94 46.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.061 -178.188 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 29' ' ' LEU . . . . . 0.478 ' CD2' ' HB1' ' D' ' 38' ' ' ALA . 22.7 mt -138.22 152.47 48.64 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.987 0.422 . . . . 0.0 110.262 177.465 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 30' ' ' SER . . . . . 0.487 ' HB3' ' HB2' ' D' ' 37' ' ' LYS . 36.7 t -145.4 -171.25 3.63 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.411 178.787 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 31' ' ' MET . . . . . 0.431 ' HE2' ' HB3' ' D' ' 31' ' ' MET . 23.5 ptp -145.85 166.57 25.56 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.84 0.352 . . . . 0.0 110.187 -179.854 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 32' ' ' ASN . . . . . 0.625 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 48.9 t30 -150.4 87.24 1.44 Allowed 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 174.769 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.83 -98.64 0.79 Allowed Glycine 0 N--CA 1.454 -0.166 0 C-N-CA 120.004 -1.093 . . . . 0.0 111.14 -171.366 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -112.6 14.46 20.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.853 0.359 . . . . 0.0 110.135 174.185 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' D' D ' 35' ' ' GLN . . . . . 0.625 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 3.5 tp-100 -89.21 159.13 17.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.601 -174.791 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . 0.953 ' HB2' ' HB2' ' D' ' 85' ' ' LYS . 0.8 OUTLIER -121.24 135.79 55.07 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.299 179.352 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' D' D ' 37' ' ' LYS . . . . . 0.487 ' HB2' ' HB3' ' D' ' 30' ' ' SER . 74.5 mmtt -133.62 139.84 46.74 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.472 -171.511 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 38' ' ' ALA . . . . . 0.478 ' HB1' ' CD2' ' D' ' 29' ' ' LEU . . . -138.6 147.6 43.16 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.861 0.362 . . . . 0.0 111.074 177.184 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 39' ' ' THR . . . . . 0.533 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 17.7 p -147.1 131.94 18.04 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.369 175.731 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 40' ' ' SER . . . . . 0.608 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 80.2 p -108.82 170.66 7.9 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 175.456 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 41' ' ' SER . . . . . 0.725 ' HB3' ' CG ' ' D' ' 26' ' ' LYS . 38.1 t -134.46 153.61 51.84 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.378 -0.929 . . . . 0.0 111.356 177.662 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 42' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' D' ' 41' ' ' SER . 75.3 m-80 79.57 9.41 1.57 Allowed 'General case' 0 N--CA 1.467 0.409 0 O-C-N 124.863 1.352 . . . . 0.0 110.462 -174.279 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 42.82 59.62 2.76 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 114.692 -1.14 . . . . 0.0 113.683 171.247 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' D' D ' 44' ' ' GLY . . . . . 0.611 ' O ' HG23 ' D' ' 71' ' ' THR . . . 112.94 35.96 1.59 Allowed Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 119.576 -1.297 . . . . 0.0 114.087 172.534 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 45' ' ' TYR . . . . . 0.831 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 1.2 m-85 -121.42 149.6 42.77 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 170.986 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . 0.591 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -100.11 -153.25 27.1 Favored Glycine 0 C--O 1.221 -0.703 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 -178.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 47' ' ' ILE . . . . . 0.623 HG12 ' CB ' ' D' ' 68' ' ' GLU . 40.3 mm -52.26 -57.82 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 CA-C-O 121.773 0.797 . . . . 0.0 109.618 175.418 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 78.7 p 179.37 -78.0 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 113.035 -1.893 . . . . 0.0 109.206 -174.569 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' D' D ' 49' ' ' TYR . . . . . 0.403 ' O ' ' HD1' ' D' ' 49' ' ' TYR . 0.1 OUTLIER -157.52 74.59 0.76 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.811 171.662 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -147.12 148.51 31.65 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.588 -178.131 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' D' D ' 51' ' ' ASP . . . . . 0.673 ' CB ' ' HD3' ' D' ' 69' ' ' LYS . 7.7 p-10 -89.59 119.39 29.97 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.214 177.04 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 52' ' ' LYS . . . . . 0.621 ' O ' ' HA ' ' D' ' 67' ' ' ASN . 11.6 mmmm -128.48 101.28 6.12 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.387 -166.127 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 53' ' ' ASN . . . . . 0.407 ' N ' HD21 ' D' ' 53' ' ' ASN . 2.6 m120 -88.99 127.01 35.66 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.07 176.765 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 54' ' ' TRP . . . . . 0.448 ' CH2' ' HA ' ' D' ' 92' ' ' LYS . 0.0 OUTLIER -124.97 164.97 18.97 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.062 -173.421 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -154.55 164.34 31.56 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.543 -1.313 . . . . 0.0 114.688 177.279 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' D' D ' 56' ' ' ILE . . . . . 0.469 HG21 ' CG2' ' D' ' 89' ' ' ILE . 72.7 mt -140.14 107.16 2.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 125.6 1.56 . . . . 0.0 107.02 -179.156 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 57' ' ' PHE . . . . . 0.515 ' HD2' ' O ' ' D' ' 90' ' ' GLU . 4.7 m-85 -114.3 109.25 18.07 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.318 -167.725 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.744 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 0.2 OUTLIER -101.29 118.71 48.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.216 0.531 . . . . 0.0 111.567 171.611 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 5.6 m120 50.57 54.14 11.7 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.845 179.082 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.16 47.89 80.56 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.73 177.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -157.01 114.52 3.14 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.4 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -80.99 99.59 8.5 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.143 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 27.5 m -82.76 -18.24 10.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.471 -173.826 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' D' D ' 64' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -147.82 130.37 15.87 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.414 -0.514 . . . . 0.0 111.01 176.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 57.9 m -115.63 125.61 53.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.368 174.491 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' D' D ' 66' ' ' PHE . . . . . 0.417 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 15.7 p90 -132.1 163.36 28.65 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.743 177.159 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 67' ' ' ASN . . . . . 0.621 ' HA ' ' O ' ' D' ' 52' ' ' LYS . 74.5 m-80 -129.76 143.02 50.61 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.296 -176.189 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 68' ' ' GLU . . . . . 0.623 ' CB ' HG12 ' D' ' 47' ' ' ILE . 3.9 mm-40 -75.37 -17.93 60.1 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 176.835 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.673 ' HD3' ' CB ' ' D' ' 51' ' ' ASP . 44.1 mtmt -60.03 -48.73 80.49 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 168.532 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 19.7 m -78.17 61.44 2.68 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 111.857 -2.428 . . . . 0.0 109.236 171.596 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' D' D ' 71' ' ' THR . . . . . 0.611 HG23 ' O ' ' D' ' 44' ' ' GLY . 74.3 p -1.62 121.84 0.0 OUTLIER 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.873 1.669 . . . . 0.0 114.992 -179.338 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 72' ' ' VAL . . . . . 0.62 HG13 ' HB2' ' D' ' 27' ' ' LEU . 0.1 OUTLIER -44.58 -21.31 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 123.436 0.694 . . . . 0.0 112.613 171.207 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' D' D ' 73' ' ' GLY . . . . . 0.608 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -60.69 -65.87 3.06 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.819 -0.628 . . . . 0.0 113.712 175.275 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 74' ' ' ASN . . . . . 0.438 ' HA ' HD21 ' D' ' 77' ' ' ASN . 4.5 m120 -71.47 -20.2 62.11 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 120.971 0.415 . . . . 0.0 110.82 -175.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 75' ' ' ILE . . . . . 0.614 ' O ' HG13 ' D' ' 79' ' ' ILE . 27.1 mm -79.34 -40.1 21.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.882 179.472 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 76' ' ' SER . . . . . 0.52 ' HA ' HG13 ' D' ' 79' ' ' ILE . 31.0 t -74.49 -19.98 60.17 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.223 -179.738 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 77' ' ' ASN . . . . . 0.438 HD21 ' HA ' ' D' ' 74' ' ' ASN . 79.4 m-20 -64.97 -32.42 74.14 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 119.368 -0.933 . . . . 0.0 108.586 166.651 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 78' ' ' ASP . . . . . 1.042 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 60.0 m-20 -79.31 -25.1 42.42 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 176.7 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . 0.614 HG13 ' O ' ' D' ' 75' ' ' ILE . 48.6 mt -72.0 -20.62 20.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 O-C-N 121.514 -0.741 . . . . 0.0 111.129 -175.37 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -71.15 -40.19 71.5 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.426 175.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' D' D ' 81' ' ' LYS . . . . . 1.042 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -73.78 -54.21 8.55 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.642 176.322 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' D' D ' 82' ' ' LEU . . . . . 0.621 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.9 mm? -47.29 -33.35 5.53 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 177.532 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 83' ' ' ASN . . . . . 0.642 HD21 ' HB3' ' D' ' 36' ' ' LEU . 0.7 OUTLIER 42.07 67.08 0.62 Allowed 'General case' 0 N--CA 1.468 0.438 0 O-C-N 124.002 0.814 . . . . 0.0 110.864 174.774 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' D' D ' 84' ' ' ILE . . . . . 0.573 ' O ' ' HG ' ' D' ' 36' ' ' LEU . 44.1 mm -94.94 98.81 8.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.165 -175.084 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 85' ' ' LYS . . . . . 0.953 ' HB2' ' HB2' ' D' ' 36' ' ' LEU . 46.4 tptt -139.97 94.47 2.76 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.171 0.51 . . . . 0.0 110.812 -178.63 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 86' ' ' GLY . . . . . 0.529 ' H ' ' CD1' ' D' ' 89' ' ' ILE . . . 69.54 161.98 3.11 Favored Glycine 0 CA--C 1.5 -0.845 0 CA-C-N 115.231 -0.895 . . . . 0.0 114.357 177.42 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 87' ' ' PRO . . . . . 0.508 ' HD2' HG23 ' D' ' 58' ' ' VAL . 61.7 Cg_endo -77.03 -172.1 10.77 Favored 'Cis proline' 0 CA--C 1.545 1.055 0 C-N-CA 122.195 -2.002 . . . . 0.0 114.128 0.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 88' ' ' TYR . . . . . 0.744 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 2.2 m-85 -9.38 94.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 125.485 1.514 . . . . 0.0 114.668 -174.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.604 HG23 HG13 ' D' ' 91' ' ' ILE . 70.1 mt -102.19 142.1 17.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.515 ' O ' ' HD2' ' D' ' 57' ' ' PHE . 46.3 mt-10 -116.32 98.58 6.67 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.528 170.557 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 91' ' ' ILE . . . . . 0.604 HG13 HG23 ' D' ' 89' ' ' ILE . 33.0 mt -94.34 100.25 10.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.024 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 92' ' ' LYS . . . . . 0.741 ' HE2' HG21 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -159.68 166.68 30.08 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.416 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . 0.652 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 3.8 pm0 -80.41 162.95 24.2 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 121.533 0.682 . . . . 0.0 110.696 175.903 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' D' D ' 94' ' ' ILE . . . . . 0.741 HG21 ' HE2' ' D' ' 92' ' ' LYS . 9.8 pt . . . . . 0 C--N 1.307 -1.26 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.585 -171.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.576 ' HA ' HG13 ' D' ' 16' ' ' VAL . 64.0 mt . . . . . 0 N--CA 1.452 -0.365 0 CA-C-O 121.606 0.717 . . . . 0.0 111.365 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -93.53 -59.12 2.08 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.395 175.183 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' D' D ' 15' ' ' SER . . . . . 0.499 ' O ' ' HE2' ' D' ' 19' ' ' LYS . 84.6 p -64.79 -15.19 61.36 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.644 0.239 . . . . 0.0 111.644 179.592 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 16' ' ' VAL . . . . . 0.576 HG13 ' HA ' ' D' ' 13' ' ' ILE . 11.8 p -60.64 -30.68 47.39 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.085 0 CA-C-O 121.527 0.679 . . . . 0.0 109.478 175.64 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 17' ' ' ASN . . . . . 0.424 ' N ' HG12 ' D' ' 16' ' ' VAL . 2.6 m120 -71.95 -39.59 69.28 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.044 177.079 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 18' ' ' ASP . . . . . 0.449 ' OD1' ' HA ' ' D' ' 15' ' ' SER . 1.2 m-20 -58.95 -15.55 13.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.691 -179.367 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.604 ' O ' ' HE3' ' D' ' 22' ' ' LYS . 31.9 mttm -91.03 -52.71 4.7 Favored 'General case' 0 CA--C 1.492 -1.259 0 CA-C-O 122.525 1.155 . . . . 0.0 108.765 179.131 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 20' ' ' LEU . . . . . 0.948 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 55.7 mt -57.1 -40.34 76.84 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 112.381 -2.19 . . . . 0.0 110.734 178.266 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 21' ' ' ASN . . . . . 0.528 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 53.3 m-20 -76.04 94.15 3.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.153 179.054 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 22' ' ' LYS . . . . . 0.626 ' HD2' HD12 ' D' ' 47' ' ' ILE . 95.7 mttt -121.81 -42.19 2.42 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -175.397 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 172.02 -92.38 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 119.589 -1.291 . . . . 0.0 113.337 -178.742 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . 0.727 ' HG2' ' HB3' ' D' ' 45' ' ' TYR . 80.4 tttt -47.22 -50.05 21.84 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.654 0.74 . . . . 0.0 109.628 178.195 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -141.54 158.08 26.42 Favored Glycine 0 N--CA 1.432 -1.626 0 CA-C-N 114.383 -1.281 . . . . 0.0 111.524 175.884 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' D' D ' 26' ' ' LYS . . . . . 0.75 ' HZ2' ' HB3' ' D' ' 26' ' ' LYS . 0.2 OUTLIER -150.47 161.3 42.79 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.672 -0.764 . . . . 0.0 110.24 -170.448 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' D' D ' 27' ' ' LEU . . . . . 0.948 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 35.5 tp -140.19 143.67 36.2 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.129 0.49 . . . . 0.0 111.116 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 28' ' ' SER . . . . . 0.463 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 13.0 t -140.6 109.78 6.17 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.703 -176.217 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 29' ' ' LEU . . . . . 0.518 HD11 ' O ' ' D' ' 29' ' ' LEU . 0.9 OUTLIER -131.61 145.75 51.85 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -179.767 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 72.8 p -160.18 -171.71 3.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.513 -177.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' D' D ' 31' ' ' MET . . . . . 0.813 ' HA ' ' O ' ' D' ' 35' ' ' GLN . 69.9 mtm -125.73 131.23 52.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.173 0.511 . . . . 0.0 111.005 176.127 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -90.78 88.87 7.24 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 172.612 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.53 -99.86 1.64 Allowed Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -164.439 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' D' D ' 34' ' ' ASN . . . . . 0.679 ' O ' ' HE3' ' D' ' 85' ' ' LYS . 75.4 m-80 -120.99 13.45 11.35 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.672 -0.311 . . . . 0.0 110.569 171.879 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 35' ' ' GLN . . . . . 0.813 ' O ' ' HA ' ' D' ' 31' ' ' MET . 52.2 tt0 -88.52 126.39 35.23 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.041 -175.102 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . 0.531 ' HG ' ' N ' ' D' ' 84' ' ' ILE . 3.0 tm? -79.08 124.67 28.51 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.278 0.561 . . . . 0.0 111.13 -179.311 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 37' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 30.9 mmmt -135.91 117.09 14.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.523 -170.756 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 38' ' ' ALA . . . . . 0.511 ' HB3' ' HB3' ' D' ' 29' ' ' LEU . . . -126.91 148.46 50.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.215 0.531 . . . . 0.0 112.068 -177.374 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 39' ' ' THR . . . . . 0.463 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 15.5 p -146.87 124.85 12.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.797 177.581 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 40' ' ' SER . . . . . 0.505 ' HB2' ' HA2' ' D' ' 73' ' ' GLY . 69.2 m -110.7 128.86 55.89 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 173.378 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 41' ' ' SER . . . . . 0.674 ' HB2' ' CD ' ' D' ' 26' ' ' LYS . 50.2 m -97.59 161.71 13.64 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.987 -174.217 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 42' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' D' ' 41' ' ' SER . 71.9 m-80 79.69 10.88 1.33 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.901 -172.006 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 39.74 61.85 1.34 Allowed 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 169.355 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' D' D ' 44' ' ' GLY . . . . . 0.458 ' O ' HG22 ' D' ' 71' ' ' THR . . . 126.54 -5.53 7.58 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 118.745 -1.693 . . . . 0.0 115.315 172.111 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 45' ' ' TYR . . . . . 0.727 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 1.6 m-85 -96.6 155.84 16.6 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 117.454 0.627 . . . . 0.0 111.882 -178.738 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . 0.64 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -101.82 -177.13 28.2 Favored Glycine 0 C--O 1.214 -1.115 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 173.088 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 47' ' ' ILE . . . . . 0.912 HG12 ' HB3' ' D' ' 68' ' ' GLU . 34.9 mm -48.09 -55.28 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.836 0 CA-C-N 118.391 1.095 . . . . 0.0 110.239 178.376 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 48' ' ' SER . . . . . 0.519 ' HA ' ' HD3' ' D' ' 24' ' ' LYS . 23.2 t 179.44 -156.67 0.02 OUTLIER 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 113.026 -1.897 . . . . 0.0 107.154 -177.268 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 49' ' ' TYR . . . . . 0.476 ' O ' ' HD1' ' D' ' 49' ' ' TYR . 0.3 OUTLIER -81.13 76.81 8.07 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.795 0.807 . . . . 0.0 109.794 167.969 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . 0.653 ' O ' ' HG2' ' D' ' 69' ' ' LYS . 71.2 mm-40 -119.24 -163.04 0.94 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.993 -171.964 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 51' ' ' ASP . . . . . 0.681 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 11.6 t70 -162.76 107.44 1.13 Allowed 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.631 170.633 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 52' ' ' LYS . . . . . 0.683 ' HG2' ' OE1' ' D' ' 68' ' ' GLU . 4.2 mptp? -138.67 109.1 6.51 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 113.755 -1.566 . . . . 0.0 109.447 -172.812 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 53' ' ' ASN . . . . . 0.446 ' HA ' ' OD1' ' D' ' 67' ' ' ASN . 2.9 m120 -83.66 131.41 34.95 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.297 177.764 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 54' ' ' TRP . . . . . 0.556 ' NE1' ' HB3' ' D' ' 93' ' ' GLN . 0.3 OUTLIER -120.55 153.52 36.62 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.82 -173.139 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -144.87 159.54 27.86 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 120.019 -1.086 . . . . 0.0 113.578 174.313 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' D' D ' 56' ' ' ILE . . . . . 0.676 HG22 HG12 ' D' ' 91' ' ' ILE . 61.8 mt -134.31 111.94 15.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 176.557 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 57' ' ' PHE . . . . . 0.59 ' HA ' ' O ' ' D' ' 61' ' ' GLU . 3.6 m-85 -110.77 105.04 13.75 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 119.214 -0.994 . . . . 0.0 111.122 -166.633 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.715 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 94.3 t -89.04 108.47 19.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.977 173.647 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 59' ' ' ASN . . . . . 0.672 HD22 ' HG2' ' D' ' 87' ' ' PRO . 77.8 m-20 60.89 52.18 4.33 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.344 -177.525 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 57.82 47.44 88.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.291 -179.5 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' D' D ' 61' ' ' GLU . . . . . 0.59 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 5.3 tp10 -151.82 125.41 8.93 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.252 -0.474 . . . . 0.0 109.904 -177.398 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -67.77 105.82 2.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.093 0.473 . . . . 0.0 109.954 177.103 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 14.6 p -86.69 -21.98 7.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.193 -178.044 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' D' D ' 64' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -156.92 135.14 11.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.324 176.429 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' D' D ' 65' ' ' THR . . . . . 0.415 HG23 ' O ' ' D' ' 54' ' ' TRP . 74.9 m -120.28 120.48 36.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.721 0.296 . . . . 0.0 110.757 176.77 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 66' ' ' PHE . . . . . 0.519 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 21.2 p90 -126.76 171.12 11.47 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 173.317 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 67' ' ' ASN . . . . . 0.446 ' OD1' ' HA ' ' D' ' 53' ' ' ASN . 75.4 m-20 -129.88 152.76 49.01 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 68' ' ' GLU . . . . . 0.912 ' HB3' HG12 ' D' ' 47' ' ' ILE . 33.5 mt-10 -76.66 -8.36 57.1 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.044 178.473 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.653 ' HG2' ' O ' ' D' ' 50' ' ' GLU . 48.6 mtpt -69.63 -50.36 45.03 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 168.759 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 13.8 t -61.93 120.46 10.81 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 113.569 -1.65 . . . . 0.0 107.685 172.621 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' D' D ' 71' ' ' THR . . . . . 0.458 HG22 ' O ' ' D' ' 44' ' ' GLY . 81.0 p -54.17 114.06 1.48 Allowed 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.929 -172.676 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 72' ' ' VAL . . . . . 0.62 HG11 ' HB2' ' D' ' 27' ' ' LEU . 0.1 OUTLIER -50.63 -23.29 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.727 -179.483 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' D' D ' 73' ' ' GLY . . . . . 0.505 ' HA2' ' HB2' ' D' ' 40' ' ' SER . . . -58.4 -66.77 2.58 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.733 -0.667 . . . . 0.0 113.62 173.231 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 74' ' ' ASN . . . . . 0.593 ' HA ' HD21 ' D' ' 77' ' ' ASN . 4.3 m120 -63.79 -24.28 67.7 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 120.796 0.331 . . . . 0.0 110.801 -178.003 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 75' ' ' ILE . . . . . 0.445 ' O ' HG12 ' D' ' 79' ' ' ILE . 36.6 mm -78.39 -38.8 23.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.606 178.348 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 76' ' ' SER . . . . . 0.902 ' HA ' HG12 ' D' ' 79' ' ' ILE . 36.9 t -76.2 -19.93 57.95 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.479 -0.489 . . . . 0.0 111.002 179.544 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 77' ' ' ASN . . . . . 0.593 HD21 ' HA ' ' D' ' 74' ' ' ASN . 75.3 m-20 -63.35 -32.39 73.8 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 166.073 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 78' ' ' ASP . . . . . 1.074 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 1.1 m-20 -79.27 -25.03 42.56 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.94 174.033 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . 0.902 HG12 ' HA ' ' D' ' 76' ' ' SER . 22.2 mm -69.03 -25.32 29.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.235 -177.729 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -73.01 -33.31 65.69 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.855 179.331 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' D' D ' 81' ' ' LYS . . . . . 1.074 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -77.82 -61.18 2.08 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.97 174.197 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' D' D ' 82' ' ' LEU . . . . . 0.601 HD21 ' O ' ' D' ' 78' ' ' ASP . 3.8 mm? -48.53 -31.81 7.02 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 176.314 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 83' ' ' ASN . . . . . 0.525 ' HA ' HD11 ' D' ' 36' ' ' LEU . 22.3 t-20 25.01 80.86 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 O-C-N 124.973 1.42 . . . . 0.0 112.533 177.0 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 84' ' ' ILE . . . . . 0.531 ' N ' ' HG ' ' D' ' 36' ' ' LEU . 2.7 mp -81.56 99.25 4.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.612 -175.174 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 85' ' ' LYS . . . . . 0.679 ' HE3' ' O ' ' D' ' 34' ' ' ASN . 21.5 ptmt -126.76 92.08 3.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.284 0.564 . . . . 0.0 111.318 179.664 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 86' ' ' GLY . . . . . 0.533 ' H ' ' CD1' ' D' ' 89' ' ' ILE . . . 65.2 154.26 0.16 Allowed Glycine 0 CA--C 1.516 0.11 0 CA-C-N 115.911 -0.586 . . . . 0.0 113.433 177.261 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 87' ' ' PRO . . . . . 0.672 ' HG2' HD22 ' D' ' 59' ' ' ASN . 56.8 Cg_endo -90.85 -179.65 12.44 Favored 'Cis proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.515 -1.452 . . . . 0.0 112.797 -0.429 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 88' ' ' TYR . . . . . 0.715 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 0.9 OUTLIER 18.65 93.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.081 1.353 . . . . 0.0 113.531 179.637 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.641 HG23 HG13 ' D' ' 91' ' ' ILE . 74.2 mt -111.02 136.78 46.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.097 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.545 ' O ' ' HD1' ' D' ' 57' ' ' PHE . 35.9 mm-40 -123.55 93.47 3.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.678 172.438 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 91' ' ' ILE . . . . . 0.676 HG12 HG22 ' D' ' 56' ' ' ILE . 32.2 mt -94.25 99.38 9.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.822 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 92' ' ' LYS . . . . . 0.754 ' HE2' HG23 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -162.65 167.34 23.32 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.198 178.432 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . 0.608 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 23.6 pt20 -81.18 164.45 22.32 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.067 175.116 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' D' D ' 94' ' ' ILE . . . . . 0.754 HG23 ' HE2' ' D' ' 92' ' ' LYS . 6.3 pt . . . . . 0 C--O 1.245 0.85 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.8 -169.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 2.7 p30 . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 120.621 0.248 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 2' ' ' ASN . . . . . 0.427 ' O ' ' HE1' ' D' ' 88' ' ' TYR . 76.3 m-20 -80.18 94.69 6.08 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.372 177.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -60.45 -47.86 84.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.861 -177.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -110.69 -9.1 14.53 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.462 -176.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 5' ' ' ALA . . . . . . . . . . . . . . . 59.74 38.08 21.85 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.734 -176.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.6 -46.12 73.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.508 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -61.48 -27.21 68.41 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.418 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.675 ' HA ' ' CB ' ' D' ' 12' ' ' SER . 55.6 mm-40 -67.48 -29.46 68.91 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.561 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . 0.458 HE21 ' HB2' ' D' ' 8' ' ' GLU . 59.9 mm-40 -89.38 6.86 38.71 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.379 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 10' ' ' MET . . . . . . . . . . . . . 91.3 mmm -107.06 -75.49 0.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.037 0.446 . . . . 0.0 111.495 -176.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -100.62 -48.34 4.55 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.03 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 12' ' ' SER . . . . . 0.675 ' CB ' ' HA ' ' D' ' 8' ' ' GLU . 41.9 t -28.37 -70.63 0.04 OUTLIER 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -172.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.503 HG22 ' O ' ' D' ' 13' ' ' ILE . 68.6 mt -71.85 -8.15 10.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.668 -172.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -95.9 -40.83 9.11 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.599 172.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 15' ' ' SER . . . . . 0.468 ' O ' ' HD2' ' D' ' 19' ' ' LYS . 79.6 p -70.98 -26.92 63.36 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.734 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 16' ' ' VAL . . . . . 0.517 HG21 ' O ' ' D' ' 91' ' ' ILE . 11.4 p -53.37 -28.91 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 121.802 0.81 . . . . 0.0 110.623 177.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 17' ' ' ASN . . . . . 0.422 ' N ' HG11 ' D' ' 16' ' ' VAL . 4.3 m120 -72.67 -43.19 63.46 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.374 -1.285 . . . . 0.0 109.668 176.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 18' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' D' ' 15' ' ' SER . 74.7 m-20 -57.97 -14.91 7.27 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -177.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.568 ' HD2' ' N ' ' D' ' 19' ' ' LYS . 0.0 OUTLIER -90.14 -41.4 11.66 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.508 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 20' ' ' LEU . . . . . 0.681 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 63.8 mt -73.87 -39.6 63.82 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 112.905 -1.952 . . . . 0.0 109.796 -176.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 21' ' ' ASN . . . . . 0.631 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 3.0 m120 -75.44 91.75 2.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.894 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 22' ' ' LYS . . . . . 0.554 ' HD3' HD11 ' D' ' 47' ' ' ILE . 28.8 mtpp -122.13 -41.77 2.41 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -176.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.9 -92.03 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 119.411 -1.375 . . . . 0.0 113.931 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . 0.717 ' HG2' ' HB3' ' D' ' 45' ' ' TYR . 58.1 tttm -48.55 -54.7 13.42 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.572 0.701 . . . . 0.0 110.152 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 25' ' ' GLY . . . . . 0.553 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -144.29 154.06 25.47 Favored Glycine 0 N--CA 1.433 -1.502 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.351 175.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 26' ' ' LYS . . . . . 0.668 ' HG3' ' HB2' ' D' ' 41' ' ' SER . 9.1 ptpt -150.94 161.37 42.85 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.482 -0.859 . . . . 0.0 111.335 -167.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 27' ' ' LEU . . . . . 0.681 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 38.3 tp -132.01 142.92 49.73 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.71 0.767 . . . . 0.0 112.185 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 28' ' ' SER . . . . . 0.752 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 48.0 m -132.77 144.91 50.58 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.423 -176.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 29' ' ' LEU . . . . . 0.54 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 0.0 OUTLIER -141.28 147.14 37.73 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 119.549 -0.861 . . . . 0.0 110.789 -177.779 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 41.3 m -149.77 176.34 10.79 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.179 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -138.23 166.13 24.95 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.105 0.479 . . . . 0.0 110.926 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 32' ' ' ASN . . . . . 0.677 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 0.7 OUTLIER -148.17 87.53 1.61 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.6 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.01 -98.87 0.66 Allowed Glycine 0 N--CA 1.455 -0.056 0 C-N-CA 119.941 -1.123 . . . . 0.0 111.011 -172.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 34' ' ' ASN . . . . . 0.648 ' O ' ' HE3' ' D' ' 85' ' ' LYS . 73.0 m-80 -116.33 31.12 6.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.048 0.452 . . . . 0.0 110.342 173.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 35' ' ' GLN . . . . . 0.677 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 70.7 tp60 -106.8 148.59 28.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.2 -178.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . 0.618 HD13 ' C ' ' D' ' 36' ' ' LEU . 2.9 tm? -118.53 136.04 54.06 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.924 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 37' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 25.5 mmmt -134.12 110.77 9.81 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.358 -171.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 38' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -118.71 146.56 44.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.163 0.506 . . . . 0.0 111.578 178.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 39' ' ' THR . . . . . 0.752 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 7.0 p -142.98 132.05 23.05 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.958 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 40' ' ' SER . . . . . 0.598 ' HA ' ' O ' ' D' ' 26' ' ' LYS . 25.2 p -107.78 129.21 55.07 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 172.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 41' ' ' SER . . . . . 0.668 ' HB2' ' HG3' ' D' ' 26' ' ' LYS . 40.6 m -95.16 146.88 24.0 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.161 -1.016 . . . . 0.0 109.687 -177.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 42' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' D' ' 41' ' ' SER . 76.1 m-20 80.2 5.46 1.78 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.995 -169.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 50.35 62.81 2.49 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 168.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.09 -11.82 7.26 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 118.672 -1.728 . . . . 0.0 115.594 170.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 45' ' ' TYR . . . . . 0.717 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 1.6 m-85 -85.36 157.46 20.52 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 117.406 0.603 . . . . 0.0 111.739 -177.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . 0.654 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -100.01 -173.93 30.36 Favored Glycine 0 C--O 1.215 -1.046 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 175.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 47' ' ' ILE . . . . . 0.708 HG12 ' HB3' ' D' ' 68' ' ' GLU . 36.1 mm -47.79 -57.86 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 CA-C-O 122.254 1.026 . . . . 0.0 110.081 177.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.586 ' HA ' ' HD3' ' D' ' 24' ' ' LYS . 78.5 p -175.63 -102.3 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 112.875 -1.966 . . . . 0.0 108.812 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.54 77.25 1.59 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.996 0.903 . . . . 0.0 110.094 166.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . 0.675 ' HB2' ' HE3' ' D' ' 52' ' ' LYS . 56.1 mt-10 -139.9 179.22 6.73 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.011 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 51' ' ' ASP . . . . . 0.644 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 2.9 p30 -124.66 140.42 52.95 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.522 0.677 . . . . 0.0 112.014 174.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 52' ' ' LYS . . . . . 0.792 ' HD3' ' HB2' ' D' ' 68' ' ' GLU . 0.3 OUTLIER -146.42 136.69 23.74 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.234 -175.457 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -109.69 129.64 55.59 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.713 -0.395 . . . . 0.0 109.962 175.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 54' ' ' TRP . . . . . 0.621 ' HZ3' ' CG2' ' D' ' 91' ' ' ILE . 1.1 m95 -124.25 165.2 18.03 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -174.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 55' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' D' ' 64' ' ' TYR . . . -155.15 170.33 33.27 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.928 174.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 56' ' ' ILE . . . . . 0.564 HG12 ' CG2' ' D' ' 91' ' ' ILE . 96.0 mt -138.28 113.7 9.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 124.917 1.287 . . . . 0.0 107.676 -177.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 57' ' ' PHE . . . . . 0.735 ' HB2' ' HB3' ' D' ' 90' ' ' GLU . 10.1 m-85 -115.59 105.89 13.29 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.934 -0.706 . . . . 0.0 112.018 -166.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.712 HG11 ' O ' ' D' ' 87' ' ' PRO . 81.8 t -82.69 101.33 7.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.227 173.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 59' ' ' ASN . . . . . 0.449 HD22 ' HG2' ' D' ' 87' ' ' PRO . 75.5 m-80 58.95 43.55 17.71 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.892 0.377 . . . . 0.0 110.287 -176.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.52 45.51 45.75 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.641 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 61' ' ' GLU . . . . . 0.621 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 86.2 mt-10 -137.05 105.69 5.84 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 177.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . 0.53 ' HB2' ' CE1' ' D' ' 57' ' ' PHE . 38.8 ttmt -70.83 99.49 1.75 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -178.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 32.7 m -88.41 -19.93 7.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -174.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 64' ' ' TYR . . . . . 0.51 ' HH ' ' CB ' ' D' ' 78' ' ' ASP . 16.1 t80 -148.17 140.42 24.22 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.307 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 60.7 m -119.73 118.02 29.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.35 176.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 66' ' ' PHE . . . . . 0.513 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 12.1 p90 -123.27 152.96 40.84 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 174.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 67' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' D' ' 52' ' ' LYS . 74.0 m-20 -119.87 135.83 54.73 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -177.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 68' ' ' GLU . . . . . 0.792 ' HB2' ' HD3' ' D' ' 52' ' ' LYS . 4.1 mm-40 -65.96 -8.19 21.24 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.792 0.329 . . . . 0.0 110.694 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.446 ' NZ ' ' HB3' ' D' ' 69' ' ' LYS . 5.9 mtpm? -60.48 -47.75 84.75 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 169.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 70' ' ' SER . . . . . 0.472 ' O ' HD13 ' D' ' 75' ' ' ILE . 22.8 t -66.87 131.43 45.9 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 113.385 -1.734 . . . . 0.0 107.87 168.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 71' ' ' THR . . . . . 0.418 ' O ' HG13 ' D' ' 75' ' ' ILE . 69.7 p -60.42 127.89 33.99 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.072 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 72' ' ' VAL . . . . . 0.667 HG12 ' HB2' ' D' ' 27' ' ' LEU . 0.1 OUTLIER -56.61 -11.79 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 120.902 0.382 . . . . 0.0 111.767 -178.757 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 73' ' ' GLY . . . . . 0.595 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -73.17 -58.3 4.76 Favored Glycine 0 N--CA 1.435 -1.37 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.084 168.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -61.2 -25.75 67.25 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-O 121.114 0.483 . . . . 0.0 110.489 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 75' ' ' ILE . . . . . 0.528 ' O ' HG12 ' D' ' 79' ' ' ILE . 76.8 mt -73.5 -40.31 55.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.637 177.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 76' ' ' SER . . . . . 0.635 ' HA ' HG12 ' D' ' 79' ' ' ILE . 31.0 t -74.72 -19.31 60.29 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.654 178.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 77' ' ' ASN . . . . . 0.443 ' O ' ' HD3' ' D' ' 81' ' ' LYS . 3.9 m120 -62.09 -41.07 97.81 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 166.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 78' ' ' ASP . . . . . 0.92 ' HA ' ' HE3' ' D' ' 81' ' ' LYS . 51.1 m-20 -67.57 -35.8 79.7 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.119 174.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . 0.635 HG12 ' HA ' ' D' ' 76' ' ' SER . 13.2 mm -67.46 -20.71 26.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.82 -176.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -69.78 -45.14 68.65 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.964 173.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . 0.92 ' HE3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -66.47 -64.61 0.82 Allowed 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.282 175.226 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 82' ' ' LEU . . . . . 0.608 HD21 ' O ' ' D' ' 78' ' ' ASP . 3.8 mm? -46.51 -31.7 2.91 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 43.93 73.18 0.16 Allowed 'General case' 0 N--CA 1.473 0.697 0 O-C-N 123.881 0.738 . . . . 0.0 110.767 176.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 84' ' ' ILE . . . . . 0.466 HG22 HD11 ' D' ' 89' ' ' ILE . 47.1 mm -72.61 99.52 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.931 -173.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 85' ' ' LYS . . . . . 0.648 ' HE3' ' O ' ' D' ' 34' ' ' ASN . 51.9 mtpt -103.04 165.11 11.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.569 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.1 178.67 0.55 Allowed Glycine 0 C--N 1.335 0.49 0 O-C-N 123.779 0.674 . . . . 0.0 113.204 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 87' ' ' PRO . . . . . 0.712 ' O ' HG11 ' D' ' 58' ' ' VAL . 32.2 Cg_endo -93.98 -179.65 9.08 Favored 'Cis proline' 0 C--N 1.327 -0.57 0 C-N-CA 123.537 -1.443 . . . . 0.0 114.19 -0.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 88' ' ' TYR . . . . . 0.708 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 0.5 OUTLIER 27.77 91.92 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.953 1.301 . . . . 0.0 112.752 178.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.51 HD13 ' O ' ' D' ' 85' ' ' LYS . 64.2 mt -110.42 119.03 58.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.536 0.684 . . . . 0.0 112.014 -177.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.735 ' HB3' ' HB2' ' D' ' 57' ' ' PHE . 16.1 tp10 -106.6 91.15 3.57 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.297 178.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 91' ' ' ILE . . . . . 0.621 ' CG2' ' HZ3' ' D' ' 54' ' ' TRP . 4.2 mt -96.68 109.76 23.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 92' ' ' LYS . . . . . 0.709 ' HE2' HG23 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -161.5 169.72 21.27 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.528 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.647 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 26.2 pt20 -80.9 162.82 23.77 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.653 175.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . 0.709 HG23 ' HE2' ' D' ' 92' ' ' LYS . 10.6 pt . . . . . 0 C--N 1.303 -1.437 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.428 -170.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 . . . . . 0 N--CA 1.484 1.264 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 2' ' ' ASN . . . . . . . . . . . . . 75.5 m-80 -120.76 30.8 6.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.193 0.521 . . . . 0.0 109.984 176.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -90.02 13.72 14.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.23 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -97.18 -20.02 18.23 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 5' ' ' ALA . . . . . . . . . . . . . . . 55.35 69.01 0.78 Allowed 'General case' 0 N--CA 1.461 0.099 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.619 -178.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . 0.476 ' H ' ' CD2' ' D' ' 6' ' ' LEU . 1.6 pt? -96.36 7.99 45.1 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.931 -177.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -57.51 -52.52 65.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.591 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.905 ' HG2' HE21 ' D' ' 9' ' ' GLN . 10.9 pm0 -80.36 -7.17 58.97 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.37 -175.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . 0.905 HE21 ' HG2' ' D' ' 8' ' ' GLU . 78.3 mm-40 -96.94 1.01 49.87 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.052 177.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 10' ' ' MET . . . . . . . . . . . . . 15.0 tpt -107.86 -75.39 0.63 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.824 -174.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -99.7 -47.94 4.9 Favored 'General case' 0 CA--C 1.488 -1.425 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.451 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 12' ' ' SER . . . . . 0.771 ' CB ' ' HA ' ' D' ' 8' ' ' GLU . 41.1 t -26.52 -68.36 0.05 OUTLIER 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 113.567 -1.651 . . . . 0.0 114.352 -171.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.527 ' C ' HG12 ' D' ' 16' ' ' VAL . 63.3 mt -78.88 -9.21 12.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.647 -172.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -94.05 -58.79 2.13 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.322 175.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 15' ' ' SER . . . . . 0.558 ' HA ' ' OD1' ' D' ' 18' ' ' ASP . 29.5 m -67.22 -18.28 65.17 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.308 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 16' ' ' VAL . . . . . 0.527 HG12 ' C ' ' D' ' 13' ' ' ILE . 10.1 p -55.09 -28.89 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.962 0.887 . . . . 0.0 110.07 174.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 17' ' ' ASN . . . . . 0.478 ' N ' HG11 ' D' ' 16' ' ' VAL . 3.9 m120 -79.92 -32.86 40.11 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.021 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 18' ' ' ASP . . . . . 0.558 ' OD1' ' HA ' ' D' ' 15' ' ' SER . 1.4 m-20 -59.64 -15.99 23.0 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 176.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.574 ' O ' ' HG3' ' D' ' 22' ' ' LYS . 0.0 OUTLIER -91.3 -52.26 4.89 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 122.285 1.041 . . . . 0.0 108.496 175.309 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 20' ' ' LEU . . . . . 0.983 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 60.8 mt -56.08 -39.26 71.83 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 112.953 -1.93 . . . . 0.0 110.516 -179.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 21' ' ' ASN . . . . . 0.583 ' OD1' ' HB2' ' D' ' 26' ' ' LYS . 56.0 m-20 -78.82 96.29 5.6 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.68 177.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 22' ' ' LYS . . . . . 0.574 ' HG3' ' O ' ' D' ' 19' ' ' LYS . 54.6 mttp -122.46 -42.7 2.33 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -178.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 170.83 -86.39 0.08 OUTLIER Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 119.606 -1.283 . . . . 0.0 113.24 -177.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . 0.706 ' HE3' ' HD1' ' D' ' 45' ' ' TYR . 53.7 tptt -46.47 -52.66 12.74 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 25' ' ' GLY . . . . . 1.073 ' HA2' HD22 ' D' ' 42' ' ' ASN . . . -146.31 151.12 23.41 Favored Glycine 0 N--CA 1.436 -1.334 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.681 177.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 26' ' ' LYS . . . . . 0.697 ' HZ2' ' HB3' ' D' ' 26' ' ' LYS . 0.4 OUTLIER -143.95 160.04 41.52 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.054 -0.573 . . . . 0.0 112.3 -170.113 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 27' ' ' LEU . . . . . 0.983 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 49.2 tp -135.75 143.44 45.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.484 0.659 . . . . 0.0 112.231 -177.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 28' ' ' SER . . . . . 0.632 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 39.2 m -127.39 151.23 49.07 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.965 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 29' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 14.4 mt -140.4 156.77 46.28 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.925 177.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 60.2 m -159.19 -173.5 4.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.704 176.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -146.9 165.32 30.14 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 32' ' ' ASN . . . . . 0.47 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 51.4 t30 -150.14 88.81 1.54 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -177.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.31 -100.51 0.88 Allowed Glycine 0 C--O 1.228 -0.228 0 C-N-CA 120.306 -0.949 . . . . 0.0 110.949 -173.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -114.5 31.44 6.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.779 0.323 . . . . 0.0 110.145 173.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 35' ' ' GLN . . . . . 0.47 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 50.5 tt0 -109.63 159.96 16.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.906 0.384 . . . . 0.0 110.967 -176.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . 0.536 ' HB3' HD21 ' D' ' 83' ' ' ASN . 1.9 tm? -123.77 134.6 53.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.87 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 37' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 13.6 mmmm -132.88 122.86 25.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.522 -168.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 38' ' ' ALA . . . . . 0.458 ' HB1' ' OG ' ' D' ' 76' ' ' SER . . . -129.65 149.75 51.27 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.828 0.347 . . . . 0.0 110.467 173.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 39' ' ' THR . . . . . 0.632 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 1.7 p -150.47 136.98 18.87 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.807 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 40' ' ' SER . . . . . 0.617 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 40.8 p -107.75 133.7 51.77 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 173.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 41' ' ' SER . . . . . 0.671 ' HB2' ' CD ' ' D' ' 26' ' ' LYS . 35.4 m -94.19 164.81 12.9 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 174.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 42' ' ' ASN . . . . . 1.073 HD22 ' HA2' ' D' ' 25' ' ' GLY . 17.6 p30 61.73 10.12 3.23 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 124.669 1.231 . . . . 0.0 111.505 -171.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 53.3 60.5 3.69 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 167.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 44' ' ' GLY . . . . . 0.775 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 104.37 37.4 2.86 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 118.472 -1.823 . . . . 0.0 115.742 164.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 45' ' ' TYR . . . . . 0.706 ' HD1' ' HE3' ' D' ' 24' ' ' LYS . 2.5 m-85 -118.17 158.18 25.56 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 117.991 0.896 . . . . 0.0 109.53 172.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . 0.628 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -92.01 -176.34 42.37 Favored Glycine 0 C--O 1.213 -1.193 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 178.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 47' ' ' ILE . . . . . 0.823 HG12 ' HB3' ' D' ' 68' ' ' GLU . 40.2 mm -47.27 -54.92 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 CA-C-N 118.251 1.025 . . . . 0.0 110.714 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 22.8 t -178.22 -147.59 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 112.92 -1.946 . . . . 0.0 106.313 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -88.01 74.33 8.93 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 119.308 -0.957 . . . . 0.0 108.437 165.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -138.13 -171.93 3.15 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.607 -176.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 51' ' ' ASP . . . . . 0.669 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 52.2 p-10 -147.25 133.58 19.57 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.965 0.888 . . . . 0.0 112.697 177.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 52' ' ' LYS . . . . . 0.669 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 3.5 mptp? -145.49 134.41 22.51 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.164 -176.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -104.99 134.21 48.47 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 174.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 54' ' ' TRP . . . . . 0.624 ' HB2' ' O ' ' D' ' 66' ' ' PHE . 0.1 OUTLIER -125.58 158.13 35.39 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 -170.636 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -151.1 162.87 29.61 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.046 -1.073 . . . . 0.0 114.127 175.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 56' ' ' ILE . . . . . 0.439 ' CG2' HG21 ' D' ' 84' ' ' ILE . 66.8 mt -135.94 110.87 11.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 57' ' ' PHE . . . . . 0.698 ' HB2' ' HB3' ' D' ' 90' ' ' GLU . 19.4 m-85 -107.67 99.45 8.93 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 119.729 -0.789 . . . . 0.0 111.735 -165.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.643 HG13 ' O ' ' D' ' 87' ' ' PRO . 85.7 t -87.86 107.51 17.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.204 175.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 59' ' ' ASN . . . . . 0.433 HD21 ' HB2' ' D' ' 88' ' ' TYR . 3.8 m120 68.79 31.16 4.54 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.937 -178.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.5 -32.35 7.48 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.581 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 61' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 11.2 pt-20 -89.83 139.3 30.71 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.36 0.6 . . . . 0.0 111.686 -175.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . 0.528 ' HB2' ' CE1' ' D' ' 57' ' ' PHE . 38.1 ttpt -81.07 103.59 10.99 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.395 -177.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 28.2 m -82.25 -32.88 11.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.584 0.586 . . . . 0.0 112.584 -174.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 64' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -134.93 131.82 37.7 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.879 -0.329 . . . . 0.0 110.966 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 57.1 m -117.16 119.96 36.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.025 175.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 66' ' ' PHE . . . . . 0.624 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 16.1 p90 -126.31 146.8 49.88 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.195 0.522 . . . . 0.0 110.244 176.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -102.96 142.72 33.57 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -177.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 68' ' ' GLU . . . . . 0.823 ' HB3' HG12 ' D' ' 47' ' ' ILE . 5.6 mm-40 -75.89 -9.29 58.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.237 0.542 . . . . 0.0 109.703 175.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.561 ' HD3' ' HB2' ' D' ' 51' ' ' ASP . 9.1 mtmp? -67.93 -37.1 81.23 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 169.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 70' ' ' SER . . . . . 0.496 ' HG ' HG12 ' D' ' 75' ' ' ILE . 19.2 t -74.81 124.81 27.5 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 113.761 -1.563 . . . . 0.0 107.567 171.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 82.8 p -51.15 124.52 11.75 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.325 -176.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 72' ' ' VAL . . . . . 0.637 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -58.49 -11.49 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-O 121.151 0.5 . . . . 0.0 110.919 -175.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 73' ' ' GLY . . . . . 0.775 ' HA3' ' HA2' ' D' ' 44' ' ' GLY . . . -72.48 -61.77 3.5 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 114.948 -1.023 . . . . 0.0 112.861 170.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -57.77 -32.63 67.68 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 120.959 0.409 . . . . 0.0 109.951 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 75' ' ' ILE . . . . . 0.637 ' O ' HG13 ' D' ' 79' ' ' ILE . 23.8 mm -73.35 -42.19 57.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.317 177.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 76' ' ' SER . . . . . 0.545 ' HA ' HG13 ' D' ' 79' ' ' ILE . 30.2 t -73.79 -20.89 60.34 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.009 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -66.83 -29.92 69.97 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 167.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 78' ' ' ASP . . . . . 1.042 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 60.7 m-20 -77.77 -33.94 52.49 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.93 172.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . 0.637 HG13 ' O ' ' D' ' 75' ' ' ILE . 25.3 mt -68.54 -17.3 21.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.239 -175.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -72.74 -37.26 67.78 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.424 175.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . 1.042 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -80.13 -51.97 8.34 Favored 'General case' 0 CA--C 1.526 0.033 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.678 176.048 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 82' ' ' LEU . . . . . 0.581 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.9 mm? -49.02 -30.82 6.6 Favored 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 177.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 83' ' ' ASN . . . . . 0.536 HD21 ' HB3' ' D' ' 36' ' ' LEU . 0.8 OUTLIER 40.14 66.23 0.63 Allowed 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.121 0.888 . . . . 0.0 111.374 172.298 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 84' ' ' ILE . . . . . 0.465 HD11 HG22 ' D' ' 84' ' ' ILE . 40.1 mm -82.1 97.74 4.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.074 -174.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.26 94.28 3.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.715 0.769 . . . . 0.0 112.807 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 86' ' ' GLY . . . . . 0.474 ' H ' ' CD1' ' D' ' 89' ' ' ILE . . . 67.57 153.61 0.38 Allowed Glycine 0 N--CA 1.453 -0.169 0 CA-C-N 115.603 -0.726 . . . . 0.0 113.74 175.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 87' ' ' PRO . . . . . 0.643 ' O ' HG13 ' D' ' 58' ' ' VAL . 42.9 Cg_endo -90.44 179.18 14.63 Favored 'Cis proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.298 -1.542 . . . . 0.0 112.668 -0.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 88' ' ' TYR . . . . . 0.596 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 10.0 m-85 11.56 93.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.622 1.569 . . . . 0.0 113.89 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.51 HG21 HG13 ' D' ' 91' ' ' ILE . 77.7 mt -106.8 135.75 44.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.076 0.465 . . . . 0.0 111.839 -178.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.698 ' HB3' ' HB2' ' D' ' 57' ' ' PHE . 5.4 tp10 -121.52 97.23 5.41 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.035 173.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 91' ' ' ILE . . . . . 0.51 HG13 HG21 ' D' ' 89' ' ' ILE . 35.2 mt -95.21 102.36 13.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.467 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 92' ' ' LYS . . . . . 0.726 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -160.44 165.6 30.74 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 178.221 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.565 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 17.9 pt20 -80.35 165.55 22.17 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.209 0.528 . . . . 0.0 111.219 177.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . 0.726 HG22 ' HE2' ' D' ' 92' ' ' LYS . 8.1 pt . . . . . 0 C--N 1.313 -1.004 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.394 -170.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 121.166 0.507 . . . . 0.0 111.459 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 2' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 60.97 28.24 18.05 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.574 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -92.84 -47.83 6.85 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.73 0.3 . . . . 0.0 110.227 174.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -110.68 6.92 22.02 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 173.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 5' ' ' ALA . . . . . . . . . . . . . . . -84.43 70.12 10.62 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.204 -178.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . 0.468 ' N ' HD23 ' D' ' 6' ' ' LEU . 3.2 mm? -104.31 0.34 29.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.007 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . 0.779 ' HA ' ' HB3' ' D' ' 10' ' ' MET . 13.5 pm0 -69.27 -0.45 6.19 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -176.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.728 ' HA ' ' CB ' ' D' ' 12' ' ' SER . 21.0 pt-20 -87.85 -40.34 14.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.747 0.784 . . . . 0.0 109.537 176.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.9 5.54 39.99 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.276 -1.329 . . . . 0.0 110.35 172.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 10' ' ' MET . . . . . 0.779 ' HB3' ' HA ' ' D' ' 7' ' ' GLU . 26.9 ttt -102.92 -76.23 0.59 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.908 -178.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -101.77 -41.43 6.54 Favored 'General case' 0 CA--C 1.493 -1.238 0 CA-C-O 120.864 0.364 . . . . 0.0 110.562 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 12' ' ' SER . . . . . 0.728 ' CB ' ' HA ' ' D' ' 8' ' ' GLU . 43.9 t -39.17 -65.46 0.37 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.258 -1.337 . . . . 0.0 112.569 -170.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.57 ' C ' HG12 ' D' ' 16' ' ' VAL . 36.3 mm -91.47 -9.37 10.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 114.911 -1.041 . . . . 0.0 111.409 -173.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -95.86 -59.43 1.86 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.107 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 15' ' ' SER . . . . . 0.733 ' O ' ' HE3' ' D' ' 19' ' ' LYS . 90.3 p -67.07 -17.35 64.85 Favored 'General case' 0 C--O 1.219 -0.509 0 O-C-N 121.975 -0.453 . . . . 0.0 110.71 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 16' ' ' VAL . . . . . 0.754 HG21 HD11 ' D' ' 29' ' ' LEU . 11.2 p -52.72 -29.68 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.588 0.709 . . . . 0.0 110.227 174.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 17' ' ' ASN . . . . . 0.492 ' HB3' ' ND2' ' D' ' 21' ' ' ASN . 4.9 m120 -75.21 -41.19 58.32 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.646 177.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.23 -16.48 13.99 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.619 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.733 ' HE3' ' O ' ' D' ' 15' ' ' SER . 21.2 mmtp -85.72 -43.28 13.52 Favored 'General case' 0 CA--C 1.504 -0.827 0 CA-C-O 122.723 1.249 . . . . 0.0 108.195 -178.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 20' ' ' LEU . . . . . 0.996 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 63.0 mt -79.91 -37.76 33.99 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 111.308 -2.678 . . . . 0.0 110.591 -173.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 21' ' ' ASN . . . . . 0.55 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 54.2 m-80 -75.6 99.53 4.32 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.351 176.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 22' ' ' LYS . . . . . 0.663 ' HG3' ' O ' ' D' ' 20' ' ' LEU . 24.0 mtpp -120.43 -40.77 2.65 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 119.075 -1.05 . . . . 0.0 113.12 -166.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 157.55 -73.31 0.23 Allowed Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.327 -177.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . 0.904 ' HG2' ' HB3' ' D' ' 45' ' ' TYR . 77.5 tttt -63.82 -61.78 2.07 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 176.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 25' ' ' GLY . . . . . 0.55 ' HA2' ' ND2' ' D' ' 42' ' ' ASN . . . -127.54 163.71 21.2 Favored Glycine 0 N--CA 1.436 -1.331 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.024 174.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 26' ' ' LYS . . . . . 0.719 ' CD ' ' HB2' ' D' ' 41' ' ' SER . 9.7 ptpt -150.9 160.6 43.8 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.157 -0.522 . . . . 0.0 111.705 -170.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 27' ' ' LEU . . . . . 0.996 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 49.0 tp -137.08 148.04 46.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.073 0.463 . . . . 0.0 111.119 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 28' ' ' SER . . . . . 0.642 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 50.5 m -140.06 142.59 36.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.766 -173.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 29' ' ' LEU . . . . . 0.754 HD11 HG21 ' D' ' 16' ' ' VAL . 0.0 OUTLIER -141.5 147.74 38.31 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 119.688 -0.805 . . . . 0.0 111.656 -176.867 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 66.6 p -155.67 -172.47 4.15 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.83 176.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -137.44 166.53 23.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.864 0.364 . . . . 0.0 110.155 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 32' ' ' ASN . . . . . 0.473 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 23.4 t-20 -147.36 88.81 1.73 Allowed 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.98 -97.98 0.95 Allowed Glycine 0 N--CA 1.454 -0.113 0 C-N-CA 120.017 -1.087 . . . . 0.0 110.718 -170.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 76.0 m-80 -120.67 22.68 11.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.023 0.439 . . . . 0.0 110.034 173.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 35' ' ' GLN . . . . . 0.473 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 3.7 tp-100 -93.53 152.36 19.1 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.025 -177.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . 0.797 ' HB2' ' HG2' ' D' ' 85' ' ' LYS . 2.3 tm? -118.41 128.57 54.75 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.984 0.421 . . . . 0.0 110.218 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 37' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 13.6 mmmm -128.42 121.74 29.72 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.905 -167.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 38' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -131.98 151.61 51.63 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.183 0.516 . . . . 0.0 110.52 174.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 39' ' ' THR . . . . . 0.642 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 2.6 p -149.5 134.81 18.28 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.8 -176.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 40' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' D' ' 26' ' ' LYS . 36.1 t -107.74 128.03 54.21 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 41' ' ' SER . . . . . 0.719 ' HB2' ' CD ' ' D' ' 26' ' ' LYS . 46.7 m -95.21 158.79 15.31 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -177.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 42' ' ' ASN . . . . . 0.617 ' ND2' ' HB2' ' D' ' 45' ' ' TYR . 0.1 OUTLIER 81.67 -17.31 0.56 Allowed 'General case' 0 N--CA 1.475 0.802 0 O-C-N 124.584 1.178 . . . . 0.0 109.313 -169.158 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 43' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' D' ' 42' ' ' ASN . . . 72.99 63.44 0.1 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 173.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 44' ' ' GLY . . . . . 0.71 ' O ' ' HB ' ' D' ' 71' ' ' THR . . . 126.92 -40.43 1.78 Allowed Glycine 0 C--N 1.341 0.825 0 C-N-CA 119.317 -1.42 . . . . 0.0 116.052 169.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 45' ' ' TYR . . . . . 0.904 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 3.3 m-30 -59.82 156.03 15.01 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 118.515 1.157 . . . . 0.0 113.798 -172.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -98.25 -153.24 28.58 Favored Glycine 0 C--O 1.218 -0.893 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.566 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 47' ' ' ILE . . . . . 0.983 HG13 ' HB2' ' D' ' 68' ' ' GLU . 0.3 OUTLIER -50.92 -58.7 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-O 122.238 1.018 . . . . 0.0 110.184 -176.6 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.556 ' HA ' ' CD ' ' D' ' 24' ' ' LYS . 34.5 p 168.77 -76.06 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 111.47 -2.604 . . . . 0.0 106.158 -169.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -163.68 75.73 0.36 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.05 -1.432 . . . . 0.0 107.609 162.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . 0.703 ' O ' ' HG2' ' D' ' 69' ' ' LYS . 4.5 mm-40 -142.21 -159.31 0.95 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.004 -173.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 51' ' ' ASP . . . . . 0.623 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 35.6 t0 -146.62 125.99 13.14 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.118 176.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 52' ' ' LYS . . . . . 0.623 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 0.2 OUTLIER -141.62 100.0 3.67 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.111 -174.102 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -73.96 127.03 31.81 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.155 0.502 . . . . 0.0 110.515 177.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 54' ' ' TRP . . . . . 0.542 ' CH2' ' HA ' ' D' ' 92' ' ' LYS . 0.1 OUTLIER -118.74 155.26 31.4 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.611 -177.293 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -143.03 155.91 26.2 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 119.888 -1.149 . . . . 0.0 113.445 176.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 56' ' ' ILE . . . . . 0.504 HG23 HG22 ' D' ' 84' ' ' ILE . 61.0 mt -132.91 110.26 15.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 174.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 57' ' ' PHE . . . . . 0.754 ' HB2' ' HB2' ' D' ' 90' ' ' GLU . 9.4 m-85 -107.84 107.68 18.53 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 119.553 -0.859 . . . . 0.0 111.222 -167.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.678 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 98.1 t -96.63 110.74 25.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 173.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 64.21 37.51 8.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.797 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.03 -33.86 5.64 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.663 -0.78 . . . . 0.0 114.084 172.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 61' ' ' GLU . . . . . 0.521 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 12.1 pt-20 -90.86 156.87 17.69 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -177.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 41.5 mttm -77.32 126.32 30.74 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 13.1 p -94.63 -26.5 4.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 121.161 0.505 . . . . 0.0 109.947 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 64' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -148.98 137.56 21.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.858 175.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 40.6 m -120.61 124.56 45.56 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 176.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 66' ' ' PHE . . . . . 0.469 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 21.6 p90 -131.94 165.21 24.42 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 175.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 67' ' ' ASN . . . . . 0.755 ' OD1' ' HG3' ' D' ' 69' ' ' LYS . 21.7 t-20 -131.77 150.88 52.01 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -176.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 68' ' ' GLU . . . . . 0.983 ' HB2' HG13 ' D' ' 47' ' ' ILE . 35.5 mm-40 -71.65 -20.67 61.92 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 119.499 -0.88 . . . . 0.0 109.731 177.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.755 ' HG3' ' OD1' ' D' ' 67' ' ' ASN . 26.2 mtpp -61.99 -48.27 81.08 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 173.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 23.9 m -71.73 77.98 0.85 Allowed 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 112.162 -2.29 . . . . 0.0 108.42 174.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 71' ' ' THR . . . . . 0.71 ' HB ' ' O ' ' D' ' 44' ' ' GLY . 59.7 p -19.82 117.39 0.03 OUTLIER 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.161 1.385 . . . . 0.0 113.933 -173.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 72' ' ' VAL . . . . . 0.795 HG13 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -51.42 -14.89 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 176.896 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 73' ' ' GLY . . . . . 0.524 ' HA3' ' HA2' ' D' ' 44' ' ' GLY . . . -67.49 -65.36 2.77 Favored Glycine 0 N--CA 1.435 -1.433 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.818 174.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 74' ' ' ASN . . . . . 0.667 ' HA ' HD21 ' D' ' 77' ' ' ASN . 4.2 m120 -67.12 -23.52 65.83 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.485 -0.358 . . . . 0.0 110.675 -177.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 75' ' ' ILE . . . . . 0.597 ' O ' HG13 ' D' ' 79' ' ' ILE . 32.6 mm -75.13 -39.85 43.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.506 177.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 76' ' ' SER . . . . . 0.443 ' HA ' HG13 ' D' ' 79' ' ' ILE . 28.7 t -73.29 -19.33 61.07 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.948 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 77' ' ' ASN . . . . . 0.667 HD21 ' HA ' ' D' ' 74' ' ' ASN . 78.6 m-20 -66.78 -31.3 71.85 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 167.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 78' ' ' ASP . . . . . 0.982 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 59.3 m-20 -78.11 -32.15 50.37 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.223 174.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . 0.597 HG13 ' O ' ' D' ' 75' ' ' ILE . 18.0 mt -71.33 -16.69 19.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 C-N-CA 120.031 -0.668 . . . . 0.0 109.507 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -67.05 -31.57 72.17 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.821 173.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . 0.982 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -92.44 -49.48 6.11 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 177.321 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 82' ' ' LEU . . . . . 0.604 HD21 ' O ' ' D' ' 78' ' ' ASP . 3.7 mm? -51.27 -28.06 10.89 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -176.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 7.1 m120 33.21 72.7 0.08 Allowed 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 84' ' ' ILE . . . . . 0.571 ' N ' ' HG ' ' D' ' 36' ' ' LEU . 41.2 mm -91.45 98.96 8.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.884 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 85' ' ' LYS . . . . . 0.797 ' HG2' ' HB2' ' D' ' 36' ' ' LEU . 30.7 mmmt -141.18 101.48 4.03 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.35 171.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 86' ' ' GLY . . . . . 0.544 ' H ' ' CD1' ' D' ' 89' ' ' ILE . . . 73.34 149.87 1.36 Allowed Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.094 -0.957 . . . . 0.0 113.393 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 87' ' ' PRO . . . . . 0.614 ' O ' HG11 ' D' ' 58' ' ' VAL . 43.2 Cg_endo -88.46 178.31 19.16 Favored 'Cis proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.917 -1.701 . . . . 0.0 112.557 0.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 88' ' ' TYR . . . . . 0.678 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 3.6 m-85 11.71 94.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 125.3 1.44 . . . . 0.0 114.366 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.555 HG22 HG13 ' D' ' 91' ' ' ILE . 62.6 mt -110.56 142.88 21.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.3 0.571 . . . . 0.0 112.468 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.754 ' HB2' ' HB2' ' D' ' 57' ' ' PHE . 59.7 mm-40 -124.06 91.08 3.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.694 172.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 91' ' ' ILE . . . . . 0.555 HG13 HG22 ' D' ' 89' ' ' ILE . 23.2 mt -95.29 99.64 9.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 92' ' ' LYS . . . . . 0.684 ' HE2' HG21 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -161.09 166.95 27.22 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.639 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.599 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 18.9 pt20 -81.5 164.46 21.97 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.274 176.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . 0.684 HG21 ' HE2' ' D' ' 92' ' ' LYS . 8.1 pt . . . . . 0 C--N 1.311 -1.071 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.351 -169.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 1' ' ' ASP . . . . . 0.516 ' O ' ' HB2' ' D' ' 5' ' ' ALA . 36.2 t70 . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 120.516 0.198 . . . . 0.0 110.639 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 2' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -91.94 29.66 1.55 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -178.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -84.38 -47.07 11.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.584 0.23 . . . . 0.0 110.892 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -111.1 5.85 20.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.14 0.495 . . . . 0.0 109.783 175.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 5' ' ' ALA . . . . . 0.516 ' HB2' ' O ' ' D' ' 1' ' ' ASP . . . -83.87 2.49 38.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.253 -178.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 82.5 mt -110.73 16.16 21.54 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.369 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -65.01 1.79 0.87 Allowed 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -175.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.537 ' C ' ' H ' ' D' ' 10' ' ' MET . 0.8 OUTLIER -89.97 1.38 56.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.819 0.342 . . . . 0.0 110.358 179.3 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . 0.59 ' HA ' ' HB3' ' D' ' 12' ' ' SER . 14.6 pt20 -56.84 14.72 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.522 1.529 . . . . 0.0 114.467 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 10' ' ' MET . . . . . 0.537 ' H ' ' C ' ' D' ' 8' ' ' GLU . 15.1 tpt -94.31 -50.25 5.34 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.753 0.311 . . . . 0.0 110.49 177.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 11' ' ' ASN . . . . . 0.545 ' HB3' ' HB3' ' D' ' 15' ' ' SER . 11.1 m-80 -103.82 -12.25 17.04 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 173.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 12' ' ' SER . . . . . 0.756 ' O ' ' HB ' ' D' ' 16' ' ' VAL . 29.3 t -40.37 -65.73 0.38 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.943 -171.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.546 ' O ' HG12 ' D' ' 16' ' ' VAL . 40.2 mm -92.36 -9.77 9.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.752 -178.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -88.35 -61.91 1.61 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.009 177.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 15' ' ' SER . . . . . 0.616 ' HA ' ' OD1' ' D' ' 18' ' ' ASP . 86.6 p -65.96 -17.14 64.47 Favored 'General case' 0 C--O 1.217 -0.607 0 O-C-N 122.005 -0.435 . . . . 0.0 110.379 176.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 16' ' ' VAL . . . . . 0.756 ' HB ' ' O ' ' D' ' 12' ' ' SER . 1.2 p -58.03 -23.2 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-O 121.652 0.739 . . . . 0.0 109.248 176.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 17' ' ' ASN . . . . . 0.534 ' HB3' ' ND2' ' D' ' 21' ' ' ASN . 4.6 m120 -89.18 -26.48 21.24 Favored 'General case' 0 C--O 1.212 -0.91 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.253 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 18' ' ' ASP . . . . . 0.616 ' OD1' ' HA ' ' D' ' 15' ' ' SER . 1.2 m-20 -61.79 -15.64 43.11 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.648 174.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.881 ' N ' ' HE2' ' D' ' 19' ' ' LYS . 0.4 OUTLIER -86.69 -55.86 3.67 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 173.891 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 20' ' ' LEU . . . . . 1.064 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 64.6 mt -56.71 -40.67 76.07 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 112.253 -2.249 . . . . 0.0 111.266 -176.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 21' ' ' ASN . . . . . 0.576 ' OD1' ' HB2' ' D' ' 26' ' ' LYS . 55.8 m-80 -81.01 99.54 8.49 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.8 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 22' ' ' LYS . . . . . 0.614 ' HE3' ' O ' ' D' ' 19' ' ' LYS . 97.8 mttt -123.12 -41.99 2.29 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -175.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.39 -88.18 0.07 OUTLIER Glycine 0 N--CA 1.437 -1.292 0 C-N-CA 119.536 -1.316 . . . . 0.0 113.055 -176.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . 0.891 ' HE2' ' HA ' ' D' ' 48' ' ' SER . 32.8 ttpt -60.85 -62.03 2.16 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 25' ' ' GLY . . . . . 0.689 ' HA2' ' ND2' ' D' ' 42' ' ' ASN . . . -116.72 153.17 17.55 Favored Glycine 0 N--CA 1.432 -1.571 0 CA-C-N 115.21 -0.905 . . . . 0.0 112.494 175.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 26' ' ' LYS . . . . . 0.722 ' CD ' ' HB3' ' D' ' 41' ' ' SER . 9.0 ptpt -149.15 160.18 43.58 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.25 -0.975 . . . . 0.0 110.757 -171.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 27' ' ' LEU . . . . . 1.064 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 53.3 tp -138.11 150.33 46.76 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.525 0.679 . . . . 0.0 111.975 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 28' ' ' SER . . . . . 0.658 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 41.0 m -135.34 150.02 49.85 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.896 -177.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 29' ' ' LEU . . . . . 0.589 HD22 ' HB2' ' D' ' 38' ' ' ALA . 13.5 mt -140.12 149.9 43.61 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.269 177.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 22.7 t -160.05 -171.68 3.32 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 3.0 ppp? -141.85 166.07 25.72 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.109 0.481 . . . . 0.0 111.132 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 32' ' ' ASN . . . . . 0.453 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 26.6 t-20 -144.85 89.36 1.97 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.34 -0.845 . . . . 0.0 108.759 -178.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.94 -97.84 0.75 Allowed Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 119.887 -1.149 . . . . 0.0 111.099 -172.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -113.08 7.45 18.02 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.667 -0.313 . . . . 0.0 110.349 176.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 35' ' ' GLN . . . . . 0.453 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 7.5 tt0 -89.11 160.85 16.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.437 -172.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . 0.549 ' HB3' HD21 ' D' ' 83' ' ' ASN . 0.9 OUTLIER -120.78 131.59 54.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.809 176.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 37' ' ' LYS . . . . . 0.636 ' HB3' ' HZ2' ' D' ' 37' ' ' LYS . 1.3 mmmp? -134.9 119.03 17.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.865 -169.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 38' ' ' ALA . . . . . 0.589 ' HB2' HD22 ' D' ' 29' ' ' LEU . . . -115.41 151.03 35.46 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.018 0.437 . . . . 0.0 111.0 175.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 39' ' ' THR . . . . . 0.658 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 7.0 p -146.33 131.71 18.6 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.747 177.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 40' ' ' SER . . . . . 0.648 ' HB3' ' HA2' ' D' ' 73' ' ' GLY . 33.2 t -106.73 133.59 51.17 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 173.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 41' ' ' SER . . . . . 0.722 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 38.6 t -92.93 148.45 22.0 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 42' ' ' ASN . . . . . 0.689 ' ND2' ' HA2' ' D' ' 25' ' ' GLY . 0.5 OUTLIER 83.6 -16.85 0.52 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.762 1.625 . . . . 0.0 109.409 -166.731 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 62.28 55.77 2.31 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 44' ' ' GLY . . . . . 0.463 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 123.46 35.3 0.71 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 119.1 -1.524 . . . . 0.0 115.495 168.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 45' ' ' TYR . . . . . 0.736 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 2.5 m-85 -122.76 158.34 30.38 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 122.111 -0.64 . . . . 0.0 109.661 170.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . 0.61 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -98.46 176.61 30.25 Favored Glycine 0 C--O 1.221 -0.66 0 CA-C-O 118.972 -0.904 . . . . 0.0 110.875 177.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 47' ' ' ILE . . . . . 0.816 HG12 ' HB3' ' D' ' 68' ' ' GLU . 33.0 mm -47.26 -56.0 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 CA-C-O 121.922 0.867 . . . . 0.0 109.712 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.891 ' HA ' ' HE2' ' D' ' 24' ' ' LYS . 16.1 t 179.27 -149.01 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 113.149 -1.841 . . . . 0.0 107.393 178.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 49' ' ' TYR . . . . . 0.409 ' HD1' ' O ' ' D' ' 49' ' ' TYR . 0.1 OUTLIER -78.9 76.69 5.38 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.453 0.644 . . . . 0.0 110.416 168.32 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . 0.68 ' HB3' ' HE2' ' D' ' 52' ' ' LYS . 71.1 mm-40 -126.3 -166.17 1.54 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.28 -174.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 51' ' ' ASP . . . . . 0.677 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 7.0 t70 -161.04 119.68 2.5 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 114.503 -1.226 . . . . 0.0 111.565 171.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 52' ' ' LYS . . . . . 0.68 ' HE2' ' HB3' ' D' ' 50' ' ' GLU . 3.6 mptp? -142.99 115.85 8.76 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 114.22 -1.355 . . . . 0.0 109.822 -174.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -90.98 135.47 33.72 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 174.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 54' ' ' TRP . . . . . 0.622 ' HB2' ' O ' ' D' ' 66' ' ' PHE . 0.0 OUTLIER -126.93 158.02 37.91 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.855 -172.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -145.87 153.44 25.3 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 119.701 -1.237 . . . . 0.0 113.883 174.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 56' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' D' ' 90' ' ' GLU . 61.8 mt -127.62 113.75 32.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 174.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 57' ' ' PHE . . . . . 0.855 ' HB2' ' HB2' ' D' ' 90' ' ' GLU . 8.4 m-85 -109.5 105.85 15.35 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.304 -168.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.732 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 94.3 t -90.48 103.63 14.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.997 173.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 59' ' ' ASN . . . . . 0.487 ' OD1' ' HG2' ' D' ' 87' ' ' PRO . 6.3 m120 61.1 47.02 7.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.36 -0.837 . . . . 0.0 111.655 -177.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.65 -33.7 5.69 Favored Glycine 0 CA--C 1.509 -0.292 0 C-N-CA 120.681 -0.771 . . . . 0.0 114.365 172.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 61' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 16.6 pt-20 -92.97 146.83 23.33 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 120.931 -0.307 . . . . 0.0 111.229 -176.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -73.58 113.86 11.17 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 173.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 14.5 p -88.68 -23.41 6.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-O 121.098 0.475 . . . . 0.0 110.21 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 64' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -152.85 135.26 15.1 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.608 175.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 88.9 m -121.15 125.92 48.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.412 176.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 66' ' ' PHE . . . . . 0.622 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 10.1 p90 -132.54 154.52 49.9 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.08 0.467 . . . . 0.0 110.409 178.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 67' ' ' ASN . . . . . 0.586 ' HA ' ' O ' ' D' ' 52' ' ' LYS . 3.9 m120 -114.1 145.51 41.53 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -178.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 68' ' ' GLU . . . . . 0.816 ' HB3' HG12 ' D' ' 47' ' ' ILE . 35.7 mt-10 -75.8 -8.94 58.09 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.42 177.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.626 ' HG2' ' O ' ' D' ' 50' ' ' GLU . 45.5 mtmt -63.83 -55.43 23.0 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 168.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 49.9 m -57.56 118.24 5.01 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 112.528 -2.124 . . . . 0.0 109.374 172.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 81.9 p -48.13 117.53 1.97 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.685 -176.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 72' ' ' VAL . . . . . 0.65 HG13 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -57.77 -11.95 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-O 120.788 0.328 . . . . 0.0 111.073 -174.565 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 73' ' ' GLY . . . . . 0.648 ' HA2' ' HB3' ' D' ' 40' ' ' SER . . . -74.42 -61.01 3.3 Favored Glycine 0 N--CA 1.436 -1.303 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.582 175.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 74' ' ' ASN . . . . . 0.706 ' HA ' HD21 ' D' ' 77' ' ' ASN . 28.5 t-20 -60.91 -28.17 68.72 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 75' ' ' ILE . . . . . 0.53 ' O ' ' HB2' ' D' ' 78' ' ' ASP . 31.3 mm -74.46 -41.14 49.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.894 175.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 76' ' ' SER . . . . . 0.538 ' OG ' ' HB3' ' D' ' 38' ' ' ALA . 28.8 t -73.18 -19.81 61.02 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.116 -177.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 77' ' ' ASN . . . . . 0.706 HD21 ' HA ' ' D' ' 74' ' ' ASN . 77.0 m-20 -61.8 -43.45 98.83 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 165.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 78' ' ' ASP . . . . . 0.919 ' HA ' ' HG2' ' D' ' 81' ' ' LYS . 1.1 m-20 -64.03 -34.78 78.78 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.978 174.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . 0.518 HG13 ' O ' ' D' ' 75' ' ' ILE . 53.6 mt -72.22 -24.56 22.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 C-N-CA 119.129 -1.028 . . . . 0.0 110.46 -174.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -78.64 -16.11 57.72 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.175 171.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . 0.919 ' HG2' ' HA ' ' D' ' 78' ' ' ASP . 25.6 mmtt -76.06 -64.54 1.07 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 172.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 82' ' ' LEU . . . . . 0.647 HD23 ' O ' ' D' ' 78' ' ' ASP . 2.8 mm? -46.71 -31.09 2.71 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 113.114 -1.857 . . . . 0.0 112.521 -179.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 83' ' ' ASN . . . . . 0.549 HD21 ' HB3' ' D' ' 36' ' ' LEU . 0.7 OUTLIER 45.55 57.59 4.85 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.668 0.605 . . . . 0.0 110.574 174.677 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 84' ' ' ILE . . . . . 0.519 ' O ' ' HG ' ' D' ' 36' ' ' LEU . 44.9 mm -83.38 97.63 4.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.913 0.387 . . . . 0.0 111.37 -173.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 85' ' ' LYS . . . . . 0.479 ' HB2' ' HB2' ' D' ' 36' ' ' LEU . 2.7 tmtm? -139.34 92.88 2.62 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.74 152.06 1.65 Allowed Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.437 -0.801 . . . . 0.0 113.516 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 87' ' ' PRO . . . . . 0.509 ' O ' HG11 ' D' ' 58' ' ' VAL . 50.0 Cg_endo -90.12 179.47 14.7 Favored 'Cis proline' 0 CA--C 1.535 0.551 0 C-N-CA 123.304 -1.54 . . . . 0.0 113.195 0.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 88' ' ' TYR . . . . . 0.732 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 1.8 m-85 24.55 93.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.925 1.29 . . . . 0.0 113.62 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.728 HG21 HG13 ' D' ' 91' ' ' ILE . 3.5 mp -108.64 125.87 65.52 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-O 121.184 0.516 . . . . 0.0 111.665 -175.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.855 ' HB2' ' HB2' ' D' ' 57' ' ' PHE . 5.5 mm-40 -119.65 89.59 3.16 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.75 171.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 91' ' ' ILE . . . . . 0.728 HG13 HG21 ' D' ' 89' ' ' ILE . 34.8 mt -95.95 101.19 12.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.076 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 92' ' ' LYS . . . . . 0.657 ' HG2' ' O ' ' D' ' 93' ' ' GLN . 0.0 OUTLIER -162.34 170.57 18.65 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.247 179.131 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.657 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 17.1 pt20 -81.15 161.94 23.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.542 0.687 . . . . 0.0 110.992 173.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . 0.643 HG23 ' HE3' ' D' ' 92' ' ' LYS . 7.7 pt . . . . . 0 C--N 1.309 -1.18 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.435 -173.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 . . . . . 0 N--CA 1.483 1.21 0 CA-C-O 120.398 0.142 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 2' ' ' ASN . . . . . 0.61 ' HB3' ' HB3' ' D' ' 5' ' ' ALA . 77.1 m-20 -137.23 108.96 7.02 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 177.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -95.93 -3.07 45.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.743 -173.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 4' ' ' LYS . . . . . 0.833 ' HA ' ' HE3' ' D' ' 4' ' ' LYS . 0.0 OUTLIER -108.96 -29.08 8.77 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.286 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 5' ' ' ALA . . . . . 0.61 ' HB3' ' HB3' ' D' ' 2' ' ' ASN . . . -81.93 71.37 8.97 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.161 -178.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 81.4 mt -101.59 23.86 10.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.352 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -82.05 -70.01 0.58 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.861 0.362 . . . . 0.0 111.084 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.774 ' HA ' ' CB ' ' D' ' 12' ' ' SER . 0.6 OUTLIER -92.35 -32.96 14.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.317 0.579 . . . . 0.0 110.891 -179.332 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . 0.675 ' HG3' ' HG2' ' D' ' 8' ' ' GLU . 45.8 mt-30 -83.96 5.62 24.92 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.133 -172.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 10' ' ' MET . . . . . . . . . . . . . 15.5 tpt -108.15 -73.31 0.69 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.41 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -100.83 -48.35 4.5 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.119 178.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 12' ' ' SER . . . . . 0.774 ' CB ' ' HA ' ' D' ' 8' ' ' GLU . 44.9 t -29.57 -61.72 0.14 Allowed 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.53 -1.214 . . . . 0.0 114.071 -172.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.507 ' O ' HG11 ' D' ' 16' ' ' VAL . 67.3 mt -82.7 -8.56 11.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.279 -172.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -94.66 -49.58 5.56 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.032 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 15' ' ' SER . . . . . 0.715 ' HA ' ' OD2' ' D' ' 18' ' ' ASP . 88.6 p -70.35 -15.95 62.93 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.965 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 16' ' ' VAL . . . . . 0.708 ' HA ' ' CE ' ' D' ' 19' ' ' LYS . 12.4 p -58.82 -34.47 52.36 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.107 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 175.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 17' ' ' ASN . . . . . 0.63 ' ND2' ' HA ' ' D' ' 28' ' ' SER . 4.5 m120 -64.79 -42.17 95.26 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.747 172.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 18' ' ' ASP . . . . . 0.715 ' OD2' ' HA ' ' D' ' 15' ' ' SER . 60.6 m-20 -57.2 -17.32 10.86 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -175.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.708 ' CE ' ' HA ' ' D' ' 16' ' ' VAL . 0.0 OUTLIER -92.04 -38.86 11.96 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 122.167 0.985 . . . . 0.0 109.202 174.523 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 20' ' ' LEU . . . . . 0.89 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 84.8 mt -78.86 -31.32 45.55 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 112.897 -1.956 . . . . 0.0 111.121 -170.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 21' ' ' ASN . . . . . 0.529 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 2.8 t-20 -99.12 95.74 7.31 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.291 -167.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 22' ' ' LYS . . . . . 0.471 ' NZ ' ' HB3' ' D' ' 22' ' ' LYS . 5.7 mtpm? -121.94 -42.91 2.37 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 118.308 -1.357 . . . . 0.0 113.926 -169.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 168.07 -80.32 0.1 Allowed Glycine 0 N--CA 1.439 -1.111 0 C-N-CA 119.912 -1.137 . . . . 0.0 112.787 -175.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . 0.801 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 23.4 tptm -47.85 -59.72 3.11 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 176.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 25' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -140.26 159.34 26.17 Favored Glycine 0 N--CA 1.431 -1.649 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.219 173.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 26' ' ' LYS . . . . . 0.678 ' CD ' ' HB3' ' D' ' 41' ' ' SER . 9.6 ptpt -149.67 160.57 43.41 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.467 -0.866 . . . . 0.0 110.771 -168.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 27' ' ' LEU . . . . . 0.89 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 41.4 tp -134.54 135.99 42.72 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.225 0.536 . . . . 0.0 111.747 178.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 28' ' ' SER . . . . . 0.63 ' HA ' ' ND2' ' D' ' 17' ' ' ASN . 50.6 m -125.27 133.29 52.72 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.709 -174.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 29' ' ' LEU . . . . . 0.432 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 0.0 OUTLIER -140.71 134.74 30.76 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.706 -174.078 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 72.6 p -146.8 174.12 11.77 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.799 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 23.2 ptm -136.42 118.84 15.76 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.496 0.665 . . . . 0.0 111.114 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -93.23 89.35 6.38 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.09 -104.78 2.61 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.499 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 76.0 m-80 -117.6 17.22 14.49 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.343 0.592 . . . . 0.0 109.651 175.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 35' ' ' GLN . . . . . 0.46 ' OE1' ' HD2' ' D' ' 37' ' ' LYS . 49.9 tt0 -94.4 142.19 27.71 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.479 -177.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . 0.576 ' HG ' ' N ' ' D' ' 84' ' ' ILE . 2.7 tm? -112.3 115.88 29.49 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.219 0.533 . . . . 0.0 111.195 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 37' ' ' LYS . . . . . 0.797 ' HA ' ' HE2' ' D' ' 37' ' ' LYS . 10.0 mmpt? -117.72 122.77 44.38 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 114.188 -1.369 . . . . 0.0 111.566 -168.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 38' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -130.5 154.76 47.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.136 0.493 . . . . 0.0 111.186 176.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 39' ' ' THR . . . . . 0.625 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 2.5 p -150.37 131.95 14.84 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.763 -177.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 40' ' ' SER . . . . . 0.6 ' HB3' ' HA2' ' D' ' 73' ' ' GLY . 40.4 t -108.17 129.77 55.16 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 172.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 41' ' ' SER . . . . . 0.678 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 32.7 t -95.87 154.47 17.21 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.432 -0.907 . . . . 0.0 109.592 -178.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 42' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' D' ' 41' ' ' SER . 77.0 m-20 78.28 6.69 2.52 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.96 -169.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 51.22 60.32 3.96 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 114.57 -1.196 . . . . 0.0 113.956 170.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 44' ' ' GLY . . . . . 0.588 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 105.99 37.01 2.61 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 119.189 -1.481 . . . . 0.0 114.357 170.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 45' ' ' TYR . . . . . 0.801 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 2.3 m-30 -113.96 153.19 29.73 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 173.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . 0.593 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -95.24 -162.86 34.45 Favored Glycine 0 C--O 1.219 -0.797 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 47' ' ' ILE . . . . . 0.798 HG12 ' HB3' ' D' ' 68' ' ' GLU . 39.0 mm -51.46 -55.72 7.55 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.706 0 CA-C-O 122.06 0.933 . . . . 0.0 109.035 174.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 62.3 p -174.77 -86.96 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 112.975 -1.92 . . . . 0.0 108.862 -176.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 49' ' ' TYR . . . . . 0.438 ' HD2' ' O ' ' D' ' 49' ' ' TYR . 0.1 OUTLIER -152.64 76.03 1.13 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.263 167.545 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . 0.724 ' O ' ' HG2' ' D' ' 69' ' ' LYS . 4.2 mm-40 -137.35 -164.93 1.67 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.443 -172.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 51' ' ' ASP . . . . . 0.616 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 8.9 t70 -138.26 127.93 25.05 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.741 173.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 52' ' ' LYS . . . . . 0.616 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 0.3 OUTLIER -143.07 121.68 12.52 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.407 -1.27 . . . . 0.0 109.482 -178.442 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -99.1 132.5 44.36 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.344 -0.542 . . . . 0.0 109.815 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 54' ' ' TRP . . . . . 0.677 ' NE1' ' HB3' ' D' ' 93' ' ' GLN . 0.9 OUTLIER -121.7 152.97 38.81 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.903 -172.465 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -137.65 156.07 23.43 Favored Glycine 0 N--CA 1.436 -1.364 0 C-N-CA 119.732 -1.223 . . . . 0.0 112.576 172.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 56' ' ' ILE . . . . . 0.585 HG12 ' CG2' ' D' ' 91' ' ' ILE . 96.2 mt -126.53 94.46 2.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 176.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 57' ' ' PHE . . . . . 0.579 ' HA ' ' O ' ' D' ' 61' ' ' GLU . 18.2 m-85 -95.39 108.35 20.54 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.668 -165.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.742 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 66.4 t -95.69 105.97 17.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.447 171.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 59' ' ' ASN . . . . . 0.525 ' ND2' ' HB2' ' D' ' 88' ' ' TYR . 4.1 m120 60.85 46.72 8.44 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.759 0.314 . . . . 0.0 111.495 -177.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.01 48.31 54.72 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.676 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 61' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 17.6 tp10 -159.61 126.15 4.46 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -73.48 109.6 7.12 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.087 176.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 34.4 m -82.91 -10.77 12.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 120.991 0.424 . . . . 0.0 110.777 176.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 64' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -158.93 137.85 11.18 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.271 174.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 71.7 m -122.81 113.5 19.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.145 177.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 66' ' ' PHE . . . . . 0.499 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 11.5 p90 -120.34 156.68 30.81 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.121 0.486 . . . . 0.0 110.061 177.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 67' ' ' ASN . . . . . 0.682 HD21 ' HB2' ' D' ' 69' ' ' LYS . 14.6 p-10 -122.96 133.91 54.36 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.317 -174.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 68' ' ' GLU . . . . . 0.798 ' HB3' HG12 ' D' ' 47' ' ' ILE . 40.6 mm-40 -68.05 -8.35 36.99 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.348 -176.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.724 ' HG2' ' O ' ' D' ' 50' ' ' GLU . 49.6 mtpt -63.5 -44.24 94.89 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 169.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 70' ' ' SER . . . . . 0.526 ' O ' HD12 ' D' ' 75' ' ' ILE . 24.2 t -64.19 125.72 25.45 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 113.667 -1.606 . . . . 0.0 107.689 167.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 71' ' ' THR . . . . . 0.504 HG22 ' O ' ' D' ' 44' ' ' GLY . 75.4 p -55.76 128.87 36.97 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 72' ' ' VAL . . . . . 0.66 HG12 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -57.09 -13.76 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-O 121.163 0.506 . . . . 0.0 110.601 -177.503 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 73' ' ' GLY . . . . . 0.6 ' HA2' ' HB3' ' D' ' 40' ' ' SER . . . -67.6 -63.45 3.71 Favored Glycine 0 N--CA 1.434 -1.433 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.568 171.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -64.79 -19.65 65.94 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.314 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 75' ' ' ILE . . . . . 0.526 HD12 ' O ' ' D' ' 70' ' ' SER . 74.7 mt -73.5 -41.06 56.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 173.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 76' ' ' SER . . . . . 0.671 ' HA ' HG12 ' D' ' 79' ' ' ILE . 41.5 t -75.26 -22.61 57.68 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.039 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -61.68 -25.22 67.26 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 167.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 78' ' ' ASP . . . . . 1.081 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 0.9 OUTLIER -90.03 -27.29 19.83 Favored 'General case' 0 C--O 1.227 -0.122 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 175.529 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . 0.671 HG12 ' HA ' ' D' ' 76' ' ' SER . 22.5 mm -68.86 -34.65 65.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.391 -176.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -66.88 -32.06 73.08 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -177.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . 1.081 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -77.25 -53.74 7.35 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.99 175.607 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 82' ' ' LEU . . . . . 0.536 ' H ' ' HG2' ' D' ' 81' ' ' LYS . 2.9 mm? -47.37 -32.22 4.69 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.008 0.523 . . . . 0.0 112.322 177.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 83' ' ' ASN . . . . . 0.512 ' HA ' ' HB3' ' D' ' 36' ' ' LEU . 9.3 t30 37.65 58.0 1.39 Allowed 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.45 1.094 . . . . 0.0 110.897 178.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 84' ' ' ILE . . . . . 0.576 ' N ' ' HG ' ' D' ' 36' ' ' LEU . 54.8 mt -80.32 104.47 8.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.993 0.425 . . . . 0.0 111.889 -172.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.21 92.97 2.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.771 0.796 . . . . 0.0 112.33 177.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.65 153.35 4.16 Favored Glycine 0 CA--C 1.509 -0.288 0 CA-C-N 115.128 -0.942 . . . . 0.0 114.196 173.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 87' ' ' PRO . . . . . 0.655 ' O ' HG12 ' D' ' 58' ' ' VAL . 50.8 Cg_endo -89.41 -179.6 14.29 Favored 'Cis proline' 0 CA--C 1.534 0.478 0 C-N-CA 123.221 -1.575 . . . . 0.0 113.247 0.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 88' ' ' TYR . . . . . 0.742 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 1.8 m-85 20.86 93.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.812 1.245 . . . . 0.0 113.897 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.9 mp -110.76 134.14 53.99 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.281 -177.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -128.2 96.5 4.47 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.495 169.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 91' ' ' ILE . . . . . 0.624 ' CG2' ' HZ3' ' D' ' 54' ' ' TRP . 6.0 mt -96.13 105.4 17.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 178.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 92' ' ' LYS . . . . . 0.758 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.1 OUTLIER -161.54 170.48 19.8 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 123.027 0.531 . . . . 0.0 111.624 -174.742 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.677 ' HB3' ' NE1' ' D' ' 54' ' ' TRP . 3.0 pt20 -90.16 155.36 19.09 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.666 0.746 . . . . 0.0 111.638 176.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . 0.758 HG22 ' HE2' ' D' ' 92' ' ' LYS . 8.2 pt . . . . . 0 C--N 1.307 -1.257 0 CA-C-N 113.98 -1.464 . . . . 0.0 111.622 -171.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 120.674 0.273 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 2' ' ' ASN . . . . . 0.618 ' HB3' ' HA ' ' D' ' 5' ' ' ALA . 75.9 m-20 53.87 67.0 1.07 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.167 -178.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -76.82 -30.12 56.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.366 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -92.29 -33.17 14.74 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 170.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 5' ' ' ALA . . . . . 0.618 ' HA ' ' HB3' ' D' ' 2' ' ' ASN . . . 66.64 -178.46 0.2 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.548 175.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 4.8 mp -100.64 -69.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.087 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -92.52 -23.64 19.03 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.557 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.698 ' O ' ' HB3' ' D' ' 12' ' ' SER . 52.9 mt-10 -64.03 -23.04 67.18 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -172.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -77.11 9.73 2.84 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 122.054 -0.404 . . . . 0.0 111.408 175.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 10' ' ' MET . . . . . 0.572 ' O ' ' HB2' ' D' ' 14' ' ' ASN . 48.7 ttm -106.65 -75.47 0.63 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.99 0.424 . . . . 0.0 111.317 -176.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 11' ' ' ASN . . . . . 0.506 ' O ' ' HB2' ' D' ' 15' ' ' SER . 9.4 p-10 -102.4 -32.45 9.99 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-O 121.211 0.529 . . . . 0.0 110.902 178.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 12' ' ' SER . . . . . 0.698 ' HB3' ' O ' ' D' ' 8' ' ' GLU . 45.0 t -55.47 -69.22 0.14 Allowed 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 113.952 -1.476 . . . . 0.0 111.099 -167.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.512 ' C ' HG13 ' D' ' 16' ' ' VAL . 48.7 mt -91.21 -13.54 8.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.736 -175.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 14' ' ' ASN . . . . . 0.572 ' HB2' ' O ' ' D' ' 10' ' ' MET . 5.8 m120 -97.28 -56.93 2.39 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.597 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 15' ' ' SER . . . . . 0.506 ' HB2' ' O ' ' D' ' 11' ' ' ASN . 50.9 m -67.84 -15.34 63.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.845 179.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 16' ' ' VAL . . . . . 0.7 ' HA ' ' CE ' ' D' ' 19' ' ' LYS . 14.3 p -56.22 -35.28 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 174.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 17' ' ' ASN . . . . . 0.417 ' N ' HG12 ' D' ' 16' ' ' VAL . 5.0 m120 -67.7 -40.23 84.34 Favored 'General case' 0 C--O 1.213 -0.856 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.92 176.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.57 -16.64 39.92 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -175.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.7 ' CE ' ' HA ' ' D' ' 16' ' ' VAL . 0.0 OUTLIER -89.97 -46.17 8.7 Favored 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 173.225 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 20' ' ' LEU . . . . . 0.806 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 84.1 mt -63.73 -35.84 81.9 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 113.594 -1.639 . . . . 0.0 110.479 -177.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 21' ' ' ASN . . . . . 0.466 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 2.8 m120 -72.65 95.93 1.93 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.8 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 22' ' ' LYS . . . . . 0.854 ' HE2' ' HA ' ' D' ' 22' ' ' LYS . 7.7 mmpt? -118.05 11.17 13.25 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -170.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.94 -74.28 1.7 Allowed Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.982 176.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . 0.764 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 55.2 tptt -53.27 -59.22 4.84 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 176.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -144.67 157.69 27.33 Favored Glycine 0 N--CA 1.43 -1.715 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.699 174.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 26' ' ' LYS . . . . . 0.876 ' HD2' ' HB3' ' D' ' 41' ' ' SER . 10.8 ptpt -151.04 160.68 43.76 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.379 -0.911 . . . . 0.0 111.354 -164.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 27' ' ' LEU . . . . . 0.806 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 28.4 tp -132.89 144.53 50.24 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.164 0.507 . . . . 0.0 111.397 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 28' ' ' SER . . . . . 0.655 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 52.4 m -137.74 143.61 41.27 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.983 -175.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 29' ' ' LEU . . . . . 0.504 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 0.0 OUTLIER -141.02 144.74 35.18 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.326 -178.7 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 35.5 m -145.66 170.07 17.2 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.035 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 31' ' ' MET . . . . . 0.567 ' SD ' ' HE2' ' D' ' 85' ' ' LYS . 61.2 mtt -130.95 111.17 11.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.043 0.449 . . . . 0.0 110.888 177.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -91.82 87.82 6.41 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.08 -125.41 8.21 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.168 -1.015 . . . . 0.0 111.48 -173.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -89.66 31.2 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 O-C-N 122.464 -0.433 . . . . 0.0 110.267 175.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 35' ' ' GLN . . . . . 0.441 ' O ' ' HA ' ' D' ' 31' ' ' MET . 3.8 tp-100 -116.88 154.45 30.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.37 -172.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . 0.899 ' HB2' ' HB2' ' D' ' 85' ' ' LYS . 1.8 tm? -118.74 126.66 52.37 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.741 176.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 37' ' ' LYS . . . . . 0.569 ' HB3' ' NZ ' ' D' ' 37' ' ' LYS . 1.1 mmmp? -129.63 117.84 21.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.587 -169.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 38' ' ' ALA . . . . . 0.502 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -119.42 152.79 36.25 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.539 0.685 . . . . 0.0 112.26 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 39' ' ' THR . . . . . 0.655 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 3.2 p -144.57 126.73 15.63 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.145 177.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 40' ' ' SER . . . . . 0.592 ' HA ' ' O ' ' D' ' 26' ' ' LYS . 14.9 p -108.49 128.9 55.2 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 172.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 41' ' ' SER . . . . . 0.876 ' HB3' ' HD2' ' D' ' 26' ' ' LYS . 42.5 t -102.43 155.72 18.07 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.161 -175.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 42' ' ' ASN . . . . . 0.522 ' ND2' ' HE3' ' D' ' 26' ' ' LYS . 74.0 m-80 76.67 8.55 3.1 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.711 -172.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 47.08 61.72 2.73 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 114.613 -1.176 . . . . 0.0 114.043 168.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.63 -14.41 7.21 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 119.004 -1.57 . . . . 0.0 114.93 172.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 45' ' ' TYR . . . . . 0.764 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 2.0 m-30 -76.19 156.75 33.38 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 117.347 0.573 . . . . 0.0 111.488 -176.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . 0.575 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -103.72 -157.5 24.5 Favored Glycine 0 C--O 1.214 -1.095 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 175.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 47' ' ' ILE . . . . . 0.844 HG13 ' HB3' ' D' ' 68' ' ' GLU . 0.8 OUTLIER -53.98 -57.33 5.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 122.778 1.275 . . . . 0.0 109.58 178.236 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 39.4 t 174.7 -116.05 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 111.205 -2.725 . . . . 0.0 105.89 -175.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -119.75 76.79 1.17 Allowed 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.888 -0.507 . . . . 0.0 109.818 165.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . 0.401 ' HB2' ' HE3' ' D' ' 52' ' ' LYS . 60.3 mm-40 -140.55 -169.3 2.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.38 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 51' ' ' ASP . . . . . 0.649 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 1.4 m-20 -139.97 134.09 31.02 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.935 173.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 52' ' ' LYS . . . . . 0.699 ' HD3' HG12 ' D' ' 47' ' ' ILE . 0.1 OUTLIER -144.66 150.15 36.88 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.787 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 53' ' ' ASN . . . . . 0.432 HD21 ' C ' ' D' ' 52' ' ' LYS . 2.8 m120 -118.95 138.72 52.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.76 0.314 . . . . 0.0 110.324 173.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 54' ' ' TRP . . . . . 0.64 ' HZ3' ' CG2' ' D' ' 91' ' ' ILE . 1.7 m95 -124.7 153.22 42.69 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -175.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -138.42 157.34 24.49 Favored Glycine 0 N--CA 1.432 -1.598 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.036 172.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 56' ' ' ILE . . . . . 0.566 HG12 ' CG2' ' D' ' 91' ' ' ILE . 95.8 mt -131.18 94.58 2.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 177.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 57' ' ' PHE . . . . . 0.52 ' CE1' ' HB2' ' D' ' 62' ' ' LYS . 48.3 m-85 -93.86 101.03 13.11 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.546 -167.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.726 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 94.7 t -83.25 102.64 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.955 173.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 59' ' ' ASN . . . . . 0.488 ' OD1' ' HG2' ' D' ' 87' ' ' PRO . 6.4 m120 59.6 45.67 12.92 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.493 -177.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.29 -30.5 7.63 Favored Glycine 0 CA--C 1.508 -0.399 0 C-N-CA 120.009 -1.091 . . . . 0.0 112.655 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -88.15 119.9 28.99 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.852 -0.674 . . . . 0.0 110.618 -174.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . 0.52 ' HB2' ' CE1' ' D' ' 57' ' ' PHE . 38.7 ttpt -70.76 98.56 1.56 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 176.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.554 HG11 ' O ' ' D' ' 56' ' ' ILE . 13.4 p -77.77 -29.01 15.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.448 -170.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 64' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -143.46 137.77 28.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.555 177.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 56.9 m -116.47 116.5 27.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.462 175.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 66' ' ' PHE . . . . . 0.475 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 18.3 p90 -122.06 154.98 36.59 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 170.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -117.64 146.89 43.36 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 68' ' ' GLU . . . . . 0.844 ' HB3' HG13 ' D' ' 47' ' ' ILE . 39.9 mm-40 -62.48 -24.96 67.75 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.214 0.531 . . . . 0.0 109.67 176.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.518 ' HD3' ' HB3' ' D' ' 51' ' ' ASP . 9.0 mtmp? -58.02 -44.16 87.15 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.495 173.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 15.4 t -76.18 92.73 3.28 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 113.798 -1.547 . . . . 0.0 107.627 172.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 73.4 p -30.84 122.85 0.21 Allowed 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.477 -1.238 . . . . 0.0 112.787 -172.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 72' ' ' VAL . . . . . 0.603 HG11 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -51.72 -17.42 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 O-C-N 123.319 0.387 . . . . 0.0 111.709 177.8 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 73' ' ' GLY . . . . . 0.571 ' HA2' ' CB ' ' D' ' 40' ' ' SER . . . -65.33 -65.41 2.93 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 115.371 -0.832 . . . . 0.0 113.193 171.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 74' ' ' ASN . . . . . 0.435 ' O ' ' HB2' ' D' ' 77' ' ' ASN . 49.7 t30 -65.49 -22.9 66.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.852 0.358 . . . . 0.0 110.705 -178.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 75' ' ' ILE . . . . . 0.516 ' O ' HG12 ' D' ' 79' ' ' ILE . 27.2 mm -76.93 -37.94 27.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.067 177.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 76' ' ' SER . . . . . 0.692 ' HA ' HG12 ' D' ' 79' ' ' ILE . 32.8 t -75.51 -19.45 59.36 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.224 -0.59 . . . . 0.0 110.284 175.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 77' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' D' ' 74' ' ' ASN . 5.1 m120 -63.14 -28.92 70.39 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 166.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 78' ' ' ASP . . . . . 1.065 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 1.0 OUTLIER -87.9 -30.03 20.42 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 115.387 -0.824 . . . . 0.0 113.166 176.114 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . 0.692 HG12 ' HA ' ' D' ' 76' ' ' SER . 24.3 mm -63.25 -28.22 44.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 O-C-N 121.379 -0.826 . . . . 0.0 110.669 -174.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -65.46 -40.45 93.21 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.509 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . 1.065 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -74.17 -51.83 14.33 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.605 176.82 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 82' ' ' LEU . . . . . 0.665 HD23 ' O ' ' D' ' 78' ' ' ASP . 4.0 mm? -48.99 -30.16 5.71 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 83' ' ' ASN . . . . . 0.63 HD21 ' HB3' ' D' ' 36' ' ' LEU . 0.7 OUTLIER 42.36 61.42 2.01 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 123.695 0.622 . . . . 0.0 110.979 174.693 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 84' ' ' ILE . . . . . 0.481 HD13 HG22 ' D' ' 84' ' ' ILE . 49.5 mt -90.94 98.19 8.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.773 -175.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 85' ' ' LYS . . . . . 0.899 ' HB2' ' HB2' ' D' ' 36' ' ' LEU . 10.9 tmtt? -141.33 94.93 2.75 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -175.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 86' ' ' GLY . . . . . 0.525 ' H ' ' CD1' ' D' ' 89' ' ' ILE . . . 69.17 150.97 0.4 Allowed Glycine 0 N--CA 1.453 -0.194 0 CA-C-N 115.283 -0.871 . . . . 0.0 113.495 -178.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 87' ' ' PRO . . . . . 0.551 ' O ' HG11 ' D' ' 58' ' ' VAL . 68.5 Cg_endo -90.21 -178.79 12.09 Favored 'Cis proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.405 -1.498 . . . . 0.0 112.835 -0.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 88' ' ' TYR . . . . . 0.726 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 1.5 m-85 13.53 93.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.175 1.39 . . . . 0.0 113.943 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.525 ' CD1' ' H ' ' D' ' 86' ' ' GLY . 67.9 mt -110.34 132.49 58.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.311 0.577 . . . . 0.0 112.363 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -123.25 93.92 4.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.867 173.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 91' ' ' ILE . . . . . 0.64 ' CG2' ' HZ3' ' D' ' 54' ' ' TRP . 7.3 mt -95.93 107.6 19.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 92' ' ' LYS . . . . . 0.776 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -163.08 171.27 16.67 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.54 -173.234 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.639 ' HB3' ' NE1' ' D' ' 54' ' ' TRP . 3.5 pp0? -87.99 156.64 19.22 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.686 0.755 . . . . 0.0 112.787 178.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . 0.776 HG22 ' HE2' ' D' ' 92' ' ' LYS . 4.9 pt . . . . . 0 C--N 1.314 -0.938 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.005 -173.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 47.6 p30 . . . . . 0 N--CA 1.479 1.019 0 CA-C-O 121.027 0.441 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 2' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -128.81 47.79 2.42 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.782 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 3.0 mm100 -61.12 -55.19 35.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.108 -177.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 4' ' ' LYS . . . . . 0.42 ' HD2' ' N ' ' D' ' 4' ' ' LYS . 12.2 mptt -93.01 -20.72 20.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.278 177.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 5' ' ' ALA . . . . . . . . . . . . . . . 55.54 78.9 0.17 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.825 178.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . 0.599 HD12 ' N ' ' D' ' 6' ' ' LEU . 5.2 mp -82.72 9.9 8.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.631 177.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' D' ' 7' ' ' GLU . 85.9 tt0 -92.82 -7.39 46.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.101 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.638 ' HA ' ' HB3' ' D' ' 12' ' ' SER . 1.9 pp20? -54.58 -43.62 72.28 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -169.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . 0.408 ' H ' ' CD ' ' D' ' 9' ' ' GLN . 2.5 pm0 -91.92 8.89 35.36 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 122.314 -0.241 . . . . 0.0 111.142 -179.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 10' ' ' MET . . . . . . . . . . . . . 46.3 tpp -107.13 -77.7 0.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.366 -174.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -102.49 -49.1 3.95 Favored 'General case' 0 CA--C 1.491 -1.307 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.015 174.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 12' ' ' SER . . . . . 0.638 ' HB3' ' HA ' ' D' ' 8' ' ' GLU . 47.4 t -32.36 -67.38 0.11 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 113.308 -1.769 . . . . 0.0 113.15 -169.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.519 ' C ' HG11 ' D' ' 16' ' ' VAL . 53.8 mt -91.65 -7.6 10.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.284 -174.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -94.43 -61.9 1.43 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.076 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 15' ' ' SER . . . . . 0.463 ' O ' ' HG3' ' D' ' 19' ' ' LYS . 89.3 p -64.69 -16.68 63.22 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 122.252 -0.28 . . . . 0.0 111.108 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 16' ' ' VAL . . . . . 0.655 ' HA ' ' HE3' ' D' ' 19' ' ' LYS . 14.2 p -58.63 -32.77 46.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-O 121.835 0.826 . . . . 0.0 110.002 178.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 17' ' ' ASN . . . . . 0.538 ' N ' HG13 ' D' ' 16' ' ' VAL . 5.2 m120 -71.55 -37.18 71.12 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.707 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.84 -15.17 58.21 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.655 ' HE3' ' HA ' ' D' ' 16' ' ' VAL . 71.3 mttt -91.03 -28.31 18.05 Favored 'General case' 0 CA--C 1.494 -1.199 0 CA-C-O 122.447 1.117 . . . . 0.0 109.229 -177.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 20' ' ' LEU . . . . . 0.873 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 76.1 mt -95.51 -41.14 9.1 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 112.223 -2.262 . . . . 0.0 109.061 -171.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 21' ' ' ASN . . . . . 0.67 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 59.9 m-20 -73.56 91.07 1.8 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.04 -1.436 . . . . 0.0 110.337 175.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 22' ' ' LYS . . . . . 0.452 ' HD3' HD12 ' D' ' 47' ' ' ILE . 28.7 mtpp -122.36 -41.38 2.41 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -170.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 171.77 -91.89 0.09 OUTLIER Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 119.63 -1.271 . . . . 0.0 113.3 -176.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . 0.573 ' HB3' ' O ' ' D' ' 46' ' ' GLY . 44.2 tptt -50.46 -53.56 28.74 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 25' ' ' GLY . . . . . 0.601 ' HA2' ' ND2' ' D' ' 42' ' ' ASN . . . -140.35 157.46 25.6 Favored Glycine 0 N--CA 1.435 -1.428 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.334 176.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 26' ' ' LYS . . . . . 0.67 ' CB ' ' HA ' ' D' ' 21' ' ' ASN . 9.3 ptpt -149.36 160.6 43.29 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.077 -0.562 . . . . 0.0 111.026 -169.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 27' ' ' LEU . . . . . 0.873 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 44.7 tp -137.08 144.69 43.25 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.34 0.59 . . . . 0.0 111.899 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 28' ' ' SER . . . . . 0.571 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 23.1 t -135.4 137.31 42.16 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.013 -178.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 29' ' ' LEU . . . . . 0.418 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 0.0 OUTLIER -140.5 114.29 8.89 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.345 -179.188 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 68.8 p -123.56 -173.08 2.65 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.975 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 31' ' ' MET . . . . . 0.443 ' SD ' ' HE2' ' D' ' 85' ' ' LYS . 23.0 ptt? -148.1 122.1 9.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.62 0.724 . . . . 0.0 110.961 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -91.92 88.42 6.6 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.43 177.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.56 -110.04 2.99 Favored Glycine 0 CA--C 1.515 0.069 0 C-N-CA 120.333 -0.937 . . . . 0.0 111.389 -172.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 73.6 m-80 -106.24 14.36 27.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.075 0.464 . . . . 0.0 110.716 175.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 35' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -89.04 155.36 19.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.603 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . 1.054 ' HB2' ' HB2' ' D' ' 85' ' ' LYS . 1.4 tm? -117.82 126.98 53.43 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 37' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 29.0 mmmt -130.65 117.79 20.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.829 -168.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 38' ' ' ALA . . . . . 0.401 ' O ' HG23 ' D' ' 39' ' ' THR . . . -121.39 148.89 43.79 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.865 175.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 39' ' ' THR . . . . . 0.571 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 16.5 p -147.89 138.94 23.37 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.516 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 40' ' ' SER . . . . . 0.463 ' HB3' ' HA2' ' D' ' 73' ' ' GLY . 36.7 t -107.69 128.19 54.34 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 169.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 41' ' ' SER . . . . . 0.575 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 35.1 t -94.67 161.63 14.11 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -177.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 42' ' ' ASN . . . . . 0.601 ' ND2' ' HA2' ' D' ' 25' ' ' GLY . 0.1 OUTLIER 83.47 -17.4 0.49 Allowed 'General case' 0 N--CA 1.477 0.879 0 O-C-N 124.706 1.254 . . . . 0.0 109.163 -167.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 71.52 62.48 0.15 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 44' ' ' GLY . . . . . 0.636 ' O ' ' HB ' ' D' ' 71' ' ' THR . . . 127.9 -40.69 1.7 Allowed Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 119.215 -1.469 . . . . 0.0 116.162 168.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 45' ' ' TYR . . . . . 0.538 ' CD2' ' HE3' ' D' ' 24' ' ' LYS . 3.2 m-30 -63.89 155.8 29.6 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.059 1.43 . . . . 0.0 112.422 -175.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . 0.573 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -91.29 -177.2 43.28 Favored Glycine 0 C--O 1.217 -0.926 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 172.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 47' ' ' ILE . . . . . 0.811 HG12 ' HB3' ' D' ' 68' ' ' GLU . 43.2 mm -45.66 -48.37 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.075 0 CA-C-N 117.903 0.852 . . . . 0.0 110.232 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' D' ' 47' ' ' ILE . 48.4 t 153.22 -142.97 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 O-C-N 126.411 2.319 . . . . 0.0 107.632 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -77.48 75.88 4.03 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.467 0.651 . . . . 0.0 111.183 173.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . 0.666 ' HB3' ' HE3' ' D' ' 52' ' ' LYS . 68.3 mm-40 -134.85 -176.39 4.22 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.481 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 51' ' ' ASP . . . . . 0.701 ' HB2' ' HD2' ' D' ' 69' ' ' LYS . 7.1 p-10 -152.89 113.39 4.05 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.559 173.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 52' ' ' LYS . . . . . 0.666 ' HE3' ' HB3' ' D' ' 50' ' ' GLU . 21.1 mmtp -129.88 139.03 51.24 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.314 -170.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 53' ' ' ASN . . . . . 0.489 HD21 ' C ' ' D' ' 52' ' ' LYS . 2.7 m120 -114.33 132.12 56.3 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.404 175.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 54' ' ' TRP . . . . . 0.677 ' HB2' ' O ' ' D' ' 66' ' ' PHE . 0.5 OUTLIER -128.27 160.97 30.49 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -170.431 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -152.7 162.45 29.99 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 114.892 -1.049 . . . . 0.0 113.56 172.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 56' ' ' ILE . . . . . 0.464 ' HA ' ' O ' ' D' ' 90' ' ' GLU . 58.6 mt -130.98 111.91 20.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 177.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 57' ' ' PHE . . . . . 0.956 ' HB2' ' HB3' ' D' ' 90' ' ' GLU . 10.3 m-85 -108.67 99.54 8.9 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 119.908 -0.717 . . . . 0.0 111.424 -165.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.736 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 84.3 t -81.57 103.89 9.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.713 173.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 6.9 m120 63.31 44.38 5.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.505 -176.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.53 -33.1 5.7 Favored Glycine 0 CA--C 1.509 -0.34 0 C-N-CA 120.49 -0.862 . . . . 0.0 114.304 172.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 61' ' ' GLU . . . . . 0.538 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 16.7 pt-20 -90.6 136.27 33.17 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.239 0.542 . . . . 0.0 111.801 -173.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . 0.46 ' HB2' ' CE2' ' D' ' 57' ' ' PHE . 38.0 ttpt -74.26 110.33 8.46 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.861 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.421 HG23 ' O ' ' D' ' 56' ' ' ILE . 29.5 m -93.65 -29.47 4.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -175.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 64' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -136.66 132.44 34.98 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 121.193 -0.203 . . . . 0.0 110.675 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 49.9 m -114.39 123.14 48.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.459 176.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 66' ' ' PHE . . . . . 0.677 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 14.1 p90 -131.48 148.76 52.67 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 173.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 67' ' ' ASN . . . . . 0.634 ' ND2' ' HB2' ' D' ' 69' ' ' LYS . 14.5 p-10 -117.94 130.95 56.52 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 68' ' ' GLU . . . . . 0.811 ' HB3' HG12 ' D' ' 47' ' ' ILE . 54.8 mm-40 -59.85 -18.27 42.92 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.009 0.433 . . . . 0.0 111.314 -173.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.701 ' HD2' ' HB2' ' D' ' 51' ' ' ASP . 46.5 mtpt -58.97 -51.9 68.07 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.393 172.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 69.8 m -64.92 103.05 0.67 Allowed 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 113.098 -1.864 . . . . 0.0 108.787 170.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 71' ' ' THR . . . . . 0.636 ' HB ' ' O ' ' D' ' 44' ' ' GLY . 72.1 p -32.73 119.05 0.3 Allowed 'General case' 0 C--N 1.322 -0.617 0 O-C-N 124.588 1.18 . . . . 0.0 112.689 -174.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 72' ' ' VAL . . . . . 0.609 HG11 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -53.34 -14.4 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.805 176.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 73' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' D' ' 40' ' ' SER . . . -66.66 -70.8 1.03 Allowed Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.743 172.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -62.15 -25.03 67.52 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 120.594 0.235 . . . . 0.0 111.286 -177.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 75' ' ' ILE . . . . . 0.625 ' O ' HG13 ' D' ' 79' ' ' ILE . 30.0 mm -73.87 -37.88 49.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.199 176.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 31.3 t -73.82 -23.13 59.61 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.817 176.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -62.28 -26.94 68.68 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 166.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 78' ' ' ASP . . . . . 1.096 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 57.6 m-20 -83.22 -36.87 24.28 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.031 -0.532 . . . . 0.0 112.089 174.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . 0.625 HG13 ' O ' ' D' ' 75' ' ' ILE . 39.2 mt -66.41 -22.64 30.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 O-C-N 121.805 -0.559 . . . . 0.0 110.878 -173.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -72.92 -31.67 64.78 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 176.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . 1.096 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -81.15 -50.37 9.69 Favored 'General case' 0 N--CA 1.457 -0.076 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.164 174.527 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 82' ' ' LEU . . . . . 0.589 HD21 ' O ' ' D' ' 78' ' ' ASP . 4.0 mm? -47.39 -32.32 4.84 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 177.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 83' ' ' ASN . . . . . 0.561 HD21 ' HB3' ' D' ' 36' ' ' LEU . 0.6 OUTLIER 43.72 61.49 2.26 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 124.062 0.851 . . . . 0.0 110.836 174.224 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 84' ' ' ILE . . . . . 0.448 ' O ' ' HG ' ' D' ' 36' ' ' LEU . 52.5 mt -93.74 98.55 8.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.045 -175.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 85' ' ' LYS . . . . . 1.054 ' HB2' ' HB2' ' D' ' 36' ' ' LEU . 9.4 tmtt? -143.01 94.91 2.69 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.86 151.87 4.38 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.67 -0.696 . . . . 0.0 113.566 176.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 87' ' ' PRO . . . . . 0.595 ' O ' HG11 ' D' ' 58' ' ' VAL . 55.9 Cg_endo -88.49 178.01 19.62 Favored 'Cis proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.83 -1.737 . . . . 0.0 112.479 -0.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 88' ' ' TYR . . . . . 0.736 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 1.7 m-85 28.7 91.19 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.626 1.17 . . . . 0.0 112.907 -177.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.6 HG22 HG13 ' D' ' 91' ' ' ILE . 3.7 mp -97.38 136.55 27.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.233 0.54 . . . . 0.0 110.834 -176.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.956 ' HB3' ' HB2' ' D' ' 57' ' ' PHE . 88.0 tt0 -134.94 87.38 2.33 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.807 173.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 91' ' ' ILE . . . . . 0.6 HG13 HG22 ' D' ' 89' ' ' ILE . 40.8 mt -96.56 99.49 9.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.649 -179.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 92' ' ' LYS . . . . . 0.749 ' HE2' HG23 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -161.76 165.96 27.24 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 121.191 -0.203 . . . . 0.0 110.519 178.33 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.643 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 18.1 pt20 -78.67 165.32 23.78 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 120.191 -0.604 . . . . 0.0 110.59 175.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . 0.749 HG23 ' HE2' ' D' ' 92' ' ' LYS . 9.5 pt . . . . . 0 C--N 1.31 -1.118 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.656 -172.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 120.858 0.361 . . . . 0.0 110.635 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 2' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -76.4 -28.21 56.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.531 -176.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -64.81 -32.14 73.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.8 0.333 . . . . 0.0 111.021 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -99.15 -3.06 35.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.335 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 5' ' ' ALA . . . . . . . . . . . . . . . 52.58 48.67 22.05 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.982 -178.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 58.8 tp -101.25 -26.06 13.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.285 -175.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -56.89 -46.59 81.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.589 -177.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.888 ' HA ' ' HB2' ' D' ' 12' ' ' SER . 52.4 mt-10 -50.24 -42.44 51.84 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -178.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . 0.526 ' H ' ' NE2' ' D' ' 9' ' ' GLN . 0.0 OUTLIER -87.3 8.69 23.18 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -177.18 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 10' ' ' MET . . . . . . . . . . . . . 26.8 ttt -106.83 -78.72 0.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.766 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -104.52 -54.17 2.57 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.402 174.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 12' ' ' SER . . . . . 0.888 ' HB2' ' HA ' ' D' ' 8' ' ' GLU . 71.1 m -25.6 -71.16 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.274 -1.785 . . . . 0.0 113.643 -171.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.505 HD12 ' HB3' ' D' ' 8' ' ' GLU . 58.4 mt -78.7 -68.78 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.199 -1.556 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.722 174.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -35.19 -33.25 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -175.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 15' ' ' SER . . . . . 0.425 ' O ' ' HD2' ' D' ' 19' ' ' LYS . 80.1 p -58.78 -27.51 65.08 Favored 'General case' 0 C--O 1.22 -0.453 0 O-C-N 121.771 -0.58 . . . . 0.0 109.909 176.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 16' ' ' VAL . . . . . 0.593 HG12 ' N ' ' D' ' 17' ' ' ASN . 7.5 p -45.28 -30.09 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.94 1.296 . . . . 0.0 111.185 174.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 17' ' ' ASN . . . . . 0.593 ' N ' HG12 ' D' ' 16' ' ' VAL . 5.9 m120 -86.37 -31.56 21.43 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.895 -177.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 18' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' D' ' 15' ' ' SER . 78.7 m-20 -60.71 -15.66 31.37 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 176.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.614 ' HD2' ' N ' ' D' ' 19' ' ' LYS . 0.0 OUTLIER -91.35 -46.57 7.95 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 122.03 0.919 . . . . 0.0 108.599 175.238 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 20' ' ' LEU . . . . . 0.885 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 63.8 mt -63.51 -40.49 97.19 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.192 -1.822 . . . . 0.0 110.348 -178.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 21' ' ' ASN . . . . . 0.635 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 55.6 m-20 -77.35 96.7 4.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.425 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 22' ' ' LYS . . . . . 0.765 ' HD2' HD13 ' D' ' 47' ' ' ILE . 65.3 mttm -122.83 -41.57 2.35 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -178.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 171.17 -86.22 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 119.575 -1.298 . . . . 0.0 113.663 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . 0.694 ' HE3' ' HD1' ' D' ' 45' ' ' TYR . 50.7 tptt -53.54 -44.47 69.23 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.85 0.833 . . . . 0.0 109.415 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 25' ' ' GLY . . . . . 0.591 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -150.2 148.13 19.03 Favored Glycine 0 N--CA 1.429 -1.802 0 CA-C-N 114.255 -1.338 . . . . 0.0 111.582 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 26' ' ' LYS . . . . . 0.635 ' CB ' ' HA ' ' D' ' 21' ' ' ASN . 10.8 ptpt -149.32 160.85 43.05 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 114.262 -0.969 . . . . 0.0 110.561 -168.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 27' ' ' LEU . . . . . 0.885 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 41.1 tp -135.65 143.58 45.57 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.237 0.541 . . . . 0.0 111.847 -178.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 28' ' ' SER . . . . . 0.632 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 27.9 t -128.18 152.62 47.83 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 29' ' ' LEU . . . . . . . . . . . . . 15.1 mt -140.78 138.75 34.33 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 177.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 60.6 m -147.05 179.16 7.81 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 31' ' ' MET . . . . . 0.427 ' HA ' ' O ' ' D' ' 35' ' ' GLN . 23.3 ptt? -134.9 122.32 21.8 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.441 0.639 . . . . 0.0 110.636 177.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -91.42 88.97 7.04 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.2 -114.74 4.03 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -169.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 34' ' ' ASN . . . . . 0.674 ' O ' ' HE3' ' D' ' 85' ' ' LYS . 4.2 m120 -109.63 31.74 5.57 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.095 0.474 . . . . 0.0 110.023 172.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 35' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' D' ' 31' ' ' MET . 3.8 tp-100 -105.81 161.35 14.5 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.601 -179.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . 0.519 ' HG ' ' N ' ' D' ' 84' ' ' ILE . 3.0 tm? -114.09 131.36 56.42 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.772 0.32 . . . . 0.0 110.766 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 37' ' ' LYS . . . . . 0.403 ' HE2' ' CG ' ' D' ' 35' ' ' GLN . 74.0 mmtt -138.34 109.05 6.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.082 -169.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 38' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -105.58 149.37 26.34 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.966 0.412 . . . . 0.0 111.229 176.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 39' ' ' THR . . . . . 0.632 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 18.0 p -143.65 129.57 19.47 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.698 175.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 40' ' ' SER . . . . . 0.722 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 72.3 p -109.38 131.56 54.95 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 41' ' ' SER . . . . . 0.611 ' HB2' ' CD ' ' D' ' 26' ' ' LYS . 52.3 m -96.56 152.82 18.27 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.714 -178.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 42' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' D' ' 41' ' ' SER . 75.9 m-80 80.09 6.12 1.76 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.005 -170.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 53.27 54.47 10.19 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 114.636 -1.166 . . . . 0.0 113.811 171.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 44' ' ' GLY . . . . . 0.742 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 104.78 35.81 3.15 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 119.431 -1.366 . . . . 0.0 114.749 168.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 45' ' ' TYR . . . . . 0.694 ' HD1' ' HE3' ' D' ' 24' ' ' LYS . 2.6 m-85 -112.78 153.81 27.21 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 168.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . 0.578 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -86.0 -174.0 49.54 Favored Glycine 0 CA--C 1.499 -0.945 0 C-N-CA 120.094 -1.05 . . . . 0.0 110.953 178.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 47' ' ' ILE . . . . . 0.78 HG12 ' HB3' ' D' ' 68' ' ' GLU . 45.3 mm -46.3 -51.33 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.231 0 CA-C-O 121.454 0.645 . . . . 0.0 109.987 177.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' D' ' 47' ' ' ILE . 41.3 t 159.31 -138.97 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.626 0 O-C-N 126.507 2.379 . . . . 0.0 107.564 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -88.88 76.01 7.99 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.474 0.655 . . . . 0.0 111.606 175.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . 0.782 ' HB2' ' HE2' ' D' ' 52' ' ' LYS . 48.6 mt-10 -150.32 179.04 8.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.541 176.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 51' ' ' ASP . . . . . 0.618 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 31.8 m-20 -133.39 134.29 43.49 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.746 173.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 52' ' ' LYS . . . . . 0.782 ' HE2' ' HB2' ' D' ' 50' ' ' GLU . 1.9 mptp? -138.43 137.58 37.36 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -176.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -115.07 134.08 55.49 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.413 174.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 54' ' ' TRP . . . . . 0.64 ' HZ3' ' CG2' ' D' ' 91' ' ' ILE . 1.1 m95 -125.73 160.09 30.65 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -172.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -148.05 158.07 27.56 Favored Glycine 0 N--CA 1.436 -1.312 0 CA-C-N 114.419 -1.264 . . . . 0.0 113.006 172.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 56' ' ' ILE . . . . . 0.604 HG12 ' CG2' ' D' ' 91' ' ' ILE . 98.1 mt -125.88 110.31 23.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-N 113.317 -1.442 . . . . 0.0 107.149 176.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 57' ' ' PHE . . . . . 0.77 ' HB2' ' HB2' ' D' ' 90' ' ' GLU . 14.0 m-85 -106.02 102.82 12.22 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 119.881 -0.728 . . . . 0.0 110.821 -167.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.689 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 95.2 t -95.5 108.97 21.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.502 178.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 59' ' ' ASN . . . . . 0.553 ' OD1' ' HG2' ' D' ' 87' ' ' PRO . 6.2 m120 59.68 52.35 5.64 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.989 -178.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.15 47.17 92.36 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.283 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 61' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 87.1 tt0 -151.45 116.17 5.17 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.315 -0.443 . . . . 0.0 109.866 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . 0.482 ' NZ ' ' HB3' ' D' ' 62' ' ' LYS . 6.1 ttpm? -70.96 99.04 1.71 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.462 HG12 ' O ' ' D' ' 56' ' ' ILE . 14.7 p -87.1 -30.99 5.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.581 -169.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 64' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -137.5 130.31 30.17 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.579 175.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 76.0 m -112.04 112.82 24.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.319 176.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 66' ' ' PHE . . . . . 0.538 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 7.6 p90 -118.67 150.5 39.62 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 173.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 67' ' ' ASN . . . . . 0.466 ' OD1' ' HB2' ' D' ' 69' ' ' LYS . 18.6 p30 -122.04 140.61 52.28 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 68' ' ' GLU . . . . . 0.78 ' HB3' HG12 ' D' ' 47' ' ' ILE . 39.2 mm-40 -68.33 -9.46 48.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.218 0.532 . . . . 0.0 110.368 -176.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.56 ' NZ ' ' HB3' ' D' ' 69' ' ' LYS . 5.3 mtpm? -62.73 -45.06 94.49 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 170.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 70' ' ' SER . . . . . 0.491 ' O ' HD13 ' D' ' 75' ' ' ILE . 31.1 t -66.29 125.65 26.27 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 113.528 -1.669 . . . . 0.0 107.571 168.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 71' ' ' THR . . . . . 0.424 ' O ' HG13 ' D' ' 75' ' ' ILE . 72.0 p -54.19 125.28 18.52 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -178.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 72' ' ' VAL . . . . . 0.671 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -55.32 -14.62 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 121.069 0.461 . . . . 0.0 110.918 -175.271 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 73' ' ' GLY . . . . . 0.742 ' HA3' ' HA2' ' D' ' 44' ' ' GLY . . . -71.05 -57.01 6.52 Favored Glycine 0 N--CA 1.437 -1.264 0 CA-C-N 115.043 -0.98 . . . . 0.0 112.627 170.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -61.76 -24.15 66.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.115 0.483 . . . . 0.0 110.342 176.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 75' ' ' ILE . . . . . 0.609 ' O ' HG13 ' D' ' 79' ' ' ILE . 66.4 mt -73.2 -41.53 58.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.359 175.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 28.4 t -76.16 -24.05 54.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.762 -0.199 . . . . 0.0 110.764 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 77' ' ' ASN . . . . . 0.564 ' O ' ' HD3' ' D' ' 81' ' ' LYS . 4.0 m120 -63.38 -19.03 64.3 Favored 'General case' 0 C--O 1.218 -0.601 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 168.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 78' ' ' ASP . . . . . 0.633 ' O ' HD22 ' D' ' 82' ' ' LEU . 72.0 m-20 -93.52 -45.41 7.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.068 174.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . 0.609 HG13 ' O ' ' D' ' 75' ' ' ILE . 43.0 mt -67.99 -33.35 60.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 O-C-N 121.743 -0.598 . . . . 0.0 111.729 -170.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -64.63 -13.49 53.85 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.191 174.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . 0.564 ' HD3' ' O ' ' D' ' 77' ' ' ASN . 16.0 mmmt -92.34 -57.8 2.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 122.185 0.993 . . . . 0.0 108.866 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 82' ' ' LEU . . . . . 0.633 HD22 ' O ' ' D' ' 78' ' ' ASP . 3.3 mm? -56.07 -23.63 34.93 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 113.821 -1.536 . . . . 0.0 112.913 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 83' ' ' ASN . . . . . 0.425 ' HA ' ' HB3' ' D' ' 36' ' ' LEU . 7.5 m120 32.72 70.46 0.1 Allowed 'General case' 0 N--CA 1.476 0.867 0 O-C-N 124.182 0.926 . . . . 0.0 112.978 -177.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 84' ' ' ILE . . . . . 0.591 HG22 HD11 ' D' ' 89' ' ' ILE . 47.2 mt -86.45 98.86 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-O 121.132 0.492 . . . . 0.0 110.991 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 85' ' ' LYS . . . . . 0.674 ' HE3' ' O ' ' D' ' 34' ' ' ASN . 0.0 OUTLIER -135.01 94.55 3.16 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.871 0.843 . . . . 0.0 111.947 -179.563 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 86' ' ' GLY . . . . . 0.552 ' H ' ' CD1' ' D' ' 89' ' ' ILE . . . 70.28 153.2 0.92 Allowed Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.622 -0.717 . . . . 0.0 113.032 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 87' ' ' PRO . . . . . 0.553 ' HG2' ' OD1' ' D' ' 59' ' ' ASN . 92.6 Cg_endo -91.18 -177.27 9.29 Favored 'Cis proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.705 -1.373 . . . . 0.0 112.52 -0.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 88' ' ' TYR . . . . . 0.689 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 14.4 m-85 8.24 93.18 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 125.473 1.509 . . . . 0.0 113.844 -177.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.625 HG12 HG23 ' D' ' 58' ' ' VAL . 67.8 mt -110.43 135.22 50.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.427 0.632 . . . . 0.0 111.83 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.77 ' HB2' ' HB2' ' D' ' 57' ' ' PHE . 5.5 mm-40 -122.58 89.52 3.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.991 176.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 91' ' ' ILE . . . . . 0.64 ' CG2' ' HZ3' ' D' ' 54' ' ' TRP . 4.7 mt -96.31 108.9 21.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 92' ' ' LYS . . . . . 0.781 ' HE2' HG23 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -162.95 172.73 14.62 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.361 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.633 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 25.1 pt20 -81.5 163.58 22.6 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 119.749 -0.781 . . . . 0.0 111.219 175.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . 0.781 HG23 ' HE2' ' D' ' 92' ' ' LYS . 9.9 pt . . . . . 0 C--N 1.307 -1.246 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.139 -172.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 . . . . . 0 N--CA 1.483 1.216 0 N-CA-C 110.652 -0.129 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 2' ' ' ASN . . . . . 0.495 ' HB3' ' HA ' ' D' ' 5' ' ' ALA . 75.3 m-20 61.2 54.15 3.36 Favored 'General case' 0 N--CA 1.462 0.163 0 O-C-N 123.692 0.62 . . . . 0.0 110.519 -176.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -64.68 -40.64 95.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.059 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 4' ' ' LYS . . . . . 0.41 ' HD3' ' HB3' ' D' ' 7' ' ' GLU . 21.4 ptmt -90.77 -18.42 24.97 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 175.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 5' ' ' ALA . . . . . 0.495 ' HA ' ' HB3' ' D' ' 2' ' ' ASN . . . 66.93 -59.7 0.37 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.942 -1.026 . . . . 0.0 113.448 172.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . 0.448 HD13 ' NE2' ' D' ' 9' ' ' GLN . 1.3 pp -67.49 1.02 2.55 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -174.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . 0.41 ' HB3' ' HD3' ' D' ' 4' ' ' LYS . 23.1 pt-20 -63.26 1.81 0.45 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.556 ' C ' ' H ' ' D' ' 10' ' ' MET . 12.5 pt-20 -100.24 0.88 41.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.759 -0.201 . . . . 0.0 111.29 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . 0.576 ' HA ' ' HB3' ' D' ' 12' ' ' SER . 14.4 pt20 -58.17 10.71 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.403 1.081 . . . . 0.0 113.853 -178.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 10' ' ' MET . . . . . 0.556 ' H ' ' C ' ' D' ' 8' ' ' GLU . 65.5 mtm -78.75 -47.94 15.83 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 174.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -100.26 -56.19 2.42 Favored 'General case' 0 C--O 1.207 -1.167 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.169 166.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 12' ' ' SER . . . . . 0.576 ' HB3' ' HA ' ' D' ' 9' ' ' GLN . 43.8 t -23.42 -68.92 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 -173.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.459 ' O ' HG23 ' D' ' 13' ' ' ILE . 41.9 mm -80.2 -9.4 12.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.451 -169.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 75.0 m-80 -94.81 -50.59 5.07 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.001 172.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 15' ' ' SER . . . . . 0.507 ' O ' ' HD2' ' D' ' 19' ' ' LYS . 80.5 p -66.62 -30.59 70.9 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.256 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 16' ' ' VAL . . . . . 0.566 HG11 ' ND2' ' D' ' 17' ' ' ASN . 11.5 p -50.75 -28.53 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 121.981 0.896 . . . . 0.0 110.31 175.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 17' ' ' ASN . . . . . 0.566 ' ND2' HG11 ' D' ' 16' ' ' VAL . 4.4 m120 -83.51 -31.29 26.53 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.911 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.92 -15.55 43.94 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 177.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.55 ' HD2' ' N ' ' D' ' 19' ' ' LYS . 0.0 OUTLIER -90.82 -42.21 10.78 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 176.006 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 20' ' ' LEU . . . . . 0.924 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 64.9 mt -70.4 -41.06 73.48 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 113.327 -1.76 . . . . 0.0 110.398 -176.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 21' ' ' ASN . . . . . 0.682 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 59.4 m-20 -74.42 100.76 3.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.656 -1.157 . . . . 0.0 110.225 177.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 22' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -121.94 -43.46 2.34 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -171.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.96 -74.81 0.2 Allowed Glycine 0 N--CA 1.435 -1.39 0 C-N-CA 120.281 -0.961 . . . . 0.0 112.231 -174.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . 0.811 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 27.2 tptp -58.41 -68.42 0.26 Allowed 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 25' ' ' GLY . . . . . 0.765 ' HA2' ' ND2' ' D' ' 42' ' ' ASN . . . -127.77 156.93 20.84 Favored Glycine 0 N--CA 1.431 -1.656 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.631 173.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 26' ' ' LYS . . . . . 0.682 ' CB ' ' HA ' ' D' ' 21' ' ' ASN . 8.5 ptpt -148.31 159.45 43.98 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 114.828 -0.686 . . . . 0.0 111.192 -170.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 27' ' ' LEU . . . . . 0.924 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 42.0 tp -137.46 142.82 41.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.717 0.77 . . . . 0.0 111.968 -177.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 28' ' ' SER . . . . . 0.668 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 50.3 m -129.05 151.32 49.86 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.296 -178.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 29' ' ' LEU . . . . . 0.527 ' CD2' ' HB3' ' D' ' 38' ' ' ALA . 17.7 mt -140.89 135.49 31.36 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 177.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 48.5 m -136.85 -173.28 3.4 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 22.7 ptm -150.14 166.01 31.12 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.675 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.19 89.3 2.09 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.07 -101.88 1.51 Allowed Glycine 0 C--O 1.227 -0.3 0 C-N-CA 120.064 -1.065 . . . . 0.0 110.901 -173.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -111.15 27.81 9.33 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.183 0.515 . . . . 0.0 109.907 173.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 35' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -96.87 164.74 12.42 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -177.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . 0.506 ' C ' HD12 ' D' ' 36' ' ' LEU . 2.8 tm? -132.18 124.19 28.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.056 174.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 37' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -132.11 100.73 5.13 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.004 -168.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 38' ' ' ALA . . . . . 0.527 ' HB3' ' CD2' ' D' ' 29' ' ' LEU . . . -98.57 146.81 25.42 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.574 0.702 . . . . 0.0 112.105 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 39' ' ' THR . . . . . 0.668 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 18.3 p -141.65 128.83 20.96 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.242 176.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 40' ' ' SER . . . . . 0.6 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 77.7 p -107.12 129.5 54.83 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 173.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 41' ' ' SER . . . . . 0.657 ' HB3' ' HG3' ' D' ' 26' ' ' LYS . 46.2 t -93.03 146.7 23.43 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -175.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 42' ' ' ASN . . . . . 0.765 ' ND2' ' HA2' ' D' ' 25' ' ' GLY . 0.9 OUTLIER 82.12 -18.74 0.45 Allowed 'General case' 0 N--CA 1.477 0.925 0 O-C-N 125.59 1.806 . . . . 0.0 109.757 -167.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 60.85 60.33 1.89 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 175.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 44' ' ' GLY . . . . . 0.438 ' O ' HG23 ' D' ' 71' ' ' THR . . . 123.88 35.98 0.65 Allowed Glycine 0 C--N 1.338 0.689 0 C-N-CA 119.166 -1.492 . . . . 0.0 115.797 168.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 45' ' ' TYR . . . . . 0.811 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 7.0 m-30 -116.02 160.87 19.7 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 170.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . 0.588 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -107.84 -152.91 17.49 Favored Glycine 0 C--O 1.223 -0.533 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.87 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 47' ' ' ILE . . . . . 1.001 HG13 ' HB2' ' D' ' 68' ' ' GLU . 1.7 mp -51.45 -57.68 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 CA-C-O 122.484 1.135 . . . . 0.0 108.486 177.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 67.2 p 167.93 -77.67 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 111.378 -2.646 . . . . 0.0 107.273 -173.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 49' ' ' TYR . . . . . 0.469 ' HD2' ' O ' ' D' ' 49' ' ' TYR . 0.1 OUTLIER -154.64 74.55 0.95 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.61 165.496 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . 0.665 ' O ' ' HG2' ' D' ' 69' ' ' LYS . 59.2 mm-40 -141.46 -158.67 0.88 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.226 -176.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 51' ' ' ASP . . . . . 0.6 ' CB ' ' HD2' ' D' ' 69' ' ' LYS . 7.2 t70 -146.51 112.26 5.65 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.234 174.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 52' ' ' LYS . . . . . 0.745 ' HD3' HG12 ' D' ' 47' ' ' ILE . 4.5 mptp? -126.15 106.15 9.36 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.904 -172.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 53' ' ' ASN . . . . . 0.485 HD21 ' N ' ' D' ' 53' ' ' ASN . 2.1 m120 -88.74 130.44 35.34 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.06 0.457 . . . . 0.0 110.401 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 54' ' ' TRP . . . . . 0.706 ' HB2' ' O ' ' D' ' 66' ' ' PHE . 0.4 OUTLIER -119.63 166.02 13.72 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.108 -175.2 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -148.84 159.93 28.21 Favored Glycine 0 N--CA 1.439 -1.138 0 C-N-CA 120.04 -1.076 . . . . 0.0 113.689 175.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 56' ' ' ILE . . . . . 0.533 ' O ' HG11 ' D' ' 63' ' ' VAL . 82.8 mt -135.61 105.06 5.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 176.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 57' ' ' PHE . . . . . 0.518 ' CE1' ' NZ ' ' D' ' 92' ' ' LYS . 13.7 m-85 -101.28 98.21 8.62 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 119.178 -1.009 . . . . 0.0 111.076 -167.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.742 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 97.9 t -89.75 115.16 28.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.835 173.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 66.11 38.04 4.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.81 -175.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.92 -32.99 4.37 Favored Glycine 0 CA--C 1.509 -0.334 0 C-N-CA 120.959 -0.638 . . . . 0.0 113.512 176.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 61' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 16.6 pt-20 -90.76 141.55 28.68 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.322 0.582 . . . . 0.0 111.399 -174.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . 0.459 ' HB2' ' CE2' ' D' ' 57' ' ' PHE . 6.2 ttpm? -74.07 100.38 3.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.1 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.533 HG11 ' O ' ' D' ' 56' ' ' ILE . 14.5 p -79.37 -28.65 13.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.672 -173.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 64' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -140.32 141.62 35.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.639 0.257 . . . . 0.0 110.657 176.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 28.3 m -121.19 130.42 53.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.882 176.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 66' ' ' PHE . . . . . 0.706 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 19.5 p90 -136.98 140.13 41.95 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.758 0.79 . . . . 0.0 110.859 174.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 67' ' ' ASN . . . . . 0.755 HD21 ' HB2' ' D' ' 69' ' ' LYS . 11.2 p-10 -111.2 135.4 51.78 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.901 -178.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 68' ' ' GLU . . . . . 1.001 ' HB2' HG13 ' D' ' 47' ' ' ILE . 28.4 mt-10 -65.05 -13.2 57.37 Favored 'General case' 0 CA--C 1.521 -0.137 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.036 -175.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.755 ' HB2' HD21 ' D' ' 67' ' ' ASN . 5.6 mtpm? -59.91 -43.21 95.01 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 172.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 70' ' ' SER . . . . . 0.523 ' HG ' ' CD1' ' D' ' 75' ' ' ILE . 25.5 t -74.56 102.18 4.44 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 113.422 -1.717 . . . . 0.0 107.185 165.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 71' ' ' THR . . . . . 0.438 HG23 ' O ' ' D' ' 44' ' ' GLY . 62.4 p -38.95 130.35 1.49 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.631 -173.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 72' ' ' VAL . . . . . 0.8 HG12 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -53.32 -14.14 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 179.242 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 73' ' ' GLY . . . . . 0.6 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -71.56 -62.49 3.42 Favored Glycine 0 N--CA 1.435 -1.367 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.303 170.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -54.79 -31.09 58.52 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.247 0.546 . . . . 0.0 110.717 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 75' ' ' ILE . . . . . 0.523 ' CD1' ' HG ' ' D' ' 70' ' ' SER . 26.6 mm -80.37 -36.3 16.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.401 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 76' ' ' SER . . . . . 0.429 ' HA ' HG12 ' D' ' 79' ' ' ILE . 27.7 t -73.84 -20.28 60.48 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.965 178.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 77' ' ' ASN . . . . . 0.416 ' O ' ' HD3' ' D' ' 81' ' ' LYS . 5.7 m120 -61.38 -46.51 89.89 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 163.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 78' ' ' ASP . . . . . 0.908 ' HA ' ' HG2' ' D' ' 81' ' ' LYS . 51.5 m-20 -60.31 -36.16 77.28 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 174.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . 0.488 HG12 ' O ' ' D' ' 75' ' ' ILE . 29.8 mm -67.06 -30.6 50.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.248 -174.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -75.98 -15.87 60.08 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.332 174.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . 0.908 ' HG2' ' HA ' ' D' ' 78' ' ' ASP . 11.0 mmtp -77.33 -63.65 1.32 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 173.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 82' ' ' LEU . . . . . 0.664 HD22 ' O ' ' D' ' 78' ' ' ASP . 3.2 mm? -49.47 -26.25 3.22 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 113.242 -1.799 . . . . 0.0 113.56 -174.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 83' ' ' ASN . . . . . 0.56 ' O ' ' HE2' ' D' ' 85' ' ' LYS . 0.8 OUTLIER 51.82 66.67 1.13 Allowed 'General case' 0 N--CA 1.468 0.46 0 O-C-N 123.386 0.429 . . . . 0.0 110.251 177.137 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 84' ' ' ILE . . . . . 0.438 ' N ' ' HG ' ' D' ' 36' ' ' LEU . 46.5 mm -76.9 99.48 2.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.897 -173.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 85' ' ' LYS . . . . . 0.56 ' HE2' ' O ' ' D' ' 83' ' ' ASN . 0.0 OUTLIER -156.26 91.75 1.28 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 174.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 86' ' ' GLY . . . . . 0.518 ' H ' ' CD1' ' D' ' 89' ' ' ILE . . . 69.17 151.27 0.43 Allowed Glycine 0 N--CA 1.453 -0.219 0 CA-C-N 115.163 -0.926 . . . . 0.0 113.222 174.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 87' ' ' PRO . . . . . 0.588 ' O ' HG12 ' D' ' 58' ' ' VAL . 59.0 Cg_endo -90.76 179.91 13.15 Favored 'Cis proline' 0 CA--C 1.535 0.534 0 C-N-CA 123.336 -1.527 . . . . 0.0 112.784 -0.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 88' ' ' TYR . . . . . 0.742 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 0.9 OUTLIER 16.85 92.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 125.142 1.377 . . . . 0.0 113.705 178.76 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.518 ' CD1' ' H ' ' D' ' 86' ' ' GLY . 70.3 mt -111.5 142.73 23.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.516 ' O ' ' HD1' ' D' ' 57' ' ' PHE . 70.9 mt-10 -136.87 95.05 3.05 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.676 172.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 91' ' ' ILE . . . . . 0.611 ' CG2' ' HZ3' ' D' ' 54' ' ' TRP . 5.5 mt -96.87 106.53 18.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 92' ' ' LYS . . . . . 0.671 ' HE2' HG21 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -161.93 170.77 18.79 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.622 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.592 ' HB3' ' NE1' ' D' ' 54' ' ' TRP . 18.9 pt20 -82.59 164.8 20.57 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.749 176.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . 0.671 HG21 ' HE2' ' D' ' 92' ' ' LYS . 10.4 pt . . . . . 0 C--N 1.31 -1.118 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.174 -172.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 1' ' ' ASP . . . . . 0.707 ' HB3' ' HB1' ' D' ' 5' ' ' ALA . 1.7 m-20 . . . . . 0 N--CA 1.482 1.153 0 CA-C-O 120.506 0.193 . . . . 0.0 110.645 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 2' ' ' ASN . . . . . 0.526 ' O ' ' HB3' ' D' ' 6' ' ' LEU . 20.2 t-20 -172.27 -44.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.59 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -60.6 -53.71 54.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.216 -175.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -112.79 -32.03 6.54 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 177.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 5' ' ' ALA . . . . . 0.707 ' HB1' ' HB3' ' D' ' 1' ' ' ASP . . . -102.36 76.28 1.54 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.075 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . 0.526 ' HB3' ' O ' ' D' ' 2' ' ' ASN . 1.8 pt? -112.13 -1.41 15.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.632 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -49.43 -68.12 0.2 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.967 ' HA ' ' HB3' ' D' ' 12' ' ' SER . 23.0 pt-20 -78.63 1.1 23.87 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -176.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . 0.68 ' NE2' ' HG3' ' D' ' 8' ' ' GLU . 17.5 mp0 -94.95 -13.14 25.62 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 10' ' ' MET . . . . . 0.466 ' HG2' ' O ' ' D' ' 6' ' ' LEU . 25.1 mmt -109.07 -77.83 0.6 Allowed 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 119.539 -0.864 . . . . 0.0 113.099 -172.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -100.92 -41.16 6.93 Favored 'General case' 0 CA--C 1.488 -1.426 0 CA-C-O 121.222 0.534 . . . . 0.0 110.422 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 12' ' ' SER . . . . . 0.967 ' HB3' ' HA ' ' D' ' 8' ' ' GLU . 34.7 t -42.05 -68.27 0.2 Allowed 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 113.373 -1.739 . . . . 0.0 112.263 -169.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.513 ' C ' HG12 ' D' ' 16' ' ' VAL . 38.2 mm -92.91 -9.69 9.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.34 -174.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 14' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' D' ' 10' ' ' MET . 78.5 m-20 -96.83 -56.27 2.62 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 177.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 37.2 m -69.39 -15.7 63.36 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 121.21 -0.196 . . . . 0.0 110.997 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 16' ' ' VAL . . . . . 0.729 ' HA ' ' HE2' ' D' ' 19' ' ' LYS . 14.1 p -56.84 -35.26 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 173.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -66.66 -44.01 82.99 Favored 'General case' 0 C--O 1.211 -0.955 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.349 175.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -56.77 -15.07 3.97 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -174.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.729 ' HE2' ' HA ' ' D' ' 16' ' ' VAL . 0.0 OUTLIER -91.54 -44.09 9.28 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-O 122.413 1.101 . . . . 0.0 108.895 174.261 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 20' ' ' LEU . . . . . 0.855 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 72.6 mt -69.76 -36.47 75.81 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 112.804 -1.998 . . . . 0.0 110.097 -174.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 21' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -69.82 98.76 1.27 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.589 177.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 22' ' ' LYS . . . . . 0.62 ' NZ ' ' HA ' ' D' ' 47' ' ' ILE . 8.8 mtmp? -121.36 -42.5 2.45 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -171.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.38 -71.66 0.32 Allowed Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.135 -1.031 . . . . 0.0 112.04 -175.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . 0.84 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 21.8 tptm -51.01 -67.42 0.25 Allowed 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 175.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.9 166.69 23.91 Favored Glycine 0 N--CA 1.43 -1.704 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.581 169.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 26' ' ' LYS . . . . . 0.8 ' HD2' ' HB2' ' D' ' 41' ' ' SER . 0.4 OUTLIER -148.15 156.93 43.17 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.543 -0.328 . . . . 0.0 110.486 -170.545 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 27' ' ' LEU . . . . . 0.855 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 46.2 tp -137.43 142.47 41.62 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.318 0.58 . . . . 0.0 111.285 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 28' ' ' SER . . . . . 0.694 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 49.0 m -137.03 143.18 42.57 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.013 -174.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 29' ' ' LEU . . . . . 0.574 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 0.2 OUTLIER -140.7 149.73 42.56 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.768 -179.113 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 36.1 t -155.01 174.45 15.16 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.17 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 31' ' ' MET . . . . . 0.413 ' SD ' ' N ' ' D' ' 31' ' ' MET . 0.0 OUTLIER -128.74 165.43 20.93 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.023 0.44 . . . . 0.0 109.884 176.838 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 32' ' ' ASN . . . . . 0.406 ' HB3' ' HB2' ' D' ' 35' ' ' GLN . 52.6 t30 -146.82 88.13 1.73 Allowed 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.61 -101.06 1.24 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.392 -168.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 34' ' ' ASN . . . . . 0.446 ' O ' ' HE2' ' D' ' 85' ' ' LYS . 4.4 m120 -116.4 20.99 13.89 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.691 -0.3 . . . . 0.0 110.705 173.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 35' ' ' GLN . . . . . 0.406 ' HB2' ' HB3' ' D' ' 32' ' ' ASN . 13.6 mm100 -88.91 163.09 15.76 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.576 0.703 . . . . 0.0 111.983 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . 0.551 ' HB3' ' ND2' ' D' ' 83' ' ' ASN . 2.4 tm? -129.93 124.95 34.32 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.933 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 37' ' ' LYS . . . . . 0.574 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 26.1 mmmt -130.38 116.15 17.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.605 -168.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 38' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -120.16 143.72 48.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.443 0.64 . . . . 0.0 111.338 176.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 39' ' ' THR . . . . . 0.694 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 4.9 p -138.55 130.11 27.62 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.095 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 40' ' ' SER . . . . . 0.712 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 24.7 p -120.75 129.52 53.65 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 41' ' ' SER . . . . . 0.8 ' HB2' ' HD2' ' D' ' 26' ' ' LYS . 49.3 m -100.92 159.45 15.19 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.174 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 42' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' D' ' 41' ' ' SER . 74.2 m-80 76.67 8.91 3.05 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 124.572 1.17 . . . . 0.0 110.707 -174.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 40.92 59.05 2.33 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 171.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 44' ' ' GLY . . . . . 0.454 ' O ' HG21 ' D' ' 71' ' ' THR . . . 114.22 35.24 1.5 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 119.419 -1.372 . . . . 0.0 114.175 172.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 45' ' ' TYR . . . . . 0.84 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 2.2 m-30 -113.18 145.74 40.45 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 122.477 -0.425 . . . . 0.0 110.02 172.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -91.63 -150.49 25.55 Favored Glycine 0 CA--C 1.504 -0.629 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.411 -178.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 47' ' ' ILE . . . . . 0.935 HG13 ' HB2' ' D' ' 68' ' ' GLU . 0.3 OUTLIER -53.77 -58.91 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 CA-C-O 122.079 0.942 . . . . 0.0 109.013 -178.585 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.444 ' O ' ' HD2' ' D' ' 49' ' ' TYR . 41.1 t 163.25 -107.32 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 111.216 -2.72 . . . . 0.0 105.381 -172.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 49' ' ' TYR . . . . . 0.444 ' HD2' ' O ' ' D' ' 48' ' ' SER . 2.7 m-30 -124.09 76.76 1.48 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 163.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . 0.556 ' HB2' HG23 ' D' ' 47' ' ' ILE . 63.8 mm-40 -148.56 -166.14 2.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.134 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 51' ' ' ASP . . . . . 0.727 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 2.8 p30 -148.41 138.7 22.6 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.382 168.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 52' ' ' LYS . . . . . 0.727 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 0.4 OUTLIER -143.44 144.35 31.98 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.098 -174.854 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 53' ' ' ASN . . . . . 0.458 HD21 ' C ' ' D' ' 52' ' ' LYS . 3.2 m120 -120.2 129.54 54.14 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 172.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 54' ' ' TRP . . . . . 0.644 ' HZ3' ' CG2' ' D' ' 91' ' ' ILE . 1.0 OUTLIER -120.99 162.04 20.59 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -173.109 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -152.19 152.96 24.6 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.414 172.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 56' ' ' ILE . . . . . 0.724 HG12 HG22 ' D' ' 91' ' ' ILE . 83.7 mt -117.3 116.93 53.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 173.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 57' ' ' PHE . . . . . 0.656 ' CE1' ' HG2' ' D' ' 62' ' ' LYS . 15.3 m-85 -107.47 98.96 8.51 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 119.467 -0.893 . . . . 0.0 111.389 -168.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.646 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 59.3 t -91.94 115.01 30.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.763 173.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 63.9 34.7 11.47 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.212 -176.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.72 -32.27 5.15 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.455 -0.878 . . . . 0.0 113.726 176.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 61' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 16.2 pt-20 -90.0 155.24 19.23 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.798 0.333 . . . . 0.0 110.799 -174.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . 0.656 ' HG2' ' CE1' ' D' ' 57' ' ' PHE . 57.8 mttp -80.49 103.03 10.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.961 0.41 . . . . 0.0 110.043 -178.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.416 HG11 ' CG2' ' D' ' 58' ' ' VAL . 14.1 p -78.7 -29.33 14.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.94 -177.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 64' ' ' TYR . . . . . 0.468 ' HH ' ' CB ' ' D' ' 78' ' ' ASP . 16.3 t80 -146.72 126.65 13.6 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.682 175.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 97.2 m -109.59 111.72 23.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.542 174.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 66' ' ' PHE . . . . . 0.487 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 15.9 p90 -116.36 160.71 20.13 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 172.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 67' ' ' ASN . . . . . 0.491 ' OD1' ' HB2' ' D' ' 69' ' ' LYS . 13.2 p30 -132.59 141.35 48.65 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 68' ' ' GLU . . . . . 0.935 ' HB2' HG13 ' D' ' 47' ' ' ILE . 31.4 mm-40 -64.21 -15.23 59.55 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -177.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.493 ' HA ' HD11 ' D' ' 47' ' ' ILE . 49.3 mtpt -56.81 -49.89 74.0 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 173.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 70' ' ' SER . . . . . 0.453 ' O ' HD13 ' D' ' 75' ' ' ILE . 23.1 t -63.8 128.37 35.53 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 113.426 -1.716 . . . . 0.0 107.51 168.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 71' ' ' THR . . . . . 0.454 HG21 ' O ' ' D' ' 44' ' ' GLY . 70.2 p -57.51 118.99 5.77 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 72' ' ' VAL . . . . . 0.828 HG13 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -53.61 -14.98 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -176.387 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 73' ' ' GLY . . . . . 0.712 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -67.96 -56.74 9.97 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.788 170.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -68.23 -19.97 64.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.988 0.423 . . . . 0.0 110.278 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 75' ' ' ILE . . . . . 0.541 ' O ' HG13 ' D' ' 79' ' ' ILE . 83.3 mt -72.59 -43.95 61.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.555 175.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 31.4 t -73.58 -19.15 60.96 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.166 -176.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 77' ' ' ASN . . . . . 0.402 ' O ' ' HD3' ' D' ' 81' ' ' LYS . 4.0 m120 -60.49 -44.47 95.91 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 165.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 78' ' ' ASP . . . . . 0.997 ' HA ' ' HG2' ' D' ' 81' ' ' LYS . 1.0 OUTLIER -69.66 -25.81 64.09 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 114.981 -1.009 . . . . 0.0 113.407 177.144 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . 0.541 HG13 ' O ' ' D' ' 75' ' ' ILE . 41.5 mt -77.72 -17.0 14.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 118.89 -1.124 . . . . 0.0 109.875 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -77.52 -26.83 51.45 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.256 169.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . 0.997 ' HG2' ' HA ' ' D' ' 78' ' ' ASP . 15.9 mmtt -74.01 -69.96 0.41 Allowed 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 176.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 82' ' ' LEU . . . . . 0.484 HD21 ' O ' ' D' ' 78' ' ' ASP . 3.5 mm? -47.28 -32.25 4.5 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 113.482 -1.69 . . . . 0.0 112.578 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 83' ' ' ASN . . . . . 0.551 ' ND2' ' HB3' ' D' ' 36' ' ' LEU . 0.7 OUTLIER 37.85 65.5 0.56 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.979 0.912 . . . . 0.0 111.269 175.821 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 84' ' ' ILE . . . . . 0.441 ' N ' ' HG ' ' D' ' 36' ' ' LEU . 2.8 mp -74.88 99.12 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.96 0.41 . . . . 0.0 111.372 -171.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 85' ' ' LYS . . . . . 0.446 ' HE2' ' O ' ' D' ' 34' ' ' ASN . 16.8 ptpt -125.9 92.3 3.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.988 0.423 . . . . 0.0 111.96 178.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.33 160.04 0.11 Allowed Glycine 0 CA--C 1.52 0.353 0 CA-C-N 115.328 -0.851 . . . . 0.0 114.146 173.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 87' ' ' PRO . . . . . 0.574 ' HD2' ' CG1' ' D' ' 58' ' ' VAL . 44.8 Cg_endo -93.68 -178.58 8.42 Favored 'Cis proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.795 -1.335 . . . . 0.0 112.176 -1.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 88' ' ' TYR . . . . . 0.646 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 16.0 m-85 24.57 92.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.823 1.249 . . . . 0.0 113.387 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.419 HD11 HG23 ' D' ' 89' ' ' ILE . 75.8 mt -111.67 130.78 64.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.581 ' O ' ' HD2' ' D' ' 57' ' ' PHE . 51.3 mt-10 -130.52 101.54 5.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.105 172.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 91' ' ' ILE . . . . . 0.724 HG22 HG12 ' D' ' 56' ' ' ILE . 4.1 mt -98.3 113.03 31.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -177.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 92' ' ' LYS . . . . . 0.711 ' HE2' HG23 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -162.28 170.57 18.71 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.084 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.617 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 25.1 pt20 -80.97 164.81 22.28 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.803 176.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . 0.711 HG23 ' HE2' ' D' ' 92' ' ' LYS . 10.7 pt . . . . . 0 C--N 1.31 -1.109 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.899 -171.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 9.0 t70 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' D' D ' 2' ' ' ASN . . . . . 0.446 ' HA ' ' HB2' ' D' ' 7' ' ' GLU . 5.6 m120 -68.33 -17.25 64.21 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -173.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -92.34 -13.28 30.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.801 0.334 . . . . 0.0 111.179 -176.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -110.82 -33.62 6.48 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.0 172.12 6.97 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.512 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . 0.51 ' O ' HD11 ' D' ' 6' ' ' LEU . 1.4 pp -84.88 24.97 0.98 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.445 177.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . 0.538 ' O ' ' HB2' ' D' ' 12' ' ' SER . 65.1 mm-40 -45.33 -34.68 3.1 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -176.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.568 ' HB2' HE21 ' D' ' 9' ' ' GLN . 82.4 mt-10 -63.09 -23.38 67.42 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 120.749 0.309 . . . . 0.0 111.233 -175.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . 0.568 HE21 ' HB2' ' D' ' 8' ' ' GLU . 65.6 mm-40 -99.1 -0.58 41.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.953 -175.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 10' ' ' MET . . . . . . . . . . . . . 53.8 ttp -106.24 -78.51 0.58 Allowed 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 119.64 -0.824 . . . . 0.0 112.718 -169.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 -104.27 -31.21 9.69 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 176.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 12' ' ' SER . . . . . 0.538 ' HB2' ' O ' ' D' ' 7' ' ' GLU . 42.4 t -21.36 -67.58 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 113.433 -1.712 . . . . 0.0 115.23 -170.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.507 HG22 ' HE2' ' D' ' 31' ' ' MET . 63.9 mt -73.73 -12.07 15.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.736 -171.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -96.19 -50.37 4.84 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.519 172.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 15' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' D' ' 18' ' ' ASP . 80.5 p -63.44 -24.94 68.05 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.328 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 16' ' ' VAL . . . . . 0.644 ' O ' ' HG ' ' D' ' 20' ' ' LEU . 9.8 p -54.16 -37.58 36.04 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-O 121.296 0.569 . . . . 0.0 109.593 176.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 17' ' ' ASN . . . . . 0.622 ' OD1' ' HA ' ' D' ' 28' ' ' SER . 78.6 m-20 -78.21 -22.3 48.72 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.461 -178.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 18' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' D' ' 15' ' ' SER . 1.0 OUTLIER -67.79 -17.14 64.43 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 176.379 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.583 ' O ' ' HE3' ' D' ' 22' ' ' LYS . 0.0 OUTLIER -91.74 -43.11 9.75 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 172.186 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 20' ' ' LEU . . . . . 1.007 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 85.4 mt -63.04 -40.95 99.24 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.009 -1.451 . . . . 0.0 110.131 -177.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 21' ' ' ASN . . . . . 0.55 ' OD1' ' HB2' ' D' ' 26' ' ' LYS . 51.6 m-80 -79.73 101.64 8.55 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.347 177.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 22' ' ' LYS . . . . . 0.923 ' HD2' HD13 ' D' ' 47' ' ' ILE . 97.4 mttt -122.18 -41.76 2.41 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -175.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 169.9 -91.13 0.1 OUTLIER Glycine 0 N--CA 1.437 -1.26 0 C-N-CA 119.604 -1.284 . . . . 0.0 112.982 -178.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . 0.657 ' HB3' ' O ' ' D' ' 46' ' ' GLY . 26.4 tptp -48.27 -52.86 19.36 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 25' ' ' GLY . . . . . 1.022 ' HA2' HD22 ' D' ' 42' ' ' ASN . . . -141.48 154.0 24.4 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.394 176.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 26' ' ' LYS . . . . . 0.812 ' HZ1' ' HB3' ' D' ' 26' ' ' LYS . 0.4 OUTLIER -144.92 161.94 38.1 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.573 -0.814 . . . . 0.0 112.248 -168.709 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 27' ' ' LEU . . . . . 1.007 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 51.5 tp -134.93 153.15 52.17 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.454 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 28' ' ' SER . . . . . 0.622 ' HA ' ' OD1' ' D' ' 17' ' ' ASN . 14.2 t -140.68 153.79 46.12 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 29' ' ' LEU . . . . . . . . . . . . . 20.2 mt -134.2 158.8 42.75 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.624 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 37.3 t -160.15 -177.13 6.07 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 31' ' ' MET . . . . . 0.507 ' HE2' HG22 ' D' ' 13' ' ' ILE . 1.3 pmm? -150.57 163.15 39.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.84 0.352 . . . . 0.0 111.007 177.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -144.25 88.48 1.95 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.1 175.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.47 -115.35 4.56 Favored Glycine 0 N--CA 1.454 -0.154 0 C-N-CA 120.205 -0.997 . . . . 0.0 110.991 -172.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -95.78 20.71 9.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.915 0.388 . . . . 0.0 110.926 174.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 35' ' ' GLN . . . . . 0.42 ' OE1' ' HA ' ' D' ' 35' ' ' GLN . 10.3 mm-40 -88.54 152.85 21.59 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 121.314 0.578 . . . . 0.0 111.989 176.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . 0.623 HD12 ' HA ' ' D' ' 83' ' ' ASN . 1.3 tm? -134.37 119.56 18.77 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.378 175.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 37' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -123.36 157.36 33.47 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.564 -169.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 38' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -148.83 152.26 36.19 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 113.216 -1.811 . . . . 0.0 111.341 176.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 39' ' ' THR . . . . . 0.578 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 20.6 p -145.54 139.03 26.46 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.198 175.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 40' ' ' SER . . . . . 0.518 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 33.8 p -106.1 128.78 54.12 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 171.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 41' ' ' SER . . . . . 0.588 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 48.0 t -92.18 162.58 14.26 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 176.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 42' ' ' ASN . . . . . 1.022 HD22 ' HA2' ' D' ' 25' ' ' GLY . 18.6 p30 64.64 3.78 2.08 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 124.605 1.19 . . . . 0.0 111.896 -169.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 52.79 63.24 2.32 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 165.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.62 -15.94 6.63 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 118.174 -1.965 . . . . 0.0 115.993 166.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 45' ' ' TYR . . . . . 0.651 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 2.2 m-30 -78.62 155.94 29.34 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 117.909 0.855 . . . . 0.0 110.683 -176.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . 0.657 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -96.79 -172.91 34.69 Favored Glycine 0 C--O 1.217 -0.968 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 172.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 47' ' ' ILE . . . . . 0.923 HD13 ' HD2' ' D' ' 22' ' ' LYS . 39.4 mm -48.41 -56.64 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.861 0 CA-C-N 117.975 0.888 . . . . 0.0 110.917 178.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 81.0 p -179.31 -147.38 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 112.574 -2.103 . . . . 0.0 108.025 -173.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -97.46 75.53 2.51 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.226 168.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . 0.413 ' OE2' ' HA ' ' D' ' 50' ' ' GLU . 36.8 mm-40 -144.0 -172.68 3.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.56 -178.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 51' ' ' ASP . . . . . 0.691 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 11.6 m-20 -134.86 120.13 18.94 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.141 173.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 52' ' ' LYS . . . . . 1.045 ' HG2' ' HB2' ' D' ' 68' ' ' GLU . 0.0 OUTLIER -139.41 130.35 26.3 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.436 -177.1 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -109.92 142.82 40.74 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 121.002 0.429 . . . . 0.0 110.967 -175.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 54' ' ' TRP . . . . . 0.69 ' NE1' ' HB3' ' D' ' 93' ' ' GLN . 0.8 OUTLIER -123.43 160.57 26.56 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.825 -176.925 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -138.56 160.85 25.68 Favored Glycine 0 N--CA 1.438 -1.233 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.95 174.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 56' ' ' ILE . . . . . 0.511 ' O ' HG13 ' D' ' 63' ' ' VAL . 97.0 mt -140.47 109.88 3.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 178.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 57' ' ' PHE . . . . . 0.638 ' HA ' ' O ' ' D' ' 61' ' ' GLU . 13.9 m-85 -107.92 101.25 10.53 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.624 -0.83 . . . . 0.0 111.7 -168.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.689 HG22 HG12 ' D' ' 89' ' ' ILE . 87.5 t -94.84 119.67 43.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.446 173.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 59' ' ' ASN . . . . . 0.42 ' OD1' HG13 ' D' ' 58' ' ' VAL . 5.5 m120 63.93 35.59 10.73 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.075 0.464 . . . . 0.0 110.776 -175.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.2 34.68 90.57 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.373 -0.83 . . . . 0.0 114.461 175.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 61' ' ' GLU . . . . . 0.638 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 16.3 pt-20 -138.69 145.33 40.23 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 171.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . 0.488 ' HB2' ' HZ3' ' D' ' 62' ' ' LYS . 3.8 ttmp? -75.34 99.39 4.09 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -177.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.511 HG13 ' O ' ' D' ' 56' ' ' ILE . 9.2 p -84.73 -33.54 8.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.577 -173.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 64' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -135.88 131.37 35.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.932 0.396 . . . . 0.0 110.595 174.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.438 HG23 ' O ' ' D' ' 54' ' ' TRP . 26.4 m -115.93 113.9 23.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.701 177.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 66' ' ' PHE . . . . . 0.555 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 10.8 p90 -116.81 130.91 57.01 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.355 0.597 . . . . 0.0 109.776 175.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -103.2 139.86 38.12 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -178.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 68' ' ' GLU . . . . . 1.045 ' HB2' ' HG2' ' D' ' 52' ' ' LYS . 40.2 mm-40 -70.63 -8.94 55.48 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.946 -174.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.581 ' HD3' ' HB3' ' D' ' 51' ' ' ASP . 47.0 mtmt -62.88 -39.73 95.35 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 169.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 31.7 t -71.45 119.9 16.26 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.502 -1.681 . . . . 0.0 107.07 165.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 70.1 p -54.87 130.59 41.73 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.255 -176.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 72' ' ' VAL . . . . . 0.605 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -55.68 -13.38 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 121.077 0.465 . . . . 0.0 111.813 -175.821 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 73' ' ' GLY . . . . . 0.518 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -74.07 -55.55 5.72 Favored Glycine 0 N--CA 1.437 -1.249 0 CA-C-N 115.212 -0.904 . . . . 0.0 112.445 169.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 74' ' ' ASN . . . . . 0.737 ' HA ' HD21 ' D' ' 77' ' ' ASN . 44.6 t30 -62.29 -23.59 66.81 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.814 0.34 . . . . 0.0 110.553 177.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 75' ' ' ILE . . . . . 0.613 ' O ' HG13 ' D' ' 79' ' ' ILE . 74.3 mt -73.83 -41.85 53.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.329 176.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 28.8 t -73.5 -20.41 60.68 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.554 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 77' ' ' ASN . . . . . 0.737 HD21 ' HA ' ' D' ' 74' ' ' ASN . 76.4 m-20 -65.84 -28.25 68.84 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 168.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 78' ' ' ASP . . . . . 1.064 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 1.0 OUTLIER -83.71 -32.22 25.64 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 115.528 -0.76 . . . . 0.0 113.032 174.823 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . 0.613 HG13 ' O ' ' D' ' 75' ' ' ILE . 25.1 mt -72.27 -16.55 18.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 120.034 -0.667 . . . . 0.0 110.041 -176.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -65.04 -49.81 68.66 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.729 172.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . 1.064 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -72.73 -57.58 4.0 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.637 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 82' ' ' LEU . . . . . 0.551 ' H ' ' HG2' ' D' ' 81' ' ' LYS . 4.1 mm? -44.98 -35.45 2.9 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 83' ' ' ASN . . . . . 0.623 ' HA ' HD12 ' D' ' 36' ' ' LEU . 22.2 t-20 29.33 70.88 0.07 Allowed 'General case' 0 N--CA 1.476 0.841 0 O-C-N 124.591 1.182 . . . . 0.0 111.811 178.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 84' ' ' ILE . . . . . 0.593 ' O ' ' HG ' ' D' ' 36' ' ' LEU . 50.1 mt -93.0 98.33 8.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.627 -176.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 85' ' ' LYS . . . . . 0.455 ' HB2' ' HB2' ' D' ' 36' ' ' LEU . 2.7 tmtm? -127.65 93.93 3.83 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -178.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 86' ' ' GLY . . . . . 0.465 ' H ' ' CD1' ' D' ' 89' ' ' ILE . . . 72.1 153.11 1.65 Allowed Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.918 -0.583 . . . . 0.0 113.165 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 87' ' ' PRO . . . . . 0.477 ' HD2' ' CG1' ' D' ' 58' ' ' VAL . 54.2 Cg_endo -91.21 -179.76 12.13 Favored 'Cis proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.395 -1.502 . . . . 0.0 112.923 -0.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 88' ' ' TYR . . . . . 0.617 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 19.3 m-85 10.99 93.87 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 125.74 1.616 . . . . 0.0 114.065 -178.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.689 HG12 HG22 ' D' ' 58' ' ' VAL . 68.5 mt -111.54 142.85 22.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.975 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.505 ' N ' HG21 ' D' ' 89' ' ' ILE . 38.3 tt0 -128.76 95.09 4.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.916 172.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 91' ' ' ILE . . . . . 0.622 ' CG2' ' HZ3' ' D' ' 54' ' ' TRP . 7.3 mt -97.18 109.15 22.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 92' ' ' LYS . . . . . 0.722 ' HE3' HG21 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -162.17 172.29 16.03 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 122.603 0.361 . . . . 0.0 110.308 -176.222 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.69 ' HB3' ' NE1' ' D' ' 54' ' ' TRP . 17.4 pt20 -89.07 153.45 20.98 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.744 174.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . 0.722 HG21 ' HE3' ' D' ' 92' ' ' LYS . 10.6 pt . . . . . 0 C--N 1.309 -1.171 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.688 -171.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 120.586 0.231 . . . . 0.0 110.658 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' D' D ' 2' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -100.27 0.09 39.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.281 -175.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -63.4 -68.06 0.37 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.787 0.327 . . . . 0.0 110.991 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 4' ' ' LYS . . . . . 0.404 ' HB3' ' CD1' ' D' ' 6' ' ' LEU . 62.1 tttp -105.59 -22.01 13.07 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 177.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 5' ' ' ALA . . . . . . . . . . . . . . . 59.51 57.51 3.27 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.621 177.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . 0.701 ' HB3' ' HE1' ' D' ' 10' ' ' MET . 3.6 mp -70.88 -37.73 73.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.258 0.551 . . . . 0.0 110.13 178.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -62.45 -16.46 55.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.065 -0.97 . . . . 0.0 113.33 -174.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.679 ' HA ' ' CB ' ' D' ' 12' ' ' SER . 55.6 mt-10 -69.42 -30.49 68.44 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.023 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . 0.463 HE21 ' HB2' ' D' ' 8' ' ' GLU . 56.7 mm-40 -96.38 -1.78 46.98 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.959 -178.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 10' ' ' MET . . . . . 0.701 ' HE1' ' HB3' ' D' ' 6' ' ' LEU . 65.3 mtt -108.51 -71.93 0.74 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.348 -173.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -92.92 -54.51 3.71 Favored 'General case' 0 CA--C 1.485 -1.54 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.404 178.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 12' ' ' SER . . . . . 0.679 ' CB ' ' HA ' ' D' ' 8' ' ' GLU . 32.7 t -23.54 -64.45 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.046 0 O-C-N 125.117 1.51 . . . . 0.0 114.824 -172.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.512 HG22 ' HE2' ' D' ' 31' ' ' MET . 63.3 mt -85.34 -8.64 11.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.43 -171.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -92.0 -46.87 7.59 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.229 173.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 15' ' ' SER . . . . . 0.47 ' O ' ' HE2' ' D' ' 19' ' ' LYS . 92.2 p -70.23 -18.66 63.16 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.78 176.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 16' ' ' VAL . . . . . 0.613 ' O ' ' HG ' ' D' ' 20' ' ' LEU . 1.3 p -62.06 -27.43 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -69.62 -41.34 75.81 Favored 'General case' 0 C--O 1.206 -1.232 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.905 175.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 18' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' D' ' 15' ' ' SER . 49.7 m-20 -61.94 -14.54 35.64 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 176.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.674 ' HB3' ' CZ2' ' D' ' 54' ' ' TRP . 1.2 mppt? -87.79 -26.85 22.65 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.367 0.603 . . . . 0.0 110.185 177.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 20' ' ' LEU . . . . . 0.99 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 84.6 mt -105.6 -38.49 6.41 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 113.547 -1.66 . . . . 0.0 110.559 -168.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 21' ' ' ASN . . . . . 0.655 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 1.2 t-20 -88.12 89.05 7.84 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 113.571 -1.65 . . . . 0.0 108.314 -172.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 22' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -120.42 -42.2 2.57 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -163.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 178.53 -88.63 0.07 OUTLIER Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 119.455 -1.355 . . . . 0.0 113.032 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . 0.791 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 53.6 tptt -50.79 -63.55 1.09 Allowed 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -127.69 162.57 21.58 Favored Glycine 0 N--CA 1.431 -1.67 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.315 171.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 26' ' ' LYS . . . . . 0.698 ' CD ' ' HB3' ' D' ' 41' ' ' SER . 0.1 OUTLIER -149.7 160.61 43.39 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.832 -0.684 . . . . 0.0 110.979 -169.165 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 27' ' ' LEU . . . . . 0.99 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 55.3 tp -138.47 143.73 39.74 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.153 0.501 . . . . 0.0 111.226 -178.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 28' ' ' SER . . . . . 0.611 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 29.5 t -130.39 136.77 49.41 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -177.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 29' ' ' LEU . . . . . 0.636 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 14.5 mt -132.48 135.28 45.91 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.302 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 61.2 m -142.2 -171.96 3.49 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.039 176.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 31' ' ' MET . . . . . 0.512 ' HE2' HG22 ' D' ' 13' ' ' ILE . 1.4 pmm? -139.59 160.39 39.97 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.037 0.446 . . . . 0.0 110.236 178.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 32' ' ' ASN . . . . . 0.469 ' HB3' ' HB2' ' D' ' 35' ' ' GLN . 24.6 t-20 -139.84 88.07 2.21 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.22 -107.88 2.31 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.823 -169.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -108.4 26.87 9.95 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 122.505 -0.409 . . . . 0.0 110.521 174.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 35' ' ' GLN . . . . . 0.469 ' HB2' ' HB3' ' D' ' 32' ' ' ASN . 22.5 mt-30 -105.09 162.68 13.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.788 -178.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . 0.746 ' HB2' ' HB2' ' D' ' 85' ' ' LYS . 0.9 OUTLIER -128.82 135.04 48.59 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.312 -178.935 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 37' ' ' LYS . . . . . 0.636 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 75.2 mmtt -129.76 111.43 12.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.052 -168.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 38' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -111.47 144.19 41.08 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.855 0.36 . . . . 0.0 111.067 175.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 39' ' ' THR . . . . . 0.611 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 16.2 p -147.42 135.88 21.75 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.353 177.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 40' ' ' SER . . . . . 0.671 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 30.4 p -109.4 129.99 55.52 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 41' ' ' SER . . . . . 0.698 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 47.4 t -95.58 148.94 21.98 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.121 -1.031 . . . . 0.0 109.337 177.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 42' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' D' ' 41' ' ' SER . 75.8 m-20 80.19 -1.64 2.0 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.389 -168.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 49.38 61.88 2.91 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 169.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 44' ' ' GLY . . . . . 0.407 ' O ' HG21 ' D' ' 71' ' ' THR . . . 125.3 1.33 7.89 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 118.517 -1.801 . . . . 0.0 115.387 170.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 45' ' ' TYR . . . . . 0.791 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 1.5 m-30 -86.05 154.15 21.62 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 116.946 0.373 . . . . 0.0 110.333 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . 0.453 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -102.33 -153.34 24.93 Favored Glycine 0 C--O 1.219 -0.827 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 178.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 47' ' ' ILE . . . . . 0.989 HG13 ' HB2' ' D' ' 68' ' ' GLU . 2.7 mp -49.04 -58.42 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 CA-C-O 122.428 1.109 . . . . 0.0 108.833 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.538 ' HA ' ' HG2' ' D' ' 24' ' ' LYS . 36.3 t 152.83 -95.28 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 110.593 -3.003 . . . . 0.0 106.544 -174.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 49' ' ' TYR . . . . . 0.469 ' HD1' ' C ' ' D' ' 48' ' ' SER . 3.7 m-30 -130.21 75.57 1.66 Allowed 'General case' 0 N--CA 1.465 0.304 0 O-C-N 122.228 -0.295 . . . . 0.0 111.047 169.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . 0.553 ' HB2' HG21 ' D' ' 47' ' ' ILE . 50.4 mt-10 -156.81 -175.63 5.53 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.348 0.259 . . . . 0.0 110.491 176.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 51' ' ' ASP . . . . . 0.708 ' HB2' ' HD2' ' D' ' 69' ' ' LYS . 7.0 p-10 -130.7 141.59 50.4 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.062 172.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 52' ' ' LYS . . . . . 0.688 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 0.7 OUTLIER -145.28 136.07 24.52 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.213 -177.136 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -113.82 139.04 49.47 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.173 170.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 54' ' ' TRP . . . . . 0.674 ' CZ2' ' HB3' ' D' ' 19' ' ' LYS . 0.9 OUTLIER -126.71 157.01 40.19 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -172.176 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -143.23 158.08 27.13 Favored Glycine 0 N--CA 1.437 -1.298 0 C-N-CA 120.133 -1.032 . . . . 0.0 113.299 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 56' ' ' ILE . . . . . 0.823 HG12 HG22 ' D' ' 91' ' ' ILE . 91.7 mt -129.13 97.24 3.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 113.289 -1.456 . . . . 0.0 107.459 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 57' ' ' PHE . . . . . 0.581 ' HA ' ' O ' ' D' ' 61' ' ' GLU . 14.2 m-85 -100.15 103.25 14.73 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -171.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.916 HG13 HG12 ' D' ' 89' ' ' ILE . 3.8 m -95.55 99.95 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.648 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 57.93 62.9 1.92 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.692 -168.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.67 48.55 85.51 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 115.879 -0.6 . . . . 0.0 113.395 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 61' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 5.4 tp10 -157.49 115.2 3.09 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . 0.476 ' HE2' ' OG1' ' D' ' 65' ' ' THR . 5.8 ttpm? -77.6 98.68 5.49 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.534 HG12 HG21 ' D' ' 58' ' ' VAL . 35.4 m -88.45 -11.5 10.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.48 -173.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 64' ' ' TYR . . . . . 0.455 ' HH ' ' CB ' ' D' ' 78' ' ' ASP . 16.9 t80 -150.42 136.6 18.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.835 0.35 . . . . 0.0 110.397 174.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.476 ' OG1' ' HE2' ' D' ' 62' ' ' LYS . 24.5 m -119.4 113.54 20.94 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.161 176.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 66' ' ' PHE . . . . . 0.522 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 10.3 p90 -123.89 159.15 30.3 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 173.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 67' ' ' ASN . . . . . 0.44 ' O ' HD11 ' D' ' 75' ' ' ILE . 13.1 p30 -131.51 137.77 48.66 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 68' ' ' GLU . . . . . 0.989 ' HB2' HG13 ' D' ' 47' ' ' ILE . 37.5 mt-10 -62.18 -16.41 52.81 Favored 'General case' 0 C--N 1.345 0.395 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -174.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.708 ' HD2' ' HB2' ' D' ' 51' ' ' ASP . 5.6 mtpm? -57.98 -47.14 83.88 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.17 174.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 31.7 t -66.66 114.06 5.29 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 166.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 71' ' ' THR . . . . . 0.407 HG21 ' O ' ' D' ' 44' ' ' GLY . 59.2 p -53.32 124.85 15.79 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.418 -173.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 72' ' ' VAL . . . . . 0.529 HG13 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -53.2 -13.01 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.756 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 73' ' ' GLY . . . . . 0.671 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -70.36 -57.48 6.72 Favored Glycine 0 N--CA 1.436 -1.359 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.261 169.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -69.71 -18.46 63.54 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.51 -0.345 . . . . 0.0 111.016 178.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 75' ' ' ILE . . . . . 0.613 ' O ' HG13 ' D' ' 79' ' ' ILE . 73.7 mt -71.74 -42.47 70.54 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.388 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.032 173.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 76' ' ' SER . . . . . 0.457 ' OG ' ' HB2' ' D' ' 38' ' ' ALA . 40.3 t -72.9 -22.69 60.7 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.434 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -60.48 -30.1 69.48 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 167.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 78' ' ' ASP . . . . . 1.02 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 50.2 m-20 -87.52 -31.83 19.72 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.585 176.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . 0.613 HG13 ' O ' ' D' ' 75' ' ' ILE . 31.1 mt -71.88 -16.78 18.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.137 -177.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -67.64 -40.7 84.56 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.922 173.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . 1.02 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -81.35 -53.59 6.2 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.837 176.592 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 82' ' ' LEU . . . . . 0.506 HD22 ' O ' ' D' ' 78' ' ' ASP . 4.0 mm? -53.08 -26.58 16.66 Favored 'General case' 0 C--O 1.227 -0.098 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 83' ' ' ASN . . . . . 0.539 ' ND2' ' HB3' ' D' ' 36' ' ' LEU . 0.6 OUTLIER 39.14 67.91 0.4 Allowed 'General case' 0 N--CA 1.474 0.761 0 O-C-N 123.998 0.811 . . . . 0.0 111.236 176.331 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 84' ' ' ILE . . . . . 0.634 HG22 HG22 ' D' ' 56' ' ' ILE . 46.3 mm -84.43 98.49 5.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.835 -173.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 85' ' ' LYS . . . . . 0.746 ' HB2' ' HB2' ' D' ' 36' ' ' LEU . 10.0 tmtt? -145.39 95.42 2.66 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.354 0.597 . . . . 0.0 109.532 177.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 86' ' ' GLY . . . . . 0.549 ' H ' ' CD1' ' D' ' 89' ' ' ILE . . . 77.13 158.79 9.58 Favored Glycine 0 CA--C 1.498 -1.007 0 CA-C-N 115.473 -0.785 . . . . 0.0 114.147 178.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 87' ' ' PRO . . . . . 0.887 ' HD2' HG22 ' D' ' 58' ' ' VAL . 90.4 Cg_endo -80.66 -176.99 18.97 Favored 'Cis proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.355 -1.935 . . . . 0.0 113.3 0.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 88' ' ' TYR . . . . . 0.613 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 1.7 m-85 -11.36 96.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.943 1.297 . . . . 0.0 114.03 -175.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.916 HG12 HG13 ' D' ' 58' ' ' VAL . 41.0 mt -92.79 143.58 11.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -173.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -130.39 91.52 3.11 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.65 173.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 91' ' ' ILE . . . . . 0.823 HG22 HG12 ' D' ' 56' ' ' ILE . 2.5 mt -96.91 117.73 42.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -176.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 92' ' ' LYS . . . . . 0.66 ' HD3' ' O ' ' D' ' 93' ' ' GLN . 0.1 OUTLIER -162.91 173.37 13.77 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.464 0.306 . . . . 0.0 110.929 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.66 ' O ' ' HD3' ' D' ' 92' ' ' LYS . 2.8 pt20 -87.03 156.89 19.57 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.33 173.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . 0.616 ' CG2' ' HE2' ' D' ' 92' ' ' LYS . 5.5 pt . . . . . 0 C--N 1.313 -1.02 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.397 -169.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 120.734 0.302 . . . . 0.0 110.583 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' D' D ' 2' ' ' ASN . . . . . 0.552 ' HB3' ' HA ' ' D' ' 5' ' ' ALA . 76.5 m-20 -101.7 80.06 2.0 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.923 178.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -77.84 -24.62 48.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.524 0.678 . . . . 0.0 109.183 175.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -90.54 -11.88 38.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.809 174.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 5' ' ' ALA . . . . . 0.552 ' HA ' ' HB3' ' D' ' 2' ' ' ASN . . . 72.4 151.77 0.11 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 114.843 -1.072 . . . . 0.0 110.882 -173.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . 0.784 ' O ' HD23 ' D' ' 6' ' ' LEU . 7.6 tt -110.46 1.78 18.49 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.929 0.871 . . . . 0.0 108.89 -174.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . 0.487 ' HA ' ' HB3' ' D' ' 10' ' ' MET . 88.6 tt0 -47.64 -37.87 13.63 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -176.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.648 ' HA ' ' HB3' ' D' ' 12' ' ' SER . 8.4 pm0 -59.28 -50.64 73.2 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -175.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -91.09 16.07 10.42 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.264 174.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 10' ' ' MET . . . . . 0.487 ' HB3' ' HA ' ' D' ' 7' ' ' GLU . 16.1 tpt -103.8 -75.67 0.61 Allowed 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.551 178.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -104.14 -39.45 6.53 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-O 120.867 0.365 . . . . 0.0 111.149 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 12' ' ' SER . . . . . 0.648 ' HB3' ' HA ' ' D' ' 8' ' ' GLU . 40.9 t -44.19 -68.63 0.18 Allowed 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.244 -1.344 . . . . 0.0 112.133 -167.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.582 ' O ' HG11 ' D' ' 16' ' ' VAL . 52.0 mt -91.1 -9.28 10.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.747 -175.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 14' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' D' ' 10' ' ' MET . 3.8 m120 -88.08 -52.59 5.16 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.885 176.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 15' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' D' ' 18' ' ' ASP . 51.1 m -65.41 -21.61 66.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.488 174.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 16' ' ' VAL . . . . . 0.799 ' HA ' ' HE2' ' D' ' 19' ' ' LYS . 0.7 OUTLIER -59.12 -31.9 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.814 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 17' ' ' ASN . . . . . 0.6 ' OD1' ' HA ' ' D' ' 28' ' ' SER . 79.9 m-20 -85.06 -18.6 33.84 Favored 'General case' 0 C--O 1.205 -1.246 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.849 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 18' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' D' ' 15' ' ' SER . 73.7 m-20 -67.88 -16.36 64.05 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 122.304 -0.248 . . . . 0.0 111.599 176.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.799 ' HE2' ' HA ' ' D' ' 16' ' ' VAL . 0.0 OUTLIER -90.43 -39.83 12.41 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-O 121.987 0.899 . . . . 0.0 108.953 174.183 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 20' ' ' LEU . . . . . 0.904 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 78.3 mt -74.09 -40.17 62.91 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 113.628 -1.624 . . . . 0.0 110.107 -174.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 21' ' ' ASN . . . . . 0.526 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 2.8 m120 -78.14 95.7 4.99 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.688 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 22' ' ' LYS . . . . . 0.833 ' HD2' HD13 ' D' ' 47' ' ' ILE . 67.6 mttm -122.58 -41.12 2.4 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -176.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.56 -103.16 0.18 Allowed Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 119.161 -1.495 . . . . 0.0 113.351 -177.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . 0.863 ' HE2' ' HA ' ' D' ' 48' ' ' SER . 32.8 ttpt -49.5 -44.06 45.83 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.62 0.724 . . . . 0.0 110.362 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 25' ' ' GLY . . . . . 0.624 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -139.8 154.45 23.77 Favored Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 114.548 -1.205 . . . . 0.0 112.132 174.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 26' ' ' LYS . . . . . 0.735 ' HZ2' ' HB3' ' D' ' 26' ' ' LYS . 0.3 OUTLIER -150.67 160.42 43.84 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.331 -0.934 . . . . 0.0 110.518 -171.038 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 27' ' ' LEU . . . . . 0.904 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 41.6 tp -132.13 144.62 50.83 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.14 0.495 . . . . 0.0 111.392 177.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 28' ' ' SER . . . . . 0.6 ' HA ' ' OD1' ' D' ' 17' ' ' ASN . 9.1 t -131.32 136.42 48.1 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 29' ' ' LEU . . . . . 0.51 ' CD2' ' HB3' ' D' ' 38' ' ' ALA . 18.3 mt -127.19 157.94 38.43 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.384 -0.527 . . . . 0.0 110.53 -179.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 34.7 t -160.45 174.53 13.96 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 59.2 mtt -133.83 163.33 29.73 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.108 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 32' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' D' ' 35' ' ' GLN . 50.3 t30 -136.95 86.87 2.24 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.714 172.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.03 -108.26 2.51 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.553 -169.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 34' ' ' ASN . . . . . 0.429 ' O ' ' HE3' ' D' ' 85' ' ' LYS . 75.3 m-80 -107.11 31.76 5.12 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.586 0.707 . . . . 0.0 109.96 174.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 35' ' ' GLN . . . . . 0.497 ' OE1' ' HA ' ' D' ' 35' ' ' GLN . 6.5 mm-40 -99.9 164.48 11.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.823 -1.081 . . . . 0.0 113.263 -177.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . 0.638 ' C ' HD12 ' D' ' 36' ' ' LEU . 2.7 tm? -132.8 125.6 30.46 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.637 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 37' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 27.9 mmmt -131.2 103.06 6.27 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.768 -170.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 38' ' ' ALA . . . . . 0.51 ' HB3' ' CD2' ' D' ' 29' ' ' LEU . . . -108.57 146.39 33.38 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.403 0.62 . . . . 0.0 112.289 -176.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 39' ' ' THR . . . . . 0.433 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 14.3 p -146.32 130.37 17.36 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.17 175.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 40' ' ' SER . . . . . 0.783 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 69.2 p -108.3 135.06 50.25 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 176.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 41' ' ' SER . . . . . 0.638 ' HB3' ' HD2' ' D' ' 26' ' ' LYS . 39.1 t -96.28 147.89 23.31 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.169 -1.012 . . . . 0.0 109.676 -178.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 42' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' D' ' 41' ' ' SER . 73.0 m-80 80.6 2.99 1.8 Allowed 'General case' 0 N--CA 1.468 0.472 0 O-C-N 124.569 1.168 . . . . 0.0 110.161 -170.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 47.28 55.5 8.1 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 171.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 44' ' ' GLY . . . . . 0.802 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 117.62 35.88 1.04 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 119.477 -1.344 . . . . 0.0 113.845 172.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 45' ' ' TYR . . . . . 0.78 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 1.8 m-85 -119.25 149.71 41.31 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 173.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . 0.644 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -93.61 179.7 38.82 Favored Glycine 0 C--O 1.221 -0.71 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 176.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 47' ' ' ILE . . . . . 0.85 HG12 ' HB3' ' D' ' 68' ' ' GLU . 32.6 mm -46.72 -57.01 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.798 0 CA-C-N 118.026 0.913 . . . . 0.0 110.28 -178.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.863 ' HA ' ' HE2' ' D' ' 24' ' ' LYS . 67.5 p -175.67 -118.39 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 113.354 -1.748 . . . . 0.0 108.683 -177.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 49' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' D' ' 49' ' ' TYR . 0.2 OUTLIER -113.72 75.56 0.93 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 168.199 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . 0.615 ' HB3' ' HE2' ' D' ' 52' ' ' LYS . 68.3 mm-40 -131.81 -175.89 3.87 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.834 -175.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 51' ' ' ASP . . . . . 0.653 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 1.1 m-20 -140.36 128.89 22.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.487 169.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 52' ' ' LYS . . . . . 0.653 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 3.9 mptp? -141.56 136.42 31.09 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.504 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 53' ' ' ASN . . . . . 0.424 HD21 ' C ' ' D' ' 52' ' ' LYS . 3.0 m120 -112.01 126.98 55.73 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 175.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 54' ' ' TRP . . . . . 0.658 ' HZ3' ' CG2' ' D' ' 91' ' ' ILE . 1.3 m95 -115.47 161.63 18.31 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -174.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -150.07 163.45 29.45 Favored Glycine 0 N--CA 1.435 -1.412 0 CA-C-N 114.566 -1.197 . . . . 0.0 112.556 172.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 56' ' ' ILE . . . . . 0.822 HD12 HG12 ' D' ' 84' ' ' ILE . 76.6 mt -134.75 109.58 11.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 -179.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 57' ' ' PHE . . . . . 0.628 ' HB2' ' HB3' ' D' ' 90' ' ' GLU . 8.3 m-85 -111.63 105.9 14.57 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.879 -165.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.836 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 54.7 t -88.67 112.31 23.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.277 172.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 7.0 m120 51.18 50.75 18.39 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.421 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.49 48.44 78.17 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.535 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 61' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 43.1 tt0 -150.88 111.24 4.18 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . 0.447 ' NZ ' ' HB3' ' D' ' 62' ' ' LYS . 6.3 ttpm? -73.65 103.01 4.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.972 0.415 . . . . 0.0 110.048 -177.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 29.0 m -79.57 -25.65 12.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.303 -174.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 64' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -149.74 147.4 28.0 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.064 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 59.4 m -125.28 121.17 33.24 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.482 175.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 66' ' ' PHE . . . . . 0.607 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 19.5 p90 -127.49 149.88 49.92 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 174.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 67' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' D' ' 52' ' ' LYS . 3.5 m120 -111.47 145.3 39.25 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -178.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 68' ' ' GLU . . . . . 0.85 ' HB3' HG12 ' D' ' 47' ' ' ILE . 51.3 mm-40 -74.88 -9.3 58.41 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.612 176.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.407 ' HG2' ' HA ' ' D' ' 51' ' ' ASP . 23.5 mtpp -59.14 -54.35 48.0 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 113.538 -1.664 . . . . 0.0 108.102 165.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 39.8 m -66.79 119.58 12.08 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 112.91 -1.95 . . . . 0.0 109.088 174.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 82.8 p -47.56 121.24 3.82 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.978 -177.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 72' ' ' VAL . . . . . 0.9 HG11 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -57.27 -12.38 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 120.994 0.426 . . . . 0.0 110.872 -178.75 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 73' ' ' GLY . . . . . 0.802 ' HA3' ' HA2' ' D' ' 44' ' ' GLY . . . -69.15 -65.61 2.55 Favored Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 115.215 -0.902 . . . . 0.0 113.185 172.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 74' ' ' ASN . . . . . 0.811 ' HA ' HD21 ' D' ' 77' ' ' ASN . 76.8 m-20 -62.72 -23.74 67.32 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 120.662 0.267 . . . . 0.0 110.89 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 75' ' ' ILE . . . . . 0.525 ' O ' HG12 ' D' ' 79' ' ' ILE . 35.9 mm -77.47 -39.96 28.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.594 176.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 76' ' ' SER . . . . . 0.669 ' HA ' HG12 ' D' ' 79' ' ' ILE . 30.9 t -73.61 -19.88 60.75 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.963 178.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 77' ' ' ASN . . . . . 0.811 HD21 ' HA ' ' D' ' 74' ' ' ASN . 80.1 m-20 -65.6 -29.77 70.41 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 168.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 78' ' ' ASP . . . . . 1.042 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 1.0 OUTLIER -84.22 -28.72 27.08 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.734 174.92 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . 0.669 HG12 ' HA ' ' D' ' 76' ' ' SER . 17.5 mm -66.88 -19.84 26.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.657 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -69.17 -39.7 78.58 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.322 176.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . 1.042 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -80.24 -53.76 6.36 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.888 176.679 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 82' ' ' LEU . . . . . 0.646 HD21 ' O ' ' D' ' 78' ' ' ASP . 4.0 mm? -48.71 -29.24 4.23 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 83' ' ' ASN . . . . . 0.546 HD21 ' HB3' ' D' ' 36' ' ' LEU . 0.6 OUTLIER 39.54 73.61 0.11 Allowed 'General case' 0 N--CA 1.472 0.671 0 O-C-N 124.016 0.823 . . . . 0.0 111.464 172.889 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 84' ' ' ILE . . . . . 0.822 HG12 HD12 ' D' ' 56' ' ' ILE . 2.1 mp -66.84 105.19 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.33 -176.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 85' ' ' LYS . . . . . 0.429 ' HE3' ' O ' ' D' ' 34' ' ' ASN . 48.6 mtpt -108.19 178.71 4.42 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.911 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . -80.09 -178.37 51.65 Favored Glycine 0 CA--C 1.504 -0.604 0 C-N-CA 121.146 -0.549 . . . . 0.0 113.39 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 87' ' ' PRO . . . . . 0.666 ' O ' HG11 ' D' ' 58' ' ' VAL . 42.8 Cg_endo -93.67 -179.79 9.47 Favored 'Cis proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.887 -1.714 . . . . 0.0 114.101 -0.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 88' ' ' TYR . . . . . 0.836 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 1.7 m-85 43.85 91.12 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.881 0.873 . . . . 0.0 112.074 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 4.0 mp -111.27 127.26 68.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.295 0.569 . . . . 0.0 110.533 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.628 ' HB3' ' HB2' ' D' ' 57' ' ' PHE . 42.0 tt0 -126.55 92.05 3.48 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.187 177.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 91' ' ' ILE . . . . . 0.658 ' CG2' ' HZ3' ' D' ' 54' ' ' TRP . 3.2 mt -100.22 109.13 24.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 92' ' ' LYS . . . . . 0.741 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -162.25 167.53 23.83 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.599 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 25.4 pt20 -82.44 160.19 22.77 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 119.125 -1.03 . . . . 0.0 110.567 175.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . 0.741 HG22 ' HE2' ' D' ' 92' ' ' LYS . 10.0 pt . . . . . 0 C--N 1.305 -1.338 0 CA-C-N 114.118 -1.401 . . . . 0.0 111.384 -168.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 120.558 0.218 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' 2' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -121.66 4.96 10.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.928 0.394 . . . . 0.0 110.495 177.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -90.91 0.11 57.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.162 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 4' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' D' ' 4' ' ' LYS . 38.0 ttpt -104.34 18.58 21.85 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.38 116.55 4.74 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.409 -176.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . 0.465 ' H ' ' CD2' ' D' ' 6' ' ' LEU . 1.7 pt? -97.26 26.23 4.97 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.421 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -71.23 -3.61 21.2 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -173.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.582 ' O ' ' HB3' ' D' ' 12' ' ' SER . 9.3 pt-20 -61.03 -51.45 69.16 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -171.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -91.75 15.45 12.78 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.576 176.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 10' ' ' MET . . . . . . . . . . . . . 93.8 mmm -105.22 -75.7 0.62 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.181 -178.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -102.97 -38.6 7.28 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.093 174.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 12' ' ' SER . . . . . 0.637 ' O ' ' HB ' ' D' ' 16' ' ' VAL . 42.4 t -44.61 -61.73 1.45 Allowed 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.452 -1.249 . . . . 0.0 112.272 -167.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.564 ' HA ' HG11 ' D' ' 16' ' ' VAL . 36.7 mm -90.88 -8.64 10.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.991 -174.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -95.19 -62.53 1.29 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.071 177.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 15' ' ' SER . . . . . 0.537 ' HA ' ' OD2' ' D' ' 18' ' ' ASP . 90.5 p -64.69 -21.45 66.75 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 120.971 -0.291 . . . . 0.0 110.531 -179.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 16' ' ' VAL . . . . . 0.637 ' HB ' ' O ' ' D' ' 12' ' ' SER . 14.8 p -52.99 -35.93 23.16 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 CA-C-O 120.918 0.39 . . . . 0.0 110.251 176.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -68.51 -41.74 79.54 Favored 'General case' 0 C--O 1.21 -1.009 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.777 177.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 18' ' ' ASP . . . . . 0.537 ' OD2' ' HA ' ' D' ' 15' ' ' SER . 55.0 m-20 -58.64 -16.58 16.74 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -177.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.673 ' O ' ' HE3' ' D' ' 22' ' ' LYS . 0.0 OUTLIER -91.83 -52.64 4.64 Favored 'General case' 0 CA--C 1.488 -1.42 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 172.37 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 20' ' ' LEU . . . . . 0.955 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 75.8 mt -57.39 -34.95 69.41 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.031 -1.441 . . . . 0.0 110.78 -177.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 21' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -77.4 97.1 4.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.223 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 22' ' ' LYS . . . . . 0.731 ' HZ3' ' HG3' ' D' ' 68' ' ' GLU . 88.5 mttt -121.73 -40.91 2.5 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 -172.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.23 -88.6 0.11 Allowed Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 119.477 -1.344 . . . . 0.0 113.315 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . 0.712 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 52.1 tptt -49.84 -54.03 21.87 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 25' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -139.14 155.82 24.12 Favored Glycine 0 N--CA 1.429 -1.792 0 CA-C-N 114.264 -1.334 . . . . 0.0 110.943 174.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 26' ' ' LYS . . . . . 0.668 ' HG3' ' HB3' ' D' ' 41' ' ' SER . 9.2 ptpt -149.99 160.83 43.32 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.301 -0.95 . . . . 0.0 110.167 -169.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 27' ' ' LEU . . . . . 0.955 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 52.2 tp -135.19 147.29 49.33 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.188 0.518 . . . . 0.0 111.932 -176.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 28' ' ' SER . . . . . 0.591 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 22.9 t -139.79 153.32 47.09 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 29' ' ' LEU . . . . . 0.603 HD11 ' CD1' ' D' ' 20' ' ' LEU . 0.2 OUTLIER -141.27 133.97 28.68 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.914 177.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 54.1 p -133.54 -171.39 2.7 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.719 175.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 21.6 ptp -148.89 166.3 28.98 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.388 0.614 . . . . 0.0 111.466 -176.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 32' ' ' ASN . . . . . 0.446 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 22.8 t-20 -144.54 88.01 1.9 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.458 177.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.85 -108.7 2.57 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.216 -171.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -100.31 9.93 41.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.841 0.353 . . . . 0.0 110.873 176.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 35' ' ' GLN . . . . . 0.446 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 3.6 tp60 -90.82 158.24 16.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.832 0.349 . . . . 0.0 110.48 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . 0.602 ' C ' HD12 ' D' ' 36' ' ' LEU . 2.5 tm? -124.92 137.39 54.27 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.62 176.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 37' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 34.3 mmtp -130.94 115.34 16.39 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.93 -171.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -115.28 152.5 32.63 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.939 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 39' ' ' THR . . . . . 0.591 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 17.2 p -145.92 135.24 22.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.737 -1.119 . . . . 0.0 111.123 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 40' ' ' SER . . . . . 0.652 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 27.0 p -108.75 133.72 52.43 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 170.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 41' ' ' SER . . . . . 0.668 ' HB3' ' HG3' ' D' ' 26' ' ' LYS . 34.0 t -95.5 147.06 23.95 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 118.97 -1.092 . . . . 0.0 109.222 178.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 42' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' D' ' 41' ' ' SER . 75.1 m-80 80.45 -3.11 1.9 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.188 -168.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.66 62.8 2.28 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 168.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.17 -1.47 8.32 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 118.508 -1.806 . . . . 0.0 115.011 170.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 45' ' ' TYR . . . . . 0.712 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 1.4 m-30 -89.91 152.12 21.39 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 120.617 0.246 . . . . 0.0 110.808 -176.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . 0.602 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -95.24 -158.67 32.88 Favored Glycine 0 C--O 1.217 -0.952 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 174.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 47' ' ' ILE . . . . . 0.894 HG13 ' HB3' ' D' ' 68' ' ' GLU . 0.4 OUTLIER -55.42 -49.13 75.35 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 CA-C-O 122.597 1.189 . . . . 0.0 108.518 176.163 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 34.0 t 168.0 -119.77 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 111.305 -2.679 . . . . 0.0 105.422 -175.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -109.34 78.33 1.12 Allowed 'General case' 0 C--N 1.318 -0.775 0 O-C-N 121.771 -0.581 . . . . 0.0 109.679 163.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . 0.598 ' HB3' ' HE3' ' D' ' 52' ' ' LYS . 52.0 mt-10 -143.37 171.68 13.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.749 -177.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 51' ' ' ASP . . . . . 0.701 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 2.4 m-20 -131.42 135.68 47.37 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.534 176.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 52' ' ' LYS . . . . . 0.747 ' HD3' HG12 ' D' ' 47' ' ' ILE . 0.1 OUTLIER -144.96 157.19 44.22 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 123.035 0.534 . . . . 0.0 110.45 -178.029 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 53' ' ' ASN . . . . . 0.533 HD21 ' C ' ' D' ' 52' ' ' LYS . 2.7 m120 -120.98 134.26 55.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.301 175.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 54' ' ' TRP . . . . . 0.678 ' NE1' ' HB3' ' D' ' 93' ' ' GLN . 0.3 OUTLIER -126.43 160.62 29.98 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.205 -178.516 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -150.27 160.31 28.49 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.113 -1.041 . . . . 0.0 114.061 176.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 56' ' ' ILE . . . . . 0.49 HG12 ' CG2' ' D' ' 91' ' ' ILE . 73.0 mt -130.68 113.77 25.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 176.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 57' ' ' PHE . . . . . 0.627 ' HD2' ' O ' ' D' ' 90' ' ' GLU . 17.1 m-85 -108.39 105.1 14.63 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 119.688 -0.805 . . . . 0.0 111.248 -167.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.724 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 90.2 t -97.88 109.56 23.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.283 176.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 5.6 m120 55.84 39.92 30.65 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.253 178.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.97 -31.07 8.85 Favored Glycine 0 CA--C 1.508 -0.37 0 C-N-CA 120.159 -1.019 . . . . 0.0 112.771 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -88.76 126.18 35.22 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.162 -0.519 . . . . 0.0 111.032 -176.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -71.98 98.17 2.01 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 174.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 11.3 p -76.36 -27.37 17.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.823 -168.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 64' ' ' TYR . . . . . 0.427 ' CE2' ' HB3' ' D' ' 66' ' ' PHE . 15.4 t80 -145.75 128.56 16.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.722 177.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 31.3 m -109.82 105.21 14.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.062 176.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 66' ' ' PHE . . . . . 0.427 ' HB3' ' CE2' ' D' ' 64' ' ' TYR . 10.0 p90 -111.48 158.79 18.73 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -128.9 143.09 50.79 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -172.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 68' ' ' GLU . . . . . 0.894 ' HB3' HG13 ' D' ' 47' ' ' ILE . 53.6 mm-40 -64.2 -21.0 66.4 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 174.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.501 ' HE3' ' OD2' ' D' ' 51' ' ' ASP . 48.2 mtpt -51.17 -54.46 25.22 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.102 171.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 70' ' ' SER . . . . . 0.419 ' O ' HD12 ' D' ' 75' ' ' ILE . 18.0 m -65.44 120.14 12.3 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 112.118 -2.31 . . . . 0.0 108.4 170.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 70.3 p -52.9 122.74 9.83 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.234 -178.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 72' ' ' VAL . . . . . 0.853 HG13 ' HB2' ' D' ' 27' ' ' LEU . 0.1 OUTLIER -54.72 -12.23 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 120.924 0.392 . . . . 0.0 111.997 -175.432 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 73' ' ' GLY . . . . . 0.652 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -73.57 -56.46 5.51 Favored Glycine 0 N--CA 1.437 -1.27 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.656 170.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 74' ' ' ASN . . . . . 0.492 ' O ' ' HB2' ' D' ' 77' ' ' ASN . 29.6 t-20 -66.3 -19.68 65.88 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 75' ' ' ILE . . . . . 0.614 ' O ' HG13 ' D' ' 79' ' ' ILE . 74.4 mt -71.78 -41.21 70.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.17 173.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 30.7 t -72.8 -19.54 61.32 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.696 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 77' ' ' ASN . . . . . 0.492 ' HB2' ' O ' ' D' ' 74' ' ' ASN . 4.2 m120 -61.15 -30.9 70.67 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 168.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 78' ' ' ASP . . . . . 1.148 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 1.0 OUTLIER -86.4 -40.91 14.92 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 114.825 -1.079 . . . . 0.0 112.936 177.877 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . 0.614 HG13 ' O ' ' D' ' 75' ' ' ILE . 33.9 mt -63.53 -24.9 37.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 O-C-N 121.433 -0.792 . . . . 0.0 111.536 -171.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -71.39 -31.18 66.98 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . 1.148 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -81.11 -47.4 13.56 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.33 175.271 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 82' ' ' LEU . . . . . 0.603 HD23 ' O ' ' D' ' 78' ' ' ASP . 4.0 mm? -51.01 -26.93 6.74 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 50.31 71.03 0.44 Allowed 'General case' 0 N--CA 1.473 0.687 0 O-C-N 123.588 0.555 . . . . 0.0 110.636 176.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 84' ' ' ILE . . . . . 0.469 ' HB ' ' HG ' ' D' ' 36' ' ' LEU . 44.4 mm -78.23 96.36 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.97 -175.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 85' ' ' LYS . . . . . 0.568 ' HG2' ' HB2' ' D' ' 36' ' ' LEU . 28.4 mmmt -153.79 92.64 1.58 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.496 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.3 154.86 0.08 OUTLIER Glycine 0 C--N 1.331 0.287 0 N-CA-C 114.547 0.579 . . . . 0.0 114.547 174.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 87' ' ' PRO . . . . . 0.526 ' O ' HG12 ' D' ' 58' ' ' VAL . 76.5 Cg_endo -90.45 -178.26 11.17 Favored 'Cis proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.493 -1.461 . . . . 0.0 112.268 -0.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 88' ' ' TYR . . . . . 0.724 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 1.7 m-85 7.71 92.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 125.32 1.448 . . . . 0.0 113.773 -177.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.504 HG12 HG21 ' D' ' 58' ' ' VAL . 71.6 mt -110.95 136.62 46.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.211 0.529 . . . . 0.0 112.24 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.627 ' O ' ' HD2' ' D' ' 57' ' ' PHE . 39.3 tt0 -128.36 95.81 4.26 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.846 175.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 91' ' ' ILE . . . . . 0.622 ' CG2' ' HZ3' ' D' ' 54' ' ' TRP . 6.5 mt -96.37 108.82 21.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -177.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 92' ' ' LYS . . . . . 0.664 ' HE2' HG21 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -161.0 169.97 21.48 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 177.906 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.678 ' HB3' ' NE1' ' D' ' 54' ' ' TRP . 17.4 pt20 -85.24 163.36 18.7 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.399 177.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . 0.664 HG21 ' HE2' ' D' ' 92' ' ' LYS . 9.3 pt . . . . . 0 C--N 1.31 -1.145 0 CA-C-N 114.197 -1.365 . . . . 0.0 111.311 -167.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 39.2 t70 . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 120.688 0.28 . . . . 0.0 110.77 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' D' D ' 2' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 58.27 61.53 2.27 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.311 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -79.02 -15.78 57.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.011 0.434 . . . . 0.0 110.483 176.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 4' ' ' LYS . . . . . 0.45 ' O ' ' HB3' ' D' ' 5' ' ' ALA . 55.3 tptt -103.55 -36.83 7.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.649 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 5' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' D' ' 4' ' ' LYS . . . 75.61 -45.33 0.54 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.512 0.725 . . . . 0.0 111.659 -177.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 5.8 mp -75.07 9.9 1.75 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.769 0.319 . . . . 0.0 111.338 177.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -73.83 -11.24 60.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.169 0.509 . . . . 0.0 110.749 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 1.011 ' HG3' HE21 ' D' ' 9' ' ' GLN . 18.2 pt-20 -72.74 -15.8 61.66 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.806 176.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . 1.011 HE21 ' HG3' ' D' ' 8' ' ' GLU . 77.1 mm-40 -97.65 4.96 49.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.001 -177.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 10' ' ' MET . . . . . 0.401 ' HG2' ' OD1' ' D' ' 11' ' ' ASN . 27.9 ttt -105.21 -79.64 0.55 Allowed 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 119.455 -0.898 . . . . 0.0 112.173 -172.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 11' ' ' ASN . . . . . 0.401 ' OD1' ' HG2' ' D' ' 10' ' ' MET . 3.7 m120 -104.59 -33.54 8.49 Favored 'General case' 0 C--O 1.203 -1.365 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 12' ' ' SER . . . . . 0.528 ' CB ' ' HA ' ' D' ' 8' ' ' GLU . 46.4 t -23.08 -68.47 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 -170.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.466 ' C ' HG13 ' D' ' 16' ' ' VAL . 64.2 mt -73.4 -7.8 10.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 122.103 0.954 . . . . 0.0 111.463 -173.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -95.93 -45.65 6.85 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.656 -1.157 . . . . 0.0 110.053 172.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 15' ' ' SER . . . . . 0.538 ' O ' ' HB2' ' D' ' 18' ' ' ASP . 39.4 m -66.17 -25.44 66.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.794 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 16' ' ' VAL . . . . . 0.767 HG21 ' CG2' ' D' ' 91' ' ' ILE . 7.1 p -58.93 -33.72 50.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.057 0.456 . . . . 0.0 110.532 179.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 17' ' ' ASN . . . . . 0.534 ' O ' ' HB2' ' D' ' 21' ' ' ASN . 5.4 m120 -66.42 -41.46 89.18 Favored 'General case' 0 C--O 1.209 -1.043 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 176.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 18' ' ' ASP . . . . . 0.538 ' HB2' ' O ' ' D' ' 15' ' ' SER . 1.2 m-20 -59.72 -14.03 12.54 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 175.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.668 ' HE2' ' HA ' ' D' ' 16' ' ' VAL . 1.7 mppt? -90.55 -44.93 9.25 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.933 0.873 . . . . 0.0 109.881 175.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 20' ' ' LEU . . . . . 0.999 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 69.8 mt -85.89 -19.02 31.18 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 112.762 -2.017 . . . . 0.0 111.812 -169.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 21' ' ' ASN . . . . . 0.534 ' HB2' ' O ' ' D' ' 17' ' ' ASN . 1.4 t-20 -106.24 98.58 8.24 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.351 -0.84 . . . . 0.0 108.891 -169.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 22' ' ' LYS . . . . . 0.621 ' CE ' ' HA ' ' D' ' 47' ' ' ILE . 2.3 mppt? -119.94 -42.95 2.57 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 118.619 -1.232 . . . . 0.0 113.112 -168.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.19 -75.94 0.16 Allowed Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.147 -1.025 . . . . 0.0 112.598 -175.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . 0.776 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 53.0 tptt -52.13 -61.16 2.44 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 25' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -137.97 157.67 24.39 Favored Glycine 0 N--CA 1.43 -1.712 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.93 174.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 26' ' ' LYS . . . . . 0.637 ' CD ' ' HB3' ' D' ' 41' ' ' SER . 9.1 ptpt -149.25 162.13 40.63 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.378 -0.911 . . . . 0.0 110.818 -167.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 27' ' ' LEU . . . . . 0.999 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 58.3 tp -136.51 136.83 39.7 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.24 0.543 . . . . 0.0 111.448 -177.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 28' ' ' SER . . . . . 0.614 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 53.9 m -124.44 142.18 51.51 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.334 -175.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 29' ' ' LEU . . . . . 0.66 HD11 HD11 ' D' ' 20' ' ' LEU . 0.1 OUTLIER -141.49 148.11 38.9 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 119.49 -0.884 . . . . 0.0 112.097 -176.233 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 50.4 m -154.33 -173.81 4.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.968 176.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 31' ' ' MET . . . . . 0.45 ' HE2' ' HB2' ' D' ' 31' ' ' MET . 24.6 ptm -145.66 162.91 36.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.289 0.566 . . . . 0.0 111.197 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 32' ' ' ASN . . . . . 0.437 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 26.4 t-20 -141.8 88.58 2.13 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.057 178.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.59 -98.45 0.53 Allowed Glycine 0 CA--C 1.516 0.146 0 C-N-CA 120.256 -0.973 . . . . 0.0 111.853 -176.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -104.77 2.89 30.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.783 0.325 . . . . 0.0 110.346 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 35' ' ' GLN . . . . . 0.437 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 3.6 tp-100 -91.32 155.9 18.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.127 -174.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . 0.626 HD13 ' C ' ' D' ' 36' ' ' LEU . 1.9 tm? -124.38 137.65 54.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.366 173.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 37' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 12.8 mmmm -131.04 115.81 16.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.774 -169.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 38' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -123.01 155.02 37.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.156 0.503 . . . . 0.0 111.559 177.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 39' ' ' THR . . . . . 0.614 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 2.4 p -150.77 139.4 20.64 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.903 -178.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 40' ' ' SER . . . . . 0.669 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 53.3 p -109.0 133.97 52.27 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 173.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 41' ' ' SER . . . . . 0.637 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 35.4 t -96.01 148.05 23.06 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.905 -1.118 . . . . 0.0 109.199 176.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 42' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' D' ' 41' ' ' SER . 75.1 m-80 80.09 -0.57 2.04 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.95 -168.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.17 60.54 3.36 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 170.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 44' ' ' GLY . . . . . 0.686 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 110.15 35.95 2.06 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.317 -1.42 . . . . 0.0 114.706 169.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 45' ' ' TYR . . . . . 0.776 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 1.3 m-85 -112.97 152.75 29.02 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 173.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -88.77 -153.81 27.59 Favored Glycine 0 C--O 1.219 -0.782 0 C-N-CA 121.124 -0.56 . . . . 0.0 111.991 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 47' ' ' ILE . . . . . 1.026 HG13 ' HB3' ' D' ' 68' ' ' GLU . 1.0 OUTLIER -57.38 -57.08 11.56 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 CA-C-O 122.338 1.066 . . . . 0.0 108.184 -179.479 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' D' ' 47' ' ' ILE . 23.1 t 169.56 -63.47 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 111.893 -2.412 . . . . 0.0 106.836 -178.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 49' ' ' TYR . . . . . 0.442 ' O ' ' HD1' ' D' ' 49' ' ' TYR . 0.2 OUTLIER -165.07 74.74 0.24 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 113.746 -1.57 . . . . 0.0 109.667 168.569 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . 0.472 ' O ' ' HG2' ' D' ' 69' ' ' LYS . 72.3 mm-40 -139.99 -158.92 0.9 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.049 -175.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 51' ' ' ASP . . . . . 0.515 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 1.1 t70 -152.39 124.37 8.01 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.615 173.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 52' ' ' LYS . . . . . 0.553 ' HB2' ' CG ' ' D' ' 68' ' ' GLU . 0.2 OUTLIER -141.15 120.01 12.66 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.528 178.672 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -93.4 129.06 39.68 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 174.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 54' ' ' TRP . . . . . 0.694 ' NE1' ' HB3' ' D' ' 93' ' ' GLN . 0.1 OUTLIER -114.87 153.18 30.94 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -171.267 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -132.57 156.16 21.93 Favored Glycine 0 N--CA 1.431 -1.685 0 C-N-CA 120.157 -1.021 . . . . 0.0 114.524 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 56' ' ' ILE . . . . . 0.633 HD13 HG12 ' D' ' 84' ' ' ILE . 65.4 mt -146.28 108.27 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 113.66 -1.27 . . . . 0.0 107.652 177.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 57' ' ' PHE . . . . . 0.858 ' HB2' ' HB3' ' D' ' 90' ' ' GLU . 7.4 m-30 -117.72 107.92 14.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.97 -169.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.762 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 53.2 t -97.04 117.15 41.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.684 173.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 59' ' ' ASN . . . . . 0.666 HD22 ' HG2' ' D' ' 87' ' ' PRO . 3.6 m120 62.37 43.46 8.13 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.258 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.4 -33.87 4.19 Favored Glycine 0 CA--C 1.508 -0.361 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.905 173.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 61' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 23.5 pt-20 -90.99 155.84 18.41 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.247 0.546 . . . . 0.0 111.479 -175.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . 0.503 ' HD2' ' OG1' ' D' ' 65' ' ' THR . 6.2 ttpm? -85.55 125.2 32.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.561 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.472 HG22 ' O ' ' D' ' 56' ' ' ILE . 25.6 m -104.57 -29.79 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -177.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 64' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -153.21 147.33 25.59 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.863 0.363 . . . . 0.0 111.384 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.503 ' OG1' ' HD2' ' D' ' 62' ' ' LYS . 86.8 m -132.29 126.75 34.12 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.016 175.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 66' ' ' PHE . . . . . 0.556 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 14.0 p90 -130.44 155.08 47.01 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 175.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 67' ' ' ASN . . . . . 0.462 ' O ' ' HB3' ' D' ' 70' ' ' SER . 72.7 m-20 -117.57 138.23 52.06 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -177.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 68' ' ' GLU . . . . . 1.026 ' HB3' HG13 ' D' ' 47' ' ' ILE . 38.5 mm-40 -61.19 -22.82 65.1 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.885 0.374 . . . . 0.0 111.144 177.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.507 ' HD3' ' HB2' ' D' ' 51' ' ' ASP . 46.3 mtmt -65.02 -39.07 92.84 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 70' ' ' SER . . . . . 0.528 ' O ' HD12 ' D' ' 75' ' ' ILE . 23.2 t -64.79 121.32 14.29 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 113.744 -1.571 . . . . 0.0 106.817 166.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 71' ' ' THR . . . . . 0.41 ' C ' ' H ' ' D' ' 73' ' ' GLY . 54.0 p -52.33 120.36 5.45 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.045 -177.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 72' ' ' VAL . . . . . 0.925 HG11 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -55.3 -11.62 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.368 0 CA-C-O 120.984 0.421 . . . . 0.0 111.395 -175.279 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 73' ' ' GLY . . . . . 0.686 ' HA3' ' HA2' ' D' ' 44' ' ' GLY . . . -67.49 -64.73 3.05 Favored Glycine 0 N--CA 1.434 -1.434 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.884 169.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -65.54 -18.05 65.03 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.987 -0.285 . . . . 0.0 111.332 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 75' ' ' ILE . . . . . 0.682 ' O ' HG13 ' D' ' 79' ' ' ILE . 76.2 mt -70.02 -41.98 79.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 172.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 38.3 t -73.3 -26.16 60.96 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.086 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -59.73 -24.55 64.1 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.367 168.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 78' ' ' ASP . . . . . 0.959 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 76.8 m-20 -90.75 -38.76 12.82 Favored 'General case' 0 C--O 1.225 -0.225 0 O-C-N 123.849 0.718 . . . . 0.0 112.333 176.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . 0.682 HG13 ' O ' ' D' ' 75' ' ' ILE . 42.8 mt -64.88 -24.4 35.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 O-C-N 121.719 -0.613 . . . . 0.0 111.106 -172.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -70.77 -25.19 62.79 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 177.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . 0.959 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -90.32 -46.68 8.24 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 120.081 -0.648 . . . . 0.0 111.829 175.174 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 82' ' ' LEU . . . . . 0.609 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.9 mm? -51.33 -25.93 6.74 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 49.71 69.36 0.61 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.038 0.535 . . . . 0.0 110.8 175.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 84' ' ' ILE . . . . . 0.747 HG22 HD12 ' D' ' 91' ' ' ILE . 2.2 mp -74.0 107.33 4.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.007 -178.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 85' ' ' LYS . . . . . 0.547 ' O ' ' HE3' ' D' ' 85' ' ' LYS . 0.0 OUTLIER -150.44 179.23 8.32 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 178.317 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.48 168.3 4.6 Favored Glycine 0 CA--C 1.509 -0.299 0 CA-C-N 115.266 -0.879 . . . . 0.0 114.923 -173.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 87' ' ' PRO . . . . . 0.713 ' O ' HG12 ' D' ' 58' ' ' VAL . 46.7 Cg_endo -91.84 178.25 13.87 Favored 'Cis proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.736 -1.777 . . . . 0.0 114.165 0.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 88' ' ' TYR . . . . . 0.762 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 11.7 m-85 31.34 93.19 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.853 1.261 . . . . 0.0 113.121 -178.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.542 ' CG2' HG13 ' D' ' 91' ' ' ILE . 3.2 mp -110.19 117.55 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 CA-C-O 121.714 0.768 . . . . 0.0 110.896 -178.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.858 ' HB3' ' HB2' ' D' ' 57' ' ' PHE . 5.0 tp10 -100.93 87.4 3.28 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.126 174.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 91' ' ' ILE . . . . . 0.767 ' CG2' HG21 ' D' ' 16' ' ' VAL . 18.8 mt -98.68 101.76 12.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.751 177.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 92' ' ' LYS . . . . . 0.685 ' HE3' ' CG2' ' D' ' 94' ' ' ILE . 0.0 OUTLIER -161.4 168.62 23.49 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.469 -179.405 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.694 ' HB3' ' NE1' ' D' ' 54' ' ' TRP . 26.3 pt20 -93.17 160.91 14.64 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 119.474 -0.89 . . . . 0.0 111.413 174.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . 0.685 ' CG2' ' HE3' ' D' ' 92' ' ' LYS . 4.7 pt . . . . . 0 C--N 1.314 -0.978 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.587 -172.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 7.7 t70 . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.974 0.416 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' D' D ' 2' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -120.47 17.26 12.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.73 0.776 . . . . 0.0 109.518 -178.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -93.9 -22.89 18.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.555 -177.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 4' ' ' LYS . . . . . 0.632 ' HA ' ' HB2' ' D' ' 7' ' ' GLU . 39.1 ttmt -109.27 10.33 25.7 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.726 0.774 . . . . 0.0 109.009 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 5' ' ' ALA . . . . . . . . . . . . . . . -67.7 -55.77 11.88 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.733 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 91.0 mt -109.9 19.5 19.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.178 0.514 . . . . 0.0 110.649 178.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . 0.632 ' HB2' ' HA ' ' D' ' 4' ' ' LYS . 5.5 tm-20 -65.4 -36.22 83.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.53 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.709 ' HA ' ' CB ' ' D' ' 12' ' ' SER . 84.3 mt-10 -61.69 -28.24 69.27 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.994 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . 0.532 HE21 ' HB2' ' D' ' 8' ' ' GLU . 62.0 mm-40 -93.73 6.47 48.24 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.259 -176.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 10' ' ' MET . . . . . . . . . . . . . 15.7 tpt -106.36 -78.38 0.58 Allowed 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.269 -0.573 . . . . 0.0 111.366 -175.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -103.64 -38.52 7.07 Favored 'General case' 0 CA--C 1.494 -1.192 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.817 175.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 12' ' ' SER . . . . . 0.709 ' CB ' ' HA ' ' D' ' 8' ' ' GLU . 37.9 t -35.87 -69.04 0.11 Allowed 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 113.731 -1.577 . . . . 0.0 113.816 -167.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 60.5 mt -81.73 -8.24 11.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.341 -171.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -95.12 -62.3 1.33 Allowed 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.897 175.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 15' ' ' SER . . . . . 0.511 ' HA ' ' OD1' ' D' ' 18' ' ' ASP . 88.6 p -68.24 -15.94 63.77 Favored 'General case' 0 C--O 1.223 -0.307 0 O-C-N 122.193 -0.317 . . . . 0.0 111.343 -178.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 16' ' ' VAL . . . . . 0.672 ' O ' ' HG ' ' D' ' 20' ' ' LEU . 7.4 p -52.49 -39.8 30.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.127 0.489 . . . . 0.0 109.711 173.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 17' ' ' ASN . . . . . 0.662 ' OD1' ' HA ' ' D' ' 28' ' ' SER . 79.9 m-20 -75.75 -25.88 56.9 Favored 'General case' 0 C--O 1.212 -0.891 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.32 -178.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 18' ' ' ASP . . . . . 0.511 ' OD1' ' HA ' ' D' ' 15' ' ' SER . 1.5 m-20 -66.74 -16.41 64.23 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 177.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.623 ' CE ' ' HA ' ' D' ' 16' ' ' VAL . 0.0 OUTLIER -92.2 -36.78 13.08 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-O 122.044 0.926 . . . . 0.0 108.742 174.087 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' D' D ' 20' ' ' LEU . . . . . 0.916 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 76.4 mt -71.93 -41.16 68.17 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 113.329 -1.76 . . . . 0.0 109.482 -175.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 21' ' ' ASN . . . . . 0.619 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 62.3 m-20 -81.24 94.69 6.75 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.026 -1.443 . . . . 0.0 111.55 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 22' ' ' LYS . . . . . 0.481 ' HB2' HG22 ' D' ' 47' ' ' ILE . 55.8 mtpt -123.01 -42.11 2.3 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -177.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . 0.531 ' O ' ' HE3' ' D' ' 26' ' ' LYS . . . 177.92 -94.03 0.09 OUTLIER Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 119.614 -1.279 . . . . 0.0 113.555 -178.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . 0.831 ' HE3' ' HA ' ' D' ' 48' ' ' SER . 25.7 ttpp -54.73 -43.31 72.51 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 122.072 0.939 . . . . 0.0 110.192 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -139.6 141.16 11.42 Favored Glycine 0 N--CA 1.427 -1.941 0 CA-C-N 114.193 -1.367 . . . . 0.0 111.98 178.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 26' ' ' LYS . . . . . 0.72 ' HA ' ' O ' ' D' ' 20' ' ' LEU . 9.7 ptpt -148.13 159.84 43.52 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 114.213 -0.994 . . . . 0.0 110.09 -170.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 27' ' ' LEU . . . . . 0.916 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 41.1 tp -139.52 148.46 42.66 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 120.864 0.364 . . . . 0.0 111.37 -177.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 28' ' ' SER . . . . . 0.662 ' HA ' ' OD1' ' D' ' 17' ' ' ASN . 21.1 t -140.47 148.47 41.18 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 29' ' ' LEU . . . . . 0.482 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 0.5 OUTLIER -141.88 144.89 34.05 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 175.61 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 50.1 m -148.07 -170.64 3.64 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.33 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -147.21 166.56 26.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.214 0.53 . . . . 0.0 112.028 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 32' ' ' ASN . . . . . 0.543 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 0.8 OUTLIER -146.96 88.74 1.76 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.788 179.839 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.75 -101.52 0.72 Allowed Glycine 0 CA--C 1.516 0.14 0 C-N-CA 120.327 -0.94 . . . . 0.0 111.568 -174.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -107.78 16.66 23.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.926 0.394 . . . . 0.0 110.615 176.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 35' ' ' GLN . . . . . 0.543 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 68.1 tp60 -99.39 156.76 16.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.627 -176.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . 0.86 ' HB2' ' HG2' ' D' ' 85' ' ' LYS . 2.3 tm? -120.62 140.12 52.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.667 174.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 37' ' ' LYS . . . . . 0.497 ' HE2' ' CG ' ' D' ' 35' ' ' GLN . 73.0 mmtt -132.02 123.76 27.94 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.169 -171.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 38' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -130.83 138.69 49.98 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.46 175.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 39' ' ' THR . . . . . 0.546 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 19.9 p -133.51 122.0 22.99 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.373 0.606 . . . . 0.0 111.36 178.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 40' ' ' SER . . . . . 0.668 ' HB2' ' HA2' ' D' ' 73' ' ' GLY . 40.7 m -109.99 129.58 55.65 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 175.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 41' ' ' SER . . . . . 0.646 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 37.2 t -95.74 154.82 17.03 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.617 -173.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 42' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' D' ' 41' ' ' SER . 73.6 m-80 80.38 11.86 1.01 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 114.053 -1.431 . . . . 0.0 110.079 -171.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 45.15 55.47 6.27 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 114.445 -1.252 . . . . 0.0 113.693 170.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 44' ' ' GLY . . . . . 0.633 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 108.79 35.54 2.38 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 119.754 -1.213 . . . . 0.0 114.126 171.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 45' ' ' TYR . . . . . 0.619 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 1.7 m-85 -116.04 157.67 24.31 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 171.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . 0.59 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -97.74 174.77 29.54 Favored Glycine 0 CA--C 1.501 -0.843 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 177.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 47' ' ' ILE . . . . . 0.679 ' CG1' ' HB3' ' D' ' 68' ' ' GLU . 46.3 mm -46.4 -60.37 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-O 121.614 0.721 . . . . 0.0 111.659 -177.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.831 ' HA ' ' HE3' ' D' ' 24' ' ' LYS . 22.1 t 172.93 -151.02 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 113.391 -1.731 . . . . 0.0 108.214 -177.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -80.69 77.0 7.57 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 120.9 0.381 . . . . 0.0 110.541 172.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . 0.571 ' HB2' ' NZ ' ' D' ' 52' ' ' LYS . 97.2 mt-10 -150.46 155.58 39.8 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.469 176.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 51' ' ' ASP . . . . . 0.629 ' HB3' ' HD3' ' D' ' 69' ' ' LYS . 18.6 m-20 -118.96 127.65 53.67 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.869 176.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 52' ' ' LYS . . . . . 0.711 ' HE2' ' CB ' ' D' ' 68' ' ' GLU . 3.5 mppt? -142.63 128.74 19.73 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.879 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -104.11 129.71 51.81 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.746 175.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 54' ' ' TRP . . . . . 0.633 ' HZ3' ' CG2' ' D' ' 91' ' ' ILE . 1.0 OUTLIER -115.69 160.8 19.58 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -174.498 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' D' D ' 55' ' ' GLY . . . . . 0.433 ' HA3' ' HE2' ' D' ' 62' ' ' LYS . . . -143.81 158.82 27.49 Favored Glycine 0 N--CA 1.434 -1.498 0 CA-C-N 114.848 -1.069 . . . . 0.0 113.371 176.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 56' ' ' ILE . . . . . 0.572 HG12 ' CG2' ' D' ' 91' ' ' ILE . 91.2 mt -140.92 115.09 5.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 N-CA-C 106.363 -1.718 . . . . 0.0 106.363 178.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 57' ' ' PHE . . . . . 0.725 ' CE1' ' HE2' ' D' ' 92' ' ' LYS . 5.6 m-85 -115.37 123.03 47.65 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 119.589 -0.844 . . . . 0.0 110.466 -171.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.642 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 85.3 t -101.01 112.59 34.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.954 173.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 59' ' ' ASN . . . . . 0.606 ' OD1' ' HG2' ' D' ' 87' ' ' PRO . 6.8 m120 60.78 35.95 19.39 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.322 -176.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.04 -33.05 6.6 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.374 -0.917 . . . . 0.0 113.998 174.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 61' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 24.5 pt-20 -90.08 148.64 22.9 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.914 0.388 . . . . 0.0 111.183 -174.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . 0.433 ' HE2' ' HA3' ' D' ' 55' ' ' GLY . 5.5 tppp? -65.66 126.56 28.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.766 175.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.527 HG12 ' O ' ' D' ' 56' ' ' ILE . 12.4 p -109.48 -29.44 2.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.663 178.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 64' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -151.5 135.22 16.35 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.758 175.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 70.6 m -117.06 125.66 51.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.133 175.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -126.8 161.02 29.19 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 121.153 0.501 . . . . 0.0 110.064 173.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 67' ' ' ASN . . . . . 0.552 ' O ' ' HB2' ' D' ' 70' ' ' SER . 73.1 m-20 -126.1 147.46 49.59 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -177.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 68' ' ' GLU . . . . . 0.711 ' CB ' ' HE2' ' D' ' 52' ' ' LYS . 39.0 mm-40 -80.98 -14.68 57.73 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.438 0.637 . . . . 0.0 109.592 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.629 ' HD3' ' HB3' ' D' ' 51' ' ' ASP . 47.6 mtmt -65.97 -48.96 69.55 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-N 113.808 -1.542 . . . . 0.0 107.27 169.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 70' ' ' SER . . . . . 0.552 ' HB2' ' O ' ' D' ' 67' ' ' ASN . 51.0 m -61.32 129.57 41.87 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 111.615 -2.539 . . . . 0.0 108.775 169.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 68.4 p -58.61 112.03 1.46 Allowed 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -178.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 72' ' ' VAL . . . . . 0.711 HG13 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -49.84 -24.36 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 121.06 0.457 . . . . 0.0 110.269 -176.557 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' D' D ' 73' ' ' GLY . . . . . 0.668 ' HA2' ' HB2' ' D' ' 40' ' ' SER . . . -60.77 -67.46 2.12 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.208 -0.905 . . . . 0.0 114.671 175.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -62.49 -19.48 63.61 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.057 0.456 . . . . 0.0 110.965 -177.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 75' ' ' ILE . . . . . 0.58 ' O ' HG13 ' D' ' 79' ' ' ILE . 34.8 mm -76.05 -39.48 36.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.017 174.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 76' ' ' SER . . . . . 0.49 ' HA ' HG13 ' D' ' 79' ' ' ILE . 40.4 t -75.01 -21.05 59.35 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.535 177.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -61.72 -30.67 70.91 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 168.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 78' ' ' ASP . . . . . 0.977 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 1.0 OUTLIER -83.65 -30.8 26.57 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.606 174.84 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . 0.58 HG13 ' O ' ' D' ' 75' ' ' ILE . 35.8 mt -69.81 -18.0 21.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.29 -177.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -66.41 -41.41 89.32 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.06 174.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . 0.977 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -80.23 -47.05 15.22 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 179.44 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' D' D ' 82' ' ' LEU . . . . . 0.656 HD21 ' O ' ' D' ' 78' ' ' ASP . 3.4 mm? -50.34 -27.81 6.86 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -178.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 83' ' ' ASN . . . . . 0.514 ' HA ' ' HB3' ' D' ' 36' ' ' LEU . 0.7 OUTLIER 46.16 62.6 2.2 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.553 0.533 . . . . 0.0 110.678 176.403 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' D' D ' 84' ' ' ILE . . . . . 0.453 ' N ' ' HG ' ' D' ' 36' ' ' LEU . 44.8 mm -86.32 97.36 5.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.535 -175.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 85' ' ' LYS . . . . . 0.86 ' HG2' ' HB2' ' D' ' 36' ' ' LEU . 28.3 mmmt -147.13 95.55 2.58 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.816 175.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 86' ' ' GLY . . . . . 0.524 ' H ' ' CD1' ' D' ' 89' ' ' ILE . . . 73.97 151.72 2.23 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.648 -0.706 . . . . 0.0 113.746 173.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 87' ' ' PRO . . . . . 0.606 ' HG2' ' OD1' ' D' ' 59' ' ' ASN . 62.5 Cg_endo -90.19 179.61 14.38 Favored 'Cis proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.17 -1.596 . . . . 0.0 112.773 -0.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 88' ' ' TYR . . . . . 0.642 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 5.8 m-85 15.54 94.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 125.43 1.492 . . . . 0.0 114.217 -178.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.524 ' CD1' ' H ' ' D' ' 86' ' ' GLY . 70.5 mt -110.52 133.31 56.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.223 0.535 . . . . 0.0 112.357 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.479 ' O ' ' HD1' ' D' ' 57' ' ' PHE . 46.3 mt-10 -118.97 96.75 5.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.536 174.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 91' ' ' ILE . . . . . 0.633 ' CG2' ' HZ3' ' D' ' 54' ' ' TRP . 4.0 mt -101.11 110.92 29.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 92' ' ' LYS . . . . . 0.88 ' HE3' HG21 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -163.55 172.76 13.93 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.023 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.584 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 23.9 pt20 -81.6 169.34 17.17 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 119.091 -1.043 . . . . 0.0 111.185 175.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . 0.88 HG21 ' HE3' ' D' ' 92' ' ' LYS . 6.7 pt . . . . . 0 C--N 1.317 -0.837 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.971 -173.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 53.5 p-10 . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 120.59 0.233 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' D' D ' 2' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -109.91 -3.62 16.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.065 0.46 . . . . 0.0 110.708 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -76.67 -3.83 39.95 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.219 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -85.55 -21.62 28.48 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 175.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 5' ' ' ALA . . . . . . . . . . . . . . . 54.99 63.25 2.19 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.192 -175.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . 0.742 HD13 ' HB2' ' D' ' 9' ' ' GLN . 28.4 tp -110.45 17.27 20.97 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.059 -174.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -56.94 -47.71 80.01 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -175.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.739 ' HA ' ' CB ' ' D' ' 12' ' ' SER . 20.9 pt-20 -70.2 -21.84 62.99 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.518 -178.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . 0.742 ' HB2' HD13 ' D' ' 6' ' ' LEU . 0.0 OUTLIER -96.59 12.07 32.98 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.142 -0.223 . . . . 0.0 110.758 174.69 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 10' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -105.05 -75.29 0.63 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -175.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -103.14 -37.43 7.73 Favored 'General case' 0 CA--C 1.495 -1.171 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.58 173.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 12' ' ' SER . . . . . 0.739 ' CB ' ' HA ' ' D' ' 8' ' ' GLU . 47.6 t -44.06 -61.69 1.39 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 113.925 -1.489 . . . . 0.0 111.956 -166.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.53 HG22 ' O ' ' D' ' 8' ' ' GLU . 12.2 tt -86.69 -22.57 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-O 120.85 0.357 . . . . 0.0 111.932 -178.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -82.13 -58.88 2.76 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -178.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 15' ' ' SER . . . . . 0.605 ' O ' ' HE2' ' D' ' 19' ' ' LYS . 97.9 p -69.97 -15.46 63.04 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.701 -178.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 16' ' ' VAL . . . . . 0.684 ' HB ' ' O ' ' D' ' 12' ' ' SER . 1.7 p -61.3 -26.56 39.68 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -78.3 -38.05 43.37 Favored 'General case' 0 C--O 1.212 -0.891 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.545 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.99 -16.36 17.72 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.649 ' O ' ' HE2' ' D' ' 22' ' ' LYS . 35.0 mttm -91.12 -39.29 12.24 Favored 'General case' 0 CA--C 1.492 -1.28 0 CA-C-O 122.487 1.137 . . . . 0.0 109.397 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 20' ' ' LEU . . . . . 0.595 ' CB ' ' HB3' ' D' ' 27' ' ' LEU . 61.0 mt -82.26 -32.82 29.44 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 112.887 -1.961 . . . . 0.0 109.581 -174.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 21' ' ' ASN . . . . . 0.744 ' OD1' ' HB2' ' D' ' 26' ' ' LYS . 57.4 m-20 -71.95 92.33 1.27 Allowed 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.449 -1.25 . . . . 0.0 109.708 172.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 22' ' ' LYS . . . . . 0.649 ' HE2' ' O ' ' D' ' 19' ' ' LYS . 61.0 mttm -121.75 -41.45 2.47 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -174.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.93 -92.64 0.09 OUTLIER Glycine 0 N--CA 1.437 -1.283 0 C-N-CA 119.658 -1.258 . . . . 0.0 112.857 -177.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . 0.727 ' HG2' ' HB3' ' D' ' 45' ' ' TYR . 76.0 tttt -47.44 -55.83 8.22 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.584 0.707 . . . . 0.0 109.786 179.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 25' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -133.99 156.21 22.22 Favored Glycine 0 N--CA 1.432 -1.573 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.906 174.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 26' ' ' LYS . . . . . 0.744 ' HB2' ' OD1' ' D' ' 21' ' ' ASN . 0.1 OUTLIER -150.3 162.48 40.44 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.301 -0.949 . . . . 0.0 110.556 -168.516 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 27' ' ' LEU . . . . . 0.921 ' HB2' HG11 ' D' ' 72' ' ' VAL . 3.4 tm? -132.46 143.23 49.64 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.762 -171.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 28' ' ' SER . . . . . 0.675 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 50.0 m -137.05 145.64 44.25 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.924 178.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 29' ' ' LEU . . . . . 0.524 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 18.3 mt -138.75 157.91 45.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.157 0.503 . . . . 0.0 110.871 177.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 39.3 t -160.3 -175.49 5.07 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 175.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 31' ' ' MET . . . . . 0.689 ' HA ' ' O ' ' D' ' 35' ' ' GLN . 26.6 ptt? -150.28 127.1 11.03 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.659 0.743 . . . . 0.0 111.06 175.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.52 89.01 7.01 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.022 176.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.51 -104.1 2.02 Favored Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -169.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -120.71 31.78 6.28 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.164 0.507 . . . . 0.0 109.938 172.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 35' ' ' GLN . . . . . 0.689 ' O ' ' HA ' ' D' ' 31' ' ' MET . 32.9 tt0 -108.11 115.95 31.07 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.579 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . 0.623 ' HB2' ' HB2' ' D' ' 85' ' ' LYS . 1.1 tm? -77.76 134.95 37.95 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.225 0.536 . . . . 0.0 111.536 -177.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 37' ' ' LYS . . . . . 0.735 ' HZ3' ' HB3' ' D' ' 37' ' ' LYS . 0.7 OUTLIER -133.79 116.71 16.03 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.491 -169.313 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 38' ' ' ALA . . . . . 0.427 ' HA ' HD23 ' D' ' 29' ' ' LEU . . . -115.09 152.88 31.75 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.408 0.623 . . . . 0.0 112.401 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 39' ' ' THR . . . . . 0.675 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 5.2 p -150.87 134.49 16.43 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.53 177.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 40' ' ' SER . . . . . 0.524 ' HB3' ' HA2' ' D' ' 73' ' ' GLY . 40.1 t -108.11 136.12 48.32 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 172.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 41' ' ' SER . . . . . 0.726 ' HB3' ' HG3' ' D' ' 26' ' ' LYS . 47.6 t -96.17 151.78 19.17 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 118.963 -1.095 . . . . 0.0 109.748 -179.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 42' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' D' ' 41' ' ' SER . 77.1 m-20 80.66 6.75 1.45 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.693 -167.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 53.94 60.13 3.82 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 114.713 -1.13 . . . . 0.0 113.455 171.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 44' ' ' GLY . . . . . 0.625 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 104.72 37.92 2.67 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.122 -1.513 . . . . 0.0 114.989 168.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 45' ' ' TYR . . . . . 0.727 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 2.3 m-85 -116.11 154.4 30.04 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 117.856 0.828 . . . . 0.0 109.944 173.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . 0.652 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -93.78 -173.58 39.56 Favored Glycine 0 C--O 1.22 -0.744 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 178.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 47' ' ' ILE . . . . . 0.786 HG12 ' HB3' ' D' ' 68' ' ' GLU . 26.9 mm -48.55 -54.81 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-O 122.025 0.917 . . . . 0.0 108.775 175.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.594 ' HA ' ' HD3' ' D' ' 24' ' ' LYS . 93.4 p 178.76 -146.22 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 112.832 -1.985 . . . . 0.0 107.561 178.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -82.54 75.9 9.43 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.462 166.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . 0.68 ' HB3' ' HE2' ' D' ' 52' ' ' LYS . 95.6 mt-10 -146.84 163.37 36.28 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.646 -176.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 51' ' ' ASP . . . . . 0.681 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 1.4 m-20 -124.1 132.7 53.68 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.804 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 52' ' ' LYS . . . . . 0.681 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 3.5 mptp? -142.93 120.7 11.89 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.453 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 53' ' ' ASN . . . . . 0.599 ' HA ' ' OD1' ' D' ' 67' ' ' ASN . 3.0 m120 -90.83 131.46 36.47 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 176.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 54' ' ' TRP . . . . . 0.605 ' HB2' ' O ' ' D' ' 66' ' ' PHE . 0.1 OUTLIER -122.93 155.0 37.63 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -172.161 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -144.81 161.14 28.07 Favored Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.254 -0.974 . . . . 0.0 113.97 174.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 56' ' ' ILE . . . . . 0.684 HD12 HG12 ' D' ' 84' ' ' ILE . 74.0 mt -137.03 111.79 10.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 57' ' ' PHE . . . . . 0.876 ' HB2' ' HB3' ' D' ' 90' ' ' GLU . 15.8 m-85 -105.59 97.8 7.58 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.894 -167.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.719 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 99.4 t -98.2 120.64 47.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.475 176.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 67.64 34.98 4.25 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 123.438 0.461 . . . . 0.0 110.539 -175.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.35 42.54 97.68 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.625 -0.716 . . . . 0.0 113.54 177.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 61' ' ' GLU . . . . . 0.614 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 24.9 pt-20 -155.41 141.63 18.46 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 176.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . 0.484 ' HB2' ' CE2' ' D' ' 57' ' ' PHE . 27.9 ttpp -73.01 99.72 2.81 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -178.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.521 HG13 ' O ' ' D' ' 56' ' ' ILE . 9.1 p -84.29 -32.43 8.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.657 -172.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 64' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -134.39 132.0 38.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.746 0.307 . . . . 0.0 110.797 176.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 35.0 m -116.4 112.46 21.51 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.124 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 66' ' ' PHE . . . . . 0.605 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 9.3 p90 -118.66 158.51 25.37 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 173.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 67' ' ' ASN . . . . . 0.599 ' OD1' ' HA ' ' D' ' 53' ' ' ASN . 73.7 m-80 -129.81 142.09 50.74 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.349 -175.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 68' ' ' GLU . . . . . 0.786 ' HB3' HG12 ' D' ' 47' ' ' ILE . 42.1 mm-40 -69.07 -8.41 44.96 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 123.574 0.546 . . . . 0.0 110.415 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.41 ' HE2' ' CB ' ' D' ' 67' ' ' ASN . 44.1 mtmt -60.62 -46.66 89.44 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 167.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 70' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' D' ' 67' ' ' ASN . 35.1 t -69.78 129.78 40.51 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 113.179 -1.828 . . . . 0.0 108.355 168.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 71' ' ' THR . . . . . 0.473 ' O ' HG13 ' D' ' 75' ' ' ILE . 74.1 p -57.86 128.86 39.19 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 178.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 72' ' ' VAL . . . . . 0.921 HG11 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -54.57 -16.84 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-O 121.294 0.568 . . . . 0.0 110.44 -175.655 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 73' ' ' GLY . . . . . 0.625 ' HA3' ' HA2' ' D' ' 44' ' ' GLY . . . -72.92 -58.58 4.72 Favored Glycine 0 N--CA 1.435 -1.39 0 CA-C-N 114.911 -1.041 . . . . 0.0 112.841 173.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -64.25 -20.25 65.93 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 120.885 0.374 . . . . 0.0 110.305 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 75' ' ' ILE . . . . . 0.637 ' O ' HG13 ' D' ' 79' ' ' ILE . 74.7 mt -73.34 -41.12 57.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.462 171.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 76' ' ' SER . . . . . 0.411 ' OG ' ' HB2' ' D' ' 38' ' ' ALA . 41.5 t -71.03 -26.8 63.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.048 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -56.12 -30.92 62.78 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 167.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 78' ' ' ASP . . . . . 1.056 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 1.1 m-20 -90.35 -33.28 16.13 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 177.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . 0.637 HG13 ' O ' ' D' ' 75' ' ' ILE . 41.5 mt -68.3 -27.81 38.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 O-C-N 121.689 -0.632 . . . . 0.0 110.595 -175.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -73.92 -20.02 60.51 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . 1.056 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -89.92 -52.38 5.0 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.601 171.416 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 82' ' ' LEU . . . . . 0.536 ' H ' ' HG2' ' D' ' 81' ' ' LYS . 3.7 mm? -48.67 -31.44 6.78 Favored 'General case' 0 C--O 1.231 0.086 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 176.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 40.6 77.77 0.05 Allowed 'General case' 0 N--CA 1.469 0.506 0 O-C-N 124.639 1.212 . . . . 0.0 111.134 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 84' ' ' ILE . . . . . 0.684 HG12 HD12 ' D' ' 56' ' ' ILE . 2.6 mp -77.97 97.05 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.362 -176.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 85' ' ' LYS . . . . . 0.623 ' HB2' ' HB2' ' D' ' 36' ' ' LEU . 0.0 OUTLIER -158.28 93.07 1.2 Allowed 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 121.431 0.634 . . . . 0.0 110.505 -177.424 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 86' ' ' GLY . . . . . 0.501 ' H ' ' CD1' ' D' ' 89' ' ' ILE . . . 68.54 148.56 0.21 Allowed Glycine 0 N--CA 1.453 -0.193 0 CA-C-N 114.59 -1.187 . . . . 0.0 113.929 178.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 87' ' ' PRO . . . . . 0.591 ' O ' HG13 ' D' ' 58' ' ' VAL . 60.8 Cg_endo -90.6 -177.53 10.12 Favored 'Cis proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.533 -1.445 . . . . 0.0 112.508 -0.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 88' ' ' TYR . . . . . 0.719 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 13.0 m-85 4.89 94.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 125.527 1.531 . . . . 0.0 114.214 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.64 HG12 HG23 ' D' ' 58' ' ' VAL . 66.5 mt -108.35 148.81 12.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.192 0.52 . . . . 0.0 111.883 -177.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.876 ' HB3' ' HB2' ' D' ' 57' ' ' PHE . 39.7 tt0 -132.13 91.41 2.95 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.281 173.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 91' ' ' ILE . . . . . 0.592 HG13 HG21 ' D' ' 89' ' ' ILE . 37.0 mt -94.14 99.84 10.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.89 -176.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 92' ' ' LYS . . . . . 0.618 ' HG2' ' O ' ' D' ' 93' ' ' GLN . 0.0 OUTLIER -160.74 164.47 31.55 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 177.379 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.618 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 24.3 pt20 -80.6 162.73 24.12 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.537 176.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . 0.448 HG22 ' HE2' ' D' ' 92' ' ' LYS . 10.6 pt . . . . . 0 C--N 1.305 -1.357 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.366 -171.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 9.4 t70 . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' D' D ' 2' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -172.48 -27.32 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 177.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 3' ' ' GLN . . . . . 0.434 ' CD ' ' H ' ' D' ' 3' ' ' GLN . 15.1 mp0 -55.93 -70.73 0.1 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.084 0.469 . . . . 0.0 110.785 -175.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -111.46 -26.01 9.3 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.71 174.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 5' ' ' ALA . . . . . 0.518 ' O ' ' HG2' ' D' ' 9' ' ' GLN . . . 61.59 31.06 18.85 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.001 -177.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 57.2 tp -70.24 -34.43 72.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.654 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -69.27 -26.21 64.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.339 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.791 ' HA ' ' CB ' ' D' ' 12' ' ' SER . 93.8 mt-10 -73.61 -21.13 60.4 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.34 176.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . 0.518 ' HG2' ' O ' ' D' ' 5' ' ' ALA . 72.0 mm-40 -89.05 11.74 17.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.833 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 10' ' ' MET . . . . . . . . . . . . . 62.6 mtt -106.05 -77.91 0.58 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.015 0.436 . . . . 0.0 111.042 -178.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -104.52 -38.5 6.75 Favored 'General case' 0 CA--C 1.493 -1.249 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.709 174.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 12' ' ' SER . . . . . 0.791 ' CB ' ' HA ' ' D' ' 8' ' ' GLU . 47.2 t -41.58 -66.03 0.38 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 113.667 -1.606 . . . . 0.0 112.83 -164.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.458 HG22 ' O ' ' D' ' 13' ' ' ILE . 57.5 mt -87.9 -7.18 10.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.623 -174.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -88.54 -57.36 2.94 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.334 176.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 15' ' ' SER . . . . . 0.552 ' O ' ' HE2' ' D' ' 19' ' ' LYS . 92.6 p -68.11 -17.74 64.45 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.673 -0.239 . . . . 0.0 111.457 -178.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 16' ' ' VAL . . . . . 0.606 HG12 ' ND2' ' D' ' 17' ' ' ASN . 9.6 p -59.97 -30.06 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-O 121.945 0.879 . . . . 0.0 109.562 176.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 17' ' ' ASN . . . . . 0.606 ' ND2' HG12 ' D' ' 16' ' ' VAL . 3.8 m120 -78.26 -33.96 49.29 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.256 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.31 -15.71 49.64 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.331 177.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.552 ' HE2' ' O ' ' D' ' 15' ' ' SER . 40.3 mttm -89.56 -39.52 13.22 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 122.726 1.25 . . . . 0.0 109.255 -179.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 20' ' ' LEU . . . . . 0.793 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 73.0 mt -77.19 -37.29 53.88 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 111.935 -2.393 . . . . 0.0 110.127 -176.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 21' ' ' ASN . . . . . 0.606 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 57.5 m-20 -75.33 95.92 3.29 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.678 177.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 22' ' ' LYS . . . . . 0.638 ' HD3' HG21 ' D' ' 47' ' ' ILE . 23.0 mtpp -120.89 -43.62 2.45 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 118.594 -1.242 . . . . 0.0 114.064 -168.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.27 -69.9 0.25 Allowed Glycine 0 N--CA 1.436 -1.315 0 C-N-CA 119.746 -1.216 . . . . 0.0 112.509 -174.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . 0.805 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 22.2 tptm -55.27 -67.07 0.31 Allowed 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 176.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 25' ' ' GLY . . . . . 1.071 ' HA2' HD22 ' D' ' 42' ' ' ASN . . . -139.38 156.49 24.61 Favored Glycine 0 CA--C 1.493 -1.337 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.279 172.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 26' ' ' LYS . . . . . 0.709 ' HB3' ' HZ3' ' D' ' 26' ' ' LYS . 0.4 OUTLIER -140.5 160.12 40.69 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -168.53 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 27' ' ' LEU . . . . . 0.793 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 45.1 tp -139.44 144.38 38.02 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.463 0.649 . . . . 0.0 112.392 -177.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 28' ' ' SER . . . . . 0.695 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 49.2 m -135.34 151.91 50.96 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.505 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 29' ' ' LEU . . . . . . . . . . . . . 16.4 mt -141.02 138.01 33.38 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 56.3 m -148.06 -179.04 6.62 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 31' ' ' MET . . . . . 0.821 ' HA ' ' O ' ' D' ' 35' ' ' GLN . 20.2 ptp -137.23 126.62 24.92 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.67 0.747 . . . . 0.0 111.057 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -90.84 88.34 7.02 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 175.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.64 -100.97 1.99 Allowed Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -165.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -120.16 12.5 11.86 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.999 0.428 . . . . 0.0 109.987 171.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 35' ' ' GLN . . . . . 0.821 ' O ' ' HA ' ' D' ' 31' ' ' MET . 25.6 mt-30 -88.63 125.94 35.06 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.471 -175.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . 0.576 HD13 ' C ' ' D' ' 36' ' ' LEU . 2.8 tm? -78.08 124.38 27.98 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.204 0.526 . . . . 0.0 111.436 -178.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 37' ' ' LYS . . . . . 0.605 ' HE2' ' HB3' ' D' ' 35' ' ' GLN . 74.9 mmtt -135.53 103.49 5.48 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.794 -173.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.28 152.64 18.38 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.322 0.582 . . . . 0.0 111.581 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 39' ' ' THR . . . . . 0.695 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 7.1 p -141.01 124.79 16.98 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.118 176.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 40' ' ' SER . . . . . 0.645 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 19.1 p -107.88 128.87 55.0 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 172.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 41' ' ' SER . . . . . 0.689 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 44.3 t -96.3 168.75 10.39 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 42' ' ' ASN . . . . . 1.071 HD22 ' HA2' ' D' ' 25' ' ' GLY . 21.3 p30 60.8 7.44 1.45 Allowed 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.975 1.422 . . . . 0.0 112.499 -174.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 41.41 60.29 2.14 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 168.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 44' ' ' GLY . . . . . 0.588 ' O ' HG21 ' D' ' 71' ' ' THR . . . 120.87 35.86 0.81 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 118.873 -1.632 . . . . 0.0 114.931 168.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 45' ' ' TYR . . . . . 0.805 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 0.7 OUTLIER -122.83 154.26 38.48 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 170.504 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . 0.586 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -99.81 -163.63 29.02 Favored Glycine 0 C--O 1.216 -1.013 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.414 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 47' ' ' ILE . . . . . 0.785 HG12 ' HB3' ' D' ' 68' ' ' GLU . 41.9 mm -55.04 -59.53 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 CA-C-O 122.088 0.947 . . . . 0.0 109.675 176.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 83.5 p 175.0 -164.61 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 112.327 -2.215 . . . . 0.0 108.789 -172.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -78.27 77.96 4.75 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.924 0.869 . . . . 0.0 111.632 173.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -145.56 -167.8 2.8 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.957 177.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 51' ' ' ASP . . . . . 0.692 ' C ' ' HD3' ' D' ' 52' ' ' LYS . 9.6 p-10 -136.34 135.18 38.65 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.359 168.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 52' ' ' LYS . . . . . 0.711 ' CE ' ' HB2' ' D' ' 68' ' ' GLU . 2.7 mppt? -139.79 128.1 22.64 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.263 -167.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 53' ' ' ASN . . . . . 0.444 HD21 ' C ' ' D' ' 52' ' ' LYS . 2.8 m120 -116.65 138.8 51.17 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 173.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 54' ' ' TRP . . . . . 0.622 ' HB2' ' O ' ' D' ' 66' ' ' PHE . 0.1 OUTLIER -125.76 160.38 29.93 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -173.077 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -140.43 156.2 25.07 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.042 -1.075 . . . . 0.0 113.908 175.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 56' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' D' ' 90' ' ' GLU . 62.8 mt -140.24 108.75 3.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 176.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 57' ' ' PHE . . . . . 0.729 ' CE2' ' HE2' ' D' ' 92' ' ' LYS . 7.0 m-85 -108.25 102.91 12.0 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.637 -168.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.716 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 78.2 t -91.97 110.17 22.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.814 170.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 59' ' ' ASN . . . . . 0.435 ' OD1' ' HG2' ' D' ' 87' ' ' PRO . 5.2 m120 63.74 44.51 4.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.436 -176.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.3 -33.91 4.7 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.793 -0.718 . . . . 0.0 114.511 172.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 61' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 12.5 pt-20 -94.81 154.06 17.44 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.966 -0.293 . . . . 0.0 111.072 -175.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -73.92 106.94 5.86 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 173.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 9.9 p -76.52 -27.9 17.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.522 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 64' ' ' TYR . . . . . 0.509 ' HH ' ' CB ' ' D' ' 78' ' ' ASP . 14.2 t80 -148.13 135.57 20.59 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.545 173.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.45 HG22 ' O ' ' D' ' 54' ' ' TRP . 65.3 m -119.87 123.04 42.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.514 174.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 66' ' ' PHE . . . . . 0.622 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 11.3 p90 -129.62 143.11 50.67 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 121.477 0.656 . . . . 0.0 110.679 178.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 67' ' ' ASN . . . . . 0.746 HD21 ' HB2' ' D' ' 69' ' ' LYS . 15.1 p-10 -110.31 130.28 55.58 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.271 -175.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 68' ' ' GLU . . . . . 0.785 ' HB3' HG12 ' D' ' 47' ' ' ILE . 35.1 mm-40 -67.62 -8.45 34.67 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.831 -177.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.746 ' HB2' HD21 ' D' ' 67' ' ' ASN . 53.3 mtpt -62.28 -40.79 97.4 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 169.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 70' ' ' SER . . . . . 0.547 ' O ' HD13 ' D' ' 75' ' ' ILE . 32.5 t -68.51 124.52 23.79 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 113.051 -1.886 . . . . 0.0 107.353 164.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 71' ' ' THR . . . . . 0.588 HG21 ' O ' ' D' ' 44' ' ' GLY . 67.3 p -55.17 130.98 44.17 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 72' ' ' VAL . . . . . 0.658 HG11 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -57.3 -14.99 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-O 120.722 0.296 . . . . 0.0 111.011 -178.582 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 73' ' ' GLY . . . . . 0.645 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -63.98 -65.45 3.02 Favored Glycine 0 N--CA 1.433 -1.562 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.156 168.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -62.62 -20.55 64.88 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.523 0.201 . . . . 0.0 111.428 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 75' ' ' ILE . . . . . 0.589 ' O ' HG13 ' D' ' 79' ' ' ILE . 69.7 mt -73.26 -40.61 57.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.148 174.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 35.9 t -75.83 -21.32 57.4 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.817 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 77' ' ' ASN . . . . . 0.615 ' O ' ' HD3' ' D' ' 81' ' ' LYS . 5.7 m120 -61.69 -23.97 66.46 Favored 'General case' 0 C--O 1.216 -0.66 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 166.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 78' ' ' ASP . . . . . 0.576 ' O ' HD22 ' D' ' 82' ' ' LEU . 1.0 OUTLIER -93.23 -41.56 9.83 Favored 'General case' 0 C--O 1.225 -0.237 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 175.913 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . 0.589 HG13 ' O ' ' D' ' 75' ' ' ILE . 56.0 mt -65.78 -34.35 69.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 O-C-N 121.449 -0.782 . . . . 0.0 111.645 -169.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -66.86 -14.05 62.29 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.126 176.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . 0.615 ' HD3' ' O ' ' D' ' 77' ' ' ASN . 0.0 OUTLIER -89.77 -57.39 2.88 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.207 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 82' ' ' LEU . . . . . 0.576 HD22 ' O ' ' D' ' 78' ' ' ASP . 3.4 mm? -53.86 -23.74 13.5 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 113.88 -1.509 . . . . 0.0 112.343 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 50.69 69.75 0.6 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.647 174.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 84' ' ' ILE . . . . . 0.515 ' HB ' ' HG ' ' D' ' 36' ' ' LEU . 2.2 mp -74.68 99.09 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.377 0.608 . . . . 0.0 111.175 -176.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 85' ' ' LYS . . . . . 0.58 ' O ' ' HE3' ' D' ' 85' ' ' LYS . 0.0 OUTLIER -131.99 179.07 6.31 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.165 174.722 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . -48.38 165.15 0.24 Allowed Glycine 0 C--N 1.334 0.463 0 O-C-N 123.696 0.623 . . . . 0.0 113.928 -174.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 87' ' ' PRO . . . . . 0.435 ' HG2' ' OD1' ' D' ' 59' ' ' ASN . 60.5 Cg_endo -93.82 -177.09 7.26 Favored 'Cis proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.898 -1.293 . . . . 0.0 114.758 -0.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 88' ' ' TYR . . . . . 0.716 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 41.5 m-85 23.04 93.06 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.504 1.521 . . . . 0.0 113.57 179.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.663 HG22 HG13 ' D' ' 91' ' ' ILE . 72.7 mt -112.36 139.27 37.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 178.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.682 ' HG2' ' HD2' ' D' ' 92' ' ' LYS . 88.9 tt0 -127.59 94.75 4.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.032 171.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 91' ' ' ILE . . . . . 0.663 HG13 HG22 ' D' ' 89' ' ' ILE . 27.4 mt -95.68 99.82 9.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.088 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 92' ' ' LYS . . . . . 0.729 ' HE2' ' CE2' ' D' ' 57' ' ' PHE . 0.0 OUTLIER -161.99 169.29 21.34 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.373 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.655 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 3.0 pt20 -79.56 157.54 27.35 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.283 173.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 9.9 pt . . . . . 0 C--N 1.308 -1.236 0 CA-C-N 114.902 -1.044 . . . . 0.0 112.186 -170.559 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' D' D ' 2' ' ' ASN . . . . . . . . . . . . . 6.0 m120 52.78 58.08 5.72 Favored 'General case' 0 N--CA 1.462 0.165 0 O-C-N 123.567 0.542 . . . . 0.0 111.001 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.08 21.93 0.32 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -88.67 -19.56 26.02 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 5' ' ' ALA . . . . . . . . . . . . . . . 59.84 64.55 1.27 Allowed 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.919 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 58.4 tp -110.03 -31.55 7.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.231 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . 0.407 ' HA ' ' SD ' ' D' ' 10' ' ' MET . 87.5 tt0 -66.68 -16.09 63.96 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.44 177.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.678 ' HA ' ' CB ' ' D' ' 12' ' ' SER . 43.7 mm-40 -64.76 -32.7 74.51 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.147 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . 0.549 ' OE1' ' HB2' ' D' ' 8' ' ' GLU . 1.3 mp0 -86.29 5.05 36.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.353 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 10' ' ' MET . . . . . 0.407 ' SD ' ' HA ' ' D' ' 7' ' ' GLU . 66.1 mtt -100.98 -77.45 0.54 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.348 -174.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -103.25 -36.79 7.95 Favored 'General case' 0 CA--C 1.488 -1.415 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.288 172.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 12' ' ' SER . . . . . 0.678 ' CB ' ' HA ' ' D' ' 8' ' ' GLU . 48.1 t -44.22 -70.45 0.1 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 113.994 -1.457 . . . . 0.0 113.235 -164.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.549 ' O ' HG11 ' D' ' 16' ' ' VAL . 57.0 mt -83.45 -8.36 11.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.902 -173.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -88.19 -41.86 12.7 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.095 175.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 15' ' ' SER . . . . . 0.546 ' HA ' ' OD2' ' D' ' 18' ' ' ASP . 88.2 p -72.01 -23.52 61.41 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 122.045 -0.409 . . . . 0.0 109.907 175.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 16' ' ' VAL . . . . . 0.549 HG11 ' O ' ' D' ' 13' ' ' ILE . 0.5 OUTLIER -56.84 -24.05 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 121.515 0.674 . . . . 0.0 109.41 178.927 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -74.65 -43.75 53.81 Favored 'General case' 0 C--O 1.209 -1.071 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.771 176.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 18' ' ' ASP . . . . . 0.546 ' OD2' ' HA ' ' D' ' 15' ' ' SER . 51.4 m-20 -55.3 -16.2 3.19 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -177.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.58 ' HD2' ' N ' ' D' ' 19' ' ' LYS . 0.0 OUTLIER -91.18 -43.16 10.03 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-O 122.306 1.051 . . . . 0.0 108.691 175.533 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 20' ' ' LEU . . . . . 0.916 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 70.7 mt -69.36 -37.74 77.76 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 113.168 -1.833 . . . . 0.0 110.258 -177.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 21' ' ' ASN . . . . . 0.429 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 3.3 m120 -79.7 94.08 5.66 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.705 -178.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 22' ' ' LYS . . . . . 0.579 ' HE3' ' O ' ' D' ' 19' ' ' LYS . 95.8 mttt -122.32 -41.95 2.38 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -176.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 165.87 -84.0 0.1 Allowed Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 119.32 -1.419 . . . . 0.0 113.231 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . 0.804 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 27.2 tptp -44.89 -57.76 3.57 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 25' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -139.86 163.95 26.16 Favored Glycine 0 N--CA 1.431 -1.685 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.967 171.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 26' ' ' LYS . . . . . 0.674 ' HD2' ' HB3' ' D' ' 41' ' ' SER . 0.3 OUTLIER -149.29 159.59 44.14 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.933 -0.634 . . . . 0.0 109.986 -171.743 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 27' ' ' LEU . . . . . 0.916 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 39.8 tp -136.16 134.49 38.29 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.436 0.636 . . . . 0.0 111.806 -178.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 28' ' ' SER . . . . . 0.624 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 26.5 t -121.36 145.96 47.36 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 29' ' ' LEU . . . . . 0.7 HD22 ' HB3' ' D' ' 38' ' ' ALA . 20.9 mt -131.43 134.96 46.75 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.754 -0.779 . . . . 0.0 110.745 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 32.1 t -137.01 -171.04 2.84 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 31' ' ' MET . . . . . 0.496 ' HB2' ' O ' ' D' ' 35' ' ' GLN . 26.3 ptt? -150.08 166.59 29.29 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.81 0.338 . . . . 0.0 110.618 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 32' ' ' ASN . . . . . 0.65 ' O ' ' HB2' ' D' ' 35' ' ' GLN . 25.9 t-20 -141.82 87.28 2.04 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 176.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.48 -113.81 4.82 Favored Glycine 0 CA--C 1.516 0.142 0 C-N-CA 119.898 -1.144 . . . . 0.0 111.121 -172.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -95.7 31.0 2.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.776 0.798 . . . . 0.0 109.92 173.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 35' ' ' GLN . . . . . 0.65 ' HB2' ' O ' ' D' ' 32' ' ' ASN . 52.5 mm-40 -110.24 164.94 12.17 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 114.928 -1.033 . . . . 0.0 112.367 -178.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . 0.544 ' C ' HD12 ' D' ' 36' ' ' LEU . 2.7 tm? -130.72 128.95 41.88 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 175.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 37' ' ' LYS . . . . . 0.413 ' N ' HD12 ' D' ' 36' ' ' LEU . 35.7 mmtp -132.4 100.6 5.04 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.145 0.498 . . . . 0.0 110.842 -176.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 38' ' ' ALA . . . . . 0.7 ' HB3' HD22 ' D' ' 29' ' ' LEU . . . -96.72 149.95 21.24 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.856 -177.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 39' ' ' THR . . . . . 0.624 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 29.8 p -137.32 126.72 24.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.916 174.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 40' ' ' SER . . . . . 0.748 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 60.6 p -109.89 135.73 50.31 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 175.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 41' ' ' SER . . . . . 0.674 ' HB3' ' HD2' ' D' ' 26' ' ' LYS . 43.9 t -104.0 156.42 17.87 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.814 -176.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 42' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' D' ' 41' ' ' SER . 74.0 m-80 78.79 9.34 1.89 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.423 -172.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 43.74 59.02 3.27 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 114.73 -1.123 . . . . 0.0 113.648 170.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 44' ' ' GLY . . . . . 0.546 ' O ' HG21 ' D' ' 71' ' ' THR . . . 110.84 34.96 2.1 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 119.732 -1.223 . . . . 0.0 113.872 172.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 45' ' ' TYR . . . . . 0.804 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 2.8 m-30 -112.89 146.72 38.45 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 170.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . 0.617 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -93.93 -162.97 35.99 Favored Glycine 0 C--O 1.218 -0.876 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 175.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 47' ' ' ILE . . . . . 0.813 HG12 ' HB3' ' D' ' 68' ' ' GLU . 38.5 mm -56.27 -57.1 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.886 0 CA-C-O 122.14 0.971 . . . . 0.0 109.514 174.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -178.97 -123.05 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 112.796 -2.002 . . . . 0.0 108.906 -177.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -114.47 76.79 1.01 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.119 0.485 . . . . 0.0 109.916 169.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . 0.548 ' CB ' ' HD3' ' D' ' 52' ' ' LYS . 51.5 mt-10 -140.16 168.73 19.13 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.53 177.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 51' ' ' ASP . . . . . 0.678 ' HB3' ' HD2' ' D' ' 69' ' ' LYS . 1.6 m-20 -114.69 122.06 45.29 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.763 175.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 52' ' ' LYS . . . . . 0.805 ' HG3' ' HB2' ' D' ' 68' ' ' GLU . 0.0 OUTLIER -131.84 107.44 8.74 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.858 -166.354 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -94.33 129.35 41.04 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.466 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 54' ' ' TRP . . . . . 0.564 ' NE1' ' HB3' ' D' ' 93' ' ' GLN . 0.1 OUTLIER -121.93 153.78 38.03 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -174.827 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -141.06 158.78 26.45 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.153 -1.022 . . . . 0.0 113.607 175.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 56' ' ' ILE . . . . . 0.675 ' HA ' ' O ' ' D' ' 90' ' ' GLU . 62.8 mt -142.97 106.51 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 -178.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 57' ' ' PHE . . . . . 0.52 ' HD2' ' HB2' ' D' ' 90' ' ' GLU . 11.8 m-85 -108.6 106.87 17.13 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.59 -168.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.704 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 49.9 t -95.79 118.36 41.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.63 173.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 58.91 34.34 23.59 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.033 -178.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.91 -32.77 6.88 Favored Glycine 0 CA--C 1.505 -0.537 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.706 174.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 61' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 25.4 pt-20 -90.19 146.91 23.9 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.078 0.466 . . . . 0.0 110.818 -175.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -79.36 101.75 8.29 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 177.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.571 HG11 ' O ' ' D' ' 56' ' ' ILE . 10.5 p -76.87 -30.32 18.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.695 -172.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 64' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -147.16 142.57 27.45 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.757 0.313 . . . . 0.0 110.979 178.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 30.5 m -124.8 125.65 44.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.587 175.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 66' ' ' PHE . . . . . 0.553 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 17.5 p90 -133.83 157.49 45.79 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 121.441 0.639 . . . . 0.0 110.43 173.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 67' ' ' ASN . . . . . 0.562 ' HA ' ' O ' ' D' ' 52' ' ' LYS . 5.2 m120 -116.92 141.61 48.01 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 68' ' ' GLU . . . . . 0.813 ' HB3' HG12 ' D' ' 47' ' ' ILE . 55.6 mm-40 -70.83 -16.75 62.74 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 175.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.678 ' HD2' ' HB3' ' D' ' 51' ' ' ASP . 25.0 mtpp -60.21 -44.31 95.24 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 114.102 -1.408 . . . . 0.0 108.159 169.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 70' ' ' SER . . . . . 0.521 ' HG ' ' CD1' ' D' ' 75' ' ' ILE . 18.8 t -76.1 90.72 3.08 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 113.633 -1.621 . . . . 0.0 107.898 171.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 71' ' ' THR . . . . . 0.546 HG21 ' O ' ' D' ' 44' ' ' GLY . 65.6 p -24.39 120.67 0.05 Allowed 'General case' 0 C--N 1.32 -0.695 0 O-C-N 124.815 1.322 . . . . 0.0 112.811 -175.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 72' ' ' VAL . . . . . 0.878 HG13 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -50.96 -15.3 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 O-C-N 123.356 0.41 . . . . 0.0 111.922 179.615 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 73' ' ' GLY . . . . . 0.748 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -65.3 -66.86 2.25 Favored Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 115.805 -0.634 . . . . 0.0 113.183 171.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -62.07 -27.24 68.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.229 -0.485 . . . . 0.0 110.332 -177.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 75' ' ' ILE . . . . . 0.624 ' O ' HG13 ' D' ' 79' ' ' ILE . 29.9 mm -78.24 -41.48 26.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.217 178.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 76' ' ' SER . . . . . 0.531 ' OG ' ' HB1' ' D' ' 38' ' ' ALA . 29.3 t -72.37 -21.33 61.31 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.449 -178.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -64.89 -34.01 77.38 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 167.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 78' ' ' ASP . . . . . 1.042 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 0.9 OUTLIER -77.89 -31.99 51.57 Favored 'General case' 0 C--O 1.224 -0.272 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 175.005 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . 0.624 HG13 ' O ' ' D' ' 75' ' ' ILE . 60.2 mt -65.49 -21.21 28.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 O-C-N 121.543 -0.723 . . . . 0.0 111.294 -174.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -73.25 -43.48 61.08 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 176.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . 1.042 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -68.79 -44.47 73.53 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.468 177.269 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 82' ' ' LEU . . . . . 0.65 HD21 ' O ' ' D' ' 78' ' ' ASP . 3.8 mm? -55.53 -22.15 20.2 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 177.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 45.57 73.2 0.17 Allowed 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.778 0.674 . . . . 0.0 110.984 175.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 84' ' ' ILE . . . . . 0.546 ' CG2' HD12 ' D' ' 91' ' ' ILE . 35.0 mt -70.71 99.8 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.315 -177.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 85' ' ' LYS . . . . . 0.589 ' HD3' ' O ' ' D' ' 35' ' ' GLN . 30.5 mmmt -139.19 177.87 7.59 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.719 176.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.67 175.89 3.44 Favored Glycine 0 CA--C 1.506 -0.481 0 N-CA-C 115.008 0.763 . . . . 0.0 115.008 -174.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 87' ' ' PRO . . . . . 0.427 ' O ' HG11 ' D' ' 58' ' ' VAL . 33.0 Cg_endo -91.67 175.73 17.48 Favored 'Cis proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.158 -2.017 . . . . 0.0 114.53 0.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 88' ' ' TYR . . . . . 0.704 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 33.4 m-85 31.52 92.47 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.32 1.448 . . . . 0.0 112.614 -179.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 3.1 mp -109.5 143.1 20.28 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.402 -177.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.675 ' O ' ' HA ' ' D' ' 56' ' ' ILE . 37.3 mt-10 -129.24 89.19 2.81 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.385 172.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 91' ' ' ILE . . . . . 0.546 HD12 ' CG2' ' D' ' 84' ' ' ILE . 21.0 mt -94.44 99.8 10.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.912 178.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 92' ' ' LYS . . . . . 0.702 ' HD3' ' O ' ' D' ' 93' ' ' GLN . 0.0 OUTLIER -161.8 169.2 21.81 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.125 -177.434 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.702 ' O ' ' HD3' ' D' ' 92' ' ' LYS . 2.5 pp0? -85.78 147.17 26.44 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.054 170.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . 0.462 HG23 ' HE3' ' D' ' 92' ' ' LYS . 8.9 pt . . . . . 0 C--N 1.304 -1.389 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.979 -169.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.483 1.183 0 CA-C-O 120.476 0.179 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' D' D ' 2' ' ' ASN . . . . . . . . . . . . . 45.4 t30 63.43 88.67 0.1 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.589 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -84.4 -71.04 0.53 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 174.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -110.85 -53.37 2.71 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 170.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 5' ' ' ALA . . . . . 0.703 ' HA ' ' HB2' ' D' ' 8' ' ' GLU . . . 30.16 53.81 0.14 Allowed 'General case' 0 N--CA 1.469 0.49 0 O-C-N 124.683 1.239 . . . . 0.0 113.8 175.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . 0.452 HD23 ' N ' ' D' ' 7' ' ' GLU . 5.8 tt -84.59 -70.6 0.57 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . 0.452 ' N ' HD23 ' D' ' 6' ' ' LEU . 88.5 tt0 -93.03 -10.16 37.18 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 174.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.703 ' HB2' ' HA ' ' D' ' 5' ' ' ALA . 50.4 mt-10 -59.62 -52.55 65.06 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.025 -174.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . 0.409 ' HG3' ' HB2' ' D' ' 5' ' ' ALA . 2.1 pp0? -89.05 14.19 11.24 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.41 176.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 10' ' ' MET . . . . . . . . . . . . . 48.3 ttm -104.3 -77.96 0.57 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.132 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -103.03 -54.61 2.58 Favored 'General case' 0 CA--C 1.492 -1.25 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.907 172.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 12' ' ' SER . . . . . 0.672 ' HB3' ' HA ' ' D' ' 8' ' ' GLU . 42.7 t -25.53 -69.28 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 113.663 -1.608 . . . . 0.0 113.899 -170.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.442 HG22 HD12 ' D' ' 13' ' ' ILE . 55.8 mt -91.69 -8.6 10.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.672 -172.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -95.06 -61.16 1.53 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.678 175.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 15' ' ' SER . . . . . 0.414 ' O ' ' HB2' ' D' ' 18' ' ' ASP . 88.5 p -60.45 -21.78 62.71 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 116.906 -0.134 . . . . 0.0 111.238 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 16' ' ' VAL . . . . . 0.67 ' HA ' ' CE ' ' D' ' 19' ' ' LYS . 9.7 p -54.51 -38.48 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 120.761 0.315 . . . . 0.0 110.647 177.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 17' ' ' ASN . . . . . 0.502 ' ND2' HG12 ' D' ' 16' ' ' VAL . 2.7 m120 -68.61 -35.79 77.81 Favored 'General case' 0 C--O 1.214 -0.793 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.7 178.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 18' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' D' ' 15' ' ' SER . 1.2 m-20 -64.42 -17.29 63.65 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -176.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.67 ' CE ' ' HA ' ' D' ' 16' ' ' VAL . 0.0 OUTLIER -90.78 -44.43 9.45 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-O 122.031 0.919 . . . . 0.0 108.563 173.778 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 20' ' ' LEU . . . . . 1.011 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 75.6 mt -61.76 -39.08 90.36 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 113.515 -1.675 . . . . 0.0 109.937 -178.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 21' ' ' ASN . . . . . 0.42 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 3.2 m120 -77.99 97.21 5.28 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.558 178.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 22' ' ' LYS . . . . . 0.817 ' HD2' HD13 ' D' ' 47' ' ' ILE . 67.5 mttm -123.12 -43.37 2.22 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -177.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.4 -96.22 0.1 Allowed Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 119.403 -1.379 . . . . 0.0 113.721 -176.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . 0.845 ' HE2' ' HA ' ' D' ' 48' ' ' SER . 35.0 ttpt -53.81 -47.36 70.92 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.737 0.78 . . . . 0.0 109.404 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 25' ' ' GLY . . . . . 0.507 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -135.96 153.71 21.55 Favored Glycine 0 N--CA 1.431 -1.642 0 CA-C-N 114.232 -1.349 . . . . 0.0 112.006 176.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 26' ' ' LYS . . . . . 0.708 ' CD ' ' HB2' ' D' ' 41' ' ' SER . 0.1 OUTLIER -150.44 160.48 43.73 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.05 -1.075 . . . . 0.0 110.213 -170.192 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 27' ' ' LEU . . . . . 1.011 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 41.8 tp -135.43 130.1 34.28 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.302 0.572 . . . . 0.0 112.023 -177.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 28' ' ' SER . . . . . 0.524 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 8.1 t -117.46 125.16 50.44 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 29' ' ' LEU . . . . . 0.569 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 1.0 OUTLIER -141.14 148.48 40.12 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 176.584 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 62.5 p -157.8 179.07 9.56 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.205 -179.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 31' ' ' MET . . . . . 0.416 ' SD ' ' N ' ' D' ' 31' ' ' MET . 0.0 OUTLIER -117.95 166.17 12.83 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.396 0.617 . . . . 0.0 110.608 179.795 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 32' ' ' ASN . . . . . 0.638 ' HB3' ' HB2' ' D' ' 35' ' ' GLN . 26.1 t-20 -144.16 87.13 1.87 Allowed 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 176.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.74 -98.65 0.7 Allowed Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.187 -1.006 . . . . 0.0 111.281 -171.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 34' ' ' ASN . . . . . 0.406 ' O ' ' HG2' ' D' ' 85' ' ' LYS . 4.8 m120 -110.66 10.36 22.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.029 0.442 . . . . 0.0 110.395 175.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 35' ' ' GLN . . . . . 0.638 ' HB2' ' HB3' ' D' ' 32' ' ' ASN . 3.8 mm100 -91.35 165.28 13.5 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 121.533 0.682 . . . . 0.0 112.222 -177.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . 0.512 HD13 ' C ' ' D' ' 36' ' ' LEU . 1.8 tm? -132.82 135.03 45.41 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.693 172.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 37' ' ' LYS . . . . . 0.569 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 34.9 mmtp -132.1 106.36 7.95 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.698 -171.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 38' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -118.52 148.46 42.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.857 0.361 . . . . 0.0 111.911 -177.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 39' ' ' THR . . . . . 0.524 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 57.2 p -145.43 148.5 33.37 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.265 178.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 40' ' ' SER . . . . . 0.553 ' HA ' ' O ' ' D' ' 26' ' ' LYS . 41.9 p -109.28 131.87 54.66 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 168.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 41' ' ' SER . . . . . 0.708 ' HB2' ' CD ' ' D' ' 26' ' ' LYS . 43.7 m -94.44 147.76 22.91 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 118.915 -1.114 . . . . 0.0 108.882 177.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 42' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' D' ' 41' ' ' SER . 75.1 m-80 80.67 2.5 1.79 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.942 -165.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.19 62.08 2.13 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 168.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 44' ' ' GLY . . . . . 0.504 ' O ' ' HB ' ' D' ' 71' ' ' THR . . . 119.19 -6.48 13.05 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 118.405 -1.855 . . . . 0.0 115.072 168.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 45' ' ' TYR . . . . . 0.734 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 1.3 m-85 -86.17 155.84 20.58 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.98 0.39 . . . . 0.0 111.784 -174.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . 0.635 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -94.84 178.95 36.63 Favored Glycine 0 C--O 1.222 -0.654 0 CA-C-O 118.812 -0.993 . . . . 0.0 110.642 174.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 47' ' ' ILE . . . . . 0.817 HD13 ' HD2' ' D' ' 22' ' ' LYS . 33.4 mm -47.65 -57.22 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 CA-C-N 118.109 0.955 . . . . 0.0 110.652 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.845 ' HA ' ' HE2' ' D' ' 24' ' ' LYS . 22.1 t 178.83 -135.24 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.02 -1.446 . . . . 0.0 107.923 -178.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -95.03 76.93 3.53 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 165.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . 0.833 ' HB3' ' HE3' ' D' ' 52' ' ' LYS . 50.6 mt-10 -144.58 164.63 30.36 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.95 -173.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 51' ' ' ASP . . . . . 0.69 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 10.7 p-10 -132.61 135.49 45.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.231 0.539 . . . . 0.0 111.337 177.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 52' ' ' LYS . . . . . 0.833 ' HE3' ' HB3' ' D' ' 50' ' ' GLU . 0.2 OUTLIER -146.97 142.35 27.44 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.392 -174.261 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 53' ' ' ASN . . . . . 0.459 HD21 ' C ' ' D' ' 52' ' ' LYS . 3.3 m120 -118.25 135.99 53.94 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 172.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 54' ' ' TRP . . . . . 0.635 ' HZ3' ' CG2' ' D' ' 91' ' ' ILE . 0.9 OUTLIER -126.29 162.49 25.35 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -170.89 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -148.69 163.46 29.03 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.204 174.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 56' ' ' ILE . . . . . 0.624 HG12 ' CG2' ' D' ' 91' ' ' ILE . 93.6 mt -135.97 108.99 8.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 C-N-CA 124.853 1.261 . . . . 0.0 107.689 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 57' ' ' PHE . . . . . 0.719 ' CE1' ' HE2' ' D' ' 92' ' ' LYS . 14.6 m-85 -107.63 101.55 10.86 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.898 -168.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.806 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 84.0 t -83.24 106.48 13.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.927 171.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 64.4 45.24 3.84 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.51 0.506 . . . . 0.0 110.692 -177.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.76 41.94 99.68 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.313 -178.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 61' ' ' GLU . . . . . 0.512 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 42.8 tt0 -142.97 112.64 6.9 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.264 -0.468 . . . . 0.0 110.059 178.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . 0.524 ' HB2' ' CE2' ' D' ' 57' ' ' PHE . 37.8 ttpt -70.36 105.65 3.1 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.446 -177.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 27.6 m -89.14 -24.48 5.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.708 -175.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 64' ' ' TYR . . . . . 0.463 ' HH ' ' CB ' ' D' ' 78' ' ' ASP . 16.4 t80 -141.36 135.45 30.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.766 0.317 . . . . 0.0 111.035 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 79.6 m -117.66 118.89 33.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.308 175.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 66' ' ' PHE . . . . . 0.456 ' CZ ' ' CE3' ' D' ' 54' ' ' TRP . 9.4 p90 -125.61 159.36 32.35 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 174.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 67' ' ' ASN . . . . . 0.711 ' ND2' ' HB2' ' D' ' 69' ' ' LYS . 16.0 p-10 -130.2 136.1 48.87 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -174.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 68' ' ' GLU . . . . . 0.754 ' HB3' HG12 ' D' ' 47' ' ' ILE . 51.9 mm-40 -68.31 -8.37 39.12 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.368 -175.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.711 ' HB2' ' ND2' ' D' ' 67' ' ' ASN . 6.0 mtpm? -64.74 -44.4 90.24 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 169.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 70' ' ' SER . . . . . 0.469 ' HB3' ' O ' ' D' ' 67' ' ' ASN . 35.0 t -64.61 125.43 24.71 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 113.32 -1.763 . . . . 0.0 107.847 168.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 71' ' ' THR . . . . . 0.504 ' HB ' ' O ' ' D' ' 44' ' ' GLY . 72.3 p -56.03 126.57 26.5 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 72' ' ' VAL . . . . . 0.819 HG13 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -57.56 -11.47 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-O 121.04 0.448 . . . . 0.0 111.341 -176.292 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 73' ' ' GLY . . . . . 0.455 ' HA3' ' HA2' ' D' ' 44' ' ' GLY . . . -73.49 -57.34 5.09 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.568 170.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -63.84 -23.84 67.51 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 177.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 75' ' ' ILE . . . . . 0.642 ' O ' HG13 ' D' ' 79' ' ' ILE . 72.0 mt -71.33 -44.8 72.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.216 174.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 76' ' ' SER . . . . . 0.493 ' HA ' HG13 ' D' ' 79' ' ' ILE . 31.8 t -71.55 -25.89 62.41 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 121.116 -0.233 . . . . 0.0 111.037 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -60.71 -26.36 67.1 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 169.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 78' ' ' ASP . . . . . 0.99 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 80.7 m-20 -86.3 -37.54 18.42 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.196 174.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . 0.642 HG13 ' O ' ' D' ' 75' ' ' ILE . 24.2 mt -64.85 -27.96 43.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 O-C-N 121.897 -0.502 . . . . 0.0 110.803 -175.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -69.11 -29.49 67.57 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.293 178.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . 0.99 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -85.04 -49.45 8.28 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 119.677 -0.809 . . . . 0.0 111.323 175.116 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 82' ' ' LEU . . . . . 0.632 HD22 ' O ' ' D' ' 78' ' ' ASP . 4.1 mm? -50.43 -26.57 5.18 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 52.89 66.91 1.09 Allowed 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.617 0.573 . . . . 0.0 110.153 178.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 84' ' ' ILE . . . . . 0.492 HG22 HG22 ' D' ' 56' ' ' ILE . 50.3 mm -73.66 99.94 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.601 -175.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 85' ' ' LYS . . . . . 0.543 ' C ' ' HE3' ' D' ' 85' ' ' LYS . 0.0 OUTLIER -142.39 -171.57 3.43 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 179.7 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . -61.22 168.12 11.54 Favored Glycine 0 CA--C 1.507 -0.45 0 CA-C-N 115.316 -0.856 . . . . 0.0 114.543 -174.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 87' ' ' PRO . . . . . 0.641 ' O ' HG12 ' D' ' 58' ' ' VAL . 45.2 Cg_endo -91.38 178.4 14.33 Favored 'Cis proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.868 -1.722 . . . . 0.0 114.171 0.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 88' ' ' TYR . . . . . 0.806 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 1.4 m-85 36.67 91.39 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 O-C-N 124.483 1.115 . . . . 0.0 112.435 178.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.58 HG21 HG13 ' D' ' 91' ' ' ILE . 3.5 mp -111.09 121.88 64.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.507 0.67 . . . . 0.0 111.03 -176.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.643 ' HB2' ' HB2' ' D' ' 57' ' ' PHE . 54.3 mt-10 -124.15 88.99 3.0 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.916 177.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 91' ' ' ILE . . . . . 0.635 ' CG2' ' HZ3' ' D' ' 54' ' ' TRP . 4.1 mt -100.06 111.05 28.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 92' ' ' LYS . . . . . 0.719 ' HE2' ' CE1' ' D' ' 57' ' ' PHE . 0.0 OUTLIER -162.57 172.47 15.37 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.642 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 17.2 pt20 -81.33 158.45 24.72 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.807 173.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 7.6 pt . . . . . 0 C--N 1.305 -1.364 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.631 -172.394 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 53.3 p30 . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 120.906 0.384 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' D' D ' 2' ' ' ASN . . . . . 0.434 ' HB3' ' HD2' ' D' ' 4' ' ' LYS . 4.5 m120 -107.9 128.76 54.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.953 -179.424 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -87.55 9.26 21.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.474 179.137 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' D' D ' 4' ' ' LYS . . . . . 0.584 ' H ' ' HD2' ' D' ' 4' ' ' LYS . 0.0 OUTLIER -108.78 15.6 23.46 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 172.485 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' D' D ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.23 133.94 55.1 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.89 -179.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . 0.453 ' N ' HD21 ' D' ' 6' ' ' LEU . 2.5 mm? -83.46 -0.13 48.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.306 -177.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . 0.682 ' HA ' ' HB2' ' D' ' 10' ' ' MET . 94.5 mt-10 -75.73 -0.83 22.23 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -176.53 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.478 ' O ' ' HB3' ' D' ' 12' ' ' SER . 10.4 pt-20 -53.57 -51.2 63.73 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -172.34 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -97.19 13.96 27.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.886 0.374 . . . . 0.0 110.667 174.17 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' D' D ' 10' ' ' MET . . . . . 0.682 ' HB2' ' HA ' ' D' ' 7' ' ' GLU . 24.3 mmt -106.03 -72.35 0.72 Allowed 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.264 -174.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -103.54 -45.08 4.94 Favored 'General case' 0 CA--C 1.495 -1.15 0 CA-C-O 120.94 0.4 . . . . 0.0 110.742 174.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' D' D ' 12' ' ' SER . . . . . 0.639 ' O ' ' HB ' ' D' ' 16' ' ' VAL . 41.3 t -35.29 -71.71 0.06 Allowed 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 113.722 -1.581 . . . . 0.0 112.872 -168.266 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.519 ' O ' HG11 ' D' ' 16' ' ' VAL . 48.4 mt -93.18 -9.45 9.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.649 -177.558 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 14' ' ' ASN . . . . . 0.591 ' HB2' ' O ' ' D' ' 10' ' ' MET . 5.2 m120 -93.87 -57.07 2.66 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.604 -176.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 15' ' ' SER . . . . . 0.662 ' HA ' ' OD2' ' D' ' 18' ' ' ASP . 97.5 p -69.65 -16.16 63.32 Favored 'General case' 0 C--O 1.218 -0.59 0 C-N-CA 120.156 -0.618 . . . . 0.0 110.199 175.23 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 16' ' ' VAL . . . . . 0.639 ' HB ' ' O ' ' D' ' 12' ' ' SER . 1.5 p -56.08 -23.9 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 121.974 0.892 . . . . 0.0 109.138 174.336 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 17' ' ' ASN . . . . . 0.617 ' HB3' ' ND2' ' D' ' 21' ' ' ASN . 5.4 m120 -84.71 -32.38 23.57 Favored 'General case' 0 C--O 1.206 -1.232 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.204 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 18' ' ' ASP . . . . . 0.662 ' OD2' ' HA ' ' D' ' 15' ' ' SER . 63.0 m-20 -61.61 -14.91 34.66 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 177.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.866 ' N ' ' HE2' ' D' ' 19' ' ' LYS . 0.3 OUTLIER -86.4 -48.54 8.36 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 174.334 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' D' D ' 20' ' ' LEU . . . . . 0.968 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 71.9 mt -64.92 -40.79 95.6 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 112.299 -2.228 . . . . 0.0 110.497 -176.122 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 21' ' ' ASN . . . . . 0.706 ' OD1' ' HB2' ' D' ' 26' ' ' LYS . 75.1 m-20 -85.33 97.74 10.14 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.434 -179.598 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 22' ' ' LYS . . . . . 0.609 ' NZ ' ' HB3' ' D' ' 22' ' ' LYS . 7.5 mtpm? -123.03 -41.67 2.32 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 118.767 -1.173 . . . . 0.0 114.125 -178.018 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 173.38 -82.52 0.08 OUTLIER Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 119.901 -1.143 . . . . 0.0 112.527 -177.473 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . 0.857 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 27.2 tptp -48.18 -60.94 2.26 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.675 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -134.73 160.14 24.15 Favored Glycine 0 N--CA 1.433 -1.542 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.451 174.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' D' D ' 26' ' ' LYS . . . . . 0.706 ' HB2' ' OD1' ' D' ' 21' ' ' ASN . 0.1 OUTLIER -149.63 159.74 44.08 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.57 -0.815 . . . . 0.0 111.099 -168.611 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' D' D ' 27' ' ' LEU . . . . . 0.968 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 44.9 tp -143.73 139.15 29.3 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.96 0.409 . . . . 0.0 111.942 -178.621 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 28' ' ' SER . . . . . 0.564 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 8.7 t -127.7 153.77 46.11 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 174.834 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 29' ' ' LEU . . . . . 0.555 HD21 ' HB2' ' D' ' 38' ' ' ALA . 18.4 mt -133.96 140.52 46.8 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.886 178.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 49.8 m -152.44 -176.28 5.64 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.731 178.065 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' D' D ' 31' ' ' MET . . . . . 0.461 ' HE2' ' HB2' ' D' ' 31' ' ' MET . 66.8 mtm -136.24 166.39 23.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.056 0.455 . . . . 0.0 110.546 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 32' ' ' ASN . . . . . 0.535 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 24.4 t-20 -146.06 88.38 1.81 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.39 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.15 -105.32 1.81 Allowed Glycine 0 N--CA 1.454 -0.144 0 C-N-CA 119.998 -1.096 . . . . 0.0 110.749 -170.344 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -114.16 29.89 7.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.177 0.513 . . . . 0.0 109.952 171.462 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' D' D ' 35' ' ' GLN . . . . . 0.535 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 65.0 tp60 -102.31 155.75 18.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.241 -178.146 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . 0.631 HD11 ' C ' ' D' ' 36' ' ' LEU . 2.5 tm? -113.43 129.16 56.61 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 175.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 37' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -136.14 99.01 4.01 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.967 -169.393 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' D' D ' 38' ' ' ALA . . . . . 0.555 ' HB2' HD21 ' D' ' 29' ' ' LEU . . . -98.21 150.76 21.16 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.017 176.115 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 39' ' ' THR . . . . . 0.564 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 74.4 p -133.67 123.01 24.26 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 174.394 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 40' ' ' SER . . . . . 0.56 ' HA ' ' O ' ' D' ' 26' ' ' LYS . 18.7 m -115.7 128.89 56.23 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.233 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 41' ' ' SER . . . . . 0.608 ' HB2' ' CD ' ' D' ' 26' ' ' LYS . 31.9 m -104.87 162.05 13.66 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.42 -173.066 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 42' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' D' ' 41' ' ' SER . 74.7 m-80 77.35 9.9 2.51 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 114.197 -1.365 . . . . 0.0 110.52 -171.68 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 49.04 60.5 3.7 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 114.799 -1.092 . . . . 0.0 113.753 169.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' D' D ' 44' ' ' GLY . . . . . 0.48 ' O ' HG22 ' D' ' 71' ' ' THR . . . 106.72 37.11 2.45 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 119.216 -1.469 . . . . 0.0 114.043 171.193 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 45' ' ' TYR . . . . . 0.857 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 3.9 m-30 -114.59 153.33 30.31 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 117.376 0.588 . . . . 0.0 110.037 176.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -97.82 -155.77 29.9 Favored Glycine 0 C--O 1.217 -0.909 0 CA-C-O 119.459 -0.634 . . . . 0.0 111.598 178.014 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 47' ' ' ILE . . . . . 0.954 HG13 ' HB3' ' D' ' 68' ' ' GLU . 0.4 OUTLIER -54.62 -56.53 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-O 122.118 0.961 . . . . 0.0 108.659 -179.994 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.461 ' HB2' ' O ' ' D' ' 47' ' ' ILE . 26.3 t 162.33 -60.3 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 111.922 -2.399 . . . . 0.0 106.909 -174.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -169.89 76.27 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.546 172.683 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . 0.65 ' O ' ' HG2' ' D' ' 69' ' ' LYS . 49.0 mt-10 -149.27 -177.94 6.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.881 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 51' ' ' ASP . . . . . 0.589 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 1.0 OUTLIER -129.07 130.15 46.17 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.457 0.646 . . . . 0.0 111.316 172.553 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' D' D ' 52' ' ' LYS . . . . . 0.589 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 0.4 OUTLIER -141.77 100.92 3.85 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.861 -179.833 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' D' D ' 53' ' ' ASN . . . . . 0.599 ' HA ' ' OD1' ' D' ' 67' ' ' ASN . 2.7 m120 -78.16 125.7 29.74 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 176.396 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 54' ' ' TRP . . . . . 0.56 ' HB2' ' O ' ' D' ' 66' ' ' PHE . 0.1 OUTLIER -118.21 155.86 29.78 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.385 -171.948 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -148.13 161.79 28.66 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 119.833 -1.175 . . . . 0.0 114.297 175.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' D' D ' 56' ' ' ILE . . . . . . . . . . . . . 71.9 mt -135.09 111.25 13.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' D' D ' 57' ' ' PHE . . . . . 0.615 ' HA ' ' O ' ' D' ' 61' ' ' GLU . 9.2 m-85 -111.83 114.16 26.95 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.654 -166.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.652 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 59.6 t -96.28 105.92 17.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.903 174.661 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 7.0 m120 56.42 51.74 10.99 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.155 -176.374 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.04 48.08 68.4 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.823 178.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' D' D ' 61' ' ' GLU . . . . . 0.615 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 86.9 tt0 -150.29 116.87 5.79 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 177.631 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . 0.456 ' HB2' ' CE1' ' D' ' 57' ' ' PHE . 27.3 ttpp -75.86 99.91 4.63 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.971 0.415 . . . . 0.0 110.282 179.086 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 30.3 m -84.96 -27.2 6.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.051 -175.205 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' D' D ' 64' ' ' TYR . . . . . 0.478 ' HH ' ' CB ' ' D' ' 78' ' ' ASP . 14.4 t80 -136.75 131.46 33.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.736 0.303 . . . . 0.0 110.373 178.367 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 19.4 m -117.98 104.6 11.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.94 177.816 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' D' D ' 66' ' ' PHE . . . . . 0.56 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 12.2 p90 -114.64 164.68 13.69 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 175.515 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 67' ' ' ASN . . . . . 0.599 ' OD1' ' HA ' ' D' ' 53' ' ' ASN . 74.8 m-20 -130.88 152.0 50.68 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.289 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 68' ' ' GLU . . . . . 0.954 ' HB3' HG13 ' D' ' 47' ' ' ILE . 84.0 mt-10 -68.78 -18.94 64.28 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.689 -0.804 . . . . 0.0 109.774 174.257 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.65 ' HG2' ' O ' ' D' ' 50' ' ' GLU . 45.4 mtmt -61.38 -42.46 98.75 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 172.61 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 70' ' ' SER . . . . . 0.423 ' O ' HD13 ' D' ' 75' ' ' ILE . 27.7 t -67.87 125.41 26.19 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 113.669 -1.605 . . . . 0.0 107.405 170.503 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 71' ' ' THR . . . . . 0.48 HG22 ' O ' ' D' ' 44' ' ' GLY . 76.6 p -58.19 116.33 3.5 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -176.539 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 72' ' ' VAL . . . . . 0.61 HG11 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -51.41 -20.56 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-O 120.674 0.273 . . . . 0.0 111.472 -173.654 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' D' D ' 73' ' ' GLY . . . . . 0.497 ' HA2' ' HB2' ' D' ' 40' ' ' SER . . . -63.39 -59.91 8.22 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.709 -0.678 . . . . 0.0 113.081 172.422 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 74' ' ' ASN . . . . . 0.772 ' HA ' HD21 ' D' ' 77' ' ' ASN . 4.3 m120 -66.61 -18.75 65.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.444 0.164 . . . . 0.0 110.902 178.62 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 75' ' ' ILE . . . . . 0.682 ' O ' HG13 ' D' ' 79' ' ' ILE . 77.7 mt -71.6 -42.39 71.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.021 173.752 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 76' ' ' SER . . . . . 0.475 ' HA ' HG13 ' D' ' 79' ' ' ILE . 47.1 t -74.1 -22.68 59.39 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.008 -177.439 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 77' ' ' ASN . . . . . 0.772 HD21 ' HA ' ' D' ' 74' ' ' ASN . 78.0 m-20 -63.93 -27.29 69.05 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 168.32 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 78' ' ' ASP . . . . . 1.014 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 51.6 m-20 -83.6 -36.14 24.13 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.943 173.187 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . 0.682 HG13 ' O ' ' D' ' 75' ' ' ILE . 22.2 mt -67.05 -16.04 20.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.266 -175.6 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -69.85 -48.83 57.37 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.108 174.127 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . 1.014 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -69.39 -47.82 63.03 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.645 178.427 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' D' D ' 82' ' ' LEU . . . . . 0.598 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.5 mm? -54.26 -23.97 16.98 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 178.195 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 83' ' ' ASN . . . . . 0.459 ' O ' ' HE2' ' D' ' 85' ' ' LYS . 0.7 OUTLIER 39.25 69.29 0.29 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.916 0.886 . . . . 0.0 111.159 176.008 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' D' D ' 84' ' ' ILE . . . . . 0.526 HG21 HD11 ' D' ' 91' ' ' ILE . 47.8 mm -75.17 99.28 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.166 -172.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 85' ' ' LYS . . . . . 0.559 ' O ' ' HE3' ' D' ' 85' ' ' LYS . 0.0 OUTLIER -158.19 91.44 1.1 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 173.972 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' D' D ' 86' ' ' GLY . . . . . 0.639 ' N ' HD11 ' D' ' 89' ' ' ILE . . . 69.63 154.51 0.97 Allowed Glycine 0 C--N 1.329 0.175 0 CA-C-N 115.127 -0.942 . . . . 0.0 114.106 173.163 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 87' ' ' PRO . . . . . 0.573 ' O ' HG12 ' D' ' 58' ' ' VAL . 68.8 Cg_endo -87.33 178.96 19.74 Favored 'Cis proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.681 -1.8 . . . . 0.0 112.09 -0.301 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 88' ' ' TYR . . . . . 0.652 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 2.3 m-85 4.67 91.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 125.253 1.421 . . . . 0.0 113.942 -175.45 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.639 HD11 ' N ' ' D' ' 86' ' ' GLY . 66.2 mt -111.38 129.19 67.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.999 -179.803 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.536 ' O ' ' HD2' ' D' ' 57' ' ' PHE . 49.2 mm-40 -112.33 100.36 8.73 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.879 175.266 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 91' ' ' ILE . . . . . 0.562 HG13 HG21 ' D' ' 89' ' ' ILE . 35.0 mt -94.38 101.19 12.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.05 -178.744 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 92' ' ' LYS . . . . . 0.774 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -160.5 163.64 32.73 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.107 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.601 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 19.7 pt20 -79.53 167.4 20.81 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 119.764 -0.774 . . . . 0.0 110.807 176.818 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . 0.774 HG22 ' HE2' ' D' ' 92' ' ' LYS . 10.9 pt . . . . . 0 C--N 1.313 -1.006 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.572 -170.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 58.6 t0 . . . . . 0 N--CA 1.483 1.178 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' D' D ' 2' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.02 120.49 20.63 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.545 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -64.5 -25.12 67.85 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -175.472 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -111.18 22.36 15.31 Favored 'General case' 0 CA--C 1.518 -0.27 0 O-C-N 122.189 -0.32 . . . . 0.0 111.32 179.123 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' D' D ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.01 -34.1 71.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.914 0.387 . . . . 0.0 111.545 -177.145 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 88.4 mt -104.76 -22.72 13.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.555 -178.527 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -90.16 -0.72 57.75 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -177.35 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.566 ' O ' ' HB3' ' D' ' 12' ' ' SER . 10.4 pt-20 -58.3 -50.51 73.34 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -174.843 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . 0.441 ' NE2' ' HG2' ' D' ' 10' ' ' MET . 1.9 pp0? -93.06 15.03 16.06 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.841 0.353 . . . . 0.0 111.526 177.196 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 10' ' ' MET . . . . . 0.441 ' HG2' ' NE2' ' D' ' 9' ' ' GLN . 95.2 mmm -103.16 -77.12 0.57 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.097 179.698 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -104.6 -38.05 6.89 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.159 173.601 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' D' D ' 12' ' ' SER . . . . . 0.687 ' O ' ' HB ' ' D' ' 16' ' ' VAL . 42.8 t -40.06 -68.29 0.18 Allowed 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.329 -1.305 . . . . 0.0 112.741 -166.618 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.597 ' O ' HG12 ' D' ' 16' ' ' VAL . 51.6 mt -90.84 -8.62 10.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.544 -175.547 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -85.25 -59.19 2.4 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.291 176.137 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' D' D ' 15' ' ' SER . . . . . 0.506 ' O ' ' HE2' ' D' ' 19' ' ' LYS . 88.7 p -68.22 -13.88 62.57 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 175.603 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 16' ' ' VAL . . . . . 0.687 ' HB ' ' O ' ' D' ' 12' ' ' SER . 0.9 OUTLIER -62.18 -25.68 38.18 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.92 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' D' D ' 17' ' ' ASN . . . . . 0.431 ' ND2' ' H ' ' D' ' 29' ' ' LEU . 2.2 m120 -73.56 -42.24 61.9 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 114.383 -1.281 . . . . 0.0 108.592 177.122 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -59.25 -14.85 12.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.864 -178.387 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.506 ' HE2' ' O ' ' D' ' 15' ' ' SER . 34.9 mttm -91.1 -45.77 8.5 Favored 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 123.198 1.475 . . . . 0.0 108.803 -179.743 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 20' ' ' LEU . . . . . 0.831 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 59.1 mt -66.53 -36.53 82.92 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 111.986 -2.37 . . . . 0.0 109.795 -179.87 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 21' ' ' ASN . . . . . 0.631 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 3.0 m120 -74.91 94.4 2.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.399 178.837 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 22' ' ' LYS . . . . . 0.422 ' HD2' HD12 ' D' ' 47' ' ' ILE . 43.3 mttp -122.46 -43.29 2.3 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -176.681 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 171.68 -87.98 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 119.125 -1.512 . . . . 0.0 113.63 -177.13 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . 0.616 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 0.0 OUTLIER -48.02 -53.42 16.35 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.943 0.877 . . . . 0.0 109.172 179.166 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' D' D ' 25' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -149.32 156.11 26.64 Favored Glycine 0 N--CA 1.43 -1.761 0 CA-C-N 113.928 -1.487 . . . . 0.0 110.918 177.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 26' ' ' LYS . . . . . 0.719 ' HD2' ' HB3' ' D' ' 41' ' ' SER . 8.7 ptpt -151.15 160.4 43.88 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 114.331 -0.934 . . . . 0.0 110.52 -167.128 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 27' ' ' LEU . . . . . 1.101 ' HB2' HG13 ' D' ' 72' ' ' VAL . 49.7 tp -134.61 147.35 50.19 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.402 0.62 . . . . 0.0 111.937 -176.645 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 28' ' ' SER . . . . . 0.579 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 33.5 t -132.5 128.65 37.8 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.437 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 29' ' ' LEU . . . . . 0.549 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 9.3 mt -126.94 144.9 50.87 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.796 177.74 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 73.1 p -160.32 176.89 11.18 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.977 177.7 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' D' D ' 31' ' ' MET . . . . . 0.509 ' HA ' ' O ' ' D' ' 35' ' ' GLN . 0.0 OUTLIER -129.65 116.89 19.5 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.377 0.608 . . . . 0.0 110.417 177.076 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -90.36 89.36 7.58 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.395 -0.821 . . . . 0.0 108.97 179.329 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.68 -103.31 2.07 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.275 -0.964 . . . . 0.0 111.064 -171.083 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -120.4 31.14 6.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.381 0.61 . . . . 0.0 109.883 174.674 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' D' D ' 35' ' ' GLN . . . . . 0.509 ' O ' ' HA ' ' D' ' 31' ' ' MET . 8.1 tt0 -108.36 158.69 17.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.308 -174.674 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . 0.635 ' HB3' HD21 ' D' ' 83' ' ' ASN . 2.5 tm? -112.77 126.96 55.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.668 0.271 . . . . 0.0 110.346 178.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 37' ' ' LYS . . . . . 0.644 ' HZ3' ' HB3' ' D' ' 37' ' ' LYS . 1.6 mmmp? -132.58 115.7 15.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.973 -168.113 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 38' ' ' ALA . . . . . 0.499 ' HB1' ' CD2' ' D' ' 29' ' ' LEU . . . -119.91 142.54 48.62 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.925 174.617 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 39' ' ' THR . . . . . 0.579 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 15.1 p -145.76 132.46 19.96 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.057 177.73 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 40' ' ' SER . . . . . 0.803 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 78.8 p -112.28 145.38 40.08 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.326 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 41' ' ' SER . . . . . 0.719 ' HB3' ' HD2' ' D' ' 26' ' ' LYS . 44.3 t -104.39 149.8 25.08 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 118.949 -1.101 . . . . 0.0 109.821 177.176 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 42' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' D' ' 41' ' ' SER . 75.2 m-80 80.31 1.42 1.96 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.891 -171.731 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 44.58 57.76 4.27 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 170.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.91 35.77 0.71 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 119.419 -1.372 . . . . 0.0 113.857 173.313 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' D' D ' 45' ' ' TYR . . . . . 0.616 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 18.2 m-85 -126.31 148.37 49.55 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 172.1 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . 0.488 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -88.2 -168.94 44.74 Favored Glycine 0 CA--C 1.497 -1.062 0 N-CA-C 110.579 -1.009 . . . . 0.0 110.579 175.782 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 47' ' ' ILE . . . . . 0.796 HG12 ' HB3' ' D' ' 68' ' ' GLU . 50.4 mm -45.41 -56.71 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 CA-C-O 121.53 0.681 . . . . 0.0 110.001 178.714 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.405 ' HA ' ' CB ' ' D' ' 24' ' ' LYS . 40.8 t 173.41 -103.18 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 112.552 -2.113 . . . . 0.0 109.258 173.868 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -119.54 74.55 1.01 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.223 0.535 . . . . 0.0 111.705 175.129 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . 0.494 ' HA ' ' OE1' ' D' ' 50' ' ' GLU . 3.7 mm-40 -155.74 -170.35 3.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.946 173.12 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 51' ' ' ASP . . . . . 0.622 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 1.8 m-20 -133.45 138.98 46.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.928 175.458 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 52' ' ' LYS . . . . . 0.622 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 0.1 OUTLIER -144.24 144.12 31.36 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 177.926 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -114.6 142.77 46.01 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 176.672 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' D' D ' 54' ' ' TRP . . . . . 0.598 ' NE1' ' HB3' ' D' ' 93' ' ' GLN . 0.7 OUTLIER -126.71 153.84 44.92 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -173.919 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -142.31 159.76 27.16 Favored Glycine 0 N--CA 1.44 -1.091 0 CA-C-N 114.832 -1.076 . . . . 0.0 113.266 174.074 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' D' D ' 56' ' ' ILE . . . . . 0.461 ' HA ' ' O ' ' D' ' 90' ' ' GLU . 72.3 mt -137.85 105.78 3.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 179.461 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 57' ' ' PHE . . . . . 0.512 ' HA ' ' O ' ' D' ' 61' ' ' GLU . 8.9 m-85 -106.47 109.87 21.91 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.676 -0.809 . . . . 0.0 111.353 -170.032 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.577 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 94.7 t -88.69 110.6 21.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.957 173.837 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 59' ' ' ASN . . . . . 0.423 ' OD1' ' HG2' ' D' ' 87' ' ' PRO . 6.0 m120 53.39 53.83 11.09 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.191 -176.926 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.9 48.71 78.62 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.941 178.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' D' D ' 61' ' ' GLU . . . . . 0.512 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 89.1 tt0 -156.73 116.43 3.5 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.686 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . 0.496 ' HB2' ' CE2' ' D' ' 57' ' ' PHE . 5.5 ttpm? -73.67 101.46 3.65 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -177.864 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 32.5 m -85.74 -25.53 6.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.998 -175.508 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' D' D ' 64' ' ' TYR . . . . . 0.471 ' HH ' ' HB3' ' D' ' 78' ' ' ASP . 15.1 t80 -140.28 137.94 34.59 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.222 178.822 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.474 ' OG1' ' HE2' ' D' ' 62' ' ' LYS . 38.5 m -120.13 119.03 32.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.102 174.531 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 66' ' ' PHE . . . . . 0.584 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 9.3 p90 -126.75 158.91 35.28 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 170.843 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -128.51 142.24 51.14 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.505 -173.21 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' D' D ' 68' ' ' GLU . . . . . 0.796 ' HB3' HG12 ' D' ' 47' ' ' ILE . 5.0 mm-40 -67.14 -10.32 48.97 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 174.586 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.569 ' HE3' ' OD2' ' D' ' 51' ' ' ASP . 48.2 mtpt -63.19 -47.44 82.57 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 114.196 -1.365 . . . . 0.0 107.597 169.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 70' ' ' SER . . . . . 0.468 ' O ' HD12 ' D' ' 75' ' ' ILE . 23.3 t -67.3 138.04 56.54 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 113.505 -1.68 . . . . 0.0 107.961 170.249 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 71' ' ' THR . . . . . 0.46 ' O ' HG13 ' D' ' 75' ' ' ILE . 79.4 p -62.51 122.33 15.5 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.294 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 72' ' ' VAL . . . . . 1.101 HG13 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -56.57 -12.93 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 120.966 0.412 . . . . 0.0 111.243 -176.228 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' D' D ' 73' ' ' GLY . . . . . 0.803 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -69.38 -59.95 5.42 Favored Glycine 0 N--CA 1.435 -1.375 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.743 170.169 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 74' ' ' ASN . . . . . 0.668 ' HA ' HD21 ' D' ' 77' ' ' ASN . 46.7 t30 -62.72 -27.34 69.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.965 0.412 . . . . 0.0 109.97 177.74 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 75' ' ' ILE . . . . . 0.629 ' O ' HG13 ' D' ' 79' ' ' ILE . 77.7 mt -68.15 -45.28 83.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.899 176.328 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 29.1 t -75.78 -19.43 58.99 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.216 -176.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' D' D ' 77' ' ' ASN . . . . . 0.668 HD21 ' HA ' ' D' ' 74' ' ' ASN . 73.4 m-20 -64.48 -31.5 72.74 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 166.198 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 78' ' ' ASP . . . . . 1.06 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 58.4 m-20 -78.52 -39.89 36.75 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.567 175.304 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . 0.629 HG13 ' O ' ' D' ' 75' ' ' ILE . 22.2 mt -67.29 -17.15 22.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.349 -174.401 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -71.29 -42.92 68.1 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.375 175.65 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . 1.06 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -73.26 -51.9 15.96 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.161 176.914 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' D' D ' 82' ' ' LEU . . . . . 0.595 HD22 ' O ' ' D' ' 78' ' ' ASP . 3.7 mm? -48.05 -32.09 6.26 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 178.226 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 83' ' ' ASN . . . . . 0.635 HD21 ' HB3' ' D' ' 36' ' ' LEU . 0.7 OUTLIER 34.41 65.24 0.34 Allowed 'General case' 0 N--CA 1.477 0.914 0 O-C-N 124.18 0.925 . . . . 0.0 111.602 175.756 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' D' D ' 84' ' ' ILE . . . . . 0.423 ' N ' ' HG ' ' D' ' 36' ' ' LEU . 44.1 mt -92.84 99.89 10.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.003 0.43 . . . . 0.0 111.974 -172.839 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.96 94.27 3.68 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.616 0.722 . . . . 0.0 112.065 177.726 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 86' ' ' GLY . . . . . 0.536 ' H ' ' CD1' ' D' ' 89' ' ' ILE . . . 71.46 155.99 2.23 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.356 177.795 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 87' ' ' PRO . . . . . 0.498 ' HD2' ' CG1' ' D' ' 58' ' ' VAL . 60.7 Cg_endo -89.31 179.99 15.09 Favored 'Cis proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.141 -1.608 . . . . 0.0 113.045 0.112 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 88' ' ' TYR . . . . . 0.577 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 10.2 m-85 8.27 93.8 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 125.48 1.512 . . . . 0.0 113.875 -176.366 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.637 ' CG2' HG13 ' D' ' 91' ' ' ILE . 72.4 mt -108.71 137.74 39.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -177.885 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' D' ' 56' ' ' ILE . 55.2 mm-40 -113.48 93.04 4.21 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.084 170.161 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 91' ' ' ILE . . . . . 0.637 HG13 ' CG2' ' D' ' 89' ' ' ILE . 23.7 mt -93.68 100.7 11.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.563 178.155 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 92' ' ' LYS . . . . . 0.69 ' HD3' ' O ' ' D' ' 93' ' ' GLN . 0.0 OUTLIER -162.82 169.45 19.83 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.177 -178.223 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.69 ' O ' ' HD3' ' D' ' 92' ' ' LYS . 25.7 pt20 -87.28 151.76 22.86 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.634 172.177 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . 0.505 ' CG2' ' HE3' ' D' ' 92' ' ' LYS . 9.1 pt . . . . . 0 C--N 1.307 -1.249 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.933 -170.539 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 2.2 p30 . . . . . 0 N--CA 1.485 1.299 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' D' D ' 2' ' ' ASN . . . . . 0.464 ' ND2' ' HB2' ' D' ' 7' ' ' GLU . 25.3 t-20 -85.61 88.02 7.48 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -179.391 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -102.05 -11.65 18.73 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -177.288 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' D' D ' 4' ' ' LYS . . . . . 0.575 ' HZ3' ' HB3' ' D' ' 4' ' ' LYS . 3.1 mmmp? -98.06 -10.97 23.46 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 121.104 -0.238 . . . . 0.0 110.702 -177.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 5' ' ' ALA . . . . . . . . . . . . . . . 59.8 34.92 21.98 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.972 179.366 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 6.2 tt -110.63 -42.05 4.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.076 0.465 . . . . 0.0 109.76 179.212 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . 0.464 ' HB2' ' ND2' ' D' ' 2' ' ' ASN . 52.8 mp0 -67.98 -7.73 31.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.086 -176.479 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.834 ' HG3' ' NE2' ' D' ' 9' ' ' GLN . 14.0 pt-20 -79.69 -18.14 52.03 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.9 -179.006 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . 0.834 ' NE2' ' HG3' ' D' ' 8' ' ' GLU . 14.6 mp0 -90.19 6.96 40.48 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.814 170.35 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 10' ' ' MET . . . . . . . . . . . . . 26.0 mmt -107.71 -76.06 0.62 Allowed 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -175.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -102.1 -37.47 8.14 Favored 'General case' 0 CA--C 1.495 -1.145 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.252 178.397 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' D' D ' 12' ' ' SER . . . . . 0.792 ' CB ' ' HA ' ' D' ' 8' ' ' GLU . 36.0 t -43.54 -59.28 2.23 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.596 -1.184 . . . . 0.0 112.504 -169.124 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.496 ' C ' HG13 ' D' ' 16' ' ' VAL . 59.1 mt -90.12 -7.5 10.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 114.506 -1.224 . . . . 0.0 110.907 -174.173 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -94.41 -60.84 1.63 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.843 175.754 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 92.8 p -65.87 -18.51 65.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.822 -0.172 . . . . 0.0 111.152 -179.088 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' D' D ' 16' ' ' VAL . . . . . 0.772 ' HA ' ' HE2' ' D' ' 19' ' ' LYS . 14.5 p -54.77 -36.27 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 175.02 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 17' ' ' ASN . . . . . 0.591 ' OD1' ' HA ' ' D' ' 28' ' ' SER . 78.8 m-20 -76.23 -27.7 56.9 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.675 -178.682 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.92 -16.14 64.13 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 179.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.772 ' HE2' ' HA ' ' D' ' 16' ' ' VAL . 0.0 OUTLIER -90.92 -28.99 17.72 Favored 'General case' 0 CA--C 1.494 -1.199 0 CA-C-O 121.68 0.752 . . . . 0.0 109.046 173.486 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' D' D ' 20' ' ' LEU . . . . . 0.895 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 79.5 mt -82.98 -40.09 20.48 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 113.98 -1.464 . . . . 0.0 109.715 -173.14 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 21' ' ' ASN . . . . . 0.629 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 53.0 m-20 -78.3 92.25 4.5 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.032 -1.44 . . . . 0.0 110.694 178.69 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 22' ' ' LYS . . . . . 0.541 ' NZ ' ' HB3' ' D' ' 22' ' ' LYS . 7.3 mtpm? -123.96 -43.58 2.1 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -172.262 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 172.1 -71.63 0.11 Allowed Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 119.195 -1.478 . . . . 0.0 113.805 -175.209 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . 0.797 ' HB3' ' O ' ' D' ' 46' ' ' GLY . 17.4 tptp -56.99 -66.02 0.52 Allowed 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 179.449 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -137.19 172.32 22.73 Favored Glycine 0 N--CA 1.426 -1.975 0 CA-C-N 113.656 -1.611 . . . . 0.0 110.256 171.578 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' D' D ' 26' ' ' LYS . . . . . 0.629 ' CB ' ' HA ' ' D' ' 21' ' ' ASN . 10.5 ptpt -148.1 161.64 41.01 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.502 -0.349 . . . . 0.0 111.629 -170.294 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 27' ' ' LEU . . . . . 0.895 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 37.4 tp -134.84 145.48 48.36 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.152 0.501 . . . . 0.0 112.007 179.486 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 28' ' ' SER . . . . . 0.591 ' HA ' ' OD1' ' D' ' 17' ' ' ASN . 29.5 t -134.04 139.23 45.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.582 -178.503 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 29' ' ' LEU . . . . . 0.502 ' CD2' ' HB2' ' D' ' 38' ' ' ALA . 15.2 mt -130.94 130.4 43.4 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.059 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 49.3 m -134.35 174.2 10.79 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 178.789 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' D' D ' 31' ' ' MET . . . . . 0.773 ' HA ' ' O ' ' D' ' 35' ' ' GLN . 25.8 ptt? -137.72 121.94 18.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.815 0.817 . . . . 0.0 111.681 176.681 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -92.2 88.32 6.44 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.025 173.531 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.69 -102.35 1.75 Allowed Glycine 0 N--CA 1.454 -0.141 0 C-N-CA 120.155 -1.021 . . . . 0.0 110.879 -170.431 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -120.21 31.25 6.58 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.179 0.514 . . . . 0.0 109.845 174.02 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' D' D ' 35' ' ' GLN . . . . . 0.773 ' O ' ' HA ' ' D' ' 31' ' ' MET . 8.1 tt0 -111.43 118.08 34.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.598 -175.519 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . 0.575 ' C ' HD12 ' D' ' 36' ' ' LEU . 2.8 tm? -79.04 135.68 36.95 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.902 0.382 . . . . 0.0 110.655 178.62 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 37' ' ' LYS . . . . . 0.401 ' HD3' ' HG2' ' D' ' 35' ' ' GLN . 13.3 mmmm -135.01 99.65 4.34 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.24 -172.754 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 38' ' ' ALA . . . . . 0.502 ' HB2' ' CD2' ' D' ' 29' ' ' LEU . . . -97.73 141.42 30.77 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.486 0.66 . . . . 0.0 111.817 -177.701 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 39' ' ' THR . . . . . 0.55 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 11.5 p -143.93 132.36 22.13 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.645 177.897 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 40' ' ' SER . . . . . 0.582 ' HA ' ' O ' ' D' ' 26' ' ' LYS . 36.8 t -106.03 128.05 53.58 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 169.38 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 41' ' ' SER . . . . . 0.657 ' O ' ' HB3' ' D' ' 42' ' ' ASN . 46.8 t -93.09 142.9 26.78 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -177.13 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 42' ' ' ASN . . . . . 0.657 ' HB3' ' O ' ' D' ' 41' ' ' SER . 5.0 t30 80.16 -15.83 0.71 Allowed 'General case' 0 CA--C 1.537 0.477 0 O-C-N 124.116 0.885 . . . . 0.0 110.705 -167.816 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 43' ' ' ALA . . . . . 0.415 ' H ' ' C ' ' D' ' 41' ' ' SER . . . 60.91 62.24 1.49 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 165.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 44' ' ' GLY . . . . . 0.515 ' C ' ' HD2' ' D' ' 45' ' ' TYR . . . 123.74 35.21 0.7 Allowed Glycine 0 CA--C 1.507 -0.42 0 C-N-CA 118.481 -1.818 . . . . 0.0 115.142 167.365 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 45' ' ' TYR . . . . . 0.706 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 3.1 m-30 -122.23 162.67 20.97 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 172.465 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . 0.797 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -100.13 -149.31 23.63 Favored Glycine 0 C--O 1.218 -0.87 0 C-N-CA 121.421 -0.419 . . . . 0.0 113.219 -175.319 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 47' ' ' ILE . . . . . 1.039 HG13 ' HB2' ' D' ' 68' ' ' GLU . 1.3 mp -63.48 -59.57 4.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -176.144 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 31.0 m 167.83 -111.96 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 111.448 -2.615 . . . . 0.0 106.477 -178.517 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -110.99 75.99 0.95 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.458 163.424 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . 0.553 ' HB3' ' HE2' ' D' ' 52' ' ' LYS . 51.4 mt-10 -148.1 177.17 9.6 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.115 -179.122 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 51' ' ' ASP . . . . . 0.753 ' HB2' ' HD2' ' D' ' 69' ' ' LYS . 2.7 p30 -143.41 129.47 19.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.338 0.59 . . . . 0.0 111.851 176.625 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 52' ' ' LYS . . . . . 0.699 ' HD3' HG12 ' D' ' 47' ' ' ILE . 4.1 mptp? -138.73 136.05 35.37 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.203 -168.55 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 53' ' ' ASN . . . . . 0.46 HD21 ' C ' ' D' ' 52' ' ' LYS . 2.6 m120 -111.98 132.54 54.71 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 172.319 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 54' ' ' TRP . . . . . 0.71 ' HB2' ' O ' ' D' ' 66' ' ' PHE . 1.4 m95 -119.04 155.27 31.75 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -173.897 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -142.64 157.9 26.85 Favored Glycine 0 N--CA 1.436 -1.333 0 CA-C-N 114.524 -1.216 . . . . 0.0 113.034 171.536 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' D' D ' 56' ' ' ILE . . . . . 0.785 HG12 HG21 ' D' ' 91' ' ' ILE . 95.1 mt -127.11 104.63 12.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-N 113.081 -1.56 . . . . 0.0 106.96 178.826 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 57' ' ' PHE . . . . . 0.66 ' HD1' ' O ' ' D' ' 90' ' ' GLU . 16.2 m-85 -103.71 106.35 16.83 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.413 -166.123 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.596 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 77.2 t -90.44 111.47 23.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.996 174.815 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 5.3 m120 53.99 45.88 26.71 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.152 -178.323 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.23 49.06 35.04 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.868 179.152 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' D' D ' 61' ' ' GLU . . . . . 0.576 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 89.0 tt0 -154.23 119.68 5.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.659 0.266 . . . . 0.0 110.548 178.386 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -73.88 107.99 6.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.08 179.407 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 23.5 m -91.77 -30.1 4.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.031 -174.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' D' D ' 64' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -140.22 134.76 31.57 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.399 179.677 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' D' ' 54' ' ' TRP . 32.4 m -117.64 105.68 12.29 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.412 178.005 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 66' ' ' PHE . . . . . 0.71 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 10.8 p90 -112.94 153.08 28.57 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 174.517 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -109.86 145.13 37.3 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 176.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' D' D ' 68' ' ' GLU . . . . . 1.039 ' HB2' HG13 ' D' ' 47' ' ' ILE . 35.7 mt-10 -70.66 -17.79 62.85 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 177.746 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.753 ' HD2' ' HB2' ' D' ' 51' ' ' ASP . 5.7 mtpm? -58.84 -43.95 90.86 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.375 171.095 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 18.6 t -72.12 99.95 2.43 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.665 -1.607 . . . . 0.0 107.298 171.296 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' D' D ' 71' ' ' THR . . . . . 0.425 HG21 ' O ' ' D' ' 44' ' ' GLY . 75.9 p -31.53 121.56 0.26 Allowed 'General case' 0 C--N 1.317 -0.833 0 O-C-N 124.731 1.27 . . . . 0.0 111.95 -173.246 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 72' ' ' VAL . . . . . 0.606 HG13 ' HB2' ' D' ' 27' ' ' LEU . 0.1 OUTLIER -54.38 -11.71 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -178.816 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' D' D ' 73' ' ' GLY . . . . . 0.458 ' HA3' ' HA2' ' D' ' 44' ' ' GLY . . . -69.52 -67.0 2.06 Favored Glycine 0 N--CA 1.435 -1.374 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.689 172.193 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -62.71 -21.0 65.45 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.727 0.299 . . . . 0.0 111.131 -177.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' D' D ' 75' ' ' ILE . . . . . 0.466 ' O ' HG12 ' D' ' 79' ' ' ILE . 28.7 mm -80.46 -35.96 15.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.464 176.757 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 76' ' ' SER . . . . . 0.552 ' HA ' HG12 ' D' ' 79' ' ' ILE . 30.2 t -74.37 -21.66 59.56 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.916 177.21 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 77' ' ' ASN . . . . . 0.403 ' O ' ' HD2' ' D' ' 81' ' ' LYS . 4.8 m120 -64.09 -31.33 72.48 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 166.08 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 78' ' ' ASP . . . . . 0.976 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 79.5 m-20 -78.0 -30.52 50.12 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.177 174.252 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . 0.552 HG12 ' HA ' ' D' ' 76' ' ' SER . 28.7 mm -69.72 -19.98 23.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.006 -0.678 . . . . 0.0 109.642 179.732 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -64.66 -41.44 96.1 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.854 174.182 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . 0.976 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -81.66 -56.02 4.27 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 177.832 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' D' D ' 82' ' ' LEU . . . . . 0.604 HD21 ' O ' ' D' ' 78' ' ' ASP . 4.0 mm? -48.0 -30.63 4.51 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 83' ' ' ASN . . . . . 0.547 ' O ' ' HE2' ' D' ' 85' ' ' LYS . 0.7 OUTLIER 51.34 81.95 0.07 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.227 0.611 . . . . 0.0 111.21 173.36 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' D' D ' 84' ' ' ILE . . . . . 0.708 HG21 HD11 ' D' ' 91' ' ' ILE . 48.3 mt -77.08 99.8 2.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -176.367 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 85' ' ' LYS . . . . . 0.547 ' HE2' ' O ' ' D' ' 83' ' ' ASN . 0.0 OUTLIER -160.03 91.24 0.94 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 171.973 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.2 155.88 0.51 Allowed Glycine 0 N--CA 1.454 -0.133 0 CA-C-N 114.85 -1.068 . . . . 0.0 114.915 169.506 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' D' D ' 87' ' ' PRO . . . . . 0.498 ' O ' HG12 ' D' ' 58' ' ' VAL . 67.2 Cg_endo -86.8 177.61 23.5 Favored 'Cis proline' 0 CA--C 1.532 0.403 0 C-N-CA 122.467 -1.889 . . . . 0.0 112.364 -0.399 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 88' ' ' TYR . . . . . 0.596 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 3.8 m-85 6.67 92.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 125.369 1.468 . . . . 0.0 114.173 -176.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.646 HD11 HG22 ' D' ' 84' ' ' ILE . 70.3 mt -112.02 133.05 58.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.66 ' O ' ' HD1' ' D' ' 57' ' ' PHE . 69.7 mm-40 -119.9 101.87 8.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.084 172.26 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 91' ' ' ILE . . . . . 0.785 HG21 HG12 ' D' ' 56' ' ' ILE . 2.7 mt -98.11 110.54 25.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -178.316 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 92' ' ' LYS . . . . . 0.727 ' HE2' HG23 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -162.36 170.59 18.59 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.986 -0.446 . . . . 0.0 110.038 178.337 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.599 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 21.7 pt20 -81.31 158.25 24.81 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.093 175.066 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . 0.727 HG23 ' HE2' ' D' ' 92' ' ' LYS . 8.0 pt . . . . . 0 C--N 1.311 -1.08 0 CA-C-N 114.11 -1.405 . . . . 0.0 111.451 -167.128 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 120.697 0.284 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' D' D ' 2' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 -70.33 103.82 2.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.847 178.472 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' D' D ' 3' ' ' GLN . . . . . 0.427 ' HB3' ' OE2' ' D' ' 7' ' ' GLU . 53.3 tt0 -79.16 -52.67 7.86 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.66 177.66 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 4' ' ' LYS . . . . . 0.639 ' HB3' ' HB3' ' D' ' 7' ' ' GLU . 62.7 tttm -110.07 -8.68 14.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.248 177.39 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 5' ' ' ALA . . . . . . . . . . . . . . . 70.81 -61.44 0.48 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.576 0.75 . . . . 0.0 112.014 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 89.4 mt -75.13 8.71 2.42 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.298 0.57 . . . . 0.0 110.676 176.567 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . 0.639 ' HB3' ' HB3' ' D' ' 4' ' ' LYS . 23.1 pt-20 -70.93 -22.59 62.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.627 -179.333 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.745 ' HA ' ' CB ' ' D' ' 12' ' ' SER . 62.7 mm-40 -69.09 -20.0 64.07 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.776 -178.183 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . 0.459 HE22 ' HB2' ' D' ' 8' ' ' GLU . 15.1 mp0 -96.92 -4.22 40.44 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -177.472 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 10' ' ' MET . . . . . 0.651 ' HG3' ' H ' ' D' ' 11' ' ' ASN . 25.9 ptt? -107.82 -69.53 0.84 Allowed 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 119.763 -0.775 . . . . 0.0 112.887 -175.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 11' ' ' ASN . . . . . 0.651 ' H ' ' HG3' ' D' ' 10' ' ' MET . 60.9 m-80 -94.27 -45.73 7.37 Favored 'General case' 0 CA--C 1.484 -1.571 0 CA-C-O 120.815 0.34 . . . . 0.0 110.42 178.104 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 12' ' ' SER . . . . . 0.745 ' CB ' ' HA ' ' D' ' 8' ' ' GLU . 30.8 t -38.11 -49.22 1.3 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 113.456 -1.702 . . . . 0.0 113.591 -170.059 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.518 ' O ' HG11 ' D' ' 16' ' ' VAL . 7.1 tp -73.93 -16.42 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 121.215 0.531 . . . . 0.0 112.373 -174.865 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 14' ' ' ASN . . . . . 0.505 ' O ' ' HB2' ' D' ' 17' ' ' ASN . 3.9 m120 -95.69 -36.42 11.21 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.532 173.647 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 15' ' ' SER . . . . . 0.538 ' O ' ' HB2' ' D' ' 18' ' ' ASP . 80.3 p -75.89 -23.71 55.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.894 0.378 . . . . 0.0 110.224 178.142 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 16' ' ' VAL . . . . . 0.518 HG11 ' O ' ' D' ' 13' ' ' ILE . 5.6 p -61.27 -22.4 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 CA-C-O 122.196 0.998 . . . . 0.0 108.85 176.264 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 17' ' ' ASN . . . . . 0.505 ' HB2' ' O ' ' D' ' 14' ' ' ASN . 4.3 m120 -74.02 -39.73 63.37 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 113.578 -1.646 . . . . 0.0 109.271 176.476 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 18' ' ' ASP . . . . . 0.538 ' HB2' ' O ' ' D' ' 15' ' ' SER . 74.9 m-20 -57.34 -17.19 11.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.4 -0.818 . . . . 0.0 113.007 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.538 ' HD2' ' N ' ' D' ' 19' ' ' LYS . 0.0 OUTLIER -90.69 -40.72 11.7 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 121.957 0.884 . . . . 0.0 108.723 174.77 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' D' D ' 20' ' ' LEU . . . . . 0.701 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 81.5 mt -68.31 -34.83 76.85 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 113.327 -1.76 . . . . 0.0 110.523 -177.54 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 21' ' ' ASN . . . . . 0.663 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 63.6 m-20 -78.61 100.55 7.03 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.203 -179.356 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 22' ' ' LYS . . . . . 0.601 ' HD3' HD12 ' D' ' 47' ' ' ILE . 38.3 mtpt -122.07 -42.55 2.38 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 119.066 -1.054 . . . . 0.0 113.263 -170.398 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 158.11 -74.28 0.22 Allowed Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.144 -1.026 . . . . 0.0 112.719 -176.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . 0.831 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 21.9 tptm -53.06 -54.84 29.45 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.239 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 25' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -150.44 154.52 25.69 Favored Glycine 0 N--CA 1.429 -1.803 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.772 175.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 26' ' ' LYS . . . . . 0.725 ' CG ' ' HB3' ' D' ' 41' ' ' SER . 10.0 ptpt -149.67 159.61 44.2 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.707 -0.747 . . . . 0.0 110.897 -166.618 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 27' ' ' LEU . . . . . 0.701 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 42.7 tp -136.97 138.34 40.45 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.446 0.641 . . . . 0.0 111.904 -176.451 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 28' ' ' SER . . . . . 0.533 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 18.0 t -128.41 153.94 46.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.061 -178.188 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 29' ' ' LEU . . . . . 0.478 ' CD2' ' HB1' ' D' ' 38' ' ' ALA . 22.7 mt -138.22 152.47 48.64 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.987 0.422 . . . . 0.0 110.262 177.465 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 30' ' ' SER . . . . . 0.487 ' HB3' ' HB2' ' D' ' 37' ' ' LYS . 36.7 t -145.4 -171.25 3.63 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.411 178.787 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 31' ' ' MET . . . . . 0.431 ' HE2' ' HB3' ' D' ' 31' ' ' MET . 23.5 ptp -145.85 166.57 25.56 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.84 0.352 . . . . 0.0 110.187 -179.854 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 32' ' ' ASN . . . . . 0.625 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 48.9 t30 -150.4 87.24 1.44 Allowed 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 174.769 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.83 -98.64 0.79 Allowed Glycine 0 N--CA 1.454 -0.166 0 C-N-CA 120.004 -1.093 . . . . 0.0 111.14 -171.366 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -112.6 14.46 20.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.853 0.359 . . . . 0.0 110.135 174.185 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' D' D ' 35' ' ' GLN . . . . . 0.625 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 3.5 tp-100 -89.21 159.13 17.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.601 -174.791 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . 0.953 ' HB2' ' HB2' ' D' ' 85' ' ' LYS . 0.8 OUTLIER -121.24 135.79 55.07 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.299 179.352 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' D' D ' 37' ' ' LYS . . . . . 0.487 ' HB2' ' HB3' ' D' ' 30' ' ' SER . 74.5 mmtt -133.62 139.84 46.74 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.472 -171.511 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 38' ' ' ALA . . . . . 0.478 ' HB1' ' CD2' ' D' ' 29' ' ' LEU . . . -138.6 147.6 43.16 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.861 0.362 . . . . 0.0 111.074 177.184 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 39' ' ' THR . . . . . 0.533 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 17.7 p -147.1 131.94 18.04 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.369 175.731 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 40' ' ' SER . . . . . 0.608 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 80.2 p -108.82 170.66 7.9 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 175.456 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 41' ' ' SER . . . . . 0.725 ' HB3' ' CG ' ' D' ' 26' ' ' LYS . 38.1 t -134.46 153.61 51.84 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.378 -0.929 . . . . 0.0 111.356 177.662 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 42' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' D' ' 41' ' ' SER . 75.3 m-80 79.57 9.41 1.57 Allowed 'General case' 0 N--CA 1.467 0.409 0 O-C-N 124.863 1.352 . . . . 0.0 110.462 -174.279 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 42.82 59.62 2.76 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 114.692 -1.14 . . . . 0.0 113.683 171.247 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' D' D ' 44' ' ' GLY . . . . . 0.611 ' O ' HG23 ' D' ' 71' ' ' THR . . . 112.94 35.96 1.59 Allowed Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 119.576 -1.297 . . . . 0.0 114.087 172.534 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 45' ' ' TYR . . . . . 0.831 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 1.2 m-85 -121.42 149.6 42.77 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 170.986 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . 0.591 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -100.11 -153.25 27.1 Favored Glycine 0 C--O 1.221 -0.703 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 -178.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 47' ' ' ILE . . . . . 0.623 HG12 ' CB ' ' D' ' 68' ' ' GLU . 40.3 mm -52.26 -57.82 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 CA-C-O 121.773 0.797 . . . . 0.0 109.618 175.418 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 78.7 p 179.37 -78.0 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 113.035 -1.893 . . . . 0.0 109.206 -174.569 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' D' D ' 49' ' ' TYR . . . . . 0.403 ' O ' ' HD1' ' D' ' 49' ' ' TYR . 0.1 OUTLIER -157.52 74.59 0.76 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.811 171.662 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -147.12 148.51 31.65 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.588 -178.131 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' D' D ' 51' ' ' ASP . . . . . 0.673 ' CB ' ' HD3' ' D' ' 69' ' ' LYS . 7.7 p-10 -89.59 119.39 29.97 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.214 177.04 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 52' ' ' LYS . . . . . 0.621 ' O ' ' HA ' ' D' ' 67' ' ' ASN . 11.6 mmmm -128.48 101.28 6.12 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.387 -166.127 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 53' ' ' ASN . . . . . 0.407 ' N ' HD21 ' D' ' 53' ' ' ASN . 2.6 m120 -88.99 127.01 35.66 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.07 176.765 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 54' ' ' TRP . . . . . 0.448 ' CH2' ' HA ' ' D' ' 92' ' ' LYS . 0.0 OUTLIER -124.97 164.97 18.97 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.062 -173.421 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -154.55 164.34 31.56 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.543 -1.313 . . . . 0.0 114.688 177.279 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' D' D ' 56' ' ' ILE . . . . . 0.469 HG21 ' CG2' ' D' ' 89' ' ' ILE . 72.7 mt -140.14 107.16 2.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 125.6 1.56 . . . . 0.0 107.02 -179.156 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 57' ' ' PHE . . . . . 0.515 ' HD2' ' O ' ' D' ' 90' ' ' GLU . 4.7 m-85 -114.3 109.25 18.07 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.318 -167.725 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.744 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 0.2 OUTLIER -101.29 118.71 48.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.216 0.531 . . . . 0.0 111.567 171.611 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 5.6 m120 50.57 54.14 11.7 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.845 179.082 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.16 47.89 80.56 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.73 177.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -157.01 114.52 3.14 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.4 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -80.99 99.59 8.5 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.143 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 27.5 m -82.76 -18.24 10.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.471 -173.826 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' D' D ' 64' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -147.82 130.37 15.87 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.414 -0.514 . . . . 0.0 111.01 176.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 57.9 m -115.63 125.61 53.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.368 174.491 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' D' D ' 66' ' ' PHE . . . . . 0.417 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 15.7 p90 -132.1 163.36 28.65 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.743 177.159 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 67' ' ' ASN . . . . . 0.621 ' HA ' ' O ' ' D' ' 52' ' ' LYS . 74.5 m-80 -129.76 143.02 50.61 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.296 -176.189 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 68' ' ' GLU . . . . . 0.623 ' CB ' HG12 ' D' ' 47' ' ' ILE . 3.9 mm-40 -75.37 -17.93 60.1 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 176.835 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.673 ' HD3' ' CB ' ' D' ' 51' ' ' ASP . 44.1 mtmt -60.03 -48.73 80.49 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 168.532 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 19.7 m -78.17 61.44 2.68 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 111.857 -2.428 . . . . 0.0 109.236 171.596 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' D' D ' 71' ' ' THR . . . . . 0.611 HG23 ' O ' ' D' ' 44' ' ' GLY . 74.3 p -1.62 121.84 0.0 OUTLIER 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.873 1.669 . . . . 0.0 114.992 -179.338 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 72' ' ' VAL . . . . . 0.62 HG13 ' HB2' ' D' ' 27' ' ' LEU . 0.1 OUTLIER -44.58 -21.31 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 123.436 0.694 . . . . 0.0 112.613 171.207 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' D' D ' 73' ' ' GLY . . . . . 0.608 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -60.69 -65.87 3.06 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.819 -0.628 . . . . 0.0 113.712 175.275 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 74' ' ' ASN . . . . . 0.438 ' HA ' HD21 ' D' ' 77' ' ' ASN . 4.5 m120 -71.47 -20.2 62.11 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 120.971 0.415 . . . . 0.0 110.82 -175.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 75' ' ' ILE . . . . . 0.614 ' O ' HG13 ' D' ' 79' ' ' ILE . 27.1 mm -79.34 -40.1 21.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.882 179.472 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 76' ' ' SER . . . . . 0.52 ' HA ' HG13 ' D' ' 79' ' ' ILE . 31.0 t -74.49 -19.98 60.17 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.223 -179.738 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 77' ' ' ASN . . . . . 0.438 HD21 ' HA ' ' D' ' 74' ' ' ASN . 79.4 m-20 -64.97 -32.42 74.14 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 119.368 -0.933 . . . . 0.0 108.586 166.651 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 78' ' ' ASP . . . . . 1.042 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 60.0 m-20 -79.31 -25.1 42.42 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 176.7 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . 0.614 HG13 ' O ' ' D' ' 75' ' ' ILE . 48.6 mt -72.0 -20.62 20.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 O-C-N 121.514 -0.741 . . . . 0.0 111.129 -175.37 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -71.15 -40.19 71.5 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.426 175.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . 1.042 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -73.78 -54.21 8.55 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.642 176.322 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' D' D ' 82' ' ' LEU . . . . . 0.621 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.9 mm? -47.29 -33.35 5.53 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 177.532 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 83' ' ' ASN . . . . . 0.642 HD21 ' HB3' ' D' ' 36' ' ' LEU . 0.7 OUTLIER 42.07 67.08 0.62 Allowed 'General case' 0 N--CA 1.468 0.438 0 O-C-N 124.002 0.814 . . . . 0.0 110.864 174.774 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' D' D ' 84' ' ' ILE . . . . . 0.573 ' O ' ' HG ' ' D' ' 36' ' ' LEU . 44.1 mm -94.94 98.81 8.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.165 -175.084 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 85' ' ' LYS . . . . . 0.953 ' HB2' ' HB2' ' D' ' 36' ' ' LEU . 46.4 tptt -139.97 94.47 2.76 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.171 0.51 . . . . 0.0 110.812 -178.63 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 86' ' ' GLY . . . . . 0.529 ' H ' ' CD1' ' D' ' 89' ' ' ILE . . . 69.54 161.98 3.11 Favored Glycine 0 CA--C 1.5 -0.845 0 CA-C-N 115.231 -0.895 . . . . 0.0 114.357 177.42 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 87' ' ' PRO . . . . . 0.508 ' HD2' HG23 ' D' ' 58' ' ' VAL . 61.7 Cg_endo -77.03 -172.1 10.77 Favored 'Cis proline' 0 CA--C 1.545 1.055 0 C-N-CA 122.195 -2.002 . . . . 0.0 114.128 0.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 88' ' ' TYR . . . . . 0.744 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 2.2 m-85 -9.38 94.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 125.485 1.514 . . . . 0.0 114.668 -174.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.604 HG23 HG13 ' D' ' 91' ' ' ILE . 70.1 mt -102.19 142.1 17.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.515 ' O ' ' HD2' ' D' ' 57' ' ' PHE . 46.3 mt-10 -116.32 98.58 6.67 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.528 170.557 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 91' ' ' ILE . . . . . 0.604 HG13 HG23 ' D' ' 89' ' ' ILE . 33.0 mt -94.34 100.25 10.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.024 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 92' ' ' LYS . . . . . 0.741 ' HE2' HG21 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -159.68 166.68 30.08 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.416 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.652 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 3.8 pm0 -80.41 162.95 24.2 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 121.533 0.682 . . . . 0.0 110.696 175.903 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . 0.741 HG21 ' HE2' ' D' ' 92' ' ' LYS . 9.8 pt . . . . . 0 C--N 1.307 -1.26 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.585 -171.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 120.757 0.313 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' D' D ' 2' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -118.55 54.24 0.95 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.633 178.655 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -82.56 -14.69 54.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.297 0.57 . . . . 0.0 109.59 173.032 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -107.63 -13.26 15.09 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.731 177.099 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' D' D ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.24 60.9 0.75 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.161 -174.734 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . 0.6 ' O ' HD22 ' D' ' 6' ' ' LEU . 6.3 tt -74.06 -26.79 60.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.169 -175.356 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . 0.648 ' HA ' ' HB2' ' D' ' 10' ' ' MET . 94.9 mt-10 -63.25 1.22 0.52 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.761 ' O ' ' HB3' ' D' ' 12' ' ' SER . 10.9 pt-20 -54.83 -50.91 67.46 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -176.037 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -97.14 14.51 25.56 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 121.715 -0.616 . . . . 0.0 110.444 175.257 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' D' D ' 10' ' ' MET . . . . . 0.648 ' HB2' ' HA ' ' D' ' 7' ' ' GLU . 95.4 mmm -102.46 -72.69 0.68 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.279 -176.954 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -100.52 -42.25 6.65 Favored 'General case' 0 CA--C 1.489 -1.388 0 CA-C-O 121.098 0.475 . . . . 0.0 110.252 176.097 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' D' D ' 12' ' ' SER . . . . . 0.761 ' HB3' ' O ' ' D' ' 8' ' ' GLU . 46.1 t -42.04 -55.1 3.3 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.137 -1.392 . . . . 0.0 112.265 -170.194 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.576 ' HA ' HG13 ' D' ' 16' ' ' VAL . 64.0 mt -91.37 -8.89 10.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.365 -174.668 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -93.53 -59.12 2.08 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.395 175.183 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' D' D ' 15' ' ' SER . . . . . 0.499 ' O ' ' HE2' ' D' ' 19' ' ' LYS . 84.6 p -64.79 -15.19 61.36 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.644 0.239 . . . . 0.0 111.644 179.592 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 16' ' ' VAL . . . . . 0.576 HG13 ' HA ' ' D' ' 13' ' ' ILE . 11.8 p -60.64 -30.68 47.39 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.085 0 CA-C-O 121.527 0.679 . . . . 0.0 109.478 175.64 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 17' ' ' ASN . . . . . 0.424 ' N ' HG12 ' D' ' 16' ' ' VAL . 2.6 m120 -71.95 -39.59 69.28 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.044 177.079 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 18' ' ' ASP . . . . . 0.449 ' OD1' ' HA ' ' D' ' 15' ' ' SER . 1.2 m-20 -58.95 -15.55 13.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.691 -179.367 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.604 ' O ' ' HE3' ' D' ' 22' ' ' LYS . 31.9 mttm -91.03 -52.71 4.7 Favored 'General case' 0 CA--C 1.492 -1.259 0 CA-C-O 122.525 1.155 . . . . 0.0 108.765 179.131 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 20' ' ' LEU . . . . . 0.948 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 55.7 mt -57.1 -40.34 76.84 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 112.381 -2.19 . . . . 0.0 110.734 178.266 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 21' ' ' ASN . . . . . 0.528 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 53.3 m-20 -76.04 94.15 3.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.153 179.054 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 22' ' ' LYS . . . . . 0.626 ' HD2' HD12 ' D' ' 47' ' ' ILE . 95.7 mttt -121.81 -42.19 2.42 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -175.397 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 172.02 -92.38 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 119.589 -1.291 . . . . 0.0 113.337 -178.742 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . 0.727 ' HG2' ' HB3' ' D' ' 45' ' ' TYR . 80.4 tttt -47.22 -50.05 21.84 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.654 0.74 . . . . 0.0 109.628 178.195 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -141.54 158.08 26.42 Favored Glycine 0 N--CA 1.432 -1.626 0 CA-C-N 114.383 -1.281 . . . . 0.0 111.524 175.884 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' D' D ' 26' ' ' LYS . . . . . 0.75 ' HZ2' ' HB3' ' D' ' 26' ' ' LYS . 0.2 OUTLIER -150.47 161.3 42.79 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.672 -0.764 . . . . 0.0 110.24 -170.448 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' D' D ' 27' ' ' LEU . . . . . 0.948 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 35.5 tp -140.19 143.67 36.2 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.129 0.49 . . . . 0.0 111.116 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 28' ' ' SER . . . . . 0.463 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 13.0 t -140.6 109.78 6.17 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.703 -176.217 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 29' ' ' LEU . . . . . 0.518 HD11 ' O ' ' D' ' 29' ' ' LEU . 0.9 OUTLIER -131.61 145.75 51.85 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -179.767 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 72.8 p -160.18 -171.71 3.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.513 -177.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' D' D ' 31' ' ' MET . . . . . 0.813 ' HA ' ' O ' ' D' ' 35' ' ' GLN . 69.9 mtm -125.73 131.23 52.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.173 0.511 . . . . 0.0 111.005 176.127 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -90.78 88.87 7.24 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 172.612 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.53 -99.86 1.64 Allowed Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -164.439 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' D' D ' 34' ' ' ASN . . . . . 0.679 ' O ' ' HE3' ' D' ' 85' ' ' LYS . 75.4 m-80 -120.99 13.45 11.35 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.672 -0.311 . . . . 0.0 110.569 171.879 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 35' ' ' GLN . . . . . 0.813 ' O ' ' HA ' ' D' ' 31' ' ' MET . 52.2 tt0 -88.52 126.39 35.23 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.041 -175.102 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . 0.531 ' HG ' ' N ' ' D' ' 84' ' ' ILE . 3.0 tm? -79.08 124.67 28.51 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.278 0.561 . . . . 0.0 111.13 -179.311 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 37' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 30.9 mmmt -135.91 117.09 14.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.523 -170.756 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 38' ' ' ALA . . . . . 0.511 ' HB3' ' HB3' ' D' ' 29' ' ' LEU . . . -126.91 148.46 50.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.215 0.531 . . . . 0.0 112.068 -177.374 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 39' ' ' THR . . . . . 0.463 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 15.5 p -146.87 124.85 12.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.797 177.581 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 40' ' ' SER . . . . . 0.505 ' HB2' ' HA2' ' D' ' 73' ' ' GLY . 69.2 m -110.7 128.86 55.89 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 173.378 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 41' ' ' SER . . . . . 0.674 ' HB2' ' CD ' ' D' ' 26' ' ' LYS . 50.2 m -97.59 161.71 13.64 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.987 -174.217 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 42' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' D' ' 41' ' ' SER . 71.9 m-80 79.69 10.88 1.33 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.901 -172.006 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 39.74 61.85 1.34 Allowed 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 169.355 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' D' D ' 44' ' ' GLY . . . . . 0.458 ' O ' HG22 ' D' ' 71' ' ' THR . . . 126.54 -5.53 7.58 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 118.745 -1.693 . . . . 0.0 115.315 172.111 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 45' ' ' TYR . . . . . 0.727 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 1.6 m-85 -96.6 155.84 16.6 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 117.454 0.627 . . . . 0.0 111.882 -178.738 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . 0.64 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -101.82 -177.13 28.2 Favored Glycine 0 C--O 1.214 -1.115 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 173.088 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 47' ' ' ILE . . . . . 0.912 HG12 ' HB3' ' D' ' 68' ' ' GLU . 34.9 mm -48.09 -55.28 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.836 0 CA-C-N 118.391 1.095 . . . . 0.0 110.239 178.376 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.519 ' HA ' ' HD3' ' D' ' 24' ' ' LYS . 23.2 t 179.44 -156.67 0.02 OUTLIER 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 113.026 -1.897 . . . . 0.0 107.154 -177.268 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 49' ' ' TYR . . . . . 0.476 ' O ' ' HD1' ' D' ' 49' ' ' TYR . 0.3 OUTLIER -81.13 76.81 8.07 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.795 0.807 . . . . 0.0 109.794 167.969 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . 0.653 ' O ' ' HG2' ' D' ' 69' ' ' LYS . 71.2 mm-40 -119.24 -163.04 0.94 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.993 -171.964 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 51' ' ' ASP . . . . . 0.681 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 11.6 t70 -162.76 107.44 1.13 Allowed 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.631 170.633 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 52' ' ' LYS . . . . . 0.683 ' HG2' ' OE1' ' D' ' 68' ' ' GLU . 4.2 mptp? -138.67 109.1 6.51 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 113.755 -1.566 . . . . 0.0 109.447 -172.812 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 53' ' ' ASN . . . . . 0.446 ' HA ' ' OD1' ' D' ' 67' ' ' ASN . 2.9 m120 -83.66 131.41 34.95 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.297 177.764 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 54' ' ' TRP . . . . . 0.556 ' NE1' ' HB3' ' D' ' 93' ' ' GLN . 0.3 OUTLIER -120.55 153.52 36.62 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.82 -173.139 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -144.87 159.54 27.86 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 120.019 -1.086 . . . . 0.0 113.578 174.313 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' D' D ' 56' ' ' ILE . . . . . 0.676 HG22 HG12 ' D' ' 91' ' ' ILE . 61.8 mt -134.31 111.94 15.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 176.557 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 57' ' ' PHE . . . . . 0.59 ' HA ' ' O ' ' D' ' 61' ' ' GLU . 3.6 m-85 -110.77 105.04 13.75 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 119.214 -0.994 . . . . 0.0 111.122 -166.633 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.715 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 94.3 t -89.04 108.47 19.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.977 173.647 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 59' ' ' ASN . . . . . 0.672 HD22 ' HG2' ' D' ' 87' ' ' PRO . 77.8 m-20 60.89 52.18 4.33 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.344 -177.525 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 57.82 47.44 88.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.291 -179.5 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' D' D ' 61' ' ' GLU . . . . . 0.59 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 5.3 tp10 -151.82 125.41 8.93 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.252 -0.474 . . . . 0.0 109.904 -177.398 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -67.77 105.82 2.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.093 0.473 . . . . 0.0 109.954 177.103 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 14.6 p -86.69 -21.98 7.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.193 -178.044 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' D' D ' 64' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -156.92 135.14 11.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.324 176.429 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.415 HG23 ' O ' ' D' ' 54' ' ' TRP . 74.9 m -120.28 120.48 36.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.721 0.296 . . . . 0.0 110.757 176.77 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 66' ' ' PHE . . . . . 0.519 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 21.2 p90 -126.76 171.12 11.47 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 173.317 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 67' ' ' ASN . . . . . 0.446 ' OD1' ' HA ' ' D' ' 53' ' ' ASN . 75.4 m-20 -129.88 152.76 49.01 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 68' ' ' GLU . . . . . 0.912 ' HB3' HG12 ' D' ' 47' ' ' ILE . 33.5 mt-10 -76.66 -8.36 57.1 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.044 178.473 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.653 ' HG2' ' O ' ' D' ' 50' ' ' GLU . 48.6 mtpt -69.63 -50.36 45.03 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 168.759 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 13.8 t -61.93 120.46 10.81 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 113.569 -1.65 . . . . 0.0 107.685 172.621 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' D' D ' 71' ' ' THR . . . . . 0.458 HG22 ' O ' ' D' ' 44' ' ' GLY . 81.0 p -54.17 114.06 1.48 Allowed 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.929 -172.676 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 72' ' ' VAL . . . . . 0.62 HG11 ' HB2' ' D' ' 27' ' ' LEU . 0.1 OUTLIER -50.63 -23.29 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.727 -179.483 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' D' D ' 73' ' ' GLY . . . . . 0.505 ' HA2' ' HB2' ' D' ' 40' ' ' SER . . . -58.4 -66.77 2.58 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.733 -0.667 . . . . 0.0 113.62 173.231 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 74' ' ' ASN . . . . . 0.593 ' HA ' HD21 ' D' ' 77' ' ' ASN . 4.3 m120 -63.79 -24.28 67.7 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 120.796 0.331 . . . . 0.0 110.801 -178.003 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 75' ' ' ILE . . . . . 0.445 ' O ' HG12 ' D' ' 79' ' ' ILE . 36.6 mm -78.39 -38.8 23.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.606 178.348 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 76' ' ' SER . . . . . 0.902 ' HA ' HG12 ' D' ' 79' ' ' ILE . 36.9 t -76.2 -19.93 57.95 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.479 -0.489 . . . . 0.0 111.002 179.544 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 77' ' ' ASN . . . . . 0.593 HD21 ' HA ' ' D' ' 74' ' ' ASN . 75.3 m-20 -63.35 -32.39 73.8 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 166.073 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 78' ' ' ASP . . . . . 1.074 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 1.1 m-20 -79.27 -25.03 42.56 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.94 174.033 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . 0.902 HG12 ' HA ' ' D' ' 76' ' ' SER . 22.2 mm -69.03 -25.32 29.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.235 -177.729 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -73.01 -33.31 65.69 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.855 179.331 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . 1.074 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -77.82 -61.18 2.08 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.97 174.197 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' D' D ' 82' ' ' LEU . . . . . 0.601 HD21 ' O ' ' D' ' 78' ' ' ASP . 3.8 mm? -48.53 -31.81 7.02 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 176.314 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 83' ' ' ASN . . . . . 0.525 ' HA ' HD11 ' D' ' 36' ' ' LEU . 22.3 t-20 25.01 80.86 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 O-C-N 124.973 1.42 . . . . 0.0 112.533 177.0 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 84' ' ' ILE . . . . . 0.531 ' N ' ' HG ' ' D' ' 36' ' ' LEU . 2.7 mp -81.56 99.25 4.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.612 -175.174 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 85' ' ' LYS . . . . . 0.679 ' HE3' ' O ' ' D' ' 34' ' ' ASN . 21.5 ptmt -126.76 92.08 3.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.284 0.564 . . . . 0.0 111.318 179.664 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 86' ' ' GLY . . . . . 0.533 ' H ' ' CD1' ' D' ' 89' ' ' ILE . . . 65.2 154.26 0.16 Allowed Glycine 0 CA--C 1.516 0.11 0 CA-C-N 115.911 -0.586 . . . . 0.0 113.433 177.261 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 87' ' ' PRO . . . . . 0.672 ' HG2' HD22 ' D' ' 59' ' ' ASN . 56.8 Cg_endo -90.85 -179.65 12.44 Favored 'Cis proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.515 -1.452 . . . . 0.0 112.797 -0.429 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 88' ' ' TYR . . . . . 0.715 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 0.9 OUTLIER 18.65 93.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.081 1.353 . . . . 0.0 113.531 179.637 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.641 HG23 HG13 ' D' ' 91' ' ' ILE . 74.2 mt -111.02 136.78 46.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.097 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.545 ' O ' ' HD1' ' D' ' 57' ' ' PHE . 35.9 mm-40 -123.55 93.47 3.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.678 172.438 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 91' ' ' ILE . . . . . 0.676 HG12 HG22 ' D' ' 56' ' ' ILE . 32.2 mt -94.25 99.38 9.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.822 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 92' ' ' LYS . . . . . 0.754 ' HE2' HG23 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -162.65 167.34 23.32 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.198 178.432 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.608 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 23.6 pt20 -81.18 164.45 22.32 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.067 175.116 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . 0.754 HG23 ' HE2' ' D' ' 92' ' ' LYS . 6.3 pt . . . . . 0 C--O 1.245 0.85 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.8 -169.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.448 ' O ' HG12 ' D' ' 16' ' ' VAL . 68.6 mt . . . . . 0 N--CA 1.463 0.193 0 CA-C-O 121.894 0.854 . . . . 0.0 111.668 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -95.9 -40.83 9.11 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.599 172.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 15' ' ' SER . . . . . 0.467 ' O ' ' HD2' ' D' ' 19' ' ' LYS . 79.6 p -70.98 -26.92 63.36 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.734 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 16' ' ' VAL . . . . . 0.596 HG21 ' HB ' ' D' ' 91' ' ' ILE . 11.4 p -53.37 -28.91 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 121.802 0.81 . . . . 0.0 110.623 177.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -72.67 -43.19 63.46 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.374 -1.285 . . . . 0.0 109.668 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 18' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' D' ' 15' ' ' SER . 74.7 m-20 -57.97 -14.91 7.27 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -177.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.581 ' N ' ' HD2' ' D' ' 19' ' ' LYS . 0.0 OUTLIER -90.14 -41.4 11.66 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.508 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 20' ' ' LEU . . . . . 0.688 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 63.8 mt -73.87 -39.6 63.82 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 112.905 -1.952 . . . . 0.0 109.796 -176.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 21' ' ' ASN . . . . . 0.649 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 46.3 m-20 -75.44 91.75 2.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.894 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 22' ' ' LYS . . . . . 0.578 ' HD3' HD12 ' D' ' 47' ' ' ILE . 28.8 mtpp -122.13 -41.77 2.41 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -176.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.9 -92.03 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 119.411 -1.375 . . . . 0.0 113.931 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 24' ' ' LYS . . . . . 0.725 ' HG2' ' HB3' ' D' ' 45' ' ' TYR . 58.1 tttm -48.55 -54.7 13.42 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.572 0.701 . . . . 0.0 110.152 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 25' ' ' GLY . . . . . 0.568 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -144.29 154.06 25.47 Favored Glycine 0 N--CA 1.433 -1.502 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.351 175.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 26' ' ' LYS . . . . . 0.677 ' HG3' ' HB2' ' D' ' 41' ' ' SER . 9.1 ptpt -150.94 161.37 42.85 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.482 -0.859 . . . . 0.0 111.335 -167.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 27' ' ' LEU . . . . . 0.688 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 38.3 tp -132.01 142.92 49.73 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.71 0.767 . . . . 0.0 112.185 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 28' ' ' SER . . . . . 0.767 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 48.0 m -132.77 144.91 50.58 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.423 -176.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 29' ' ' LEU . . . . . 0.544 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 0.0 OUTLIER -141.28 147.14 37.73 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 119.549 -0.861 . . . . 0.0 110.789 -177.779 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 41.3 m -149.77 176.34 10.79 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.179 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -138.23 166.13 24.95 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.105 0.479 . . . . 0.0 110.926 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 32' ' ' ASN . . . . . 0.714 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 52.5 t-20 -148.17 87.53 1.61 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.01 -98.87 0.66 Allowed Glycine 0 N--CA 1.455 -0.056 0 C-N-CA 119.941 -1.123 . . . . 0.0 111.011 -172.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 34' ' ' ASN . . . . . 0.66 ' O ' ' HE3' ' D' ' 85' ' ' LYS . 73.0 m-80 -116.33 31.12 6.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.048 0.452 . . . . 0.0 110.342 173.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 35' ' ' GLN . . . . . 0.714 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 70.7 tp60 -106.8 148.59 28.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.2 -178.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.702 HD11 HG22 ' D' ' 79' ' ' ILE . 2.9 tm? -118.53 136.04 54.06 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.924 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 37' ' ' LYS . . . . . 0.544 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 25.5 mmmt -134.12 110.77 9.81 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.358 -171.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 38' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -118.71 146.56 44.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.163 0.506 . . . . 0.0 111.578 178.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 39' ' ' THR . . . . . 0.767 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 7.0 p -142.98 132.05 23.05 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.958 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 40' ' ' SER . . . . . 0.598 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 25.2 p -107.78 129.21 55.07 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 172.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 41' ' ' SER . . . . . 0.677 ' HB2' ' HG3' ' D' ' 26' ' ' LYS . 40.6 m -95.16 146.88 24.0 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.161 -1.016 . . . . 0.0 109.687 -177.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 42' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' D' ' 41' ' ' SER . 76.1 m-20 80.2 5.46 1.78 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.995 -169.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 50.35 62.81 2.49 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 168.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.09 -11.82 7.26 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 118.672 -1.728 . . . . 0.0 115.594 170.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 45' ' ' TYR . . . . . 0.725 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 1.6 m-85 -85.36 157.46 20.52 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 117.406 0.603 . . . . 0.0 111.739 -177.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 46' ' ' GLY . . . . . 0.626 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -100.01 -173.93 30.36 Favored Glycine 0 C--O 1.215 -1.046 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 175.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 47' ' ' ILE . . . . . 0.731 HG12 ' HB3' ' D' ' 68' ' ' GLU . 36.1 mm -47.79 -57.86 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 CA-C-O 122.254 1.026 . . . . 0.0 110.081 177.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 48' ' ' SER . . . . . 0.585 ' HA ' ' HD3' ' D' ' 24' ' ' LYS . 78.5 p -175.63 -102.3 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 112.875 -1.966 . . . . 0.0 108.812 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.54 77.25 1.59 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.996 0.903 . . . . 0.0 110.094 166.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 50' ' ' GLU . . . . . 0.713 ' HB2' ' HE3' ' D' ' 52' ' ' LYS . 56.1 mt-10 -139.9 179.22 6.73 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.011 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 51' ' ' ASP . . . . . 0.644 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 2.9 p30 -124.66 140.42 52.95 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.522 0.677 . . . . 0.0 112.014 174.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 52' ' ' LYS . . . . . 0.822 ' HD3' ' HB2' ' D' ' 68' ' ' GLU . 0.3 OUTLIER -146.42 136.69 23.74 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.234 -175.457 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -109.69 129.64 55.59 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.713 -0.395 . . . . 0.0 109.962 175.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 54' ' ' TRP . . . . . 1.085 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 1.1 m95 -124.25 165.2 18.03 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -174.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 55' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' D' ' 64' ' ' TYR . . . -155.15 170.33 33.27 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.928 174.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 56' ' ' ILE . . . . . 1.08 HG12 HG23 ' D' ' 91' ' ' ILE . 96.0 mt -138.28 113.7 9.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 124.917 1.287 . . . . 0.0 107.676 -177.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 57' ' ' PHE . . . . . 0.738 ' HB2' ' HB3' ' D' ' 90' ' ' GLU . 10.1 m-85 -115.59 105.89 13.29 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.934 -0.706 . . . . 0.0 112.018 -166.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.725 HG13 ' O ' ' D' ' 87' ' ' PRO . 81.8 t -82.69 101.33 7.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.227 173.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 35.0 m120 58.95 43.55 17.71 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.892 0.377 . . . . 0.0 110.287 -176.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.52 45.51 45.75 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.641 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 61' ' ' GLU . . . . . 0.631 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 86.2 mt-10 -137.05 105.69 5.84 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 177.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 62' ' ' LYS . . . . . 0.52 ' HB2' ' CE1' ' D' ' 57' ' ' PHE . 38.8 ttmt -70.83 99.49 1.75 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -178.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 32.7 m -88.41 -19.93 7.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -174.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 64' ' ' TYR . . . . . 0.465 ' HB3' HD12 ' D' ' 56' ' ' ILE . 16.1 t80 -148.17 140.42 24.22 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.307 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 60.7 m -119.73 118.02 29.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.35 176.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 66' ' ' PHE . . . . . 0.521 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 12.1 p90 -123.27 152.96 40.84 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 174.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 67' ' ' ASN . . . . . 0.481 ' O ' HD11 ' D' ' 75' ' ' ILE . 74.0 m-20 -119.87 135.83 54.73 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -177.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 68' ' ' GLU . . . . . 0.822 ' HB2' ' HD3' ' D' ' 52' ' ' LYS . 4.1 mm-40 -65.96 -8.19 21.24 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.792 0.329 . . . . 0.0 110.694 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.454 ' HB3' ' NZ ' ' D' ' 69' ' ' LYS . 5.9 mtpm? -60.48 -47.75 84.75 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 169.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 22.8 t -66.87 131.43 45.9 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 113.385 -1.734 . . . . 0.0 107.87 168.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 71' ' ' THR . . . . . 0.409 ' O ' HG13 ' D' ' 75' ' ' ILE . 69.7 p -60.42 127.89 33.99 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.072 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 72' ' ' VAL . . . . . 0.535 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.1 OUTLIER -56.61 -11.79 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 120.902 0.382 . . . . 0.0 111.767 -178.757 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 73' ' ' GLY . . . . . 0.598 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -73.17 -58.3 4.76 Favored Glycine 0 N--CA 1.435 -1.37 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.084 168.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -61.2 -25.75 67.25 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-O 121.114 0.483 . . . . 0.0 110.489 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 75' ' ' ILE . . . . . 0.516 ' O ' HG12 ' D' ' 79' ' ' ILE . 76.8 mt -73.5 -40.31 55.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.637 177.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 76' ' ' SER . . . . . 0.651 ' HA ' HG12 ' D' ' 79' ' ' ILE . 31.0 t -74.72 -19.31 60.29 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.654 178.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 77' ' ' ASN . . . . . 0.419 ' O ' ' HD3' ' D' ' 81' ' ' LYS . 64.0 m-20 -62.09 -41.07 97.81 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 166.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 78' ' ' ASP . . . . . 0.925 ' HA ' ' HE3' ' D' ' 81' ' ' LYS . 51.1 m-20 -67.57 -35.8 79.7 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.119 174.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 79' ' ' ILE . . . . . 0.702 HG22 HD11 ' D' ' 36' ' ' LEU . 13.2 mm -67.46 -20.71 26.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.82 -176.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 -69.78 -45.14 68.65 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.964 173.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 81' ' ' LYS . . . . . 0.925 ' HE3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -66.47 -64.61 0.82 Allowed 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.282 175.226 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 82' ' ' LEU . . . . . 0.545 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.8 mm? -46.51 -31.7 2.91 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 43.93 73.18 0.16 Allowed 'General case' 0 N--CA 1.473 0.697 0 O-C-N 123.881 0.738 . . . . 0.0 110.767 176.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 84' ' ' ILE . . . . . 0.802 HG22 HD13 ' D' ' 89' ' ' ILE . 47.1 mm -72.61 99.52 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.931 -173.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 85' ' ' LYS . . . . . 0.66 ' HE3' ' O ' ' D' ' 34' ' ' ASN . 51.9 mtpt -103.04 165.11 11.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.569 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.1 178.67 0.55 Allowed Glycine 0 C--N 1.335 0.49 0 O-C-N 123.779 0.674 . . . . 0.0 113.204 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 87' ' ' PRO . . . . . 0.725 ' O ' HG13 ' D' ' 58' ' ' VAL . 32.2 Cg_endo -93.98 -179.65 9.08 Favored 'Cis proline' 0 C--N 1.327 -0.57 0 C-N-CA 123.537 -1.443 . . . . 0.0 114.19 -0.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 88' ' ' TYR . . . . . 0.711 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 0.5 OUTLIER 27.77 91.92 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.953 1.301 . . . . 0.0 112.752 178.842 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.802 HD13 HG22 ' D' ' 84' ' ' ILE . 64.2 mt -110.42 119.03 58.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.536 0.684 . . . . 0.0 112.014 -177.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 90' ' ' GLU . . . . . 0.738 ' HB3' ' HB2' ' D' ' 57' ' ' PHE . 16.1 tp10 -106.6 91.15 3.57 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.297 178.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 91' ' ' ILE . . . . . 1.085 HG22 ' HZ3' ' D' ' 54' ' ' TRP . 4.2 mt -96.68 109.76 23.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 92' ' ' LYS . . . . . 0.656 ' HG2' ' O ' ' D' ' 93' ' ' GLN . 0.0 OUTLIER -161.5 169.72 21.27 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.528 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 93' ' ' GLN . . . . . 0.656 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 26.2 pt20 -80.9 162.82 23.77 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.653 175.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 94' ' ' ILE . . . . . 0.506 HG22 ' HE2' ' D' ' 92' ' ' LYS . 10.6 pt . . . . . 0 C--N 1.303 -1.437 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.428 -170.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.441 ' C ' HG12 ' D' ' 16' ' ' VAL . 63.3 mt . . . . . 0 C--O 1.233 0.197 0 CA-C-O 121.744 0.783 . . . . 0.0 111.647 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -94.05 -58.79 2.13 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.322 175.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 15' ' ' SER . . . . . 0.571 ' HA ' ' OD1' ' D' ' 18' ' ' ASP . 29.5 m -67.22 -18.28 65.17 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.308 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 16' ' ' VAL . . . . . 0.62 HG13 ' ND2' ' D' ' 17' ' ' ASN . 10.1 p -55.09 -28.89 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.962 0.887 . . . . 0.0 110.07 174.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 17' ' ' ASN . . . . . 0.62 ' ND2' HG13 ' D' ' 16' ' ' VAL . 3.9 m120 -79.92 -32.86 40.11 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.021 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 18' ' ' ASP . . . . . 0.571 ' OD1' ' HA ' ' D' ' 15' ' ' SER . 1.4 m-20 -59.64 -15.99 23.0 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 176.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.581 ' O ' ' HG3' ' D' ' 22' ' ' LYS . 0.0 OUTLIER -91.3 -52.26 4.89 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 122.285 1.041 . . . . 0.0 108.496 175.309 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 20' ' ' LEU . . . . . 0.989 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 60.8 mt -56.08 -39.26 71.83 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 112.953 -1.93 . . . . 0.0 110.516 -179.082 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 21' ' ' ASN . . . . . 0.613 ' OD1' ' HB2' ' D' ' 26' ' ' LYS . 56.0 m-20 -78.82 96.29 5.6 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.68 177.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 22' ' ' LYS . . . . . 0.581 ' HG3' ' O ' ' D' ' 19' ' ' LYS . 54.6 mttp -122.46 -42.7 2.33 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -178.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 170.83 -86.39 0.08 OUTLIER Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 119.606 -1.283 . . . . 0.0 113.24 -177.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 24' ' ' LYS . . . . . 0.705 ' HE3' ' HD1' ' D' ' 45' ' ' TYR . 53.7 tptt -46.47 -52.66 12.74 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 25' ' ' GLY . . . . . 0.652 ' HA2' ' OD1' ' D' ' 42' ' ' ASN . . . -146.31 151.12 23.41 Favored Glycine 0 N--CA 1.436 -1.334 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.681 177.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 26' ' ' LYS . . . . . 0.688 ' CD ' ' HB2' ' D' ' 41' ' ' SER . 0.4 OUTLIER -143.95 160.04 41.52 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.054 -0.573 . . . . 0.0 112.3 -170.113 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 27' ' ' LEU . . . . . 0.989 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 49.2 tp -135.75 143.44 45.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.484 0.659 . . . . 0.0 112.231 -177.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 28' ' ' SER . . . . . 0.647 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 39.2 m -127.39 151.23 49.07 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.965 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 29' ' ' LEU . . . . . 0.476 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 14.4 mt -140.4 156.77 46.28 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.925 177.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 60.2 m -159.19 -173.5 4.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.704 176.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -146.9 165.32 30.14 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 32' ' ' ASN . . . . . 0.501 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 51.4 t30 -150.14 88.81 1.54 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -177.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.31 -100.51 0.88 Allowed Glycine 0 C--O 1.228 -0.228 0 C-N-CA 120.306 -0.949 . . . . 0.0 110.949 -173.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -114.5 31.44 6.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.779 0.323 . . . . 0.0 110.145 173.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 35' ' ' GLN . . . . . 0.501 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 50.5 tt0 -109.63 159.96 16.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.906 0.384 . . . . 0.0 110.967 -176.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.675 HD11 HG22 ' D' ' 79' ' ' ILE . 1.9 tm? -123.77 134.6 53.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.87 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 37' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 13.6 mmmm -132.88 122.86 25.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.522 -168.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -129.65 149.75 51.27 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.828 0.347 . . . . 0.0 110.467 173.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 39' ' ' THR . . . . . 0.647 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 1.7 p -150.47 136.98 18.87 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.807 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 40' ' ' SER . . . . . 0.616 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 40.8 p -107.75 133.7 51.77 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 173.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 41' ' ' SER . . . . . 0.688 ' HB2' ' CD ' ' D' ' 26' ' ' LYS . 35.4 m -94.19 164.81 12.9 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 174.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 42' ' ' ASN . . . . . 0.652 ' OD1' ' HA2' ' D' ' 25' ' ' GLY . 0.3 OUTLIER 61.73 10.12 3.23 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 124.669 1.231 . . . . 0.0 111.505 -171.586 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 53.3 60.5 3.69 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 167.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 44' ' ' GLY . . . . . 0.787 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 104.37 37.4 2.86 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 118.472 -1.823 . . . . 0.0 115.742 164.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 45' ' ' TYR . . . . . 0.705 ' HD1' ' HE3' ' D' ' 24' ' ' LYS . 2.5 m-85 -118.17 158.18 25.56 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 117.991 0.896 . . . . 0.0 109.53 172.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 46' ' ' GLY . . . . . 0.606 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -92.01 -176.34 42.37 Favored Glycine 0 C--O 1.213 -1.193 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 178.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 47' ' ' ILE . . . . . 0.845 HG12 ' HB3' ' D' ' 68' ' ' GLU . 40.2 mm -47.27 -54.92 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 CA-C-N 118.251 1.025 . . . . 0.0 110.714 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 22.8 t -178.22 -147.59 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 112.92 -1.946 . . . . 0.0 106.313 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -88.01 74.33 8.93 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 119.308 -0.957 . . . . 0.0 108.437 165.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -138.13 -171.93 3.15 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.607 -176.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 51' ' ' ASP . . . . . 0.67 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 52.2 p-10 -147.25 133.58 19.57 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.965 0.888 . . . . 0.0 112.697 177.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 52' ' ' LYS . . . . . 0.67 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 3.5 mptp? -145.49 134.41 22.51 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.164 -176.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 -104.99 134.21 48.47 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 174.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 54' ' ' TRP . . . . . 0.635 ' HB2' ' O ' ' D' ' 66' ' ' PHE . 0.1 OUTLIER -125.58 158.13 35.39 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 -170.636 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -151.1 162.87 29.61 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.046 -1.073 . . . . 0.0 114.127 175.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 56' ' ' ILE . . . . . 0.682 HG23 HG12 ' D' ' 91' ' ' ILE . 66.8 mt -135.94 110.87 11.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 57' ' ' PHE . . . . . 0.702 ' HB2' ' HB3' ' D' ' 90' ' ' GLU . 19.4 m-85 -107.67 99.45 8.93 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 119.729 -0.789 . . . . 0.0 111.735 -165.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.678 HG22 HG12 ' D' ' 89' ' ' ILE . 85.7 t -87.86 107.51 17.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.204 175.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 53.1 m-20 68.79 31.16 4.54 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.937 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.5 -32.35 7.48 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.581 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 61' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 11.2 pt-20 -89.83 139.3 30.71 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.36 0.6 . . . . 0.0 111.686 -175.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 62' ' ' LYS . . . . . 0.521 ' HB2' ' CE1' ' D' ' 57' ' ' PHE . 38.1 ttpt -81.07 103.59 10.99 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.395 -177.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 28.2 m -82.25 -32.88 11.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.584 0.586 . . . . 0.0 112.584 -174.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 64' ' ' TYR . . . . . 0.465 ' HB3' HD12 ' D' ' 56' ' ' ILE . 19.6 t80 -134.93 131.82 37.7 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.879 -0.329 . . . . 0.0 110.966 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 57.1 m -117.16 119.96 36.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.025 175.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 66' ' ' PHE . . . . . 0.635 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 16.1 p90 -126.31 146.8 49.88 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.195 0.522 . . . . 0.0 110.244 176.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -102.96 142.72 33.57 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -177.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 68' ' ' GLU . . . . . 0.845 ' HB3' HG12 ' D' ' 47' ' ' ILE . 5.6 mm-40 -75.89 -9.29 58.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.237 0.542 . . . . 0.0 109.703 175.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.544 ' HD3' ' HB2' ' D' ' 51' ' ' ASP . 9.1 mtmp? -67.93 -37.1 81.23 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 169.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 19.2 t -74.81 124.81 27.5 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 113.761 -1.563 . . . . 0.0 107.567 171.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 82.8 p -51.15 124.52 11.75 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.325 -176.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 72' ' ' VAL . . . . . 0.665 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -58.49 -11.49 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-O 121.151 0.5 . . . . 0.0 110.919 -175.993 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 73' ' ' GLY . . . . . 0.787 ' HA3' ' HA2' ' D' ' 44' ' ' GLY . . . -72.48 -61.77 3.5 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 114.948 -1.023 . . . . 0.0 112.861 170.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -57.77 -32.63 67.68 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 120.959 0.409 . . . . 0.0 109.951 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 75' ' ' ILE . . . . . 0.646 ' O ' HG13 ' D' ' 79' ' ' ILE . 23.8 mm -73.35 -42.19 57.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.317 177.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 76' ' ' SER . . . . . 0.511 ' HA ' HG13 ' D' ' 79' ' ' ILE . 30.2 t -73.79 -20.89 60.34 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.009 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -66.83 -29.92 69.97 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 167.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 78' ' ' ASP . . . . . 1.069 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 60.7 m-20 -77.77 -33.94 52.49 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.93 172.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 79' ' ' ILE . . . . . 0.675 HG22 HD11 ' D' ' 36' ' ' LEU . 25.3 mt -68.54 -17.3 21.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.239 -175.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 58.6 m-20 -72.74 -37.26 67.78 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.424 175.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 81' ' ' LYS . . . . . 1.069 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -80.13 -51.97 8.34 Favored 'General case' 0 CA--C 1.526 0.033 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.678 176.048 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 82' ' ' LEU . . . . . 0.564 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.9 mm? -49.02 -30.82 6.6 Favored 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 177.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 40.14 66.23 0.63 Allowed 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.121 0.888 . . . . 0.0 111.374 172.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 84' ' ' ILE . . . . . 0.613 HG21 HG21 ' D' ' 56' ' ' ILE . 40.1 mm -82.1 97.74 4.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.074 -174.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.26 94.28 3.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.715 0.769 . . . . 0.0 112.807 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 86' ' ' GLY . . . . . 0.705 ' H ' HD11 ' D' ' 89' ' ' ILE . . . 67.57 153.61 0.38 Allowed Glycine 0 N--CA 1.453 -0.169 0 CA-C-N 115.603 -0.726 . . . . 0.0 113.74 175.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 87' ' ' PRO . . . . . 0.651 ' O ' HG13 ' D' ' 58' ' ' VAL . 42.9 Cg_endo -90.44 179.18 14.63 Favored 'Cis proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.298 -1.542 . . . . 0.0 112.668 -0.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 88' ' ' TYR . . . . . 0.598 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 10.0 m-85 11.56 93.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.622 1.569 . . . . 0.0 113.89 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.705 HD11 ' H ' ' D' ' 86' ' ' GLY . 77.7 mt -106.8 135.75 44.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.076 0.465 . . . . 0.0 111.839 -178.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 90' ' ' GLU . . . . . 0.702 ' HB3' ' HB2' ' D' ' 57' ' ' PHE . 5.4 tp10 -121.52 97.23 5.41 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.035 173.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 91' ' ' ILE . . . . . 0.682 HG12 HG23 ' D' ' 56' ' ' ILE . 35.2 mt -95.21 102.36 13.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.467 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 92' ' ' LYS . . . . . 0.68 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -160.44 165.6 30.74 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 178.221 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 93' ' ' GLN . . . . . 0.573 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 17.9 pt20 -80.35 165.55 22.17 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.209 0.528 . . . . 0.0 111.219 177.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 94' ' ' ILE . . . . . 0.68 HG22 ' HE2' ' D' ' 92' ' ' LYS . 8.1 pt . . . . . 0 C--N 1.313 -1.004 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.394 -170.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.434 ' C ' HG12 ' D' ' 16' ' ' VAL . 36.3 mm . . . . . 0 N--CA 1.453 -0.322 0 CA-C-O 121.518 0.675 . . . . 0.0 111.409 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -95.86 -59.43 1.86 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.107 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 15' ' ' SER . . . . . 0.72 ' O ' ' HE3' ' D' ' 19' ' ' LYS . 90.3 p -67.07 -17.35 64.85 Favored 'General case' 0 C--O 1.219 -0.509 0 O-C-N 121.975 -0.453 . . . . 0.0 110.71 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 16' ' ' VAL . . . . . 0.439 ' O ' ' HG ' ' D' ' 20' ' ' LEU . 11.2 p -52.72 -29.68 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.588 0.709 . . . . 0.0 110.227 174.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 17' ' ' ASN . . . . . 0.502 ' HB3' ' ND2' ' D' ' 21' ' ' ASN . 4.9 m120 -75.21 -41.19 58.32 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.646 177.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.23 -16.48 13.99 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.619 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.72 ' HE3' ' O ' ' D' ' 15' ' ' SER . 21.2 mmtp -85.72 -43.28 13.52 Favored 'General case' 0 CA--C 1.504 -0.827 0 CA-C-O 122.723 1.249 . . . . 0.0 108.195 -178.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 20' ' ' LEU . . . . . 0.997 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 63.0 mt -79.91 -37.76 33.99 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 111.308 -2.678 . . . . 0.0 110.591 -173.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 21' ' ' ASN . . . . . 0.567 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 54.2 m-80 -75.6 99.53 4.32 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.351 176.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 22' ' ' LYS . . . . . 0.677 ' HG3' ' O ' ' D' ' 20' ' ' LEU . 24.0 mtpp -120.43 -40.77 2.65 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 119.075 -1.05 . . . . 0.0 113.12 -166.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 157.55 -73.31 0.23 Allowed Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.327 -177.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 24' ' ' LYS . . . . . 0.925 ' HG2' ' HB3' ' D' ' 45' ' ' TYR . 77.5 tttt -63.82 -61.78 2.07 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 176.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 25' ' ' GLY . . . . . 0.518 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -127.54 163.71 21.2 Favored Glycine 0 N--CA 1.436 -1.331 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.024 174.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 26' ' ' LYS . . . . . 0.733 ' CD ' ' HB2' ' D' ' 41' ' ' SER . 9.7 ptpt -150.9 160.6 43.8 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.157 -0.522 . . . . 0.0 111.705 -170.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 27' ' ' LEU . . . . . 0.997 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 49.0 tp -137.08 148.04 46.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.073 0.463 . . . . 0.0 111.119 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 28' ' ' SER . . . . . 0.656 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 50.5 m -140.06 142.59 36.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.766 -173.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 29' ' ' LEU . . . . . 0.565 HD11 ' CD1' ' D' ' 20' ' ' LEU . 0.0 OUTLIER -141.5 147.74 38.31 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 119.688 -0.805 . . . . 0.0 111.656 -176.867 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 66.6 p -155.67 -172.47 4.15 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.83 176.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -137.44 166.53 23.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.864 0.364 . . . . 0.0 110.155 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 32' ' ' ASN . . . . . 0.5 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 23.4 t-20 -147.36 88.81 1.73 Allowed 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.98 -97.98 0.95 Allowed Glycine 0 N--CA 1.454 -0.113 0 C-N-CA 120.017 -1.087 . . . . 0.0 110.718 -170.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 76.0 m-80 -120.67 22.68 11.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.023 0.439 . . . . 0.0 110.034 173.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 35' ' ' GLN . . . . . 0.5 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 3.7 tp-100 -93.53 152.36 19.1 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.025 -177.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.793 ' HB2' ' HG2' ' D' ' 85' ' ' LYS . 2.3 tm? -118.41 128.57 54.75 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.984 0.421 . . . . 0.0 110.218 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 37' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 13.6 mmmm -128.42 121.74 29.72 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.905 -167.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 38' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -131.98 151.61 51.63 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.183 0.516 . . . . 0.0 110.52 174.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 39' ' ' THR . . . . . 0.656 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 2.6 p -149.5 134.81 18.28 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.8 -176.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 40' ' ' SER . . . . . 0.54 ' HA ' ' O ' ' D' ' 26' ' ' LYS . 36.1 t -107.74 128.03 54.21 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 41' ' ' SER . . . . . 0.733 ' HB2' ' CD ' ' D' ' 26' ' ' LYS . 46.7 m -95.21 158.79 15.31 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -177.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 42' ' ' ASN . . . . . 0.47 ' OD1' ' HB2' ' D' ' 45' ' ' TYR . 0.0 OUTLIER 81.67 -17.31 0.56 Allowed 'General case' 0 N--CA 1.475 0.802 0 O-C-N 124.584 1.178 . . . . 0.0 109.313 -169.158 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 72.99 63.44 0.1 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 173.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 44' ' ' GLY . . . . . 0.711 ' O ' ' HB ' ' D' ' 71' ' ' THR . . . 126.92 -40.43 1.78 Allowed Glycine 0 C--N 1.341 0.825 0 C-N-CA 119.317 -1.42 . . . . 0.0 116.052 169.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 45' ' ' TYR . . . . . 0.925 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 3.3 m-30 -59.82 156.03 15.01 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 118.515 1.157 . . . . 0.0 113.798 -172.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 46' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -98.25 -153.24 28.58 Favored Glycine 0 C--O 1.218 -0.893 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.566 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 47' ' ' ILE . . . . . 0.98 HG13 ' HB2' ' D' ' 68' ' ' GLU . 0.3 OUTLIER -50.92 -58.7 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-O 122.238 1.018 . . . . 0.0 110.184 -176.6 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 48' ' ' SER . . . . . 0.524 ' HA ' ' CD ' ' D' ' 24' ' ' LYS . 34.5 p 168.77 -76.06 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 111.47 -2.604 . . . . 0.0 106.158 -169.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -163.68 75.73 0.36 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.05 -1.432 . . . . 0.0 107.609 162.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 50' ' ' GLU . . . . . 0.705 ' O ' ' HG2' ' D' ' 69' ' ' LYS . 4.5 mm-40 -142.21 -159.31 0.95 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.004 -173.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 51' ' ' ASP . . . . . 0.623 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 35.6 t0 -146.62 125.99 13.14 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.118 176.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 52' ' ' LYS . . . . . 0.623 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 0.2 OUTLIER -141.62 100.0 3.67 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.111 -174.102 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 42.2 m-20 -73.96 127.03 31.81 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.155 0.502 . . . . 0.0 110.515 177.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 54' ' ' TRP . . . . . 0.517 ' CH2' ' HA ' ' D' ' 92' ' ' LYS . 0.1 OUTLIER -118.74 155.26 31.4 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.611 -177.293 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -143.03 155.91 26.2 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 119.888 -1.149 . . . . 0.0 113.445 176.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 56' ' ' ILE . . . . . 0.78 HG23 HG12 ' D' ' 91' ' ' ILE . 61.0 mt -132.91 110.26 15.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 174.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 57' ' ' PHE . . . . . 0.728 ' HB2' ' HB2' ' D' ' 90' ' ' GLU . 9.4 m-85 -107.84 107.68 18.53 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 119.553 -0.859 . . . . 0.0 111.222 -167.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.681 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 98.1 t -96.63 110.74 25.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 173.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 34.0 m120 64.21 37.51 8.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.797 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.03 -33.86 5.64 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.663 -0.78 . . . . 0.0 114.084 172.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 61' ' ' GLU . . . . . 0.516 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 12.1 pt-20 -90.86 156.87 17.69 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -177.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 41.5 mttm -77.32 126.32 30.74 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 13.1 p -94.63 -26.5 4.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 121.161 0.505 . . . . 0.0 109.947 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 64' ' ' TYR . . . . . 0.463 ' HB3' HD12 ' D' ' 56' ' ' ILE . 29.7 t80 -148.98 137.56 21.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.858 175.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 40.6 m -120.61 124.56 45.56 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 176.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 66' ' ' PHE . . . . . 0.478 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 21.6 p90 -131.94 165.21 24.42 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 175.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 67' ' ' ASN . . . . . 0.731 ' OD1' ' HG3' ' D' ' 69' ' ' LYS . 21.7 t-20 -131.77 150.88 52.01 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -176.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 68' ' ' GLU . . . . . 0.98 ' HB2' HG13 ' D' ' 47' ' ' ILE . 35.5 mm-40 -71.65 -20.67 61.92 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 119.499 -0.88 . . . . 0.0 109.731 177.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.731 ' HG3' ' OD1' ' D' ' 67' ' ' ASN . 26.2 mtpp -61.99 -48.27 81.08 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 173.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 23.9 m -71.73 77.98 0.85 Allowed 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 112.162 -2.29 . . . . 0.0 108.42 174.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 71' ' ' THR . . . . . 0.711 ' HB ' ' O ' ' D' ' 44' ' ' GLY . 59.7 p -19.82 117.39 0.03 OUTLIER 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.161 1.385 . . . . 0.0 113.933 -173.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 72' ' ' VAL . . . . . 0.481 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -51.42 -14.89 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 176.896 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 73' ' ' GLY . . . . . 0.536 ' HA3' ' HA2' ' D' ' 44' ' ' GLY . . . -67.49 -65.36 2.77 Favored Glycine 0 N--CA 1.435 -1.433 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.818 174.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -67.12 -23.52 65.83 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.485 -0.358 . . . . 0.0 110.675 -177.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 75' ' ' ILE . . . . . 0.605 ' O ' HG13 ' D' ' 79' ' ' ILE . 32.6 mm -75.13 -39.85 43.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.506 177.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 76' ' ' SER . . . . . 0.413 ' HA ' HG13 ' D' ' 79' ' ' ILE . 28.7 t -73.29 -19.33 61.07 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.948 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -66.78 -31.3 71.85 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 167.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 78' ' ' ASP . . . . . 1.01 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 59.3 m-20 -78.11 -32.15 50.37 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.223 174.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 79' ' ' ILE . . . . . 0.626 HG22 HD11 ' D' ' 36' ' ' LEU . 18.0 mt -71.33 -16.69 19.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 C-N-CA 120.031 -0.668 . . . . 0.0 109.507 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -67.05 -31.57 72.17 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.821 173.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 81' ' ' LYS . . . . . 1.01 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -92.44 -49.48 6.11 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 177.321 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 82' ' ' LEU . . . . . 0.624 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.7 mm? -51.27 -28.06 10.89 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -176.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 83' ' ' ASN . . . . . 0.647 ' HA ' HD12 ' D' ' 36' ' ' LEU . 7.1 m120 33.21 72.7 0.08 Allowed 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 84' ' ' ILE . . . . . 0.649 HG22 HD13 ' D' ' 89' ' ' ILE . 41.2 mm -91.45 98.96 8.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.884 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 85' ' ' LYS . . . . . 0.793 ' HG2' ' HB2' ' D' ' 36' ' ' LEU . 30.7 mmmt -141.18 101.48 4.03 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.35 171.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 86' ' ' GLY . . . . . 0.626 ' H ' HD11 ' D' ' 89' ' ' ILE . . . 73.34 149.87 1.36 Allowed Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.094 -0.957 . . . . 0.0 113.393 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 87' ' ' PRO . . . . . 0.632 ' O ' HG13 ' D' ' 58' ' ' VAL . 43.2 Cg_endo -88.46 178.31 19.16 Favored 'Cis proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.917 -1.701 . . . . 0.0 112.557 0.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 88' ' ' TYR . . . . . 0.681 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 3.6 m-85 11.71 94.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 125.3 1.44 . . . . 0.0 114.366 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.677 HG12 HG22 ' D' ' 58' ' ' VAL . 62.6 mt -110.56 142.88 21.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.3 0.571 . . . . 0.0 112.468 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 90' ' ' GLU . . . . . 0.728 ' HB2' ' HB2' ' D' ' 57' ' ' PHE . 59.7 mm-40 -124.06 91.08 3.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.694 172.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 91' ' ' ILE . . . . . 0.78 HG12 HG23 ' D' ' 56' ' ' ILE . 23.2 mt -95.29 99.64 9.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 92' ' ' LYS . . . . . 0.633 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -161.09 166.95 27.22 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.639 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 93' ' ' GLN . . . . . 0.605 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 18.9 pt20 -81.5 164.46 21.97 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.274 176.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 94' ' ' ILE . . . . . 0.633 HG21 ' HZ ' ' D' ' 57' ' ' PHE . 8.1 pt . . . . . 0 C--N 1.311 -1.071 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.351 -169.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.593 ' O ' HG12 ' D' ' 16' ' ' VAL . 40.2 mm . . . . . 0 N--CA 1.45 -0.448 0 CA-C-O 121.87 0.843 . . . . 0.0 110.752 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -88.35 -61.91 1.61 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.009 177.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 15' ' ' SER . . . . . 0.63 ' HA ' ' OD1' ' D' ' 18' ' ' ASP . 86.6 p -65.96 -17.14 64.47 Favored 'General case' 0 C--O 1.217 -0.607 0 O-C-N 122.005 -0.435 . . . . 0.0 110.379 176.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 16' ' ' VAL . . . . . 0.593 HG12 ' O ' ' D' ' 13' ' ' ILE . 1.2 p -58.03 -23.2 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-O 121.652 0.739 . . . . 0.0 109.248 176.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 17' ' ' ASN . . . . . 0.62 HD22 ' H ' ' D' ' 29' ' ' LEU . 74.8 m-20 -89.18 -26.48 21.24 Favored 'General case' 0 C--O 1.212 -0.91 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.253 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 18' ' ' ASP . . . . . 0.63 ' OD1' ' HA ' ' D' ' 15' ' ' SER . 1.2 m-20 -61.79 -15.64 43.11 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.648 174.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.879 ' HE2' ' N ' ' D' ' 19' ' ' LYS . 0.4 OUTLIER -86.69 -55.86 3.67 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 173.891 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 20' ' ' LEU . . . . . 1.079 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 64.6 mt -56.71 -40.67 76.07 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 112.253 -2.249 . . . . 0.0 111.266 -176.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 21' ' ' ASN . . . . . 0.59 ' OD1' ' HB2' ' D' ' 26' ' ' LYS . 55.8 m-80 -81.01 99.54 8.49 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.8 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 22' ' ' LYS . . . . . 0.733 ' HD2' HD12 ' D' ' 47' ' ' ILE . 97.8 mttt -123.12 -41.99 2.29 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -175.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.39 -88.18 0.07 OUTLIER Glycine 0 N--CA 1.437 -1.292 0 C-N-CA 119.536 -1.316 . . . . 0.0 113.055 -176.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 24' ' ' LYS . . . . . 0.9 ' HE2' ' HA ' ' D' ' 48' ' ' SER . 32.8 ttpt -60.85 -62.03 2.16 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 25' ' ' GLY . . . . . 0.714 ' HA2' ' ND2' ' D' ' 42' ' ' ASN . . . -116.72 153.17 17.55 Favored Glycine 0 N--CA 1.432 -1.571 0 CA-C-N 115.21 -0.905 . . . . 0.0 112.494 175.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 26' ' ' LYS . . . . . 0.716 ' CD ' ' HB3' ' D' ' 41' ' ' SER . 9.0 ptpt -149.15 160.18 43.58 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.25 -0.975 . . . . 0.0 110.757 -171.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 27' ' ' LEU . . . . . 1.079 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 53.3 tp -138.11 150.33 46.76 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.525 0.679 . . . . 0.0 111.975 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 28' ' ' SER . . . . . 0.672 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 41.0 m -135.34 150.02 49.85 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.896 -177.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 29' ' ' LEU . . . . . 0.62 ' H ' HD22 ' D' ' 17' ' ' ASN . 13.5 mt -140.12 149.9 43.61 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.269 177.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 22.7 t -160.05 -171.68 3.32 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 3.0 ppp? -141.85 166.07 25.72 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.109 0.481 . . . . 0.0 111.132 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 32' ' ' ASN . . . . . 0.491 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 26.6 t-20 -144.85 89.36 1.97 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.34 -0.845 . . . . 0.0 108.759 -178.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.94 -97.84 0.75 Allowed Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 119.887 -1.149 . . . . 0.0 111.099 -172.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 59.1 m-20 -113.08 7.45 18.02 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.667 -0.313 . . . . 0.0 110.349 176.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 35' ' ' GLN . . . . . 0.491 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 56.8 tt0 -89.11 160.85 16.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.437 -172.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.536 HD13 ' C ' ' D' ' 36' ' ' LEU . 0.9 OUTLIER -120.78 131.59 54.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.809 176.942 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 37' ' ' LYS . . . . . 0.506 ' HZ2' ' HB3' ' D' ' 37' ' ' LYS . 1.3 mmmp? -134.9 119.03 17.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.865 -169.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 38' ' ' ALA . . . . . 0.434 ' HB1' HD11 ' D' ' 27' ' ' LEU . . . -115.41 151.03 35.46 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.018 0.437 . . . . 0.0 111.0 175.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 39' ' ' THR . . . . . 0.672 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 7.0 p -146.33 131.71 18.6 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.747 177.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 40' ' ' SER . . . . . 0.668 ' HB3' ' HA2' ' D' ' 73' ' ' GLY . 33.2 t -106.73 133.59 51.17 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 173.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 41' ' ' SER . . . . . 0.716 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 38.6 t -92.93 148.45 22.0 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 42' ' ' ASN . . . . . 0.714 ' ND2' ' HA2' ' D' ' 25' ' ' GLY . 0.5 OUTLIER 83.6 -16.85 0.52 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.762 1.625 . . . . 0.0 109.409 -166.731 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 62.28 55.77 2.31 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 44' ' ' GLY . . . . . 0.436 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 123.46 35.3 0.71 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 119.1 -1.524 . . . . 0.0 115.495 168.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 45' ' ' TYR . . . . . 0.771 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 2.5 m-85 -122.76 158.34 30.38 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 122.111 -0.64 . . . . 0.0 109.661 170.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 46' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -98.46 176.61 30.25 Favored Glycine 0 C--O 1.221 -0.66 0 CA-C-O 118.972 -0.904 . . . . 0.0 110.875 177.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 47' ' ' ILE . . . . . 0.843 HG12 ' HB3' ' D' ' 68' ' ' GLU . 33.0 mm -47.26 -56.0 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 CA-C-O 121.922 0.867 . . . . 0.0 109.712 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 48' ' ' SER . . . . . 0.9 ' HA ' ' HE2' ' D' ' 24' ' ' LYS . 16.1 t 179.27 -149.01 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 113.149 -1.841 . . . . 0.0 107.393 178.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 49' ' ' TYR . . . . . 0.406 ' HD1' ' O ' ' D' ' 49' ' ' TYR . 0.1 OUTLIER -78.9 76.69 5.38 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.453 0.644 . . . . 0.0 110.416 168.32 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 50' ' ' GLU . . . . . 0.678 ' HB3' ' HE2' ' D' ' 52' ' ' LYS . 71.1 mm-40 -126.3 -166.17 1.54 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.28 -174.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 51' ' ' ASP . . . . . 0.683 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 7.0 t70 -161.04 119.68 2.5 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 114.503 -1.226 . . . . 0.0 111.565 171.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 52' ' ' LYS . . . . . 0.683 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 3.6 mptp? -142.99 115.85 8.76 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 114.22 -1.355 . . . . 0.0 109.822 -174.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 38.8 m-20 -90.98 135.47 33.72 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 174.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 54' ' ' TRP . . . . . 0.633 ' HB2' ' O ' ' D' ' 66' ' ' PHE . 0.0 OUTLIER -126.93 158.02 37.91 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.855 -172.913 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -145.87 153.44 25.3 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 119.701 -1.237 . . . . 0.0 113.883 174.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 56' ' ' ILE . . . . . 0.665 HG23 HG12 ' D' ' 91' ' ' ILE . 61.8 mt -127.62 113.75 32.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 174.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 57' ' ' PHE . . . . . 0.849 ' HB2' ' HB2' ' D' ' 90' ' ' GLU . 8.4 m-85 -109.5 105.85 15.35 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.304 -168.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.73 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 94.3 t -90.48 103.63 14.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.997 173.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 59' ' ' ASN . . . . . 0.484 ' OD1' ' HG2' ' D' ' 87' ' ' PRO . 6.3 m120 61.1 47.02 7.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.36 -0.837 . . . . 0.0 111.655 -177.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.65 -33.7 5.69 Favored Glycine 0 CA--C 1.509 -0.292 0 C-N-CA 120.681 -0.771 . . . . 0.0 114.365 172.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 61' ' ' GLU . . . . . 0.536 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 16.6 pt-20 -92.97 146.83 23.33 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 120.931 -0.307 . . . . 0.0 111.229 -176.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -73.58 113.86 11.17 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 173.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 14.5 p -88.68 -23.41 6.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-O 121.098 0.475 . . . . 0.0 110.21 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 64' ' ' TYR . . . . . 0.483 ' HB3' HD12 ' D' ' 56' ' ' ILE . 26.4 t80 -152.85 135.26 15.1 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.608 175.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 65' ' ' THR . . . . . 0.49 HG23 ' O ' ' D' ' 54' ' ' TRP . 88.9 m -121.15 125.92 48.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.412 176.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 66' ' ' PHE . . . . . 0.633 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 10.1 p90 -132.54 154.52 49.9 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.08 0.467 . . . . 0.0 110.409 178.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 67' ' ' ASN . . . . . 0.604 ' HA ' ' O ' ' D' ' 52' ' ' LYS . 3.9 m120 -114.1 145.51 41.53 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -178.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 68' ' ' GLU . . . . . 0.843 ' HB3' HG12 ' D' ' 47' ' ' ILE . 35.7 mt-10 -75.8 -8.94 58.09 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.42 177.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.622 ' HG2' ' O ' ' D' ' 50' ' ' GLU . 45.5 mtmt -63.83 -55.43 23.0 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 168.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 49.9 m -57.56 118.24 5.01 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 112.528 -2.124 . . . . 0.0 109.374 172.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 81.9 p -48.13 117.53 1.97 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.685 -176.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 72' ' ' VAL . . . . . 0.696 HG11 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -57.77 -11.95 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-O 120.788 0.328 . . . . 0.0 111.073 -174.565 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 73' ' ' GLY . . . . . 0.668 ' HA2' ' HB3' ' D' ' 40' ' ' SER . . . -74.42 -61.01 3.3 Favored Glycine 0 N--CA 1.436 -1.303 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.582 175.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -60.91 -28.17 68.72 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 75' ' ' ILE . . . . . 0.522 ' O ' ' HB2' ' D' ' 78' ' ' ASP . 31.3 mm -74.46 -41.14 49.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.894 175.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 76' ' ' SER . . . . . 0.451 ' HB2' HD13 ' D' ' 27' ' ' LEU . 28.8 t -73.18 -19.81 61.02 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.116 -177.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -61.8 -43.45 98.83 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 165.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 78' ' ' ASP . . . . . 0.962 ' HA ' ' HG2' ' D' ' 81' ' ' LYS . 1.1 m-20 -64.03 -34.78 78.78 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.978 174.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 79' ' ' ILE . . . . . 0.519 HG13 ' O ' ' D' ' 75' ' ' ILE . 53.6 mt -72.22 -24.56 22.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 C-N-CA 119.129 -1.028 . . . . 0.0 110.46 -174.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -78.64 -16.11 57.72 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.175 171.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 81' ' ' LYS . . . . . 0.962 ' HG2' ' HA ' ' D' ' 78' ' ' ASP . 25.6 mmtt -76.06 -64.54 1.07 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 172.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 82' ' ' LEU . . . . . 0.636 HD23 ' O ' ' D' ' 78' ' ' ASP . 2.8 mm? -46.71 -31.09 2.71 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 113.114 -1.857 . . . . 0.0 112.521 -179.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 45.55 57.59 4.85 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.668 0.605 . . . . 0.0 110.574 174.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 84' ' ' ILE . . . . . 0.527 ' O ' ' HG ' ' D' ' 36' ' ' LEU . 44.9 mm -83.38 97.63 4.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.913 0.387 . . . . 0.0 111.37 -173.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 85' ' ' LYS . . . . . 0.508 ' HB2' ' HB2' ' D' ' 36' ' ' LEU . 2.7 tmtm? -139.34 92.88 2.62 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 86' ' ' GLY . . . . . 0.732 ' HA2' HD11 ' D' ' 89' ' ' ILE . . . 72.74 152.06 1.65 Allowed Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.437 -0.801 . . . . 0.0 113.516 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 87' ' ' PRO . . . . . 0.595 ' O ' HG13 ' D' ' 58' ' ' VAL . 50.0 Cg_endo -90.12 179.47 14.7 Favored 'Cis proline' 0 CA--C 1.535 0.551 0 C-N-CA 123.304 -1.54 . . . . 0.0 113.195 0.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 88' ' ' TYR . . . . . 0.73 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 1.8 m-85 24.55 93.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.925 1.29 . . . . 0.0 113.62 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.732 HD11 ' HA2' ' D' ' 86' ' ' GLY . 3.5 mp -108.64 125.87 65.52 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-O 121.184 0.516 . . . . 0.0 111.665 -175.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 90' ' ' GLU . . . . . 0.849 ' HB2' ' HB2' ' D' ' 57' ' ' PHE . 5.5 mm-40 -119.65 89.59 3.16 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.75 171.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 91' ' ' ILE . . . . . 0.717 HG13 HG22 ' D' ' 89' ' ' ILE . 34.8 mt -95.95 101.19 12.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.076 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 92' ' ' LYS . . . . . 0.661 ' HG2' ' O ' ' D' ' 93' ' ' GLN . 0.0 OUTLIER -162.34 170.57 18.65 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.247 179.131 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 93' ' ' GLN . . . . . 0.661 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 17.1 pt20 -81.15 161.94 23.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.542 0.687 . . . . 0.0 110.992 173.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 94' ' ' ILE . . . . . 0.429 HG22 ' HE3' ' D' ' 92' ' ' LYS . 7.7 pt . . . . . 0 C--N 1.309 -1.18 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.435 -173.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.476 ' O ' HG12 ' D' ' 16' ' ' VAL . 67.3 mt . . . . . 0 C--O 1.228 -0.067 0 CA-C-O 121.798 0.809 . . . . 0.0 111.279 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 -94.66 -49.58 5.56 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.032 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 15' ' ' SER . . . . . 0.729 ' HA ' ' OD2' ' D' ' 18' ' ' ASP . 88.6 p -70.35 -15.95 62.93 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.965 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 16' ' ' VAL . . . . . 0.715 ' HA ' ' HE2' ' D' ' 19' ' ' LYS . 12.4 p -58.82 -34.47 52.36 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.107 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 175.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 17' ' ' ASN . . . . . 0.651 ' ND2' ' HA ' ' D' ' 28' ' ' SER . 4.5 m120 -64.79 -42.17 95.26 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.747 172.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 18' ' ' ASP . . . . . 0.729 ' OD2' ' HA ' ' D' ' 15' ' ' SER . 60.6 m-20 -57.2 -17.32 10.86 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -175.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.715 ' HE2' ' HA ' ' D' ' 16' ' ' VAL . 0.0 OUTLIER -92.04 -38.86 11.96 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 122.167 0.985 . . . . 0.0 109.202 174.523 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 20' ' ' LEU . . . . . 0.903 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 84.8 mt -78.86 -31.32 45.55 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 112.897 -1.956 . . . . 0.0 111.121 -170.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 21' ' ' ASN . . . . . 0.553 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 2.8 t-20 -99.12 95.74 7.31 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.291 -167.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 22' ' ' LYS . . . . . 0.841 ' HD3' HG23 ' D' ' 47' ' ' ILE . 5.7 mtpm? -121.94 -42.91 2.37 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 118.308 -1.357 . . . . 0.0 113.926 -169.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 168.07 -80.32 0.1 Allowed Glycine 0 N--CA 1.439 -1.111 0 C-N-CA 119.912 -1.137 . . . . 0.0 112.787 -175.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 24' ' ' LYS . . . . . 0.813 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 23.4 tptm -47.85 -59.72 3.11 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 176.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 25' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -140.26 159.34 26.17 Favored Glycine 0 N--CA 1.431 -1.649 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.219 173.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 26' ' ' LYS . . . . . 0.707 ' HA ' ' O ' ' D' ' 20' ' ' LEU . 9.6 ptpt -149.67 160.57 43.41 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.467 -0.866 . . . . 0.0 110.771 -168.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 27' ' ' LEU . . . . . 0.903 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 41.4 tp -134.54 135.99 42.72 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.225 0.536 . . . . 0.0 111.747 178.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 28' ' ' SER . . . . . 0.651 ' HA ' ' ND2' ' D' ' 17' ' ' ASN . 50.6 m -125.27 133.29 52.72 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.709 -174.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 29' ' ' LEU . . . . . 0.712 HD11 HD12 ' D' ' 20' ' ' LEU . 0.0 OUTLIER -140.71 134.74 30.76 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.706 -174.078 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 72.6 p -146.8 174.12 11.77 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.799 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 23.2 ptm -136.42 118.84 15.76 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.496 0.665 . . . . 0.0 111.114 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -93.23 89.35 6.38 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.09 -104.78 2.61 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.499 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 76.0 m-80 -117.6 17.22 14.49 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.343 0.592 . . . . 0.0 109.651 175.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 35' ' ' GLN . . . . . 0.472 ' OE1' ' HD2' ' D' ' 37' ' ' LYS . 49.9 tt0 -94.4 142.19 27.71 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.479 -177.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.68 HD11 HG22 ' D' ' 79' ' ' ILE . 2.7 tm? -112.3 115.88 29.49 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.219 0.533 . . . . 0.0 111.195 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 37' ' ' LYS . . . . . 0.773 ' HA ' ' HE2' ' D' ' 37' ' ' LYS . 10.0 mmpt? -117.72 122.77 44.38 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 114.188 -1.369 . . . . 0.0 111.566 -168.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 38' ' ' ALA . . . . . 0.584 ' HB1' HD11 ' D' ' 27' ' ' LEU . . . -130.5 154.76 47.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.136 0.493 . . . . 0.0 111.186 176.023 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 39' ' ' THR . . . . . 0.639 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 2.5 p -150.37 131.95 14.84 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.763 -177.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 40' ' ' SER . . . . . 0.626 ' HB3' ' HA2' ' D' ' 73' ' ' GLY . 40.4 t -108.17 129.77 55.16 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 172.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 41' ' ' SER . . . . . 0.686 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 32.7 t -95.87 154.47 17.21 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.432 -0.907 . . . . 0.0 109.592 -178.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 42' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' D' ' 41' ' ' SER . 77.0 m-20 78.28 6.69 2.52 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.96 -169.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 51.22 60.32 3.96 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 114.57 -1.196 . . . . 0.0 113.956 170.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 44' ' ' GLY . . . . . 0.581 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 105.99 37.01 2.61 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 119.189 -1.481 . . . . 0.0 114.357 170.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 45' ' ' TYR . . . . . 0.813 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 2.3 m-30 -113.96 153.19 29.73 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 173.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 46' ' ' GLY . . . . . 0.57 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -95.24 -162.86 34.45 Favored Glycine 0 C--O 1.219 -0.797 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 47' ' ' ILE . . . . . 0.841 HG23 ' HD3' ' D' ' 22' ' ' LYS . 39.0 mm -51.46 -55.72 7.55 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.706 0 CA-C-O 122.06 0.933 . . . . 0.0 109.035 174.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 62.3 p -174.77 -86.96 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 112.975 -1.92 . . . . 0.0 108.862 -176.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 49' ' ' TYR . . . . . 0.434 ' O ' ' HD2' ' D' ' 49' ' ' TYR . 0.1 OUTLIER -152.64 76.03 1.13 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.263 167.545 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 50' ' ' GLU . . . . . 0.724 ' O ' ' HG2' ' D' ' 69' ' ' LYS . 4.2 mm-40 -137.35 -164.93 1.67 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.443 -172.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 51' ' ' ASP . . . . . 0.613 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 8.9 t70 -138.26 127.93 25.05 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.741 173.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 52' ' ' LYS . . . . . 0.613 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 0.3 OUTLIER -143.07 121.68 12.52 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.407 -1.27 . . . . 0.0 109.482 -178.442 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 45.2 m-20 -99.1 132.5 44.36 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.344 -0.542 . . . . 0.0 109.815 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 54' ' ' TRP . . . . . 1.018 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 0.9 OUTLIER -121.7 152.97 38.81 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.903 -172.465 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -137.65 156.07 23.43 Favored Glycine 0 N--CA 1.436 -1.364 0 C-N-CA 119.732 -1.223 . . . . 0.0 112.576 172.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 56' ' ' ILE . . . . . 1.103 HG12 HG23 ' D' ' 91' ' ' ILE . 96.2 mt -126.53 94.46 2.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 176.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 57' ' ' PHE . . . . . 0.571 ' HA ' ' O ' ' D' ' 61' ' ' GLU . 18.2 m-85 -95.39 108.35 20.54 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.668 -165.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.745 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 66.4 t -95.69 105.97 17.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.447 171.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 60.85 46.72 8.44 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.759 0.314 . . . . 0.0 111.495 -177.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.01 48.31 54.72 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.676 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 61' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 17.6 tp10 -159.61 126.15 4.46 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -73.48 109.6 7.12 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.087 176.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.441 HG23 HD13 ' D' ' 84' ' ' ILE . 34.4 m -82.91 -10.77 12.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 120.991 0.424 . . . . 0.0 110.777 176.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 64' ' ' TYR . . . . . 0.562 ' HB3' HD12 ' D' ' 56' ' ' ILE . 13.9 t80 -158.93 137.85 11.18 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.271 174.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 71.7 m -122.81 113.5 19.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.145 177.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 66' ' ' PHE . . . . . 0.505 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 11.5 p90 -120.34 156.68 30.81 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.121 0.486 . . . . 0.0 110.061 177.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 67' ' ' ASN . . . . . 0.736 HD22 ' HB2' ' D' ' 69' ' ' LYS . 14.6 p-10 -122.96 133.91 54.36 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.317 -174.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 68' ' ' GLU . . . . . 0.814 ' HB3' HG12 ' D' ' 47' ' ' ILE . 40.6 mm-40 -68.05 -8.35 36.99 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.348 -176.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.736 ' HB2' HD22 ' D' ' 67' ' ' ASN . 49.6 mtpt -63.5 -44.24 94.89 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 169.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 70' ' ' SER . . . . . 0.411 ' HB3' ' O ' ' D' ' 67' ' ' ASN . 24.2 t -64.19 125.72 25.45 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 113.667 -1.606 . . . . 0.0 107.689 167.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 71' ' ' THR . . . . . 0.418 ' O ' HG13 ' D' ' 75' ' ' ILE . 75.4 p -55.76 128.87 36.97 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 72' ' ' VAL . . . . . 0.688 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -57.09 -13.76 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-O 121.163 0.506 . . . . 0.0 110.601 -177.503 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 73' ' ' GLY . . . . . 0.626 ' HA2' ' HB3' ' D' ' 40' ' ' SER . . . -67.6 -63.45 3.71 Favored Glycine 0 N--CA 1.434 -1.433 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.568 171.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -64.79 -19.65 65.94 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.314 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 75' ' ' ILE . . . . . 0.488 HD12 ' HA ' ' D' ' 72' ' ' VAL . 74.7 mt -73.5 -41.06 56.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 173.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 76' ' ' SER . . . . . 0.7 ' HA ' HG12 ' D' ' 79' ' ' ILE . 41.5 t -75.26 -22.61 57.68 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.039 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 77' ' ' ASN . . . . . 0.404 ' O ' ' HD2' ' D' ' 81' ' ' LYS . 2.6 m-80 -61.68 -25.22 67.26 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 167.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 78' ' ' ASP . . . . . 1.104 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 0.9 OUTLIER -90.03 -27.29 19.83 Favored 'General case' 0 C--O 1.227 -0.122 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 175.529 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 79' ' ' ILE . . . . . 0.7 HG12 ' HA ' ' D' ' 76' ' ' SER . 22.5 mm -68.86 -34.65 65.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.391 -176.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -66.88 -32.06 73.08 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -177.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 81' ' ' LYS . . . . . 1.104 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -77.25 -53.74 7.35 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.99 175.607 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 82' ' ' LEU . . . . . 0.58 HD23 ' O ' ' D' ' 78' ' ' ASP . 2.9 mm? -47.37 -32.22 4.69 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.008 0.523 . . . . 0.0 112.322 177.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 83' ' ' ASN . . . . . 0.584 ' HA ' HD12 ' D' ' 36' ' ' LEU . 9.3 t30 37.65 58.0 1.39 Allowed 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.45 1.094 . . . . 0.0 110.897 178.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 84' ' ' ILE . . . . . 0.585 ' N ' ' HG ' ' D' ' 36' ' ' LEU . 54.8 mt -80.32 104.47 8.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.993 0.425 . . . . 0.0 111.889 -172.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.21 92.97 2.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.771 0.796 . . . . 0.0 112.33 177.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 86' ' ' GLY . . . . . 0.741 ' HA2' HD11 ' D' ' 89' ' ' ILE . . . 75.65 153.35 4.16 Favored Glycine 0 CA--C 1.509 -0.288 0 CA-C-N 115.128 -0.942 . . . . 0.0 114.196 173.06 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 87' ' ' PRO . . . . . 0.65 ' O ' HG13 ' D' ' 58' ' ' VAL . 50.8 Cg_endo -89.41 -179.6 14.29 Favored 'Cis proline' 0 CA--C 1.534 0.478 0 C-N-CA 123.221 -1.575 . . . . 0.0 113.247 0.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 88' ' ' TYR . . . . . 0.745 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 1.8 m-85 20.86 93.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.812 1.245 . . . . 0.0 113.897 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.741 HD11 ' HA2' ' D' ' 86' ' ' GLY . 2.9 mp -110.76 134.14 53.99 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.281 -177.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -128.2 96.5 4.47 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.495 169.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 91' ' ' ILE . . . . . 1.103 HG23 HG12 ' D' ' 56' ' ' ILE . 6.0 mt -96.13 105.4 17.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 178.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 92' ' ' LYS . . . . . 0.654 ' HE3' ' O ' ' D' ' 93' ' ' GLN . 0.1 OUTLIER -161.54 170.48 19.8 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 123.027 0.531 . . . . 0.0 111.624 -174.742 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 93' ' ' GLN . . . . . 0.682 ' HB3' ' NE1' ' D' ' 54' ' ' TRP . 20.0 pt20 -90.16 155.36 19.09 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.666 0.746 . . . . 0.0 111.638 176.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 94' ' ' ILE . . . . . 0.493 HG21 ' HZ ' ' D' ' 57' ' ' PHE . 8.2 pt . . . . . 0 C--N 1.307 -1.257 0 CA-C-N 113.98 -1.464 . . . . 0.0 111.622 -171.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.448 ' C ' HG12 ' D' ' 16' ' ' VAL . 48.7 mt . . . . . 0 N--CA 1.45 -0.442 0 CA-C-O 121.744 0.783 . . . . 0.0 110.736 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -97.28 -56.93 2.39 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.597 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 50.9 m -67.84 -15.34 63.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.845 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 16' ' ' VAL . . . . . 0.701 ' HA ' ' HE2' ' D' ' 19' ' ' LYS . 14.3 p -56.22 -35.28 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 174.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -67.7 -40.23 84.34 Favored 'General case' 0 C--O 1.213 -0.856 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.92 176.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.57 -16.64 39.92 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -175.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.701 ' HE2' ' HA ' ' D' ' 16' ' ' VAL . 0.0 OUTLIER -89.97 -46.17 8.7 Favored 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 173.225 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 20' ' ' LEU . . . . . 0.811 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 84.1 mt -63.73 -35.84 81.9 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 113.594 -1.639 . . . . 0.0 110.479 -177.075 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 21' ' ' ASN . . . . . 0.484 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 40.7 m-20 -72.65 95.93 1.93 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.8 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 22' ' ' LYS . . . . . 0.853 ' HA ' ' HE2' ' D' ' 22' ' ' LYS . 7.7 mmpt? -118.05 11.17 13.25 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -170.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.94 -74.28 1.7 Allowed Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.982 176.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 24' ' ' LYS . . . . . 0.775 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 55.2 tptt -53.27 -59.22 4.84 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 176.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -144.67 157.69 27.33 Favored Glycine 0 N--CA 1.43 -1.715 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.699 174.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 26' ' ' LYS . . . . . 0.876 ' HD2' ' HB3' ' D' ' 41' ' ' SER . 10.8 ptpt -151.04 160.68 43.76 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.379 -0.911 . . . . 0.0 111.354 -164.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 27' ' ' LEU . . . . . 0.824 HD13 ' HB2' ' D' ' 76' ' ' SER . 28.4 tp -132.89 144.53 50.24 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.164 0.507 . . . . 0.0 111.397 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 28' ' ' SER . . . . . 0.673 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 52.4 m -137.74 143.61 41.27 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.983 -175.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 29' ' ' LEU . . . . . 0.588 HD11 ' CD1' ' D' ' 20' ' ' LEU . 0.0 OUTLIER -141.02 144.74 35.18 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.326 -178.7 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 35.5 m -145.66 170.07 17.2 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.035 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 31' ' ' MET . . . . . 0.575 ' SD ' ' HE2' ' D' ' 85' ' ' LYS . 61.2 mtt -130.95 111.17 11.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.043 0.449 . . . . 0.0 110.888 177.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -91.82 87.82 6.41 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.08 -125.41 8.21 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.168 -1.015 . . . . 0.0 111.48 -173.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 38.9 m-20 -89.66 31.2 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 O-C-N 122.464 -0.433 . . . . 0.0 110.267 175.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 35' ' ' GLN . . . . . 0.437 ' CG ' ' HD3' ' D' ' 37' ' ' LYS . 3.8 tp-100 -116.88 154.45 30.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.37 -172.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.914 ' HB2' ' HB2' ' D' ' 85' ' ' LYS . 1.8 tm? -118.74 126.66 52.37 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.741 176.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 37' ' ' LYS . . . . . 0.552 ' NZ ' ' HB3' ' D' ' 37' ' ' LYS . 1.1 mmmp? -129.63 117.84 21.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.587 -169.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 38' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -119.42 152.79 36.25 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.539 0.685 . . . . 0.0 112.26 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 39' ' ' THR . . . . . 0.673 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 3.2 p -144.57 126.73 15.63 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.145 177.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 40' ' ' SER . . . . . 0.591 ' HA ' ' O ' ' D' ' 26' ' ' LYS . 14.9 p -108.49 128.9 55.2 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 172.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 41' ' ' SER . . . . . 0.876 ' HB3' ' HD2' ' D' ' 26' ' ' LYS . 42.5 t -102.43 155.72 18.07 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.161 -175.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 42' ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' D' ' 41' ' ' SER . 33.8 m120 76.67 8.55 3.1 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.711 -172.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 47.08 61.72 2.73 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 114.613 -1.176 . . . . 0.0 114.043 168.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.63 -14.41 7.21 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 119.004 -1.57 . . . . 0.0 114.93 172.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 45' ' ' TYR . . . . . 0.775 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 2.0 m-30 -76.19 156.75 33.38 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 117.347 0.573 . . . . 0.0 111.488 -176.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 46' ' ' GLY . . . . . 0.554 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -103.72 -157.5 24.5 Favored Glycine 0 C--O 1.214 -1.095 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 175.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 47' ' ' ILE . . . . . 0.834 HG13 ' HB3' ' D' ' 68' ' ' GLU . 0.8 OUTLIER -53.98 -57.33 5.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 122.778 1.275 . . . . 0.0 109.58 178.236 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 39.4 t 174.7 -116.05 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 111.205 -2.725 . . . . 0.0 105.89 -175.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -119.75 76.79 1.17 Allowed 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.888 -0.507 . . . . 0.0 109.818 165.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 50' ' ' GLU . . . . . 0.425 ' HB2' ' HE3' ' D' ' 52' ' ' LYS . 60.3 mm-40 -140.55 -169.3 2.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.38 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 51' ' ' ASP . . . . . 0.647 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 1.4 m-20 -139.97 134.09 31.02 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.935 173.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 52' ' ' LYS . . . . . 0.746 ' HD3' HG12 ' D' ' 47' ' ' ILE . 0.1 OUTLIER -144.66 150.15 36.88 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.787 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 44.7 m-20 -118.95 138.72 52.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.76 0.314 . . . . 0.0 110.324 173.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 54' ' ' TRP . . . . . 1.082 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 1.7 m95 -124.7 153.22 42.69 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -175.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -138.42 157.34 24.49 Favored Glycine 0 N--CA 1.432 -1.598 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.036 172.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 56' ' ' ILE . . . . . 1.029 HG12 HG23 ' D' ' 91' ' ' ILE . 95.8 mt -131.18 94.58 2.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 177.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 57' ' ' PHE . . . . . 0.512 ' CE1' ' HB2' ' D' ' 62' ' ' LYS . 48.3 m-85 -93.86 101.03 13.11 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.546 -167.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.723 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 94.7 t -83.25 102.64 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.955 173.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 59' ' ' ASN . . . . . 0.485 ' OD1' ' HG2' ' D' ' 87' ' ' PRO . 6.4 m120 59.6 45.67 12.92 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.493 -177.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.29 -30.5 7.63 Favored Glycine 0 CA--C 1.508 -0.399 0 C-N-CA 120.009 -1.091 . . . . 0.0 112.655 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -88.15 119.9 28.99 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.852 -0.674 . . . . 0.0 110.618 -174.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 62' ' ' LYS . . . . . 0.512 ' HB2' ' CE1' ' D' ' 57' ' ' PHE . 38.7 ttpt -70.76 98.56 1.56 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 176.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.551 HG12 ' O ' ' D' ' 56' ' ' ILE . 13.4 p -77.77 -29.01 15.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.448 -170.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 64' ' ' TYR . . . . . 0.401 ' HB3' HD12 ' D' ' 56' ' ' ILE . 23.0 t80 -143.46 137.77 28.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.555 177.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 56.9 m -116.47 116.5 27.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.462 175.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 66' ' ' PHE . . . . . 0.483 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 18.3 p90 -122.06 154.98 36.59 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 170.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -117.64 146.89 43.36 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 68' ' ' GLU . . . . . 0.834 ' HB3' HG13 ' D' ' 47' ' ' ILE . 39.9 mm-40 -62.48 -24.96 67.75 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.214 0.531 . . . . 0.0 109.67 176.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.5 ' HD3' ' HB3' ' D' ' 51' ' ' ASP . 9.0 mtmp? -58.02 -44.16 87.15 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.495 173.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 70' ' ' SER . . . . . 0.454 ' OG ' HD11 ' D' ' 75' ' ' ILE . 15.4 t -76.18 92.73 3.28 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 113.798 -1.547 . . . . 0.0 107.627 172.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 73.4 p -30.84 122.85 0.21 Allowed 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.477 -1.238 . . . . 0.0 112.787 -172.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 72' ' ' VAL . . . . . 0.434 ' O ' ' HB3' ' D' ' 40' ' ' SER . 0.0 OUTLIER -51.72 -17.42 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 O-C-N 123.319 0.387 . . . . 0.0 111.709 177.8 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 73' ' ' GLY . . . . . 0.587 ' HA2' ' CB ' ' D' ' 40' ' ' SER . . . -65.33 -65.41 2.93 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 115.371 -0.832 . . . . 0.0 113.193 171.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 74' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' D' ' 77' ' ' ASN . 49.7 t30 -65.49 -22.9 66.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.852 0.358 . . . . 0.0 110.705 -178.243 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 75' ' ' ILE . . . . . 0.506 ' O ' HG12 ' D' ' 79' ' ' ILE . 27.2 mm -76.93 -37.94 27.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.067 177.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 76' ' ' SER . . . . . 0.824 ' HB2' HD13 ' D' ' 27' ' ' LEU . 32.8 t -75.51 -19.45 59.36 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.224 -0.59 . . . . 0.0 110.284 175.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 77' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' D' ' 74' ' ' ASN . 75.0 m-20 -63.14 -28.92 70.39 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 166.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 78' ' ' ASP . . . . . 1.063 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 1.0 OUTLIER -87.9 -30.03 20.42 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 115.387 -0.824 . . . . 0.0 113.166 176.114 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 79' ' ' ILE . . . . . 0.703 HG12 ' HA ' ' D' ' 76' ' ' SER . 24.3 mm -63.25 -28.22 44.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 O-C-N 121.379 -0.826 . . . . 0.0 110.669 -174.094 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -65.46 -40.45 93.21 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.509 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 81' ' ' LYS . . . . . 1.063 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -74.17 -51.83 14.33 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.605 176.82 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 82' ' ' LEU . . . . . 0.613 HD23 ' O ' ' D' ' 78' ' ' ASP . 4.0 mm? -48.99 -30.16 5.71 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 42.36 61.42 2.01 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 123.695 0.622 . . . . 0.0 110.979 174.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 84' ' ' ILE . . . . . 0.495 HG22 HD13 ' D' ' 89' ' ' ILE . 49.5 mt -90.94 98.19 8.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.773 -175.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 85' ' ' LYS . . . . . 0.914 ' HB2' ' HB2' ' D' ' 36' ' ' LEU . 10.9 tmtt? -141.33 94.93 2.75 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -175.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 86' ' ' GLY . . . . . 0.567 ' H ' HD11 ' D' ' 89' ' ' ILE . . . 69.17 150.97 0.4 Allowed Glycine 0 N--CA 1.453 -0.194 0 CA-C-N 115.283 -0.871 . . . . 0.0 113.495 -178.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 87' ' ' PRO . . . . . 0.596 ' O ' HG13 ' D' ' 58' ' ' VAL . 68.5 Cg_endo -90.21 -178.79 12.09 Favored 'Cis proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.405 -1.498 . . . . 0.0 112.835 -0.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 88' ' ' TYR . . . . . 0.723 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 1.5 m-85 13.53 93.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.175 1.39 . . . . 0.0 113.943 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.587 HG12 HG22 ' D' ' 58' ' ' VAL . 67.9 mt -110.34 132.49 58.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.311 0.577 . . . . 0.0 112.363 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -123.25 93.92 4.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.867 173.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 91' ' ' ILE . . . . . 1.082 HG22 ' HZ3' ' D' ' 54' ' ' TRP . 7.3 mt -95.93 107.6 19.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 92' ' ' LYS . . . . . 0.648 ' HE3' ' O ' ' D' ' 93' ' ' GLN . 0.0 OUTLIER -163.08 171.27 16.67 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.54 -173.234 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 93' ' ' GLN . . . . . 0.648 ' O ' ' HE3' ' D' ' 92' ' ' LYS . 3.5 pp0? -87.99 156.64 19.22 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.686 0.755 . . . . 0.0 112.787 178.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 94' ' ' ILE . . . . . 0.57 ' CG2' ' HE2' ' D' ' 92' ' ' LYS . 4.9 pt . . . . . 0 C--N 1.314 -0.938 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.005 -173.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.43 ' C ' HG12 ' D' ' 16' ' ' VAL . 53.8 mt . . . . . 0 N--CA 1.452 -0.359 0 CA-C-O 121.51 0.671 . . . . 0.0 111.284 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -94.43 -61.9 1.43 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.076 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 15' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' D' ' 19' ' ' LYS . 89.3 p -64.69 -16.68 63.22 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 122.252 -0.28 . . . . 0.0 111.108 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 16' ' ' VAL . . . . . 0.648 ' HA ' ' HE3' ' D' ' 19' ' ' LYS . 14.2 p -58.63 -32.77 46.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-O 121.835 0.826 . . . . 0.0 110.002 178.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 17' ' ' ASN . . . . . 0.427 ' HB3' ' ND2' ' D' ' 21' ' ' ASN . 5.2 m120 -71.55 -37.18 71.12 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.707 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.84 -15.17 58.21 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.648 ' HE3' ' HA ' ' D' ' 16' ' ' VAL . 71.3 mttt -91.03 -28.31 18.05 Favored 'General case' 0 CA--C 1.494 -1.199 0 CA-C-O 122.447 1.117 . . . . 0.0 109.229 -177.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 20' ' ' LEU . . . . . 0.88 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 76.1 mt -95.51 -41.14 9.1 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 112.223 -2.262 . . . . 0.0 109.061 -171.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 21' ' ' ASN . . . . . 0.69 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 59.9 m-20 -73.56 91.07 1.8 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.04 -1.436 . . . . 0.0 110.337 175.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 22' ' ' LYS . . . . . 0.471 ' HD3' HD12 ' D' ' 47' ' ' ILE . 28.7 mtpp -122.36 -41.38 2.41 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -170.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 171.77 -91.89 0.09 OUTLIER Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 119.63 -1.271 . . . . 0.0 113.3 -176.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 24' ' ' LYS . . . . . 0.552 ' HB3' ' O ' ' D' ' 46' ' ' GLY . 44.2 tptt -50.46 -53.56 28.74 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 25' ' ' GLY . . . . . 0.624 ' HA2' ' ND2' ' D' ' 42' ' ' ASN . . . -140.35 157.46 25.6 Favored Glycine 0 N--CA 1.435 -1.428 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.334 176.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 26' ' ' LYS . . . . . 0.69 ' CB ' ' HA ' ' D' ' 21' ' ' ASN . 9.3 ptpt -149.36 160.6 43.29 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.077 -0.562 . . . . 0.0 111.026 -169.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 27' ' ' LEU . . . . . 0.88 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 44.7 tp -137.08 144.69 43.25 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.34 0.59 . . . . 0.0 111.899 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 28' ' ' SER . . . . . 0.575 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 23.1 t -135.4 137.31 42.16 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.013 -178.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 29' ' ' LEU . . . . . 0.484 HD11 ' CD1' ' D' ' 20' ' ' LEU . 0.0 OUTLIER -140.5 114.29 8.89 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.345 -179.188 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 68.8 p -123.56 -173.08 2.65 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.975 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 31' ' ' MET . . . . . 0.463 ' SD ' ' HE2' ' D' ' 85' ' ' LYS . 23.0 ptt? -148.1 122.1 9.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.62 0.724 . . . . 0.0 110.961 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -91.92 88.42 6.6 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.43 177.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.56 -110.04 2.99 Favored Glycine 0 CA--C 1.515 0.069 0 C-N-CA 120.333 -0.937 . . . . 0.0 111.389 -172.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 73.6 m-80 -106.24 14.36 27.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.075 0.464 . . . . 0.0 110.716 175.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 35' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -89.04 155.36 19.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.603 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 1.099 ' HB2' ' HB2' ' D' ' 85' ' ' LYS . 1.4 tm? -117.82 126.98 53.43 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 37' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 29.0 mmmt -130.65 117.79 20.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.829 -168.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 38' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -121.39 148.89 43.79 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.865 175.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 39' ' ' THR . . . . . 0.575 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 16.5 p -147.89 138.94 23.37 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.516 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 40' ' ' SER . . . . . 0.482 ' HB3' ' HA2' ' D' ' 73' ' ' GLY . 36.7 t -107.69 128.19 54.34 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 169.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 41' ' ' SER . . . . . 0.574 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 35.1 t -94.67 161.63 14.11 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -177.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 42' ' ' ASN . . . . . 0.624 ' ND2' ' HA2' ' D' ' 25' ' ' GLY . 0.1 OUTLIER 83.47 -17.4 0.49 Allowed 'General case' 0 N--CA 1.477 0.879 0 O-C-N 124.706 1.254 . . . . 0.0 109.163 -167.929 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 71.52 62.48 0.15 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 44' ' ' GLY . . . . . 0.628 ' O ' ' HB ' ' D' ' 71' ' ' THR . . . 127.9 -40.69 1.7 Allowed Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 119.215 -1.469 . . . . 0.0 116.162 168.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 45' ' ' TYR . . . . . 0.538 ' CD2' ' HE3' ' D' ' 24' ' ' LYS . 3.2 m-30 -63.89 155.8 29.6 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.059 1.43 . . . . 0.0 112.422 -175.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 46' ' ' GLY . . . . . 0.552 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -91.29 -177.2 43.28 Favored Glycine 0 C--O 1.217 -0.926 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 172.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 47' ' ' ILE . . . . . 0.84 HG12 ' HB3' ' D' ' 68' ' ' GLU . 43.2 mm -45.66 -48.37 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.075 0 CA-C-N 117.903 0.852 . . . . 0.0 110.232 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 48' ' ' SER . . . . . 0.512 ' HB2' ' O ' ' D' ' 47' ' ' ILE . 48.4 t 153.22 -142.97 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 O-C-N 126.411 2.319 . . . . 0.0 107.632 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -77.48 75.88 4.03 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.467 0.651 . . . . 0.0 111.183 173.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 50' ' ' GLU . . . . . 0.678 ' HB3' ' HE3' ' D' ' 52' ' ' LYS . 68.3 mm-40 -134.85 -176.39 4.22 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.481 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 51' ' ' ASP . . . . . 0.717 ' HA ' ' CG ' ' D' ' 69' ' ' LYS . 7.1 p-10 -152.89 113.39 4.05 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.559 173.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 52' ' ' LYS . . . . . 0.678 ' HE3' ' HB3' ' D' ' 50' ' ' GLU . 21.1 mmtp -129.88 139.03 51.24 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.314 -170.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 38.6 m-20 -114.33 132.12 56.3 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.404 175.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 54' ' ' TRP . . . . . 0.685 ' HB2' ' O ' ' D' ' 66' ' ' PHE . 0.5 OUTLIER -128.27 160.97 30.49 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -170.431 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -152.7 162.45 29.99 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 114.892 -1.049 . . . . 0.0 113.56 172.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 56' ' ' ILE . . . . . 0.636 HG23 HG12 ' D' ' 91' ' ' ILE . 58.6 mt -130.98 111.91 20.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 177.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 57' ' ' PHE . . . . . 0.956 ' HB2' ' HB3' ' D' ' 90' ' ' GLU . 10.3 m-85 -108.67 99.54 8.9 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 119.908 -0.717 . . . . 0.0 111.424 -165.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.733 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 84.3 t -81.57 103.89 9.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.713 173.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 6.9 m120 63.31 44.38 5.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.505 -176.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.53 -33.1 5.7 Favored Glycine 0 CA--C 1.509 -0.34 0 C-N-CA 120.49 -0.862 . . . . 0.0 114.304 172.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 61' ' ' GLU . . . . . 0.543 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 16.7 pt-20 -90.6 136.27 33.17 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.239 0.542 . . . . 0.0 111.801 -173.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 62' ' ' LYS . . . . . 0.454 ' HB2' ' CE2' ' D' ' 57' ' ' PHE . 38.0 ttpt -74.26 110.33 8.46 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.861 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.455 HG22 ' O ' ' D' ' 56' ' ' ILE . 29.5 m -93.65 -29.47 4.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -175.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 64' ' ' TYR . . . . . 0.428 ' HB3' HD12 ' D' ' 56' ' ' ILE . 30.4 t80 -136.66 132.44 34.98 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 121.193 -0.203 . . . . 0.0 110.675 178.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 49.9 m -114.39 123.14 48.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.459 176.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 66' ' ' PHE . . . . . 0.685 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 14.1 p90 -131.48 148.76 52.67 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 173.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 67' ' ' ASN . . . . . 0.633 HD22 ' HB2' ' D' ' 69' ' ' LYS . 14.5 p-10 -117.94 130.95 56.52 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 68' ' ' GLU . . . . . 0.84 ' HB3' HG12 ' D' ' 47' ' ' ILE . 54.8 mm-40 -59.85 -18.27 42.92 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.009 0.433 . . . . 0.0 111.314 -173.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.717 ' CG ' ' HA ' ' D' ' 51' ' ' ASP . 46.5 mtpt -58.97 -51.9 68.07 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.393 172.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 69.8 m -64.92 103.05 0.67 Allowed 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 113.098 -1.864 . . . . 0.0 108.787 170.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 71' ' ' THR . . . . . 0.628 ' HB ' ' O ' ' D' ' 44' ' ' GLY . 72.1 p -32.73 119.05 0.3 Allowed 'General case' 0 C--N 1.322 -0.617 0 O-C-N 124.588 1.18 . . . . 0.0 112.689 -174.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 72' ' ' VAL . . . . . 0.633 HG11 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -53.34 -14.4 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.805 176.982 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 73' ' ' GLY . . . . . 0.482 ' HA2' ' HB3' ' D' ' 40' ' ' SER . . . -66.66 -70.8 1.03 Allowed Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.743 172.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -62.15 -25.03 67.52 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 120.594 0.235 . . . . 0.0 111.286 -177.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 75' ' ' ILE . . . . . 0.629 ' O ' HG13 ' D' ' 79' ' ' ILE . 30.0 mm -73.87 -37.88 49.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.199 176.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 31.3 t -73.82 -23.13 59.61 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.817 176.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -62.28 -26.94 68.68 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 166.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 78' ' ' ASP . . . . . 1.112 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 57.6 m-20 -83.22 -36.87 24.28 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.031 -0.532 . . . . 0.0 112.089 174.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 79' ' ' ILE . . . . . 0.629 HG13 ' O ' ' D' ' 75' ' ' ILE . 39.2 mt -66.41 -22.64 30.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 O-C-N 121.805 -0.559 . . . . 0.0 110.878 -173.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -72.92 -31.67 64.78 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 176.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 81' ' ' LYS . . . . . 1.112 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -81.15 -50.37 9.69 Favored 'General case' 0 N--CA 1.457 -0.076 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.164 174.527 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 82' ' ' LEU . . . . . 0.62 HD23 ' O ' ' D' ' 78' ' ' ASP . 4.0 mm? -47.39 -32.32 4.84 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 177.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 43.72 61.49 2.26 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 124.062 0.851 . . . . 0.0 110.836 174.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 84' ' ' ILE . . . . . 0.443 ' O ' ' HG ' ' D' ' 36' ' ' LEU . 52.5 mt -93.74 98.55 8.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.045 -175.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 85' ' ' LYS . . . . . 1.099 ' HB2' ' HB2' ' D' ' 36' ' ' LEU . 9.4 tmtt? -143.01 94.91 2.69 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 86' ' ' GLY . . . . . 0.48 ' HA2' HD11 ' D' ' 89' ' ' ILE . . . 76.86 151.87 4.38 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.67 -0.696 . . . . 0.0 113.566 176.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 87' ' ' PRO . . . . . 0.631 ' O ' HG13 ' D' ' 58' ' ' VAL . 55.9 Cg_endo -88.49 178.01 19.62 Favored 'Cis proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.83 -1.737 . . . . 0.0 112.479 -0.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 88' ' ' TYR . . . . . 0.733 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 1.7 m-85 28.7 91.19 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.626 1.17 . . . . 0.0 112.907 -177.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.592 HG22 HG13 ' D' ' 91' ' ' ILE . 3.7 mp -97.38 136.55 27.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.233 0.54 . . . . 0.0 110.834 -176.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 90' ' ' GLU . . . . . 0.956 ' HB3' ' HB2' ' D' ' 57' ' ' PHE . 88.0 tt0 -134.94 87.38 2.33 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.807 173.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 91' ' ' ILE . . . . . 0.636 HG12 HG23 ' D' ' 56' ' ' ILE . 40.8 mt -96.56 99.49 9.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.649 -179.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 92' ' ' LYS . . . . . 0.652 ' HG2' ' O ' ' D' ' 93' ' ' GLN . 0.0 OUTLIER -161.76 165.96 27.24 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 121.191 -0.203 . . . . 0.0 110.519 178.33 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 93' ' ' GLN . . . . . 0.652 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 18.1 pt20 -78.67 165.32 23.78 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 120.191 -0.604 . . . . 0.0 110.59 175.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 94' ' ' ILE . . . . . 0.58 HG21 ' HZ ' ' D' ' 57' ' ' PHE . 9.5 pt . . . . . 0 C--N 1.31 -1.118 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.656 -172.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.431 ' O ' HG12 ' D' ' 16' ' ' VAL . 58.4 mt . . . . . 0 C--O 1.199 -1.556 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -35.19 -33.25 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -175.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 15' ' ' SER . . . . . 0.427 ' O ' ' HD2' ' D' ' 19' ' ' LYS . 80.1 p -58.78 -27.51 65.08 Favored 'General case' 0 C--O 1.22 -0.453 0 O-C-N 121.771 -0.58 . . . . 0.0 109.909 176.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 16' ' ' VAL . . . . . 0.694 HG13 ' ND2' ' D' ' 17' ' ' ASN . 7.5 p -45.28 -30.09 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.94 1.296 . . . . 0.0 111.185 174.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 17' ' ' ASN . . . . . 0.694 ' ND2' HG13 ' D' ' 16' ' ' VAL . 5.9 m120 -86.37 -31.56 21.43 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.895 -177.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 18' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' D' ' 15' ' ' SER . 78.7 m-20 -60.71 -15.66 31.37 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 176.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.622 ' N ' ' HD2' ' D' ' 19' ' ' LYS . 0.0 OUTLIER -91.35 -46.57 7.95 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 122.03 0.919 . . . . 0.0 108.599 175.238 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 20' ' ' LEU . . . . . 0.89 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 63.8 mt -63.51 -40.49 97.19 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.192 -1.822 . . . . 0.0 110.348 -178.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 21' ' ' ASN . . . . . 0.651 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 55.6 m-20 -77.35 96.7 4.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.425 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 22' ' ' LYS . . . . . 0.789 ' HD2' HD12 ' D' ' 47' ' ' ILE . 65.3 mttm -122.83 -41.57 2.35 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -178.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 171.17 -86.22 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 119.575 -1.298 . . . . 0.0 113.663 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 24' ' ' LYS . . . . . 0.706 ' HE3' ' HD1' ' D' ' 45' ' ' TYR . 50.7 tptt -53.54 -44.47 69.23 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.85 0.833 . . . . 0.0 109.415 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 25' ' ' GLY . . . . . 0.613 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -150.2 148.13 19.03 Favored Glycine 0 N--CA 1.429 -1.802 0 CA-C-N 114.255 -1.338 . . . . 0.0 111.582 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 26' ' ' LYS . . . . . 0.651 ' CB ' ' HA ' ' D' ' 21' ' ' ASN . 10.8 ptpt -149.32 160.85 43.05 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 114.262 -0.969 . . . . 0.0 110.561 -168.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 27' ' ' LEU . . . . . 0.89 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 41.1 tp -135.65 143.58 45.57 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.237 0.541 . . . . 0.0 111.847 -178.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 28' ' ' SER . . . . . 0.638 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 27.9 t -128.18 152.62 47.83 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 29' ' ' LEU . . . . . . . . . . . . . 15.1 mt -140.78 138.75 34.33 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 177.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 60.6 m -147.05 179.16 7.81 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 31' ' ' MET . . . . . 0.43 ' HA ' ' O ' ' D' ' 35' ' ' GLN . 23.3 ptt? -134.9 122.32 21.8 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.441 0.639 . . . . 0.0 110.636 177.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -91.42 88.97 7.04 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.2 -114.74 4.03 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -169.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 34' ' ' ASN . . . . . 0.688 ' O ' ' HE3' ' D' ' 85' ' ' LYS . 70.0 m-20 -109.63 31.74 5.57 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.095 0.474 . . . . 0.0 110.023 172.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 35' ' ' GLN . . . . . 0.43 ' O ' ' HA ' ' D' ' 31' ' ' MET . 3.8 tp-100 -105.81 161.35 14.5 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.601 -179.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.707 HD11 HG22 ' D' ' 79' ' ' ILE . 3.0 tm? -114.09 131.36 56.42 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.772 0.32 . . . . 0.0 110.766 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 37' ' ' LYS . . . . . 0.426 ' HE2' ' HG2' ' D' ' 35' ' ' GLN . 74.0 mmtt -138.34 109.05 6.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.082 -169.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 38' ' ' ALA . . . . . 0.488 ' HB1' HD11 ' D' ' 27' ' ' LEU . . . -105.58 149.37 26.34 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.966 0.412 . . . . 0.0 111.229 176.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 39' ' ' THR . . . . . 0.638 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 18.0 p -143.65 129.57 19.47 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.698 175.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 40' ' ' SER . . . . . 0.729 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 72.3 p -109.38 131.56 54.95 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 41' ' ' SER . . . . . 0.625 ' HB2' ' CD ' ' D' ' 26' ' ' LYS . 52.3 m -96.56 152.82 18.27 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.714 -178.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 42' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' D' ' 41' ' ' SER . 75.9 m-80 80.09 6.12 1.76 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.005 -170.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 53.27 54.47 10.19 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 114.636 -1.166 . . . . 0.0 113.811 171.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 44' ' ' GLY . . . . . 0.744 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 104.78 35.81 3.15 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 119.431 -1.366 . . . . 0.0 114.749 168.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 45' ' ' TYR . . . . . 0.706 ' HD1' ' HE3' ' D' ' 24' ' ' LYS . 2.6 m-85 -112.78 153.81 27.21 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 168.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 46' ' ' GLY . . . . . 0.558 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -86.0 -174.0 49.54 Favored Glycine 0 CA--C 1.499 -0.945 0 C-N-CA 120.094 -1.05 . . . . 0.0 110.953 178.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 47' ' ' ILE . . . . . 0.806 HG12 ' HB3' ' D' ' 68' ' ' GLU . 45.3 mm -46.3 -51.33 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.231 0 CA-C-O 121.454 0.645 . . . . 0.0 109.987 177.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 48' ' ' SER . . . . . 0.487 ' HB2' ' O ' ' D' ' 47' ' ' ILE . 41.3 t 159.31 -138.97 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.626 0 O-C-N 126.507 2.379 . . . . 0.0 107.564 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -88.88 76.01 7.99 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.474 0.655 . . . . 0.0 111.606 175.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 50' ' ' GLU . . . . . 0.798 ' HB2' ' HE2' ' D' ' 52' ' ' LYS . 48.6 mt-10 -150.32 179.04 8.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.541 176.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 51' ' ' ASP . . . . . 0.66 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 31.8 m-20 -133.39 134.29 43.49 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.746 173.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 52' ' ' LYS . . . . . 0.798 ' HE2' ' HB2' ' D' ' 50' ' ' GLU . 1.9 mptp? -138.43 137.58 37.36 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -176.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 51.2 m-20 -115.07 134.08 55.49 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.413 174.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 54' ' ' TRP . . . . . 1.136 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 1.1 m95 -125.73 160.09 30.65 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -172.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -148.05 158.07 27.56 Favored Glycine 0 N--CA 1.436 -1.312 0 CA-C-N 114.419 -1.264 . . . . 0.0 113.006 172.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 56' ' ' ILE . . . . . 1.06 HG12 HG23 ' D' ' 91' ' ' ILE . 98.1 mt -125.88 110.31 23.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-N 113.317 -1.442 . . . . 0.0 107.149 176.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 57' ' ' PHE . . . . . 0.768 ' HB2' ' HB2' ' D' ' 90' ' ' GLU . 14.0 m-85 -106.02 102.82 12.22 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 119.881 -0.728 . . . . 0.0 110.821 -167.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.912 HG22 HG12 ' D' ' 89' ' ' ILE . 95.2 t -95.5 108.97 21.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.502 178.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 59' ' ' ASN . . . . . 0.552 ' OD1' ' HG2' ' D' ' 87' ' ' PRO . 6.2 m120 59.68 52.35 5.64 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.989 -178.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.15 47.17 92.36 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.283 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 61' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 87.1 tt0 -151.45 116.17 5.17 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.315 -0.443 . . . . 0.0 109.866 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 62' ' ' LYS . . . . . 0.492 ' NZ ' ' HB3' ' D' ' 62' ' ' LYS . 6.1 ttpm? -70.96 99.04 1.71 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.446 HG12 ' O ' ' D' ' 56' ' ' ILE . 14.7 p -87.1 -30.99 5.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.581 -169.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 64' ' ' TYR . . . . . 0.409 ' HB3' HD12 ' D' ' 56' ' ' ILE . 17.3 t80 -137.5 130.31 30.17 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.579 175.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 76.0 m -112.04 112.82 24.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.319 176.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 66' ' ' PHE . . . . . 0.549 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 7.6 p90 -118.67 150.5 39.62 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 173.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 67' ' ' ASN . . . . . 0.491 ' O ' HD11 ' D' ' 75' ' ' ILE . 18.6 p30 -122.04 140.61 52.28 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 68' ' ' GLU . . . . . 0.806 ' HB3' HG12 ' D' ' 47' ' ' ILE . 39.2 mm-40 -68.33 -9.46 48.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.218 0.532 . . . . 0.0 110.368 -176.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.569 ' HB3' ' NZ ' ' D' ' 69' ' ' LYS . 5.3 mtpm? -62.73 -45.06 94.49 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 170.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 31.1 t -66.29 125.65 26.27 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 113.528 -1.669 . . . . 0.0 107.571 168.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 71' ' ' THR . . . . . 0.407 ' O ' HG13 ' D' ' 75' ' ' ILE . 72.0 p -54.19 125.28 18.52 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -178.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 72' ' ' VAL . . . . . 0.693 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -55.32 -14.62 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 121.069 0.461 . . . . 0.0 110.918 -175.271 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 73' ' ' GLY . . . . . 0.744 ' HA3' ' HA2' ' D' ' 44' ' ' GLY . . . -71.05 -57.01 6.52 Favored Glycine 0 N--CA 1.437 -1.264 0 CA-C-N 115.043 -0.98 . . . . 0.0 112.627 170.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -61.76 -24.15 66.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.115 0.483 . . . . 0.0 110.342 176.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 75' ' ' ILE . . . . . 0.613 ' O ' HG13 ' D' ' 79' ' ' ILE . 66.4 mt -73.2 -41.53 58.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.359 175.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 28.4 t -76.16 -24.05 54.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.762 -0.199 . . . . 0.0 110.764 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 77' ' ' ASN . . . . . 0.553 ' O ' ' HD3' ' D' ' 81' ' ' LYS . 66.0 m-20 -63.38 -19.03 64.3 Favored 'General case' 0 C--O 1.218 -0.601 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 168.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 78' ' ' ASP . . . . . 0.665 ' O ' HD23 ' D' ' 82' ' ' LEU . 72.0 m-20 -93.52 -45.41 7.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.068 174.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 79' ' ' ILE . . . . . 0.707 HG22 HD11 ' D' ' 36' ' ' LEU . 43.0 mt -67.99 -33.35 60.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 O-C-N 121.743 -0.598 . . . . 0.0 111.729 -170.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -64.63 -13.49 53.85 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.191 174.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 81' ' ' LYS . . . . . 0.553 ' HD3' ' O ' ' D' ' 77' ' ' ASN . 16.0 mmmt -92.34 -57.8 2.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 122.185 0.993 . . . . 0.0 108.866 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 82' ' ' LEU . . . . . 0.665 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.3 mm? -56.07 -23.63 34.93 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 113.821 -1.536 . . . . 0.0 112.913 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 83' ' ' ASN . . . . . 0.589 ' HA ' HD12 ' D' ' 36' ' ' LEU . 7.5 m120 32.72 70.46 0.1 Allowed 'General case' 0 N--CA 1.476 0.867 0 O-C-N 124.182 0.926 . . . . 0.0 112.978 -177.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 84' ' ' ILE . . . . . 0.578 HG22 HD13 ' D' ' 89' ' ' ILE . 47.2 mt -86.45 98.86 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-O 121.132 0.492 . . . . 0.0 110.991 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 85' ' ' LYS . . . . . 0.688 ' HE3' ' O ' ' D' ' 34' ' ' ASN . 0.0 OUTLIER -135.01 94.55 3.16 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.871 0.843 . . . . 0.0 111.947 -179.563 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 86' ' ' GLY . . . . . 0.585 ' H ' ' CD1' ' D' ' 89' ' ' ILE . . . 70.28 153.2 0.92 Allowed Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.622 -0.717 . . . . 0.0 113.032 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 87' ' ' PRO . . . . . 0.578 ' O ' HG13 ' D' ' 58' ' ' VAL . 92.6 Cg_endo -91.18 -177.27 9.29 Favored 'Cis proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.705 -1.373 . . . . 0.0 112.52 -0.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 88' ' ' TYR . . . . . 0.693 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 14.4 m-85 8.24 93.18 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 125.473 1.509 . . . . 0.0 113.844 -177.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.912 HG12 HG22 ' D' ' 58' ' ' VAL . 67.8 mt -110.43 135.22 50.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.427 0.632 . . . . 0.0 111.83 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 90' ' ' GLU . . . . . 0.768 ' HB2' ' HB2' ' D' ' 57' ' ' PHE . 5.5 mm-40 -122.58 89.52 3.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.991 176.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 91' ' ' ILE . . . . . 1.136 HG22 ' HZ3' ' D' ' 54' ' ' TRP . 4.7 mt -96.31 108.9 21.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 92' ' ' LYS . . . . . 0.643 ' HG2' ' O ' ' D' ' 93' ' ' GLN . 0.0 OUTLIER -162.95 172.73 14.62 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.361 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 93' ' ' GLN . . . . . 0.643 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 25.1 pt20 -81.5 163.58 22.6 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 119.749 -0.781 . . . . 0.0 111.219 175.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 94' ' ' ILE . . . . . 0.569 HG22 ' HE2' ' D' ' 92' ' ' LYS . 9.9 pt . . . . . 0 C--N 1.307 -1.246 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.139 -172.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 41.9 mm . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 121.747 0.784 . . . . 0.0 111.451 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 75.0 m-80 -94.81 -50.59 5.07 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.001 172.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 15' ' ' SER . . . . . 0.506 ' O ' ' HD2' ' D' ' 19' ' ' LYS . 80.5 p -66.62 -30.59 70.9 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.256 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 16' ' ' VAL . . . . . 0.504 HG13 ' OD1' ' D' ' 17' ' ' ASN . 11.5 p -50.75 -28.53 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 121.981 0.896 . . . . 0.0 110.31 175.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 17' ' ' ASN . . . . . 0.677 HD22 ' H ' ' D' ' 29' ' ' LEU . 65.2 m-20 -83.51 -31.29 26.53 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.911 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.92 -15.55 43.94 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 177.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.56 ' N ' ' HD2' ' D' ' 19' ' ' LYS . 0.0 OUTLIER -90.82 -42.21 10.78 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 176.006 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 20' ' ' LEU . . . . . 0.929 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 64.9 mt -70.4 -41.06 73.48 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 113.327 -1.76 . . . . 0.0 110.398 -176.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 21' ' ' ASN . . . . . 0.697 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 59.4 m-20 -74.42 100.76 3.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.656 -1.157 . . . . 0.0 110.225 177.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 22' ' ' LYS . . . . . 0.573 ' NZ ' HG23 ' D' ' 47' ' ' ILE . 54.3 mtpt -121.94 -43.46 2.34 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -171.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.96 -74.81 0.2 Allowed Glycine 0 N--CA 1.435 -1.39 0 C-N-CA 120.281 -0.961 . . . . 0.0 112.231 -174.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 24' ' ' LYS . . . . . 0.823 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 27.2 tptp -58.41 -68.42 0.26 Allowed 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 25' ' ' GLY . . . . . 0.795 ' HA2' ' ND2' ' D' ' 42' ' ' ASN . . . -127.77 156.93 20.84 Favored Glycine 0 N--CA 1.431 -1.656 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.631 173.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 26' ' ' LYS . . . . . 0.697 ' CB ' ' HA ' ' D' ' 21' ' ' ASN . 8.5 ptpt -148.31 159.45 43.98 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 114.828 -0.686 . . . . 0.0 111.192 -170.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 27' ' ' LEU . . . . . 0.929 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 42.0 tp -137.46 142.82 41.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.717 0.77 . . . . 0.0 111.968 -177.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 28' ' ' SER . . . . . 0.688 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 50.3 m -129.05 151.32 49.86 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.296 -178.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 29' ' ' LEU . . . . . 0.677 ' H ' HD22 ' D' ' 17' ' ' ASN . 17.7 mt -140.89 135.49 31.36 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 177.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 48.5 m -136.85 -173.28 3.4 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 22.7 ptm -150.14 166.01 31.12 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.675 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 32' ' ' ASN . . . . . 0.413 ' H ' ' HB2' ' D' ' 35' ' ' GLN . 52.7 t-20 -143.19 89.3 2.09 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.07 -101.88 1.51 Allowed Glycine 0 C--O 1.227 -0.3 0 C-N-CA 120.064 -1.065 . . . . 0.0 110.901 -173.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -111.15 27.81 9.33 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.183 0.515 . . . . 0.0 109.907 173.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 35' ' ' GLN . . . . . 0.413 ' HB2' ' H ' ' D' ' 32' ' ' ASN . 73.8 mm-40 -96.87 164.74 12.42 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -177.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.763 HD11 HG22 ' D' ' 79' ' ' ILE . 2.8 tm? -132.18 124.19 28.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.056 174.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 37' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -132.11 100.73 5.13 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.004 -168.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.57 146.81 25.42 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.574 0.702 . . . . 0.0 112.105 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 39' ' ' THR . . . . . 0.688 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 18.3 p -141.65 128.83 20.96 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.242 176.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 40' ' ' SER . . . . . 0.61 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 77.7 p -107.12 129.5 54.83 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 173.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 41' ' ' SER . . . . . 0.687 ' HB3' ' HG3' ' D' ' 26' ' ' LYS . 46.2 t -93.03 146.7 23.43 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -175.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 42' ' ' ASN . . . . . 0.795 ' ND2' ' HA2' ' D' ' 25' ' ' GLY . 0.9 OUTLIER 82.12 -18.74 0.45 Allowed 'General case' 0 N--CA 1.477 0.925 0 O-C-N 125.59 1.806 . . . . 0.0 109.757 -167.944 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 60.85 60.33 1.89 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 175.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 123.88 35.98 0.65 Allowed Glycine 0 C--N 1.338 0.689 0 C-N-CA 119.166 -1.492 . . . . 0.0 115.797 168.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 45' ' ' TYR . . . . . 0.823 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 7.0 m-30 -116.02 160.87 19.7 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 170.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 46' ' ' GLY . . . . . 0.571 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -107.84 -152.91 17.49 Favored Glycine 0 C--O 1.223 -0.533 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.87 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 47' ' ' ILE . . . . . 0.995 HG13 ' HB2' ' D' ' 68' ' ' GLU . 1.7 mp -51.45 -57.68 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 CA-C-O 122.484 1.135 . . . . 0.0 108.486 177.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 67.2 p 167.93 -77.67 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 111.378 -2.646 . . . . 0.0 107.273 -173.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 49' ' ' TYR . . . . . 0.464 ' O ' ' HD2' ' D' ' 49' ' ' TYR . 0.1 OUTLIER -154.64 74.55 0.95 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.61 165.496 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 50' ' ' GLU . . . . . 0.663 ' O ' ' HG2' ' D' ' 69' ' ' LYS . 59.2 mm-40 -141.46 -158.67 0.88 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.226 -176.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 51' ' ' ASP . . . . . 0.603 ' CB ' ' HD2' ' D' ' 69' ' ' LYS . 7.2 t70 -146.51 112.26 5.65 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.234 174.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 52' ' ' LYS . . . . . 0.757 ' HD3' HG12 ' D' ' 47' ' ' ILE . 4.5 mptp? -126.15 106.15 9.36 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.904 -172.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 19.7 m-20 -88.74 130.44 35.34 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.06 0.457 . . . . 0.0 110.401 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 54' ' ' TRP . . . . . 1.04 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 0.4 OUTLIER -119.63 166.02 13.72 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.108 -175.2 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -148.84 159.93 28.21 Favored Glycine 0 N--CA 1.439 -1.138 0 C-N-CA 120.04 -1.076 . . . . 0.0 113.689 175.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 56' ' ' ILE . . . . . 1.005 HG12 HG23 ' D' ' 91' ' ' ILE . 82.8 mt -135.61 105.06 5.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 176.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 57' ' ' PHE . . . . . 0.524 ' HD1' ' O ' ' D' ' 90' ' ' GLU . 13.7 m-85 -101.28 98.21 8.62 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 119.178 -1.009 . . . . 0.0 111.076 -167.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.744 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 97.9 t -89.75 115.16 28.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.835 173.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 32.3 m120 66.11 38.04 4.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.81 -175.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.92 -32.99 4.37 Favored Glycine 0 CA--C 1.509 -0.334 0 C-N-CA 120.959 -0.638 . . . . 0.0 113.512 176.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 61' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 16.6 pt-20 -90.76 141.55 28.68 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.322 0.582 . . . . 0.0 111.399 -174.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 62' ' ' LYS . . . . . 0.459 ' NZ ' ' HB3' ' D' ' 62' ' ' LYS . 6.2 ttpm? -74.07 100.38 3.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.1 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.51 HG12 ' O ' ' D' ' 56' ' ' ILE . 14.5 p -79.37 -28.65 13.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.672 -173.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 64' ' ' TYR . . . . . 0.406 ' HB3' HD12 ' D' ' 56' ' ' ILE . 22.0 t80 -140.32 141.62 35.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.639 0.257 . . . . 0.0 110.657 176.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 28.3 m -121.19 130.42 53.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.882 176.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 66' ' ' PHE . . . . . 0.709 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 19.5 p90 -136.98 140.13 41.95 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.758 0.79 . . . . 0.0 110.859 174.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 67' ' ' ASN . . . . . 0.807 HD22 ' HB2' ' D' ' 69' ' ' LYS . 11.2 p-10 -111.2 135.4 51.78 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.901 -178.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 68' ' ' GLU . . . . . 0.995 ' HB2' HG13 ' D' ' 47' ' ' ILE . 28.4 mt-10 -65.05 -13.2 57.37 Favored 'General case' 0 CA--C 1.521 -0.137 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.036 -175.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.807 ' HB2' HD22 ' D' ' 67' ' ' ASN . 5.6 mtpm? -59.91 -43.21 95.01 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 172.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 25.5 t -74.56 102.18 4.44 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 113.422 -1.717 . . . . 0.0 107.185 165.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 62.4 p -38.95 130.35 1.49 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.631 -173.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 72' ' ' VAL . . . . . 0.523 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -53.32 -14.14 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 179.242 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 73' ' ' GLY . . . . . 0.61 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -71.56 -62.49 3.42 Favored Glycine 0 N--CA 1.435 -1.367 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.303 170.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -54.79 -31.09 58.52 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.247 0.546 . . . . 0.0 110.717 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 75' ' ' ILE . . . . . 0.485 ' O ' ' HB2' ' D' ' 78' ' ' ASP . 26.6 mm -80.37 -36.3 16.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.401 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 76' ' ' SER . . . . . 0.649 ' HB2' HD13 ' D' ' 27' ' ' LEU . 27.7 t -73.84 -20.28 60.48 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.965 178.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -61.38 -46.51 89.89 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 163.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 78' ' ' ASP . . . . . 0.944 ' HA ' ' HG2' ' D' ' 81' ' ' LYS . 51.5 m-20 -60.31 -36.16 77.28 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 174.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 79' ' ' ILE . . . . . 0.763 HG22 HD11 ' D' ' 36' ' ' LEU . 29.8 mm -67.06 -30.6 50.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.248 -174.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -75.98 -15.87 60.08 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.332 174.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 81' ' ' LYS . . . . . 0.944 ' HG2' ' HA ' ' D' ' 78' ' ' ASP . 11.0 mmtp -77.33 -63.65 1.32 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 173.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 82' ' ' LEU . . . . . 0.644 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.2 mm? -49.47 -26.25 3.22 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 113.242 -1.799 . . . . 0.0 113.56 -174.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 83' ' ' ASN . . . . . 0.575 ' O ' ' HE2' ' D' ' 85' ' ' LYS . 49.8 t-20 51.82 66.67 1.13 Allowed 'General case' 0 N--CA 1.468 0.46 0 O-C-N 123.386 0.429 . . . . 0.0 110.251 177.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 84' ' ' ILE . . . . . 0.6 HG22 HD13 ' D' ' 89' ' ' ILE . 46.5 mm -76.9 99.48 2.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.897 -173.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 85' ' ' LYS . . . . . 0.575 ' HE2' ' O ' ' D' ' 83' ' ' ASN . 0.0 OUTLIER -156.26 91.75 1.28 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 174.889 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 86' ' ' GLY . . . . . 0.712 ' H ' HD11 ' D' ' 89' ' ' ILE . . . 69.17 151.27 0.43 Allowed Glycine 0 N--CA 1.453 -0.219 0 CA-C-N 115.163 -0.926 . . . . 0.0 113.222 174.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 87' ' ' PRO . . . . . 0.634 ' O ' HG13 ' D' ' 58' ' ' VAL . 59.0 Cg_endo -90.76 179.91 13.15 Favored 'Cis proline' 0 CA--C 1.535 0.534 0 C-N-CA 123.336 -1.527 . . . . 0.0 112.784 -0.095 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 88' ' ' TYR . . . . . 0.744 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 0.9 OUTLIER 16.85 92.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 125.142 1.377 . . . . 0.0 113.705 178.76 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.712 HD11 ' H ' ' D' ' 86' ' ' GLY . 70.3 mt -111.5 142.73 23.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 90' ' ' GLU . . . . . 0.524 ' O ' ' HD1' ' D' ' 57' ' ' PHE . 70.9 mt-10 -136.87 95.05 3.05 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.676 172.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 91' ' ' ILE . . . . . 1.04 HG22 ' HZ3' ' D' ' 54' ' ' TRP . 5.5 mt -96.87 106.53 18.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 92' ' ' LYS . . . . . 0.613 ' HA ' ' CH2' ' D' ' 54' ' ' TRP . 0.0 OUTLIER -161.93 170.77 18.79 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.622 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 93' ' ' GLN . . . . . 0.601 ' HB3' ' NE1' ' D' ' 54' ' ' TRP . 18.9 pt20 -82.59 164.8 20.57 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.749 176.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 94' ' ' ILE . . . . . 0.507 HG22 ' HE2' ' D' ' 92' ' ' LYS . 10.4 pt . . . . . 0 C--N 1.31 -1.118 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.174 -172.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.475 HG21 ' SD ' ' D' ' 31' ' ' MET . 38.2 mm . . . . . 0 N--CA 1.453 -0.309 0 CA-C-O 121.497 0.665 . . . . 0.0 111.34 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -96.83 -56.27 2.62 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 177.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 37.2 m -69.39 -15.7 63.36 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 121.21 -0.196 . . . . 0.0 110.997 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 16' ' ' VAL . . . . . 0.746 ' HA ' ' HE2' ' D' ' 19' ' ' LYS . 14.1 p -56.84 -35.26 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 173.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -66.66 -44.01 82.99 Favored 'General case' 0 C--O 1.211 -0.955 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.349 175.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -56.77 -15.07 3.97 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -174.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.746 ' HE2' ' HA ' ' D' ' 16' ' ' VAL . 0.0 OUTLIER -91.54 -44.09 9.28 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-O 122.413 1.101 . . . . 0.0 108.895 174.261 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 20' ' ' LEU . . . . . 0.862 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 72.6 mt -69.76 -36.47 75.81 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 112.804 -1.998 . . . . 0.0 110.097 -174.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 21' ' ' ASN . . . . . . . . . . . . . 48.2 m-20 -69.82 98.76 1.27 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.589 177.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 22' ' ' LYS . . . . . 0.624 ' NZ ' ' HA ' ' D' ' 47' ' ' ILE . 8.8 mtmp? -121.36 -42.5 2.45 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -171.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.38 -71.66 0.32 Allowed Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.135 -1.031 . . . . 0.0 112.04 -175.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 24' ' ' LYS . . . . . 0.831 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 21.8 tptm -51.01 -67.42 0.25 Allowed 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 175.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.9 166.69 23.91 Favored Glycine 0 N--CA 1.43 -1.704 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.581 169.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 26' ' ' LYS . . . . . 0.831 ' HD2' ' HB2' ' D' ' 41' ' ' SER . 0.4 OUTLIER -148.15 156.93 43.17 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.543 -0.328 . . . . 0.0 110.486 -170.545 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 27' ' ' LEU . . . . . 0.862 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 46.2 tp -137.43 142.47 41.62 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.318 0.58 . . . . 0.0 111.285 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 28' ' ' SER . . . . . 0.709 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 49.0 m -137.03 143.18 42.57 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.013 -174.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 29' ' ' LEU . . . . . 0.586 HD11 ' CD1' ' D' ' 20' ' ' LEU . 0.2 OUTLIER -140.7 149.73 42.56 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.768 -179.113 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 36.1 t -155.01 174.45 15.16 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.17 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 31' ' ' MET . . . . . 0.475 ' SD ' HG21 ' D' ' 13' ' ' ILE . 0.0 OUTLIER -128.74 165.43 20.93 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.023 0.44 . . . . 0.0 109.884 176.838 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 32' ' ' ASN . . . . . 0.423 ' HB3' ' HB2' ' D' ' 35' ' ' GLN . 52.6 t30 -146.82 88.13 1.73 Allowed 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.61 -101.06 1.24 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.392 -168.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 34' ' ' ASN . . . . . 0.428 ' O ' ' HE2' ' D' ' 85' ' ' LYS . 72.3 m-20 -116.4 20.99 13.89 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.691 -0.3 . . . . 0.0 110.705 173.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 35' ' ' GLN . . . . . 0.423 ' HB2' ' HB3' ' D' ' 32' ' ' ASN . 13.6 mm100 -88.91 163.09 15.76 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.576 0.703 . . . . 0.0 111.983 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.716 HD11 HG22 ' D' ' 79' ' ' ILE . 2.4 tm? -129.93 124.95 34.32 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.933 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 37' ' ' LYS . . . . . 0.581 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 26.1 mmmt -130.38 116.15 17.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.605 -168.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 38' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -120.16 143.72 48.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.443 0.64 . . . . 0.0 111.338 176.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 39' ' ' THR . . . . . 0.709 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 4.9 p -138.55 130.11 27.62 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.095 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 40' ' ' SER . . . . . 0.723 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 24.7 p -120.75 129.52 53.65 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 41' ' ' SER . . . . . 0.831 ' HB2' ' HD2' ' D' ' 26' ' ' LYS . 49.3 m -100.92 159.45 15.19 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.174 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 42' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' D' ' 41' ' ' SER . 74.2 m-80 76.67 8.91 3.05 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 124.572 1.17 . . . . 0.0 110.707 -174.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 40.92 59.05 2.33 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 171.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 114.22 35.24 1.5 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 119.419 -1.372 . . . . 0.0 114.175 172.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 45' ' ' TYR . . . . . 0.831 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 2.2 m-30 -113.18 145.74 40.45 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 122.477 -0.425 . . . . 0.0 110.02 172.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -91.63 -150.49 25.55 Favored Glycine 0 CA--C 1.504 -0.629 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.411 -178.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 47' ' ' ILE . . . . . 0.939 HG13 ' HB2' ' D' ' 68' ' ' GLU . 0.3 OUTLIER -53.77 -58.91 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 CA-C-O 122.079 0.942 . . . . 0.0 109.013 -178.585 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 48' ' ' SER . . . . . 0.444 ' O ' ' HD2' ' D' ' 49' ' ' TYR . 41.1 t 163.25 -107.32 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 111.216 -2.72 . . . . 0.0 105.381 -172.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 49' ' ' TYR . . . . . 0.444 ' HD2' ' O ' ' D' ' 48' ' ' SER . 2.7 m-30 -124.09 76.76 1.48 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 163.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 50' ' ' GLU . . . . . 0.459 ' HB2' HG21 ' D' ' 47' ' ' ILE . 63.8 mm-40 -148.56 -166.14 2.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.134 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 51' ' ' ASP . . . . . 0.725 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 2.8 p30 -148.41 138.7 22.6 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.382 168.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 52' ' ' LYS . . . . . 0.725 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 0.4 OUTLIER -143.44 144.35 31.98 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.098 -174.854 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 52.5 m-20 -120.2 129.54 54.14 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 172.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 54' ' ' TRP . . . . . 1.057 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 1.0 OUTLIER -120.99 162.04 20.59 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -173.109 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -152.19 152.96 24.6 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.414 172.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 56' ' ' ILE . . . . . 1.106 HG12 HG23 ' D' ' 91' ' ' ILE . 83.7 mt -117.3 116.93 53.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 173.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 57' ' ' PHE . . . . . 0.684 ' CE1' ' HG2' ' D' ' 62' ' ' LYS . 15.3 m-85 -107.47 98.96 8.51 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 119.467 -0.893 . . . . 0.0 111.389 -168.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 59.3 t -91.94 115.01 30.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.763 173.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 63.9 34.7 11.47 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.212 -176.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.72 -32.27 5.15 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.455 -0.878 . . . . 0.0 113.726 176.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 61' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 16.2 pt-20 -90.0 155.24 19.23 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.798 0.333 . . . . 0.0 110.799 -174.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 62' ' ' LYS . . . . . 0.684 ' HG2' ' CE1' ' D' ' 57' ' ' PHE . 57.8 mttp -80.49 103.03 10.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.961 0.41 . . . . 0.0 110.043 -178.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 14.1 p -78.7 -29.33 14.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.94 -177.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 64' ' ' TYR . . . . . 0.445 ' HB3' HD12 ' D' ' 56' ' ' ILE . 16.3 t80 -146.72 126.65 13.6 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.682 175.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 97.2 m -109.59 111.72 23.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.542 174.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 66' ' ' PHE . . . . . 0.498 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 15.9 p90 -116.36 160.71 20.13 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 172.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 67' ' ' ASN . . . . . 0.505 ' O ' HD11 ' D' ' 75' ' ' ILE . 13.2 p30 -132.59 141.35 48.65 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 68' ' ' GLU . . . . . 0.939 ' HB2' HG13 ' D' ' 47' ' ' ILE . 31.4 mm-40 -64.21 -15.23 59.55 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -177.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.613 ' HA ' HD11 ' D' ' 47' ' ' ILE . 49.3 mtpt -56.81 -49.89 74.0 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 173.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 23.1 t -63.8 128.37 35.53 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 113.426 -1.716 . . . . 0.0 107.51 168.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 70.2 p -57.51 118.99 5.77 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 72' ' ' VAL . . . . . 0.65 ' HA ' HD12 ' D' ' 75' ' ' ILE . 0.0 OUTLIER -53.61 -14.98 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -176.387 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 73' ' ' GLY . . . . . 0.723 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -67.96 -56.74 9.97 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.788 170.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -68.23 -19.97 64.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.988 0.423 . . . . 0.0 110.278 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 75' ' ' ILE . . . . . 0.65 HD12 ' HA ' ' D' ' 72' ' ' VAL . 83.3 mt -72.59 -43.95 61.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.555 175.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 31.4 t -73.58 -19.15 60.96 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.166 -176.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -60.49 -44.47 95.91 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 165.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 78' ' ' ASP . . . . . 1.018 ' HA ' ' HG2' ' D' ' 81' ' ' LYS . 1.0 OUTLIER -69.66 -25.81 64.09 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 114.981 -1.009 . . . . 0.0 113.407 177.144 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 79' ' ' ILE . . . . . 0.716 HG22 HD11 ' D' ' 36' ' ' LEU . 41.5 mt -77.72 -17.0 14.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 118.89 -1.124 . . . . 0.0 109.875 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -77.52 -26.83 51.45 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.256 169.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 81' ' ' LYS . . . . . 1.018 ' HG2' ' HA ' ' D' ' 78' ' ' ASP . 15.9 mmtt -74.01 -69.96 0.41 Allowed 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 176.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 82' ' ' LEU . . . . . 0.491 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.5 mm? -47.28 -32.25 4.5 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 113.482 -1.69 . . . . 0.0 112.578 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 37.85 65.5 0.56 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.979 0.912 . . . . 0.0 111.269 175.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 84' ' ' ILE . . . . . 0.622 ' H ' HD12 ' D' ' 84' ' ' ILE . 2.8 mp -74.88 99.12 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.96 0.41 . . . . 0.0 111.372 -171.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 85' ' ' LYS . . . . . 0.428 ' HE2' ' O ' ' D' ' 34' ' ' ASN . 16.8 ptpt -125.9 92.3 3.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.988 0.423 . . . . 0.0 111.96 178.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 86' ' ' GLY . . . . . 0.805 ' H ' HD11 ' D' ' 89' ' ' ILE . . . 61.33 160.04 0.11 Allowed Glycine 0 CA--C 1.52 0.353 0 CA-C-N 115.328 -0.851 . . . . 0.0 114.146 173.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 87' ' ' PRO . . . . . 0.584 ' O ' HG13 ' D' ' 58' ' ' VAL . 44.8 Cg_endo -93.68 -178.58 8.42 Favored 'Cis proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.795 -1.335 . . . . 0.0 112.176 -1.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 88' ' ' TYR . . . . . 0.647 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 16.0 m-85 24.57 92.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.823 1.249 . . . . 0.0 113.387 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.805 HD11 ' H ' ' D' ' 86' ' ' GLY . 75.8 mt -111.67 130.78 64.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 90' ' ' GLU . . . . . 0.581 ' O ' ' HD2' ' D' ' 57' ' ' PHE . 51.3 mt-10 -130.52 101.54 5.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.105 172.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 91' ' ' ILE . . . . . 1.106 HG23 HG12 ' D' ' 56' ' ' ILE . 4.1 mt -98.3 113.03 31.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -177.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 92' ' ' LYS . . . . . 0.627 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -162.28 170.57 18.71 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.084 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 93' ' ' GLN . . . . . 0.626 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 25.1 pt20 -80.97 164.81 22.28 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.803 176.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 94' ' ' ILE . . . . . 0.627 HG22 ' HE2' ' D' ' 92' ' ' LYS . 10.7 pt . . . . . 0 C--N 1.31 -1.109 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.899 -171.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.549 HG21 ' HE1' ' D' ' 31' ' ' MET . 63.9 mt . . . . . 0 N--CA 1.456 -0.149 0 CA-C-O 121.729 0.776 . . . . 0.0 111.736 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -96.19 -50.37 4.84 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.519 172.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 15' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' D' ' 18' ' ' ASP . 80.5 p -63.44 -24.94 68.05 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.328 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 16' ' ' VAL . . . . . 0.653 ' O ' ' HG ' ' D' ' 20' ' ' LEU . 9.8 p -54.16 -37.58 36.04 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-O 121.296 0.569 . . . . 0.0 109.593 176.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 17' ' ' ASN . . . . . 0.617 ' OD1' ' HA ' ' D' ' 28' ' ' SER . 78.6 m-20 -78.21 -22.3 48.72 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.461 -178.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 18' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' D' ' 15' ' ' SER . 1.0 OUTLIER -67.79 -17.14 64.43 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 176.379 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.587 ' O ' ' HE3' ' D' ' 22' ' ' LYS . 0.0 OUTLIER -91.74 -43.11 9.75 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 172.186 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 20' ' ' LEU . . . . . 1.018 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 85.4 mt -63.04 -40.95 99.24 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.009 -1.451 . . . . 0.0 110.131 -177.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 21' ' ' ASN . . . . . 0.576 ' OD1' ' HB2' ' D' ' 26' ' ' LYS . 51.6 m-80 -79.73 101.64 8.55 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.347 177.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 22' ' ' LYS . . . . . 0.966 ' HD2' HD12 ' D' ' 47' ' ' ILE . 97.4 mttt -122.18 -41.76 2.41 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -175.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 169.9 -91.13 0.1 OUTLIER Glycine 0 N--CA 1.437 -1.26 0 C-N-CA 119.604 -1.284 . . . . 0.0 112.982 -178.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 24' ' ' LYS . . . . . 0.656 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 26.4 tptp -48.27 -52.86 19.36 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 25' ' ' GLY . . . . . 0.694 ' HA2' ' OD1' ' D' ' 42' ' ' ASN . . . -141.48 154.0 24.4 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.394 176.26 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 26' ' ' LYS . . . . . 0.588 ' CD ' ' HB3' ' D' ' 41' ' ' SER . 0.4 OUTLIER -144.92 161.94 38.1 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.573 -0.814 . . . . 0.0 112.248 -168.709 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 27' ' ' LEU . . . . . 1.018 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 51.5 tp -134.93 153.15 52.17 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.454 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 28' ' ' SER . . . . . 0.617 ' HA ' ' OD1' ' D' ' 17' ' ' ASN . 14.2 t -140.68 153.79 46.12 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 29' ' ' LEU . . . . . . . . . . . . . 20.2 mt -134.2 158.8 42.75 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.624 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 37.3 t -160.15 -177.13 6.07 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 31' ' ' MET . . . . . 0.549 ' HE1' HG21 ' D' ' 13' ' ' ILE . 1.3 pmm? -150.57 163.15 39.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.84 0.352 . . . . 0.0 111.007 177.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 32' ' ' ASN . . . . . 0.444 ' H ' ' HB2' ' D' ' 35' ' ' GLN . 51.3 t30 -144.25 88.48 1.95 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.1 175.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.47 -115.35 4.56 Favored Glycine 0 N--CA 1.454 -0.154 0 C-N-CA 120.205 -0.997 . . . . 0.0 110.991 -172.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -95.78 20.71 9.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.915 0.388 . . . . 0.0 110.926 174.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 35' ' ' GLN . . . . . 0.444 ' HB2' ' H ' ' D' ' 32' ' ' ASN . 10.3 mm-40 -88.54 152.85 21.59 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 121.314 0.578 . . . . 0.0 111.989 176.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.824 HD12 ' HA ' ' D' ' 83' ' ' ASN . 1.3 tm? -134.37 119.56 18.77 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.378 175.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 37' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -123.36 157.36 33.47 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.564 -169.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 38' ' ' ALA . . . . . 0.599 ' HB1' HD11 ' D' ' 27' ' ' LEU . . . -148.83 152.26 36.19 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 113.216 -1.811 . . . . 0.0 111.341 176.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 39' ' ' THR . . . . . 0.586 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 20.6 p -145.54 139.03 26.46 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.198 175.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 40' ' ' SER . . . . . 0.52 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 33.8 p -106.1 128.78 54.12 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 171.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 41' ' ' SER . . . . . 0.588 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 48.0 t -92.18 162.58 14.26 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 176.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 42' ' ' ASN . . . . . 0.694 ' OD1' ' HA2' ' D' ' 25' ' ' GLY . 0.4 OUTLIER 64.64 3.78 2.08 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 124.605 1.19 . . . . 0.0 111.896 -169.268 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 43' ' ' ALA . . . . . 0.41 ' H ' ' C ' ' D' ' 41' ' ' SER . . . 52.79 63.24 2.32 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 165.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.62 -15.94 6.63 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 118.174 -1.965 . . . . 0.0 115.993 166.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 45' ' ' TYR . . . . . 0.656 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 2.2 m-30 -78.62 155.94 29.34 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 117.909 0.855 . . . . 0.0 110.683 -176.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 46' ' ' GLY . . . . . 0.635 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -96.79 -172.91 34.69 Favored Glycine 0 C--O 1.217 -0.968 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 172.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 47' ' ' ILE . . . . . 0.966 HD12 ' HD2' ' D' ' 22' ' ' LYS . 39.4 mm -48.41 -56.64 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.861 0 CA-C-N 117.975 0.888 . . . . 0.0 110.917 178.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 81.0 p -179.31 -147.38 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 112.574 -2.103 . . . . 0.0 108.025 -173.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -97.46 75.53 2.51 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.226 168.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 50' ' ' GLU . . . . . 0.402 ' OE2' ' HA ' ' D' ' 50' ' ' GLU . 36.8 mm-40 -144.0 -172.68 3.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.56 -178.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 51' ' ' ASP . . . . . 0.689 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 11.6 m-20 -134.86 120.13 18.94 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.141 173.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 52' ' ' LYS . . . . . 1.053 ' HG2' ' HB2' ' D' ' 68' ' ' GLU . 0.0 OUTLIER -139.41 130.35 26.3 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.436 -177.1 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 49.5 m-20 -109.92 142.82 40.74 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 121.002 0.429 . . . . 0.0 110.967 -175.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 54' ' ' TRP . . . . . 1.068 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 0.8 OUTLIER -123.43 160.57 26.56 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.825 -176.925 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -138.56 160.85 25.68 Favored Glycine 0 N--CA 1.438 -1.233 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.95 174.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 56' ' ' ILE . . . . . 0.943 HG12 HG23 ' D' ' 91' ' ' ILE . 97.0 mt -140.47 109.88 3.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 178.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 57' ' ' PHE . . . . . 0.633 ' HA ' ' O ' ' D' ' 61' ' ' GLU . 13.9 m-85 -107.92 101.25 10.53 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.624 -0.83 . . . . 0.0 111.7 -168.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.861 HG22 HG12 ' D' ' 89' ' ' ILE . 87.5 t -94.84 119.67 43.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.446 173.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 5.5 m120 63.93 35.59 10.73 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.075 0.464 . . . . 0.0 110.776 -175.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.2 34.68 90.57 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.373 -0.83 . . . . 0.0 114.461 175.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 61' ' ' GLU . . . . . 0.633 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 16.3 pt-20 -138.69 145.33 40.23 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 171.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 62' ' ' LYS . . . . . 0.449 ' NZ ' ' HB2' ' D' ' 62' ' ' LYS . 3.8 ttmp? -75.34 99.39 4.09 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -177.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.467 HG12 ' O ' ' D' ' 56' ' ' ILE . 9.2 p -84.73 -33.54 8.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.577 -173.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 64' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -135.88 131.37 35.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.932 0.396 . . . . 0.0 110.595 174.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 26.4 m -115.93 113.9 23.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.701 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 66' ' ' PHE . . . . . 0.563 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 10.8 p90 -116.81 130.91 57.01 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.355 0.597 . . . . 0.0 109.776 175.091 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -103.2 139.86 38.12 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -178.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 68' ' ' GLU . . . . . 1.053 ' HB2' ' HG2' ' D' ' 52' ' ' LYS . 40.2 mm-40 -70.63 -8.94 55.48 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.946 -174.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.556 ' HD3' ' HB3' ' D' ' 51' ' ' ASP . 47.0 mtmt -62.88 -39.73 95.35 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 169.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 31.7 t -71.45 119.9 16.26 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.502 -1.681 . . . . 0.0 107.07 165.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 70.1 p -54.87 130.59 41.73 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.255 -176.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 72' ' ' VAL . . . . . 0.636 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -55.68 -13.38 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 121.077 0.465 . . . . 0.0 111.813 -175.821 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 73' ' ' GLY . . . . . 0.52 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -74.07 -55.55 5.72 Favored Glycine 0 N--CA 1.437 -1.249 0 CA-C-N 115.212 -0.904 . . . . 0.0 112.445 169.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -62.29 -23.59 66.81 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.814 0.34 . . . . 0.0 110.553 177.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 75' ' ' ILE . . . . . 0.62 ' O ' HG13 ' D' ' 79' ' ' ILE . 74.3 mt -73.83 -41.85 53.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.329 176.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 28.8 t -73.5 -20.41 60.68 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.554 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -65.84 -28.25 68.84 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 168.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 78' ' ' ASP . . . . . 1.094 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 1.0 OUTLIER -83.71 -32.22 25.64 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 115.528 -0.76 . . . . 0.0 113.032 174.823 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 79' ' ' ILE . . . . . 0.62 HG13 ' O ' ' D' ' 75' ' ' ILE . 25.1 mt -72.27 -16.55 18.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 120.034 -0.667 . . . . 0.0 110.041 -176.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -65.04 -49.81 68.66 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.729 172.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 81' ' ' LYS . . . . . 1.094 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -72.73 -57.58 4.0 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.637 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 82' ' ' LEU . . . . . 0.544 HD23 ' O ' ' D' ' 78' ' ' ASP . 4.1 mm? -44.98 -35.45 2.9 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 83' ' ' ASN . . . . . 0.824 ' HA ' HD12 ' D' ' 36' ' ' LEU . 22.2 t-20 29.33 70.88 0.07 Allowed 'General case' 0 N--CA 1.476 0.841 0 O-C-N 124.591 1.182 . . . . 0.0 111.811 178.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 84' ' ' ILE . . . . . 0.602 ' O ' ' HG ' ' D' ' 36' ' ' LEU . 50.1 mt -93.0 98.33 8.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.627 -176.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 85' ' ' LYS . . . . . 0.491 ' HB2' ' HB2' ' D' ' 36' ' ' LEU . 2.7 tmtm? -127.65 93.93 3.83 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -178.077 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 86' ' ' GLY . . . . . 0.609 ' H ' HD11 ' D' ' 89' ' ' ILE . . . 72.1 153.11 1.65 Allowed Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.918 -0.583 . . . . 0.0 113.165 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 87' ' ' PRO . . . . . 0.541 ' O ' HG13 ' D' ' 58' ' ' VAL . 54.2 Cg_endo -91.21 -179.76 12.13 Favored 'Cis proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.395 -1.502 . . . . 0.0 112.923 -0.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 88' ' ' TYR . . . . . 0.616 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 19.3 m-85 10.99 93.87 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 125.74 1.616 . . . . 0.0 114.065 -178.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.861 HG12 HG22 ' D' ' 58' ' ' VAL . 68.5 mt -111.54 142.85 22.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.975 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 90' ' ' GLU . . . . . 0.426 ' HG2' ' HG3' ' D' ' 92' ' ' LYS . 38.3 tt0 -128.76 95.09 4.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.916 172.273 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 91' ' ' ILE . . . . . 1.068 HG22 ' HZ3' ' D' ' 54' ' ' TRP . 7.3 mt -97.18 109.15 22.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 92' ' ' LYS . . . . . 0.78 ' HE3' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -162.17 172.29 16.03 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 122.603 0.361 . . . . 0.0 110.308 -176.222 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 93' ' ' GLN . . . . . 0.696 ' HB3' ' NE1' ' D' ' 54' ' ' TRP . 17.4 pt20 -89.07 153.45 20.98 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.744 174.271 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 94' ' ' ILE . . . . . 0.78 HG22 ' HE3' ' D' ' 92' ' ' LYS . 10.6 pt . . . . . 0 C--N 1.309 -1.171 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.688 -171.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.592 ' O ' HG12 ' D' ' 16' ' ' VAL . 63.3 mt . . . . . 0 C--O 1.223 -0.309 0 CA-C-O 121.678 0.751 . . . . 0.0 111.43 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 -92.0 -46.87 7.59 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.229 173.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 15' ' ' SER . . . . . 0.451 ' O ' ' HE2' ' D' ' 19' ' ' LYS . 92.2 p -70.23 -18.66 63.16 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.78 176.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 16' ' ' VAL . . . . . 0.62 ' O ' ' HG ' ' D' ' 20' ' ' LEU . 1.3 p -62.06 -27.43 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -69.62 -41.34 75.81 Favored 'General case' 0 C--O 1.206 -1.232 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.905 175.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 18' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' D' ' 15' ' ' SER . 49.7 m-20 -61.94 -14.54 35.64 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 176.279 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.687 ' HB3' ' CZ2' ' D' ' 54' ' ' TRP . 1.2 mppt? -87.79 -26.85 22.65 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.367 0.603 . . . . 0.0 110.185 177.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 20' ' ' LEU . . . . . 0.993 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 84.6 mt -105.6 -38.49 6.41 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 113.547 -1.66 . . . . 0.0 110.559 -168.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 21' ' ' ASN . . . . . 0.685 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 1.2 t-20 -88.12 89.05 7.84 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 113.571 -1.65 . . . . 0.0 108.314 -172.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 22' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -120.42 -42.2 2.57 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -163.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 178.53 -88.63 0.07 OUTLIER Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 119.455 -1.355 . . . . 0.0 113.032 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 24' ' ' LYS . . . . . 0.782 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 53.6 tptt -50.79 -63.55 1.09 Allowed 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.246 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -127.69 162.57 21.58 Favored Glycine 0 N--CA 1.431 -1.67 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.315 171.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 26' ' ' LYS . . . . . 0.703 ' CD ' ' HB3' ' D' ' 41' ' ' SER . 0.1 OUTLIER -149.7 160.61 43.39 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.832 -0.684 . . . . 0.0 110.979 -169.165 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 27' ' ' LEU . . . . . 0.993 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 55.3 tp -138.47 143.73 39.74 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.153 0.501 . . . . 0.0 111.226 -178.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 28' ' ' SER . . . . . 0.62 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 29.5 t -130.39 136.77 49.41 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -177.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 29' ' ' LEU . . . . . 0.651 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 14.5 mt -132.48 135.28 45.91 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.302 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 61.2 m -142.2 -171.96 3.49 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.039 176.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -139.59 160.39 39.97 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.037 0.446 . . . . 0.0 110.236 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 32' ' ' ASN . . . . . 0.488 ' HB3' ' HB2' ' D' ' 35' ' ' GLN . 24.6 t-20 -139.84 88.07 2.21 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.22 -107.88 2.31 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.823 -169.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -108.4 26.87 9.95 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 122.505 -0.409 . . . . 0.0 110.521 174.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 35' ' ' GLN . . . . . 0.488 ' HB2' ' HB3' ' D' ' 32' ' ' ASN . 76.9 mt-30 -105.09 162.68 13.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.788 -178.214 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.779 ' HB2' ' HB2' ' D' ' 85' ' ' LYS . 0.9 OUTLIER -128.82 135.04 48.59 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.312 -178.935 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 37' ' ' LYS . . . . . 0.651 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 75.2 mmtt -129.76 111.43 12.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.052 -168.086 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 38' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -111.47 144.19 41.08 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.855 0.36 . . . . 0.0 111.067 175.157 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 39' ' ' THR . . . . . 0.62 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 16.2 p -147.42 135.88 21.75 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.353 177.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 40' ' ' SER . . . . . 0.677 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 30.4 p -109.4 129.99 55.52 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 41' ' ' SER . . . . . 0.703 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 47.4 t -95.58 148.94 21.98 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.121 -1.031 . . . . 0.0 109.337 177.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 42' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' D' ' 41' ' ' SER . 75.8 m-20 80.19 -1.64 2.0 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.389 -168.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 49.38 61.88 2.91 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 169.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.3 1.33 7.89 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 118.517 -1.801 . . . . 0.0 115.387 170.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 45' ' ' TYR . . . . . 0.782 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 1.5 m-30 -86.05 154.15 21.62 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 116.946 0.373 . . . . 0.0 110.333 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 46' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -102.33 -153.34 24.93 Favored Glycine 0 C--O 1.219 -0.827 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 178.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 47' ' ' ILE . . . . . 0.961 HG13 ' HB2' ' D' ' 68' ' ' GLU . 2.7 mp -49.04 -58.42 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 CA-C-O 122.428 1.109 . . . . 0.0 108.833 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 48' ' ' SER . . . . . 0.511 ' HA ' ' HG2' ' D' ' 24' ' ' LYS . 36.3 t 152.83 -95.28 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 110.593 -3.003 . . . . 0.0 106.544 -174.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 49' ' ' TYR . . . . . 0.466 ' HD1' ' C ' ' D' ' 48' ' ' SER . 3.7 m-30 -130.21 75.57 1.66 Allowed 'General case' 0 N--CA 1.465 0.304 0 O-C-N 122.228 -0.295 . . . . 0.0 111.047 169.221 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 50' ' ' GLU . . . . . 0.54 ' HB2' HG21 ' D' ' 47' ' ' ILE . 50.4 mt-10 -156.81 -175.63 5.53 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.348 0.259 . . . . 0.0 110.491 176.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 51' ' ' ASP . . . . . 0.704 ' HB2' ' HD2' ' D' ' 69' ' ' LYS . 7.0 p-10 -130.7 141.59 50.4 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.062 172.068 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 52' ' ' LYS . . . . . 0.767 ' HD3' HG12 ' D' ' 47' ' ' ILE . 0.7 OUTLIER -145.28 136.07 24.52 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.213 -177.136 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -113.82 139.04 49.47 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.173 170.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 54' ' ' TRP . . . . . 1.091 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 0.9 OUTLIER -126.71 157.01 40.19 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -172.176 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -143.23 158.08 27.13 Favored Glycine 0 N--CA 1.437 -1.298 0 C-N-CA 120.133 -1.032 . . . . 0.0 113.299 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 56' ' ' ILE . . . . . 1.024 HG12 HG23 ' D' ' 91' ' ' ILE . 91.7 mt -129.13 97.24 3.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 113.289 -1.456 . . . . 0.0 107.459 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 57' ' ' PHE . . . . . 0.578 ' HA ' ' O ' ' D' ' 61' ' ' GLU . 14.2 m-85 -100.15 103.25 14.73 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -171.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.796 HG12 HG12 ' D' ' 89' ' ' ILE . 3.8 m -95.55 99.95 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.648 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 59' ' ' ASN . . . . . 0.439 ' ND2' ' HB2' ' D' ' 88' ' ' TYR . 31.4 m120 57.93 62.9 1.92 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.692 -168.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.67 48.55 85.51 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 115.879 -0.6 . . . . 0.0 113.395 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 61' ' ' GLU . . . . . 0.578 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 5.4 tp10 -157.49 115.2 3.09 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 62' ' ' LYS . . . . . 0.489 ' HE2' ' OG1' ' D' ' 65' ' ' THR . 5.8 ttpm? -77.6 98.68 5.49 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 35.4 m -88.45 -11.5 10.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.48 -173.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 64' ' ' TYR . . . . . 0.549 ' HB3' HD12 ' D' ' 56' ' ' ILE . 16.9 t80 -150.42 136.6 18.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.835 0.35 . . . . 0.0 110.397 174.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 65' ' ' THR . . . . . 0.489 ' OG1' ' HE2' ' D' ' 62' ' ' LYS . 24.5 m -119.4 113.54 20.94 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.161 176.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 66' ' ' PHE . . . . . 0.535 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 10.3 p90 -123.89 159.15 30.3 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 173.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 67' ' ' ASN . . . . . 0.437 ' O ' HD11 ' D' ' 75' ' ' ILE . 13.1 p30 -131.51 137.77 48.66 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 68' ' ' GLU . . . . . 0.961 ' HB2' HG13 ' D' ' 47' ' ' ILE . 37.5 mt-10 -62.18 -16.41 52.81 Favored 'General case' 0 C--N 1.345 0.395 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -174.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.704 ' HD2' ' HB2' ' D' ' 51' ' ' ASP . 5.6 mtpm? -57.98 -47.14 83.88 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.17 174.013 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 31.7 t -66.66 114.06 5.29 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 166.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 59.2 p -53.32 124.85 15.79 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.418 -173.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 72' ' ' VAL . . . . . 0.488 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -53.2 -13.01 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.756 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 73' ' ' GLY . . . . . 0.677 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -70.36 -57.48 6.72 Favored Glycine 0 N--CA 1.436 -1.359 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.261 169.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -69.71 -18.46 63.54 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.51 -0.345 . . . . 0.0 111.016 178.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 75' ' ' ILE . . . . . 0.616 ' O ' HG13 ' D' ' 79' ' ' ILE . 73.7 mt -71.74 -42.47 70.54 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.388 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.032 173.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 40.3 t -72.9 -22.69 60.7 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.434 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -60.48 -30.1 69.48 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 167.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 78' ' ' ASP . . . . . 1.049 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 50.2 m-20 -87.52 -31.83 19.72 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.585 176.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 79' ' ' ILE . . . . . 0.616 HG13 ' O ' ' D' ' 75' ' ' ILE . 31.1 mt -71.88 -16.78 18.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.137 -177.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -67.64 -40.7 84.56 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.922 173.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 81' ' ' LYS . . . . . 1.049 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -81.35 -53.59 6.2 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.837 176.592 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 82' ' ' LEU . . . . . 0.503 HD23 ' O ' ' D' ' 78' ' ' ASP . 4.0 mm? -53.08 -26.58 16.66 Favored 'General case' 0 C--O 1.227 -0.098 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 39.14 67.91 0.4 Allowed 'General case' 0 N--CA 1.474 0.761 0 O-C-N 123.998 0.811 . . . . 0.0 111.236 176.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 84' ' ' ILE . . . . . 0.979 HG21 HG21 ' D' ' 56' ' ' ILE . 46.3 mm -84.43 98.49 5.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.835 -173.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 85' ' ' LYS . . . . . 0.779 ' HB2' ' HB2' ' D' ' 36' ' ' LEU . 10.0 tmtt? -145.39 95.42 2.66 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.354 0.597 . . . . 0.0 109.532 177.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 86' ' ' GLY . . . . . 0.985 ' H ' HD11 ' D' ' 89' ' ' ILE . . . 77.13 158.79 9.58 Favored Glycine 0 CA--C 1.498 -1.007 0 CA-C-N 115.473 -0.785 . . . . 0.0 114.147 178.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 87' ' ' PRO . . . . . 0.76 ' O ' ' HB ' ' D' ' 58' ' ' VAL . 90.4 Cg_endo -80.66 -176.99 18.97 Favored 'Cis proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.355 -1.935 . . . . 0.0 113.3 0.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 88' ' ' TYR . . . . . 0.656 ' H ' ' HD1' ' D' ' 88' ' ' TYR . 1.7 m-85 -11.36 96.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.943 1.297 . . . . 0.0 114.03 -175.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.985 HD11 ' H ' ' D' ' 86' ' ' GLY . 41.0 mt -92.79 143.58 11.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -173.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -130.39 91.52 3.11 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.65 173.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 91' ' ' ILE . . . . . 1.091 HG22 ' HZ3' ' D' ' 54' ' ' TRP . 2.5 mt -96.91 117.73 42.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -176.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 92' ' ' LYS . . . . . 0.755 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.1 OUTLIER -162.91 173.37 13.77 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.464 0.306 . . . . 0.0 110.929 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 93' ' ' GLN . . . . . 0.669 ' O ' ' HD3' ' D' ' 92' ' ' LYS . 19.8 pt20 -87.03 156.89 19.57 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.33 173.219 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 94' ' ' ILE . . . . . 0.755 HG22 ' HE2' ' D' ' 92' ' ' LYS . 5.5 pt . . . . . 0 C--N 1.313 -1.02 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.397 -169.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.646 ' O ' HG12 ' D' ' 16' ' ' VAL . 52.0 mt . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 121.631 0.729 . . . . 0.0 110.747 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 -88.08 -52.59 5.16 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.885 176.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 15' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' D' ' 18' ' ' ASP . 51.1 m -65.41 -21.61 66.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.488 174.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 16' ' ' VAL . . . . . 0.8 ' HA ' ' HE2' ' D' ' 19' ' ' LYS . 0.7 OUTLIER -59.12 -31.9 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.814 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 17' ' ' ASN . . . . . 0.603 ' OD1' ' HA ' ' D' ' 28' ' ' SER . 79.9 m-20 -85.06 -18.6 33.84 Favored 'General case' 0 C--O 1.205 -1.246 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.849 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 18' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' D' ' 15' ' ' SER . 73.7 m-20 -67.88 -16.36 64.05 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 122.304 -0.248 . . . . 0.0 111.599 176.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.8 ' HE2' ' HA ' ' D' ' 16' ' ' VAL . 0.0 OUTLIER -90.43 -39.83 12.41 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-O 121.987 0.899 . . . . 0.0 108.953 174.183 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 20' ' ' LEU . . . . . 0.913 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 78.3 mt -74.09 -40.17 62.91 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 113.628 -1.624 . . . . 0.0 110.107 -174.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 21' ' ' ASN . . . . . 0.543 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 44.9 m-20 -78.14 95.7 4.99 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.688 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 22' ' ' LYS . . . . . 0.779 ' HD2' HD12 ' D' ' 47' ' ' ILE . 67.6 mttm -122.58 -41.12 2.4 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -176.077 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.56 -103.16 0.18 Allowed Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 119.161 -1.495 . . . . 0.0 113.351 -177.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 24' ' ' LYS . . . . . 0.842 ' HE2' ' HA ' ' D' ' 48' ' ' SER . 32.8 ttpt -49.5 -44.06 45.83 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.62 0.724 . . . . 0.0 110.362 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 25' ' ' GLY . . . . . 0.645 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -139.8 154.45 23.77 Favored Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 114.548 -1.205 . . . . 0.0 112.132 174.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 26' ' ' LYS . . . . . 0.649 ' HD2' ' HB3' ' D' ' 41' ' ' SER . 0.3 OUTLIER -150.67 160.42 43.84 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.331 -0.934 . . . . 0.0 110.518 -171.038 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 27' ' ' LEU . . . . . 0.913 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 41.6 tp -132.13 144.62 50.83 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.14 0.495 . . . . 0.0 111.392 177.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 28' ' ' SER . . . . . 0.603 ' HA ' ' OD1' ' D' ' 17' ' ' ASN . 9.1 t -131.32 136.42 48.1 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 29' ' ' LEU . . . . . 0.415 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 18.3 mt -127.19 157.94 38.43 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.384 -0.527 . . . . 0.0 110.53 -179.118 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 34.7 t -160.45 174.53 13.96 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 59.2 mtt -133.83 163.33 29.73 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.108 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 32' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' D' ' 35' ' ' GLN . 50.3 t30 -136.95 86.87 2.24 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.714 172.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.03 -108.26 2.51 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.553 -169.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 34' ' ' ASN . . . . . 0.445 ' O ' ' HE3' ' D' ' 85' ' ' LYS . 75.3 m-80 -107.11 31.76 5.12 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.586 0.707 . . . . 0.0 109.96 174.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 35' ' ' GLN . . . . . 0.474 ' HA ' ' OE1' ' D' ' 35' ' ' GLN . 6.5 mm-40 -99.9 164.48 11.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.823 -1.081 . . . . 0.0 113.263 -177.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.693 HD11 HG22 ' D' ' 79' ' ' ILE . 2.7 tm? -132.8 125.6 30.46 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.637 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 37' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 27.9 mmmt -131.2 103.06 6.27 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.768 -170.07 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 38' ' ' ALA . . . . . 0.479 ' HB1' HD11 ' D' ' 27' ' ' LEU . . . -108.57 146.39 33.38 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.403 0.62 . . . . 0.0 112.289 -176.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 39' ' ' THR . . . . . 0.44 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 14.3 p -146.32 130.37 17.36 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.17 175.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 40' ' ' SER . . . . . 0.791 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 69.2 p -108.3 135.06 50.25 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 176.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 41' ' ' SER . . . . . 0.649 ' HB3' ' HD2' ' D' ' 26' ' ' LYS . 39.1 t -96.28 147.89 23.31 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.169 -1.012 . . . . 0.0 109.676 -178.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 42' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' D' ' 41' ' ' SER . 73.0 m-80 80.6 2.99 1.8 Allowed 'General case' 0 N--CA 1.468 0.472 0 O-C-N 124.569 1.168 . . . . 0.0 110.161 -170.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 47.28 55.5 8.1 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 171.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 44' ' ' GLY . . . . . 0.784 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 117.62 35.88 1.04 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 119.477 -1.344 . . . . 0.0 113.845 172.08 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 45' ' ' TYR . . . . . 0.799 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 1.8 m-85 -119.25 149.71 41.31 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 173.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 46' ' ' GLY . . . . . 0.616 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -93.61 179.7 38.82 Favored Glycine 0 C--O 1.221 -0.71 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 176.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 47' ' ' ILE . . . . . 0.874 HG12 ' HB3' ' D' ' 68' ' ' GLU . 32.6 mm -46.72 -57.01 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.798 0 CA-C-N 118.026 0.913 . . . . 0.0 110.28 -178.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 48' ' ' SER . . . . . 0.842 ' HA ' ' HE2' ' D' ' 24' ' ' LYS . 67.5 p -175.67 -118.39 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 113.354 -1.748 . . . . 0.0 108.683 -177.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 49' ' ' TYR . . . . . 0.414 ' N ' ' CD1' ' D' ' 49' ' ' TYR . 0.2 OUTLIER -113.72 75.56 0.93 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 168.199 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 50' ' ' GLU . . . . . 0.604 ' HB3' ' HE2' ' D' ' 52' ' ' LYS . 68.3 mm-40 -131.81 -175.89 3.87 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.834 -175.197 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 51' ' ' ASP . . . . . 0.654 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 1.1 m-20 -140.36 128.89 22.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.487 169.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 52' ' ' LYS . . . . . 0.654 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 3.9 mptp? -141.56 136.42 31.09 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.504 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 45.2 m-20 -112.01 126.98 55.73 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 175.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 54' ' ' TRP . . . . . 1.126 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 1.3 m95 -115.47 161.63 18.31 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -174.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -150.07 163.45 29.45 Favored Glycine 0 N--CA 1.435 -1.412 0 CA-C-N 114.566 -1.197 . . . . 0.0 112.556 172.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 56' ' ' ILE . . . . . 1.078 HG12 HG23 ' D' ' 91' ' ' ILE . 76.6 mt -134.75 109.58 11.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 -179.06 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 57' ' ' PHE . . . . . 0.629 ' HB2' ' HB3' ' D' ' 90' ' ' GLU . 8.3 m-85 -111.63 105.9 14.57 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.879 -165.12 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.841 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 54.7 t -88.67 112.31 23.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.277 172.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 7.0 m120 51.18 50.75 18.39 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.421 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.49 48.44 78.17 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.535 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 61' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 43.1 tt0 -150.88 111.24 4.18 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 62' ' ' LYS . . . . . 0.452 ' NZ ' ' HB3' ' D' ' 62' ' ' LYS . 6.3 ttpm? -73.65 103.01 4.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.972 0.415 . . . . 0.0 110.048 -177.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 29.0 m -79.57 -25.65 12.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.303 -174.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 64' ' ' TYR . . . . . 0.444 ' HB3' HD12 ' D' ' 56' ' ' ILE . 14.9 t80 -149.74 147.4 28.0 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.064 -178.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 59.4 m -125.28 121.17 33.24 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.482 175.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 66' ' ' PHE . . . . . 0.614 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 19.5 p90 -127.49 149.88 49.92 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 174.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 67' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' D' ' 52' ' ' LYS . 54.4 m-20 -111.47 145.3 39.25 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -178.103 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 68' ' ' GLU . . . . . 0.874 ' HB3' HG12 ' D' ' 47' ' ' ILE . 51.3 mm-40 -74.88 -9.3 58.41 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.612 176.03 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.475 ' HG2' ' HA ' ' D' ' 51' ' ' ASP . 23.5 mtpp -59.14 -54.35 48.0 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 113.538 -1.664 . . . . 0.0 108.102 165.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 39.8 m -66.79 119.58 12.08 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 112.91 -1.95 . . . . 0.0 109.088 174.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 82.8 p -47.56 121.24 3.82 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.978 -177.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 72' ' ' VAL . . . . . 0.616 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -57.27 -12.38 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 120.994 0.426 . . . . 0.0 110.872 -178.75 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 73' ' ' GLY . . . . . 0.791 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -69.15 -65.61 2.55 Favored Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 115.215 -0.902 . . . . 0.0 113.185 172.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -62.72 -23.74 67.32 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 120.662 0.267 . . . . 0.0 110.89 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 75' ' ' ILE . . . . . 0.515 ' O ' HG12 ' D' ' 79' ' ' ILE . 35.9 mm -77.47 -39.96 28.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.594 176.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 76' ' ' SER . . . . . 0.698 ' HA ' HG12 ' D' ' 79' ' ' ILE . 30.9 t -73.61 -19.88 60.75 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.963 178.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -65.6 -29.77 70.41 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 168.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 78' ' ' ASP . . . . . 1.051 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 1.0 OUTLIER -84.22 -28.72 27.08 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.734 174.92 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 79' ' ' ILE . . . . . 0.698 HG12 ' HA ' ' D' ' 76' ' ' SER . 17.5 mm -66.88 -19.84 26.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.657 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -69.17 -39.7 78.58 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.322 176.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 81' ' ' LYS . . . . . 1.051 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -80.24 -53.76 6.36 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.888 176.679 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 82' ' ' LEU . . . . . 0.604 HD23 ' O ' ' D' ' 78' ' ' ASP . 4.0 mm? -48.71 -29.24 4.23 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 39.54 73.61 0.11 Allowed 'General case' 0 N--CA 1.472 0.671 0 O-C-N 124.016 0.823 . . . . 0.0 111.464 172.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 84' ' ' ILE . . . . . 0.817 HG12 HD13 ' D' ' 56' ' ' ILE . 2.1 mp -66.84 105.19 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.33 -176.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 85' ' ' LYS . . . . . 0.445 ' HE3' ' O ' ' D' ' 34' ' ' ASN . 48.6 mtpt -108.19 178.71 4.42 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.911 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 86' ' ' GLY . . . . . 0.715 ' HA2' HD11 ' D' ' 89' ' ' ILE . . . -80.09 -178.37 51.65 Favored Glycine 0 CA--C 1.504 -0.604 0 C-N-CA 121.146 -0.549 . . . . 0.0 113.39 -179.06 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 87' ' ' PRO . . . . . 0.678 ' O ' HG13 ' D' ' 58' ' ' VAL . 42.8 Cg_endo -93.67 -179.79 9.47 Favored 'Cis proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.887 -1.714 . . . . 0.0 114.101 -0.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 88' ' ' TYR . . . . . 0.841 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 1.7 m-85 43.85 91.12 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.881 0.873 . . . . 0.0 112.074 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.715 HD11 ' HA2' ' D' ' 86' ' ' GLY . 4.0 mp -111.27 127.26 68.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.295 0.569 . . . . 0.0 110.533 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 90' ' ' GLU . . . . . 0.629 ' HB3' ' HB2' ' D' ' 57' ' ' PHE . 42.0 tt0 -126.55 92.05 3.48 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.187 177.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 91' ' ' ILE . . . . . 1.126 HG22 ' HZ3' ' D' ' 54' ' ' TRP . 3.2 mt -100.22 109.13 24.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 92' ' ' LYS . . . . . 0.71 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -162.25 167.53 23.83 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.873 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 93' ' ' GLN . . . . . 0.609 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 25.4 pt20 -82.44 160.19 22.77 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 119.125 -1.03 . . . . 0.0 110.567 175.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 94' ' ' ILE . . . . . 0.71 HG22 ' HE2' ' D' ' 92' ' ' LYS . 10.0 pt . . . . . 0 C--N 1.305 -1.338 0 CA-C-N 114.118 -1.401 . . . . 0.0 111.384 -168.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.461 ' C ' HG12 ' D' ' 16' ' ' VAL . 36.7 mm . . . . . 0 N--CA 1.45 -0.456 0 CA-C-O 121.783 0.802 . . . . 0.0 110.991 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 -95.19 -62.53 1.29 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.071 177.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 15' ' ' SER . . . . . 0.549 ' HA ' ' OD2' ' D' ' 18' ' ' ASP . 90.5 p -64.69 -21.45 66.75 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 120.971 -0.291 . . . . 0.0 110.531 -179.038 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 16' ' ' VAL . . . . . 0.626 ' O ' ' HG ' ' D' ' 20' ' ' LEU . 14.8 p -52.99 -35.93 23.16 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 CA-C-O 120.918 0.39 . . . . 0.0 110.251 176.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 46.9 m-20 -68.51 -41.74 79.54 Favored 'General case' 0 C--O 1.21 -1.009 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.777 177.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 18' ' ' ASP . . . . . 0.549 ' OD2' ' HA ' ' D' ' 15' ' ' SER . 55.0 m-20 -58.64 -16.58 16.74 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -177.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.671 ' O ' ' HE3' ' D' ' 22' ' ' LYS . 0.0 OUTLIER -91.83 -52.64 4.64 Favored 'General case' 0 CA--C 1.488 -1.42 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 172.37 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 20' ' ' LEU . . . . . 0.964 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 75.8 mt -57.39 -34.95 69.41 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.031 -1.441 . . . . 0.0 110.78 -177.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 21' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 -77.4 97.1 4.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.223 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 22' ' ' LYS . . . . . 0.671 ' HE3' ' O ' ' D' ' 19' ' ' LYS . 88.5 mttt -121.73 -40.91 2.5 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 -172.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.23 -88.6 0.11 Allowed Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 119.477 -1.344 . . . . 0.0 113.315 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 24' ' ' LYS . . . . . 0.72 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 52.1 tptt -49.84 -54.03 21.87 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 25' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -139.14 155.82 24.12 Favored Glycine 0 N--CA 1.429 -1.792 0 CA-C-N 114.264 -1.334 . . . . 0.0 110.943 174.206 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 26' ' ' LYS . . . . . 0.698 ' HG3' ' HB3' ' D' ' 41' ' ' SER . 9.2 ptpt -149.99 160.83 43.32 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.301 -0.95 . . . . 0.0 110.167 -169.011 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 27' ' ' LEU . . . . . 0.964 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 52.2 tp -135.19 147.29 49.33 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.188 0.518 . . . . 0.0 111.932 -176.257 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 28' ' ' SER . . . . . 0.596 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 22.9 t -139.79 153.32 47.09 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 29' ' ' LEU . . . . . 0.516 HD11 ' CD1' ' D' ' 20' ' ' LEU . 0.2 OUTLIER -141.27 133.97 28.68 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.914 177.987 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 54.1 p -133.54 -171.39 2.7 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.719 175.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 21.6 ptp -148.89 166.3 28.98 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.388 0.614 . . . . 0.0 111.466 -176.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 32' ' ' ASN . . . . . 0.471 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 22.8 t-20 -144.54 88.01 1.9 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.458 177.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.85 -108.7 2.57 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.216 -171.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -100.31 9.93 41.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.841 0.353 . . . . 0.0 110.873 176.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 35' ' ' GLN . . . . . 0.471 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 3.6 tp60 -90.82 158.24 16.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.832 0.349 . . . . 0.0 110.48 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.689 HD11 HG22 ' D' ' 79' ' ' ILE . 2.5 tm? -124.92 137.39 54.27 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.62 176.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 37' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 34.3 mmtp -130.94 115.34 16.39 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.93 -171.018 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -115.28 152.5 32.63 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.939 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 39' ' ' THR . . . . . 0.596 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 17.2 p -145.92 135.24 22.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.737 -1.119 . . . . 0.0 111.123 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 40' ' ' SER . . . . . 0.653 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 27.0 p -108.75 133.72 52.43 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 170.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 41' ' ' SER . . . . . 0.698 ' HB3' ' HG3' ' D' ' 26' ' ' LYS . 34.0 t -95.5 147.06 23.95 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 118.97 -1.092 . . . . 0.0 109.222 178.041 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 42' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' D' ' 41' ' ' SER . 75.1 m-80 80.45 -3.11 1.9 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.188 -168.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.66 62.8 2.28 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 168.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.17 -1.47 8.32 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 118.508 -1.806 . . . . 0.0 115.011 170.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 45' ' ' TYR . . . . . 0.72 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 1.4 m-30 -89.91 152.12 21.39 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 120.617 0.246 . . . . 0.0 110.808 -176.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 46' ' ' GLY . . . . . 0.589 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -95.24 -158.67 32.88 Favored Glycine 0 C--O 1.217 -0.952 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 174.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 47' ' ' ILE . . . . . 0.898 HG13 ' HB3' ' D' ' 68' ' ' GLU . 0.4 OUTLIER -55.42 -49.13 75.35 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 CA-C-O 122.597 1.189 . . . . 0.0 108.518 176.163 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 34.0 t 168.0 -119.77 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 111.305 -2.679 . . . . 0.0 105.422 -175.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -109.34 78.33 1.12 Allowed 'General case' 0 C--N 1.318 -0.775 0 O-C-N 121.771 -0.581 . . . . 0.0 109.679 163.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 50' ' ' GLU . . . . . 0.621 ' HB3' ' HE3' ' D' ' 52' ' ' LYS . 52.0 mt-10 -143.37 171.68 13.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.749 -177.135 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 51' ' ' ASP . . . . . 0.692 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 2.4 m-20 -131.42 135.68 47.37 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.534 176.075 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 52' ' ' LYS . . . . . 0.768 ' HD3' HG12 ' D' ' 47' ' ' ILE . 0.1 OUTLIER -144.96 157.19 44.22 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 123.035 0.534 . . . . 0.0 110.45 -178.029 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -120.98 134.26 55.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.301 175.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 54' ' ' TRP . . . . . 1.02 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 0.3 OUTLIER -126.43 160.62 29.98 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.205 -178.516 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -150.27 160.31 28.49 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.113 -1.041 . . . . 0.0 114.061 176.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 56' ' ' ILE . . . . . 1.001 HG12 HG23 ' D' ' 91' ' ' ILE . 73.0 mt -130.68 113.77 25.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 176.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 57' ' ' PHE . . . . . 0.629 ' HD2' ' O ' ' D' ' 90' ' ' GLU . 17.1 m-85 -108.39 105.1 14.63 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 119.688 -0.805 . . . . 0.0 111.248 -167.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.839 HG22 HG12 ' D' ' 89' ' ' ILE . 90.2 t -97.88 109.56 23.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.283 176.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 5.6 m120 55.84 39.92 30.65 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.253 178.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.97 -31.07 8.85 Favored Glycine 0 CA--C 1.508 -0.37 0 C-N-CA 120.159 -1.019 . . . . 0.0 112.771 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -88.76 126.18 35.22 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.162 -0.519 . . . . 0.0 111.032 -176.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -71.98 98.17 2.01 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 174.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 11.3 p -76.36 -27.37 17.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.823 -168.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 64' ' ' TYR . . . . . 0.442 ' HB3' HD12 ' D' ' 56' ' ' ILE . 15.4 t80 -145.75 128.56 16.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.722 177.149 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 31.3 m -109.82 105.21 14.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.062 176.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 66' ' ' PHE . . . . . 0.426 ' HB3' ' CE2' ' D' ' 64' ' ' TYR . 10.0 p90 -111.48 158.79 18.73 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 67' ' ' ASN . . . . . 0.584 ' O ' HD11 ' D' ' 75' ' ' ILE . 5.3 m120 -128.9 143.09 50.79 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -172.039 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 68' ' ' GLU . . . . . 0.898 ' HB3' HG13 ' D' ' 47' ' ' ILE . 53.6 mm-40 -64.2 -21.0 66.4 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 174.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.509 ' HE3' ' OD2' ' D' ' 51' ' ' ASP . 48.2 mtpt -51.17 -54.46 25.22 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.102 171.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 18.0 m -65.44 120.14 12.3 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 112.118 -2.31 . . . . 0.0 108.4 170.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 70.3 p -52.9 122.74 9.83 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.234 -178.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 72' ' ' VAL . . . . . 0.646 ' HA ' HD12 ' D' ' 75' ' ' ILE . 0.1 OUTLIER -54.72 -12.23 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 120.924 0.392 . . . . 0.0 111.997 -175.432 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 73' ' ' GLY . . . . . 0.653 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -73.57 -56.46 5.51 Favored Glycine 0 N--CA 1.437 -1.27 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.656 170.163 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 74' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' D' ' 77' ' ' ASN . 29.6 t-20 -66.3 -19.68 65.88 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 75' ' ' ILE . . . . . 0.646 HD12 ' HA ' ' D' ' 72' ' ' VAL . 74.4 mt -71.78 -41.21 70.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.17 173.156 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 30.7 t -72.8 -19.54 61.32 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.696 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 77' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' D' ' 74' ' ' ASN . 65.3 m-20 -61.15 -30.9 70.67 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 168.116 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 78' ' ' ASP . . . . . 1.146 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 1.0 OUTLIER -86.4 -40.91 14.92 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 114.825 -1.079 . . . . 0.0 112.936 177.877 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 79' ' ' ILE . . . . . 0.689 HG22 HD11 ' D' ' 36' ' ' LEU . 33.9 mt -63.53 -24.9 37.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 O-C-N 121.433 -0.792 . . . . 0.0 111.536 -171.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -71.39 -31.18 66.98 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 81' ' ' LYS . . . . . 1.146 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -81.11 -47.4 13.56 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.33 175.271 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 82' ' ' LEU . . . . . 0.628 HD23 ' O ' ' D' ' 78' ' ' ASP . 4.0 mm? -51.01 -26.93 6.74 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 50.31 71.03 0.44 Allowed 'General case' 0 N--CA 1.473 0.687 0 O-C-N 123.588 0.555 . . . . 0.0 110.636 176.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 84' ' ' ILE . . . . . 0.476 ' HB ' ' HG ' ' D' ' 36' ' ' LEU . 44.4 mm -78.23 96.36 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.97 -175.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 85' ' ' LYS . . . . . 0.602 ' HG2' ' HB2' ' D' ' 36' ' ' LEU . 28.4 mmmt -153.79 92.64 1.58 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.496 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.3 154.86 0.08 OUTLIER Glycine 0 C--N 1.331 0.287 0 N-CA-C 114.547 0.579 . . . . 0.0 114.547 174.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 87' ' ' PRO . . . . . 0.587 ' O ' HG13 ' D' ' 58' ' ' VAL . 76.5 Cg_endo -90.45 -178.26 11.17 Favored 'Cis proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.493 -1.461 . . . . 0.0 112.268 -0.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 88' ' ' TYR . . . . . 0.728 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 1.7 m-85 7.71 92.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 125.32 1.448 . . . . 0.0 113.773 -177.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.839 HG12 HG22 ' D' ' 58' ' ' VAL . 71.6 mt -110.95 136.62 46.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.211 0.529 . . . . 0.0 112.24 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 90' ' ' GLU . . . . . 0.629 ' O ' ' HD2' ' D' ' 57' ' ' PHE . 39.3 tt0 -128.36 95.81 4.26 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.846 175.036 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 91' ' ' ILE . . . . . 1.02 HG22 ' HZ3' ' D' ' 54' ' ' TRP . 6.5 mt -96.37 108.82 21.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -177.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 92' ' ' LYS . . . . . 0.662 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -161.0 169.97 21.48 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 177.906 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 93' ' ' GLN . . . . . 0.682 ' HB3' ' NE1' ' D' ' 54' ' ' TRP . 17.4 pt20 -85.24 163.36 18.7 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.399 177.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 94' ' ' ILE . . . . . 0.662 HG22 ' HE2' ' D' ' 92' ' ' LYS . 9.3 pt . . . . . 0 C--N 1.31 -1.145 0 CA-C-N 114.197 -1.365 . . . . 0.0 111.311 -167.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.404 ' O ' HG12 ' D' ' 16' ' ' VAL . 64.2 mt . . . . . 0 N--CA 1.463 0.203 0 CA-C-O 122.103 0.954 . . . . 0.0 111.463 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -95.93 -45.65 6.85 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.656 -1.157 . . . . 0.0 110.053 172.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 15' ' ' SER . . . . . 0.529 ' O ' ' HB2' ' D' ' 18' ' ' ASP . 39.4 m -66.17 -25.44 66.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.794 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 16' ' ' VAL . . . . . 0.698 ' HA ' ' HE2' ' D' ' 19' ' ' LYS . 7.1 p -58.93 -33.72 50.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.057 0.456 . . . . 0.0 110.532 179.036 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 17' ' ' ASN . . . . . 0.556 ' O ' ' HB2' ' D' ' 21' ' ' ASN . 5.4 m120 -66.42 -41.46 89.18 Favored 'General case' 0 C--O 1.209 -1.043 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 176.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 18' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' D' ' 15' ' ' SER . 1.2 m-20 -59.72 -14.03 12.54 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 175.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.698 ' HE2' ' HA ' ' D' ' 16' ' ' VAL . 1.7 mppt? -90.55 -44.93 9.25 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.933 0.873 . . . . 0.0 109.881 175.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 20' ' ' LEU . . . . . 1.008 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 69.8 mt -85.89 -19.02 31.18 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 112.762 -2.017 . . . . 0.0 111.812 -169.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 21' ' ' ASN . . . . . 0.556 ' HB2' ' O ' ' D' ' 17' ' ' ASN . 1.4 t-20 -106.24 98.58 8.24 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.351 -0.84 . . . . 0.0 108.891 -169.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 22' ' ' LYS . . . . . 0.633 ' CE ' ' HA ' ' D' ' 47' ' ' ILE . 2.3 mppt? -119.94 -42.95 2.57 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 118.619 -1.232 . . . . 0.0 113.112 -168.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.19 -75.94 0.16 Allowed Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.147 -1.025 . . . . 0.0 112.598 -175.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 24' ' ' LYS . . . . . 0.785 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 53.0 tptt -52.13 -61.16 2.44 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 25' ' ' GLY . . . . . 0.548 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -137.97 157.67 24.39 Favored Glycine 0 N--CA 1.43 -1.712 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.93 174.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 26' ' ' LYS . . . . . 0.67 ' HA ' ' O ' ' D' ' 20' ' ' LEU . 9.1 ptpt -149.25 162.13 40.63 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.378 -0.911 . . . . 0.0 110.818 -167.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 27' ' ' LEU . . . . . 1.008 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 58.3 tp -136.51 136.83 39.7 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.24 0.543 . . . . 0.0 111.448 -177.187 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 28' ' ' SER . . . . . 0.629 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 53.9 m -124.44 142.18 51.51 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.334 -175.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 29' ' ' LEU . . . . . 0.843 HD11 HD12 ' D' ' 20' ' ' LEU . 0.1 OUTLIER -141.49 148.11 38.9 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 119.49 -0.884 . . . . 0.0 112.097 -176.233 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 50.4 m -154.33 -173.81 4.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.968 176.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 24.6 ptm -145.66 162.91 36.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.289 0.566 . . . . 0.0 111.197 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 32' ' ' ASN . . . . . 0.475 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 26.4 t-20 -141.8 88.58 2.13 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.057 178.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.59 -98.45 0.53 Allowed Glycine 0 CA--C 1.516 0.146 0 C-N-CA 120.256 -0.973 . . . . 0.0 111.853 -176.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -104.77 2.89 30.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.783 0.325 . . . . 0.0 110.346 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 35' ' ' GLN . . . . . 0.475 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 3.6 tp-100 -91.32 155.9 18.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.127 -174.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.737 HD11 HG22 ' D' ' 79' ' ' ILE . 1.9 tm? -124.38 137.65 54.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.366 173.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 37' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 12.8 mmmm -131.04 115.81 16.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.774 -169.348 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 38' ' ' ALA . . . . . 0.533 ' HB1' HD11 ' D' ' 27' ' ' LEU . . . -123.01 155.02 37.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.156 0.503 . . . . 0.0 111.559 177.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 39' ' ' THR . . . . . 0.629 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 2.4 p -150.77 139.4 20.64 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.903 -178.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 40' ' ' SER . . . . . 0.676 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 53.3 p -109.0 133.97 52.27 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 173.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 41' ' ' SER . . . . . 0.647 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 35.4 t -96.01 148.05 23.06 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.905 -1.118 . . . . 0.0 109.199 176.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 42' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' D' ' 41' ' ' SER . 75.1 m-80 80.09 -0.57 2.04 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.95 -168.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.17 60.54 3.36 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 170.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 44' ' ' GLY . . . . . 0.684 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 110.15 35.95 2.06 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.317 -1.42 . . . . 0.0 114.706 169.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 45' ' ' TYR . . . . . 0.785 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 1.3 m-85 -112.97 152.75 29.02 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 173.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -88.77 -153.81 27.59 Favored Glycine 0 C--O 1.219 -0.782 0 C-N-CA 121.124 -0.56 . . . . 0.0 111.991 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 47' ' ' ILE . . . . . 1.058 HG13 ' HB3' ' D' ' 68' ' ' GLU . 1.0 OUTLIER -57.38 -57.08 11.56 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 CA-C-O 122.338 1.066 . . . . 0.0 108.184 -179.479 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 48' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' D' ' 47' ' ' ILE . 23.1 t 169.56 -63.47 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 111.893 -2.412 . . . . 0.0 106.836 -178.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 49' ' ' TYR . . . . . 0.437 ' O ' ' HD1' ' D' ' 49' ' ' TYR . 0.2 OUTLIER -165.07 74.74 0.24 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 113.746 -1.57 . . . . 0.0 109.667 168.569 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 50' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' D' ' 69' ' ' LYS . 72.3 mm-40 -139.99 -158.92 0.9 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.049 -175.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 51' ' ' ASP . . . . . 0.51 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 1.1 t70 -152.39 124.37 8.01 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.615 173.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 52' ' ' LYS . . . . . 0.572 ' HB2' ' CG ' ' D' ' 68' ' ' GLU . 0.2 OUTLIER -141.15 120.01 12.66 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.528 178.672 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -93.4 129.06 39.68 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 174.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 54' ' ' TRP . . . . . 0.701 ' NE1' ' HB3' ' D' ' 93' ' ' GLN . 0.1 OUTLIER -114.87 153.18 30.94 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -171.267 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -132.57 156.16 21.93 Favored Glycine 0 N--CA 1.431 -1.685 0 C-N-CA 120.157 -1.021 . . . . 0.0 114.524 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 56' ' ' ILE . . . . . 0.814 HD13 HG12 ' D' ' 84' ' ' ILE . 65.4 mt -146.28 108.27 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 113.66 -1.27 . . . . 0.0 107.652 177.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 57' ' ' PHE . . . . . 0.869 ' HB2' ' HB3' ' D' ' 90' ' ' GLU . 7.4 m-30 -117.72 107.92 14.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.97 -169.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.767 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 53.2 t -97.04 117.15 41.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.684 173.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 54.5 m-20 62.37 43.46 8.13 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.258 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.4 -33.87 4.19 Favored Glycine 0 CA--C 1.508 -0.361 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.905 173.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 61' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 23.5 pt-20 -90.99 155.84 18.41 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.247 0.546 . . . . 0.0 111.479 -175.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 62' ' ' LYS . . . . . 0.501 ' HD2' ' OG1' ' D' ' 65' ' ' THR . 6.2 ttpm? -85.55 125.2 32.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.561 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.43 HG22 ' O ' ' D' ' 56' ' ' ILE . 25.6 m -104.57 -29.79 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -177.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 64' ' ' TYR . . . . . 0.433 ' HB3' HD12 ' D' ' 56' ' ' ILE . 17.4 t80 -153.21 147.33 25.59 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.863 0.363 . . . . 0.0 111.384 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 65' ' ' THR . . . . . 0.501 ' OG1' ' HD2' ' D' ' 62' ' ' LYS . 86.8 m -132.29 126.75 34.12 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.016 175.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 66' ' ' PHE . . . . . 0.566 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 14.0 p90 -130.44 155.08 47.01 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 175.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 67' ' ' ASN . . . . . 0.557 ' O ' HD11 ' D' ' 75' ' ' ILE . 72.7 m-20 -117.57 138.23 52.06 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -177.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 68' ' ' GLU . . . . . 1.058 ' HB3' HG13 ' D' ' 47' ' ' ILE . 38.5 mm-40 -61.19 -22.82 65.1 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.885 0.374 . . . . 0.0 111.144 177.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' D' ' 50' ' ' GLU . 46.3 mtmt -65.02 -39.07 92.84 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 70' ' ' SER . . . . . 0.47 ' HB3' ' O ' ' D' ' 67' ' ' ASN . 23.2 t -64.79 121.32 14.29 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 113.744 -1.571 . . . . 0.0 106.817 166.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 54.0 p -52.33 120.36 5.45 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.045 -177.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 72' ' ' VAL . . . . . 0.656 ' HA ' HD12 ' D' ' 75' ' ' ILE . 0.0 OUTLIER -55.3 -11.62 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.368 0 CA-C-O 120.984 0.421 . . . . 0.0 111.395 -175.279 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 73' ' ' GLY . . . . . 0.684 ' HA3' ' HA2' ' D' ' 44' ' ' GLY . . . -67.49 -64.73 3.05 Favored Glycine 0 N--CA 1.434 -1.434 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.884 169.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -65.54 -18.05 65.03 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.987 -0.285 . . . . 0.0 111.332 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 75' ' ' ILE . . . . . 0.684 ' O ' HG13 ' D' ' 79' ' ' ILE . 76.2 mt -70.02 -41.98 79.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 172.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 38.3 t -73.3 -26.16 60.96 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.086 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -59.73 -24.55 64.1 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.367 168.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 78' ' ' ASP . . . . . 0.988 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 76.8 m-20 -90.75 -38.76 12.82 Favored 'General case' 0 C--O 1.225 -0.225 0 O-C-N 123.849 0.718 . . . . 0.0 112.333 176.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 79' ' ' ILE . . . . . 0.737 HG22 HD11 ' D' ' 36' ' ' LEU . 42.8 mt -64.88 -24.4 35.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 O-C-N 121.719 -0.613 . . . . 0.0 111.106 -172.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -70.77 -25.19 62.79 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 177.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 81' ' ' LYS . . . . . 0.988 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -90.32 -46.68 8.24 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 120.081 -0.648 . . . . 0.0 111.829 175.174 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 82' ' ' LEU . . . . . 0.637 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.9 mm? -51.33 -25.93 6.74 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 49.71 69.36 0.61 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.038 0.535 . . . . 0.0 110.8 175.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 84' ' ' ILE . . . . . 0.814 HG12 HD13 ' D' ' 56' ' ' ILE . 2.2 mp -74.0 107.33 4.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.007 -178.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 85' ' ' LYS . . . . . 0.552 ' O ' ' HE3' ' D' ' 85' ' ' LYS . 0.0 OUTLIER -150.44 179.23 8.32 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 178.317 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 86' ' ' GLY . . . . . 0.712 ' HA2' HD11 ' D' ' 89' ' ' ILE . . . -57.48 168.3 4.6 Favored Glycine 0 CA--C 1.509 -0.299 0 CA-C-N 115.266 -0.879 . . . . 0.0 114.923 -173.202 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 87' ' ' PRO . . . . . 0.729 ' O ' HG13 ' D' ' 58' ' ' VAL . 46.7 Cg_endo -91.84 178.25 13.87 Favored 'Cis proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.736 -1.777 . . . . 0.0 114.165 0.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 88' ' ' TYR . . . . . 0.767 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 11.7 m-85 31.34 93.19 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.853 1.261 . . . . 0.0 113.121 -178.105 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.855 HG22 HG13 ' D' ' 91' ' ' ILE . 3.2 mp -110.19 117.55 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 CA-C-O 121.714 0.768 . . . . 0.0 110.896 -178.012 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 90' ' ' GLU . . . . . 0.869 ' HB3' ' HB2' ' D' ' 57' ' ' PHE . 5.0 tp10 -100.93 87.4 3.28 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.126 174.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 91' ' ' ILE . . . . . 0.855 HG13 HG22 ' D' ' 89' ' ' ILE . 18.8 mt -98.68 101.76 12.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.751 177.081 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 92' ' ' LYS . . . . . 0.669 ' HE3' ' CG2' ' D' ' 94' ' ' ILE . 0.0 OUTLIER -161.4 168.62 23.49 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.469 -179.405 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 93' ' ' GLN . . . . . 0.701 ' HB3' ' NE1' ' D' ' 54' ' ' TRP . 26.3 pt20 -93.17 160.91 14.64 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 119.474 -0.89 . . . . 0.0 111.413 174.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 94' ' ' ILE . . . . . 0.669 ' CG2' ' HE3' ' D' ' 92' ' ' LYS . 4.7 pt . . . . . 0 C--N 1.314 -0.978 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.587 -172.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.437 ' C ' HG12 ' D' ' 16' ' ' VAL . 60.5 mt . . . . . 0 N--CA 1.454 -0.235 0 CA-C-O 121.731 0.777 . . . . 0.0 111.341 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -95.12 -62.3 1.33 Allowed 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.897 175.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 15' ' ' SER . . . . . 0.518 ' HA ' ' OD1' ' D' ' 18' ' ' ASP . 88.6 p -68.24 -15.94 63.77 Favored 'General case' 0 C--O 1.223 -0.307 0 O-C-N 122.193 -0.317 . . . . 0.0 111.343 -178.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 16' ' ' VAL . . . . . 0.789 HG11 HD11 ' D' ' 29' ' ' LEU . 7.4 p -52.49 -39.8 30.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.127 0.489 . . . . 0.0 109.711 173.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 17' ' ' ASN . . . . . 0.664 ' OD1' ' HA ' ' D' ' 28' ' ' SER . 79.9 m-20 -75.75 -25.88 56.9 Favored 'General case' 0 C--O 1.212 -0.891 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.32 -178.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 18' ' ' ASP . . . . . 0.518 ' OD1' ' HA ' ' D' ' 15' ' ' SER . 1.5 m-20 -66.74 -16.41 64.23 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 177.296 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.628 ' HE2' ' HA ' ' D' ' 16' ' ' VAL . 0.0 OUTLIER -92.2 -36.78 13.08 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-O 122.044 0.926 . . . . 0.0 108.742 174.087 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' D' D ' 20' ' ' LEU . . . . . 0.92 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 76.4 mt -71.93 -41.16 68.17 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 113.329 -1.76 . . . . 0.0 109.482 -175.02 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 21' ' ' ASN . . . . . 0.632 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 62.3 m-20 -81.24 94.69 6.75 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.026 -1.443 . . . . 0.0 111.55 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 22' ' ' LYS . . . . . 0.497 ' HB2' HG23 ' D' ' 47' ' ' ILE . 55.8 mtpt -123.01 -42.11 2.3 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -177.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 23' ' ' GLY . . . . . 0.538 ' O ' ' HE3' ' D' ' 26' ' ' LYS . . . 177.92 -94.03 0.09 OUTLIER Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 119.614 -1.279 . . . . 0.0 113.555 -178.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 24' ' ' LYS . . . . . 0.849 ' HE3' ' HA ' ' D' ' 48' ' ' SER . 25.7 ttpp -54.73 -43.31 72.51 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 122.072 0.939 . . . . 0.0 110.192 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -139.6 141.16 11.42 Favored Glycine 0 N--CA 1.427 -1.941 0 CA-C-N 114.193 -1.367 . . . . 0.0 111.98 178.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 26' ' ' LYS . . . . . 0.753 ' HA ' ' O ' ' D' ' 20' ' ' LEU . 9.7 ptpt -148.13 159.84 43.52 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 114.213 -0.994 . . . . 0.0 110.09 -170.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 27' ' ' LEU . . . . . 0.92 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 41.1 tp -139.52 148.46 42.66 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 120.864 0.364 . . . . 0.0 111.37 -177.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 28' ' ' SER . . . . . 0.664 ' HA ' ' OD1' ' D' ' 17' ' ' ASN . 21.1 t -140.47 148.47 41.18 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 29' ' ' LEU . . . . . 0.789 HD11 HG11 ' D' ' 16' ' ' VAL . 0.5 OUTLIER -141.88 144.89 34.05 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 175.61 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 50.1 m -148.07 -170.64 3.64 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.33 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -147.21 166.56 26.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.214 0.53 . . . . 0.0 112.028 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 32' ' ' ASN . . . . . 0.572 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 50.9 t-20 -146.96 88.74 1.76 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.788 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.75 -101.52 0.72 Allowed Glycine 0 CA--C 1.516 0.14 0 C-N-CA 120.327 -0.94 . . . . 0.0 111.568 -174.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -107.78 16.66 23.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.926 0.394 . . . . 0.0 110.615 176.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 35' ' ' GLN . . . . . 0.572 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 68.1 tp60 -99.39 156.76 16.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.627 -176.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.866 ' HB2' ' HG2' ' D' ' 85' ' ' LYS . 2.3 tm? -120.62 140.12 52.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.667 174.257 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 37' ' ' LYS . . . . . 0.54 ' H ' HD22 ' D' ' 36' ' ' LEU . 73.0 mmtt -132.02 123.76 27.94 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.169 -171.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 38' ' ' ALA . . . . . 0.502 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -130.83 138.69 49.98 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.46 175.197 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 39' ' ' THR . . . . . 0.553 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 19.9 p -133.51 122.0 22.99 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.373 0.606 . . . . 0.0 111.36 178.304 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 40' ' ' SER . . . . . 0.693 ' HB2' ' HA2' ' D' ' 73' ' ' GLY . 40.7 m -109.99 129.58 55.65 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 175.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 41' ' ' SER . . . . . 0.656 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 37.2 t -95.74 154.82 17.03 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.617 -173.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 42' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' D' ' 41' ' ' SER . 73.6 m-80 80.38 11.86 1.01 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 114.053 -1.431 . . . . 0.0 110.079 -171.01 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 45.15 55.47 6.27 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 114.445 -1.252 . . . . 0.0 113.693 170.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 44' ' ' GLY . . . . . 0.614 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 108.79 35.54 2.38 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 119.754 -1.213 . . . . 0.0 114.126 171.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 45' ' ' TYR . . . . . 0.681 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 1.7 m-85 -116.04 157.67 24.31 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 171.107 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 46' ' ' GLY . . . . . 0.543 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -97.74 174.77 29.54 Favored Glycine 0 CA--C 1.501 -0.843 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 177.127 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 47' ' ' ILE . . . . . 0.689 ' CG1' ' HB3' ' D' ' 68' ' ' GLU . 46.3 mm -46.4 -60.37 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-O 121.614 0.721 . . . . 0.0 111.659 -177.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 48' ' ' SER . . . . . 0.849 ' HA ' ' HE3' ' D' ' 24' ' ' LYS . 22.1 t 172.93 -151.02 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 113.391 -1.731 . . . . 0.0 108.214 -177.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -80.69 77.0 7.57 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 120.9 0.381 . . . . 0.0 110.541 172.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 50' ' ' GLU . . . . . 0.642 ' HB2' ' HZ3' ' D' ' 52' ' ' LYS . 97.2 mt-10 -150.46 155.58 39.8 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.469 176.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 51' ' ' ASP . . . . . 0.608 ' HB3' ' HD3' ' D' ' 69' ' ' LYS . 18.6 m-20 -118.96 127.65 53.67 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.869 176.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 52' ' ' LYS . . . . . 0.714 ' HE2' ' CB ' ' D' ' 68' ' ' GLU . 3.5 mppt? -142.63 128.74 19.73 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.879 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -104.11 129.71 51.81 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.746 175.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 54' ' ' TRP . . . . . 1.035 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 1.0 OUTLIER -115.69 160.8 19.58 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -174.498 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' D' D ' 55' ' ' GLY . . . . . 0.448 ' HA3' ' HE2' ' D' ' 62' ' ' LYS . . . -143.81 158.82 27.49 Favored Glycine 0 N--CA 1.434 -1.498 0 CA-C-N 114.848 -1.069 . . . . 0.0 113.371 176.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 56' ' ' ILE . . . . . 1.073 HG12 HG23 ' D' ' 91' ' ' ILE . 91.2 mt -140.92 115.09 5.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 N-CA-C 106.363 -1.718 . . . . 0.0 106.363 178.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 57' ' ' PHE . . . . . 0.739 ' CE1' ' HE2' ' D' ' 92' ' ' LYS . 5.6 m-85 -115.37 123.03 47.65 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 119.589 -0.844 . . . . 0.0 110.466 -171.165 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.643 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 85.3 t -101.01 112.59 34.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.954 173.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 59' ' ' ASN . . . . . 0.611 ' OD1' ' HG2' ' D' ' 87' ' ' PRO . 6.8 m120 60.78 35.95 19.39 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.322 -176.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.04 -33.05 6.6 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.374 -0.917 . . . . 0.0 113.998 174.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 61' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 24.5 pt-20 -90.08 148.64 22.9 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.914 0.388 . . . . 0.0 111.183 -174.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 62' ' ' LYS . . . . . 0.448 ' HE2' ' HA3' ' D' ' 55' ' ' GLY . 5.5 tppp? -65.66 126.56 28.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.766 175.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.543 HG11 HG23 ' D' ' 58' ' ' VAL . 12.4 p -109.48 -29.44 2.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.663 178.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 64' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -151.5 135.22 16.35 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.758 175.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 65' ' ' THR . . . . . 0.409 HG23 ' O ' ' D' ' 54' ' ' TRP . 70.6 m -117.06 125.66 51.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.133 175.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 66' ' ' PHE . . . . . 0.461 ' HB2' HG21 ' D' ' 75' ' ' ILE . 16.6 p90 -126.8 161.02 29.19 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 121.153 0.501 . . . . 0.0 110.064 173.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 67' ' ' ASN . . . . . 0.535 ' O ' ' HB2' ' D' ' 70' ' ' SER . 73.1 m-20 -126.1 147.46 49.59 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -177.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 68' ' ' GLU . . . . . 0.714 ' CB ' ' HE2' ' D' ' 52' ' ' LYS . 39.0 mm-40 -80.98 -14.68 57.73 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.438 0.637 . . . . 0.0 109.592 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.608 ' HD3' ' HB3' ' D' ' 51' ' ' ASP . 47.6 mtmt -65.97 -48.96 69.55 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-N 113.808 -1.542 . . . . 0.0 107.27 169.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 70' ' ' SER . . . . . 0.535 ' HB2' ' O ' ' D' ' 67' ' ' ASN . 51.0 m -61.32 129.57 41.87 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 111.615 -2.539 . . . . 0.0 108.775 169.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 68.4 p -58.61 112.03 1.46 Allowed 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -178.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 72' ' ' VAL . . . . . 0.608 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -49.84 -24.36 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 121.06 0.457 . . . . 0.0 110.269 -176.557 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' D' D ' 73' ' ' GLY . . . . . 0.693 ' HA2' ' HB2' ' D' ' 40' ' ' SER . . . -60.77 -67.46 2.12 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.208 -0.905 . . . . 0.0 114.671 175.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -62.49 -19.48 63.61 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.057 0.456 . . . . 0.0 110.965 -177.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 75' ' ' ILE . . . . . 0.584 ' O ' HG13 ' D' ' 79' ' ' ILE . 34.8 mm -76.05 -39.48 36.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.017 174.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 76' ' ' SER . . . . . 0.471 ' HA ' HG13 ' D' ' 79' ' ' ILE . 40.4 t -75.01 -21.05 59.35 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.535 177.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 58.5 m-20 -61.72 -30.67 70.91 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 168.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 78' ' ' ASP . . . . . 1.001 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 1.0 OUTLIER -83.65 -30.8 26.57 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.606 174.84 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' D' D ' 79' ' ' ILE . . . . . 0.717 HG22 HD11 ' D' ' 36' ' ' LEU . 35.8 mt -69.81 -18.0 21.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.29 -177.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 37.2 m-20 -66.41 -41.41 89.32 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.06 174.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 81' ' ' LYS . . . . . 1.001 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -80.23 -47.05 15.22 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 179.44 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' D' D ' 82' ' ' LEU . . . . . 0.699 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.4 mm? -50.34 -27.81 6.86 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -178.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 83' ' ' ASN . . . . . 0.533 ' HA ' ' HB3' ' D' ' 36' ' ' LEU . 55.8 t-20 46.16 62.6 2.2 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.553 0.533 . . . . 0.0 110.678 176.403 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 84' ' ' ILE . . . . . 0.583 HG22 HD13 ' D' ' 89' ' ' ILE . 44.8 mm -86.32 97.36 5.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.535 -175.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 85' ' ' LYS . . . . . 0.866 ' HG2' ' HB2' ' D' ' 36' ' ' LEU . 28.3 mmmt -147.13 95.55 2.58 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.816 175.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 86' ' ' GLY . . . . . 0.724 ' H ' HD11 ' D' ' 89' ' ' ILE . . . 73.97 151.72 2.23 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.648 -0.706 . . . . 0.0 113.746 173.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 87' ' ' PRO . . . . . 0.611 ' HG2' ' OD1' ' D' ' 59' ' ' ASN . 62.5 Cg_endo -90.19 179.61 14.38 Favored 'Cis proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.17 -1.596 . . . . 0.0 112.773 -0.114 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 88' ' ' TYR . . . . . 0.643 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 5.8 m-85 15.54 94.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 125.43 1.492 . . . . 0.0 114.217 -178.246 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.724 HD11 ' H ' ' D' ' 86' ' ' GLY . 70.5 mt -110.52 133.31 56.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.223 0.535 . . . . 0.0 112.357 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 90' ' ' GLU . . . . . 0.481 ' O ' ' HD1' ' D' ' 57' ' ' PHE . 46.3 mt-10 -118.97 96.75 5.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.536 174.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 91' ' ' ILE . . . . . 1.073 HG23 HG12 ' D' ' 56' ' ' ILE . 4.0 mt -101.11 110.92 29.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 92' ' ' LYS . . . . . 0.739 ' HE2' ' CE1' ' D' ' 57' ' ' PHE . 0.0 OUTLIER -163.55 172.76 13.93 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.023 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' D' D ' 93' ' ' GLN . . . . . 0.587 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 23.9 pt20 -81.6 169.34 17.17 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 119.091 -1.043 . . . . 0.0 111.185 175.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 94' ' ' ILE . . . . . 0.519 ' CG2' ' HE3' ' D' ' 92' ' ' LYS . 6.7 pt . . . . . 0 C--N 1.317 -0.837 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.971 -173.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.573 ' O ' HG12 ' D' ' 16' ' ' VAL . 12.2 tt . . . . . 0 N--CA 1.428 -1.553 0 CA-C-O 120.85 0.357 . . . . 0.0 111.932 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -82.13 -58.88 2.76 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -178.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 15' ' ' SER . . . . . 0.573 ' O ' ' HE2' ' D' ' 19' ' ' LYS . 97.9 p -69.97 -15.46 63.04 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.701 -178.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 16' ' ' VAL . . . . . 0.573 HG12 ' O ' ' D' ' 13' ' ' ILE . 1.7 p -61.3 -26.56 39.68 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.29 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -78.3 -38.05 43.37 Favored 'General case' 0 C--O 1.212 -0.891 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.545 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.99 -16.36 17.72 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.644 ' O ' ' HE2' ' D' ' 22' ' ' LYS . 35.0 mttm -91.12 -39.29 12.24 Favored 'General case' 0 CA--C 1.492 -1.28 0 CA-C-O 122.487 1.137 . . . . 0.0 109.397 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 20' ' ' LEU . . . . . 0.63 HD12 HD12 ' D' ' 27' ' ' LEU . 61.0 mt -82.26 -32.82 29.44 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 112.887 -1.961 . . . . 0.0 109.581 -174.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 21' ' ' ASN . . . . . 0.774 ' OD1' ' HB2' ' D' ' 26' ' ' LYS . 57.4 m-20 -71.95 92.33 1.27 Allowed 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.449 -1.25 . . . . 0.0 109.708 172.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 22' ' ' LYS . . . . . 0.644 ' HE2' ' O ' ' D' ' 19' ' ' LYS . 61.0 mttm -121.75 -41.45 2.47 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -174.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 23' ' ' GLY . . . . . 0.407 ' O ' ' HE2' ' D' ' 26' ' ' LYS . . . 176.93 -92.64 0.09 OUTLIER Glycine 0 N--CA 1.437 -1.283 0 C-N-CA 119.658 -1.258 . . . . 0.0 112.857 -177.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 24' ' ' LYS . . . . . 0.742 ' HG2' ' HB3' ' D' ' 45' ' ' TYR . 76.0 tttt -47.44 -55.83 8.22 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.584 0.707 . . . . 0.0 109.786 179.048 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 25' ' ' GLY . . . . . 0.644 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -133.99 156.21 22.22 Favored Glycine 0 N--CA 1.432 -1.573 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.906 174.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 26' ' ' LYS . . . . . 0.774 ' HB2' ' OD1' ' D' ' 21' ' ' ASN . 0.1 OUTLIER -150.3 162.48 40.44 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.301 -0.949 . . . . 0.0 110.556 -168.516 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 27' ' ' LEU . . . . . 0.746 ' HB2' HG11 ' D' ' 72' ' ' VAL . 3.4 tm? -132.46 143.23 49.64 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.762 -171.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 28' ' ' SER . . . . . 0.689 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 50.0 m -137.05 145.64 44.25 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.924 178.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 29' ' ' LEU . . . . . 0.525 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 18.3 mt -138.75 157.91 45.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.157 0.503 . . . . 0.0 110.871 177.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 39.3 t -160.3 -175.49 5.07 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 175.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 31' ' ' MET . . . . . 0.687 ' HA ' ' O ' ' D' ' 35' ' ' GLN . 26.6 ptt? -150.28 127.1 11.03 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.659 0.743 . . . . 0.0 111.06 175.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -91.52 89.01 7.01 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.022 176.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.51 -104.1 2.02 Favored Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -169.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -120.71 31.78 6.28 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.164 0.507 . . . . 0.0 109.938 172.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 35' ' ' GLN . . . . . 0.687 ' O ' ' HA ' ' D' ' 31' ' ' MET . 32.9 tt0 -108.11 115.95 31.07 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.579 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.672 ' HB2' ' HB2' ' D' ' 85' ' ' LYS . 1.1 tm? -77.76 134.95 37.95 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.225 0.536 . . . . 0.0 111.536 -177.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 37' ' ' LYS . . . . . 0.588 ' NZ ' ' HB3' ' D' ' 37' ' ' LYS . 0.7 OUTLIER -133.79 116.71 16.03 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.491 -169.313 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 38' ' ' ALA . . . . . 0.41 ' HA ' HD23 ' D' ' 29' ' ' LEU . . . -115.09 152.88 31.75 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.408 0.623 . . . . 0.0 112.401 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 39' ' ' THR . . . . . 0.689 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 5.2 p -150.87 134.49 16.43 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.53 177.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 40' ' ' SER . . . . . 0.544 ' HB3' ' HA2' ' D' ' 73' ' ' GLY . 40.1 t -108.11 136.12 48.32 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 172.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 41' ' ' SER . . . . . 0.744 ' HB3' ' HG3' ' D' ' 26' ' ' LYS . 47.6 t -96.17 151.78 19.17 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 118.963 -1.095 . . . . 0.0 109.748 -179.086 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 42' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' D' ' 41' ' ' SER . 77.1 m-20 80.66 6.75 1.45 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.693 -167.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 53.94 60.13 3.82 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 114.713 -1.13 . . . . 0.0 113.455 171.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 44' ' ' GLY . . . . . 0.61 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 104.72 37.92 2.67 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.122 -1.513 . . . . 0.0 114.989 168.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 45' ' ' TYR . . . . . 0.742 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 2.3 m-85 -116.11 154.4 30.04 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 117.856 0.828 . . . . 0.0 109.944 173.272 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 46' ' ' GLY . . . . . 0.628 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -93.78 -173.58 39.56 Favored Glycine 0 C--O 1.22 -0.744 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 178.192 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 47' ' ' ILE . . . . . 0.812 HG12 ' HB3' ' D' ' 68' ' ' GLU . 26.9 mm -48.55 -54.81 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-O 122.025 0.917 . . . . 0.0 108.775 175.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 48' ' ' SER . . . . . 0.589 ' HA ' ' HD3' ' D' ' 24' ' ' LYS . 93.4 p 178.76 -146.22 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 112.832 -1.985 . . . . 0.0 107.561 178.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -82.54 75.9 9.43 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.462 166.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 50' ' ' GLU . . . . . 0.677 ' HB3' ' HE2' ' D' ' 52' ' ' LYS . 95.6 mt-10 -146.84 163.37 36.28 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.646 -176.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 51' ' ' ASP . . . . . 0.678 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 1.4 m-20 -124.1 132.7 53.68 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.804 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 52' ' ' LYS . . . . . 0.678 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 3.5 mptp? -142.93 120.7 11.89 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.453 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 53' ' ' ASN . . . . . 0.615 ' HA ' ' OD1' ' D' ' 67' ' ' ASN . 44.0 m-20 -90.83 131.46 36.47 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 176.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 54' ' ' TRP . . . . . 0.617 ' HB2' ' O ' ' D' ' 66' ' ' PHE . 0.1 OUTLIER -122.93 155.0 37.63 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -172.161 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -144.81 161.14 28.07 Favored Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.254 -0.974 . . . . 0.0 113.97 174.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 56' ' ' ILE . . . . . 0.857 HD13 HG12 ' D' ' 84' ' ' ILE . 74.0 mt -137.03 111.79 10.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 57' ' ' PHE . . . . . 0.882 ' HB2' ' HB3' ' D' ' 90' ' ' GLU . 15.8 m-85 -105.59 97.8 7.58 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.894 -167.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.867 HG22 HG12 ' D' ' 89' ' ' ILE . 99.4 t -98.2 120.64 47.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.475 176.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 33.7 m120 67.64 34.98 4.25 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 123.438 0.461 . . . . 0.0 110.539 -175.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.35 42.54 97.68 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.625 -0.716 . . . . 0.0 113.54 177.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 61' ' ' GLU . . . . . 0.634 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 24.9 pt-20 -155.41 141.63 18.46 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 176.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 62' ' ' LYS . . . . . 0.476 ' HB2' ' CE2' ' D' ' 57' ' ' PHE . 27.9 ttpp -73.01 99.72 2.81 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -178.166 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.491 HG12 ' O ' ' D' ' 56' ' ' ILE . 9.1 p -84.29 -32.43 8.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.657 -172.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 64' ' ' TYR . . . . . 0.43 ' HB3' HD12 ' D' ' 56' ' ' ILE . 17.2 t80 -134.39 132.0 38.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.746 0.307 . . . . 0.0 110.797 176.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 35.0 m -116.4 112.46 21.51 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.124 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 66' ' ' PHE . . . . . 0.617 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 9.3 p90 -118.66 158.51 25.37 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 173.129 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 67' ' ' ASN . . . . . 0.615 ' OD1' ' HA ' ' D' ' 53' ' ' ASN . 73.7 m-80 -129.81 142.09 50.74 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.349 -175.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 68' ' ' GLU . . . . . 0.812 ' HB3' HG12 ' D' ' 47' ' ' ILE . 42.1 mm-40 -69.07 -8.41 44.96 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 123.574 0.546 . . . . 0.0 110.415 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.432 ' HE2' ' CB ' ' D' ' 67' ' ' ASN . 44.1 mtmt -60.62 -46.66 89.44 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 167.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 70' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' D' ' 67' ' ' ASN . 35.1 t -69.78 129.78 40.51 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 113.179 -1.828 . . . . 0.0 108.355 168.427 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 71' ' ' THR . . . . . 0.461 ' O ' HG13 ' D' ' 75' ' ' ILE . 74.1 p -57.86 128.86 39.19 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 178.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 72' ' ' VAL . . . . . 0.746 HG11 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -54.57 -16.84 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-O 121.294 0.568 . . . . 0.0 110.44 -175.655 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 73' ' ' GLY . . . . . 0.61 ' HA3' ' HA2' ' D' ' 44' ' ' GLY . . . -72.92 -58.58 4.72 Favored Glycine 0 N--CA 1.435 -1.39 0 CA-C-N 114.911 -1.041 . . . . 0.0 112.841 173.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -64.25 -20.25 65.93 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 120.885 0.374 . . . . 0.0 110.305 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 75' ' ' ILE . . . . . 0.645 ' O ' HG13 ' D' ' 79' ' ' ILE . 74.7 mt -73.34 -41.12 57.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.462 171.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 41.5 t -71.03 -26.8 63.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.048 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -56.12 -30.92 62.78 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 167.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 78' ' ' ASP . . . . . 1.084 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 1.1 m-20 -90.35 -33.28 16.13 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 177.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 79' ' ' ILE . . . . . 0.645 HG13 ' O ' ' D' ' 75' ' ' ILE . 41.5 mt -68.3 -27.81 38.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 O-C-N 121.689 -0.632 . . . . 0.0 110.595 -175.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -73.92 -20.02 60.51 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 81' ' ' LYS . . . . . 1.084 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -89.92 -52.38 5.0 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.601 171.416 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 82' ' ' LEU . . . . . 0.57 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.7 mm? -48.67 -31.44 6.78 Favored 'General case' 0 C--O 1.231 0.086 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 176.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 83' ' ' ASN . . . . . 0.496 ' HA ' HD12 ' D' ' 36' ' ' LEU . 22.2 t-20 40.6 77.77 0.05 Allowed 'General case' 0 N--CA 1.469 0.506 0 O-C-N 124.639 1.212 . . . . 0.0 111.134 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 84' ' ' ILE . . . . . 0.857 HG12 HD13 ' D' ' 56' ' ' ILE . 2.6 mp -77.97 97.05 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.362 -176.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 85' ' ' LYS . . . . . 0.672 ' HB2' ' HB2' ' D' ' 36' ' ' LEU . 0.0 OUTLIER -158.28 93.07 1.2 Allowed 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 121.431 0.634 . . . . 0.0 110.505 -177.424 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 86' ' ' GLY . . . . . 0.659 ' H ' HD11 ' D' ' 89' ' ' ILE . . . 68.54 148.56 0.21 Allowed Glycine 0 N--CA 1.453 -0.193 0 CA-C-N 114.59 -1.187 . . . . 0.0 113.929 178.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 87' ' ' PRO . . . . . 0.6 ' O ' HG13 ' D' ' 58' ' ' VAL . 60.8 Cg_endo -90.6 -177.53 10.12 Favored 'Cis proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.533 -1.445 . . . . 0.0 112.508 -0.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 88' ' ' TYR . . . . . 0.721 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 13.0 m-85 4.89 94.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 125.527 1.531 . . . . 0.0 114.214 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.867 HG12 HG22 ' D' ' 58' ' ' VAL . 66.5 mt -108.35 148.81 12.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.192 0.52 . . . . 0.0 111.883 -177.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 90' ' ' GLU . . . . . 0.882 ' HB3' ' HB2' ' D' ' 57' ' ' PHE . 39.7 tt0 -132.13 91.41 2.95 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.281 173.342 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 91' ' ' ILE . . . . . 0.582 HG13 HG22 ' D' ' 89' ' ' ILE . 37.0 mt -94.14 99.84 10.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.89 -176.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 92' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' D' ' 93' ' ' GLN . 0.0 OUTLIER -160.74 164.47 31.55 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 177.379 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 93' ' ' GLN . . . . . 0.625 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 24.3 pt20 -80.6 162.73 24.12 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.537 176.118 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 94' ' ' ILE . . . . . 0.406 HG22 ' HE2' ' D' ' 92' ' ' LYS . 10.6 pt . . . . . 0 C--N 1.305 -1.357 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.366 -171.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.488 ' C ' HG12 ' D' ' 16' ' ' VAL . 57.5 mt . . . . . 0 N--CA 1.452 -0.332 0 CA-C-O 122.0 0.905 . . . . 0.0 110.623 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -88.54 -57.36 2.94 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.334 176.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 15' ' ' SER . . . . . 0.513 ' O ' ' HE2' ' D' ' 19' ' ' LYS . 92.6 p -68.11 -17.74 64.45 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.673 -0.239 . . . . 0.0 111.457 -178.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 16' ' ' VAL . . . . . 0.645 HG13 ' ND2' ' D' ' 17' ' ' ASN . 9.6 p -59.97 -30.06 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-O 121.945 0.879 . . . . 0.0 109.562 176.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 17' ' ' ASN . . . . . 0.645 ' ND2' HG13 ' D' ' 16' ' ' VAL . 3.8 m120 -78.26 -33.96 49.29 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.256 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.31 -15.71 49.64 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.331 177.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.513 ' HE2' ' O ' ' D' ' 15' ' ' SER . 40.3 mttm -89.56 -39.52 13.22 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 122.726 1.25 . . . . 0.0 109.255 -179.274 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 20' ' ' LEU . . . . . 0.805 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 73.0 mt -77.19 -37.29 53.88 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 111.935 -2.393 . . . . 0.0 110.127 -176.131 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 21' ' ' ASN . . . . . 0.627 ' OD1' ' HB2' ' D' ' 26' ' ' LYS . 57.5 m-20 -75.33 95.92 3.29 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.678 177.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 22' ' ' LYS . . . . . 0.805 ' HD3' HG23 ' D' ' 47' ' ' ILE . 23.0 mtpp -120.89 -43.62 2.45 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 118.594 -1.242 . . . . 0.0 114.064 -168.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.27 -69.9 0.25 Allowed Glycine 0 N--CA 1.436 -1.315 0 C-N-CA 119.746 -1.216 . . . . 0.0 112.509 -174.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 24' ' ' LYS . . . . . 0.819 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 22.2 tptm -55.27 -67.07 0.31 Allowed 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 176.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 25' ' ' GLY . . . . . 0.718 ' HA2' ' OD1' ' D' ' 42' ' ' ASN . . . -139.38 156.49 24.61 Favored Glycine 0 CA--C 1.493 -1.337 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.279 172.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 26' ' ' LYS . . . . . 0.691 ' CD ' ' HB3' ' D' ' 41' ' ' SER . 0.4 OUTLIER -140.5 160.12 40.69 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -168.53 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 27' ' ' LEU . . . . . 0.805 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 45.1 tp -139.44 144.38 38.02 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.463 0.649 . . . . 0.0 112.392 -177.299 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 28' ' ' SER . . . . . 0.715 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 49.2 m -135.34 151.91 50.96 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.505 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 29' ' ' LEU . . . . . . . . . . . . . 16.4 mt -141.02 138.01 33.38 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 56.3 m -148.06 -179.04 6.62 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 31' ' ' MET . . . . . 0.813 ' HA ' ' O ' ' D' ' 35' ' ' GLN . 20.2 ptp -137.23 126.62 24.92 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.67 0.747 . . . . 0.0 111.057 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -90.84 88.34 7.02 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 175.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.64 -100.97 1.99 Allowed Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -165.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -120.16 12.5 11.86 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.999 0.428 . . . . 0.0 109.987 171.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 35' ' ' GLN . . . . . 0.813 ' O ' ' HA ' ' D' ' 31' ' ' MET . 85.0 mt-30 -88.63 125.94 35.06 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.471 -175.131 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.686 HD11 HG22 ' D' ' 79' ' ' ILE . 2.8 tm? -78.08 124.38 27.98 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.204 0.526 . . . . 0.0 111.436 -178.102 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 37' ' ' LYS . . . . . 0.642 ' HE2' ' HB3' ' D' ' 35' ' ' GLN . 74.9 mmtt -135.53 103.49 5.48 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.794 -173.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.28 152.64 18.38 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.322 0.582 . . . . 0.0 111.581 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 39' ' ' THR . . . . . 0.715 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 7.1 p -141.01 124.79 16.98 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.118 176.097 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 40' ' ' SER . . . . . 0.654 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 19.1 p -107.88 128.87 55.0 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 172.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 41' ' ' SER . . . . . 0.691 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 44.3 t -96.3 168.75 10.39 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 42' ' ' ASN . . . . . 0.718 ' OD1' ' HA2' ' D' ' 25' ' ' GLY . 0.5 OUTLIER 60.8 7.44 1.45 Allowed 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.975 1.422 . . . . 0.0 112.499 -174.409 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 41.41 60.29 2.14 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 168.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.87 35.86 0.81 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 118.873 -1.632 . . . . 0.0 114.931 168.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 45' ' ' TYR . . . . . 0.819 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 0.7 OUTLIER -122.83 154.26 38.48 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 170.504 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 46' ' ' GLY . . . . . 0.562 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -99.81 -163.63 29.02 Favored Glycine 0 C--O 1.216 -1.013 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.414 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 47' ' ' ILE . . . . . 0.805 HG23 ' HD3' ' D' ' 22' ' ' LYS . 41.9 mm -55.04 -59.53 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 CA-C-O 122.088 0.947 . . . . 0.0 109.675 176.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 83.5 p 175.0 -164.61 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 112.327 -2.215 . . . . 0.0 108.789 -172.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -78.27 77.96 4.75 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.924 0.869 . . . . 0.0 111.632 173.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -145.56 -167.8 2.8 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.957 177.073 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 51' ' ' ASP . . . . . 0.691 ' C ' ' HD3' ' D' ' 52' ' ' LYS . 9.6 p-10 -136.34 135.18 38.65 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.359 168.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 52' ' ' LYS . . . . . 0.732 ' CE ' ' HB2' ' D' ' 68' ' ' GLU . 2.7 mppt? -139.79 128.1 22.64 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.263 -167.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -116.65 138.8 51.17 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 173.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 54' ' ' TRP . . . . . 0.651 ' HZ3' HG23 ' D' ' 91' ' ' ILE . 0.1 OUTLIER -125.76 160.38 29.93 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -173.077 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -140.43 156.2 25.07 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.042 -1.075 . . . . 0.0 113.908 175.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 56' ' ' ILE . . . . . 0.628 HD13 HG12 ' D' ' 84' ' ' ILE . 62.8 mt -140.24 108.75 3.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 176.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 57' ' ' PHE . . . . . 0.738 ' CE2' ' HE2' ' D' ' 92' ' ' LYS . 7.0 m-85 -108.25 102.91 12.0 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.637 -168.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.713 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 78.2 t -91.97 110.17 22.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.814 170.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 59' ' ' ASN . . . . . 0.44 ' OD1' ' HG2' ' D' ' 87' ' ' PRO . 5.2 m120 63.74 44.51 4.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.436 -176.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.3 -33.91 4.7 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.793 -0.718 . . . . 0.0 114.511 172.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 61' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 12.5 pt-20 -94.81 154.06 17.44 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.966 -0.293 . . . . 0.0 111.072 -175.319 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -73.92 106.94 5.86 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 173.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 9.9 p -76.52 -27.9 17.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.522 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 64' ' ' TYR . . . . . 0.551 ' HB3' HD12 ' D' ' 56' ' ' ILE . 14.2 t80 -148.13 135.57 20.59 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.545 173.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 65' ' ' THR . . . . . 0.422 HG23 ' O ' ' D' ' 54' ' ' TRP . 65.3 m -119.87 123.04 42.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.514 174.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 66' ' ' PHE . . . . . 0.632 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 11.3 p90 -129.62 143.11 50.67 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 121.477 0.656 . . . . 0.0 110.679 178.136 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 67' ' ' ASN . . . . . 0.803 HD22 ' HB2' ' D' ' 69' ' ' LYS . 15.1 p-10 -110.31 130.28 55.58 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.271 -175.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 68' ' ' GLU . . . . . 0.804 ' HB3' HG12 ' D' ' 47' ' ' ILE . 35.1 mm-40 -67.62 -8.45 34.67 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.831 -177.077 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.803 ' HB2' HD22 ' D' ' 67' ' ' ASN . 53.3 mtpt -62.28 -40.79 97.4 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 169.283 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 70' ' ' SER . . . . . 0.489 ' HB3' ' O ' ' D' ' 67' ' ' ASN . 32.5 t -68.51 124.52 23.79 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 113.051 -1.886 . . . . 0.0 107.353 164.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 71' ' ' THR . . . . . 0.422 ' O ' HG13 ' D' ' 75' ' ' ILE . 67.3 p -55.17 130.98 44.17 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 72' ' ' VAL . . . . . 0.66 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -57.3 -14.99 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-O 120.722 0.296 . . . . 0.0 111.011 -178.582 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 73' ' ' GLY . . . . . 0.654 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -63.98 -65.45 3.02 Favored Glycine 0 N--CA 1.433 -1.562 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.156 168.231 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -62.62 -20.55 64.88 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.523 0.201 . . . . 0.0 111.428 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 75' ' ' ILE . . . . . 0.592 ' O ' HG13 ' D' ' 79' ' ' ILE . 69.7 mt -73.26 -40.61 57.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.148 174.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 35.9 t -75.83 -21.32 57.4 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.817 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 77' ' ' ASN . . . . . 0.605 ' O ' ' HD3' ' D' ' 81' ' ' LYS . 2.5 m-80 -61.69 -23.97 66.46 Favored 'General case' 0 C--O 1.216 -0.66 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 166.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 78' ' ' ASP . . . . . 0.627 ' O ' HD23 ' D' ' 82' ' ' LEU . 1.0 OUTLIER -93.23 -41.56 9.83 Favored 'General case' 0 C--O 1.225 -0.237 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 175.913 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 79' ' ' ILE . . . . . 0.686 HG22 HD11 ' D' ' 36' ' ' LEU . 56.0 mt -65.78 -34.35 69.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 O-C-N 121.449 -0.782 . . . . 0.0 111.645 -169.08 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -66.86 -14.05 62.29 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.126 176.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 81' ' ' LYS . . . . . 0.605 ' HD3' ' O ' ' D' ' 77' ' ' ASN . 0.0 OUTLIER -89.77 -57.39 2.88 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.207 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 82' ' ' LEU . . . . . 0.627 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.4 mm? -53.86 -23.74 13.5 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 113.88 -1.509 . . . . 0.0 112.343 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 50.69 69.75 0.6 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.647 174.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 84' ' ' ILE . . . . . 0.628 HG12 HD13 ' D' ' 56' ' ' ILE . 2.2 mp -74.68 99.09 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.377 0.608 . . . . 0.0 111.175 -176.251 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 85' ' ' LYS . . . . . 0.62 ' C ' HD11 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -131.99 179.07 6.31 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.165 174.722 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . -48.38 165.15 0.24 Allowed Glycine 0 C--N 1.334 0.463 0 O-C-N 123.696 0.623 . . . . 0.0 113.928 -174.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 87' ' ' PRO . . . . . 0.534 ' O ' HG13 ' D' ' 58' ' ' VAL . 60.5 Cg_endo -93.82 -177.09 7.26 Favored 'Cis proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.898 -1.293 . . . . 0.0 114.758 -0.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 88' ' ' TYR . . . . . 0.713 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 41.5 m-85 23.04 93.06 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.504 1.521 . . . . 0.0 113.57 179.232 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.62 HD11 ' C ' ' D' ' 85' ' ' LYS . 72.7 mt -112.36 139.27 37.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 178.334 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 90' ' ' GLU . . . . . 0.704 ' HG2' ' HD2' ' D' ' 92' ' ' LYS . 88.9 tt0 -127.59 94.75 4.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.032 171.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 91' ' ' ILE . . . . . 0.651 HG23 ' HZ3' ' D' ' 54' ' ' TRP . 27.4 mt -95.68 99.82 9.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.088 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 92' ' ' LYS . . . . . 0.738 ' HE2' ' CE2' ' D' ' 57' ' ' PHE . 0.0 OUTLIER -161.99 169.29 21.34 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.373 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 93' ' ' GLN . . . . . 0.664 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 21.1 pt20 -79.56 157.54 27.35 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.283 173.231 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 94' ' ' ILE . . . . . 0.429 HG22 ' HE3' ' D' ' 92' ' ' LYS . 9.9 pt . . . . . 0 C--N 1.308 -1.236 0 CA-C-N 114.902 -1.044 . . . . 0.0 112.186 -170.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.636 ' O ' HG12 ' D' ' 16' ' ' VAL . 57.0 mt . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 121.666 0.746 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -88.19 -41.86 12.7 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.095 175.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 15' ' ' SER . . . . . 0.559 ' HA ' ' OD2' ' D' ' 18' ' ' ASP . 88.2 p -72.01 -23.52 61.41 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 122.045 -0.409 . . . . 0.0 109.907 175.345 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 16' ' ' VAL . . . . . 0.636 HG12 ' O ' ' D' ' 13' ' ' ILE . 0.5 OUTLIER -56.84 -24.05 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 121.515 0.674 . . . . 0.0 109.41 178.927 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -74.65 -43.75 53.81 Favored 'General case' 0 C--O 1.209 -1.071 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.771 176.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 18' ' ' ASP . . . . . 0.559 ' OD2' ' HA ' ' D' ' 15' ' ' SER . 51.4 m-20 -55.3 -16.2 3.19 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -177.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.588 ' N ' ' HD2' ' D' ' 19' ' ' LYS . 0.0 OUTLIER -91.18 -43.16 10.03 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-O 122.306 1.051 . . . . 0.0 108.691 175.533 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 20' ' ' LEU . . . . . 0.927 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 70.7 mt -69.36 -37.74 77.76 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 113.168 -1.833 . . . . 0.0 110.258 -177.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 21' ' ' ASN . . . . . 0.443 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 53.1 m-20 -79.7 94.08 5.66 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.705 -178.067 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 22' ' ' LYS . . . . . 0.701 ' HD2' HD12 ' D' ' 47' ' ' ILE . 95.8 mttt -122.32 -41.95 2.38 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -176.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 165.87 -84.0 0.1 Allowed Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 119.32 -1.419 . . . . 0.0 113.231 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 24' ' ' LYS . . . . . 0.807 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 27.2 tptp -44.89 -57.76 3.57 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.388 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 25' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -139.86 163.95 26.16 Favored Glycine 0 N--CA 1.431 -1.685 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.967 171.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 26' ' ' LYS . . . . . 0.679 ' HD2' ' HB3' ' D' ' 41' ' ' SER . 0.3 OUTLIER -149.29 159.59 44.14 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.933 -0.634 . . . . 0.0 109.986 -171.743 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 27' ' ' LEU . . . . . 0.927 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 39.8 tp -136.16 134.49 38.29 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.436 0.636 . . . . 0.0 111.806 -178.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 28' ' ' SER . . . . . 0.637 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 26.5 t -121.36 145.96 47.36 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 29' ' ' LEU . . . . . . . . . . . . . 20.9 mt -131.43 134.96 46.75 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.754 -0.779 . . . . 0.0 110.745 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 32.1 t -137.01 -171.04 2.84 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 31' ' ' MET . . . . . 0.502 ' HB2' ' O ' ' D' ' 35' ' ' GLN . 26.3 ptt? -150.08 166.59 29.29 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.81 0.338 . . . . 0.0 110.618 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 32' ' ' ASN . . . . . 0.637 ' O ' ' HB2' ' D' ' 35' ' ' GLN . 25.9 t-20 -141.82 87.28 2.04 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 176.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.48 -113.81 4.82 Favored Glycine 0 CA--C 1.516 0.142 0 C-N-CA 119.898 -1.144 . . . . 0.0 111.121 -172.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -95.7 31.0 2.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.776 0.798 . . . . 0.0 109.92 173.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 35' ' ' GLN . . . . . 0.637 ' HB2' ' O ' ' D' ' 32' ' ' ASN . 52.5 mm-40 -110.24 164.94 12.17 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 114.928 -1.033 . . . . 0.0 112.367 -178.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.586 HD11 HG22 ' D' ' 79' ' ' ILE . 2.7 tm? -130.72 128.95 41.88 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 175.08 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 37' ' ' LYS . . . . . 0.401 ' N ' HD13 ' D' ' 36' ' ' LEU . 35.7 mmtp -132.4 100.6 5.04 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.145 0.498 . . . . 0.0 110.842 -176.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.72 149.95 21.24 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.856 -177.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 39' ' ' THR . . . . . 0.637 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 29.8 p -137.32 126.72 24.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.916 174.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 40' ' ' SER . . . . . 0.761 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 60.6 p -109.89 135.73 50.31 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 175.329 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 41' ' ' SER . . . . . 0.679 ' HB3' ' HD2' ' D' ' 26' ' ' LYS . 43.9 t -104.0 156.42 17.87 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.814 -176.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 42' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' D' ' 41' ' ' SER . 74.0 m-80 78.79 9.34 1.89 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.423 -172.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 43.74 59.02 3.27 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 114.73 -1.123 . . . . 0.0 113.648 170.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.84 34.96 2.1 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 119.732 -1.223 . . . . 0.0 113.872 172.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 45' ' ' TYR . . . . . 0.807 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 2.8 m-30 -112.89 146.72 38.45 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 170.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 46' ' ' GLY . . . . . 0.597 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -93.93 -162.97 35.99 Favored Glycine 0 C--O 1.218 -0.876 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 175.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 47' ' ' ILE . . . . . 0.832 HG12 ' HB3' ' D' ' 68' ' ' GLU . 38.5 mm -56.27 -57.1 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.886 0 CA-C-O 122.14 0.971 . . . . 0.0 109.514 174.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -178.97 -123.05 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 112.796 -2.002 . . . . 0.0 108.906 -177.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -114.47 76.79 1.01 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.119 0.485 . . . . 0.0 109.916 169.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 50' ' ' GLU . . . . . 0.563 ' CB ' ' HD3' ' D' ' 52' ' ' LYS . 51.5 mt-10 -140.16 168.73 19.13 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.53 177.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 51' ' ' ASP . . . . . 0.634 ' CB ' ' HD2' ' D' ' 69' ' ' LYS . 1.6 m-20 -114.69 122.06 45.29 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.763 175.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 52' ' ' LYS . . . . . 0.823 ' HG3' ' HB2' ' D' ' 68' ' ' GLU . 0.0 OUTLIER -131.84 107.44 8.74 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.858 -166.354 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 44.9 m-20 -94.33 129.35 41.04 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.466 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 54' ' ' TRP . . . . . 0.61 ' HZ3' HG23 ' D' ' 91' ' ' ILE . 0.1 OUTLIER -121.93 153.78 38.03 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -174.827 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -141.06 158.78 26.45 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.153 -1.022 . . . . 0.0 113.607 175.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 56' ' ' ILE . . . . . 0.681 HD13 HD13 ' D' ' 84' ' ' ILE . 62.8 mt -142.97 106.51 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 -178.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 57' ' ' PHE . . . . . 0.536 ' HD2' ' HB2' ' D' ' 90' ' ' GLU . 11.8 m-85 -108.6 106.87 17.13 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.59 -168.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.71 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 49.9 t -95.79 118.36 41.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.63 173.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 58.91 34.34 23.59 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.033 -178.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.91 -32.77 6.88 Favored Glycine 0 CA--C 1.505 -0.537 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.706 174.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 61' ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 25.4 pt-20 -90.19 146.91 23.9 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.078 0.466 . . . . 0.0 110.818 -175.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -79.36 101.75 8.29 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 177.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.518 HG12 ' O ' ' D' ' 56' ' ' ILE . 10.5 p -76.87 -30.32 18.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.695 -172.297 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 64' ' ' TYR . . . . . 0.529 ' HB3' HD12 ' D' ' 56' ' ' ILE . 20.5 t80 -147.16 142.57 27.45 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.757 0.313 . . . . 0.0 110.979 178.129 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 30.5 m -124.8 125.65 44.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.587 175.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 66' ' ' PHE . . . . . 0.561 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 17.5 p90 -133.83 157.49 45.79 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 121.441 0.639 . . . . 0.0 110.43 173.384 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 67' ' ' ASN . . . . . 0.589 ' HA ' ' O ' ' D' ' 52' ' ' LYS . 5.2 m120 -116.92 141.61 48.01 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 68' ' ' GLU . . . . . 0.832 ' HB3' HG12 ' D' ' 47' ' ' ILE . 55.6 mm-40 -70.83 -16.75 62.74 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 175.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.634 ' HD2' ' CB ' ' D' ' 51' ' ' ASP . 25.0 mtpp -60.21 -44.31 95.24 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 114.102 -1.408 . . . . 0.0 108.159 169.111 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 18.8 t -76.1 90.72 3.08 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 113.633 -1.621 . . . . 0.0 107.898 171.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 65.6 p -24.39 120.67 0.05 Allowed 'General case' 0 C--N 1.32 -0.695 0 O-C-N 124.815 1.322 . . . . 0.0 112.811 -175.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 72' ' ' VAL . . . . . 0.535 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -50.96 -15.3 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 O-C-N 123.356 0.41 . . . . 0.0 111.922 179.615 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 73' ' ' GLY . . . . . 0.761 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -65.3 -66.86 2.25 Favored Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 115.805 -0.634 . . . . 0.0 113.183 171.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -62.07 -27.24 68.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.229 -0.485 . . . . 0.0 110.332 -177.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 75' ' ' ILE . . . . . 0.629 ' O ' HG13 ' D' ' 79' ' ' ILE . 29.9 mm -78.24 -41.48 26.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.217 178.022 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 76' ' ' SER . . . . . 0.566 ' HB2' HD13 ' D' ' 27' ' ' LEU . 29.3 t -72.37 -21.33 61.31 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.449 -178.492 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -64.89 -34.01 77.38 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 167.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 78' ' ' ASP . . . . . 1.047 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 0.9 OUTLIER -77.89 -31.99 51.57 Favored 'General case' 0 C--O 1.224 -0.272 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 175.005 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 79' ' ' ILE . . . . . 0.629 HG13 ' O ' ' D' ' 75' ' ' ILE . 60.2 mt -65.49 -21.21 28.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 O-C-N 121.543 -0.723 . . . . 0.0 111.294 -174.16 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -73.25 -43.48 61.08 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 176.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 81' ' ' LYS . . . . . 1.047 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -68.79 -44.47 73.53 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.468 177.269 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 82' ' ' LEU . . . . . 0.659 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.8 mm? -55.53 -22.15 20.2 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 177.229 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 45.57 73.2 0.17 Allowed 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.778 0.674 . . . . 0.0 110.984 175.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 84' ' ' ILE . . . . . 0.865 HG21 HD11 ' D' ' 91' ' ' ILE . 35.0 mt -70.71 99.8 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.315 -177.262 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 85' ' ' LYS . . . . . 0.594 ' HD3' ' O ' ' D' ' 35' ' ' GLN . 30.5 mmmt -139.19 177.87 7.59 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.719 176.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 86' ' ' GLY . . . . . 0.716 ' HA2' HD11 ' D' ' 89' ' ' ILE . . . -59.67 175.89 3.44 Favored Glycine 0 CA--C 1.506 -0.481 0 N-CA-C 115.008 0.763 . . . . 0.0 115.008 -174.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 87' ' ' PRO . . . . . 0.603 ' O ' HG13 ' D' ' 58' ' ' VAL . 33.0 Cg_endo -91.67 175.73 17.48 Favored 'Cis proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.158 -2.017 . . . . 0.0 114.53 0.432 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 88' ' ' TYR . . . . . 0.71 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 33.4 m-85 31.52 92.47 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.32 1.448 . . . . 0.0 112.614 -179.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.716 HD11 ' HA2' ' D' ' 86' ' ' GLY . 3.1 mp -109.5 143.1 20.28 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.402 -177.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 90' ' ' GLU . . . . . 0.656 ' O ' ' HA ' ' D' ' 56' ' ' ILE . 37.3 mt-10 -129.24 89.19 2.81 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.385 172.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 91' ' ' ILE . . . . . 0.865 HD11 HG21 ' D' ' 84' ' ' ILE . 21.0 mt -94.44 99.8 10.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.912 178.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 92' ' ' LYS . . . . . 0.844 ' HE3' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -161.8 169.2 21.81 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.125 -177.434 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 93' ' ' GLN . . . . . 0.716 ' O ' ' HD3' ' D' ' 92' ' ' LYS . 2.5 pp0? -85.78 147.17 26.44 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.054 170.462 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 94' ' ' ILE . . . . . 0.844 HG22 ' HE3' ' D' ' 92' ' ' LYS . 8.9 pt . . . . . 0 C--N 1.304 -1.389 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.979 -169.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.449 ' C ' HG12 ' D' ' 16' ' ' VAL . 55.8 mt . . . . . 0 N--CA 1.455 -0.222 0 CA-C-O 121.47 0.653 . . . . 0.0 111.672 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -95.06 -61.16 1.53 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.678 175.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 15' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' D' ' 18' ' ' ASP . 88.5 p -60.45 -21.78 62.71 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 116.906 -0.134 . . . . 0.0 111.238 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 16' ' ' VAL . . . . . 0.687 ' HA ' ' HE2' ' D' ' 19' ' ' LYS . 9.7 p -54.51 -38.48 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 120.761 0.315 . . . . 0.0 110.647 177.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 17' ' ' ASN . . . . . 0.41 ' OD1' HG13 ' D' ' 16' ' ' VAL . 33.0 m-20 -68.61 -35.79 77.81 Favored 'General case' 0 C--O 1.214 -0.793 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.7 178.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 18' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' D' ' 15' ' ' SER . 1.2 m-20 -64.42 -17.29 63.65 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -176.435 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.687 ' HE2' ' HA ' ' D' ' 16' ' ' VAL . 0.0 OUTLIER -90.78 -44.43 9.45 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-O 122.031 0.919 . . . . 0.0 108.563 173.778 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 20' ' ' LEU . . . . . 1.014 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 75.6 mt -61.76 -39.08 90.36 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 113.515 -1.675 . . . . 0.0 109.937 -178.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 21' ' ' ASN . . . . . 0.437 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 50.7 m-20 -77.99 97.21 5.28 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.558 178.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 22' ' ' LYS . . . . . 0.781 ' HD2' HD12 ' D' ' 47' ' ' ILE . 67.5 mttm -123.12 -43.37 2.22 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -177.169 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.4 -96.22 0.1 Allowed Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 119.403 -1.379 . . . . 0.0 113.721 -176.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 24' ' ' LYS . . . . . 0.799 ' HE2' ' HA ' ' D' ' 48' ' ' SER . 35.0 ttpt -53.81 -47.36 70.92 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.737 0.78 . . . . 0.0 109.404 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 25' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -135.96 153.71 21.55 Favored Glycine 0 N--CA 1.431 -1.642 0 CA-C-N 114.232 -1.349 . . . . 0.0 112.006 176.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 26' ' ' LYS . . . . . 0.723 ' CD ' ' HB2' ' D' ' 41' ' ' SER . 0.1 OUTLIER -150.44 160.48 43.73 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.05 -1.075 . . . . 0.0 110.213 -170.192 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 27' ' ' LEU . . . . . 1.014 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 41.8 tp -135.43 130.1 34.28 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.302 0.572 . . . . 0.0 112.023 -177.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 28' ' ' SER . . . . . 0.547 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 8.1 t -117.46 125.16 50.44 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 29' ' ' LEU . . . . . 0.62 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 1.0 OUTLIER -141.14 148.48 40.12 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 176.584 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 62.5 p -157.8 179.07 9.56 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.205 -179.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 31' ' ' MET . . . . . 0.416 ' SD ' ' N ' ' D' ' 31' ' ' MET . 0.0 OUTLIER -117.95 166.17 12.83 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.396 0.617 . . . . 0.0 110.608 179.795 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 32' ' ' ASN . . . . . 0.653 ' HB3' ' HB2' ' D' ' 35' ' ' GLN . 26.1 t-20 -144.16 87.13 1.87 Allowed 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 176.186 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.74 -98.65 0.7 Allowed Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.187 -1.006 . . . . 0.0 111.281 -171.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 34' ' ' ASN . . . . . 0.417 ' O ' ' HG2' ' D' ' 85' ' ' LYS . 72.4 m-20 -110.66 10.36 22.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.029 0.442 . . . . 0.0 110.395 175.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 35' ' ' GLN . . . . . 0.653 ' HB2' ' HB3' ' D' ' 32' ' ' ASN . 55.9 mm-40 -91.35 165.28 13.5 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 121.533 0.682 . . . . 0.0 112.222 -177.08 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.947 HD11 HG22 ' D' ' 79' ' ' ILE . 1.8 tm? -132.82 135.03 45.41 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.693 172.155 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 37' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 34.9 mmtp -132.1 106.36 7.95 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.698 -171.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 38' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -118.52 148.46 42.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.857 0.361 . . . . 0.0 111.911 -177.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 39' ' ' THR . . . . . 0.547 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 57.2 p -145.43 148.5 33.37 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.265 178.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 40' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' D' ' 26' ' ' LYS . 41.9 p -109.28 131.87 54.66 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 168.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 41' ' ' SER . . . . . 0.723 ' HB2' ' CD ' ' D' ' 26' ' ' LYS . 43.7 m -94.44 147.76 22.91 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 118.915 -1.114 . . . . 0.0 108.882 177.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 42' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' D' ' 41' ' ' SER . 75.1 m-80 80.67 2.5 1.79 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.942 -165.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.19 62.08 2.13 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 168.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 44' ' ' GLY . . . . . 0.479 ' O ' ' HB ' ' D' ' 71' ' ' THR . . . 119.19 -6.48 13.05 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 118.405 -1.855 . . . . 0.0 115.072 168.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 45' ' ' TYR . . . . . 0.766 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 1.3 m-85 -86.17 155.84 20.58 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.98 0.39 . . . . 0.0 111.784 -174.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 46' ' ' GLY . . . . . 0.6 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -94.84 178.95 36.63 Favored Glycine 0 C--O 1.222 -0.654 0 CA-C-O 118.812 -0.993 . . . . 0.0 110.642 174.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 47' ' ' ILE . . . . . 0.781 HD12 ' HD2' ' D' ' 22' ' ' LYS . 33.4 mm -47.65 -57.22 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 CA-C-N 118.109 0.955 . . . . 0.0 110.652 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 48' ' ' SER . . . . . 0.799 ' HA ' ' HE2' ' D' ' 24' ' ' LYS . 22.1 t 178.83 -135.24 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.02 -1.446 . . . . 0.0 107.923 -178.175 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -95.03 76.93 3.53 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 165.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 50' ' ' GLU . . . . . 0.853 ' HB3' ' HE3' ' D' ' 52' ' ' LYS . 50.6 mt-10 -144.58 164.63 30.36 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.95 -173.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 51' ' ' ASP . . . . . 0.686 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 10.7 p-10 -132.61 135.49 45.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.231 0.539 . . . . 0.0 111.337 177.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 52' ' ' LYS . . . . . 0.853 ' HE3' ' HB3' ' D' ' 50' ' ' GLU . 0.2 OUTLIER -146.97 142.35 27.44 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.392 -174.261 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 52.6 m-20 -118.25 135.99 53.94 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 172.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 54' ' ' TRP . . . . . 1.065 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 0.9 OUTLIER -126.29 162.49 25.35 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -170.89 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -148.69 163.46 29.03 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.204 174.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 56' ' ' ILE . . . . . 1.064 HG12 HG23 ' D' ' 91' ' ' ILE . 93.6 mt -135.97 108.99 8.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 C-N-CA 124.853 1.261 . . . . 0.0 107.689 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 57' ' ' PHE . . . . . 0.726 ' CE1' ' HE2' ' D' ' 92' ' ' LYS . 14.6 m-85 -107.63 101.55 10.86 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.898 -168.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.806 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 84.0 t -83.24 106.48 13.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.927 171.474 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 34.9 m120 64.4 45.24 3.84 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.51 0.506 . . . . 0.0 110.692 -177.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.76 41.94 99.68 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.313 -178.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 61' ' ' GLU . . . . . 0.515 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 42.8 tt0 -142.97 112.64 6.9 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.264 -0.468 . . . . 0.0 110.059 178.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 62' ' ' LYS . . . . . 0.524 ' HB2' ' CE2' ' D' ' 57' ' ' PHE . 37.8 ttpt -70.36 105.65 3.1 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.446 -177.254 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 27.6 m -89.14 -24.48 5.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.708 -175.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 64' ' ' TYR . . . . . 0.451 ' HB3' HD12 ' D' ' 56' ' ' ILE . 16.4 t80 -141.36 135.45 30.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.766 0.317 . . . . 0.0 111.035 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 79.6 m -117.66 118.89 33.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.308 175.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 66' ' ' PHE . . . . . 0.456 ' CZ ' ' CE3' ' D' ' 54' ' ' TRP . 9.4 p90 -125.61 159.36 32.35 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 174.243 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 67' ' ' ASN . . . . . 0.561 ' OD1' ' HB2' ' D' ' 69' ' ' LYS . 0.1 OUTLIER -130.2 136.1 48.87 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -174.58 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 68' ' ' GLU . . . . . 0.778 ' HB3' HG12 ' D' ' 47' ' ' ILE . 51.9 mm-40 -68.31 -8.37 39.12 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.368 -175.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.561 ' HB2' ' OD1' ' D' ' 67' ' ' ASN . 6.0 mtpm? -64.74 -44.4 90.24 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 169.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 70' ' ' SER . . . . . 0.475 ' HB3' ' O ' ' D' ' 67' ' ' ASN . 35.0 t -64.61 125.43 24.71 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 113.32 -1.763 . . . . 0.0 107.847 168.165 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 71' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' D' ' 44' ' ' GLY . 72.3 p -56.03 126.57 26.5 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 72' ' ' VAL . . . . . 0.618 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -57.56 -11.47 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-O 121.04 0.448 . . . . 0.0 111.341 -176.292 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 73' ' ' GLY . . . . . 0.47 ' HA3' ' HA2' ' D' ' 44' ' ' GLY . . . -73.49 -57.34 5.09 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.568 170.005 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -63.84 -23.84 67.51 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 177.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 75' ' ' ILE . . . . . 0.65 ' O ' HG13 ' D' ' 79' ' ' ILE . 72.0 mt -71.33 -44.8 72.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.216 174.136 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 76' ' ' SER . . . . . 0.469 ' HA ' HG13 ' D' ' 79' ' ' ILE . 31.8 t -71.55 -25.89 62.41 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 121.116 -0.233 . . . . 0.0 111.037 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 77' ' ' ASN . . . . . 0.423 ' O ' ' HD2' ' D' ' 81' ' ' LYS . 69.1 m-20 -60.71 -26.36 67.1 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 169.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 78' ' ' ASP . . . . . 1.023 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 80.7 m-20 -86.3 -37.54 18.42 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.196 174.457 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 79' ' ' ILE . . . . . 0.947 HG22 HD11 ' D' ' 36' ' ' LEU . 24.2 mt -64.85 -27.96 43.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 O-C-N 121.897 -0.502 . . . . 0.0 110.803 -175.043 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -69.11 -29.49 67.57 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.293 178.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 81' ' ' LYS . . . . . 1.023 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -85.04 -49.45 8.28 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 119.677 -0.809 . . . . 0.0 111.323 175.116 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 82' ' ' LEU . . . . . 0.642 HD23 ' O ' ' D' ' 78' ' ' ASP . 4.1 mm? -50.43 -26.57 5.18 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 52.89 66.91 1.09 Allowed 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.617 0.573 . . . . 0.0 110.153 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 84' ' ' ILE . . . . . 0.53 HG23 HG21 ' D' ' 56' ' ' ILE . 50.3 mm -73.66 99.94 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.601 -175.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 85' ' ' LYS . . . . . 0.54 ' C ' ' HE3' ' D' ' 85' ' ' LYS . 0.0 OUTLIER -142.39 -171.57 3.43 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 179.7 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 86' ' ' GLY . . . . . 0.694 ' HA2' HD11 ' D' ' 89' ' ' ILE . . . -61.22 168.12 11.54 Favored Glycine 0 CA--C 1.507 -0.45 0 CA-C-N 115.316 -0.856 . . . . 0.0 114.543 -174.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 87' ' ' PRO . . . . . 0.671 ' O ' HG13 ' D' ' 58' ' ' VAL . 45.2 Cg_endo -91.38 178.4 14.33 Favored 'Cis proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.868 -1.722 . . . . 0.0 114.171 0.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 88' ' ' TYR . . . . . 0.806 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 1.4 m-85 36.67 91.39 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 O-C-N 124.483 1.115 . . . . 0.0 112.435 178.34 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.694 HD11 ' HA2' ' D' ' 86' ' ' GLY . 3.5 mp -111.09 121.88 64.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.507 0.67 . . . . 0.0 111.03 -176.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 90' ' ' GLU . . . . . 0.638 ' HB2' ' HB2' ' D' ' 57' ' ' PHE . 54.3 mt-10 -124.15 88.99 3.0 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.916 177.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 91' ' ' ILE . . . . . 1.065 HG22 ' HZ3' ' D' ' 54' ' ' TRP . 4.1 mt -100.06 111.05 28.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 92' ' ' LYS . . . . . 0.726 ' HE2' ' CE1' ' D' ' 57' ' ' PHE . 0.0 OUTLIER -162.57 172.47 15.37 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 93' ' ' GLN . . . . . 0.651 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 17.2 pt20 -81.33 158.45 24.72 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.807 173.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 7.6 pt . . . . . 0 C--N 1.305 -1.364 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.631 -172.394 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.567 ' O ' HG12 ' D' ' 16' ' ' VAL . 48.4 mt . . . . . 0 N--CA 1.45 -0.472 0 CA-C-O 121.841 0.829 . . . . 0.0 110.649 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -93.87 -57.07 2.66 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.604 -176.992 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' D' D ' 15' ' ' SER . . . . . 0.688 ' HA ' ' OD2' ' D' ' 18' ' ' ASP . 97.5 p -69.65 -16.16 63.32 Favored 'General case' 0 C--O 1.218 -0.59 0 C-N-CA 120.156 -0.618 . . . . 0.0 110.199 175.23 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 16' ' ' VAL . . . . . 0.567 HG12 ' O ' ' D' ' 13' ' ' ILE . 1.5 p -56.08 -23.9 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 121.974 0.892 . . . . 0.0 109.138 174.336 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 17' ' ' ASN . . . . . 0.63 ' HB3' ' ND2' ' D' ' 21' ' ' ASN . 5.4 m120 -84.71 -32.38 23.57 Favored 'General case' 0 C--O 1.206 -1.232 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.204 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 18' ' ' ASP . . . . . 0.688 ' OD2' ' HA ' ' D' ' 15' ' ' SER . 63.0 m-20 -61.61 -14.91 34.66 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 177.667 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.862 ' HE2' ' N ' ' D' ' 19' ' ' LYS . 0.3 OUTLIER -86.4 -48.54 8.36 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 174.334 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' D' D ' 20' ' ' LEU . . . . . 0.98 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 71.9 mt -64.92 -40.79 95.6 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 112.299 -2.228 . . . . 0.0 110.497 -176.122 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 21' ' ' ASN . . . . . 0.734 ' OD1' ' HB2' ' D' ' 26' ' ' LYS . 75.1 m-20 -85.33 97.74 10.14 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.434 -179.598 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 22' ' ' LYS . . . . . 0.607 ' HB3' ' NZ ' ' D' ' 22' ' ' LYS . 7.5 mtpm? -123.03 -41.67 2.32 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 118.767 -1.173 . . . . 0.0 114.125 -178.018 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 173.38 -82.52 0.08 OUTLIER Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 119.901 -1.143 . . . . 0.0 112.527 -177.473 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' D' D ' 24' ' ' LYS . . . . . 0.866 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 27.2 tptp -48.18 -60.94 2.26 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.675 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -134.73 160.14 24.15 Favored Glycine 0 N--CA 1.433 -1.542 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.451 174.646 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' D' D ' 26' ' ' LYS . . . . . 0.734 ' HB2' ' OD1' ' D' ' 21' ' ' ASN . 0.1 OUTLIER -149.63 159.74 44.08 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.57 -0.815 . . . . 0.0 111.099 -168.611 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' D' D ' 27' ' ' LEU . . . . . 0.98 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 44.9 tp -143.73 139.15 29.3 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.96 0.409 . . . . 0.0 111.942 -178.621 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 28' ' ' SER . . . . . 0.599 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 8.7 t -127.7 153.77 46.11 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 174.834 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 29' ' ' LEU . . . . . . . . . . . . . 18.4 mt -133.96 140.52 46.8 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.886 178.717 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 49.8 m -152.44 -176.28 5.64 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.731 178.065 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 66.8 mtm -136.24 166.39 23.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.056 0.455 . . . . 0.0 110.546 -179.849 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' D' D ' 32' ' ' ASN . . . . . 0.556 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 24.4 t-20 -146.06 88.38 1.81 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.39 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.15 -105.32 1.81 Allowed Glycine 0 N--CA 1.454 -0.144 0 C-N-CA 119.998 -1.096 . . . . 0.0 110.749 -170.344 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -114.16 29.89 7.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.177 0.513 . . . . 0.0 109.952 171.462 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' D' D ' 35' ' ' GLN . . . . . 0.556 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 12.5 tp-100 -102.31 155.75 18.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.241 -178.146 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.636 HD11 HG22 ' D' ' 79' ' ' ILE . 2.5 tm? -113.43 129.16 56.61 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 175.888 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 37' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -136.14 99.01 4.01 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.967 -169.393 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' D' D ' 38' ' ' ALA . . . . . 0.681 ' HB1' HD11 ' D' ' 27' ' ' LEU . . . -98.21 150.76 21.16 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.017 176.115 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 39' ' ' THR . . . . . 0.599 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 74.4 p -133.67 123.01 24.26 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 174.394 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 40' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' D' ' 26' ' ' LYS . 18.7 m -115.7 128.89 56.23 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.233 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 41' ' ' SER . . . . . 0.62 ' HB2' ' CD ' ' D' ' 26' ' ' LYS . 31.9 m -104.87 162.05 13.66 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.42 -173.066 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 42' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' D' ' 41' ' ' SER . 74.7 m-80 77.35 9.9 2.51 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 114.197 -1.365 . . . . 0.0 110.52 -171.68 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 49.04 60.5 3.7 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 114.799 -1.092 . . . . 0.0 113.753 169.902 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' D' D ' 44' ' ' GLY . . . . . 0.455 ' C ' ' HD2' ' D' ' 45' ' ' TYR . . . 106.72 37.11 2.45 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 119.216 -1.469 . . . . 0.0 114.043 171.193 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 45' ' ' TYR . . . . . 0.866 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 3.9 m-30 -114.59 153.33 30.31 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 117.376 0.588 . . . . 0.0 110.037 176.921 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 46' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -97.82 -155.77 29.9 Favored Glycine 0 C--O 1.217 -0.909 0 CA-C-O 119.459 -0.634 . . . . 0.0 111.598 178.014 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 47' ' ' ILE . . . . . 0.963 HG13 ' HB3' ' D' ' 68' ' ' GLU . 0.4 OUTLIER -54.62 -56.53 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-O 122.118 0.961 . . . . 0.0 108.659 -179.994 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' D' D ' 48' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' D' ' 47' ' ' ILE . 26.3 t 162.33 -60.3 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 111.922 -2.399 . . . . 0.0 106.909 -174.991 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -169.89 76.27 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.546 172.683 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 50' ' ' GLU . . . . . 0.661 ' O ' ' HG2' ' D' ' 69' ' ' LYS . 49.0 mt-10 -149.27 -177.94 6.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.881 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 51' ' ' ASP . . . . . 0.592 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 1.0 OUTLIER -129.07 130.15 46.17 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.457 0.646 . . . . 0.0 111.316 172.553 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' D' D ' 52' ' ' LYS . . . . . 0.592 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 0.4 OUTLIER -141.77 100.92 3.85 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.861 -179.833 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' D' D ' 53' ' ' ASN . . . . . 0.618 ' HA ' ' OD1' ' D' ' 67' ' ' ASN . 38.3 m-20 -78.16 125.7 29.74 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 176.396 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 54' ' ' TRP . . . . . 0.572 ' HB2' ' O ' ' D' ' 66' ' ' PHE . 0.1 OUTLIER -118.21 155.86 29.78 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.385 -171.948 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -148.13 161.79 28.66 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 119.833 -1.175 . . . . 0.0 114.297 175.751 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' D' D ' 56' ' ' ILE . . . . . 0.506 HG23 HG12 ' D' ' 91' ' ' ILE . 71.9 mt -135.09 111.25 13.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 57' ' ' PHE . . . . . 0.65 ' HZ ' HG21 ' D' ' 94' ' ' ILE . 9.2 m-85 -111.83 114.16 26.95 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.654 -166.872 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.938 HG22 HG12 ' D' ' 89' ' ' ILE . 59.6 t -96.28 105.92 17.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.903 174.661 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 7.0 m120 56.42 51.74 10.99 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.155 -176.374 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.04 48.08 68.4 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.823 178.941 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' D' D ' 61' ' ' GLU . . . . . 0.619 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 86.9 tt0 -150.29 116.87 5.79 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 177.631 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 62' ' ' LYS . . . . . 0.447 ' HB2' ' CE1' ' D' ' 57' ' ' PHE . 27.3 ttpp -75.86 99.91 4.63 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.971 0.415 . . . . 0.0 110.282 179.086 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 30.3 m -84.96 -27.2 6.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.051 -175.205 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' D' D ' 64' ' ' TYR . . . . . 0.449 ' HB3' HD12 ' D' ' 56' ' ' ILE . 14.4 t80 -136.75 131.46 33.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.736 0.303 . . . . 0.0 110.373 178.367 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 19.4 m -117.98 104.6 11.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.94 177.816 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' D' D ' 66' ' ' PHE . . . . . 0.572 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 12.2 p90 -114.64 164.68 13.69 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 175.515 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 67' ' ' ASN . . . . . 0.618 ' OD1' ' HA ' ' D' ' 53' ' ' ASN . 74.8 m-20 -130.88 152.0 50.68 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.289 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 68' ' ' GLU . . . . . 0.963 ' HB3' HG13 ' D' ' 47' ' ' ILE . 84.0 mt-10 -68.78 -18.94 64.28 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.689 -0.804 . . . . 0.0 109.774 174.257 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.661 ' HG2' ' O ' ' D' ' 50' ' ' GLU . 45.4 mtmt -61.38 -42.46 98.75 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 172.61 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 70' ' ' SER . . . . . 0.403 ' HB3' ' O ' ' D' ' 67' ' ' ASN . 27.7 t -67.87 125.41 26.19 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 113.669 -1.605 . . . . 0.0 107.405 170.503 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 76.6 p -58.19 116.33 3.5 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -176.539 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' D' D ' 72' ' ' VAL . . . . . 0.745 ' HA ' HD12 ' D' ' 75' ' ' ILE . 0.0 OUTLIER -51.41 -20.56 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-O 120.674 0.273 . . . . 0.0 111.472 -173.654 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' D' D ' 73' ' ' GLY . . . . . 0.533 ' HA2' ' HB2' ' D' ' 40' ' ' SER . . . -63.39 -59.91 8.22 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.709 -0.678 . . . . 0.0 113.081 172.422 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -66.61 -18.75 65.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.444 0.164 . . . . 0.0 110.902 178.62 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' D' D ' 75' ' ' ILE . . . . . 0.745 HD12 ' HA ' ' D' ' 72' ' ' VAL . 77.7 mt -71.6 -42.39 71.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.021 173.752 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 76' ' ' SER . . . . . 0.444 ' HA ' HG13 ' D' ' 79' ' ' ILE . 47.1 t -74.1 -22.68 59.39 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.008 -177.439 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -63.93 -27.29 69.05 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 168.32 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' D' D ' 78' ' ' ASP . . . . . 1.035 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 51.6 m-20 -83.6 -36.14 24.13 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.943 173.187 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 79' ' ' ILE . . . . . 0.687 HG13 ' O ' ' D' ' 75' ' ' ILE . 22.2 mt -67.05 -16.04 20.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.266 -175.6 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 -69.85 -48.83 57.37 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.108 174.127 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' D' D ' 81' ' ' LYS . . . . . 1.035 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -69.39 -47.82 63.03 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.645 178.427 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' D' D ' 82' ' ' LEU . . . . . 0.618 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.5 mm? -54.26 -23.97 16.98 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 178.195 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 83' ' ' ASN . . . . . 0.474 ' O ' ' HE2' ' D' ' 85' ' ' LYS . 49.0 t-20 39.25 69.29 0.29 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.916 0.886 . . . . 0.0 111.159 176.008 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 84' ' ' ILE . . . . . 0.597 HG23 HD13 ' D' ' 89' ' ' ILE . 47.8 mm -75.17 99.28 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.166 -172.991 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 85' ' ' LYS . . . . . 0.542 ' O ' ' HE3' ' D' ' 85' ' ' LYS . 0.0 OUTLIER -158.19 91.44 1.1 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 173.972 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' D' D ' 86' ' ' GLY . . . . . 0.549 ' H ' HD12 ' D' ' 89' ' ' ILE . . . 69.63 154.51 0.97 Allowed Glycine 0 C--N 1.329 0.175 0 CA-C-N 115.127 -0.942 . . . . 0.0 114.106 173.163 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 87' ' ' PRO . . . . . 0.619 ' O ' HG13 ' D' ' 58' ' ' VAL . 68.8 Cg_endo -87.33 178.96 19.74 Favored 'Cis proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.681 -1.8 . . . . 0.0 112.09 -0.301 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 88' ' ' TYR . . . . . 0.648 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 2.3 m-85 4.67 91.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 125.253 1.421 . . . . 0.0 113.942 -175.45 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.938 HG12 HG22 ' D' ' 58' ' ' VAL . 66.2 mt -111.38 129.19 67.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.999 -179.803 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 90' ' ' GLU . . . . . 0.542 ' O ' ' HD2' ' D' ' 57' ' ' PHE . 49.2 mm-40 -112.33 100.36 8.73 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.879 175.266 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 91' ' ' ILE . . . . . 0.582 HG13 HG22 ' D' ' 89' ' ' ILE . 35.0 mt -94.38 101.19 12.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.05 -178.744 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 92' ' ' LYS . . . . . 0.627 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -160.5 163.64 32.73 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.107 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' D' D ' 93' ' ' GLN . . . . . 0.609 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 19.7 pt20 -79.53 167.4 20.81 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 119.764 -0.774 . . . . 0.0 110.807 176.818 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' D' D ' 94' ' ' ILE . . . . . 0.65 HG21 ' HZ ' ' D' ' 57' ' ' PHE . 10.9 pt . . . . . 0 C--N 1.313 -1.006 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.572 -170.991 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.645 ' O ' HG12 ' D' ' 16' ' ' VAL . 51.6 mt . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 121.701 0.762 . . . . 0.0 110.544 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 52.6 m-20 -85.25 -59.19 2.4 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.291 176.137 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' D' D ' 15' ' ' SER . . . . . 0.476 ' O ' ' HE2' ' D' ' 19' ' ' LYS . 88.7 p -68.22 -13.88 62.57 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 175.603 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 16' ' ' VAL . . . . . 0.645 HG12 ' O ' ' D' ' 13' ' ' ILE . 0.9 OUTLIER -62.18 -25.68 38.18 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.92 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 19.7 m-20 -73.56 -42.24 61.9 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 114.383 -1.281 . . . . 0.0 108.592 177.122 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' D' D ' 18' ' ' ASP . . . . . 0.401 ' OD1' ' HA ' ' D' ' 15' ' ' SER . 1.6 m-20 -59.25 -14.85 12.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.864 -178.387 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.498 ' CE ' ' HA ' ' D' ' 16' ' ' VAL . 34.9 mttm -91.1 -45.77 8.5 Favored 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 123.198 1.475 . . . . 0.0 108.803 -179.743 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 20' ' ' LEU . . . . . 0.841 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 59.1 mt -66.53 -36.53 82.92 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 111.986 -2.37 . . . . 0.0 109.795 -179.87 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 21' ' ' ASN . . . . . 0.657 ' HA ' ' HB2' ' D' ' 26' ' ' LYS . 43.7 m-20 -74.91 94.4 2.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.399 178.837 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 22' ' ' LYS . . . . . 0.467 ' HD2' HD12 ' D' ' 47' ' ' ILE . 43.3 mttp -122.46 -43.29 2.3 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -176.681 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 171.68 -87.98 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 119.125 -1.512 . . . . 0.0 113.63 -177.13 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' D' D ' 24' ' ' LYS . . . . . 0.637 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 0.0 OUTLIER -48.02 -53.42 16.35 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.943 0.877 . . . . 0.0 109.172 179.166 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' D' D ' 25' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -149.32 156.11 26.64 Favored Glycine 0 N--CA 1.43 -1.761 0 CA-C-N 113.928 -1.487 . . . . 0.0 110.918 177.898 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 26' ' ' LYS . . . . . 0.717 ' HD2' ' HB3' ' D' ' 41' ' ' SER . 8.7 ptpt -151.15 160.4 43.88 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 114.331 -0.934 . . . . 0.0 110.52 -167.128 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 27' ' ' LEU . . . . . 0.841 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 49.7 tp -134.61 147.35 50.19 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.402 0.62 . . . . 0.0 111.937 -176.645 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 28' ' ' SER . . . . . 0.582 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 33.5 t -132.5 128.65 37.8 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.437 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 29' ' ' LEU . . . . . 0.561 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 9.3 mt -126.94 144.9 50.87 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.796 177.74 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 73.1 p -160.32 176.89 11.18 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.977 177.7 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' D' D ' 31' ' ' MET . . . . . 0.515 ' HA ' ' O ' ' D' ' 35' ' ' GLN . 0.0 OUTLIER -129.65 116.89 19.5 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.377 0.608 . . . . 0.0 110.417 177.076 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -90.36 89.36 7.58 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.395 -0.821 . . . . 0.0 108.97 179.329 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.68 -103.31 2.07 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.275 -0.964 . . . . 0.0 111.064 -171.083 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -120.4 31.14 6.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.381 0.61 . . . . 0.0 109.883 174.674 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' D' D ' 35' ' ' GLN . . . . . 0.515 ' O ' ' HA ' ' D' ' 31' ' ' MET . 64.6 tt0 -108.36 158.69 17.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.308 -174.674 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.644 HD11 HG22 ' D' ' 79' ' ' ILE . 2.5 tm? -112.77 126.96 55.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.668 0.271 . . . . 0.0 110.346 178.951 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 37' ' ' LYS . . . . . 0.567 ' NZ ' ' HB3' ' D' ' 37' ' ' LYS . 1.6 mmmp? -132.58 115.7 15.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.973 -168.113 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 38' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -119.91 142.54 48.62 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.925 174.617 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 39' ' ' THR . . . . . 0.582 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 15.1 p -145.76 132.46 19.96 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.057 177.73 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 40' ' ' SER . . . . . 0.809 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 78.8 p -112.28 145.38 40.08 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.326 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 41' ' ' SER . . . . . 0.717 ' HB3' ' HD2' ' D' ' 26' ' ' LYS . 44.3 t -104.39 149.8 25.08 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 118.949 -1.101 . . . . 0.0 109.821 177.176 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 42' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' D' ' 41' ' ' SER . 33.3 m120 80.31 1.42 1.96 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.891 -171.731 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 44.58 57.76 4.27 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 170.927 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.91 35.77 0.71 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 119.419 -1.372 . . . . 0.0 113.857 173.313 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' D' D ' 45' ' ' TYR . . . . . 0.637 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 18.2 m-85 -126.31 148.37 49.55 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 172.1 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 46' ' ' GLY . . . . . 0.473 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -88.2 -168.94 44.74 Favored Glycine 0 CA--C 1.497 -1.062 0 N-CA-C 110.579 -1.009 . . . . 0.0 110.579 175.782 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 47' ' ' ILE . . . . . 0.818 HG12 ' HB3' ' D' ' 68' ' ' GLU . 50.4 mm -45.41 -56.71 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 CA-C-O 121.53 0.681 . . . . 0.0 110.001 178.714 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 48' ' ' SER . . . . . 0.414 ' HA ' ' CB ' ' D' ' 24' ' ' LYS . 40.8 t 173.41 -103.18 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 112.552 -2.113 . . . . 0.0 109.258 173.868 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -119.54 74.55 1.01 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.223 0.535 . . . . 0.0 111.705 175.129 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 50' ' ' GLU . . . . . 0.499 ' HA ' ' OE1' ' D' ' 50' ' ' GLU . 3.7 mm-40 -155.74 -170.35 3.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.946 173.12 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 51' ' ' ASP . . . . . 0.615 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 1.8 m-20 -133.45 138.98 46.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.928 175.458 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 52' ' ' LYS . . . . . 0.615 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 0.1 OUTLIER -144.24 144.12 31.36 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 177.926 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 53.8 m-20 -114.6 142.77 46.01 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 176.672 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' D' D ' 54' ' ' TRP . . . . . 0.71 ' HZ3' HG23 ' D' ' 91' ' ' ILE . 0.7 OUTLIER -126.71 153.84 44.92 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -173.919 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -142.31 159.76 27.16 Favored Glycine 0 N--CA 1.44 -1.091 0 CA-C-N 114.832 -1.076 . . . . 0.0 113.266 174.074 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' D' D ' 56' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' D' ' 90' ' ' GLU . 72.3 mt -137.85 105.78 3.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 179.461 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 57' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' D' ' 61' ' ' GLU . 8.9 m-85 -106.47 109.87 21.91 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.676 -0.809 . . . . 0.0 111.353 -170.032 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 94.7 t -88.69 110.6 21.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.957 173.837 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 59' ' ' ASN . . . . . 0.417 ' OD1' ' HG2' ' D' ' 87' ' ' PRO . 6.0 m120 53.39 53.83 11.09 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.191 -176.926 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.9 48.71 78.62 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.941 178.594 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' D' D ' 61' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 89.1 tt0 -156.73 116.43 3.5 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.686 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 62' ' ' LYS . . . . . 0.488 ' HB2' ' CE2' ' D' ' 57' ' ' PHE . 5.5 ttpm? -73.67 101.46 3.65 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -177.864 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 32.5 m -85.74 -25.53 6.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.998 -175.508 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' D' D ' 64' ' ' TYR . . . . . 0.405 ' HB3' HD12 ' D' ' 56' ' ' ILE . 15.1 t80 -140.28 137.94 34.59 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.222 178.822 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 65' ' ' THR . . . . . 0.487 ' OG1' ' HE2' ' D' ' 62' ' ' LYS . 38.5 m -120.13 119.03 32.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.102 174.531 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 66' ' ' PHE . . . . . 0.594 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 9.3 p90 -126.75 158.91 35.28 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 170.843 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 67' ' ' ASN . . . . . 0.674 ' O ' HD11 ' D' ' 75' ' ' ILE . 72.4 m-80 -128.51 142.24 51.14 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.505 -173.21 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 68' ' ' GLU . . . . . 0.818 ' HB3' HG12 ' D' ' 47' ' ' ILE . 5.0 mm-40 -67.14 -10.32 48.97 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 174.586 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.573 ' HE3' ' OD2' ' D' ' 51' ' ' ASP . 48.2 mtpt -63.19 -47.44 82.57 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 114.196 -1.365 . . . . 0.0 107.597 169.947 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t -67.3 138.04 56.54 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 113.505 -1.68 . . . . 0.0 107.961 170.249 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' D' D ' 71' ' ' THR . . . . . 0.448 ' O ' HG13 ' D' ' 75' ' ' ILE . 79.4 p -62.51 122.33 15.5 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.294 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 72' ' ' VAL . . . . . 0.687 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -56.57 -12.93 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 120.966 0.412 . . . . 0.0 111.243 -176.228 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' D' D ' 73' ' ' GLY . . . . . 0.809 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -69.38 -59.95 5.42 Favored Glycine 0 N--CA 1.435 -1.375 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.743 170.169 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -62.72 -27.34 69.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.965 0.412 . . . . 0.0 109.97 177.74 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' D' D ' 75' ' ' ILE . . . . . 0.674 HD11 ' O ' ' D' ' 67' ' ' ASN . 77.7 mt -68.15 -45.28 83.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.899 176.328 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 29.1 t -75.78 -19.43 58.99 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.216 -176.98 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' D' D ' 77' ' ' ASN . . . . . 0.445 ' O ' ' HD2' ' D' ' 81' ' ' LYS . 29.1 m120 -64.48 -31.5 72.74 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 166.198 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 78' ' ' ASP . . . . . 1.091 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 58.4 m-20 -78.52 -39.89 36.75 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.567 175.304 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 79' ' ' ILE . . . . . 0.644 HG22 HD11 ' D' ' 36' ' ' LEU . 22.2 mt -67.29 -17.15 22.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.349 -174.401 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -71.29 -42.92 68.1 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.375 175.65 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' D' D ' 81' ' ' LYS . . . . . 1.091 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -73.26 -51.9 15.96 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.161 176.914 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' D' D ' 82' ' ' LEU . . . . . 0.611 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.7 mm? -48.05 -32.09 6.26 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 178.226 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 34.41 65.24 0.34 Allowed 'General case' 0 N--CA 1.477 0.914 0 O-C-N 124.18 0.925 . . . . 0.0 111.602 175.756 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' D' D ' 84' ' ' ILE . . . . . 0.474 HG22 HD13 ' D' ' 89' ' ' ILE . 44.1 mt -92.84 99.89 10.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.003 0.43 . . . . 0.0 111.974 -172.839 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.96 94.27 3.68 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.616 0.722 . . . . 0.0 112.065 177.726 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 86' ' ' GLY . . . . . 0.655 ' H ' HD11 ' D' ' 89' ' ' ILE . . . 71.46 155.99 2.23 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.356 177.795 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 87' ' ' PRO . . . . . 0.493 ' O ' HG13 ' D' ' 58' ' ' VAL . 60.7 Cg_endo -89.31 179.99 15.09 Favored 'Cis proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.141 -1.608 . . . . 0.0 113.045 0.112 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 88' ' ' TYR . . . . . 0.578 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 10.2 m-85 8.27 93.8 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 125.48 1.512 . . . . 0.0 113.875 -176.366 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.655 HD11 ' H ' ' D' ' 86' ' ' GLY . 72.4 mt -108.71 137.74 39.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -177.885 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 90' ' ' GLU . . . . . 0.443 ' HB2' ' HD1' ' D' ' 57' ' ' PHE . 55.2 mm-40 -113.48 93.04 4.21 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.084 170.161 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 91' ' ' ILE . . . . . 0.71 HG23 ' HZ3' ' D' ' 54' ' ' TRP . 23.7 mt -93.68 100.7 11.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.563 178.155 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 92' ' ' LYS . . . . . 0.841 ' HE3' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -162.82 169.45 19.83 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.177 -178.223 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' D' D ' 93' ' ' GLN . . . . . 0.707 ' O ' ' HD3' ' D' ' 92' ' ' LYS . 25.7 pt20 -87.28 151.76 22.86 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.634 172.177 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' D' D ' 94' ' ' ILE . . . . . 0.841 HG22 ' HE3' ' D' ' 92' ' ' LYS . 9.1 pt . . . . . 0 C--N 1.307 -1.249 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.933 -170.539 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.434 ' C ' HG12 ' D' ' 16' ' ' VAL . 59.1 mt . . . . . 0 N--CA 1.45 -0.428 0 CA-C-O 121.625 0.726 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -94.41 -60.84 1.63 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.843 175.754 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 92.8 p -65.87 -18.51 65.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.822 -0.172 . . . . 0.0 111.152 -179.088 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' D' D ' 16' ' ' VAL . . . . . 0.792 ' HA ' ' HE2' ' D' ' 19' ' ' LYS . 14.5 p -54.77 -36.27 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 175.02 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 17' ' ' ASN . . . . . 0.591 ' OD1' ' HA ' ' D' ' 28' ' ' SER . 78.8 m-20 -76.23 -27.7 56.9 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.675 -178.682 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.92 -16.14 64.13 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 179.509 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.792 ' HE2' ' HA ' ' D' ' 16' ' ' VAL . 0.0 OUTLIER -90.92 -28.99 17.72 Favored 'General case' 0 CA--C 1.494 -1.199 0 CA-C-O 121.68 0.752 . . . . 0.0 109.046 173.486 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' D' D ' 20' ' ' LEU . . . . . 0.902 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 79.5 mt -82.98 -40.09 20.48 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 113.98 -1.464 . . . . 0.0 109.715 -173.14 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 21' ' ' ASN . . . . . 0.643 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 53.0 m-20 -78.3 92.25 4.5 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.032 -1.44 . . . . 0.0 110.694 178.69 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 22' ' ' LYS . . . . . 0.549 ' HD3' HG23 ' D' ' 47' ' ' ILE . 7.3 mtpm? -123.96 -43.58 2.1 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -172.262 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 172.1 -71.63 0.11 Allowed Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 119.195 -1.478 . . . . 0.0 113.805 -175.209 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' D' D ' 24' ' ' LYS . . . . . 0.828 ' HB3' ' O ' ' D' ' 46' ' ' GLY . 17.4 tptp -56.99 -66.02 0.52 Allowed 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 179.449 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -137.19 172.32 22.73 Favored Glycine 0 N--CA 1.426 -1.975 0 CA-C-N 113.656 -1.611 . . . . 0.0 110.256 171.578 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' D' D ' 26' ' ' LYS . . . . . 0.643 ' CB ' ' HA ' ' D' ' 21' ' ' ASN . 10.5 ptpt -148.1 161.64 41.01 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.502 -0.349 . . . . 0.0 111.629 -170.294 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 27' ' ' LEU . . . . . 0.902 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 37.4 tp -134.84 145.48 48.36 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.152 0.501 . . . . 0.0 112.007 179.486 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 28' ' ' SER . . . . . 0.647 ' H ' HD12 ' D' ' 27' ' ' LEU . 29.5 t -134.04 139.23 45.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.582 -178.503 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 29' ' ' LEU . . . . . . . . . . . . . 15.2 mt -130.94 130.4 43.4 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.059 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 49.3 m -134.35 174.2 10.79 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 178.789 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' D' D ' 31' ' ' MET . . . . . 0.769 ' HA ' ' O ' ' D' ' 35' ' ' GLN . 25.8 ptt? -137.72 121.94 18.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.815 0.817 . . . . 0.0 111.681 176.681 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -92.2 88.32 6.44 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.025 173.531 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.69 -102.35 1.75 Allowed Glycine 0 N--CA 1.454 -0.141 0 C-N-CA 120.155 -1.021 . . . . 0.0 110.879 -170.431 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -120.21 31.25 6.58 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.179 0.514 . . . . 0.0 109.845 174.02 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' D' D ' 35' ' ' GLN . . . . . 0.769 ' O ' ' HA ' ' D' ' 31' ' ' MET . 64.1 tt0 -111.43 118.08 34.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.598 -175.519 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.547 HD11 HG22 ' D' ' 79' ' ' ILE . 2.8 tm? -79.04 135.68 36.95 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.902 0.382 . . . . 0.0 110.655 178.62 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 37' ' ' LYS . . . . . 0.417 ' N ' HD13 ' D' ' 36' ' ' LEU . 13.3 mmmm -135.01 99.65 4.34 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.24 -172.754 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 38' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -97.73 141.42 30.77 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.486 0.66 . . . . 0.0 111.817 -177.701 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 39' ' ' THR . . . . . 0.545 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 11.5 p -143.93 132.36 22.13 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.645 177.897 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 40' ' ' SER . . . . . 0.599 ' HA ' ' O ' ' D' ' 26' ' ' LYS . 36.8 t -106.03 128.05 53.58 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 169.38 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 41' ' ' SER . . . . . 0.642 ' O ' ' HB3' ' D' ' 42' ' ' ASN . 46.8 t -93.09 142.9 26.78 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -177.13 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 42' ' ' ASN . . . . . 0.642 ' HB3' ' O ' ' D' ' 41' ' ' SER . 5.0 t30 80.16 -15.83 0.71 Allowed 'General case' 0 CA--C 1.537 0.477 0 O-C-N 124.116 0.885 . . . . 0.0 110.705 -167.816 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 60.91 62.24 1.49 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 165.985 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' D' D ' 44' ' ' GLY . . . . . 0.514 ' C ' ' HD2' ' D' ' 45' ' ' TYR . . . 123.74 35.21 0.7 Allowed Glycine 0 CA--C 1.507 -0.42 0 C-N-CA 118.481 -1.818 . . . . 0.0 115.142 167.365 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 45' ' ' TYR . . . . . 0.716 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 3.1 m-30 -122.23 162.67 20.97 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 172.465 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 46' ' ' GLY . . . . . 0.828 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -100.13 -149.31 23.63 Favored Glycine 0 C--O 1.218 -0.87 0 C-N-CA 121.421 -0.419 . . . . 0.0 113.219 -175.319 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 47' ' ' ILE . . . . . 1.038 HG13 ' HB2' ' D' ' 68' ' ' GLU . 1.3 mp -63.48 -59.57 4.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -176.144 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 48' ' ' SER . . . . . 0.421 ' HA ' ' HB2' ' D' ' 24' ' ' LYS . 31.0 m 167.83 -111.96 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 111.448 -2.615 . . . . 0.0 106.477 -178.517 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -110.99 75.99 0.95 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.458 163.424 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' D' D ' 50' ' ' GLU . . . . . 0.565 ' HB3' ' HE2' ' D' ' 52' ' ' LYS . 51.4 mt-10 -148.1 177.17 9.6 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.115 -179.122 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 51' ' ' ASP . . . . . 0.751 ' HB2' ' HD2' ' D' ' 69' ' ' LYS . 2.7 p30 -143.41 129.47 19.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.338 0.59 . . . . 0.0 111.851 176.625 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 52' ' ' LYS . . . . . 0.708 ' HD3' HG12 ' D' ' 47' ' ' ILE . 4.1 mptp? -138.73 136.05 35.37 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.203 -168.55 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 53' ' ' ASN . . . . . 0.423 ' O ' HG12 ' D' ' 94' ' ' ILE . 33.2 m-20 -111.98 132.54 54.71 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 172.319 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 54' ' ' TRP . . . . . 1.101 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 1.4 m95 -119.04 155.27 31.75 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -173.897 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -142.64 157.9 26.85 Favored Glycine 0 N--CA 1.436 -1.333 0 CA-C-N 114.524 -1.216 . . . . 0.0 113.034 171.536 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' D' D ' 56' ' ' ILE . . . . . 1.061 HG12 HG23 ' D' ' 91' ' ' ILE . 95.1 mt -127.11 104.63 12.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-N 113.081 -1.56 . . . . 0.0 106.96 178.826 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 57' ' ' PHE . . . . . 0.671 ' HD1' ' O ' ' D' ' 90' ' ' GLU . 16.2 m-85 -103.71 106.35 16.83 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.413 -166.123 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.878 HG22 HG12 ' D' ' 89' ' ' ILE . 77.2 t -90.44 111.47 23.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.996 174.815 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 5.3 m120 53.99 45.88 26.71 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.152 -178.323 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.23 49.06 35.04 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.868 179.152 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' D' D ' 61' ' ' GLU . . . . . 0.578 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 89.0 tt0 -154.23 119.68 5.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.659 0.266 . . . . 0.0 110.548 178.386 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -73.88 107.99 6.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.08 179.407 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 23.5 m -91.77 -30.1 4.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.031 -174.742 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' D' D ' 64' ' ' TYR . . . . . 0.525 ' HB3' HD12 ' D' ' 56' ' ' ILE . 13.4 t80 -140.22 134.76 31.57 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.399 179.677 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 65' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' D' ' 54' ' ' TRP . 32.4 m -117.64 105.68 12.29 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.412 178.005 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 66' ' ' PHE . . . . . 0.72 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 10.8 p90 -112.94 153.08 28.57 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 174.517 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -109.86 145.13 37.3 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 176.995 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' D' D ' 68' ' ' GLU . . . . . 1.038 ' HB2' HG13 ' D' ' 47' ' ' ILE . 35.7 mt-10 -70.66 -17.79 62.85 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 177.746 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.751 ' HD2' ' HB2' ' D' ' 51' ' ' ASP . 5.7 mtpm? -58.84 -43.95 90.86 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.375 171.095 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 18.6 t -72.12 99.95 2.43 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.665 -1.607 . . . . 0.0 107.298 171.296 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 75.9 p -31.53 121.56 0.26 Allowed 'General case' 0 C--N 1.317 -0.833 0 O-C-N 124.731 1.27 . . . . 0.0 111.95 -173.246 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' D' D ' 72' ' ' VAL . . . . . 0.56 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.1 OUTLIER -54.38 -11.71 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -178.816 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' D' D ' 73' ' ' GLY . . . . . 0.448 ' HA3' ' HA2' ' D' ' 44' ' ' GLY . . . -69.52 -67.0 2.06 Favored Glycine 0 N--CA 1.435 -1.374 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.689 172.193 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -62.71 -21.0 65.45 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.727 0.299 . . . . 0.0 111.131 -177.858 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' D' D ' 75' ' ' ILE . . . . . 0.456 ' O ' HG12 ' D' ' 79' ' ' ILE . 28.7 mm -80.46 -35.96 15.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.464 176.757 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 76' ' ' SER . . . . . 0.735 ' HB2' HD13 ' D' ' 27' ' ' LEU . 30.2 t -74.37 -21.66 59.56 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.916 177.21 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 77' ' ' ASN . . . . . 0.426 ' O ' ' HD2' ' D' ' 81' ' ' LYS . 2.1 m-80 -64.09 -31.33 72.48 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 166.08 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 78' ' ' ASP . . . . . 1.006 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 79.5 m-20 -78.0 -30.52 50.12 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.177 174.252 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 79' ' ' ILE . . . . . 0.565 HG12 ' HA ' ' D' ' 76' ' ' SER . 28.7 mm -69.72 -19.98 23.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.006 -0.678 . . . . 0.0 109.642 179.732 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -64.66 -41.44 96.1 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.854 174.182 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' D' D ' 81' ' ' LYS . . . . . 1.006 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -81.66 -56.02 4.27 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 177.832 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' D' D ' 82' ' ' LEU . . . . . 0.563 HD23 ' O ' ' D' ' 78' ' ' ASP . 4.0 mm? -48.0 -30.63 4.51 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 83' ' ' ASN . . . . . 0.564 ' O ' ' HE2' ' D' ' 85' ' ' LYS . 47.8 t-20 51.34 81.95 0.07 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.227 0.611 . . . . 0.0 111.21 173.36 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 84' ' ' ILE . . . . . 0.509 ' HB ' ' HG ' ' D' ' 36' ' ' LEU . 48.3 mt -77.08 99.8 2.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -176.367 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 85' ' ' LYS . . . . . 0.564 ' HE2' ' O ' ' D' ' 83' ' ' ASN . 0.0 OUTLIER -160.03 91.24 0.94 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 171.973 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.2 155.88 0.51 Allowed Glycine 0 N--CA 1.454 -0.133 0 CA-C-N 114.85 -1.068 . . . . 0.0 114.915 169.506 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' D' D ' 87' ' ' PRO . . . . . 0.566 ' O ' HG13 ' D' ' 58' ' ' VAL . 67.2 Cg_endo -86.8 177.61 23.5 Favored 'Cis proline' 0 CA--C 1.532 0.403 0 C-N-CA 122.467 -1.889 . . . . 0.0 112.364 -0.399 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 88' ' ' TYR . . . . . 0.597 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 3.8 m-85 6.67 92.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 125.369 1.468 . . . . 0.0 114.173 -176.985 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.878 HG12 HG22 ' D' ' 58' ' ' VAL . 70.3 mt -112.02 133.05 58.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 90' ' ' GLU . . . . . 0.671 ' O ' ' HD1' ' D' ' 57' ' ' PHE . 69.7 mm-40 -119.9 101.87 8.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.084 172.26 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 91' ' ' ILE . . . . . 1.101 HG22 ' HZ3' ' D' ' 54' ' ' TRP . 2.7 mt -98.11 110.54 25.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -178.316 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 92' ' ' LYS . . . . . 0.77 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -162.36 170.59 18.59 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.986 -0.446 . . . . 0.0 110.038 178.337 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' D' D ' 93' ' ' GLN . . . . . 0.612 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 21.7 pt20 -81.31 158.25 24.81 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.093 175.066 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' D' D ' 94' ' ' ILE . . . . . 0.77 HG22 ' HE2' ' D' ' 92' ' ' LYS . 8.0 pt . . . . . 0 C--N 1.311 -1.08 0 CA-C-N 114.11 -1.405 . . . . 0.0 111.451 -167.128 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.545 ' O ' HG12 ' D' ' 16' ' ' VAL . 7.1 tp . . . . . 0 N--CA 1.43 -1.431 0 CA-C-O 121.215 0.531 . . . . 0.0 112.373 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' D' D ' 14' ' ' ASN . . . . . 0.5 ' O ' ' HB2' ' D' ' 17' ' ' ASN . 62.8 m-20 -95.69 -36.42 11.21 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.532 173.647 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 15' ' ' SER . . . . . 0.528 ' O ' ' HB2' ' D' ' 18' ' ' ASP . 80.3 p -75.89 -23.71 55.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.894 0.378 . . . . 0.0 110.224 178.142 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 16' ' ' VAL . . . . . 0.545 HG12 ' O ' ' D' ' 13' ' ' ILE . 5.6 p -61.27 -22.4 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 CA-C-O 122.196 0.998 . . . . 0.0 108.85 176.264 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 17' ' ' ASN . . . . . 0.5 ' HB2' ' O ' ' D' ' 14' ' ' ASN . 4.3 m120 -74.02 -39.73 63.37 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 113.578 -1.646 . . . . 0.0 109.271 176.476 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 18' ' ' ASP . . . . . 0.528 ' HB2' ' O ' ' D' ' 15' ' ' SER . 74.9 m-20 -57.34 -17.19 11.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.4 -0.818 . . . . 0.0 113.007 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.607 ' H ' ' HD2' ' D' ' 19' ' ' LYS . 0.0 OUTLIER -90.69 -40.72 11.7 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 121.957 0.884 . . . . 0.0 108.723 174.77 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' D' D ' 20' ' ' LEU . . . . . 0.708 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 81.5 mt -68.31 -34.83 76.85 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 113.327 -1.76 . . . . 0.0 110.523 -177.54 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 21' ' ' ASN . . . . . 0.682 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 63.6 m-20 -78.61 100.55 7.03 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.203 -179.356 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 22' ' ' LYS . . . . . 0.493 ' HD3' HD12 ' D' ' 47' ' ' ILE . 38.3 mtpt -122.07 -42.55 2.38 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 119.066 -1.054 . . . . 0.0 113.263 -170.398 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 158.11 -74.28 0.22 Allowed Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.144 -1.026 . . . . 0.0 112.719 -176.821 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' D' D ' 24' ' ' LYS . . . . . 0.837 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 21.9 tptm -53.06 -54.84 29.45 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.239 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 25' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -150.44 154.52 25.69 Favored Glycine 0 N--CA 1.429 -1.803 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.772 175.999 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 26' ' ' LYS . . . . . 0.733 ' CG ' ' HB3' ' D' ' 41' ' ' SER . 10.0 ptpt -149.67 159.61 44.2 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.707 -0.747 . . . . 0.0 110.897 -166.618 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 27' ' ' LEU . . . . . 0.708 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 42.7 tp -136.97 138.34 40.45 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.446 0.641 . . . . 0.0 111.904 -176.451 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 28' ' ' SER . . . . . 0.543 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 18.0 t -128.41 153.94 46.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.061 -178.188 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 29' ' ' LEU . . . . . 0.44 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 22.7 mt -138.22 152.47 48.64 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.987 0.422 . . . . 0.0 110.262 177.465 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 30' ' ' SER . . . . . 0.501 ' HB3' ' HB2' ' D' ' 37' ' ' LYS . 36.7 t -145.4 -171.25 3.63 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.411 178.787 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 23.5 ptp -145.85 166.57 25.56 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.84 0.352 . . . . 0.0 110.187 -179.854 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' D' D ' 32' ' ' ASN . . . . . 0.657 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 48.9 t30 -150.4 87.24 1.44 Allowed 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 174.769 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.83 -98.64 0.79 Allowed Glycine 0 N--CA 1.454 -0.166 0 C-N-CA 120.004 -1.093 . . . . 0.0 111.14 -171.366 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -112.6 14.46 20.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.853 0.359 . . . . 0.0 110.135 174.185 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' D' D ' 35' ' ' GLN . . . . . 0.657 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 3.5 tp-100 -89.21 159.13 17.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.601 -174.791 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.998 ' HB2' ' HB2' ' D' ' 85' ' ' LYS . 0.8 OUTLIER -121.24 135.79 55.07 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.299 179.352 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' D' D ' 37' ' ' LYS . . . . . 0.501 ' HB2' ' HB3' ' D' ' 30' ' ' SER . 74.5 mmtt -133.62 139.84 46.74 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.472 -171.511 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 38' ' ' ALA . . . . . 0.409 ' HB3' ' HB ' ' D' ' 79' ' ' ILE . . . -138.6 147.6 43.16 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.861 0.362 . . . . 0.0 111.074 177.184 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 39' ' ' THR . . . . . 0.543 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 17.7 p -147.1 131.94 18.04 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.369 175.731 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 40' ' ' SER . . . . . 0.622 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 80.2 p -108.82 170.66 7.9 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 175.456 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 41' ' ' SER . . . . . 0.733 ' HB3' ' CG ' ' D' ' 26' ' ' LYS . 38.1 t -134.46 153.61 51.84 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.378 -0.929 . . . . 0.0 111.356 177.662 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 42' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' D' ' 41' ' ' SER . 34.8 m120 79.57 9.41 1.57 Allowed 'General case' 0 N--CA 1.467 0.409 0 O-C-N 124.863 1.352 . . . . 0.0 110.462 -174.279 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 42.82 59.62 2.76 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 114.692 -1.14 . . . . 0.0 113.683 171.247 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' D' D ' 44' ' ' GLY . . . . . 0.435 ' O ' HG21 ' D' ' 71' ' ' THR . . . 112.94 35.96 1.59 Allowed Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 119.576 -1.297 . . . . 0.0 114.087 172.534 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 45' ' ' TYR . . . . . 0.837 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 1.2 m-85 -121.42 149.6 42.77 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 170.986 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 46' ' ' GLY . . . . . 0.57 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -100.11 -153.25 27.1 Favored Glycine 0 C--O 1.221 -0.703 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 -178.975 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 47' ' ' ILE . . . . . 0.899 HD11 ' HG3' ' D' ' 68' ' ' GLU . 40.3 mm -52.26 -57.82 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 CA-C-O 121.773 0.797 . . . . 0.0 109.618 175.418 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 78.7 p 179.37 -78.0 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 113.035 -1.893 . . . . 0.0 109.206 -174.569 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.52 74.59 0.76 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.811 171.662 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -147.12 148.51 31.65 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.588 -178.131 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' D' D ' 51' ' ' ASP . . . . . 0.689 ' HA ' ' HD3' ' D' ' 69' ' ' LYS . 7.7 p-10 -89.59 119.39 29.97 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.214 177.04 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 52' ' ' LYS . . . . . 0.641 ' O ' ' HA ' ' D' ' 67' ' ' ASN . 11.6 mmmm -128.48 101.28 6.12 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.387 -166.127 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 -88.99 127.01 35.66 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.07 176.765 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' D' D ' 54' ' ' TRP . . . . . 0.486 ' HZ3' HG23 ' D' ' 91' ' ' ILE . 0.0 OUTLIER -124.97 164.97 18.97 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.062 -173.421 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -154.55 164.34 31.56 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.543 -1.313 . . . . 0.0 114.688 177.279 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' D' D ' 56' ' ' ILE . . . . . 0.497 HG21 HG21 ' D' ' 84' ' ' ILE . 72.7 mt -140.14 107.16 2.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 125.6 1.56 . . . . 0.0 107.02 -179.156 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 57' ' ' PHE . . . . . 0.517 ' HD2' ' O ' ' D' ' 90' ' ' GLU . 4.7 m-85 -114.3 109.25 18.07 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.318 -167.725 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.75 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 0.2 OUTLIER -101.29 118.71 48.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.216 0.531 . . . . 0.0 111.567 171.611 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 5.6 m120 50.57 54.14 11.7 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.845 179.082 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.16 47.89 80.56 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.73 177.846 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -157.01 114.52 3.14 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.4 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -80.99 99.59 8.5 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.143 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 27.5 m -82.76 -18.24 10.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.471 -173.826 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' D' D ' 64' ' ' TYR . . . . . 0.471 ' HB3' HD12 ' D' ' 56' ' ' ILE . 24.4 t80 -147.82 130.37 15.87 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.414 -0.514 . . . . 0.0 111.01 176.922 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 57.9 m -115.63 125.61 53.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.368 174.491 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' D' D ' 66' ' ' PHE . . . . . 0.429 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 15.7 p90 -132.1 163.36 28.65 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.743 177.159 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 67' ' ' ASN . . . . . 0.641 ' HA ' ' O ' ' D' ' 52' ' ' LYS . 74.5 m-80 -129.76 143.02 50.61 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.296 -176.189 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 68' ' ' GLU . . . . . 0.899 ' HG3' HD11 ' D' ' 47' ' ' ILE . 3.9 mm-40 -75.37 -17.93 60.1 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 176.835 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.689 ' HD3' ' HA ' ' D' ' 51' ' ' ASP . 44.1 mtmt -60.03 -48.73 80.49 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 168.532 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 19.7 m -78.17 61.44 2.68 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 111.857 -2.428 . . . . 0.0 109.236 171.596 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' D' D ' 71' ' ' THR . . . . . 0.435 HG21 ' O ' ' D' ' 44' ' ' GLY . 74.3 p -1.62 121.84 0.0 OUTLIER 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.873 1.669 . . . . 0.0 114.992 -179.338 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 72' ' ' VAL . . . . . 0.475 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.1 OUTLIER -44.58 -21.31 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 123.436 0.694 . . . . 0.0 112.613 171.207 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' D' D ' 73' ' ' GLY . . . . . 0.622 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -60.69 -65.87 3.06 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.819 -0.628 . . . . 0.0 113.712 175.275 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -71.47 -20.2 62.11 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 120.971 0.415 . . . . 0.0 110.82 -175.95 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' D' D ' 75' ' ' ILE . . . . . 0.621 ' O ' HG13 ' D' ' 79' ' ' ILE . 27.1 mm -79.34 -40.1 21.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.882 179.472 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 76' ' ' SER . . . . . 0.494 ' HA ' HG13 ' D' ' 79' ' ' ILE . 31.0 t -74.49 -19.98 60.17 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.223 -179.738 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -64.97 -32.42 74.14 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 119.368 -0.933 . . . . 0.0 108.586 166.651 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' D' D ' 78' ' ' ASP . . . . . 1.042 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 60.0 m-20 -79.31 -25.1 42.42 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 176.7 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 79' ' ' ILE . . . . . 0.621 HG13 ' O ' ' D' ' 75' ' ' ILE . 48.6 mt -72.0 -20.62 20.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 O-C-N 121.514 -0.741 . . . . 0.0 111.129 -175.37 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -71.15 -40.19 71.5 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.426 175.777 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' D' D ' 81' ' ' LYS . . . . . 1.042 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -73.78 -54.21 8.55 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.642 176.322 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' D' D ' 82' ' ' LEU . . . . . 0.623 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.9 mm? -47.29 -33.35 5.53 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 177.532 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 83' ' ' ASN . . . . . 0.566 ' HA ' HD12 ' D' ' 36' ' ' LEU . 55.4 t-20 42.07 67.08 0.62 Allowed 'General case' 0 N--CA 1.468 0.438 0 O-C-N 124.002 0.814 . . . . 0.0 110.864 174.774 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 84' ' ' ILE . . . . . 0.574 ' O ' ' HG ' ' D' ' 36' ' ' LEU . 44.1 mm -94.94 98.81 8.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.165 -175.084 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 85' ' ' LYS . . . . . 0.998 ' HB2' ' HB2' ' D' ' 36' ' ' LEU . 46.4 tptt -139.97 94.47 2.76 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.171 0.51 . . . . 0.0 110.812 -178.63 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 86' ' ' GLY . . . . . 0.597 ' H ' ' CD1' ' D' ' 89' ' ' ILE . . . 69.54 161.98 3.11 Favored Glycine 0 CA--C 1.5 -0.845 0 CA-C-N 115.231 -0.895 . . . . 0.0 114.357 177.42 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 87' ' ' PRO . . . . . 0.697 ' HD2' HG21 ' D' ' 58' ' ' VAL . 61.7 Cg_endo -77.03 -172.1 10.77 Favored 'Cis proline' 0 CA--C 1.545 1.055 0 C-N-CA 122.195 -2.002 . . . . 0.0 114.128 0.896 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 88' ' ' TYR . . . . . 0.75 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 2.2 m-85 -9.38 94.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 125.485 1.514 . . . . 0.0 114.668 -174.967 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.597 ' CD1' ' H ' ' D' ' 86' ' ' GLY . 70.1 mt -102.19 142.1 17.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 90' ' ' GLU . . . . . 0.517 ' O ' ' HD2' ' D' ' 57' ' ' PHE . 46.3 mt-10 -116.32 98.58 6.67 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.528 170.557 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 91' ' ' ILE . . . . . 0.543 HG13 HG22 ' D' ' 89' ' ' ILE . 33.0 mt -94.34 100.25 10.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.024 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 92' ' ' LYS . . . . . 0.661 ' HG2' ' O ' ' D' ' 93' ' ' GLN . 0.0 OUTLIER -159.68 166.68 30.08 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.416 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' D' D ' 93' ' ' GLN . . . . . 0.661 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 3.8 pm0 -80.41 162.95 24.2 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 121.533 0.682 . . . . 0.0 110.696 175.903 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' D' D ' 94' ' ' ILE . . . . . 0.575 HG22 ' HE2' ' D' ' 92' ' ' LYS . 9.8 pt . . . . . 0 C--N 1.307 -1.26 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.585 -171.946 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.434 ' C ' HG12 ' D' ' 16' ' ' VAL . 64.0 mt . . . . . 0 N--CA 1.452 -0.365 0 CA-C-O 121.606 0.717 . . . . 0.0 111.365 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 -93.53 -59.12 2.08 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.395 175.183 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' D' D ' 15' ' ' SER . . . . . 0.481 ' O ' ' HE2' ' D' ' 19' ' ' LYS . 84.6 p -64.79 -15.19 61.36 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.644 0.239 . . . . 0.0 111.644 179.592 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 16' ' ' VAL . . . . . 0.586 ' HA ' ' HE2' ' D' ' 19' ' ' LYS . 11.8 p -60.64 -30.68 47.39 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.085 0 CA-C-O 121.527 0.679 . . . . 0.0 109.478 175.64 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -71.95 -39.59 69.28 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.044 177.079 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' D' D ' 18' ' ' ASP . . . . . 0.465 ' OD1' ' HA ' ' D' ' 15' ' ' SER . 1.2 m-20 -58.95 -15.55 13.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.691 -179.367 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.604 ' O ' ' HE3' ' D' ' 22' ' ' LYS . 31.9 mttm -91.03 -52.71 4.7 Favored 'General case' 0 CA--C 1.492 -1.259 0 CA-C-O 122.525 1.155 . . . . 0.0 108.765 179.131 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 20' ' ' LEU . . . . . 0.958 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 55.7 mt -57.1 -40.34 76.84 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 112.381 -2.19 . . . . 0.0 110.734 178.266 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 21' ' ' ASN . . . . . 0.547 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 53.3 m-20 -76.04 94.15 3.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.153 179.054 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 22' ' ' LYS . . . . . 0.772 ' HD2' HD12 ' D' ' 47' ' ' ILE . 95.7 mttt -121.81 -42.19 2.42 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -175.397 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 172.02 -92.38 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 119.589 -1.291 . . . . 0.0 113.337 -178.742 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' D' D ' 24' ' ' LYS . . . . . 0.735 ' HG2' ' HB3' ' D' ' 45' ' ' TYR . 80.4 tttt -47.22 -50.05 21.84 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.654 0.74 . . . . 0.0 109.628 178.195 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -141.54 158.08 26.42 Favored Glycine 0 N--CA 1.432 -1.626 0 CA-C-N 114.383 -1.281 . . . . 0.0 111.524 175.884 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' D' D ' 26' ' ' LYS . . . . . 0.688 ' CD ' ' HB2' ' D' ' 41' ' ' SER . 0.2 OUTLIER -150.47 161.3 42.79 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.672 -0.764 . . . . 0.0 110.24 -170.448 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' D' D ' 27' ' ' LEU . . . . . 0.958 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 35.5 tp -140.19 143.67 36.2 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.129 0.49 . . . . 0.0 111.116 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 28' ' ' SER . . . . . 0.575 ' H ' HD12 ' D' ' 27' ' ' LEU . 13.0 t -140.6 109.78 6.17 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.703 -176.217 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 29' ' ' LEU . . . . . 0.524 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 0.9 OUTLIER -131.61 145.75 51.85 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -179.767 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 72.8 p -160.18 -171.71 3.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.513 -177.308 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' D' D ' 31' ' ' MET . . . . . 0.798 ' HA ' ' O ' ' D' ' 35' ' ' GLN . 69.9 mtm -125.73 131.23 52.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.173 0.511 . . . . 0.0 111.005 176.127 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 32' ' ' ASN . . . . . 0.407 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 49.2 t30 -90.78 88.87 7.24 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 172.612 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.53 -99.86 1.64 Allowed Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -164.439 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' D' D ' 34' ' ' ASN . . . . . 0.686 ' O ' ' HE3' ' D' ' 85' ' ' LYS . 75.4 m-80 -120.99 13.45 11.35 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.672 -0.311 . . . . 0.0 110.569 171.879 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 35' ' ' GLN . . . . . 0.798 ' O ' ' HA ' ' D' ' 31' ' ' MET . 52.2 tt0 -88.52 126.39 35.23 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.041 -175.102 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.778 HD12 ' HA ' ' D' ' 83' ' ' ASN . 3.0 tm? -79.08 124.67 28.51 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.278 0.561 . . . . 0.0 111.13 -179.311 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 37' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 30.9 mmmt -135.91 117.09 14.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.523 -170.756 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 38' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -126.91 148.46 50.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.215 0.531 . . . . 0.0 112.068 -177.374 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 39' ' ' THR . . . . . 0.468 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 15.5 p -146.87 124.85 12.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.797 177.581 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 40' ' ' SER . . . . . 0.544 ' HB2' ' HA2' ' D' ' 73' ' ' GLY . 69.2 m -110.7 128.86 55.89 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 173.378 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 41' ' ' SER . . . . . 0.688 ' HB2' ' CD ' ' D' ' 26' ' ' LYS . 50.2 m -97.59 161.71 13.64 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.987 -174.217 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 42' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' D' ' 41' ' ' SER . 71.9 m-80 79.69 10.88 1.33 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.901 -172.006 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 39.74 61.85 1.34 Allowed 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 169.355 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.54 -5.53 7.58 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 118.745 -1.693 . . . . 0.0 115.315 172.111 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' D' D ' 45' ' ' TYR . . . . . 0.735 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 1.6 m-85 -96.6 155.84 16.6 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 117.454 0.627 . . . . 0.0 111.882 -178.738 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 46' ' ' GLY . . . . . 0.607 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -101.82 -177.13 28.2 Favored Glycine 0 C--O 1.214 -1.115 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 173.088 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 47' ' ' ILE . . . . . 0.938 HG12 ' HB3' ' D' ' 68' ' ' GLU . 34.9 mm -48.09 -55.28 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.836 0 CA-C-N 118.391 1.095 . . . . 0.0 110.239 178.376 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 48' ' ' SER . . . . . 0.512 ' HA ' ' HD3' ' D' ' 24' ' ' LYS . 23.2 t 179.44 -156.67 0.02 OUTLIER 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 113.026 -1.897 . . . . 0.0 107.154 -177.268 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 49' ' ' TYR . . . . . 0.473 ' O ' ' HD1' ' D' ' 49' ' ' TYR . 0.3 OUTLIER -81.13 76.81 8.07 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.795 0.807 . . . . 0.0 109.794 167.969 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' D' D ' 50' ' ' GLU . . . . . 0.654 ' O ' ' HG2' ' D' ' 69' ' ' LYS . 71.2 mm-40 -119.24 -163.04 0.94 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.993 -171.964 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 51' ' ' ASP . . . . . 0.71 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 11.6 t70 -162.76 107.44 1.13 Allowed 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.631 170.633 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 52' ' ' LYS . . . . . 0.71 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 4.2 mptp? -138.67 109.1 6.51 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 113.755 -1.566 . . . . 0.0 109.447 -172.812 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 53' ' ' ASN . . . . . 0.459 ' HA ' ' OD1' ' D' ' 67' ' ' ASN . 43.0 m-20 -83.66 131.41 34.95 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.297 177.764 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 54' ' ' TRP . . . . . 0.607 ' HZ3' HG23 ' D' ' 91' ' ' ILE . 0.3 OUTLIER -120.55 153.52 36.62 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.82 -173.139 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -144.87 159.54 27.86 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 120.019 -1.086 . . . . 0.0 113.578 174.313 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' D' D ' 56' ' ' ILE . . . . . 0.652 HG23 HG12 ' D' ' 91' ' ' ILE . 61.8 mt -134.31 111.94 15.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 176.557 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 57' ' ' PHE . . . . . 0.65 ' HZ ' HG21 ' D' ' 94' ' ' ILE . 3.6 m-85 -110.77 105.04 13.75 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 119.214 -0.994 . . . . 0.0 111.122 -166.633 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.714 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 94.3 t -89.04 108.47 19.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.977 173.647 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 33.7 m120 60.89 52.18 4.33 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.344 -177.525 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 57.82 47.44 88.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.291 -179.5 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' D' D ' 61' ' ' GLU . . . . . 0.582 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 5.3 tp10 -151.82 125.41 8.93 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.252 -0.474 . . . . 0.0 109.904 -177.398 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -67.77 105.82 2.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.093 0.473 . . . . 0.0 109.954 177.103 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.443 HG12 ' O ' ' D' ' 56' ' ' ILE . 14.6 p -86.69 -21.98 7.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.193 -178.044 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 64' ' ' TYR . . . . . 0.505 ' HB3' HD12 ' D' ' 56' ' ' ILE . 31.6 t80 -156.92 135.14 11.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.324 176.429 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 65' ' ' THR . . . . . 0.406 HG23 ' O ' ' D' ' 54' ' ' TRP . 74.9 m -120.28 120.48 36.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.721 0.296 . . . . 0.0 110.757 176.77 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 66' ' ' PHE . . . . . 0.531 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 21.2 p90 -126.76 171.12 11.47 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 173.317 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 67' ' ' ASN . . . . . 0.459 ' OD1' ' HA ' ' D' ' 53' ' ' ASN . 75.4 m-20 -129.88 152.76 49.01 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 68' ' ' GLU . . . . . 0.938 ' HB3' HG12 ' D' ' 47' ' ' ILE . 33.5 mt-10 -76.66 -8.36 57.1 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.044 178.473 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.654 ' HG2' ' O ' ' D' ' 50' ' ' GLU . 48.6 mtpt -69.63 -50.36 45.03 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 168.759 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 13.8 t -61.93 120.46 10.81 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 113.569 -1.65 . . . . 0.0 107.685 172.621 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 81.0 p -54.17 114.06 1.48 Allowed 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.929 -172.676 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' D' D ' 72' ' ' VAL . . . . . 0.532 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.1 OUTLIER -50.63 -23.29 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.727 -179.483 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' D' D ' 73' ' ' GLY . . . . . 0.544 ' HA2' ' HB2' ' D' ' 40' ' ' SER . . . -58.4 -66.77 2.58 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.733 -0.667 . . . . 0.0 113.62 173.231 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -63.79 -24.28 67.7 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 120.796 0.331 . . . . 0.0 110.801 -178.003 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' D' D ' 75' ' ' ILE . . . . . 0.435 ' O ' HG12 ' D' ' 79' ' ' ILE . 36.6 mm -78.39 -38.8 23.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.606 178.348 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 76' ' ' SER . . . . . 0.922 ' HA ' HG12 ' D' ' 79' ' ' ILE . 36.9 t -76.2 -19.93 57.95 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.479 -0.489 . . . . 0.0 111.002 179.544 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -63.35 -32.39 73.8 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 166.073 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' D' D ' 78' ' ' ASP . . . . . 1.106 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 1.1 m-20 -79.27 -25.03 42.56 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.94 174.033 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 79' ' ' ILE . . . . . 0.922 HG12 ' HA ' ' D' ' 76' ' ' SER . 22.2 mm -69.03 -25.32 29.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.235 -177.729 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -73.01 -33.31 65.69 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.855 179.331 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' D' D ' 81' ' ' LYS . . . . . 1.106 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -77.82 -61.18 2.08 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.97 174.197 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' D' D ' 82' ' ' LEU . . . . . 0.525 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.8 mm? -48.53 -31.81 7.02 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 176.314 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 83' ' ' ASN . . . . . 0.778 ' HA ' HD12 ' D' ' 36' ' ' LEU . 22.3 t-20 25.01 80.86 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 O-C-N 124.973 1.42 . . . . 0.0 112.533 177.0 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 84' ' ' ILE . . . . . 0.543 ' N ' ' HG ' ' D' ' 36' ' ' LEU . 2.7 mp -81.56 99.25 4.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.612 -175.174 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 85' ' ' LYS . . . . . 0.686 ' HE3' ' O ' ' D' ' 34' ' ' ASN . 21.5 ptmt -126.76 92.08 3.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.284 0.564 . . . . 0.0 111.318 179.664 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 86' ' ' GLY . . . . . 0.863 ' H ' HD11 ' D' ' 89' ' ' ILE . . . 65.2 154.26 0.16 Allowed Glycine 0 CA--C 1.516 0.11 0 CA-C-N 115.911 -0.586 . . . . 0.0 113.433 177.261 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 87' ' ' PRO . . . . . 0.588 ' O ' HG13 ' D' ' 58' ' ' VAL . 56.8 Cg_endo -90.85 -179.65 12.44 Favored 'Cis proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.515 -1.452 . . . . 0.0 112.797 -0.429 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 88' ' ' TYR . . . . . 0.714 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 0.9 OUTLIER 18.65 93.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.081 1.353 . . . . 0.0 113.531 179.637 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.863 HD11 ' H ' ' D' ' 86' ' ' GLY . 74.2 mt -111.02 136.78 46.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.097 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 90' ' ' GLU . . . . . 0.55 ' O ' ' HD1' ' D' ' 57' ' ' PHE . 35.9 mm-40 -123.55 93.47 3.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.678 172.438 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 91' ' ' ILE . . . . . 0.652 HG12 HG23 ' D' ' 56' ' ' ILE . 32.2 mt -94.25 99.38 9.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.822 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 92' ' ' LYS . . . . . 0.695 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -162.65 167.34 23.32 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.198 178.432 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' D' D ' 93' ' ' GLN . . . . . 0.615 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 23.6 pt20 -81.18 164.45 22.32 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.067 175.116 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' D' D ' 94' ' ' ILE . . . . . 0.695 HG22 ' HE2' ' D' ' 92' ' ' LYS . 6.3 pt . . . . . 0 C--O 1.245 0.85 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.8 -169.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 2.7 p30 . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 120.621 0.248 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 2' ' ' ASN . . . . . 0.424 ' O ' ' HE1' ' D' ' 88' ' ' TYR . 76.3 m-20 -80.18 94.69 6.08 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.372 177.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -60.45 -47.86 84.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.861 -177.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -110.69 -9.1 14.53 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.462 -176.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 5' ' ' ALA . . . . . . . . . . . . . . . 59.74 38.08 21.85 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.734 -176.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 6' ' ' LEU . . . . . 0.41 ' O ' ' HG2' ' D' ' 10' ' ' MET . 2.9 tm? -67.6 -46.12 73.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.508 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -61.48 -27.21 68.41 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.418 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.688 ' HA ' ' CB ' ' D' ' 12' ' ' SER . 55.6 mm-40 -67.48 -29.46 68.91 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.561 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -89.38 6.86 38.71 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.379 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 10' ' ' MET . . . . . 0.41 ' HG2' ' O ' ' D' ' 6' ' ' LEU . 91.3 mmm -107.06 -75.49 0.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.037 0.446 . . . . 0.0 111.495 -176.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -100.62 -48.34 4.55 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.03 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 12' ' ' SER . . . . . 0.688 ' CB ' ' HA ' ' D' ' 8' ' ' GLU . 41.9 t -28.37 -70.63 0.04 OUTLIER 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -172.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.448 ' O ' HG12 ' D' ' 16' ' ' VAL . 68.6 mt -71.85 -8.15 10.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.668 -172.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -95.9 -40.83 9.11 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.599 172.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 15' ' ' SER . . . . . 0.467 ' O ' ' HD2' ' D' ' 19' ' ' LYS . 79.6 p -70.98 -26.92 63.36 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.734 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 16' ' ' VAL . . . . . 0.596 HG21 ' HB ' ' D' ' 91' ' ' ILE . 11.4 p -53.37 -28.91 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 121.802 0.81 . . . . 0.0 110.623 177.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -72.67 -43.19 63.46 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.374 -1.285 . . . . 0.0 109.668 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 18' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' D' ' 15' ' ' SER . 74.7 m-20 -57.97 -14.91 7.27 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -177.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.581 ' N ' ' HD2' ' D' ' 19' ' ' LYS . 0.0 OUTLIER -90.14 -41.4 11.66 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.508 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 20' ' ' LEU . . . . . 0.688 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 63.8 mt -73.87 -39.6 63.82 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 112.905 -1.952 . . . . 0.0 109.796 -176.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 21' ' ' ASN . . . . . 0.649 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 46.3 m-20 -75.44 91.75 2.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.894 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 22' ' ' LYS . . . . . 0.578 ' HD3' HD12 ' D' ' 47' ' ' ILE . 28.8 mtpp -122.13 -41.77 2.41 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -176.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.9 -92.03 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 119.411 -1.375 . . . . 0.0 113.931 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 24' ' ' LYS . . . . . 0.725 ' HG2' ' HB3' ' D' ' 45' ' ' TYR . 58.1 tttm -48.55 -54.7 13.42 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.572 0.701 . . . . 0.0 110.152 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 25' ' ' GLY . . . . . 0.568 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -144.29 154.06 25.47 Favored Glycine 0 N--CA 1.433 -1.502 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.351 175.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 26' ' ' LYS . . . . . 0.677 ' HG3' ' HB2' ' D' ' 41' ' ' SER . 9.1 ptpt -150.94 161.37 42.85 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.482 -0.859 . . . . 0.0 111.335 -167.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 27' ' ' LEU . . . . . 0.688 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 38.3 tp -132.01 142.92 49.73 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.71 0.767 . . . . 0.0 112.185 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 28' ' ' SER . . . . . 0.767 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 48.0 m -132.77 144.91 50.58 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.423 -176.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 29' ' ' LEU . . . . . 0.544 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 0.0 OUTLIER -141.28 147.14 37.73 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 119.549 -0.861 . . . . 0.0 110.789 -177.779 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 41.3 m -149.77 176.34 10.79 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.179 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -138.23 166.13 24.95 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.105 0.479 . . . . 0.0 110.926 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 32' ' ' ASN . . . . . 0.714 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 52.5 t-20 -148.17 87.53 1.61 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.01 -98.87 0.66 Allowed Glycine 0 N--CA 1.455 -0.056 0 C-N-CA 119.941 -1.123 . . . . 0.0 111.011 -172.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 34' ' ' ASN . . . . . 0.66 ' O ' ' HE3' ' D' ' 85' ' ' LYS . 73.0 m-80 -116.33 31.12 6.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.048 0.452 . . . . 0.0 110.342 173.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 35' ' ' GLN . . . . . 0.714 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 70.7 tp60 -106.8 148.59 28.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.2 -178.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.702 HD11 HG22 ' D' ' 79' ' ' ILE . 2.9 tm? -118.53 136.04 54.06 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.924 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 37' ' ' LYS . . . . . 0.544 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 25.5 mmmt -134.12 110.77 9.81 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.358 -171.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 38' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -118.71 146.56 44.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.163 0.506 . . . . 0.0 111.578 178.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 39' ' ' THR . . . . . 0.767 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 7.0 p -142.98 132.05 23.05 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.958 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 40' ' ' SER . . . . . 0.598 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 25.2 p -107.78 129.21 55.07 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 172.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 41' ' ' SER . . . . . 0.677 ' HB2' ' HG3' ' D' ' 26' ' ' LYS . 40.6 m -95.16 146.88 24.0 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.161 -1.016 . . . . 0.0 109.687 -177.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 42' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' D' ' 41' ' ' SER . 76.1 m-20 80.2 5.46 1.78 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.995 -169.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 50.35 62.81 2.49 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 168.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.09 -11.82 7.26 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 118.672 -1.728 . . . . 0.0 115.594 170.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 45' ' ' TYR . . . . . 0.725 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 1.6 m-85 -85.36 157.46 20.52 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 117.406 0.603 . . . . 0.0 111.739 -177.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 46' ' ' GLY . . . . . 0.626 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -100.01 -173.93 30.36 Favored Glycine 0 C--O 1.215 -1.046 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 175.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 47' ' ' ILE . . . . . 0.731 HG12 ' HB3' ' D' ' 68' ' ' GLU . 36.1 mm -47.79 -57.86 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 CA-C-O 122.254 1.026 . . . . 0.0 110.081 177.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.585 ' HA ' ' HD3' ' D' ' 24' ' ' LYS . 78.5 p -175.63 -102.3 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 112.875 -1.966 . . . . 0.0 108.812 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.54 77.25 1.59 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.996 0.903 . . . . 0.0 110.094 166.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 50' ' ' GLU . . . . . 0.713 ' HB2' ' HE3' ' D' ' 52' ' ' LYS . 56.1 mt-10 -139.9 179.22 6.73 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.011 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 51' ' ' ASP . . . . . 0.644 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 2.9 p30 -124.66 140.42 52.95 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.522 0.677 . . . . 0.0 112.014 174.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 52' ' ' LYS . . . . . 0.822 ' HD3' ' HB2' ' D' ' 68' ' ' GLU . 0.3 OUTLIER -146.42 136.69 23.74 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.234 -175.457 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -109.69 129.64 55.59 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.713 -0.395 . . . . 0.0 109.962 175.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 54' ' ' TRP . . . . . 1.085 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 1.1 m95 -124.25 165.2 18.03 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -174.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 55' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' D' ' 64' ' ' TYR . . . -155.15 170.33 33.27 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.928 174.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 56' ' ' ILE . . . . . 1.08 HG12 HG23 ' D' ' 91' ' ' ILE . 96.0 mt -138.28 113.7 9.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 124.917 1.287 . . . . 0.0 107.676 -177.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 57' ' ' PHE . . . . . 0.738 ' HB2' ' HB3' ' D' ' 90' ' ' GLU . 10.1 m-85 -115.59 105.89 13.29 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.934 -0.706 . . . . 0.0 112.018 -166.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.725 HG13 ' O ' ' D' ' 87' ' ' PRO . 81.8 t -82.69 101.33 7.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.227 173.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 35.0 m120 58.95 43.55 17.71 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.892 0.377 . . . . 0.0 110.287 -176.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.52 45.51 45.75 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.641 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 61' ' ' GLU . . . . . 0.631 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 86.2 mt-10 -137.05 105.69 5.84 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 177.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 62' ' ' LYS . . . . . 0.52 ' HB2' ' CE1' ' D' ' 57' ' ' PHE . 38.8 ttmt -70.83 99.49 1.75 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -178.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 32.7 m -88.41 -19.93 7.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -174.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 64' ' ' TYR . . . . . 0.465 ' HB3' HD12 ' D' ' 56' ' ' ILE . 16.1 t80 -148.17 140.42 24.22 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.307 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 60.7 m -119.73 118.02 29.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.35 176.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 66' ' ' PHE . . . . . 0.521 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 12.1 p90 -123.27 152.96 40.84 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 174.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 67' ' ' ASN . . . . . 0.481 ' O ' HD11 ' D' ' 75' ' ' ILE . 74.0 m-20 -119.87 135.83 54.73 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -177.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 68' ' ' GLU . . . . . 0.822 ' HB2' ' HD3' ' D' ' 52' ' ' LYS . 4.1 mm-40 -65.96 -8.19 21.24 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.792 0.329 . . . . 0.0 110.694 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.454 ' HB3' ' NZ ' ' D' ' 69' ' ' LYS . 5.9 mtpm? -60.48 -47.75 84.75 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 169.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 22.8 t -66.87 131.43 45.9 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 113.385 -1.734 . . . . 0.0 107.87 168.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 71' ' ' THR . . . . . 0.409 ' O ' HG13 ' D' ' 75' ' ' ILE . 69.7 p -60.42 127.89 33.99 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.072 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 72' ' ' VAL . . . . . 0.535 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.1 OUTLIER -56.61 -11.79 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 120.902 0.382 . . . . 0.0 111.767 -178.757 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 73' ' ' GLY . . . . . 0.598 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -73.17 -58.3 4.76 Favored Glycine 0 N--CA 1.435 -1.37 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.084 168.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -61.2 -25.75 67.25 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-O 121.114 0.483 . . . . 0.0 110.489 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 75' ' ' ILE . . . . . 0.516 ' O ' HG12 ' D' ' 79' ' ' ILE . 76.8 mt -73.5 -40.31 55.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.637 177.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 76' ' ' SER . . . . . 0.651 ' HA ' HG12 ' D' ' 79' ' ' ILE . 31.0 t -74.72 -19.31 60.29 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.654 178.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 77' ' ' ASN . . . . . 0.419 ' O ' ' HD3' ' D' ' 81' ' ' LYS . 64.0 m-20 -62.09 -41.07 97.81 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 166.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 78' ' ' ASP . . . . . 0.925 ' HA ' ' HE3' ' D' ' 81' ' ' LYS . 51.1 m-20 -67.57 -35.8 79.7 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.119 174.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 79' ' ' ILE . . . . . 0.702 HG22 HD11 ' D' ' 36' ' ' LEU . 13.2 mm -67.46 -20.71 26.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.82 -176.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 -69.78 -45.14 68.65 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.964 173.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 81' ' ' LYS . . . . . 0.925 ' HE3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -66.47 -64.61 0.82 Allowed 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.282 175.226 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 82' ' ' LEU . . . . . 0.545 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.8 mm? -46.51 -31.7 2.91 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 43.93 73.18 0.16 Allowed 'General case' 0 N--CA 1.473 0.697 0 O-C-N 123.881 0.738 . . . . 0.0 110.767 176.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 84' ' ' ILE . . . . . 0.802 HG22 HD13 ' D' ' 89' ' ' ILE . 47.1 mm -72.61 99.52 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.931 -173.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 85' ' ' LYS . . . . . 0.66 ' HE3' ' O ' ' D' ' 34' ' ' ASN . 51.9 mtpt -103.04 165.11 11.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.569 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.1 178.67 0.55 Allowed Glycine 0 C--N 1.335 0.49 0 O-C-N 123.779 0.674 . . . . 0.0 113.204 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 87' ' ' PRO . . . . . 0.725 ' O ' HG13 ' D' ' 58' ' ' VAL . 32.2 Cg_endo -93.98 -179.65 9.08 Favored 'Cis proline' 0 C--N 1.327 -0.57 0 C-N-CA 123.537 -1.443 . . . . 0.0 114.19 -0.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 88' ' ' TYR . . . . . 0.711 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 0.5 OUTLIER 27.77 91.92 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.953 1.301 . . . . 0.0 112.752 178.842 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.802 HD13 HG22 ' D' ' 84' ' ' ILE . 64.2 mt -110.42 119.03 58.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.536 0.684 . . . . 0.0 112.014 -177.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.738 ' HB3' ' HB2' ' D' ' 57' ' ' PHE . 16.1 tp10 -106.6 91.15 3.57 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.297 178.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 91' ' ' ILE . . . . . 1.085 HG22 ' HZ3' ' D' ' 54' ' ' TRP . 4.2 mt -96.68 109.76 23.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 92' ' ' LYS . . . . . 0.656 ' HG2' ' O ' ' D' ' 93' ' ' GLN . 0.0 OUTLIER -161.5 169.72 21.27 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.528 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 93' ' ' GLN . . . . . 0.656 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 26.2 pt20 -80.9 162.82 23.77 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.653 175.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 94' ' ' ILE . . . . . 0.506 HG22 ' HE2' ' D' ' 92' ' ' LYS . 10.6 pt . . . . . 0 C--N 1.303 -1.437 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.428 -170.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 . . . . . 0 N--CA 1.484 1.264 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 2' ' ' ASN . . . . . . . . . . . . . 75.5 m-80 -120.76 30.8 6.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.193 0.521 . . . . 0.0 109.984 176.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -90.02 13.72 14.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.23 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -97.18 -20.02 18.23 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 5' ' ' ALA . . . . . . . . . . . . . . . 55.35 69.01 0.78 Allowed 'General case' 0 N--CA 1.461 0.099 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.619 -178.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 6' ' ' LEU . . . . . 0.865 HD23 ' H ' ' D' ' 6' ' ' LEU . 1.6 pt? -96.36 7.99 45.1 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.931 -177.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -57.51 -52.52 65.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.591 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.786 ' HA ' ' CB ' ' D' ' 12' ' ' SER . 10.9 pm0 -80.36 -7.17 58.97 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.37 -175.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 9' ' ' GLN . . . . . 0.474 ' OE1' ' HG2' ' D' ' 8' ' ' GLU . 21.9 mm100 -96.94 1.01 49.87 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.052 177.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 10' ' ' MET . . . . . . . . . . . . . 15.0 tpt -107.86 -75.39 0.63 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.824 -174.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -99.7 -47.94 4.9 Favored 'General case' 0 CA--C 1.488 -1.425 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.451 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 12' ' ' SER . . . . . 0.786 ' CB ' ' HA ' ' D' ' 8' ' ' GLU . 41.1 t -26.52 -68.36 0.05 OUTLIER 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 113.567 -1.651 . . . . 0.0 114.352 -171.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.441 ' C ' HG12 ' D' ' 16' ' ' VAL . 63.3 mt -78.88 -9.21 12.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.647 -172.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -94.05 -58.79 2.13 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.322 175.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 15' ' ' SER . . . . . 0.571 ' HA ' ' OD1' ' D' ' 18' ' ' ASP . 29.5 m -67.22 -18.28 65.17 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.308 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 16' ' ' VAL . . . . . 0.62 HG13 ' ND2' ' D' ' 17' ' ' ASN . 10.1 p -55.09 -28.89 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.962 0.887 . . . . 0.0 110.07 174.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 17' ' ' ASN . . . . . 0.62 ' ND2' HG13 ' D' ' 16' ' ' VAL . 3.9 m120 -79.92 -32.86 40.11 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.021 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 18' ' ' ASP . . . . . 0.571 ' OD1' ' HA ' ' D' ' 15' ' ' SER . 1.4 m-20 -59.64 -15.99 23.0 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 176.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.581 ' O ' ' HG3' ' D' ' 22' ' ' LYS . 0.0 OUTLIER -91.3 -52.26 4.89 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 122.285 1.041 . . . . 0.0 108.496 175.309 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 20' ' ' LEU . . . . . 0.989 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 60.8 mt -56.08 -39.26 71.83 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 112.953 -1.93 . . . . 0.0 110.516 -179.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 21' ' ' ASN . . . . . 0.613 ' OD1' ' HB2' ' D' ' 26' ' ' LYS . 56.0 m-20 -78.82 96.29 5.6 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.68 177.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 22' ' ' LYS . . . . . 0.581 ' HG3' ' O ' ' D' ' 19' ' ' LYS . 54.6 mttp -122.46 -42.7 2.33 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -178.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 170.83 -86.39 0.08 OUTLIER Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 119.606 -1.283 . . . . 0.0 113.24 -177.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 24' ' ' LYS . . . . . 0.705 ' HE3' ' HD1' ' D' ' 45' ' ' TYR . 53.7 tptt -46.47 -52.66 12.74 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 25' ' ' GLY . . . . . 0.652 ' HA2' ' OD1' ' D' ' 42' ' ' ASN . . . -146.31 151.12 23.41 Favored Glycine 0 N--CA 1.436 -1.334 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.681 177.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 26' ' ' LYS . . . . . 0.688 ' CD ' ' HB2' ' D' ' 41' ' ' SER . 0.4 OUTLIER -143.95 160.04 41.52 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.054 -0.573 . . . . 0.0 112.3 -170.113 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 27' ' ' LEU . . . . . 0.989 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 49.2 tp -135.75 143.44 45.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.484 0.659 . . . . 0.0 112.231 -177.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 28' ' ' SER . . . . . 0.647 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 39.2 m -127.39 151.23 49.07 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.965 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 29' ' ' LEU . . . . . 0.476 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 14.4 mt -140.4 156.77 46.28 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.925 177.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 60.2 m -159.19 -173.5 4.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.704 176.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -146.9 165.32 30.14 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 32' ' ' ASN . . . . . 0.501 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 51.4 t30 -150.14 88.81 1.54 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -177.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.31 -100.51 0.88 Allowed Glycine 0 C--O 1.228 -0.228 0 C-N-CA 120.306 -0.949 . . . . 0.0 110.949 -173.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -114.5 31.44 6.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.779 0.323 . . . . 0.0 110.145 173.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 35' ' ' GLN . . . . . 0.501 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 50.5 tt0 -109.63 159.96 16.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.906 0.384 . . . . 0.0 110.967 -176.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.675 HD11 HG22 ' D' ' 79' ' ' ILE . 1.9 tm? -123.77 134.6 53.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.87 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 37' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 13.6 mmmm -132.88 122.86 25.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.522 -168.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -129.65 149.75 51.27 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.828 0.347 . . . . 0.0 110.467 173.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 39' ' ' THR . . . . . 0.647 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 1.7 p -150.47 136.98 18.87 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.807 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 40' ' ' SER . . . . . 0.616 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 40.8 p -107.75 133.7 51.77 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 173.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 41' ' ' SER . . . . . 0.688 ' HB2' ' CD ' ' D' ' 26' ' ' LYS . 35.4 m -94.19 164.81 12.9 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 174.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 42' ' ' ASN . . . . . 0.652 ' OD1' ' HA2' ' D' ' 25' ' ' GLY . 0.3 OUTLIER 61.73 10.12 3.23 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 124.669 1.231 . . . . 0.0 111.505 -171.586 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 53.3 60.5 3.69 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 167.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 44' ' ' GLY . . . . . 0.787 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 104.37 37.4 2.86 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 118.472 -1.823 . . . . 0.0 115.742 164.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 45' ' ' TYR . . . . . 0.705 ' HD1' ' HE3' ' D' ' 24' ' ' LYS . 2.5 m-85 -118.17 158.18 25.56 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 117.991 0.896 . . . . 0.0 109.53 172.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 46' ' ' GLY . . . . . 0.606 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -92.01 -176.34 42.37 Favored Glycine 0 C--O 1.213 -1.193 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 178.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 47' ' ' ILE . . . . . 0.845 HG12 ' HB3' ' D' ' 68' ' ' GLU . 40.2 mm -47.27 -54.92 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 CA-C-N 118.251 1.025 . . . . 0.0 110.714 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 22.8 t -178.22 -147.59 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 112.92 -1.946 . . . . 0.0 106.313 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -88.01 74.33 8.93 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 119.308 -0.957 . . . . 0.0 108.437 165.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -138.13 -171.93 3.15 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.607 -176.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 51' ' ' ASP . . . . . 0.67 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 52.2 p-10 -147.25 133.58 19.57 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.965 0.888 . . . . 0.0 112.697 177.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 52' ' ' LYS . . . . . 0.67 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 3.5 mptp? -145.49 134.41 22.51 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.164 -176.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 -104.99 134.21 48.47 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 174.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 54' ' ' TRP . . . . . 0.635 ' HB2' ' O ' ' D' ' 66' ' ' PHE . 0.1 OUTLIER -125.58 158.13 35.39 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 -170.636 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -151.1 162.87 29.61 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.046 -1.073 . . . . 0.0 114.127 175.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 56' ' ' ILE . . . . . 0.682 HG23 HG12 ' D' ' 91' ' ' ILE . 66.8 mt -135.94 110.87 11.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 57' ' ' PHE . . . . . 0.702 ' HB2' ' HB3' ' D' ' 90' ' ' GLU . 19.4 m-85 -107.67 99.45 8.93 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 119.729 -0.789 . . . . 0.0 111.735 -165.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.678 HG22 HG12 ' D' ' 89' ' ' ILE . 85.7 t -87.86 107.51 17.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.204 175.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 53.1 m-20 68.79 31.16 4.54 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.937 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.5 -32.35 7.48 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.581 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 61' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 11.2 pt-20 -89.83 139.3 30.71 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.36 0.6 . . . . 0.0 111.686 -175.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 62' ' ' LYS . . . . . 0.521 ' HB2' ' CE1' ' D' ' 57' ' ' PHE . 38.1 ttpt -81.07 103.59 10.99 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.395 -177.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 28.2 m -82.25 -32.88 11.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.584 0.586 . . . . 0.0 112.584 -174.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 64' ' ' TYR . . . . . 0.465 ' HB3' HD12 ' D' ' 56' ' ' ILE . 19.6 t80 -134.93 131.82 37.7 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.879 -0.329 . . . . 0.0 110.966 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 57.1 m -117.16 119.96 36.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.025 175.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 66' ' ' PHE . . . . . 0.635 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 16.1 p90 -126.31 146.8 49.88 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.195 0.522 . . . . 0.0 110.244 176.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -102.96 142.72 33.57 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -177.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 68' ' ' GLU . . . . . 0.845 ' HB3' HG12 ' D' ' 47' ' ' ILE . 5.6 mm-40 -75.89 -9.29 58.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.237 0.542 . . . . 0.0 109.703 175.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.544 ' HD3' ' HB2' ' D' ' 51' ' ' ASP . 9.1 mtmp? -67.93 -37.1 81.23 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 169.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 19.2 t -74.81 124.81 27.5 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 113.761 -1.563 . . . . 0.0 107.567 171.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 82.8 p -51.15 124.52 11.75 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.325 -176.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 72' ' ' VAL . . . . . 0.665 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -58.49 -11.49 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-O 121.151 0.5 . . . . 0.0 110.919 -175.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 73' ' ' GLY . . . . . 0.787 ' HA3' ' HA2' ' D' ' 44' ' ' GLY . . . -72.48 -61.77 3.5 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 114.948 -1.023 . . . . 0.0 112.861 170.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -57.77 -32.63 67.68 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 120.959 0.409 . . . . 0.0 109.951 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 75' ' ' ILE . . . . . 0.646 ' O ' HG13 ' D' ' 79' ' ' ILE . 23.8 mm -73.35 -42.19 57.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.317 177.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 76' ' ' SER . . . . . 0.511 ' HA ' HG13 ' D' ' 79' ' ' ILE . 30.2 t -73.79 -20.89 60.34 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.009 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -66.83 -29.92 69.97 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 167.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 78' ' ' ASP . . . . . 1.069 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 60.7 m-20 -77.77 -33.94 52.49 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.93 172.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 79' ' ' ILE . . . . . 0.675 HG22 HD11 ' D' ' 36' ' ' LEU . 25.3 mt -68.54 -17.3 21.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.239 -175.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 58.6 m-20 -72.74 -37.26 67.78 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.424 175.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 81' ' ' LYS . . . . . 1.069 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -80.13 -51.97 8.34 Favored 'General case' 0 CA--C 1.526 0.033 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.678 176.048 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 82' ' ' LEU . . . . . 0.564 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.9 mm? -49.02 -30.82 6.6 Favored 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 177.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 40.14 66.23 0.63 Allowed 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.121 0.888 . . . . 0.0 111.374 172.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 84' ' ' ILE . . . . . 0.613 HG21 HG21 ' D' ' 56' ' ' ILE . 40.1 mm -82.1 97.74 4.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.074 -174.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.26 94.28 3.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.715 0.769 . . . . 0.0 112.807 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 86' ' ' GLY . . . . . 0.705 ' H ' HD11 ' D' ' 89' ' ' ILE . . . 67.57 153.61 0.38 Allowed Glycine 0 N--CA 1.453 -0.169 0 CA-C-N 115.603 -0.726 . . . . 0.0 113.74 175.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 87' ' ' PRO . . . . . 0.651 ' O ' HG13 ' D' ' 58' ' ' VAL . 42.9 Cg_endo -90.44 179.18 14.63 Favored 'Cis proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.298 -1.542 . . . . 0.0 112.668 -0.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 88' ' ' TYR . . . . . 0.598 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 10.0 m-85 11.56 93.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.622 1.569 . . . . 0.0 113.89 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.705 HD11 ' H ' ' D' ' 86' ' ' GLY . 77.7 mt -106.8 135.75 44.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.076 0.465 . . . . 0.0 111.839 -178.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.702 ' HB3' ' HB2' ' D' ' 57' ' ' PHE . 5.4 tp10 -121.52 97.23 5.41 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.035 173.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 91' ' ' ILE . . . . . 0.682 HG12 HG23 ' D' ' 56' ' ' ILE . 35.2 mt -95.21 102.36 13.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.467 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 92' ' ' LYS . . . . . 0.68 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -160.44 165.6 30.74 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 178.221 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 93' ' ' GLN . . . . . 0.573 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 17.9 pt20 -80.35 165.55 22.17 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.209 0.528 . . . . 0.0 111.219 177.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 94' ' ' ILE . . . . . 0.68 HG22 ' HE2' ' D' ' 92' ' ' LYS . 8.1 pt . . . . . 0 C--N 1.313 -1.004 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.394 -170.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 121.166 0.507 . . . . 0.0 111.459 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 2' ' ' ASN . . . . . 0.857 ' HA ' ' HB3' ' D' ' 5' ' ' ALA . 77.0 m-20 60.97 28.24 18.05 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.574 176.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -92.84 -47.83 6.85 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.73 0.3 . . . . 0.0 110.227 174.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -110.68 6.92 22.02 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 173.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 5' ' ' ALA . . . . . 0.857 ' HB3' ' HA ' ' D' ' 2' ' ' ASN . . . -84.43 70.12 10.62 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.204 -178.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -104.31 0.34 29.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.007 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 7' ' ' GLU . . . . . 0.802 ' HA ' ' HB3' ' D' ' 10' ' ' MET . 13.5 pm0 -69.27 -0.45 6.19 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -176.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.731 ' HA ' ' CB ' ' D' ' 12' ' ' SER . 21.0 pt-20 -87.85 -40.34 14.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.747 0.784 . . . . 0.0 109.537 176.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -87.9 5.54 39.99 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.276 -1.329 . . . . 0.0 110.35 172.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 10' ' ' MET . . . . . 0.802 ' HB3' ' HA ' ' D' ' 7' ' ' GLU . 26.9 ttt -102.92 -76.23 0.59 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.908 -178.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -101.77 -41.43 6.54 Favored 'General case' 0 CA--C 1.493 -1.238 0 CA-C-O 120.864 0.364 . . . . 0.0 110.562 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 12' ' ' SER . . . . . 0.731 ' CB ' ' HA ' ' D' ' 8' ' ' GLU . 43.9 t -39.17 -65.46 0.37 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.258 -1.337 . . . . 0.0 112.569 -170.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.434 ' C ' HG12 ' D' ' 16' ' ' VAL . 36.3 mm -91.47 -9.37 10.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 114.911 -1.041 . . . . 0.0 111.409 -173.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -95.86 -59.43 1.86 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.107 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 15' ' ' SER . . . . . 0.72 ' O ' ' HE3' ' D' ' 19' ' ' LYS . 90.3 p -67.07 -17.35 64.85 Favored 'General case' 0 C--O 1.219 -0.509 0 O-C-N 121.975 -0.453 . . . . 0.0 110.71 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 16' ' ' VAL . . . . . 0.489 ' HB ' ' O ' ' D' ' 12' ' ' SER . 11.2 p -52.72 -29.68 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.588 0.709 . . . . 0.0 110.227 174.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 17' ' ' ASN . . . . . 0.502 ' HB3' ' ND2' ' D' ' 21' ' ' ASN . 4.9 m120 -75.21 -41.19 58.32 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.646 177.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.23 -16.48 13.99 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.619 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.72 ' HE3' ' O ' ' D' ' 15' ' ' SER . 21.2 mmtp -85.72 -43.28 13.52 Favored 'General case' 0 CA--C 1.504 -0.827 0 CA-C-O 122.723 1.249 . . . . 0.0 108.195 -178.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 20' ' ' LEU . . . . . 0.997 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 63.0 mt -79.91 -37.76 33.99 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 111.308 -2.678 . . . . 0.0 110.591 -173.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 21' ' ' ASN . . . . . 0.567 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 54.2 m-80 -75.6 99.53 4.32 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.351 176.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 22' ' ' LYS . . . . . 0.677 ' HG3' ' O ' ' D' ' 20' ' ' LEU . 24.0 mtpp -120.43 -40.77 2.65 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 119.075 -1.05 . . . . 0.0 113.12 -166.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 157.55 -73.31 0.23 Allowed Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.327 -177.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 24' ' ' LYS . . . . . 0.925 ' HG2' ' HB3' ' D' ' 45' ' ' TYR . 77.5 tttt -63.82 -61.78 2.07 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 176.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 25' ' ' GLY . . . . . 0.518 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -127.54 163.71 21.2 Favored Glycine 0 N--CA 1.436 -1.331 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.024 174.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 26' ' ' LYS . . . . . 0.733 ' CD ' ' HB2' ' D' ' 41' ' ' SER . 9.7 ptpt -150.9 160.6 43.8 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.157 -0.522 . . . . 0.0 111.705 -170.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 27' ' ' LEU . . . . . 0.997 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 49.0 tp -137.08 148.04 46.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.073 0.463 . . . . 0.0 111.119 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 28' ' ' SER . . . . . 0.656 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 50.5 m -140.06 142.59 36.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.766 -173.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 29' ' ' LEU . . . . . 0.565 HD11 ' CD1' ' D' ' 20' ' ' LEU . 0.0 OUTLIER -141.5 147.74 38.31 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 119.688 -0.805 . . . . 0.0 111.656 -176.867 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 66.6 p -155.67 -172.47 4.15 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.83 176.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -137.44 166.53 23.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.864 0.364 . . . . 0.0 110.155 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 32' ' ' ASN . . . . . 0.5 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 23.4 t-20 -147.36 88.81 1.73 Allowed 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.98 -97.98 0.95 Allowed Glycine 0 N--CA 1.454 -0.113 0 C-N-CA 120.017 -1.087 . . . . 0.0 110.718 -170.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 76.0 m-80 -120.67 22.68 11.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.023 0.439 . . . . 0.0 110.034 173.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 35' ' ' GLN . . . . . 0.5 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 3.7 tp-100 -93.53 152.36 19.1 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.025 -177.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.793 ' HB2' ' HG2' ' D' ' 85' ' ' LYS . 2.3 tm? -118.41 128.57 54.75 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.984 0.421 . . . . 0.0 110.218 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 37' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 13.6 mmmm -128.42 121.74 29.72 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.905 -167.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 38' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -131.98 151.61 51.63 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.183 0.516 . . . . 0.0 110.52 174.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 39' ' ' THR . . . . . 0.656 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 2.6 p -149.5 134.81 18.28 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.8 -176.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 40' ' ' SER . . . . . 0.54 ' HA ' ' O ' ' D' ' 26' ' ' LYS . 36.1 t -107.74 128.03 54.21 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 41' ' ' SER . . . . . 0.733 ' HB2' ' CD ' ' D' ' 26' ' ' LYS . 46.7 m -95.21 158.79 15.31 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -177.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 42' ' ' ASN . . . . . 0.47 ' OD1' ' HB2' ' D' ' 45' ' ' TYR . 0.0 OUTLIER 81.67 -17.31 0.56 Allowed 'General case' 0 N--CA 1.475 0.802 0 O-C-N 124.584 1.178 . . . . 0.0 109.313 -169.158 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 72.99 63.44 0.1 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 173.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 44' ' ' GLY . . . . . 0.711 ' O ' ' HB ' ' D' ' 71' ' ' THR . . . 126.92 -40.43 1.78 Allowed Glycine 0 C--N 1.341 0.825 0 C-N-CA 119.317 -1.42 . . . . 0.0 116.052 169.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 45' ' ' TYR . . . . . 0.925 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 3.3 m-30 -59.82 156.03 15.01 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 118.515 1.157 . . . . 0.0 113.798 -172.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 46' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -98.25 -153.24 28.58 Favored Glycine 0 C--O 1.218 -0.893 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.566 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 47' ' ' ILE . . . . . 0.98 HG13 ' HB2' ' D' ' 68' ' ' GLU . 0.3 OUTLIER -50.92 -58.7 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-O 122.238 1.018 . . . . 0.0 110.184 -176.6 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.524 ' HA ' ' CD ' ' D' ' 24' ' ' LYS . 34.5 p 168.77 -76.06 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 111.47 -2.604 . . . . 0.0 106.158 -169.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -163.68 75.73 0.36 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.05 -1.432 . . . . 0.0 107.609 162.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 50' ' ' GLU . . . . . 0.705 ' O ' ' HG2' ' D' ' 69' ' ' LYS . 4.5 mm-40 -142.21 -159.31 0.95 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.004 -173.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 51' ' ' ASP . . . . . 0.623 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 35.6 t0 -146.62 125.99 13.14 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.118 176.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 52' ' ' LYS . . . . . 0.623 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 0.2 OUTLIER -141.62 100.0 3.67 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.111 -174.102 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 42.2 m-20 -73.96 127.03 31.81 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.155 0.502 . . . . 0.0 110.515 177.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 54' ' ' TRP . . . . . 0.517 ' CH2' ' HA ' ' D' ' 92' ' ' LYS . 0.1 OUTLIER -118.74 155.26 31.4 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.611 -177.293 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -143.03 155.91 26.2 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 119.888 -1.149 . . . . 0.0 113.445 176.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 56' ' ' ILE . . . . . 0.78 HG23 HG12 ' D' ' 91' ' ' ILE . 61.0 mt -132.91 110.26 15.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 174.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 57' ' ' PHE . . . . . 0.728 ' HB2' ' HB2' ' D' ' 90' ' ' GLU . 9.4 m-85 -107.84 107.68 18.53 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 119.553 -0.859 . . . . 0.0 111.222 -167.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.681 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 98.1 t -96.63 110.74 25.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 173.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 34.0 m120 64.21 37.51 8.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.797 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.03 -33.86 5.64 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.663 -0.78 . . . . 0.0 114.084 172.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 61' ' ' GLU . . . . . 0.516 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 12.1 pt-20 -90.86 156.87 17.69 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -177.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 41.5 mttm -77.32 126.32 30.74 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 13.1 p -94.63 -26.5 4.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 121.161 0.505 . . . . 0.0 109.947 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 64' ' ' TYR . . . . . 0.463 ' HB3' HD12 ' D' ' 56' ' ' ILE . 29.7 t80 -148.98 137.56 21.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.858 175.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 40.6 m -120.61 124.56 45.56 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 176.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 66' ' ' PHE . . . . . 0.478 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 21.6 p90 -131.94 165.21 24.42 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 175.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 67' ' ' ASN . . . . . 0.731 ' OD1' ' HG3' ' D' ' 69' ' ' LYS . 21.7 t-20 -131.77 150.88 52.01 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -176.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 68' ' ' GLU . . . . . 0.98 ' HB2' HG13 ' D' ' 47' ' ' ILE . 35.5 mm-40 -71.65 -20.67 61.92 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 119.499 -0.88 . . . . 0.0 109.731 177.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.731 ' HG3' ' OD1' ' D' ' 67' ' ' ASN . 26.2 mtpp -61.99 -48.27 81.08 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 173.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 23.9 m -71.73 77.98 0.85 Allowed 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 112.162 -2.29 . . . . 0.0 108.42 174.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 71' ' ' THR . . . . . 0.711 ' HB ' ' O ' ' D' ' 44' ' ' GLY . 59.7 p -19.82 117.39 0.03 OUTLIER 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.161 1.385 . . . . 0.0 113.933 -173.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 72' ' ' VAL . . . . . 0.481 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -51.42 -14.89 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 176.896 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 73' ' ' GLY . . . . . 0.536 ' HA3' ' HA2' ' D' ' 44' ' ' GLY . . . -67.49 -65.36 2.77 Favored Glycine 0 N--CA 1.435 -1.433 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.818 174.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -67.12 -23.52 65.83 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.485 -0.358 . . . . 0.0 110.675 -177.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 75' ' ' ILE . . . . . 0.605 ' O ' HG13 ' D' ' 79' ' ' ILE . 32.6 mm -75.13 -39.85 43.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.506 177.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 76' ' ' SER . . . . . 0.413 ' HA ' HG13 ' D' ' 79' ' ' ILE . 28.7 t -73.29 -19.33 61.07 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.948 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -66.78 -31.3 71.85 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 167.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 78' ' ' ASP . . . . . 1.01 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 59.3 m-20 -78.11 -32.15 50.37 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.223 174.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 79' ' ' ILE . . . . . 0.626 HG22 HD11 ' D' ' 36' ' ' LEU . 18.0 mt -71.33 -16.69 19.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 C-N-CA 120.031 -0.668 . . . . 0.0 109.507 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -67.05 -31.57 72.17 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.821 173.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 81' ' ' LYS . . . . . 1.01 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -92.44 -49.48 6.11 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 177.321 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 82' ' ' LEU . . . . . 0.624 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.7 mm? -51.27 -28.06 10.89 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -176.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 83' ' ' ASN . . . . . 0.647 ' HA ' HD12 ' D' ' 36' ' ' LEU . 7.1 m120 33.21 72.7 0.08 Allowed 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 84' ' ' ILE . . . . . 0.649 HG22 HD13 ' D' ' 89' ' ' ILE . 41.2 mm -91.45 98.96 8.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.884 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 85' ' ' LYS . . . . . 0.793 ' HG2' ' HB2' ' D' ' 36' ' ' LEU . 30.7 mmmt -141.18 101.48 4.03 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.35 171.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 86' ' ' GLY . . . . . 0.626 ' H ' HD11 ' D' ' 89' ' ' ILE . . . 73.34 149.87 1.36 Allowed Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.094 -0.957 . . . . 0.0 113.393 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 87' ' ' PRO . . . . . 0.632 ' O ' HG13 ' D' ' 58' ' ' VAL . 43.2 Cg_endo -88.46 178.31 19.16 Favored 'Cis proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.917 -1.701 . . . . 0.0 112.557 0.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 88' ' ' TYR . . . . . 0.681 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 3.6 m-85 11.71 94.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 125.3 1.44 . . . . 0.0 114.366 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.677 HG12 HG22 ' D' ' 58' ' ' VAL . 62.6 mt -110.56 142.88 21.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.3 0.571 . . . . 0.0 112.468 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.728 ' HB2' ' HB2' ' D' ' 57' ' ' PHE . 59.7 mm-40 -124.06 91.08 3.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.694 172.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 91' ' ' ILE . . . . . 0.78 HG12 HG23 ' D' ' 56' ' ' ILE . 23.2 mt -95.29 99.64 9.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 92' ' ' LYS . . . . . 0.633 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -161.09 166.95 27.22 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.639 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 93' ' ' GLN . . . . . 0.605 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 18.9 pt20 -81.5 164.46 21.97 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.274 176.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 94' ' ' ILE . . . . . 0.633 HG21 ' HZ ' ' D' ' 57' ' ' PHE . 8.1 pt . . . . . 0 C--N 1.311 -1.071 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.351 -169.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 36.2 t70 . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 120.516 0.198 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 2' ' ' ASN . . . . . 0.762 ' HA ' ' HB3' ' D' ' 5' ' ' ALA . 16.0 p-10 -91.94 29.66 1.55 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -178.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -84.38 -47.07 11.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.584 0.23 . . . . 0.0 110.892 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -111.1 5.85 20.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.14 0.495 . . . . 0.0 109.783 175.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 5' ' ' ALA . . . . . 0.762 ' HB3' ' HA ' ' D' ' 2' ' ' ASN . . . -83.87 2.49 38.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.253 -178.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 82.5 mt -110.73 16.16 21.54 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.369 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -65.01 1.79 0.87 Allowed 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -175.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.547 ' O ' ' HB2' ' D' ' 12' ' ' SER . 0.8 OUTLIER -89.97 1.38 56.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.819 0.342 . . . . 0.0 110.358 179.3 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 9' ' ' GLN . . . . . 0.678 ' HA ' ' HB3' ' D' ' 12' ' ' SER . 12.9 pt20 -56.84 14.72 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.522 1.529 . . . . 0.0 114.467 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 10' ' ' MET . . . . . 0.497 ' H ' ' C ' ' D' ' 8' ' ' GLU . 15.1 tpt -94.31 -50.25 5.34 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.753 0.311 . . . . 0.0 110.49 177.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 11' ' ' ASN . . . . . 0.55 ' HB3' ' HB3' ' D' ' 15' ' ' SER . 11.1 m-80 -103.82 -12.25 17.04 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 173.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 12' ' ' SER . . . . . 0.768 ' O ' ' HB ' ' D' ' 16' ' ' VAL . 29.3 t -40.37 -65.73 0.38 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.943 -171.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.593 ' O ' HG12 ' D' ' 16' ' ' VAL . 40.2 mm -92.36 -9.77 9.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.752 -178.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -88.35 -61.91 1.61 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.009 177.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 15' ' ' SER . . . . . 0.63 ' HA ' ' OD1' ' D' ' 18' ' ' ASP . 86.6 p -65.96 -17.14 64.47 Favored 'General case' 0 C--O 1.217 -0.607 0 O-C-N 122.005 -0.435 . . . . 0.0 110.379 176.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 16' ' ' VAL . . . . . 0.768 ' HB ' ' O ' ' D' ' 12' ' ' SER . 1.2 p -58.03 -23.2 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-O 121.652 0.739 . . . . 0.0 109.248 176.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 17' ' ' ASN . . . . . 0.62 HD22 ' H ' ' D' ' 29' ' ' LEU . 74.8 m-20 -89.18 -26.48 21.24 Favored 'General case' 0 C--O 1.212 -0.91 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.253 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 18' ' ' ASP . . . . . 0.63 ' OD1' ' HA ' ' D' ' 15' ' ' SER . 1.2 m-20 -61.79 -15.64 43.11 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.648 174.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.879 ' HE2' ' N ' ' D' ' 19' ' ' LYS . 0.4 OUTLIER -86.69 -55.86 3.67 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 173.891 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 20' ' ' LEU . . . . . 1.079 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 64.6 mt -56.71 -40.67 76.07 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 112.253 -2.249 . . . . 0.0 111.266 -176.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 21' ' ' ASN . . . . . 0.59 ' OD1' ' HB2' ' D' ' 26' ' ' LYS . 55.8 m-80 -81.01 99.54 8.49 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.8 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 22' ' ' LYS . . . . . 0.733 ' HD2' HD12 ' D' ' 47' ' ' ILE . 97.8 mttt -123.12 -41.99 2.29 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -175.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.39 -88.18 0.07 OUTLIER Glycine 0 N--CA 1.437 -1.292 0 C-N-CA 119.536 -1.316 . . . . 0.0 113.055 -176.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 24' ' ' LYS . . . . . 0.9 ' HE2' ' HA ' ' D' ' 48' ' ' SER . 32.8 ttpt -60.85 -62.03 2.16 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 25' ' ' GLY . . . . . 0.714 ' HA2' ' ND2' ' D' ' 42' ' ' ASN . . . -116.72 153.17 17.55 Favored Glycine 0 N--CA 1.432 -1.571 0 CA-C-N 115.21 -0.905 . . . . 0.0 112.494 175.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 26' ' ' LYS . . . . . 0.716 ' CD ' ' HB3' ' D' ' 41' ' ' SER . 9.0 ptpt -149.15 160.18 43.58 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.25 -0.975 . . . . 0.0 110.757 -171.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 27' ' ' LEU . . . . . 1.079 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 53.3 tp -138.11 150.33 46.76 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.525 0.679 . . . . 0.0 111.975 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 28' ' ' SER . . . . . 0.672 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 41.0 m -135.34 150.02 49.85 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.896 -177.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 29' ' ' LEU . . . . . 0.62 ' H ' HD22 ' D' ' 17' ' ' ASN . 13.5 mt -140.12 149.9 43.61 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.269 177.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 22.7 t -160.05 -171.68 3.32 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 3.0 ppp? -141.85 166.07 25.72 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.109 0.481 . . . . 0.0 111.132 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 32' ' ' ASN . . . . . 0.491 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 26.6 t-20 -144.85 89.36 1.97 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.34 -0.845 . . . . 0.0 108.759 -178.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.94 -97.84 0.75 Allowed Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 119.887 -1.149 . . . . 0.0 111.099 -172.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 59.1 m-20 -113.08 7.45 18.02 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.667 -0.313 . . . . 0.0 110.349 176.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 35' ' ' GLN . . . . . 0.491 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 56.8 tt0 -89.11 160.85 16.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.437 -172.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.536 HD13 ' C ' ' D' ' 36' ' ' LEU . 0.9 OUTLIER -120.78 131.59 54.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.809 176.942 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 37' ' ' LYS . . . . . 0.506 ' HZ2' ' HB3' ' D' ' 37' ' ' LYS . 1.3 mmmp? -134.9 119.03 17.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.865 -169.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 38' ' ' ALA . . . . . 0.434 ' HB1' HD11 ' D' ' 27' ' ' LEU . . . -115.41 151.03 35.46 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.018 0.437 . . . . 0.0 111.0 175.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 39' ' ' THR . . . . . 0.672 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 7.0 p -146.33 131.71 18.6 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.747 177.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 40' ' ' SER . . . . . 0.668 ' HB3' ' HA2' ' D' ' 73' ' ' GLY . 33.2 t -106.73 133.59 51.17 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 173.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 41' ' ' SER . . . . . 0.716 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 38.6 t -92.93 148.45 22.0 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 42' ' ' ASN . . . . . 0.714 ' ND2' ' HA2' ' D' ' 25' ' ' GLY . 0.5 OUTLIER 83.6 -16.85 0.52 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.762 1.625 . . . . 0.0 109.409 -166.731 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 62.28 55.77 2.31 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 44' ' ' GLY . . . . . 0.436 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 123.46 35.3 0.71 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 119.1 -1.524 . . . . 0.0 115.495 168.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 45' ' ' TYR . . . . . 0.771 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 2.5 m-85 -122.76 158.34 30.38 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 122.111 -0.64 . . . . 0.0 109.661 170.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 46' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -98.46 176.61 30.25 Favored Glycine 0 C--O 1.221 -0.66 0 CA-C-O 118.972 -0.904 . . . . 0.0 110.875 177.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 47' ' ' ILE . . . . . 0.843 HG12 ' HB3' ' D' ' 68' ' ' GLU . 33.0 mm -47.26 -56.0 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 CA-C-O 121.922 0.867 . . . . 0.0 109.712 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.9 ' HA ' ' HE2' ' D' ' 24' ' ' LYS . 16.1 t 179.27 -149.01 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 113.149 -1.841 . . . . 0.0 107.393 178.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 49' ' ' TYR . . . . . 0.406 ' HD1' ' O ' ' D' ' 49' ' ' TYR . 0.1 OUTLIER -78.9 76.69 5.38 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.453 0.644 . . . . 0.0 110.416 168.32 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 50' ' ' GLU . . . . . 0.678 ' HB3' ' HE2' ' D' ' 52' ' ' LYS . 71.1 mm-40 -126.3 -166.17 1.54 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.28 -174.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 51' ' ' ASP . . . . . 0.683 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 7.0 t70 -161.04 119.68 2.5 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 114.503 -1.226 . . . . 0.0 111.565 171.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 52' ' ' LYS . . . . . 0.683 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 3.6 mptp? -142.99 115.85 8.76 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 114.22 -1.355 . . . . 0.0 109.822 -174.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 38.8 m-20 -90.98 135.47 33.72 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 174.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 54' ' ' TRP . . . . . 0.633 ' HB2' ' O ' ' D' ' 66' ' ' PHE . 0.0 OUTLIER -126.93 158.02 37.91 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.855 -172.913 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -145.87 153.44 25.3 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 119.701 -1.237 . . . . 0.0 113.883 174.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 56' ' ' ILE . . . . . 0.665 HG23 HG12 ' D' ' 91' ' ' ILE . 61.8 mt -127.62 113.75 32.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 174.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 57' ' ' PHE . . . . . 0.849 ' HB2' ' HB2' ' D' ' 90' ' ' GLU . 8.4 m-85 -109.5 105.85 15.35 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.304 -168.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.73 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 94.3 t -90.48 103.63 14.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.997 173.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 59' ' ' ASN . . . . . 0.484 ' OD1' ' HG2' ' D' ' 87' ' ' PRO . 6.3 m120 61.1 47.02 7.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.36 -0.837 . . . . 0.0 111.655 -177.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.65 -33.7 5.69 Favored Glycine 0 CA--C 1.509 -0.292 0 C-N-CA 120.681 -0.771 . . . . 0.0 114.365 172.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 61' ' ' GLU . . . . . 0.536 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 16.6 pt-20 -92.97 146.83 23.33 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 120.931 -0.307 . . . . 0.0 111.229 -176.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -73.58 113.86 11.17 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 173.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 14.5 p -88.68 -23.41 6.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-O 121.098 0.475 . . . . 0.0 110.21 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 64' ' ' TYR . . . . . 0.483 ' HB3' HD12 ' D' ' 56' ' ' ILE . 26.4 t80 -152.85 135.26 15.1 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.608 175.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.49 HG23 ' O ' ' D' ' 54' ' ' TRP . 88.9 m -121.15 125.92 48.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.412 176.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 66' ' ' PHE . . . . . 0.633 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 10.1 p90 -132.54 154.52 49.9 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.08 0.467 . . . . 0.0 110.409 178.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 67' ' ' ASN . . . . . 0.604 ' HA ' ' O ' ' D' ' 52' ' ' LYS . 3.9 m120 -114.1 145.51 41.53 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -178.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 68' ' ' GLU . . . . . 0.843 ' HB3' HG12 ' D' ' 47' ' ' ILE . 35.7 mt-10 -75.8 -8.94 58.09 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.42 177.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.622 ' HG2' ' O ' ' D' ' 50' ' ' GLU . 45.5 mtmt -63.83 -55.43 23.0 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 168.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 49.9 m -57.56 118.24 5.01 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 112.528 -2.124 . . . . 0.0 109.374 172.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 81.9 p -48.13 117.53 1.97 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.685 -176.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 72' ' ' VAL . . . . . 0.696 HG11 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -57.77 -11.95 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-O 120.788 0.328 . . . . 0.0 111.073 -174.565 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 73' ' ' GLY . . . . . 0.668 ' HA2' ' HB3' ' D' ' 40' ' ' SER . . . -74.42 -61.01 3.3 Favored Glycine 0 N--CA 1.436 -1.303 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.582 175.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -60.91 -28.17 68.72 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 75' ' ' ILE . . . . . 0.522 ' O ' ' HB2' ' D' ' 78' ' ' ASP . 31.3 mm -74.46 -41.14 49.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.894 175.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 76' ' ' SER . . . . . 0.451 ' HB2' HD13 ' D' ' 27' ' ' LEU . 28.8 t -73.18 -19.81 61.02 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.116 -177.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -61.8 -43.45 98.83 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 165.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 78' ' ' ASP . . . . . 0.962 ' HA ' ' HG2' ' D' ' 81' ' ' LYS . 1.1 m-20 -64.03 -34.78 78.78 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.978 174.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 79' ' ' ILE . . . . . 0.519 HG13 ' O ' ' D' ' 75' ' ' ILE . 53.6 mt -72.22 -24.56 22.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 C-N-CA 119.129 -1.028 . . . . 0.0 110.46 -174.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -78.64 -16.11 57.72 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.175 171.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 81' ' ' LYS . . . . . 0.962 ' HG2' ' HA ' ' D' ' 78' ' ' ASP . 25.6 mmtt -76.06 -64.54 1.07 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 172.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 82' ' ' LEU . . . . . 0.636 HD23 ' O ' ' D' ' 78' ' ' ASP . 2.8 mm? -46.71 -31.09 2.71 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 113.114 -1.857 . . . . 0.0 112.521 -179.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 45.55 57.59 4.85 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.668 0.605 . . . . 0.0 110.574 174.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 84' ' ' ILE . . . . . 0.527 ' O ' ' HG ' ' D' ' 36' ' ' LEU . 44.9 mm -83.38 97.63 4.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.913 0.387 . . . . 0.0 111.37 -173.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 85' ' ' LYS . . . . . 0.508 ' HB2' ' HB2' ' D' ' 36' ' ' LEU . 2.7 tmtm? -139.34 92.88 2.62 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 86' ' ' GLY . . . . . 0.732 ' HA2' HD11 ' D' ' 89' ' ' ILE . . . 72.74 152.06 1.65 Allowed Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.437 -0.801 . . . . 0.0 113.516 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 87' ' ' PRO . . . . . 0.595 ' O ' HG13 ' D' ' 58' ' ' VAL . 50.0 Cg_endo -90.12 179.47 14.7 Favored 'Cis proline' 0 CA--C 1.535 0.551 0 C-N-CA 123.304 -1.54 . . . . 0.0 113.195 0.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 88' ' ' TYR . . . . . 0.73 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 1.8 m-85 24.55 93.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.925 1.29 . . . . 0.0 113.62 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.732 HD11 ' HA2' ' D' ' 86' ' ' GLY . 3.5 mp -108.64 125.87 65.52 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-O 121.184 0.516 . . . . 0.0 111.665 -175.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.849 ' HB2' ' HB2' ' D' ' 57' ' ' PHE . 5.5 mm-40 -119.65 89.59 3.16 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.75 171.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 91' ' ' ILE . . . . . 0.717 HG13 HG22 ' D' ' 89' ' ' ILE . 34.8 mt -95.95 101.19 12.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.076 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 92' ' ' LYS . . . . . 0.661 ' HG2' ' O ' ' D' ' 93' ' ' GLN . 0.0 OUTLIER -162.34 170.57 18.65 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.247 179.131 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 93' ' ' GLN . . . . . 0.661 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 17.1 pt20 -81.15 161.94 23.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.542 0.687 . . . . 0.0 110.992 173.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 94' ' ' ILE . . . . . 0.429 HG22 ' HE3' ' D' ' 92' ' ' LYS . 7.7 pt . . . . . 0 C--N 1.309 -1.18 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.435 -173.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 . . . . . 0 N--CA 1.483 1.21 0 CA-C-O 120.398 0.142 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 2' ' ' ASN . . . . . 0.451 ' HB3' ' HB3' ' D' ' 5' ' ' ALA . 77.1 m-20 -137.23 108.96 7.02 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 177.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -95.93 -3.07 45.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.743 -173.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 4' ' ' LYS . . . . . 0.862 ' HA ' ' HE3' ' D' ' 4' ' ' LYS . 0.0 OUTLIER -108.96 -29.08 8.77 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.286 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 5' ' ' ALA . . . . . 0.451 ' HB3' ' HB3' ' D' ' 2' ' ' ASN . . . -81.93 71.37 8.97 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.161 -178.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 81.4 mt -101.59 23.86 10.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.352 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -82.05 -70.01 0.58 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.861 0.362 . . . . 0.0 111.084 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.783 ' HA ' ' CB ' ' D' ' 12' ' ' SER . 0.6 OUTLIER -92.35 -32.96 14.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.317 0.579 . . . . 0.0 110.891 -179.332 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 9' ' ' GLN . . . . . 0.692 ' HG3' ' HG2' ' D' ' 8' ' ' GLU . 45.8 mt-30 -83.96 5.62 24.92 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.133 -172.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 10' ' ' MET . . . . . . . . . . . . . 15.5 tpt -108.15 -73.31 0.69 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.41 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -100.83 -48.35 4.5 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.119 178.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 12' ' ' SER . . . . . 0.783 ' CB ' ' HA ' ' D' ' 8' ' ' GLU . 44.9 t -29.57 -61.72 0.14 Allowed 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.53 -1.214 . . . . 0.0 114.071 -172.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.476 ' O ' HG12 ' D' ' 16' ' ' VAL . 67.3 mt -82.7 -8.56 11.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.279 -172.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 -94.66 -49.58 5.56 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.032 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 15' ' ' SER . . . . . 0.729 ' HA ' ' OD2' ' D' ' 18' ' ' ASP . 88.6 p -70.35 -15.95 62.93 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.965 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 16' ' ' VAL . . . . . 0.715 ' HA ' ' HE2' ' D' ' 19' ' ' LYS . 12.4 p -58.82 -34.47 52.36 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.107 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 175.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 17' ' ' ASN . . . . . 0.651 ' ND2' ' HA ' ' D' ' 28' ' ' SER . 4.5 m120 -64.79 -42.17 95.26 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.747 172.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 18' ' ' ASP . . . . . 0.729 ' OD2' ' HA ' ' D' ' 15' ' ' SER . 60.6 m-20 -57.2 -17.32 10.86 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -175.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.715 ' HE2' ' HA ' ' D' ' 16' ' ' VAL . 0.0 OUTLIER -92.04 -38.86 11.96 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 122.167 0.985 . . . . 0.0 109.202 174.523 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 20' ' ' LEU . . . . . 0.903 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 84.8 mt -78.86 -31.32 45.55 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 112.897 -1.956 . . . . 0.0 111.121 -170.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 21' ' ' ASN . . . . . 0.553 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 2.8 t-20 -99.12 95.74 7.31 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.291 -167.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 22' ' ' LYS . . . . . 0.841 ' HD3' HG23 ' D' ' 47' ' ' ILE . 5.7 mtpm? -121.94 -42.91 2.37 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 118.308 -1.357 . . . . 0.0 113.926 -169.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 168.07 -80.32 0.1 Allowed Glycine 0 N--CA 1.439 -1.111 0 C-N-CA 119.912 -1.137 . . . . 0.0 112.787 -175.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 24' ' ' LYS . . . . . 0.813 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 23.4 tptm -47.85 -59.72 3.11 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 176.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 25' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -140.26 159.34 26.17 Favored Glycine 0 N--CA 1.431 -1.649 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.219 173.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 26' ' ' LYS . . . . . 0.707 ' HA ' ' O ' ' D' ' 20' ' ' LEU . 9.6 ptpt -149.67 160.57 43.41 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.467 -0.866 . . . . 0.0 110.771 -168.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 27' ' ' LEU . . . . . 0.903 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 41.4 tp -134.54 135.99 42.72 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.225 0.536 . . . . 0.0 111.747 178.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 28' ' ' SER . . . . . 0.651 ' HA ' ' ND2' ' D' ' 17' ' ' ASN . 50.6 m -125.27 133.29 52.72 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.709 -174.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 29' ' ' LEU . . . . . 0.712 HD11 HD12 ' D' ' 20' ' ' LEU . 0.0 OUTLIER -140.71 134.74 30.76 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.706 -174.078 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 72.6 p -146.8 174.12 11.77 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.799 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 23.2 ptm -136.42 118.84 15.76 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.496 0.665 . . . . 0.0 111.114 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -93.23 89.35 6.38 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.09 -104.78 2.61 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.499 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 76.0 m-80 -117.6 17.22 14.49 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.343 0.592 . . . . 0.0 109.651 175.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 35' ' ' GLN . . . . . 0.472 ' OE1' ' HD2' ' D' ' 37' ' ' LYS . 49.9 tt0 -94.4 142.19 27.71 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.479 -177.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.68 HD11 HG22 ' D' ' 79' ' ' ILE . 2.7 tm? -112.3 115.88 29.49 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.219 0.533 . . . . 0.0 111.195 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 37' ' ' LYS . . . . . 0.773 ' HA ' ' HE2' ' D' ' 37' ' ' LYS . 10.0 mmpt? -117.72 122.77 44.38 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 114.188 -1.369 . . . . 0.0 111.566 -168.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 38' ' ' ALA . . . . . 0.584 ' HB1' HD11 ' D' ' 27' ' ' LEU . . . -130.5 154.76 47.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.136 0.493 . . . . 0.0 111.186 176.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 39' ' ' THR . . . . . 0.639 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 2.5 p -150.37 131.95 14.84 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.763 -177.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 40' ' ' SER . . . . . 0.626 ' HB3' ' HA2' ' D' ' 73' ' ' GLY . 40.4 t -108.17 129.77 55.16 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 172.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 41' ' ' SER . . . . . 0.686 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 32.7 t -95.87 154.47 17.21 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.432 -0.907 . . . . 0.0 109.592 -178.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 42' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' D' ' 41' ' ' SER . 77.0 m-20 78.28 6.69 2.52 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.96 -169.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 51.22 60.32 3.96 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 114.57 -1.196 . . . . 0.0 113.956 170.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 44' ' ' GLY . . . . . 0.581 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 105.99 37.01 2.61 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 119.189 -1.481 . . . . 0.0 114.357 170.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 45' ' ' TYR . . . . . 0.813 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 2.3 m-30 -113.96 153.19 29.73 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 173.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 46' ' ' GLY . . . . . 0.57 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -95.24 -162.86 34.45 Favored Glycine 0 C--O 1.219 -0.797 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 47' ' ' ILE . . . . . 0.841 HG23 ' HD3' ' D' ' 22' ' ' LYS . 39.0 mm -51.46 -55.72 7.55 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.706 0 CA-C-O 122.06 0.933 . . . . 0.0 109.035 174.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 62.3 p -174.77 -86.96 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 112.975 -1.92 . . . . 0.0 108.862 -176.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 49' ' ' TYR . . . . . 0.434 ' O ' ' HD2' ' D' ' 49' ' ' TYR . 0.1 OUTLIER -152.64 76.03 1.13 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.263 167.545 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 50' ' ' GLU . . . . . 0.724 ' O ' ' HG2' ' D' ' 69' ' ' LYS . 4.2 mm-40 -137.35 -164.93 1.67 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.443 -172.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 51' ' ' ASP . . . . . 0.613 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 8.9 t70 -138.26 127.93 25.05 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.741 173.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 52' ' ' LYS . . . . . 0.613 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 0.3 OUTLIER -143.07 121.68 12.52 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.407 -1.27 . . . . 0.0 109.482 -178.442 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 45.2 m-20 -99.1 132.5 44.36 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.344 -0.542 . . . . 0.0 109.815 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 54' ' ' TRP . . . . . 1.018 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 0.9 OUTLIER -121.7 152.97 38.81 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.903 -172.465 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -137.65 156.07 23.43 Favored Glycine 0 N--CA 1.436 -1.364 0 C-N-CA 119.732 -1.223 . . . . 0.0 112.576 172.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 56' ' ' ILE . . . . . 1.103 HG12 HG23 ' D' ' 91' ' ' ILE . 96.2 mt -126.53 94.46 2.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 176.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 57' ' ' PHE . . . . . 0.571 ' HA ' ' O ' ' D' ' 61' ' ' GLU . 18.2 m-85 -95.39 108.35 20.54 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.668 -165.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.745 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 66.4 t -95.69 105.97 17.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.447 171.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 60.85 46.72 8.44 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.759 0.314 . . . . 0.0 111.495 -177.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.01 48.31 54.72 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.676 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 61' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 17.6 tp10 -159.61 126.15 4.46 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -73.48 109.6 7.12 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.087 176.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.441 HG23 HD13 ' D' ' 84' ' ' ILE . 34.4 m -82.91 -10.77 12.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 120.991 0.424 . . . . 0.0 110.777 176.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 64' ' ' TYR . . . . . 0.562 ' HB3' HD12 ' D' ' 56' ' ' ILE . 13.9 t80 -158.93 137.85 11.18 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.271 174.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 71.7 m -122.81 113.5 19.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.145 177.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 66' ' ' PHE . . . . . 0.505 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 11.5 p90 -120.34 156.68 30.81 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.121 0.486 . . . . 0.0 110.061 177.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 67' ' ' ASN . . . . . 0.736 HD22 ' HB2' ' D' ' 69' ' ' LYS . 14.6 p-10 -122.96 133.91 54.36 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.317 -174.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 68' ' ' GLU . . . . . 0.814 ' HB3' HG12 ' D' ' 47' ' ' ILE . 40.6 mm-40 -68.05 -8.35 36.99 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.348 -176.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.736 ' HB2' HD22 ' D' ' 67' ' ' ASN . 49.6 mtpt -63.5 -44.24 94.89 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 169.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 70' ' ' SER . . . . . 0.411 ' HB3' ' O ' ' D' ' 67' ' ' ASN . 24.2 t -64.19 125.72 25.45 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 113.667 -1.606 . . . . 0.0 107.689 167.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 71' ' ' THR . . . . . 0.418 ' O ' HG13 ' D' ' 75' ' ' ILE . 75.4 p -55.76 128.87 36.97 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 72' ' ' VAL . . . . . 0.688 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -57.09 -13.76 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-O 121.163 0.506 . . . . 0.0 110.601 -177.503 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 73' ' ' GLY . . . . . 0.626 ' HA2' ' HB3' ' D' ' 40' ' ' SER . . . -67.6 -63.45 3.71 Favored Glycine 0 N--CA 1.434 -1.433 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.568 171.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -64.79 -19.65 65.94 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.314 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 75' ' ' ILE . . . . . 0.488 HD12 ' HA ' ' D' ' 72' ' ' VAL . 74.7 mt -73.5 -41.06 56.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 173.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 76' ' ' SER . . . . . 0.7 ' HA ' HG12 ' D' ' 79' ' ' ILE . 41.5 t -75.26 -22.61 57.68 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.039 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 77' ' ' ASN . . . . . 0.404 ' O ' ' HD2' ' D' ' 81' ' ' LYS . 2.6 m-80 -61.68 -25.22 67.26 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 167.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 78' ' ' ASP . . . . . 1.104 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 0.9 OUTLIER -90.03 -27.29 19.83 Favored 'General case' 0 C--O 1.227 -0.122 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 175.529 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 79' ' ' ILE . . . . . 0.7 HG12 ' HA ' ' D' ' 76' ' ' SER . 22.5 mm -68.86 -34.65 65.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.391 -176.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -66.88 -32.06 73.08 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -177.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 81' ' ' LYS . . . . . 1.104 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -77.25 -53.74 7.35 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.99 175.607 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 82' ' ' LEU . . . . . 0.58 HD23 ' O ' ' D' ' 78' ' ' ASP . 2.9 mm? -47.37 -32.22 4.69 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.008 0.523 . . . . 0.0 112.322 177.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 83' ' ' ASN . . . . . 0.584 ' HA ' HD12 ' D' ' 36' ' ' LEU . 9.3 t30 37.65 58.0 1.39 Allowed 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.45 1.094 . . . . 0.0 110.897 178.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 84' ' ' ILE . . . . . 0.585 ' N ' ' HG ' ' D' ' 36' ' ' LEU . 54.8 mt -80.32 104.47 8.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.993 0.425 . . . . 0.0 111.889 -172.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.21 92.97 2.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.771 0.796 . . . . 0.0 112.33 177.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 86' ' ' GLY . . . . . 0.741 ' HA2' HD11 ' D' ' 89' ' ' ILE . . . 75.65 153.35 4.16 Favored Glycine 0 CA--C 1.509 -0.288 0 CA-C-N 115.128 -0.942 . . . . 0.0 114.196 173.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 87' ' ' PRO . . . . . 0.65 ' O ' HG13 ' D' ' 58' ' ' VAL . 50.8 Cg_endo -89.41 -179.6 14.29 Favored 'Cis proline' 0 CA--C 1.534 0.478 0 C-N-CA 123.221 -1.575 . . . . 0.0 113.247 0.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 88' ' ' TYR . . . . . 0.745 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 1.8 m-85 20.86 93.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.812 1.245 . . . . 0.0 113.897 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.741 HD11 ' HA2' ' D' ' 86' ' ' GLY . 2.9 mp -110.76 134.14 53.99 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.281 -177.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -128.2 96.5 4.47 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.495 169.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 91' ' ' ILE . . . . . 1.103 HG23 HG12 ' D' ' 56' ' ' ILE . 6.0 mt -96.13 105.4 17.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 178.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 92' ' ' LYS . . . . . 0.654 ' HE3' ' O ' ' D' ' 93' ' ' GLN . 0.1 OUTLIER -161.54 170.48 19.8 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 123.027 0.531 . . . . 0.0 111.624 -174.742 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 93' ' ' GLN . . . . . 0.682 ' HB3' ' NE1' ' D' ' 54' ' ' TRP . 20.0 pt20 -90.16 155.36 19.09 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.666 0.746 . . . . 0.0 111.638 176.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 94' ' ' ILE . . . . . 0.493 HG21 ' HZ ' ' D' ' 57' ' ' PHE . 8.2 pt . . . . . 0 C--N 1.307 -1.257 0 CA-C-N 113.98 -1.464 . . . . 0.0 111.622 -171.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 120.674 0.273 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 2' ' ' ASN . . . . . 0.617 ' HB3' ' HA ' ' D' ' 5' ' ' ALA . 75.9 m-20 53.87 67.0 1.07 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.167 -178.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -76.82 -30.12 56.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.366 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -92.29 -33.17 14.74 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 170.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 5' ' ' ALA . . . . . 0.617 ' HA ' ' HB3' ' D' ' 2' ' ' ASN . . . 66.64 -178.46 0.2 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.548 175.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 6' ' ' LEU . . . . . 0.478 ' N ' HD12 ' D' ' 6' ' ' LEU . 4.8 mp -100.64 -69.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.087 -178.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -92.52 -23.64 19.03 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.557 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.682 ' O ' ' HB3' ' D' ' 12' ' ' SER . 52.9 mt-10 -64.03 -23.04 67.18 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -172.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 9' ' ' GLN . . . . . 0.4 ' HG3' ' H ' ' D' ' 9' ' ' GLN . 1.8 pp0? -77.11 9.73 2.84 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 122.054 -0.404 . . . . 0.0 111.408 175.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 10' ' ' MET . . . . . 0.578 ' O ' ' HB2' ' D' ' 14' ' ' ASN . 48.7 ttm -106.65 -75.47 0.63 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.99 0.424 . . . . 0.0 111.317 -176.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 11' ' ' ASN . . . . . 0.501 ' O ' ' HB2' ' D' ' 15' ' ' SER . 9.4 p-10 -102.4 -32.45 9.99 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-O 121.211 0.529 . . . . 0.0 110.902 178.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 12' ' ' SER . . . . . 0.682 ' HB3' ' O ' ' D' ' 8' ' ' GLU . 45.0 t -55.47 -69.22 0.14 Allowed 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 113.952 -1.476 . . . . 0.0 111.099 -167.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.448 ' C ' HG12 ' D' ' 16' ' ' VAL . 48.7 mt -91.21 -13.54 8.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.736 -175.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 14' ' ' ASN . . . . . 0.578 ' HB2' ' O ' ' D' ' 10' ' ' MET . 5.8 m120 -97.28 -56.93 2.39 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.597 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 15' ' ' SER . . . . . 0.501 ' HB2' ' O ' ' D' ' 11' ' ' ASN . 50.9 m -67.84 -15.34 63.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.845 179.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 16' ' ' VAL . . . . . 0.701 ' HA ' ' HE2' ' D' ' 19' ' ' LYS . 14.3 p -56.22 -35.28 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 174.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -67.7 -40.23 84.34 Favored 'General case' 0 C--O 1.213 -0.856 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.92 176.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.57 -16.64 39.92 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -175.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.701 ' HE2' ' HA ' ' D' ' 16' ' ' VAL . 0.0 OUTLIER -89.97 -46.17 8.7 Favored 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 173.225 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 20' ' ' LEU . . . . . 0.811 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 84.1 mt -63.73 -35.84 81.9 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 113.594 -1.639 . . . . 0.0 110.479 -177.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 21' ' ' ASN . . . . . 0.484 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 40.7 m-20 -72.65 95.93 1.93 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.8 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 22' ' ' LYS . . . . . 0.853 ' HA ' ' HE2' ' D' ' 22' ' ' LYS . 7.7 mmpt? -118.05 11.17 13.25 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -170.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.94 -74.28 1.7 Allowed Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.982 176.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 24' ' ' LYS . . . . . 0.775 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 55.2 tptt -53.27 -59.22 4.84 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 176.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -144.67 157.69 27.33 Favored Glycine 0 N--CA 1.43 -1.715 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.699 174.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 26' ' ' LYS . . . . . 0.876 ' HD2' ' HB3' ' D' ' 41' ' ' SER . 10.8 ptpt -151.04 160.68 43.76 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.379 -0.911 . . . . 0.0 111.354 -164.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 27' ' ' LEU . . . . . 0.824 HD13 ' HB2' ' D' ' 76' ' ' SER . 28.4 tp -132.89 144.53 50.24 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.164 0.507 . . . . 0.0 111.397 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 28' ' ' SER . . . . . 0.673 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 52.4 m -137.74 143.61 41.27 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.983 -175.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 29' ' ' LEU . . . . . 0.588 HD11 ' CD1' ' D' ' 20' ' ' LEU . 0.0 OUTLIER -141.02 144.74 35.18 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.326 -178.7 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 35.5 m -145.66 170.07 17.2 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.035 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 31' ' ' MET . . . . . 0.575 ' SD ' ' HE2' ' D' ' 85' ' ' LYS . 61.2 mtt -130.95 111.17 11.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.043 0.449 . . . . 0.0 110.888 177.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -91.82 87.82 6.41 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.08 -125.41 8.21 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.168 -1.015 . . . . 0.0 111.48 -173.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 38.9 m-20 -89.66 31.2 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 O-C-N 122.464 -0.433 . . . . 0.0 110.267 175.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 35' ' ' GLN . . . . . 0.437 ' CG ' ' HD3' ' D' ' 37' ' ' LYS . 3.8 tp-100 -116.88 154.45 30.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.37 -172.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.914 ' HB2' ' HB2' ' D' ' 85' ' ' LYS . 1.8 tm? -118.74 126.66 52.37 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.741 176.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 37' ' ' LYS . . . . . 0.552 ' NZ ' ' HB3' ' D' ' 37' ' ' LYS . 1.1 mmmp? -129.63 117.84 21.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.587 -169.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 38' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -119.42 152.79 36.25 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.539 0.685 . . . . 0.0 112.26 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 39' ' ' THR . . . . . 0.673 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 3.2 p -144.57 126.73 15.63 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.145 177.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 40' ' ' SER . . . . . 0.591 ' HA ' ' O ' ' D' ' 26' ' ' LYS . 14.9 p -108.49 128.9 55.2 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 172.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 41' ' ' SER . . . . . 0.876 ' HB3' ' HD2' ' D' ' 26' ' ' LYS . 42.5 t -102.43 155.72 18.07 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.161 -175.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 42' ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' D' ' 41' ' ' SER . 33.8 m120 76.67 8.55 3.1 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.711 -172.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 47.08 61.72 2.73 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 114.613 -1.176 . . . . 0.0 114.043 168.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.63 -14.41 7.21 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 119.004 -1.57 . . . . 0.0 114.93 172.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 45' ' ' TYR . . . . . 0.775 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 2.0 m-30 -76.19 156.75 33.38 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 117.347 0.573 . . . . 0.0 111.488 -176.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 46' ' ' GLY . . . . . 0.554 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -103.72 -157.5 24.5 Favored Glycine 0 C--O 1.214 -1.095 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 175.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 47' ' ' ILE . . . . . 0.834 HG13 ' HB3' ' D' ' 68' ' ' GLU . 0.8 OUTLIER -53.98 -57.33 5.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 122.778 1.275 . . . . 0.0 109.58 178.236 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 39.4 t 174.7 -116.05 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 111.205 -2.725 . . . . 0.0 105.89 -175.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -119.75 76.79 1.17 Allowed 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.888 -0.507 . . . . 0.0 109.818 165.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 50' ' ' GLU . . . . . 0.425 ' HB2' ' HE3' ' D' ' 52' ' ' LYS . 60.3 mm-40 -140.55 -169.3 2.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.38 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 51' ' ' ASP . . . . . 0.647 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 1.4 m-20 -139.97 134.09 31.02 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.935 173.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 52' ' ' LYS . . . . . 0.746 ' HD3' HG12 ' D' ' 47' ' ' ILE . 0.1 OUTLIER -144.66 150.15 36.88 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.787 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 44.7 m-20 -118.95 138.72 52.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.76 0.314 . . . . 0.0 110.324 173.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 54' ' ' TRP . . . . . 1.082 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 1.7 m95 -124.7 153.22 42.69 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -175.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -138.42 157.34 24.49 Favored Glycine 0 N--CA 1.432 -1.598 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.036 172.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 56' ' ' ILE . . . . . 1.029 HG12 HG23 ' D' ' 91' ' ' ILE . 95.8 mt -131.18 94.58 2.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 177.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 57' ' ' PHE . . . . . 0.512 ' CE1' ' HB2' ' D' ' 62' ' ' LYS . 48.3 m-85 -93.86 101.03 13.11 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.546 -167.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.723 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 94.7 t -83.25 102.64 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.955 173.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 59' ' ' ASN . . . . . 0.485 ' OD1' ' HG2' ' D' ' 87' ' ' PRO . 6.4 m120 59.6 45.67 12.92 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.493 -177.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.29 -30.5 7.63 Favored Glycine 0 CA--C 1.508 -0.399 0 C-N-CA 120.009 -1.091 . . . . 0.0 112.655 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -88.15 119.9 28.99 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.852 -0.674 . . . . 0.0 110.618 -174.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 62' ' ' LYS . . . . . 0.512 ' HB2' ' CE1' ' D' ' 57' ' ' PHE . 38.7 ttpt -70.76 98.56 1.56 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 176.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.551 HG12 ' O ' ' D' ' 56' ' ' ILE . 13.4 p -77.77 -29.01 15.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.448 -170.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 64' ' ' TYR . . . . . 0.401 ' HB3' HD12 ' D' ' 56' ' ' ILE . 23.0 t80 -143.46 137.77 28.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.555 177.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 56.9 m -116.47 116.5 27.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.462 175.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 66' ' ' PHE . . . . . 0.483 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 18.3 p90 -122.06 154.98 36.59 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 170.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -117.64 146.89 43.36 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 68' ' ' GLU . . . . . 0.834 ' HB3' HG13 ' D' ' 47' ' ' ILE . 39.9 mm-40 -62.48 -24.96 67.75 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.214 0.531 . . . . 0.0 109.67 176.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.5 ' HD3' ' HB3' ' D' ' 51' ' ' ASP . 9.0 mtmp? -58.02 -44.16 87.15 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.495 173.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 70' ' ' SER . . . . . 0.454 ' OG ' HD11 ' D' ' 75' ' ' ILE . 15.4 t -76.18 92.73 3.28 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 113.798 -1.547 . . . . 0.0 107.627 172.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 73.4 p -30.84 122.85 0.21 Allowed 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.477 -1.238 . . . . 0.0 112.787 -172.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 72' ' ' VAL . . . . . 0.434 ' O ' ' HB3' ' D' ' 40' ' ' SER . 0.0 OUTLIER -51.72 -17.42 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 O-C-N 123.319 0.387 . . . . 0.0 111.709 177.8 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 73' ' ' GLY . . . . . 0.587 ' HA2' ' CB ' ' D' ' 40' ' ' SER . . . -65.33 -65.41 2.93 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 115.371 -0.832 . . . . 0.0 113.193 171.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 74' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' D' ' 77' ' ' ASN . 49.7 t30 -65.49 -22.9 66.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.852 0.358 . . . . 0.0 110.705 -178.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 75' ' ' ILE . . . . . 0.506 ' O ' HG12 ' D' ' 79' ' ' ILE . 27.2 mm -76.93 -37.94 27.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.067 177.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 76' ' ' SER . . . . . 0.824 ' HB2' HD13 ' D' ' 27' ' ' LEU . 32.8 t -75.51 -19.45 59.36 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.224 -0.59 . . . . 0.0 110.284 175.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 77' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' D' ' 74' ' ' ASN . 75.0 m-20 -63.14 -28.92 70.39 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 166.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 78' ' ' ASP . . . . . 1.063 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 1.0 OUTLIER -87.9 -30.03 20.42 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 115.387 -0.824 . . . . 0.0 113.166 176.114 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 79' ' ' ILE . . . . . 0.703 HG12 ' HA ' ' D' ' 76' ' ' SER . 24.3 mm -63.25 -28.22 44.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 O-C-N 121.379 -0.826 . . . . 0.0 110.669 -174.094 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -65.46 -40.45 93.21 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.509 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 81' ' ' LYS . . . . . 1.063 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -74.17 -51.83 14.33 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.605 176.82 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 82' ' ' LEU . . . . . 0.613 HD23 ' O ' ' D' ' 78' ' ' ASP . 4.0 mm? -48.99 -30.16 5.71 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 42.36 61.42 2.01 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 123.695 0.622 . . . . 0.0 110.979 174.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 84' ' ' ILE . . . . . 0.495 HG22 HD13 ' D' ' 89' ' ' ILE . 49.5 mt -90.94 98.19 8.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.773 -175.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 85' ' ' LYS . . . . . 0.914 ' HB2' ' HB2' ' D' ' 36' ' ' LEU . 10.9 tmtt? -141.33 94.93 2.75 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -175.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 86' ' ' GLY . . . . . 0.567 ' H ' HD11 ' D' ' 89' ' ' ILE . . . 69.17 150.97 0.4 Allowed Glycine 0 N--CA 1.453 -0.194 0 CA-C-N 115.283 -0.871 . . . . 0.0 113.495 -178.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 87' ' ' PRO . . . . . 0.596 ' O ' HG13 ' D' ' 58' ' ' VAL . 68.5 Cg_endo -90.21 -178.79 12.09 Favored 'Cis proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.405 -1.498 . . . . 0.0 112.835 -0.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 88' ' ' TYR . . . . . 0.723 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 1.5 m-85 13.53 93.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.175 1.39 . . . . 0.0 113.943 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.587 HG12 HG22 ' D' ' 58' ' ' VAL . 67.9 mt -110.34 132.49 58.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.311 0.577 . . . . 0.0 112.363 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -123.25 93.92 4.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.867 173.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 91' ' ' ILE . . . . . 1.082 HG22 ' HZ3' ' D' ' 54' ' ' TRP . 7.3 mt -95.93 107.6 19.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 92' ' ' LYS . . . . . 0.648 ' HE3' ' O ' ' D' ' 93' ' ' GLN . 0.0 OUTLIER -163.08 171.27 16.67 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.54 -173.234 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 93' ' ' GLN . . . . . 0.648 ' O ' ' HE3' ' D' ' 92' ' ' LYS . 3.5 pp0? -87.99 156.64 19.22 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.686 0.755 . . . . 0.0 112.787 178.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 94' ' ' ILE . . . . . 0.57 ' CG2' ' HE2' ' D' ' 92' ' ' LYS . 4.9 pt . . . . . 0 C--N 1.314 -0.938 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.005 -173.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 47.6 p30 . . . . . 0 N--CA 1.479 1.019 0 CA-C-O 121.027 0.441 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 2' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -128.81 47.79 2.42 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.782 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 -61.12 -55.19 35.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.108 -177.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 4' ' ' LYS . . . . . 0.43 ' N ' ' HD2' ' D' ' 4' ' ' LYS . 12.2 mptt -93.01 -20.72 20.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.278 177.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 5' ' ' ALA . . . . . . . . . . . . . . . 55.54 78.9 0.17 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.825 178.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 6' ' ' LEU . . . . . 0.462 ' N ' HD12 ' D' ' 6' ' ' LEU . 5.2 mp -82.72 9.9 8.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.631 177.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 7' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' D' ' 7' ' ' GLU . 85.9 tt0 -92.82 -7.39 46.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.101 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.68 ' HA ' ' HB3' ' D' ' 12' ' ' SER . 1.9 pp20? -54.58 -43.62 72.28 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -169.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 9' ' ' GLN . . . . . 0.499 ' H ' ' CD ' ' D' ' 9' ' ' GLN . 2.5 pm0 -91.92 8.89 35.36 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 122.314 -0.241 . . . . 0.0 111.142 -179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 10' ' ' MET . . . . . . . . . . . . . 46.3 tpp -107.13 -77.7 0.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.366 -174.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -102.49 -49.1 3.95 Favored 'General case' 0 CA--C 1.491 -1.307 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.015 174.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 12' ' ' SER . . . . . 0.68 ' HB3' ' HA ' ' D' ' 8' ' ' GLU . 47.4 t -32.36 -67.38 0.11 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 113.308 -1.769 . . . . 0.0 113.15 -169.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.43 ' C ' HG12 ' D' ' 16' ' ' VAL . 53.8 mt -91.65 -7.6 10.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.284 -174.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -94.43 -61.9 1.43 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.076 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 15' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' D' ' 19' ' ' LYS . 89.3 p -64.69 -16.68 63.22 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 122.252 -0.28 . . . . 0.0 111.108 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 16' ' ' VAL . . . . . 0.648 ' HA ' ' HE3' ' D' ' 19' ' ' LYS . 14.2 p -58.63 -32.77 46.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-O 121.835 0.826 . . . . 0.0 110.002 178.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 17' ' ' ASN . . . . . 0.427 ' HB3' ' ND2' ' D' ' 21' ' ' ASN . 5.2 m120 -71.55 -37.18 71.12 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.707 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.84 -15.17 58.21 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.648 ' HE3' ' HA ' ' D' ' 16' ' ' VAL . 71.3 mttt -91.03 -28.31 18.05 Favored 'General case' 0 CA--C 1.494 -1.199 0 CA-C-O 122.447 1.117 . . . . 0.0 109.229 -177.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 20' ' ' LEU . . . . . 0.88 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 76.1 mt -95.51 -41.14 9.1 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 112.223 -2.262 . . . . 0.0 109.061 -171.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 21' ' ' ASN . . . . . 0.69 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 59.9 m-20 -73.56 91.07 1.8 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.04 -1.436 . . . . 0.0 110.337 175.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 22' ' ' LYS . . . . . 0.471 ' HD3' HD12 ' D' ' 47' ' ' ILE . 28.7 mtpp -122.36 -41.38 2.41 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -170.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 171.77 -91.89 0.09 OUTLIER Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 119.63 -1.271 . . . . 0.0 113.3 -176.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 24' ' ' LYS . . . . . 0.552 ' HB3' ' O ' ' D' ' 46' ' ' GLY . 44.2 tptt -50.46 -53.56 28.74 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 25' ' ' GLY . . . . . 0.624 ' HA2' ' ND2' ' D' ' 42' ' ' ASN . . . -140.35 157.46 25.6 Favored Glycine 0 N--CA 1.435 -1.428 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.334 176.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 26' ' ' LYS . . . . . 0.69 ' CB ' ' HA ' ' D' ' 21' ' ' ASN . 9.3 ptpt -149.36 160.6 43.29 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.077 -0.562 . . . . 0.0 111.026 -169.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 27' ' ' LEU . . . . . 0.88 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 44.7 tp -137.08 144.69 43.25 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.34 0.59 . . . . 0.0 111.899 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 28' ' ' SER . . . . . 0.575 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 23.1 t -135.4 137.31 42.16 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.013 -178.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 29' ' ' LEU . . . . . 0.484 HD11 ' CD1' ' D' ' 20' ' ' LEU . 0.0 OUTLIER -140.5 114.29 8.89 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.345 -179.188 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 68.8 p -123.56 -173.08 2.65 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.975 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 31' ' ' MET . . . . . 0.463 ' SD ' ' HE2' ' D' ' 85' ' ' LYS . 23.0 ptt? -148.1 122.1 9.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.62 0.724 . . . . 0.0 110.961 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -91.92 88.42 6.6 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.43 177.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.56 -110.04 2.99 Favored Glycine 0 CA--C 1.515 0.069 0 C-N-CA 120.333 -0.937 . . . . 0.0 111.389 -172.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 73.6 m-80 -106.24 14.36 27.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.075 0.464 . . . . 0.0 110.716 175.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 35' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -89.04 155.36 19.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.603 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 1.099 ' HB2' ' HB2' ' D' ' 85' ' ' LYS . 1.4 tm? -117.82 126.98 53.43 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 37' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 29.0 mmmt -130.65 117.79 20.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.829 -168.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 38' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -121.39 148.89 43.79 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.865 175.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 39' ' ' THR . . . . . 0.575 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 16.5 p -147.89 138.94 23.37 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.516 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 40' ' ' SER . . . . . 0.482 ' HB3' ' HA2' ' D' ' 73' ' ' GLY . 36.7 t -107.69 128.19 54.34 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 169.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 41' ' ' SER . . . . . 0.574 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 35.1 t -94.67 161.63 14.11 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -177.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 42' ' ' ASN . . . . . 0.624 ' ND2' ' HA2' ' D' ' 25' ' ' GLY . 0.1 OUTLIER 83.47 -17.4 0.49 Allowed 'General case' 0 N--CA 1.477 0.879 0 O-C-N 124.706 1.254 . . . . 0.0 109.163 -167.929 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 71.52 62.48 0.15 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 44' ' ' GLY . . . . . 0.628 ' O ' ' HB ' ' D' ' 71' ' ' THR . . . 127.9 -40.69 1.7 Allowed Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 119.215 -1.469 . . . . 0.0 116.162 168.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 45' ' ' TYR . . . . . 0.538 ' CD2' ' HE3' ' D' ' 24' ' ' LYS . 3.2 m-30 -63.89 155.8 29.6 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.059 1.43 . . . . 0.0 112.422 -175.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 46' ' ' GLY . . . . . 0.552 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -91.29 -177.2 43.28 Favored Glycine 0 C--O 1.217 -0.926 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 172.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 47' ' ' ILE . . . . . 0.84 HG12 ' HB3' ' D' ' 68' ' ' GLU . 43.2 mm -45.66 -48.37 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.075 0 CA-C-N 117.903 0.852 . . . . 0.0 110.232 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.512 ' HB2' ' O ' ' D' ' 47' ' ' ILE . 48.4 t 153.22 -142.97 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 O-C-N 126.411 2.319 . . . . 0.0 107.632 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -77.48 75.88 4.03 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.467 0.651 . . . . 0.0 111.183 173.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 50' ' ' GLU . . . . . 0.678 ' HB3' ' HE3' ' D' ' 52' ' ' LYS . 68.3 mm-40 -134.85 -176.39 4.22 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.481 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 51' ' ' ASP . . . . . 0.717 ' HA ' ' CG ' ' D' ' 69' ' ' LYS . 7.1 p-10 -152.89 113.39 4.05 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.559 173.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 52' ' ' LYS . . . . . 0.678 ' HE3' ' HB3' ' D' ' 50' ' ' GLU . 21.1 mmtp -129.88 139.03 51.24 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.314 -170.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 38.6 m-20 -114.33 132.12 56.3 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.404 175.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 54' ' ' TRP . . . . . 0.685 ' HB2' ' O ' ' D' ' 66' ' ' PHE . 0.5 OUTLIER -128.27 160.97 30.49 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -170.431 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -152.7 162.45 29.99 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 114.892 -1.049 . . . . 0.0 113.56 172.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 56' ' ' ILE . . . . . 0.636 HG23 HG12 ' D' ' 91' ' ' ILE . 58.6 mt -130.98 111.91 20.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 177.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 57' ' ' PHE . . . . . 0.956 ' HB2' ' HB3' ' D' ' 90' ' ' GLU . 10.3 m-85 -108.67 99.54 8.9 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 119.908 -0.717 . . . . 0.0 111.424 -165.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.733 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 84.3 t -81.57 103.89 9.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.713 173.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 6.9 m120 63.31 44.38 5.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.505 -176.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.53 -33.1 5.7 Favored Glycine 0 CA--C 1.509 -0.34 0 C-N-CA 120.49 -0.862 . . . . 0.0 114.304 172.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 61' ' ' GLU . . . . . 0.543 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 16.7 pt-20 -90.6 136.27 33.17 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.239 0.542 . . . . 0.0 111.801 -173.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 62' ' ' LYS . . . . . 0.454 ' HB2' ' CE2' ' D' ' 57' ' ' PHE . 38.0 ttpt -74.26 110.33 8.46 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.861 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.455 HG22 ' O ' ' D' ' 56' ' ' ILE . 29.5 m -93.65 -29.47 4.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -175.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 64' ' ' TYR . . . . . 0.428 ' HB3' HD12 ' D' ' 56' ' ' ILE . 30.4 t80 -136.66 132.44 34.98 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 121.193 -0.203 . . . . 0.0 110.675 178.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 49.9 m -114.39 123.14 48.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.459 176.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 66' ' ' PHE . . . . . 0.685 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 14.1 p90 -131.48 148.76 52.67 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 173.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 67' ' ' ASN . . . . . 0.633 HD22 ' HB2' ' D' ' 69' ' ' LYS . 14.5 p-10 -117.94 130.95 56.52 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 68' ' ' GLU . . . . . 0.84 ' HB3' HG12 ' D' ' 47' ' ' ILE . 54.8 mm-40 -59.85 -18.27 42.92 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.009 0.433 . . . . 0.0 111.314 -173.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.717 ' CG ' ' HA ' ' D' ' 51' ' ' ASP . 46.5 mtpt -58.97 -51.9 68.07 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.393 172.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 69.8 m -64.92 103.05 0.67 Allowed 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 113.098 -1.864 . . . . 0.0 108.787 170.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 71' ' ' THR . . . . . 0.628 ' HB ' ' O ' ' D' ' 44' ' ' GLY . 72.1 p -32.73 119.05 0.3 Allowed 'General case' 0 C--N 1.322 -0.617 0 O-C-N 124.588 1.18 . . . . 0.0 112.689 -174.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 72' ' ' VAL . . . . . 0.633 HG11 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -53.34 -14.4 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.805 176.982 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 73' ' ' GLY . . . . . 0.482 ' HA2' ' HB3' ' D' ' 40' ' ' SER . . . -66.66 -70.8 1.03 Allowed Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.743 172.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -62.15 -25.03 67.52 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 120.594 0.235 . . . . 0.0 111.286 -177.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 75' ' ' ILE . . . . . 0.629 ' O ' HG13 ' D' ' 79' ' ' ILE . 30.0 mm -73.87 -37.88 49.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.199 176.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 31.3 t -73.82 -23.13 59.61 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.817 176.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -62.28 -26.94 68.68 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 166.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 78' ' ' ASP . . . . . 1.112 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 57.6 m-20 -83.22 -36.87 24.28 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.031 -0.532 . . . . 0.0 112.089 174.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 79' ' ' ILE . . . . . 0.629 HG13 ' O ' ' D' ' 75' ' ' ILE . 39.2 mt -66.41 -22.64 30.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 O-C-N 121.805 -0.559 . . . . 0.0 110.878 -173.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -72.92 -31.67 64.78 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 176.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 81' ' ' LYS . . . . . 1.112 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -81.15 -50.37 9.69 Favored 'General case' 0 N--CA 1.457 -0.076 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.164 174.527 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 82' ' ' LEU . . . . . 0.62 HD23 ' O ' ' D' ' 78' ' ' ASP . 4.0 mm? -47.39 -32.32 4.84 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 177.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 43.72 61.49 2.26 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 124.062 0.851 . . . . 0.0 110.836 174.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 84' ' ' ILE . . . . . 0.443 ' O ' ' HG ' ' D' ' 36' ' ' LEU . 52.5 mt -93.74 98.55 8.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.045 -175.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 85' ' ' LYS . . . . . 1.099 ' HB2' ' HB2' ' D' ' 36' ' ' LEU . 9.4 tmtt? -143.01 94.91 2.69 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 86' ' ' GLY . . . . . 0.48 ' HA2' HD11 ' D' ' 89' ' ' ILE . . . 76.86 151.87 4.38 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.67 -0.696 . . . . 0.0 113.566 176.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 87' ' ' PRO . . . . . 0.631 ' O ' HG13 ' D' ' 58' ' ' VAL . 55.9 Cg_endo -88.49 178.01 19.62 Favored 'Cis proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.83 -1.737 . . . . 0.0 112.479 -0.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 88' ' ' TYR . . . . . 0.733 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 1.7 m-85 28.7 91.19 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.626 1.17 . . . . 0.0 112.907 -177.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.592 HG22 HG13 ' D' ' 91' ' ' ILE . 3.7 mp -97.38 136.55 27.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.233 0.54 . . . . 0.0 110.834 -176.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.956 ' HB3' ' HB2' ' D' ' 57' ' ' PHE . 88.0 tt0 -134.94 87.38 2.33 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.807 173.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 91' ' ' ILE . . . . . 0.636 HG12 HG23 ' D' ' 56' ' ' ILE . 40.8 mt -96.56 99.49 9.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.649 -179.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 92' ' ' LYS . . . . . 0.652 ' HG2' ' O ' ' D' ' 93' ' ' GLN . 0.0 OUTLIER -161.76 165.96 27.24 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 121.191 -0.203 . . . . 0.0 110.519 178.33 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 93' ' ' GLN . . . . . 0.652 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 18.1 pt20 -78.67 165.32 23.78 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 120.191 -0.604 . . . . 0.0 110.59 175.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 94' ' ' ILE . . . . . 0.58 HG21 ' HZ ' ' D' ' 57' ' ' PHE . 9.5 pt . . . . . 0 C--N 1.31 -1.118 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.656 -172.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 120.858 0.361 . . . . 0.0 110.635 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 2' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -76.4 -28.21 56.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.531 -176.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -64.81 -32.14 73.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.8 0.333 . . . . 0.0 111.021 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -99.15 -3.06 35.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.335 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 5' ' ' ALA . . . . . . . . . . . . . . . 52.58 48.67 22.05 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.982 -178.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 58.8 tp -101.25 -26.06 13.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.285 -175.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -56.89 -46.59 81.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.589 -177.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.932 ' HA ' ' HB2' ' D' ' 12' ' ' SER . 52.4 mt-10 -50.24 -42.44 51.84 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -178.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 9' ' ' GLN . . . . . 0.401 HE21 ' CE ' ' D' ' 31' ' ' MET . 23.3 mp0 -87.3 8.69 23.18 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -177.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 10' ' ' MET . . . . . . . . . . . . . 26.8 ttt -106.83 -78.72 0.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.766 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -104.52 -54.17 2.57 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.402 174.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 12' ' ' SER . . . . . 0.932 ' HB2' ' HA ' ' D' ' 8' ' ' GLU . 71.1 m -25.6 -71.16 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.274 -1.785 . . . . 0.0 113.643 -171.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.431 ' O ' HG12 ' D' ' 16' ' ' VAL . 58.4 mt -78.7 -68.78 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.199 -1.556 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.722 174.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -35.19 -33.25 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -175.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 15' ' ' SER . . . . . 0.427 ' O ' ' HD2' ' D' ' 19' ' ' LYS . 80.1 p -58.78 -27.51 65.08 Favored 'General case' 0 C--O 1.22 -0.453 0 O-C-N 121.771 -0.58 . . . . 0.0 109.909 176.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 16' ' ' VAL . . . . . 0.694 HG13 ' ND2' ' D' ' 17' ' ' ASN . 7.5 p -45.28 -30.09 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.94 1.296 . . . . 0.0 111.185 174.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 17' ' ' ASN . . . . . 0.694 ' ND2' HG13 ' D' ' 16' ' ' VAL . 5.9 m120 -86.37 -31.56 21.43 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.895 -177.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 18' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' D' ' 15' ' ' SER . 78.7 m-20 -60.71 -15.66 31.37 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 176.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.622 ' N ' ' HD2' ' D' ' 19' ' ' LYS . 0.0 OUTLIER -91.35 -46.57 7.95 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 122.03 0.919 . . . . 0.0 108.599 175.238 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 20' ' ' LEU . . . . . 0.89 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 63.8 mt -63.51 -40.49 97.19 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.192 -1.822 . . . . 0.0 110.348 -178.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 21' ' ' ASN . . . . . 0.651 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 55.6 m-20 -77.35 96.7 4.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.425 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 22' ' ' LYS . . . . . 0.789 ' HD2' HD12 ' D' ' 47' ' ' ILE . 65.3 mttm -122.83 -41.57 2.35 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -178.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 171.17 -86.22 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 119.575 -1.298 . . . . 0.0 113.663 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 24' ' ' LYS . . . . . 0.706 ' HE3' ' HD1' ' D' ' 45' ' ' TYR . 50.7 tptt -53.54 -44.47 69.23 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.85 0.833 . . . . 0.0 109.415 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 25' ' ' GLY . . . . . 0.613 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -150.2 148.13 19.03 Favored Glycine 0 N--CA 1.429 -1.802 0 CA-C-N 114.255 -1.338 . . . . 0.0 111.582 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 26' ' ' LYS . . . . . 0.651 ' CB ' ' HA ' ' D' ' 21' ' ' ASN . 10.8 ptpt -149.32 160.85 43.05 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 114.262 -0.969 . . . . 0.0 110.561 -168.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 27' ' ' LEU . . . . . 0.89 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 41.1 tp -135.65 143.58 45.57 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.237 0.541 . . . . 0.0 111.847 -178.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 28' ' ' SER . . . . . 0.638 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 27.9 t -128.18 152.62 47.83 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 29' ' ' LEU . . . . . . . . . . . . . 15.1 mt -140.78 138.75 34.33 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 177.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 60.6 m -147.05 179.16 7.81 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 31' ' ' MET . . . . . 0.43 ' HA ' ' O ' ' D' ' 35' ' ' GLN . 23.3 ptt? -134.9 122.32 21.8 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.441 0.639 . . . . 0.0 110.636 177.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -91.42 88.97 7.04 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.2 -114.74 4.03 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -169.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 34' ' ' ASN . . . . . 0.688 ' O ' ' HE3' ' D' ' 85' ' ' LYS . 70.0 m-20 -109.63 31.74 5.57 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.095 0.474 . . . . 0.0 110.023 172.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 35' ' ' GLN . . . . . 0.43 ' O ' ' HA ' ' D' ' 31' ' ' MET . 3.8 tp-100 -105.81 161.35 14.5 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.601 -179.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.707 HD11 HG22 ' D' ' 79' ' ' ILE . 3.0 tm? -114.09 131.36 56.42 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.772 0.32 . . . . 0.0 110.766 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 37' ' ' LYS . . . . . 0.426 ' HE2' ' HG2' ' D' ' 35' ' ' GLN . 74.0 mmtt -138.34 109.05 6.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.082 -169.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 38' ' ' ALA . . . . . 0.488 ' HB1' HD11 ' D' ' 27' ' ' LEU . . . -105.58 149.37 26.34 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.966 0.412 . . . . 0.0 111.229 176.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 39' ' ' THR . . . . . 0.638 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 18.0 p -143.65 129.57 19.47 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.698 175.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 40' ' ' SER . . . . . 0.729 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 72.3 p -109.38 131.56 54.95 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 41' ' ' SER . . . . . 0.625 ' HB2' ' CD ' ' D' ' 26' ' ' LYS . 52.3 m -96.56 152.82 18.27 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.714 -178.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 42' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' D' ' 41' ' ' SER . 75.9 m-80 80.09 6.12 1.76 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.005 -170.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 53.27 54.47 10.19 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 114.636 -1.166 . . . . 0.0 113.811 171.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 44' ' ' GLY . . . . . 0.744 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 104.78 35.81 3.15 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 119.431 -1.366 . . . . 0.0 114.749 168.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 45' ' ' TYR . . . . . 0.706 ' HD1' ' HE3' ' D' ' 24' ' ' LYS . 2.6 m-85 -112.78 153.81 27.21 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 168.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 46' ' ' GLY . . . . . 0.558 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -86.0 -174.0 49.54 Favored Glycine 0 CA--C 1.499 -0.945 0 C-N-CA 120.094 -1.05 . . . . 0.0 110.953 178.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 47' ' ' ILE . . . . . 0.806 HG12 ' HB3' ' D' ' 68' ' ' GLU . 45.3 mm -46.3 -51.33 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.231 0 CA-C-O 121.454 0.645 . . . . 0.0 109.987 177.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.487 ' HB2' ' O ' ' D' ' 47' ' ' ILE . 41.3 t 159.31 -138.97 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.626 0 O-C-N 126.507 2.379 . . . . 0.0 107.564 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -88.88 76.01 7.99 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.474 0.655 . . . . 0.0 111.606 175.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 50' ' ' GLU . . . . . 0.798 ' HB2' ' HE2' ' D' ' 52' ' ' LYS . 48.6 mt-10 -150.32 179.04 8.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.541 176.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 51' ' ' ASP . . . . . 0.66 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 31.8 m-20 -133.39 134.29 43.49 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.746 173.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 52' ' ' LYS . . . . . 0.798 ' HE2' ' HB2' ' D' ' 50' ' ' GLU . 1.9 mptp? -138.43 137.58 37.36 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -176.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 51.2 m-20 -115.07 134.08 55.49 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.413 174.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 54' ' ' TRP . . . . . 1.136 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 1.1 m95 -125.73 160.09 30.65 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -172.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -148.05 158.07 27.56 Favored Glycine 0 N--CA 1.436 -1.312 0 CA-C-N 114.419 -1.264 . . . . 0.0 113.006 172.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 56' ' ' ILE . . . . . 1.06 HG12 HG23 ' D' ' 91' ' ' ILE . 98.1 mt -125.88 110.31 23.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-N 113.317 -1.442 . . . . 0.0 107.149 176.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 57' ' ' PHE . . . . . 0.768 ' HB2' ' HB2' ' D' ' 90' ' ' GLU . 14.0 m-85 -106.02 102.82 12.22 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 119.881 -0.728 . . . . 0.0 110.821 -167.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.912 HG22 HG12 ' D' ' 89' ' ' ILE . 95.2 t -95.5 108.97 21.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.502 178.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 59' ' ' ASN . . . . . 0.552 ' OD1' ' HG2' ' D' ' 87' ' ' PRO . 6.2 m120 59.68 52.35 5.64 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.989 -178.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.15 47.17 92.36 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.283 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 61' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 87.1 tt0 -151.45 116.17 5.17 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.315 -0.443 . . . . 0.0 109.866 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 62' ' ' LYS . . . . . 0.492 ' NZ ' ' HB3' ' D' ' 62' ' ' LYS . 6.1 ttpm? -70.96 99.04 1.71 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.446 HG12 ' O ' ' D' ' 56' ' ' ILE . 14.7 p -87.1 -30.99 5.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.581 -169.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 64' ' ' TYR . . . . . 0.409 ' HB3' HD12 ' D' ' 56' ' ' ILE . 17.3 t80 -137.5 130.31 30.17 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.579 175.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 76.0 m -112.04 112.82 24.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.319 176.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 66' ' ' PHE . . . . . 0.549 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 7.6 p90 -118.67 150.5 39.62 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 173.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 67' ' ' ASN . . . . . 0.491 ' O ' HD11 ' D' ' 75' ' ' ILE . 18.6 p30 -122.04 140.61 52.28 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 68' ' ' GLU . . . . . 0.806 ' HB3' HG12 ' D' ' 47' ' ' ILE . 39.2 mm-40 -68.33 -9.46 48.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.218 0.532 . . . . 0.0 110.368 -176.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.569 ' HB3' ' NZ ' ' D' ' 69' ' ' LYS . 5.3 mtpm? -62.73 -45.06 94.49 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 170.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 31.1 t -66.29 125.65 26.27 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 113.528 -1.669 . . . . 0.0 107.571 168.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 71' ' ' THR . . . . . 0.407 ' O ' HG13 ' D' ' 75' ' ' ILE . 72.0 p -54.19 125.28 18.52 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -178.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 72' ' ' VAL . . . . . 0.693 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -55.32 -14.62 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 121.069 0.461 . . . . 0.0 110.918 -175.271 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 73' ' ' GLY . . . . . 0.744 ' HA3' ' HA2' ' D' ' 44' ' ' GLY . . . -71.05 -57.01 6.52 Favored Glycine 0 N--CA 1.437 -1.264 0 CA-C-N 115.043 -0.98 . . . . 0.0 112.627 170.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -61.76 -24.15 66.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.115 0.483 . . . . 0.0 110.342 176.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 75' ' ' ILE . . . . . 0.613 ' O ' HG13 ' D' ' 79' ' ' ILE . 66.4 mt -73.2 -41.53 58.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.359 175.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 28.4 t -76.16 -24.05 54.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.762 -0.199 . . . . 0.0 110.764 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 77' ' ' ASN . . . . . 0.553 ' O ' ' HD3' ' D' ' 81' ' ' LYS . 66.0 m-20 -63.38 -19.03 64.3 Favored 'General case' 0 C--O 1.218 -0.601 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 168.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 78' ' ' ASP . . . . . 0.665 ' O ' HD23 ' D' ' 82' ' ' LEU . 72.0 m-20 -93.52 -45.41 7.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.068 174.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 79' ' ' ILE . . . . . 0.707 HG22 HD11 ' D' ' 36' ' ' LEU . 43.0 mt -67.99 -33.35 60.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 O-C-N 121.743 -0.598 . . . . 0.0 111.729 -170.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -64.63 -13.49 53.85 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.191 174.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 81' ' ' LYS . . . . . 0.553 ' HD3' ' O ' ' D' ' 77' ' ' ASN . 16.0 mmmt -92.34 -57.8 2.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 122.185 0.993 . . . . 0.0 108.866 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 82' ' ' LEU . . . . . 0.665 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.3 mm? -56.07 -23.63 34.93 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 113.821 -1.536 . . . . 0.0 112.913 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 83' ' ' ASN . . . . . 0.589 ' HA ' HD12 ' D' ' 36' ' ' LEU . 7.5 m120 32.72 70.46 0.1 Allowed 'General case' 0 N--CA 1.476 0.867 0 O-C-N 124.182 0.926 . . . . 0.0 112.978 -177.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 84' ' ' ILE . . . . . 0.578 HG22 HD13 ' D' ' 89' ' ' ILE . 47.2 mt -86.45 98.86 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-O 121.132 0.492 . . . . 0.0 110.991 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 85' ' ' LYS . . . . . 0.688 ' HE3' ' O ' ' D' ' 34' ' ' ASN . 0.0 OUTLIER -135.01 94.55 3.16 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.871 0.843 . . . . 0.0 111.947 -179.563 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 86' ' ' GLY . . . . . 0.585 ' H ' ' CD1' ' D' ' 89' ' ' ILE . . . 70.28 153.2 0.92 Allowed Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.622 -0.717 . . . . 0.0 113.032 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 87' ' ' PRO . . . . . 0.578 ' O ' HG13 ' D' ' 58' ' ' VAL . 92.6 Cg_endo -91.18 -177.27 9.29 Favored 'Cis proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.705 -1.373 . . . . 0.0 112.52 -0.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 88' ' ' TYR . . . . . 0.693 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 14.4 m-85 8.24 93.18 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 125.473 1.509 . . . . 0.0 113.844 -177.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.912 HG12 HG22 ' D' ' 58' ' ' VAL . 67.8 mt -110.43 135.22 50.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.427 0.632 . . . . 0.0 111.83 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.768 ' HB2' ' HB2' ' D' ' 57' ' ' PHE . 5.5 mm-40 -122.58 89.52 3.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.991 176.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 91' ' ' ILE . . . . . 1.136 HG22 ' HZ3' ' D' ' 54' ' ' TRP . 4.7 mt -96.31 108.9 21.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 92' ' ' LYS . . . . . 0.643 ' HG2' ' O ' ' D' ' 93' ' ' GLN . 0.0 OUTLIER -162.95 172.73 14.62 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.361 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 93' ' ' GLN . . . . . 0.643 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 25.1 pt20 -81.5 163.58 22.6 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 119.749 -0.781 . . . . 0.0 111.219 175.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 94' ' ' ILE . . . . . 0.569 HG22 ' HE2' ' D' ' 92' ' ' LYS . 9.9 pt . . . . . 0 C--N 1.307 -1.246 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.139 -172.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 . . . . . 0 N--CA 1.483 1.216 0 N-CA-C 110.652 -0.129 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 2' ' ' ASN . . . . . 0.5 ' HB3' ' HA ' ' D' ' 5' ' ' ALA . 75.3 m-20 61.2 54.15 3.36 Favored 'General case' 0 N--CA 1.462 0.163 0 O-C-N 123.692 0.62 . . . . 0.0 110.519 -176.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -64.68 -40.64 95.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.059 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 4' ' ' LYS . . . . . 0.403 ' HD3' ' HB3' ' D' ' 7' ' ' GLU . 21.4 ptmt -90.77 -18.42 24.97 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 175.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 5' ' ' ALA . . . . . 0.5 ' HA ' ' HB3' ' D' ' 2' ' ' ASN . . . 66.93 -59.7 0.37 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.942 -1.026 . . . . 0.0 113.448 172.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 1.3 pp -67.49 1.02 2.55 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -174.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 7' ' ' GLU . . . . . 0.403 ' HB3' ' HD3' ' D' ' 4' ' ' LYS . 23.1 pt-20 -63.26 1.81 0.45 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.511 ' C ' ' H ' ' D' ' 10' ' ' MET . 12.5 pt-20 -100.24 0.88 41.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.759 -0.201 . . . . 0.0 111.29 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 9' ' ' GLN . . . . . 0.607 ' HA ' ' HB3' ' D' ' 12' ' ' SER . 13.9 pt20 -58.17 10.71 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.403 1.081 . . . . 0.0 113.853 -178.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 10' ' ' MET . . . . . 0.511 ' H ' ' C ' ' D' ' 8' ' ' GLU . 65.5 mtm -78.75 -47.94 15.83 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 174.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -100.26 -56.19 2.42 Favored 'General case' 0 C--O 1.207 -1.167 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.169 166.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 12' ' ' SER . . . . . 0.607 ' HB3' ' HA ' ' D' ' 9' ' ' GLN . 43.8 t -23.42 -68.92 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 -173.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 41.9 mm -80.2 -9.4 12.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.451 -169.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 75.0 m-80 -94.81 -50.59 5.07 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.001 172.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 15' ' ' SER . . . . . 0.506 ' O ' ' HD2' ' D' ' 19' ' ' LYS . 80.5 p -66.62 -30.59 70.9 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.256 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 16' ' ' VAL . . . . . 0.504 HG13 ' OD1' ' D' ' 17' ' ' ASN . 11.5 p -50.75 -28.53 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 121.981 0.896 . . . . 0.0 110.31 175.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 17' ' ' ASN . . . . . 0.677 HD22 ' H ' ' D' ' 29' ' ' LEU . 65.2 m-20 -83.51 -31.29 26.53 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.911 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.92 -15.55 43.94 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 177.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.56 ' N ' ' HD2' ' D' ' 19' ' ' LYS . 0.0 OUTLIER -90.82 -42.21 10.78 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 176.006 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 20' ' ' LEU . . . . . 0.929 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 64.9 mt -70.4 -41.06 73.48 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 113.327 -1.76 . . . . 0.0 110.398 -176.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 21' ' ' ASN . . . . . 0.697 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 59.4 m-20 -74.42 100.76 3.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.656 -1.157 . . . . 0.0 110.225 177.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 22' ' ' LYS . . . . . 0.573 ' NZ ' HG23 ' D' ' 47' ' ' ILE . 54.3 mtpt -121.94 -43.46 2.34 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -171.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.96 -74.81 0.2 Allowed Glycine 0 N--CA 1.435 -1.39 0 C-N-CA 120.281 -0.961 . . . . 0.0 112.231 -174.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 24' ' ' LYS . . . . . 0.823 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 27.2 tptp -58.41 -68.42 0.26 Allowed 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 25' ' ' GLY . . . . . 0.795 ' HA2' ' ND2' ' D' ' 42' ' ' ASN . . . -127.77 156.93 20.84 Favored Glycine 0 N--CA 1.431 -1.656 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.631 173.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 26' ' ' LYS . . . . . 0.697 ' CB ' ' HA ' ' D' ' 21' ' ' ASN . 8.5 ptpt -148.31 159.45 43.98 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 114.828 -0.686 . . . . 0.0 111.192 -170.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 27' ' ' LEU . . . . . 0.929 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 42.0 tp -137.46 142.82 41.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.717 0.77 . . . . 0.0 111.968 -177.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 28' ' ' SER . . . . . 0.688 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 50.3 m -129.05 151.32 49.86 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.296 -178.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 29' ' ' LEU . . . . . 0.677 ' H ' HD22 ' D' ' 17' ' ' ASN . 17.7 mt -140.89 135.49 31.36 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 177.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 48.5 m -136.85 -173.28 3.4 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 22.7 ptm -150.14 166.01 31.12 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.675 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 32' ' ' ASN . . . . . 0.413 ' H ' ' HB2' ' D' ' 35' ' ' GLN . 52.7 t-20 -143.19 89.3 2.09 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.07 -101.88 1.51 Allowed Glycine 0 C--O 1.227 -0.3 0 C-N-CA 120.064 -1.065 . . . . 0.0 110.901 -173.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -111.15 27.81 9.33 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.183 0.515 . . . . 0.0 109.907 173.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 35' ' ' GLN . . . . . 0.413 ' HB2' ' H ' ' D' ' 32' ' ' ASN . 73.8 mm-40 -96.87 164.74 12.42 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -177.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.763 HD11 HG22 ' D' ' 79' ' ' ILE . 2.8 tm? -132.18 124.19 28.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.056 174.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 37' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -132.11 100.73 5.13 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.004 -168.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.57 146.81 25.42 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.574 0.702 . . . . 0.0 112.105 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 39' ' ' THR . . . . . 0.688 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 18.3 p -141.65 128.83 20.96 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.242 176.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 40' ' ' SER . . . . . 0.61 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 77.7 p -107.12 129.5 54.83 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 173.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 41' ' ' SER . . . . . 0.687 ' HB3' ' HG3' ' D' ' 26' ' ' LYS . 46.2 t -93.03 146.7 23.43 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -175.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 42' ' ' ASN . . . . . 0.795 ' ND2' ' HA2' ' D' ' 25' ' ' GLY . 0.9 OUTLIER 82.12 -18.74 0.45 Allowed 'General case' 0 N--CA 1.477 0.925 0 O-C-N 125.59 1.806 . . . . 0.0 109.757 -167.944 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 60.85 60.33 1.89 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 175.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 123.88 35.98 0.65 Allowed Glycine 0 C--N 1.338 0.689 0 C-N-CA 119.166 -1.492 . . . . 0.0 115.797 168.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 45' ' ' TYR . . . . . 0.823 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 7.0 m-30 -116.02 160.87 19.7 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 170.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 46' ' ' GLY . . . . . 0.571 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -107.84 -152.91 17.49 Favored Glycine 0 C--O 1.223 -0.533 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.87 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 47' ' ' ILE . . . . . 0.995 HG13 ' HB2' ' D' ' 68' ' ' GLU . 1.7 mp -51.45 -57.68 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 CA-C-O 122.484 1.135 . . . . 0.0 108.486 177.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 67.2 p 167.93 -77.67 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 111.378 -2.646 . . . . 0.0 107.273 -173.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 49' ' ' TYR . . . . . 0.464 ' O ' ' HD2' ' D' ' 49' ' ' TYR . 0.1 OUTLIER -154.64 74.55 0.95 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.61 165.496 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 50' ' ' GLU . . . . . 0.663 ' O ' ' HG2' ' D' ' 69' ' ' LYS . 59.2 mm-40 -141.46 -158.67 0.88 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.226 -176.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 51' ' ' ASP . . . . . 0.603 ' CB ' ' HD2' ' D' ' 69' ' ' LYS . 7.2 t70 -146.51 112.26 5.65 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.234 174.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 52' ' ' LYS . . . . . 0.757 ' HD3' HG12 ' D' ' 47' ' ' ILE . 4.5 mptp? -126.15 106.15 9.36 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.904 -172.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 19.7 m-20 -88.74 130.44 35.34 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.06 0.457 . . . . 0.0 110.401 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 54' ' ' TRP . . . . . 1.04 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 0.4 OUTLIER -119.63 166.02 13.72 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.108 -175.2 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -148.84 159.93 28.21 Favored Glycine 0 N--CA 1.439 -1.138 0 C-N-CA 120.04 -1.076 . . . . 0.0 113.689 175.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 56' ' ' ILE . . . . . 1.005 HG12 HG23 ' D' ' 91' ' ' ILE . 82.8 mt -135.61 105.06 5.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 176.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 57' ' ' PHE . . . . . 0.524 ' HD1' ' O ' ' D' ' 90' ' ' GLU . 13.7 m-85 -101.28 98.21 8.62 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 119.178 -1.009 . . . . 0.0 111.076 -167.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.744 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 97.9 t -89.75 115.16 28.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.835 173.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 32.3 m120 66.11 38.04 4.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.81 -175.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.92 -32.99 4.37 Favored Glycine 0 CA--C 1.509 -0.334 0 C-N-CA 120.959 -0.638 . . . . 0.0 113.512 176.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 61' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 16.6 pt-20 -90.76 141.55 28.68 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.322 0.582 . . . . 0.0 111.399 -174.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 62' ' ' LYS . . . . . 0.459 ' NZ ' ' HB3' ' D' ' 62' ' ' LYS . 6.2 ttpm? -74.07 100.38 3.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.1 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.51 HG12 ' O ' ' D' ' 56' ' ' ILE . 14.5 p -79.37 -28.65 13.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.672 -173.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 64' ' ' TYR . . . . . 0.406 ' HB3' HD12 ' D' ' 56' ' ' ILE . 22.0 t80 -140.32 141.62 35.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.639 0.257 . . . . 0.0 110.657 176.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 28.3 m -121.19 130.42 53.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.882 176.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 66' ' ' PHE . . . . . 0.709 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 19.5 p90 -136.98 140.13 41.95 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.758 0.79 . . . . 0.0 110.859 174.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 67' ' ' ASN . . . . . 0.807 HD22 ' HB2' ' D' ' 69' ' ' LYS . 11.2 p-10 -111.2 135.4 51.78 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.901 -178.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 68' ' ' GLU . . . . . 0.995 ' HB2' HG13 ' D' ' 47' ' ' ILE . 28.4 mt-10 -65.05 -13.2 57.37 Favored 'General case' 0 CA--C 1.521 -0.137 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.036 -175.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.807 ' HB2' HD22 ' D' ' 67' ' ' ASN . 5.6 mtpm? -59.91 -43.21 95.01 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 172.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 25.5 t -74.56 102.18 4.44 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 113.422 -1.717 . . . . 0.0 107.185 165.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 62.4 p -38.95 130.35 1.49 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.631 -173.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 72' ' ' VAL . . . . . 0.523 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -53.32 -14.14 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 179.242 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 73' ' ' GLY . . . . . 0.61 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -71.56 -62.49 3.42 Favored Glycine 0 N--CA 1.435 -1.367 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.303 170.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -54.79 -31.09 58.52 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.247 0.546 . . . . 0.0 110.717 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 75' ' ' ILE . . . . . 0.485 ' O ' ' HB2' ' D' ' 78' ' ' ASP . 26.6 mm -80.37 -36.3 16.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.401 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 76' ' ' SER . . . . . 0.649 ' HB2' HD13 ' D' ' 27' ' ' LEU . 27.7 t -73.84 -20.28 60.48 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.965 178.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -61.38 -46.51 89.89 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 163.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 78' ' ' ASP . . . . . 0.944 ' HA ' ' HG2' ' D' ' 81' ' ' LYS . 51.5 m-20 -60.31 -36.16 77.28 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 174.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 79' ' ' ILE . . . . . 0.763 HG22 HD11 ' D' ' 36' ' ' LEU . 29.8 mm -67.06 -30.6 50.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.248 -174.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -75.98 -15.87 60.08 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.332 174.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 81' ' ' LYS . . . . . 0.944 ' HG2' ' HA ' ' D' ' 78' ' ' ASP . 11.0 mmtp -77.33 -63.65 1.32 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 173.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 82' ' ' LEU . . . . . 0.644 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.2 mm? -49.47 -26.25 3.22 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 113.242 -1.799 . . . . 0.0 113.56 -174.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 83' ' ' ASN . . . . . 0.575 ' O ' ' HE2' ' D' ' 85' ' ' LYS . 49.8 t-20 51.82 66.67 1.13 Allowed 'General case' 0 N--CA 1.468 0.46 0 O-C-N 123.386 0.429 . . . . 0.0 110.251 177.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 84' ' ' ILE . . . . . 0.6 HG22 HD13 ' D' ' 89' ' ' ILE . 46.5 mm -76.9 99.48 2.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.897 -173.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 85' ' ' LYS . . . . . 0.575 ' HE2' ' O ' ' D' ' 83' ' ' ASN . 0.0 OUTLIER -156.26 91.75 1.28 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 174.889 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 86' ' ' GLY . . . . . 0.712 ' H ' HD11 ' D' ' 89' ' ' ILE . . . 69.17 151.27 0.43 Allowed Glycine 0 N--CA 1.453 -0.219 0 CA-C-N 115.163 -0.926 . . . . 0.0 113.222 174.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 87' ' ' PRO . . . . . 0.634 ' O ' HG13 ' D' ' 58' ' ' VAL . 59.0 Cg_endo -90.76 179.91 13.15 Favored 'Cis proline' 0 CA--C 1.535 0.534 0 C-N-CA 123.336 -1.527 . . . . 0.0 112.784 -0.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 88' ' ' TYR . . . . . 0.744 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 0.9 OUTLIER 16.85 92.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 125.142 1.377 . . . . 0.0 113.705 178.76 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.712 HD11 ' H ' ' D' ' 86' ' ' GLY . 70.3 mt -111.5 142.73 23.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.524 ' O ' ' HD1' ' D' ' 57' ' ' PHE . 70.9 mt-10 -136.87 95.05 3.05 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.676 172.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 91' ' ' ILE . . . . . 1.04 HG22 ' HZ3' ' D' ' 54' ' ' TRP . 5.5 mt -96.87 106.53 18.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 92' ' ' LYS . . . . . 0.613 ' HA ' ' CH2' ' D' ' 54' ' ' TRP . 0.0 OUTLIER -161.93 170.77 18.79 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.622 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 93' ' ' GLN . . . . . 0.601 ' HB3' ' NE1' ' D' ' 54' ' ' TRP . 18.9 pt20 -82.59 164.8 20.57 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.749 176.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 94' ' ' ILE . . . . . 0.507 HG22 ' HE2' ' D' ' 92' ' ' LYS . 10.4 pt . . . . . 0 C--N 1.31 -1.118 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.174 -172.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 1' ' ' ASP . . . . . 0.455 ' HB3' ' HB3' ' D' ' 5' ' ' ALA . 1.7 m-20 . . . . . 0 N--CA 1.482 1.153 0 CA-C-O 120.506 0.193 . . . . 0.0 110.645 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 2' ' ' ASN . . . . . 0.534 ' O ' ' HB3' ' D' ' 6' ' ' LEU . 20.2 t-20 -172.27 -44.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.59 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -60.6 -53.71 54.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.216 -175.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -112.79 -32.03 6.54 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 177.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 5' ' ' ALA . . . . . 0.455 ' HB3' ' HB3' ' D' ' 1' ' ' ASP . . . -102.36 76.28 1.54 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.075 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 6' ' ' LEU . . . . . 0.808 HD23 ' H ' ' D' ' 6' ' ' LEU . 1.8 pt? -112.13 -1.41 15.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.632 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -49.43 -68.12 0.2 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 1.024 ' HA ' ' HB3' ' D' ' 12' ' ' SER . 23.0 pt-20 -78.63 1.1 23.87 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -176.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 9' ' ' GLN . . . . . 0.7 ' NE2' ' HG3' ' D' ' 8' ' ' GLU . 17.5 mp0 -94.95 -13.14 25.62 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 10' ' ' MET . . . . . 0.477 ' HG2' ' O ' ' D' ' 6' ' ' LEU . 25.1 mmt -109.07 -77.83 0.6 Allowed 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 119.539 -0.864 . . . . 0.0 113.099 -172.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -100.92 -41.16 6.93 Favored 'General case' 0 CA--C 1.488 -1.426 0 CA-C-O 121.222 0.534 . . . . 0.0 110.422 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 12' ' ' SER . . . . . 1.024 ' HB3' ' HA ' ' D' ' 8' ' ' GLU . 34.7 t -42.05 -68.27 0.2 Allowed 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 113.373 -1.739 . . . . 0.0 112.263 -169.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.475 HG21 ' SD ' ' D' ' 31' ' ' MET . 38.2 mm -92.91 -9.69 9.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.34 -174.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 14' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' D' ' 10' ' ' MET . 78.5 m-20 -96.83 -56.27 2.62 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 177.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 37.2 m -69.39 -15.7 63.36 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 121.21 -0.196 . . . . 0.0 110.997 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 16' ' ' VAL . . . . . 0.746 ' HA ' ' HE2' ' D' ' 19' ' ' LYS . 14.1 p -56.84 -35.26 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 173.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -66.66 -44.01 82.99 Favored 'General case' 0 C--O 1.211 -0.955 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.349 175.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -56.77 -15.07 3.97 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -174.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.746 ' HE2' ' HA ' ' D' ' 16' ' ' VAL . 0.0 OUTLIER -91.54 -44.09 9.28 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-O 122.413 1.101 . . . . 0.0 108.895 174.261 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 20' ' ' LEU . . . . . 0.862 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 72.6 mt -69.76 -36.47 75.81 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 112.804 -1.998 . . . . 0.0 110.097 -174.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 21' ' ' ASN . . . . . . . . . . . . . 48.2 m-20 -69.82 98.76 1.27 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.589 177.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 22' ' ' LYS . . . . . 0.624 ' NZ ' ' HA ' ' D' ' 47' ' ' ILE . 8.8 mtmp? -121.36 -42.5 2.45 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -171.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.38 -71.66 0.32 Allowed Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.135 -1.031 . . . . 0.0 112.04 -175.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 24' ' ' LYS . . . . . 0.831 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 21.8 tptm -51.01 -67.42 0.25 Allowed 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 175.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.9 166.69 23.91 Favored Glycine 0 N--CA 1.43 -1.704 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.581 169.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 26' ' ' LYS . . . . . 0.831 ' HD2' ' HB2' ' D' ' 41' ' ' SER . 0.4 OUTLIER -148.15 156.93 43.17 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.543 -0.328 . . . . 0.0 110.486 -170.545 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 27' ' ' LEU . . . . . 0.862 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 46.2 tp -137.43 142.47 41.62 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.318 0.58 . . . . 0.0 111.285 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 28' ' ' SER . . . . . 0.709 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 49.0 m -137.03 143.18 42.57 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.013 -174.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 29' ' ' LEU . . . . . 0.586 HD11 ' CD1' ' D' ' 20' ' ' LEU . 0.2 OUTLIER -140.7 149.73 42.56 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.768 -179.113 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 36.1 t -155.01 174.45 15.16 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.17 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 31' ' ' MET . . . . . 0.475 ' SD ' HG21 ' D' ' 13' ' ' ILE . 0.0 OUTLIER -128.74 165.43 20.93 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.023 0.44 . . . . 0.0 109.884 176.838 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 32' ' ' ASN . . . . . 0.423 ' HB3' ' HB2' ' D' ' 35' ' ' GLN . 52.6 t30 -146.82 88.13 1.73 Allowed 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.61 -101.06 1.24 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.392 -168.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 34' ' ' ASN . . . . . 0.428 ' O ' ' HE2' ' D' ' 85' ' ' LYS . 72.3 m-20 -116.4 20.99 13.89 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.691 -0.3 . . . . 0.0 110.705 173.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 35' ' ' GLN . . . . . 0.423 ' HB2' ' HB3' ' D' ' 32' ' ' ASN . 13.6 mm100 -88.91 163.09 15.76 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.576 0.703 . . . . 0.0 111.983 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.716 HD11 HG22 ' D' ' 79' ' ' ILE . 2.4 tm? -129.93 124.95 34.32 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.933 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 37' ' ' LYS . . . . . 0.581 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 26.1 mmmt -130.38 116.15 17.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.605 -168.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 38' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -120.16 143.72 48.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.443 0.64 . . . . 0.0 111.338 176.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 39' ' ' THR . . . . . 0.709 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 4.9 p -138.55 130.11 27.62 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.095 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 40' ' ' SER . . . . . 0.723 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 24.7 p -120.75 129.52 53.65 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 41' ' ' SER . . . . . 0.831 ' HB2' ' HD2' ' D' ' 26' ' ' LYS . 49.3 m -100.92 159.45 15.19 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.174 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 42' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' D' ' 41' ' ' SER . 74.2 m-80 76.67 8.91 3.05 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 124.572 1.17 . . . . 0.0 110.707 -174.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 40.92 59.05 2.33 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 171.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 114.22 35.24 1.5 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 119.419 -1.372 . . . . 0.0 114.175 172.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 45' ' ' TYR . . . . . 0.831 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 2.2 m-30 -113.18 145.74 40.45 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 122.477 -0.425 . . . . 0.0 110.02 172.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -91.63 -150.49 25.55 Favored Glycine 0 CA--C 1.504 -0.629 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.411 -178.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 47' ' ' ILE . . . . . 0.939 HG13 ' HB2' ' D' ' 68' ' ' GLU . 0.3 OUTLIER -53.77 -58.91 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 CA-C-O 122.079 0.942 . . . . 0.0 109.013 -178.585 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.444 ' O ' ' HD2' ' D' ' 49' ' ' TYR . 41.1 t 163.25 -107.32 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 111.216 -2.72 . . . . 0.0 105.381 -172.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 49' ' ' TYR . . . . . 0.444 ' HD2' ' O ' ' D' ' 48' ' ' SER . 2.7 m-30 -124.09 76.76 1.48 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 163.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 50' ' ' GLU . . . . . 0.459 ' HB2' HG21 ' D' ' 47' ' ' ILE . 63.8 mm-40 -148.56 -166.14 2.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.134 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 51' ' ' ASP . . . . . 0.725 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 2.8 p30 -148.41 138.7 22.6 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.382 168.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 52' ' ' LYS . . . . . 0.725 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 0.4 OUTLIER -143.44 144.35 31.98 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.098 -174.854 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 52.5 m-20 -120.2 129.54 54.14 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 172.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 54' ' ' TRP . . . . . 1.057 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 1.0 OUTLIER -120.99 162.04 20.59 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -173.109 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -152.19 152.96 24.6 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.414 172.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 56' ' ' ILE . . . . . 1.106 HG12 HG23 ' D' ' 91' ' ' ILE . 83.7 mt -117.3 116.93 53.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 173.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 57' ' ' PHE . . . . . 0.684 ' CE1' ' HG2' ' D' ' 62' ' ' LYS . 15.3 m-85 -107.47 98.96 8.51 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 119.467 -0.893 . . . . 0.0 111.389 -168.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 59.3 t -91.94 115.01 30.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.763 173.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 63.9 34.7 11.47 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.212 -176.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.72 -32.27 5.15 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.455 -0.878 . . . . 0.0 113.726 176.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 61' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 16.2 pt-20 -90.0 155.24 19.23 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.798 0.333 . . . . 0.0 110.799 -174.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 62' ' ' LYS . . . . . 0.684 ' HG2' ' CE1' ' D' ' 57' ' ' PHE . 57.8 mttp -80.49 103.03 10.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.961 0.41 . . . . 0.0 110.043 -178.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 14.1 p -78.7 -29.33 14.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.94 -177.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 64' ' ' TYR . . . . . 0.445 ' HB3' HD12 ' D' ' 56' ' ' ILE . 16.3 t80 -146.72 126.65 13.6 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.682 175.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 97.2 m -109.59 111.72 23.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.542 174.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 66' ' ' PHE . . . . . 0.498 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 15.9 p90 -116.36 160.71 20.13 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 172.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 67' ' ' ASN . . . . . 0.505 ' O ' HD11 ' D' ' 75' ' ' ILE . 13.2 p30 -132.59 141.35 48.65 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 68' ' ' GLU . . . . . 0.939 ' HB2' HG13 ' D' ' 47' ' ' ILE . 31.4 mm-40 -64.21 -15.23 59.55 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -177.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.613 ' HA ' HD11 ' D' ' 47' ' ' ILE . 49.3 mtpt -56.81 -49.89 74.0 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 173.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 23.1 t -63.8 128.37 35.53 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 113.426 -1.716 . . . . 0.0 107.51 168.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 70.2 p -57.51 118.99 5.77 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 72' ' ' VAL . . . . . 0.65 ' HA ' HD12 ' D' ' 75' ' ' ILE . 0.0 OUTLIER -53.61 -14.98 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -176.387 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 73' ' ' GLY . . . . . 0.723 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -67.96 -56.74 9.97 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.788 170.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -68.23 -19.97 64.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.988 0.423 . . . . 0.0 110.278 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 75' ' ' ILE . . . . . 0.65 HD12 ' HA ' ' D' ' 72' ' ' VAL . 83.3 mt -72.59 -43.95 61.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.555 175.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 31.4 t -73.58 -19.15 60.96 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.166 -176.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -60.49 -44.47 95.91 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 165.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 78' ' ' ASP . . . . . 1.018 ' HA ' ' HG2' ' D' ' 81' ' ' LYS . 1.0 OUTLIER -69.66 -25.81 64.09 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 114.981 -1.009 . . . . 0.0 113.407 177.144 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 79' ' ' ILE . . . . . 0.716 HG22 HD11 ' D' ' 36' ' ' LEU . 41.5 mt -77.72 -17.0 14.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 118.89 -1.124 . . . . 0.0 109.875 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -77.52 -26.83 51.45 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.256 169.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 81' ' ' LYS . . . . . 1.018 ' HG2' ' HA ' ' D' ' 78' ' ' ASP . 15.9 mmtt -74.01 -69.96 0.41 Allowed 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 176.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 82' ' ' LEU . . . . . 0.491 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.5 mm? -47.28 -32.25 4.5 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 113.482 -1.69 . . . . 0.0 112.578 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 37.85 65.5 0.56 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.979 0.912 . . . . 0.0 111.269 175.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 84' ' ' ILE . . . . . 0.622 ' H ' HD12 ' D' ' 84' ' ' ILE . 2.8 mp -74.88 99.12 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.96 0.41 . . . . 0.0 111.372 -171.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 85' ' ' LYS . . . . . 0.428 ' HE2' ' O ' ' D' ' 34' ' ' ASN . 16.8 ptpt -125.9 92.3 3.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.988 0.423 . . . . 0.0 111.96 178.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 86' ' ' GLY . . . . . 0.805 ' H ' HD11 ' D' ' 89' ' ' ILE . . . 61.33 160.04 0.11 Allowed Glycine 0 CA--C 1.52 0.353 0 CA-C-N 115.328 -0.851 . . . . 0.0 114.146 173.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 87' ' ' PRO . . . . . 0.584 ' O ' HG13 ' D' ' 58' ' ' VAL . 44.8 Cg_endo -93.68 -178.58 8.42 Favored 'Cis proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.795 -1.335 . . . . 0.0 112.176 -1.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 88' ' ' TYR . . . . . 0.647 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 16.0 m-85 24.57 92.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.823 1.249 . . . . 0.0 113.387 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.805 HD11 ' H ' ' D' ' 86' ' ' GLY . 75.8 mt -111.67 130.78 64.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.581 ' O ' ' HD2' ' D' ' 57' ' ' PHE . 51.3 mt-10 -130.52 101.54 5.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.105 172.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 91' ' ' ILE . . . . . 1.106 HG23 HG12 ' D' ' 56' ' ' ILE . 4.1 mt -98.3 113.03 31.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -177.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 92' ' ' LYS . . . . . 0.627 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -162.28 170.57 18.71 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.084 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 93' ' ' GLN . . . . . 0.626 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 25.1 pt20 -80.97 164.81 22.28 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.803 176.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 94' ' ' ILE . . . . . 0.627 HG22 ' HE2' ' D' ' 92' ' ' LYS . 10.7 pt . . . . . 0 C--N 1.31 -1.109 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.899 -171.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 9.0 t70 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' D' D ' 2' ' ' ASN . . . . . 0.422 ' HA ' ' HB2' ' D' ' 7' ' ' GLU . 5.6 m120 -68.33 -17.25 64.21 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -173.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -92.34 -13.28 30.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.801 0.334 . . . . 0.0 111.179 -176.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -110.82 -33.62 6.48 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 5' ' ' ALA . . . . . 0.693 ' HB3' ' HG2' ' D' ' 7' ' ' GLU . . . -104.0 172.12 6.97 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.512 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 1.4 pp -84.88 24.97 0.98 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.445 177.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 7' ' ' GLU . . . . . 0.693 ' HG2' ' HB3' ' D' ' 5' ' ' ALA . 65.1 mm-40 -45.33 -34.68 3.1 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -176.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.478 ' HA ' ' CB ' ' D' ' 12' ' ' SER . 82.4 mt-10 -63.09 -23.38 67.42 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 120.749 0.309 . . . . 0.0 111.233 -175.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -99.1 -0.58 41.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.953 -175.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 10' ' ' MET . . . . . . . . . . . . . 53.8 ttp -106.24 -78.51 0.58 Allowed 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 119.64 -0.824 . . . . 0.0 112.718 -169.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 -104.27 -31.21 9.69 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 176.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 12' ' ' SER . . . . . 0.555 ' HB2' ' O ' ' D' ' 7' ' ' GLU . 42.4 t -21.36 -67.58 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 113.433 -1.712 . . . . 0.0 115.23 -170.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.549 HG21 ' HE1' ' D' ' 31' ' ' MET . 63.9 mt -73.73 -12.07 15.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.736 -171.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -96.19 -50.37 4.84 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.519 172.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 15' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' D' ' 18' ' ' ASP . 80.5 p -63.44 -24.94 68.05 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.328 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 16' ' ' VAL . . . . . 0.653 ' O ' ' HG ' ' D' ' 20' ' ' LEU . 9.8 p -54.16 -37.58 36.04 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-O 121.296 0.569 . . . . 0.0 109.593 176.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 17' ' ' ASN . . . . . 0.617 ' OD1' ' HA ' ' D' ' 28' ' ' SER . 78.6 m-20 -78.21 -22.3 48.72 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.461 -178.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 18' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' D' ' 15' ' ' SER . 1.0 OUTLIER -67.79 -17.14 64.43 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 176.379 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.587 ' O ' ' HE3' ' D' ' 22' ' ' LYS . 0.0 OUTLIER -91.74 -43.11 9.75 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 172.186 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 20' ' ' LEU . . . . . 1.018 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 85.4 mt -63.04 -40.95 99.24 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.009 -1.451 . . . . 0.0 110.131 -177.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 21' ' ' ASN . . . . . 0.576 ' OD1' ' HB2' ' D' ' 26' ' ' LYS . 51.6 m-80 -79.73 101.64 8.55 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.347 177.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 22' ' ' LYS . . . . . 0.966 ' HD2' HD12 ' D' ' 47' ' ' ILE . 97.4 mttt -122.18 -41.76 2.41 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -175.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 169.9 -91.13 0.1 OUTLIER Glycine 0 N--CA 1.437 -1.26 0 C-N-CA 119.604 -1.284 . . . . 0.0 112.982 -178.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 24' ' ' LYS . . . . . 0.656 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 26.4 tptp -48.27 -52.86 19.36 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 25' ' ' GLY . . . . . 0.694 ' HA2' ' OD1' ' D' ' 42' ' ' ASN . . . -141.48 154.0 24.4 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.394 176.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 26' ' ' LYS . . . . . 0.588 ' CD ' ' HB3' ' D' ' 41' ' ' SER . 0.4 OUTLIER -144.92 161.94 38.1 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.573 -0.814 . . . . 0.0 112.248 -168.709 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 27' ' ' LEU . . . . . 1.018 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 51.5 tp -134.93 153.15 52.17 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.454 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 28' ' ' SER . . . . . 0.617 ' HA ' ' OD1' ' D' ' 17' ' ' ASN . 14.2 t -140.68 153.79 46.12 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 29' ' ' LEU . . . . . . . . . . . . . 20.2 mt -134.2 158.8 42.75 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.624 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 37.3 t -160.15 -177.13 6.07 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 31' ' ' MET . . . . . 0.549 ' HE1' HG21 ' D' ' 13' ' ' ILE . 1.3 pmm? -150.57 163.15 39.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.84 0.352 . . . . 0.0 111.007 177.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 32' ' ' ASN . . . . . 0.444 ' H ' ' HB2' ' D' ' 35' ' ' GLN . 51.3 t30 -144.25 88.48 1.95 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.1 175.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.47 -115.35 4.56 Favored Glycine 0 N--CA 1.454 -0.154 0 C-N-CA 120.205 -0.997 . . . . 0.0 110.991 -172.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -95.78 20.71 9.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.915 0.388 . . . . 0.0 110.926 174.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 35' ' ' GLN . . . . . 0.444 ' HB2' ' H ' ' D' ' 32' ' ' ASN . 10.3 mm-40 -88.54 152.85 21.59 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 121.314 0.578 . . . . 0.0 111.989 176.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.824 HD12 ' HA ' ' D' ' 83' ' ' ASN . 1.3 tm? -134.37 119.56 18.77 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.378 175.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 37' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -123.36 157.36 33.47 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.564 -169.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 38' ' ' ALA . . . . . 0.599 ' HB1' HD11 ' D' ' 27' ' ' LEU . . . -148.83 152.26 36.19 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 113.216 -1.811 . . . . 0.0 111.341 176.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 39' ' ' THR . . . . . 0.586 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 20.6 p -145.54 139.03 26.46 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.198 175.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 40' ' ' SER . . . . . 0.52 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 33.8 p -106.1 128.78 54.12 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 171.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 41' ' ' SER . . . . . 0.588 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 48.0 t -92.18 162.58 14.26 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 176.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 42' ' ' ASN . . . . . 0.694 ' OD1' ' HA2' ' D' ' 25' ' ' GLY . 0.4 OUTLIER 64.64 3.78 2.08 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 124.605 1.19 . . . . 0.0 111.896 -169.268 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 43' ' ' ALA . . . . . 0.41 ' H ' ' C ' ' D' ' 41' ' ' SER . . . 52.79 63.24 2.32 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 165.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.62 -15.94 6.63 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 118.174 -1.965 . . . . 0.0 115.993 166.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 45' ' ' TYR . . . . . 0.656 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 2.2 m-30 -78.62 155.94 29.34 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 117.909 0.855 . . . . 0.0 110.683 -176.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 46' ' ' GLY . . . . . 0.635 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -96.79 -172.91 34.69 Favored Glycine 0 C--O 1.217 -0.968 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 172.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 47' ' ' ILE . . . . . 0.966 HD12 ' HD2' ' D' ' 22' ' ' LYS . 39.4 mm -48.41 -56.64 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.861 0 CA-C-N 117.975 0.888 . . . . 0.0 110.917 178.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 81.0 p -179.31 -147.38 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 112.574 -2.103 . . . . 0.0 108.025 -173.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -97.46 75.53 2.51 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.226 168.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 50' ' ' GLU . . . . . 0.402 ' OE2' ' HA ' ' D' ' 50' ' ' GLU . 36.8 mm-40 -144.0 -172.68 3.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.56 -178.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 51' ' ' ASP . . . . . 0.689 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 11.6 m-20 -134.86 120.13 18.94 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.141 173.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 52' ' ' LYS . . . . . 1.053 ' HG2' ' HB2' ' D' ' 68' ' ' GLU . 0.0 OUTLIER -139.41 130.35 26.3 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.436 -177.1 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 49.5 m-20 -109.92 142.82 40.74 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 121.002 0.429 . . . . 0.0 110.967 -175.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 54' ' ' TRP . . . . . 1.068 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 0.8 OUTLIER -123.43 160.57 26.56 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.825 -176.925 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -138.56 160.85 25.68 Favored Glycine 0 N--CA 1.438 -1.233 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.95 174.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 56' ' ' ILE . . . . . 0.943 HG12 HG23 ' D' ' 91' ' ' ILE . 97.0 mt -140.47 109.88 3.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 178.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 57' ' ' PHE . . . . . 0.633 ' HA ' ' O ' ' D' ' 61' ' ' GLU . 13.9 m-85 -107.92 101.25 10.53 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.624 -0.83 . . . . 0.0 111.7 -168.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.861 HG22 HG12 ' D' ' 89' ' ' ILE . 87.5 t -94.84 119.67 43.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.446 173.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 5.5 m120 63.93 35.59 10.73 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.075 0.464 . . . . 0.0 110.776 -175.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.2 34.68 90.57 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.373 -0.83 . . . . 0.0 114.461 175.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 61' ' ' GLU . . . . . 0.633 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 16.3 pt-20 -138.69 145.33 40.23 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 171.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 62' ' ' LYS . . . . . 0.449 ' NZ ' ' HB2' ' D' ' 62' ' ' LYS . 3.8 ttmp? -75.34 99.39 4.09 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -177.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.467 HG12 ' O ' ' D' ' 56' ' ' ILE . 9.2 p -84.73 -33.54 8.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.577 -173.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 64' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -135.88 131.37 35.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.932 0.396 . . . . 0.0 110.595 174.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 26.4 m -115.93 113.9 23.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.701 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 66' ' ' PHE . . . . . 0.563 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 10.8 p90 -116.81 130.91 57.01 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.355 0.597 . . . . 0.0 109.776 175.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -103.2 139.86 38.12 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -178.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 68' ' ' GLU . . . . . 1.053 ' HB2' ' HG2' ' D' ' 52' ' ' LYS . 40.2 mm-40 -70.63 -8.94 55.48 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.946 -174.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.556 ' HD3' ' HB3' ' D' ' 51' ' ' ASP . 47.0 mtmt -62.88 -39.73 95.35 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 169.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 31.7 t -71.45 119.9 16.26 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.502 -1.681 . . . . 0.0 107.07 165.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 70.1 p -54.87 130.59 41.73 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.255 -176.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 72' ' ' VAL . . . . . 0.636 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -55.68 -13.38 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 121.077 0.465 . . . . 0.0 111.813 -175.821 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 73' ' ' GLY . . . . . 0.52 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -74.07 -55.55 5.72 Favored Glycine 0 N--CA 1.437 -1.249 0 CA-C-N 115.212 -0.904 . . . . 0.0 112.445 169.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -62.29 -23.59 66.81 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.814 0.34 . . . . 0.0 110.553 177.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 75' ' ' ILE . . . . . 0.62 ' O ' HG13 ' D' ' 79' ' ' ILE . 74.3 mt -73.83 -41.85 53.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.329 176.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 28.8 t -73.5 -20.41 60.68 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.554 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -65.84 -28.25 68.84 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 168.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 78' ' ' ASP . . . . . 1.094 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 1.0 OUTLIER -83.71 -32.22 25.64 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 115.528 -0.76 . . . . 0.0 113.032 174.823 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 79' ' ' ILE . . . . . 0.62 HG13 ' O ' ' D' ' 75' ' ' ILE . 25.1 mt -72.27 -16.55 18.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 120.034 -0.667 . . . . 0.0 110.041 -176.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -65.04 -49.81 68.66 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.729 172.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 81' ' ' LYS . . . . . 1.094 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -72.73 -57.58 4.0 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.637 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 82' ' ' LEU . . . . . 0.544 HD23 ' O ' ' D' ' 78' ' ' ASP . 4.1 mm? -44.98 -35.45 2.9 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 83' ' ' ASN . . . . . 0.824 ' HA ' HD12 ' D' ' 36' ' ' LEU . 22.2 t-20 29.33 70.88 0.07 Allowed 'General case' 0 N--CA 1.476 0.841 0 O-C-N 124.591 1.182 . . . . 0.0 111.811 178.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 84' ' ' ILE . . . . . 0.602 ' O ' ' HG ' ' D' ' 36' ' ' LEU . 50.1 mt -93.0 98.33 8.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.627 -176.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 85' ' ' LYS . . . . . 0.491 ' HB2' ' HB2' ' D' ' 36' ' ' LEU . 2.7 tmtm? -127.65 93.93 3.83 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -178.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 86' ' ' GLY . . . . . 0.609 ' H ' HD11 ' D' ' 89' ' ' ILE . . . 72.1 153.11 1.65 Allowed Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.918 -0.583 . . . . 0.0 113.165 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 87' ' ' PRO . . . . . 0.541 ' O ' HG13 ' D' ' 58' ' ' VAL . 54.2 Cg_endo -91.21 -179.76 12.13 Favored 'Cis proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.395 -1.502 . . . . 0.0 112.923 -0.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 88' ' ' TYR . . . . . 0.616 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 19.3 m-85 10.99 93.87 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 125.74 1.616 . . . . 0.0 114.065 -178.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.861 HG12 HG22 ' D' ' 58' ' ' VAL . 68.5 mt -111.54 142.85 22.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.975 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.426 ' HG2' ' HG3' ' D' ' 92' ' ' LYS . 38.3 tt0 -128.76 95.09 4.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.916 172.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 91' ' ' ILE . . . . . 1.068 HG22 ' HZ3' ' D' ' 54' ' ' TRP . 7.3 mt -97.18 109.15 22.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 92' ' ' LYS . . . . . 0.78 ' HE3' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -162.17 172.29 16.03 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 122.603 0.361 . . . . 0.0 110.308 -176.222 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 93' ' ' GLN . . . . . 0.696 ' HB3' ' NE1' ' D' ' 54' ' ' TRP . 17.4 pt20 -89.07 153.45 20.98 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.744 174.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 94' ' ' ILE . . . . . 0.78 HG22 ' HE3' ' D' ' 92' ' ' LYS . 10.6 pt . . . . . 0 C--N 1.309 -1.171 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.688 -171.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 120.586 0.231 . . . . 0.0 110.658 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' D' D ' 2' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -100.27 0.09 39.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.281 -175.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -63.4 -68.06 0.37 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.787 0.327 . . . . 0.0 110.991 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 4' ' ' LYS . . . . . 0.403 ' HB3' ' CD1' ' D' ' 6' ' ' LEU . 62.1 tttp -105.59 -22.01 13.07 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 177.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 5' ' ' ALA . . . . . . . . . . . . . . . 59.51 57.51 3.27 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.621 177.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 6' ' ' LEU . . . . . 0.536 ' H ' HD12 ' D' ' 6' ' ' LEU . 3.6 mp -70.88 -37.73 73.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.258 0.551 . . . . 0.0 110.13 178.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -62.45 -16.46 55.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.065 -0.97 . . . . 0.0 113.33 -174.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.681 ' HA ' ' CB ' ' D' ' 12' ' ' SER . 55.6 mt-10 -69.42 -30.49 68.44 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.023 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -96.38 -1.78 46.98 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.959 -178.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 10' ' ' MET . . . . . . . . . . . . . 65.3 mtt -108.51 -71.93 0.74 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.348 -173.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -92.92 -54.51 3.71 Favored 'General case' 0 CA--C 1.485 -1.54 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.404 178.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 12' ' ' SER . . . . . 0.681 ' CB ' ' HA ' ' D' ' 8' ' ' GLU . 32.7 t -23.54 -64.45 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.046 0 O-C-N 125.117 1.51 . . . . 0.0 114.824 -172.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.592 ' O ' HG12 ' D' ' 16' ' ' VAL . 63.3 mt -85.34 -8.64 11.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.43 -171.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 -92.0 -46.87 7.59 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.229 173.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 15' ' ' SER . . . . . 0.451 ' O ' ' HE2' ' D' ' 19' ' ' LYS . 92.2 p -70.23 -18.66 63.16 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.78 176.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 16' ' ' VAL . . . . . 0.62 ' O ' ' HG ' ' D' ' 20' ' ' LEU . 1.3 p -62.06 -27.43 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -69.62 -41.34 75.81 Favored 'General case' 0 C--O 1.206 -1.232 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.905 175.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 18' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' D' ' 15' ' ' SER . 49.7 m-20 -61.94 -14.54 35.64 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 176.279 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.687 ' HB3' ' CZ2' ' D' ' 54' ' ' TRP . 1.2 mppt? -87.79 -26.85 22.65 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.367 0.603 . . . . 0.0 110.185 177.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 20' ' ' LEU . . . . . 0.993 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 84.6 mt -105.6 -38.49 6.41 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 113.547 -1.66 . . . . 0.0 110.559 -168.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 21' ' ' ASN . . . . . 0.685 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 1.2 t-20 -88.12 89.05 7.84 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 113.571 -1.65 . . . . 0.0 108.314 -172.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 22' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -120.42 -42.2 2.57 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -163.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 178.53 -88.63 0.07 OUTLIER Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 119.455 -1.355 . . . . 0.0 113.032 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 24' ' ' LYS . . . . . 0.782 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 53.6 tptt -50.79 -63.55 1.09 Allowed 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.246 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -127.69 162.57 21.58 Favored Glycine 0 N--CA 1.431 -1.67 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.315 171.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 26' ' ' LYS . . . . . 0.703 ' CD ' ' HB3' ' D' ' 41' ' ' SER . 0.1 OUTLIER -149.7 160.61 43.39 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.832 -0.684 . . . . 0.0 110.979 -169.165 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 27' ' ' LEU . . . . . 0.993 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 55.3 tp -138.47 143.73 39.74 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.153 0.501 . . . . 0.0 111.226 -178.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 28' ' ' SER . . . . . 0.62 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 29.5 t -130.39 136.77 49.41 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -177.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 29' ' ' LEU . . . . . 0.651 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 14.5 mt -132.48 135.28 45.91 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.302 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 61.2 m -142.2 -171.96 3.49 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.039 176.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -139.59 160.39 39.97 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.037 0.446 . . . . 0.0 110.236 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 32' ' ' ASN . . . . . 0.488 ' HB3' ' HB2' ' D' ' 35' ' ' GLN . 24.6 t-20 -139.84 88.07 2.21 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.22 -107.88 2.31 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.823 -169.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -108.4 26.87 9.95 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 122.505 -0.409 . . . . 0.0 110.521 174.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 35' ' ' GLN . . . . . 0.488 ' HB2' ' HB3' ' D' ' 32' ' ' ASN . 76.9 mt-30 -105.09 162.68 13.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.788 -178.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.779 ' HB2' ' HB2' ' D' ' 85' ' ' LYS . 0.9 OUTLIER -128.82 135.04 48.59 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.312 -178.935 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 37' ' ' LYS . . . . . 0.651 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 75.2 mmtt -129.76 111.43 12.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.052 -168.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 38' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -111.47 144.19 41.08 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.855 0.36 . . . . 0.0 111.067 175.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 39' ' ' THR . . . . . 0.62 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 16.2 p -147.42 135.88 21.75 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.353 177.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 40' ' ' SER . . . . . 0.677 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 30.4 p -109.4 129.99 55.52 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 41' ' ' SER . . . . . 0.703 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 47.4 t -95.58 148.94 21.98 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.121 -1.031 . . . . 0.0 109.337 177.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 42' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' D' ' 41' ' ' SER . 75.8 m-20 80.19 -1.64 2.0 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.389 -168.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 49.38 61.88 2.91 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 169.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.3 1.33 7.89 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 118.517 -1.801 . . . . 0.0 115.387 170.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 45' ' ' TYR . . . . . 0.782 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 1.5 m-30 -86.05 154.15 21.62 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 116.946 0.373 . . . . 0.0 110.333 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 46' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -102.33 -153.34 24.93 Favored Glycine 0 C--O 1.219 -0.827 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 178.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 47' ' ' ILE . . . . . 0.961 HG13 ' HB2' ' D' ' 68' ' ' GLU . 2.7 mp -49.04 -58.42 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 CA-C-O 122.428 1.109 . . . . 0.0 108.833 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.511 ' HA ' ' HG2' ' D' ' 24' ' ' LYS . 36.3 t 152.83 -95.28 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 110.593 -3.003 . . . . 0.0 106.544 -174.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 49' ' ' TYR . . . . . 0.466 ' HD1' ' C ' ' D' ' 48' ' ' SER . 3.7 m-30 -130.21 75.57 1.66 Allowed 'General case' 0 N--CA 1.465 0.304 0 O-C-N 122.228 -0.295 . . . . 0.0 111.047 169.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 50' ' ' GLU . . . . . 0.54 ' HB2' HG21 ' D' ' 47' ' ' ILE . 50.4 mt-10 -156.81 -175.63 5.53 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.348 0.259 . . . . 0.0 110.491 176.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 51' ' ' ASP . . . . . 0.704 ' HB2' ' HD2' ' D' ' 69' ' ' LYS . 7.0 p-10 -130.7 141.59 50.4 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.062 172.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 52' ' ' LYS . . . . . 0.767 ' HD3' HG12 ' D' ' 47' ' ' ILE . 0.7 OUTLIER -145.28 136.07 24.52 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.213 -177.136 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -113.82 139.04 49.47 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.173 170.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 54' ' ' TRP . . . . . 1.091 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 0.9 OUTLIER -126.71 157.01 40.19 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -172.176 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -143.23 158.08 27.13 Favored Glycine 0 N--CA 1.437 -1.298 0 C-N-CA 120.133 -1.032 . . . . 0.0 113.299 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 56' ' ' ILE . . . . . 1.024 HG12 HG23 ' D' ' 91' ' ' ILE . 91.7 mt -129.13 97.24 3.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 113.289 -1.456 . . . . 0.0 107.459 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 57' ' ' PHE . . . . . 0.578 ' HA ' ' O ' ' D' ' 61' ' ' GLU . 14.2 m-85 -100.15 103.25 14.73 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -171.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.796 HG12 HG12 ' D' ' 89' ' ' ILE . 3.8 m -95.55 99.95 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.648 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 59' ' ' ASN . . . . . 0.439 ' ND2' ' HB2' ' D' ' 88' ' ' TYR . 31.4 m120 57.93 62.9 1.92 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.692 -168.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.67 48.55 85.51 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 115.879 -0.6 . . . . 0.0 113.395 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 61' ' ' GLU . . . . . 0.578 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 5.4 tp10 -157.49 115.2 3.09 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 62' ' ' LYS . . . . . 0.489 ' HE2' ' OG1' ' D' ' 65' ' ' THR . 5.8 ttpm? -77.6 98.68 5.49 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 35.4 m -88.45 -11.5 10.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.48 -173.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 64' ' ' TYR . . . . . 0.549 ' HB3' HD12 ' D' ' 56' ' ' ILE . 16.9 t80 -150.42 136.6 18.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.835 0.35 . . . . 0.0 110.397 174.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.489 ' OG1' ' HE2' ' D' ' 62' ' ' LYS . 24.5 m -119.4 113.54 20.94 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.161 176.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 66' ' ' PHE . . . . . 0.535 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 10.3 p90 -123.89 159.15 30.3 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 173.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 67' ' ' ASN . . . . . 0.437 ' O ' HD11 ' D' ' 75' ' ' ILE . 13.1 p30 -131.51 137.77 48.66 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 68' ' ' GLU . . . . . 0.961 ' HB2' HG13 ' D' ' 47' ' ' ILE . 37.5 mt-10 -62.18 -16.41 52.81 Favored 'General case' 0 C--N 1.345 0.395 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -174.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.704 ' HD2' ' HB2' ' D' ' 51' ' ' ASP . 5.6 mtpm? -57.98 -47.14 83.88 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.17 174.013 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 31.7 t -66.66 114.06 5.29 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 166.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 59.2 p -53.32 124.85 15.79 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.418 -173.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 72' ' ' VAL . . . . . 0.488 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -53.2 -13.01 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.756 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 73' ' ' GLY . . . . . 0.677 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -70.36 -57.48 6.72 Favored Glycine 0 N--CA 1.436 -1.359 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.261 169.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -69.71 -18.46 63.54 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.51 -0.345 . . . . 0.0 111.016 178.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 75' ' ' ILE . . . . . 0.616 ' O ' HG13 ' D' ' 79' ' ' ILE . 73.7 mt -71.74 -42.47 70.54 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.388 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.032 173.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 40.3 t -72.9 -22.69 60.7 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.434 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -60.48 -30.1 69.48 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 167.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 78' ' ' ASP . . . . . 1.049 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 50.2 m-20 -87.52 -31.83 19.72 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.585 176.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 79' ' ' ILE . . . . . 0.616 HG13 ' O ' ' D' ' 75' ' ' ILE . 31.1 mt -71.88 -16.78 18.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.137 -177.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -67.64 -40.7 84.56 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.922 173.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 81' ' ' LYS . . . . . 1.049 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -81.35 -53.59 6.2 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.837 176.592 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 82' ' ' LEU . . . . . 0.503 HD23 ' O ' ' D' ' 78' ' ' ASP . 4.0 mm? -53.08 -26.58 16.66 Favored 'General case' 0 C--O 1.227 -0.098 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 39.14 67.91 0.4 Allowed 'General case' 0 N--CA 1.474 0.761 0 O-C-N 123.998 0.811 . . . . 0.0 111.236 176.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 84' ' ' ILE . . . . . 0.979 HG21 HG21 ' D' ' 56' ' ' ILE . 46.3 mm -84.43 98.49 5.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.835 -173.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 85' ' ' LYS . . . . . 0.779 ' HB2' ' HB2' ' D' ' 36' ' ' LEU . 10.0 tmtt? -145.39 95.42 2.66 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.354 0.597 . . . . 0.0 109.532 177.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 86' ' ' GLY . . . . . 0.985 ' H ' HD11 ' D' ' 89' ' ' ILE . . . 77.13 158.79 9.58 Favored Glycine 0 CA--C 1.498 -1.007 0 CA-C-N 115.473 -0.785 . . . . 0.0 114.147 178.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 87' ' ' PRO . . . . . 0.76 ' O ' ' HB ' ' D' ' 58' ' ' VAL . 90.4 Cg_endo -80.66 -176.99 18.97 Favored 'Cis proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.355 -1.935 . . . . 0.0 113.3 0.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 88' ' ' TYR . . . . . 0.656 ' H ' ' HD1' ' D' ' 88' ' ' TYR . 1.7 m-85 -11.36 96.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.943 1.297 . . . . 0.0 114.03 -175.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.985 HD11 ' H ' ' D' ' 86' ' ' GLY . 41.0 mt -92.79 143.58 11.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -173.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -130.39 91.52 3.11 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.65 173.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 91' ' ' ILE . . . . . 1.091 HG22 ' HZ3' ' D' ' 54' ' ' TRP . 2.5 mt -96.91 117.73 42.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -176.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 92' ' ' LYS . . . . . 0.755 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.1 OUTLIER -162.91 173.37 13.77 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.464 0.306 . . . . 0.0 110.929 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 93' ' ' GLN . . . . . 0.669 ' O ' ' HD3' ' D' ' 92' ' ' LYS . 19.8 pt20 -87.03 156.89 19.57 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.33 173.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 94' ' ' ILE . . . . . 0.755 HG22 ' HE2' ' D' ' 92' ' ' LYS . 5.5 pt . . . . . 0 C--N 1.313 -1.02 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.397 -169.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 120.734 0.302 . . . . 0.0 110.583 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' D' D ' 2' ' ' ASN . . . . . 0.562 ' HB3' ' HA ' ' D' ' 5' ' ' ALA . 76.5 m-20 -101.7 80.06 2.0 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.923 178.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -77.84 -24.62 48.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.524 0.678 . . . . 0.0 109.183 175.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -90.54 -11.88 38.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.809 174.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 5' ' ' ALA . . . . . 0.562 ' HA ' ' HB3' ' D' ' 2' ' ' ASN . . . 72.4 151.77 0.11 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 114.843 -1.072 . . . . 0.0 110.882 -173.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 6' ' ' LEU . . . . . 0.749 ' O ' HD23 ' D' ' 6' ' ' LEU . 7.6 tt -110.46 1.78 18.49 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.929 0.871 . . . . 0.0 108.89 -174.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 7' ' ' GLU . . . . . 0.544 ' HA ' ' HB3' ' D' ' 10' ' ' MET . 88.6 tt0 -47.64 -37.87 13.63 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -176.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.671 ' HA ' ' HB3' ' D' ' 12' ' ' SER . 8.4 pm0 -59.28 -50.64 73.2 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -175.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -91.09 16.07 10.42 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.264 174.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 10' ' ' MET . . . . . 0.544 ' HB3' ' HA ' ' D' ' 7' ' ' GLU . 16.1 tpt -103.8 -75.67 0.61 Allowed 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.551 178.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -104.14 -39.45 6.53 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-O 120.867 0.365 . . . . 0.0 111.149 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 12' ' ' SER . . . . . 0.671 ' HB3' ' HA ' ' D' ' 8' ' ' GLU . 40.9 t -44.19 -68.63 0.18 Allowed 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.244 -1.344 . . . . 0.0 112.133 -167.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.646 ' O ' HG12 ' D' ' 16' ' ' VAL . 52.0 mt -91.1 -9.28 10.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.747 -175.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 14' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' D' ' 10' ' ' MET . 60.0 m-20 -88.08 -52.59 5.16 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.885 176.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 15' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' D' ' 18' ' ' ASP . 51.1 m -65.41 -21.61 66.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.488 174.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 16' ' ' VAL . . . . . 0.8 ' HA ' ' HE2' ' D' ' 19' ' ' LYS . 0.7 OUTLIER -59.12 -31.9 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.814 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 17' ' ' ASN . . . . . 0.603 ' OD1' ' HA ' ' D' ' 28' ' ' SER . 79.9 m-20 -85.06 -18.6 33.84 Favored 'General case' 0 C--O 1.205 -1.246 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.849 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 18' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' D' ' 15' ' ' SER . 73.7 m-20 -67.88 -16.36 64.05 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 122.304 -0.248 . . . . 0.0 111.599 176.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.8 ' HE2' ' HA ' ' D' ' 16' ' ' VAL . 0.0 OUTLIER -90.43 -39.83 12.41 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-O 121.987 0.899 . . . . 0.0 108.953 174.183 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 20' ' ' LEU . . . . . 0.913 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 78.3 mt -74.09 -40.17 62.91 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 113.628 -1.624 . . . . 0.0 110.107 -174.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 21' ' ' ASN . . . . . 0.543 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 44.9 m-20 -78.14 95.7 4.99 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.688 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 22' ' ' LYS . . . . . 0.779 ' HD2' HD12 ' D' ' 47' ' ' ILE . 67.6 mttm -122.58 -41.12 2.4 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -176.077 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.56 -103.16 0.18 Allowed Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 119.161 -1.495 . . . . 0.0 113.351 -177.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 24' ' ' LYS . . . . . 0.842 ' HE2' ' HA ' ' D' ' 48' ' ' SER . 32.8 ttpt -49.5 -44.06 45.83 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.62 0.724 . . . . 0.0 110.362 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 25' ' ' GLY . . . . . 0.645 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -139.8 154.45 23.77 Favored Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 114.548 -1.205 . . . . 0.0 112.132 174.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 26' ' ' LYS . . . . . 0.649 ' HD2' ' HB3' ' D' ' 41' ' ' SER . 0.3 OUTLIER -150.67 160.42 43.84 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.331 -0.934 . . . . 0.0 110.518 -171.038 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 27' ' ' LEU . . . . . 0.913 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 41.6 tp -132.13 144.62 50.83 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.14 0.495 . . . . 0.0 111.392 177.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 28' ' ' SER . . . . . 0.603 ' HA ' ' OD1' ' D' ' 17' ' ' ASN . 9.1 t -131.32 136.42 48.1 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 29' ' ' LEU . . . . . 0.415 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 18.3 mt -127.19 157.94 38.43 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.384 -0.527 . . . . 0.0 110.53 -179.118 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 34.7 t -160.45 174.53 13.96 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 59.2 mtt -133.83 163.33 29.73 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.108 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 32' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' D' ' 35' ' ' GLN . 50.3 t30 -136.95 86.87 2.24 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.714 172.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.03 -108.26 2.51 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.553 -169.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 34' ' ' ASN . . . . . 0.445 ' O ' ' HE3' ' D' ' 85' ' ' LYS . 75.3 m-80 -107.11 31.76 5.12 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.586 0.707 . . . . 0.0 109.96 174.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 35' ' ' GLN . . . . . 0.474 ' HA ' ' OE1' ' D' ' 35' ' ' GLN . 6.5 mm-40 -99.9 164.48 11.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.823 -1.081 . . . . 0.0 113.263 -177.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.693 HD11 HG22 ' D' ' 79' ' ' ILE . 2.7 tm? -132.8 125.6 30.46 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.637 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 37' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 27.9 mmmt -131.2 103.06 6.27 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.768 -170.07 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 38' ' ' ALA . . . . . 0.479 ' HB1' HD11 ' D' ' 27' ' ' LEU . . . -108.57 146.39 33.38 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.403 0.62 . . . . 0.0 112.289 -176.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 39' ' ' THR . . . . . 0.44 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 14.3 p -146.32 130.37 17.36 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.17 175.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 40' ' ' SER . . . . . 0.791 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 69.2 p -108.3 135.06 50.25 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 176.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 41' ' ' SER . . . . . 0.649 ' HB3' ' HD2' ' D' ' 26' ' ' LYS . 39.1 t -96.28 147.89 23.31 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.169 -1.012 . . . . 0.0 109.676 -178.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 42' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' D' ' 41' ' ' SER . 73.0 m-80 80.6 2.99 1.8 Allowed 'General case' 0 N--CA 1.468 0.472 0 O-C-N 124.569 1.168 . . . . 0.0 110.161 -170.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 47.28 55.5 8.1 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 171.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 44' ' ' GLY . . . . . 0.784 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 117.62 35.88 1.04 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 119.477 -1.344 . . . . 0.0 113.845 172.08 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 45' ' ' TYR . . . . . 0.799 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 1.8 m-85 -119.25 149.71 41.31 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 173.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 46' ' ' GLY . . . . . 0.616 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -93.61 179.7 38.82 Favored Glycine 0 C--O 1.221 -0.71 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 176.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 47' ' ' ILE . . . . . 0.874 HG12 ' HB3' ' D' ' 68' ' ' GLU . 32.6 mm -46.72 -57.01 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.798 0 CA-C-N 118.026 0.913 . . . . 0.0 110.28 -178.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.842 ' HA ' ' HE2' ' D' ' 24' ' ' LYS . 67.5 p -175.67 -118.39 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 113.354 -1.748 . . . . 0.0 108.683 -177.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 49' ' ' TYR . . . . . 0.414 ' N ' ' CD1' ' D' ' 49' ' ' TYR . 0.2 OUTLIER -113.72 75.56 0.93 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 168.199 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 50' ' ' GLU . . . . . 0.604 ' HB3' ' HE2' ' D' ' 52' ' ' LYS . 68.3 mm-40 -131.81 -175.89 3.87 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.834 -175.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 51' ' ' ASP . . . . . 0.654 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 1.1 m-20 -140.36 128.89 22.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.487 169.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 52' ' ' LYS . . . . . 0.654 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 3.9 mptp? -141.56 136.42 31.09 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.504 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 45.2 m-20 -112.01 126.98 55.73 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 175.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 54' ' ' TRP . . . . . 1.126 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 1.3 m95 -115.47 161.63 18.31 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -174.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -150.07 163.45 29.45 Favored Glycine 0 N--CA 1.435 -1.412 0 CA-C-N 114.566 -1.197 . . . . 0.0 112.556 172.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 56' ' ' ILE . . . . . 1.078 HG12 HG23 ' D' ' 91' ' ' ILE . 76.6 mt -134.75 109.58 11.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 -179.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 57' ' ' PHE . . . . . 0.629 ' HB2' ' HB3' ' D' ' 90' ' ' GLU . 8.3 m-85 -111.63 105.9 14.57 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.879 -165.12 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.841 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 54.7 t -88.67 112.31 23.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.277 172.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 7.0 m120 51.18 50.75 18.39 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.421 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.49 48.44 78.17 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.535 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 61' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 43.1 tt0 -150.88 111.24 4.18 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 62' ' ' LYS . . . . . 0.452 ' NZ ' ' HB3' ' D' ' 62' ' ' LYS . 6.3 ttpm? -73.65 103.01 4.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.972 0.415 . . . . 0.0 110.048 -177.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 29.0 m -79.57 -25.65 12.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.303 -174.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 64' ' ' TYR . . . . . 0.444 ' HB3' HD12 ' D' ' 56' ' ' ILE . 14.9 t80 -149.74 147.4 28.0 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.064 -178.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 59.4 m -125.28 121.17 33.24 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.482 175.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 66' ' ' PHE . . . . . 0.614 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 19.5 p90 -127.49 149.88 49.92 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 174.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 67' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' D' ' 52' ' ' LYS . 54.4 m-20 -111.47 145.3 39.25 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -178.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 68' ' ' GLU . . . . . 0.874 ' HB3' HG12 ' D' ' 47' ' ' ILE . 51.3 mm-40 -74.88 -9.3 58.41 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.612 176.03 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.475 ' HG2' ' HA ' ' D' ' 51' ' ' ASP . 23.5 mtpp -59.14 -54.35 48.0 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 113.538 -1.664 . . . . 0.0 108.102 165.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 39.8 m -66.79 119.58 12.08 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 112.91 -1.95 . . . . 0.0 109.088 174.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 82.8 p -47.56 121.24 3.82 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.978 -177.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 72' ' ' VAL . . . . . 0.616 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -57.27 -12.38 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 120.994 0.426 . . . . 0.0 110.872 -178.75 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 73' ' ' GLY . . . . . 0.791 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -69.15 -65.61 2.55 Favored Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 115.215 -0.902 . . . . 0.0 113.185 172.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -62.72 -23.74 67.32 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 120.662 0.267 . . . . 0.0 110.89 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 75' ' ' ILE . . . . . 0.515 ' O ' HG12 ' D' ' 79' ' ' ILE . 35.9 mm -77.47 -39.96 28.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.594 176.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 76' ' ' SER . . . . . 0.698 ' HA ' HG12 ' D' ' 79' ' ' ILE . 30.9 t -73.61 -19.88 60.75 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.963 178.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -65.6 -29.77 70.41 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 168.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 78' ' ' ASP . . . . . 1.051 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 1.0 OUTLIER -84.22 -28.72 27.08 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.734 174.92 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 79' ' ' ILE . . . . . 0.698 HG12 ' HA ' ' D' ' 76' ' ' SER . 17.5 mm -66.88 -19.84 26.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.657 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -69.17 -39.7 78.58 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.322 176.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 81' ' ' LYS . . . . . 1.051 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -80.24 -53.76 6.36 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.888 176.679 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 82' ' ' LEU . . . . . 0.604 HD23 ' O ' ' D' ' 78' ' ' ASP . 4.0 mm? -48.71 -29.24 4.23 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 39.54 73.61 0.11 Allowed 'General case' 0 N--CA 1.472 0.671 0 O-C-N 124.016 0.823 . . . . 0.0 111.464 172.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 84' ' ' ILE . . . . . 0.817 HG12 HD13 ' D' ' 56' ' ' ILE . 2.1 mp -66.84 105.19 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.33 -176.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 85' ' ' LYS . . . . . 0.445 ' HE3' ' O ' ' D' ' 34' ' ' ASN . 48.6 mtpt -108.19 178.71 4.42 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.911 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 86' ' ' GLY . . . . . 0.715 ' HA2' HD11 ' D' ' 89' ' ' ILE . . . -80.09 -178.37 51.65 Favored Glycine 0 CA--C 1.504 -0.604 0 C-N-CA 121.146 -0.549 . . . . 0.0 113.39 -179.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 87' ' ' PRO . . . . . 0.678 ' O ' HG13 ' D' ' 58' ' ' VAL . 42.8 Cg_endo -93.67 -179.79 9.47 Favored 'Cis proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.887 -1.714 . . . . 0.0 114.101 -0.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 88' ' ' TYR . . . . . 0.841 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 1.7 m-85 43.85 91.12 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.881 0.873 . . . . 0.0 112.074 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.715 HD11 ' HA2' ' D' ' 86' ' ' GLY . 4.0 mp -111.27 127.26 68.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.295 0.569 . . . . 0.0 110.533 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.629 ' HB3' ' HB2' ' D' ' 57' ' ' PHE . 42.0 tt0 -126.55 92.05 3.48 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.187 177.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 91' ' ' ILE . . . . . 1.126 HG22 ' HZ3' ' D' ' 54' ' ' TRP . 3.2 mt -100.22 109.13 24.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 92' ' ' LYS . . . . . 0.71 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -162.25 167.53 23.83 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.873 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 93' ' ' GLN . . . . . 0.609 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 25.4 pt20 -82.44 160.19 22.77 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 119.125 -1.03 . . . . 0.0 110.567 175.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 94' ' ' ILE . . . . . 0.71 HG22 ' HE2' ' D' ' 92' ' ' LYS . 10.0 pt . . . . . 0 C--N 1.305 -1.338 0 CA-C-N 114.118 -1.401 . . . . 0.0 111.384 -168.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 120.558 0.218 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' D' D ' 2' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -121.66 4.96 10.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.928 0.394 . . . . 0.0 110.495 177.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -90.91 0.11 57.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.162 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 4' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' D' ' 4' ' ' LYS . 38.0 ttpt -104.34 18.58 21.85 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.38 116.55 4.74 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.409 -176.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 6' ' ' LEU . . . . . 0.863 HD23 ' H ' ' D' ' 6' ' ' LEU . 1.7 pt? -97.26 26.23 4.97 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.421 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -71.23 -3.61 21.2 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -173.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.573 ' O ' ' HB3' ' D' ' 12' ' ' SER . 9.3 pt-20 -61.03 -51.45 69.16 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -171.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 9' ' ' GLN . . . . . 0.441 ' H ' ' CD ' ' D' ' 9' ' ' GLN . 3.2 pm0 -91.75 15.45 12.78 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.576 176.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 10' ' ' MET . . . . . . . . . . . . . 93.8 mmm -105.22 -75.7 0.62 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.181 -178.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -102.97 -38.6 7.28 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.093 174.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 12' ' ' SER . . . . . 0.641 ' O ' ' HB ' ' D' ' 16' ' ' VAL . 42.4 t -44.61 -61.73 1.45 Allowed 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.452 -1.249 . . . . 0.0 112.272 -167.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.461 ' C ' HG12 ' D' ' 16' ' ' VAL . 36.7 mm -90.88 -8.64 10.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.991 -174.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 -95.19 -62.53 1.29 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.071 177.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 15' ' ' SER . . . . . 0.549 ' HA ' ' OD2' ' D' ' 18' ' ' ASP . 90.5 p -64.69 -21.45 66.75 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 120.971 -0.291 . . . . 0.0 110.531 -179.038 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 16' ' ' VAL . . . . . 0.641 ' HB ' ' O ' ' D' ' 12' ' ' SER . 14.8 p -52.99 -35.93 23.16 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 CA-C-O 120.918 0.39 . . . . 0.0 110.251 176.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 46.9 m-20 -68.51 -41.74 79.54 Favored 'General case' 0 C--O 1.21 -1.009 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.777 177.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 18' ' ' ASP . . . . . 0.549 ' OD2' ' HA ' ' D' ' 15' ' ' SER . 55.0 m-20 -58.64 -16.58 16.74 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -177.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.671 ' O ' ' HE3' ' D' ' 22' ' ' LYS . 0.0 OUTLIER -91.83 -52.64 4.64 Favored 'General case' 0 CA--C 1.488 -1.42 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 172.37 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 20' ' ' LEU . . . . . 0.964 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 75.8 mt -57.39 -34.95 69.41 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.031 -1.441 . . . . 0.0 110.78 -177.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 21' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 -77.4 97.1 4.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.223 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 22' ' ' LYS . . . . . 0.671 ' HE3' ' O ' ' D' ' 19' ' ' LYS . 88.5 mttt -121.73 -40.91 2.5 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 -172.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.23 -88.6 0.11 Allowed Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 119.477 -1.344 . . . . 0.0 113.315 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 24' ' ' LYS . . . . . 0.72 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 52.1 tptt -49.84 -54.03 21.87 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 25' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -139.14 155.82 24.12 Favored Glycine 0 N--CA 1.429 -1.792 0 CA-C-N 114.264 -1.334 . . . . 0.0 110.943 174.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 26' ' ' LYS . . . . . 0.698 ' HG3' ' HB3' ' D' ' 41' ' ' SER . 9.2 ptpt -149.99 160.83 43.32 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.301 -0.95 . . . . 0.0 110.167 -169.011 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 27' ' ' LEU . . . . . 0.964 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 52.2 tp -135.19 147.29 49.33 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.188 0.518 . . . . 0.0 111.932 -176.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 28' ' ' SER . . . . . 0.596 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 22.9 t -139.79 153.32 47.09 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 29' ' ' LEU . . . . . 0.516 HD11 ' CD1' ' D' ' 20' ' ' LEU . 0.2 OUTLIER -141.27 133.97 28.68 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.914 177.987 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 54.1 p -133.54 -171.39 2.7 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.719 175.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 21.6 ptp -148.89 166.3 28.98 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.388 0.614 . . . . 0.0 111.466 -176.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 32' ' ' ASN . . . . . 0.471 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 22.8 t-20 -144.54 88.01 1.9 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.458 177.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.85 -108.7 2.57 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.216 -171.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -100.31 9.93 41.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.841 0.353 . . . . 0.0 110.873 176.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 35' ' ' GLN . . . . . 0.471 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 3.6 tp60 -90.82 158.24 16.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.832 0.349 . . . . 0.0 110.48 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.689 HD11 HG22 ' D' ' 79' ' ' ILE . 2.5 tm? -124.92 137.39 54.27 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.62 176.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 37' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 34.3 mmtp -130.94 115.34 16.39 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.93 -171.018 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -115.28 152.5 32.63 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.939 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 39' ' ' THR . . . . . 0.596 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 17.2 p -145.92 135.24 22.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.737 -1.119 . . . . 0.0 111.123 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 40' ' ' SER . . . . . 0.653 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 27.0 p -108.75 133.72 52.43 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 170.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 41' ' ' SER . . . . . 0.698 ' HB3' ' HG3' ' D' ' 26' ' ' LYS . 34.0 t -95.5 147.06 23.95 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 118.97 -1.092 . . . . 0.0 109.222 178.041 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 42' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' D' ' 41' ' ' SER . 75.1 m-80 80.45 -3.11 1.9 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.188 -168.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.66 62.8 2.28 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 168.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.17 -1.47 8.32 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 118.508 -1.806 . . . . 0.0 115.011 170.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 45' ' ' TYR . . . . . 0.72 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 1.4 m-30 -89.91 152.12 21.39 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 120.617 0.246 . . . . 0.0 110.808 -176.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 46' ' ' GLY . . . . . 0.589 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -95.24 -158.67 32.88 Favored Glycine 0 C--O 1.217 -0.952 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 174.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 47' ' ' ILE . . . . . 0.898 HG13 ' HB3' ' D' ' 68' ' ' GLU . 0.4 OUTLIER -55.42 -49.13 75.35 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 CA-C-O 122.597 1.189 . . . . 0.0 108.518 176.163 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 34.0 t 168.0 -119.77 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 111.305 -2.679 . . . . 0.0 105.422 -175.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -109.34 78.33 1.12 Allowed 'General case' 0 C--N 1.318 -0.775 0 O-C-N 121.771 -0.581 . . . . 0.0 109.679 163.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 50' ' ' GLU . . . . . 0.621 ' HB3' ' HE3' ' D' ' 52' ' ' LYS . 52.0 mt-10 -143.37 171.68 13.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.749 -177.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 51' ' ' ASP . . . . . 0.692 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 2.4 m-20 -131.42 135.68 47.37 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.534 176.075 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 52' ' ' LYS . . . . . 0.768 ' HD3' HG12 ' D' ' 47' ' ' ILE . 0.1 OUTLIER -144.96 157.19 44.22 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 123.035 0.534 . . . . 0.0 110.45 -178.029 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -120.98 134.26 55.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.301 175.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 54' ' ' TRP . . . . . 1.02 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 0.3 OUTLIER -126.43 160.62 29.98 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.205 -178.516 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -150.27 160.31 28.49 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.113 -1.041 . . . . 0.0 114.061 176.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 56' ' ' ILE . . . . . 1.001 HG12 HG23 ' D' ' 91' ' ' ILE . 73.0 mt -130.68 113.77 25.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 176.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 57' ' ' PHE . . . . . 0.629 ' HD2' ' O ' ' D' ' 90' ' ' GLU . 17.1 m-85 -108.39 105.1 14.63 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 119.688 -0.805 . . . . 0.0 111.248 -167.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.839 HG22 HG12 ' D' ' 89' ' ' ILE . 90.2 t -97.88 109.56 23.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.283 176.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 5.6 m120 55.84 39.92 30.65 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.253 178.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.97 -31.07 8.85 Favored Glycine 0 CA--C 1.508 -0.37 0 C-N-CA 120.159 -1.019 . . . . 0.0 112.771 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -88.76 126.18 35.22 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.162 -0.519 . . . . 0.0 111.032 -176.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -71.98 98.17 2.01 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 174.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 11.3 p -76.36 -27.37 17.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.823 -168.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 64' ' ' TYR . . . . . 0.442 ' HB3' HD12 ' D' ' 56' ' ' ILE . 15.4 t80 -145.75 128.56 16.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.722 177.149 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 31.3 m -109.82 105.21 14.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.062 176.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 66' ' ' PHE . . . . . 0.426 ' HB3' ' CE2' ' D' ' 64' ' ' TYR . 10.0 p90 -111.48 158.79 18.73 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 67' ' ' ASN . . . . . 0.584 ' O ' HD11 ' D' ' 75' ' ' ILE . 5.3 m120 -128.9 143.09 50.79 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -172.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 68' ' ' GLU . . . . . 0.898 ' HB3' HG13 ' D' ' 47' ' ' ILE . 53.6 mm-40 -64.2 -21.0 66.4 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 174.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.509 ' HE3' ' OD2' ' D' ' 51' ' ' ASP . 48.2 mtpt -51.17 -54.46 25.22 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.102 171.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 18.0 m -65.44 120.14 12.3 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 112.118 -2.31 . . . . 0.0 108.4 170.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 70.3 p -52.9 122.74 9.83 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.234 -178.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 72' ' ' VAL . . . . . 0.646 ' HA ' HD12 ' D' ' 75' ' ' ILE . 0.1 OUTLIER -54.72 -12.23 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 120.924 0.392 . . . . 0.0 111.997 -175.432 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 73' ' ' GLY . . . . . 0.653 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -73.57 -56.46 5.51 Favored Glycine 0 N--CA 1.437 -1.27 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.656 170.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 74' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' D' ' 77' ' ' ASN . 29.6 t-20 -66.3 -19.68 65.88 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 75' ' ' ILE . . . . . 0.646 HD12 ' HA ' ' D' ' 72' ' ' VAL . 74.4 mt -71.78 -41.21 70.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.17 173.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 30.7 t -72.8 -19.54 61.32 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.696 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 77' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' D' ' 74' ' ' ASN . 65.3 m-20 -61.15 -30.9 70.67 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 168.116 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 78' ' ' ASP . . . . . 1.146 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 1.0 OUTLIER -86.4 -40.91 14.92 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 114.825 -1.079 . . . . 0.0 112.936 177.877 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 79' ' ' ILE . . . . . 0.689 HG22 HD11 ' D' ' 36' ' ' LEU . 33.9 mt -63.53 -24.9 37.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 O-C-N 121.433 -0.792 . . . . 0.0 111.536 -171.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -71.39 -31.18 66.98 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 81' ' ' LYS . . . . . 1.146 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -81.11 -47.4 13.56 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.33 175.271 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 82' ' ' LEU . . . . . 0.628 HD23 ' O ' ' D' ' 78' ' ' ASP . 4.0 mm? -51.01 -26.93 6.74 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 50.31 71.03 0.44 Allowed 'General case' 0 N--CA 1.473 0.687 0 O-C-N 123.588 0.555 . . . . 0.0 110.636 176.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 84' ' ' ILE . . . . . 0.476 ' HB ' ' HG ' ' D' ' 36' ' ' LEU . 44.4 mm -78.23 96.36 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.97 -175.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 85' ' ' LYS . . . . . 0.602 ' HG2' ' HB2' ' D' ' 36' ' ' LEU . 28.4 mmmt -153.79 92.64 1.58 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.496 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.3 154.86 0.08 OUTLIER Glycine 0 C--N 1.331 0.287 0 N-CA-C 114.547 0.579 . . . . 0.0 114.547 174.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 87' ' ' PRO . . . . . 0.587 ' O ' HG13 ' D' ' 58' ' ' VAL . 76.5 Cg_endo -90.45 -178.26 11.17 Favored 'Cis proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.493 -1.461 . . . . 0.0 112.268 -0.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 88' ' ' TYR . . . . . 0.728 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 1.7 m-85 7.71 92.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 125.32 1.448 . . . . 0.0 113.773 -177.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.839 HG12 HG22 ' D' ' 58' ' ' VAL . 71.6 mt -110.95 136.62 46.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.211 0.529 . . . . 0.0 112.24 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.629 ' O ' ' HD2' ' D' ' 57' ' ' PHE . 39.3 tt0 -128.36 95.81 4.26 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.846 175.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 91' ' ' ILE . . . . . 1.02 HG22 ' HZ3' ' D' ' 54' ' ' TRP . 6.5 mt -96.37 108.82 21.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -177.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 92' ' ' LYS . . . . . 0.662 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -161.0 169.97 21.48 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 177.906 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 93' ' ' GLN . . . . . 0.682 ' HB3' ' NE1' ' D' ' 54' ' ' TRP . 17.4 pt20 -85.24 163.36 18.7 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.399 177.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 94' ' ' ILE . . . . . 0.662 HG22 ' HE2' ' D' ' 92' ' ' LYS . 9.3 pt . . . . . 0 C--N 1.31 -1.145 0 CA-C-N 114.197 -1.365 . . . . 0.0 111.311 -167.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 39.2 t70 . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 120.688 0.28 . . . . 0.0 110.77 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' D' D ' 2' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 58.27 61.53 2.27 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.311 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -79.02 -15.78 57.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.011 0.434 . . . . 0.0 110.483 176.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -103.55 -36.83 7.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.649 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 5' ' ' ALA . . . . . . . . . . . . . . . 75.61 -45.33 0.54 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.512 0.725 . . . . 0.0 111.659 -177.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 6' ' ' LEU . . . . . 0.424 ' N ' HD12 ' D' ' 6' ' ' LEU . 5.8 mp -75.07 9.9 1.75 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.769 0.319 . . . . 0.0 111.338 177.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -73.83 -11.24 60.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.169 0.509 . . . . 0.0 110.749 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.556 ' HA ' ' CB ' ' D' ' 12' ' ' SER . 18.2 pt-20 -72.74 -15.8 61.66 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.806 176.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 9' ' ' GLN . . . . . 0.487 ' OE1' ' HG3' ' D' ' 8' ' ' GLU . 21.0 mm100 -97.65 4.96 49.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.001 -177.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 10' ' ' MET . . . . . . . . . . . . . 27.9 ttt -105.21 -79.64 0.55 Allowed 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 119.455 -0.898 . . . . 0.0 112.173 -172.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -104.59 -33.54 8.49 Favored 'General case' 0 C--O 1.203 -1.365 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 12' ' ' SER . . . . . 0.556 ' CB ' ' HA ' ' D' ' 8' ' ' GLU . 46.4 t -23.08 -68.47 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 -170.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.404 ' O ' HG12 ' D' ' 16' ' ' VAL . 64.2 mt -73.4 -7.8 10.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 122.103 0.954 . . . . 0.0 111.463 -173.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -95.93 -45.65 6.85 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.656 -1.157 . . . . 0.0 110.053 172.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 15' ' ' SER . . . . . 0.529 ' O ' ' HB2' ' D' ' 18' ' ' ASP . 39.4 m -66.17 -25.44 66.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.794 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 16' ' ' VAL . . . . . 0.698 ' HA ' ' HE2' ' D' ' 19' ' ' LYS . 7.1 p -58.93 -33.72 50.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.057 0.456 . . . . 0.0 110.532 179.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 17' ' ' ASN . . . . . 0.556 ' O ' ' HB2' ' D' ' 21' ' ' ASN . 5.4 m120 -66.42 -41.46 89.18 Favored 'General case' 0 C--O 1.209 -1.043 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 176.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 18' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' D' ' 15' ' ' SER . 1.2 m-20 -59.72 -14.03 12.54 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 175.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.698 ' HE2' ' HA ' ' D' ' 16' ' ' VAL . 1.7 mppt? -90.55 -44.93 9.25 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.933 0.873 . . . . 0.0 109.881 175.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 20' ' ' LEU . . . . . 1.008 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 69.8 mt -85.89 -19.02 31.18 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 112.762 -2.017 . . . . 0.0 111.812 -169.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 21' ' ' ASN . . . . . 0.556 ' HB2' ' O ' ' D' ' 17' ' ' ASN . 1.4 t-20 -106.24 98.58 8.24 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.351 -0.84 . . . . 0.0 108.891 -169.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 22' ' ' LYS . . . . . 0.633 ' CE ' ' HA ' ' D' ' 47' ' ' ILE . 2.3 mppt? -119.94 -42.95 2.57 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 118.619 -1.232 . . . . 0.0 113.112 -168.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.19 -75.94 0.16 Allowed Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.147 -1.025 . . . . 0.0 112.598 -175.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 24' ' ' LYS . . . . . 0.785 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 53.0 tptt -52.13 -61.16 2.44 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 25' ' ' GLY . . . . . 0.548 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -137.97 157.67 24.39 Favored Glycine 0 N--CA 1.43 -1.712 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.93 174.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 26' ' ' LYS . . . . . 0.67 ' HA ' ' O ' ' D' ' 20' ' ' LEU . 9.1 ptpt -149.25 162.13 40.63 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.378 -0.911 . . . . 0.0 110.818 -167.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 27' ' ' LEU . . . . . 1.008 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 58.3 tp -136.51 136.83 39.7 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.24 0.543 . . . . 0.0 111.448 -177.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 28' ' ' SER . . . . . 0.629 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 53.9 m -124.44 142.18 51.51 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.334 -175.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 29' ' ' LEU . . . . . 0.843 HD11 HD12 ' D' ' 20' ' ' LEU . 0.1 OUTLIER -141.49 148.11 38.9 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 119.49 -0.884 . . . . 0.0 112.097 -176.233 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 50.4 m -154.33 -173.81 4.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.968 176.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 24.6 ptm -145.66 162.91 36.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.289 0.566 . . . . 0.0 111.197 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 32' ' ' ASN . . . . . 0.475 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 26.4 t-20 -141.8 88.58 2.13 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.057 178.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.59 -98.45 0.53 Allowed Glycine 0 CA--C 1.516 0.146 0 C-N-CA 120.256 -0.973 . . . . 0.0 111.853 -176.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -104.77 2.89 30.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.783 0.325 . . . . 0.0 110.346 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 35' ' ' GLN . . . . . 0.475 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 3.6 tp-100 -91.32 155.9 18.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.127 -174.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.737 HD11 HG22 ' D' ' 79' ' ' ILE . 1.9 tm? -124.38 137.65 54.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.366 173.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 37' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 12.8 mmmm -131.04 115.81 16.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.774 -169.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 38' ' ' ALA . . . . . 0.533 ' HB1' HD11 ' D' ' 27' ' ' LEU . . . -123.01 155.02 37.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.156 0.503 . . . . 0.0 111.559 177.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 39' ' ' THR . . . . . 0.629 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 2.4 p -150.77 139.4 20.64 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.903 -178.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 40' ' ' SER . . . . . 0.676 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 53.3 p -109.0 133.97 52.27 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 173.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 41' ' ' SER . . . . . 0.647 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 35.4 t -96.01 148.05 23.06 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.905 -1.118 . . . . 0.0 109.199 176.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 42' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' D' ' 41' ' ' SER . 75.1 m-80 80.09 -0.57 2.04 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.95 -168.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.17 60.54 3.36 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 170.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 44' ' ' GLY . . . . . 0.684 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 110.15 35.95 2.06 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.317 -1.42 . . . . 0.0 114.706 169.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 45' ' ' TYR . . . . . 0.785 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 1.3 m-85 -112.97 152.75 29.02 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 173.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -88.77 -153.81 27.59 Favored Glycine 0 C--O 1.219 -0.782 0 C-N-CA 121.124 -0.56 . . . . 0.0 111.991 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 47' ' ' ILE . . . . . 1.058 HG13 ' HB3' ' D' ' 68' ' ' GLU . 1.0 OUTLIER -57.38 -57.08 11.56 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 CA-C-O 122.338 1.066 . . . . 0.0 108.184 -179.479 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' D' ' 47' ' ' ILE . 23.1 t 169.56 -63.47 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 111.893 -2.412 . . . . 0.0 106.836 -178.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 49' ' ' TYR . . . . . 0.437 ' O ' ' HD1' ' D' ' 49' ' ' TYR . 0.2 OUTLIER -165.07 74.74 0.24 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 113.746 -1.57 . . . . 0.0 109.667 168.569 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 50' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' D' ' 69' ' ' LYS . 72.3 mm-40 -139.99 -158.92 0.9 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.049 -175.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 51' ' ' ASP . . . . . 0.51 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 1.1 t70 -152.39 124.37 8.01 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.615 173.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 52' ' ' LYS . . . . . 0.572 ' HB2' ' CG ' ' D' ' 68' ' ' GLU . 0.2 OUTLIER -141.15 120.01 12.66 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.528 178.672 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -93.4 129.06 39.68 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 174.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 54' ' ' TRP . . . . . 0.701 ' NE1' ' HB3' ' D' ' 93' ' ' GLN . 0.1 OUTLIER -114.87 153.18 30.94 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -171.267 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -132.57 156.16 21.93 Favored Glycine 0 N--CA 1.431 -1.685 0 C-N-CA 120.157 -1.021 . . . . 0.0 114.524 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 56' ' ' ILE . . . . . 0.814 HD13 HG12 ' D' ' 84' ' ' ILE . 65.4 mt -146.28 108.27 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 113.66 -1.27 . . . . 0.0 107.652 177.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 57' ' ' PHE . . . . . 0.869 ' HB2' ' HB3' ' D' ' 90' ' ' GLU . 7.4 m-30 -117.72 107.92 14.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.97 -169.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.767 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 53.2 t -97.04 117.15 41.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.684 173.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 54.5 m-20 62.37 43.46 8.13 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.258 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.4 -33.87 4.19 Favored Glycine 0 CA--C 1.508 -0.361 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.905 173.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 61' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 23.5 pt-20 -90.99 155.84 18.41 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.247 0.546 . . . . 0.0 111.479 -175.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 62' ' ' LYS . . . . . 0.501 ' HD2' ' OG1' ' D' ' 65' ' ' THR . 6.2 ttpm? -85.55 125.2 32.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.561 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.43 HG22 ' O ' ' D' ' 56' ' ' ILE . 25.6 m -104.57 -29.79 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -177.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 64' ' ' TYR . . . . . 0.433 ' HB3' HD12 ' D' ' 56' ' ' ILE . 17.4 t80 -153.21 147.33 25.59 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.863 0.363 . . . . 0.0 111.384 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.501 ' OG1' ' HD2' ' D' ' 62' ' ' LYS . 86.8 m -132.29 126.75 34.12 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.016 175.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 66' ' ' PHE . . . . . 0.566 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 14.0 p90 -130.44 155.08 47.01 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 175.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 67' ' ' ASN . . . . . 0.557 ' O ' HD11 ' D' ' 75' ' ' ILE . 72.7 m-20 -117.57 138.23 52.06 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -177.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 68' ' ' GLU . . . . . 1.058 ' HB3' HG13 ' D' ' 47' ' ' ILE . 38.5 mm-40 -61.19 -22.82 65.1 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.885 0.374 . . . . 0.0 111.144 177.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' D' ' 50' ' ' GLU . 46.3 mtmt -65.02 -39.07 92.84 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 70' ' ' SER . . . . . 0.47 ' HB3' ' O ' ' D' ' 67' ' ' ASN . 23.2 t -64.79 121.32 14.29 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 113.744 -1.571 . . . . 0.0 106.817 166.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 54.0 p -52.33 120.36 5.45 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.045 -177.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 72' ' ' VAL . . . . . 0.656 ' HA ' HD12 ' D' ' 75' ' ' ILE . 0.0 OUTLIER -55.3 -11.62 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.368 0 CA-C-O 120.984 0.421 . . . . 0.0 111.395 -175.279 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 73' ' ' GLY . . . . . 0.684 ' HA3' ' HA2' ' D' ' 44' ' ' GLY . . . -67.49 -64.73 3.05 Favored Glycine 0 N--CA 1.434 -1.434 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.884 169.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -65.54 -18.05 65.03 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.987 -0.285 . . . . 0.0 111.332 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 75' ' ' ILE . . . . . 0.684 ' O ' HG13 ' D' ' 79' ' ' ILE . 76.2 mt -70.02 -41.98 79.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 172.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 38.3 t -73.3 -26.16 60.96 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.086 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -59.73 -24.55 64.1 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.367 168.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 78' ' ' ASP . . . . . 0.988 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 76.8 m-20 -90.75 -38.76 12.82 Favored 'General case' 0 C--O 1.225 -0.225 0 O-C-N 123.849 0.718 . . . . 0.0 112.333 176.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 79' ' ' ILE . . . . . 0.737 HG22 HD11 ' D' ' 36' ' ' LEU . 42.8 mt -64.88 -24.4 35.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 O-C-N 121.719 -0.613 . . . . 0.0 111.106 -172.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -70.77 -25.19 62.79 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 177.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 81' ' ' LYS . . . . . 0.988 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -90.32 -46.68 8.24 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 120.081 -0.648 . . . . 0.0 111.829 175.174 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 82' ' ' LEU . . . . . 0.637 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.9 mm? -51.33 -25.93 6.74 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 49.71 69.36 0.61 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.038 0.535 . . . . 0.0 110.8 175.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 84' ' ' ILE . . . . . 0.814 HG12 HD13 ' D' ' 56' ' ' ILE . 2.2 mp -74.0 107.33 4.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.007 -178.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 85' ' ' LYS . . . . . 0.552 ' O ' ' HE3' ' D' ' 85' ' ' LYS . 0.0 OUTLIER -150.44 179.23 8.32 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 178.317 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 86' ' ' GLY . . . . . 0.712 ' HA2' HD11 ' D' ' 89' ' ' ILE . . . -57.48 168.3 4.6 Favored Glycine 0 CA--C 1.509 -0.299 0 CA-C-N 115.266 -0.879 . . . . 0.0 114.923 -173.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 87' ' ' PRO . . . . . 0.729 ' O ' HG13 ' D' ' 58' ' ' VAL . 46.7 Cg_endo -91.84 178.25 13.87 Favored 'Cis proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.736 -1.777 . . . . 0.0 114.165 0.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 88' ' ' TYR . . . . . 0.767 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 11.7 m-85 31.34 93.19 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.853 1.261 . . . . 0.0 113.121 -178.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.855 HG22 HG13 ' D' ' 91' ' ' ILE . 3.2 mp -110.19 117.55 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 CA-C-O 121.714 0.768 . . . . 0.0 110.896 -178.012 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.869 ' HB3' ' HB2' ' D' ' 57' ' ' PHE . 5.0 tp10 -100.93 87.4 3.28 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.126 174.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 91' ' ' ILE . . . . . 0.855 HG13 HG22 ' D' ' 89' ' ' ILE . 18.8 mt -98.68 101.76 12.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.751 177.081 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 92' ' ' LYS . . . . . 0.669 ' HE3' ' CG2' ' D' ' 94' ' ' ILE . 0.0 OUTLIER -161.4 168.62 23.49 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.469 -179.405 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 93' ' ' GLN . . . . . 0.701 ' HB3' ' NE1' ' D' ' 54' ' ' TRP . 26.3 pt20 -93.17 160.91 14.64 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 119.474 -0.89 . . . . 0.0 111.413 174.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 94' ' ' ILE . . . . . 0.669 ' CG2' ' HE3' ' D' ' 92' ' ' LYS . 4.7 pt . . . . . 0 C--N 1.314 -0.978 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.587 -172.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 7.7 t70 . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.974 0.416 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' D' D ' 2' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -120.47 17.26 12.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.73 0.776 . . . . 0.0 109.518 -178.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -93.9 -22.89 18.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.555 -177.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 4' ' ' LYS . . . . . 0.639 ' HA ' ' HB2' ' D' ' 7' ' ' GLU . 39.1 ttmt -109.27 10.33 25.7 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.726 0.774 . . . . 0.0 109.009 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 5' ' ' ALA . . . . . . . . . . . . . . . -67.7 -55.77 11.88 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.733 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 91.0 mt -109.9 19.5 19.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.178 0.514 . . . . 0.0 110.649 178.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 7' ' ' GLU . . . . . 0.639 ' HB2' ' HA ' ' D' ' 4' ' ' LYS . 5.5 tm-20 -65.4 -36.22 83.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.53 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.722 ' HA ' ' CB ' ' D' ' 12' ' ' SER . 84.3 mt-10 -61.69 -28.24 69.27 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.994 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -93.73 6.47 48.24 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.259 -176.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 10' ' ' MET . . . . . . . . . . . . . 15.7 tpt -106.36 -78.38 0.58 Allowed 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.269 -0.573 . . . . 0.0 111.366 -175.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -103.64 -38.52 7.07 Favored 'General case' 0 CA--C 1.494 -1.192 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.817 175.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 12' ' ' SER . . . . . 0.722 ' CB ' ' HA ' ' D' ' 8' ' ' GLU . 37.9 t -35.87 -69.04 0.11 Allowed 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 113.731 -1.577 . . . . 0.0 113.816 -167.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.437 ' C ' HG12 ' D' ' 16' ' ' VAL . 60.5 mt -81.73 -8.24 11.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.341 -171.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -95.12 -62.3 1.33 Allowed 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.897 175.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 15' ' ' SER . . . . . 0.518 ' HA ' ' OD1' ' D' ' 18' ' ' ASP . 88.6 p -68.24 -15.94 63.77 Favored 'General case' 0 C--O 1.223 -0.307 0 O-C-N 122.193 -0.317 . . . . 0.0 111.343 -178.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 16' ' ' VAL . . . . . 0.789 HG11 HD11 ' D' ' 29' ' ' LEU . 7.4 p -52.49 -39.8 30.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.127 0.489 . . . . 0.0 109.711 173.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 17' ' ' ASN . . . . . 0.664 ' OD1' ' HA ' ' D' ' 28' ' ' SER . 79.9 m-20 -75.75 -25.88 56.9 Favored 'General case' 0 C--O 1.212 -0.891 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.32 -178.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 18' ' ' ASP . . . . . 0.518 ' OD1' ' HA ' ' D' ' 15' ' ' SER . 1.5 m-20 -66.74 -16.41 64.23 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 177.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.628 ' HE2' ' HA ' ' D' ' 16' ' ' VAL . 0.0 OUTLIER -92.2 -36.78 13.08 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-O 122.044 0.926 . . . . 0.0 108.742 174.087 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 20' ' ' LEU . . . . . 0.92 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 76.4 mt -71.93 -41.16 68.17 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 113.329 -1.76 . . . . 0.0 109.482 -175.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 21' ' ' ASN . . . . . 0.632 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 62.3 m-20 -81.24 94.69 6.75 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.026 -1.443 . . . . 0.0 111.55 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 22' ' ' LYS . . . . . 0.497 ' HB2' HG23 ' D' ' 47' ' ' ILE . 55.8 mtpt -123.01 -42.11 2.3 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -177.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 23' ' ' GLY . . . . . 0.538 ' O ' ' HE3' ' D' ' 26' ' ' LYS . . . 177.92 -94.03 0.09 OUTLIER Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 119.614 -1.279 . . . . 0.0 113.555 -178.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 24' ' ' LYS . . . . . 0.849 ' HE3' ' HA ' ' D' ' 48' ' ' SER . 25.7 ttpp -54.73 -43.31 72.51 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 122.072 0.939 . . . . 0.0 110.192 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -139.6 141.16 11.42 Favored Glycine 0 N--CA 1.427 -1.941 0 CA-C-N 114.193 -1.367 . . . . 0.0 111.98 178.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 26' ' ' LYS . . . . . 0.753 ' HA ' ' O ' ' D' ' 20' ' ' LEU . 9.7 ptpt -148.13 159.84 43.52 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 114.213 -0.994 . . . . 0.0 110.09 -170.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 27' ' ' LEU . . . . . 0.92 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 41.1 tp -139.52 148.46 42.66 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 120.864 0.364 . . . . 0.0 111.37 -177.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 28' ' ' SER . . . . . 0.664 ' HA ' ' OD1' ' D' ' 17' ' ' ASN . 21.1 t -140.47 148.47 41.18 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 29' ' ' LEU . . . . . 0.789 HD11 HG11 ' D' ' 16' ' ' VAL . 0.5 OUTLIER -141.88 144.89 34.05 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 175.61 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 50.1 m -148.07 -170.64 3.64 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.33 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -147.21 166.56 26.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.214 0.53 . . . . 0.0 112.028 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 32' ' ' ASN . . . . . 0.572 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 50.9 t-20 -146.96 88.74 1.76 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.788 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.75 -101.52 0.72 Allowed Glycine 0 CA--C 1.516 0.14 0 C-N-CA 120.327 -0.94 . . . . 0.0 111.568 -174.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -107.78 16.66 23.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.926 0.394 . . . . 0.0 110.615 176.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 35' ' ' GLN . . . . . 0.572 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 68.1 tp60 -99.39 156.76 16.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.627 -176.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.866 ' HB2' ' HG2' ' D' ' 85' ' ' LYS . 2.3 tm? -120.62 140.12 52.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.667 174.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 37' ' ' LYS . . . . . 0.54 ' H ' HD22 ' D' ' 36' ' ' LEU . 73.0 mmtt -132.02 123.76 27.94 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.169 -171.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 38' ' ' ALA . . . . . 0.502 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -130.83 138.69 49.98 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.46 175.197 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 39' ' ' THR . . . . . 0.553 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 19.9 p -133.51 122.0 22.99 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.373 0.606 . . . . 0.0 111.36 178.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 40' ' ' SER . . . . . 0.693 ' HB2' ' HA2' ' D' ' 73' ' ' GLY . 40.7 m -109.99 129.58 55.65 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 175.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 41' ' ' SER . . . . . 0.656 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 37.2 t -95.74 154.82 17.03 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.617 -173.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 42' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' D' ' 41' ' ' SER . 73.6 m-80 80.38 11.86 1.01 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 114.053 -1.431 . . . . 0.0 110.079 -171.01 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 45.15 55.47 6.27 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 114.445 -1.252 . . . . 0.0 113.693 170.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 44' ' ' GLY . . . . . 0.614 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 108.79 35.54 2.38 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 119.754 -1.213 . . . . 0.0 114.126 171.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 45' ' ' TYR . . . . . 0.681 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 1.7 m-85 -116.04 157.67 24.31 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 171.107 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 46' ' ' GLY . . . . . 0.543 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -97.74 174.77 29.54 Favored Glycine 0 CA--C 1.501 -0.843 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 177.127 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 47' ' ' ILE . . . . . 0.689 ' CG1' ' HB3' ' D' ' 68' ' ' GLU . 46.3 mm -46.4 -60.37 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-O 121.614 0.721 . . . . 0.0 111.659 -177.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.849 ' HA ' ' HE3' ' D' ' 24' ' ' LYS . 22.1 t 172.93 -151.02 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 113.391 -1.731 . . . . 0.0 108.214 -177.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -80.69 77.0 7.57 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 120.9 0.381 . . . . 0.0 110.541 172.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 50' ' ' GLU . . . . . 0.642 ' HB2' ' HZ3' ' D' ' 52' ' ' LYS . 97.2 mt-10 -150.46 155.58 39.8 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.469 176.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 51' ' ' ASP . . . . . 0.608 ' HB3' ' HD3' ' D' ' 69' ' ' LYS . 18.6 m-20 -118.96 127.65 53.67 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.869 176.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 52' ' ' LYS . . . . . 0.714 ' HE2' ' CB ' ' D' ' 68' ' ' GLU . 3.5 mppt? -142.63 128.74 19.73 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.879 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -104.11 129.71 51.81 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.746 175.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 54' ' ' TRP . . . . . 1.035 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 1.0 OUTLIER -115.69 160.8 19.58 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -174.498 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 55' ' ' GLY . . . . . 0.448 ' HA3' ' HE2' ' D' ' 62' ' ' LYS . . . -143.81 158.82 27.49 Favored Glycine 0 N--CA 1.434 -1.498 0 CA-C-N 114.848 -1.069 . . . . 0.0 113.371 176.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 56' ' ' ILE . . . . . 1.073 HG12 HG23 ' D' ' 91' ' ' ILE . 91.2 mt -140.92 115.09 5.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 N-CA-C 106.363 -1.718 . . . . 0.0 106.363 178.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 57' ' ' PHE . . . . . 0.739 ' CE1' ' HE2' ' D' ' 92' ' ' LYS . 5.6 m-85 -115.37 123.03 47.65 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 119.589 -0.844 . . . . 0.0 110.466 -171.165 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.643 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 85.3 t -101.01 112.59 34.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.954 173.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 59' ' ' ASN . . . . . 0.611 ' OD1' ' HG2' ' D' ' 87' ' ' PRO . 6.8 m120 60.78 35.95 19.39 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.322 -176.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.04 -33.05 6.6 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.374 -0.917 . . . . 0.0 113.998 174.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 61' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 24.5 pt-20 -90.08 148.64 22.9 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.914 0.388 . . . . 0.0 111.183 -174.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 62' ' ' LYS . . . . . 0.448 ' HE2' ' HA3' ' D' ' 55' ' ' GLY . 5.5 tppp? -65.66 126.56 28.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.766 175.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.543 HG11 HG23 ' D' ' 58' ' ' VAL . 12.4 p -109.48 -29.44 2.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.663 178.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 64' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -151.5 135.22 16.35 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.758 175.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.409 HG23 ' O ' ' D' ' 54' ' ' TRP . 70.6 m -117.06 125.66 51.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.133 175.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 66' ' ' PHE . . . . . 0.461 ' HB2' HG21 ' D' ' 75' ' ' ILE . 16.6 p90 -126.8 161.02 29.19 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 121.153 0.501 . . . . 0.0 110.064 173.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 67' ' ' ASN . . . . . 0.535 ' O ' ' HB2' ' D' ' 70' ' ' SER . 73.1 m-20 -126.1 147.46 49.59 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -177.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 68' ' ' GLU . . . . . 0.714 ' CB ' ' HE2' ' D' ' 52' ' ' LYS . 39.0 mm-40 -80.98 -14.68 57.73 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.438 0.637 . . . . 0.0 109.592 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.608 ' HD3' ' HB3' ' D' ' 51' ' ' ASP . 47.6 mtmt -65.97 -48.96 69.55 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-N 113.808 -1.542 . . . . 0.0 107.27 169.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 70' ' ' SER . . . . . 0.535 ' HB2' ' O ' ' D' ' 67' ' ' ASN . 51.0 m -61.32 129.57 41.87 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 111.615 -2.539 . . . . 0.0 108.775 169.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 68.4 p -58.61 112.03 1.46 Allowed 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -178.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 72' ' ' VAL . . . . . 0.608 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -49.84 -24.36 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 121.06 0.457 . . . . 0.0 110.269 -176.557 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 73' ' ' GLY . . . . . 0.693 ' HA2' ' HB2' ' D' ' 40' ' ' SER . . . -60.77 -67.46 2.12 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.208 -0.905 . . . . 0.0 114.671 175.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -62.49 -19.48 63.61 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.057 0.456 . . . . 0.0 110.965 -177.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 75' ' ' ILE . . . . . 0.584 ' O ' HG13 ' D' ' 79' ' ' ILE . 34.8 mm -76.05 -39.48 36.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.017 174.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 76' ' ' SER . . . . . 0.471 ' HA ' HG13 ' D' ' 79' ' ' ILE . 40.4 t -75.01 -21.05 59.35 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.535 177.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 58.5 m-20 -61.72 -30.67 70.91 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 168.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 78' ' ' ASP . . . . . 1.001 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 1.0 OUTLIER -83.65 -30.8 26.57 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.606 174.84 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 79' ' ' ILE . . . . . 0.717 HG22 HD11 ' D' ' 36' ' ' LEU . 35.8 mt -69.81 -18.0 21.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.29 -177.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 37.2 m-20 -66.41 -41.41 89.32 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.06 174.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 81' ' ' LYS . . . . . 1.001 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -80.23 -47.05 15.22 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 179.44 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 82' ' ' LEU . . . . . 0.699 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.4 mm? -50.34 -27.81 6.86 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -178.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 83' ' ' ASN . . . . . 0.533 ' HA ' ' HB3' ' D' ' 36' ' ' LEU . 55.8 t-20 46.16 62.6 2.2 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.553 0.533 . . . . 0.0 110.678 176.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 84' ' ' ILE . . . . . 0.583 HG22 HD13 ' D' ' 89' ' ' ILE . 44.8 mm -86.32 97.36 5.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.535 -175.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 85' ' ' LYS . . . . . 0.866 ' HG2' ' HB2' ' D' ' 36' ' ' LEU . 28.3 mmmt -147.13 95.55 2.58 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.816 175.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 86' ' ' GLY . . . . . 0.724 ' H ' HD11 ' D' ' 89' ' ' ILE . . . 73.97 151.72 2.23 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.648 -0.706 . . . . 0.0 113.746 173.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 87' ' ' PRO . . . . . 0.611 ' HG2' ' OD1' ' D' ' 59' ' ' ASN . 62.5 Cg_endo -90.19 179.61 14.38 Favored 'Cis proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.17 -1.596 . . . . 0.0 112.773 -0.114 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 88' ' ' TYR . . . . . 0.643 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 5.8 m-85 15.54 94.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 125.43 1.492 . . . . 0.0 114.217 -178.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.724 HD11 ' H ' ' D' ' 86' ' ' GLY . 70.5 mt -110.52 133.31 56.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.223 0.535 . . . . 0.0 112.357 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.481 ' O ' ' HD1' ' D' ' 57' ' ' PHE . 46.3 mt-10 -118.97 96.75 5.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.536 174.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 91' ' ' ILE . . . . . 1.073 HG23 HG12 ' D' ' 56' ' ' ILE . 4.0 mt -101.11 110.92 29.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 92' ' ' LYS . . . . . 0.739 ' HE2' ' CE1' ' D' ' 57' ' ' PHE . 0.0 OUTLIER -163.55 172.76 13.93 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.023 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 93' ' ' GLN . . . . . 0.587 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 23.9 pt20 -81.6 169.34 17.17 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 119.091 -1.043 . . . . 0.0 111.185 175.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 94' ' ' ILE . . . . . 0.519 ' CG2' ' HE3' ' D' ' 92' ' ' LYS . 6.7 pt . . . . . 0 C--N 1.317 -0.837 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.971 -173.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 53.5 p-10 . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 120.59 0.233 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' D' D ' 2' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -109.91 -3.62 16.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.065 0.46 . . . . 0.0 110.708 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -76.67 -3.83 39.95 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.219 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -85.55 -21.62 28.48 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 175.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 5' ' ' ALA . . . . . . . . . . . . . . . 54.99 63.25 2.19 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.192 -175.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 28.4 tp -110.45 17.27 20.97 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.059 -174.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -56.94 -47.71 80.01 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -175.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.747 ' HA ' ' CB ' ' D' ' 12' ' ' SER . 20.9 pt-20 -70.2 -21.84 62.99 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.518 -178.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -96.59 12.07 32.98 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.142 -0.223 . . . . 0.0 110.758 174.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 10' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -105.05 -75.29 0.63 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -175.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -103.14 -37.43 7.73 Favored 'General case' 0 CA--C 1.495 -1.171 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.58 173.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 12' ' ' SER . . . . . 0.747 ' CB ' ' HA ' ' D' ' 8' ' ' GLU . 47.6 t -44.06 -61.69 1.39 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 113.925 -1.489 . . . . 0.0 111.956 -166.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.573 ' O ' HG12 ' D' ' 16' ' ' VAL . 12.2 tt -86.69 -22.57 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-O 120.85 0.357 . . . . 0.0 111.932 -178.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -82.13 -58.88 2.76 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -178.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 15' ' ' SER . . . . . 0.573 ' O ' ' HE2' ' D' ' 19' ' ' LYS . 97.9 p -69.97 -15.46 63.04 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.701 -178.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 16' ' ' VAL . . . . . 0.695 ' HB ' ' O ' ' D' ' 12' ' ' SER . 1.7 p -61.3 -26.56 39.68 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.29 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -78.3 -38.05 43.37 Favored 'General case' 0 C--O 1.212 -0.891 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.545 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.99 -16.36 17.72 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.644 ' O ' ' HE2' ' D' ' 22' ' ' LYS . 35.0 mttm -91.12 -39.29 12.24 Favored 'General case' 0 CA--C 1.492 -1.28 0 CA-C-O 122.487 1.137 . . . . 0.0 109.397 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 20' ' ' LEU . . . . . 0.63 HD12 HD12 ' D' ' 27' ' ' LEU . 61.0 mt -82.26 -32.82 29.44 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 112.887 -1.961 . . . . 0.0 109.581 -174.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 21' ' ' ASN . . . . . 0.774 ' OD1' ' HB2' ' D' ' 26' ' ' LYS . 57.4 m-20 -71.95 92.33 1.27 Allowed 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.449 -1.25 . . . . 0.0 109.708 172.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 22' ' ' LYS . . . . . 0.644 ' HE2' ' O ' ' D' ' 19' ' ' LYS . 61.0 mttm -121.75 -41.45 2.47 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -174.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 23' ' ' GLY . . . . . 0.407 ' O ' ' HE2' ' D' ' 26' ' ' LYS . . . 176.93 -92.64 0.09 OUTLIER Glycine 0 N--CA 1.437 -1.283 0 C-N-CA 119.658 -1.258 . . . . 0.0 112.857 -177.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 24' ' ' LYS . . . . . 0.742 ' HG2' ' HB3' ' D' ' 45' ' ' TYR . 76.0 tttt -47.44 -55.83 8.22 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.584 0.707 . . . . 0.0 109.786 179.048 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 25' ' ' GLY . . . . . 0.644 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -133.99 156.21 22.22 Favored Glycine 0 N--CA 1.432 -1.573 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.906 174.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 26' ' ' LYS . . . . . 0.774 ' HB2' ' OD1' ' D' ' 21' ' ' ASN . 0.1 OUTLIER -150.3 162.48 40.44 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.301 -0.949 . . . . 0.0 110.556 -168.516 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 27' ' ' LEU . . . . . 0.746 ' HB2' HG11 ' D' ' 72' ' ' VAL . 3.4 tm? -132.46 143.23 49.64 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.762 -171.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 28' ' ' SER . . . . . 0.689 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 50.0 m -137.05 145.64 44.25 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.924 178.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 29' ' ' LEU . . . . . 0.525 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 18.3 mt -138.75 157.91 45.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.157 0.503 . . . . 0.0 110.871 177.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 39.3 t -160.3 -175.49 5.07 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 175.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 31' ' ' MET . . . . . 0.687 ' HA ' ' O ' ' D' ' 35' ' ' GLN . 26.6 ptt? -150.28 127.1 11.03 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.659 0.743 . . . . 0.0 111.06 175.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -91.52 89.01 7.01 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.022 176.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.51 -104.1 2.02 Favored Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -169.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -120.71 31.78 6.28 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.164 0.507 . . . . 0.0 109.938 172.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 35' ' ' GLN . . . . . 0.687 ' O ' ' HA ' ' D' ' 31' ' ' MET . 32.9 tt0 -108.11 115.95 31.07 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.579 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.672 ' HB2' ' HB2' ' D' ' 85' ' ' LYS . 1.1 tm? -77.76 134.95 37.95 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.225 0.536 . . . . 0.0 111.536 -177.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 37' ' ' LYS . . . . . 0.588 ' NZ ' ' HB3' ' D' ' 37' ' ' LYS . 0.7 OUTLIER -133.79 116.71 16.03 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.491 -169.313 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 38' ' ' ALA . . . . . 0.41 ' HA ' HD23 ' D' ' 29' ' ' LEU . . . -115.09 152.88 31.75 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.408 0.623 . . . . 0.0 112.401 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 39' ' ' THR . . . . . 0.689 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 5.2 p -150.87 134.49 16.43 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.53 177.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 40' ' ' SER . . . . . 0.544 ' HB3' ' HA2' ' D' ' 73' ' ' GLY . 40.1 t -108.11 136.12 48.32 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 172.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 41' ' ' SER . . . . . 0.744 ' HB3' ' HG3' ' D' ' 26' ' ' LYS . 47.6 t -96.17 151.78 19.17 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 118.963 -1.095 . . . . 0.0 109.748 -179.086 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 42' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' D' ' 41' ' ' SER . 77.1 m-20 80.66 6.75 1.45 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.693 -167.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 53.94 60.13 3.82 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 114.713 -1.13 . . . . 0.0 113.455 171.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 44' ' ' GLY . . . . . 0.61 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 104.72 37.92 2.67 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.122 -1.513 . . . . 0.0 114.989 168.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 45' ' ' TYR . . . . . 0.742 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 2.3 m-85 -116.11 154.4 30.04 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 117.856 0.828 . . . . 0.0 109.944 173.272 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 46' ' ' GLY . . . . . 0.628 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -93.78 -173.58 39.56 Favored Glycine 0 C--O 1.22 -0.744 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 178.192 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 47' ' ' ILE . . . . . 0.812 HG12 ' HB3' ' D' ' 68' ' ' GLU . 26.9 mm -48.55 -54.81 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-O 122.025 0.917 . . . . 0.0 108.775 175.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.589 ' HA ' ' HD3' ' D' ' 24' ' ' LYS . 93.4 p 178.76 -146.22 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 112.832 -1.985 . . . . 0.0 107.561 178.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -82.54 75.9 9.43 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.462 166.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 50' ' ' GLU . . . . . 0.677 ' HB3' ' HE2' ' D' ' 52' ' ' LYS . 95.6 mt-10 -146.84 163.37 36.28 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.646 -176.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 51' ' ' ASP . . . . . 0.678 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 1.4 m-20 -124.1 132.7 53.68 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.804 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 52' ' ' LYS . . . . . 0.678 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 3.5 mptp? -142.93 120.7 11.89 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.453 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 53' ' ' ASN . . . . . 0.615 ' HA ' ' OD1' ' D' ' 67' ' ' ASN . 44.0 m-20 -90.83 131.46 36.47 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 176.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 54' ' ' TRP . . . . . 0.617 ' HB2' ' O ' ' D' ' 66' ' ' PHE . 0.1 OUTLIER -122.93 155.0 37.63 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -172.161 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -144.81 161.14 28.07 Favored Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.254 -0.974 . . . . 0.0 113.97 174.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 56' ' ' ILE . . . . . 0.857 HD13 HG12 ' D' ' 84' ' ' ILE . 74.0 mt -137.03 111.79 10.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 57' ' ' PHE . . . . . 0.882 ' HB2' ' HB3' ' D' ' 90' ' ' GLU . 15.8 m-85 -105.59 97.8 7.58 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.894 -167.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.867 HG22 HG12 ' D' ' 89' ' ' ILE . 99.4 t -98.2 120.64 47.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.475 176.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 33.7 m120 67.64 34.98 4.25 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 123.438 0.461 . . . . 0.0 110.539 -175.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.35 42.54 97.68 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.625 -0.716 . . . . 0.0 113.54 177.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 61' ' ' GLU . . . . . 0.634 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 24.9 pt-20 -155.41 141.63 18.46 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 176.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 62' ' ' LYS . . . . . 0.476 ' HB2' ' CE2' ' D' ' 57' ' ' PHE . 27.9 ttpp -73.01 99.72 2.81 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -178.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.491 HG12 ' O ' ' D' ' 56' ' ' ILE . 9.1 p -84.29 -32.43 8.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.657 -172.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 64' ' ' TYR . . . . . 0.43 ' HB3' HD12 ' D' ' 56' ' ' ILE . 17.2 t80 -134.39 132.0 38.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.746 0.307 . . . . 0.0 110.797 176.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 35.0 m -116.4 112.46 21.51 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.124 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 66' ' ' PHE . . . . . 0.617 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 9.3 p90 -118.66 158.51 25.37 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 173.129 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 67' ' ' ASN . . . . . 0.615 ' OD1' ' HA ' ' D' ' 53' ' ' ASN . 73.7 m-80 -129.81 142.09 50.74 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.349 -175.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 68' ' ' GLU . . . . . 0.812 ' HB3' HG12 ' D' ' 47' ' ' ILE . 42.1 mm-40 -69.07 -8.41 44.96 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 123.574 0.546 . . . . 0.0 110.415 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.432 ' HE2' ' CB ' ' D' ' 67' ' ' ASN . 44.1 mtmt -60.62 -46.66 89.44 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 167.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 70' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' D' ' 67' ' ' ASN . 35.1 t -69.78 129.78 40.51 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 113.179 -1.828 . . . . 0.0 108.355 168.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 71' ' ' THR . . . . . 0.461 ' O ' HG13 ' D' ' 75' ' ' ILE . 74.1 p -57.86 128.86 39.19 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 178.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 72' ' ' VAL . . . . . 0.746 HG11 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -54.57 -16.84 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-O 121.294 0.568 . . . . 0.0 110.44 -175.655 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 73' ' ' GLY . . . . . 0.61 ' HA3' ' HA2' ' D' ' 44' ' ' GLY . . . -72.92 -58.58 4.72 Favored Glycine 0 N--CA 1.435 -1.39 0 CA-C-N 114.911 -1.041 . . . . 0.0 112.841 173.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -64.25 -20.25 65.93 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 120.885 0.374 . . . . 0.0 110.305 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 75' ' ' ILE . . . . . 0.645 ' O ' HG13 ' D' ' 79' ' ' ILE . 74.7 mt -73.34 -41.12 57.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.462 171.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 41.5 t -71.03 -26.8 63.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.048 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -56.12 -30.92 62.78 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 167.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 78' ' ' ASP . . . . . 1.084 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 1.1 m-20 -90.35 -33.28 16.13 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 177.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 79' ' ' ILE . . . . . 0.645 HG13 ' O ' ' D' ' 75' ' ' ILE . 41.5 mt -68.3 -27.81 38.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 O-C-N 121.689 -0.632 . . . . 0.0 110.595 -175.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -73.92 -20.02 60.51 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 81' ' ' LYS . . . . . 1.084 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -89.92 -52.38 5.0 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.601 171.416 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 82' ' ' LEU . . . . . 0.57 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.7 mm? -48.67 -31.44 6.78 Favored 'General case' 0 C--O 1.231 0.086 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 176.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 83' ' ' ASN . . . . . 0.496 ' HA ' HD12 ' D' ' 36' ' ' LEU . 22.2 t-20 40.6 77.77 0.05 Allowed 'General case' 0 N--CA 1.469 0.506 0 O-C-N 124.639 1.212 . . . . 0.0 111.134 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 84' ' ' ILE . . . . . 0.857 HG12 HD13 ' D' ' 56' ' ' ILE . 2.6 mp -77.97 97.05 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.362 -176.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 85' ' ' LYS . . . . . 0.672 ' HB2' ' HB2' ' D' ' 36' ' ' LEU . 0.0 OUTLIER -158.28 93.07 1.2 Allowed 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 121.431 0.634 . . . . 0.0 110.505 -177.424 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 86' ' ' GLY . . . . . 0.659 ' H ' HD11 ' D' ' 89' ' ' ILE . . . 68.54 148.56 0.21 Allowed Glycine 0 N--CA 1.453 -0.193 0 CA-C-N 114.59 -1.187 . . . . 0.0 113.929 178.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 87' ' ' PRO . . . . . 0.6 ' O ' HG13 ' D' ' 58' ' ' VAL . 60.8 Cg_endo -90.6 -177.53 10.12 Favored 'Cis proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.533 -1.445 . . . . 0.0 112.508 -0.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 88' ' ' TYR . . . . . 0.721 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 13.0 m-85 4.89 94.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 125.527 1.531 . . . . 0.0 114.214 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.867 HG12 HG22 ' D' ' 58' ' ' VAL . 66.5 mt -108.35 148.81 12.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.192 0.52 . . . . 0.0 111.883 -177.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.882 ' HB3' ' HB2' ' D' ' 57' ' ' PHE . 39.7 tt0 -132.13 91.41 2.95 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.281 173.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 91' ' ' ILE . . . . . 0.582 HG13 HG22 ' D' ' 89' ' ' ILE . 37.0 mt -94.14 99.84 10.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.89 -176.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 92' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' D' ' 93' ' ' GLN . 0.0 OUTLIER -160.74 164.47 31.55 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 177.379 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 93' ' ' GLN . . . . . 0.625 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 24.3 pt20 -80.6 162.73 24.12 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.537 176.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 94' ' ' ILE . . . . . 0.406 HG22 ' HE2' ' D' ' 92' ' ' LYS . 10.6 pt . . . . . 0 C--N 1.305 -1.357 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.366 -171.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 9.4 t70 . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' D' D ' 2' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -172.48 -27.32 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 177.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 3' ' ' GLN . . . . . 0.473 ' H ' ' CD ' ' D' ' 3' ' ' GLN . 15.1 mp0 -55.93 -70.73 0.1 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.084 0.469 . . . . 0.0 110.785 -175.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -111.46 -26.01 9.3 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.71 174.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 5' ' ' ALA . . . . . 0.523 ' O ' ' HG2' ' D' ' 9' ' ' GLN . . . 61.59 31.06 18.85 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.001 -177.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 57.2 tp -70.24 -34.43 72.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.654 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -69.27 -26.21 64.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.339 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.81 ' HA ' ' CB ' ' D' ' 12' ' ' SER . 93.8 mt-10 -73.61 -21.13 60.4 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.34 176.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 9' ' ' GLN . . . . . 0.523 ' HG2' ' O ' ' D' ' 5' ' ' ALA . 72.0 mm-40 -89.05 11.74 17.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.833 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 10' ' ' MET . . . . . . . . . . . . . 62.6 mtt -106.05 -77.91 0.58 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.015 0.436 . . . . 0.0 111.042 -178.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -104.52 -38.5 6.75 Favored 'General case' 0 CA--C 1.493 -1.249 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.709 174.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 12' ' ' SER . . . . . 0.81 ' CB ' ' HA ' ' D' ' 8' ' ' GLU . 47.2 t -41.58 -66.03 0.38 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 113.667 -1.606 . . . . 0.0 112.83 -164.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.488 ' C ' HG12 ' D' ' 16' ' ' VAL . 57.5 mt -87.9 -7.18 10.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.623 -174.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -88.54 -57.36 2.94 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.334 176.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 15' ' ' SER . . . . . 0.513 ' O ' ' HE2' ' D' ' 19' ' ' LYS . 92.6 p -68.11 -17.74 64.45 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.673 -0.239 . . . . 0.0 111.457 -178.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 16' ' ' VAL . . . . . 0.645 HG13 ' ND2' ' D' ' 17' ' ' ASN . 9.6 p -59.97 -30.06 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-O 121.945 0.879 . . . . 0.0 109.562 176.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 17' ' ' ASN . . . . . 0.645 ' ND2' HG13 ' D' ' 16' ' ' VAL . 3.8 m120 -78.26 -33.96 49.29 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.256 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.31 -15.71 49.64 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.331 177.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.513 ' HE2' ' O ' ' D' ' 15' ' ' SER . 40.3 mttm -89.56 -39.52 13.22 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 122.726 1.25 . . . . 0.0 109.255 -179.274 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 20' ' ' LEU . . . . . 0.805 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 73.0 mt -77.19 -37.29 53.88 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 111.935 -2.393 . . . . 0.0 110.127 -176.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 21' ' ' ASN . . . . . 0.627 ' OD1' ' HB2' ' D' ' 26' ' ' LYS . 57.5 m-20 -75.33 95.92 3.29 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.678 177.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 22' ' ' LYS . . . . . 0.805 ' HD3' HG23 ' D' ' 47' ' ' ILE . 23.0 mtpp -120.89 -43.62 2.45 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 118.594 -1.242 . . . . 0.0 114.064 -168.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.27 -69.9 0.25 Allowed Glycine 0 N--CA 1.436 -1.315 0 C-N-CA 119.746 -1.216 . . . . 0.0 112.509 -174.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 24' ' ' LYS . . . . . 0.819 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 22.2 tptm -55.27 -67.07 0.31 Allowed 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 176.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 25' ' ' GLY . . . . . 0.718 ' HA2' ' OD1' ' D' ' 42' ' ' ASN . . . -139.38 156.49 24.61 Favored Glycine 0 CA--C 1.493 -1.337 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.279 172.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 26' ' ' LYS . . . . . 0.691 ' CD ' ' HB3' ' D' ' 41' ' ' SER . 0.4 OUTLIER -140.5 160.12 40.69 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -168.53 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 27' ' ' LEU . . . . . 0.805 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 45.1 tp -139.44 144.38 38.02 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.463 0.649 . . . . 0.0 112.392 -177.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 28' ' ' SER . . . . . 0.715 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 49.2 m -135.34 151.91 50.96 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.505 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 29' ' ' LEU . . . . . . . . . . . . . 16.4 mt -141.02 138.01 33.38 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 56.3 m -148.06 -179.04 6.62 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 31' ' ' MET . . . . . 0.813 ' HA ' ' O ' ' D' ' 35' ' ' GLN . 20.2 ptp -137.23 126.62 24.92 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.67 0.747 . . . . 0.0 111.057 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -90.84 88.34 7.02 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 175.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.64 -100.97 1.99 Allowed Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -165.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -120.16 12.5 11.86 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.999 0.428 . . . . 0.0 109.987 171.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 35' ' ' GLN . . . . . 0.813 ' O ' ' HA ' ' D' ' 31' ' ' MET . 85.0 mt-30 -88.63 125.94 35.06 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.471 -175.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.686 HD11 HG22 ' D' ' 79' ' ' ILE . 2.8 tm? -78.08 124.38 27.98 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.204 0.526 . . . . 0.0 111.436 -178.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 37' ' ' LYS . . . . . 0.642 ' HE2' ' HB3' ' D' ' 35' ' ' GLN . 74.9 mmtt -135.53 103.49 5.48 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.794 -173.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.28 152.64 18.38 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.322 0.582 . . . . 0.0 111.581 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 39' ' ' THR . . . . . 0.715 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 7.1 p -141.01 124.79 16.98 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.118 176.097 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 40' ' ' SER . . . . . 0.654 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 19.1 p -107.88 128.87 55.0 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 172.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 41' ' ' SER . . . . . 0.691 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 44.3 t -96.3 168.75 10.39 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 42' ' ' ASN . . . . . 0.718 ' OD1' ' HA2' ' D' ' 25' ' ' GLY . 0.5 OUTLIER 60.8 7.44 1.45 Allowed 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.975 1.422 . . . . 0.0 112.499 -174.409 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 41.41 60.29 2.14 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 168.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.87 35.86 0.81 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 118.873 -1.632 . . . . 0.0 114.931 168.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 45' ' ' TYR . . . . . 0.819 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 0.7 OUTLIER -122.83 154.26 38.48 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 170.504 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 46' ' ' GLY . . . . . 0.562 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -99.81 -163.63 29.02 Favored Glycine 0 C--O 1.216 -1.013 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.414 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 47' ' ' ILE . . . . . 0.805 HG23 ' HD3' ' D' ' 22' ' ' LYS . 41.9 mm -55.04 -59.53 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 CA-C-O 122.088 0.947 . . . . 0.0 109.675 176.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 83.5 p 175.0 -164.61 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 112.327 -2.215 . . . . 0.0 108.789 -172.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -78.27 77.96 4.75 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.924 0.869 . . . . 0.0 111.632 173.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -145.56 -167.8 2.8 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.957 177.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 51' ' ' ASP . . . . . 0.691 ' C ' ' HD3' ' D' ' 52' ' ' LYS . 9.6 p-10 -136.34 135.18 38.65 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.359 168.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 52' ' ' LYS . . . . . 0.732 ' CE ' ' HB2' ' D' ' 68' ' ' GLU . 2.7 mppt? -139.79 128.1 22.64 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.263 -167.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -116.65 138.8 51.17 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 173.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 54' ' ' TRP . . . . . 0.651 ' HZ3' HG23 ' D' ' 91' ' ' ILE . 0.1 OUTLIER -125.76 160.38 29.93 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -173.077 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -140.43 156.2 25.07 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.042 -1.075 . . . . 0.0 113.908 175.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 56' ' ' ILE . . . . . 0.628 HD13 HG12 ' D' ' 84' ' ' ILE . 62.8 mt -140.24 108.75 3.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 176.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 57' ' ' PHE . . . . . 0.738 ' CE2' ' HE2' ' D' ' 92' ' ' LYS . 7.0 m-85 -108.25 102.91 12.0 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.637 -168.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.713 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 78.2 t -91.97 110.17 22.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.814 170.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 59' ' ' ASN . . . . . 0.44 ' OD1' ' HG2' ' D' ' 87' ' ' PRO . 5.2 m120 63.74 44.51 4.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.436 -176.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.3 -33.91 4.7 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.793 -0.718 . . . . 0.0 114.511 172.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 61' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 12.5 pt-20 -94.81 154.06 17.44 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.966 -0.293 . . . . 0.0 111.072 -175.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -73.92 106.94 5.86 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 173.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 9.9 p -76.52 -27.9 17.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.522 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 64' ' ' TYR . . . . . 0.551 ' HB3' HD12 ' D' ' 56' ' ' ILE . 14.2 t80 -148.13 135.57 20.59 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.545 173.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.422 HG23 ' O ' ' D' ' 54' ' ' TRP . 65.3 m -119.87 123.04 42.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.514 174.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 66' ' ' PHE . . . . . 0.632 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 11.3 p90 -129.62 143.11 50.67 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 121.477 0.656 . . . . 0.0 110.679 178.136 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 67' ' ' ASN . . . . . 0.803 HD22 ' HB2' ' D' ' 69' ' ' LYS . 15.1 p-10 -110.31 130.28 55.58 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.271 -175.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 68' ' ' GLU . . . . . 0.804 ' HB3' HG12 ' D' ' 47' ' ' ILE . 35.1 mm-40 -67.62 -8.45 34.67 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.831 -177.077 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.803 ' HB2' HD22 ' D' ' 67' ' ' ASN . 53.3 mtpt -62.28 -40.79 97.4 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 169.283 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 70' ' ' SER . . . . . 0.489 ' HB3' ' O ' ' D' ' 67' ' ' ASN . 32.5 t -68.51 124.52 23.79 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 113.051 -1.886 . . . . 0.0 107.353 164.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 71' ' ' THR . . . . . 0.422 ' O ' HG13 ' D' ' 75' ' ' ILE . 67.3 p -55.17 130.98 44.17 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 72' ' ' VAL . . . . . 0.66 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -57.3 -14.99 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-O 120.722 0.296 . . . . 0.0 111.011 -178.582 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 73' ' ' GLY . . . . . 0.654 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -63.98 -65.45 3.02 Favored Glycine 0 N--CA 1.433 -1.562 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.156 168.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -62.62 -20.55 64.88 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.523 0.201 . . . . 0.0 111.428 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 75' ' ' ILE . . . . . 0.592 ' O ' HG13 ' D' ' 79' ' ' ILE . 69.7 mt -73.26 -40.61 57.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.148 174.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 35.9 t -75.83 -21.32 57.4 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.817 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 77' ' ' ASN . . . . . 0.605 ' O ' ' HD3' ' D' ' 81' ' ' LYS . 2.5 m-80 -61.69 -23.97 66.46 Favored 'General case' 0 C--O 1.216 -0.66 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 166.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 78' ' ' ASP . . . . . 0.627 ' O ' HD23 ' D' ' 82' ' ' LEU . 1.0 OUTLIER -93.23 -41.56 9.83 Favored 'General case' 0 C--O 1.225 -0.237 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 175.913 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 79' ' ' ILE . . . . . 0.686 HG22 HD11 ' D' ' 36' ' ' LEU . 56.0 mt -65.78 -34.35 69.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 O-C-N 121.449 -0.782 . . . . 0.0 111.645 -169.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -66.86 -14.05 62.29 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.126 176.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 81' ' ' LYS . . . . . 0.605 ' HD3' ' O ' ' D' ' 77' ' ' ASN . 0.0 OUTLIER -89.77 -57.39 2.88 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.207 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 82' ' ' LEU . . . . . 0.627 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.4 mm? -53.86 -23.74 13.5 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 113.88 -1.509 . . . . 0.0 112.343 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 50.69 69.75 0.6 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.647 174.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 84' ' ' ILE . . . . . 0.628 HG12 HD13 ' D' ' 56' ' ' ILE . 2.2 mp -74.68 99.09 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.377 0.608 . . . . 0.0 111.175 -176.251 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 85' ' ' LYS . . . . . 0.62 ' C ' HD11 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -131.99 179.07 6.31 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.165 174.722 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . -48.38 165.15 0.24 Allowed Glycine 0 C--N 1.334 0.463 0 O-C-N 123.696 0.623 . . . . 0.0 113.928 -174.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 87' ' ' PRO . . . . . 0.534 ' O ' HG13 ' D' ' 58' ' ' VAL . 60.5 Cg_endo -93.82 -177.09 7.26 Favored 'Cis proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.898 -1.293 . . . . 0.0 114.758 -0.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 88' ' ' TYR . . . . . 0.713 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 41.5 m-85 23.04 93.06 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.504 1.521 . . . . 0.0 113.57 179.232 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.62 HD11 ' C ' ' D' ' 85' ' ' LYS . 72.7 mt -112.36 139.27 37.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 178.334 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.704 ' HG2' ' HD2' ' D' ' 92' ' ' LYS . 88.9 tt0 -127.59 94.75 4.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.032 171.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 91' ' ' ILE . . . . . 0.651 HG23 ' HZ3' ' D' ' 54' ' ' TRP . 27.4 mt -95.68 99.82 9.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.088 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 92' ' ' LYS . . . . . 0.738 ' HE2' ' CE2' ' D' ' 57' ' ' PHE . 0.0 OUTLIER -161.99 169.29 21.34 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.373 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 93' ' ' GLN . . . . . 0.664 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 21.1 pt20 -79.56 157.54 27.35 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.283 173.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 94' ' ' ILE . . . . . 0.429 HG22 ' HE3' ' D' ' 92' ' ' LYS . 9.9 pt . . . . . 0 C--N 1.308 -1.236 0 CA-C-N 114.902 -1.044 . . . . 0.0 112.186 -170.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' D' D ' 2' ' ' ASN . . . . . . . . . . . . . 6.0 m120 52.78 58.08 5.72 Favored 'General case' 0 N--CA 1.462 0.165 0 O-C-N 123.567 0.542 . . . . 0.0 111.001 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.08 21.93 0.32 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -88.67 -19.56 26.02 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 5' ' ' ALA . . . . . . . . . . . . . . . 59.84 64.55 1.27 Allowed 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.919 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 58.4 tp -110.03 -31.55 7.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.231 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 7' ' ' GLU . . . . . 0.414 ' HA ' ' SD ' ' D' ' 10' ' ' MET . 87.5 tt0 -66.68 -16.09 63.96 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.44 177.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.698 ' HA ' ' CB ' ' D' ' 12' ' ' SER . 43.7 mm-40 -64.76 -32.7 74.51 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.147 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 9' ' ' GLN . . . . . 0.562 ' OE1' ' HB2' ' D' ' 8' ' ' GLU . 1.3 mp0 -86.29 5.05 36.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.353 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 10' ' ' MET . . . . . 0.414 ' SD ' ' HA ' ' D' ' 7' ' ' GLU . 66.1 mtt -100.98 -77.45 0.54 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.348 -174.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -103.25 -36.79 7.95 Favored 'General case' 0 CA--C 1.488 -1.415 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.288 172.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 12' ' ' SER . . . . . 0.698 ' CB ' ' HA ' ' D' ' 8' ' ' GLU . 48.1 t -44.22 -70.45 0.1 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 113.994 -1.457 . . . . 0.0 113.235 -164.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.636 ' O ' HG12 ' D' ' 16' ' ' VAL . 57.0 mt -83.45 -8.36 11.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.902 -173.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -88.19 -41.86 12.7 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.095 175.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 15' ' ' SER . . . . . 0.559 ' HA ' ' OD2' ' D' ' 18' ' ' ASP . 88.2 p -72.01 -23.52 61.41 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 122.045 -0.409 . . . . 0.0 109.907 175.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 16' ' ' VAL . . . . . 0.636 HG12 ' O ' ' D' ' 13' ' ' ILE . 0.5 OUTLIER -56.84 -24.05 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 121.515 0.674 . . . . 0.0 109.41 178.927 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -74.65 -43.75 53.81 Favored 'General case' 0 C--O 1.209 -1.071 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.771 176.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 18' ' ' ASP . . . . . 0.559 ' OD2' ' HA ' ' D' ' 15' ' ' SER . 51.4 m-20 -55.3 -16.2 3.19 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -177.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.588 ' N ' ' HD2' ' D' ' 19' ' ' LYS . 0.0 OUTLIER -91.18 -43.16 10.03 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-O 122.306 1.051 . . . . 0.0 108.691 175.533 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 20' ' ' LEU . . . . . 0.927 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 70.7 mt -69.36 -37.74 77.76 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 113.168 -1.833 . . . . 0.0 110.258 -177.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 21' ' ' ASN . . . . . 0.443 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 53.1 m-20 -79.7 94.08 5.66 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.705 -178.067 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 22' ' ' LYS . . . . . 0.701 ' HD2' HD12 ' D' ' 47' ' ' ILE . 95.8 mttt -122.32 -41.95 2.38 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -176.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 165.87 -84.0 0.1 Allowed Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 119.32 -1.419 . . . . 0.0 113.231 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 24' ' ' LYS . . . . . 0.807 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 27.2 tptp -44.89 -57.76 3.57 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 25' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -139.86 163.95 26.16 Favored Glycine 0 N--CA 1.431 -1.685 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.967 171.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 26' ' ' LYS . . . . . 0.679 ' HD2' ' HB3' ' D' ' 41' ' ' SER . 0.3 OUTLIER -149.29 159.59 44.14 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.933 -0.634 . . . . 0.0 109.986 -171.743 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 27' ' ' LEU . . . . . 0.927 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 39.8 tp -136.16 134.49 38.29 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.436 0.636 . . . . 0.0 111.806 -178.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 28' ' ' SER . . . . . 0.637 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 26.5 t -121.36 145.96 47.36 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 29' ' ' LEU . . . . . . . . . . . . . 20.9 mt -131.43 134.96 46.75 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.754 -0.779 . . . . 0.0 110.745 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 32.1 t -137.01 -171.04 2.84 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 31' ' ' MET . . . . . 0.502 ' HB2' ' O ' ' D' ' 35' ' ' GLN . 26.3 ptt? -150.08 166.59 29.29 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.81 0.338 . . . . 0.0 110.618 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 32' ' ' ASN . . . . . 0.637 ' O ' ' HB2' ' D' ' 35' ' ' GLN . 25.9 t-20 -141.82 87.28 2.04 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 176.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.48 -113.81 4.82 Favored Glycine 0 CA--C 1.516 0.142 0 C-N-CA 119.898 -1.144 . . . . 0.0 111.121 -172.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -95.7 31.0 2.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.776 0.798 . . . . 0.0 109.92 173.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 35' ' ' GLN . . . . . 0.637 ' HB2' ' O ' ' D' ' 32' ' ' ASN . 52.5 mm-40 -110.24 164.94 12.17 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 114.928 -1.033 . . . . 0.0 112.367 -178.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.586 HD11 HG22 ' D' ' 79' ' ' ILE . 2.7 tm? -130.72 128.95 41.88 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 175.08 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 37' ' ' LYS . . . . . 0.401 ' N ' HD13 ' D' ' 36' ' ' LEU . 35.7 mmtp -132.4 100.6 5.04 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.145 0.498 . . . . 0.0 110.842 -176.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.72 149.95 21.24 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.856 -177.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 39' ' ' THR . . . . . 0.637 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 29.8 p -137.32 126.72 24.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.916 174.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 40' ' ' SER . . . . . 0.761 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 60.6 p -109.89 135.73 50.31 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 175.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 41' ' ' SER . . . . . 0.679 ' HB3' ' HD2' ' D' ' 26' ' ' LYS . 43.9 t -104.0 156.42 17.87 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.814 -176.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 42' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' D' ' 41' ' ' SER . 74.0 m-80 78.79 9.34 1.89 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.423 -172.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 43.74 59.02 3.27 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 114.73 -1.123 . . . . 0.0 113.648 170.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.84 34.96 2.1 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 119.732 -1.223 . . . . 0.0 113.872 172.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 45' ' ' TYR . . . . . 0.807 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 2.8 m-30 -112.89 146.72 38.45 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 170.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 46' ' ' GLY . . . . . 0.597 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -93.93 -162.97 35.99 Favored Glycine 0 C--O 1.218 -0.876 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 175.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 47' ' ' ILE . . . . . 0.832 HG12 ' HB3' ' D' ' 68' ' ' GLU . 38.5 mm -56.27 -57.1 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.886 0 CA-C-O 122.14 0.971 . . . . 0.0 109.514 174.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -178.97 -123.05 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 112.796 -2.002 . . . . 0.0 108.906 -177.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -114.47 76.79 1.01 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.119 0.485 . . . . 0.0 109.916 169.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 50' ' ' GLU . . . . . 0.563 ' CB ' ' HD3' ' D' ' 52' ' ' LYS . 51.5 mt-10 -140.16 168.73 19.13 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.53 177.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 51' ' ' ASP . . . . . 0.634 ' CB ' ' HD2' ' D' ' 69' ' ' LYS . 1.6 m-20 -114.69 122.06 45.29 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.763 175.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 52' ' ' LYS . . . . . 0.823 ' HG3' ' HB2' ' D' ' 68' ' ' GLU . 0.0 OUTLIER -131.84 107.44 8.74 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.858 -166.354 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 44.9 m-20 -94.33 129.35 41.04 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.466 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 54' ' ' TRP . . . . . 0.61 ' HZ3' HG23 ' D' ' 91' ' ' ILE . 0.1 OUTLIER -121.93 153.78 38.03 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -174.827 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -141.06 158.78 26.45 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.153 -1.022 . . . . 0.0 113.607 175.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 56' ' ' ILE . . . . . 0.681 HD13 HD13 ' D' ' 84' ' ' ILE . 62.8 mt -142.97 106.51 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 -178.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 57' ' ' PHE . . . . . 0.536 ' HD2' ' HB2' ' D' ' 90' ' ' GLU . 11.8 m-85 -108.6 106.87 17.13 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.59 -168.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.71 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 49.9 t -95.79 118.36 41.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.63 173.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 58.91 34.34 23.59 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.033 -178.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.91 -32.77 6.88 Favored Glycine 0 CA--C 1.505 -0.537 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.706 174.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 61' ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 25.4 pt-20 -90.19 146.91 23.9 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.078 0.466 . . . . 0.0 110.818 -175.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -79.36 101.75 8.29 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 177.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.518 HG12 ' O ' ' D' ' 56' ' ' ILE . 10.5 p -76.87 -30.32 18.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.695 -172.297 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 64' ' ' TYR . . . . . 0.529 ' HB3' HD12 ' D' ' 56' ' ' ILE . 20.5 t80 -147.16 142.57 27.45 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.757 0.313 . . . . 0.0 110.979 178.129 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 30.5 m -124.8 125.65 44.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.587 175.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 66' ' ' PHE . . . . . 0.561 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 17.5 p90 -133.83 157.49 45.79 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 121.441 0.639 . . . . 0.0 110.43 173.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 67' ' ' ASN . . . . . 0.589 ' HA ' ' O ' ' D' ' 52' ' ' LYS . 5.2 m120 -116.92 141.61 48.01 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 68' ' ' GLU . . . . . 0.832 ' HB3' HG12 ' D' ' 47' ' ' ILE . 55.6 mm-40 -70.83 -16.75 62.74 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 175.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.634 ' HD2' ' CB ' ' D' ' 51' ' ' ASP . 25.0 mtpp -60.21 -44.31 95.24 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 114.102 -1.408 . . . . 0.0 108.159 169.111 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 18.8 t -76.1 90.72 3.08 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 113.633 -1.621 . . . . 0.0 107.898 171.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 65.6 p -24.39 120.67 0.05 Allowed 'General case' 0 C--N 1.32 -0.695 0 O-C-N 124.815 1.322 . . . . 0.0 112.811 -175.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 72' ' ' VAL . . . . . 0.535 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -50.96 -15.3 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 O-C-N 123.356 0.41 . . . . 0.0 111.922 179.615 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 73' ' ' GLY . . . . . 0.761 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -65.3 -66.86 2.25 Favored Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 115.805 -0.634 . . . . 0.0 113.183 171.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -62.07 -27.24 68.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.229 -0.485 . . . . 0.0 110.332 -177.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 75' ' ' ILE . . . . . 0.629 ' O ' HG13 ' D' ' 79' ' ' ILE . 29.9 mm -78.24 -41.48 26.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.217 178.022 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 76' ' ' SER . . . . . 0.566 ' HB2' HD13 ' D' ' 27' ' ' LEU . 29.3 t -72.37 -21.33 61.31 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.449 -178.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -64.89 -34.01 77.38 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 167.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 78' ' ' ASP . . . . . 1.047 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 0.9 OUTLIER -77.89 -31.99 51.57 Favored 'General case' 0 C--O 1.224 -0.272 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 175.005 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 79' ' ' ILE . . . . . 0.629 HG13 ' O ' ' D' ' 75' ' ' ILE . 60.2 mt -65.49 -21.21 28.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 O-C-N 121.543 -0.723 . . . . 0.0 111.294 -174.16 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -73.25 -43.48 61.08 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 176.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 81' ' ' LYS . . . . . 1.047 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -68.79 -44.47 73.53 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.468 177.269 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 82' ' ' LEU . . . . . 0.659 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.8 mm? -55.53 -22.15 20.2 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 177.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 45.57 73.2 0.17 Allowed 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.778 0.674 . . . . 0.0 110.984 175.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 84' ' ' ILE . . . . . 0.865 HG21 HD11 ' D' ' 91' ' ' ILE . 35.0 mt -70.71 99.8 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.315 -177.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 85' ' ' LYS . . . . . 0.594 ' HD3' ' O ' ' D' ' 35' ' ' GLN . 30.5 mmmt -139.19 177.87 7.59 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.719 176.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 86' ' ' GLY . . . . . 0.716 ' HA2' HD11 ' D' ' 89' ' ' ILE . . . -59.67 175.89 3.44 Favored Glycine 0 CA--C 1.506 -0.481 0 N-CA-C 115.008 0.763 . . . . 0.0 115.008 -174.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 87' ' ' PRO . . . . . 0.603 ' O ' HG13 ' D' ' 58' ' ' VAL . 33.0 Cg_endo -91.67 175.73 17.48 Favored 'Cis proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.158 -2.017 . . . . 0.0 114.53 0.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 88' ' ' TYR . . . . . 0.71 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 33.4 m-85 31.52 92.47 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.32 1.448 . . . . 0.0 112.614 -179.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.716 HD11 ' HA2' ' D' ' 86' ' ' GLY . 3.1 mp -109.5 143.1 20.28 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.402 -177.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.656 ' O ' ' HA ' ' D' ' 56' ' ' ILE . 37.3 mt-10 -129.24 89.19 2.81 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.385 172.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 91' ' ' ILE . . . . . 0.865 HD11 HG21 ' D' ' 84' ' ' ILE . 21.0 mt -94.44 99.8 10.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.912 178.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 92' ' ' LYS . . . . . 0.844 ' HE3' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -161.8 169.2 21.81 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.125 -177.434 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 93' ' ' GLN . . . . . 0.716 ' O ' ' HD3' ' D' ' 92' ' ' LYS . 2.5 pp0? -85.78 147.17 26.44 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.054 170.462 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 94' ' ' ILE . . . . . 0.844 HG22 ' HE3' ' D' ' 92' ' ' LYS . 8.9 pt . . . . . 0 C--N 1.304 -1.389 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.979 -169.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.483 1.183 0 CA-C-O 120.476 0.179 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' D' D ' 2' ' ' ASN . . . . . . . . . . . . . 45.4 t30 63.43 88.67 0.1 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.589 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -84.4 -71.04 0.53 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 174.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -110.85 -53.37 2.71 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 170.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 5' ' ' ALA . . . . . 0.722 ' HA ' ' HB2' ' D' ' 8' ' ' GLU . . . 30.16 53.81 0.14 Allowed 'General case' 0 N--CA 1.469 0.49 0 O-C-N 124.683 1.239 . . . . 0.0 113.8 175.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 6' ' ' LEU . . . . . 0.41 HD23 ' C ' ' D' ' 6' ' ' LEU . 5.8 tt -84.59 -70.6 0.57 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -93.03 -10.16 37.18 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 174.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.722 ' HB2' ' HA ' ' D' ' 5' ' ' ALA . 50.4 mt-10 -59.62 -52.55 65.06 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.025 -174.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 9' ' ' GLN . . . . . 0.502 ' HG3' ' HB1' ' D' ' 5' ' ' ALA . 2.1 pp0? -89.05 14.19 11.24 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.41 176.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 10' ' ' MET . . . . . . . . . . . . . 48.3 ttm -104.3 -77.96 0.57 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.132 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -103.03 -54.61 2.58 Favored 'General case' 0 CA--C 1.492 -1.25 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.907 172.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 12' ' ' SER . . . . . 0.715 ' HB3' ' HA ' ' D' ' 8' ' ' GLU . 42.7 t -25.53 -69.28 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 113.663 -1.608 . . . . 0.0 113.899 -170.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.449 ' C ' HG12 ' D' ' 16' ' ' VAL . 55.8 mt -91.69 -8.6 10.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.672 -172.191 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -95.06 -61.16 1.53 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.678 175.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 15' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' D' ' 18' ' ' ASP . 88.5 p -60.45 -21.78 62.71 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 116.906 -0.134 . . . . 0.0 111.238 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 16' ' ' VAL . . . . . 0.687 ' HA ' ' HE2' ' D' ' 19' ' ' LYS . 9.7 p -54.51 -38.48 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 120.761 0.315 . . . . 0.0 110.647 177.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 17' ' ' ASN . . . . . 0.41 ' OD1' HG13 ' D' ' 16' ' ' VAL . 33.0 m-20 -68.61 -35.79 77.81 Favored 'General case' 0 C--O 1.214 -0.793 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.7 178.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 18' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' D' ' 15' ' ' SER . 1.2 m-20 -64.42 -17.29 63.65 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -176.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.687 ' HE2' ' HA ' ' D' ' 16' ' ' VAL . 0.0 OUTLIER -90.78 -44.43 9.45 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-O 122.031 0.919 . . . . 0.0 108.563 173.778 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 20' ' ' LEU . . . . . 1.014 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 75.6 mt -61.76 -39.08 90.36 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 113.515 -1.675 . . . . 0.0 109.937 -178.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 21' ' ' ASN . . . . . 0.437 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 50.7 m-20 -77.99 97.21 5.28 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.558 178.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 22' ' ' LYS . . . . . 0.781 ' HD2' HD12 ' D' ' 47' ' ' ILE . 67.5 mttm -123.12 -43.37 2.22 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -177.169 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.4 -96.22 0.1 Allowed Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 119.403 -1.379 . . . . 0.0 113.721 -176.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 24' ' ' LYS . . . . . 0.799 ' HE2' ' HA ' ' D' ' 48' ' ' SER . 35.0 ttpt -53.81 -47.36 70.92 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.737 0.78 . . . . 0.0 109.404 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 25' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -135.96 153.71 21.55 Favored Glycine 0 N--CA 1.431 -1.642 0 CA-C-N 114.232 -1.349 . . . . 0.0 112.006 176.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 26' ' ' LYS . . . . . 0.723 ' CD ' ' HB2' ' D' ' 41' ' ' SER . 0.1 OUTLIER -150.44 160.48 43.73 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.05 -1.075 . . . . 0.0 110.213 -170.192 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 27' ' ' LEU . . . . . 1.014 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 41.8 tp -135.43 130.1 34.28 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.302 0.572 . . . . 0.0 112.023 -177.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 28' ' ' SER . . . . . 0.547 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 8.1 t -117.46 125.16 50.44 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 29' ' ' LEU . . . . . 0.62 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 1.0 OUTLIER -141.14 148.48 40.12 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 176.584 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 62.5 p -157.8 179.07 9.56 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.205 -179.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 31' ' ' MET . . . . . 0.416 ' SD ' ' N ' ' D' ' 31' ' ' MET . 0.0 OUTLIER -117.95 166.17 12.83 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.396 0.617 . . . . 0.0 110.608 179.795 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 32' ' ' ASN . . . . . 0.653 ' HB3' ' HB2' ' D' ' 35' ' ' GLN . 26.1 t-20 -144.16 87.13 1.87 Allowed 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 176.186 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.74 -98.65 0.7 Allowed Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.187 -1.006 . . . . 0.0 111.281 -171.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 34' ' ' ASN . . . . . 0.417 ' O ' ' HG2' ' D' ' 85' ' ' LYS . 72.4 m-20 -110.66 10.36 22.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.029 0.442 . . . . 0.0 110.395 175.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 35' ' ' GLN . . . . . 0.653 ' HB2' ' HB3' ' D' ' 32' ' ' ASN . 55.9 mm-40 -91.35 165.28 13.5 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 121.533 0.682 . . . . 0.0 112.222 -177.08 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.947 HD11 HG22 ' D' ' 79' ' ' ILE . 1.8 tm? -132.82 135.03 45.41 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.693 172.155 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 37' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 34.9 mmtp -132.1 106.36 7.95 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.698 -171.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 38' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -118.52 148.46 42.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.857 0.361 . . . . 0.0 111.911 -177.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 39' ' ' THR . . . . . 0.547 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 57.2 p -145.43 148.5 33.37 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.265 178.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 40' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' D' ' 26' ' ' LYS . 41.9 p -109.28 131.87 54.66 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 168.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 41' ' ' SER . . . . . 0.723 ' HB2' ' CD ' ' D' ' 26' ' ' LYS . 43.7 m -94.44 147.76 22.91 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 118.915 -1.114 . . . . 0.0 108.882 177.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 42' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' D' ' 41' ' ' SER . 75.1 m-80 80.67 2.5 1.79 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.942 -165.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.19 62.08 2.13 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 168.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 44' ' ' GLY . . . . . 0.479 ' O ' ' HB ' ' D' ' 71' ' ' THR . . . 119.19 -6.48 13.05 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 118.405 -1.855 . . . . 0.0 115.072 168.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 45' ' ' TYR . . . . . 0.766 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 1.3 m-85 -86.17 155.84 20.58 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.98 0.39 . . . . 0.0 111.784 -174.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 46' ' ' GLY . . . . . 0.6 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -94.84 178.95 36.63 Favored Glycine 0 C--O 1.222 -0.654 0 CA-C-O 118.812 -0.993 . . . . 0.0 110.642 174.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 47' ' ' ILE . . . . . 0.781 HD12 ' HD2' ' D' ' 22' ' ' LYS . 33.4 mm -47.65 -57.22 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 CA-C-N 118.109 0.955 . . . . 0.0 110.652 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.799 ' HA ' ' HE2' ' D' ' 24' ' ' LYS . 22.1 t 178.83 -135.24 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.02 -1.446 . . . . 0.0 107.923 -178.175 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -95.03 76.93 3.53 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 165.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 50' ' ' GLU . . . . . 0.853 ' HB3' ' HE3' ' D' ' 52' ' ' LYS . 50.6 mt-10 -144.58 164.63 30.36 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.95 -173.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 51' ' ' ASP . . . . . 0.686 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 10.7 p-10 -132.61 135.49 45.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.231 0.539 . . . . 0.0 111.337 177.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 52' ' ' LYS . . . . . 0.853 ' HE3' ' HB3' ' D' ' 50' ' ' GLU . 0.2 OUTLIER -146.97 142.35 27.44 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.392 -174.261 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 52.6 m-20 -118.25 135.99 53.94 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 172.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 54' ' ' TRP . . . . . 1.065 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 0.9 OUTLIER -126.29 162.49 25.35 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -170.89 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -148.69 163.46 29.03 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.204 174.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 56' ' ' ILE . . . . . 1.064 HG12 HG23 ' D' ' 91' ' ' ILE . 93.6 mt -135.97 108.99 8.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 C-N-CA 124.853 1.261 . . . . 0.0 107.689 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 57' ' ' PHE . . . . . 0.726 ' CE1' ' HE2' ' D' ' 92' ' ' LYS . 14.6 m-85 -107.63 101.55 10.86 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.898 -168.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.806 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 84.0 t -83.24 106.48 13.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.927 171.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 34.9 m120 64.4 45.24 3.84 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.51 0.506 . . . . 0.0 110.692 -177.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.76 41.94 99.68 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.313 -178.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 61' ' ' GLU . . . . . 0.515 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 42.8 tt0 -142.97 112.64 6.9 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.264 -0.468 . . . . 0.0 110.059 178.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 62' ' ' LYS . . . . . 0.524 ' HB2' ' CE2' ' D' ' 57' ' ' PHE . 37.8 ttpt -70.36 105.65 3.1 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.446 -177.254 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 27.6 m -89.14 -24.48 5.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.708 -175.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 64' ' ' TYR . . . . . 0.451 ' HB3' HD12 ' D' ' 56' ' ' ILE . 16.4 t80 -141.36 135.45 30.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.766 0.317 . . . . 0.0 111.035 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 79.6 m -117.66 118.89 33.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.308 175.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 66' ' ' PHE . . . . . 0.456 ' CZ ' ' CE3' ' D' ' 54' ' ' TRP . 9.4 p90 -125.61 159.36 32.35 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 174.243 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 67' ' ' ASN . . . . . 0.561 ' OD1' ' HB2' ' D' ' 69' ' ' LYS . 0.1 OUTLIER -130.2 136.1 48.87 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -174.58 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 68' ' ' GLU . . . . . 0.778 ' HB3' HG12 ' D' ' 47' ' ' ILE . 51.9 mm-40 -68.31 -8.37 39.12 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.368 -175.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.561 ' HB2' ' OD1' ' D' ' 67' ' ' ASN . 6.0 mtpm? -64.74 -44.4 90.24 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 169.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 70' ' ' SER . . . . . 0.475 ' HB3' ' O ' ' D' ' 67' ' ' ASN . 35.0 t -64.61 125.43 24.71 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 113.32 -1.763 . . . . 0.0 107.847 168.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 71' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' D' ' 44' ' ' GLY . 72.3 p -56.03 126.57 26.5 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 72' ' ' VAL . . . . . 0.618 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -57.56 -11.47 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-O 121.04 0.448 . . . . 0.0 111.341 -176.292 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 73' ' ' GLY . . . . . 0.47 ' HA3' ' HA2' ' D' ' 44' ' ' GLY . . . -73.49 -57.34 5.09 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.568 170.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -63.84 -23.84 67.51 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 177.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 75' ' ' ILE . . . . . 0.65 ' O ' HG13 ' D' ' 79' ' ' ILE . 72.0 mt -71.33 -44.8 72.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.216 174.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 76' ' ' SER . . . . . 0.469 ' HA ' HG13 ' D' ' 79' ' ' ILE . 31.8 t -71.55 -25.89 62.41 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 121.116 -0.233 . . . . 0.0 111.037 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 77' ' ' ASN . . . . . 0.423 ' O ' ' HD2' ' D' ' 81' ' ' LYS . 69.1 m-20 -60.71 -26.36 67.1 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 169.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 78' ' ' ASP . . . . . 1.023 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 80.7 m-20 -86.3 -37.54 18.42 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.196 174.457 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 79' ' ' ILE . . . . . 0.947 HG22 HD11 ' D' ' 36' ' ' LEU . 24.2 mt -64.85 -27.96 43.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 O-C-N 121.897 -0.502 . . . . 0.0 110.803 -175.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -69.11 -29.49 67.57 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.293 178.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 81' ' ' LYS . . . . . 1.023 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -85.04 -49.45 8.28 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 119.677 -0.809 . . . . 0.0 111.323 175.116 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 82' ' ' LEU . . . . . 0.642 HD23 ' O ' ' D' ' 78' ' ' ASP . 4.1 mm? -50.43 -26.57 5.18 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 52.89 66.91 1.09 Allowed 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.617 0.573 . . . . 0.0 110.153 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 84' ' ' ILE . . . . . 0.53 HG23 HG21 ' D' ' 56' ' ' ILE . 50.3 mm -73.66 99.94 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.601 -175.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 85' ' ' LYS . . . . . 0.54 ' C ' ' HE3' ' D' ' 85' ' ' LYS . 0.0 OUTLIER -142.39 -171.57 3.43 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 179.7 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 86' ' ' GLY . . . . . 0.694 ' HA2' HD11 ' D' ' 89' ' ' ILE . . . -61.22 168.12 11.54 Favored Glycine 0 CA--C 1.507 -0.45 0 CA-C-N 115.316 -0.856 . . . . 0.0 114.543 -174.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 87' ' ' PRO . . . . . 0.671 ' O ' HG13 ' D' ' 58' ' ' VAL . 45.2 Cg_endo -91.38 178.4 14.33 Favored 'Cis proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.868 -1.722 . . . . 0.0 114.171 0.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 88' ' ' TYR . . . . . 0.806 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 1.4 m-85 36.67 91.39 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 O-C-N 124.483 1.115 . . . . 0.0 112.435 178.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.694 HD11 ' HA2' ' D' ' 86' ' ' GLY . 3.5 mp -111.09 121.88 64.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.507 0.67 . . . . 0.0 111.03 -176.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.638 ' HB2' ' HB2' ' D' ' 57' ' ' PHE . 54.3 mt-10 -124.15 88.99 3.0 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.916 177.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 91' ' ' ILE . . . . . 1.065 HG22 ' HZ3' ' D' ' 54' ' ' TRP . 4.1 mt -100.06 111.05 28.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 92' ' ' LYS . . . . . 0.726 ' HE2' ' CE1' ' D' ' 57' ' ' PHE . 0.0 OUTLIER -162.57 172.47 15.37 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 93' ' ' GLN . . . . . 0.651 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 17.2 pt20 -81.33 158.45 24.72 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.807 173.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 7.6 pt . . . . . 0 C--N 1.305 -1.364 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.631 -172.394 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 53.3 p30 . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 120.906 0.384 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' D' D ' 2' ' ' ASN . . . . . 0.463 ' HB3' ' HD2' ' D' ' 4' ' ' LYS . 71.7 m-20 -107.9 128.76 54.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.953 -179.424 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -87.55 9.26 21.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.474 179.137 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' D' D ' 4' ' ' LYS . . . . . 0.715 ' H ' ' HD2' ' D' ' 4' ' ' LYS . 0.0 OUTLIER -108.78 15.6 23.46 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 172.485 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' D' D ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.23 133.94 55.1 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.89 -179.624 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' D' D ' 6' ' ' LEU . . . . . 0.463 ' N ' HD22 ' D' ' 6' ' ' LEU . 2.5 mm? -83.46 -0.13 48.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.306 -177.839 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 7' ' ' GLU . . . . . 0.67 ' HA ' ' HB2' ' D' ' 10' ' ' MET . 94.5 mt-10 -75.73 -0.83 22.23 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -176.53 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.478 ' HG3' ' NE2' ' D' ' 9' ' ' GLN . 10.4 pt-20 -53.57 -51.2 63.73 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -172.34 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 9' ' ' GLN . . . . . 0.478 ' NE2' ' HG3' ' D' ' 8' ' ' GLU . 0.1 OUTLIER -97.19 13.96 27.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.886 0.374 . . . . 0.0 110.667 174.17 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' D' D ' 10' ' ' MET . . . . . 0.67 ' HB2' ' HA ' ' D' ' 7' ' ' GLU . 24.3 mmt -106.03 -72.35 0.72 Allowed 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.264 -174.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -103.54 -45.08 4.94 Favored 'General case' 0 CA--C 1.495 -1.15 0 CA-C-O 120.94 0.4 . . . . 0.0 110.742 174.867 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' D' D ' 12' ' ' SER . . . . . 0.647 ' O ' ' HB ' ' D' ' 16' ' ' VAL . 41.3 t -35.29 -71.71 0.06 Allowed 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 113.722 -1.581 . . . . 0.0 112.872 -168.266 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.567 ' O ' HG12 ' D' ' 16' ' ' VAL . 48.4 mt -93.18 -9.45 9.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.649 -177.558 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 14' ' ' ASN . . . . . 0.598 ' HB2' ' O ' ' D' ' 10' ' ' MET . 5.2 m120 -93.87 -57.07 2.66 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.604 -176.992 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 15' ' ' SER . . . . . 0.688 ' HA ' ' OD2' ' D' ' 18' ' ' ASP . 97.5 p -69.65 -16.16 63.32 Favored 'General case' 0 C--O 1.218 -0.59 0 C-N-CA 120.156 -0.618 . . . . 0.0 110.199 175.23 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 16' ' ' VAL . . . . . 0.647 ' HB ' ' O ' ' D' ' 12' ' ' SER . 1.5 p -56.08 -23.9 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 121.974 0.892 . . . . 0.0 109.138 174.336 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 17' ' ' ASN . . . . . 0.63 ' HB3' ' ND2' ' D' ' 21' ' ' ASN . 5.4 m120 -84.71 -32.38 23.57 Favored 'General case' 0 C--O 1.206 -1.232 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.204 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 18' ' ' ASP . . . . . 0.688 ' OD2' ' HA ' ' D' ' 15' ' ' SER . 63.0 m-20 -61.61 -14.91 34.66 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 177.667 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.862 ' HE2' ' N ' ' D' ' 19' ' ' LYS . 0.3 OUTLIER -86.4 -48.54 8.36 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 174.334 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' D' D ' 20' ' ' LEU . . . . . 0.98 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 71.9 mt -64.92 -40.79 95.6 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 112.299 -2.228 . . . . 0.0 110.497 -176.122 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 21' ' ' ASN . . . . . 0.734 ' OD1' ' HB2' ' D' ' 26' ' ' LYS . 75.1 m-20 -85.33 97.74 10.14 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.434 -179.598 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 22' ' ' LYS . . . . . 0.607 ' HB3' ' NZ ' ' D' ' 22' ' ' LYS . 7.5 mtpm? -123.03 -41.67 2.32 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 118.767 -1.173 . . . . 0.0 114.125 -178.018 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 173.38 -82.52 0.08 OUTLIER Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 119.901 -1.143 . . . . 0.0 112.527 -177.473 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' D' D ' 24' ' ' LYS . . . . . 0.866 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 27.2 tptp -48.18 -60.94 2.26 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.675 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -134.73 160.14 24.15 Favored Glycine 0 N--CA 1.433 -1.542 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.451 174.646 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' D' D ' 26' ' ' LYS . . . . . 0.734 ' HB2' ' OD1' ' D' ' 21' ' ' ASN . 0.1 OUTLIER -149.63 159.74 44.08 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.57 -0.815 . . . . 0.0 111.099 -168.611 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' D' D ' 27' ' ' LEU . . . . . 0.98 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 44.9 tp -143.73 139.15 29.3 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.96 0.409 . . . . 0.0 111.942 -178.621 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 28' ' ' SER . . . . . 0.599 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 8.7 t -127.7 153.77 46.11 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 174.834 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 29' ' ' LEU . . . . . . . . . . . . . 18.4 mt -133.96 140.52 46.8 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.886 178.717 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 49.8 m -152.44 -176.28 5.64 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.731 178.065 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 66.8 mtm -136.24 166.39 23.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.056 0.455 . . . . 0.0 110.546 -179.849 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' D' D ' 32' ' ' ASN . . . . . 0.556 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 24.4 t-20 -146.06 88.38 1.81 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.39 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.15 -105.32 1.81 Allowed Glycine 0 N--CA 1.454 -0.144 0 C-N-CA 119.998 -1.096 . . . . 0.0 110.749 -170.344 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -114.16 29.89 7.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.177 0.513 . . . . 0.0 109.952 171.462 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' D' D ' 35' ' ' GLN . . . . . 0.556 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 12.5 tp-100 -102.31 155.75 18.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.241 -178.146 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.636 HD11 HG22 ' D' ' 79' ' ' ILE . 2.5 tm? -113.43 129.16 56.61 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 175.888 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 37' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -136.14 99.01 4.01 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.967 -169.393 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' D' D ' 38' ' ' ALA . . . . . 0.681 ' HB1' HD11 ' D' ' 27' ' ' LEU . . . -98.21 150.76 21.16 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.017 176.115 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 39' ' ' THR . . . . . 0.599 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 74.4 p -133.67 123.01 24.26 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 174.394 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 40' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' D' ' 26' ' ' LYS . 18.7 m -115.7 128.89 56.23 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.233 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 41' ' ' SER . . . . . 0.62 ' HB2' ' CD ' ' D' ' 26' ' ' LYS . 31.9 m -104.87 162.05 13.66 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.42 -173.066 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 42' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' D' ' 41' ' ' SER . 74.7 m-80 77.35 9.9 2.51 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 114.197 -1.365 . . . . 0.0 110.52 -171.68 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 49.04 60.5 3.7 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 114.799 -1.092 . . . . 0.0 113.753 169.902 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' D' D ' 44' ' ' GLY . . . . . 0.455 ' C ' ' HD2' ' D' ' 45' ' ' TYR . . . 106.72 37.11 2.45 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 119.216 -1.469 . . . . 0.0 114.043 171.193 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 45' ' ' TYR . . . . . 0.866 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 3.9 m-30 -114.59 153.33 30.31 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 117.376 0.588 . . . . 0.0 110.037 176.921 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 46' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -97.82 -155.77 29.9 Favored Glycine 0 C--O 1.217 -0.909 0 CA-C-O 119.459 -0.634 . . . . 0.0 111.598 178.014 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 47' ' ' ILE . . . . . 0.963 HG13 ' HB3' ' D' ' 68' ' ' GLU . 0.4 OUTLIER -54.62 -56.53 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-O 122.118 0.961 . . . . 0.0 108.659 -179.994 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' D' ' 47' ' ' ILE . 26.3 t 162.33 -60.3 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 111.922 -2.399 . . . . 0.0 106.909 -174.991 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -169.89 76.27 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.546 172.683 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 50' ' ' GLU . . . . . 0.661 ' O ' ' HG2' ' D' ' 69' ' ' LYS . 49.0 mt-10 -149.27 -177.94 6.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.881 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 51' ' ' ASP . . . . . 0.592 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 1.0 OUTLIER -129.07 130.15 46.17 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.457 0.646 . . . . 0.0 111.316 172.553 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' D' D ' 52' ' ' LYS . . . . . 0.592 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 0.4 OUTLIER -141.77 100.92 3.85 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.861 -179.833 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' D' D ' 53' ' ' ASN . . . . . 0.618 ' HA ' ' OD1' ' D' ' 67' ' ' ASN . 38.3 m-20 -78.16 125.7 29.74 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 176.396 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 54' ' ' TRP . . . . . 0.572 ' HB2' ' O ' ' D' ' 66' ' ' PHE . 0.1 OUTLIER -118.21 155.86 29.78 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.385 -171.948 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -148.13 161.79 28.66 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 119.833 -1.175 . . . . 0.0 114.297 175.751 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' D' D ' 56' ' ' ILE . . . . . 0.506 HG23 HG12 ' D' ' 91' ' ' ILE . 71.9 mt -135.09 111.25 13.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 57' ' ' PHE . . . . . 0.65 ' HZ ' HG21 ' D' ' 94' ' ' ILE . 9.2 m-85 -111.83 114.16 26.95 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.654 -166.872 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.938 HG22 HG12 ' D' ' 89' ' ' ILE . 59.6 t -96.28 105.92 17.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.903 174.661 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 7.0 m120 56.42 51.74 10.99 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.155 -176.374 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.04 48.08 68.4 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.823 178.941 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' D' D ' 61' ' ' GLU . . . . . 0.619 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 86.9 tt0 -150.29 116.87 5.79 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 177.631 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 62' ' ' LYS . . . . . 0.447 ' HB2' ' CE1' ' D' ' 57' ' ' PHE . 27.3 ttpp -75.86 99.91 4.63 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.971 0.415 . . . . 0.0 110.282 179.086 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 30.3 m -84.96 -27.2 6.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.051 -175.205 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' D' D ' 64' ' ' TYR . . . . . 0.449 ' HB3' HD12 ' D' ' 56' ' ' ILE . 14.4 t80 -136.75 131.46 33.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.736 0.303 . . . . 0.0 110.373 178.367 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 19.4 m -117.98 104.6 11.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.94 177.816 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' D' D ' 66' ' ' PHE . . . . . 0.572 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 12.2 p90 -114.64 164.68 13.69 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 175.515 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 67' ' ' ASN . . . . . 0.618 ' OD1' ' HA ' ' D' ' 53' ' ' ASN . 74.8 m-20 -130.88 152.0 50.68 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.289 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 68' ' ' GLU . . . . . 0.963 ' HB3' HG13 ' D' ' 47' ' ' ILE . 84.0 mt-10 -68.78 -18.94 64.28 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.689 -0.804 . . . . 0.0 109.774 174.257 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.661 ' HG2' ' O ' ' D' ' 50' ' ' GLU . 45.4 mtmt -61.38 -42.46 98.75 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 172.61 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 70' ' ' SER . . . . . 0.403 ' HB3' ' O ' ' D' ' 67' ' ' ASN . 27.7 t -67.87 125.41 26.19 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 113.669 -1.605 . . . . 0.0 107.405 170.503 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 76.6 p -58.19 116.33 3.5 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -176.539 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' D' D ' 72' ' ' VAL . . . . . 0.745 ' HA ' HD12 ' D' ' 75' ' ' ILE . 0.0 OUTLIER -51.41 -20.56 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-O 120.674 0.273 . . . . 0.0 111.472 -173.654 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' D' D ' 73' ' ' GLY . . . . . 0.533 ' HA2' ' HB2' ' D' ' 40' ' ' SER . . . -63.39 -59.91 8.22 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.709 -0.678 . . . . 0.0 113.081 172.422 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -66.61 -18.75 65.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.444 0.164 . . . . 0.0 110.902 178.62 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' D' D ' 75' ' ' ILE . . . . . 0.745 HD12 ' HA ' ' D' ' 72' ' ' VAL . 77.7 mt -71.6 -42.39 71.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.021 173.752 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 76' ' ' SER . . . . . 0.444 ' HA ' HG13 ' D' ' 79' ' ' ILE . 47.1 t -74.1 -22.68 59.39 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.008 -177.439 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -63.93 -27.29 69.05 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 168.32 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' D' D ' 78' ' ' ASP . . . . . 1.035 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 51.6 m-20 -83.6 -36.14 24.13 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.943 173.187 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 79' ' ' ILE . . . . . 0.687 HG13 ' O ' ' D' ' 75' ' ' ILE . 22.2 mt -67.05 -16.04 20.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.266 -175.6 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 -69.85 -48.83 57.37 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.108 174.127 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' D' D ' 81' ' ' LYS . . . . . 1.035 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -69.39 -47.82 63.03 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.645 178.427 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' D' D ' 82' ' ' LEU . . . . . 0.618 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.5 mm? -54.26 -23.97 16.98 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 178.195 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 83' ' ' ASN . . . . . 0.474 ' O ' ' HE2' ' D' ' 85' ' ' LYS . 49.0 t-20 39.25 69.29 0.29 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.916 0.886 . . . . 0.0 111.159 176.008 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 84' ' ' ILE . . . . . 0.597 HG23 HD13 ' D' ' 89' ' ' ILE . 47.8 mm -75.17 99.28 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.166 -172.991 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 85' ' ' LYS . . . . . 0.542 ' O ' ' HE3' ' D' ' 85' ' ' LYS . 0.0 OUTLIER -158.19 91.44 1.1 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 173.972 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' D' D ' 86' ' ' GLY . . . . . 0.549 ' H ' HD12 ' D' ' 89' ' ' ILE . . . 69.63 154.51 0.97 Allowed Glycine 0 C--N 1.329 0.175 0 CA-C-N 115.127 -0.942 . . . . 0.0 114.106 173.163 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 87' ' ' PRO . . . . . 0.619 ' O ' HG13 ' D' ' 58' ' ' VAL . 68.8 Cg_endo -87.33 178.96 19.74 Favored 'Cis proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.681 -1.8 . . . . 0.0 112.09 -0.301 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 88' ' ' TYR . . . . . 0.648 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 2.3 m-85 4.67 91.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 125.253 1.421 . . . . 0.0 113.942 -175.45 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.938 HG12 HG22 ' D' ' 58' ' ' VAL . 66.2 mt -111.38 129.19 67.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.999 -179.803 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.542 ' O ' ' HD2' ' D' ' 57' ' ' PHE . 49.2 mm-40 -112.33 100.36 8.73 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.879 175.266 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 91' ' ' ILE . . . . . 0.582 HG13 HG22 ' D' ' 89' ' ' ILE . 35.0 mt -94.38 101.19 12.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.05 -178.744 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 92' ' ' LYS . . . . . 0.627 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -160.5 163.64 32.73 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.107 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' D' D ' 93' ' ' GLN . . . . . 0.609 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 19.7 pt20 -79.53 167.4 20.81 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 119.764 -0.774 . . . . 0.0 110.807 176.818 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' D' D ' 94' ' ' ILE . . . . . 0.65 HG21 ' HZ ' ' D' ' 57' ' ' PHE . 10.9 pt . . . . . 0 C--N 1.313 -1.006 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.572 -170.991 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 58.6 t0 . . . . . 0 N--CA 1.483 1.178 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' D' D ' 2' ' ' ASN . . . . . 0.711 ' HB3' ' HB2' ' D' ' 5' ' ' ALA . 50.9 t-20 -75.02 120.49 20.63 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.545 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -64.5 -25.12 67.85 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -175.472 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -111.18 22.36 15.31 Favored 'General case' 0 CA--C 1.518 -0.27 0 O-C-N 122.189 -0.32 . . . . 0.0 111.32 179.123 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' D' D ' 5' ' ' ALA . . . . . 0.711 ' HB2' ' HB3' ' D' ' 2' ' ' ASN . . . -59.01 -34.1 71.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.914 0.387 . . . . 0.0 111.545 -177.145 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 88.4 mt -104.76 -22.72 13.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.555 -178.527 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -90.16 -0.72 57.75 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -177.35 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.559 ' O ' ' HB3' ' D' ' 12' ' ' SER . 10.4 pt-20 -58.3 -50.51 73.34 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -174.843 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.06 15.03 16.06 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.841 0.353 . . . . 0.0 111.526 177.196 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 10' ' ' MET . . . . . . . . . . . . . 95.2 mmm -103.16 -77.12 0.57 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.097 179.698 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -104.6 -38.05 6.89 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.159 173.601 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' D' D ' 12' ' ' SER . . . . . 0.696 ' O ' ' HB ' ' D' ' 16' ' ' VAL . 42.8 t -40.06 -68.29 0.18 Allowed 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.329 -1.305 . . . . 0.0 112.741 -166.618 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.645 ' O ' HG12 ' D' ' 16' ' ' VAL . 51.6 mt -90.84 -8.62 10.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.544 -175.547 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 52.6 m-20 -85.25 -59.19 2.4 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.291 176.137 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' D' D ' 15' ' ' SER . . . . . 0.476 ' O ' ' HE2' ' D' ' 19' ' ' LYS . 88.7 p -68.22 -13.88 62.57 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 175.603 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 16' ' ' VAL . . . . . 0.696 ' HB ' ' O ' ' D' ' 12' ' ' SER . 0.9 OUTLIER -62.18 -25.68 38.18 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.92 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 19.7 m-20 -73.56 -42.24 61.9 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 114.383 -1.281 . . . . 0.0 108.592 177.122 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' D' D ' 18' ' ' ASP . . . . . 0.401 ' OD1' ' HA ' ' D' ' 15' ' ' SER . 1.6 m-20 -59.25 -14.85 12.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.864 -178.387 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.498 ' CE ' ' HA ' ' D' ' 16' ' ' VAL . 34.9 mttm -91.1 -45.77 8.5 Favored 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 123.198 1.475 . . . . 0.0 108.803 -179.743 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 20' ' ' LEU . . . . . 0.841 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 59.1 mt -66.53 -36.53 82.92 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 111.986 -2.37 . . . . 0.0 109.795 -179.87 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 21' ' ' ASN . . . . . 0.657 ' HA ' ' HB2' ' D' ' 26' ' ' LYS . 43.7 m-20 -74.91 94.4 2.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.399 178.837 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 22' ' ' LYS . . . . . 0.467 ' HD2' HD12 ' D' ' 47' ' ' ILE . 43.3 mttp -122.46 -43.29 2.3 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -176.681 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 171.68 -87.98 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 119.125 -1.512 . . . . 0.0 113.63 -177.13 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' D' D ' 24' ' ' LYS . . . . . 0.637 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 0.0 OUTLIER -48.02 -53.42 16.35 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.943 0.877 . . . . 0.0 109.172 179.166 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' D' D ' 25' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -149.32 156.11 26.64 Favored Glycine 0 N--CA 1.43 -1.761 0 CA-C-N 113.928 -1.487 . . . . 0.0 110.918 177.898 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 26' ' ' LYS . . . . . 0.717 ' HD2' ' HB3' ' D' ' 41' ' ' SER . 8.7 ptpt -151.15 160.4 43.88 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 114.331 -0.934 . . . . 0.0 110.52 -167.128 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 27' ' ' LEU . . . . . 0.841 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 49.7 tp -134.61 147.35 50.19 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.402 0.62 . . . . 0.0 111.937 -176.645 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 28' ' ' SER . . . . . 0.582 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 33.5 t -132.5 128.65 37.8 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.437 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 29' ' ' LEU . . . . . 0.561 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 9.3 mt -126.94 144.9 50.87 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.796 177.74 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 73.1 p -160.32 176.89 11.18 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.977 177.7 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' D' D ' 31' ' ' MET . . . . . 0.515 ' HA ' ' O ' ' D' ' 35' ' ' GLN . 0.0 OUTLIER -129.65 116.89 19.5 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.377 0.608 . . . . 0.0 110.417 177.076 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -90.36 89.36 7.58 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.395 -0.821 . . . . 0.0 108.97 179.329 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.68 -103.31 2.07 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.275 -0.964 . . . . 0.0 111.064 -171.083 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -120.4 31.14 6.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.381 0.61 . . . . 0.0 109.883 174.674 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' D' D ' 35' ' ' GLN . . . . . 0.515 ' O ' ' HA ' ' D' ' 31' ' ' MET . 64.6 tt0 -108.36 158.69 17.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.308 -174.674 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.644 HD11 HG22 ' D' ' 79' ' ' ILE . 2.5 tm? -112.77 126.96 55.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.668 0.271 . . . . 0.0 110.346 178.951 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 37' ' ' LYS . . . . . 0.567 ' NZ ' ' HB3' ' D' ' 37' ' ' LYS . 1.6 mmmp? -132.58 115.7 15.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.973 -168.113 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 38' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -119.91 142.54 48.62 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.925 174.617 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 39' ' ' THR . . . . . 0.582 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 15.1 p -145.76 132.46 19.96 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.057 177.73 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 40' ' ' SER . . . . . 0.809 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 78.8 p -112.28 145.38 40.08 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.326 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 41' ' ' SER . . . . . 0.717 ' HB3' ' HD2' ' D' ' 26' ' ' LYS . 44.3 t -104.39 149.8 25.08 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 118.949 -1.101 . . . . 0.0 109.821 177.176 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 42' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' D' ' 41' ' ' SER . 33.3 m120 80.31 1.42 1.96 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.891 -171.731 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 44.58 57.76 4.27 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 170.927 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.91 35.77 0.71 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 119.419 -1.372 . . . . 0.0 113.857 173.313 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' D' D ' 45' ' ' TYR . . . . . 0.637 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 18.2 m-85 -126.31 148.37 49.55 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 172.1 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 46' ' ' GLY . . . . . 0.473 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -88.2 -168.94 44.74 Favored Glycine 0 CA--C 1.497 -1.062 0 N-CA-C 110.579 -1.009 . . . . 0.0 110.579 175.782 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 47' ' ' ILE . . . . . 0.818 HG12 ' HB3' ' D' ' 68' ' ' GLU . 50.4 mm -45.41 -56.71 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 CA-C-O 121.53 0.681 . . . . 0.0 110.001 178.714 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.414 ' HA ' ' CB ' ' D' ' 24' ' ' LYS . 40.8 t 173.41 -103.18 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 112.552 -2.113 . . . . 0.0 109.258 173.868 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -119.54 74.55 1.01 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.223 0.535 . . . . 0.0 111.705 175.129 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 50' ' ' GLU . . . . . 0.499 ' HA ' ' OE1' ' D' ' 50' ' ' GLU . 3.7 mm-40 -155.74 -170.35 3.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.946 173.12 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 51' ' ' ASP . . . . . 0.615 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 1.8 m-20 -133.45 138.98 46.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.928 175.458 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 52' ' ' LYS . . . . . 0.615 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 0.1 OUTLIER -144.24 144.12 31.36 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 177.926 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 53.8 m-20 -114.6 142.77 46.01 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 176.672 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' D' D ' 54' ' ' TRP . . . . . 0.71 ' HZ3' HG23 ' D' ' 91' ' ' ILE . 0.7 OUTLIER -126.71 153.84 44.92 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -173.919 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -142.31 159.76 27.16 Favored Glycine 0 N--CA 1.44 -1.091 0 CA-C-N 114.832 -1.076 . . . . 0.0 113.266 174.074 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' D' D ' 56' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' D' ' 90' ' ' GLU . 72.3 mt -137.85 105.78 3.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 179.461 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 57' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' D' ' 61' ' ' GLU . 8.9 m-85 -106.47 109.87 21.91 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.676 -0.809 . . . . 0.0 111.353 -170.032 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 94.7 t -88.69 110.6 21.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.957 173.837 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 59' ' ' ASN . . . . . 0.417 ' OD1' ' HG2' ' D' ' 87' ' ' PRO . 6.0 m120 53.39 53.83 11.09 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.191 -176.926 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.9 48.71 78.62 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.941 178.594 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' D' D ' 61' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 89.1 tt0 -156.73 116.43 3.5 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.686 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 62' ' ' LYS . . . . . 0.488 ' HB2' ' CE2' ' D' ' 57' ' ' PHE . 5.5 ttpm? -73.67 101.46 3.65 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -177.864 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 32.5 m -85.74 -25.53 6.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.998 -175.508 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' D' D ' 64' ' ' TYR . . . . . 0.405 ' HB3' HD12 ' D' ' 56' ' ' ILE . 15.1 t80 -140.28 137.94 34.59 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.222 178.822 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.487 ' OG1' ' HE2' ' D' ' 62' ' ' LYS . 38.5 m -120.13 119.03 32.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.102 174.531 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 66' ' ' PHE . . . . . 0.594 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 9.3 p90 -126.75 158.91 35.28 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 170.843 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 67' ' ' ASN . . . . . 0.674 ' O ' HD11 ' D' ' 75' ' ' ILE . 72.4 m-80 -128.51 142.24 51.14 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.505 -173.21 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 68' ' ' GLU . . . . . 0.818 ' HB3' HG12 ' D' ' 47' ' ' ILE . 5.0 mm-40 -67.14 -10.32 48.97 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 174.586 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.573 ' HE3' ' OD2' ' D' ' 51' ' ' ASP . 48.2 mtpt -63.19 -47.44 82.57 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 114.196 -1.365 . . . . 0.0 107.597 169.947 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t -67.3 138.04 56.54 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 113.505 -1.68 . . . . 0.0 107.961 170.249 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' D' D ' 71' ' ' THR . . . . . 0.448 ' O ' HG13 ' D' ' 75' ' ' ILE . 79.4 p -62.51 122.33 15.5 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.294 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 72' ' ' VAL . . . . . 0.687 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -56.57 -12.93 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 120.966 0.412 . . . . 0.0 111.243 -176.228 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' D' D ' 73' ' ' GLY . . . . . 0.809 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -69.38 -59.95 5.42 Favored Glycine 0 N--CA 1.435 -1.375 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.743 170.169 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -62.72 -27.34 69.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.965 0.412 . . . . 0.0 109.97 177.74 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' D' D ' 75' ' ' ILE . . . . . 0.674 HD11 ' O ' ' D' ' 67' ' ' ASN . 77.7 mt -68.15 -45.28 83.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.899 176.328 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 29.1 t -75.78 -19.43 58.99 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.216 -176.98 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' D' D ' 77' ' ' ASN . . . . . 0.445 ' O ' ' HD2' ' D' ' 81' ' ' LYS . 29.1 m120 -64.48 -31.5 72.74 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 166.198 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 78' ' ' ASP . . . . . 1.091 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 58.4 m-20 -78.52 -39.89 36.75 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.567 175.304 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 79' ' ' ILE . . . . . 0.644 HG22 HD11 ' D' ' 36' ' ' LEU . 22.2 mt -67.29 -17.15 22.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.349 -174.401 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -71.29 -42.92 68.1 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.375 175.65 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' D' D ' 81' ' ' LYS . . . . . 1.091 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -73.26 -51.9 15.96 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.161 176.914 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' D' D ' 82' ' ' LEU . . . . . 0.611 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.7 mm? -48.05 -32.09 6.26 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 178.226 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 34.41 65.24 0.34 Allowed 'General case' 0 N--CA 1.477 0.914 0 O-C-N 124.18 0.925 . . . . 0.0 111.602 175.756 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' D' D ' 84' ' ' ILE . . . . . 0.474 HG22 HD13 ' D' ' 89' ' ' ILE . 44.1 mt -92.84 99.89 10.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.003 0.43 . . . . 0.0 111.974 -172.839 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.96 94.27 3.68 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.616 0.722 . . . . 0.0 112.065 177.726 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 86' ' ' GLY . . . . . 0.655 ' H ' HD11 ' D' ' 89' ' ' ILE . . . 71.46 155.99 2.23 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.356 177.795 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 87' ' ' PRO . . . . . 0.493 ' O ' HG13 ' D' ' 58' ' ' VAL . 60.7 Cg_endo -89.31 179.99 15.09 Favored 'Cis proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.141 -1.608 . . . . 0.0 113.045 0.112 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 88' ' ' TYR . . . . . 0.578 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 10.2 m-85 8.27 93.8 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 125.48 1.512 . . . . 0.0 113.875 -176.366 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.655 HD11 ' H ' ' D' ' 86' ' ' GLY . 72.4 mt -108.71 137.74 39.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -177.885 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.443 ' HB2' ' HD1' ' D' ' 57' ' ' PHE . 55.2 mm-40 -113.48 93.04 4.21 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.084 170.161 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 91' ' ' ILE . . . . . 0.71 HG23 ' HZ3' ' D' ' 54' ' ' TRP . 23.7 mt -93.68 100.7 11.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.563 178.155 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 92' ' ' LYS . . . . . 0.841 ' HE3' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -162.82 169.45 19.83 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.177 -178.223 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' D' D ' 93' ' ' GLN . . . . . 0.707 ' O ' ' HD3' ' D' ' 92' ' ' LYS . 25.7 pt20 -87.28 151.76 22.86 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.634 172.177 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' D' D ' 94' ' ' ILE . . . . . 0.841 HG22 ' HE3' ' D' ' 92' ' ' LYS . 9.1 pt . . . . . 0 C--N 1.307 -1.249 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.933 -170.539 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 2.2 p30 . . . . . 0 N--CA 1.485 1.299 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' D' D ' 2' ' ' ASN . . . . . 0.472 ' ND2' ' HB2' ' D' ' 7' ' ' GLU . 25.3 t-20 -85.61 88.02 7.48 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -179.391 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -102.05 -11.65 18.73 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -177.288 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' D' D ' 4' ' ' LYS . . . . . 0.425 ' HB3' ' NZ ' ' D' ' 4' ' ' LYS . 3.1 mmmp? -98.06 -10.97 23.46 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 121.104 -0.238 . . . . 0.0 110.702 -177.844 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 5' ' ' ALA . . . . . . . . . . . . . . . 59.8 34.92 21.98 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.972 179.366 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' D' D ' 6' ' ' LEU . . . . . 0.476 ' O ' HD23 ' D' ' 6' ' ' LEU . 6.2 tt -110.63 -42.05 4.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.076 0.465 . . . . 0.0 109.76 179.212 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 7' ' ' GLU . . . . . 0.472 ' HB2' ' ND2' ' D' ' 2' ' ' ASN . 52.8 mp0 -67.98 -7.73 31.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.086 -176.479 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.81 ' HA ' ' CB ' ' D' ' 12' ' ' SER . 14.0 pt-20 -79.69 -18.14 52.03 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.9 -179.006 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 9' ' ' GLN . . . . . 0.698 ' OE1' ' HG3' ' D' ' 8' ' ' GLU . 3.7 mp0 -90.19 6.96 40.48 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.814 170.35 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 10' ' ' MET . . . . . . . . . . . . . 26.0 mmt -107.71 -76.06 0.62 Allowed 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -175.752 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -102.1 -37.47 8.14 Favored 'General case' 0 CA--C 1.495 -1.145 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.252 178.397 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' D' D ' 12' ' ' SER . . . . . 0.81 ' CB ' ' HA ' ' D' ' 8' ' ' GLU . 36.0 t -43.54 -59.28 2.23 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.596 -1.184 . . . . 0.0 112.504 -169.124 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.434 ' C ' HG12 ' D' ' 16' ' ' VAL . 59.1 mt -90.12 -7.5 10.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 114.506 -1.224 . . . . 0.0 110.907 -174.173 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -94.41 -60.84 1.63 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.843 175.754 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 92.8 p -65.87 -18.51 65.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.822 -0.172 . . . . 0.0 111.152 -179.088 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' D' D ' 16' ' ' VAL . . . . . 0.792 ' HA ' ' HE2' ' D' ' 19' ' ' LYS . 14.5 p -54.77 -36.27 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 175.02 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 17' ' ' ASN . . . . . 0.591 ' OD1' ' HA ' ' D' ' 28' ' ' SER . 78.8 m-20 -76.23 -27.7 56.9 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.675 -178.682 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.92 -16.14 64.13 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 179.509 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.792 ' HE2' ' HA ' ' D' ' 16' ' ' VAL . 0.0 OUTLIER -90.92 -28.99 17.72 Favored 'General case' 0 CA--C 1.494 -1.199 0 CA-C-O 121.68 0.752 . . . . 0.0 109.046 173.486 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' D' D ' 20' ' ' LEU . . . . . 0.902 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 79.5 mt -82.98 -40.09 20.48 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 113.98 -1.464 . . . . 0.0 109.715 -173.14 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 21' ' ' ASN . . . . . 0.643 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 53.0 m-20 -78.3 92.25 4.5 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.032 -1.44 . . . . 0.0 110.694 178.69 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 22' ' ' LYS . . . . . 0.549 ' HD3' HG23 ' D' ' 47' ' ' ILE . 7.3 mtpm? -123.96 -43.58 2.1 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -172.262 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 172.1 -71.63 0.11 Allowed Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 119.195 -1.478 . . . . 0.0 113.805 -175.209 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' D' D ' 24' ' ' LYS . . . . . 0.828 ' HB3' ' O ' ' D' ' 46' ' ' GLY . 17.4 tptp -56.99 -66.02 0.52 Allowed 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 179.449 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -137.19 172.32 22.73 Favored Glycine 0 N--CA 1.426 -1.975 0 CA-C-N 113.656 -1.611 . . . . 0.0 110.256 171.578 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' D' D ' 26' ' ' LYS . . . . . 0.643 ' CB ' ' HA ' ' D' ' 21' ' ' ASN . 10.5 ptpt -148.1 161.64 41.01 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.502 -0.349 . . . . 0.0 111.629 -170.294 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 27' ' ' LEU . . . . . 0.902 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 37.4 tp -134.84 145.48 48.36 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.152 0.501 . . . . 0.0 112.007 179.486 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 28' ' ' SER . . . . . 0.647 ' H ' HD12 ' D' ' 27' ' ' LEU . 29.5 t -134.04 139.23 45.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.582 -178.503 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 29' ' ' LEU . . . . . . . . . . . . . 15.2 mt -130.94 130.4 43.4 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.059 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 49.3 m -134.35 174.2 10.79 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 178.789 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' D' D ' 31' ' ' MET . . . . . 0.769 ' HA ' ' O ' ' D' ' 35' ' ' GLN . 25.8 ptt? -137.72 121.94 18.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.815 0.817 . . . . 0.0 111.681 176.681 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -92.2 88.32 6.44 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.025 173.531 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.69 -102.35 1.75 Allowed Glycine 0 N--CA 1.454 -0.141 0 C-N-CA 120.155 -1.021 . . . . 0.0 110.879 -170.431 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -120.21 31.25 6.58 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.179 0.514 . . . . 0.0 109.845 174.02 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' D' D ' 35' ' ' GLN . . . . . 0.769 ' O ' ' HA ' ' D' ' 31' ' ' MET . 64.1 tt0 -111.43 118.08 34.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.598 -175.519 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.547 HD11 HG22 ' D' ' 79' ' ' ILE . 2.8 tm? -79.04 135.68 36.95 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.902 0.382 . . . . 0.0 110.655 178.62 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 37' ' ' LYS . . . . . 0.417 ' N ' HD13 ' D' ' 36' ' ' LEU . 13.3 mmmm -135.01 99.65 4.34 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.24 -172.754 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 38' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -97.73 141.42 30.77 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.486 0.66 . . . . 0.0 111.817 -177.701 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 39' ' ' THR . . . . . 0.545 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 11.5 p -143.93 132.36 22.13 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.645 177.897 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 40' ' ' SER . . . . . 0.599 ' HA ' ' O ' ' D' ' 26' ' ' LYS . 36.8 t -106.03 128.05 53.58 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 169.38 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 41' ' ' SER . . . . . 0.642 ' O ' ' HB3' ' D' ' 42' ' ' ASN . 46.8 t -93.09 142.9 26.78 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -177.13 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 42' ' ' ASN . . . . . 0.642 ' HB3' ' O ' ' D' ' 41' ' ' SER . 5.0 t30 80.16 -15.83 0.71 Allowed 'General case' 0 CA--C 1.537 0.477 0 O-C-N 124.116 0.885 . . . . 0.0 110.705 -167.816 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 60.91 62.24 1.49 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 165.985 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' D' D ' 44' ' ' GLY . . . . . 0.514 ' C ' ' HD2' ' D' ' 45' ' ' TYR . . . 123.74 35.21 0.7 Allowed Glycine 0 CA--C 1.507 -0.42 0 C-N-CA 118.481 -1.818 . . . . 0.0 115.142 167.365 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 45' ' ' TYR . . . . . 0.716 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 3.1 m-30 -122.23 162.67 20.97 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 172.465 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 46' ' ' GLY . . . . . 0.828 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -100.13 -149.31 23.63 Favored Glycine 0 C--O 1.218 -0.87 0 C-N-CA 121.421 -0.419 . . . . 0.0 113.219 -175.319 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 47' ' ' ILE . . . . . 1.038 HG13 ' HB2' ' D' ' 68' ' ' GLU . 1.3 mp -63.48 -59.57 4.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -176.144 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.421 ' HA ' ' HB2' ' D' ' 24' ' ' LYS . 31.0 m 167.83 -111.96 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 111.448 -2.615 . . . . 0.0 106.477 -178.517 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -110.99 75.99 0.95 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.458 163.424 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' D' D ' 50' ' ' GLU . . . . . 0.565 ' HB3' ' HE2' ' D' ' 52' ' ' LYS . 51.4 mt-10 -148.1 177.17 9.6 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.115 -179.122 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 51' ' ' ASP . . . . . 0.751 ' HB2' ' HD2' ' D' ' 69' ' ' LYS . 2.7 p30 -143.41 129.47 19.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.338 0.59 . . . . 0.0 111.851 176.625 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 52' ' ' LYS . . . . . 0.708 ' HD3' HG12 ' D' ' 47' ' ' ILE . 4.1 mptp? -138.73 136.05 35.37 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.203 -168.55 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 53' ' ' ASN . . . . . 0.423 ' O ' HG12 ' D' ' 94' ' ' ILE . 33.2 m-20 -111.98 132.54 54.71 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 172.319 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 54' ' ' TRP . . . . . 1.101 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 1.4 m95 -119.04 155.27 31.75 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -173.897 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -142.64 157.9 26.85 Favored Glycine 0 N--CA 1.436 -1.333 0 CA-C-N 114.524 -1.216 . . . . 0.0 113.034 171.536 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' D' D ' 56' ' ' ILE . . . . . 1.061 HG12 HG23 ' D' ' 91' ' ' ILE . 95.1 mt -127.11 104.63 12.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-N 113.081 -1.56 . . . . 0.0 106.96 178.826 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 57' ' ' PHE . . . . . 0.671 ' HD1' ' O ' ' D' ' 90' ' ' GLU . 16.2 m-85 -103.71 106.35 16.83 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.413 -166.123 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.878 HG22 HG12 ' D' ' 89' ' ' ILE . 77.2 t -90.44 111.47 23.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.996 174.815 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 5.3 m120 53.99 45.88 26.71 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.152 -178.323 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.23 49.06 35.04 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.868 179.152 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' D' D ' 61' ' ' GLU . . . . . 0.578 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 89.0 tt0 -154.23 119.68 5.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.659 0.266 . . . . 0.0 110.548 178.386 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -73.88 107.99 6.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.08 179.407 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 23.5 m -91.77 -30.1 4.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.031 -174.742 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' D' D ' 64' ' ' TYR . . . . . 0.525 ' HB3' HD12 ' D' ' 56' ' ' ILE . 13.4 t80 -140.22 134.76 31.57 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.399 179.677 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' D' ' 54' ' ' TRP . 32.4 m -117.64 105.68 12.29 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.412 178.005 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 66' ' ' PHE . . . . . 0.72 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 10.8 p90 -112.94 153.08 28.57 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 174.517 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -109.86 145.13 37.3 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 176.995 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' D' D ' 68' ' ' GLU . . . . . 1.038 ' HB2' HG13 ' D' ' 47' ' ' ILE . 35.7 mt-10 -70.66 -17.79 62.85 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 177.746 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.751 ' HD2' ' HB2' ' D' ' 51' ' ' ASP . 5.7 mtpm? -58.84 -43.95 90.86 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.375 171.095 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 18.6 t -72.12 99.95 2.43 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.665 -1.607 . . . . 0.0 107.298 171.296 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 75.9 p -31.53 121.56 0.26 Allowed 'General case' 0 C--N 1.317 -0.833 0 O-C-N 124.731 1.27 . . . . 0.0 111.95 -173.246 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' D' D ' 72' ' ' VAL . . . . . 0.56 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.1 OUTLIER -54.38 -11.71 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -178.816 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' D' D ' 73' ' ' GLY . . . . . 0.448 ' HA3' ' HA2' ' D' ' 44' ' ' GLY . . . -69.52 -67.0 2.06 Favored Glycine 0 N--CA 1.435 -1.374 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.689 172.193 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -62.71 -21.0 65.45 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.727 0.299 . . . . 0.0 111.131 -177.858 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' D' D ' 75' ' ' ILE . . . . . 0.456 ' O ' HG12 ' D' ' 79' ' ' ILE . 28.7 mm -80.46 -35.96 15.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.464 176.757 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 76' ' ' SER . . . . . 0.735 ' HB2' HD13 ' D' ' 27' ' ' LEU . 30.2 t -74.37 -21.66 59.56 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.916 177.21 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 77' ' ' ASN . . . . . 0.426 ' O ' ' HD2' ' D' ' 81' ' ' LYS . 2.1 m-80 -64.09 -31.33 72.48 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 166.08 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 78' ' ' ASP . . . . . 1.006 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 79.5 m-20 -78.0 -30.52 50.12 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.177 174.252 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 79' ' ' ILE . . . . . 0.565 HG12 ' HA ' ' D' ' 76' ' ' SER . 28.7 mm -69.72 -19.98 23.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.006 -0.678 . . . . 0.0 109.642 179.732 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -64.66 -41.44 96.1 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.854 174.182 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' D' D ' 81' ' ' LYS . . . . . 1.006 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -81.66 -56.02 4.27 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 177.832 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' D' D ' 82' ' ' LEU . . . . . 0.563 HD23 ' O ' ' D' ' 78' ' ' ASP . 4.0 mm? -48.0 -30.63 4.51 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 83' ' ' ASN . . . . . 0.564 ' O ' ' HE2' ' D' ' 85' ' ' LYS . 47.8 t-20 51.34 81.95 0.07 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.227 0.611 . . . . 0.0 111.21 173.36 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 84' ' ' ILE . . . . . 0.509 ' HB ' ' HG ' ' D' ' 36' ' ' LEU . 48.3 mt -77.08 99.8 2.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -176.367 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 85' ' ' LYS . . . . . 0.564 ' HE2' ' O ' ' D' ' 83' ' ' ASN . 0.0 OUTLIER -160.03 91.24 0.94 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 171.973 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.2 155.88 0.51 Allowed Glycine 0 N--CA 1.454 -0.133 0 CA-C-N 114.85 -1.068 . . . . 0.0 114.915 169.506 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' D' D ' 87' ' ' PRO . . . . . 0.566 ' O ' HG13 ' D' ' 58' ' ' VAL . 67.2 Cg_endo -86.8 177.61 23.5 Favored 'Cis proline' 0 CA--C 1.532 0.403 0 C-N-CA 122.467 -1.889 . . . . 0.0 112.364 -0.399 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 88' ' ' TYR . . . . . 0.597 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 3.8 m-85 6.67 92.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 125.369 1.468 . . . . 0.0 114.173 -176.985 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.878 HG12 HG22 ' D' ' 58' ' ' VAL . 70.3 mt -112.02 133.05 58.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.671 ' O ' ' HD1' ' D' ' 57' ' ' PHE . 69.7 mm-40 -119.9 101.87 8.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.084 172.26 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 91' ' ' ILE . . . . . 1.101 HG22 ' HZ3' ' D' ' 54' ' ' TRP . 2.7 mt -98.11 110.54 25.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -178.316 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 92' ' ' LYS . . . . . 0.77 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -162.36 170.59 18.59 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.986 -0.446 . . . . 0.0 110.038 178.337 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' D' D ' 93' ' ' GLN . . . . . 0.612 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 21.7 pt20 -81.31 158.25 24.81 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.093 175.066 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' D' D ' 94' ' ' ILE . . . . . 0.77 HG22 ' HE2' ' D' ' 92' ' ' LYS . 8.0 pt . . . . . 0 C--N 1.311 -1.08 0 CA-C-N 114.11 -1.405 . . . . 0.0 111.451 -167.128 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 120.697 0.284 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' D' D ' 2' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 -70.33 103.82 2.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.847 178.472 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' D' D ' 3' ' ' GLN . . . . . 0.438 ' HB3' ' OE2' ' D' ' 7' ' ' GLU . 53.3 tt0 -79.16 -52.67 7.86 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.66 177.66 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 4' ' ' LYS . . . . . 0.652 ' HB3' ' HB3' ' D' ' 7' ' ' GLU . 62.7 tttm -110.07 -8.68 14.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.248 177.39 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 5' ' ' ALA . . . . . . . . . . . . . . . 70.81 -61.44 0.48 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.576 0.75 . . . . 0.0 112.014 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 89.4 mt -75.13 8.71 2.42 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.298 0.57 . . . . 0.0 110.676 176.567 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' D' D ' 7' ' ' GLU . . . . . 0.652 ' HB3' ' HB3' ' D' ' 4' ' ' LYS . 23.1 pt-20 -70.93 -22.59 62.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.627 -179.333 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.763 ' HA ' ' CB ' ' D' ' 12' ' ' SER . 62.7 mm-40 -69.09 -20.0 64.07 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.776 -178.183 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 9' ' ' GLN . . . . . 0.469 HE22 ' HB2' ' D' ' 8' ' ' GLU . 15.1 mp0 -96.92 -4.22 40.44 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -177.472 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 10' ' ' MET . . . . . 0.679 ' HG3' ' H ' ' D' ' 11' ' ' ASN . 25.9 ptt? -107.82 -69.53 0.84 Allowed 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 119.763 -0.775 . . . . 0.0 112.887 -175.957 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 11' ' ' ASN . . . . . 0.679 ' H ' ' HG3' ' D' ' 10' ' ' MET . 60.9 m-80 -94.27 -45.73 7.37 Favored 'General case' 0 CA--C 1.484 -1.571 0 CA-C-O 120.815 0.34 . . . . 0.0 110.42 178.104 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 12' ' ' SER . . . . . 0.763 ' CB ' ' HA ' ' D' ' 8' ' ' GLU . 30.8 t -38.11 -49.22 1.3 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 113.456 -1.702 . . . . 0.0 113.591 -170.059 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.545 ' O ' HG12 ' D' ' 16' ' ' VAL . 7.1 tp -73.93 -16.42 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 121.215 0.531 . . . . 0.0 112.373 -174.865 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 14' ' ' ASN . . . . . 0.5 ' O ' ' HB2' ' D' ' 17' ' ' ASN . 62.8 m-20 -95.69 -36.42 11.21 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.532 173.647 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 15' ' ' SER . . . . . 0.528 ' O ' ' HB2' ' D' ' 18' ' ' ASP . 80.3 p -75.89 -23.71 55.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.894 0.378 . . . . 0.0 110.224 178.142 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 16' ' ' VAL . . . . . 0.545 HG12 ' O ' ' D' ' 13' ' ' ILE . 5.6 p -61.27 -22.4 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 CA-C-O 122.196 0.998 . . . . 0.0 108.85 176.264 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 17' ' ' ASN . . . . . 0.5 ' HB2' ' O ' ' D' ' 14' ' ' ASN . 4.3 m120 -74.02 -39.73 63.37 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 113.578 -1.646 . . . . 0.0 109.271 176.476 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 18' ' ' ASP . . . . . 0.528 ' HB2' ' O ' ' D' ' 15' ' ' SER . 74.9 m-20 -57.34 -17.19 11.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.4 -0.818 . . . . 0.0 113.007 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.607 ' H ' ' HD2' ' D' ' 19' ' ' LYS . 0.0 OUTLIER -90.69 -40.72 11.7 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 121.957 0.884 . . . . 0.0 108.723 174.77 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' D' D ' 20' ' ' LEU . . . . . 0.708 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 81.5 mt -68.31 -34.83 76.85 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 113.327 -1.76 . . . . 0.0 110.523 -177.54 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 21' ' ' ASN . . . . . 0.682 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 63.6 m-20 -78.61 100.55 7.03 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.203 -179.356 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 22' ' ' LYS . . . . . 0.493 ' HD3' HD12 ' D' ' 47' ' ' ILE . 38.3 mtpt -122.07 -42.55 2.38 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 119.066 -1.054 . . . . 0.0 113.263 -170.398 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 158.11 -74.28 0.22 Allowed Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.144 -1.026 . . . . 0.0 112.719 -176.821 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' D' D ' 24' ' ' LYS . . . . . 0.837 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 21.9 tptm -53.06 -54.84 29.45 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.239 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 25' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -150.44 154.52 25.69 Favored Glycine 0 N--CA 1.429 -1.803 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.772 175.999 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 26' ' ' LYS . . . . . 0.733 ' CG ' ' HB3' ' D' ' 41' ' ' SER . 10.0 ptpt -149.67 159.61 44.2 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.707 -0.747 . . . . 0.0 110.897 -166.618 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 27' ' ' LEU . . . . . 0.708 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 42.7 tp -136.97 138.34 40.45 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.446 0.641 . . . . 0.0 111.904 -176.451 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 28' ' ' SER . . . . . 0.543 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 18.0 t -128.41 153.94 46.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.061 -178.188 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 29' ' ' LEU . . . . . 0.44 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 22.7 mt -138.22 152.47 48.64 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.987 0.422 . . . . 0.0 110.262 177.465 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 30' ' ' SER . . . . . 0.501 ' HB3' ' HB2' ' D' ' 37' ' ' LYS . 36.7 t -145.4 -171.25 3.63 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.411 178.787 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 23.5 ptp -145.85 166.57 25.56 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.84 0.352 . . . . 0.0 110.187 -179.854 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' D' D ' 32' ' ' ASN . . . . . 0.657 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 48.9 t30 -150.4 87.24 1.44 Allowed 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 174.769 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.83 -98.64 0.79 Allowed Glycine 0 N--CA 1.454 -0.166 0 C-N-CA 120.004 -1.093 . . . . 0.0 111.14 -171.366 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -112.6 14.46 20.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.853 0.359 . . . . 0.0 110.135 174.185 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' D' D ' 35' ' ' GLN . . . . . 0.657 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 3.5 tp-100 -89.21 159.13 17.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.601 -174.791 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.998 ' HB2' ' HB2' ' D' ' 85' ' ' LYS . 0.8 OUTLIER -121.24 135.79 55.07 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.299 179.352 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' D' D ' 37' ' ' LYS . . . . . 0.501 ' HB2' ' HB3' ' D' ' 30' ' ' SER . 74.5 mmtt -133.62 139.84 46.74 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.472 -171.511 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 38' ' ' ALA . . . . . 0.409 ' HB3' ' HB ' ' D' ' 79' ' ' ILE . . . -138.6 147.6 43.16 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.861 0.362 . . . . 0.0 111.074 177.184 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 39' ' ' THR . . . . . 0.543 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 17.7 p -147.1 131.94 18.04 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.369 175.731 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 40' ' ' SER . . . . . 0.622 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 80.2 p -108.82 170.66 7.9 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 175.456 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 41' ' ' SER . . . . . 0.733 ' HB3' ' CG ' ' D' ' 26' ' ' LYS . 38.1 t -134.46 153.61 51.84 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.378 -0.929 . . . . 0.0 111.356 177.662 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 42' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' D' ' 41' ' ' SER . 34.8 m120 79.57 9.41 1.57 Allowed 'General case' 0 N--CA 1.467 0.409 0 O-C-N 124.863 1.352 . . . . 0.0 110.462 -174.279 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 42.82 59.62 2.76 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 114.692 -1.14 . . . . 0.0 113.683 171.247 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' D' D ' 44' ' ' GLY . . . . . 0.435 ' O ' HG21 ' D' ' 71' ' ' THR . . . 112.94 35.96 1.59 Allowed Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 119.576 -1.297 . . . . 0.0 114.087 172.534 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 45' ' ' TYR . . . . . 0.837 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 1.2 m-85 -121.42 149.6 42.77 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 170.986 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 46' ' ' GLY . . . . . 0.57 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -100.11 -153.25 27.1 Favored Glycine 0 C--O 1.221 -0.703 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 -178.975 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 47' ' ' ILE . . . . . 0.899 HD11 ' HG3' ' D' ' 68' ' ' GLU . 40.3 mm -52.26 -57.82 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 CA-C-O 121.773 0.797 . . . . 0.0 109.618 175.418 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 78.7 p 179.37 -78.0 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 113.035 -1.893 . . . . 0.0 109.206 -174.569 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.52 74.59 0.76 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.811 171.662 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -147.12 148.51 31.65 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.588 -178.131 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' D' D ' 51' ' ' ASP . . . . . 0.689 ' HA ' ' HD3' ' D' ' 69' ' ' LYS . 7.7 p-10 -89.59 119.39 29.97 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.214 177.04 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 52' ' ' LYS . . . . . 0.641 ' O ' ' HA ' ' D' ' 67' ' ' ASN . 11.6 mmmm -128.48 101.28 6.12 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.387 -166.127 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 -88.99 127.01 35.66 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.07 176.765 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' D' D ' 54' ' ' TRP . . . . . 0.486 ' HZ3' HG23 ' D' ' 91' ' ' ILE . 0.0 OUTLIER -124.97 164.97 18.97 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.062 -173.421 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -154.55 164.34 31.56 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.543 -1.313 . . . . 0.0 114.688 177.279 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' D' D ' 56' ' ' ILE . . . . . 0.497 HG21 HG21 ' D' ' 84' ' ' ILE . 72.7 mt -140.14 107.16 2.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 125.6 1.56 . . . . 0.0 107.02 -179.156 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 57' ' ' PHE . . . . . 0.517 ' HD2' ' O ' ' D' ' 90' ' ' GLU . 4.7 m-85 -114.3 109.25 18.07 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.318 -167.725 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.75 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 0.2 OUTLIER -101.29 118.71 48.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.216 0.531 . . . . 0.0 111.567 171.611 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 5.6 m120 50.57 54.14 11.7 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.845 179.082 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.16 47.89 80.56 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.73 177.846 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -157.01 114.52 3.14 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.4 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -80.99 99.59 8.5 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.143 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 27.5 m -82.76 -18.24 10.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.471 -173.826 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' D' D ' 64' ' ' TYR . . . . . 0.471 ' HB3' HD12 ' D' ' 56' ' ' ILE . 24.4 t80 -147.82 130.37 15.87 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.414 -0.514 . . . . 0.0 111.01 176.922 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 57.9 m -115.63 125.61 53.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.368 174.491 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' D' D ' 66' ' ' PHE . . . . . 0.429 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 15.7 p90 -132.1 163.36 28.65 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.743 177.159 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 67' ' ' ASN . . . . . 0.641 ' HA ' ' O ' ' D' ' 52' ' ' LYS . 74.5 m-80 -129.76 143.02 50.61 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.296 -176.189 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 68' ' ' GLU . . . . . 0.899 ' HG3' HD11 ' D' ' 47' ' ' ILE . 3.9 mm-40 -75.37 -17.93 60.1 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 176.835 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.689 ' HD3' ' HA ' ' D' ' 51' ' ' ASP . 44.1 mtmt -60.03 -48.73 80.49 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 168.532 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 19.7 m -78.17 61.44 2.68 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 111.857 -2.428 . . . . 0.0 109.236 171.596 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' D' D ' 71' ' ' THR . . . . . 0.435 HG21 ' O ' ' D' ' 44' ' ' GLY . 74.3 p -1.62 121.84 0.0 OUTLIER 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.873 1.669 . . . . 0.0 114.992 -179.338 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 72' ' ' VAL . . . . . 0.475 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.1 OUTLIER -44.58 -21.31 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 123.436 0.694 . . . . 0.0 112.613 171.207 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' D' D ' 73' ' ' GLY . . . . . 0.622 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -60.69 -65.87 3.06 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.819 -0.628 . . . . 0.0 113.712 175.275 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -71.47 -20.2 62.11 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 120.971 0.415 . . . . 0.0 110.82 -175.95 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' D' D ' 75' ' ' ILE . . . . . 0.621 ' O ' HG13 ' D' ' 79' ' ' ILE . 27.1 mm -79.34 -40.1 21.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.882 179.472 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 76' ' ' SER . . . . . 0.494 ' HA ' HG13 ' D' ' 79' ' ' ILE . 31.0 t -74.49 -19.98 60.17 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.223 -179.738 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -64.97 -32.42 74.14 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 119.368 -0.933 . . . . 0.0 108.586 166.651 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' D' D ' 78' ' ' ASP . . . . . 1.042 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 60.0 m-20 -79.31 -25.1 42.42 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 176.7 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 79' ' ' ILE . . . . . 0.621 HG13 ' O ' ' D' ' 75' ' ' ILE . 48.6 mt -72.0 -20.62 20.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 O-C-N 121.514 -0.741 . . . . 0.0 111.129 -175.37 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -71.15 -40.19 71.5 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.426 175.777 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' D' D ' 81' ' ' LYS . . . . . 1.042 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -73.78 -54.21 8.55 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.642 176.322 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' D' D ' 82' ' ' LEU . . . . . 0.623 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.9 mm? -47.29 -33.35 5.53 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 177.532 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 83' ' ' ASN . . . . . 0.566 ' HA ' HD12 ' D' ' 36' ' ' LEU . 55.4 t-20 42.07 67.08 0.62 Allowed 'General case' 0 N--CA 1.468 0.438 0 O-C-N 124.002 0.814 . . . . 0.0 110.864 174.774 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 84' ' ' ILE . . . . . 0.574 ' O ' ' HG ' ' D' ' 36' ' ' LEU . 44.1 mm -94.94 98.81 8.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.165 -175.084 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 85' ' ' LYS . . . . . 0.998 ' HB2' ' HB2' ' D' ' 36' ' ' LEU . 46.4 tptt -139.97 94.47 2.76 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.171 0.51 . . . . 0.0 110.812 -178.63 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 86' ' ' GLY . . . . . 0.597 ' H ' ' CD1' ' D' ' 89' ' ' ILE . . . 69.54 161.98 3.11 Favored Glycine 0 CA--C 1.5 -0.845 0 CA-C-N 115.231 -0.895 . . . . 0.0 114.357 177.42 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 87' ' ' PRO . . . . . 0.697 ' HD2' HG21 ' D' ' 58' ' ' VAL . 61.7 Cg_endo -77.03 -172.1 10.77 Favored 'Cis proline' 0 CA--C 1.545 1.055 0 C-N-CA 122.195 -2.002 . . . . 0.0 114.128 0.896 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 88' ' ' TYR . . . . . 0.75 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 2.2 m-85 -9.38 94.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 125.485 1.514 . . . . 0.0 114.668 -174.967 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.597 ' CD1' ' H ' ' D' ' 86' ' ' GLY . 70.1 mt -102.19 142.1 17.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.517 ' O ' ' HD2' ' D' ' 57' ' ' PHE . 46.3 mt-10 -116.32 98.58 6.67 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.528 170.557 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 91' ' ' ILE . . . . . 0.543 HG13 HG22 ' D' ' 89' ' ' ILE . 33.0 mt -94.34 100.25 10.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.024 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 92' ' ' LYS . . . . . 0.661 ' HG2' ' O ' ' D' ' 93' ' ' GLN . 0.0 OUTLIER -159.68 166.68 30.08 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.416 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' D' D ' 93' ' ' GLN . . . . . 0.661 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 3.8 pm0 -80.41 162.95 24.2 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 121.533 0.682 . . . . 0.0 110.696 175.903 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' D' D ' 94' ' ' ILE . . . . . 0.575 HG22 ' HE2' ' D' ' 92' ' ' LYS . 9.8 pt . . . . . 0 C--N 1.307 -1.26 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.585 -171.946 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 120.757 0.313 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' D' D ' 2' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -118.55 54.24 0.95 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.633 178.655 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -82.56 -14.69 54.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.297 0.57 . . . . 0.0 109.59 173.032 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -107.63 -13.26 15.09 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.731 177.099 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' D' D ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.24 60.9 0.75 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.161 -174.734 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' D' D ' 6' ' ' LEU . . . . . 0.658 ' O ' HD23 ' D' ' 6' ' ' LEU . 6.3 tt -74.06 -26.79 60.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.169 -175.356 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 7' ' ' GLU . . . . . 0.637 ' HA ' ' HB2' ' D' ' 10' ' ' MET . 94.9 mt-10 -63.25 1.22 0.52 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.758 ' O ' ' HB3' ' D' ' 12' ' ' SER . 10.9 pt-20 -54.83 -50.91 67.46 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -176.037 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 9' ' ' GLN . . . . . 0.425 ' H ' ' CD ' ' D' ' 9' ' ' GLN . 3.0 pm0 -97.14 14.51 25.56 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 121.715 -0.616 . . . . 0.0 110.444 175.257 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 10' ' ' MET . . . . . 0.637 ' HB2' ' HA ' ' D' ' 7' ' ' GLU . 95.4 mmm -102.46 -72.69 0.68 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.279 -176.954 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -100.52 -42.25 6.65 Favored 'General case' 0 CA--C 1.489 -1.388 0 CA-C-O 121.098 0.475 . . . . 0.0 110.252 176.097 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' D' D ' 12' ' ' SER . . . . . 0.758 ' HB3' ' O ' ' D' ' 8' ' ' GLU . 46.1 t -42.04 -55.1 3.3 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.137 -1.392 . . . . 0.0 112.265 -170.194 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.465 HG13 ' O ' ' D' ' 8' ' ' GLU . 64.0 mt -91.37 -8.89 10.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.365 -174.668 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 -93.53 -59.12 2.08 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.395 175.183 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' D' D ' 15' ' ' SER . . . . . 0.481 ' O ' ' HE2' ' D' ' 19' ' ' LYS . 84.6 p -64.79 -15.19 61.36 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.644 0.239 . . . . 0.0 111.644 179.592 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 16' ' ' VAL . . . . . 0.586 ' HA ' ' HE2' ' D' ' 19' ' ' LYS . 11.8 p -60.64 -30.68 47.39 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.085 0 CA-C-O 121.527 0.679 . . . . 0.0 109.478 175.64 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -71.95 -39.59 69.28 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.044 177.079 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' D' D ' 18' ' ' ASP . . . . . 0.465 ' OD1' ' HA ' ' D' ' 15' ' ' SER . 1.2 m-20 -58.95 -15.55 13.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.691 -179.367 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.604 ' O ' ' HE3' ' D' ' 22' ' ' LYS . 31.9 mttm -91.03 -52.71 4.7 Favored 'General case' 0 CA--C 1.492 -1.259 0 CA-C-O 122.525 1.155 . . . . 0.0 108.765 179.131 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 20' ' ' LEU . . . . . 0.958 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 55.7 mt -57.1 -40.34 76.84 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 112.381 -2.19 . . . . 0.0 110.734 178.266 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 21' ' ' ASN . . . . . 0.547 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 53.3 m-20 -76.04 94.15 3.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.153 179.054 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 22' ' ' LYS . . . . . 0.772 ' HD2' HD12 ' D' ' 47' ' ' ILE . 95.7 mttt -121.81 -42.19 2.42 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -175.397 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 172.02 -92.38 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 119.589 -1.291 . . . . 0.0 113.337 -178.742 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' D' D ' 24' ' ' LYS . . . . . 0.735 ' HG2' ' HB3' ' D' ' 45' ' ' TYR . 80.4 tttt -47.22 -50.05 21.84 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.654 0.74 . . . . 0.0 109.628 178.195 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -141.54 158.08 26.42 Favored Glycine 0 N--CA 1.432 -1.626 0 CA-C-N 114.383 -1.281 . . . . 0.0 111.524 175.884 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' D' D ' 26' ' ' LYS . . . . . 0.688 ' CD ' ' HB2' ' D' ' 41' ' ' SER . 0.2 OUTLIER -150.47 161.3 42.79 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.672 -0.764 . . . . 0.0 110.24 -170.448 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' D' D ' 27' ' ' LEU . . . . . 0.958 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 35.5 tp -140.19 143.67 36.2 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.129 0.49 . . . . 0.0 111.116 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 28' ' ' SER . . . . . 0.575 ' H ' HD12 ' D' ' 27' ' ' LEU . 13.0 t -140.6 109.78 6.17 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.703 -176.217 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 29' ' ' LEU . . . . . 0.524 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 0.9 OUTLIER -131.61 145.75 51.85 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -179.767 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 72.8 p -160.18 -171.71 3.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.513 -177.308 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' D' D ' 31' ' ' MET . . . . . 0.798 ' HA ' ' O ' ' D' ' 35' ' ' GLN . 69.9 mtm -125.73 131.23 52.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.173 0.511 . . . . 0.0 111.005 176.127 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 32' ' ' ASN . . . . . 0.407 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 49.2 t30 -90.78 88.87 7.24 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 172.612 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.53 -99.86 1.64 Allowed Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -164.439 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' D' D ' 34' ' ' ASN . . . . . 0.686 ' O ' ' HE3' ' D' ' 85' ' ' LYS . 75.4 m-80 -120.99 13.45 11.35 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.672 -0.311 . . . . 0.0 110.569 171.879 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 35' ' ' GLN . . . . . 0.798 ' O ' ' HA ' ' D' ' 31' ' ' MET . 52.2 tt0 -88.52 126.39 35.23 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.041 -175.102 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.778 HD12 ' HA ' ' D' ' 83' ' ' ASN . 3.0 tm? -79.08 124.67 28.51 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.278 0.561 . . . . 0.0 111.13 -179.311 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 37' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 30.9 mmmt -135.91 117.09 14.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.523 -170.756 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 38' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -126.91 148.46 50.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.215 0.531 . . . . 0.0 112.068 -177.374 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 39' ' ' THR . . . . . 0.468 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 15.5 p -146.87 124.85 12.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.797 177.581 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 40' ' ' SER . . . . . 0.544 ' HB2' ' HA2' ' D' ' 73' ' ' GLY . 69.2 m -110.7 128.86 55.89 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 173.378 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 41' ' ' SER . . . . . 0.688 ' HB2' ' CD ' ' D' ' 26' ' ' LYS . 50.2 m -97.59 161.71 13.64 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.987 -174.217 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 42' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' D' ' 41' ' ' SER . 71.9 m-80 79.69 10.88 1.33 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.901 -172.006 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 39.74 61.85 1.34 Allowed 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 169.355 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.54 -5.53 7.58 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 118.745 -1.693 . . . . 0.0 115.315 172.111 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' D' D ' 45' ' ' TYR . . . . . 0.735 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 1.6 m-85 -96.6 155.84 16.6 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 117.454 0.627 . . . . 0.0 111.882 -178.738 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 46' ' ' GLY . . . . . 0.607 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -101.82 -177.13 28.2 Favored Glycine 0 C--O 1.214 -1.115 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 173.088 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 47' ' ' ILE . . . . . 0.938 HG12 ' HB3' ' D' ' 68' ' ' GLU . 34.9 mm -48.09 -55.28 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.836 0 CA-C-N 118.391 1.095 . . . . 0.0 110.239 178.376 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.512 ' HA ' ' HD3' ' D' ' 24' ' ' LYS . 23.2 t 179.44 -156.67 0.02 OUTLIER 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 113.026 -1.897 . . . . 0.0 107.154 -177.268 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 49' ' ' TYR . . . . . 0.473 ' O ' ' HD1' ' D' ' 49' ' ' TYR . 0.3 OUTLIER -81.13 76.81 8.07 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.795 0.807 . . . . 0.0 109.794 167.969 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' D' D ' 50' ' ' GLU . . . . . 0.654 ' O ' ' HG2' ' D' ' 69' ' ' LYS . 71.2 mm-40 -119.24 -163.04 0.94 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.993 -171.964 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 51' ' ' ASP . . . . . 0.71 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 11.6 t70 -162.76 107.44 1.13 Allowed 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.631 170.633 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 52' ' ' LYS . . . . . 0.71 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 4.2 mptp? -138.67 109.1 6.51 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 113.755 -1.566 . . . . 0.0 109.447 -172.812 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 53' ' ' ASN . . . . . 0.459 ' HA ' ' OD1' ' D' ' 67' ' ' ASN . 43.0 m-20 -83.66 131.41 34.95 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.297 177.764 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 54' ' ' TRP . . . . . 0.607 ' HZ3' HG23 ' D' ' 91' ' ' ILE . 0.3 OUTLIER -120.55 153.52 36.62 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.82 -173.139 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -144.87 159.54 27.86 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 120.019 -1.086 . . . . 0.0 113.578 174.313 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' D' D ' 56' ' ' ILE . . . . . 0.652 HG23 HG12 ' D' ' 91' ' ' ILE . 61.8 mt -134.31 111.94 15.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 176.557 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 57' ' ' PHE . . . . . 0.65 ' HZ ' HG21 ' D' ' 94' ' ' ILE . 3.6 m-85 -110.77 105.04 13.75 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 119.214 -0.994 . . . . 0.0 111.122 -166.633 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.714 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 94.3 t -89.04 108.47 19.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.977 173.647 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 33.7 m120 60.89 52.18 4.33 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.344 -177.525 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 57.82 47.44 88.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.291 -179.5 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' D' D ' 61' ' ' GLU . . . . . 0.582 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 5.3 tp10 -151.82 125.41 8.93 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.252 -0.474 . . . . 0.0 109.904 -177.398 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -67.77 105.82 2.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.093 0.473 . . . . 0.0 109.954 177.103 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.443 HG12 ' O ' ' D' ' 56' ' ' ILE . 14.6 p -86.69 -21.98 7.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.193 -178.044 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 64' ' ' TYR . . . . . 0.505 ' HB3' HD12 ' D' ' 56' ' ' ILE . 31.6 t80 -156.92 135.14 11.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.324 176.429 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.406 HG23 ' O ' ' D' ' 54' ' ' TRP . 74.9 m -120.28 120.48 36.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.721 0.296 . . . . 0.0 110.757 176.77 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 66' ' ' PHE . . . . . 0.531 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 21.2 p90 -126.76 171.12 11.47 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 173.317 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 67' ' ' ASN . . . . . 0.459 ' OD1' ' HA ' ' D' ' 53' ' ' ASN . 75.4 m-20 -129.88 152.76 49.01 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 68' ' ' GLU . . . . . 0.938 ' HB3' HG12 ' D' ' 47' ' ' ILE . 33.5 mt-10 -76.66 -8.36 57.1 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.044 178.473 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.654 ' HG2' ' O ' ' D' ' 50' ' ' GLU . 48.6 mtpt -69.63 -50.36 45.03 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 168.759 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 13.8 t -61.93 120.46 10.81 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 113.569 -1.65 . . . . 0.0 107.685 172.621 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 81.0 p -54.17 114.06 1.48 Allowed 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.929 -172.676 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' D' D ' 72' ' ' VAL . . . . . 0.532 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.1 OUTLIER -50.63 -23.29 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.727 -179.483 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' D' D ' 73' ' ' GLY . . . . . 0.544 ' HA2' ' HB2' ' D' ' 40' ' ' SER . . . -58.4 -66.77 2.58 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.733 -0.667 . . . . 0.0 113.62 173.231 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -63.79 -24.28 67.7 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 120.796 0.331 . . . . 0.0 110.801 -178.003 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' D' D ' 75' ' ' ILE . . . . . 0.435 ' O ' HG12 ' D' ' 79' ' ' ILE . 36.6 mm -78.39 -38.8 23.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.606 178.348 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 76' ' ' SER . . . . . 0.922 ' HA ' HG12 ' D' ' 79' ' ' ILE . 36.9 t -76.2 -19.93 57.95 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.479 -0.489 . . . . 0.0 111.002 179.544 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -63.35 -32.39 73.8 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 166.073 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' D' D ' 78' ' ' ASP . . . . . 1.106 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 1.1 m-20 -79.27 -25.03 42.56 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.94 174.033 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 79' ' ' ILE . . . . . 0.922 HG12 ' HA ' ' D' ' 76' ' ' SER . 22.2 mm -69.03 -25.32 29.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.235 -177.729 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -73.01 -33.31 65.69 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.855 179.331 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' D' D ' 81' ' ' LYS . . . . . 1.106 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -77.82 -61.18 2.08 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.97 174.197 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' D' D ' 82' ' ' LEU . . . . . 0.525 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.8 mm? -48.53 -31.81 7.02 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 176.314 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 83' ' ' ASN . . . . . 0.778 ' HA ' HD12 ' D' ' 36' ' ' LEU . 22.3 t-20 25.01 80.86 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 O-C-N 124.973 1.42 . . . . 0.0 112.533 177.0 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 84' ' ' ILE . . . . . 0.543 ' N ' ' HG ' ' D' ' 36' ' ' LEU . 2.7 mp -81.56 99.25 4.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.612 -175.174 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 85' ' ' LYS . . . . . 0.686 ' HE3' ' O ' ' D' ' 34' ' ' ASN . 21.5 ptmt -126.76 92.08 3.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.284 0.564 . . . . 0.0 111.318 179.664 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 86' ' ' GLY . . . . . 0.863 ' H ' HD11 ' D' ' 89' ' ' ILE . . . 65.2 154.26 0.16 Allowed Glycine 0 CA--C 1.516 0.11 0 CA-C-N 115.911 -0.586 . . . . 0.0 113.433 177.261 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 87' ' ' PRO . . . . . 0.588 ' O ' HG13 ' D' ' 58' ' ' VAL . 56.8 Cg_endo -90.85 -179.65 12.44 Favored 'Cis proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.515 -1.452 . . . . 0.0 112.797 -0.429 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 88' ' ' TYR . . . . . 0.714 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 0.9 OUTLIER 18.65 93.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.081 1.353 . . . . 0.0 113.531 179.637 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.863 HD11 ' H ' ' D' ' 86' ' ' GLY . 74.2 mt -111.02 136.78 46.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.097 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.55 ' O ' ' HD1' ' D' ' 57' ' ' PHE . 35.9 mm-40 -123.55 93.47 3.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.678 172.438 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 91' ' ' ILE . . . . . 0.652 HG12 HG23 ' D' ' 56' ' ' ILE . 32.2 mt -94.25 99.38 9.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.822 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 92' ' ' LYS . . . . . 0.695 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -162.65 167.34 23.32 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.198 178.432 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' D' D ' 93' ' ' GLN . . . . . 0.615 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 23.6 pt20 -81.18 164.45 22.32 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.067 175.116 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' D' D ' 94' ' ' ILE . . . . . 0.695 HG22 ' HE2' ' D' ' 92' ' ' LYS . 6.3 pt . . . . . 0 C--O 1.245 0.85 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.8 -169.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.448 ' O ' HG12 ' D' ' 16' ' ' VAL . 68.6 mt . . . . . 0 N--CA 1.463 0.193 0 CA-C-O 121.894 0.854 . . . . 0.0 111.668 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -95.9 -40.83 9.11 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.599 172.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 15' ' ' SER . . . . . 0.467 ' O ' ' HD2' ' D' ' 19' ' ' LYS . 79.6 p -70.98 -26.92 63.36 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.734 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 16' ' ' VAL . . . . . 0.596 HG21 ' HB ' ' D' ' 91' ' ' ILE . 11.4 p -53.37 -28.91 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 121.802 0.81 . . . . 0.0 110.623 177.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -72.67 -43.19 63.46 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.374 -1.285 . . . . 0.0 109.668 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 18' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' D' ' 15' ' ' SER . 74.7 m-20 -57.97 -14.91 7.27 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -177.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.581 ' HD2' ' N ' ' D' ' 19' ' ' LYS . 0.0 OUTLIER -90.14 -41.4 11.66 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.508 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 20' ' ' LEU . . . . . 0.688 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 63.8 mt -73.87 -39.6 63.82 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 112.905 -1.952 . . . . 0.0 109.796 -176.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 21' ' ' ASN . . . . . 0.649 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 3.0 m120 -75.44 91.75 2.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.894 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 22' ' ' LYS . . . . . 0.578 ' HD3' HD12 ' D' ' 47' ' ' ILE . 28.8 mtpp -122.13 -41.77 2.41 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -176.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.9 -92.03 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 119.411 -1.375 . . . . 0.0 113.931 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . 0.725 ' HG2' ' HB3' ' D' ' 45' ' ' TYR . 58.1 tttm -48.55 -54.7 13.42 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.572 0.701 . . . . 0.0 110.152 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 25' ' ' GLY . . . . . 0.568 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -144.29 154.06 25.47 Favored Glycine 0 N--CA 1.433 -1.502 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.351 175.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 26' ' ' LYS . . . . . 0.677 ' HG3' ' HB2' ' D' ' 41' ' ' SER . 9.1 ptpt -150.94 161.37 42.85 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.482 -0.859 . . . . 0.0 111.335 -167.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 27' ' ' LEU . . . . . 0.688 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 38.3 tp -132.01 142.92 49.73 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.71 0.767 . . . . 0.0 112.185 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 28' ' ' SER . . . . . 0.767 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 48.0 m -132.77 144.91 50.58 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.423 -176.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 29' ' ' LEU . . . . . 0.544 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 0.0 OUTLIER -141.28 147.14 37.73 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 119.549 -0.861 . . . . 0.0 110.789 -177.779 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 41.3 m -149.77 176.34 10.79 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.179 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -138.23 166.13 24.95 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.105 0.479 . . . . 0.0 110.926 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 32' ' ' ASN . . . . . 0.714 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 0.7 OUTLIER -148.17 87.53 1.61 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.6 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.01 -98.87 0.66 Allowed Glycine 0 N--CA 1.455 -0.056 0 C-N-CA 119.941 -1.123 . . . . 0.0 111.011 -172.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 34' ' ' ASN . . . . . 0.66 ' O ' ' HE3' ' D' ' 85' ' ' LYS . 73.0 m-80 -116.33 31.12 6.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.048 0.452 . . . . 0.0 110.342 173.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 35' ' ' GLN . . . . . 0.714 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 70.7 tp60 -106.8 148.59 28.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.2 -178.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.702 HD11 HG22 ' D' ' 79' ' ' ILE . 2.9 tm? -118.53 136.04 54.06 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.924 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 37' ' ' LYS . . . . . 0.544 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 25.5 mmmt -134.12 110.77 9.81 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.358 -171.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 38' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -118.71 146.56 44.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.163 0.506 . . . . 0.0 111.578 178.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 39' ' ' THR . . . . . 0.767 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 7.0 p -142.98 132.05 23.05 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.958 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . 0.598 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 25.2 p -107.78 129.21 55.07 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 172.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 41' ' ' SER . . . . . 0.677 ' HB2' ' HG3' ' D' ' 26' ' ' LYS . 40.6 m -95.16 146.88 24.0 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.161 -1.016 . . . . 0.0 109.687 -177.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 42' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' D' ' 41' ' ' SER . 76.1 m-20 80.2 5.46 1.78 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.995 -169.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 50.35 62.81 2.49 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 168.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.09 -11.82 7.26 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 118.672 -1.728 . . . . 0.0 115.594 170.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 45' ' ' TYR . . . . . 0.725 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 1.6 m-85 -85.36 157.46 20.52 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 117.406 0.603 . . . . 0.0 111.739 -177.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . 0.626 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -100.01 -173.93 30.36 Favored Glycine 0 C--O 1.215 -1.046 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 175.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 47' ' ' ILE . . . . . 0.731 HG12 ' HB3' ' D' ' 68' ' ' GLU . 36.1 mm -47.79 -57.86 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 CA-C-O 122.254 1.026 . . . . 0.0 110.081 177.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . 0.585 ' HA ' ' HD3' ' D' ' 24' ' ' LYS . 78.5 p -175.63 -102.3 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 112.875 -1.966 . . . . 0.0 108.812 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.54 77.25 1.59 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.996 0.903 . . . . 0.0 110.094 166.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . 0.713 ' HB2' ' HE3' ' D' ' 52' ' ' LYS . 56.1 mt-10 -139.9 179.22 6.73 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.011 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 51' ' ' ASP . . . . . 0.644 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 2.9 p30 -124.66 140.42 52.95 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.522 0.677 . . . . 0.0 112.014 174.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 52' ' ' LYS . . . . . 0.822 ' HD3' ' HB2' ' D' ' 68' ' ' GLU . 0.3 OUTLIER -146.42 136.69 23.74 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.234 -175.457 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -109.69 129.64 55.59 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.713 -0.395 . . . . 0.0 109.962 175.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 54' ' ' TRP . . . . . 1.085 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 1.1 m95 -124.25 165.2 18.03 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -174.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 55' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' D' ' 64' ' ' TYR . . . -155.15 170.33 33.27 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.928 174.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 56' ' ' ILE . . . . . 1.08 HG12 HG23 ' D' ' 91' ' ' ILE . 96.0 mt -138.28 113.7 9.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 124.917 1.287 . . . . 0.0 107.676 -177.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 57' ' ' PHE . . . . . 0.738 ' HB2' ' HB3' ' D' ' 90' ' ' GLU . 10.1 m-85 -115.59 105.89 13.29 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.934 -0.706 . . . . 0.0 112.018 -166.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.725 HG13 ' O ' ' D' ' 87' ' ' PRO . 81.8 t -82.69 101.33 7.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.227 173.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 59' ' ' ASN . . . . . 0.511 HD21 ' HG2' ' D' ' 87' ' ' PRO . 75.5 m-80 58.95 43.55 17.71 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.892 0.377 . . . . 0.0 110.287 -176.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.52 45.51 45.75 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.641 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 61' ' ' GLU . . . . . 0.631 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 86.2 mt-10 -137.05 105.69 5.84 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 177.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 62' ' ' LYS . . . . . 0.52 ' HB2' ' CE1' ' D' ' 57' ' ' PHE . 38.8 ttmt -70.83 99.49 1.75 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -178.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 32.7 m -88.41 -19.93 7.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -174.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 64' ' ' TYR . . . . . 0.465 ' HB3' HD12 ' D' ' 56' ' ' ILE . 16.1 t80 -148.17 140.42 24.22 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.307 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 60.7 m -119.73 118.02 29.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.35 176.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 66' ' ' PHE . . . . . 0.521 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 12.1 p90 -123.27 152.96 40.84 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 174.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 67' ' ' ASN . . . . . 0.481 ' O ' HD11 ' D' ' 75' ' ' ILE . 74.0 m-20 -119.87 135.83 54.73 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -177.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 68' ' ' GLU . . . . . 0.822 ' HB2' ' HD3' ' D' ' 52' ' ' LYS . 4.1 mm-40 -65.96 -8.19 21.24 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.792 0.329 . . . . 0.0 110.694 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.454 ' NZ ' ' HB3' ' D' ' 69' ' ' LYS . 5.9 mtpm? -60.48 -47.75 84.75 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 169.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 22.8 t -66.87 131.43 45.9 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 113.385 -1.734 . . . . 0.0 107.87 168.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 71' ' ' THR . . . . . 0.409 ' O ' HG13 ' D' ' 75' ' ' ILE . 69.7 p -60.42 127.89 33.99 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.072 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 72' ' ' VAL . . . . . 0.535 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.1 OUTLIER -56.61 -11.79 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 120.902 0.382 . . . . 0.0 111.767 -178.757 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 73' ' ' GLY . . . . . 0.598 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -73.17 -58.3 4.76 Favored Glycine 0 N--CA 1.435 -1.37 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.084 168.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -61.2 -25.75 67.25 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-O 121.114 0.483 . . . . 0.0 110.489 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 75' ' ' ILE . . . . . 0.516 ' O ' ' HB2' ' D' ' 78' ' ' ASP . 76.8 mt -73.5 -40.31 55.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.637 177.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 76' ' ' SER . . . . . 0.651 ' HA ' HG12 ' D' ' 79' ' ' ILE . 31.0 t -74.72 -19.31 60.29 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.654 178.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 77' ' ' ASN . . . . . 0.419 ' O ' ' HD3' ' D' ' 81' ' ' LYS . 3.9 m120 -62.09 -41.07 97.81 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 166.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 78' ' ' ASP . . . . . 0.925 ' HA ' ' HE3' ' D' ' 81' ' ' LYS . 51.1 m-20 -67.57 -35.8 79.7 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.119 174.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . 0.702 HG22 HD11 ' D' ' 36' ' ' LEU . 13.2 mm -67.46 -20.71 26.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.82 -176.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -69.78 -45.14 68.65 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.964 173.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 81' ' ' LYS . . . . . 0.925 ' HE3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -66.47 -64.61 0.82 Allowed 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.282 175.226 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 82' ' ' LEU . . . . . 0.545 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.8 mm? -46.51 -31.7 2.91 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 43.93 73.18 0.16 Allowed 'General case' 0 N--CA 1.473 0.697 0 O-C-N 123.881 0.738 . . . . 0.0 110.767 176.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 84' ' ' ILE . . . . . 0.802 HG22 HD13 ' D' ' 89' ' ' ILE . 47.1 mm -72.61 99.52 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.931 -173.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 85' ' ' LYS . . . . . 0.66 ' HE3' ' O ' ' D' ' 34' ' ' ASN . 51.9 mtpt -103.04 165.11 11.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.569 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.1 178.67 0.55 Allowed Glycine 0 C--N 1.335 0.49 0 O-C-N 123.779 0.674 . . . . 0.0 113.204 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 87' ' ' PRO . . . . . 0.725 ' O ' HG13 ' D' ' 58' ' ' VAL . 32.2 Cg_endo -93.98 -179.65 9.08 Favored 'Cis proline' 0 C--N 1.327 -0.57 0 C-N-CA 123.537 -1.443 . . . . 0.0 114.19 -0.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 88' ' ' TYR . . . . . 0.711 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 0.5 OUTLIER 27.77 91.92 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.953 1.301 . . . . 0.0 112.752 178.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.802 HD13 HG22 ' D' ' 84' ' ' ILE . 64.2 mt -110.42 119.03 58.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.536 0.684 . . . . 0.0 112.014 -177.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . 0.738 ' HB3' ' HB2' ' D' ' 57' ' ' PHE . 16.1 tp10 -106.6 91.15 3.57 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.297 178.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 91' ' ' ILE . . . . . 1.085 HG22 ' HZ3' ' D' ' 54' ' ' TRP . 4.2 mt -96.68 109.76 23.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 92' ' ' LYS . . . . . 0.656 ' HG2' ' O ' ' D' ' 93' ' ' GLN . 0.0 OUTLIER -161.5 169.72 21.27 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.528 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . 0.656 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 26.2 pt20 -80.9 162.82 23.77 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.653 175.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 94' ' ' ILE . . . . . 0.506 HG22 ' HE2' ' D' ' 92' ' ' LYS . 10.6 pt . . . . . 0 C--N 1.303 -1.437 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.428 -170.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.441 ' C ' HG12 ' D' ' 16' ' ' VAL . 63.3 mt . . . . . 0 C--O 1.233 0.197 0 CA-C-O 121.744 0.783 . . . . 0.0 111.647 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -94.05 -58.79 2.13 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.322 175.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 15' ' ' SER . . . . . 0.571 ' HA ' ' OD1' ' D' ' 18' ' ' ASP . 29.5 m -67.22 -18.28 65.17 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.308 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 16' ' ' VAL . . . . . 0.62 HG13 ' ND2' ' D' ' 17' ' ' ASN . 10.1 p -55.09 -28.89 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.962 0.887 . . . . 0.0 110.07 174.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 17' ' ' ASN . . . . . 0.62 ' ND2' HG13 ' D' ' 16' ' ' VAL . 3.9 m120 -79.92 -32.86 40.11 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.021 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 18' ' ' ASP . . . . . 0.571 ' OD1' ' HA ' ' D' ' 15' ' ' SER . 1.4 m-20 -59.64 -15.99 23.0 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 176.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.581 ' O ' ' HG3' ' D' ' 22' ' ' LYS . 0.0 OUTLIER -91.3 -52.26 4.89 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 122.285 1.041 . . . . 0.0 108.496 175.309 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 20' ' ' LEU . . . . . 0.989 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 60.8 mt -56.08 -39.26 71.83 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 112.953 -1.93 . . . . 0.0 110.516 -179.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 21' ' ' ASN . . . . . 0.613 ' OD1' ' HB2' ' D' ' 26' ' ' LYS . 56.0 m-20 -78.82 96.29 5.6 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.68 177.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 22' ' ' LYS . . . . . 0.581 ' HG3' ' O ' ' D' ' 19' ' ' LYS . 54.6 mttp -122.46 -42.7 2.33 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -178.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 170.83 -86.39 0.08 OUTLIER Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 119.606 -1.283 . . . . 0.0 113.24 -177.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . 0.705 ' HE3' ' HD1' ' D' ' 45' ' ' TYR . 53.7 tptt -46.47 -52.66 12.74 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 25' ' ' GLY . . . . . 1.017 ' HA2' HD21 ' D' ' 42' ' ' ASN . . . -146.31 151.12 23.41 Favored Glycine 0 N--CA 1.436 -1.334 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.681 177.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 26' ' ' LYS . . . . . 0.688 ' CD ' ' HB2' ' D' ' 41' ' ' SER . 0.4 OUTLIER -143.95 160.04 41.52 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.054 -0.573 . . . . 0.0 112.3 -170.113 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 27' ' ' LEU . . . . . 0.989 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 49.2 tp -135.75 143.44 45.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.484 0.659 . . . . 0.0 112.231 -177.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 28' ' ' SER . . . . . 0.647 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 39.2 m -127.39 151.23 49.07 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.965 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 29' ' ' LEU . . . . . 0.476 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 14.4 mt -140.4 156.77 46.28 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.925 177.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 60.2 m -159.19 -173.5 4.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.704 176.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -146.9 165.32 30.14 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 32' ' ' ASN . . . . . 0.501 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 51.4 t30 -150.14 88.81 1.54 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -177.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.31 -100.51 0.88 Allowed Glycine 0 C--O 1.228 -0.228 0 C-N-CA 120.306 -0.949 . . . . 0.0 110.949 -173.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -114.5 31.44 6.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.779 0.323 . . . . 0.0 110.145 173.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 35' ' ' GLN . . . . . 0.501 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 50.5 tt0 -109.63 159.96 16.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.906 0.384 . . . . 0.0 110.967 -176.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.675 HD11 HG22 ' D' ' 79' ' ' ILE . 1.9 tm? -123.77 134.6 53.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.87 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 37' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 13.6 mmmm -132.88 122.86 25.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.522 -168.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -129.65 149.75 51.27 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.828 0.347 . . . . 0.0 110.467 173.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 39' ' ' THR . . . . . 0.647 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 1.7 p -150.47 136.98 18.87 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.807 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . 0.616 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 40.8 p -107.75 133.7 51.77 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 173.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 41' ' ' SER . . . . . 0.688 ' HB2' ' CD ' ' D' ' 26' ' ' LYS . 35.4 m -94.19 164.81 12.9 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 174.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 42' ' ' ASN . . . . . 1.017 HD21 ' HA2' ' D' ' 25' ' ' GLY . 17.6 p30 61.73 10.12 3.23 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 124.669 1.231 . . . . 0.0 111.505 -171.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 53.3 60.5 3.69 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 167.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 44' ' ' GLY . . . . . 0.787 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 104.37 37.4 2.86 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 118.472 -1.823 . . . . 0.0 115.742 164.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 45' ' ' TYR . . . . . 0.705 ' HD1' ' HE3' ' D' ' 24' ' ' LYS . 2.5 m-85 -118.17 158.18 25.56 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 117.991 0.896 . . . . 0.0 109.53 172.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . 0.606 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -92.01 -176.34 42.37 Favored Glycine 0 C--O 1.213 -1.193 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 178.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 47' ' ' ILE . . . . . 0.845 HG12 ' HB3' ' D' ' 68' ' ' GLU . 40.2 mm -47.27 -54.92 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 CA-C-N 118.251 1.025 . . . . 0.0 110.714 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 22.8 t -178.22 -147.59 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 112.92 -1.946 . . . . 0.0 106.313 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -88.01 74.33 8.93 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 119.308 -0.957 . . . . 0.0 108.437 165.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -138.13 -171.93 3.15 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.607 -176.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 51' ' ' ASP . . . . . 0.67 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 52.2 p-10 -147.25 133.58 19.57 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.965 0.888 . . . . 0.0 112.697 177.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 52' ' ' LYS . . . . . 0.67 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 3.5 mptp? -145.49 134.41 22.51 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.164 -176.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -104.99 134.21 48.47 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 174.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 54' ' ' TRP . . . . . 0.635 ' HB2' ' O ' ' D' ' 66' ' ' PHE . 0.1 OUTLIER -125.58 158.13 35.39 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 -170.636 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -151.1 162.87 29.61 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.046 -1.073 . . . . 0.0 114.127 175.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 56' ' ' ILE . . . . . 0.682 HG23 HG12 ' D' ' 91' ' ' ILE . 66.8 mt -135.94 110.87 11.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 57' ' ' PHE . . . . . 0.702 ' HB2' ' HB3' ' D' ' 90' ' ' GLU . 19.4 m-85 -107.67 99.45 8.93 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 119.729 -0.789 . . . . 0.0 111.735 -165.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.678 HG22 HG12 ' D' ' 89' ' ' ILE . 85.7 t -87.86 107.51 17.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.204 175.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 59' ' ' ASN . . . . . 0.47 HD22 ' HB2' ' D' ' 88' ' ' TYR . 3.8 m120 68.79 31.16 4.54 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.937 -178.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.5 -32.35 7.48 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.581 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 61' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 11.2 pt-20 -89.83 139.3 30.71 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.36 0.6 . . . . 0.0 111.686 -175.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 62' ' ' LYS . . . . . 0.521 ' HB2' ' CE1' ' D' ' 57' ' ' PHE . 38.1 ttpt -81.07 103.59 10.99 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.395 -177.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 28.2 m -82.25 -32.88 11.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.584 0.586 . . . . 0.0 112.584 -174.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 64' ' ' TYR . . . . . 0.465 ' HB3' HD12 ' D' ' 56' ' ' ILE . 19.6 t80 -134.93 131.82 37.7 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.879 -0.329 . . . . 0.0 110.966 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 57.1 m -117.16 119.96 36.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.025 175.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 66' ' ' PHE . . . . . 0.635 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 16.1 p90 -126.31 146.8 49.88 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.195 0.522 . . . . 0.0 110.244 176.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -102.96 142.72 33.57 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -177.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 68' ' ' GLU . . . . . 0.845 ' HB3' HG12 ' D' ' 47' ' ' ILE . 5.6 mm-40 -75.89 -9.29 58.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.237 0.542 . . . . 0.0 109.703 175.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.544 ' HD3' ' HB2' ' D' ' 51' ' ' ASP . 9.1 mtmp? -67.93 -37.1 81.23 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 169.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 19.2 t -74.81 124.81 27.5 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 113.761 -1.563 . . . . 0.0 107.567 171.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 82.8 p -51.15 124.52 11.75 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.325 -176.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 72' ' ' VAL . . . . . 0.665 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -58.49 -11.49 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-O 121.151 0.5 . . . . 0.0 110.919 -175.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 73' ' ' GLY . . . . . 0.787 ' HA3' ' HA2' ' D' ' 44' ' ' GLY . . . -72.48 -61.77 3.5 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 114.948 -1.023 . . . . 0.0 112.861 170.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -57.77 -32.63 67.68 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 120.959 0.409 . . . . 0.0 109.951 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 75' ' ' ILE . . . . . 0.646 ' O ' HG13 ' D' ' 79' ' ' ILE . 23.8 mm -73.35 -42.19 57.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.317 177.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 76' ' ' SER . . . . . 0.511 ' HA ' HG13 ' D' ' 79' ' ' ILE . 30.2 t -73.79 -20.89 60.34 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.009 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -66.83 -29.92 69.97 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 167.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 78' ' ' ASP . . . . . 1.069 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 60.7 m-20 -77.77 -33.94 52.49 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.93 172.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . 0.675 HG22 HD11 ' D' ' 36' ' ' LEU . 25.3 mt -68.54 -17.3 21.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.239 -175.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -72.74 -37.26 67.78 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.424 175.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 81' ' ' LYS . . . . . 1.069 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -80.13 -51.97 8.34 Favored 'General case' 0 CA--C 1.526 0.033 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.678 176.048 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 82' ' ' LEU . . . . . 0.564 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.9 mm? -49.02 -30.82 6.6 Favored 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 177.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 83' ' ' ASN . . . . . 0.586 HD22 ' HB3' ' D' ' 36' ' ' LEU . 0.8 OUTLIER 40.14 66.23 0.63 Allowed 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.121 0.888 . . . . 0.0 111.374 172.298 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 84' ' ' ILE . . . . . 0.613 HG21 HG21 ' D' ' 56' ' ' ILE . 40.1 mm -82.1 97.74 4.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.074 -174.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.26 94.28 3.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.715 0.769 . . . . 0.0 112.807 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 86' ' ' GLY . . . . . 0.705 ' H ' HD11 ' D' ' 89' ' ' ILE . . . 67.57 153.61 0.38 Allowed Glycine 0 N--CA 1.453 -0.169 0 CA-C-N 115.603 -0.726 . . . . 0.0 113.74 175.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 87' ' ' PRO . . . . . 0.651 ' O ' HG13 ' D' ' 58' ' ' VAL . 42.9 Cg_endo -90.44 179.18 14.63 Favored 'Cis proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.298 -1.542 . . . . 0.0 112.668 -0.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 88' ' ' TYR . . . . . 0.598 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 10.0 m-85 11.56 93.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.622 1.569 . . . . 0.0 113.89 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.705 HD11 ' H ' ' D' ' 86' ' ' GLY . 77.7 mt -106.8 135.75 44.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.076 0.465 . . . . 0.0 111.839 -178.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . 0.702 ' HB3' ' HB2' ' D' ' 57' ' ' PHE . 5.4 tp10 -121.52 97.23 5.41 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.035 173.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 91' ' ' ILE . . . . . 0.682 HG12 HG23 ' D' ' 56' ' ' ILE . 35.2 mt -95.21 102.36 13.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.467 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 92' ' ' LYS . . . . . 0.68 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -160.44 165.6 30.74 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 178.221 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . 0.573 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 17.9 pt20 -80.35 165.55 22.17 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.209 0.528 . . . . 0.0 111.219 177.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 94' ' ' ILE . . . . . 0.68 HG22 ' HE2' ' D' ' 92' ' ' LYS . 8.1 pt . . . . . 0 C--N 1.313 -1.004 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.394 -170.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.434 ' C ' HG12 ' D' ' 16' ' ' VAL . 36.3 mm . . . . . 0 N--CA 1.453 -0.322 0 CA-C-O 121.518 0.675 . . . . 0.0 111.409 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -95.86 -59.43 1.86 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.107 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 15' ' ' SER . . . . . 0.72 ' O ' ' HE3' ' D' ' 19' ' ' LYS . 90.3 p -67.07 -17.35 64.85 Favored 'General case' 0 C--O 1.219 -0.509 0 O-C-N 121.975 -0.453 . . . . 0.0 110.71 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 16' ' ' VAL . . . . . 0.439 ' O ' ' HG ' ' D' ' 20' ' ' LEU . 11.2 p -52.72 -29.68 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.588 0.709 . . . . 0.0 110.227 174.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 17' ' ' ASN . . . . . 0.502 ' HB3' ' ND2' ' D' ' 21' ' ' ASN . 4.9 m120 -75.21 -41.19 58.32 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.646 177.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.23 -16.48 13.99 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.619 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.72 ' HE3' ' O ' ' D' ' 15' ' ' SER . 21.2 mmtp -85.72 -43.28 13.52 Favored 'General case' 0 CA--C 1.504 -0.827 0 CA-C-O 122.723 1.249 . . . . 0.0 108.195 -178.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 20' ' ' LEU . . . . . 0.997 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 63.0 mt -79.91 -37.76 33.99 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 111.308 -2.678 . . . . 0.0 110.591 -173.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 21' ' ' ASN . . . . . 0.567 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 54.2 m-80 -75.6 99.53 4.32 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.351 176.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 22' ' ' LYS . . . . . 0.677 ' HG3' ' O ' ' D' ' 20' ' ' LEU . 24.0 mtpp -120.43 -40.77 2.65 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 119.075 -1.05 . . . . 0.0 113.12 -166.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 157.55 -73.31 0.23 Allowed Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.327 -177.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . 0.925 ' HG2' ' HB3' ' D' ' 45' ' ' TYR . 77.5 tttt -63.82 -61.78 2.07 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 176.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 25' ' ' GLY . . . . . 0.632 ' HA2' HD22 ' D' ' 42' ' ' ASN . . . -127.54 163.71 21.2 Favored Glycine 0 N--CA 1.436 -1.331 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.024 174.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 26' ' ' LYS . . . . . 0.733 ' CD ' ' HB2' ' D' ' 41' ' ' SER . 9.7 ptpt -150.9 160.6 43.8 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.157 -0.522 . . . . 0.0 111.705 -170.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 27' ' ' LEU . . . . . 0.997 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 49.0 tp -137.08 148.04 46.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.073 0.463 . . . . 0.0 111.119 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 28' ' ' SER . . . . . 0.656 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 50.5 m -140.06 142.59 36.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.766 -173.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 29' ' ' LEU . . . . . 0.565 HD11 ' CD1' ' D' ' 20' ' ' LEU . 0.0 OUTLIER -141.5 147.74 38.31 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 119.688 -0.805 . . . . 0.0 111.656 -176.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 66.6 p -155.67 -172.47 4.15 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.83 176.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -137.44 166.53 23.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.864 0.364 . . . . 0.0 110.155 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 32' ' ' ASN . . . . . 0.5 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 23.4 t-20 -147.36 88.81 1.73 Allowed 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.98 -97.98 0.95 Allowed Glycine 0 N--CA 1.454 -0.113 0 C-N-CA 120.017 -1.087 . . . . 0.0 110.718 -170.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 76.0 m-80 -120.67 22.68 11.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.023 0.439 . . . . 0.0 110.034 173.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 35' ' ' GLN . . . . . 0.5 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 3.7 tp-100 -93.53 152.36 19.1 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.025 -177.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.793 ' HB2' ' HG2' ' D' ' 85' ' ' LYS . 2.3 tm? -118.41 128.57 54.75 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.984 0.421 . . . . 0.0 110.218 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 37' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 13.6 mmmm -128.42 121.74 29.72 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.905 -167.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 38' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -131.98 151.61 51.63 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.183 0.516 . . . . 0.0 110.52 174.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 39' ' ' THR . . . . . 0.656 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 2.6 p -149.5 134.81 18.28 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.8 -176.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . 0.54 ' HA ' ' O ' ' D' ' 26' ' ' LYS . 36.1 t -107.74 128.03 54.21 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 41' ' ' SER . . . . . 0.733 ' HB2' ' CD ' ' D' ' 26' ' ' LYS . 46.7 m -95.21 158.79 15.31 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -177.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 42' ' ' ASN . . . . . 0.632 HD22 ' HA2' ' D' ' 25' ' ' GLY . 0.1 OUTLIER 81.67 -17.31 0.56 Allowed 'General case' 0 N--CA 1.475 0.802 0 O-C-N 124.584 1.178 . . . . 0.0 109.313 -169.158 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 72.99 63.44 0.1 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 173.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 44' ' ' GLY . . . . . 0.711 ' O ' ' HB ' ' D' ' 71' ' ' THR . . . 126.92 -40.43 1.78 Allowed Glycine 0 C--N 1.341 0.825 0 C-N-CA 119.317 -1.42 . . . . 0.0 116.052 169.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 45' ' ' TYR . . . . . 0.925 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 3.3 m-30 -59.82 156.03 15.01 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 118.515 1.157 . . . . 0.0 113.798 -172.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -98.25 -153.24 28.58 Favored Glycine 0 C--O 1.218 -0.893 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.566 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 47' ' ' ILE . . . . . 0.98 HG13 ' HB2' ' D' ' 68' ' ' GLU . 0.3 OUTLIER -50.92 -58.7 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-O 122.238 1.018 . . . . 0.0 110.184 -176.6 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . 0.524 ' HA ' ' CD ' ' D' ' 24' ' ' LYS . 34.5 p 168.77 -76.06 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 111.47 -2.604 . . . . 0.0 106.158 -169.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -163.68 75.73 0.36 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.05 -1.432 . . . . 0.0 107.609 162.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . 0.705 ' O ' ' HG2' ' D' ' 69' ' ' LYS . 4.5 mm-40 -142.21 -159.31 0.95 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.004 -173.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 51' ' ' ASP . . . . . 0.623 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 35.6 t0 -146.62 125.99 13.14 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.118 176.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 52' ' ' LYS . . . . . 0.623 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 0.2 OUTLIER -141.62 100.0 3.67 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.111 -174.102 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -73.96 127.03 31.81 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.155 0.502 . . . . 0.0 110.515 177.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 54' ' ' TRP . . . . . 0.517 ' CH2' ' HA ' ' D' ' 92' ' ' LYS . 0.1 OUTLIER -118.74 155.26 31.4 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.611 -177.293 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -143.03 155.91 26.2 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 119.888 -1.149 . . . . 0.0 113.445 176.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 56' ' ' ILE . . . . . 0.78 HG23 HG12 ' D' ' 91' ' ' ILE . 61.0 mt -132.91 110.26 15.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 174.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 57' ' ' PHE . . . . . 0.728 ' HB2' ' HB2' ' D' ' 90' ' ' GLU . 9.4 m-85 -107.84 107.68 18.53 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 119.553 -0.859 . . . . 0.0 111.222 -167.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.681 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 98.1 t -96.63 110.74 25.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 173.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 64.21 37.51 8.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.797 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.03 -33.86 5.64 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.663 -0.78 . . . . 0.0 114.084 172.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 61' ' ' GLU . . . . . 0.516 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 12.1 pt-20 -90.86 156.87 17.69 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -177.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 41.5 mttm -77.32 126.32 30.74 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 13.1 p -94.63 -26.5 4.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 121.161 0.505 . . . . 0.0 109.947 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 64' ' ' TYR . . . . . 0.463 ' HB3' HD12 ' D' ' 56' ' ' ILE . 29.7 t80 -148.98 137.56 21.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.858 175.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 40.6 m -120.61 124.56 45.56 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 176.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 66' ' ' PHE . . . . . 0.478 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 21.6 p90 -131.94 165.21 24.42 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 175.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 67' ' ' ASN . . . . . 0.731 ' OD1' ' HG3' ' D' ' 69' ' ' LYS . 21.7 t-20 -131.77 150.88 52.01 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -176.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 68' ' ' GLU . . . . . 0.98 ' HB2' HG13 ' D' ' 47' ' ' ILE . 35.5 mm-40 -71.65 -20.67 61.92 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 119.499 -0.88 . . . . 0.0 109.731 177.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.731 ' HG3' ' OD1' ' D' ' 67' ' ' ASN . 26.2 mtpp -61.99 -48.27 81.08 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 173.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 23.9 m -71.73 77.98 0.85 Allowed 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 112.162 -2.29 . . . . 0.0 108.42 174.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 71' ' ' THR . . . . . 0.711 ' HB ' ' O ' ' D' ' 44' ' ' GLY . 59.7 p -19.82 117.39 0.03 OUTLIER 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.161 1.385 . . . . 0.0 113.933 -173.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 72' ' ' VAL . . . . . 0.481 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -51.42 -14.89 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 176.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 73' ' ' GLY . . . . . 0.536 ' HA3' ' HA2' ' D' ' 44' ' ' GLY . . . -67.49 -65.36 2.77 Favored Glycine 0 N--CA 1.435 -1.433 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.818 174.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 74' ' ' ASN . . . . . 0.728 ' HA ' HD22 ' D' ' 77' ' ' ASN . 4.2 m120 -67.12 -23.52 65.83 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.485 -0.358 . . . . 0.0 110.675 -177.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 75' ' ' ILE . . . . . 0.605 ' O ' HG13 ' D' ' 79' ' ' ILE . 32.6 mm -75.13 -39.85 43.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.506 177.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 76' ' ' SER . . . . . 0.413 ' HA ' HG13 ' D' ' 79' ' ' ILE . 28.7 t -73.29 -19.33 61.07 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.948 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 77' ' ' ASN . . . . . 0.728 HD22 ' HA ' ' D' ' 74' ' ' ASN . 78.6 m-20 -66.78 -31.3 71.85 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 167.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 78' ' ' ASP . . . . . 1.01 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 59.3 m-20 -78.11 -32.15 50.37 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.223 174.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . 0.626 HG22 HD11 ' D' ' 36' ' ' LEU . 18.0 mt -71.33 -16.69 19.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 C-N-CA 120.031 -0.668 . . . . 0.0 109.507 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -67.05 -31.57 72.17 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.821 173.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 81' ' ' LYS . . . . . 1.01 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -92.44 -49.48 6.11 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 177.321 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 82' ' ' LEU . . . . . 0.624 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.7 mm? -51.27 -28.06 10.89 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -176.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 83' ' ' ASN . . . . . 0.647 ' HA ' HD12 ' D' ' 36' ' ' LEU . 7.1 m120 33.21 72.7 0.08 Allowed 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 84' ' ' ILE . . . . . 0.649 HG22 HD13 ' D' ' 89' ' ' ILE . 41.2 mm -91.45 98.96 8.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.884 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 85' ' ' LYS . . . . . 0.793 ' HG2' ' HB2' ' D' ' 36' ' ' LEU . 30.7 mmmt -141.18 101.48 4.03 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.35 171.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 86' ' ' GLY . . . . . 0.626 ' H ' HD11 ' D' ' 89' ' ' ILE . . . 73.34 149.87 1.36 Allowed Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.094 -0.957 . . . . 0.0 113.393 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 87' ' ' PRO . . . . . 0.632 ' O ' HG13 ' D' ' 58' ' ' VAL . 43.2 Cg_endo -88.46 178.31 19.16 Favored 'Cis proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.917 -1.701 . . . . 0.0 112.557 0.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 88' ' ' TYR . . . . . 0.681 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 3.6 m-85 11.71 94.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 125.3 1.44 . . . . 0.0 114.366 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.677 HG12 HG22 ' D' ' 58' ' ' VAL . 62.6 mt -110.56 142.88 21.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.3 0.571 . . . . 0.0 112.468 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . 0.728 ' HB2' ' HB2' ' D' ' 57' ' ' PHE . 59.7 mm-40 -124.06 91.08 3.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.694 172.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 91' ' ' ILE . . . . . 0.78 HG12 HG23 ' D' ' 56' ' ' ILE . 23.2 mt -95.29 99.64 9.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 92' ' ' LYS . . . . . 0.633 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -161.09 166.95 27.22 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.639 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . 0.605 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 18.9 pt20 -81.5 164.46 21.97 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.274 176.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 94' ' ' ILE . . . . . 0.633 HG21 ' HZ ' ' D' ' 57' ' ' PHE . 8.1 pt . . . . . 0 C--N 1.311 -1.071 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.351 -169.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.593 ' O ' HG12 ' D' ' 16' ' ' VAL . 40.2 mm . . . . . 0 N--CA 1.45 -0.448 0 CA-C-O 121.87 0.843 . . . . 0.0 110.752 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -88.35 -61.91 1.61 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.009 177.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 15' ' ' SER . . . . . 0.63 ' HA ' ' OD1' ' D' ' 18' ' ' ASP . 86.6 p -65.96 -17.14 64.47 Favored 'General case' 0 C--O 1.217 -0.607 0 O-C-N 122.005 -0.435 . . . . 0.0 110.379 176.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 16' ' ' VAL . . . . . 0.593 HG12 ' O ' ' D' ' 13' ' ' ILE . 1.2 p -58.03 -23.2 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-O 121.652 0.739 . . . . 0.0 109.248 176.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 17' ' ' ASN . . . . . 0.543 ' HB3' ' ND2' ' D' ' 21' ' ' ASN . 4.6 m120 -89.18 -26.48 21.24 Favored 'General case' 0 C--O 1.212 -0.91 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.253 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 18' ' ' ASP . . . . . 0.63 ' OD1' ' HA ' ' D' ' 15' ' ' SER . 1.2 m-20 -61.79 -15.64 43.11 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.648 174.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.879 ' N ' ' HE2' ' D' ' 19' ' ' LYS . 0.4 OUTLIER -86.69 -55.86 3.67 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 173.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 20' ' ' LEU . . . . . 1.079 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 64.6 mt -56.71 -40.67 76.07 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 112.253 -2.249 . . . . 0.0 111.266 -176.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 21' ' ' ASN . . . . . 0.59 ' OD1' ' HB2' ' D' ' 26' ' ' LYS . 55.8 m-80 -81.01 99.54 8.49 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.8 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 22' ' ' LYS . . . . . 0.733 ' HD2' HD12 ' D' ' 47' ' ' ILE . 97.8 mttt -123.12 -41.99 2.29 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -175.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.39 -88.18 0.07 OUTLIER Glycine 0 N--CA 1.437 -1.292 0 C-N-CA 119.536 -1.316 . . . . 0.0 113.055 -176.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . 0.9 ' HE2' ' HA ' ' D' ' 48' ' ' SER . 32.8 ttpt -60.85 -62.03 2.16 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 25' ' ' GLY . . . . . 0.714 ' HA2' ' ND2' ' D' ' 42' ' ' ASN . . . -116.72 153.17 17.55 Favored Glycine 0 N--CA 1.432 -1.571 0 CA-C-N 115.21 -0.905 . . . . 0.0 112.494 175.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 26' ' ' LYS . . . . . 0.716 ' CD ' ' HB3' ' D' ' 41' ' ' SER . 9.0 ptpt -149.15 160.18 43.58 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.25 -0.975 . . . . 0.0 110.757 -171.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 27' ' ' LEU . . . . . 1.079 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 53.3 tp -138.11 150.33 46.76 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.525 0.679 . . . . 0.0 111.975 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 28' ' ' SER . . . . . 0.672 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 41.0 m -135.34 150.02 49.85 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.896 -177.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 29' ' ' LEU . . . . . . . . . . . . . 13.5 mt -140.12 149.9 43.61 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.269 177.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 22.7 t -160.05 -171.68 3.32 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 3.0 ppp? -141.85 166.07 25.72 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.109 0.481 . . . . 0.0 111.132 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 32' ' ' ASN . . . . . 0.491 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 26.6 t-20 -144.85 89.36 1.97 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.34 -0.845 . . . . 0.0 108.759 -178.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.94 -97.84 0.75 Allowed Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 119.887 -1.149 . . . . 0.0 111.099 -172.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -113.08 7.45 18.02 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.667 -0.313 . . . . 0.0 110.349 176.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 35' ' ' GLN . . . . . 0.491 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 7.5 tt0 -89.11 160.85 16.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.437 -172.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.598 ' HB3' HD22 ' D' ' 83' ' ' ASN . 0.9 OUTLIER -120.78 131.59 54.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.809 176.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 37' ' ' LYS . . . . . 0.506 ' HB3' ' HZ2' ' D' ' 37' ' ' LYS . 1.3 mmmp? -134.9 119.03 17.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.865 -169.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 38' ' ' ALA . . . . . 0.434 ' HB1' HD11 ' D' ' 27' ' ' LEU . . . -115.41 151.03 35.46 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.018 0.437 . . . . 0.0 111.0 175.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 39' ' ' THR . . . . . 0.672 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 7.0 p -146.33 131.71 18.6 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.747 177.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . 0.668 ' HB3' ' HA2' ' D' ' 73' ' ' GLY . 33.2 t -106.73 133.59 51.17 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 173.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 41' ' ' SER . . . . . 0.716 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 38.6 t -92.93 148.45 22.0 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 42' ' ' ASN . . . . . 0.714 ' ND2' ' HA2' ' D' ' 25' ' ' GLY . 0.5 OUTLIER 83.6 -16.85 0.52 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.762 1.625 . . . . 0.0 109.409 -166.731 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 62.28 55.77 2.31 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 44' ' ' GLY . . . . . 0.436 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 123.46 35.3 0.71 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 119.1 -1.524 . . . . 0.0 115.495 168.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 45' ' ' TYR . . . . . 0.771 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 2.5 m-85 -122.76 158.34 30.38 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 122.111 -0.64 . . . . 0.0 109.661 170.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -98.46 176.61 30.25 Favored Glycine 0 C--O 1.221 -0.66 0 CA-C-O 118.972 -0.904 . . . . 0.0 110.875 177.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 47' ' ' ILE . . . . . 0.843 HG12 ' HB3' ' D' ' 68' ' ' GLU . 33.0 mm -47.26 -56.0 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 CA-C-O 121.922 0.867 . . . . 0.0 109.712 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . 0.9 ' HA ' ' HE2' ' D' ' 24' ' ' LYS . 16.1 t 179.27 -149.01 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 113.149 -1.841 . . . . 0.0 107.393 178.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 49' ' ' TYR . . . . . 0.406 ' HD1' ' O ' ' D' ' 49' ' ' TYR . 0.1 OUTLIER -78.9 76.69 5.38 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.453 0.644 . . . . 0.0 110.416 168.32 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . 0.678 ' HB3' ' HE2' ' D' ' 52' ' ' LYS . 71.1 mm-40 -126.3 -166.17 1.54 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.28 -174.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 51' ' ' ASP . . . . . 0.683 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 7.0 t70 -161.04 119.68 2.5 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 114.503 -1.226 . . . . 0.0 111.565 171.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 52' ' ' LYS . . . . . 0.683 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 3.6 mptp? -142.99 115.85 8.76 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 114.22 -1.355 . . . . 0.0 109.822 -174.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -90.98 135.47 33.72 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 174.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 54' ' ' TRP . . . . . 0.633 ' HB2' ' O ' ' D' ' 66' ' ' PHE . 0.0 OUTLIER -126.93 158.02 37.91 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.855 -172.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -145.87 153.44 25.3 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 119.701 -1.237 . . . . 0.0 113.883 174.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 56' ' ' ILE . . . . . 0.665 HG23 HG12 ' D' ' 91' ' ' ILE . 61.8 mt -127.62 113.75 32.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 174.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 57' ' ' PHE . . . . . 0.849 ' HB2' ' HB2' ' D' ' 90' ' ' GLU . 8.4 m-85 -109.5 105.85 15.35 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.304 -168.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.73 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 94.3 t -90.48 103.63 14.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.997 173.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 59' ' ' ASN . . . . . 0.484 ' OD1' ' HG2' ' D' ' 87' ' ' PRO . 6.3 m120 61.1 47.02 7.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.36 -0.837 . . . . 0.0 111.655 -177.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.65 -33.7 5.69 Favored Glycine 0 CA--C 1.509 -0.292 0 C-N-CA 120.681 -0.771 . . . . 0.0 114.365 172.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 61' ' ' GLU . . . . . 0.536 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 16.6 pt-20 -92.97 146.83 23.33 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 120.931 -0.307 . . . . 0.0 111.229 -176.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -73.58 113.86 11.17 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 173.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 14.5 p -88.68 -23.41 6.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-O 121.098 0.475 . . . . 0.0 110.21 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 64' ' ' TYR . . . . . 0.483 ' HB3' HD12 ' D' ' 56' ' ' ILE . 26.4 t80 -152.85 135.26 15.1 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.608 175.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . 0.49 HG23 ' O ' ' D' ' 54' ' ' TRP . 88.9 m -121.15 125.92 48.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.412 176.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 66' ' ' PHE . . . . . 0.633 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 10.1 p90 -132.54 154.52 49.9 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.08 0.467 . . . . 0.0 110.409 178.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 67' ' ' ASN . . . . . 0.604 ' HA ' ' O ' ' D' ' 52' ' ' LYS . 3.9 m120 -114.1 145.51 41.53 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -178.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 68' ' ' GLU . . . . . 0.843 ' HB3' HG12 ' D' ' 47' ' ' ILE . 35.7 mt-10 -75.8 -8.94 58.09 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.42 177.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.622 ' HG2' ' O ' ' D' ' 50' ' ' GLU . 45.5 mtmt -63.83 -55.43 23.0 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 168.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 49.9 m -57.56 118.24 5.01 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 112.528 -2.124 . . . . 0.0 109.374 172.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 81.9 p -48.13 117.53 1.97 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.685 -176.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 72' ' ' VAL . . . . . 0.696 HG11 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -57.77 -11.95 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-O 120.788 0.328 . . . . 0.0 111.073 -174.565 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 73' ' ' GLY . . . . . 0.668 ' HA2' ' HB3' ' D' ' 40' ' ' SER . . . -74.42 -61.01 3.3 Favored Glycine 0 N--CA 1.436 -1.303 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.582 175.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 74' ' ' ASN . . . . . 0.763 ' HA ' HD22 ' D' ' 77' ' ' ASN . 28.5 t-20 -60.91 -28.17 68.72 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 75' ' ' ILE . . . . . 0.522 ' O ' ' HB2' ' D' ' 78' ' ' ASP . 31.3 mm -74.46 -41.14 49.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.894 175.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 76' ' ' SER . . . . . 0.451 ' HB2' HD13 ' D' ' 27' ' ' LEU . 28.8 t -73.18 -19.81 61.02 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.116 -177.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 77' ' ' ASN . . . . . 0.763 HD22 ' HA ' ' D' ' 74' ' ' ASN . 77.0 m-20 -61.8 -43.45 98.83 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 165.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 78' ' ' ASP . . . . . 0.962 ' HA ' ' HG2' ' D' ' 81' ' ' LYS . 1.1 m-20 -64.03 -34.78 78.78 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.978 174.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . 0.519 HG13 ' O ' ' D' ' 75' ' ' ILE . 53.6 mt -72.22 -24.56 22.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 C-N-CA 119.129 -1.028 . . . . 0.0 110.46 -174.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -78.64 -16.11 57.72 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.175 171.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 81' ' ' LYS . . . . . 0.962 ' HG2' ' HA ' ' D' ' 78' ' ' ASP . 25.6 mmtt -76.06 -64.54 1.07 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 172.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 82' ' ' LEU . . . . . 0.636 HD23 ' O ' ' D' ' 78' ' ' ASP . 2.8 mm? -46.71 -31.09 2.71 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 113.114 -1.857 . . . . 0.0 112.521 -179.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 83' ' ' ASN . . . . . 0.598 HD22 ' HB3' ' D' ' 36' ' ' LEU . 0.7 OUTLIER 45.55 57.59 4.85 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.668 0.605 . . . . 0.0 110.574 174.677 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 84' ' ' ILE . . . . . 0.527 ' O ' ' HG ' ' D' ' 36' ' ' LEU . 44.9 mm -83.38 97.63 4.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.913 0.387 . . . . 0.0 111.37 -173.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 85' ' ' LYS . . . . . 0.508 ' HB2' ' HB2' ' D' ' 36' ' ' LEU . 2.7 tmtm? -139.34 92.88 2.62 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 86' ' ' GLY . . . . . 0.732 ' HA2' HD11 ' D' ' 89' ' ' ILE . . . 72.74 152.06 1.65 Allowed Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.437 -0.801 . . . . 0.0 113.516 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 87' ' ' PRO . . . . . 0.595 ' O ' HG13 ' D' ' 58' ' ' VAL . 50.0 Cg_endo -90.12 179.47 14.7 Favored 'Cis proline' 0 CA--C 1.535 0.551 0 C-N-CA 123.304 -1.54 . . . . 0.0 113.195 0.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 88' ' ' TYR . . . . . 0.73 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 1.8 m-85 24.55 93.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.925 1.29 . . . . 0.0 113.62 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.732 HD11 ' HA2' ' D' ' 86' ' ' GLY . 3.5 mp -108.64 125.87 65.52 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-O 121.184 0.516 . . . . 0.0 111.665 -175.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . 0.849 ' HB2' ' HB2' ' D' ' 57' ' ' PHE . 5.5 mm-40 -119.65 89.59 3.16 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.75 171.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 91' ' ' ILE . . . . . 0.717 HG13 HG22 ' D' ' 89' ' ' ILE . 34.8 mt -95.95 101.19 12.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.076 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 92' ' ' LYS . . . . . 0.661 ' HG2' ' O ' ' D' ' 93' ' ' GLN . 0.0 OUTLIER -162.34 170.57 18.65 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.247 179.131 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . 0.661 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 17.1 pt20 -81.15 161.94 23.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.542 0.687 . . . . 0.0 110.992 173.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 94' ' ' ILE . . . . . 0.429 HG22 ' HE3' ' D' ' 92' ' ' LYS . 7.7 pt . . . . . 0 C--N 1.309 -1.18 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.435 -173.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.476 ' O ' HG12 ' D' ' 16' ' ' VAL . 67.3 mt . . . . . 0 C--O 1.228 -0.067 0 CA-C-O 121.798 0.809 . . . . 0.0 111.279 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -94.66 -49.58 5.56 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.032 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 15' ' ' SER . . . . . 0.729 ' HA ' ' OD2' ' D' ' 18' ' ' ASP . 88.6 p -70.35 -15.95 62.93 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.965 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 16' ' ' VAL . . . . . 0.715 ' HA ' ' HE2' ' D' ' 19' ' ' LYS . 12.4 p -58.82 -34.47 52.36 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.107 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 175.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 17' ' ' ASN . . . . . 0.651 ' ND2' ' HA ' ' D' ' 28' ' ' SER . 4.5 m120 -64.79 -42.17 95.26 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.747 172.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 18' ' ' ASP . . . . . 0.729 ' OD2' ' HA ' ' D' ' 15' ' ' SER . 60.6 m-20 -57.2 -17.32 10.86 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -175.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.715 ' HE2' ' HA ' ' D' ' 16' ' ' VAL . 0.0 OUTLIER -92.04 -38.86 11.96 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 122.167 0.985 . . . . 0.0 109.202 174.523 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 20' ' ' LEU . . . . . 0.903 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 84.8 mt -78.86 -31.32 45.55 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 112.897 -1.956 . . . . 0.0 111.121 -170.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 21' ' ' ASN . . . . . 0.553 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 2.8 t-20 -99.12 95.74 7.31 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.291 -167.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 22' ' ' LYS . . . . . 0.841 ' HD3' HG23 ' D' ' 47' ' ' ILE . 5.7 mtpm? -121.94 -42.91 2.37 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 118.308 -1.357 . . . . 0.0 113.926 -169.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 168.07 -80.32 0.1 Allowed Glycine 0 N--CA 1.439 -1.111 0 C-N-CA 119.912 -1.137 . . . . 0.0 112.787 -175.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . 0.813 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 23.4 tptm -47.85 -59.72 3.11 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 176.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 25' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -140.26 159.34 26.17 Favored Glycine 0 N--CA 1.431 -1.649 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.219 173.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 26' ' ' LYS . . . . . 0.707 ' HA ' ' O ' ' D' ' 20' ' ' LEU . 9.6 ptpt -149.67 160.57 43.41 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.467 -0.866 . . . . 0.0 110.771 -168.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 27' ' ' LEU . . . . . 0.903 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 41.4 tp -134.54 135.99 42.72 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.225 0.536 . . . . 0.0 111.747 178.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 28' ' ' SER . . . . . 0.651 ' HA ' ' ND2' ' D' ' 17' ' ' ASN . 50.6 m -125.27 133.29 52.72 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.709 -174.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 29' ' ' LEU . . . . . 0.712 HD11 HD12 ' D' ' 20' ' ' LEU . 0.0 OUTLIER -140.71 134.74 30.76 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.706 -174.078 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 72.6 p -146.8 174.12 11.77 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.799 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 23.2 ptm -136.42 118.84 15.76 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.496 0.665 . . . . 0.0 111.114 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -93.23 89.35 6.38 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.09 -104.78 2.61 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.499 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 76.0 m-80 -117.6 17.22 14.49 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.343 0.592 . . . . 0.0 109.651 175.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 35' ' ' GLN . . . . . 0.472 ' OE1' ' HD2' ' D' ' 37' ' ' LYS . 49.9 tt0 -94.4 142.19 27.71 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.479 -177.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.68 HD11 HG22 ' D' ' 79' ' ' ILE . 2.7 tm? -112.3 115.88 29.49 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.219 0.533 . . . . 0.0 111.195 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 37' ' ' LYS . . . . . 0.773 ' HA ' ' HE2' ' D' ' 37' ' ' LYS . 10.0 mmpt? -117.72 122.77 44.38 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 114.188 -1.369 . . . . 0.0 111.566 -168.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 38' ' ' ALA . . . . . 0.584 ' HB1' HD11 ' D' ' 27' ' ' LEU . . . -130.5 154.76 47.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.136 0.493 . . . . 0.0 111.186 176.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 39' ' ' THR . . . . . 0.639 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 2.5 p -150.37 131.95 14.84 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.763 -177.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . 0.626 ' HB3' ' HA2' ' D' ' 73' ' ' GLY . 40.4 t -108.17 129.77 55.16 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 172.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 41' ' ' SER . . . . . 0.686 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 32.7 t -95.87 154.47 17.21 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.432 -0.907 . . . . 0.0 109.592 -178.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 42' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' D' ' 41' ' ' SER . 77.0 m-20 78.28 6.69 2.52 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.96 -169.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 51.22 60.32 3.96 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 114.57 -1.196 . . . . 0.0 113.956 170.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 44' ' ' GLY . . . . . 0.581 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 105.99 37.01 2.61 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 119.189 -1.481 . . . . 0.0 114.357 170.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 45' ' ' TYR . . . . . 0.813 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 2.3 m-30 -113.96 153.19 29.73 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 173.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . 0.57 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -95.24 -162.86 34.45 Favored Glycine 0 C--O 1.219 -0.797 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 47' ' ' ILE . . . . . 0.841 HG23 ' HD3' ' D' ' 22' ' ' LYS . 39.0 mm -51.46 -55.72 7.55 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.706 0 CA-C-O 122.06 0.933 . . . . 0.0 109.035 174.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 62.3 p -174.77 -86.96 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 112.975 -1.92 . . . . 0.0 108.862 -176.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 49' ' ' TYR . . . . . 0.434 ' HD2' ' O ' ' D' ' 49' ' ' TYR . 0.1 OUTLIER -152.64 76.03 1.13 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.263 167.545 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . 0.724 ' O ' ' HG2' ' D' ' 69' ' ' LYS . 4.2 mm-40 -137.35 -164.93 1.67 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.443 -172.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 51' ' ' ASP . . . . . 0.613 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 8.9 t70 -138.26 127.93 25.05 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.741 173.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 52' ' ' LYS . . . . . 0.613 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 0.3 OUTLIER -143.07 121.68 12.52 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.407 -1.27 . . . . 0.0 109.482 -178.442 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -99.1 132.5 44.36 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.344 -0.542 . . . . 0.0 109.815 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 54' ' ' TRP . . . . . 1.018 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 0.9 OUTLIER -121.7 152.97 38.81 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.903 -172.465 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -137.65 156.07 23.43 Favored Glycine 0 N--CA 1.436 -1.364 0 C-N-CA 119.732 -1.223 . . . . 0.0 112.576 172.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 56' ' ' ILE . . . . . 1.103 HG12 HG23 ' D' ' 91' ' ' ILE . 96.2 mt -126.53 94.46 2.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 176.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 57' ' ' PHE . . . . . 0.571 ' HA ' ' O ' ' D' ' 61' ' ' GLU . 18.2 m-85 -95.39 108.35 20.54 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.668 -165.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.745 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 66.4 t -95.69 105.97 17.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.447 171.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 59' ' ' ASN . . . . . 0.512 ' ND2' ' HB2' ' D' ' 88' ' ' TYR . 4.1 m120 60.85 46.72 8.44 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.759 0.314 . . . . 0.0 111.495 -177.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.01 48.31 54.72 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.676 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 61' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 17.6 tp10 -159.61 126.15 4.46 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -73.48 109.6 7.12 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.087 176.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.441 HG23 HD13 ' D' ' 84' ' ' ILE . 34.4 m -82.91 -10.77 12.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 120.991 0.424 . . . . 0.0 110.777 176.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 64' ' ' TYR . . . . . 0.562 ' HB3' HD12 ' D' ' 56' ' ' ILE . 13.9 t80 -158.93 137.85 11.18 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.271 174.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 71.7 m -122.81 113.5 19.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.145 177.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 66' ' ' PHE . . . . . 0.505 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 11.5 p90 -120.34 156.68 30.81 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.121 0.486 . . . . 0.0 110.061 177.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 67' ' ' ASN . . . . . 0.736 HD22 ' HB2' ' D' ' 69' ' ' LYS . 14.6 p-10 -122.96 133.91 54.36 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.317 -174.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 68' ' ' GLU . . . . . 0.814 ' HB3' HG12 ' D' ' 47' ' ' ILE . 40.6 mm-40 -68.05 -8.35 36.99 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.348 -176.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.736 ' HB2' HD22 ' D' ' 67' ' ' ASN . 49.6 mtpt -63.5 -44.24 94.89 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 169.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 70' ' ' SER . . . . . 0.411 ' HB3' ' O ' ' D' ' 67' ' ' ASN . 24.2 t -64.19 125.72 25.45 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 113.667 -1.606 . . . . 0.0 107.689 167.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 71' ' ' THR . . . . . 0.418 ' O ' HG13 ' D' ' 75' ' ' ILE . 75.4 p -55.76 128.87 36.97 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 72' ' ' VAL . . . . . 0.688 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -57.09 -13.76 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-O 121.163 0.506 . . . . 0.0 110.601 -177.503 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 73' ' ' GLY . . . . . 0.626 ' HA2' ' HB3' ' D' ' 40' ' ' SER . . . -67.6 -63.45 3.71 Favored Glycine 0 N--CA 1.434 -1.433 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.568 171.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -64.79 -19.65 65.94 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.314 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 75' ' ' ILE . . . . . 0.488 HD12 ' HA ' ' D' ' 72' ' ' VAL . 74.7 mt -73.5 -41.06 56.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 173.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 76' ' ' SER . . . . . 0.7 ' HA ' HG12 ' D' ' 79' ' ' ILE . 41.5 t -75.26 -22.61 57.68 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.039 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 77' ' ' ASN . . . . . 0.404 ' O ' ' HD2' ' D' ' 81' ' ' LYS . 5.6 m120 -61.68 -25.22 67.26 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 167.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 78' ' ' ASP . . . . . 1.104 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 0.9 OUTLIER -90.03 -27.29 19.83 Favored 'General case' 0 C--O 1.227 -0.122 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 175.529 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . 0.7 HG12 ' HA ' ' D' ' 76' ' ' SER . 22.5 mm -68.86 -34.65 65.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.391 -176.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -66.88 -32.06 73.08 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -177.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 81' ' ' LYS . . . . . 1.104 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -77.25 -53.74 7.35 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.99 175.607 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 82' ' ' LEU . . . . . 0.58 HD23 ' O ' ' D' ' 78' ' ' ASP . 2.9 mm? -47.37 -32.22 4.69 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.008 0.523 . . . . 0.0 112.322 177.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 83' ' ' ASN . . . . . 0.584 ' HA ' HD12 ' D' ' 36' ' ' LEU . 9.3 t30 37.65 58.0 1.39 Allowed 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.45 1.094 . . . . 0.0 110.897 178.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 84' ' ' ILE . . . . . 0.585 ' N ' ' HG ' ' D' ' 36' ' ' LEU . 54.8 mt -80.32 104.47 8.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.993 0.425 . . . . 0.0 111.889 -172.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.21 92.97 2.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.771 0.796 . . . . 0.0 112.33 177.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 86' ' ' GLY . . . . . 0.741 ' HA2' HD11 ' D' ' 89' ' ' ILE . . . 75.65 153.35 4.16 Favored Glycine 0 CA--C 1.509 -0.288 0 CA-C-N 115.128 -0.942 . . . . 0.0 114.196 173.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 87' ' ' PRO . . . . . 0.65 ' O ' HG13 ' D' ' 58' ' ' VAL . 50.8 Cg_endo -89.41 -179.6 14.29 Favored 'Cis proline' 0 CA--C 1.534 0.478 0 C-N-CA 123.221 -1.575 . . . . 0.0 113.247 0.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 88' ' ' TYR . . . . . 0.745 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 1.8 m-85 20.86 93.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.812 1.245 . . . . 0.0 113.897 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.741 HD11 ' HA2' ' D' ' 86' ' ' GLY . 2.9 mp -110.76 134.14 53.99 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.281 -177.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -128.2 96.5 4.47 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.495 169.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 91' ' ' ILE . . . . . 1.103 HG23 HG12 ' D' ' 56' ' ' ILE . 6.0 mt -96.13 105.4 17.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 178.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 92' ' ' LYS . . . . . 0.654 ' HE3' ' O ' ' D' ' 93' ' ' GLN . 0.1 OUTLIER -161.54 170.48 19.8 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 123.027 0.531 . . . . 0.0 111.624 -174.742 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . 0.682 ' HB3' ' NE1' ' D' ' 54' ' ' TRP . 3.0 pt20 -90.16 155.36 19.09 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.666 0.746 . . . . 0.0 111.638 176.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 94' ' ' ILE . . . . . 0.493 HG21 ' HZ ' ' D' ' 57' ' ' PHE . 8.2 pt . . . . . 0 C--N 1.307 -1.257 0 CA-C-N 113.98 -1.464 . . . . 0.0 111.622 -171.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.448 ' C ' HG12 ' D' ' 16' ' ' VAL . 48.7 mt . . . . . 0 N--CA 1.45 -0.442 0 CA-C-O 121.744 0.783 . . . . 0.0 110.736 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -97.28 -56.93 2.39 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.597 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 50.9 m -67.84 -15.34 63.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.845 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 16' ' ' VAL . . . . . 0.701 ' HA ' ' HE2' ' D' ' 19' ' ' LYS . 14.3 p -56.22 -35.28 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 174.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -67.7 -40.23 84.34 Favored 'General case' 0 C--O 1.213 -0.856 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.92 176.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.57 -16.64 39.92 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -175.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.701 ' HE2' ' HA ' ' D' ' 16' ' ' VAL . 0.0 OUTLIER -89.97 -46.17 8.7 Favored 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 173.225 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 20' ' ' LEU . . . . . 0.811 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 84.1 mt -63.73 -35.84 81.9 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 113.594 -1.639 . . . . 0.0 110.479 -177.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 21' ' ' ASN . . . . . 0.484 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 2.8 m120 -72.65 95.93 1.93 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.8 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 22' ' ' LYS . . . . . 0.853 ' HE2' ' HA ' ' D' ' 22' ' ' LYS . 7.7 mmpt? -118.05 11.17 13.25 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -170.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.94 -74.28 1.7 Allowed Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.982 176.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . 0.775 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 55.2 tptt -53.27 -59.22 4.84 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 176.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -144.67 157.69 27.33 Favored Glycine 0 N--CA 1.43 -1.715 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.699 174.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 26' ' ' LYS . . . . . 0.876 ' HD2' ' HB3' ' D' ' 41' ' ' SER . 10.8 ptpt -151.04 160.68 43.76 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.379 -0.911 . . . . 0.0 111.354 -164.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 27' ' ' LEU . . . . . 0.824 HD13 ' HB2' ' D' ' 76' ' ' SER . 28.4 tp -132.89 144.53 50.24 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.164 0.507 . . . . 0.0 111.397 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 28' ' ' SER . . . . . 0.673 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 52.4 m -137.74 143.61 41.27 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.983 -175.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 29' ' ' LEU . . . . . 0.588 HD11 ' CD1' ' D' ' 20' ' ' LEU . 0.0 OUTLIER -141.02 144.74 35.18 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.326 -178.7 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 35.5 m -145.66 170.07 17.2 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.035 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 31' ' ' MET . . . . . 0.575 ' SD ' ' HE2' ' D' ' 85' ' ' LYS . 61.2 mtt -130.95 111.17 11.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.043 0.449 . . . . 0.0 110.888 177.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -91.82 87.82 6.41 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.08 -125.41 8.21 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.168 -1.015 . . . . 0.0 111.48 -173.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -89.66 31.2 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 O-C-N 122.464 -0.433 . . . . 0.0 110.267 175.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 35' ' ' GLN . . . . . 0.437 ' CG ' ' HD3' ' D' ' 37' ' ' LYS . 3.8 tp-100 -116.88 154.45 30.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.37 -172.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.914 ' HB2' ' HB2' ' D' ' 85' ' ' LYS . 1.8 tm? -118.74 126.66 52.37 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.741 176.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 37' ' ' LYS . . . . . 0.552 ' HB3' ' NZ ' ' D' ' 37' ' ' LYS . 1.1 mmmp? -129.63 117.84 21.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.587 -169.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 38' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -119.42 152.79 36.25 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.539 0.685 . . . . 0.0 112.26 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 39' ' ' THR . . . . . 0.673 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 3.2 p -144.57 126.73 15.63 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.145 177.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . 0.591 ' HA ' ' O ' ' D' ' 26' ' ' LYS . 14.9 p -108.49 128.9 55.2 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 172.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 41' ' ' SER . . . . . 0.876 ' HB3' ' HD2' ' D' ' 26' ' ' LYS . 42.5 t -102.43 155.72 18.07 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.161 -175.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 42' ' ' ASN . . . . . 0.525 ' ND2' ' HE3' ' D' ' 26' ' ' LYS . 74.0 m-80 76.67 8.55 3.1 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.711 -172.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 47.08 61.72 2.73 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 114.613 -1.176 . . . . 0.0 114.043 168.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.63 -14.41 7.21 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 119.004 -1.57 . . . . 0.0 114.93 172.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 45' ' ' TYR . . . . . 0.775 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 2.0 m-30 -76.19 156.75 33.38 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 117.347 0.573 . . . . 0.0 111.488 -176.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . 0.554 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -103.72 -157.5 24.5 Favored Glycine 0 C--O 1.214 -1.095 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 175.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 47' ' ' ILE . . . . . 0.834 HG13 ' HB3' ' D' ' 68' ' ' GLU . 0.8 OUTLIER -53.98 -57.33 5.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 122.778 1.275 . . . . 0.0 109.58 178.236 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 39.4 t 174.7 -116.05 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 111.205 -2.725 . . . . 0.0 105.89 -175.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -119.75 76.79 1.17 Allowed 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.888 -0.507 . . . . 0.0 109.818 165.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . 0.425 ' HB2' ' HE3' ' D' ' 52' ' ' LYS . 60.3 mm-40 -140.55 -169.3 2.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.38 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 51' ' ' ASP . . . . . 0.647 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 1.4 m-20 -139.97 134.09 31.02 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.935 173.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 52' ' ' LYS . . . . . 0.746 ' HD3' HG12 ' D' ' 47' ' ' ILE . 0.1 OUTLIER -144.66 150.15 36.88 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 53' ' ' ASN . . . . . 0.435 HD22 ' C ' ' D' ' 52' ' ' LYS . 2.8 m120 -118.95 138.72 52.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.76 0.314 . . . . 0.0 110.324 173.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 54' ' ' TRP . . . . . 1.082 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 1.7 m95 -124.7 153.22 42.69 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -175.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -138.42 157.34 24.49 Favored Glycine 0 N--CA 1.432 -1.598 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.036 172.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 56' ' ' ILE . . . . . 1.029 HG12 HG23 ' D' ' 91' ' ' ILE . 95.8 mt -131.18 94.58 2.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 177.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 57' ' ' PHE . . . . . 0.512 ' CE1' ' HB2' ' D' ' 62' ' ' LYS . 48.3 m-85 -93.86 101.03 13.11 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.546 -167.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.723 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 94.7 t -83.25 102.64 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.955 173.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 59' ' ' ASN . . . . . 0.485 ' OD1' ' HG2' ' D' ' 87' ' ' PRO . 6.4 m120 59.6 45.67 12.92 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.493 -177.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.29 -30.5 7.63 Favored Glycine 0 CA--C 1.508 -0.399 0 C-N-CA 120.009 -1.091 . . . . 0.0 112.655 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -88.15 119.9 28.99 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.852 -0.674 . . . . 0.0 110.618 -174.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 62' ' ' LYS . . . . . 0.512 ' HB2' ' CE1' ' D' ' 57' ' ' PHE . 38.7 ttpt -70.76 98.56 1.56 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 176.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.551 HG12 ' O ' ' D' ' 56' ' ' ILE . 13.4 p -77.77 -29.01 15.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.448 -170.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 64' ' ' TYR . . . . . 0.401 ' HB3' HD12 ' D' ' 56' ' ' ILE . 23.0 t80 -143.46 137.77 28.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.555 177.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 56.9 m -116.47 116.5 27.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.462 175.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 66' ' ' PHE . . . . . 0.483 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 18.3 p90 -122.06 154.98 36.59 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 170.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -117.64 146.89 43.36 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 68' ' ' GLU . . . . . 0.834 ' HB3' HG13 ' D' ' 47' ' ' ILE . 39.9 mm-40 -62.48 -24.96 67.75 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.214 0.531 . . . . 0.0 109.67 176.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.5 ' HD3' ' HB3' ' D' ' 51' ' ' ASP . 9.0 mtmp? -58.02 -44.16 87.15 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.495 173.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 70' ' ' SER . . . . . 0.454 ' OG ' HD11 ' D' ' 75' ' ' ILE . 15.4 t -76.18 92.73 3.28 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 113.798 -1.547 . . . . 0.0 107.627 172.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 73.4 p -30.84 122.85 0.21 Allowed 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.477 -1.238 . . . . 0.0 112.787 -172.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 72' ' ' VAL . . . . . 0.434 ' O ' ' HB3' ' D' ' 40' ' ' SER . 0.0 OUTLIER -51.72 -17.42 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 O-C-N 123.319 0.387 . . . . 0.0 111.709 177.8 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 73' ' ' GLY . . . . . 0.587 ' HA2' ' CB ' ' D' ' 40' ' ' SER . . . -65.33 -65.41 2.93 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 115.371 -0.832 . . . . 0.0 113.193 171.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 74' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' D' ' 77' ' ' ASN . 49.7 t30 -65.49 -22.9 66.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.852 0.358 . . . . 0.0 110.705 -178.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 75' ' ' ILE . . . . . 0.506 ' O ' HG12 ' D' ' 79' ' ' ILE . 27.2 mm -76.93 -37.94 27.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.067 177.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 76' ' ' SER . . . . . 0.824 ' HB2' HD13 ' D' ' 27' ' ' LEU . 32.8 t -75.51 -19.45 59.36 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.224 -0.59 . . . . 0.0 110.284 175.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 77' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' D' ' 74' ' ' ASN . 5.1 m120 -63.14 -28.92 70.39 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 166.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 78' ' ' ASP . . . . . 1.063 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 1.0 OUTLIER -87.9 -30.03 20.42 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 115.387 -0.824 . . . . 0.0 113.166 176.114 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . 0.703 HG12 ' HA ' ' D' ' 76' ' ' SER . 24.3 mm -63.25 -28.22 44.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 O-C-N 121.379 -0.826 . . . . 0.0 110.669 -174.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -65.46 -40.45 93.21 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.509 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 81' ' ' LYS . . . . . 1.063 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -74.17 -51.83 14.33 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.605 176.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 82' ' ' LEU . . . . . 0.613 HD23 ' O ' ' D' ' 78' ' ' ASP . 4.0 mm? -48.99 -30.16 5.71 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 83' ' ' ASN . . . . . 0.662 HD22 ' HB3' ' D' ' 36' ' ' LEU . 0.7 OUTLIER 42.36 61.42 2.01 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 123.695 0.622 . . . . 0.0 110.979 174.693 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 84' ' ' ILE . . . . . 0.495 HG22 HD13 ' D' ' 89' ' ' ILE . 49.5 mt -90.94 98.19 8.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.773 -175.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 85' ' ' LYS . . . . . 0.914 ' HB2' ' HB2' ' D' ' 36' ' ' LEU . 10.9 tmtt? -141.33 94.93 2.75 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -175.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 86' ' ' GLY . . . . . 0.567 ' H ' HD11 ' D' ' 89' ' ' ILE . . . 69.17 150.97 0.4 Allowed Glycine 0 N--CA 1.453 -0.194 0 CA-C-N 115.283 -0.871 . . . . 0.0 113.495 -178.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 87' ' ' PRO . . . . . 0.596 ' O ' HG13 ' D' ' 58' ' ' VAL . 68.5 Cg_endo -90.21 -178.79 12.09 Favored 'Cis proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.405 -1.498 . . . . 0.0 112.835 -0.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 88' ' ' TYR . . . . . 0.723 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 1.5 m-85 13.53 93.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.175 1.39 . . . . 0.0 113.943 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.587 HG12 HG22 ' D' ' 58' ' ' VAL . 67.9 mt -110.34 132.49 58.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.311 0.577 . . . . 0.0 112.363 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -123.25 93.92 4.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.867 173.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 91' ' ' ILE . . . . . 1.082 HG22 ' HZ3' ' D' ' 54' ' ' TRP . 7.3 mt -95.93 107.6 19.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 92' ' ' LYS . . . . . 0.648 ' HE3' ' O ' ' D' ' 93' ' ' GLN . 0.0 OUTLIER -163.08 171.27 16.67 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.54 -173.234 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . 0.648 ' O ' ' HE3' ' D' ' 92' ' ' LYS . 3.5 pp0? -87.99 156.64 19.22 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.686 0.755 . . . . 0.0 112.787 178.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 94' ' ' ILE . . . . . 0.57 ' CG2' ' HE2' ' D' ' 92' ' ' LYS . 4.9 pt . . . . . 0 C--N 1.314 -0.938 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.005 -173.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.43 ' C ' HG12 ' D' ' 16' ' ' VAL . 53.8 mt . . . . . 0 N--CA 1.452 -0.359 0 CA-C-O 121.51 0.671 . . . . 0.0 111.284 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -94.43 -61.9 1.43 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.076 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 15' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' D' ' 19' ' ' LYS . 89.3 p -64.69 -16.68 63.22 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 122.252 -0.28 . . . . 0.0 111.108 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 16' ' ' VAL . . . . . 0.648 ' HA ' ' HE3' ' D' ' 19' ' ' LYS . 14.2 p -58.63 -32.77 46.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-O 121.835 0.826 . . . . 0.0 110.002 178.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 17' ' ' ASN . . . . . 0.427 ' HB3' ' ND2' ' D' ' 21' ' ' ASN . 5.2 m120 -71.55 -37.18 71.12 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.707 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.84 -15.17 58.21 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.648 ' HE3' ' HA ' ' D' ' 16' ' ' VAL . 71.3 mttt -91.03 -28.31 18.05 Favored 'General case' 0 CA--C 1.494 -1.199 0 CA-C-O 122.447 1.117 . . . . 0.0 109.229 -177.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 20' ' ' LEU . . . . . 0.88 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 76.1 mt -95.51 -41.14 9.1 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 112.223 -2.262 . . . . 0.0 109.061 -171.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 21' ' ' ASN . . . . . 0.69 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 59.9 m-20 -73.56 91.07 1.8 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.04 -1.436 . . . . 0.0 110.337 175.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 22' ' ' LYS . . . . . 0.471 ' HD3' HD12 ' D' ' 47' ' ' ILE . 28.7 mtpp -122.36 -41.38 2.41 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -170.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 171.77 -91.89 0.09 OUTLIER Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 119.63 -1.271 . . . . 0.0 113.3 -176.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . 0.552 ' HB3' ' O ' ' D' ' 46' ' ' GLY . 44.2 tptt -50.46 -53.56 28.74 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 25' ' ' GLY . . . . . 0.624 ' HA2' ' ND2' ' D' ' 42' ' ' ASN . . . -140.35 157.46 25.6 Favored Glycine 0 N--CA 1.435 -1.428 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.334 176.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 26' ' ' LYS . . . . . 0.69 ' CB ' ' HA ' ' D' ' 21' ' ' ASN . 9.3 ptpt -149.36 160.6 43.29 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.077 -0.562 . . . . 0.0 111.026 -169.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 27' ' ' LEU . . . . . 0.88 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 44.7 tp -137.08 144.69 43.25 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.34 0.59 . . . . 0.0 111.899 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 28' ' ' SER . . . . . 0.575 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 23.1 t -135.4 137.31 42.16 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.013 -178.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 29' ' ' LEU . . . . . 0.484 HD11 ' CD1' ' D' ' 20' ' ' LEU . 0.0 OUTLIER -140.5 114.29 8.89 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.345 -179.188 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 68.8 p -123.56 -173.08 2.65 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.975 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 31' ' ' MET . . . . . 0.463 ' SD ' ' HE2' ' D' ' 85' ' ' LYS . 23.0 ptt? -148.1 122.1 9.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.62 0.724 . . . . 0.0 110.961 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -91.92 88.42 6.6 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.43 177.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.56 -110.04 2.99 Favored Glycine 0 CA--C 1.515 0.069 0 C-N-CA 120.333 -0.937 . . . . 0.0 111.389 -172.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 73.6 m-80 -106.24 14.36 27.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.075 0.464 . . . . 0.0 110.716 175.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 35' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -89.04 155.36 19.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.603 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 1.099 ' HB2' ' HB2' ' D' ' 85' ' ' LYS . 1.4 tm? -117.82 126.98 53.43 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 37' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 29.0 mmmt -130.65 117.79 20.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.829 -168.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 38' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -121.39 148.89 43.79 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.865 175.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 39' ' ' THR . . . . . 0.575 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 16.5 p -147.89 138.94 23.37 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.516 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . 0.482 ' HB3' ' HA2' ' D' ' 73' ' ' GLY . 36.7 t -107.69 128.19 54.34 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 169.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 41' ' ' SER . . . . . 0.574 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 35.1 t -94.67 161.63 14.11 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -177.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 42' ' ' ASN . . . . . 0.624 ' ND2' ' HA2' ' D' ' 25' ' ' GLY . 0.1 OUTLIER 83.47 -17.4 0.49 Allowed 'General case' 0 N--CA 1.477 0.879 0 O-C-N 124.706 1.254 . . . . 0.0 109.163 -167.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 71.52 62.48 0.15 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 44' ' ' GLY . . . . . 0.628 ' O ' ' HB ' ' D' ' 71' ' ' THR . . . 127.9 -40.69 1.7 Allowed Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 119.215 -1.469 . . . . 0.0 116.162 168.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 45' ' ' TYR . . . . . 0.538 ' CD2' ' HE3' ' D' ' 24' ' ' LYS . 3.2 m-30 -63.89 155.8 29.6 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.059 1.43 . . . . 0.0 112.422 -175.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . 0.552 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -91.29 -177.2 43.28 Favored Glycine 0 C--O 1.217 -0.926 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 172.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 47' ' ' ILE . . . . . 0.84 HG12 ' HB3' ' D' ' 68' ' ' GLU . 43.2 mm -45.66 -48.37 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.075 0 CA-C-N 117.903 0.852 . . . . 0.0 110.232 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . 0.512 ' HB2' ' O ' ' D' ' 47' ' ' ILE . 48.4 t 153.22 -142.97 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 O-C-N 126.411 2.319 . . . . 0.0 107.632 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -77.48 75.88 4.03 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.467 0.651 . . . . 0.0 111.183 173.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . 0.678 ' HB3' ' HE3' ' D' ' 52' ' ' LYS . 68.3 mm-40 -134.85 -176.39 4.22 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.481 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 51' ' ' ASP . . . . . 0.717 ' HA ' ' CG ' ' D' ' 69' ' ' LYS . 7.1 p-10 -152.89 113.39 4.05 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.559 173.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 52' ' ' LYS . . . . . 0.678 ' HE3' ' HB3' ' D' ' 50' ' ' GLU . 21.1 mmtp -129.88 139.03 51.24 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.314 -170.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 53' ' ' ASN . . . . . 0.493 HD22 ' C ' ' D' ' 52' ' ' LYS . 2.7 m120 -114.33 132.12 56.3 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.404 175.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 54' ' ' TRP . . . . . 0.685 ' HB2' ' O ' ' D' ' 66' ' ' PHE . 0.5 OUTLIER -128.27 160.97 30.49 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -170.431 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -152.7 162.45 29.99 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 114.892 -1.049 . . . . 0.0 113.56 172.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 56' ' ' ILE . . . . . 0.636 HG23 HG12 ' D' ' 91' ' ' ILE . 58.6 mt -130.98 111.91 20.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 177.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 57' ' ' PHE . . . . . 0.956 ' HB2' ' HB3' ' D' ' 90' ' ' GLU . 10.3 m-85 -108.67 99.54 8.9 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 119.908 -0.717 . . . . 0.0 111.424 -165.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.733 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 84.3 t -81.57 103.89 9.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.713 173.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 6.9 m120 63.31 44.38 5.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.505 -176.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.53 -33.1 5.7 Favored Glycine 0 CA--C 1.509 -0.34 0 C-N-CA 120.49 -0.862 . . . . 0.0 114.304 172.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 61' ' ' GLU . . . . . 0.543 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 16.7 pt-20 -90.6 136.27 33.17 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.239 0.542 . . . . 0.0 111.801 -173.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 62' ' ' LYS . . . . . 0.454 ' HB2' ' CE2' ' D' ' 57' ' ' PHE . 38.0 ttpt -74.26 110.33 8.46 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.861 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.455 HG22 ' O ' ' D' ' 56' ' ' ILE . 29.5 m -93.65 -29.47 4.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -175.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 64' ' ' TYR . . . . . 0.428 ' HB3' HD12 ' D' ' 56' ' ' ILE . 30.4 t80 -136.66 132.44 34.98 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 121.193 -0.203 . . . . 0.0 110.675 178.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 49.9 m -114.39 123.14 48.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.459 176.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 66' ' ' PHE . . . . . 0.685 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 14.1 p90 -131.48 148.76 52.67 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 173.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 67' ' ' ASN . . . . . 0.633 HD22 ' HB2' ' D' ' 69' ' ' LYS . 14.5 p-10 -117.94 130.95 56.52 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 68' ' ' GLU . . . . . 0.84 ' HB3' HG12 ' D' ' 47' ' ' ILE . 54.8 mm-40 -59.85 -18.27 42.92 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.009 0.433 . . . . 0.0 111.314 -173.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.717 ' CG ' ' HA ' ' D' ' 51' ' ' ASP . 46.5 mtpt -58.97 -51.9 68.07 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.393 172.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 69.8 m -64.92 103.05 0.67 Allowed 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 113.098 -1.864 . . . . 0.0 108.787 170.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 71' ' ' THR . . . . . 0.628 ' HB ' ' O ' ' D' ' 44' ' ' GLY . 72.1 p -32.73 119.05 0.3 Allowed 'General case' 0 C--N 1.322 -0.617 0 O-C-N 124.588 1.18 . . . . 0.0 112.689 -174.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 72' ' ' VAL . . . . . 0.633 HG11 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -53.34 -14.4 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.805 176.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 73' ' ' GLY . . . . . 0.482 ' HA2' ' HB3' ' D' ' 40' ' ' SER . . . -66.66 -70.8 1.03 Allowed Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.743 172.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -62.15 -25.03 67.52 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 120.594 0.235 . . . . 0.0 111.286 -177.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 75' ' ' ILE . . . . . 0.629 ' O ' HG13 ' D' ' 79' ' ' ILE . 30.0 mm -73.87 -37.88 49.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.199 176.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 31.3 t -73.82 -23.13 59.61 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.817 176.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -62.28 -26.94 68.68 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 166.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 78' ' ' ASP . . . . . 1.112 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 57.6 m-20 -83.22 -36.87 24.28 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.031 -0.532 . . . . 0.0 112.089 174.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . 0.629 HG13 ' O ' ' D' ' 75' ' ' ILE . 39.2 mt -66.41 -22.64 30.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 O-C-N 121.805 -0.559 . . . . 0.0 110.878 -173.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -72.92 -31.67 64.78 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 176.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 81' ' ' LYS . . . . . 1.112 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -81.15 -50.37 9.69 Favored 'General case' 0 N--CA 1.457 -0.076 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.164 174.527 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 82' ' ' LEU . . . . . 0.62 HD23 ' O ' ' D' ' 78' ' ' ASP . 4.0 mm? -47.39 -32.32 4.84 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 177.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 83' ' ' ASN . . . . . 0.603 HD22 ' HB3' ' D' ' 36' ' ' LEU . 0.6 OUTLIER 43.72 61.49 2.26 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 124.062 0.851 . . . . 0.0 110.836 174.224 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 84' ' ' ILE . . . . . 0.443 ' O ' ' HG ' ' D' ' 36' ' ' LEU . 52.5 mt -93.74 98.55 8.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.045 -175.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 85' ' ' LYS . . . . . 1.099 ' HB2' ' HB2' ' D' ' 36' ' ' LEU . 9.4 tmtt? -143.01 94.91 2.69 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 86' ' ' GLY . . . . . 0.48 ' HA2' HD11 ' D' ' 89' ' ' ILE . . . 76.86 151.87 4.38 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.67 -0.696 . . . . 0.0 113.566 176.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 87' ' ' PRO . . . . . 0.631 ' O ' HG13 ' D' ' 58' ' ' VAL . 55.9 Cg_endo -88.49 178.01 19.62 Favored 'Cis proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.83 -1.737 . . . . 0.0 112.479 -0.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 88' ' ' TYR . . . . . 0.733 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 1.7 m-85 28.7 91.19 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.626 1.17 . . . . 0.0 112.907 -177.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.592 HG22 HG13 ' D' ' 91' ' ' ILE . 3.7 mp -97.38 136.55 27.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.233 0.54 . . . . 0.0 110.834 -176.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . 0.956 ' HB3' ' HB2' ' D' ' 57' ' ' PHE . 88.0 tt0 -134.94 87.38 2.33 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.807 173.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 91' ' ' ILE . . . . . 0.636 HG12 HG23 ' D' ' 56' ' ' ILE . 40.8 mt -96.56 99.49 9.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.649 -179.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 92' ' ' LYS . . . . . 0.652 ' HG2' ' O ' ' D' ' 93' ' ' GLN . 0.0 OUTLIER -161.76 165.96 27.24 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 121.191 -0.203 . . . . 0.0 110.519 178.33 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . 0.652 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 18.1 pt20 -78.67 165.32 23.78 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 120.191 -0.604 . . . . 0.0 110.59 175.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 94' ' ' ILE . . . . . 0.58 HG21 ' HZ ' ' D' ' 57' ' ' PHE . 9.5 pt . . . . . 0 C--N 1.31 -1.118 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.656 -172.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.431 ' O ' HG12 ' D' ' 16' ' ' VAL . 58.4 mt . . . . . 0 C--O 1.199 -1.556 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -35.19 -33.25 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -175.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 15' ' ' SER . . . . . 0.427 ' O ' ' HD2' ' D' ' 19' ' ' LYS . 80.1 p -58.78 -27.51 65.08 Favored 'General case' 0 C--O 1.22 -0.453 0 O-C-N 121.771 -0.58 . . . . 0.0 109.909 176.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 16' ' ' VAL . . . . . 0.694 HG13 ' ND2' ' D' ' 17' ' ' ASN . 7.5 p -45.28 -30.09 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.94 1.296 . . . . 0.0 111.185 174.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 17' ' ' ASN . . . . . 0.694 ' ND2' HG13 ' D' ' 16' ' ' VAL . 5.9 m120 -86.37 -31.56 21.43 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.895 -177.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 18' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' D' ' 15' ' ' SER . 78.7 m-20 -60.71 -15.66 31.37 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 176.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.622 ' HD2' ' N ' ' D' ' 19' ' ' LYS . 0.0 OUTLIER -91.35 -46.57 7.95 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 122.03 0.919 . . . . 0.0 108.599 175.238 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 20' ' ' LEU . . . . . 0.89 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 63.8 mt -63.51 -40.49 97.19 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.192 -1.822 . . . . 0.0 110.348 -178.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 21' ' ' ASN . . . . . 0.651 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 55.6 m-20 -77.35 96.7 4.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.425 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 22' ' ' LYS . . . . . 0.789 ' HD2' HD12 ' D' ' 47' ' ' ILE . 65.3 mttm -122.83 -41.57 2.35 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -178.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 171.17 -86.22 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 119.575 -1.298 . . . . 0.0 113.663 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . 0.706 ' HE3' ' HD1' ' D' ' 45' ' ' TYR . 50.7 tptt -53.54 -44.47 69.23 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.85 0.833 . . . . 0.0 109.415 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 25' ' ' GLY . . . . . 0.613 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -150.2 148.13 19.03 Favored Glycine 0 N--CA 1.429 -1.802 0 CA-C-N 114.255 -1.338 . . . . 0.0 111.582 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 26' ' ' LYS . . . . . 0.651 ' CB ' ' HA ' ' D' ' 21' ' ' ASN . 10.8 ptpt -149.32 160.85 43.05 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 114.262 -0.969 . . . . 0.0 110.561 -168.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 27' ' ' LEU . . . . . 0.89 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 41.1 tp -135.65 143.58 45.57 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.237 0.541 . . . . 0.0 111.847 -178.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 28' ' ' SER . . . . . 0.638 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 27.9 t -128.18 152.62 47.83 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 29' ' ' LEU . . . . . . . . . . . . . 15.1 mt -140.78 138.75 34.33 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 177.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 60.6 m -147.05 179.16 7.81 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 31' ' ' MET . . . . . 0.43 ' HA ' ' O ' ' D' ' 35' ' ' GLN . 23.3 ptt? -134.9 122.32 21.8 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.441 0.639 . . . . 0.0 110.636 177.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -91.42 88.97 7.04 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.2 -114.74 4.03 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -169.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 34' ' ' ASN . . . . . 0.688 ' O ' ' HE3' ' D' ' 85' ' ' LYS . 4.2 m120 -109.63 31.74 5.57 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.095 0.474 . . . . 0.0 110.023 172.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 35' ' ' GLN . . . . . 0.43 ' O ' ' HA ' ' D' ' 31' ' ' MET . 3.8 tp-100 -105.81 161.35 14.5 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.601 -179.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.707 HD11 HG22 ' D' ' 79' ' ' ILE . 3.0 tm? -114.09 131.36 56.42 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.772 0.32 . . . . 0.0 110.766 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 37' ' ' LYS . . . . . 0.426 ' HE2' ' HG2' ' D' ' 35' ' ' GLN . 74.0 mmtt -138.34 109.05 6.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.082 -169.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 38' ' ' ALA . . . . . 0.488 ' HB1' HD11 ' D' ' 27' ' ' LEU . . . -105.58 149.37 26.34 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.966 0.412 . . . . 0.0 111.229 176.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 39' ' ' THR . . . . . 0.638 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 18.0 p -143.65 129.57 19.47 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.698 175.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . 0.729 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 72.3 p -109.38 131.56 54.95 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 41' ' ' SER . . . . . 0.625 ' HB2' ' CD ' ' D' ' 26' ' ' LYS . 52.3 m -96.56 152.82 18.27 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.714 -178.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 42' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' D' ' 41' ' ' SER . 75.9 m-80 80.09 6.12 1.76 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.005 -170.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 53.27 54.47 10.19 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 114.636 -1.166 . . . . 0.0 113.811 171.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 44' ' ' GLY . . . . . 0.744 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 104.78 35.81 3.15 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 119.431 -1.366 . . . . 0.0 114.749 168.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 45' ' ' TYR . . . . . 0.706 ' HD1' ' HE3' ' D' ' 24' ' ' LYS . 2.6 m-85 -112.78 153.81 27.21 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 168.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . 0.558 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -86.0 -174.0 49.54 Favored Glycine 0 CA--C 1.499 -0.945 0 C-N-CA 120.094 -1.05 . . . . 0.0 110.953 178.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 47' ' ' ILE . . . . . 0.806 HG12 ' HB3' ' D' ' 68' ' ' GLU . 45.3 mm -46.3 -51.33 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.231 0 CA-C-O 121.454 0.645 . . . . 0.0 109.987 177.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . 0.487 ' HB2' ' O ' ' D' ' 47' ' ' ILE . 41.3 t 159.31 -138.97 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.626 0 O-C-N 126.507 2.379 . . . . 0.0 107.564 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -88.88 76.01 7.99 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.474 0.655 . . . . 0.0 111.606 175.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . 0.798 ' HB2' ' HE2' ' D' ' 52' ' ' LYS . 48.6 mt-10 -150.32 179.04 8.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.541 176.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 51' ' ' ASP . . . . . 0.66 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 31.8 m-20 -133.39 134.29 43.49 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.746 173.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 52' ' ' LYS . . . . . 0.798 ' HE2' ' HB2' ' D' ' 50' ' ' GLU . 1.9 mptp? -138.43 137.58 37.36 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -176.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -115.07 134.08 55.49 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.413 174.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 54' ' ' TRP . . . . . 1.136 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 1.1 m95 -125.73 160.09 30.65 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -172.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -148.05 158.07 27.56 Favored Glycine 0 N--CA 1.436 -1.312 0 CA-C-N 114.419 -1.264 . . . . 0.0 113.006 172.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 56' ' ' ILE . . . . . 1.06 HG12 HG23 ' D' ' 91' ' ' ILE . 98.1 mt -125.88 110.31 23.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-N 113.317 -1.442 . . . . 0.0 107.149 176.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 57' ' ' PHE . . . . . 0.768 ' HB2' ' HB2' ' D' ' 90' ' ' GLU . 14.0 m-85 -106.02 102.82 12.22 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 119.881 -0.728 . . . . 0.0 110.821 -167.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.912 HG22 HG12 ' D' ' 89' ' ' ILE . 95.2 t -95.5 108.97 21.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.502 178.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 59' ' ' ASN . . . . . 0.552 ' OD1' ' HG2' ' D' ' 87' ' ' PRO . 6.2 m120 59.68 52.35 5.64 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.989 -178.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.15 47.17 92.36 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.283 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 61' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 87.1 tt0 -151.45 116.17 5.17 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.315 -0.443 . . . . 0.0 109.866 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 62' ' ' LYS . . . . . 0.492 ' NZ ' ' HB3' ' D' ' 62' ' ' LYS . 6.1 ttpm? -70.96 99.04 1.71 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.446 HG12 ' O ' ' D' ' 56' ' ' ILE . 14.7 p -87.1 -30.99 5.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.581 -169.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 64' ' ' TYR . . . . . 0.409 ' HB3' HD12 ' D' ' 56' ' ' ILE . 17.3 t80 -137.5 130.31 30.17 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.579 175.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 76.0 m -112.04 112.82 24.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.319 176.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 66' ' ' PHE . . . . . 0.549 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 7.6 p90 -118.67 150.5 39.62 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 173.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 67' ' ' ASN . . . . . 0.491 ' O ' HD11 ' D' ' 75' ' ' ILE . 18.6 p30 -122.04 140.61 52.28 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 68' ' ' GLU . . . . . 0.806 ' HB3' HG12 ' D' ' 47' ' ' ILE . 39.2 mm-40 -68.33 -9.46 48.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.218 0.532 . . . . 0.0 110.368 -176.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.569 ' NZ ' ' HB3' ' D' ' 69' ' ' LYS . 5.3 mtpm? -62.73 -45.06 94.49 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 170.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 31.1 t -66.29 125.65 26.27 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 113.528 -1.669 . . . . 0.0 107.571 168.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 71' ' ' THR . . . . . 0.407 ' O ' HG13 ' D' ' 75' ' ' ILE . 72.0 p -54.19 125.28 18.52 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -178.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 72' ' ' VAL . . . . . 0.693 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -55.32 -14.62 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 121.069 0.461 . . . . 0.0 110.918 -175.271 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 73' ' ' GLY . . . . . 0.744 ' HA3' ' HA2' ' D' ' 44' ' ' GLY . . . -71.05 -57.01 6.52 Favored Glycine 0 N--CA 1.437 -1.264 0 CA-C-N 115.043 -0.98 . . . . 0.0 112.627 170.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -61.76 -24.15 66.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.115 0.483 . . . . 0.0 110.342 176.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 75' ' ' ILE . . . . . 0.613 ' O ' HG13 ' D' ' 79' ' ' ILE . 66.4 mt -73.2 -41.53 58.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.359 175.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 28.4 t -76.16 -24.05 54.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.762 -0.199 . . . . 0.0 110.764 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 77' ' ' ASN . . . . . 0.553 ' O ' ' HD3' ' D' ' 81' ' ' LYS . 4.0 m120 -63.38 -19.03 64.3 Favored 'General case' 0 C--O 1.218 -0.601 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 168.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 78' ' ' ASP . . . . . 0.665 ' O ' HD23 ' D' ' 82' ' ' LEU . 72.0 m-20 -93.52 -45.41 7.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.068 174.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . 0.707 HG22 HD11 ' D' ' 36' ' ' LEU . 43.0 mt -67.99 -33.35 60.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 O-C-N 121.743 -0.598 . . . . 0.0 111.729 -170.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -64.63 -13.49 53.85 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.191 174.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 81' ' ' LYS . . . . . 0.553 ' HD3' ' O ' ' D' ' 77' ' ' ASN . 16.0 mmmt -92.34 -57.8 2.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 122.185 0.993 . . . . 0.0 108.866 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 82' ' ' LEU . . . . . 0.665 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.3 mm? -56.07 -23.63 34.93 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 113.821 -1.536 . . . . 0.0 112.913 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 83' ' ' ASN . . . . . 0.589 ' HA ' HD12 ' D' ' 36' ' ' LEU . 7.5 m120 32.72 70.46 0.1 Allowed 'General case' 0 N--CA 1.476 0.867 0 O-C-N 124.182 0.926 . . . . 0.0 112.978 -177.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 84' ' ' ILE . . . . . 0.578 HG22 HD13 ' D' ' 89' ' ' ILE . 47.2 mt -86.45 98.86 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-O 121.132 0.492 . . . . 0.0 110.991 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 85' ' ' LYS . . . . . 0.688 ' HE3' ' O ' ' D' ' 34' ' ' ASN . 0.0 OUTLIER -135.01 94.55 3.16 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.871 0.843 . . . . 0.0 111.947 -179.563 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 86' ' ' GLY . . . . . 0.585 ' H ' ' CD1' ' D' ' 89' ' ' ILE . . . 70.28 153.2 0.92 Allowed Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.622 -0.717 . . . . 0.0 113.032 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 87' ' ' PRO . . . . . 0.578 ' O ' HG13 ' D' ' 58' ' ' VAL . 92.6 Cg_endo -91.18 -177.27 9.29 Favored 'Cis proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.705 -1.373 . . . . 0.0 112.52 -0.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 88' ' ' TYR . . . . . 0.693 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 14.4 m-85 8.24 93.18 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 125.473 1.509 . . . . 0.0 113.844 -177.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.912 HG12 HG22 ' D' ' 58' ' ' VAL . 67.8 mt -110.43 135.22 50.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.427 0.632 . . . . 0.0 111.83 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . 0.768 ' HB2' ' HB2' ' D' ' 57' ' ' PHE . 5.5 mm-40 -122.58 89.52 3.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.991 176.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 91' ' ' ILE . . . . . 1.136 HG22 ' HZ3' ' D' ' 54' ' ' TRP . 4.7 mt -96.31 108.9 21.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 92' ' ' LYS . . . . . 0.643 ' HG2' ' O ' ' D' ' 93' ' ' GLN . 0.0 OUTLIER -162.95 172.73 14.62 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.361 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . 0.643 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 25.1 pt20 -81.5 163.58 22.6 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 119.749 -0.781 . . . . 0.0 111.219 175.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 94' ' ' ILE . . . . . 0.569 HG22 ' HE2' ' D' ' 92' ' ' LYS . 9.9 pt . . . . . 0 C--N 1.307 -1.246 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.139 -172.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 41.9 mm . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 121.747 0.784 . . . . 0.0 111.451 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 75.0 m-80 -94.81 -50.59 5.07 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.001 172.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 15' ' ' SER . . . . . 0.506 ' O ' ' HD2' ' D' ' 19' ' ' LYS . 80.5 p -66.62 -30.59 70.9 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.256 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 16' ' ' VAL . . . . . 0.666 HG13 ' ND2' ' D' ' 17' ' ' ASN . 11.5 p -50.75 -28.53 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 121.981 0.896 . . . . 0.0 110.31 175.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 17' ' ' ASN . . . . . 0.666 ' ND2' HG13 ' D' ' 16' ' ' VAL . 4.4 m120 -83.51 -31.29 26.53 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.911 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.92 -15.55 43.94 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 177.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.56 ' HD2' ' N ' ' D' ' 19' ' ' LYS . 0.0 OUTLIER -90.82 -42.21 10.78 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 176.006 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 20' ' ' LEU . . . . . 0.929 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 64.9 mt -70.4 -41.06 73.48 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 113.327 -1.76 . . . . 0.0 110.398 -176.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 21' ' ' ASN . . . . . 0.697 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 59.4 m-20 -74.42 100.76 3.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.656 -1.157 . . . . 0.0 110.225 177.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 22' ' ' LYS . . . . . 0.573 ' NZ ' HG23 ' D' ' 47' ' ' ILE . 54.3 mtpt -121.94 -43.46 2.34 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -171.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.96 -74.81 0.2 Allowed Glycine 0 N--CA 1.435 -1.39 0 C-N-CA 120.281 -0.961 . . . . 0.0 112.231 -174.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . 0.823 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 27.2 tptp -58.41 -68.42 0.26 Allowed 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 25' ' ' GLY . . . . . 0.795 ' HA2' ' ND2' ' D' ' 42' ' ' ASN . . . -127.77 156.93 20.84 Favored Glycine 0 N--CA 1.431 -1.656 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.631 173.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 26' ' ' LYS . . . . . 0.697 ' CB ' ' HA ' ' D' ' 21' ' ' ASN . 8.5 ptpt -148.31 159.45 43.98 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 114.828 -0.686 . . . . 0.0 111.192 -170.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 27' ' ' LEU . . . . . 0.929 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 42.0 tp -137.46 142.82 41.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.717 0.77 . . . . 0.0 111.968 -177.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 28' ' ' SER . . . . . 0.688 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 50.3 m -129.05 151.32 49.86 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.296 -178.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 29' ' ' LEU . . . . . . . . . . . . . 17.7 mt -140.89 135.49 31.36 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 177.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 48.5 m -136.85 -173.28 3.4 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 22.7 ptm -150.14 166.01 31.12 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.675 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 32' ' ' ASN . . . . . 0.413 ' H ' ' HB2' ' D' ' 35' ' ' GLN . 0.7 OUTLIER -143.19 89.3 2.09 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.163 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.07 -101.88 1.51 Allowed Glycine 0 C--O 1.227 -0.3 0 C-N-CA 120.064 -1.065 . . . . 0.0 110.901 -173.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -111.15 27.81 9.33 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.183 0.515 . . . . 0.0 109.907 173.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 35' ' ' GLN . . . . . 0.413 ' HB2' ' H ' ' D' ' 32' ' ' ASN . 73.8 mm-40 -96.87 164.74 12.42 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -177.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.763 HD11 HG22 ' D' ' 79' ' ' ILE . 2.8 tm? -132.18 124.19 28.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.056 174.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 37' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -132.11 100.73 5.13 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.004 -168.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.57 146.81 25.42 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.574 0.702 . . . . 0.0 112.105 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 39' ' ' THR . . . . . 0.688 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 18.3 p -141.65 128.83 20.96 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.242 176.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . 0.61 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 77.7 p -107.12 129.5 54.83 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 173.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 41' ' ' SER . . . . . 0.687 ' HB3' ' HG3' ' D' ' 26' ' ' LYS . 46.2 t -93.03 146.7 23.43 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -175.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 42' ' ' ASN . . . . . 0.795 ' ND2' ' HA2' ' D' ' 25' ' ' GLY . 0.9 OUTLIER 82.12 -18.74 0.45 Allowed 'General case' 0 N--CA 1.477 0.925 0 O-C-N 125.59 1.806 . . . . 0.0 109.757 -167.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 60.85 60.33 1.89 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 175.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 123.88 35.98 0.65 Allowed Glycine 0 C--N 1.338 0.689 0 C-N-CA 119.166 -1.492 . . . . 0.0 115.797 168.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 45' ' ' TYR . . . . . 0.823 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 7.0 m-30 -116.02 160.87 19.7 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 170.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . 0.571 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -107.84 -152.91 17.49 Favored Glycine 0 C--O 1.223 -0.533 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.87 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 47' ' ' ILE . . . . . 0.995 HG13 ' HB2' ' D' ' 68' ' ' GLU . 1.7 mp -51.45 -57.68 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 CA-C-O 122.484 1.135 . . . . 0.0 108.486 177.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 67.2 p 167.93 -77.67 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 111.378 -2.646 . . . . 0.0 107.273 -173.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 49' ' ' TYR . . . . . 0.464 ' HD2' ' O ' ' D' ' 49' ' ' TYR . 0.1 OUTLIER -154.64 74.55 0.95 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.61 165.496 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . 0.663 ' O ' ' HG2' ' D' ' 69' ' ' LYS . 59.2 mm-40 -141.46 -158.67 0.88 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.226 -176.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 51' ' ' ASP . . . . . 0.603 ' CB ' ' HD2' ' D' ' 69' ' ' LYS . 7.2 t70 -146.51 112.26 5.65 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.234 174.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 52' ' ' LYS . . . . . 0.757 ' HD3' HG12 ' D' ' 47' ' ' ILE . 4.5 mptp? -126.15 106.15 9.36 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.904 -172.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 53' ' ' ASN . . . . . 0.462 HD22 ' N ' ' D' ' 53' ' ' ASN . 2.1 m120 -88.74 130.44 35.34 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.06 0.457 . . . . 0.0 110.401 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 54' ' ' TRP . . . . . 1.04 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 0.4 OUTLIER -119.63 166.02 13.72 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.108 -175.2 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -148.84 159.93 28.21 Favored Glycine 0 N--CA 1.439 -1.138 0 C-N-CA 120.04 -1.076 . . . . 0.0 113.689 175.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 56' ' ' ILE . . . . . 1.005 HG12 HG23 ' D' ' 91' ' ' ILE . 82.8 mt -135.61 105.06 5.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 176.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 57' ' ' PHE . . . . . 0.524 ' HD1' ' O ' ' D' ' 90' ' ' GLU . 13.7 m-85 -101.28 98.21 8.62 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 119.178 -1.009 . . . . 0.0 111.076 -167.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.744 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 97.9 t -89.75 115.16 28.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.835 173.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 66.11 38.04 4.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.81 -175.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.92 -32.99 4.37 Favored Glycine 0 CA--C 1.509 -0.334 0 C-N-CA 120.959 -0.638 . . . . 0.0 113.512 176.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 61' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 16.6 pt-20 -90.76 141.55 28.68 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.322 0.582 . . . . 0.0 111.399 -174.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 62' ' ' LYS . . . . . 0.459 ' NZ ' ' HB3' ' D' ' 62' ' ' LYS . 6.2 ttpm? -74.07 100.38 3.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.1 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.51 HG12 ' O ' ' D' ' 56' ' ' ILE . 14.5 p -79.37 -28.65 13.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.672 -173.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 64' ' ' TYR . . . . . 0.406 ' HB3' HD12 ' D' ' 56' ' ' ILE . 22.0 t80 -140.32 141.62 35.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.639 0.257 . . . . 0.0 110.657 176.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 28.3 m -121.19 130.42 53.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.882 176.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 66' ' ' PHE . . . . . 0.709 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 19.5 p90 -136.98 140.13 41.95 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.758 0.79 . . . . 0.0 110.859 174.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 67' ' ' ASN . . . . . 0.807 HD22 ' HB2' ' D' ' 69' ' ' LYS . 11.2 p-10 -111.2 135.4 51.78 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.901 -178.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 68' ' ' GLU . . . . . 0.995 ' HB2' HG13 ' D' ' 47' ' ' ILE . 28.4 mt-10 -65.05 -13.2 57.37 Favored 'General case' 0 CA--C 1.521 -0.137 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.036 -175.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.807 ' HB2' HD22 ' D' ' 67' ' ' ASN . 5.6 mtpm? -59.91 -43.21 95.01 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 172.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 25.5 t -74.56 102.18 4.44 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 113.422 -1.717 . . . . 0.0 107.185 165.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 62.4 p -38.95 130.35 1.49 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.631 -173.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 72' ' ' VAL . . . . . 0.523 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -53.32 -14.14 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 179.242 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 73' ' ' GLY . . . . . 0.61 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -71.56 -62.49 3.42 Favored Glycine 0 N--CA 1.435 -1.367 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.303 170.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -54.79 -31.09 58.52 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.247 0.546 . . . . 0.0 110.717 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 75' ' ' ILE . . . . . 0.485 ' O ' ' HB2' ' D' ' 78' ' ' ASP . 26.6 mm -80.37 -36.3 16.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.401 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 76' ' ' SER . . . . . 0.649 ' HB2' HD13 ' D' ' 27' ' ' LEU . 27.7 t -73.84 -20.28 60.48 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.965 178.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -61.38 -46.51 89.89 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 163.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 78' ' ' ASP . . . . . 0.944 ' HA ' ' HG2' ' D' ' 81' ' ' LYS . 51.5 m-20 -60.31 -36.16 77.28 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 174.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . 0.763 HG22 HD11 ' D' ' 36' ' ' LEU . 29.8 mm -67.06 -30.6 50.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.248 -174.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -75.98 -15.87 60.08 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.332 174.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 81' ' ' LYS . . . . . 0.944 ' HG2' ' HA ' ' D' ' 78' ' ' ASP . 11.0 mmtp -77.33 -63.65 1.32 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 173.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 82' ' ' LEU . . . . . 0.644 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.2 mm? -49.47 -26.25 3.22 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 113.242 -1.799 . . . . 0.0 113.56 -174.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 83' ' ' ASN . . . . . 0.575 ' O ' ' HE2' ' D' ' 85' ' ' LYS . 0.8 OUTLIER 51.82 66.67 1.13 Allowed 'General case' 0 N--CA 1.468 0.46 0 O-C-N 123.386 0.429 . . . . 0.0 110.251 177.137 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 84' ' ' ILE . . . . . 0.6 HG22 HD13 ' D' ' 89' ' ' ILE . 46.5 mm -76.9 99.48 2.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.897 -173.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 85' ' ' LYS . . . . . 0.575 ' HE2' ' O ' ' D' ' 83' ' ' ASN . 0.0 OUTLIER -156.26 91.75 1.28 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 174.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 86' ' ' GLY . . . . . 0.712 ' H ' HD11 ' D' ' 89' ' ' ILE . . . 69.17 151.27 0.43 Allowed Glycine 0 N--CA 1.453 -0.219 0 CA-C-N 115.163 -0.926 . . . . 0.0 113.222 174.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 87' ' ' PRO . . . . . 0.634 ' O ' HG13 ' D' ' 58' ' ' VAL . 59.0 Cg_endo -90.76 179.91 13.15 Favored 'Cis proline' 0 CA--C 1.535 0.534 0 C-N-CA 123.336 -1.527 . . . . 0.0 112.784 -0.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 88' ' ' TYR . . . . . 0.744 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 0.9 OUTLIER 16.85 92.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 125.142 1.377 . . . . 0.0 113.705 178.76 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.712 HD11 ' H ' ' D' ' 86' ' ' GLY . 70.3 mt -111.5 142.73 23.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . 0.524 ' O ' ' HD1' ' D' ' 57' ' ' PHE . 70.9 mt-10 -136.87 95.05 3.05 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.676 172.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 91' ' ' ILE . . . . . 1.04 HG22 ' HZ3' ' D' ' 54' ' ' TRP . 5.5 mt -96.87 106.53 18.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 92' ' ' LYS . . . . . 0.613 ' HA ' ' CH2' ' D' ' 54' ' ' TRP . 0.0 OUTLIER -161.93 170.77 18.79 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.622 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . 0.601 ' HB3' ' NE1' ' D' ' 54' ' ' TRP . 18.9 pt20 -82.59 164.8 20.57 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.749 176.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 94' ' ' ILE . . . . . 0.507 HG22 ' HE2' ' D' ' 92' ' ' LYS . 10.4 pt . . . . . 0 C--N 1.31 -1.118 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.174 -172.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.475 HG21 ' SD ' ' D' ' 31' ' ' MET . 38.2 mm . . . . . 0 N--CA 1.453 -0.309 0 CA-C-O 121.497 0.665 . . . . 0.0 111.34 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -96.83 -56.27 2.62 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 177.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 37.2 m -69.39 -15.7 63.36 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 121.21 -0.196 . . . . 0.0 110.997 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 16' ' ' VAL . . . . . 0.746 ' HA ' ' HE2' ' D' ' 19' ' ' LYS . 14.1 p -56.84 -35.26 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 173.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -66.66 -44.01 82.99 Favored 'General case' 0 C--O 1.211 -0.955 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.349 175.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -56.77 -15.07 3.97 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -174.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.746 ' HE2' ' HA ' ' D' ' 16' ' ' VAL . 0.0 OUTLIER -91.54 -44.09 9.28 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-O 122.413 1.101 . . . . 0.0 108.895 174.261 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 20' ' ' LEU . . . . . 0.862 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 72.6 mt -69.76 -36.47 75.81 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 112.804 -1.998 . . . . 0.0 110.097 -174.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 21' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -69.82 98.76 1.27 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.589 177.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 22' ' ' LYS . . . . . 0.624 ' NZ ' ' HA ' ' D' ' 47' ' ' ILE . 8.8 mtmp? -121.36 -42.5 2.45 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -171.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.38 -71.66 0.32 Allowed Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.135 -1.031 . . . . 0.0 112.04 -175.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . 0.831 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 21.8 tptm -51.01 -67.42 0.25 Allowed 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 175.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.9 166.69 23.91 Favored Glycine 0 N--CA 1.43 -1.704 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.581 169.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 26' ' ' LYS . . . . . 0.831 ' HD2' ' HB2' ' D' ' 41' ' ' SER . 0.4 OUTLIER -148.15 156.93 43.17 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.543 -0.328 . . . . 0.0 110.486 -170.545 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 27' ' ' LEU . . . . . 0.862 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 46.2 tp -137.43 142.47 41.62 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.318 0.58 . . . . 0.0 111.285 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 28' ' ' SER . . . . . 0.709 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 49.0 m -137.03 143.18 42.57 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.013 -174.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 29' ' ' LEU . . . . . 0.586 HD11 ' CD1' ' D' ' 20' ' ' LEU . 0.2 OUTLIER -140.7 149.73 42.56 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.768 -179.113 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 36.1 t -155.01 174.45 15.16 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.17 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 31' ' ' MET . . . . . 0.475 ' SD ' HG21 ' D' ' 13' ' ' ILE . 0.0 OUTLIER -128.74 165.43 20.93 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.023 0.44 . . . . 0.0 109.884 176.838 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 32' ' ' ASN . . . . . 0.423 ' HB3' ' HB2' ' D' ' 35' ' ' GLN . 52.6 t30 -146.82 88.13 1.73 Allowed 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.61 -101.06 1.24 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.392 -168.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 34' ' ' ASN . . . . . 0.428 ' O ' ' HE2' ' D' ' 85' ' ' LYS . 4.4 m120 -116.4 20.99 13.89 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.691 -0.3 . . . . 0.0 110.705 173.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 35' ' ' GLN . . . . . 0.423 ' HB2' ' HB3' ' D' ' 32' ' ' ASN . 13.6 mm100 -88.91 163.09 15.76 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.576 0.703 . . . . 0.0 111.983 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.716 HD11 HG22 ' D' ' 79' ' ' ILE . 2.4 tm? -129.93 124.95 34.32 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.933 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 37' ' ' LYS . . . . . 0.581 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 26.1 mmmt -130.38 116.15 17.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.605 -168.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 38' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -120.16 143.72 48.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.443 0.64 . . . . 0.0 111.338 176.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 39' ' ' THR . . . . . 0.709 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 4.9 p -138.55 130.11 27.62 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.095 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . 0.723 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 24.7 p -120.75 129.52 53.65 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 41' ' ' SER . . . . . 0.831 ' HB2' ' HD2' ' D' ' 26' ' ' LYS . 49.3 m -100.92 159.45 15.19 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.174 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 42' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' D' ' 41' ' ' SER . 74.2 m-80 76.67 8.91 3.05 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 124.572 1.17 . . . . 0.0 110.707 -174.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 40.92 59.05 2.33 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 171.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 114.22 35.24 1.5 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 119.419 -1.372 . . . . 0.0 114.175 172.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 45' ' ' TYR . . . . . 0.831 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 2.2 m-30 -113.18 145.74 40.45 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 122.477 -0.425 . . . . 0.0 110.02 172.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -91.63 -150.49 25.55 Favored Glycine 0 CA--C 1.504 -0.629 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.411 -178.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 47' ' ' ILE . . . . . 0.939 HG13 ' HB2' ' D' ' 68' ' ' GLU . 0.3 OUTLIER -53.77 -58.91 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 CA-C-O 122.079 0.942 . . . . 0.0 109.013 -178.585 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . 0.444 ' O ' ' HD2' ' D' ' 49' ' ' TYR . 41.1 t 163.25 -107.32 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 111.216 -2.72 . . . . 0.0 105.381 -172.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 49' ' ' TYR . . . . . 0.444 ' HD2' ' O ' ' D' ' 48' ' ' SER . 2.7 m-30 -124.09 76.76 1.48 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 163.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . 0.459 ' HB2' HG21 ' D' ' 47' ' ' ILE . 63.8 mm-40 -148.56 -166.14 2.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.134 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 51' ' ' ASP . . . . . 0.725 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 2.8 p30 -148.41 138.7 22.6 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.382 168.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 52' ' ' LYS . . . . . 0.725 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 0.4 OUTLIER -143.44 144.35 31.98 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.098 -174.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 53' ' ' ASN . . . . . 0.454 HD22 ' C ' ' D' ' 52' ' ' LYS . 3.2 m120 -120.2 129.54 54.14 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 172.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 54' ' ' TRP . . . . . 1.057 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 1.0 OUTLIER -120.99 162.04 20.59 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -173.109 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -152.19 152.96 24.6 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.414 172.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 56' ' ' ILE . . . . . 1.106 HG12 HG23 ' D' ' 91' ' ' ILE . 83.7 mt -117.3 116.93 53.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 173.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 57' ' ' PHE . . . . . 0.684 ' CE1' ' HG2' ' D' ' 62' ' ' LYS . 15.3 m-85 -107.47 98.96 8.51 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 119.467 -0.893 . . . . 0.0 111.389 -168.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 59.3 t -91.94 115.01 30.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.763 173.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 63.9 34.7 11.47 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.212 -176.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.72 -32.27 5.15 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.455 -0.878 . . . . 0.0 113.726 176.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 61' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 16.2 pt-20 -90.0 155.24 19.23 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.798 0.333 . . . . 0.0 110.799 -174.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 62' ' ' LYS . . . . . 0.684 ' HG2' ' CE1' ' D' ' 57' ' ' PHE . 57.8 mttp -80.49 103.03 10.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.961 0.41 . . . . 0.0 110.043 -178.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 14.1 p -78.7 -29.33 14.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.94 -177.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 64' ' ' TYR . . . . . 0.445 ' HB3' HD12 ' D' ' 56' ' ' ILE . 16.3 t80 -146.72 126.65 13.6 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.682 175.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 97.2 m -109.59 111.72 23.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.542 174.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 66' ' ' PHE . . . . . 0.498 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 15.9 p90 -116.36 160.71 20.13 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 172.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 67' ' ' ASN . . . . . 0.505 ' O ' HD11 ' D' ' 75' ' ' ILE . 13.2 p30 -132.59 141.35 48.65 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 68' ' ' GLU . . . . . 0.939 ' HB2' HG13 ' D' ' 47' ' ' ILE . 31.4 mm-40 -64.21 -15.23 59.55 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -177.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.613 ' HA ' HD11 ' D' ' 47' ' ' ILE . 49.3 mtpt -56.81 -49.89 74.0 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 173.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 23.1 t -63.8 128.37 35.53 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 113.426 -1.716 . . . . 0.0 107.51 168.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 70.2 p -57.51 118.99 5.77 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 72' ' ' VAL . . . . . 0.65 ' HA ' HD12 ' D' ' 75' ' ' ILE . 0.0 OUTLIER -53.61 -14.98 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -176.387 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 73' ' ' GLY . . . . . 0.723 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -67.96 -56.74 9.97 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.788 170.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -68.23 -19.97 64.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.988 0.423 . . . . 0.0 110.278 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 75' ' ' ILE . . . . . 0.65 HD12 ' HA ' ' D' ' 72' ' ' VAL . 83.3 mt -72.59 -43.95 61.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.555 175.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 31.4 t -73.58 -19.15 60.96 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.166 -176.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -60.49 -44.47 95.91 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 165.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 78' ' ' ASP . . . . . 1.018 ' HA ' ' HG2' ' D' ' 81' ' ' LYS . 1.0 OUTLIER -69.66 -25.81 64.09 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 114.981 -1.009 . . . . 0.0 113.407 177.144 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . 0.716 HG22 HD11 ' D' ' 36' ' ' LEU . 41.5 mt -77.72 -17.0 14.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 118.89 -1.124 . . . . 0.0 109.875 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -77.52 -26.83 51.45 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.256 169.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 81' ' ' LYS . . . . . 1.018 ' HG2' ' HA ' ' D' ' 78' ' ' ASP . 15.9 mmtt -74.01 -69.96 0.41 Allowed 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 176.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 82' ' ' LEU . . . . . 0.491 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.5 mm? -47.28 -32.25 4.5 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 113.482 -1.69 . . . . 0.0 112.578 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 83' ' ' ASN . . . . . 0.548 ' ND2' ' HB3' ' D' ' 36' ' ' LEU . 0.7 OUTLIER 37.85 65.5 0.56 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.979 0.912 . . . . 0.0 111.269 175.821 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 84' ' ' ILE . . . . . 0.622 ' H ' HD12 ' D' ' 84' ' ' ILE . 2.8 mp -74.88 99.12 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.96 0.41 . . . . 0.0 111.372 -171.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 85' ' ' LYS . . . . . 0.428 ' HE2' ' O ' ' D' ' 34' ' ' ASN . 16.8 ptpt -125.9 92.3 3.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.988 0.423 . . . . 0.0 111.96 178.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 86' ' ' GLY . . . . . 0.805 ' H ' HD11 ' D' ' 89' ' ' ILE . . . 61.33 160.04 0.11 Allowed Glycine 0 CA--C 1.52 0.353 0 CA-C-N 115.328 -0.851 . . . . 0.0 114.146 173.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 87' ' ' PRO . . . . . 0.584 ' O ' HG13 ' D' ' 58' ' ' VAL . 44.8 Cg_endo -93.68 -178.58 8.42 Favored 'Cis proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.795 -1.335 . . . . 0.0 112.176 -1.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 88' ' ' TYR . . . . . 0.647 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 16.0 m-85 24.57 92.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.823 1.249 . . . . 0.0 113.387 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.805 HD11 ' H ' ' D' ' 86' ' ' GLY . 75.8 mt -111.67 130.78 64.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . 0.581 ' O ' ' HD2' ' D' ' 57' ' ' PHE . 51.3 mt-10 -130.52 101.54 5.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.105 172.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 91' ' ' ILE . . . . . 1.106 HG23 HG12 ' D' ' 56' ' ' ILE . 4.1 mt -98.3 113.03 31.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -177.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 92' ' ' LYS . . . . . 0.627 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -162.28 170.57 18.71 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.084 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . 0.626 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 25.1 pt20 -80.97 164.81 22.28 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.803 176.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 94' ' ' ILE . . . . . 0.627 HG22 ' HE2' ' D' ' 92' ' ' LYS . 10.7 pt . . . . . 0 C--N 1.31 -1.109 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.899 -171.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.549 HG21 ' HE1' ' D' ' 31' ' ' MET . 63.9 mt . . . . . 0 N--CA 1.456 -0.149 0 CA-C-O 121.729 0.776 . . . . 0.0 111.736 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -96.19 -50.37 4.84 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.519 172.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 15' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' D' ' 18' ' ' ASP . 80.5 p -63.44 -24.94 68.05 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.328 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 16' ' ' VAL . . . . . 0.653 ' O ' ' HG ' ' D' ' 20' ' ' LEU . 9.8 p -54.16 -37.58 36.04 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-O 121.296 0.569 . . . . 0.0 109.593 176.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 17' ' ' ASN . . . . . 0.617 ' OD1' ' HA ' ' D' ' 28' ' ' SER . 78.6 m-20 -78.21 -22.3 48.72 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.461 -178.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 18' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' D' ' 15' ' ' SER . 1.0 OUTLIER -67.79 -17.14 64.43 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 176.379 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.587 ' O ' ' HE3' ' D' ' 22' ' ' LYS . 0.0 OUTLIER -91.74 -43.11 9.75 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 172.186 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 20' ' ' LEU . . . . . 1.018 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 85.4 mt -63.04 -40.95 99.24 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.009 -1.451 . . . . 0.0 110.131 -177.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 21' ' ' ASN . . . . . 0.576 ' OD1' ' HB2' ' D' ' 26' ' ' LYS . 51.6 m-80 -79.73 101.64 8.55 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.347 177.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 22' ' ' LYS . . . . . 0.966 ' HD2' HD12 ' D' ' 47' ' ' ILE . 97.4 mttt -122.18 -41.76 2.41 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -175.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 169.9 -91.13 0.1 OUTLIER Glycine 0 N--CA 1.437 -1.26 0 C-N-CA 119.604 -1.284 . . . . 0.0 112.982 -178.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . 0.656 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 26.4 tptp -48.27 -52.86 19.36 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 25' ' ' GLY . . . . . 0.99 ' HA2' HD21 ' D' ' 42' ' ' ASN . . . -141.48 154.0 24.4 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.394 176.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 26' ' ' LYS . . . . . 0.588 ' CD ' ' HB3' ' D' ' 41' ' ' SER . 0.4 OUTLIER -144.92 161.94 38.1 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.573 -0.814 . . . . 0.0 112.248 -168.709 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 27' ' ' LEU . . . . . 1.018 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 51.5 tp -134.93 153.15 52.17 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.454 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 28' ' ' SER . . . . . 0.617 ' HA ' ' OD1' ' D' ' 17' ' ' ASN . 14.2 t -140.68 153.79 46.12 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 29' ' ' LEU . . . . . . . . . . . . . 20.2 mt -134.2 158.8 42.75 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.624 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 37.3 t -160.15 -177.13 6.07 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 31' ' ' MET . . . . . 0.549 ' HE1' HG21 ' D' ' 13' ' ' ILE . 1.3 pmm? -150.57 163.15 39.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.84 0.352 . . . . 0.0 111.007 177.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 32' ' ' ASN . . . . . 0.444 ' H ' ' HB2' ' D' ' 35' ' ' GLN . 51.3 t30 -144.25 88.48 1.95 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.1 175.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.47 -115.35 4.56 Favored Glycine 0 N--CA 1.454 -0.154 0 C-N-CA 120.205 -0.997 . . . . 0.0 110.991 -172.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -95.78 20.71 9.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.915 0.388 . . . . 0.0 110.926 174.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 35' ' ' GLN . . . . . 0.444 ' HB2' ' H ' ' D' ' 32' ' ' ASN . 10.3 mm-40 -88.54 152.85 21.59 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 121.314 0.578 . . . . 0.0 111.989 176.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.824 HD12 ' HA ' ' D' ' 83' ' ' ASN . 1.3 tm? -134.37 119.56 18.77 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.378 175.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 37' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -123.36 157.36 33.47 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.564 -169.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 38' ' ' ALA . . . . . 0.599 ' HB1' HD11 ' D' ' 27' ' ' LEU . . . -148.83 152.26 36.19 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 113.216 -1.811 . . . . 0.0 111.341 176.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 39' ' ' THR . . . . . 0.586 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 20.6 p -145.54 139.03 26.46 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.198 175.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . 0.52 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 33.8 p -106.1 128.78 54.12 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 171.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 41' ' ' SER . . . . . 0.588 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 48.0 t -92.18 162.58 14.26 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 176.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 42' ' ' ASN . . . . . 0.99 HD21 ' HA2' ' D' ' 25' ' ' GLY . 18.6 p30 64.64 3.78 2.08 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 124.605 1.19 . . . . 0.0 111.896 -169.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 43' ' ' ALA . . . . . 0.41 ' H ' ' C ' ' D' ' 41' ' ' SER . . . 52.79 63.24 2.32 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 165.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.62 -15.94 6.63 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 118.174 -1.965 . . . . 0.0 115.993 166.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 45' ' ' TYR . . . . . 0.656 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 2.2 m-30 -78.62 155.94 29.34 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 117.909 0.855 . . . . 0.0 110.683 -176.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . 0.635 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -96.79 -172.91 34.69 Favored Glycine 0 C--O 1.217 -0.968 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 172.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 47' ' ' ILE . . . . . 0.966 HD12 ' HD2' ' D' ' 22' ' ' LYS . 39.4 mm -48.41 -56.64 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.861 0 CA-C-N 117.975 0.888 . . . . 0.0 110.917 178.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 81.0 p -179.31 -147.38 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 112.574 -2.103 . . . . 0.0 108.025 -173.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -97.46 75.53 2.51 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.226 168.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . 0.402 ' OE2' ' HA ' ' D' ' 50' ' ' GLU . 36.8 mm-40 -144.0 -172.68 3.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.56 -178.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 51' ' ' ASP . . . . . 0.689 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 11.6 m-20 -134.86 120.13 18.94 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.141 173.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 52' ' ' LYS . . . . . 1.053 ' HG2' ' HB2' ' D' ' 68' ' ' GLU . 0.0 OUTLIER -139.41 130.35 26.3 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.436 -177.1 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -109.92 142.82 40.74 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 121.002 0.429 . . . . 0.0 110.967 -175.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 54' ' ' TRP . . . . . 1.068 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 0.8 OUTLIER -123.43 160.57 26.56 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.825 -176.925 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -138.56 160.85 25.68 Favored Glycine 0 N--CA 1.438 -1.233 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.95 174.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 56' ' ' ILE . . . . . 0.943 HG12 HG23 ' D' ' 91' ' ' ILE . 97.0 mt -140.47 109.88 3.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 178.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 57' ' ' PHE . . . . . 0.633 ' HA ' ' O ' ' D' ' 61' ' ' GLU . 13.9 m-85 -107.92 101.25 10.53 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.624 -0.83 . . . . 0.0 111.7 -168.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.861 HG22 HG12 ' D' ' 89' ' ' ILE . 87.5 t -94.84 119.67 43.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.446 173.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 5.5 m120 63.93 35.59 10.73 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.075 0.464 . . . . 0.0 110.776 -175.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.2 34.68 90.57 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.373 -0.83 . . . . 0.0 114.461 175.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 61' ' ' GLU . . . . . 0.633 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 16.3 pt-20 -138.69 145.33 40.23 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 171.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 62' ' ' LYS . . . . . 0.449 ' HB2' ' NZ ' ' D' ' 62' ' ' LYS . 3.8 ttmp? -75.34 99.39 4.09 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -177.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.467 HG12 ' O ' ' D' ' 56' ' ' ILE . 9.2 p -84.73 -33.54 8.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.577 -173.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 64' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -135.88 131.37 35.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.932 0.396 . . . . 0.0 110.595 174.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 26.4 m -115.93 113.9 23.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.701 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 66' ' ' PHE . . . . . 0.563 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 10.8 p90 -116.81 130.91 57.01 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.355 0.597 . . . . 0.0 109.776 175.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -103.2 139.86 38.12 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -178.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 68' ' ' GLU . . . . . 1.053 ' HB2' ' HG2' ' D' ' 52' ' ' LYS . 40.2 mm-40 -70.63 -8.94 55.48 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.946 -174.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.556 ' HD3' ' HB3' ' D' ' 51' ' ' ASP . 47.0 mtmt -62.88 -39.73 95.35 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 169.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 31.7 t -71.45 119.9 16.26 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.502 -1.681 . . . . 0.0 107.07 165.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 70.1 p -54.87 130.59 41.73 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.255 -176.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 72' ' ' VAL . . . . . 0.636 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -55.68 -13.38 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 121.077 0.465 . . . . 0.0 111.813 -175.821 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 73' ' ' GLY . . . . . 0.52 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -74.07 -55.55 5.72 Favored Glycine 0 N--CA 1.437 -1.249 0 CA-C-N 115.212 -0.904 . . . . 0.0 112.445 169.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 74' ' ' ASN . . . . . 0.795 ' HA ' HD22 ' D' ' 77' ' ' ASN . 44.6 t30 -62.29 -23.59 66.81 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.814 0.34 . . . . 0.0 110.553 177.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 75' ' ' ILE . . . . . 0.62 ' O ' HG13 ' D' ' 79' ' ' ILE . 74.3 mt -73.83 -41.85 53.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.329 176.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 28.8 t -73.5 -20.41 60.68 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.554 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 77' ' ' ASN . . . . . 0.795 HD22 ' HA ' ' D' ' 74' ' ' ASN . 76.4 m-20 -65.84 -28.25 68.84 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 168.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 78' ' ' ASP . . . . . 1.094 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 1.0 OUTLIER -83.71 -32.22 25.64 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 115.528 -0.76 . . . . 0.0 113.032 174.823 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . 0.62 HG13 ' O ' ' D' ' 75' ' ' ILE . 25.1 mt -72.27 -16.55 18.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 120.034 -0.667 . . . . 0.0 110.041 -176.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -65.04 -49.81 68.66 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.729 172.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 81' ' ' LYS . . . . . 1.094 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -72.73 -57.58 4.0 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.637 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 82' ' ' LEU . . . . . 0.544 HD23 ' O ' ' D' ' 78' ' ' ASP . 4.1 mm? -44.98 -35.45 2.9 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 83' ' ' ASN . . . . . 0.824 ' HA ' HD12 ' D' ' 36' ' ' LEU . 22.2 t-20 29.33 70.88 0.07 Allowed 'General case' 0 N--CA 1.476 0.841 0 O-C-N 124.591 1.182 . . . . 0.0 111.811 178.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 84' ' ' ILE . . . . . 0.602 ' O ' ' HG ' ' D' ' 36' ' ' LEU . 50.1 mt -93.0 98.33 8.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.627 -176.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 85' ' ' LYS . . . . . 0.491 ' HB2' ' HB2' ' D' ' 36' ' ' LEU . 2.7 tmtm? -127.65 93.93 3.83 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -178.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 86' ' ' GLY . . . . . 0.609 ' H ' HD11 ' D' ' 89' ' ' ILE . . . 72.1 153.11 1.65 Allowed Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.918 -0.583 . . . . 0.0 113.165 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 87' ' ' PRO . . . . . 0.541 ' O ' HG13 ' D' ' 58' ' ' VAL . 54.2 Cg_endo -91.21 -179.76 12.13 Favored 'Cis proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.395 -1.502 . . . . 0.0 112.923 -0.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 88' ' ' TYR . . . . . 0.616 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 19.3 m-85 10.99 93.87 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 125.74 1.616 . . . . 0.0 114.065 -178.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.861 HG12 HG22 ' D' ' 58' ' ' VAL . 68.5 mt -111.54 142.85 22.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.975 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . 0.426 ' HG2' ' HG3' ' D' ' 92' ' ' LYS . 38.3 tt0 -128.76 95.09 4.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.916 172.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 91' ' ' ILE . . . . . 1.068 HG22 ' HZ3' ' D' ' 54' ' ' TRP . 7.3 mt -97.18 109.15 22.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 92' ' ' LYS . . . . . 0.78 ' HE3' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -162.17 172.29 16.03 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 122.603 0.361 . . . . 0.0 110.308 -176.222 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . 0.696 ' HB3' ' NE1' ' D' ' 54' ' ' TRP . 17.4 pt20 -89.07 153.45 20.98 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.744 174.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 94' ' ' ILE . . . . . 0.78 HG22 ' HE3' ' D' ' 92' ' ' LYS . 10.6 pt . . . . . 0 C--N 1.309 -1.171 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.688 -171.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.592 ' O ' HG12 ' D' ' 16' ' ' VAL . 63.3 mt . . . . . 0 C--O 1.223 -0.309 0 CA-C-O 121.678 0.751 . . . . 0.0 111.43 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -92.0 -46.87 7.59 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.229 173.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 15' ' ' SER . . . . . 0.451 ' O ' ' HE2' ' D' ' 19' ' ' LYS . 92.2 p -70.23 -18.66 63.16 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.78 176.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 16' ' ' VAL . . . . . 0.62 ' O ' ' HG ' ' D' ' 20' ' ' LEU . 1.3 p -62.06 -27.43 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -69.62 -41.34 75.81 Favored 'General case' 0 C--O 1.206 -1.232 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.905 175.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 18' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' D' ' 15' ' ' SER . 49.7 m-20 -61.94 -14.54 35.64 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 176.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.687 ' HB3' ' CZ2' ' D' ' 54' ' ' TRP . 1.2 mppt? -87.79 -26.85 22.65 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.367 0.603 . . . . 0.0 110.185 177.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 20' ' ' LEU . . . . . 0.993 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 84.6 mt -105.6 -38.49 6.41 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 113.547 -1.66 . . . . 0.0 110.559 -168.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 21' ' ' ASN . . . . . 0.685 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 1.2 t-20 -88.12 89.05 7.84 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 113.571 -1.65 . . . . 0.0 108.314 -172.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 22' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -120.42 -42.2 2.57 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -163.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 178.53 -88.63 0.07 OUTLIER Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 119.455 -1.355 . . . . 0.0 113.032 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . 0.782 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 53.6 tptt -50.79 -63.55 1.09 Allowed 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -127.69 162.57 21.58 Favored Glycine 0 N--CA 1.431 -1.67 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.315 171.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 26' ' ' LYS . . . . . 0.703 ' CD ' ' HB3' ' D' ' 41' ' ' SER . 0.1 OUTLIER -149.7 160.61 43.39 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.832 -0.684 . . . . 0.0 110.979 -169.165 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 27' ' ' LEU . . . . . 0.993 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 55.3 tp -138.47 143.73 39.74 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.153 0.501 . . . . 0.0 111.226 -178.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 28' ' ' SER . . . . . 0.62 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 29.5 t -130.39 136.77 49.41 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -177.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 29' ' ' LEU . . . . . 0.651 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 14.5 mt -132.48 135.28 45.91 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.302 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 61.2 m -142.2 -171.96 3.49 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.039 176.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -139.59 160.39 39.97 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.037 0.446 . . . . 0.0 110.236 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 32' ' ' ASN . . . . . 0.488 ' HB3' ' HB2' ' D' ' 35' ' ' GLN . 24.6 t-20 -139.84 88.07 2.21 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.22 -107.88 2.31 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.823 -169.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -108.4 26.87 9.95 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 122.505 -0.409 . . . . 0.0 110.521 174.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 35' ' ' GLN . . . . . 0.488 ' HB2' ' HB3' ' D' ' 32' ' ' ASN . 22.5 mt-30 -105.09 162.68 13.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.788 -178.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.779 ' HB2' ' HB2' ' D' ' 85' ' ' LYS . 0.9 OUTLIER -128.82 135.04 48.59 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.312 -178.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 37' ' ' LYS . . . . . 0.651 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 75.2 mmtt -129.76 111.43 12.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.052 -168.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 38' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -111.47 144.19 41.08 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.855 0.36 . . . . 0.0 111.067 175.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 39' ' ' THR . . . . . 0.62 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 16.2 p -147.42 135.88 21.75 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.353 177.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . 0.677 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 30.4 p -109.4 129.99 55.52 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 41' ' ' SER . . . . . 0.703 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 47.4 t -95.58 148.94 21.98 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.121 -1.031 . . . . 0.0 109.337 177.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 42' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' D' ' 41' ' ' SER . 75.8 m-20 80.19 -1.64 2.0 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.389 -168.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 49.38 61.88 2.91 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 169.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.3 1.33 7.89 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 118.517 -1.801 . . . . 0.0 115.387 170.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 45' ' ' TYR . . . . . 0.782 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 1.5 m-30 -86.05 154.15 21.62 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 116.946 0.373 . . . . 0.0 110.333 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -102.33 -153.34 24.93 Favored Glycine 0 C--O 1.219 -0.827 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 178.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 47' ' ' ILE . . . . . 0.961 HG13 ' HB2' ' D' ' 68' ' ' GLU . 2.7 mp -49.04 -58.42 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 CA-C-O 122.428 1.109 . . . . 0.0 108.833 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . 0.511 ' HA ' ' HG2' ' D' ' 24' ' ' LYS . 36.3 t 152.83 -95.28 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 110.593 -3.003 . . . . 0.0 106.544 -174.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 49' ' ' TYR . . . . . 0.466 ' HD1' ' C ' ' D' ' 48' ' ' SER . 3.7 m-30 -130.21 75.57 1.66 Allowed 'General case' 0 N--CA 1.465 0.304 0 O-C-N 122.228 -0.295 . . . . 0.0 111.047 169.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . 0.54 ' HB2' HG21 ' D' ' 47' ' ' ILE . 50.4 mt-10 -156.81 -175.63 5.53 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.348 0.259 . . . . 0.0 110.491 176.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 51' ' ' ASP . . . . . 0.704 ' HB2' ' HD2' ' D' ' 69' ' ' LYS . 7.0 p-10 -130.7 141.59 50.4 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.062 172.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 52' ' ' LYS . . . . . 0.767 ' HD3' HG12 ' D' ' 47' ' ' ILE . 0.7 OUTLIER -145.28 136.07 24.52 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.213 -177.136 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -113.82 139.04 49.47 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.173 170.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 54' ' ' TRP . . . . . 1.091 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 0.9 OUTLIER -126.71 157.01 40.19 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -172.176 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -143.23 158.08 27.13 Favored Glycine 0 N--CA 1.437 -1.298 0 C-N-CA 120.133 -1.032 . . . . 0.0 113.299 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 56' ' ' ILE . . . . . 1.024 HG12 HG23 ' D' ' 91' ' ' ILE . 91.7 mt -129.13 97.24 3.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 113.289 -1.456 . . . . 0.0 107.459 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 57' ' ' PHE . . . . . 0.578 ' HA ' ' O ' ' D' ' 61' ' ' GLU . 14.2 m-85 -100.15 103.25 14.73 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -171.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.796 HG12 HG12 ' D' ' 89' ' ' ILE . 3.8 m -95.55 99.95 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.648 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 57.93 62.9 1.92 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.692 -168.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.67 48.55 85.51 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 115.879 -0.6 . . . . 0.0 113.395 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 61' ' ' GLU . . . . . 0.578 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 5.4 tp10 -157.49 115.2 3.09 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 62' ' ' LYS . . . . . 0.489 ' HE2' ' OG1' ' D' ' 65' ' ' THR . 5.8 ttpm? -77.6 98.68 5.49 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 35.4 m -88.45 -11.5 10.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.48 -173.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 64' ' ' TYR . . . . . 0.549 ' HB3' HD12 ' D' ' 56' ' ' ILE . 16.9 t80 -150.42 136.6 18.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.835 0.35 . . . . 0.0 110.397 174.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . 0.489 ' OG1' ' HE2' ' D' ' 62' ' ' LYS . 24.5 m -119.4 113.54 20.94 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.161 176.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 66' ' ' PHE . . . . . 0.535 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 10.3 p90 -123.89 159.15 30.3 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 173.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 67' ' ' ASN . . . . . 0.437 ' O ' HD11 ' D' ' 75' ' ' ILE . 13.1 p30 -131.51 137.77 48.66 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 68' ' ' GLU . . . . . 0.961 ' HB2' HG13 ' D' ' 47' ' ' ILE . 37.5 mt-10 -62.18 -16.41 52.81 Favored 'General case' 0 C--N 1.345 0.395 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -174.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.704 ' HD2' ' HB2' ' D' ' 51' ' ' ASP . 5.6 mtpm? -57.98 -47.14 83.88 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.17 174.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 31.7 t -66.66 114.06 5.29 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 166.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 59.2 p -53.32 124.85 15.79 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.418 -173.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 72' ' ' VAL . . . . . 0.488 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -53.2 -13.01 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.756 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 73' ' ' GLY . . . . . 0.677 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -70.36 -57.48 6.72 Favored Glycine 0 N--CA 1.436 -1.359 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.261 169.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -69.71 -18.46 63.54 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.51 -0.345 . . . . 0.0 111.016 178.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 75' ' ' ILE . . . . . 0.616 ' O ' HG13 ' D' ' 79' ' ' ILE . 73.7 mt -71.74 -42.47 70.54 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.388 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.032 173.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 40.3 t -72.9 -22.69 60.7 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.434 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -60.48 -30.1 69.48 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 167.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 78' ' ' ASP . . . . . 1.049 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 50.2 m-20 -87.52 -31.83 19.72 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.585 176.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . 0.616 HG13 ' O ' ' D' ' 75' ' ' ILE . 31.1 mt -71.88 -16.78 18.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.137 -177.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -67.64 -40.7 84.56 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.922 173.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 81' ' ' LYS . . . . . 1.049 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -81.35 -53.59 6.2 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.837 176.592 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 82' ' ' LEU . . . . . 0.503 HD23 ' O ' ' D' ' 78' ' ' ASP . 4.0 mm? -53.08 -26.58 16.66 Favored 'General case' 0 C--O 1.227 -0.098 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 83' ' ' ASN . . . . . 0.543 HD22 ' HB3' ' D' ' 36' ' ' LEU . 0.6 OUTLIER 39.14 67.91 0.4 Allowed 'General case' 0 N--CA 1.474 0.761 0 O-C-N 123.998 0.811 . . . . 0.0 111.236 176.331 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 84' ' ' ILE . . . . . 0.979 HG21 HG21 ' D' ' 56' ' ' ILE . 46.3 mm -84.43 98.49 5.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.835 -173.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 85' ' ' LYS . . . . . 0.779 ' HB2' ' HB2' ' D' ' 36' ' ' LEU . 10.0 tmtt? -145.39 95.42 2.66 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.354 0.597 . . . . 0.0 109.532 177.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 86' ' ' GLY . . . . . 0.985 ' H ' HD11 ' D' ' 89' ' ' ILE . . . 77.13 158.79 9.58 Favored Glycine 0 CA--C 1.498 -1.007 0 CA-C-N 115.473 -0.785 . . . . 0.0 114.147 178.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 87' ' ' PRO . . . . . 0.76 ' O ' ' HB ' ' D' ' 58' ' ' VAL . 90.4 Cg_endo -80.66 -176.99 18.97 Favored 'Cis proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.355 -1.935 . . . . 0.0 113.3 0.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 88' ' ' TYR . . . . . 0.656 ' H ' ' HD1' ' D' ' 88' ' ' TYR . 1.7 m-85 -11.36 96.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.943 1.297 . . . . 0.0 114.03 -175.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.985 HD11 ' H ' ' D' ' 86' ' ' GLY . 41.0 mt -92.79 143.58 11.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -173.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -130.39 91.52 3.11 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.65 173.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 91' ' ' ILE . . . . . 1.091 HG22 ' HZ3' ' D' ' 54' ' ' TRP . 2.5 mt -96.91 117.73 42.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -176.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 92' ' ' LYS . . . . . 0.755 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.1 OUTLIER -162.91 173.37 13.77 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.464 0.306 . . . . 0.0 110.929 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . 0.669 ' O ' ' HD3' ' D' ' 92' ' ' LYS . 2.8 pt20 -87.03 156.89 19.57 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.33 173.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 94' ' ' ILE . . . . . 0.755 HG22 ' HE2' ' D' ' 92' ' ' LYS . 5.5 pt . . . . . 0 C--N 1.313 -1.02 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.397 -169.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.646 ' O ' HG12 ' D' ' 16' ' ' VAL . 52.0 mt . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 121.631 0.729 . . . . 0.0 110.747 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -88.08 -52.59 5.16 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.885 176.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 15' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' D' ' 18' ' ' ASP . 51.1 m -65.41 -21.61 66.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.488 174.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 16' ' ' VAL . . . . . 0.8 ' HA ' ' HE2' ' D' ' 19' ' ' LYS . 0.7 OUTLIER -59.12 -31.9 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.814 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 17' ' ' ASN . . . . . 0.603 ' OD1' ' HA ' ' D' ' 28' ' ' SER . 79.9 m-20 -85.06 -18.6 33.84 Favored 'General case' 0 C--O 1.205 -1.246 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.849 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 18' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' D' ' 15' ' ' SER . 73.7 m-20 -67.88 -16.36 64.05 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 122.304 -0.248 . . . . 0.0 111.599 176.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.8 ' HE2' ' HA ' ' D' ' 16' ' ' VAL . 0.0 OUTLIER -90.43 -39.83 12.41 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-O 121.987 0.899 . . . . 0.0 108.953 174.183 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 20' ' ' LEU . . . . . 0.913 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 78.3 mt -74.09 -40.17 62.91 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 113.628 -1.624 . . . . 0.0 110.107 -174.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 21' ' ' ASN . . . . . 0.543 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 2.8 m120 -78.14 95.7 4.99 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.688 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 22' ' ' LYS . . . . . 0.779 ' HD2' HD12 ' D' ' 47' ' ' ILE . 67.6 mttm -122.58 -41.12 2.4 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -176.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.56 -103.16 0.18 Allowed Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 119.161 -1.495 . . . . 0.0 113.351 -177.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . 0.842 ' HE2' ' HA ' ' D' ' 48' ' ' SER . 32.8 ttpt -49.5 -44.06 45.83 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.62 0.724 . . . . 0.0 110.362 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 25' ' ' GLY . . . . . 0.645 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -139.8 154.45 23.77 Favored Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 114.548 -1.205 . . . . 0.0 112.132 174.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 26' ' ' LYS . . . . . 0.649 ' HD2' ' HB3' ' D' ' 41' ' ' SER . 0.3 OUTLIER -150.67 160.42 43.84 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.331 -0.934 . . . . 0.0 110.518 -171.038 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 27' ' ' LEU . . . . . 0.913 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 41.6 tp -132.13 144.62 50.83 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.14 0.495 . . . . 0.0 111.392 177.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 28' ' ' SER . . . . . 0.603 ' HA ' ' OD1' ' D' ' 17' ' ' ASN . 9.1 t -131.32 136.42 48.1 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 29' ' ' LEU . . . . . 0.415 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 18.3 mt -127.19 157.94 38.43 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.384 -0.527 . . . . 0.0 110.53 -179.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 34.7 t -160.45 174.53 13.96 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 59.2 mtt -133.83 163.33 29.73 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.108 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 32' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' D' ' 35' ' ' GLN . 50.3 t30 -136.95 86.87 2.24 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.714 172.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.03 -108.26 2.51 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.553 -169.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 34' ' ' ASN . . . . . 0.445 ' O ' ' HE3' ' D' ' 85' ' ' LYS . 75.3 m-80 -107.11 31.76 5.12 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.586 0.707 . . . . 0.0 109.96 174.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 35' ' ' GLN . . . . . 0.474 ' OE1' ' HA ' ' D' ' 35' ' ' GLN . 6.5 mm-40 -99.9 164.48 11.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.823 -1.081 . . . . 0.0 113.263 -177.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.693 HD11 HG22 ' D' ' 79' ' ' ILE . 2.7 tm? -132.8 125.6 30.46 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.637 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 37' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 27.9 mmmt -131.2 103.06 6.27 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.768 -170.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 38' ' ' ALA . . . . . 0.479 ' HB1' HD11 ' D' ' 27' ' ' LEU . . . -108.57 146.39 33.38 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.403 0.62 . . . . 0.0 112.289 -176.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 39' ' ' THR . . . . . 0.44 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 14.3 p -146.32 130.37 17.36 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.17 175.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . 0.791 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 69.2 p -108.3 135.06 50.25 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 176.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 41' ' ' SER . . . . . 0.649 ' HB3' ' HD2' ' D' ' 26' ' ' LYS . 39.1 t -96.28 147.89 23.31 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.169 -1.012 . . . . 0.0 109.676 -178.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 42' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' D' ' 41' ' ' SER . 73.0 m-80 80.6 2.99 1.8 Allowed 'General case' 0 N--CA 1.468 0.472 0 O-C-N 124.569 1.168 . . . . 0.0 110.161 -170.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 47.28 55.5 8.1 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 171.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 44' ' ' GLY . . . . . 0.784 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 117.62 35.88 1.04 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 119.477 -1.344 . . . . 0.0 113.845 172.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 45' ' ' TYR . . . . . 0.799 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 1.8 m-85 -119.25 149.71 41.31 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 173.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . 0.616 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -93.61 179.7 38.82 Favored Glycine 0 C--O 1.221 -0.71 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 176.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 47' ' ' ILE . . . . . 0.874 HG12 ' HB3' ' D' ' 68' ' ' GLU . 32.6 mm -46.72 -57.01 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.798 0 CA-C-N 118.026 0.913 . . . . 0.0 110.28 -178.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . 0.842 ' HA ' ' HE2' ' D' ' 24' ' ' LYS . 67.5 p -175.67 -118.39 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 113.354 -1.748 . . . . 0.0 108.683 -177.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 49' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' D' ' 49' ' ' TYR . 0.2 OUTLIER -113.72 75.56 0.93 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 168.199 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . 0.604 ' HB3' ' HE2' ' D' ' 52' ' ' LYS . 68.3 mm-40 -131.81 -175.89 3.87 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.834 -175.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 51' ' ' ASP . . . . . 0.654 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 1.1 m-20 -140.36 128.89 22.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.487 169.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 52' ' ' LYS . . . . . 0.654 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 3.9 mptp? -141.56 136.42 31.09 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.504 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 53' ' ' ASN . . . . . 0.432 HD22 ' C ' ' D' ' 52' ' ' LYS . 3.0 m120 -112.01 126.98 55.73 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 175.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 54' ' ' TRP . . . . . 1.126 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 1.3 m95 -115.47 161.63 18.31 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -174.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -150.07 163.45 29.45 Favored Glycine 0 N--CA 1.435 -1.412 0 CA-C-N 114.566 -1.197 . . . . 0.0 112.556 172.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 56' ' ' ILE . . . . . 1.078 HG12 HG23 ' D' ' 91' ' ' ILE . 76.6 mt -134.75 109.58 11.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 -179.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 57' ' ' PHE . . . . . 0.629 ' HB2' ' HB3' ' D' ' 90' ' ' GLU . 8.3 m-85 -111.63 105.9 14.57 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.879 -165.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.841 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 54.7 t -88.67 112.31 23.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.277 172.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 7.0 m120 51.18 50.75 18.39 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.421 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.49 48.44 78.17 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.535 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 61' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 43.1 tt0 -150.88 111.24 4.18 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 62' ' ' LYS . . . . . 0.452 ' NZ ' ' HB3' ' D' ' 62' ' ' LYS . 6.3 ttpm? -73.65 103.01 4.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.972 0.415 . . . . 0.0 110.048 -177.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 29.0 m -79.57 -25.65 12.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.303 -174.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 64' ' ' TYR . . . . . 0.444 ' HB3' HD12 ' D' ' 56' ' ' ILE . 14.9 t80 -149.74 147.4 28.0 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.064 -178.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 59.4 m -125.28 121.17 33.24 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.482 175.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 66' ' ' PHE . . . . . 0.614 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 19.5 p90 -127.49 149.88 49.92 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 174.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 67' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' D' ' 52' ' ' LYS . 3.5 m120 -111.47 145.3 39.25 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -178.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 68' ' ' GLU . . . . . 0.874 ' HB3' HG12 ' D' ' 47' ' ' ILE . 51.3 mm-40 -74.88 -9.3 58.41 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.612 176.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.475 ' HG2' ' HA ' ' D' ' 51' ' ' ASP . 23.5 mtpp -59.14 -54.35 48.0 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 113.538 -1.664 . . . . 0.0 108.102 165.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 39.8 m -66.79 119.58 12.08 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 112.91 -1.95 . . . . 0.0 109.088 174.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 82.8 p -47.56 121.24 3.82 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.978 -177.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 72' ' ' VAL . . . . . 0.616 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -57.27 -12.38 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 120.994 0.426 . . . . 0.0 110.872 -178.75 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 73' ' ' GLY . . . . . 0.791 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -69.15 -65.61 2.55 Favored Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 115.215 -0.902 . . . . 0.0 113.185 172.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 74' ' ' ASN . . . . . 0.861 ' HA ' HD22 ' D' ' 77' ' ' ASN . 76.8 m-20 -62.72 -23.74 67.32 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 120.662 0.267 . . . . 0.0 110.89 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 75' ' ' ILE . . . . . 0.515 ' O ' HG12 ' D' ' 79' ' ' ILE . 35.9 mm -77.47 -39.96 28.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.594 176.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 76' ' ' SER . . . . . 0.698 ' HA ' HG12 ' D' ' 79' ' ' ILE . 30.9 t -73.61 -19.88 60.75 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.963 178.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 77' ' ' ASN . . . . . 0.861 HD22 ' HA ' ' D' ' 74' ' ' ASN . 80.1 m-20 -65.6 -29.77 70.41 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 168.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 78' ' ' ASP . . . . . 1.051 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 1.0 OUTLIER -84.22 -28.72 27.08 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.734 174.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . 0.698 HG12 ' HA ' ' D' ' 76' ' ' SER . 17.5 mm -66.88 -19.84 26.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.657 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -69.17 -39.7 78.58 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.322 176.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 81' ' ' LYS . . . . . 1.051 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -80.24 -53.76 6.36 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.888 176.679 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 82' ' ' LEU . . . . . 0.604 HD23 ' O ' ' D' ' 78' ' ' ASP . 4.0 mm? -48.71 -29.24 4.23 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 83' ' ' ASN . . . . . 0.582 HD22 ' HB3' ' D' ' 36' ' ' LEU . 0.6 OUTLIER 39.54 73.61 0.11 Allowed 'General case' 0 N--CA 1.472 0.671 0 O-C-N 124.016 0.823 . . . . 0.0 111.464 172.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 84' ' ' ILE . . . . . 0.817 HG12 HD13 ' D' ' 56' ' ' ILE . 2.1 mp -66.84 105.19 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.33 -176.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 85' ' ' LYS . . . . . 0.445 ' HE3' ' O ' ' D' ' 34' ' ' ASN . 48.6 mtpt -108.19 178.71 4.42 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.911 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 86' ' ' GLY . . . . . 0.715 ' HA2' HD11 ' D' ' 89' ' ' ILE . . . -80.09 -178.37 51.65 Favored Glycine 0 CA--C 1.504 -0.604 0 C-N-CA 121.146 -0.549 . . . . 0.0 113.39 -179.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 87' ' ' PRO . . . . . 0.678 ' O ' HG13 ' D' ' 58' ' ' VAL . 42.8 Cg_endo -93.67 -179.79 9.47 Favored 'Cis proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.887 -1.714 . . . . 0.0 114.101 -0.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 88' ' ' TYR . . . . . 0.841 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 1.7 m-85 43.85 91.12 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.881 0.873 . . . . 0.0 112.074 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.715 HD11 ' HA2' ' D' ' 86' ' ' GLY . 4.0 mp -111.27 127.26 68.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.295 0.569 . . . . 0.0 110.533 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . 0.629 ' HB3' ' HB2' ' D' ' 57' ' ' PHE . 42.0 tt0 -126.55 92.05 3.48 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.187 177.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 91' ' ' ILE . . . . . 1.126 HG22 ' HZ3' ' D' ' 54' ' ' TRP . 3.2 mt -100.22 109.13 24.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 92' ' ' LYS . . . . . 0.71 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -162.25 167.53 23.83 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . 0.609 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 25.4 pt20 -82.44 160.19 22.77 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 119.125 -1.03 . . . . 0.0 110.567 175.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 94' ' ' ILE . . . . . 0.71 HG22 ' HE2' ' D' ' 92' ' ' LYS . 10.0 pt . . . . . 0 C--N 1.305 -1.338 0 CA-C-N 114.118 -1.401 . . . . 0.0 111.384 -168.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.461 ' C ' HG12 ' D' ' 16' ' ' VAL . 36.7 mm . . . . . 0 N--CA 1.45 -0.456 0 CA-C-O 121.783 0.802 . . . . 0.0 110.991 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -95.19 -62.53 1.29 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.071 177.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 15' ' ' SER . . . . . 0.549 ' HA ' ' OD2' ' D' ' 18' ' ' ASP . 90.5 p -64.69 -21.45 66.75 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 120.971 -0.291 . . . . 0.0 110.531 -179.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 16' ' ' VAL . . . . . 0.626 ' O ' ' HG ' ' D' ' 20' ' ' LEU . 14.8 p -52.99 -35.93 23.16 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 CA-C-O 120.918 0.39 . . . . 0.0 110.251 176.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 17' ' ' ASN . . . . . 0.483 ' ND2' HG13 ' D' ' 16' ' ' VAL . 3.4 m120 -68.51 -41.74 79.54 Favored 'General case' 0 C--O 1.21 -1.009 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.777 177.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 18' ' ' ASP . . . . . 0.549 ' OD2' ' HA ' ' D' ' 15' ' ' SER . 55.0 m-20 -58.64 -16.58 16.74 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -177.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.671 ' O ' ' HE3' ' D' ' 22' ' ' LYS . 0.0 OUTLIER -91.83 -52.64 4.64 Favored 'General case' 0 CA--C 1.488 -1.42 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 172.37 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 20' ' ' LEU . . . . . 0.964 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 75.8 mt -57.39 -34.95 69.41 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.031 -1.441 . . . . 0.0 110.78 -177.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 21' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -77.4 97.1 4.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.223 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 22' ' ' LYS . . . . . 0.671 ' HE3' ' O ' ' D' ' 19' ' ' LYS . 88.5 mttt -121.73 -40.91 2.5 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 -172.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.23 -88.6 0.11 Allowed Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 119.477 -1.344 . . . . 0.0 113.315 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . 0.72 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 52.1 tptt -49.84 -54.03 21.87 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 25' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -139.14 155.82 24.12 Favored Glycine 0 N--CA 1.429 -1.792 0 CA-C-N 114.264 -1.334 . . . . 0.0 110.943 174.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 26' ' ' LYS . . . . . 0.698 ' HG3' ' HB3' ' D' ' 41' ' ' SER . 9.2 ptpt -149.99 160.83 43.32 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.301 -0.95 . . . . 0.0 110.167 -169.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 27' ' ' LEU . . . . . 0.964 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 52.2 tp -135.19 147.29 49.33 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.188 0.518 . . . . 0.0 111.932 -176.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 28' ' ' SER . . . . . 0.596 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 22.9 t -139.79 153.32 47.09 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 29' ' ' LEU . . . . . 0.516 HD11 ' CD1' ' D' ' 20' ' ' LEU . 0.2 OUTLIER -141.27 133.97 28.68 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.914 177.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 54.1 p -133.54 -171.39 2.7 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.719 175.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 21.6 ptp -148.89 166.3 28.98 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.388 0.614 . . . . 0.0 111.466 -176.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 32' ' ' ASN . . . . . 0.471 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 22.8 t-20 -144.54 88.01 1.9 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.458 177.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.85 -108.7 2.57 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.216 -171.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -100.31 9.93 41.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.841 0.353 . . . . 0.0 110.873 176.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 35' ' ' GLN . . . . . 0.471 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 3.6 tp60 -90.82 158.24 16.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.832 0.349 . . . . 0.0 110.48 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.689 HD11 HG22 ' D' ' 79' ' ' ILE . 2.5 tm? -124.92 137.39 54.27 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.62 176.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 37' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 34.3 mmtp -130.94 115.34 16.39 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.93 -171.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -115.28 152.5 32.63 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.939 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 39' ' ' THR . . . . . 0.596 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 17.2 p -145.92 135.24 22.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.737 -1.119 . . . . 0.0 111.123 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . 0.653 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 27.0 p -108.75 133.72 52.43 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 170.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 41' ' ' SER . . . . . 0.698 ' HB3' ' HG3' ' D' ' 26' ' ' LYS . 34.0 t -95.5 147.06 23.95 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 118.97 -1.092 . . . . 0.0 109.222 178.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 42' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' D' ' 41' ' ' SER . 75.1 m-80 80.45 -3.11 1.9 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.188 -168.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.66 62.8 2.28 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 168.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.17 -1.47 8.32 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 118.508 -1.806 . . . . 0.0 115.011 170.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 45' ' ' TYR . . . . . 0.72 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 1.4 m-30 -89.91 152.12 21.39 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 120.617 0.246 . . . . 0.0 110.808 -176.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . 0.589 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -95.24 -158.67 32.88 Favored Glycine 0 C--O 1.217 -0.952 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 174.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 47' ' ' ILE . . . . . 0.898 HG13 ' HB3' ' D' ' 68' ' ' GLU . 0.4 OUTLIER -55.42 -49.13 75.35 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 CA-C-O 122.597 1.189 . . . . 0.0 108.518 176.163 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 34.0 t 168.0 -119.77 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 111.305 -2.679 . . . . 0.0 105.422 -175.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -109.34 78.33 1.12 Allowed 'General case' 0 C--N 1.318 -0.775 0 O-C-N 121.771 -0.581 . . . . 0.0 109.679 163.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . 0.621 ' HB3' ' HE3' ' D' ' 52' ' ' LYS . 52.0 mt-10 -143.37 171.68 13.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.749 -177.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 51' ' ' ASP . . . . . 0.692 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 2.4 m-20 -131.42 135.68 47.37 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.534 176.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 52' ' ' LYS . . . . . 0.768 ' HD3' HG12 ' D' ' 47' ' ' ILE . 0.1 OUTLIER -144.96 157.19 44.22 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 123.035 0.534 . . . . 0.0 110.45 -178.029 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 53' ' ' ASN . . . . . 0.533 HD22 ' C ' ' D' ' 52' ' ' LYS . 2.7 m120 -120.98 134.26 55.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.301 175.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 54' ' ' TRP . . . . . 1.02 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 0.3 OUTLIER -126.43 160.62 29.98 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.205 -178.516 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -150.27 160.31 28.49 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.113 -1.041 . . . . 0.0 114.061 176.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 56' ' ' ILE . . . . . 1.001 HG12 HG23 ' D' ' 91' ' ' ILE . 73.0 mt -130.68 113.77 25.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 176.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 57' ' ' PHE . . . . . 0.629 ' HD2' ' O ' ' D' ' 90' ' ' GLU . 17.1 m-85 -108.39 105.1 14.63 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 119.688 -0.805 . . . . 0.0 111.248 -167.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.839 HG22 HG12 ' D' ' 89' ' ' ILE . 90.2 t -97.88 109.56 23.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.283 176.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 5.6 m120 55.84 39.92 30.65 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.253 178.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.97 -31.07 8.85 Favored Glycine 0 CA--C 1.508 -0.37 0 C-N-CA 120.159 -1.019 . . . . 0.0 112.771 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -88.76 126.18 35.22 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.162 -0.519 . . . . 0.0 111.032 -176.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -71.98 98.17 2.01 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 174.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 11.3 p -76.36 -27.37 17.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.823 -168.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 64' ' ' TYR . . . . . 0.442 ' HB3' HD12 ' D' ' 56' ' ' ILE . 15.4 t80 -145.75 128.56 16.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.722 177.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 31.3 m -109.82 105.21 14.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.062 176.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 66' ' ' PHE . . . . . 0.426 ' HB3' ' CE2' ' D' ' 64' ' ' TYR . 10.0 p90 -111.48 158.79 18.73 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 67' ' ' ASN . . . . . 0.584 ' O ' HD11 ' D' ' 75' ' ' ILE . 5.3 m120 -128.9 143.09 50.79 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -172.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 68' ' ' GLU . . . . . 0.898 ' HB3' HG13 ' D' ' 47' ' ' ILE . 53.6 mm-40 -64.2 -21.0 66.4 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 174.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.509 ' HE3' ' OD2' ' D' ' 51' ' ' ASP . 48.2 mtpt -51.17 -54.46 25.22 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.102 171.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 18.0 m -65.44 120.14 12.3 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 112.118 -2.31 . . . . 0.0 108.4 170.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 70.3 p -52.9 122.74 9.83 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.234 -178.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 72' ' ' VAL . . . . . 0.646 ' HA ' HD12 ' D' ' 75' ' ' ILE . 0.1 OUTLIER -54.72 -12.23 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 120.924 0.392 . . . . 0.0 111.997 -175.432 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 73' ' ' GLY . . . . . 0.653 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -73.57 -56.46 5.51 Favored Glycine 0 N--CA 1.437 -1.27 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.656 170.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 74' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' D' ' 77' ' ' ASN . 29.6 t-20 -66.3 -19.68 65.88 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 75' ' ' ILE . . . . . 0.646 HD12 ' HA ' ' D' ' 72' ' ' VAL . 74.4 mt -71.78 -41.21 70.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.17 173.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 30.7 t -72.8 -19.54 61.32 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.696 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 77' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' D' ' 74' ' ' ASN . 4.2 m120 -61.15 -30.9 70.67 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 168.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 78' ' ' ASP . . . . . 1.146 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 1.0 OUTLIER -86.4 -40.91 14.92 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 114.825 -1.079 . . . . 0.0 112.936 177.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . 0.689 HG22 HD11 ' D' ' 36' ' ' LEU . 33.9 mt -63.53 -24.9 37.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 O-C-N 121.433 -0.792 . . . . 0.0 111.536 -171.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -71.39 -31.18 66.98 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 81' ' ' LYS . . . . . 1.146 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -81.11 -47.4 13.56 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.33 175.271 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 82' ' ' LEU . . . . . 0.628 HD23 ' O ' ' D' ' 78' ' ' ASP . 4.0 mm? -51.01 -26.93 6.74 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 50.31 71.03 0.44 Allowed 'General case' 0 N--CA 1.473 0.687 0 O-C-N 123.588 0.555 . . . . 0.0 110.636 176.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 84' ' ' ILE . . . . . 0.476 ' HB ' ' HG ' ' D' ' 36' ' ' LEU . 44.4 mm -78.23 96.36 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.97 -175.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 85' ' ' LYS . . . . . 0.602 ' HG2' ' HB2' ' D' ' 36' ' ' LEU . 28.4 mmmt -153.79 92.64 1.58 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.496 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.3 154.86 0.08 OUTLIER Glycine 0 C--N 1.331 0.287 0 N-CA-C 114.547 0.579 . . . . 0.0 114.547 174.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 87' ' ' PRO . . . . . 0.587 ' O ' HG13 ' D' ' 58' ' ' VAL . 76.5 Cg_endo -90.45 -178.26 11.17 Favored 'Cis proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.493 -1.461 . . . . 0.0 112.268 -0.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 88' ' ' TYR . . . . . 0.728 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 1.7 m-85 7.71 92.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 125.32 1.448 . . . . 0.0 113.773 -177.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.839 HG12 HG22 ' D' ' 58' ' ' VAL . 71.6 mt -110.95 136.62 46.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.211 0.529 . . . . 0.0 112.24 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . 0.629 ' O ' ' HD2' ' D' ' 57' ' ' PHE . 39.3 tt0 -128.36 95.81 4.26 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.846 175.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 91' ' ' ILE . . . . . 1.02 HG22 ' HZ3' ' D' ' 54' ' ' TRP . 6.5 mt -96.37 108.82 21.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -177.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 92' ' ' LYS . . . . . 0.662 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -161.0 169.97 21.48 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 177.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . 0.682 ' HB3' ' NE1' ' D' ' 54' ' ' TRP . 17.4 pt20 -85.24 163.36 18.7 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.399 177.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 94' ' ' ILE . . . . . 0.662 HG22 ' HE2' ' D' ' 92' ' ' LYS . 9.3 pt . . . . . 0 C--N 1.31 -1.145 0 CA-C-N 114.197 -1.365 . . . . 0.0 111.311 -167.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.404 ' O ' HG12 ' D' ' 16' ' ' VAL . 64.2 mt . . . . . 0 N--CA 1.463 0.203 0 CA-C-O 122.103 0.954 . . . . 0.0 111.463 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -95.93 -45.65 6.85 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.656 -1.157 . . . . 0.0 110.053 172.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 15' ' ' SER . . . . . 0.529 ' O ' ' HB2' ' D' ' 18' ' ' ASP . 39.4 m -66.17 -25.44 66.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.794 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 16' ' ' VAL . . . . . 0.698 ' HA ' ' HE2' ' D' ' 19' ' ' LYS . 7.1 p -58.93 -33.72 50.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.057 0.456 . . . . 0.0 110.532 179.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 17' ' ' ASN . . . . . 0.556 ' O ' ' HB2' ' D' ' 21' ' ' ASN . 5.4 m120 -66.42 -41.46 89.18 Favored 'General case' 0 C--O 1.209 -1.043 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 176.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 18' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' D' ' 15' ' ' SER . 1.2 m-20 -59.72 -14.03 12.54 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 175.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.698 ' HE2' ' HA ' ' D' ' 16' ' ' VAL . 1.7 mppt? -90.55 -44.93 9.25 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.933 0.873 . . . . 0.0 109.881 175.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 20' ' ' LEU . . . . . 1.008 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 69.8 mt -85.89 -19.02 31.18 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 112.762 -2.017 . . . . 0.0 111.812 -169.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 21' ' ' ASN . . . . . 0.556 ' HB2' ' O ' ' D' ' 17' ' ' ASN . 1.4 t-20 -106.24 98.58 8.24 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.351 -0.84 . . . . 0.0 108.891 -169.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 22' ' ' LYS . . . . . 0.633 ' CE ' ' HA ' ' D' ' 47' ' ' ILE . 2.3 mppt? -119.94 -42.95 2.57 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 118.619 -1.232 . . . . 0.0 113.112 -168.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.19 -75.94 0.16 Allowed Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.147 -1.025 . . . . 0.0 112.598 -175.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . 0.785 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 53.0 tptt -52.13 -61.16 2.44 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 25' ' ' GLY . . . . . 0.548 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -137.97 157.67 24.39 Favored Glycine 0 N--CA 1.43 -1.712 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.93 174.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 26' ' ' LYS . . . . . 0.67 ' HA ' ' O ' ' D' ' 20' ' ' LEU . 9.1 ptpt -149.25 162.13 40.63 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.378 -0.911 . . . . 0.0 110.818 -167.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 27' ' ' LEU . . . . . 1.008 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 58.3 tp -136.51 136.83 39.7 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.24 0.543 . . . . 0.0 111.448 -177.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 28' ' ' SER . . . . . 0.629 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 53.9 m -124.44 142.18 51.51 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.334 -175.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 29' ' ' LEU . . . . . 0.843 HD11 HD12 ' D' ' 20' ' ' LEU . 0.1 OUTLIER -141.49 148.11 38.9 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 119.49 -0.884 . . . . 0.0 112.097 -176.233 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 50.4 m -154.33 -173.81 4.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.968 176.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 24.6 ptm -145.66 162.91 36.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.289 0.566 . . . . 0.0 111.197 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 32' ' ' ASN . . . . . 0.475 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 26.4 t-20 -141.8 88.58 2.13 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.057 178.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.59 -98.45 0.53 Allowed Glycine 0 CA--C 1.516 0.146 0 C-N-CA 120.256 -0.973 . . . . 0.0 111.853 -176.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -104.77 2.89 30.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.783 0.325 . . . . 0.0 110.346 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 35' ' ' GLN . . . . . 0.475 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 3.6 tp-100 -91.32 155.9 18.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.127 -174.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.737 HD11 HG22 ' D' ' 79' ' ' ILE . 1.9 tm? -124.38 137.65 54.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.366 173.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 37' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 12.8 mmmm -131.04 115.81 16.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.774 -169.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 38' ' ' ALA . . . . . 0.533 ' HB1' HD11 ' D' ' 27' ' ' LEU . . . -123.01 155.02 37.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.156 0.503 . . . . 0.0 111.559 177.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 39' ' ' THR . . . . . 0.629 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 2.4 p -150.77 139.4 20.64 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.903 -178.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . 0.676 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 53.3 p -109.0 133.97 52.27 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 173.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 41' ' ' SER . . . . . 0.647 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 35.4 t -96.01 148.05 23.06 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.905 -1.118 . . . . 0.0 109.199 176.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 42' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' D' ' 41' ' ' SER . 75.1 m-80 80.09 -0.57 2.04 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.95 -168.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.17 60.54 3.36 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 170.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 44' ' ' GLY . . . . . 0.684 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 110.15 35.95 2.06 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.317 -1.42 . . . . 0.0 114.706 169.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 45' ' ' TYR . . . . . 0.785 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 1.3 m-85 -112.97 152.75 29.02 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 173.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -88.77 -153.81 27.59 Favored Glycine 0 C--O 1.219 -0.782 0 C-N-CA 121.124 -0.56 . . . . 0.0 111.991 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 47' ' ' ILE . . . . . 1.058 HG13 ' HB3' ' D' ' 68' ' ' GLU . 1.0 OUTLIER -57.38 -57.08 11.56 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 CA-C-O 122.338 1.066 . . . . 0.0 108.184 -179.479 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' D' ' 47' ' ' ILE . 23.1 t 169.56 -63.47 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 111.893 -2.412 . . . . 0.0 106.836 -178.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 49' ' ' TYR . . . . . 0.437 ' O ' ' HD1' ' D' ' 49' ' ' TYR . 0.2 OUTLIER -165.07 74.74 0.24 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 113.746 -1.57 . . . . 0.0 109.667 168.569 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' D' ' 69' ' ' LYS . 72.3 mm-40 -139.99 -158.92 0.9 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.049 -175.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 51' ' ' ASP . . . . . 0.51 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 1.1 t70 -152.39 124.37 8.01 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.615 173.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 52' ' ' LYS . . . . . 0.572 ' HB2' ' CG ' ' D' ' 68' ' ' GLU . 0.2 OUTLIER -141.15 120.01 12.66 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.528 178.672 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -93.4 129.06 39.68 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 174.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 54' ' ' TRP . . . . . 0.701 ' NE1' ' HB3' ' D' ' 93' ' ' GLN . 0.1 OUTLIER -114.87 153.18 30.94 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -171.267 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -132.57 156.16 21.93 Favored Glycine 0 N--CA 1.431 -1.685 0 C-N-CA 120.157 -1.021 . . . . 0.0 114.524 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 56' ' ' ILE . . . . . 0.814 HD13 HG12 ' D' ' 84' ' ' ILE . 65.4 mt -146.28 108.27 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 113.66 -1.27 . . . . 0.0 107.652 177.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 57' ' ' PHE . . . . . 0.869 ' HB2' ' HB3' ' D' ' 90' ' ' GLU . 7.4 m-30 -117.72 107.92 14.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.97 -169.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.767 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 53.2 t -97.04 117.15 41.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.684 173.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 59' ' ' ASN . . . . . 0.673 HD21 ' HG2' ' D' ' 87' ' ' PRO . 3.6 m120 62.37 43.46 8.13 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.258 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.4 -33.87 4.19 Favored Glycine 0 CA--C 1.508 -0.361 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.905 173.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 61' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 23.5 pt-20 -90.99 155.84 18.41 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.247 0.546 . . . . 0.0 111.479 -175.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 62' ' ' LYS . . . . . 0.501 ' HD2' ' OG1' ' D' ' 65' ' ' THR . 6.2 ttpm? -85.55 125.2 32.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.561 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.43 HG22 ' O ' ' D' ' 56' ' ' ILE . 25.6 m -104.57 -29.79 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -177.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 64' ' ' TYR . . . . . 0.433 ' HB3' HD12 ' D' ' 56' ' ' ILE . 17.4 t80 -153.21 147.33 25.59 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.863 0.363 . . . . 0.0 111.384 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . 0.501 ' OG1' ' HD2' ' D' ' 62' ' ' LYS . 86.8 m -132.29 126.75 34.12 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.016 175.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 66' ' ' PHE . . . . . 0.566 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 14.0 p90 -130.44 155.08 47.01 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 175.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 67' ' ' ASN . . . . . 0.557 ' O ' HD11 ' D' ' 75' ' ' ILE . 72.7 m-20 -117.57 138.23 52.06 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -177.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 68' ' ' GLU . . . . . 1.058 ' HB3' HG13 ' D' ' 47' ' ' ILE . 38.5 mm-40 -61.19 -22.82 65.1 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.885 0.374 . . . . 0.0 111.144 177.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' D' ' 50' ' ' GLU . 46.3 mtmt -65.02 -39.07 92.84 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 70' ' ' SER . . . . . 0.47 ' HB3' ' O ' ' D' ' 67' ' ' ASN . 23.2 t -64.79 121.32 14.29 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 113.744 -1.571 . . . . 0.0 106.817 166.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 54.0 p -52.33 120.36 5.45 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.045 -177.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 72' ' ' VAL . . . . . 0.656 ' HA ' HD12 ' D' ' 75' ' ' ILE . 0.0 OUTLIER -55.3 -11.62 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.368 0 CA-C-O 120.984 0.421 . . . . 0.0 111.395 -175.279 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 73' ' ' GLY . . . . . 0.684 ' HA3' ' HA2' ' D' ' 44' ' ' GLY . . . -67.49 -64.73 3.05 Favored Glycine 0 N--CA 1.434 -1.434 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.884 169.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -65.54 -18.05 65.03 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.987 -0.285 . . . . 0.0 111.332 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 75' ' ' ILE . . . . . 0.684 ' O ' HG13 ' D' ' 79' ' ' ILE . 76.2 mt -70.02 -41.98 79.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 172.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 38.3 t -73.3 -26.16 60.96 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.086 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -59.73 -24.55 64.1 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.367 168.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 78' ' ' ASP . . . . . 0.988 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 76.8 m-20 -90.75 -38.76 12.82 Favored 'General case' 0 C--O 1.225 -0.225 0 O-C-N 123.849 0.718 . . . . 0.0 112.333 176.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . 0.737 HG22 HD11 ' D' ' 36' ' ' LEU . 42.8 mt -64.88 -24.4 35.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 O-C-N 121.719 -0.613 . . . . 0.0 111.106 -172.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -70.77 -25.19 62.79 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 177.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 81' ' ' LYS . . . . . 0.988 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -90.32 -46.68 8.24 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 120.081 -0.648 . . . . 0.0 111.829 175.174 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 82' ' ' LEU . . . . . 0.637 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.9 mm? -51.33 -25.93 6.74 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 49.71 69.36 0.61 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.038 0.535 . . . . 0.0 110.8 175.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 84' ' ' ILE . . . . . 0.814 HG12 HD13 ' D' ' 56' ' ' ILE . 2.2 mp -74.0 107.33 4.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.007 -178.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 85' ' ' LYS . . . . . 0.552 ' O ' ' HE3' ' D' ' 85' ' ' LYS . 0.0 OUTLIER -150.44 179.23 8.32 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 178.317 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 86' ' ' GLY . . . . . 0.712 ' HA2' HD11 ' D' ' 89' ' ' ILE . . . -57.48 168.3 4.6 Favored Glycine 0 CA--C 1.509 -0.299 0 CA-C-N 115.266 -0.879 . . . . 0.0 114.923 -173.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 87' ' ' PRO . . . . . 0.729 ' O ' HG13 ' D' ' 58' ' ' VAL . 46.7 Cg_endo -91.84 178.25 13.87 Favored 'Cis proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.736 -1.777 . . . . 0.0 114.165 0.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 88' ' ' TYR . . . . . 0.767 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 11.7 m-85 31.34 93.19 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.853 1.261 . . . . 0.0 113.121 -178.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.855 HG22 HG13 ' D' ' 91' ' ' ILE . 3.2 mp -110.19 117.55 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 CA-C-O 121.714 0.768 . . . . 0.0 110.896 -178.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . 0.869 ' HB3' ' HB2' ' D' ' 57' ' ' PHE . 5.0 tp10 -100.93 87.4 3.28 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.126 174.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 91' ' ' ILE . . . . . 0.855 HG13 HG22 ' D' ' 89' ' ' ILE . 18.8 mt -98.68 101.76 12.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.751 177.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 92' ' ' LYS . . . . . 0.669 ' HE3' ' CG2' ' D' ' 94' ' ' ILE . 0.0 OUTLIER -161.4 168.62 23.49 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.469 -179.405 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . 0.701 ' HB3' ' NE1' ' D' ' 54' ' ' TRP . 26.3 pt20 -93.17 160.91 14.64 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 119.474 -0.89 . . . . 0.0 111.413 174.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 94' ' ' ILE . . . . . 0.669 ' CG2' ' HE3' ' D' ' 92' ' ' LYS . 4.7 pt . . . . . 0 C--N 1.314 -0.978 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.587 -172.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.437 ' C ' HG12 ' D' ' 16' ' ' VAL . 60.5 mt . . . . . 0 N--CA 1.454 -0.235 0 CA-C-O 121.731 0.777 . . . . 0.0 111.341 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -95.12 -62.3 1.33 Allowed 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.897 175.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 15' ' ' SER . . . . . 0.518 ' HA ' ' OD1' ' D' ' 18' ' ' ASP . 88.6 p -68.24 -15.94 63.77 Favored 'General case' 0 C--O 1.223 -0.307 0 O-C-N 122.193 -0.317 . . . . 0.0 111.343 -178.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 16' ' ' VAL . . . . . 0.789 HG11 HD11 ' D' ' 29' ' ' LEU . 7.4 p -52.49 -39.8 30.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.127 0.489 . . . . 0.0 109.711 173.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 17' ' ' ASN . . . . . 0.664 ' OD1' ' HA ' ' D' ' 28' ' ' SER . 79.9 m-20 -75.75 -25.88 56.9 Favored 'General case' 0 C--O 1.212 -0.891 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.32 -178.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 18' ' ' ASP . . . . . 0.518 ' OD1' ' HA ' ' D' ' 15' ' ' SER . 1.5 m-20 -66.74 -16.41 64.23 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 177.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.628 ' HE2' ' HA ' ' D' ' 16' ' ' VAL . 0.0 OUTLIER -92.2 -36.78 13.08 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-O 122.044 0.926 . . . . 0.0 108.742 174.087 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' D' D ' 20' ' ' LEU . . . . . 0.92 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 76.4 mt -71.93 -41.16 68.17 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 113.329 -1.76 . . . . 0.0 109.482 -175.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 21' ' ' ASN . . . . . 0.632 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 62.3 m-20 -81.24 94.69 6.75 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.026 -1.443 . . . . 0.0 111.55 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 22' ' ' LYS . . . . . 0.497 ' HB2' HG23 ' D' ' 47' ' ' ILE . 55.8 mtpt -123.01 -42.11 2.3 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -177.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . 0.538 ' O ' ' HE3' ' D' ' 26' ' ' LYS . . . 177.92 -94.03 0.09 OUTLIER Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 119.614 -1.279 . . . . 0.0 113.555 -178.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . 0.849 ' HE3' ' HA ' ' D' ' 48' ' ' SER . 25.7 ttpp -54.73 -43.31 72.51 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 122.072 0.939 . . . . 0.0 110.192 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -139.6 141.16 11.42 Favored Glycine 0 N--CA 1.427 -1.941 0 CA-C-N 114.193 -1.367 . . . . 0.0 111.98 178.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 26' ' ' LYS . . . . . 0.753 ' HA ' ' O ' ' D' ' 20' ' ' LEU . 9.7 ptpt -148.13 159.84 43.52 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 114.213 -0.994 . . . . 0.0 110.09 -170.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 27' ' ' LEU . . . . . 0.92 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 41.1 tp -139.52 148.46 42.66 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 120.864 0.364 . . . . 0.0 111.37 -177.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 28' ' ' SER . . . . . 0.664 ' HA ' ' OD1' ' D' ' 17' ' ' ASN . 21.1 t -140.47 148.47 41.18 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 29' ' ' LEU . . . . . 0.789 HD11 HG11 ' D' ' 16' ' ' VAL . 0.5 OUTLIER -141.88 144.89 34.05 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 175.61 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 50.1 m -148.07 -170.64 3.64 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.33 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -147.21 166.56 26.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.214 0.53 . . . . 0.0 112.028 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 32' ' ' ASN . . . . . 0.572 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 0.8 OUTLIER -146.96 88.74 1.76 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.788 179.839 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.75 -101.52 0.72 Allowed Glycine 0 CA--C 1.516 0.14 0 C-N-CA 120.327 -0.94 . . . . 0.0 111.568 -174.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -107.78 16.66 23.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.926 0.394 . . . . 0.0 110.615 176.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 35' ' ' GLN . . . . . 0.572 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 68.1 tp60 -99.39 156.76 16.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.627 -176.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.866 ' HB2' ' HG2' ' D' ' 85' ' ' LYS . 2.3 tm? -120.62 140.12 52.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.667 174.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 37' ' ' LYS . . . . . 0.54 ' H ' HD22 ' D' ' 36' ' ' LEU . 73.0 mmtt -132.02 123.76 27.94 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.169 -171.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 38' ' ' ALA . . . . . 0.502 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -130.83 138.69 49.98 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.46 175.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 39' ' ' THR . . . . . 0.553 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 19.9 p -133.51 122.0 22.99 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.373 0.606 . . . . 0.0 111.36 178.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . 0.693 ' HB2' ' HA2' ' D' ' 73' ' ' GLY . 40.7 m -109.99 129.58 55.65 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 175.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 41' ' ' SER . . . . . 0.656 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 37.2 t -95.74 154.82 17.03 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.617 -173.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 42' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' D' ' 41' ' ' SER . 73.6 m-80 80.38 11.86 1.01 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 114.053 -1.431 . . . . 0.0 110.079 -171.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 45.15 55.47 6.27 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 114.445 -1.252 . . . . 0.0 113.693 170.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 44' ' ' GLY . . . . . 0.614 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 108.79 35.54 2.38 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 119.754 -1.213 . . . . 0.0 114.126 171.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 45' ' ' TYR . . . . . 0.681 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 1.7 m-85 -116.04 157.67 24.31 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 171.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . 0.543 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -97.74 174.77 29.54 Favored Glycine 0 CA--C 1.501 -0.843 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 177.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 47' ' ' ILE . . . . . 0.689 ' CG1' ' HB3' ' D' ' 68' ' ' GLU . 46.3 mm -46.4 -60.37 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-O 121.614 0.721 . . . . 0.0 111.659 -177.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . 0.849 ' HA ' ' HE3' ' D' ' 24' ' ' LYS . 22.1 t 172.93 -151.02 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 113.391 -1.731 . . . . 0.0 108.214 -177.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -80.69 77.0 7.57 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 120.9 0.381 . . . . 0.0 110.541 172.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . 0.642 ' HB2' ' HZ3' ' D' ' 52' ' ' LYS . 97.2 mt-10 -150.46 155.58 39.8 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.469 176.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 51' ' ' ASP . . . . . 0.608 ' HB3' ' HD3' ' D' ' 69' ' ' LYS . 18.6 m-20 -118.96 127.65 53.67 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.869 176.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 52' ' ' LYS . . . . . 0.714 ' HE2' ' CB ' ' D' ' 68' ' ' GLU . 3.5 mppt? -142.63 128.74 19.73 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.879 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -104.11 129.71 51.81 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.746 175.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 54' ' ' TRP . . . . . 1.035 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 1.0 OUTLIER -115.69 160.8 19.58 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -174.498 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' D' D ' 55' ' ' GLY . . . . . 0.448 ' HA3' ' HE2' ' D' ' 62' ' ' LYS . . . -143.81 158.82 27.49 Favored Glycine 0 N--CA 1.434 -1.498 0 CA-C-N 114.848 -1.069 . . . . 0.0 113.371 176.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 56' ' ' ILE . . . . . 1.073 HG12 HG23 ' D' ' 91' ' ' ILE . 91.2 mt -140.92 115.09 5.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 N-CA-C 106.363 -1.718 . . . . 0.0 106.363 178.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 57' ' ' PHE . . . . . 0.739 ' CE1' ' HE2' ' D' ' 92' ' ' LYS . 5.6 m-85 -115.37 123.03 47.65 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 119.589 -0.844 . . . . 0.0 110.466 -171.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.643 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 85.3 t -101.01 112.59 34.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.954 173.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 59' ' ' ASN . . . . . 0.611 ' OD1' ' HG2' ' D' ' 87' ' ' PRO . 6.8 m120 60.78 35.95 19.39 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.322 -176.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.04 -33.05 6.6 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.374 -0.917 . . . . 0.0 113.998 174.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 61' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 24.5 pt-20 -90.08 148.64 22.9 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.914 0.388 . . . . 0.0 111.183 -174.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 62' ' ' LYS . . . . . 0.448 ' HE2' ' HA3' ' D' ' 55' ' ' GLY . 5.5 tppp? -65.66 126.56 28.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.766 175.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.543 HG11 HG23 ' D' ' 58' ' ' VAL . 12.4 p -109.48 -29.44 2.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.663 178.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 64' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -151.5 135.22 16.35 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.758 175.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . 0.409 HG23 ' O ' ' D' ' 54' ' ' TRP . 70.6 m -117.06 125.66 51.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.133 175.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 66' ' ' PHE . . . . . 0.461 ' HB2' HG21 ' D' ' 75' ' ' ILE . 16.6 p90 -126.8 161.02 29.19 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 121.153 0.501 . . . . 0.0 110.064 173.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 67' ' ' ASN . . . . . 0.535 ' O ' ' HB2' ' D' ' 70' ' ' SER . 73.1 m-20 -126.1 147.46 49.59 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -177.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 68' ' ' GLU . . . . . 0.714 ' CB ' ' HE2' ' D' ' 52' ' ' LYS . 39.0 mm-40 -80.98 -14.68 57.73 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.438 0.637 . . . . 0.0 109.592 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.608 ' HD3' ' HB3' ' D' ' 51' ' ' ASP . 47.6 mtmt -65.97 -48.96 69.55 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-N 113.808 -1.542 . . . . 0.0 107.27 169.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 70' ' ' SER . . . . . 0.535 ' HB2' ' O ' ' D' ' 67' ' ' ASN . 51.0 m -61.32 129.57 41.87 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 111.615 -2.539 . . . . 0.0 108.775 169.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 68.4 p -58.61 112.03 1.46 Allowed 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -178.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 72' ' ' VAL . . . . . 0.608 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -49.84 -24.36 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 121.06 0.457 . . . . 0.0 110.269 -176.557 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' D' D ' 73' ' ' GLY . . . . . 0.693 ' HA2' ' HB2' ' D' ' 40' ' ' SER . . . -60.77 -67.46 2.12 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.208 -0.905 . . . . 0.0 114.671 175.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -62.49 -19.48 63.61 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.057 0.456 . . . . 0.0 110.965 -177.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 75' ' ' ILE . . . . . 0.584 ' O ' HG13 ' D' ' 79' ' ' ILE . 34.8 mm -76.05 -39.48 36.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.017 174.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 76' ' ' SER . . . . . 0.471 ' HA ' HG13 ' D' ' 79' ' ' ILE . 40.4 t -75.01 -21.05 59.35 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.535 177.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -61.72 -30.67 70.91 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 168.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 78' ' ' ASP . . . . . 1.001 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 1.0 OUTLIER -83.65 -30.8 26.57 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.606 174.84 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . 0.717 HG22 HD11 ' D' ' 36' ' ' LEU . 35.8 mt -69.81 -18.0 21.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.29 -177.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -66.41 -41.41 89.32 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.06 174.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 81' ' ' LYS . . . . . 1.001 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -80.23 -47.05 15.22 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 179.44 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' D' D ' 82' ' ' LEU . . . . . 0.699 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.4 mm? -50.34 -27.81 6.86 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -178.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 83' ' ' ASN . . . . . 0.533 ' HA ' ' HB3' ' D' ' 36' ' ' LEU . 0.7 OUTLIER 46.16 62.6 2.2 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.553 0.533 . . . . 0.0 110.678 176.403 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' D' D ' 84' ' ' ILE . . . . . 0.583 HG22 HD13 ' D' ' 89' ' ' ILE . 44.8 mm -86.32 97.36 5.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.535 -175.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 85' ' ' LYS . . . . . 0.866 ' HG2' ' HB2' ' D' ' 36' ' ' LEU . 28.3 mmmt -147.13 95.55 2.58 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.816 175.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 86' ' ' GLY . . . . . 0.724 ' H ' HD11 ' D' ' 89' ' ' ILE . . . 73.97 151.72 2.23 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.648 -0.706 . . . . 0.0 113.746 173.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 87' ' ' PRO . . . . . 0.611 ' HG2' ' OD1' ' D' ' 59' ' ' ASN . 62.5 Cg_endo -90.19 179.61 14.38 Favored 'Cis proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.17 -1.596 . . . . 0.0 112.773 -0.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 88' ' ' TYR . . . . . 0.643 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 5.8 m-85 15.54 94.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 125.43 1.492 . . . . 0.0 114.217 -178.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.724 HD11 ' H ' ' D' ' 86' ' ' GLY . 70.5 mt -110.52 133.31 56.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.223 0.535 . . . . 0.0 112.357 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . 0.481 ' O ' ' HD1' ' D' ' 57' ' ' PHE . 46.3 mt-10 -118.97 96.75 5.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.536 174.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 91' ' ' ILE . . . . . 1.073 HG23 HG12 ' D' ' 56' ' ' ILE . 4.0 mt -101.11 110.92 29.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 92' ' ' LYS . . . . . 0.739 ' HE2' ' CE1' ' D' ' 57' ' ' PHE . 0.0 OUTLIER -163.55 172.76 13.93 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.023 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . 0.587 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 23.9 pt20 -81.6 169.34 17.17 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 119.091 -1.043 . . . . 0.0 111.185 175.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 94' ' ' ILE . . . . . 0.519 ' CG2' ' HE3' ' D' ' 92' ' ' LYS . 6.7 pt . . . . . 0 C--N 1.317 -0.837 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.971 -173.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.573 ' O ' HG12 ' D' ' 16' ' ' VAL . 12.2 tt . . . . . 0 N--CA 1.428 -1.553 0 CA-C-O 120.85 0.357 . . . . 0.0 111.932 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -82.13 -58.88 2.76 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -178.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 15' ' ' SER . . . . . 0.573 ' O ' ' HE2' ' D' ' 19' ' ' LYS . 97.9 p -69.97 -15.46 63.04 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.701 -178.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 16' ' ' VAL . . . . . 0.573 HG12 ' O ' ' D' ' 13' ' ' ILE . 1.7 p -61.3 -26.56 39.68 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -78.3 -38.05 43.37 Favored 'General case' 0 C--O 1.212 -0.891 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.545 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.99 -16.36 17.72 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.644 ' O ' ' HE2' ' D' ' 22' ' ' LYS . 35.0 mttm -91.12 -39.29 12.24 Favored 'General case' 0 CA--C 1.492 -1.28 0 CA-C-O 122.487 1.137 . . . . 0.0 109.397 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 20' ' ' LEU . . . . . 0.63 HD12 HD12 ' D' ' 27' ' ' LEU . 61.0 mt -82.26 -32.82 29.44 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 112.887 -1.961 . . . . 0.0 109.581 -174.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 21' ' ' ASN . . . . . 0.774 ' OD1' ' HB2' ' D' ' 26' ' ' LYS . 57.4 m-20 -71.95 92.33 1.27 Allowed 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.449 -1.25 . . . . 0.0 109.708 172.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 22' ' ' LYS . . . . . 0.644 ' HE2' ' O ' ' D' ' 19' ' ' LYS . 61.0 mttm -121.75 -41.45 2.47 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -174.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . 0.407 ' O ' ' HE2' ' D' ' 26' ' ' LYS . . . 176.93 -92.64 0.09 OUTLIER Glycine 0 N--CA 1.437 -1.283 0 C-N-CA 119.658 -1.258 . . . . 0.0 112.857 -177.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . 0.742 ' HG2' ' HB3' ' D' ' 45' ' ' TYR . 76.0 tttt -47.44 -55.83 8.22 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.584 0.707 . . . . 0.0 109.786 179.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 25' ' ' GLY . . . . . 0.644 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -133.99 156.21 22.22 Favored Glycine 0 N--CA 1.432 -1.573 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.906 174.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 26' ' ' LYS . . . . . 0.774 ' HB2' ' OD1' ' D' ' 21' ' ' ASN . 0.1 OUTLIER -150.3 162.48 40.44 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.301 -0.949 . . . . 0.0 110.556 -168.516 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 27' ' ' LEU . . . . . 0.746 ' HB2' HG11 ' D' ' 72' ' ' VAL . 3.4 tm? -132.46 143.23 49.64 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.762 -171.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 28' ' ' SER . . . . . 0.689 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 50.0 m -137.05 145.64 44.25 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.924 178.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 29' ' ' LEU . . . . . 0.525 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 18.3 mt -138.75 157.91 45.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.157 0.503 . . . . 0.0 110.871 177.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 39.3 t -160.3 -175.49 5.07 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 175.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 31' ' ' MET . . . . . 0.687 ' HA ' ' O ' ' D' ' 35' ' ' GLN . 26.6 ptt? -150.28 127.1 11.03 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.659 0.743 . . . . 0.0 111.06 175.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.52 89.01 7.01 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.022 176.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.51 -104.1 2.02 Favored Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -169.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -120.71 31.78 6.28 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.164 0.507 . . . . 0.0 109.938 172.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 35' ' ' GLN . . . . . 0.687 ' O ' ' HA ' ' D' ' 31' ' ' MET . 32.9 tt0 -108.11 115.95 31.07 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.579 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.672 ' HB2' ' HB2' ' D' ' 85' ' ' LYS . 1.1 tm? -77.76 134.95 37.95 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.225 0.536 . . . . 0.0 111.536 -177.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 37' ' ' LYS . . . . . 0.588 ' HB3' ' NZ ' ' D' ' 37' ' ' LYS . 0.7 OUTLIER -133.79 116.71 16.03 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.491 -169.313 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 38' ' ' ALA . . . . . 0.41 ' HA ' HD23 ' D' ' 29' ' ' LEU . . . -115.09 152.88 31.75 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.408 0.623 . . . . 0.0 112.401 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 39' ' ' THR . . . . . 0.689 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 5.2 p -150.87 134.49 16.43 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.53 177.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . 0.544 ' HB3' ' HA2' ' D' ' 73' ' ' GLY . 40.1 t -108.11 136.12 48.32 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 172.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 41' ' ' SER . . . . . 0.744 ' HB3' ' HG3' ' D' ' 26' ' ' LYS . 47.6 t -96.17 151.78 19.17 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 118.963 -1.095 . . . . 0.0 109.748 -179.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 42' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' D' ' 41' ' ' SER . 77.1 m-20 80.66 6.75 1.45 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.693 -167.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 53.94 60.13 3.82 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 114.713 -1.13 . . . . 0.0 113.455 171.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 44' ' ' GLY . . . . . 0.61 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 104.72 37.92 2.67 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.122 -1.513 . . . . 0.0 114.989 168.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 45' ' ' TYR . . . . . 0.742 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 2.3 m-85 -116.11 154.4 30.04 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 117.856 0.828 . . . . 0.0 109.944 173.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . 0.628 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -93.78 -173.58 39.56 Favored Glycine 0 C--O 1.22 -0.744 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 178.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 47' ' ' ILE . . . . . 0.812 HG12 ' HB3' ' D' ' 68' ' ' GLU . 26.9 mm -48.55 -54.81 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-O 122.025 0.917 . . . . 0.0 108.775 175.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . 0.589 ' HA ' ' HD3' ' D' ' 24' ' ' LYS . 93.4 p 178.76 -146.22 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 112.832 -1.985 . . . . 0.0 107.561 178.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -82.54 75.9 9.43 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.462 166.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . 0.677 ' HB3' ' HE2' ' D' ' 52' ' ' LYS . 95.6 mt-10 -146.84 163.37 36.28 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.646 -176.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 51' ' ' ASP . . . . . 0.678 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 1.4 m-20 -124.1 132.7 53.68 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.804 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 52' ' ' LYS . . . . . 0.678 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 3.5 mptp? -142.93 120.7 11.89 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.453 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 53' ' ' ASN . . . . . 0.615 ' HA ' ' OD1' ' D' ' 67' ' ' ASN . 3.0 m120 -90.83 131.46 36.47 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 176.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 54' ' ' TRP . . . . . 0.617 ' HB2' ' O ' ' D' ' 66' ' ' PHE . 0.1 OUTLIER -122.93 155.0 37.63 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -172.161 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -144.81 161.14 28.07 Favored Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.254 -0.974 . . . . 0.0 113.97 174.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 56' ' ' ILE . . . . . 0.857 HD13 HG12 ' D' ' 84' ' ' ILE . 74.0 mt -137.03 111.79 10.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 57' ' ' PHE . . . . . 0.882 ' HB2' ' HB3' ' D' ' 90' ' ' GLU . 15.8 m-85 -105.59 97.8 7.58 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.894 -167.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.867 HG22 HG12 ' D' ' 89' ' ' ILE . 99.4 t -98.2 120.64 47.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.475 176.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 67.64 34.98 4.25 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 123.438 0.461 . . . . 0.0 110.539 -175.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.35 42.54 97.68 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.625 -0.716 . . . . 0.0 113.54 177.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 61' ' ' GLU . . . . . 0.634 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 24.9 pt-20 -155.41 141.63 18.46 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 176.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 62' ' ' LYS . . . . . 0.476 ' HB2' ' CE2' ' D' ' 57' ' ' PHE . 27.9 ttpp -73.01 99.72 2.81 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -178.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.491 HG12 ' O ' ' D' ' 56' ' ' ILE . 9.1 p -84.29 -32.43 8.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.657 -172.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 64' ' ' TYR . . . . . 0.43 ' HB3' HD12 ' D' ' 56' ' ' ILE . 17.2 t80 -134.39 132.0 38.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.746 0.307 . . . . 0.0 110.797 176.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 35.0 m -116.4 112.46 21.51 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.124 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 66' ' ' PHE . . . . . 0.617 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 9.3 p90 -118.66 158.51 25.37 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 173.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 67' ' ' ASN . . . . . 0.615 ' OD1' ' HA ' ' D' ' 53' ' ' ASN . 73.7 m-80 -129.81 142.09 50.74 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.349 -175.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 68' ' ' GLU . . . . . 0.812 ' HB3' HG12 ' D' ' 47' ' ' ILE . 42.1 mm-40 -69.07 -8.41 44.96 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 123.574 0.546 . . . . 0.0 110.415 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.432 ' HE2' ' CB ' ' D' ' 67' ' ' ASN . 44.1 mtmt -60.62 -46.66 89.44 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 167.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 70' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' D' ' 67' ' ' ASN . 35.1 t -69.78 129.78 40.51 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 113.179 -1.828 . . . . 0.0 108.355 168.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 71' ' ' THR . . . . . 0.461 ' O ' HG13 ' D' ' 75' ' ' ILE . 74.1 p -57.86 128.86 39.19 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 178.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 72' ' ' VAL . . . . . 0.746 HG11 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -54.57 -16.84 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-O 121.294 0.568 . . . . 0.0 110.44 -175.655 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 73' ' ' GLY . . . . . 0.61 ' HA3' ' HA2' ' D' ' 44' ' ' GLY . . . -72.92 -58.58 4.72 Favored Glycine 0 N--CA 1.435 -1.39 0 CA-C-N 114.911 -1.041 . . . . 0.0 112.841 173.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -64.25 -20.25 65.93 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 120.885 0.374 . . . . 0.0 110.305 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 75' ' ' ILE . . . . . 0.645 ' O ' HG13 ' D' ' 79' ' ' ILE . 74.7 mt -73.34 -41.12 57.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.462 171.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 41.5 t -71.03 -26.8 63.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.048 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -56.12 -30.92 62.78 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 167.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 78' ' ' ASP . . . . . 1.084 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 1.1 m-20 -90.35 -33.28 16.13 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 177.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . 0.645 HG13 ' O ' ' D' ' 75' ' ' ILE . 41.5 mt -68.3 -27.81 38.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 O-C-N 121.689 -0.632 . . . . 0.0 110.595 -175.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -73.92 -20.02 60.51 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 81' ' ' LYS . . . . . 1.084 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -89.92 -52.38 5.0 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.601 171.416 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 82' ' ' LEU . . . . . 0.57 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.7 mm? -48.67 -31.44 6.78 Favored 'General case' 0 C--O 1.231 0.086 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 176.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 83' ' ' ASN . . . . . 0.496 ' HA ' HD12 ' D' ' 36' ' ' LEU . 22.2 t-20 40.6 77.77 0.05 Allowed 'General case' 0 N--CA 1.469 0.506 0 O-C-N 124.639 1.212 . . . . 0.0 111.134 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 84' ' ' ILE . . . . . 0.857 HG12 HD13 ' D' ' 56' ' ' ILE . 2.6 mp -77.97 97.05 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.362 -176.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 85' ' ' LYS . . . . . 0.672 ' HB2' ' HB2' ' D' ' 36' ' ' LEU . 0.0 OUTLIER -158.28 93.07 1.2 Allowed 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 121.431 0.634 . . . . 0.0 110.505 -177.424 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 86' ' ' GLY . . . . . 0.659 ' H ' HD11 ' D' ' 89' ' ' ILE . . . 68.54 148.56 0.21 Allowed Glycine 0 N--CA 1.453 -0.193 0 CA-C-N 114.59 -1.187 . . . . 0.0 113.929 178.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 87' ' ' PRO . . . . . 0.6 ' O ' HG13 ' D' ' 58' ' ' VAL . 60.8 Cg_endo -90.6 -177.53 10.12 Favored 'Cis proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.533 -1.445 . . . . 0.0 112.508 -0.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 88' ' ' TYR . . . . . 0.721 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 13.0 m-85 4.89 94.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 125.527 1.531 . . . . 0.0 114.214 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.867 HG12 HG22 ' D' ' 58' ' ' VAL . 66.5 mt -108.35 148.81 12.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.192 0.52 . . . . 0.0 111.883 -177.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . 0.882 ' HB3' ' HB2' ' D' ' 57' ' ' PHE . 39.7 tt0 -132.13 91.41 2.95 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.281 173.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 91' ' ' ILE . . . . . 0.582 HG13 HG22 ' D' ' 89' ' ' ILE . 37.0 mt -94.14 99.84 10.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.89 -176.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 92' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' D' ' 93' ' ' GLN . 0.0 OUTLIER -160.74 164.47 31.55 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 177.379 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . 0.625 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 24.3 pt20 -80.6 162.73 24.12 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.537 176.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 94' ' ' ILE . . . . . 0.406 HG22 ' HE2' ' D' ' 92' ' ' LYS . 10.6 pt . . . . . 0 C--N 1.305 -1.357 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.366 -171.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.488 ' C ' HG12 ' D' ' 16' ' ' VAL . 57.5 mt . . . . . 0 N--CA 1.452 -0.332 0 CA-C-O 122.0 0.905 . . . . 0.0 110.623 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -88.54 -57.36 2.94 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.334 176.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 15' ' ' SER . . . . . 0.513 ' O ' ' HE2' ' D' ' 19' ' ' LYS . 92.6 p -68.11 -17.74 64.45 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.673 -0.239 . . . . 0.0 111.457 -178.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 16' ' ' VAL . . . . . 0.645 HG13 ' ND2' ' D' ' 17' ' ' ASN . 9.6 p -59.97 -30.06 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-O 121.945 0.879 . . . . 0.0 109.562 176.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 17' ' ' ASN . . . . . 0.645 ' ND2' HG13 ' D' ' 16' ' ' VAL . 3.8 m120 -78.26 -33.96 49.29 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.256 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.31 -15.71 49.64 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.331 177.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.513 ' HE2' ' O ' ' D' ' 15' ' ' SER . 40.3 mttm -89.56 -39.52 13.22 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 122.726 1.25 . . . . 0.0 109.255 -179.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 20' ' ' LEU . . . . . 0.805 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 73.0 mt -77.19 -37.29 53.88 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 111.935 -2.393 . . . . 0.0 110.127 -176.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 21' ' ' ASN . . . . . 0.627 ' OD1' ' HB2' ' D' ' 26' ' ' LYS . 57.5 m-20 -75.33 95.92 3.29 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.678 177.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 22' ' ' LYS . . . . . 0.805 ' HD3' HG23 ' D' ' 47' ' ' ILE . 23.0 mtpp -120.89 -43.62 2.45 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 118.594 -1.242 . . . . 0.0 114.064 -168.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.27 -69.9 0.25 Allowed Glycine 0 N--CA 1.436 -1.315 0 C-N-CA 119.746 -1.216 . . . . 0.0 112.509 -174.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . 0.819 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 22.2 tptm -55.27 -67.07 0.31 Allowed 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 176.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 25' ' ' GLY . . . . . 1.061 ' HA2' HD21 ' D' ' 42' ' ' ASN . . . -139.38 156.49 24.61 Favored Glycine 0 CA--C 1.493 -1.337 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.279 172.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 26' ' ' LYS . . . . . 0.691 ' CD ' ' HB3' ' D' ' 41' ' ' SER . 0.4 OUTLIER -140.5 160.12 40.69 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -168.53 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 27' ' ' LEU . . . . . 0.805 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 45.1 tp -139.44 144.38 38.02 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.463 0.649 . . . . 0.0 112.392 -177.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 28' ' ' SER . . . . . 0.715 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 49.2 m -135.34 151.91 50.96 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.505 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 29' ' ' LEU . . . . . . . . . . . . . 16.4 mt -141.02 138.01 33.38 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 56.3 m -148.06 -179.04 6.62 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 31' ' ' MET . . . . . 0.813 ' HA ' ' O ' ' D' ' 35' ' ' GLN . 20.2 ptp -137.23 126.62 24.92 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.67 0.747 . . . . 0.0 111.057 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -90.84 88.34 7.02 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 175.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.64 -100.97 1.99 Allowed Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -165.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -120.16 12.5 11.86 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.999 0.428 . . . . 0.0 109.987 171.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 35' ' ' GLN . . . . . 0.813 ' O ' ' HA ' ' D' ' 31' ' ' MET . 25.6 mt-30 -88.63 125.94 35.06 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.471 -175.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.686 HD11 HG22 ' D' ' 79' ' ' ILE . 2.8 tm? -78.08 124.38 27.98 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.204 0.526 . . . . 0.0 111.436 -178.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 37' ' ' LYS . . . . . 0.642 ' HE2' ' HB3' ' D' ' 35' ' ' GLN . 74.9 mmtt -135.53 103.49 5.48 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.794 -173.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.28 152.64 18.38 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.322 0.582 . . . . 0.0 111.581 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 39' ' ' THR . . . . . 0.715 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 7.1 p -141.01 124.79 16.98 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.118 176.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . 0.654 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 19.1 p -107.88 128.87 55.0 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 172.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 41' ' ' SER . . . . . 0.691 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 44.3 t -96.3 168.75 10.39 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 42' ' ' ASN . . . . . 1.061 HD21 ' HA2' ' D' ' 25' ' ' GLY . 21.3 p30 60.8 7.44 1.45 Allowed 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.975 1.422 . . . . 0.0 112.499 -174.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 41.41 60.29 2.14 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 168.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.87 35.86 0.81 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 118.873 -1.632 . . . . 0.0 114.931 168.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 45' ' ' TYR . . . . . 0.819 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 0.7 OUTLIER -122.83 154.26 38.48 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 170.504 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . 0.562 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -99.81 -163.63 29.02 Favored Glycine 0 C--O 1.216 -1.013 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.414 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 47' ' ' ILE . . . . . 0.805 HG23 ' HD3' ' D' ' 22' ' ' LYS . 41.9 mm -55.04 -59.53 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 CA-C-O 122.088 0.947 . . . . 0.0 109.675 176.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 83.5 p 175.0 -164.61 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 112.327 -2.215 . . . . 0.0 108.789 -172.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -78.27 77.96 4.75 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.924 0.869 . . . . 0.0 111.632 173.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -145.56 -167.8 2.8 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.957 177.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 51' ' ' ASP . . . . . 0.691 ' C ' ' HD3' ' D' ' 52' ' ' LYS . 9.6 p-10 -136.34 135.18 38.65 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.359 168.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 52' ' ' LYS . . . . . 0.732 ' CE ' ' HB2' ' D' ' 68' ' ' GLU . 2.7 mppt? -139.79 128.1 22.64 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.263 -167.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 53' ' ' ASN . . . . . 0.448 HD22 ' C ' ' D' ' 52' ' ' LYS . 2.8 m120 -116.65 138.8 51.17 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 173.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 54' ' ' TRP . . . . . 0.651 ' HZ3' HG23 ' D' ' 91' ' ' ILE . 0.1 OUTLIER -125.76 160.38 29.93 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -173.077 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -140.43 156.2 25.07 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.042 -1.075 . . . . 0.0 113.908 175.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 56' ' ' ILE . . . . . 0.628 HD13 HG12 ' D' ' 84' ' ' ILE . 62.8 mt -140.24 108.75 3.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 176.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 57' ' ' PHE . . . . . 0.738 ' CE2' ' HE2' ' D' ' 92' ' ' LYS . 7.0 m-85 -108.25 102.91 12.0 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.637 -168.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.713 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 78.2 t -91.97 110.17 22.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.814 170.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 59' ' ' ASN . . . . . 0.44 ' OD1' ' HG2' ' D' ' 87' ' ' PRO . 5.2 m120 63.74 44.51 4.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.436 -176.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.3 -33.91 4.7 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.793 -0.718 . . . . 0.0 114.511 172.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 61' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 12.5 pt-20 -94.81 154.06 17.44 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.966 -0.293 . . . . 0.0 111.072 -175.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -73.92 106.94 5.86 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 173.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 9.9 p -76.52 -27.9 17.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.522 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 64' ' ' TYR . . . . . 0.551 ' HB3' HD12 ' D' ' 56' ' ' ILE . 14.2 t80 -148.13 135.57 20.59 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.545 173.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . 0.422 HG23 ' O ' ' D' ' 54' ' ' TRP . 65.3 m -119.87 123.04 42.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.514 174.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 66' ' ' PHE . . . . . 0.632 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 11.3 p90 -129.62 143.11 50.67 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 121.477 0.656 . . . . 0.0 110.679 178.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 67' ' ' ASN . . . . . 0.803 HD22 ' HB2' ' D' ' 69' ' ' LYS . 15.1 p-10 -110.31 130.28 55.58 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.271 -175.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 68' ' ' GLU . . . . . 0.804 ' HB3' HG12 ' D' ' 47' ' ' ILE . 35.1 mm-40 -67.62 -8.45 34.67 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.831 -177.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.803 ' HB2' HD22 ' D' ' 67' ' ' ASN . 53.3 mtpt -62.28 -40.79 97.4 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 169.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 70' ' ' SER . . . . . 0.489 ' HB3' ' O ' ' D' ' 67' ' ' ASN . 32.5 t -68.51 124.52 23.79 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 113.051 -1.886 . . . . 0.0 107.353 164.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 71' ' ' THR . . . . . 0.422 ' O ' HG13 ' D' ' 75' ' ' ILE . 67.3 p -55.17 130.98 44.17 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 72' ' ' VAL . . . . . 0.66 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -57.3 -14.99 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-O 120.722 0.296 . . . . 0.0 111.011 -178.582 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 73' ' ' GLY . . . . . 0.654 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -63.98 -65.45 3.02 Favored Glycine 0 N--CA 1.433 -1.562 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.156 168.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -62.62 -20.55 64.88 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.523 0.201 . . . . 0.0 111.428 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 75' ' ' ILE . . . . . 0.592 ' O ' HG13 ' D' ' 79' ' ' ILE . 69.7 mt -73.26 -40.61 57.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.148 174.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 35.9 t -75.83 -21.32 57.4 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.817 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 77' ' ' ASN . . . . . 0.605 ' O ' ' HD3' ' D' ' 81' ' ' LYS . 5.7 m120 -61.69 -23.97 66.46 Favored 'General case' 0 C--O 1.216 -0.66 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 166.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 78' ' ' ASP . . . . . 0.627 ' O ' HD23 ' D' ' 82' ' ' LEU . 1.0 OUTLIER -93.23 -41.56 9.83 Favored 'General case' 0 C--O 1.225 -0.237 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 175.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . 0.686 HG22 HD11 ' D' ' 36' ' ' LEU . 56.0 mt -65.78 -34.35 69.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 O-C-N 121.449 -0.782 . . . . 0.0 111.645 -169.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -66.86 -14.05 62.29 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.126 176.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 81' ' ' LYS . . . . . 0.605 ' HD3' ' O ' ' D' ' 77' ' ' ASN . 0.0 OUTLIER -89.77 -57.39 2.88 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.207 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 82' ' ' LEU . . . . . 0.627 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.4 mm? -53.86 -23.74 13.5 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 113.88 -1.509 . . . . 0.0 112.343 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 83' ' ' ASN . . . . . 0.409 HD22 ' HB3' ' D' ' 36' ' ' LEU . 0.7 OUTLIER 50.69 69.75 0.6 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.647 174.093 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 84' ' ' ILE . . . . . 0.628 HG12 HD13 ' D' ' 56' ' ' ILE . 2.2 mp -74.68 99.09 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.377 0.608 . . . . 0.0 111.175 -176.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 85' ' ' LYS . . . . . 0.62 ' C ' HD11 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -131.99 179.07 6.31 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.165 174.722 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . -48.38 165.15 0.24 Allowed Glycine 0 C--N 1.334 0.463 0 O-C-N 123.696 0.623 . . . . 0.0 113.928 -174.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 87' ' ' PRO . . . . . 0.534 ' O ' HG13 ' D' ' 58' ' ' VAL . 60.5 Cg_endo -93.82 -177.09 7.26 Favored 'Cis proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.898 -1.293 . . . . 0.0 114.758 -0.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 88' ' ' TYR . . . . . 0.713 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 41.5 m-85 23.04 93.06 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.504 1.521 . . . . 0.0 113.57 179.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.62 HD11 ' C ' ' D' ' 85' ' ' LYS . 72.7 mt -112.36 139.27 37.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 178.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . 0.704 ' HG2' ' HD2' ' D' ' 92' ' ' LYS . 88.9 tt0 -127.59 94.75 4.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.032 171.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 91' ' ' ILE . . . . . 0.651 HG23 ' HZ3' ' D' ' 54' ' ' TRP . 27.4 mt -95.68 99.82 9.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.088 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 92' ' ' LYS . . . . . 0.738 ' HE2' ' CE2' ' D' ' 57' ' ' PHE . 0.0 OUTLIER -161.99 169.29 21.34 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.373 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . 0.664 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 3.0 pt20 -79.56 157.54 27.35 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.283 173.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 94' ' ' ILE . . . . . 0.429 HG22 ' HE3' ' D' ' 92' ' ' LYS . 9.9 pt . . . . . 0 C--N 1.308 -1.236 0 CA-C-N 114.902 -1.044 . . . . 0.0 112.186 -170.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.636 ' O ' HG12 ' D' ' 16' ' ' VAL . 57.0 mt . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 121.666 0.746 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -88.19 -41.86 12.7 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.095 175.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 15' ' ' SER . . . . . 0.559 ' HA ' ' OD2' ' D' ' 18' ' ' ASP . 88.2 p -72.01 -23.52 61.41 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 122.045 -0.409 . . . . 0.0 109.907 175.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 16' ' ' VAL . . . . . 0.636 HG12 ' O ' ' D' ' 13' ' ' ILE . 0.5 OUTLIER -56.84 -24.05 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 121.515 0.674 . . . . 0.0 109.41 178.927 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -74.65 -43.75 53.81 Favored 'General case' 0 C--O 1.209 -1.071 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.771 176.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 18' ' ' ASP . . . . . 0.559 ' OD2' ' HA ' ' D' ' 15' ' ' SER . 51.4 m-20 -55.3 -16.2 3.19 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -177.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.588 ' HD2' ' N ' ' D' ' 19' ' ' LYS . 0.0 OUTLIER -91.18 -43.16 10.03 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-O 122.306 1.051 . . . . 0.0 108.691 175.533 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 20' ' ' LEU . . . . . 0.927 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 70.7 mt -69.36 -37.74 77.76 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 113.168 -1.833 . . . . 0.0 110.258 -177.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 21' ' ' ASN . . . . . 0.443 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 3.3 m120 -79.7 94.08 5.66 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.705 -178.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 22' ' ' LYS . . . . . 0.701 ' HD2' HD12 ' D' ' 47' ' ' ILE . 95.8 mttt -122.32 -41.95 2.38 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -176.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 165.87 -84.0 0.1 Allowed Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 119.32 -1.419 . . . . 0.0 113.231 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . 0.807 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 27.2 tptp -44.89 -57.76 3.57 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 25' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -139.86 163.95 26.16 Favored Glycine 0 N--CA 1.431 -1.685 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.967 171.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 26' ' ' LYS . . . . . 0.679 ' HD2' ' HB3' ' D' ' 41' ' ' SER . 0.3 OUTLIER -149.29 159.59 44.14 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.933 -0.634 . . . . 0.0 109.986 -171.743 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 27' ' ' LEU . . . . . 0.927 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 39.8 tp -136.16 134.49 38.29 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.436 0.636 . . . . 0.0 111.806 -178.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 28' ' ' SER . . . . . 0.637 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 26.5 t -121.36 145.96 47.36 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 29' ' ' LEU . . . . . . . . . . . . . 20.9 mt -131.43 134.96 46.75 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.754 -0.779 . . . . 0.0 110.745 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 32.1 t -137.01 -171.04 2.84 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 31' ' ' MET . . . . . 0.502 ' HB2' ' O ' ' D' ' 35' ' ' GLN . 26.3 ptt? -150.08 166.59 29.29 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.81 0.338 . . . . 0.0 110.618 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 32' ' ' ASN . . . . . 0.637 ' O ' ' HB2' ' D' ' 35' ' ' GLN . 25.9 t-20 -141.82 87.28 2.04 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 176.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.48 -113.81 4.82 Favored Glycine 0 CA--C 1.516 0.142 0 C-N-CA 119.898 -1.144 . . . . 0.0 111.121 -172.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -95.7 31.0 2.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.776 0.798 . . . . 0.0 109.92 173.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 35' ' ' GLN . . . . . 0.637 ' HB2' ' O ' ' D' ' 32' ' ' ASN . 52.5 mm-40 -110.24 164.94 12.17 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 114.928 -1.033 . . . . 0.0 112.367 -178.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.586 HD11 HG22 ' D' ' 79' ' ' ILE . 2.7 tm? -130.72 128.95 41.88 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 175.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 37' ' ' LYS . . . . . 0.401 ' N ' HD13 ' D' ' 36' ' ' LEU . 35.7 mmtp -132.4 100.6 5.04 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.145 0.498 . . . . 0.0 110.842 -176.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.72 149.95 21.24 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.856 -177.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 39' ' ' THR . . . . . 0.637 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 29.8 p -137.32 126.72 24.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.916 174.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . 0.761 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 60.6 p -109.89 135.73 50.31 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 175.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 41' ' ' SER . . . . . 0.679 ' HB3' ' HD2' ' D' ' 26' ' ' LYS . 43.9 t -104.0 156.42 17.87 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.814 -176.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 42' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' D' ' 41' ' ' SER . 74.0 m-80 78.79 9.34 1.89 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.423 -172.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 43.74 59.02 3.27 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 114.73 -1.123 . . . . 0.0 113.648 170.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.84 34.96 2.1 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 119.732 -1.223 . . . . 0.0 113.872 172.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 45' ' ' TYR . . . . . 0.807 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 2.8 m-30 -112.89 146.72 38.45 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 170.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . 0.597 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -93.93 -162.97 35.99 Favored Glycine 0 C--O 1.218 -0.876 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 175.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 47' ' ' ILE . . . . . 0.832 HG12 ' HB3' ' D' ' 68' ' ' GLU . 38.5 mm -56.27 -57.1 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.886 0 CA-C-O 122.14 0.971 . . . . 0.0 109.514 174.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -178.97 -123.05 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 112.796 -2.002 . . . . 0.0 108.906 -177.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -114.47 76.79 1.01 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.119 0.485 . . . . 0.0 109.916 169.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . 0.563 ' CB ' ' HD3' ' D' ' 52' ' ' LYS . 51.5 mt-10 -140.16 168.73 19.13 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.53 177.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 51' ' ' ASP . . . . . 0.634 ' CB ' ' HD2' ' D' ' 69' ' ' LYS . 1.6 m-20 -114.69 122.06 45.29 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.763 175.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 52' ' ' LYS . . . . . 0.823 ' HG3' ' HB2' ' D' ' 68' ' ' GLU . 0.0 OUTLIER -131.84 107.44 8.74 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.858 -166.354 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -94.33 129.35 41.04 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.466 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 54' ' ' TRP . . . . . 0.61 ' HZ3' HG23 ' D' ' 91' ' ' ILE . 0.1 OUTLIER -121.93 153.78 38.03 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -174.827 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -141.06 158.78 26.45 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.153 -1.022 . . . . 0.0 113.607 175.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 56' ' ' ILE . . . . . 0.681 HD13 HD13 ' D' ' 84' ' ' ILE . 62.8 mt -142.97 106.51 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 -178.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 57' ' ' PHE . . . . . 0.536 ' HD2' ' HB2' ' D' ' 90' ' ' GLU . 11.8 m-85 -108.6 106.87 17.13 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.59 -168.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.71 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 49.9 t -95.79 118.36 41.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.63 173.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 58.91 34.34 23.59 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.033 -178.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.91 -32.77 6.88 Favored Glycine 0 CA--C 1.505 -0.537 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.706 174.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 61' ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 25.4 pt-20 -90.19 146.91 23.9 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.078 0.466 . . . . 0.0 110.818 -175.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -79.36 101.75 8.29 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 177.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.518 HG12 ' O ' ' D' ' 56' ' ' ILE . 10.5 p -76.87 -30.32 18.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.695 -172.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 64' ' ' TYR . . . . . 0.529 ' HB3' HD12 ' D' ' 56' ' ' ILE . 20.5 t80 -147.16 142.57 27.45 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.757 0.313 . . . . 0.0 110.979 178.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 30.5 m -124.8 125.65 44.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.587 175.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 66' ' ' PHE . . . . . 0.561 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 17.5 p90 -133.83 157.49 45.79 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 121.441 0.639 . . . . 0.0 110.43 173.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 67' ' ' ASN . . . . . 0.589 ' HA ' ' O ' ' D' ' 52' ' ' LYS . 5.2 m120 -116.92 141.61 48.01 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 68' ' ' GLU . . . . . 0.832 ' HB3' HG12 ' D' ' 47' ' ' ILE . 55.6 mm-40 -70.83 -16.75 62.74 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 175.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.634 ' HD2' ' CB ' ' D' ' 51' ' ' ASP . 25.0 mtpp -60.21 -44.31 95.24 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 114.102 -1.408 . . . . 0.0 108.159 169.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 18.8 t -76.1 90.72 3.08 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 113.633 -1.621 . . . . 0.0 107.898 171.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 65.6 p -24.39 120.67 0.05 Allowed 'General case' 0 C--N 1.32 -0.695 0 O-C-N 124.815 1.322 . . . . 0.0 112.811 -175.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 72' ' ' VAL . . . . . 0.535 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -50.96 -15.3 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 O-C-N 123.356 0.41 . . . . 0.0 111.922 179.615 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 73' ' ' GLY . . . . . 0.761 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -65.3 -66.86 2.25 Favored Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 115.805 -0.634 . . . . 0.0 113.183 171.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -62.07 -27.24 68.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.229 -0.485 . . . . 0.0 110.332 -177.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 75' ' ' ILE . . . . . 0.629 ' O ' HG13 ' D' ' 79' ' ' ILE . 29.9 mm -78.24 -41.48 26.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.217 178.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 76' ' ' SER . . . . . 0.566 ' HB2' HD13 ' D' ' 27' ' ' LEU . 29.3 t -72.37 -21.33 61.31 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.449 -178.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -64.89 -34.01 77.38 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 167.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 78' ' ' ASP . . . . . 1.047 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 0.9 OUTLIER -77.89 -31.99 51.57 Favored 'General case' 0 C--O 1.224 -0.272 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 175.005 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . 0.629 HG13 ' O ' ' D' ' 75' ' ' ILE . 60.2 mt -65.49 -21.21 28.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 O-C-N 121.543 -0.723 . . . . 0.0 111.294 -174.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -73.25 -43.48 61.08 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 176.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 81' ' ' LYS . . . . . 1.047 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -68.79 -44.47 73.53 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.468 177.269 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 82' ' ' LEU . . . . . 0.659 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.8 mm? -55.53 -22.15 20.2 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 177.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 45.57 73.2 0.17 Allowed 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.778 0.674 . . . . 0.0 110.984 175.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 84' ' ' ILE . . . . . 0.865 HG21 HD11 ' D' ' 91' ' ' ILE . 35.0 mt -70.71 99.8 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.315 -177.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 85' ' ' LYS . . . . . 0.594 ' HD3' ' O ' ' D' ' 35' ' ' GLN . 30.5 mmmt -139.19 177.87 7.59 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.719 176.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 86' ' ' GLY . . . . . 0.716 ' HA2' HD11 ' D' ' 89' ' ' ILE . . . -59.67 175.89 3.44 Favored Glycine 0 CA--C 1.506 -0.481 0 N-CA-C 115.008 0.763 . . . . 0.0 115.008 -174.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 87' ' ' PRO . . . . . 0.603 ' O ' HG13 ' D' ' 58' ' ' VAL . 33.0 Cg_endo -91.67 175.73 17.48 Favored 'Cis proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.158 -2.017 . . . . 0.0 114.53 0.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 88' ' ' TYR . . . . . 0.71 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 33.4 m-85 31.52 92.47 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.32 1.448 . . . . 0.0 112.614 -179.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.716 HD11 ' HA2' ' D' ' 86' ' ' GLY . 3.1 mp -109.5 143.1 20.28 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.402 -177.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . 0.656 ' O ' ' HA ' ' D' ' 56' ' ' ILE . 37.3 mt-10 -129.24 89.19 2.81 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.385 172.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 91' ' ' ILE . . . . . 0.865 HD11 HG21 ' D' ' 84' ' ' ILE . 21.0 mt -94.44 99.8 10.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.912 178.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 92' ' ' LYS . . . . . 0.844 ' HE3' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -161.8 169.2 21.81 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.125 -177.434 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . 0.716 ' O ' ' HD3' ' D' ' 92' ' ' LYS . 2.5 pp0? -85.78 147.17 26.44 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.054 170.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 94' ' ' ILE . . . . . 0.844 HG22 ' HE3' ' D' ' 92' ' ' LYS . 8.9 pt . . . . . 0 C--N 1.304 -1.389 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.979 -169.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.449 ' C ' HG12 ' D' ' 16' ' ' VAL . 55.8 mt . . . . . 0 N--CA 1.455 -0.222 0 CA-C-O 121.47 0.653 . . . . 0.0 111.672 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -95.06 -61.16 1.53 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.678 175.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 15' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' D' ' 18' ' ' ASP . 88.5 p -60.45 -21.78 62.71 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 116.906 -0.134 . . . . 0.0 111.238 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 16' ' ' VAL . . . . . 0.687 ' HA ' ' HE2' ' D' ' 19' ' ' LYS . 9.7 p -54.51 -38.48 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 120.761 0.315 . . . . 0.0 110.647 177.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 17' ' ' ASN . . . . . 0.562 ' ND2' HG13 ' D' ' 16' ' ' VAL . 2.7 m120 -68.61 -35.79 77.81 Favored 'General case' 0 C--O 1.214 -0.793 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.7 178.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 18' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' D' ' 15' ' ' SER . 1.2 m-20 -64.42 -17.29 63.65 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -176.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.687 ' HE2' ' HA ' ' D' ' 16' ' ' VAL . 0.0 OUTLIER -90.78 -44.43 9.45 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-O 122.031 0.919 . . . . 0.0 108.563 173.778 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 20' ' ' LEU . . . . . 1.014 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 75.6 mt -61.76 -39.08 90.36 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 113.515 -1.675 . . . . 0.0 109.937 -178.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 21' ' ' ASN . . . . . 0.437 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 3.2 m120 -77.99 97.21 5.28 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.558 178.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 22' ' ' LYS . . . . . 0.781 ' HD2' HD12 ' D' ' 47' ' ' ILE . 67.5 mttm -123.12 -43.37 2.22 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -177.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.4 -96.22 0.1 Allowed Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 119.403 -1.379 . . . . 0.0 113.721 -176.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . 0.799 ' HE2' ' HA ' ' D' ' 48' ' ' SER . 35.0 ttpt -53.81 -47.36 70.92 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.737 0.78 . . . . 0.0 109.404 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 25' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -135.96 153.71 21.55 Favored Glycine 0 N--CA 1.431 -1.642 0 CA-C-N 114.232 -1.349 . . . . 0.0 112.006 176.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 26' ' ' LYS . . . . . 0.723 ' CD ' ' HB2' ' D' ' 41' ' ' SER . 0.1 OUTLIER -150.44 160.48 43.73 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.05 -1.075 . . . . 0.0 110.213 -170.192 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 27' ' ' LEU . . . . . 1.014 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 41.8 tp -135.43 130.1 34.28 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.302 0.572 . . . . 0.0 112.023 -177.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 28' ' ' SER . . . . . 0.547 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 8.1 t -117.46 125.16 50.44 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 29' ' ' LEU . . . . . 0.62 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 1.0 OUTLIER -141.14 148.48 40.12 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 176.584 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 62.5 p -157.8 179.07 9.56 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.205 -179.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 31' ' ' MET . . . . . 0.416 ' SD ' ' N ' ' D' ' 31' ' ' MET . 0.0 OUTLIER -117.95 166.17 12.83 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.396 0.617 . . . . 0.0 110.608 179.795 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 32' ' ' ASN . . . . . 0.653 ' HB3' ' HB2' ' D' ' 35' ' ' GLN . 26.1 t-20 -144.16 87.13 1.87 Allowed 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 176.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.74 -98.65 0.7 Allowed Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.187 -1.006 . . . . 0.0 111.281 -171.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 34' ' ' ASN . . . . . 0.417 ' O ' ' HG2' ' D' ' 85' ' ' LYS . 4.8 m120 -110.66 10.36 22.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.029 0.442 . . . . 0.0 110.395 175.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 35' ' ' GLN . . . . . 0.653 ' HB2' ' HB3' ' D' ' 32' ' ' ASN . 3.8 mm100 -91.35 165.28 13.5 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 121.533 0.682 . . . . 0.0 112.222 -177.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.947 HD11 HG22 ' D' ' 79' ' ' ILE . 1.8 tm? -132.82 135.03 45.41 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.693 172.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 37' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 34.9 mmtp -132.1 106.36 7.95 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.698 -171.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 38' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -118.52 148.46 42.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.857 0.361 . . . . 0.0 111.911 -177.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 39' ' ' THR . . . . . 0.547 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 57.2 p -145.43 148.5 33.37 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.265 178.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' D' ' 26' ' ' LYS . 41.9 p -109.28 131.87 54.66 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 168.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 41' ' ' SER . . . . . 0.723 ' HB2' ' CD ' ' D' ' 26' ' ' LYS . 43.7 m -94.44 147.76 22.91 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 118.915 -1.114 . . . . 0.0 108.882 177.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 42' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' D' ' 41' ' ' SER . 75.1 m-80 80.67 2.5 1.79 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.942 -165.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.19 62.08 2.13 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 168.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 44' ' ' GLY . . . . . 0.479 ' O ' ' HB ' ' D' ' 71' ' ' THR . . . 119.19 -6.48 13.05 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 118.405 -1.855 . . . . 0.0 115.072 168.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 45' ' ' TYR . . . . . 0.766 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 1.3 m-85 -86.17 155.84 20.58 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.98 0.39 . . . . 0.0 111.784 -174.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . 0.6 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -94.84 178.95 36.63 Favored Glycine 0 C--O 1.222 -0.654 0 CA-C-O 118.812 -0.993 . . . . 0.0 110.642 174.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 47' ' ' ILE . . . . . 0.781 HD12 ' HD2' ' D' ' 22' ' ' LYS . 33.4 mm -47.65 -57.22 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 CA-C-N 118.109 0.955 . . . . 0.0 110.652 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . 0.799 ' HA ' ' HE2' ' D' ' 24' ' ' LYS . 22.1 t 178.83 -135.24 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.02 -1.446 . . . . 0.0 107.923 -178.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -95.03 76.93 3.53 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 165.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . 0.853 ' HB3' ' HE3' ' D' ' 52' ' ' LYS . 50.6 mt-10 -144.58 164.63 30.36 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.95 -173.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 51' ' ' ASP . . . . . 0.686 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 10.7 p-10 -132.61 135.49 45.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.231 0.539 . . . . 0.0 111.337 177.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 52' ' ' LYS . . . . . 0.853 ' HE3' ' HB3' ' D' ' 50' ' ' GLU . 0.2 OUTLIER -146.97 142.35 27.44 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.392 -174.261 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 53' ' ' ASN . . . . . 0.46 HD22 ' C ' ' D' ' 52' ' ' LYS . 3.3 m120 -118.25 135.99 53.94 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 172.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 54' ' ' TRP . . . . . 1.065 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 0.9 OUTLIER -126.29 162.49 25.35 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -170.89 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -148.69 163.46 29.03 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.204 174.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 56' ' ' ILE . . . . . 1.064 HG12 HG23 ' D' ' 91' ' ' ILE . 93.6 mt -135.97 108.99 8.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 C-N-CA 124.853 1.261 . . . . 0.0 107.689 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 57' ' ' PHE . . . . . 0.726 ' CE1' ' HE2' ' D' ' 92' ' ' LYS . 14.6 m-85 -107.63 101.55 10.86 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.898 -168.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.806 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 84.0 t -83.24 106.48 13.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.927 171.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 64.4 45.24 3.84 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.51 0.506 . . . . 0.0 110.692 -177.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.76 41.94 99.68 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.313 -178.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 61' ' ' GLU . . . . . 0.515 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 42.8 tt0 -142.97 112.64 6.9 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.264 -0.468 . . . . 0.0 110.059 178.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 62' ' ' LYS . . . . . 0.524 ' HB2' ' CE2' ' D' ' 57' ' ' PHE . 37.8 ttpt -70.36 105.65 3.1 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.446 -177.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 27.6 m -89.14 -24.48 5.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.708 -175.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 64' ' ' TYR . . . . . 0.451 ' HB3' HD12 ' D' ' 56' ' ' ILE . 16.4 t80 -141.36 135.45 30.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.766 0.317 . . . . 0.0 111.035 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 79.6 m -117.66 118.89 33.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.308 175.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 66' ' ' PHE . . . . . 0.456 ' CZ ' ' CE3' ' D' ' 54' ' ' TRP . 9.4 p90 -125.61 159.36 32.35 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 174.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 67' ' ' ASN . . . . . 0.713 ' ND2' ' HB2' ' D' ' 69' ' ' LYS . 16.0 p-10 -130.2 136.1 48.87 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -174.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 68' ' ' GLU . . . . . 0.778 ' HB3' HG12 ' D' ' 47' ' ' ILE . 51.9 mm-40 -68.31 -8.37 39.12 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.368 -175.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.713 ' HB2' ' ND2' ' D' ' 67' ' ' ASN . 6.0 mtpm? -64.74 -44.4 90.24 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 169.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 70' ' ' SER . . . . . 0.475 ' HB3' ' O ' ' D' ' 67' ' ' ASN . 35.0 t -64.61 125.43 24.71 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 113.32 -1.763 . . . . 0.0 107.847 168.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 71' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' D' ' 44' ' ' GLY . 72.3 p -56.03 126.57 26.5 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 72' ' ' VAL . . . . . 0.618 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -57.56 -11.47 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-O 121.04 0.448 . . . . 0.0 111.341 -176.292 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 73' ' ' GLY . . . . . 0.47 ' HA3' ' HA2' ' D' ' 44' ' ' GLY . . . -73.49 -57.34 5.09 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.568 170.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -63.84 -23.84 67.51 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 177.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 75' ' ' ILE . . . . . 0.65 ' O ' HG13 ' D' ' 79' ' ' ILE . 72.0 mt -71.33 -44.8 72.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.216 174.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 76' ' ' SER . . . . . 0.469 ' HA ' HG13 ' D' ' 79' ' ' ILE . 31.8 t -71.55 -25.89 62.41 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 121.116 -0.233 . . . . 0.0 111.037 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 77' ' ' ASN . . . . . 0.423 ' O ' ' HD2' ' D' ' 81' ' ' LYS . 4.4 m120 -60.71 -26.36 67.1 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 169.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 78' ' ' ASP . . . . . 1.023 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 80.7 m-20 -86.3 -37.54 18.42 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.196 174.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . 0.947 HG22 HD11 ' D' ' 36' ' ' LEU . 24.2 mt -64.85 -27.96 43.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 O-C-N 121.897 -0.502 . . . . 0.0 110.803 -175.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -69.11 -29.49 67.57 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.293 178.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 81' ' ' LYS . . . . . 1.023 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -85.04 -49.45 8.28 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 119.677 -0.809 . . . . 0.0 111.323 175.116 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 82' ' ' LEU . . . . . 0.642 HD23 ' O ' ' D' ' 78' ' ' ASP . 4.1 mm? -50.43 -26.57 5.18 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 52.89 66.91 1.09 Allowed 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.617 0.573 . . . . 0.0 110.153 178.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 84' ' ' ILE . . . . . 0.53 HG23 HG21 ' D' ' 56' ' ' ILE . 50.3 mm -73.66 99.94 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.601 -175.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 85' ' ' LYS . . . . . 0.54 ' C ' ' HE3' ' D' ' 85' ' ' LYS . 0.0 OUTLIER -142.39 -171.57 3.43 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 179.7 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 86' ' ' GLY . . . . . 0.694 ' HA2' HD11 ' D' ' 89' ' ' ILE . . . -61.22 168.12 11.54 Favored Glycine 0 CA--C 1.507 -0.45 0 CA-C-N 115.316 -0.856 . . . . 0.0 114.543 -174.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 87' ' ' PRO . . . . . 0.671 ' O ' HG13 ' D' ' 58' ' ' VAL . 45.2 Cg_endo -91.38 178.4 14.33 Favored 'Cis proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.868 -1.722 . . . . 0.0 114.171 0.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 88' ' ' TYR . . . . . 0.806 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 1.4 m-85 36.67 91.39 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 O-C-N 124.483 1.115 . . . . 0.0 112.435 178.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.694 HD11 ' HA2' ' D' ' 86' ' ' GLY . 3.5 mp -111.09 121.88 64.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.507 0.67 . . . . 0.0 111.03 -176.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . 0.638 ' HB2' ' HB2' ' D' ' 57' ' ' PHE . 54.3 mt-10 -124.15 88.99 3.0 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.916 177.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 91' ' ' ILE . . . . . 1.065 HG22 ' HZ3' ' D' ' 54' ' ' TRP . 4.1 mt -100.06 111.05 28.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 92' ' ' LYS . . . . . 0.726 ' HE2' ' CE1' ' D' ' 57' ' ' PHE . 0.0 OUTLIER -162.57 172.47 15.37 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . 0.651 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 17.2 pt20 -81.33 158.45 24.72 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.807 173.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 7.6 pt . . . . . 0 C--N 1.305 -1.364 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.631 -172.394 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.567 ' O ' HG12 ' D' ' 16' ' ' VAL . 48.4 mt . . . . . 0 N--CA 1.45 -0.472 0 CA-C-O 121.841 0.829 . . . . 0.0 110.649 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -93.87 -57.07 2.66 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.604 -176.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' D' D ' 15' ' ' SER . . . . . 0.688 ' HA ' ' OD2' ' D' ' 18' ' ' ASP . 97.5 p -69.65 -16.16 63.32 Favored 'General case' 0 C--O 1.218 -0.59 0 C-N-CA 120.156 -0.618 . . . . 0.0 110.199 175.23 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 16' ' ' VAL . . . . . 0.567 HG12 ' O ' ' D' ' 13' ' ' ILE . 1.5 p -56.08 -23.9 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 121.974 0.892 . . . . 0.0 109.138 174.336 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 17' ' ' ASN . . . . . 0.63 ' HB3' ' ND2' ' D' ' 21' ' ' ASN . 5.4 m120 -84.71 -32.38 23.57 Favored 'General case' 0 C--O 1.206 -1.232 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.204 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 18' ' ' ASP . . . . . 0.688 ' OD2' ' HA ' ' D' ' 15' ' ' SER . 63.0 m-20 -61.61 -14.91 34.66 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 177.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.862 ' N ' ' HE2' ' D' ' 19' ' ' LYS . 0.3 OUTLIER -86.4 -48.54 8.36 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 174.334 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' D' D ' 20' ' ' LEU . . . . . 0.98 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 71.9 mt -64.92 -40.79 95.6 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 112.299 -2.228 . . . . 0.0 110.497 -176.122 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 21' ' ' ASN . . . . . 0.734 ' OD1' ' HB2' ' D' ' 26' ' ' LYS . 75.1 m-20 -85.33 97.74 10.14 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.434 -179.598 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 22' ' ' LYS . . . . . 0.607 ' NZ ' ' HB3' ' D' ' 22' ' ' LYS . 7.5 mtpm? -123.03 -41.67 2.32 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 118.767 -1.173 . . . . 0.0 114.125 -178.018 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 173.38 -82.52 0.08 OUTLIER Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 119.901 -1.143 . . . . 0.0 112.527 -177.473 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . 0.866 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 27.2 tptp -48.18 -60.94 2.26 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.675 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -134.73 160.14 24.15 Favored Glycine 0 N--CA 1.433 -1.542 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.451 174.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' D' D ' 26' ' ' LYS . . . . . 0.734 ' HB2' ' OD1' ' D' ' 21' ' ' ASN . 0.1 OUTLIER -149.63 159.74 44.08 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.57 -0.815 . . . . 0.0 111.099 -168.611 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' D' D ' 27' ' ' LEU . . . . . 0.98 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 44.9 tp -143.73 139.15 29.3 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.96 0.409 . . . . 0.0 111.942 -178.621 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 28' ' ' SER . . . . . 0.599 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 8.7 t -127.7 153.77 46.11 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 174.834 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 29' ' ' LEU . . . . . . . . . . . . . 18.4 mt -133.96 140.52 46.8 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.886 178.717 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 49.8 m -152.44 -176.28 5.64 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.731 178.065 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 66.8 mtm -136.24 166.39 23.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.056 0.455 . . . . 0.0 110.546 -179.849 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' D' D ' 32' ' ' ASN . . . . . 0.556 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 24.4 t-20 -146.06 88.38 1.81 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.39 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.15 -105.32 1.81 Allowed Glycine 0 N--CA 1.454 -0.144 0 C-N-CA 119.998 -1.096 . . . . 0.0 110.749 -170.344 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -114.16 29.89 7.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.177 0.513 . . . . 0.0 109.952 171.462 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' D' D ' 35' ' ' GLN . . . . . 0.556 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 65.0 tp60 -102.31 155.75 18.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.241 -178.146 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.636 HD11 HG22 ' D' ' 79' ' ' ILE . 2.5 tm? -113.43 129.16 56.61 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 175.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 37' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -136.14 99.01 4.01 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.967 -169.393 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' D' D ' 38' ' ' ALA . . . . . 0.681 ' HB1' HD11 ' D' ' 27' ' ' LEU . . . -98.21 150.76 21.16 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.017 176.115 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 39' ' ' THR . . . . . 0.599 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 74.4 p -133.67 123.01 24.26 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 174.394 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' D' ' 26' ' ' LYS . 18.7 m -115.7 128.89 56.23 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.233 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 41' ' ' SER . . . . . 0.62 ' HB2' ' CD ' ' D' ' 26' ' ' LYS . 31.9 m -104.87 162.05 13.66 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.42 -173.066 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 42' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' D' ' 41' ' ' SER . 74.7 m-80 77.35 9.9 2.51 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 114.197 -1.365 . . . . 0.0 110.52 -171.68 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 49.04 60.5 3.7 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 114.799 -1.092 . . . . 0.0 113.753 169.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' D' D ' 44' ' ' GLY . . . . . 0.455 ' C ' ' HD2' ' D' ' 45' ' ' TYR . . . 106.72 37.11 2.45 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 119.216 -1.469 . . . . 0.0 114.043 171.193 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 45' ' ' TYR . . . . . 0.866 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 3.9 m-30 -114.59 153.33 30.31 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 117.376 0.588 . . . . 0.0 110.037 176.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -97.82 -155.77 29.9 Favored Glycine 0 C--O 1.217 -0.909 0 CA-C-O 119.459 -0.634 . . . . 0.0 111.598 178.014 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 47' ' ' ILE . . . . . 0.963 HG13 ' HB3' ' D' ' 68' ' ' GLU . 0.4 OUTLIER -54.62 -56.53 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-O 122.118 0.961 . . . . 0.0 108.659 -179.994 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' D' ' 47' ' ' ILE . 26.3 t 162.33 -60.3 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 111.922 -2.399 . . . . 0.0 106.909 -174.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -169.89 76.27 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.546 172.683 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . 0.661 ' O ' ' HG2' ' D' ' 69' ' ' LYS . 49.0 mt-10 -149.27 -177.94 6.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.881 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 51' ' ' ASP . . . . . 0.592 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 1.0 OUTLIER -129.07 130.15 46.17 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.457 0.646 . . . . 0.0 111.316 172.553 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' D' D ' 52' ' ' LYS . . . . . 0.592 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 0.4 OUTLIER -141.77 100.92 3.85 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.861 -179.833 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' D' D ' 53' ' ' ASN . . . . . 0.618 ' HA ' ' OD1' ' D' ' 67' ' ' ASN . 2.7 m120 -78.16 125.7 29.74 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 176.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 54' ' ' TRP . . . . . 0.572 ' HB2' ' O ' ' D' ' 66' ' ' PHE . 0.1 OUTLIER -118.21 155.86 29.78 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.385 -171.948 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -148.13 161.79 28.66 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 119.833 -1.175 . . . . 0.0 114.297 175.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' D' D ' 56' ' ' ILE . . . . . 0.506 HG23 HG12 ' D' ' 91' ' ' ILE . 71.9 mt -135.09 111.25 13.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 57' ' ' PHE . . . . . 0.65 ' HZ ' HG21 ' D' ' 94' ' ' ILE . 9.2 m-85 -111.83 114.16 26.95 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.654 -166.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.938 HG22 HG12 ' D' ' 89' ' ' ILE . 59.6 t -96.28 105.92 17.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.903 174.661 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 7.0 m120 56.42 51.74 10.99 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.155 -176.374 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.04 48.08 68.4 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.823 178.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' D' D ' 61' ' ' GLU . . . . . 0.619 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 86.9 tt0 -150.29 116.87 5.79 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 177.631 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 62' ' ' LYS . . . . . 0.447 ' HB2' ' CE1' ' D' ' 57' ' ' PHE . 27.3 ttpp -75.86 99.91 4.63 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.971 0.415 . . . . 0.0 110.282 179.086 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 30.3 m -84.96 -27.2 6.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.051 -175.205 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' D' D ' 64' ' ' TYR . . . . . 0.449 ' HB3' HD12 ' D' ' 56' ' ' ILE . 14.4 t80 -136.75 131.46 33.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.736 0.303 . . . . 0.0 110.373 178.367 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 19.4 m -117.98 104.6 11.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.94 177.816 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' D' D ' 66' ' ' PHE . . . . . 0.572 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 12.2 p90 -114.64 164.68 13.69 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 175.515 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 67' ' ' ASN . . . . . 0.618 ' OD1' ' HA ' ' D' ' 53' ' ' ASN . 74.8 m-20 -130.88 152.0 50.68 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.289 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 68' ' ' GLU . . . . . 0.963 ' HB3' HG13 ' D' ' 47' ' ' ILE . 84.0 mt-10 -68.78 -18.94 64.28 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.689 -0.804 . . . . 0.0 109.774 174.257 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.661 ' HG2' ' O ' ' D' ' 50' ' ' GLU . 45.4 mtmt -61.38 -42.46 98.75 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 172.61 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 70' ' ' SER . . . . . 0.403 ' HB3' ' O ' ' D' ' 67' ' ' ASN . 27.7 t -67.87 125.41 26.19 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 113.669 -1.605 . . . . 0.0 107.405 170.503 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 76.6 p -58.19 116.33 3.5 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -176.539 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' D' D ' 72' ' ' VAL . . . . . 0.745 ' HA ' HD12 ' D' ' 75' ' ' ILE . 0.0 OUTLIER -51.41 -20.56 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-O 120.674 0.273 . . . . 0.0 111.472 -173.654 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' D' D ' 73' ' ' GLY . . . . . 0.533 ' HA2' ' HB2' ' D' ' 40' ' ' SER . . . -63.39 -59.91 8.22 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.709 -0.678 . . . . 0.0 113.081 172.422 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 74' ' ' ASN . . . . . 0.828 ' HA ' HD22 ' D' ' 77' ' ' ASN . 4.3 m120 -66.61 -18.75 65.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.444 0.164 . . . . 0.0 110.902 178.62 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 75' ' ' ILE . . . . . 0.745 HD12 ' HA ' ' D' ' 72' ' ' VAL . 77.7 mt -71.6 -42.39 71.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.021 173.752 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 76' ' ' SER . . . . . 0.444 ' HA ' HG13 ' D' ' 79' ' ' ILE . 47.1 t -74.1 -22.68 59.39 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.008 -177.439 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 77' ' ' ASN . . . . . 0.828 HD22 ' HA ' ' D' ' 74' ' ' ASN . 78.0 m-20 -63.93 -27.29 69.05 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 168.32 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 78' ' ' ASP . . . . . 1.035 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 51.6 m-20 -83.6 -36.14 24.13 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.943 173.187 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . 0.687 HG13 ' O ' ' D' ' 75' ' ' ILE . 22.2 mt -67.05 -16.04 20.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.266 -175.6 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -69.85 -48.83 57.37 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.108 174.127 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' D' D ' 81' ' ' LYS . . . . . 1.035 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -69.39 -47.82 63.03 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.645 178.427 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' D' D ' 82' ' ' LEU . . . . . 0.618 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.5 mm? -54.26 -23.97 16.98 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 178.195 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 83' ' ' ASN . . . . . 0.474 ' O ' ' HE2' ' D' ' 85' ' ' LYS . 0.7 OUTLIER 39.25 69.29 0.29 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.916 0.886 . . . . 0.0 111.159 176.008 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' D' D ' 84' ' ' ILE . . . . . 0.597 HG23 HD13 ' D' ' 89' ' ' ILE . 47.8 mm -75.17 99.28 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.166 -172.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 85' ' ' LYS . . . . . 0.542 ' O ' ' HE3' ' D' ' 85' ' ' LYS . 0.0 OUTLIER -158.19 91.44 1.1 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 173.972 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' D' D ' 86' ' ' GLY . . . . . 0.549 ' H ' HD12 ' D' ' 89' ' ' ILE . . . 69.63 154.51 0.97 Allowed Glycine 0 C--N 1.329 0.175 0 CA-C-N 115.127 -0.942 . . . . 0.0 114.106 173.163 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 87' ' ' PRO . . . . . 0.619 ' O ' HG13 ' D' ' 58' ' ' VAL . 68.8 Cg_endo -87.33 178.96 19.74 Favored 'Cis proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.681 -1.8 . . . . 0.0 112.09 -0.301 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 88' ' ' TYR . . . . . 0.648 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 2.3 m-85 4.67 91.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 125.253 1.421 . . . . 0.0 113.942 -175.45 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.938 HG12 HG22 ' D' ' 58' ' ' VAL . 66.2 mt -111.38 129.19 67.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.999 -179.803 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . 0.542 ' O ' ' HD2' ' D' ' 57' ' ' PHE . 49.2 mm-40 -112.33 100.36 8.73 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.879 175.266 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 91' ' ' ILE . . . . . 0.582 HG13 HG22 ' D' ' 89' ' ' ILE . 35.0 mt -94.38 101.19 12.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.05 -178.744 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 92' ' ' LYS . . . . . 0.627 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -160.5 163.64 32.73 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.107 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . 0.609 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 19.7 pt20 -79.53 167.4 20.81 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 119.764 -0.774 . . . . 0.0 110.807 176.818 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' D' D ' 94' ' ' ILE . . . . . 0.65 HG21 ' HZ ' ' D' ' 57' ' ' PHE . 10.9 pt . . . . . 0 C--N 1.313 -1.006 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.572 -170.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.645 ' O ' HG12 ' D' ' 16' ' ' VAL . 51.6 mt . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 121.701 0.762 . . . . 0.0 110.544 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -85.25 -59.19 2.4 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.291 176.137 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' D' D ' 15' ' ' SER . . . . . 0.476 ' O ' ' HE2' ' D' ' 19' ' ' LYS . 88.7 p -68.22 -13.88 62.57 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 175.603 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 16' ' ' VAL . . . . . 0.645 HG12 ' O ' ' D' ' 13' ' ' ILE . 0.9 OUTLIER -62.18 -25.68 38.18 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.92 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' D' D ' 17' ' ' ASN . . . . . 0.469 ' ND2' ' H ' ' D' ' 29' ' ' LEU . 2.2 m120 -73.56 -42.24 61.9 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 114.383 -1.281 . . . . 0.0 108.592 177.122 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 18' ' ' ASP . . . . . 0.401 ' OD1' ' HA ' ' D' ' 15' ' ' SER . 1.6 m-20 -59.25 -14.85 12.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.864 -178.387 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.498 ' CE ' ' HA ' ' D' ' 16' ' ' VAL . 34.9 mttm -91.1 -45.77 8.5 Favored 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 123.198 1.475 . . . . 0.0 108.803 -179.743 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 20' ' ' LEU . . . . . 0.841 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 59.1 mt -66.53 -36.53 82.92 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 111.986 -2.37 . . . . 0.0 109.795 -179.87 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 21' ' ' ASN . . . . . 0.657 ' HA ' ' HB2' ' D' ' 26' ' ' LYS . 3.0 m120 -74.91 94.4 2.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.399 178.837 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 22' ' ' LYS . . . . . 0.467 ' HD2' HD12 ' D' ' 47' ' ' ILE . 43.3 mttp -122.46 -43.29 2.3 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -176.681 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 171.68 -87.98 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 119.125 -1.512 . . . . 0.0 113.63 -177.13 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . 0.637 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 0.0 OUTLIER -48.02 -53.42 16.35 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.943 0.877 . . . . 0.0 109.172 179.166 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' D' D ' 25' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -149.32 156.11 26.64 Favored Glycine 0 N--CA 1.43 -1.761 0 CA-C-N 113.928 -1.487 . . . . 0.0 110.918 177.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 26' ' ' LYS . . . . . 0.717 ' HD2' ' HB3' ' D' ' 41' ' ' SER . 8.7 ptpt -151.15 160.4 43.88 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 114.331 -0.934 . . . . 0.0 110.52 -167.128 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 27' ' ' LEU . . . . . 0.841 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 49.7 tp -134.61 147.35 50.19 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.402 0.62 . . . . 0.0 111.937 -176.645 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 28' ' ' SER . . . . . 0.582 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 33.5 t -132.5 128.65 37.8 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.437 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 29' ' ' LEU . . . . . 0.561 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 9.3 mt -126.94 144.9 50.87 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.796 177.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 73.1 p -160.32 176.89 11.18 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.977 177.7 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' D' D ' 31' ' ' MET . . . . . 0.515 ' HA ' ' O ' ' D' ' 35' ' ' GLN . 0.0 OUTLIER -129.65 116.89 19.5 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.377 0.608 . . . . 0.0 110.417 177.076 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -90.36 89.36 7.58 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.395 -0.821 . . . . 0.0 108.97 179.329 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.68 -103.31 2.07 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.275 -0.964 . . . . 0.0 111.064 -171.083 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -120.4 31.14 6.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.381 0.61 . . . . 0.0 109.883 174.674 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' D' D ' 35' ' ' GLN . . . . . 0.515 ' O ' ' HA ' ' D' ' 31' ' ' MET . 8.1 tt0 -108.36 158.69 17.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.308 -174.674 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.673 ' HB3' HD22 ' D' ' 83' ' ' ASN . 2.5 tm? -112.77 126.96 55.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.668 0.271 . . . . 0.0 110.346 178.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 37' ' ' LYS . . . . . 0.567 ' HB3' ' NZ ' ' D' ' 37' ' ' LYS . 1.6 mmmp? -132.58 115.7 15.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.973 -168.113 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 38' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -119.91 142.54 48.62 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.925 174.617 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 39' ' ' THR . . . . . 0.582 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 15.1 p -145.76 132.46 19.96 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.057 177.73 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . 0.809 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 78.8 p -112.28 145.38 40.08 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.326 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 41' ' ' SER . . . . . 0.717 ' HB3' ' HD2' ' D' ' 26' ' ' LYS . 44.3 t -104.39 149.8 25.08 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 118.949 -1.101 . . . . 0.0 109.821 177.176 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 42' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' D' ' 41' ' ' SER . 75.2 m-80 80.31 1.42 1.96 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.891 -171.731 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 44.58 57.76 4.27 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 170.927 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.91 35.77 0.71 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 119.419 -1.372 . . . . 0.0 113.857 173.313 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' D' D ' 45' ' ' TYR . . . . . 0.637 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 18.2 m-85 -126.31 148.37 49.55 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 172.1 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . 0.473 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -88.2 -168.94 44.74 Favored Glycine 0 CA--C 1.497 -1.062 0 N-CA-C 110.579 -1.009 . . . . 0.0 110.579 175.782 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 47' ' ' ILE . . . . . 0.818 HG12 ' HB3' ' D' ' 68' ' ' GLU . 50.4 mm -45.41 -56.71 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 CA-C-O 121.53 0.681 . . . . 0.0 110.001 178.714 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . 0.414 ' HA ' ' CB ' ' D' ' 24' ' ' LYS . 40.8 t 173.41 -103.18 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 112.552 -2.113 . . . . 0.0 109.258 173.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -119.54 74.55 1.01 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.223 0.535 . . . . 0.0 111.705 175.129 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . 0.499 ' HA ' ' OE1' ' D' ' 50' ' ' GLU . 3.7 mm-40 -155.74 -170.35 3.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.946 173.12 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 51' ' ' ASP . . . . . 0.615 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 1.8 m-20 -133.45 138.98 46.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.928 175.458 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 52' ' ' LYS . . . . . 0.615 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 0.1 OUTLIER -144.24 144.12 31.36 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 177.926 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -114.6 142.77 46.01 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 176.672 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' D' D ' 54' ' ' TRP . . . . . 0.71 ' HZ3' HG23 ' D' ' 91' ' ' ILE . 0.7 OUTLIER -126.71 153.84 44.92 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -173.919 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -142.31 159.76 27.16 Favored Glycine 0 N--CA 1.44 -1.091 0 CA-C-N 114.832 -1.076 . . . . 0.0 113.266 174.074 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' D' D ' 56' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' D' ' 90' ' ' GLU . 72.3 mt -137.85 105.78 3.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 179.461 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 57' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' D' ' 61' ' ' GLU . 8.9 m-85 -106.47 109.87 21.91 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.676 -0.809 . . . . 0.0 111.353 -170.032 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 94.7 t -88.69 110.6 21.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.957 173.837 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 59' ' ' ASN . . . . . 0.417 ' OD1' ' HG2' ' D' ' 87' ' ' PRO . 6.0 m120 53.39 53.83 11.09 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.191 -176.926 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.9 48.71 78.62 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.941 178.594 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' D' D ' 61' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 89.1 tt0 -156.73 116.43 3.5 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.686 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 62' ' ' LYS . . . . . 0.488 ' HB2' ' CE2' ' D' ' 57' ' ' PHE . 5.5 ttpm? -73.67 101.46 3.65 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -177.864 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 32.5 m -85.74 -25.53 6.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.998 -175.508 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' D' D ' 64' ' ' TYR . . . . . 0.405 ' HB3' HD12 ' D' ' 56' ' ' ILE . 15.1 t80 -140.28 137.94 34.59 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.222 178.822 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . 0.487 ' OG1' ' HE2' ' D' ' 62' ' ' LYS . 38.5 m -120.13 119.03 32.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.102 174.531 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 66' ' ' PHE . . . . . 0.594 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 9.3 p90 -126.75 158.91 35.28 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 170.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 67' ' ' ASN . . . . . 0.674 ' O ' HD11 ' D' ' 75' ' ' ILE . 72.4 m-80 -128.51 142.24 51.14 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.505 -173.21 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 68' ' ' GLU . . . . . 0.818 ' HB3' HG12 ' D' ' 47' ' ' ILE . 5.0 mm-40 -67.14 -10.32 48.97 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 174.586 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.573 ' HE3' ' OD2' ' D' ' 51' ' ' ASP . 48.2 mtpt -63.19 -47.44 82.57 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 114.196 -1.365 . . . . 0.0 107.597 169.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t -67.3 138.04 56.54 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 113.505 -1.68 . . . . 0.0 107.961 170.249 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' D' D ' 71' ' ' THR . . . . . 0.448 ' O ' HG13 ' D' ' 75' ' ' ILE . 79.4 p -62.51 122.33 15.5 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.294 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 72' ' ' VAL . . . . . 0.687 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -56.57 -12.93 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 120.966 0.412 . . . . 0.0 111.243 -176.228 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' D' D ' 73' ' ' GLY . . . . . 0.809 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -69.38 -59.95 5.42 Favored Glycine 0 N--CA 1.435 -1.375 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.743 170.169 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 74' ' ' ASN . . . . . 0.721 ' HA ' HD22 ' D' ' 77' ' ' ASN . 46.7 t30 -62.72 -27.34 69.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.965 0.412 . . . . 0.0 109.97 177.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 75' ' ' ILE . . . . . 0.674 HD11 ' O ' ' D' ' 67' ' ' ASN . 77.7 mt -68.15 -45.28 83.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.899 176.328 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 29.1 t -75.78 -19.43 58.99 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.216 -176.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' D' D ' 77' ' ' ASN . . . . . 0.721 HD22 ' HA ' ' D' ' 74' ' ' ASN . 73.4 m-20 -64.48 -31.5 72.74 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 166.198 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 78' ' ' ASP . . . . . 1.091 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 58.4 m-20 -78.52 -39.89 36.75 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.567 175.304 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . 0.644 HG22 HD11 ' D' ' 36' ' ' LEU . 22.2 mt -67.29 -17.15 22.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.349 -174.401 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -71.29 -42.92 68.1 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.375 175.65 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' D' D ' 81' ' ' LYS . . . . . 1.091 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -73.26 -51.9 15.96 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.161 176.914 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' D' D ' 82' ' ' LEU . . . . . 0.611 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.7 mm? -48.05 -32.09 6.26 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 178.226 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 83' ' ' ASN . . . . . 0.673 HD22 ' HB3' ' D' ' 36' ' ' LEU . 0.7 OUTLIER 34.41 65.24 0.34 Allowed 'General case' 0 N--CA 1.477 0.914 0 O-C-N 124.18 0.925 . . . . 0.0 111.602 175.756 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' D' D ' 84' ' ' ILE . . . . . 0.474 HG22 HD13 ' D' ' 89' ' ' ILE . 44.1 mt -92.84 99.89 10.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.003 0.43 . . . . 0.0 111.974 -172.839 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.96 94.27 3.68 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.616 0.722 . . . . 0.0 112.065 177.726 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 86' ' ' GLY . . . . . 0.655 ' H ' HD11 ' D' ' 89' ' ' ILE . . . 71.46 155.99 2.23 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.356 177.795 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 87' ' ' PRO . . . . . 0.493 ' O ' HG13 ' D' ' 58' ' ' VAL . 60.7 Cg_endo -89.31 179.99 15.09 Favored 'Cis proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.141 -1.608 . . . . 0.0 113.045 0.112 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 88' ' ' TYR . . . . . 0.578 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 10.2 m-85 8.27 93.8 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 125.48 1.512 . . . . 0.0 113.875 -176.366 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.655 HD11 ' H ' ' D' ' 86' ' ' GLY . 72.4 mt -108.71 137.74 39.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -177.885 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . 0.443 ' HB2' ' HD1' ' D' ' 57' ' ' PHE . 55.2 mm-40 -113.48 93.04 4.21 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.084 170.161 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 91' ' ' ILE . . . . . 0.71 HG23 ' HZ3' ' D' ' 54' ' ' TRP . 23.7 mt -93.68 100.7 11.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.563 178.155 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 92' ' ' LYS . . . . . 0.841 ' HE3' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -162.82 169.45 19.83 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.177 -178.223 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . 0.707 ' O ' ' HD3' ' D' ' 92' ' ' LYS . 25.7 pt20 -87.28 151.76 22.86 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.634 172.177 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' D' D ' 94' ' ' ILE . . . . . 0.841 HG22 ' HE3' ' D' ' 92' ' ' LYS . 9.1 pt . . . . . 0 C--N 1.307 -1.249 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.933 -170.539 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.434 ' C ' HG12 ' D' ' 16' ' ' VAL . 59.1 mt . . . . . 0 N--CA 1.45 -0.428 0 CA-C-O 121.625 0.726 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -94.41 -60.84 1.63 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.843 175.754 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 92.8 p -65.87 -18.51 65.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.822 -0.172 . . . . 0.0 111.152 -179.088 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' D' D ' 16' ' ' VAL . . . . . 0.792 ' HA ' ' HE2' ' D' ' 19' ' ' LYS . 14.5 p -54.77 -36.27 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 175.02 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 17' ' ' ASN . . . . . 0.591 ' OD1' ' HA ' ' D' ' 28' ' ' SER . 78.8 m-20 -76.23 -27.7 56.9 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.675 -178.682 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.92 -16.14 64.13 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 179.509 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.792 ' HE2' ' HA ' ' D' ' 16' ' ' VAL . 0.0 OUTLIER -90.92 -28.99 17.72 Favored 'General case' 0 CA--C 1.494 -1.199 0 CA-C-O 121.68 0.752 . . . . 0.0 109.046 173.486 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' D' D ' 20' ' ' LEU . . . . . 0.902 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 79.5 mt -82.98 -40.09 20.48 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 113.98 -1.464 . . . . 0.0 109.715 -173.14 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 21' ' ' ASN . . . . . 0.643 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 53.0 m-20 -78.3 92.25 4.5 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.032 -1.44 . . . . 0.0 110.694 178.69 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 22' ' ' LYS . . . . . 0.549 ' HD3' HG23 ' D' ' 47' ' ' ILE . 7.3 mtpm? -123.96 -43.58 2.1 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -172.262 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 172.1 -71.63 0.11 Allowed Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 119.195 -1.478 . . . . 0.0 113.805 -175.209 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . 0.828 ' HB3' ' O ' ' D' ' 46' ' ' GLY . 17.4 tptp -56.99 -66.02 0.52 Allowed 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 179.449 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -137.19 172.32 22.73 Favored Glycine 0 N--CA 1.426 -1.975 0 CA-C-N 113.656 -1.611 . . . . 0.0 110.256 171.578 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' D' D ' 26' ' ' LYS . . . . . 0.643 ' CB ' ' HA ' ' D' ' 21' ' ' ASN . 10.5 ptpt -148.1 161.64 41.01 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.502 -0.349 . . . . 0.0 111.629 -170.294 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 27' ' ' LEU . . . . . 0.902 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 37.4 tp -134.84 145.48 48.36 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.152 0.501 . . . . 0.0 112.007 179.486 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 28' ' ' SER . . . . . 0.647 ' H ' HD12 ' D' ' 27' ' ' LEU . 29.5 t -134.04 139.23 45.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.582 -178.503 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 29' ' ' LEU . . . . . . . . . . . . . 15.2 mt -130.94 130.4 43.4 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.059 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 49.3 m -134.35 174.2 10.79 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 178.789 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' D' D ' 31' ' ' MET . . . . . 0.769 ' HA ' ' O ' ' D' ' 35' ' ' GLN . 25.8 ptt? -137.72 121.94 18.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.815 0.817 . . . . 0.0 111.681 176.681 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -92.2 88.32 6.44 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.025 173.531 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.69 -102.35 1.75 Allowed Glycine 0 N--CA 1.454 -0.141 0 C-N-CA 120.155 -1.021 . . . . 0.0 110.879 -170.431 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -120.21 31.25 6.58 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.179 0.514 . . . . 0.0 109.845 174.02 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' D' D ' 35' ' ' GLN . . . . . 0.769 ' O ' ' HA ' ' D' ' 31' ' ' MET . 8.1 tt0 -111.43 118.08 34.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.598 -175.519 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.547 HD11 HG22 ' D' ' 79' ' ' ILE . 2.8 tm? -79.04 135.68 36.95 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.902 0.382 . . . . 0.0 110.655 178.62 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 37' ' ' LYS . . . . . 0.417 ' N ' HD13 ' D' ' 36' ' ' LEU . 13.3 mmmm -135.01 99.65 4.34 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.24 -172.754 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 38' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -97.73 141.42 30.77 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.486 0.66 . . . . 0.0 111.817 -177.701 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 39' ' ' THR . . . . . 0.545 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 11.5 p -143.93 132.36 22.13 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.645 177.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . 0.599 ' HA ' ' O ' ' D' ' 26' ' ' LYS . 36.8 t -106.03 128.05 53.58 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 169.38 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 41' ' ' SER . . . . . 0.642 ' O ' ' HB3' ' D' ' 42' ' ' ASN . 46.8 t -93.09 142.9 26.78 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -177.13 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 42' ' ' ASN . . . . . 0.642 ' HB3' ' O ' ' D' ' 41' ' ' SER . 5.0 t30 80.16 -15.83 0.71 Allowed 'General case' 0 CA--C 1.537 0.477 0 O-C-N 124.116 0.885 . . . . 0.0 110.705 -167.816 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 60.91 62.24 1.49 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 165.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' D' D ' 44' ' ' GLY . . . . . 0.514 ' C ' ' HD2' ' D' ' 45' ' ' TYR . . . 123.74 35.21 0.7 Allowed Glycine 0 CA--C 1.507 -0.42 0 C-N-CA 118.481 -1.818 . . . . 0.0 115.142 167.365 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 45' ' ' TYR . . . . . 0.716 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 3.1 m-30 -122.23 162.67 20.97 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 172.465 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . 0.828 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -100.13 -149.31 23.63 Favored Glycine 0 C--O 1.218 -0.87 0 C-N-CA 121.421 -0.419 . . . . 0.0 113.219 -175.319 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 47' ' ' ILE . . . . . 1.038 HG13 ' HB2' ' D' ' 68' ' ' GLU . 1.3 mp -63.48 -59.57 4.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -176.144 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . 0.421 ' HA ' ' HB2' ' D' ' 24' ' ' LYS . 31.0 m 167.83 -111.96 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 111.448 -2.615 . . . . 0.0 106.477 -178.517 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -110.99 75.99 0.95 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.458 163.424 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . 0.565 ' HB3' ' HE2' ' D' ' 52' ' ' LYS . 51.4 mt-10 -148.1 177.17 9.6 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.115 -179.122 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 51' ' ' ASP . . . . . 0.751 ' HB2' ' HD2' ' D' ' 69' ' ' LYS . 2.7 p30 -143.41 129.47 19.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.338 0.59 . . . . 0.0 111.851 176.625 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 52' ' ' LYS . . . . . 0.708 ' HD3' HG12 ' D' ' 47' ' ' ILE . 4.1 mptp? -138.73 136.05 35.37 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.203 -168.55 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 53' ' ' ASN . . . . . 0.462 HD22 ' C ' ' D' ' 52' ' ' LYS . 2.6 m120 -111.98 132.54 54.71 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 172.319 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 54' ' ' TRP . . . . . 1.101 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 1.4 m95 -119.04 155.27 31.75 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -173.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -142.64 157.9 26.85 Favored Glycine 0 N--CA 1.436 -1.333 0 CA-C-N 114.524 -1.216 . . . . 0.0 113.034 171.536 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' D' D ' 56' ' ' ILE . . . . . 1.061 HG12 HG23 ' D' ' 91' ' ' ILE . 95.1 mt -127.11 104.63 12.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-N 113.081 -1.56 . . . . 0.0 106.96 178.826 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 57' ' ' PHE . . . . . 0.671 ' HD1' ' O ' ' D' ' 90' ' ' GLU . 16.2 m-85 -103.71 106.35 16.83 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.413 -166.123 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.878 HG22 HG12 ' D' ' 89' ' ' ILE . 77.2 t -90.44 111.47 23.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.996 174.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 5.3 m120 53.99 45.88 26.71 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.152 -178.323 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.23 49.06 35.04 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.868 179.152 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' D' D ' 61' ' ' GLU . . . . . 0.578 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 89.0 tt0 -154.23 119.68 5.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.659 0.266 . . . . 0.0 110.548 178.386 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -73.88 107.99 6.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.08 179.407 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 23.5 m -91.77 -30.1 4.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.031 -174.742 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' D' D ' 64' ' ' TYR . . . . . 0.525 ' HB3' HD12 ' D' ' 56' ' ' ILE . 13.4 t80 -140.22 134.76 31.57 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.399 179.677 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' D' ' 54' ' ' TRP . 32.4 m -117.64 105.68 12.29 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.412 178.005 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 66' ' ' PHE . . . . . 0.72 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 10.8 p90 -112.94 153.08 28.57 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 174.517 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -109.86 145.13 37.3 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 176.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' D' D ' 68' ' ' GLU . . . . . 1.038 ' HB2' HG13 ' D' ' 47' ' ' ILE . 35.7 mt-10 -70.66 -17.79 62.85 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 177.746 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.751 ' HD2' ' HB2' ' D' ' 51' ' ' ASP . 5.7 mtpm? -58.84 -43.95 90.86 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.375 171.095 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 18.6 t -72.12 99.95 2.43 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.665 -1.607 . . . . 0.0 107.298 171.296 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 75.9 p -31.53 121.56 0.26 Allowed 'General case' 0 C--N 1.317 -0.833 0 O-C-N 124.731 1.27 . . . . 0.0 111.95 -173.246 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' D' D ' 72' ' ' VAL . . . . . 0.56 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.1 OUTLIER -54.38 -11.71 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -178.816 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' D' D ' 73' ' ' GLY . . . . . 0.448 ' HA3' ' HA2' ' D' ' 44' ' ' GLY . . . -69.52 -67.0 2.06 Favored Glycine 0 N--CA 1.435 -1.374 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.689 172.193 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -62.71 -21.0 65.45 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.727 0.299 . . . . 0.0 111.131 -177.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' D' D ' 75' ' ' ILE . . . . . 0.456 ' O ' HG12 ' D' ' 79' ' ' ILE . 28.7 mm -80.46 -35.96 15.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.464 176.757 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 76' ' ' SER . . . . . 0.735 ' HB2' HD13 ' D' ' 27' ' ' LEU . 30.2 t -74.37 -21.66 59.56 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.916 177.21 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 77' ' ' ASN . . . . . 0.426 ' O ' ' HD2' ' D' ' 81' ' ' LYS . 4.8 m120 -64.09 -31.33 72.48 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 166.08 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 78' ' ' ASP . . . . . 1.006 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 79.5 m-20 -78.0 -30.52 50.12 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.177 174.252 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . 0.565 HG12 ' HA ' ' D' ' 76' ' ' SER . 28.7 mm -69.72 -19.98 23.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.006 -0.678 . . . . 0.0 109.642 179.732 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -64.66 -41.44 96.1 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.854 174.182 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' D' D ' 81' ' ' LYS . . . . . 1.006 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -81.66 -56.02 4.27 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 177.832 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' D' D ' 82' ' ' LEU . . . . . 0.563 HD23 ' O ' ' D' ' 78' ' ' ASP . 4.0 mm? -48.0 -30.63 4.51 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 83' ' ' ASN . . . . . 0.564 ' O ' ' HE2' ' D' ' 85' ' ' LYS . 0.7 OUTLIER 51.34 81.95 0.07 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.227 0.611 . . . . 0.0 111.21 173.36 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' D' D ' 84' ' ' ILE . . . . . 0.509 ' HB ' ' HG ' ' D' ' 36' ' ' LEU . 48.3 mt -77.08 99.8 2.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -176.367 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 85' ' ' LYS . . . . . 0.564 ' HE2' ' O ' ' D' ' 83' ' ' ASN . 0.0 OUTLIER -160.03 91.24 0.94 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 171.973 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.2 155.88 0.51 Allowed Glycine 0 N--CA 1.454 -0.133 0 CA-C-N 114.85 -1.068 . . . . 0.0 114.915 169.506 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' D' D ' 87' ' ' PRO . . . . . 0.566 ' O ' HG13 ' D' ' 58' ' ' VAL . 67.2 Cg_endo -86.8 177.61 23.5 Favored 'Cis proline' 0 CA--C 1.532 0.403 0 C-N-CA 122.467 -1.889 . . . . 0.0 112.364 -0.399 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 88' ' ' TYR . . . . . 0.597 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 3.8 m-85 6.67 92.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 125.369 1.468 . . . . 0.0 114.173 -176.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.878 HG12 HG22 ' D' ' 58' ' ' VAL . 70.3 mt -112.02 133.05 58.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . 0.671 ' O ' ' HD1' ' D' ' 57' ' ' PHE . 69.7 mm-40 -119.9 101.87 8.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.084 172.26 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 91' ' ' ILE . . . . . 1.101 HG22 ' HZ3' ' D' ' 54' ' ' TRP . 2.7 mt -98.11 110.54 25.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -178.316 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 92' ' ' LYS . . . . . 0.77 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -162.36 170.59 18.59 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.986 -0.446 . . . . 0.0 110.038 178.337 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . 0.612 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 21.7 pt20 -81.31 158.25 24.81 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.093 175.066 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' D' D ' 94' ' ' ILE . . . . . 0.77 HG22 ' HE2' ' D' ' 92' ' ' LYS . 8.0 pt . . . . . 0 C--N 1.311 -1.08 0 CA-C-N 114.11 -1.405 . . . . 0.0 111.451 -167.128 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.545 ' O ' HG12 ' D' ' 16' ' ' VAL . 7.1 tp . . . . . 0 N--CA 1.43 -1.431 0 CA-C-O 121.215 0.531 . . . . 0.0 112.373 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' D' D ' 14' ' ' ASN . . . . . 0.5 ' O ' ' HB2' ' D' ' 17' ' ' ASN . 3.9 m120 -95.69 -36.42 11.21 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.532 173.647 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 15' ' ' SER . . . . . 0.528 ' O ' ' HB2' ' D' ' 18' ' ' ASP . 80.3 p -75.89 -23.71 55.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.894 0.378 . . . . 0.0 110.224 178.142 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 16' ' ' VAL . . . . . 0.545 HG12 ' O ' ' D' ' 13' ' ' ILE . 5.6 p -61.27 -22.4 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 CA-C-O 122.196 0.998 . . . . 0.0 108.85 176.264 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 17' ' ' ASN . . . . . 0.5 ' HB2' ' O ' ' D' ' 14' ' ' ASN . 4.3 m120 -74.02 -39.73 63.37 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 113.578 -1.646 . . . . 0.0 109.271 176.476 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 18' ' ' ASP . . . . . 0.528 ' HB2' ' O ' ' D' ' 15' ' ' SER . 74.9 m-20 -57.34 -17.19 11.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.4 -0.818 . . . . 0.0 113.007 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.607 ' HD2' ' H ' ' D' ' 19' ' ' LYS . 0.0 OUTLIER -90.69 -40.72 11.7 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 121.957 0.884 . . . . 0.0 108.723 174.77 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' D' D ' 20' ' ' LEU . . . . . 0.708 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 81.5 mt -68.31 -34.83 76.85 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 113.327 -1.76 . . . . 0.0 110.523 -177.54 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 21' ' ' ASN . . . . . 0.682 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 63.6 m-20 -78.61 100.55 7.03 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.203 -179.356 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 22' ' ' LYS . . . . . 0.493 ' HD3' HD12 ' D' ' 47' ' ' ILE . 38.3 mtpt -122.07 -42.55 2.38 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 119.066 -1.054 . . . . 0.0 113.263 -170.398 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 158.11 -74.28 0.22 Allowed Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.144 -1.026 . . . . 0.0 112.719 -176.821 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . 0.837 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 21.9 tptm -53.06 -54.84 29.45 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.239 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 25' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -150.44 154.52 25.69 Favored Glycine 0 N--CA 1.429 -1.803 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.772 175.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 26' ' ' LYS . . . . . 0.733 ' CG ' ' HB3' ' D' ' 41' ' ' SER . 10.0 ptpt -149.67 159.61 44.2 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.707 -0.747 . . . . 0.0 110.897 -166.618 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 27' ' ' LEU . . . . . 0.708 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 42.7 tp -136.97 138.34 40.45 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.446 0.641 . . . . 0.0 111.904 -176.451 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 28' ' ' SER . . . . . 0.543 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 18.0 t -128.41 153.94 46.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.061 -178.188 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 29' ' ' LEU . . . . . 0.44 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 22.7 mt -138.22 152.47 48.64 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.987 0.422 . . . . 0.0 110.262 177.465 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . 0.501 ' HB3' ' HB2' ' D' ' 37' ' ' LYS . 36.7 t -145.4 -171.25 3.63 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.411 178.787 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 23.5 ptp -145.85 166.57 25.56 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.84 0.352 . . . . 0.0 110.187 -179.854 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' D' D ' 32' ' ' ASN . . . . . 0.657 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 48.9 t30 -150.4 87.24 1.44 Allowed 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 174.769 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.83 -98.64 0.79 Allowed Glycine 0 N--CA 1.454 -0.166 0 C-N-CA 120.004 -1.093 . . . . 0.0 111.14 -171.366 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -112.6 14.46 20.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.853 0.359 . . . . 0.0 110.135 174.185 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' D' D ' 35' ' ' GLN . . . . . 0.657 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 3.5 tp-100 -89.21 159.13 17.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.601 -174.791 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.998 ' HB2' ' HB2' ' D' ' 85' ' ' LYS . 0.8 OUTLIER -121.24 135.79 55.07 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.299 179.352 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' D' D ' 37' ' ' LYS . . . . . 0.501 ' HB2' ' HB3' ' D' ' 30' ' ' SER . 74.5 mmtt -133.62 139.84 46.74 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.472 -171.511 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 38' ' ' ALA . . . . . 0.409 ' HB3' ' HB ' ' D' ' 79' ' ' ILE . . . -138.6 147.6 43.16 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.861 0.362 . . . . 0.0 111.074 177.184 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 39' ' ' THR . . . . . 0.543 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 17.7 p -147.1 131.94 18.04 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.369 175.731 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . 0.622 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 80.2 p -108.82 170.66 7.9 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 175.456 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 41' ' ' SER . . . . . 0.733 ' HB3' ' CG ' ' D' ' 26' ' ' LYS . 38.1 t -134.46 153.61 51.84 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.378 -0.929 . . . . 0.0 111.356 177.662 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 42' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' D' ' 41' ' ' SER . 75.3 m-80 79.57 9.41 1.57 Allowed 'General case' 0 N--CA 1.467 0.409 0 O-C-N 124.863 1.352 . . . . 0.0 110.462 -174.279 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 42.82 59.62 2.76 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 114.692 -1.14 . . . . 0.0 113.683 171.247 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' D' D ' 44' ' ' GLY . . . . . 0.435 ' O ' HG21 ' D' ' 71' ' ' THR . . . 112.94 35.96 1.59 Allowed Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 119.576 -1.297 . . . . 0.0 114.087 172.534 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 45' ' ' TYR . . . . . 0.837 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 1.2 m-85 -121.42 149.6 42.77 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 170.986 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . 0.57 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -100.11 -153.25 27.1 Favored Glycine 0 C--O 1.221 -0.703 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 -178.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 47' ' ' ILE . . . . . 0.899 HD11 ' HG3' ' D' ' 68' ' ' GLU . 40.3 mm -52.26 -57.82 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 CA-C-O 121.773 0.797 . . . . 0.0 109.618 175.418 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 78.7 p 179.37 -78.0 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 113.035 -1.893 . . . . 0.0 109.206 -174.569 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.52 74.59 0.76 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.811 171.662 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -147.12 148.51 31.65 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.588 -178.131 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' D' D ' 51' ' ' ASP . . . . . 0.689 ' HA ' ' HD3' ' D' ' 69' ' ' LYS . 7.7 p-10 -89.59 119.39 29.97 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.214 177.04 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 52' ' ' LYS . . . . . 0.641 ' O ' ' HA ' ' D' ' 67' ' ' ASN . 11.6 mmmm -128.48 101.28 6.12 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.387 -166.127 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -88.99 127.01 35.66 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.07 176.765 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' D' D ' 54' ' ' TRP . . . . . 0.486 ' HZ3' HG23 ' D' ' 91' ' ' ILE . 0.0 OUTLIER -124.97 164.97 18.97 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.062 -173.421 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -154.55 164.34 31.56 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.543 -1.313 . . . . 0.0 114.688 177.279 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' D' D ' 56' ' ' ILE . . . . . 0.497 HG21 HG21 ' D' ' 84' ' ' ILE . 72.7 mt -140.14 107.16 2.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 125.6 1.56 . . . . 0.0 107.02 -179.156 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 57' ' ' PHE . . . . . 0.517 ' HD2' ' O ' ' D' ' 90' ' ' GLU . 4.7 m-85 -114.3 109.25 18.07 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.318 -167.725 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.75 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 0.2 OUTLIER -101.29 118.71 48.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.216 0.531 . . . . 0.0 111.567 171.611 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 5.6 m120 50.57 54.14 11.7 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.845 179.082 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.16 47.89 80.56 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.73 177.846 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -157.01 114.52 3.14 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.4 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -80.99 99.59 8.5 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.143 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 27.5 m -82.76 -18.24 10.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.471 -173.826 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' D' D ' 64' ' ' TYR . . . . . 0.471 ' HB3' HD12 ' D' ' 56' ' ' ILE . 24.4 t80 -147.82 130.37 15.87 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.414 -0.514 . . . . 0.0 111.01 176.922 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 57.9 m -115.63 125.61 53.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.368 174.491 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' D' D ' 66' ' ' PHE . . . . . 0.429 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 15.7 p90 -132.1 163.36 28.65 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.743 177.159 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 67' ' ' ASN . . . . . 0.641 ' HA ' ' O ' ' D' ' 52' ' ' LYS . 74.5 m-80 -129.76 143.02 50.61 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.296 -176.189 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 68' ' ' GLU . . . . . 0.899 ' HG3' HD11 ' D' ' 47' ' ' ILE . 3.9 mm-40 -75.37 -17.93 60.1 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 176.835 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.689 ' HD3' ' HA ' ' D' ' 51' ' ' ASP . 44.1 mtmt -60.03 -48.73 80.49 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 168.532 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 19.7 m -78.17 61.44 2.68 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 111.857 -2.428 . . . . 0.0 109.236 171.596 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' D' D ' 71' ' ' THR . . . . . 0.435 HG21 ' O ' ' D' ' 44' ' ' GLY . 74.3 p -1.62 121.84 0.0 OUTLIER 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.873 1.669 . . . . 0.0 114.992 -179.338 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 72' ' ' VAL . . . . . 0.475 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.1 OUTLIER -44.58 -21.31 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 123.436 0.694 . . . . 0.0 112.613 171.207 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' D' D ' 73' ' ' GLY . . . . . 0.622 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -60.69 -65.87 3.06 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.819 -0.628 . . . . 0.0 113.712 175.275 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 74' ' ' ASN . . . . . 0.503 ' HA ' HD22 ' D' ' 77' ' ' ASN . 4.5 m120 -71.47 -20.2 62.11 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 120.971 0.415 . . . . 0.0 110.82 -175.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 75' ' ' ILE . . . . . 0.621 ' O ' HG13 ' D' ' 79' ' ' ILE . 27.1 mm -79.34 -40.1 21.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.882 179.472 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 76' ' ' SER . . . . . 0.494 ' HA ' HG13 ' D' ' 79' ' ' ILE . 31.0 t -74.49 -19.98 60.17 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.223 -179.738 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 77' ' ' ASN . . . . . 0.503 HD22 ' HA ' ' D' ' 74' ' ' ASN . 79.4 m-20 -64.97 -32.42 74.14 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 119.368 -0.933 . . . . 0.0 108.586 166.651 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 78' ' ' ASP . . . . . 1.042 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 60.0 m-20 -79.31 -25.1 42.42 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 176.7 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . 0.621 HG13 ' O ' ' D' ' 75' ' ' ILE . 48.6 mt -72.0 -20.62 20.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 O-C-N 121.514 -0.741 . . . . 0.0 111.129 -175.37 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -71.15 -40.19 71.5 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.426 175.777 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' D' D ' 81' ' ' LYS . . . . . 1.042 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -73.78 -54.21 8.55 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.642 176.322 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' D' D ' 82' ' ' LEU . . . . . 0.623 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.9 mm? -47.29 -33.35 5.53 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 177.532 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 83' ' ' ASN . . . . . 0.684 HD22 ' HB3' ' D' ' 36' ' ' LEU . 0.7 OUTLIER 42.07 67.08 0.62 Allowed 'General case' 0 N--CA 1.468 0.438 0 O-C-N 124.002 0.814 . . . . 0.0 110.864 174.774 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' D' D ' 84' ' ' ILE . . . . . 0.574 ' O ' ' HG ' ' D' ' 36' ' ' LEU . 44.1 mm -94.94 98.81 8.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.165 -175.084 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 85' ' ' LYS . . . . . 0.998 ' HB2' ' HB2' ' D' ' 36' ' ' LEU . 46.4 tptt -139.97 94.47 2.76 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.171 0.51 . . . . 0.0 110.812 -178.63 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 86' ' ' GLY . . . . . 0.597 ' H ' ' CD1' ' D' ' 89' ' ' ILE . . . 69.54 161.98 3.11 Favored Glycine 0 CA--C 1.5 -0.845 0 CA-C-N 115.231 -0.895 . . . . 0.0 114.357 177.42 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 87' ' ' PRO . . . . . 0.697 ' HD2' HG21 ' D' ' 58' ' ' VAL . 61.7 Cg_endo -77.03 -172.1 10.77 Favored 'Cis proline' 0 CA--C 1.545 1.055 0 C-N-CA 122.195 -2.002 . . . . 0.0 114.128 0.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 88' ' ' TYR . . . . . 0.75 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 2.2 m-85 -9.38 94.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 125.485 1.514 . . . . 0.0 114.668 -174.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.597 ' CD1' ' H ' ' D' ' 86' ' ' GLY . 70.1 mt -102.19 142.1 17.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . 0.517 ' O ' ' HD2' ' D' ' 57' ' ' PHE . 46.3 mt-10 -116.32 98.58 6.67 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.528 170.557 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 91' ' ' ILE . . . . . 0.543 HG13 HG22 ' D' ' 89' ' ' ILE . 33.0 mt -94.34 100.25 10.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.024 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 92' ' ' LYS . . . . . 0.661 ' HG2' ' O ' ' D' ' 93' ' ' GLN . 0.0 OUTLIER -159.68 166.68 30.08 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.416 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . 0.661 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 3.8 pm0 -80.41 162.95 24.2 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 121.533 0.682 . . . . 0.0 110.696 175.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' D' D ' 94' ' ' ILE . . . . . 0.575 HG22 ' HE2' ' D' ' 92' ' ' LYS . 9.8 pt . . . . . 0 C--N 1.307 -1.26 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.585 -171.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.434 ' C ' HG12 ' D' ' 16' ' ' VAL . 64.0 mt . . . . . 0 N--CA 1.452 -0.365 0 CA-C-O 121.606 0.717 . . . . 0.0 111.365 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -93.53 -59.12 2.08 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.395 175.183 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' D' D ' 15' ' ' SER . . . . . 0.481 ' O ' ' HE2' ' D' ' 19' ' ' LYS . 84.6 p -64.79 -15.19 61.36 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.644 0.239 . . . . 0.0 111.644 179.592 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 16' ' ' VAL . . . . . 0.586 ' HA ' ' HE2' ' D' ' 19' ' ' LYS . 11.8 p -60.64 -30.68 47.39 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.085 0 CA-C-O 121.527 0.679 . . . . 0.0 109.478 175.64 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 17' ' ' ASN . . . . . 0.517 HD22 HG13 ' D' ' 16' ' ' VAL . 2.6 m120 -71.95 -39.59 69.28 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.044 177.079 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 18' ' ' ASP . . . . . 0.465 ' OD1' ' HA ' ' D' ' 15' ' ' SER . 1.2 m-20 -58.95 -15.55 13.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.691 -179.367 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.604 ' O ' ' HE3' ' D' ' 22' ' ' LYS . 31.9 mttm -91.03 -52.71 4.7 Favored 'General case' 0 CA--C 1.492 -1.259 0 CA-C-O 122.525 1.155 . . . . 0.0 108.765 179.131 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 20' ' ' LEU . . . . . 0.958 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 55.7 mt -57.1 -40.34 76.84 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 112.381 -2.19 . . . . 0.0 110.734 178.266 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 21' ' ' ASN . . . . . 0.547 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 53.3 m-20 -76.04 94.15 3.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.153 179.054 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 22' ' ' LYS . . . . . 0.772 ' HD2' HD12 ' D' ' 47' ' ' ILE . 95.7 mttt -121.81 -42.19 2.42 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -175.397 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 172.02 -92.38 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 119.589 -1.291 . . . . 0.0 113.337 -178.742 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . 0.735 ' HG2' ' HB3' ' D' ' 45' ' ' TYR . 80.4 tttt -47.22 -50.05 21.84 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.654 0.74 . . . . 0.0 109.628 178.195 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -141.54 158.08 26.42 Favored Glycine 0 N--CA 1.432 -1.626 0 CA-C-N 114.383 -1.281 . . . . 0.0 111.524 175.884 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' D' D ' 26' ' ' LYS . . . . . 0.688 ' CD ' ' HB2' ' D' ' 41' ' ' SER . 0.2 OUTLIER -150.47 161.3 42.79 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.672 -0.764 . . . . 0.0 110.24 -170.448 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' D' D ' 27' ' ' LEU . . . . . 0.958 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 35.5 tp -140.19 143.67 36.2 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.129 0.49 . . . . 0.0 111.116 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 28' ' ' SER . . . . . 0.575 ' H ' HD12 ' D' ' 27' ' ' LEU . 13.0 t -140.6 109.78 6.17 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.703 -176.217 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 29' ' ' LEU . . . . . 0.524 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 0.9 OUTLIER -131.61 145.75 51.85 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -179.767 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 72.8 p -160.18 -171.71 3.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.513 -177.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' D' D ' 31' ' ' MET . . . . . 0.798 ' HA ' ' O ' ' D' ' 35' ' ' GLN . 69.9 mtm -125.73 131.23 52.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.173 0.511 . . . . 0.0 111.005 176.127 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 32' ' ' ASN . . . . . 0.407 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 49.2 t30 -90.78 88.87 7.24 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 172.612 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.53 -99.86 1.64 Allowed Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -164.439 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' D' D ' 34' ' ' ASN . . . . . 0.686 ' O ' ' HE3' ' D' ' 85' ' ' LYS . 75.4 m-80 -120.99 13.45 11.35 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.672 -0.311 . . . . 0.0 110.569 171.879 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 35' ' ' GLN . . . . . 0.798 ' O ' ' HA ' ' D' ' 31' ' ' MET . 52.2 tt0 -88.52 126.39 35.23 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.041 -175.102 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.778 HD12 ' HA ' ' D' ' 83' ' ' ASN . 3.0 tm? -79.08 124.67 28.51 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.278 0.561 . . . . 0.0 111.13 -179.311 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 37' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 30.9 mmmt -135.91 117.09 14.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.523 -170.756 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 38' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -126.91 148.46 50.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.215 0.531 . . . . 0.0 112.068 -177.374 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 39' ' ' THR . . . . . 0.468 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 15.5 p -146.87 124.85 12.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.797 177.581 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . 0.544 ' HB2' ' HA2' ' D' ' 73' ' ' GLY . 69.2 m -110.7 128.86 55.89 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 173.378 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 41' ' ' SER . . . . . 0.688 ' HB2' ' CD ' ' D' ' 26' ' ' LYS . 50.2 m -97.59 161.71 13.64 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.987 -174.217 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 42' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' D' ' 41' ' ' SER . 71.9 m-80 79.69 10.88 1.33 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.901 -172.006 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 39.74 61.85 1.34 Allowed 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 169.355 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.54 -5.53 7.58 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 118.745 -1.693 . . . . 0.0 115.315 172.111 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' D' D ' 45' ' ' TYR . . . . . 0.735 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 1.6 m-85 -96.6 155.84 16.6 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 117.454 0.627 . . . . 0.0 111.882 -178.738 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . 0.607 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -101.82 -177.13 28.2 Favored Glycine 0 C--O 1.214 -1.115 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 173.088 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 47' ' ' ILE . . . . . 0.938 HG12 ' HB3' ' D' ' 68' ' ' GLU . 34.9 mm -48.09 -55.28 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.836 0 CA-C-N 118.391 1.095 . . . . 0.0 110.239 178.376 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . 0.512 ' HA ' ' HD3' ' D' ' 24' ' ' LYS . 23.2 t 179.44 -156.67 0.02 OUTLIER 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 113.026 -1.897 . . . . 0.0 107.154 -177.268 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 49' ' ' TYR . . . . . 0.473 ' O ' ' HD1' ' D' ' 49' ' ' TYR . 0.3 OUTLIER -81.13 76.81 8.07 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.795 0.807 . . . . 0.0 109.794 167.969 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . 0.654 ' O ' ' HG2' ' D' ' 69' ' ' LYS . 71.2 mm-40 -119.24 -163.04 0.94 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.993 -171.964 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 51' ' ' ASP . . . . . 0.71 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 11.6 t70 -162.76 107.44 1.13 Allowed 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.631 170.633 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 52' ' ' LYS . . . . . 0.71 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 4.2 mptp? -138.67 109.1 6.51 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 113.755 -1.566 . . . . 0.0 109.447 -172.812 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 53' ' ' ASN . . . . . 0.459 ' HA ' ' OD1' ' D' ' 67' ' ' ASN . 2.9 m120 -83.66 131.41 34.95 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.297 177.764 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 54' ' ' TRP . . . . . 0.607 ' HZ3' HG23 ' D' ' 91' ' ' ILE . 0.3 OUTLIER -120.55 153.52 36.62 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.82 -173.139 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -144.87 159.54 27.86 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 120.019 -1.086 . . . . 0.0 113.578 174.313 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' D' D ' 56' ' ' ILE . . . . . 0.652 HG23 HG12 ' D' ' 91' ' ' ILE . 61.8 mt -134.31 111.94 15.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 176.557 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 57' ' ' PHE . . . . . 0.65 ' HZ ' HG21 ' D' ' 94' ' ' ILE . 3.6 m-85 -110.77 105.04 13.75 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 119.214 -0.994 . . . . 0.0 111.122 -166.633 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.714 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 94.3 t -89.04 108.47 19.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.977 173.647 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 59' ' ' ASN . . . . . 0.719 HD21 ' HG2' ' D' ' 87' ' ' PRO . 77.8 m-20 60.89 52.18 4.33 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.344 -177.525 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 57.82 47.44 88.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.291 -179.5 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' D' D ' 61' ' ' GLU . . . . . 0.582 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 5.3 tp10 -151.82 125.41 8.93 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.252 -0.474 . . . . 0.0 109.904 -177.398 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -67.77 105.82 2.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.093 0.473 . . . . 0.0 109.954 177.103 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.443 HG12 ' O ' ' D' ' 56' ' ' ILE . 14.6 p -86.69 -21.98 7.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.193 -178.044 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 64' ' ' TYR . . . . . 0.505 ' HB3' HD12 ' D' ' 56' ' ' ILE . 31.6 t80 -156.92 135.14 11.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.324 176.429 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . 0.406 HG23 ' O ' ' D' ' 54' ' ' TRP . 74.9 m -120.28 120.48 36.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.721 0.296 . . . . 0.0 110.757 176.77 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 66' ' ' PHE . . . . . 0.531 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 21.2 p90 -126.76 171.12 11.47 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 173.317 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 67' ' ' ASN . . . . . 0.459 ' OD1' ' HA ' ' D' ' 53' ' ' ASN . 75.4 m-20 -129.88 152.76 49.01 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 68' ' ' GLU . . . . . 0.938 ' HB3' HG12 ' D' ' 47' ' ' ILE . 33.5 mt-10 -76.66 -8.36 57.1 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.044 178.473 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.654 ' HG2' ' O ' ' D' ' 50' ' ' GLU . 48.6 mtpt -69.63 -50.36 45.03 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 168.759 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 13.8 t -61.93 120.46 10.81 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 113.569 -1.65 . . . . 0.0 107.685 172.621 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 81.0 p -54.17 114.06 1.48 Allowed 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.929 -172.676 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' D' D ' 72' ' ' VAL . . . . . 0.532 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.1 OUTLIER -50.63 -23.29 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.727 -179.483 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' D' D ' 73' ' ' GLY . . . . . 0.544 ' HA2' ' HB2' ' D' ' 40' ' ' SER . . . -58.4 -66.77 2.58 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.733 -0.667 . . . . 0.0 113.62 173.231 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 74' ' ' ASN . . . . . 0.651 ' HA ' HD22 ' D' ' 77' ' ' ASN . 4.3 m120 -63.79 -24.28 67.7 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 120.796 0.331 . . . . 0.0 110.801 -178.003 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 75' ' ' ILE . . . . . 0.435 ' O ' HG12 ' D' ' 79' ' ' ILE . 36.6 mm -78.39 -38.8 23.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.606 178.348 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 76' ' ' SER . . . . . 0.922 ' HA ' HG12 ' D' ' 79' ' ' ILE . 36.9 t -76.2 -19.93 57.95 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.479 -0.489 . . . . 0.0 111.002 179.544 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 77' ' ' ASN . . . . . 0.651 HD22 ' HA ' ' D' ' 74' ' ' ASN . 75.3 m-20 -63.35 -32.39 73.8 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 166.073 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 78' ' ' ASP . . . . . 1.106 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 1.1 m-20 -79.27 -25.03 42.56 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.94 174.033 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . 0.922 HG12 ' HA ' ' D' ' 76' ' ' SER . 22.2 mm -69.03 -25.32 29.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.235 -177.729 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -73.01 -33.31 65.69 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.855 179.331 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' D' D ' 81' ' ' LYS . . . . . 1.106 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -77.82 -61.18 2.08 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.97 174.197 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' D' D ' 82' ' ' LEU . . . . . 0.525 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.8 mm? -48.53 -31.81 7.02 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 176.314 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 83' ' ' ASN . . . . . 0.778 ' HA ' HD12 ' D' ' 36' ' ' LEU . 22.3 t-20 25.01 80.86 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 O-C-N 124.973 1.42 . . . . 0.0 112.533 177.0 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 84' ' ' ILE . . . . . 0.543 ' N ' ' HG ' ' D' ' 36' ' ' LEU . 2.7 mp -81.56 99.25 4.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.612 -175.174 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 85' ' ' LYS . . . . . 0.686 ' HE3' ' O ' ' D' ' 34' ' ' ASN . 21.5 ptmt -126.76 92.08 3.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.284 0.564 . . . . 0.0 111.318 179.664 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 86' ' ' GLY . . . . . 0.863 ' H ' HD11 ' D' ' 89' ' ' ILE . . . 65.2 154.26 0.16 Allowed Glycine 0 CA--C 1.516 0.11 0 CA-C-N 115.911 -0.586 . . . . 0.0 113.433 177.261 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 87' ' ' PRO . . . . . 0.719 ' HG2' HD21 ' D' ' 59' ' ' ASN . 56.8 Cg_endo -90.85 -179.65 12.44 Favored 'Cis proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.515 -1.452 . . . . 0.0 112.797 -0.429 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 88' ' ' TYR . . . . . 0.714 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 0.9 OUTLIER 18.65 93.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.081 1.353 . . . . 0.0 113.531 179.637 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.863 HD11 ' H ' ' D' ' 86' ' ' GLY . 74.2 mt -111.02 136.78 46.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.097 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . 0.55 ' O ' ' HD1' ' D' ' 57' ' ' PHE . 35.9 mm-40 -123.55 93.47 3.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.678 172.438 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 91' ' ' ILE . . . . . 0.652 HG12 HG23 ' D' ' 56' ' ' ILE . 32.2 mt -94.25 99.38 9.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.822 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 92' ' ' LYS . . . . . 0.695 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -162.65 167.34 23.32 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.198 178.432 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . 0.615 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 23.6 pt20 -81.18 164.45 22.32 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.067 175.116 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' D' D ' 94' ' ' ILE . . . . . 0.695 HG22 ' HE2' ' D' ' 92' ' ' LYS . 6.3 pt . . . . . 0 C--O 1.245 0.85 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.8 -169.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 2.7 p30 . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 120.621 0.248 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 2' ' ' ASN . . . . . 0.424 ' O ' ' HE1' ' D' ' 88' ' ' TYR . 76.3 m-20 -80.18 94.69 6.08 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.372 177.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -60.45 -47.86 84.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.861 -177.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -110.69 -9.1 14.53 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.462 -176.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 5' ' ' ALA . . . . . . . . . . . . . . . 59.74 38.08 21.85 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.734 -176.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . 0.41 ' O ' ' HG2' ' D' ' 10' ' ' MET . 2.9 tm? -67.6 -46.12 73.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.508 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -61.48 -27.21 68.41 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.418 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.688 ' HA ' ' CB ' ' D' ' 12' ' ' SER . 55.6 mm-40 -67.48 -29.46 68.91 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.561 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . 0.506 HE21 ' HB2' ' D' ' 8' ' ' GLU . 59.9 mm-40 -89.38 6.86 38.71 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.379 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 10' ' ' MET . . . . . 0.41 ' HG2' ' O ' ' D' ' 6' ' ' LEU . 91.3 mmm -107.06 -75.49 0.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.037 0.446 . . . . 0.0 111.495 -176.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -100.62 -48.34 4.55 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.03 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 12' ' ' SER . . . . . 0.688 ' CB ' ' HA ' ' D' ' 8' ' ' GLU . 41.9 t -28.37 -70.63 0.04 OUTLIER 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -172.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.448 ' O ' HG12 ' D' ' 16' ' ' VAL . 68.6 mt -71.85 -8.15 10.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.668 -172.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -95.9 -40.83 9.11 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.599 172.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 15' ' ' SER . . . . . 0.467 ' O ' ' HD2' ' D' ' 19' ' ' LYS . 79.6 p -70.98 -26.92 63.36 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.734 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 16' ' ' VAL . . . . . 0.596 HG21 ' HB ' ' D' ' 91' ' ' ILE . 11.4 p -53.37 -28.91 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 121.802 0.81 . . . . 0.0 110.623 177.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -72.67 -43.19 63.46 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.374 -1.285 . . . . 0.0 109.668 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 18' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' D' ' 15' ' ' SER . 74.7 m-20 -57.97 -14.91 7.27 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -177.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.581 ' HD2' ' N ' ' D' ' 19' ' ' LYS . 0.0 OUTLIER -90.14 -41.4 11.66 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.508 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 20' ' ' LEU . . . . . 0.688 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 63.8 mt -73.87 -39.6 63.82 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 112.905 -1.952 . . . . 0.0 109.796 -176.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 21' ' ' ASN . . . . . 0.649 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 3.0 m120 -75.44 91.75 2.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.894 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 22' ' ' LYS . . . . . 0.578 ' HD3' HD12 ' D' ' 47' ' ' ILE . 28.8 mtpp -122.13 -41.77 2.41 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -176.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.9 -92.03 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 119.411 -1.375 . . . . 0.0 113.931 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . 0.725 ' HG2' ' HB3' ' D' ' 45' ' ' TYR . 58.1 tttm -48.55 -54.7 13.42 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.572 0.701 . . . . 0.0 110.152 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 25' ' ' GLY . . . . . 0.568 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -144.29 154.06 25.47 Favored Glycine 0 N--CA 1.433 -1.502 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.351 175.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 26' ' ' LYS . . . . . 0.677 ' HG3' ' HB2' ' D' ' 41' ' ' SER . 9.1 ptpt -150.94 161.37 42.85 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.482 -0.859 . . . . 0.0 111.335 -167.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 27' ' ' LEU . . . . . 0.688 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 38.3 tp -132.01 142.92 49.73 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.71 0.767 . . . . 0.0 112.185 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 28' ' ' SER . . . . . 0.767 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 48.0 m -132.77 144.91 50.58 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.423 -176.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 29' ' ' LEU . . . . . 0.544 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 0.0 OUTLIER -141.28 147.14 37.73 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 119.549 -0.861 . . . . 0.0 110.789 -177.779 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 41.3 m -149.77 176.34 10.79 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.179 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -138.23 166.13 24.95 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.105 0.479 . . . . 0.0 110.926 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 32' ' ' ASN . . . . . 0.714 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 0.7 OUTLIER -148.17 87.53 1.61 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.6 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.01 -98.87 0.66 Allowed Glycine 0 N--CA 1.455 -0.056 0 C-N-CA 119.941 -1.123 . . . . 0.0 111.011 -172.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 34' ' ' ASN . . . . . 0.66 ' O ' ' HE3' ' D' ' 85' ' ' LYS . 73.0 m-80 -116.33 31.12 6.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.048 0.452 . . . . 0.0 110.342 173.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 35' ' ' GLN . . . . . 0.714 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 70.7 tp60 -106.8 148.59 28.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.2 -178.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.702 HD11 HG22 ' D' ' 79' ' ' ILE . 2.9 tm? -118.53 136.04 54.06 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.924 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 37' ' ' LYS . . . . . 0.544 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 25.5 mmmt -134.12 110.77 9.81 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.358 -171.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 38' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -118.71 146.56 44.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.163 0.506 . . . . 0.0 111.578 178.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 39' ' ' THR . . . . . 0.767 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 7.0 p -142.98 132.05 23.05 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.958 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . 0.598 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 25.2 p -107.78 129.21 55.07 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 172.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 41' ' ' SER . . . . . 0.677 ' HB2' ' HG3' ' D' ' 26' ' ' LYS . 40.6 m -95.16 146.88 24.0 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.161 -1.016 . . . . 0.0 109.687 -177.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 42' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' D' ' 41' ' ' SER . 76.1 m-20 80.2 5.46 1.78 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.995 -169.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 50.35 62.81 2.49 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 168.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.09 -11.82 7.26 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 118.672 -1.728 . . . . 0.0 115.594 170.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 45' ' ' TYR . . . . . 0.725 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 1.6 m-85 -85.36 157.46 20.52 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 117.406 0.603 . . . . 0.0 111.739 -177.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . 0.626 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -100.01 -173.93 30.36 Favored Glycine 0 C--O 1.215 -1.046 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 175.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 47' ' ' ILE . . . . . 0.731 HG12 ' HB3' ' D' ' 68' ' ' GLU . 36.1 mm -47.79 -57.86 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 CA-C-O 122.254 1.026 . . . . 0.0 110.081 177.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.585 ' HA ' ' HD3' ' D' ' 24' ' ' LYS . 78.5 p -175.63 -102.3 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 112.875 -1.966 . . . . 0.0 108.812 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.54 77.25 1.59 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.996 0.903 . . . . 0.0 110.094 166.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . 0.713 ' HB2' ' HE3' ' D' ' 52' ' ' LYS . 56.1 mt-10 -139.9 179.22 6.73 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.011 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 51' ' ' ASP . . . . . 0.644 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 2.9 p30 -124.66 140.42 52.95 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.522 0.677 . . . . 0.0 112.014 174.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 52' ' ' LYS . . . . . 0.822 ' HD3' ' HB2' ' D' ' 68' ' ' GLU . 0.3 OUTLIER -146.42 136.69 23.74 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.234 -175.457 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -109.69 129.64 55.59 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.713 -0.395 . . . . 0.0 109.962 175.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 54' ' ' TRP . . . . . 1.085 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 1.1 m95 -124.25 165.2 18.03 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -174.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 55' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' D' ' 64' ' ' TYR . . . -155.15 170.33 33.27 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.928 174.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 56' ' ' ILE . . . . . 1.08 HG12 HG23 ' D' ' 91' ' ' ILE . 96.0 mt -138.28 113.7 9.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 124.917 1.287 . . . . 0.0 107.676 -177.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 57' ' ' PHE . . . . . 0.738 ' HB2' ' HB3' ' D' ' 90' ' ' GLU . 10.1 m-85 -115.59 105.89 13.29 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.934 -0.706 . . . . 0.0 112.018 -166.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.725 HG13 ' O ' ' D' ' 87' ' ' PRO . 81.8 t -82.69 101.33 7.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.227 173.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 59' ' ' ASN . . . . . 0.511 HD21 ' HG2' ' D' ' 87' ' ' PRO . 75.5 m-80 58.95 43.55 17.71 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.892 0.377 . . . . 0.0 110.287 -176.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.52 45.51 45.75 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.641 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 61' ' ' GLU . . . . . 0.631 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 86.2 mt-10 -137.05 105.69 5.84 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 177.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . 0.52 ' HB2' ' CE1' ' D' ' 57' ' ' PHE . 38.8 ttmt -70.83 99.49 1.75 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -178.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 32.7 m -88.41 -19.93 7.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -174.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 64' ' ' TYR . . . . . 0.465 ' HB3' HD12 ' D' ' 56' ' ' ILE . 16.1 t80 -148.17 140.42 24.22 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.307 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 60.7 m -119.73 118.02 29.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.35 176.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 66' ' ' PHE . . . . . 0.521 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 12.1 p90 -123.27 152.96 40.84 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 174.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 67' ' ' ASN . . . . . 0.481 ' O ' HD11 ' D' ' 75' ' ' ILE . 74.0 m-20 -119.87 135.83 54.73 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -177.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 68' ' ' GLU . . . . . 0.822 ' HB2' ' HD3' ' D' ' 52' ' ' LYS . 4.1 mm-40 -65.96 -8.19 21.24 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.792 0.329 . . . . 0.0 110.694 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.454 ' NZ ' ' HB3' ' D' ' 69' ' ' LYS . 5.9 mtpm? -60.48 -47.75 84.75 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 169.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 22.8 t -66.87 131.43 45.9 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 113.385 -1.734 . . . . 0.0 107.87 168.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 71' ' ' THR . . . . . 0.409 ' O ' HG13 ' D' ' 75' ' ' ILE . 69.7 p -60.42 127.89 33.99 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.072 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 72' ' ' VAL . . . . . 0.535 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.1 OUTLIER -56.61 -11.79 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 120.902 0.382 . . . . 0.0 111.767 -178.757 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 73' ' ' GLY . . . . . 0.598 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -73.17 -58.3 4.76 Favored Glycine 0 N--CA 1.435 -1.37 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.084 168.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -61.2 -25.75 67.25 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-O 121.114 0.483 . . . . 0.0 110.489 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 75' ' ' ILE . . . . . 0.516 ' O ' ' HB2' ' D' ' 78' ' ' ASP . 76.8 mt -73.5 -40.31 55.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.637 177.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 76' ' ' SER . . . . . 0.651 ' HA ' HG12 ' D' ' 79' ' ' ILE . 31.0 t -74.72 -19.31 60.29 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.654 178.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 77' ' ' ASN . . . . . 0.419 ' O ' ' HD3' ' D' ' 81' ' ' LYS . 3.9 m120 -62.09 -41.07 97.81 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 166.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 78' ' ' ASP . . . . . 0.925 ' HA ' ' HE3' ' D' ' 81' ' ' LYS . 51.1 m-20 -67.57 -35.8 79.7 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.119 174.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . 0.702 HG22 HD11 ' D' ' 36' ' ' LEU . 13.2 mm -67.46 -20.71 26.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.82 -176.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -69.78 -45.14 68.65 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.964 173.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . 0.925 ' HE3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -66.47 -64.61 0.82 Allowed 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.282 175.226 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 82' ' ' LEU . . . . . 0.545 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.8 mm? -46.51 -31.7 2.91 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 43.93 73.18 0.16 Allowed 'General case' 0 N--CA 1.473 0.697 0 O-C-N 123.881 0.738 . . . . 0.0 110.767 176.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 84' ' ' ILE . . . . . 0.802 HG22 HD13 ' D' ' 89' ' ' ILE . 47.1 mm -72.61 99.52 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.931 -173.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 85' ' ' LYS . . . . . 0.66 ' HE3' ' O ' ' D' ' 34' ' ' ASN . 51.9 mtpt -103.04 165.11 11.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.569 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.1 178.67 0.55 Allowed Glycine 0 C--N 1.335 0.49 0 O-C-N 123.779 0.674 . . . . 0.0 113.204 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 87' ' ' PRO . . . . . 0.725 ' O ' HG13 ' D' ' 58' ' ' VAL . 32.2 Cg_endo -93.98 -179.65 9.08 Favored 'Cis proline' 0 C--N 1.327 -0.57 0 C-N-CA 123.537 -1.443 . . . . 0.0 114.19 -0.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 88' ' ' TYR . . . . . 0.711 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 0.5 OUTLIER 27.77 91.92 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.953 1.301 . . . . 0.0 112.752 178.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.802 HD13 HG22 ' D' ' 84' ' ' ILE . 64.2 mt -110.42 119.03 58.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.536 0.684 . . . . 0.0 112.014 -177.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.738 ' HB3' ' HB2' ' D' ' 57' ' ' PHE . 16.1 tp10 -106.6 91.15 3.57 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.297 178.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 91' ' ' ILE . . . . . 1.085 HG22 ' HZ3' ' D' ' 54' ' ' TRP . 4.2 mt -96.68 109.76 23.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 92' ' ' LYS . . . . . 0.656 ' HG2' ' O ' ' D' ' 93' ' ' GLN . 0.0 OUTLIER -161.5 169.72 21.27 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.528 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.656 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 26.2 pt20 -80.9 162.82 23.77 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.653 175.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . 0.506 HG22 ' HE2' ' D' ' 92' ' ' LYS . 10.6 pt . . . . . 0 C--N 1.303 -1.437 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.428 -170.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 . . . . . 0 N--CA 1.484 1.264 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 2' ' ' ASN . . . . . . . . . . . . . 75.5 m-80 -120.76 30.8 6.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.193 0.521 . . . . 0.0 109.984 176.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -90.02 13.72 14.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.23 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -97.18 -20.02 18.23 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 5' ' ' ALA . . . . . . . . . . . . . . . 55.35 69.01 0.78 Allowed 'General case' 0 N--CA 1.461 0.099 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.619 -178.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . 0.865 ' H ' HD23 ' D' ' 6' ' ' LEU . 1.6 pt? -96.36 7.99 45.1 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.931 -177.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -57.51 -52.52 65.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.591 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.947 ' HG2' HE21 ' D' ' 9' ' ' GLN . 10.9 pm0 -80.36 -7.17 58.97 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.37 -175.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . 0.947 HE21 ' HG2' ' D' ' 8' ' ' GLU . 78.3 mm-40 -96.94 1.01 49.87 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.052 177.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 10' ' ' MET . . . . . . . . . . . . . 15.0 tpt -107.86 -75.39 0.63 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.824 -174.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -99.7 -47.94 4.9 Favored 'General case' 0 CA--C 1.488 -1.425 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.451 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 12' ' ' SER . . . . . 0.786 ' CB ' ' HA ' ' D' ' 8' ' ' GLU . 41.1 t -26.52 -68.36 0.05 OUTLIER 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 113.567 -1.651 . . . . 0.0 114.352 -171.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.441 ' C ' HG12 ' D' ' 16' ' ' VAL . 63.3 mt -78.88 -9.21 12.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.647 -172.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -94.05 -58.79 2.13 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.322 175.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 15' ' ' SER . . . . . 0.571 ' HA ' ' OD1' ' D' ' 18' ' ' ASP . 29.5 m -67.22 -18.28 65.17 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.308 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 16' ' ' VAL . . . . . 0.62 HG13 ' ND2' ' D' ' 17' ' ' ASN . 10.1 p -55.09 -28.89 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.962 0.887 . . . . 0.0 110.07 174.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 17' ' ' ASN . . . . . 0.62 ' ND2' HG13 ' D' ' 16' ' ' VAL . 3.9 m120 -79.92 -32.86 40.11 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.021 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 18' ' ' ASP . . . . . 0.571 ' OD1' ' HA ' ' D' ' 15' ' ' SER . 1.4 m-20 -59.64 -15.99 23.0 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 176.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.581 ' O ' ' HG3' ' D' ' 22' ' ' LYS . 0.0 OUTLIER -91.3 -52.26 4.89 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 122.285 1.041 . . . . 0.0 108.496 175.309 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 20' ' ' LEU . . . . . 0.989 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 60.8 mt -56.08 -39.26 71.83 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 112.953 -1.93 . . . . 0.0 110.516 -179.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 21' ' ' ASN . . . . . 0.613 ' OD1' ' HB2' ' D' ' 26' ' ' LYS . 56.0 m-20 -78.82 96.29 5.6 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.68 177.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 22' ' ' LYS . . . . . 0.581 ' HG3' ' O ' ' D' ' 19' ' ' LYS . 54.6 mttp -122.46 -42.7 2.33 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -178.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 170.83 -86.39 0.08 OUTLIER Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 119.606 -1.283 . . . . 0.0 113.24 -177.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . 0.705 ' HE3' ' HD1' ' D' ' 45' ' ' TYR . 53.7 tptt -46.47 -52.66 12.74 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 25' ' ' GLY . . . . . 1.017 ' HA2' HD21 ' D' ' 42' ' ' ASN . . . -146.31 151.12 23.41 Favored Glycine 0 N--CA 1.436 -1.334 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.681 177.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 26' ' ' LYS . . . . . 0.688 ' CD ' ' HB2' ' D' ' 41' ' ' SER . 0.4 OUTLIER -143.95 160.04 41.52 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.054 -0.573 . . . . 0.0 112.3 -170.113 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 27' ' ' LEU . . . . . 0.989 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 49.2 tp -135.75 143.44 45.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.484 0.659 . . . . 0.0 112.231 -177.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 28' ' ' SER . . . . . 0.647 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 39.2 m -127.39 151.23 49.07 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.965 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 29' ' ' LEU . . . . . 0.476 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 14.4 mt -140.4 156.77 46.28 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.925 177.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 60.2 m -159.19 -173.5 4.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.704 176.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -146.9 165.32 30.14 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 32' ' ' ASN . . . . . 0.501 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 51.4 t30 -150.14 88.81 1.54 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -177.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.31 -100.51 0.88 Allowed Glycine 0 C--O 1.228 -0.228 0 C-N-CA 120.306 -0.949 . . . . 0.0 110.949 -173.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -114.5 31.44 6.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.779 0.323 . . . . 0.0 110.145 173.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 35' ' ' GLN . . . . . 0.501 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 50.5 tt0 -109.63 159.96 16.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.906 0.384 . . . . 0.0 110.967 -176.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.675 HD11 HG22 ' D' ' 79' ' ' ILE . 1.9 tm? -123.77 134.6 53.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.87 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 37' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 13.6 mmmm -132.88 122.86 25.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.522 -168.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -129.65 149.75 51.27 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.828 0.347 . . . . 0.0 110.467 173.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 39' ' ' THR . . . . . 0.647 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 1.7 p -150.47 136.98 18.87 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.807 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . 0.616 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 40.8 p -107.75 133.7 51.77 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 173.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 41' ' ' SER . . . . . 0.688 ' HB2' ' CD ' ' D' ' 26' ' ' LYS . 35.4 m -94.19 164.81 12.9 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 174.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 42' ' ' ASN . . . . . 1.017 HD21 ' HA2' ' D' ' 25' ' ' GLY . 17.6 p30 61.73 10.12 3.23 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 124.669 1.231 . . . . 0.0 111.505 -171.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 53.3 60.5 3.69 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 167.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 44' ' ' GLY . . . . . 0.787 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 104.37 37.4 2.86 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 118.472 -1.823 . . . . 0.0 115.742 164.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 45' ' ' TYR . . . . . 0.705 ' HD1' ' HE3' ' D' ' 24' ' ' LYS . 2.5 m-85 -118.17 158.18 25.56 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 117.991 0.896 . . . . 0.0 109.53 172.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . 0.606 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -92.01 -176.34 42.37 Favored Glycine 0 C--O 1.213 -1.193 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 178.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 47' ' ' ILE . . . . . 0.845 HG12 ' HB3' ' D' ' 68' ' ' GLU . 40.2 mm -47.27 -54.92 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 CA-C-N 118.251 1.025 . . . . 0.0 110.714 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 22.8 t -178.22 -147.59 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 112.92 -1.946 . . . . 0.0 106.313 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -88.01 74.33 8.93 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 119.308 -0.957 . . . . 0.0 108.437 165.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -138.13 -171.93 3.15 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.607 -176.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 51' ' ' ASP . . . . . 0.67 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 52.2 p-10 -147.25 133.58 19.57 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.965 0.888 . . . . 0.0 112.697 177.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 52' ' ' LYS . . . . . 0.67 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 3.5 mptp? -145.49 134.41 22.51 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.164 -176.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -104.99 134.21 48.47 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 174.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 54' ' ' TRP . . . . . 0.635 ' HB2' ' O ' ' D' ' 66' ' ' PHE . 0.1 OUTLIER -125.58 158.13 35.39 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 -170.636 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -151.1 162.87 29.61 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.046 -1.073 . . . . 0.0 114.127 175.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 56' ' ' ILE . . . . . 0.682 HG23 HG12 ' D' ' 91' ' ' ILE . 66.8 mt -135.94 110.87 11.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 57' ' ' PHE . . . . . 0.702 ' HB2' ' HB3' ' D' ' 90' ' ' GLU . 19.4 m-85 -107.67 99.45 8.93 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 119.729 -0.789 . . . . 0.0 111.735 -165.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.678 HG22 HG12 ' D' ' 89' ' ' ILE . 85.7 t -87.86 107.51 17.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.204 175.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 59' ' ' ASN . . . . . 0.47 HD22 ' HB2' ' D' ' 88' ' ' TYR . 3.8 m120 68.79 31.16 4.54 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.937 -178.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.5 -32.35 7.48 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.581 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 61' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 11.2 pt-20 -89.83 139.3 30.71 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.36 0.6 . . . . 0.0 111.686 -175.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . 0.521 ' HB2' ' CE1' ' D' ' 57' ' ' PHE . 38.1 ttpt -81.07 103.59 10.99 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.395 -177.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 28.2 m -82.25 -32.88 11.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.584 0.586 . . . . 0.0 112.584 -174.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 64' ' ' TYR . . . . . 0.465 ' HB3' HD12 ' D' ' 56' ' ' ILE . 19.6 t80 -134.93 131.82 37.7 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.879 -0.329 . . . . 0.0 110.966 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 57.1 m -117.16 119.96 36.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.025 175.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 66' ' ' PHE . . . . . 0.635 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 16.1 p90 -126.31 146.8 49.88 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.195 0.522 . . . . 0.0 110.244 176.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -102.96 142.72 33.57 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -177.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 68' ' ' GLU . . . . . 0.845 ' HB3' HG12 ' D' ' 47' ' ' ILE . 5.6 mm-40 -75.89 -9.29 58.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.237 0.542 . . . . 0.0 109.703 175.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.544 ' HD3' ' HB2' ' D' ' 51' ' ' ASP . 9.1 mtmp? -67.93 -37.1 81.23 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 169.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 19.2 t -74.81 124.81 27.5 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 113.761 -1.563 . . . . 0.0 107.567 171.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 82.8 p -51.15 124.52 11.75 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.325 -176.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 72' ' ' VAL . . . . . 0.665 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -58.49 -11.49 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-O 121.151 0.5 . . . . 0.0 110.919 -175.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 73' ' ' GLY . . . . . 0.787 ' HA3' ' HA2' ' D' ' 44' ' ' GLY . . . -72.48 -61.77 3.5 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 114.948 -1.023 . . . . 0.0 112.861 170.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -57.77 -32.63 67.68 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 120.959 0.409 . . . . 0.0 109.951 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 75' ' ' ILE . . . . . 0.646 ' O ' HG13 ' D' ' 79' ' ' ILE . 23.8 mm -73.35 -42.19 57.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.317 177.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 76' ' ' SER . . . . . 0.511 ' HA ' HG13 ' D' ' 79' ' ' ILE . 30.2 t -73.79 -20.89 60.34 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.009 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -66.83 -29.92 69.97 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 167.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 78' ' ' ASP . . . . . 1.069 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 60.7 m-20 -77.77 -33.94 52.49 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.93 172.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . 0.675 HG22 HD11 ' D' ' 36' ' ' LEU . 25.3 mt -68.54 -17.3 21.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.239 -175.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -72.74 -37.26 67.78 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.424 175.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . 1.069 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -80.13 -51.97 8.34 Favored 'General case' 0 CA--C 1.526 0.033 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.678 176.048 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 82' ' ' LEU . . . . . 0.564 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.9 mm? -49.02 -30.82 6.6 Favored 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 177.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 83' ' ' ASN . . . . . 0.586 HD22 ' HB3' ' D' ' 36' ' ' LEU . 0.8 OUTLIER 40.14 66.23 0.63 Allowed 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.121 0.888 . . . . 0.0 111.374 172.298 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 84' ' ' ILE . . . . . 0.613 HG21 HG21 ' D' ' 56' ' ' ILE . 40.1 mm -82.1 97.74 4.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.074 -174.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.26 94.28 3.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.715 0.769 . . . . 0.0 112.807 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 86' ' ' GLY . . . . . 0.705 ' H ' HD11 ' D' ' 89' ' ' ILE . . . 67.57 153.61 0.38 Allowed Glycine 0 N--CA 1.453 -0.169 0 CA-C-N 115.603 -0.726 . . . . 0.0 113.74 175.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 87' ' ' PRO . . . . . 0.651 ' O ' HG13 ' D' ' 58' ' ' VAL . 42.9 Cg_endo -90.44 179.18 14.63 Favored 'Cis proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.298 -1.542 . . . . 0.0 112.668 -0.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 88' ' ' TYR . . . . . 0.598 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 10.0 m-85 11.56 93.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.622 1.569 . . . . 0.0 113.89 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.705 HD11 ' H ' ' D' ' 86' ' ' GLY . 77.7 mt -106.8 135.75 44.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.076 0.465 . . . . 0.0 111.839 -178.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.702 ' HB3' ' HB2' ' D' ' 57' ' ' PHE . 5.4 tp10 -121.52 97.23 5.41 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.035 173.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 91' ' ' ILE . . . . . 0.682 HG12 HG23 ' D' ' 56' ' ' ILE . 35.2 mt -95.21 102.36 13.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.467 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 92' ' ' LYS . . . . . 0.68 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -160.44 165.6 30.74 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 178.221 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.573 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 17.9 pt20 -80.35 165.55 22.17 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.209 0.528 . . . . 0.0 111.219 177.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . 0.68 HG22 ' HE2' ' D' ' 92' ' ' LYS . 8.1 pt . . . . . 0 C--N 1.313 -1.004 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.394 -170.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 121.166 0.507 . . . . 0.0 111.459 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 2' ' ' ASN . . . . . 0.857 ' HA ' ' HB3' ' D' ' 5' ' ' ALA . 77.0 m-20 60.97 28.24 18.05 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.574 176.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -92.84 -47.83 6.85 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.73 0.3 . . . . 0.0 110.227 174.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -110.68 6.92 22.02 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 173.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 5' ' ' ALA . . . . . 0.857 ' HB3' ' HA ' ' D' ' 2' ' ' ASN . . . -84.43 70.12 10.62 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.204 -178.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -104.31 0.34 29.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.007 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . 0.802 ' HA ' ' HB3' ' D' ' 10' ' ' MET . 13.5 pm0 -69.27 -0.45 6.19 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -176.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.731 ' HA ' ' CB ' ' D' ' 12' ' ' SER . 21.0 pt-20 -87.85 -40.34 14.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.747 0.784 . . . . 0.0 109.537 176.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.9 5.54 39.99 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.276 -1.329 . . . . 0.0 110.35 172.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 10' ' ' MET . . . . . 0.802 ' HB3' ' HA ' ' D' ' 7' ' ' GLU . 26.9 ttt -102.92 -76.23 0.59 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.908 -178.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -101.77 -41.43 6.54 Favored 'General case' 0 CA--C 1.493 -1.238 0 CA-C-O 120.864 0.364 . . . . 0.0 110.562 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 12' ' ' SER . . . . . 0.731 ' CB ' ' HA ' ' D' ' 8' ' ' GLU . 43.9 t -39.17 -65.46 0.37 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.258 -1.337 . . . . 0.0 112.569 -170.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.434 ' C ' HG12 ' D' ' 16' ' ' VAL . 36.3 mm -91.47 -9.37 10.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 114.911 -1.041 . . . . 0.0 111.409 -173.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -95.86 -59.43 1.86 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.107 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 15' ' ' SER . . . . . 0.72 ' O ' ' HE3' ' D' ' 19' ' ' LYS . 90.3 p -67.07 -17.35 64.85 Favored 'General case' 0 C--O 1.219 -0.509 0 O-C-N 121.975 -0.453 . . . . 0.0 110.71 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 16' ' ' VAL . . . . . 0.489 ' HB ' ' O ' ' D' ' 12' ' ' SER . 11.2 p -52.72 -29.68 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.588 0.709 . . . . 0.0 110.227 174.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 17' ' ' ASN . . . . . 0.502 ' HB3' ' ND2' ' D' ' 21' ' ' ASN . 4.9 m120 -75.21 -41.19 58.32 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.646 177.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.23 -16.48 13.99 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.619 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.72 ' HE3' ' O ' ' D' ' 15' ' ' SER . 21.2 mmtp -85.72 -43.28 13.52 Favored 'General case' 0 CA--C 1.504 -0.827 0 CA-C-O 122.723 1.249 . . . . 0.0 108.195 -178.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 20' ' ' LEU . . . . . 0.997 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 63.0 mt -79.91 -37.76 33.99 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 111.308 -2.678 . . . . 0.0 110.591 -173.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 21' ' ' ASN . . . . . 0.567 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 54.2 m-80 -75.6 99.53 4.32 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.351 176.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 22' ' ' LYS . . . . . 0.677 ' HG3' ' O ' ' D' ' 20' ' ' LEU . 24.0 mtpp -120.43 -40.77 2.65 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 119.075 -1.05 . . . . 0.0 113.12 -166.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 157.55 -73.31 0.23 Allowed Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.327 -177.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . 0.925 ' HG2' ' HB3' ' D' ' 45' ' ' TYR . 77.5 tttt -63.82 -61.78 2.07 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 176.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 25' ' ' GLY . . . . . 0.632 ' HA2' HD22 ' D' ' 42' ' ' ASN . . . -127.54 163.71 21.2 Favored Glycine 0 N--CA 1.436 -1.331 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.024 174.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 26' ' ' LYS . . . . . 0.733 ' CD ' ' HB2' ' D' ' 41' ' ' SER . 9.7 ptpt -150.9 160.6 43.8 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.157 -0.522 . . . . 0.0 111.705 -170.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 27' ' ' LEU . . . . . 0.997 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 49.0 tp -137.08 148.04 46.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.073 0.463 . . . . 0.0 111.119 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 28' ' ' SER . . . . . 0.656 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 50.5 m -140.06 142.59 36.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.766 -173.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 29' ' ' LEU . . . . . 0.565 HD11 ' CD1' ' D' ' 20' ' ' LEU . 0.0 OUTLIER -141.5 147.74 38.31 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 119.688 -0.805 . . . . 0.0 111.656 -176.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 66.6 p -155.67 -172.47 4.15 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.83 176.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -137.44 166.53 23.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.864 0.364 . . . . 0.0 110.155 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 32' ' ' ASN . . . . . 0.5 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 23.4 t-20 -147.36 88.81 1.73 Allowed 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.98 -97.98 0.95 Allowed Glycine 0 N--CA 1.454 -0.113 0 C-N-CA 120.017 -1.087 . . . . 0.0 110.718 -170.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 76.0 m-80 -120.67 22.68 11.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.023 0.439 . . . . 0.0 110.034 173.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 35' ' ' GLN . . . . . 0.5 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 3.7 tp-100 -93.53 152.36 19.1 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.025 -177.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.793 ' HB2' ' HG2' ' D' ' 85' ' ' LYS . 2.3 tm? -118.41 128.57 54.75 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.984 0.421 . . . . 0.0 110.218 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 37' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 13.6 mmmm -128.42 121.74 29.72 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.905 -167.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 38' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -131.98 151.61 51.63 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.183 0.516 . . . . 0.0 110.52 174.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 39' ' ' THR . . . . . 0.656 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 2.6 p -149.5 134.81 18.28 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.8 -176.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . 0.54 ' HA ' ' O ' ' D' ' 26' ' ' LYS . 36.1 t -107.74 128.03 54.21 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 41' ' ' SER . . . . . 0.733 ' HB2' ' CD ' ' D' ' 26' ' ' LYS . 46.7 m -95.21 158.79 15.31 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -177.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 42' ' ' ASN . . . . . 0.632 HD22 ' HA2' ' D' ' 25' ' ' GLY . 0.1 OUTLIER 81.67 -17.31 0.56 Allowed 'General case' 0 N--CA 1.475 0.802 0 O-C-N 124.584 1.178 . . . . 0.0 109.313 -169.158 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 72.99 63.44 0.1 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 173.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 44' ' ' GLY . . . . . 0.711 ' O ' ' HB ' ' D' ' 71' ' ' THR . . . 126.92 -40.43 1.78 Allowed Glycine 0 C--N 1.341 0.825 0 C-N-CA 119.317 -1.42 . . . . 0.0 116.052 169.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 45' ' ' TYR . . . . . 0.925 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 3.3 m-30 -59.82 156.03 15.01 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 118.515 1.157 . . . . 0.0 113.798 -172.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -98.25 -153.24 28.58 Favored Glycine 0 C--O 1.218 -0.893 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.566 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 47' ' ' ILE . . . . . 0.98 HG13 ' HB2' ' D' ' 68' ' ' GLU . 0.3 OUTLIER -50.92 -58.7 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-O 122.238 1.018 . . . . 0.0 110.184 -176.6 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.524 ' HA ' ' CD ' ' D' ' 24' ' ' LYS . 34.5 p 168.77 -76.06 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 111.47 -2.604 . . . . 0.0 106.158 -169.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -163.68 75.73 0.36 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.05 -1.432 . . . . 0.0 107.609 162.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . 0.705 ' O ' ' HG2' ' D' ' 69' ' ' LYS . 4.5 mm-40 -142.21 -159.31 0.95 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.004 -173.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 51' ' ' ASP . . . . . 0.623 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 35.6 t0 -146.62 125.99 13.14 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.118 176.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 52' ' ' LYS . . . . . 0.623 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 0.2 OUTLIER -141.62 100.0 3.67 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.111 -174.102 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -73.96 127.03 31.81 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.155 0.502 . . . . 0.0 110.515 177.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 54' ' ' TRP . . . . . 0.517 ' CH2' ' HA ' ' D' ' 92' ' ' LYS . 0.1 OUTLIER -118.74 155.26 31.4 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.611 -177.293 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -143.03 155.91 26.2 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 119.888 -1.149 . . . . 0.0 113.445 176.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 56' ' ' ILE . . . . . 0.78 HG23 HG12 ' D' ' 91' ' ' ILE . 61.0 mt -132.91 110.26 15.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 174.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 57' ' ' PHE . . . . . 0.728 ' HB2' ' HB2' ' D' ' 90' ' ' GLU . 9.4 m-85 -107.84 107.68 18.53 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 119.553 -0.859 . . . . 0.0 111.222 -167.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.681 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 98.1 t -96.63 110.74 25.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 173.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 64.21 37.51 8.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.797 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.03 -33.86 5.64 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.663 -0.78 . . . . 0.0 114.084 172.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 61' ' ' GLU . . . . . 0.516 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 12.1 pt-20 -90.86 156.87 17.69 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -177.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 41.5 mttm -77.32 126.32 30.74 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 13.1 p -94.63 -26.5 4.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 121.161 0.505 . . . . 0.0 109.947 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 64' ' ' TYR . . . . . 0.463 ' HB3' HD12 ' D' ' 56' ' ' ILE . 29.7 t80 -148.98 137.56 21.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.858 175.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 40.6 m -120.61 124.56 45.56 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 176.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 66' ' ' PHE . . . . . 0.478 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 21.6 p90 -131.94 165.21 24.42 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 175.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 67' ' ' ASN . . . . . 0.731 ' OD1' ' HG3' ' D' ' 69' ' ' LYS . 21.7 t-20 -131.77 150.88 52.01 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -176.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 68' ' ' GLU . . . . . 0.98 ' HB2' HG13 ' D' ' 47' ' ' ILE . 35.5 mm-40 -71.65 -20.67 61.92 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 119.499 -0.88 . . . . 0.0 109.731 177.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.731 ' HG3' ' OD1' ' D' ' 67' ' ' ASN . 26.2 mtpp -61.99 -48.27 81.08 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 173.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 23.9 m -71.73 77.98 0.85 Allowed 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 112.162 -2.29 . . . . 0.0 108.42 174.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 71' ' ' THR . . . . . 0.711 ' HB ' ' O ' ' D' ' 44' ' ' GLY . 59.7 p -19.82 117.39 0.03 OUTLIER 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.161 1.385 . . . . 0.0 113.933 -173.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 72' ' ' VAL . . . . . 0.481 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -51.42 -14.89 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 176.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 73' ' ' GLY . . . . . 0.536 ' HA3' ' HA2' ' D' ' 44' ' ' GLY . . . -67.49 -65.36 2.77 Favored Glycine 0 N--CA 1.435 -1.433 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.818 174.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 74' ' ' ASN . . . . . 0.728 ' HA ' HD22 ' D' ' 77' ' ' ASN . 4.2 m120 -67.12 -23.52 65.83 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.485 -0.358 . . . . 0.0 110.675 -177.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 75' ' ' ILE . . . . . 0.605 ' O ' HG13 ' D' ' 79' ' ' ILE . 32.6 mm -75.13 -39.85 43.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.506 177.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 76' ' ' SER . . . . . 0.413 ' HA ' HG13 ' D' ' 79' ' ' ILE . 28.7 t -73.29 -19.33 61.07 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.948 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 77' ' ' ASN . . . . . 0.728 HD22 ' HA ' ' D' ' 74' ' ' ASN . 78.6 m-20 -66.78 -31.3 71.85 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 167.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 78' ' ' ASP . . . . . 1.01 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 59.3 m-20 -78.11 -32.15 50.37 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.223 174.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . 0.626 HG22 HD11 ' D' ' 36' ' ' LEU . 18.0 mt -71.33 -16.69 19.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 C-N-CA 120.031 -0.668 . . . . 0.0 109.507 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -67.05 -31.57 72.17 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.821 173.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . 1.01 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -92.44 -49.48 6.11 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 177.321 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 82' ' ' LEU . . . . . 0.624 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.7 mm? -51.27 -28.06 10.89 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -176.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 83' ' ' ASN . . . . . 0.647 ' HA ' HD12 ' D' ' 36' ' ' LEU . 7.1 m120 33.21 72.7 0.08 Allowed 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 84' ' ' ILE . . . . . 0.649 HG22 HD13 ' D' ' 89' ' ' ILE . 41.2 mm -91.45 98.96 8.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.884 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 85' ' ' LYS . . . . . 0.793 ' HG2' ' HB2' ' D' ' 36' ' ' LEU . 30.7 mmmt -141.18 101.48 4.03 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.35 171.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 86' ' ' GLY . . . . . 0.626 ' H ' HD11 ' D' ' 89' ' ' ILE . . . 73.34 149.87 1.36 Allowed Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.094 -0.957 . . . . 0.0 113.393 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 87' ' ' PRO . . . . . 0.632 ' O ' HG13 ' D' ' 58' ' ' VAL . 43.2 Cg_endo -88.46 178.31 19.16 Favored 'Cis proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.917 -1.701 . . . . 0.0 112.557 0.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 88' ' ' TYR . . . . . 0.681 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 3.6 m-85 11.71 94.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 125.3 1.44 . . . . 0.0 114.366 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.677 HG12 HG22 ' D' ' 58' ' ' VAL . 62.6 mt -110.56 142.88 21.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.3 0.571 . . . . 0.0 112.468 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.728 ' HB2' ' HB2' ' D' ' 57' ' ' PHE . 59.7 mm-40 -124.06 91.08 3.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.694 172.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 91' ' ' ILE . . . . . 0.78 HG12 HG23 ' D' ' 56' ' ' ILE . 23.2 mt -95.29 99.64 9.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 92' ' ' LYS . . . . . 0.633 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -161.09 166.95 27.22 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.639 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.605 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 18.9 pt20 -81.5 164.46 21.97 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.274 176.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . 0.633 HG21 ' HZ ' ' D' ' 57' ' ' PHE . 8.1 pt . . . . . 0 C--N 1.311 -1.071 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.351 -169.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 36.2 t70 . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 120.516 0.198 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 2' ' ' ASN . . . . . 0.762 ' HA ' ' HB3' ' D' ' 5' ' ' ALA . 16.0 p-10 -91.94 29.66 1.55 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -178.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -84.38 -47.07 11.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.584 0.23 . . . . 0.0 110.892 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -111.1 5.85 20.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.14 0.495 . . . . 0.0 109.783 175.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 5' ' ' ALA . . . . . 0.762 ' HB3' ' HA ' ' D' ' 2' ' ' ASN . . . -83.87 2.49 38.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.253 -178.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 82.5 mt -110.73 16.16 21.54 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.369 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . 0.462 ' HA ' HE21 ' D' ' 9' ' ' GLN . 10.9 pt-20 -65.01 1.79 0.87 Allowed 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -175.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.547 ' O ' ' HB2' ' D' ' 12' ' ' SER . 0.8 OUTLIER -89.97 1.38 56.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.819 0.342 . . . . 0.0 110.358 179.3 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . 0.678 ' HA ' ' HB3' ' D' ' 12' ' ' SER . 14.6 pt20 -56.84 14.72 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.522 1.529 . . . . 0.0 114.467 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 10' ' ' MET . . . . . 0.497 ' H ' ' C ' ' D' ' 8' ' ' GLU . 15.1 tpt -94.31 -50.25 5.34 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.753 0.311 . . . . 0.0 110.49 177.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 11' ' ' ASN . . . . . 0.55 ' HB3' ' HB3' ' D' ' 15' ' ' SER . 11.1 m-80 -103.82 -12.25 17.04 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 173.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 12' ' ' SER . . . . . 0.768 ' O ' ' HB ' ' D' ' 16' ' ' VAL . 29.3 t -40.37 -65.73 0.38 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.943 -171.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.593 ' O ' HG12 ' D' ' 16' ' ' VAL . 40.2 mm -92.36 -9.77 9.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.752 -178.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -88.35 -61.91 1.61 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.009 177.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 15' ' ' SER . . . . . 0.63 ' HA ' ' OD1' ' D' ' 18' ' ' ASP . 86.6 p -65.96 -17.14 64.47 Favored 'General case' 0 C--O 1.217 -0.607 0 O-C-N 122.005 -0.435 . . . . 0.0 110.379 176.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 16' ' ' VAL . . . . . 0.768 ' HB ' ' O ' ' D' ' 12' ' ' SER . 1.2 p -58.03 -23.2 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-O 121.652 0.739 . . . . 0.0 109.248 176.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 17' ' ' ASN . . . . . 0.543 ' HB3' ' ND2' ' D' ' 21' ' ' ASN . 4.6 m120 -89.18 -26.48 21.24 Favored 'General case' 0 C--O 1.212 -0.91 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.253 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 18' ' ' ASP . . . . . 0.63 ' OD1' ' HA ' ' D' ' 15' ' ' SER . 1.2 m-20 -61.79 -15.64 43.11 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.648 174.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.879 ' N ' ' HE2' ' D' ' 19' ' ' LYS . 0.4 OUTLIER -86.69 -55.86 3.67 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 173.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 20' ' ' LEU . . . . . 1.079 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 64.6 mt -56.71 -40.67 76.07 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 112.253 -2.249 . . . . 0.0 111.266 -176.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 21' ' ' ASN . . . . . 0.59 ' OD1' ' HB2' ' D' ' 26' ' ' LYS . 55.8 m-80 -81.01 99.54 8.49 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.8 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 22' ' ' LYS . . . . . 0.733 ' HD2' HD12 ' D' ' 47' ' ' ILE . 97.8 mttt -123.12 -41.99 2.29 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -175.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.39 -88.18 0.07 OUTLIER Glycine 0 N--CA 1.437 -1.292 0 C-N-CA 119.536 -1.316 . . . . 0.0 113.055 -176.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . 0.9 ' HE2' ' HA ' ' D' ' 48' ' ' SER . 32.8 ttpt -60.85 -62.03 2.16 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 25' ' ' GLY . . . . . 0.714 ' HA2' ' ND2' ' D' ' 42' ' ' ASN . . . -116.72 153.17 17.55 Favored Glycine 0 N--CA 1.432 -1.571 0 CA-C-N 115.21 -0.905 . . . . 0.0 112.494 175.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 26' ' ' LYS . . . . . 0.716 ' CD ' ' HB3' ' D' ' 41' ' ' SER . 9.0 ptpt -149.15 160.18 43.58 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.25 -0.975 . . . . 0.0 110.757 -171.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 27' ' ' LEU . . . . . 1.079 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 53.3 tp -138.11 150.33 46.76 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.525 0.679 . . . . 0.0 111.975 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 28' ' ' SER . . . . . 0.672 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 41.0 m -135.34 150.02 49.85 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.896 -177.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 29' ' ' LEU . . . . . . . . . . . . . 13.5 mt -140.12 149.9 43.61 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.269 177.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 22.7 t -160.05 -171.68 3.32 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 3.0 ppp? -141.85 166.07 25.72 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.109 0.481 . . . . 0.0 111.132 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 32' ' ' ASN . . . . . 0.491 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 26.6 t-20 -144.85 89.36 1.97 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.34 -0.845 . . . . 0.0 108.759 -178.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.94 -97.84 0.75 Allowed Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 119.887 -1.149 . . . . 0.0 111.099 -172.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -113.08 7.45 18.02 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.667 -0.313 . . . . 0.0 110.349 176.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 35' ' ' GLN . . . . . 0.491 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 7.5 tt0 -89.11 160.85 16.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.437 -172.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.598 ' HB3' HD22 ' D' ' 83' ' ' ASN . 0.9 OUTLIER -120.78 131.59 54.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.809 176.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 37' ' ' LYS . . . . . 0.506 ' HB3' ' HZ2' ' D' ' 37' ' ' LYS . 1.3 mmmp? -134.9 119.03 17.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.865 -169.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 38' ' ' ALA . . . . . 0.434 ' HB1' HD11 ' D' ' 27' ' ' LEU . . . -115.41 151.03 35.46 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.018 0.437 . . . . 0.0 111.0 175.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 39' ' ' THR . . . . . 0.672 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 7.0 p -146.33 131.71 18.6 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.747 177.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . 0.668 ' HB3' ' HA2' ' D' ' 73' ' ' GLY . 33.2 t -106.73 133.59 51.17 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 173.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 41' ' ' SER . . . . . 0.716 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 38.6 t -92.93 148.45 22.0 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 42' ' ' ASN . . . . . 0.714 ' ND2' ' HA2' ' D' ' 25' ' ' GLY . 0.5 OUTLIER 83.6 -16.85 0.52 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.762 1.625 . . . . 0.0 109.409 -166.731 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 62.28 55.77 2.31 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 44' ' ' GLY . . . . . 0.436 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 123.46 35.3 0.71 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 119.1 -1.524 . . . . 0.0 115.495 168.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 45' ' ' TYR . . . . . 0.771 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 2.5 m-85 -122.76 158.34 30.38 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 122.111 -0.64 . . . . 0.0 109.661 170.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -98.46 176.61 30.25 Favored Glycine 0 C--O 1.221 -0.66 0 CA-C-O 118.972 -0.904 . . . . 0.0 110.875 177.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 47' ' ' ILE . . . . . 0.843 HG12 ' HB3' ' D' ' 68' ' ' GLU . 33.0 mm -47.26 -56.0 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 CA-C-O 121.922 0.867 . . . . 0.0 109.712 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.9 ' HA ' ' HE2' ' D' ' 24' ' ' LYS . 16.1 t 179.27 -149.01 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 113.149 -1.841 . . . . 0.0 107.393 178.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 49' ' ' TYR . . . . . 0.406 ' HD1' ' O ' ' D' ' 49' ' ' TYR . 0.1 OUTLIER -78.9 76.69 5.38 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.453 0.644 . . . . 0.0 110.416 168.32 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . 0.678 ' HB3' ' HE2' ' D' ' 52' ' ' LYS . 71.1 mm-40 -126.3 -166.17 1.54 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.28 -174.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 51' ' ' ASP . . . . . 0.683 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 7.0 t70 -161.04 119.68 2.5 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 114.503 -1.226 . . . . 0.0 111.565 171.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 52' ' ' LYS . . . . . 0.683 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 3.6 mptp? -142.99 115.85 8.76 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 114.22 -1.355 . . . . 0.0 109.822 -174.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -90.98 135.47 33.72 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 174.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 54' ' ' TRP . . . . . 0.633 ' HB2' ' O ' ' D' ' 66' ' ' PHE . 0.0 OUTLIER -126.93 158.02 37.91 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.855 -172.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -145.87 153.44 25.3 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 119.701 -1.237 . . . . 0.0 113.883 174.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 56' ' ' ILE . . . . . 0.665 HG23 HG12 ' D' ' 91' ' ' ILE . 61.8 mt -127.62 113.75 32.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 174.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 57' ' ' PHE . . . . . 0.849 ' HB2' ' HB2' ' D' ' 90' ' ' GLU . 8.4 m-85 -109.5 105.85 15.35 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.304 -168.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.73 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 94.3 t -90.48 103.63 14.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.997 173.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 59' ' ' ASN . . . . . 0.484 ' OD1' ' HG2' ' D' ' 87' ' ' PRO . 6.3 m120 61.1 47.02 7.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.36 -0.837 . . . . 0.0 111.655 -177.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.65 -33.7 5.69 Favored Glycine 0 CA--C 1.509 -0.292 0 C-N-CA 120.681 -0.771 . . . . 0.0 114.365 172.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 61' ' ' GLU . . . . . 0.536 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 16.6 pt-20 -92.97 146.83 23.33 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 120.931 -0.307 . . . . 0.0 111.229 -176.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -73.58 113.86 11.17 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 173.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 14.5 p -88.68 -23.41 6.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-O 121.098 0.475 . . . . 0.0 110.21 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 64' ' ' TYR . . . . . 0.483 ' HB3' HD12 ' D' ' 56' ' ' ILE . 26.4 t80 -152.85 135.26 15.1 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.608 175.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.49 HG23 ' O ' ' D' ' 54' ' ' TRP . 88.9 m -121.15 125.92 48.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.412 176.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 66' ' ' PHE . . . . . 0.633 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 10.1 p90 -132.54 154.52 49.9 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.08 0.467 . . . . 0.0 110.409 178.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 67' ' ' ASN . . . . . 0.604 ' HA ' ' O ' ' D' ' 52' ' ' LYS . 3.9 m120 -114.1 145.51 41.53 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -178.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 68' ' ' GLU . . . . . 0.843 ' HB3' HG12 ' D' ' 47' ' ' ILE . 35.7 mt-10 -75.8 -8.94 58.09 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.42 177.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.622 ' HG2' ' O ' ' D' ' 50' ' ' GLU . 45.5 mtmt -63.83 -55.43 23.0 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 168.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 49.9 m -57.56 118.24 5.01 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 112.528 -2.124 . . . . 0.0 109.374 172.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 81.9 p -48.13 117.53 1.97 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.685 -176.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 72' ' ' VAL . . . . . 0.696 HG11 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -57.77 -11.95 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-O 120.788 0.328 . . . . 0.0 111.073 -174.565 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 73' ' ' GLY . . . . . 0.668 ' HA2' ' HB3' ' D' ' 40' ' ' SER . . . -74.42 -61.01 3.3 Favored Glycine 0 N--CA 1.436 -1.303 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.582 175.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 74' ' ' ASN . . . . . 0.763 ' HA ' HD22 ' D' ' 77' ' ' ASN . 28.5 t-20 -60.91 -28.17 68.72 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 75' ' ' ILE . . . . . 0.522 ' O ' ' HB2' ' D' ' 78' ' ' ASP . 31.3 mm -74.46 -41.14 49.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.894 175.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 76' ' ' SER . . . . . 0.451 ' HB2' HD13 ' D' ' 27' ' ' LEU . 28.8 t -73.18 -19.81 61.02 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.116 -177.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 77' ' ' ASN . . . . . 0.763 HD22 ' HA ' ' D' ' 74' ' ' ASN . 77.0 m-20 -61.8 -43.45 98.83 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 165.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 78' ' ' ASP . . . . . 0.962 ' HA ' ' HG2' ' D' ' 81' ' ' LYS . 1.1 m-20 -64.03 -34.78 78.78 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.978 174.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . 0.519 HG13 ' O ' ' D' ' 75' ' ' ILE . 53.6 mt -72.22 -24.56 22.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 C-N-CA 119.129 -1.028 . . . . 0.0 110.46 -174.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -78.64 -16.11 57.72 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.175 171.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . 0.962 ' HG2' ' HA ' ' D' ' 78' ' ' ASP . 25.6 mmtt -76.06 -64.54 1.07 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 172.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 82' ' ' LEU . . . . . 0.636 HD23 ' O ' ' D' ' 78' ' ' ASP . 2.8 mm? -46.71 -31.09 2.71 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 113.114 -1.857 . . . . 0.0 112.521 -179.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 83' ' ' ASN . . . . . 0.598 HD22 ' HB3' ' D' ' 36' ' ' LEU . 0.7 OUTLIER 45.55 57.59 4.85 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.668 0.605 . . . . 0.0 110.574 174.677 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 84' ' ' ILE . . . . . 0.527 ' O ' ' HG ' ' D' ' 36' ' ' LEU . 44.9 mm -83.38 97.63 4.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.913 0.387 . . . . 0.0 111.37 -173.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 85' ' ' LYS . . . . . 0.508 ' HB2' ' HB2' ' D' ' 36' ' ' LEU . 2.7 tmtm? -139.34 92.88 2.62 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 86' ' ' GLY . . . . . 0.732 ' HA2' HD11 ' D' ' 89' ' ' ILE . . . 72.74 152.06 1.65 Allowed Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.437 -0.801 . . . . 0.0 113.516 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 87' ' ' PRO . . . . . 0.595 ' O ' HG13 ' D' ' 58' ' ' VAL . 50.0 Cg_endo -90.12 179.47 14.7 Favored 'Cis proline' 0 CA--C 1.535 0.551 0 C-N-CA 123.304 -1.54 . . . . 0.0 113.195 0.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 88' ' ' TYR . . . . . 0.73 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 1.8 m-85 24.55 93.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.925 1.29 . . . . 0.0 113.62 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.732 HD11 ' HA2' ' D' ' 86' ' ' GLY . 3.5 mp -108.64 125.87 65.52 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-O 121.184 0.516 . . . . 0.0 111.665 -175.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.849 ' HB2' ' HB2' ' D' ' 57' ' ' PHE . 5.5 mm-40 -119.65 89.59 3.16 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.75 171.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 91' ' ' ILE . . . . . 0.717 HG13 HG22 ' D' ' 89' ' ' ILE . 34.8 mt -95.95 101.19 12.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.076 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 92' ' ' LYS . . . . . 0.661 ' HG2' ' O ' ' D' ' 93' ' ' GLN . 0.0 OUTLIER -162.34 170.57 18.65 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.247 179.131 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.661 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 17.1 pt20 -81.15 161.94 23.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.542 0.687 . . . . 0.0 110.992 173.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . 0.429 HG22 ' HE3' ' D' ' 92' ' ' LYS . 7.7 pt . . . . . 0 C--N 1.309 -1.18 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.435 -173.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 . . . . . 0 N--CA 1.483 1.21 0 CA-C-O 120.398 0.142 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 2' ' ' ASN . . . . . 0.451 ' HB3' ' HB3' ' D' ' 5' ' ' ALA . 77.1 m-20 -137.23 108.96 7.02 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 177.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -95.93 -3.07 45.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.743 -173.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 4' ' ' LYS . . . . . 0.862 ' HA ' ' HE3' ' D' ' 4' ' ' LYS . 0.0 OUTLIER -108.96 -29.08 8.77 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.286 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 5' ' ' ALA . . . . . 0.451 ' HB3' ' HB3' ' D' ' 2' ' ' ASN . . . -81.93 71.37 8.97 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.161 -178.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 81.4 mt -101.59 23.86 10.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.352 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -82.05 -70.01 0.58 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.861 0.362 . . . . 0.0 111.084 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.783 ' HA ' ' CB ' ' D' ' 12' ' ' SER . 0.6 OUTLIER -92.35 -32.96 14.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.317 0.579 . . . . 0.0 110.891 -179.332 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . 0.692 ' HG3' ' HG2' ' D' ' 8' ' ' GLU . 45.8 mt-30 -83.96 5.62 24.92 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.133 -172.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 10' ' ' MET . . . . . . . . . . . . . 15.5 tpt -108.15 -73.31 0.69 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.41 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -100.83 -48.35 4.5 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.119 178.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 12' ' ' SER . . . . . 0.783 ' CB ' ' HA ' ' D' ' 8' ' ' GLU . 44.9 t -29.57 -61.72 0.14 Allowed 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.53 -1.214 . . . . 0.0 114.071 -172.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.476 ' O ' HG12 ' D' ' 16' ' ' VAL . 67.3 mt -82.7 -8.56 11.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.279 -172.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -94.66 -49.58 5.56 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.032 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 15' ' ' SER . . . . . 0.729 ' HA ' ' OD2' ' D' ' 18' ' ' ASP . 88.6 p -70.35 -15.95 62.93 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.965 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 16' ' ' VAL . . . . . 0.715 ' HA ' ' HE2' ' D' ' 19' ' ' LYS . 12.4 p -58.82 -34.47 52.36 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.107 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 175.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 17' ' ' ASN . . . . . 0.651 ' ND2' ' HA ' ' D' ' 28' ' ' SER . 4.5 m120 -64.79 -42.17 95.26 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.747 172.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 18' ' ' ASP . . . . . 0.729 ' OD2' ' HA ' ' D' ' 15' ' ' SER . 60.6 m-20 -57.2 -17.32 10.86 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -175.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.715 ' HE2' ' HA ' ' D' ' 16' ' ' VAL . 0.0 OUTLIER -92.04 -38.86 11.96 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 122.167 0.985 . . . . 0.0 109.202 174.523 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 20' ' ' LEU . . . . . 0.903 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 84.8 mt -78.86 -31.32 45.55 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 112.897 -1.956 . . . . 0.0 111.121 -170.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 21' ' ' ASN . . . . . 0.553 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 2.8 t-20 -99.12 95.74 7.31 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.291 -167.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 22' ' ' LYS . . . . . 0.841 ' HD3' HG23 ' D' ' 47' ' ' ILE . 5.7 mtpm? -121.94 -42.91 2.37 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 118.308 -1.357 . . . . 0.0 113.926 -169.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 168.07 -80.32 0.1 Allowed Glycine 0 N--CA 1.439 -1.111 0 C-N-CA 119.912 -1.137 . . . . 0.0 112.787 -175.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . 0.813 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 23.4 tptm -47.85 -59.72 3.11 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 176.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 25' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -140.26 159.34 26.17 Favored Glycine 0 N--CA 1.431 -1.649 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.219 173.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 26' ' ' LYS . . . . . 0.707 ' HA ' ' O ' ' D' ' 20' ' ' LEU . 9.6 ptpt -149.67 160.57 43.41 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.467 -0.866 . . . . 0.0 110.771 -168.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 27' ' ' LEU . . . . . 0.903 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 41.4 tp -134.54 135.99 42.72 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.225 0.536 . . . . 0.0 111.747 178.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 28' ' ' SER . . . . . 0.651 ' HA ' ' ND2' ' D' ' 17' ' ' ASN . 50.6 m -125.27 133.29 52.72 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.709 -174.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 29' ' ' LEU . . . . . 0.712 HD11 HD12 ' D' ' 20' ' ' LEU . 0.0 OUTLIER -140.71 134.74 30.76 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.706 -174.078 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 72.6 p -146.8 174.12 11.77 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.799 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 23.2 ptm -136.42 118.84 15.76 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.496 0.665 . . . . 0.0 111.114 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -93.23 89.35 6.38 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.09 -104.78 2.61 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.499 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 76.0 m-80 -117.6 17.22 14.49 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.343 0.592 . . . . 0.0 109.651 175.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 35' ' ' GLN . . . . . 0.472 ' OE1' ' HD2' ' D' ' 37' ' ' LYS . 49.9 tt0 -94.4 142.19 27.71 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.479 -177.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.68 HD11 HG22 ' D' ' 79' ' ' ILE . 2.7 tm? -112.3 115.88 29.49 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.219 0.533 . . . . 0.0 111.195 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 37' ' ' LYS . . . . . 0.773 ' HA ' ' HE2' ' D' ' 37' ' ' LYS . 10.0 mmpt? -117.72 122.77 44.38 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 114.188 -1.369 . . . . 0.0 111.566 -168.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 38' ' ' ALA . . . . . 0.584 ' HB1' HD11 ' D' ' 27' ' ' LEU . . . -130.5 154.76 47.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.136 0.493 . . . . 0.0 111.186 176.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 39' ' ' THR . . . . . 0.639 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 2.5 p -150.37 131.95 14.84 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.763 -177.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . 0.626 ' HB3' ' HA2' ' D' ' 73' ' ' GLY . 40.4 t -108.17 129.77 55.16 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 172.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 41' ' ' SER . . . . . 0.686 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 32.7 t -95.87 154.47 17.21 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.432 -0.907 . . . . 0.0 109.592 -178.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 42' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' D' ' 41' ' ' SER . 77.0 m-20 78.28 6.69 2.52 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.96 -169.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 51.22 60.32 3.96 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 114.57 -1.196 . . . . 0.0 113.956 170.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 44' ' ' GLY . . . . . 0.581 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 105.99 37.01 2.61 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 119.189 -1.481 . . . . 0.0 114.357 170.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 45' ' ' TYR . . . . . 0.813 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 2.3 m-30 -113.96 153.19 29.73 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 173.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . 0.57 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -95.24 -162.86 34.45 Favored Glycine 0 C--O 1.219 -0.797 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 47' ' ' ILE . . . . . 0.841 HG23 ' HD3' ' D' ' 22' ' ' LYS . 39.0 mm -51.46 -55.72 7.55 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.706 0 CA-C-O 122.06 0.933 . . . . 0.0 109.035 174.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 62.3 p -174.77 -86.96 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 112.975 -1.92 . . . . 0.0 108.862 -176.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 49' ' ' TYR . . . . . 0.434 ' HD2' ' O ' ' D' ' 49' ' ' TYR . 0.1 OUTLIER -152.64 76.03 1.13 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.263 167.545 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . 0.724 ' O ' ' HG2' ' D' ' 69' ' ' LYS . 4.2 mm-40 -137.35 -164.93 1.67 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.443 -172.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 51' ' ' ASP . . . . . 0.613 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 8.9 t70 -138.26 127.93 25.05 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.741 173.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 52' ' ' LYS . . . . . 0.613 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 0.3 OUTLIER -143.07 121.68 12.52 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.407 -1.27 . . . . 0.0 109.482 -178.442 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -99.1 132.5 44.36 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.344 -0.542 . . . . 0.0 109.815 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 54' ' ' TRP . . . . . 1.018 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 0.9 OUTLIER -121.7 152.97 38.81 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.903 -172.465 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -137.65 156.07 23.43 Favored Glycine 0 N--CA 1.436 -1.364 0 C-N-CA 119.732 -1.223 . . . . 0.0 112.576 172.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 56' ' ' ILE . . . . . 1.103 HG12 HG23 ' D' ' 91' ' ' ILE . 96.2 mt -126.53 94.46 2.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 176.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 57' ' ' PHE . . . . . 0.571 ' HA ' ' O ' ' D' ' 61' ' ' GLU . 18.2 m-85 -95.39 108.35 20.54 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.668 -165.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.745 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 66.4 t -95.69 105.97 17.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.447 171.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 59' ' ' ASN . . . . . 0.512 ' ND2' ' HB2' ' D' ' 88' ' ' TYR . 4.1 m120 60.85 46.72 8.44 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.759 0.314 . . . . 0.0 111.495 -177.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.01 48.31 54.72 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.676 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 61' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 17.6 tp10 -159.61 126.15 4.46 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -73.48 109.6 7.12 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.087 176.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.441 HG23 HD13 ' D' ' 84' ' ' ILE . 34.4 m -82.91 -10.77 12.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 120.991 0.424 . . . . 0.0 110.777 176.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 64' ' ' TYR . . . . . 0.562 ' HB3' HD12 ' D' ' 56' ' ' ILE . 13.9 t80 -158.93 137.85 11.18 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.271 174.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 71.7 m -122.81 113.5 19.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.145 177.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 66' ' ' PHE . . . . . 0.505 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 11.5 p90 -120.34 156.68 30.81 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.121 0.486 . . . . 0.0 110.061 177.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 67' ' ' ASN . . . . . 0.736 HD22 ' HB2' ' D' ' 69' ' ' LYS . 14.6 p-10 -122.96 133.91 54.36 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.317 -174.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 68' ' ' GLU . . . . . 0.814 ' HB3' HG12 ' D' ' 47' ' ' ILE . 40.6 mm-40 -68.05 -8.35 36.99 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.348 -176.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.736 ' HB2' HD22 ' D' ' 67' ' ' ASN . 49.6 mtpt -63.5 -44.24 94.89 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 169.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 70' ' ' SER . . . . . 0.411 ' HB3' ' O ' ' D' ' 67' ' ' ASN . 24.2 t -64.19 125.72 25.45 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 113.667 -1.606 . . . . 0.0 107.689 167.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 71' ' ' THR . . . . . 0.418 ' O ' HG13 ' D' ' 75' ' ' ILE . 75.4 p -55.76 128.87 36.97 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 72' ' ' VAL . . . . . 0.688 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -57.09 -13.76 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-O 121.163 0.506 . . . . 0.0 110.601 -177.503 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 73' ' ' GLY . . . . . 0.626 ' HA2' ' HB3' ' D' ' 40' ' ' SER . . . -67.6 -63.45 3.71 Favored Glycine 0 N--CA 1.434 -1.433 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.568 171.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -64.79 -19.65 65.94 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.314 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 75' ' ' ILE . . . . . 0.488 HD12 ' HA ' ' D' ' 72' ' ' VAL . 74.7 mt -73.5 -41.06 56.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 173.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 76' ' ' SER . . . . . 0.7 ' HA ' HG12 ' D' ' 79' ' ' ILE . 41.5 t -75.26 -22.61 57.68 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.039 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 77' ' ' ASN . . . . . 0.404 ' O ' ' HD2' ' D' ' 81' ' ' LYS . 5.6 m120 -61.68 -25.22 67.26 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 167.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 78' ' ' ASP . . . . . 1.104 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 0.9 OUTLIER -90.03 -27.29 19.83 Favored 'General case' 0 C--O 1.227 -0.122 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 175.529 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . 0.7 HG12 ' HA ' ' D' ' 76' ' ' SER . 22.5 mm -68.86 -34.65 65.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.391 -176.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -66.88 -32.06 73.08 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -177.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . 1.104 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -77.25 -53.74 7.35 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.99 175.607 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 82' ' ' LEU . . . . . 0.58 HD23 ' O ' ' D' ' 78' ' ' ASP . 2.9 mm? -47.37 -32.22 4.69 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.008 0.523 . . . . 0.0 112.322 177.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 83' ' ' ASN . . . . . 0.584 ' HA ' HD12 ' D' ' 36' ' ' LEU . 9.3 t30 37.65 58.0 1.39 Allowed 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.45 1.094 . . . . 0.0 110.897 178.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 84' ' ' ILE . . . . . 0.585 ' N ' ' HG ' ' D' ' 36' ' ' LEU . 54.8 mt -80.32 104.47 8.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.993 0.425 . . . . 0.0 111.889 -172.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.21 92.97 2.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.771 0.796 . . . . 0.0 112.33 177.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 86' ' ' GLY . . . . . 0.741 ' HA2' HD11 ' D' ' 89' ' ' ILE . . . 75.65 153.35 4.16 Favored Glycine 0 CA--C 1.509 -0.288 0 CA-C-N 115.128 -0.942 . . . . 0.0 114.196 173.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 87' ' ' PRO . . . . . 0.65 ' O ' HG13 ' D' ' 58' ' ' VAL . 50.8 Cg_endo -89.41 -179.6 14.29 Favored 'Cis proline' 0 CA--C 1.534 0.478 0 C-N-CA 123.221 -1.575 . . . . 0.0 113.247 0.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 88' ' ' TYR . . . . . 0.745 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 1.8 m-85 20.86 93.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.812 1.245 . . . . 0.0 113.897 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.741 HD11 ' HA2' ' D' ' 86' ' ' GLY . 2.9 mp -110.76 134.14 53.99 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.281 -177.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -128.2 96.5 4.47 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.495 169.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 91' ' ' ILE . . . . . 1.103 HG23 HG12 ' D' ' 56' ' ' ILE . 6.0 mt -96.13 105.4 17.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 178.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 92' ' ' LYS . . . . . 0.654 ' HE3' ' O ' ' D' ' 93' ' ' GLN . 0.1 OUTLIER -161.54 170.48 19.8 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 123.027 0.531 . . . . 0.0 111.624 -174.742 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.682 ' HB3' ' NE1' ' D' ' 54' ' ' TRP . 3.0 pt20 -90.16 155.36 19.09 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.666 0.746 . . . . 0.0 111.638 176.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . 0.493 HG21 ' HZ ' ' D' ' 57' ' ' PHE . 8.2 pt . . . . . 0 C--N 1.307 -1.257 0 CA-C-N 113.98 -1.464 . . . . 0.0 111.622 -171.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 120.674 0.273 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 2' ' ' ASN . . . . . 0.617 ' HB3' ' HA ' ' D' ' 5' ' ' ALA . 75.9 m-20 53.87 67.0 1.07 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.167 -178.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -76.82 -30.12 56.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.366 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -92.29 -33.17 14.74 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 170.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 5' ' ' ALA . . . . . 0.617 ' HA ' ' HB3' ' D' ' 2' ' ' ASN . . . 66.64 -178.46 0.2 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.548 175.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . 0.478 HD12 ' N ' ' D' ' 6' ' ' LEU . 4.8 mp -100.64 -69.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.087 -178.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -92.52 -23.64 19.03 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.557 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.682 ' O ' ' HB3' ' D' ' 12' ' ' SER . 52.9 mt-10 -64.03 -23.04 67.18 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -172.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . 0.4 ' HG3' ' H ' ' D' ' 9' ' ' GLN . 1.8 pp0? -77.11 9.73 2.84 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 122.054 -0.404 . . . . 0.0 111.408 175.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 10' ' ' MET . . . . . 0.578 ' O ' ' HB2' ' D' ' 14' ' ' ASN . 48.7 ttm -106.65 -75.47 0.63 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.99 0.424 . . . . 0.0 111.317 -176.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 11' ' ' ASN . . . . . 0.501 ' O ' ' HB2' ' D' ' 15' ' ' SER . 9.4 p-10 -102.4 -32.45 9.99 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-O 121.211 0.529 . . . . 0.0 110.902 178.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 12' ' ' SER . . . . . 0.682 ' HB3' ' O ' ' D' ' 8' ' ' GLU . 45.0 t -55.47 -69.22 0.14 Allowed 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 113.952 -1.476 . . . . 0.0 111.099 -167.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.448 ' C ' HG12 ' D' ' 16' ' ' VAL . 48.7 mt -91.21 -13.54 8.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.736 -175.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 14' ' ' ASN . . . . . 0.578 ' HB2' ' O ' ' D' ' 10' ' ' MET . 5.8 m120 -97.28 -56.93 2.39 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.597 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 15' ' ' SER . . . . . 0.501 ' HB2' ' O ' ' D' ' 11' ' ' ASN . 50.9 m -67.84 -15.34 63.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.845 179.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 16' ' ' VAL . . . . . 0.701 ' HA ' ' HE2' ' D' ' 19' ' ' LYS . 14.3 p -56.22 -35.28 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 174.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -67.7 -40.23 84.34 Favored 'General case' 0 C--O 1.213 -0.856 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.92 176.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.57 -16.64 39.92 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -175.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.701 ' HE2' ' HA ' ' D' ' 16' ' ' VAL . 0.0 OUTLIER -89.97 -46.17 8.7 Favored 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 173.225 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 20' ' ' LEU . . . . . 0.811 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 84.1 mt -63.73 -35.84 81.9 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 113.594 -1.639 . . . . 0.0 110.479 -177.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 21' ' ' ASN . . . . . 0.484 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 2.8 m120 -72.65 95.93 1.93 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.8 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 22' ' ' LYS . . . . . 0.853 ' HE2' ' HA ' ' D' ' 22' ' ' LYS . 7.7 mmpt? -118.05 11.17 13.25 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -170.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.94 -74.28 1.7 Allowed Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.982 176.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . 0.775 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 55.2 tptt -53.27 -59.22 4.84 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 176.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -144.67 157.69 27.33 Favored Glycine 0 N--CA 1.43 -1.715 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.699 174.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 26' ' ' LYS . . . . . 0.876 ' HD2' ' HB3' ' D' ' 41' ' ' SER . 10.8 ptpt -151.04 160.68 43.76 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.379 -0.911 . . . . 0.0 111.354 -164.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 27' ' ' LEU . . . . . 0.824 HD13 ' HB2' ' D' ' 76' ' ' SER . 28.4 tp -132.89 144.53 50.24 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.164 0.507 . . . . 0.0 111.397 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 28' ' ' SER . . . . . 0.673 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 52.4 m -137.74 143.61 41.27 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.983 -175.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 29' ' ' LEU . . . . . 0.588 HD11 ' CD1' ' D' ' 20' ' ' LEU . 0.0 OUTLIER -141.02 144.74 35.18 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.326 -178.7 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 35.5 m -145.66 170.07 17.2 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.035 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 31' ' ' MET . . . . . 0.575 ' SD ' ' HE2' ' D' ' 85' ' ' LYS . 61.2 mtt -130.95 111.17 11.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.043 0.449 . . . . 0.0 110.888 177.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -91.82 87.82 6.41 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.08 -125.41 8.21 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.168 -1.015 . . . . 0.0 111.48 -173.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -89.66 31.2 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 O-C-N 122.464 -0.433 . . . . 0.0 110.267 175.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 35' ' ' GLN . . . . . 0.437 ' CG ' ' HD3' ' D' ' 37' ' ' LYS . 3.8 tp-100 -116.88 154.45 30.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.37 -172.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.914 ' HB2' ' HB2' ' D' ' 85' ' ' LYS . 1.8 tm? -118.74 126.66 52.37 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.741 176.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 37' ' ' LYS . . . . . 0.552 ' HB3' ' NZ ' ' D' ' 37' ' ' LYS . 1.1 mmmp? -129.63 117.84 21.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.587 -169.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 38' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -119.42 152.79 36.25 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.539 0.685 . . . . 0.0 112.26 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 39' ' ' THR . . . . . 0.673 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 3.2 p -144.57 126.73 15.63 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.145 177.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . 0.591 ' HA ' ' O ' ' D' ' 26' ' ' LYS . 14.9 p -108.49 128.9 55.2 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 172.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 41' ' ' SER . . . . . 0.876 ' HB3' ' HD2' ' D' ' 26' ' ' LYS . 42.5 t -102.43 155.72 18.07 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.161 -175.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 42' ' ' ASN . . . . . 0.525 ' ND2' ' HE3' ' D' ' 26' ' ' LYS . 74.0 m-80 76.67 8.55 3.1 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.711 -172.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 47.08 61.72 2.73 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 114.613 -1.176 . . . . 0.0 114.043 168.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.63 -14.41 7.21 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 119.004 -1.57 . . . . 0.0 114.93 172.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 45' ' ' TYR . . . . . 0.775 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 2.0 m-30 -76.19 156.75 33.38 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 117.347 0.573 . . . . 0.0 111.488 -176.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . 0.554 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -103.72 -157.5 24.5 Favored Glycine 0 C--O 1.214 -1.095 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 175.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 47' ' ' ILE . . . . . 0.834 HG13 ' HB3' ' D' ' 68' ' ' GLU . 0.8 OUTLIER -53.98 -57.33 5.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 122.778 1.275 . . . . 0.0 109.58 178.236 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 39.4 t 174.7 -116.05 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 111.205 -2.725 . . . . 0.0 105.89 -175.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -119.75 76.79 1.17 Allowed 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.888 -0.507 . . . . 0.0 109.818 165.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . 0.425 ' HB2' ' HE3' ' D' ' 52' ' ' LYS . 60.3 mm-40 -140.55 -169.3 2.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.38 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 51' ' ' ASP . . . . . 0.647 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 1.4 m-20 -139.97 134.09 31.02 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.935 173.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 52' ' ' LYS . . . . . 0.746 ' HD3' HG12 ' D' ' 47' ' ' ILE . 0.1 OUTLIER -144.66 150.15 36.88 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 53' ' ' ASN . . . . . 0.435 HD22 ' C ' ' D' ' 52' ' ' LYS . 2.8 m120 -118.95 138.72 52.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.76 0.314 . . . . 0.0 110.324 173.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 54' ' ' TRP . . . . . 1.082 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 1.7 m95 -124.7 153.22 42.69 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -175.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -138.42 157.34 24.49 Favored Glycine 0 N--CA 1.432 -1.598 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.036 172.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 56' ' ' ILE . . . . . 1.029 HG12 HG23 ' D' ' 91' ' ' ILE . 95.8 mt -131.18 94.58 2.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 177.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 57' ' ' PHE . . . . . 0.512 ' CE1' ' HB2' ' D' ' 62' ' ' LYS . 48.3 m-85 -93.86 101.03 13.11 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.546 -167.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.723 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 94.7 t -83.25 102.64 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.955 173.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 59' ' ' ASN . . . . . 0.485 ' OD1' ' HG2' ' D' ' 87' ' ' PRO . 6.4 m120 59.6 45.67 12.92 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.493 -177.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.29 -30.5 7.63 Favored Glycine 0 CA--C 1.508 -0.399 0 C-N-CA 120.009 -1.091 . . . . 0.0 112.655 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -88.15 119.9 28.99 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.852 -0.674 . . . . 0.0 110.618 -174.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . 0.512 ' HB2' ' CE1' ' D' ' 57' ' ' PHE . 38.7 ttpt -70.76 98.56 1.56 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 176.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.551 HG12 ' O ' ' D' ' 56' ' ' ILE . 13.4 p -77.77 -29.01 15.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.448 -170.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 64' ' ' TYR . . . . . 0.401 ' HB3' HD12 ' D' ' 56' ' ' ILE . 23.0 t80 -143.46 137.77 28.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.555 177.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 56.9 m -116.47 116.5 27.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.462 175.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 66' ' ' PHE . . . . . 0.483 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 18.3 p90 -122.06 154.98 36.59 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 170.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -117.64 146.89 43.36 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 68' ' ' GLU . . . . . 0.834 ' HB3' HG13 ' D' ' 47' ' ' ILE . 39.9 mm-40 -62.48 -24.96 67.75 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.214 0.531 . . . . 0.0 109.67 176.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.5 ' HD3' ' HB3' ' D' ' 51' ' ' ASP . 9.0 mtmp? -58.02 -44.16 87.15 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.495 173.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 70' ' ' SER . . . . . 0.454 ' OG ' HD11 ' D' ' 75' ' ' ILE . 15.4 t -76.18 92.73 3.28 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 113.798 -1.547 . . . . 0.0 107.627 172.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 73.4 p -30.84 122.85 0.21 Allowed 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.477 -1.238 . . . . 0.0 112.787 -172.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 72' ' ' VAL . . . . . 0.434 ' O ' ' HB3' ' D' ' 40' ' ' SER . 0.0 OUTLIER -51.72 -17.42 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 O-C-N 123.319 0.387 . . . . 0.0 111.709 177.8 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 73' ' ' GLY . . . . . 0.587 ' HA2' ' CB ' ' D' ' 40' ' ' SER . . . -65.33 -65.41 2.93 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 115.371 -0.832 . . . . 0.0 113.193 171.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 74' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' D' ' 77' ' ' ASN . 49.7 t30 -65.49 -22.9 66.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.852 0.358 . . . . 0.0 110.705 -178.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 75' ' ' ILE . . . . . 0.506 ' O ' HG12 ' D' ' 79' ' ' ILE . 27.2 mm -76.93 -37.94 27.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.067 177.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 76' ' ' SER . . . . . 0.824 ' HB2' HD13 ' D' ' 27' ' ' LEU . 32.8 t -75.51 -19.45 59.36 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.224 -0.59 . . . . 0.0 110.284 175.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 77' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' D' ' 74' ' ' ASN . 5.1 m120 -63.14 -28.92 70.39 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 166.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 78' ' ' ASP . . . . . 1.063 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 1.0 OUTLIER -87.9 -30.03 20.42 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 115.387 -0.824 . . . . 0.0 113.166 176.114 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . 0.703 HG12 ' HA ' ' D' ' 76' ' ' SER . 24.3 mm -63.25 -28.22 44.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 O-C-N 121.379 -0.826 . . . . 0.0 110.669 -174.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -65.46 -40.45 93.21 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.509 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . 1.063 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -74.17 -51.83 14.33 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.605 176.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 82' ' ' LEU . . . . . 0.613 HD23 ' O ' ' D' ' 78' ' ' ASP . 4.0 mm? -48.99 -30.16 5.71 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 83' ' ' ASN . . . . . 0.662 HD22 ' HB3' ' D' ' 36' ' ' LEU . 0.7 OUTLIER 42.36 61.42 2.01 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 123.695 0.622 . . . . 0.0 110.979 174.693 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 84' ' ' ILE . . . . . 0.495 HG22 HD13 ' D' ' 89' ' ' ILE . 49.5 mt -90.94 98.19 8.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.773 -175.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 85' ' ' LYS . . . . . 0.914 ' HB2' ' HB2' ' D' ' 36' ' ' LEU . 10.9 tmtt? -141.33 94.93 2.75 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -175.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 86' ' ' GLY . . . . . 0.567 ' H ' HD11 ' D' ' 89' ' ' ILE . . . 69.17 150.97 0.4 Allowed Glycine 0 N--CA 1.453 -0.194 0 CA-C-N 115.283 -0.871 . . . . 0.0 113.495 -178.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 87' ' ' PRO . . . . . 0.596 ' O ' HG13 ' D' ' 58' ' ' VAL . 68.5 Cg_endo -90.21 -178.79 12.09 Favored 'Cis proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.405 -1.498 . . . . 0.0 112.835 -0.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 88' ' ' TYR . . . . . 0.723 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 1.5 m-85 13.53 93.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.175 1.39 . . . . 0.0 113.943 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.587 HG12 HG22 ' D' ' 58' ' ' VAL . 67.9 mt -110.34 132.49 58.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.311 0.577 . . . . 0.0 112.363 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -123.25 93.92 4.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.867 173.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 91' ' ' ILE . . . . . 1.082 HG22 ' HZ3' ' D' ' 54' ' ' TRP . 7.3 mt -95.93 107.6 19.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 92' ' ' LYS . . . . . 0.648 ' HE3' ' O ' ' D' ' 93' ' ' GLN . 0.0 OUTLIER -163.08 171.27 16.67 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.54 -173.234 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.648 ' O ' ' HE3' ' D' ' 92' ' ' LYS . 3.5 pp0? -87.99 156.64 19.22 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.686 0.755 . . . . 0.0 112.787 178.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . 0.57 ' CG2' ' HE2' ' D' ' 92' ' ' LYS . 4.9 pt . . . . . 0 C--N 1.314 -0.938 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.005 -173.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 47.6 p30 . . . . . 0 N--CA 1.479 1.019 0 CA-C-O 121.027 0.441 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 2' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -128.81 47.79 2.42 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.782 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 3.0 mm100 -61.12 -55.19 35.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.108 -177.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 4' ' ' LYS . . . . . 0.43 ' HD2' ' N ' ' D' ' 4' ' ' LYS . 12.2 mptt -93.01 -20.72 20.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.278 177.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 5' ' ' ALA . . . . . . . . . . . . . . . 55.54 78.9 0.17 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.825 178.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . 0.462 HD12 ' N ' ' D' ' 6' ' ' LEU . 5.2 mp -82.72 9.9 8.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.631 177.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . 0.422 ' O ' ' HG2' ' D' ' 7' ' ' GLU . 85.9 tt0 -92.82 -7.39 46.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.101 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.68 ' HA ' ' HB3' ' D' ' 12' ' ' SER . 1.9 pp20? -54.58 -43.62 72.28 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -169.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . 0.499 ' H ' ' CD ' ' D' ' 9' ' ' GLN . 2.5 pm0 -91.92 8.89 35.36 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 122.314 -0.241 . . . . 0.0 111.142 -179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 10' ' ' MET . . . . . . . . . . . . . 46.3 tpp -107.13 -77.7 0.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.366 -174.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -102.49 -49.1 3.95 Favored 'General case' 0 CA--C 1.491 -1.307 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.015 174.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 12' ' ' SER . . . . . 0.68 ' HB3' ' HA ' ' D' ' 8' ' ' GLU . 47.4 t -32.36 -67.38 0.11 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 113.308 -1.769 . . . . 0.0 113.15 -169.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.43 ' C ' HG12 ' D' ' 16' ' ' VAL . 53.8 mt -91.65 -7.6 10.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.284 -174.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -94.43 -61.9 1.43 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.076 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 15' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' D' ' 19' ' ' LYS . 89.3 p -64.69 -16.68 63.22 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 122.252 -0.28 . . . . 0.0 111.108 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 16' ' ' VAL . . . . . 0.648 ' HA ' ' HE3' ' D' ' 19' ' ' LYS . 14.2 p -58.63 -32.77 46.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-O 121.835 0.826 . . . . 0.0 110.002 178.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 17' ' ' ASN . . . . . 0.427 ' HB3' ' ND2' ' D' ' 21' ' ' ASN . 5.2 m120 -71.55 -37.18 71.12 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.707 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.84 -15.17 58.21 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.648 ' HE3' ' HA ' ' D' ' 16' ' ' VAL . 71.3 mttt -91.03 -28.31 18.05 Favored 'General case' 0 CA--C 1.494 -1.199 0 CA-C-O 122.447 1.117 . . . . 0.0 109.229 -177.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 20' ' ' LEU . . . . . 0.88 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 76.1 mt -95.51 -41.14 9.1 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 112.223 -2.262 . . . . 0.0 109.061 -171.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 21' ' ' ASN . . . . . 0.69 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 59.9 m-20 -73.56 91.07 1.8 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.04 -1.436 . . . . 0.0 110.337 175.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 22' ' ' LYS . . . . . 0.471 ' HD3' HD12 ' D' ' 47' ' ' ILE . 28.7 mtpp -122.36 -41.38 2.41 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -170.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 171.77 -91.89 0.09 OUTLIER Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 119.63 -1.271 . . . . 0.0 113.3 -176.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . 0.552 ' HB3' ' O ' ' D' ' 46' ' ' GLY . 44.2 tptt -50.46 -53.56 28.74 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 25' ' ' GLY . . . . . 0.624 ' HA2' ' ND2' ' D' ' 42' ' ' ASN . . . -140.35 157.46 25.6 Favored Glycine 0 N--CA 1.435 -1.428 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.334 176.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 26' ' ' LYS . . . . . 0.69 ' CB ' ' HA ' ' D' ' 21' ' ' ASN . 9.3 ptpt -149.36 160.6 43.29 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.077 -0.562 . . . . 0.0 111.026 -169.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 27' ' ' LEU . . . . . 0.88 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 44.7 tp -137.08 144.69 43.25 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.34 0.59 . . . . 0.0 111.899 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 28' ' ' SER . . . . . 0.575 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 23.1 t -135.4 137.31 42.16 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.013 -178.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 29' ' ' LEU . . . . . 0.484 HD11 ' CD1' ' D' ' 20' ' ' LEU . 0.0 OUTLIER -140.5 114.29 8.89 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.345 -179.188 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 68.8 p -123.56 -173.08 2.65 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.975 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 31' ' ' MET . . . . . 0.463 ' SD ' ' HE2' ' D' ' 85' ' ' LYS . 23.0 ptt? -148.1 122.1 9.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.62 0.724 . . . . 0.0 110.961 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -91.92 88.42 6.6 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.43 177.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.56 -110.04 2.99 Favored Glycine 0 CA--C 1.515 0.069 0 C-N-CA 120.333 -0.937 . . . . 0.0 111.389 -172.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 73.6 m-80 -106.24 14.36 27.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.075 0.464 . . . . 0.0 110.716 175.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 35' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -89.04 155.36 19.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.603 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 1.099 ' HB2' ' HB2' ' D' ' 85' ' ' LYS . 1.4 tm? -117.82 126.98 53.43 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 37' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 29.0 mmmt -130.65 117.79 20.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.829 -168.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 38' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -121.39 148.89 43.79 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.865 175.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 39' ' ' THR . . . . . 0.575 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 16.5 p -147.89 138.94 23.37 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.516 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . 0.482 ' HB3' ' HA2' ' D' ' 73' ' ' GLY . 36.7 t -107.69 128.19 54.34 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 169.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 41' ' ' SER . . . . . 0.574 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 35.1 t -94.67 161.63 14.11 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -177.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 42' ' ' ASN . . . . . 0.624 ' ND2' ' HA2' ' D' ' 25' ' ' GLY . 0.1 OUTLIER 83.47 -17.4 0.49 Allowed 'General case' 0 N--CA 1.477 0.879 0 O-C-N 124.706 1.254 . . . . 0.0 109.163 -167.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 71.52 62.48 0.15 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 44' ' ' GLY . . . . . 0.628 ' O ' ' HB ' ' D' ' 71' ' ' THR . . . 127.9 -40.69 1.7 Allowed Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 119.215 -1.469 . . . . 0.0 116.162 168.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 45' ' ' TYR . . . . . 0.538 ' CD2' ' HE3' ' D' ' 24' ' ' LYS . 3.2 m-30 -63.89 155.8 29.6 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.059 1.43 . . . . 0.0 112.422 -175.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . 0.552 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -91.29 -177.2 43.28 Favored Glycine 0 C--O 1.217 -0.926 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 172.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 47' ' ' ILE . . . . . 0.84 HG12 ' HB3' ' D' ' 68' ' ' GLU . 43.2 mm -45.66 -48.37 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.075 0 CA-C-N 117.903 0.852 . . . . 0.0 110.232 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.512 ' HB2' ' O ' ' D' ' 47' ' ' ILE . 48.4 t 153.22 -142.97 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 O-C-N 126.411 2.319 . . . . 0.0 107.632 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -77.48 75.88 4.03 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.467 0.651 . . . . 0.0 111.183 173.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . 0.678 ' HB3' ' HE3' ' D' ' 52' ' ' LYS . 68.3 mm-40 -134.85 -176.39 4.22 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.481 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 51' ' ' ASP . . . . . 0.717 ' HA ' ' CG ' ' D' ' 69' ' ' LYS . 7.1 p-10 -152.89 113.39 4.05 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.559 173.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 52' ' ' LYS . . . . . 0.678 ' HE3' ' HB3' ' D' ' 50' ' ' GLU . 21.1 mmtp -129.88 139.03 51.24 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.314 -170.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 53' ' ' ASN . . . . . 0.493 HD22 ' C ' ' D' ' 52' ' ' LYS . 2.7 m120 -114.33 132.12 56.3 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.404 175.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 54' ' ' TRP . . . . . 0.685 ' HB2' ' O ' ' D' ' 66' ' ' PHE . 0.5 OUTLIER -128.27 160.97 30.49 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -170.431 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -152.7 162.45 29.99 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 114.892 -1.049 . . . . 0.0 113.56 172.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 56' ' ' ILE . . . . . 0.636 HG23 HG12 ' D' ' 91' ' ' ILE . 58.6 mt -130.98 111.91 20.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 177.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 57' ' ' PHE . . . . . 0.956 ' HB2' ' HB3' ' D' ' 90' ' ' GLU . 10.3 m-85 -108.67 99.54 8.9 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 119.908 -0.717 . . . . 0.0 111.424 -165.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.733 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 84.3 t -81.57 103.89 9.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.713 173.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 6.9 m120 63.31 44.38 5.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.505 -176.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.53 -33.1 5.7 Favored Glycine 0 CA--C 1.509 -0.34 0 C-N-CA 120.49 -0.862 . . . . 0.0 114.304 172.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 61' ' ' GLU . . . . . 0.543 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 16.7 pt-20 -90.6 136.27 33.17 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.239 0.542 . . . . 0.0 111.801 -173.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . 0.454 ' HB2' ' CE2' ' D' ' 57' ' ' PHE . 38.0 ttpt -74.26 110.33 8.46 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.861 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.455 HG22 ' O ' ' D' ' 56' ' ' ILE . 29.5 m -93.65 -29.47 4.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -175.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 64' ' ' TYR . . . . . 0.428 ' HB3' HD12 ' D' ' 56' ' ' ILE . 30.4 t80 -136.66 132.44 34.98 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 121.193 -0.203 . . . . 0.0 110.675 178.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 49.9 m -114.39 123.14 48.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.459 176.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 66' ' ' PHE . . . . . 0.685 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 14.1 p90 -131.48 148.76 52.67 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 173.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 67' ' ' ASN . . . . . 0.633 HD22 ' HB2' ' D' ' 69' ' ' LYS . 14.5 p-10 -117.94 130.95 56.52 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 68' ' ' GLU . . . . . 0.84 ' HB3' HG12 ' D' ' 47' ' ' ILE . 54.8 mm-40 -59.85 -18.27 42.92 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.009 0.433 . . . . 0.0 111.314 -173.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.717 ' CG ' ' HA ' ' D' ' 51' ' ' ASP . 46.5 mtpt -58.97 -51.9 68.07 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.393 172.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 69.8 m -64.92 103.05 0.67 Allowed 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 113.098 -1.864 . . . . 0.0 108.787 170.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 71' ' ' THR . . . . . 0.628 ' HB ' ' O ' ' D' ' 44' ' ' GLY . 72.1 p -32.73 119.05 0.3 Allowed 'General case' 0 C--N 1.322 -0.617 0 O-C-N 124.588 1.18 . . . . 0.0 112.689 -174.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 72' ' ' VAL . . . . . 0.633 HG11 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -53.34 -14.4 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.805 176.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 73' ' ' GLY . . . . . 0.482 ' HA2' ' HB3' ' D' ' 40' ' ' SER . . . -66.66 -70.8 1.03 Allowed Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.743 172.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -62.15 -25.03 67.52 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 120.594 0.235 . . . . 0.0 111.286 -177.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 75' ' ' ILE . . . . . 0.629 ' O ' HG13 ' D' ' 79' ' ' ILE . 30.0 mm -73.87 -37.88 49.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.199 176.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 31.3 t -73.82 -23.13 59.61 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.817 176.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -62.28 -26.94 68.68 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 166.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 78' ' ' ASP . . . . . 1.112 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 57.6 m-20 -83.22 -36.87 24.28 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.031 -0.532 . . . . 0.0 112.089 174.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . 0.629 HG13 ' O ' ' D' ' 75' ' ' ILE . 39.2 mt -66.41 -22.64 30.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 O-C-N 121.805 -0.559 . . . . 0.0 110.878 -173.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -72.92 -31.67 64.78 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 176.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . 1.112 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -81.15 -50.37 9.69 Favored 'General case' 0 N--CA 1.457 -0.076 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.164 174.527 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 82' ' ' LEU . . . . . 0.62 HD23 ' O ' ' D' ' 78' ' ' ASP . 4.0 mm? -47.39 -32.32 4.84 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 177.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 83' ' ' ASN . . . . . 0.603 HD22 ' HB3' ' D' ' 36' ' ' LEU . 0.6 OUTLIER 43.72 61.49 2.26 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 124.062 0.851 . . . . 0.0 110.836 174.224 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 84' ' ' ILE . . . . . 0.443 ' O ' ' HG ' ' D' ' 36' ' ' LEU . 52.5 mt -93.74 98.55 8.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.045 -175.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 85' ' ' LYS . . . . . 1.099 ' HB2' ' HB2' ' D' ' 36' ' ' LEU . 9.4 tmtt? -143.01 94.91 2.69 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 86' ' ' GLY . . . . . 0.48 ' HA2' HD11 ' D' ' 89' ' ' ILE . . . 76.86 151.87 4.38 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.67 -0.696 . . . . 0.0 113.566 176.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 87' ' ' PRO . . . . . 0.631 ' O ' HG13 ' D' ' 58' ' ' VAL . 55.9 Cg_endo -88.49 178.01 19.62 Favored 'Cis proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.83 -1.737 . . . . 0.0 112.479 -0.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 88' ' ' TYR . . . . . 0.733 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 1.7 m-85 28.7 91.19 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.626 1.17 . . . . 0.0 112.907 -177.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.592 HG22 HG13 ' D' ' 91' ' ' ILE . 3.7 mp -97.38 136.55 27.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.233 0.54 . . . . 0.0 110.834 -176.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.956 ' HB3' ' HB2' ' D' ' 57' ' ' PHE . 88.0 tt0 -134.94 87.38 2.33 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.807 173.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 91' ' ' ILE . . . . . 0.636 HG12 HG23 ' D' ' 56' ' ' ILE . 40.8 mt -96.56 99.49 9.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.649 -179.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 92' ' ' LYS . . . . . 0.652 ' HG2' ' O ' ' D' ' 93' ' ' GLN . 0.0 OUTLIER -161.76 165.96 27.24 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 121.191 -0.203 . . . . 0.0 110.519 178.33 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.652 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 18.1 pt20 -78.67 165.32 23.78 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 120.191 -0.604 . . . . 0.0 110.59 175.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . 0.58 HG21 ' HZ ' ' D' ' 57' ' ' PHE . 9.5 pt . . . . . 0 C--N 1.31 -1.118 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.656 -172.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 120.858 0.361 . . . . 0.0 110.635 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 2' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -76.4 -28.21 56.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.531 -176.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -64.81 -32.14 73.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.8 0.333 . . . . 0.0 111.021 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -99.15 -3.06 35.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.335 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 5' ' ' ALA . . . . . . . . . . . . . . . 52.58 48.67 22.05 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.982 -178.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 58.8 tp -101.25 -26.06 13.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.285 -175.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -56.89 -46.59 81.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.589 -177.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.932 ' HA ' ' HB2' ' D' ' 12' ' ' SER . 52.4 mt-10 -50.24 -42.44 51.84 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -178.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . 0.568 ' H ' ' NE2' ' D' ' 9' ' ' GLN . 0.0 OUTLIER -87.3 8.69 23.18 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -177.18 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 10' ' ' MET . . . . . . . . . . . . . 26.8 ttt -106.83 -78.72 0.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.766 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -104.52 -54.17 2.57 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.402 174.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 12' ' ' SER . . . . . 0.932 ' HB2' ' HA ' ' D' ' 8' ' ' GLU . 71.1 m -25.6 -71.16 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.274 -1.785 . . . . 0.0 113.643 -171.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.431 ' O ' HG12 ' D' ' 16' ' ' VAL . 58.4 mt -78.7 -68.78 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.199 -1.556 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.722 174.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -35.19 -33.25 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -175.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 15' ' ' SER . . . . . 0.427 ' O ' ' HD2' ' D' ' 19' ' ' LYS . 80.1 p -58.78 -27.51 65.08 Favored 'General case' 0 C--O 1.22 -0.453 0 O-C-N 121.771 -0.58 . . . . 0.0 109.909 176.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 16' ' ' VAL . . . . . 0.694 HG13 ' ND2' ' D' ' 17' ' ' ASN . 7.5 p -45.28 -30.09 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.94 1.296 . . . . 0.0 111.185 174.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 17' ' ' ASN . . . . . 0.694 ' ND2' HG13 ' D' ' 16' ' ' VAL . 5.9 m120 -86.37 -31.56 21.43 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.895 -177.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 18' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' D' ' 15' ' ' SER . 78.7 m-20 -60.71 -15.66 31.37 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 176.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.622 ' HD2' ' N ' ' D' ' 19' ' ' LYS . 0.0 OUTLIER -91.35 -46.57 7.95 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 122.03 0.919 . . . . 0.0 108.599 175.238 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 20' ' ' LEU . . . . . 0.89 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 63.8 mt -63.51 -40.49 97.19 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.192 -1.822 . . . . 0.0 110.348 -178.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 21' ' ' ASN . . . . . 0.651 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 55.6 m-20 -77.35 96.7 4.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.425 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 22' ' ' LYS . . . . . 0.789 ' HD2' HD12 ' D' ' 47' ' ' ILE . 65.3 mttm -122.83 -41.57 2.35 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -178.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 171.17 -86.22 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 119.575 -1.298 . . . . 0.0 113.663 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . 0.706 ' HE3' ' HD1' ' D' ' 45' ' ' TYR . 50.7 tptt -53.54 -44.47 69.23 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.85 0.833 . . . . 0.0 109.415 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 25' ' ' GLY . . . . . 0.613 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -150.2 148.13 19.03 Favored Glycine 0 N--CA 1.429 -1.802 0 CA-C-N 114.255 -1.338 . . . . 0.0 111.582 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 26' ' ' LYS . . . . . 0.651 ' CB ' ' HA ' ' D' ' 21' ' ' ASN . 10.8 ptpt -149.32 160.85 43.05 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 114.262 -0.969 . . . . 0.0 110.561 -168.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 27' ' ' LEU . . . . . 0.89 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 41.1 tp -135.65 143.58 45.57 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.237 0.541 . . . . 0.0 111.847 -178.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 28' ' ' SER . . . . . 0.638 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 27.9 t -128.18 152.62 47.83 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 29' ' ' LEU . . . . . . . . . . . . . 15.1 mt -140.78 138.75 34.33 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 177.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 60.6 m -147.05 179.16 7.81 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 31' ' ' MET . . . . . 0.43 ' HA ' ' O ' ' D' ' 35' ' ' GLN . 23.3 ptt? -134.9 122.32 21.8 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.441 0.639 . . . . 0.0 110.636 177.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -91.42 88.97 7.04 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.2 -114.74 4.03 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -169.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 34' ' ' ASN . . . . . 0.688 ' O ' ' HE3' ' D' ' 85' ' ' LYS . 4.2 m120 -109.63 31.74 5.57 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.095 0.474 . . . . 0.0 110.023 172.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 35' ' ' GLN . . . . . 0.43 ' O ' ' HA ' ' D' ' 31' ' ' MET . 3.8 tp-100 -105.81 161.35 14.5 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.601 -179.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.707 HD11 HG22 ' D' ' 79' ' ' ILE . 3.0 tm? -114.09 131.36 56.42 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.772 0.32 . . . . 0.0 110.766 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 37' ' ' LYS . . . . . 0.426 ' HE2' ' HG2' ' D' ' 35' ' ' GLN . 74.0 mmtt -138.34 109.05 6.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.082 -169.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 38' ' ' ALA . . . . . 0.488 ' HB1' HD11 ' D' ' 27' ' ' LEU . . . -105.58 149.37 26.34 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.966 0.412 . . . . 0.0 111.229 176.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 39' ' ' THR . . . . . 0.638 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 18.0 p -143.65 129.57 19.47 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.698 175.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . 0.729 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 72.3 p -109.38 131.56 54.95 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 41' ' ' SER . . . . . 0.625 ' HB2' ' CD ' ' D' ' 26' ' ' LYS . 52.3 m -96.56 152.82 18.27 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.714 -178.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 42' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' D' ' 41' ' ' SER . 75.9 m-80 80.09 6.12 1.76 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.005 -170.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 53.27 54.47 10.19 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 114.636 -1.166 . . . . 0.0 113.811 171.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 44' ' ' GLY . . . . . 0.744 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 104.78 35.81 3.15 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 119.431 -1.366 . . . . 0.0 114.749 168.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 45' ' ' TYR . . . . . 0.706 ' HD1' ' HE3' ' D' ' 24' ' ' LYS . 2.6 m-85 -112.78 153.81 27.21 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 168.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . 0.558 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -86.0 -174.0 49.54 Favored Glycine 0 CA--C 1.499 -0.945 0 C-N-CA 120.094 -1.05 . . . . 0.0 110.953 178.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 47' ' ' ILE . . . . . 0.806 HG12 ' HB3' ' D' ' 68' ' ' GLU . 45.3 mm -46.3 -51.33 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.231 0 CA-C-O 121.454 0.645 . . . . 0.0 109.987 177.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.487 ' HB2' ' O ' ' D' ' 47' ' ' ILE . 41.3 t 159.31 -138.97 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.626 0 O-C-N 126.507 2.379 . . . . 0.0 107.564 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -88.88 76.01 7.99 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.474 0.655 . . . . 0.0 111.606 175.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . 0.798 ' HB2' ' HE2' ' D' ' 52' ' ' LYS . 48.6 mt-10 -150.32 179.04 8.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.541 176.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 51' ' ' ASP . . . . . 0.66 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 31.8 m-20 -133.39 134.29 43.49 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.746 173.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 52' ' ' LYS . . . . . 0.798 ' HE2' ' HB2' ' D' ' 50' ' ' GLU . 1.9 mptp? -138.43 137.58 37.36 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -176.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -115.07 134.08 55.49 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.413 174.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 54' ' ' TRP . . . . . 1.136 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 1.1 m95 -125.73 160.09 30.65 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -172.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -148.05 158.07 27.56 Favored Glycine 0 N--CA 1.436 -1.312 0 CA-C-N 114.419 -1.264 . . . . 0.0 113.006 172.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 56' ' ' ILE . . . . . 1.06 HG12 HG23 ' D' ' 91' ' ' ILE . 98.1 mt -125.88 110.31 23.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-N 113.317 -1.442 . . . . 0.0 107.149 176.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 57' ' ' PHE . . . . . 0.768 ' HB2' ' HB2' ' D' ' 90' ' ' GLU . 14.0 m-85 -106.02 102.82 12.22 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 119.881 -0.728 . . . . 0.0 110.821 -167.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.912 HG22 HG12 ' D' ' 89' ' ' ILE . 95.2 t -95.5 108.97 21.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.502 178.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 59' ' ' ASN . . . . . 0.552 ' OD1' ' HG2' ' D' ' 87' ' ' PRO . 6.2 m120 59.68 52.35 5.64 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.989 -178.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.15 47.17 92.36 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.283 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 61' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 87.1 tt0 -151.45 116.17 5.17 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.315 -0.443 . . . . 0.0 109.866 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . 0.492 ' NZ ' ' HB3' ' D' ' 62' ' ' LYS . 6.1 ttpm? -70.96 99.04 1.71 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.446 HG12 ' O ' ' D' ' 56' ' ' ILE . 14.7 p -87.1 -30.99 5.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.581 -169.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 64' ' ' TYR . . . . . 0.409 ' HB3' HD12 ' D' ' 56' ' ' ILE . 17.3 t80 -137.5 130.31 30.17 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.579 175.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 76.0 m -112.04 112.82 24.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.319 176.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 66' ' ' PHE . . . . . 0.549 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 7.6 p90 -118.67 150.5 39.62 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 173.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 67' ' ' ASN . . . . . 0.491 ' O ' HD11 ' D' ' 75' ' ' ILE . 18.6 p30 -122.04 140.61 52.28 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 68' ' ' GLU . . . . . 0.806 ' HB3' HG12 ' D' ' 47' ' ' ILE . 39.2 mm-40 -68.33 -9.46 48.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.218 0.532 . . . . 0.0 110.368 -176.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.569 ' NZ ' ' HB3' ' D' ' 69' ' ' LYS . 5.3 mtpm? -62.73 -45.06 94.49 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 170.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 31.1 t -66.29 125.65 26.27 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 113.528 -1.669 . . . . 0.0 107.571 168.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 71' ' ' THR . . . . . 0.407 ' O ' HG13 ' D' ' 75' ' ' ILE . 72.0 p -54.19 125.28 18.52 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -178.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 72' ' ' VAL . . . . . 0.693 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -55.32 -14.62 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 121.069 0.461 . . . . 0.0 110.918 -175.271 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 73' ' ' GLY . . . . . 0.744 ' HA3' ' HA2' ' D' ' 44' ' ' GLY . . . -71.05 -57.01 6.52 Favored Glycine 0 N--CA 1.437 -1.264 0 CA-C-N 115.043 -0.98 . . . . 0.0 112.627 170.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -61.76 -24.15 66.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.115 0.483 . . . . 0.0 110.342 176.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 75' ' ' ILE . . . . . 0.613 ' O ' HG13 ' D' ' 79' ' ' ILE . 66.4 mt -73.2 -41.53 58.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.359 175.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 28.4 t -76.16 -24.05 54.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.762 -0.199 . . . . 0.0 110.764 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 77' ' ' ASN . . . . . 0.553 ' O ' ' HD3' ' D' ' 81' ' ' LYS . 4.0 m120 -63.38 -19.03 64.3 Favored 'General case' 0 C--O 1.218 -0.601 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 168.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 78' ' ' ASP . . . . . 0.665 ' O ' HD23 ' D' ' 82' ' ' LEU . 72.0 m-20 -93.52 -45.41 7.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.068 174.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . 0.707 HG22 HD11 ' D' ' 36' ' ' LEU . 43.0 mt -67.99 -33.35 60.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 O-C-N 121.743 -0.598 . . . . 0.0 111.729 -170.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -64.63 -13.49 53.85 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.191 174.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . 0.553 ' HD3' ' O ' ' D' ' 77' ' ' ASN . 16.0 mmmt -92.34 -57.8 2.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 122.185 0.993 . . . . 0.0 108.866 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 82' ' ' LEU . . . . . 0.665 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.3 mm? -56.07 -23.63 34.93 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 113.821 -1.536 . . . . 0.0 112.913 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 83' ' ' ASN . . . . . 0.589 ' HA ' HD12 ' D' ' 36' ' ' LEU . 7.5 m120 32.72 70.46 0.1 Allowed 'General case' 0 N--CA 1.476 0.867 0 O-C-N 124.182 0.926 . . . . 0.0 112.978 -177.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 84' ' ' ILE . . . . . 0.578 HG22 HD13 ' D' ' 89' ' ' ILE . 47.2 mt -86.45 98.86 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-O 121.132 0.492 . . . . 0.0 110.991 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 85' ' ' LYS . . . . . 0.688 ' HE3' ' O ' ' D' ' 34' ' ' ASN . 0.0 OUTLIER -135.01 94.55 3.16 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.871 0.843 . . . . 0.0 111.947 -179.563 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 86' ' ' GLY . . . . . 0.585 ' H ' ' CD1' ' D' ' 89' ' ' ILE . . . 70.28 153.2 0.92 Allowed Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.622 -0.717 . . . . 0.0 113.032 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 87' ' ' PRO . . . . . 0.578 ' O ' HG13 ' D' ' 58' ' ' VAL . 92.6 Cg_endo -91.18 -177.27 9.29 Favored 'Cis proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.705 -1.373 . . . . 0.0 112.52 -0.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 88' ' ' TYR . . . . . 0.693 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 14.4 m-85 8.24 93.18 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 125.473 1.509 . . . . 0.0 113.844 -177.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.912 HG12 HG22 ' D' ' 58' ' ' VAL . 67.8 mt -110.43 135.22 50.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.427 0.632 . . . . 0.0 111.83 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.768 ' HB2' ' HB2' ' D' ' 57' ' ' PHE . 5.5 mm-40 -122.58 89.52 3.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.991 176.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 91' ' ' ILE . . . . . 1.136 HG22 ' HZ3' ' D' ' 54' ' ' TRP . 4.7 mt -96.31 108.9 21.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 92' ' ' LYS . . . . . 0.643 ' HG2' ' O ' ' D' ' 93' ' ' GLN . 0.0 OUTLIER -162.95 172.73 14.62 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.361 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.643 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 25.1 pt20 -81.5 163.58 22.6 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 119.749 -0.781 . . . . 0.0 111.219 175.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . 0.569 HG22 ' HE2' ' D' ' 92' ' ' LYS . 9.9 pt . . . . . 0 C--N 1.307 -1.246 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.139 -172.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 . . . . . 0 N--CA 1.483 1.216 0 N-CA-C 110.652 -0.129 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 2' ' ' ASN . . . . . 0.5 ' HB3' ' HA ' ' D' ' 5' ' ' ALA . 75.3 m-20 61.2 54.15 3.36 Favored 'General case' 0 N--CA 1.462 0.163 0 O-C-N 123.692 0.62 . . . . 0.0 110.519 -176.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -64.68 -40.64 95.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.059 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 4' ' ' LYS . . . . . 0.403 ' HD3' ' HB3' ' D' ' 7' ' ' GLU . 21.4 ptmt -90.77 -18.42 24.97 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 175.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 5' ' ' ALA . . . . . 0.5 ' HA ' ' HB3' ' D' ' 2' ' ' ASN . . . 66.93 -59.7 0.37 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.942 -1.026 . . . . 0.0 113.448 172.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . 0.498 HD13 HE22 ' D' ' 9' ' ' GLN . 1.3 pp -67.49 1.02 2.55 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -174.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . 0.403 ' HB3' ' HD3' ' D' ' 4' ' ' LYS . 23.1 pt-20 -63.26 1.81 0.45 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.511 ' C ' ' H ' ' D' ' 10' ' ' MET . 12.5 pt-20 -100.24 0.88 41.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.759 -0.201 . . . . 0.0 111.29 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . 0.607 ' HA ' ' HB3' ' D' ' 12' ' ' SER . 14.4 pt20 -58.17 10.71 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.403 1.081 . . . . 0.0 113.853 -178.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 10' ' ' MET . . . . . 0.511 ' H ' ' C ' ' D' ' 8' ' ' GLU . 65.5 mtm -78.75 -47.94 15.83 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 174.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -100.26 -56.19 2.42 Favored 'General case' 0 C--O 1.207 -1.167 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.169 166.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 12' ' ' SER . . . . . 0.607 ' HB3' ' HA ' ' D' ' 9' ' ' GLN . 43.8 t -23.42 -68.92 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 -173.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 41.9 mm -80.2 -9.4 12.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.451 -169.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 75.0 m-80 -94.81 -50.59 5.07 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.001 172.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 15' ' ' SER . . . . . 0.506 ' O ' ' HD2' ' D' ' 19' ' ' LYS . 80.5 p -66.62 -30.59 70.9 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.256 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 16' ' ' VAL . . . . . 0.666 HG13 ' ND2' ' D' ' 17' ' ' ASN . 11.5 p -50.75 -28.53 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 121.981 0.896 . . . . 0.0 110.31 175.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 17' ' ' ASN . . . . . 0.666 ' ND2' HG13 ' D' ' 16' ' ' VAL . 4.4 m120 -83.51 -31.29 26.53 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.911 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.92 -15.55 43.94 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 177.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.56 ' HD2' ' N ' ' D' ' 19' ' ' LYS . 0.0 OUTLIER -90.82 -42.21 10.78 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 176.006 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 20' ' ' LEU . . . . . 0.929 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 64.9 mt -70.4 -41.06 73.48 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 113.327 -1.76 . . . . 0.0 110.398 -176.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 21' ' ' ASN . . . . . 0.697 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 59.4 m-20 -74.42 100.76 3.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.656 -1.157 . . . . 0.0 110.225 177.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 22' ' ' LYS . . . . . 0.573 ' NZ ' HG23 ' D' ' 47' ' ' ILE . 54.3 mtpt -121.94 -43.46 2.34 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -171.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.96 -74.81 0.2 Allowed Glycine 0 N--CA 1.435 -1.39 0 C-N-CA 120.281 -0.961 . . . . 0.0 112.231 -174.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . 0.823 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 27.2 tptp -58.41 -68.42 0.26 Allowed 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 25' ' ' GLY . . . . . 0.795 ' HA2' ' ND2' ' D' ' 42' ' ' ASN . . . -127.77 156.93 20.84 Favored Glycine 0 N--CA 1.431 -1.656 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.631 173.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 26' ' ' LYS . . . . . 0.697 ' CB ' ' HA ' ' D' ' 21' ' ' ASN . 8.5 ptpt -148.31 159.45 43.98 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 114.828 -0.686 . . . . 0.0 111.192 -170.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 27' ' ' LEU . . . . . 0.929 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 42.0 tp -137.46 142.82 41.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.717 0.77 . . . . 0.0 111.968 -177.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 28' ' ' SER . . . . . 0.688 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 50.3 m -129.05 151.32 49.86 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.296 -178.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 29' ' ' LEU . . . . . . . . . . . . . 17.7 mt -140.89 135.49 31.36 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 177.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 48.5 m -136.85 -173.28 3.4 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 22.7 ptm -150.14 166.01 31.12 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.675 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 32' ' ' ASN . . . . . 0.413 ' H ' ' HB2' ' D' ' 35' ' ' GLN . 0.7 OUTLIER -143.19 89.3 2.09 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.163 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.07 -101.88 1.51 Allowed Glycine 0 C--O 1.227 -0.3 0 C-N-CA 120.064 -1.065 . . . . 0.0 110.901 -173.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -111.15 27.81 9.33 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.183 0.515 . . . . 0.0 109.907 173.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 35' ' ' GLN . . . . . 0.413 ' HB2' ' H ' ' D' ' 32' ' ' ASN . 73.8 mm-40 -96.87 164.74 12.42 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -177.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.763 HD11 HG22 ' D' ' 79' ' ' ILE . 2.8 tm? -132.18 124.19 28.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.056 174.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 37' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -132.11 100.73 5.13 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.004 -168.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.57 146.81 25.42 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.574 0.702 . . . . 0.0 112.105 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 39' ' ' THR . . . . . 0.688 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 18.3 p -141.65 128.83 20.96 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.242 176.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . 0.61 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 77.7 p -107.12 129.5 54.83 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 173.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 41' ' ' SER . . . . . 0.687 ' HB3' ' HG3' ' D' ' 26' ' ' LYS . 46.2 t -93.03 146.7 23.43 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -175.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 42' ' ' ASN . . . . . 0.795 ' ND2' ' HA2' ' D' ' 25' ' ' GLY . 0.9 OUTLIER 82.12 -18.74 0.45 Allowed 'General case' 0 N--CA 1.477 0.925 0 O-C-N 125.59 1.806 . . . . 0.0 109.757 -167.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 60.85 60.33 1.89 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 175.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 123.88 35.98 0.65 Allowed Glycine 0 C--N 1.338 0.689 0 C-N-CA 119.166 -1.492 . . . . 0.0 115.797 168.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 45' ' ' TYR . . . . . 0.823 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 7.0 m-30 -116.02 160.87 19.7 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 170.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . 0.571 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -107.84 -152.91 17.49 Favored Glycine 0 C--O 1.223 -0.533 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.87 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 47' ' ' ILE . . . . . 0.995 HG13 ' HB2' ' D' ' 68' ' ' GLU . 1.7 mp -51.45 -57.68 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 CA-C-O 122.484 1.135 . . . . 0.0 108.486 177.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 67.2 p 167.93 -77.67 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 111.378 -2.646 . . . . 0.0 107.273 -173.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 49' ' ' TYR . . . . . 0.464 ' HD2' ' O ' ' D' ' 49' ' ' TYR . 0.1 OUTLIER -154.64 74.55 0.95 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.61 165.496 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . 0.663 ' O ' ' HG2' ' D' ' 69' ' ' LYS . 59.2 mm-40 -141.46 -158.67 0.88 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.226 -176.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 51' ' ' ASP . . . . . 0.603 ' CB ' ' HD2' ' D' ' 69' ' ' LYS . 7.2 t70 -146.51 112.26 5.65 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.234 174.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 52' ' ' LYS . . . . . 0.757 ' HD3' HG12 ' D' ' 47' ' ' ILE . 4.5 mptp? -126.15 106.15 9.36 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.904 -172.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 53' ' ' ASN . . . . . 0.462 HD22 ' N ' ' D' ' 53' ' ' ASN . 2.1 m120 -88.74 130.44 35.34 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.06 0.457 . . . . 0.0 110.401 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 54' ' ' TRP . . . . . 1.04 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 0.4 OUTLIER -119.63 166.02 13.72 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.108 -175.2 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -148.84 159.93 28.21 Favored Glycine 0 N--CA 1.439 -1.138 0 C-N-CA 120.04 -1.076 . . . . 0.0 113.689 175.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 56' ' ' ILE . . . . . 1.005 HG12 HG23 ' D' ' 91' ' ' ILE . 82.8 mt -135.61 105.06 5.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 176.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 57' ' ' PHE . . . . . 0.524 ' HD1' ' O ' ' D' ' 90' ' ' GLU . 13.7 m-85 -101.28 98.21 8.62 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 119.178 -1.009 . . . . 0.0 111.076 -167.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.744 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 97.9 t -89.75 115.16 28.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.835 173.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 66.11 38.04 4.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.81 -175.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.92 -32.99 4.37 Favored Glycine 0 CA--C 1.509 -0.334 0 C-N-CA 120.959 -0.638 . . . . 0.0 113.512 176.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 61' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 16.6 pt-20 -90.76 141.55 28.68 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.322 0.582 . . . . 0.0 111.399 -174.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . 0.459 ' NZ ' ' HB3' ' D' ' 62' ' ' LYS . 6.2 ttpm? -74.07 100.38 3.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.1 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.51 HG12 ' O ' ' D' ' 56' ' ' ILE . 14.5 p -79.37 -28.65 13.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.672 -173.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 64' ' ' TYR . . . . . 0.406 ' HB3' HD12 ' D' ' 56' ' ' ILE . 22.0 t80 -140.32 141.62 35.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.639 0.257 . . . . 0.0 110.657 176.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 28.3 m -121.19 130.42 53.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.882 176.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 66' ' ' PHE . . . . . 0.709 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 19.5 p90 -136.98 140.13 41.95 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.758 0.79 . . . . 0.0 110.859 174.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 67' ' ' ASN . . . . . 0.807 HD22 ' HB2' ' D' ' 69' ' ' LYS . 11.2 p-10 -111.2 135.4 51.78 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.901 -178.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 68' ' ' GLU . . . . . 0.995 ' HB2' HG13 ' D' ' 47' ' ' ILE . 28.4 mt-10 -65.05 -13.2 57.37 Favored 'General case' 0 CA--C 1.521 -0.137 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.036 -175.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.807 ' HB2' HD22 ' D' ' 67' ' ' ASN . 5.6 mtpm? -59.91 -43.21 95.01 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 172.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 25.5 t -74.56 102.18 4.44 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 113.422 -1.717 . . . . 0.0 107.185 165.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 62.4 p -38.95 130.35 1.49 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.631 -173.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 72' ' ' VAL . . . . . 0.523 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -53.32 -14.14 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 179.242 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 73' ' ' GLY . . . . . 0.61 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -71.56 -62.49 3.42 Favored Glycine 0 N--CA 1.435 -1.367 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.303 170.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -54.79 -31.09 58.52 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.247 0.546 . . . . 0.0 110.717 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 75' ' ' ILE . . . . . 0.485 ' O ' ' HB2' ' D' ' 78' ' ' ASP . 26.6 mm -80.37 -36.3 16.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.401 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 76' ' ' SER . . . . . 0.649 ' HB2' HD13 ' D' ' 27' ' ' LEU . 27.7 t -73.84 -20.28 60.48 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.965 178.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -61.38 -46.51 89.89 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 163.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 78' ' ' ASP . . . . . 0.944 ' HA ' ' HG2' ' D' ' 81' ' ' LYS . 51.5 m-20 -60.31 -36.16 77.28 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 174.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . 0.763 HG22 HD11 ' D' ' 36' ' ' LEU . 29.8 mm -67.06 -30.6 50.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.248 -174.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -75.98 -15.87 60.08 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.332 174.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . 0.944 ' HG2' ' HA ' ' D' ' 78' ' ' ASP . 11.0 mmtp -77.33 -63.65 1.32 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 173.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 82' ' ' LEU . . . . . 0.644 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.2 mm? -49.47 -26.25 3.22 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 113.242 -1.799 . . . . 0.0 113.56 -174.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 83' ' ' ASN . . . . . 0.575 ' O ' ' HE2' ' D' ' 85' ' ' LYS . 0.8 OUTLIER 51.82 66.67 1.13 Allowed 'General case' 0 N--CA 1.468 0.46 0 O-C-N 123.386 0.429 . . . . 0.0 110.251 177.137 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 84' ' ' ILE . . . . . 0.6 HG22 HD13 ' D' ' 89' ' ' ILE . 46.5 mm -76.9 99.48 2.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.897 -173.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 85' ' ' LYS . . . . . 0.575 ' HE2' ' O ' ' D' ' 83' ' ' ASN . 0.0 OUTLIER -156.26 91.75 1.28 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 174.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 86' ' ' GLY . . . . . 0.712 ' H ' HD11 ' D' ' 89' ' ' ILE . . . 69.17 151.27 0.43 Allowed Glycine 0 N--CA 1.453 -0.219 0 CA-C-N 115.163 -0.926 . . . . 0.0 113.222 174.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 87' ' ' PRO . . . . . 0.634 ' O ' HG13 ' D' ' 58' ' ' VAL . 59.0 Cg_endo -90.76 179.91 13.15 Favored 'Cis proline' 0 CA--C 1.535 0.534 0 C-N-CA 123.336 -1.527 . . . . 0.0 112.784 -0.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 88' ' ' TYR . . . . . 0.744 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 0.9 OUTLIER 16.85 92.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 125.142 1.377 . . . . 0.0 113.705 178.76 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.712 HD11 ' H ' ' D' ' 86' ' ' GLY . 70.3 mt -111.5 142.73 23.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.524 ' O ' ' HD1' ' D' ' 57' ' ' PHE . 70.9 mt-10 -136.87 95.05 3.05 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.676 172.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 91' ' ' ILE . . . . . 1.04 HG22 ' HZ3' ' D' ' 54' ' ' TRP . 5.5 mt -96.87 106.53 18.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 92' ' ' LYS . . . . . 0.613 ' HA ' ' CH2' ' D' ' 54' ' ' TRP . 0.0 OUTLIER -161.93 170.77 18.79 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.622 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.601 ' HB3' ' NE1' ' D' ' 54' ' ' TRP . 18.9 pt20 -82.59 164.8 20.57 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.749 176.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . 0.507 HG22 ' HE2' ' D' ' 92' ' ' LYS . 10.4 pt . . . . . 0 C--N 1.31 -1.118 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.174 -172.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 1' ' ' ASP . . . . . 0.455 ' HB3' ' HB3' ' D' ' 5' ' ' ALA . 1.7 m-20 . . . . . 0 N--CA 1.482 1.153 0 CA-C-O 120.506 0.193 . . . . 0.0 110.645 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 2' ' ' ASN . . . . . 0.534 ' O ' ' HB3' ' D' ' 6' ' ' LEU . 20.2 t-20 -172.27 -44.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.59 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -60.6 -53.71 54.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.216 -175.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -112.79 -32.03 6.54 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 177.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 5' ' ' ALA . . . . . 0.455 ' HB3' ' HB3' ' D' ' 1' ' ' ASP . . . -102.36 76.28 1.54 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.075 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . 0.808 ' H ' HD23 ' D' ' 6' ' ' LEU . 1.8 pt? -112.13 -1.41 15.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.632 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -49.43 -68.12 0.2 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 1.024 ' HA ' ' HB3' ' D' ' 12' ' ' SER . 23.0 pt-20 -78.63 1.1 23.87 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -176.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . 0.7 ' NE2' ' HG3' ' D' ' 8' ' ' GLU . 17.5 mp0 -94.95 -13.14 25.62 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 10' ' ' MET . . . . . 0.477 ' HG2' ' O ' ' D' ' 6' ' ' LEU . 25.1 mmt -109.07 -77.83 0.6 Allowed 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 119.539 -0.864 . . . . 0.0 113.099 -172.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -100.92 -41.16 6.93 Favored 'General case' 0 CA--C 1.488 -1.426 0 CA-C-O 121.222 0.534 . . . . 0.0 110.422 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 12' ' ' SER . . . . . 1.024 ' HB3' ' HA ' ' D' ' 8' ' ' GLU . 34.7 t -42.05 -68.27 0.2 Allowed 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 113.373 -1.739 . . . . 0.0 112.263 -169.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.475 HG21 ' SD ' ' D' ' 31' ' ' MET . 38.2 mm -92.91 -9.69 9.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.34 -174.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 14' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' D' ' 10' ' ' MET . 78.5 m-20 -96.83 -56.27 2.62 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 177.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 37.2 m -69.39 -15.7 63.36 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 121.21 -0.196 . . . . 0.0 110.997 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 16' ' ' VAL . . . . . 0.746 ' HA ' ' HE2' ' D' ' 19' ' ' LYS . 14.1 p -56.84 -35.26 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 173.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -66.66 -44.01 82.99 Favored 'General case' 0 C--O 1.211 -0.955 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.349 175.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -56.77 -15.07 3.97 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -174.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.746 ' HE2' ' HA ' ' D' ' 16' ' ' VAL . 0.0 OUTLIER -91.54 -44.09 9.28 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-O 122.413 1.101 . . . . 0.0 108.895 174.261 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 20' ' ' LEU . . . . . 0.862 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 72.6 mt -69.76 -36.47 75.81 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 112.804 -1.998 . . . . 0.0 110.097 -174.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 21' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -69.82 98.76 1.27 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.589 177.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 22' ' ' LYS . . . . . 0.624 ' NZ ' ' HA ' ' D' ' 47' ' ' ILE . 8.8 mtmp? -121.36 -42.5 2.45 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -171.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.38 -71.66 0.32 Allowed Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.135 -1.031 . . . . 0.0 112.04 -175.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . 0.831 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 21.8 tptm -51.01 -67.42 0.25 Allowed 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 175.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.9 166.69 23.91 Favored Glycine 0 N--CA 1.43 -1.704 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.581 169.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 26' ' ' LYS . . . . . 0.831 ' HD2' ' HB2' ' D' ' 41' ' ' SER . 0.4 OUTLIER -148.15 156.93 43.17 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.543 -0.328 . . . . 0.0 110.486 -170.545 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 27' ' ' LEU . . . . . 0.862 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 46.2 tp -137.43 142.47 41.62 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.318 0.58 . . . . 0.0 111.285 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 28' ' ' SER . . . . . 0.709 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 49.0 m -137.03 143.18 42.57 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.013 -174.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 29' ' ' LEU . . . . . 0.586 HD11 ' CD1' ' D' ' 20' ' ' LEU . 0.2 OUTLIER -140.7 149.73 42.56 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.768 -179.113 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 36.1 t -155.01 174.45 15.16 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.17 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 31' ' ' MET . . . . . 0.475 ' SD ' HG21 ' D' ' 13' ' ' ILE . 0.0 OUTLIER -128.74 165.43 20.93 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.023 0.44 . . . . 0.0 109.884 176.838 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 32' ' ' ASN . . . . . 0.423 ' HB3' ' HB2' ' D' ' 35' ' ' GLN . 52.6 t30 -146.82 88.13 1.73 Allowed 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.61 -101.06 1.24 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.392 -168.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 34' ' ' ASN . . . . . 0.428 ' O ' ' HE2' ' D' ' 85' ' ' LYS . 4.4 m120 -116.4 20.99 13.89 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.691 -0.3 . . . . 0.0 110.705 173.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 35' ' ' GLN . . . . . 0.423 ' HB2' ' HB3' ' D' ' 32' ' ' ASN . 13.6 mm100 -88.91 163.09 15.76 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.576 0.703 . . . . 0.0 111.983 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.716 HD11 HG22 ' D' ' 79' ' ' ILE . 2.4 tm? -129.93 124.95 34.32 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.933 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 37' ' ' LYS . . . . . 0.581 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 26.1 mmmt -130.38 116.15 17.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.605 -168.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 38' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -120.16 143.72 48.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.443 0.64 . . . . 0.0 111.338 176.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 39' ' ' THR . . . . . 0.709 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 4.9 p -138.55 130.11 27.62 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.095 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . 0.723 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 24.7 p -120.75 129.52 53.65 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 41' ' ' SER . . . . . 0.831 ' HB2' ' HD2' ' D' ' 26' ' ' LYS . 49.3 m -100.92 159.45 15.19 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.174 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 42' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' D' ' 41' ' ' SER . 74.2 m-80 76.67 8.91 3.05 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 124.572 1.17 . . . . 0.0 110.707 -174.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 40.92 59.05 2.33 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 171.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 114.22 35.24 1.5 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 119.419 -1.372 . . . . 0.0 114.175 172.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 45' ' ' TYR . . . . . 0.831 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 2.2 m-30 -113.18 145.74 40.45 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 122.477 -0.425 . . . . 0.0 110.02 172.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -91.63 -150.49 25.55 Favored Glycine 0 CA--C 1.504 -0.629 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.411 -178.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 47' ' ' ILE . . . . . 0.939 HG13 ' HB2' ' D' ' 68' ' ' GLU . 0.3 OUTLIER -53.77 -58.91 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 CA-C-O 122.079 0.942 . . . . 0.0 109.013 -178.585 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.444 ' O ' ' HD2' ' D' ' 49' ' ' TYR . 41.1 t 163.25 -107.32 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 111.216 -2.72 . . . . 0.0 105.381 -172.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 49' ' ' TYR . . . . . 0.444 ' HD2' ' O ' ' D' ' 48' ' ' SER . 2.7 m-30 -124.09 76.76 1.48 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 163.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . 0.459 ' HB2' HG21 ' D' ' 47' ' ' ILE . 63.8 mm-40 -148.56 -166.14 2.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.134 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 51' ' ' ASP . . . . . 0.725 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 2.8 p30 -148.41 138.7 22.6 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.382 168.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 52' ' ' LYS . . . . . 0.725 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 0.4 OUTLIER -143.44 144.35 31.98 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.098 -174.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 53' ' ' ASN . . . . . 0.454 HD22 ' C ' ' D' ' 52' ' ' LYS . 3.2 m120 -120.2 129.54 54.14 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 172.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 54' ' ' TRP . . . . . 1.057 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 1.0 OUTLIER -120.99 162.04 20.59 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -173.109 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -152.19 152.96 24.6 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.414 172.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 56' ' ' ILE . . . . . 1.106 HG12 HG23 ' D' ' 91' ' ' ILE . 83.7 mt -117.3 116.93 53.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 173.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 57' ' ' PHE . . . . . 0.684 ' CE1' ' HG2' ' D' ' 62' ' ' LYS . 15.3 m-85 -107.47 98.96 8.51 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 119.467 -0.893 . . . . 0.0 111.389 -168.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 59.3 t -91.94 115.01 30.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.763 173.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 63.9 34.7 11.47 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.212 -176.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.72 -32.27 5.15 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.455 -0.878 . . . . 0.0 113.726 176.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 61' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 16.2 pt-20 -90.0 155.24 19.23 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.798 0.333 . . . . 0.0 110.799 -174.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . 0.684 ' HG2' ' CE1' ' D' ' 57' ' ' PHE . 57.8 mttp -80.49 103.03 10.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.961 0.41 . . . . 0.0 110.043 -178.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 14.1 p -78.7 -29.33 14.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.94 -177.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 64' ' ' TYR . . . . . 0.445 ' HB3' HD12 ' D' ' 56' ' ' ILE . 16.3 t80 -146.72 126.65 13.6 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.682 175.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 97.2 m -109.59 111.72 23.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.542 174.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 66' ' ' PHE . . . . . 0.498 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 15.9 p90 -116.36 160.71 20.13 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 172.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 67' ' ' ASN . . . . . 0.505 ' O ' HD11 ' D' ' 75' ' ' ILE . 13.2 p30 -132.59 141.35 48.65 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 68' ' ' GLU . . . . . 0.939 ' HB2' HG13 ' D' ' 47' ' ' ILE . 31.4 mm-40 -64.21 -15.23 59.55 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -177.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.613 ' HA ' HD11 ' D' ' 47' ' ' ILE . 49.3 mtpt -56.81 -49.89 74.0 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 173.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 23.1 t -63.8 128.37 35.53 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 113.426 -1.716 . . . . 0.0 107.51 168.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 70.2 p -57.51 118.99 5.77 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 72' ' ' VAL . . . . . 0.65 ' HA ' HD12 ' D' ' 75' ' ' ILE . 0.0 OUTLIER -53.61 -14.98 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -176.387 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 73' ' ' GLY . . . . . 0.723 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -67.96 -56.74 9.97 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.788 170.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -68.23 -19.97 64.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.988 0.423 . . . . 0.0 110.278 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 75' ' ' ILE . . . . . 0.65 HD12 ' HA ' ' D' ' 72' ' ' VAL . 83.3 mt -72.59 -43.95 61.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.555 175.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 31.4 t -73.58 -19.15 60.96 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.166 -176.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -60.49 -44.47 95.91 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 165.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 78' ' ' ASP . . . . . 1.018 ' HA ' ' HG2' ' D' ' 81' ' ' LYS . 1.0 OUTLIER -69.66 -25.81 64.09 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 114.981 -1.009 . . . . 0.0 113.407 177.144 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . 0.716 HG22 HD11 ' D' ' 36' ' ' LEU . 41.5 mt -77.72 -17.0 14.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 118.89 -1.124 . . . . 0.0 109.875 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -77.52 -26.83 51.45 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.256 169.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . 1.018 ' HG2' ' HA ' ' D' ' 78' ' ' ASP . 15.9 mmtt -74.01 -69.96 0.41 Allowed 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 176.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 82' ' ' LEU . . . . . 0.491 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.5 mm? -47.28 -32.25 4.5 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 113.482 -1.69 . . . . 0.0 112.578 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 83' ' ' ASN . . . . . 0.548 ' ND2' ' HB3' ' D' ' 36' ' ' LEU . 0.7 OUTLIER 37.85 65.5 0.56 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.979 0.912 . . . . 0.0 111.269 175.821 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 84' ' ' ILE . . . . . 0.622 ' H ' HD12 ' D' ' 84' ' ' ILE . 2.8 mp -74.88 99.12 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.96 0.41 . . . . 0.0 111.372 -171.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 85' ' ' LYS . . . . . 0.428 ' HE2' ' O ' ' D' ' 34' ' ' ASN . 16.8 ptpt -125.9 92.3 3.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.988 0.423 . . . . 0.0 111.96 178.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 86' ' ' GLY . . . . . 0.805 ' H ' HD11 ' D' ' 89' ' ' ILE . . . 61.33 160.04 0.11 Allowed Glycine 0 CA--C 1.52 0.353 0 CA-C-N 115.328 -0.851 . . . . 0.0 114.146 173.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 87' ' ' PRO . . . . . 0.584 ' O ' HG13 ' D' ' 58' ' ' VAL . 44.8 Cg_endo -93.68 -178.58 8.42 Favored 'Cis proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.795 -1.335 . . . . 0.0 112.176 -1.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 88' ' ' TYR . . . . . 0.647 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 16.0 m-85 24.57 92.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.823 1.249 . . . . 0.0 113.387 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.805 HD11 ' H ' ' D' ' 86' ' ' GLY . 75.8 mt -111.67 130.78 64.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.581 ' O ' ' HD2' ' D' ' 57' ' ' PHE . 51.3 mt-10 -130.52 101.54 5.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.105 172.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 91' ' ' ILE . . . . . 1.106 HG23 HG12 ' D' ' 56' ' ' ILE . 4.1 mt -98.3 113.03 31.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -177.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 92' ' ' LYS . . . . . 0.627 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -162.28 170.57 18.71 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.084 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.626 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 25.1 pt20 -80.97 164.81 22.28 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.803 176.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . 0.627 HG22 ' HE2' ' D' ' 92' ' ' LYS . 10.7 pt . . . . . 0 C--N 1.31 -1.109 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.899 -171.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 9.0 t70 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' D' D ' 2' ' ' ASN . . . . . 0.422 ' HA ' ' HB2' ' D' ' 7' ' ' GLU . 5.6 m120 -68.33 -17.25 64.21 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -173.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -92.34 -13.28 30.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.801 0.334 . . . . 0.0 111.179 -176.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -110.82 -33.62 6.48 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 5' ' ' ALA . . . . . 0.693 ' HB3' ' HG2' ' D' ' 7' ' ' GLU . . . -104.0 172.12 6.97 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.512 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 1.4 pp -84.88 24.97 0.98 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.445 177.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . 0.693 ' HG2' ' HB3' ' D' ' 5' ' ' ALA . 65.1 mm-40 -45.33 -34.68 3.1 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -176.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.616 ' HB2' HE21 ' D' ' 9' ' ' GLN . 82.4 mt-10 -63.09 -23.38 67.42 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 120.749 0.309 . . . . 0.0 111.233 -175.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . 0.616 HE21 ' HB2' ' D' ' 8' ' ' GLU . 65.6 mm-40 -99.1 -0.58 41.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.953 -175.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 10' ' ' MET . . . . . . . . . . . . . 53.8 ttp -106.24 -78.51 0.58 Allowed 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 119.64 -0.824 . . . . 0.0 112.718 -169.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 -104.27 -31.21 9.69 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 176.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 12' ' ' SER . . . . . 0.555 ' HB2' ' O ' ' D' ' 7' ' ' GLU . 42.4 t -21.36 -67.58 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 113.433 -1.712 . . . . 0.0 115.23 -170.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.549 HG21 ' HE1' ' D' ' 31' ' ' MET . 63.9 mt -73.73 -12.07 15.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.736 -171.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -96.19 -50.37 4.84 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.519 172.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 15' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' D' ' 18' ' ' ASP . 80.5 p -63.44 -24.94 68.05 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.328 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 16' ' ' VAL . . . . . 0.653 ' O ' ' HG ' ' D' ' 20' ' ' LEU . 9.8 p -54.16 -37.58 36.04 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-O 121.296 0.569 . . . . 0.0 109.593 176.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 17' ' ' ASN . . . . . 0.617 ' OD1' ' HA ' ' D' ' 28' ' ' SER . 78.6 m-20 -78.21 -22.3 48.72 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.461 -178.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 18' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' D' ' 15' ' ' SER . 1.0 OUTLIER -67.79 -17.14 64.43 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 176.379 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.587 ' O ' ' HE3' ' D' ' 22' ' ' LYS . 0.0 OUTLIER -91.74 -43.11 9.75 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 172.186 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 20' ' ' LEU . . . . . 1.018 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 85.4 mt -63.04 -40.95 99.24 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.009 -1.451 . . . . 0.0 110.131 -177.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 21' ' ' ASN . . . . . 0.576 ' OD1' ' HB2' ' D' ' 26' ' ' LYS . 51.6 m-80 -79.73 101.64 8.55 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.347 177.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 22' ' ' LYS . . . . . 0.966 ' HD2' HD12 ' D' ' 47' ' ' ILE . 97.4 mttt -122.18 -41.76 2.41 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -175.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 169.9 -91.13 0.1 OUTLIER Glycine 0 N--CA 1.437 -1.26 0 C-N-CA 119.604 -1.284 . . . . 0.0 112.982 -178.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . 0.656 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 26.4 tptp -48.27 -52.86 19.36 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 25' ' ' GLY . . . . . 0.99 ' HA2' HD21 ' D' ' 42' ' ' ASN . . . -141.48 154.0 24.4 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.394 176.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 26' ' ' LYS . . . . . 0.588 ' CD ' ' HB3' ' D' ' 41' ' ' SER . 0.4 OUTLIER -144.92 161.94 38.1 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.573 -0.814 . . . . 0.0 112.248 -168.709 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 27' ' ' LEU . . . . . 1.018 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 51.5 tp -134.93 153.15 52.17 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.454 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 28' ' ' SER . . . . . 0.617 ' HA ' ' OD1' ' D' ' 17' ' ' ASN . 14.2 t -140.68 153.79 46.12 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 29' ' ' LEU . . . . . . . . . . . . . 20.2 mt -134.2 158.8 42.75 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.624 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 37.3 t -160.15 -177.13 6.07 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 31' ' ' MET . . . . . 0.549 ' HE1' HG21 ' D' ' 13' ' ' ILE . 1.3 pmm? -150.57 163.15 39.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.84 0.352 . . . . 0.0 111.007 177.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 32' ' ' ASN . . . . . 0.444 ' H ' ' HB2' ' D' ' 35' ' ' GLN . 51.3 t30 -144.25 88.48 1.95 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.1 175.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.47 -115.35 4.56 Favored Glycine 0 N--CA 1.454 -0.154 0 C-N-CA 120.205 -0.997 . . . . 0.0 110.991 -172.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -95.78 20.71 9.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.915 0.388 . . . . 0.0 110.926 174.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 35' ' ' GLN . . . . . 0.444 ' HB2' ' H ' ' D' ' 32' ' ' ASN . 10.3 mm-40 -88.54 152.85 21.59 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 121.314 0.578 . . . . 0.0 111.989 176.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.824 HD12 ' HA ' ' D' ' 83' ' ' ASN . 1.3 tm? -134.37 119.56 18.77 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.378 175.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 37' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -123.36 157.36 33.47 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.564 -169.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 38' ' ' ALA . . . . . 0.599 ' HB1' HD11 ' D' ' 27' ' ' LEU . . . -148.83 152.26 36.19 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 113.216 -1.811 . . . . 0.0 111.341 176.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 39' ' ' THR . . . . . 0.586 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 20.6 p -145.54 139.03 26.46 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.198 175.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . 0.52 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 33.8 p -106.1 128.78 54.12 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 171.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 41' ' ' SER . . . . . 0.588 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 48.0 t -92.18 162.58 14.26 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 176.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 42' ' ' ASN . . . . . 0.99 HD21 ' HA2' ' D' ' 25' ' ' GLY . 18.6 p30 64.64 3.78 2.08 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 124.605 1.19 . . . . 0.0 111.896 -169.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 43' ' ' ALA . . . . . 0.41 ' H ' ' C ' ' D' ' 41' ' ' SER . . . 52.79 63.24 2.32 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 165.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.62 -15.94 6.63 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 118.174 -1.965 . . . . 0.0 115.993 166.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 45' ' ' TYR . . . . . 0.656 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 2.2 m-30 -78.62 155.94 29.34 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 117.909 0.855 . . . . 0.0 110.683 -176.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . 0.635 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -96.79 -172.91 34.69 Favored Glycine 0 C--O 1.217 -0.968 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 172.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 47' ' ' ILE . . . . . 0.966 HD12 ' HD2' ' D' ' 22' ' ' LYS . 39.4 mm -48.41 -56.64 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.861 0 CA-C-N 117.975 0.888 . . . . 0.0 110.917 178.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 81.0 p -179.31 -147.38 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 112.574 -2.103 . . . . 0.0 108.025 -173.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -97.46 75.53 2.51 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.226 168.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . 0.402 ' OE2' ' HA ' ' D' ' 50' ' ' GLU . 36.8 mm-40 -144.0 -172.68 3.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.56 -178.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 51' ' ' ASP . . . . . 0.689 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 11.6 m-20 -134.86 120.13 18.94 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.141 173.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 52' ' ' LYS . . . . . 1.053 ' HG2' ' HB2' ' D' ' 68' ' ' GLU . 0.0 OUTLIER -139.41 130.35 26.3 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.436 -177.1 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -109.92 142.82 40.74 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 121.002 0.429 . . . . 0.0 110.967 -175.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 54' ' ' TRP . . . . . 1.068 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 0.8 OUTLIER -123.43 160.57 26.56 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.825 -176.925 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -138.56 160.85 25.68 Favored Glycine 0 N--CA 1.438 -1.233 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.95 174.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 56' ' ' ILE . . . . . 0.943 HG12 HG23 ' D' ' 91' ' ' ILE . 97.0 mt -140.47 109.88 3.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 178.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 57' ' ' PHE . . . . . 0.633 ' HA ' ' O ' ' D' ' 61' ' ' GLU . 13.9 m-85 -107.92 101.25 10.53 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.624 -0.83 . . . . 0.0 111.7 -168.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.861 HG22 HG12 ' D' ' 89' ' ' ILE . 87.5 t -94.84 119.67 43.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.446 173.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 5.5 m120 63.93 35.59 10.73 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.075 0.464 . . . . 0.0 110.776 -175.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.2 34.68 90.57 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.373 -0.83 . . . . 0.0 114.461 175.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 61' ' ' GLU . . . . . 0.633 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 16.3 pt-20 -138.69 145.33 40.23 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 171.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . 0.449 ' HB2' ' NZ ' ' D' ' 62' ' ' LYS . 3.8 ttmp? -75.34 99.39 4.09 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -177.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.467 HG12 ' O ' ' D' ' 56' ' ' ILE . 9.2 p -84.73 -33.54 8.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.577 -173.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 64' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -135.88 131.37 35.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.932 0.396 . . . . 0.0 110.595 174.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 26.4 m -115.93 113.9 23.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.701 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 66' ' ' PHE . . . . . 0.563 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 10.8 p90 -116.81 130.91 57.01 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.355 0.597 . . . . 0.0 109.776 175.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -103.2 139.86 38.12 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -178.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 68' ' ' GLU . . . . . 1.053 ' HB2' ' HG2' ' D' ' 52' ' ' LYS . 40.2 mm-40 -70.63 -8.94 55.48 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.946 -174.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.556 ' HD3' ' HB3' ' D' ' 51' ' ' ASP . 47.0 mtmt -62.88 -39.73 95.35 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 169.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 31.7 t -71.45 119.9 16.26 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.502 -1.681 . . . . 0.0 107.07 165.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 70.1 p -54.87 130.59 41.73 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.255 -176.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 72' ' ' VAL . . . . . 0.636 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -55.68 -13.38 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 121.077 0.465 . . . . 0.0 111.813 -175.821 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 73' ' ' GLY . . . . . 0.52 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -74.07 -55.55 5.72 Favored Glycine 0 N--CA 1.437 -1.249 0 CA-C-N 115.212 -0.904 . . . . 0.0 112.445 169.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 74' ' ' ASN . . . . . 0.795 ' HA ' HD22 ' D' ' 77' ' ' ASN . 44.6 t30 -62.29 -23.59 66.81 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.814 0.34 . . . . 0.0 110.553 177.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 75' ' ' ILE . . . . . 0.62 ' O ' HG13 ' D' ' 79' ' ' ILE . 74.3 mt -73.83 -41.85 53.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.329 176.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 28.8 t -73.5 -20.41 60.68 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.554 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 77' ' ' ASN . . . . . 0.795 HD22 ' HA ' ' D' ' 74' ' ' ASN . 76.4 m-20 -65.84 -28.25 68.84 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 168.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 78' ' ' ASP . . . . . 1.094 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 1.0 OUTLIER -83.71 -32.22 25.64 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 115.528 -0.76 . . . . 0.0 113.032 174.823 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . 0.62 HG13 ' O ' ' D' ' 75' ' ' ILE . 25.1 mt -72.27 -16.55 18.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 120.034 -0.667 . . . . 0.0 110.041 -176.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -65.04 -49.81 68.66 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.729 172.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . 1.094 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -72.73 -57.58 4.0 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.637 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 82' ' ' LEU . . . . . 0.544 HD23 ' O ' ' D' ' 78' ' ' ASP . 4.1 mm? -44.98 -35.45 2.9 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 83' ' ' ASN . . . . . 0.824 ' HA ' HD12 ' D' ' 36' ' ' LEU . 22.2 t-20 29.33 70.88 0.07 Allowed 'General case' 0 N--CA 1.476 0.841 0 O-C-N 124.591 1.182 . . . . 0.0 111.811 178.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 84' ' ' ILE . . . . . 0.602 ' O ' ' HG ' ' D' ' 36' ' ' LEU . 50.1 mt -93.0 98.33 8.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.627 -176.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 85' ' ' LYS . . . . . 0.491 ' HB2' ' HB2' ' D' ' 36' ' ' LEU . 2.7 tmtm? -127.65 93.93 3.83 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -178.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 86' ' ' GLY . . . . . 0.609 ' H ' HD11 ' D' ' 89' ' ' ILE . . . 72.1 153.11 1.65 Allowed Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.918 -0.583 . . . . 0.0 113.165 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 87' ' ' PRO . . . . . 0.541 ' O ' HG13 ' D' ' 58' ' ' VAL . 54.2 Cg_endo -91.21 -179.76 12.13 Favored 'Cis proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.395 -1.502 . . . . 0.0 112.923 -0.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 88' ' ' TYR . . . . . 0.616 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 19.3 m-85 10.99 93.87 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 125.74 1.616 . . . . 0.0 114.065 -178.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.861 HG12 HG22 ' D' ' 58' ' ' VAL . 68.5 mt -111.54 142.85 22.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.975 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.426 ' HG2' ' HG3' ' D' ' 92' ' ' LYS . 38.3 tt0 -128.76 95.09 4.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.916 172.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 91' ' ' ILE . . . . . 1.068 HG22 ' HZ3' ' D' ' 54' ' ' TRP . 7.3 mt -97.18 109.15 22.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 92' ' ' LYS . . . . . 0.78 ' HE3' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -162.17 172.29 16.03 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 122.603 0.361 . . . . 0.0 110.308 -176.222 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.696 ' HB3' ' NE1' ' D' ' 54' ' ' TRP . 17.4 pt20 -89.07 153.45 20.98 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.744 174.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . 0.78 HG22 ' HE3' ' D' ' 92' ' ' LYS . 10.6 pt . . . . . 0 C--N 1.309 -1.171 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.688 -171.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 120.586 0.231 . . . . 0.0 110.658 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' D' D ' 2' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -100.27 0.09 39.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.281 -175.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -63.4 -68.06 0.37 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.787 0.327 . . . . 0.0 110.991 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 4' ' ' LYS . . . . . 0.403 ' HB3' ' CD1' ' D' ' 6' ' ' LEU . 62.1 tttp -105.59 -22.01 13.07 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 177.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 5' ' ' ALA . . . . . . . . . . . . . . . 59.51 57.51 3.27 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.621 177.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . 0.536 ' H ' HD12 ' D' ' 6' ' ' LEU . 3.6 mp -70.88 -37.73 73.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.258 0.551 . . . . 0.0 110.13 178.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -62.45 -16.46 55.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.065 -0.97 . . . . 0.0 113.33 -174.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.681 ' HA ' ' CB ' ' D' ' 12' ' ' SER . 55.6 mt-10 -69.42 -30.49 68.44 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.023 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . 0.516 HE21 ' HB2' ' D' ' 8' ' ' GLU . 56.7 mm-40 -96.38 -1.78 46.98 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.959 -178.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 10' ' ' MET . . . . . . . . . . . . . 65.3 mtt -108.51 -71.93 0.74 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.348 -173.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -92.92 -54.51 3.71 Favored 'General case' 0 CA--C 1.485 -1.54 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.404 178.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 12' ' ' SER . . . . . 0.681 ' CB ' ' HA ' ' D' ' 8' ' ' GLU . 32.7 t -23.54 -64.45 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.046 0 O-C-N 125.117 1.51 . . . . 0.0 114.824 -172.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.592 ' O ' HG12 ' D' ' 16' ' ' VAL . 63.3 mt -85.34 -8.64 11.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.43 -171.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -92.0 -46.87 7.59 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.229 173.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 15' ' ' SER . . . . . 0.451 ' O ' ' HE2' ' D' ' 19' ' ' LYS . 92.2 p -70.23 -18.66 63.16 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.78 176.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 16' ' ' VAL . . . . . 0.62 ' O ' ' HG ' ' D' ' 20' ' ' LEU . 1.3 p -62.06 -27.43 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -69.62 -41.34 75.81 Favored 'General case' 0 C--O 1.206 -1.232 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.905 175.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 18' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' D' ' 15' ' ' SER . 49.7 m-20 -61.94 -14.54 35.64 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 176.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.687 ' HB3' ' CZ2' ' D' ' 54' ' ' TRP . 1.2 mppt? -87.79 -26.85 22.65 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.367 0.603 . . . . 0.0 110.185 177.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 20' ' ' LEU . . . . . 0.993 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 84.6 mt -105.6 -38.49 6.41 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 113.547 -1.66 . . . . 0.0 110.559 -168.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 21' ' ' ASN . . . . . 0.685 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 1.2 t-20 -88.12 89.05 7.84 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 113.571 -1.65 . . . . 0.0 108.314 -172.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 22' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -120.42 -42.2 2.57 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -163.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 178.53 -88.63 0.07 OUTLIER Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 119.455 -1.355 . . . . 0.0 113.032 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . 0.782 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 53.6 tptt -50.79 -63.55 1.09 Allowed 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -127.69 162.57 21.58 Favored Glycine 0 N--CA 1.431 -1.67 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.315 171.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 26' ' ' LYS . . . . . 0.703 ' CD ' ' HB3' ' D' ' 41' ' ' SER . 0.1 OUTLIER -149.7 160.61 43.39 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.832 -0.684 . . . . 0.0 110.979 -169.165 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 27' ' ' LEU . . . . . 0.993 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 55.3 tp -138.47 143.73 39.74 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.153 0.501 . . . . 0.0 111.226 -178.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 28' ' ' SER . . . . . 0.62 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 29.5 t -130.39 136.77 49.41 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -177.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 29' ' ' LEU . . . . . 0.651 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 14.5 mt -132.48 135.28 45.91 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.302 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 61.2 m -142.2 -171.96 3.49 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.039 176.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -139.59 160.39 39.97 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.037 0.446 . . . . 0.0 110.236 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 32' ' ' ASN . . . . . 0.488 ' HB3' ' HB2' ' D' ' 35' ' ' GLN . 24.6 t-20 -139.84 88.07 2.21 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.22 -107.88 2.31 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.823 -169.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -108.4 26.87 9.95 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 122.505 -0.409 . . . . 0.0 110.521 174.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 35' ' ' GLN . . . . . 0.488 ' HB2' ' HB3' ' D' ' 32' ' ' ASN . 22.5 mt-30 -105.09 162.68 13.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.788 -178.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.779 ' HB2' ' HB2' ' D' ' 85' ' ' LYS . 0.9 OUTLIER -128.82 135.04 48.59 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.312 -178.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 37' ' ' LYS . . . . . 0.651 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 75.2 mmtt -129.76 111.43 12.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.052 -168.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 38' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -111.47 144.19 41.08 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.855 0.36 . . . . 0.0 111.067 175.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 39' ' ' THR . . . . . 0.62 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 16.2 p -147.42 135.88 21.75 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.353 177.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . 0.677 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 30.4 p -109.4 129.99 55.52 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 41' ' ' SER . . . . . 0.703 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 47.4 t -95.58 148.94 21.98 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.121 -1.031 . . . . 0.0 109.337 177.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 42' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' D' ' 41' ' ' SER . 75.8 m-20 80.19 -1.64 2.0 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.389 -168.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 49.38 61.88 2.91 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 169.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.3 1.33 7.89 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 118.517 -1.801 . . . . 0.0 115.387 170.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 45' ' ' TYR . . . . . 0.782 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 1.5 m-30 -86.05 154.15 21.62 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 116.946 0.373 . . . . 0.0 110.333 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -102.33 -153.34 24.93 Favored Glycine 0 C--O 1.219 -0.827 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 178.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 47' ' ' ILE . . . . . 0.961 HG13 ' HB2' ' D' ' 68' ' ' GLU . 2.7 mp -49.04 -58.42 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 CA-C-O 122.428 1.109 . . . . 0.0 108.833 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.511 ' HA ' ' HG2' ' D' ' 24' ' ' LYS . 36.3 t 152.83 -95.28 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 110.593 -3.003 . . . . 0.0 106.544 -174.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 49' ' ' TYR . . . . . 0.466 ' HD1' ' C ' ' D' ' 48' ' ' SER . 3.7 m-30 -130.21 75.57 1.66 Allowed 'General case' 0 N--CA 1.465 0.304 0 O-C-N 122.228 -0.295 . . . . 0.0 111.047 169.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . 0.54 ' HB2' HG21 ' D' ' 47' ' ' ILE . 50.4 mt-10 -156.81 -175.63 5.53 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.348 0.259 . . . . 0.0 110.491 176.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 51' ' ' ASP . . . . . 0.704 ' HB2' ' HD2' ' D' ' 69' ' ' LYS . 7.0 p-10 -130.7 141.59 50.4 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.062 172.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 52' ' ' LYS . . . . . 0.767 ' HD3' HG12 ' D' ' 47' ' ' ILE . 0.7 OUTLIER -145.28 136.07 24.52 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.213 -177.136 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -113.82 139.04 49.47 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.173 170.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 54' ' ' TRP . . . . . 1.091 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 0.9 OUTLIER -126.71 157.01 40.19 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -172.176 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -143.23 158.08 27.13 Favored Glycine 0 N--CA 1.437 -1.298 0 C-N-CA 120.133 -1.032 . . . . 0.0 113.299 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 56' ' ' ILE . . . . . 1.024 HG12 HG23 ' D' ' 91' ' ' ILE . 91.7 mt -129.13 97.24 3.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 113.289 -1.456 . . . . 0.0 107.459 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 57' ' ' PHE . . . . . 0.578 ' HA ' ' O ' ' D' ' 61' ' ' GLU . 14.2 m-85 -100.15 103.25 14.73 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -171.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.796 HG12 HG12 ' D' ' 89' ' ' ILE . 3.8 m -95.55 99.95 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.648 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 57.93 62.9 1.92 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.692 -168.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.67 48.55 85.51 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 115.879 -0.6 . . . . 0.0 113.395 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 61' ' ' GLU . . . . . 0.578 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 5.4 tp10 -157.49 115.2 3.09 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . 0.489 ' HE2' ' OG1' ' D' ' 65' ' ' THR . 5.8 ttpm? -77.6 98.68 5.49 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 35.4 m -88.45 -11.5 10.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.48 -173.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 64' ' ' TYR . . . . . 0.549 ' HB3' HD12 ' D' ' 56' ' ' ILE . 16.9 t80 -150.42 136.6 18.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.835 0.35 . . . . 0.0 110.397 174.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.489 ' OG1' ' HE2' ' D' ' 62' ' ' LYS . 24.5 m -119.4 113.54 20.94 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.161 176.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 66' ' ' PHE . . . . . 0.535 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 10.3 p90 -123.89 159.15 30.3 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 173.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 67' ' ' ASN . . . . . 0.437 ' O ' HD11 ' D' ' 75' ' ' ILE . 13.1 p30 -131.51 137.77 48.66 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 68' ' ' GLU . . . . . 0.961 ' HB2' HG13 ' D' ' 47' ' ' ILE . 37.5 mt-10 -62.18 -16.41 52.81 Favored 'General case' 0 C--N 1.345 0.395 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -174.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.704 ' HD2' ' HB2' ' D' ' 51' ' ' ASP . 5.6 mtpm? -57.98 -47.14 83.88 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.17 174.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 31.7 t -66.66 114.06 5.29 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 166.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 59.2 p -53.32 124.85 15.79 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.418 -173.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 72' ' ' VAL . . . . . 0.488 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -53.2 -13.01 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.756 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 73' ' ' GLY . . . . . 0.677 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -70.36 -57.48 6.72 Favored Glycine 0 N--CA 1.436 -1.359 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.261 169.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -69.71 -18.46 63.54 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.51 -0.345 . . . . 0.0 111.016 178.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 75' ' ' ILE . . . . . 0.616 ' O ' HG13 ' D' ' 79' ' ' ILE . 73.7 mt -71.74 -42.47 70.54 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.388 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.032 173.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 40.3 t -72.9 -22.69 60.7 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.434 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -60.48 -30.1 69.48 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 167.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 78' ' ' ASP . . . . . 1.049 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 50.2 m-20 -87.52 -31.83 19.72 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.585 176.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . 0.616 HG13 ' O ' ' D' ' 75' ' ' ILE . 31.1 mt -71.88 -16.78 18.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.137 -177.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -67.64 -40.7 84.56 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.922 173.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . 1.049 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -81.35 -53.59 6.2 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.837 176.592 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 82' ' ' LEU . . . . . 0.503 HD23 ' O ' ' D' ' 78' ' ' ASP . 4.0 mm? -53.08 -26.58 16.66 Favored 'General case' 0 C--O 1.227 -0.098 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 83' ' ' ASN . . . . . 0.543 HD22 ' HB3' ' D' ' 36' ' ' LEU . 0.6 OUTLIER 39.14 67.91 0.4 Allowed 'General case' 0 N--CA 1.474 0.761 0 O-C-N 123.998 0.811 . . . . 0.0 111.236 176.331 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 84' ' ' ILE . . . . . 0.979 HG21 HG21 ' D' ' 56' ' ' ILE . 46.3 mm -84.43 98.49 5.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.835 -173.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 85' ' ' LYS . . . . . 0.779 ' HB2' ' HB2' ' D' ' 36' ' ' LEU . 10.0 tmtt? -145.39 95.42 2.66 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.354 0.597 . . . . 0.0 109.532 177.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 86' ' ' GLY . . . . . 0.985 ' H ' HD11 ' D' ' 89' ' ' ILE . . . 77.13 158.79 9.58 Favored Glycine 0 CA--C 1.498 -1.007 0 CA-C-N 115.473 -0.785 . . . . 0.0 114.147 178.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 87' ' ' PRO . . . . . 0.76 ' O ' ' HB ' ' D' ' 58' ' ' VAL . 90.4 Cg_endo -80.66 -176.99 18.97 Favored 'Cis proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.355 -1.935 . . . . 0.0 113.3 0.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 88' ' ' TYR . . . . . 0.656 ' H ' ' HD1' ' D' ' 88' ' ' TYR . 1.7 m-85 -11.36 96.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.943 1.297 . . . . 0.0 114.03 -175.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.985 HD11 ' H ' ' D' ' 86' ' ' GLY . 41.0 mt -92.79 143.58 11.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -173.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -130.39 91.52 3.11 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.65 173.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 91' ' ' ILE . . . . . 1.091 HG22 ' HZ3' ' D' ' 54' ' ' TRP . 2.5 mt -96.91 117.73 42.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -176.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 92' ' ' LYS . . . . . 0.755 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.1 OUTLIER -162.91 173.37 13.77 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.464 0.306 . . . . 0.0 110.929 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.669 ' O ' ' HD3' ' D' ' 92' ' ' LYS . 2.8 pt20 -87.03 156.89 19.57 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.33 173.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . 0.755 HG22 ' HE2' ' D' ' 92' ' ' LYS . 5.5 pt . . . . . 0 C--N 1.313 -1.02 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.397 -169.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 120.734 0.302 . . . . 0.0 110.583 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' D' D ' 2' ' ' ASN . . . . . 0.562 ' HB3' ' HA ' ' D' ' 5' ' ' ALA . 76.5 m-20 -101.7 80.06 2.0 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.923 178.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -77.84 -24.62 48.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.524 0.678 . . . . 0.0 109.183 175.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -90.54 -11.88 38.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.809 174.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 5' ' ' ALA . . . . . 0.562 ' HA ' ' HB3' ' D' ' 2' ' ' ASN . . . 72.4 151.77 0.11 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 114.843 -1.072 . . . . 0.0 110.882 -173.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . 0.749 ' O ' HD23 ' D' ' 6' ' ' LEU . 7.6 tt -110.46 1.78 18.49 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.929 0.871 . . . . 0.0 108.89 -174.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . 0.544 ' HA ' ' HB3' ' D' ' 10' ' ' MET . 88.6 tt0 -47.64 -37.87 13.63 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -176.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.671 ' HA ' ' HB3' ' D' ' 12' ' ' SER . 8.4 pm0 -59.28 -50.64 73.2 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -175.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -91.09 16.07 10.42 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.264 174.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 10' ' ' MET . . . . . 0.544 ' HB3' ' HA ' ' D' ' 7' ' ' GLU . 16.1 tpt -103.8 -75.67 0.61 Allowed 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.551 178.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -104.14 -39.45 6.53 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-O 120.867 0.365 . . . . 0.0 111.149 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 12' ' ' SER . . . . . 0.671 ' HB3' ' HA ' ' D' ' 8' ' ' GLU . 40.9 t -44.19 -68.63 0.18 Allowed 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.244 -1.344 . . . . 0.0 112.133 -167.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.646 ' O ' HG12 ' D' ' 16' ' ' VAL . 52.0 mt -91.1 -9.28 10.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.747 -175.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 14' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' D' ' 10' ' ' MET . 3.8 m120 -88.08 -52.59 5.16 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.885 176.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 15' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' D' ' 18' ' ' ASP . 51.1 m -65.41 -21.61 66.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.488 174.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 16' ' ' VAL . . . . . 0.8 ' HA ' ' HE2' ' D' ' 19' ' ' LYS . 0.7 OUTLIER -59.12 -31.9 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.814 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 17' ' ' ASN . . . . . 0.603 ' OD1' ' HA ' ' D' ' 28' ' ' SER . 79.9 m-20 -85.06 -18.6 33.84 Favored 'General case' 0 C--O 1.205 -1.246 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.849 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 18' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' D' ' 15' ' ' SER . 73.7 m-20 -67.88 -16.36 64.05 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 122.304 -0.248 . . . . 0.0 111.599 176.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.8 ' HE2' ' HA ' ' D' ' 16' ' ' VAL . 0.0 OUTLIER -90.43 -39.83 12.41 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-O 121.987 0.899 . . . . 0.0 108.953 174.183 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 20' ' ' LEU . . . . . 0.913 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 78.3 mt -74.09 -40.17 62.91 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 113.628 -1.624 . . . . 0.0 110.107 -174.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 21' ' ' ASN . . . . . 0.543 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 2.8 m120 -78.14 95.7 4.99 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.688 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 22' ' ' LYS . . . . . 0.779 ' HD2' HD12 ' D' ' 47' ' ' ILE . 67.6 mttm -122.58 -41.12 2.4 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -176.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.56 -103.16 0.18 Allowed Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 119.161 -1.495 . . . . 0.0 113.351 -177.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . 0.842 ' HE2' ' HA ' ' D' ' 48' ' ' SER . 32.8 ttpt -49.5 -44.06 45.83 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.62 0.724 . . . . 0.0 110.362 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 25' ' ' GLY . . . . . 0.645 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -139.8 154.45 23.77 Favored Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 114.548 -1.205 . . . . 0.0 112.132 174.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 26' ' ' LYS . . . . . 0.649 ' HD2' ' HB3' ' D' ' 41' ' ' SER . 0.3 OUTLIER -150.67 160.42 43.84 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.331 -0.934 . . . . 0.0 110.518 -171.038 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 27' ' ' LEU . . . . . 0.913 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 41.6 tp -132.13 144.62 50.83 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.14 0.495 . . . . 0.0 111.392 177.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 28' ' ' SER . . . . . 0.603 ' HA ' ' OD1' ' D' ' 17' ' ' ASN . 9.1 t -131.32 136.42 48.1 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 29' ' ' LEU . . . . . 0.415 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 18.3 mt -127.19 157.94 38.43 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.384 -0.527 . . . . 0.0 110.53 -179.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 34.7 t -160.45 174.53 13.96 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 59.2 mtt -133.83 163.33 29.73 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.108 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 32' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' D' ' 35' ' ' GLN . 50.3 t30 -136.95 86.87 2.24 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.714 172.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.03 -108.26 2.51 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.553 -169.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 34' ' ' ASN . . . . . 0.445 ' O ' ' HE3' ' D' ' 85' ' ' LYS . 75.3 m-80 -107.11 31.76 5.12 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.586 0.707 . . . . 0.0 109.96 174.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 35' ' ' GLN . . . . . 0.474 ' OE1' ' HA ' ' D' ' 35' ' ' GLN . 6.5 mm-40 -99.9 164.48 11.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.823 -1.081 . . . . 0.0 113.263 -177.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.693 HD11 HG22 ' D' ' 79' ' ' ILE . 2.7 tm? -132.8 125.6 30.46 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.637 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 37' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 27.9 mmmt -131.2 103.06 6.27 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.768 -170.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 38' ' ' ALA . . . . . 0.479 ' HB1' HD11 ' D' ' 27' ' ' LEU . . . -108.57 146.39 33.38 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.403 0.62 . . . . 0.0 112.289 -176.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 39' ' ' THR . . . . . 0.44 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 14.3 p -146.32 130.37 17.36 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.17 175.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . 0.791 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 69.2 p -108.3 135.06 50.25 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 176.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 41' ' ' SER . . . . . 0.649 ' HB3' ' HD2' ' D' ' 26' ' ' LYS . 39.1 t -96.28 147.89 23.31 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.169 -1.012 . . . . 0.0 109.676 -178.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 42' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' D' ' 41' ' ' SER . 73.0 m-80 80.6 2.99 1.8 Allowed 'General case' 0 N--CA 1.468 0.472 0 O-C-N 124.569 1.168 . . . . 0.0 110.161 -170.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 47.28 55.5 8.1 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 171.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 44' ' ' GLY . . . . . 0.784 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 117.62 35.88 1.04 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 119.477 -1.344 . . . . 0.0 113.845 172.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 45' ' ' TYR . . . . . 0.799 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 1.8 m-85 -119.25 149.71 41.31 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 173.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . 0.616 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -93.61 179.7 38.82 Favored Glycine 0 C--O 1.221 -0.71 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 176.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 47' ' ' ILE . . . . . 0.874 HG12 ' HB3' ' D' ' 68' ' ' GLU . 32.6 mm -46.72 -57.01 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.798 0 CA-C-N 118.026 0.913 . . . . 0.0 110.28 -178.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.842 ' HA ' ' HE2' ' D' ' 24' ' ' LYS . 67.5 p -175.67 -118.39 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 113.354 -1.748 . . . . 0.0 108.683 -177.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 49' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' D' ' 49' ' ' TYR . 0.2 OUTLIER -113.72 75.56 0.93 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 168.199 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . 0.604 ' HB3' ' HE2' ' D' ' 52' ' ' LYS . 68.3 mm-40 -131.81 -175.89 3.87 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.834 -175.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 51' ' ' ASP . . . . . 0.654 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 1.1 m-20 -140.36 128.89 22.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.487 169.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 52' ' ' LYS . . . . . 0.654 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 3.9 mptp? -141.56 136.42 31.09 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.504 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 53' ' ' ASN . . . . . 0.432 HD22 ' C ' ' D' ' 52' ' ' LYS . 3.0 m120 -112.01 126.98 55.73 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 175.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 54' ' ' TRP . . . . . 1.126 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 1.3 m95 -115.47 161.63 18.31 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -174.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -150.07 163.45 29.45 Favored Glycine 0 N--CA 1.435 -1.412 0 CA-C-N 114.566 -1.197 . . . . 0.0 112.556 172.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 56' ' ' ILE . . . . . 1.078 HG12 HG23 ' D' ' 91' ' ' ILE . 76.6 mt -134.75 109.58 11.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 -179.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 57' ' ' PHE . . . . . 0.629 ' HB2' ' HB3' ' D' ' 90' ' ' GLU . 8.3 m-85 -111.63 105.9 14.57 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.879 -165.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.841 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 54.7 t -88.67 112.31 23.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.277 172.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 7.0 m120 51.18 50.75 18.39 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.421 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.49 48.44 78.17 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.535 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 61' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 43.1 tt0 -150.88 111.24 4.18 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . 0.452 ' NZ ' ' HB3' ' D' ' 62' ' ' LYS . 6.3 ttpm? -73.65 103.01 4.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.972 0.415 . . . . 0.0 110.048 -177.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 29.0 m -79.57 -25.65 12.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.303 -174.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 64' ' ' TYR . . . . . 0.444 ' HB3' HD12 ' D' ' 56' ' ' ILE . 14.9 t80 -149.74 147.4 28.0 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.064 -178.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 59.4 m -125.28 121.17 33.24 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.482 175.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 66' ' ' PHE . . . . . 0.614 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 19.5 p90 -127.49 149.88 49.92 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 174.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 67' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' D' ' 52' ' ' LYS . 3.5 m120 -111.47 145.3 39.25 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -178.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 68' ' ' GLU . . . . . 0.874 ' HB3' HG12 ' D' ' 47' ' ' ILE . 51.3 mm-40 -74.88 -9.3 58.41 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.612 176.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.475 ' HG2' ' HA ' ' D' ' 51' ' ' ASP . 23.5 mtpp -59.14 -54.35 48.0 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 113.538 -1.664 . . . . 0.0 108.102 165.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 39.8 m -66.79 119.58 12.08 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 112.91 -1.95 . . . . 0.0 109.088 174.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 82.8 p -47.56 121.24 3.82 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.978 -177.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 72' ' ' VAL . . . . . 0.616 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -57.27 -12.38 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 120.994 0.426 . . . . 0.0 110.872 -178.75 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 73' ' ' GLY . . . . . 0.791 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -69.15 -65.61 2.55 Favored Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 115.215 -0.902 . . . . 0.0 113.185 172.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 74' ' ' ASN . . . . . 0.861 ' HA ' HD22 ' D' ' 77' ' ' ASN . 76.8 m-20 -62.72 -23.74 67.32 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 120.662 0.267 . . . . 0.0 110.89 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 75' ' ' ILE . . . . . 0.515 ' O ' HG12 ' D' ' 79' ' ' ILE . 35.9 mm -77.47 -39.96 28.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.594 176.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 76' ' ' SER . . . . . 0.698 ' HA ' HG12 ' D' ' 79' ' ' ILE . 30.9 t -73.61 -19.88 60.75 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.963 178.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 77' ' ' ASN . . . . . 0.861 HD22 ' HA ' ' D' ' 74' ' ' ASN . 80.1 m-20 -65.6 -29.77 70.41 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 168.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 78' ' ' ASP . . . . . 1.051 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 1.0 OUTLIER -84.22 -28.72 27.08 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.734 174.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . 0.698 HG12 ' HA ' ' D' ' 76' ' ' SER . 17.5 mm -66.88 -19.84 26.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.657 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -69.17 -39.7 78.58 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.322 176.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . 1.051 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -80.24 -53.76 6.36 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.888 176.679 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 82' ' ' LEU . . . . . 0.604 HD23 ' O ' ' D' ' 78' ' ' ASP . 4.0 mm? -48.71 -29.24 4.23 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 83' ' ' ASN . . . . . 0.582 HD22 ' HB3' ' D' ' 36' ' ' LEU . 0.6 OUTLIER 39.54 73.61 0.11 Allowed 'General case' 0 N--CA 1.472 0.671 0 O-C-N 124.016 0.823 . . . . 0.0 111.464 172.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 84' ' ' ILE . . . . . 0.817 HG12 HD13 ' D' ' 56' ' ' ILE . 2.1 mp -66.84 105.19 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.33 -176.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 85' ' ' LYS . . . . . 0.445 ' HE3' ' O ' ' D' ' 34' ' ' ASN . 48.6 mtpt -108.19 178.71 4.42 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.911 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 86' ' ' GLY . . . . . 0.715 ' HA2' HD11 ' D' ' 89' ' ' ILE . . . -80.09 -178.37 51.65 Favored Glycine 0 CA--C 1.504 -0.604 0 C-N-CA 121.146 -0.549 . . . . 0.0 113.39 -179.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 87' ' ' PRO . . . . . 0.678 ' O ' HG13 ' D' ' 58' ' ' VAL . 42.8 Cg_endo -93.67 -179.79 9.47 Favored 'Cis proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.887 -1.714 . . . . 0.0 114.101 -0.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 88' ' ' TYR . . . . . 0.841 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 1.7 m-85 43.85 91.12 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.881 0.873 . . . . 0.0 112.074 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.715 HD11 ' HA2' ' D' ' 86' ' ' GLY . 4.0 mp -111.27 127.26 68.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.295 0.569 . . . . 0.0 110.533 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.629 ' HB3' ' HB2' ' D' ' 57' ' ' PHE . 42.0 tt0 -126.55 92.05 3.48 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.187 177.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 91' ' ' ILE . . . . . 1.126 HG22 ' HZ3' ' D' ' 54' ' ' TRP . 3.2 mt -100.22 109.13 24.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 92' ' ' LYS . . . . . 0.71 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -162.25 167.53 23.83 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.609 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 25.4 pt20 -82.44 160.19 22.77 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 119.125 -1.03 . . . . 0.0 110.567 175.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . 0.71 HG22 ' HE2' ' D' ' 92' ' ' LYS . 10.0 pt . . . . . 0 C--N 1.305 -1.338 0 CA-C-N 114.118 -1.401 . . . . 0.0 111.384 -168.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 120.558 0.218 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' D' D ' 2' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -121.66 4.96 10.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.928 0.394 . . . . 0.0 110.495 177.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -90.91 0.11 57.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.162 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 4' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' D' ' 4' ' ' LYS . 38.0 ttpt -104.34 18.58 21.85 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.38 116.55 4.74 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.409 -176.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . 0.863 ' H ' HD23 ' D' ' 6' ' ' LEU . 1.7 pt? -97.26 26.23 4.97 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.421 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -71.23 -3.61 21.2 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -173.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.573 ' O ' ' HB3' ' D' ' 12' ' ' SER . 9.3 pt-20 -61.03 -51.45 69.16 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -171.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . 0.441 ' H ' ' CD ' ' D' ' 9' ' ' GLN . 3.2 pm0 -91.75 15.45 12.78 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.576 176.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 10' ' ' MET . . . . . . . . . . . . . 93.8 mmm -105.22 -75.7 0.62 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.181 -178.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -102.97 -38.6 7.28 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.093 174.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 12' ' ' SER . . . . . 0.641 ' O ' ' HB ' ' D' ' 16' ' ' VAL . 42.4 t -44.61 -61.73 1.45 Allowed 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.452 -1.249 . . . . 0.0 112.272 -167.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.461 ' C ' HG12 ' D' ' 16' ' ' VAL . 36.7 mm -90.88 -8.64 10.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.991 -174.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -95.19 -62.53 1.29 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.071 177.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 15' ' ' SER . . . . . 0.549 ' HA ' ' OD2' ' D' ' 18' ' ' ASP . 90.5 p -64.69 -21.45 66.75 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 120.971 -0.291 . . . . 0.0 110.531 -179.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 16' ' ' VAL . . . . . 0.641 ' HB ' ' O ' ' D' ' 12' ' ' SER . 14.8 p -52.99 -35.93 23.16 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 CA-C-O 120.918 0.39 . . . . 0.0 110.251 176.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 17' ' ' ASN . . . . . 0.483 ' ND2' HG13 ' D' ' 16' ' ' VAL . 3.4 m120 -68.51 -41.74 79.54 Favored 'General case' 0 C--O 1.21 -1.009 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.777 177.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 18' ' ' ASP . . . . . 0.549 ' OD2' ' HA ' ' D' ' 15' ' ' SER . 55.0 m-20 -58.64 -16.58 16.74 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -177.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.671 ' O ' ' HE3' ' D' ' 22' ' ' LYS . 0.0 OUTLIER -91.83 -52.64 4.64 Favored 'General case' 0 CA--C 1.488 -1.42 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 172.37 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 20' ' ' LEU . . . . . 0.964 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 75.8 mt -57.39 -34.95 69.41 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.031 -1.441 . . . . 0.0 110.78 -177.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 21' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -77.4 97.1 4.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.223 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 22' ' ' LYS . . . . . 0.671 ' HE3' ' O ' ' D' ' 19' ' ' LYS . 88.5 mttt -121.73 -40.91 2.5 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 -172.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.23 -88.6 0.11 Allowed Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 119.477 -1.344 . . . . 0.0 113.315 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . 0.72 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 52.1 tptt -49.84 -54.03 21.87 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 25' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -139.14 155.82 24.12 Favored Glycine 0 N--CA 1.429 -1.792 0 CA-C-N 114.264 -1.334 . . . . 0.0 110.943 174.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 26' ' ' LYS . . . . . 0.698 ' HG3' ' HB3' ' D' ' 41' ' ' SER . 9.2 ptpt -149.99 160.83 43.32 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.301 -0.95 . . . . 0.0 110.167 -169.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 27' ' ' LEU . . . . . 0.964 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 52.2 tp -135.19 147.29 49.33 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.188 0.518 . . . . 0.0 111.932 -176.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 28' ' ' SER . . . . . 0.596 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 22.9 t -139.79 153.32 47.09 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 29' ' ' LEU . . . . . 0.516 HD11 ' CD1' ' D' ' 20' ' ' LEU . 0.2 OUTLIER -141.27 133.97 28.68 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.914 177.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 54.1 p -133.54 -171.39 2.7 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.719 175.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 21.6 ptp -148.89 166.3 28.98 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.388 0.614 . . . . 0.0 111.466 -176.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 32' ' ' ASN . . . . . 0.471 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 22.8 t-20 -144.54 88.01 1.9 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.458 177.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.85 -108.7 2.57 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.216 -171.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -100.31 9.93 41.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.841 0.353 . . . . 0.0 110.873 176.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 35' ' ' GLN . . . . . 0.471 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 3.6 tp60 -90.82 158.24 16.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.832 0.349 . . . . 0.0 110.48 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.689 HD11 HG22 ' D' ' 79' ' ' ILE . 2.5 tm? -124.92 137.39 54.27 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.62 176.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 37' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 34.3 mmtp -130.94 115.34 16.39 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.93 -171.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -115.28 152.5 32.63 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.939 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 39' ' ' THR . . . . . 0.596 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 17.2 p -145.92 135.24 22.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.737 -1.119 . . . . 0.0 111.123 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . 0.653 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 27.0 p -108.75 133.72 52.43 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 170.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 41' ' ' SER . . . . . 0.698 ' HB3' ' HG3' ' D' ' 26' ' ' LYS . 34.0 t -95.5 147.06 23.95 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 118.97 -1.092 . . . . 0.0 109.222 178.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 42' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' D' ' 41' ' ' SER . 75.1 m-80 80.45 -3.11 1.9 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.188 -168.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.66 62.8 2.28 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 168.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.17 -1.47 8.32 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 118.508 -1.806 . . . . 0.0 115.011 170.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 45' ' ' TYR . . . . . 0.72 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 1.4 m-30 -89.91 152.12 21.39 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 120.617 0.246 . . . . 0.0 110.808 -176.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . 0.589 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -95.24 -158.67 32.88 Favored Glycine 0 C--O 1.217 -0.952 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 174.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 47' ' ' ILE . . . . . 0.898 HG13 ' HB3' ' D' ' 68' ' ' GLU . 0.4 OUTLIER -55.42 -49.13 75.35 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 CA-C-O 122.597 1.189 . . . . 0.0 108.518 176.163 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 34.0 t 168.0 -119.77 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 111.305 -2.679 . . . . 0.0 105.422 -175.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -109.34 78.33 1.12 Allowed 'General case' 0 C--N 1.318 -0.775 0 O-C-N 121.771 -0.581 . . . . 0.0 109.679 163.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . 0.621 ' HB3' ' HE3' ' D' ' 52' ' ' LYS . 52.0 mt-10 -143.37 171.68 13.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.749 -177.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 51' ' ' ASP . . . . . 0.692 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 2.4 m-20 -131.42 135.68 47.37 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.534 176.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 52' ' ' LYS . . . . . 0.768 ' HD3' HG12 ' D' ' 47' ' ' ILE . 0.1 OUTLIER -144.96 157.19 44.22 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 123.035 0.534 . . . . 0.0 110.45 -178.029 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 53' ' ' ASN . . . . . 0.533 HD22 ' C ' ' D' ' 52' ' ' LYS . 2.7 m120 -120.98 134.26 55.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.301 175.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 54' ' ' TRP . . . . . 1.02 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 0.3 OUTLIER -126.43 160.62 29.98 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.205 -178.516 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -150.27 160.31 28.49 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.113 -1.041 . . . . 0.0 114.061 176.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 56' ' ' ILE . . . . . 1.001 HG12 HG23 ' D' ' 91' ' ' ILE . 73.0 mt -130.68 113.77 25.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 176.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 57' ' ' PHE . . . . . 0.629 ' HD2' ' O ' ' D' ' 90' ' ' GLU . 17.1 m-85 -108.39 105.1 14.63 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 119.688 -0.805 . . . . 0.0 111.248 -167.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.839 HG22 HG12 ' D' ' 89' ' ' ILE . 90.2 t -97.88 109.56 23.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.283 176.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 5.6 m120 55.84 39.92 30.65 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.253 178.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.97 -31.07 8.85 Favored Glycine 0 CA--C 1.508 -0.37 0 C-N-CA 120.159 -1.019 . . . . 0.0 112.771 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -88.76 126.18 35.22 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.162 -0.519 . . . . 0.0 111.032 -176.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -71.98 98.17 2.01 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 174.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 11.3 p -76.36 -27.37 17.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.823 -168.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 64' ' ' TYR . . . . . 0.442 ' HB3' HD12 ' D' ' 56' ' ' ILE . 15.4 t80 -145.75 128.56 16.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.722 177.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 31.3 m -109.82 105.21 14.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.062 176.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 66' ' ' PHE . . . . . 0.426 ' HB3' ' CE2' ' D' ' 64' ' ' TYR . 10.0 p90 -111.48 158.79 18.73 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 67' ' ' ASN . . . . . 0.584 ' O ' HD11 ' D' ' 75' ' ' ILE . 5.3 m120 -128.9 143.09 50.79 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -172.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 68' ' ' GLU . . . . . 0.898 ' HB3' HG13 ' D' ' 47' ' ' ILE . 53.6 mm-40 -64.2 -21.0 66.4 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 174.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.509 ' HE3' ' OD2' ' D' ' 51' ' ' ASP . 48.2 mtpt -51.17 -54.46 25.22 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.102 171.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 18.0 m -65.44 120.14 12.3 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 112.118 -2.31 . . . . 0.0 108.4 170.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 70.3 p -52.9 122.74 9.83 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.234 -178.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 72' ' ' VAL . . . . . 0.646 ' HA ' HD12 ' D' ' 75' ' ' ILE . 0.1 OUTLIER -54.72 -12.23 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 120.924 0.392 . . . . 0.0 111.997 -175.432 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 73' ' ' GLY . . . . . 0.653 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -73.57 -56.46 5.51 Favored Glycine 0 N--CA 1.437 -1.27 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.656 170.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 74' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' D' ' 77' ' ' ASN . 29.6 t-20 -66.3 -19.68 65.88 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 75' ' ' ILE . . . . . 0.646 HD12 ' HA ' ' D' ' 72' ' ' VAL . 74.4 mt -71.78 -41.21 70.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.17 173.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 30.7 t -72.8 -19.54 61.32 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.696 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 77' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' D' ' 74' ' ' ASN . 4.2 m120 -61.15 -30.9 70.67 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 168.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 78' ' ' ASP . . . . . 1.146 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 1.0 OUTLIER -86.4 -40.91 14.92 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 114.825 -1.079 . . . . 0.0 112.936 177.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . 0.689 HG22 HD11 ' D' ' 36' ' ' LEU . 33.9 mt -63.53 -24.9 37.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 O-C-N 121.433 -0.792 . . . . 0.0 111.536 -171.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -71.39 -31.18 66.98 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . 1.146 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -81.11 -47.4 13.56 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.33 175.271 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 82' ' ' LEU . . . . . 0.628 HD23 ' O ' ' D' ' 78' ' ' ASP . 4.0 mm? -51.01 -26.93 6.74 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 50.31 71.03 0.44 Allowed 'General case' 0 N--CA 1.473 0.687 0 O-C-N 123.588 0.555 . . . . 0.0 110.636 176.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 84' ' ' ILE . . . . . 0.476 ' HB ' ' HG ' ' D' ' 36' ' ' LEU . 44.4 mm -78.23 96.36 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.97 -175.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 85' ' ' LYS . . . . . 0.602 ' HG2' ' HB2' ' D' ' 36' ' ' LEU . 28.4 mmmt -153.79 92.64 1.58 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.496 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.3 154.86 0.08 OUTLIER Glycine 0 C--N 1.331 0.287 0 N-CA-C 114.547 0.579 . . . . 0.0 114.547 174.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 87' ' ' PRO . . . . . 0.587 ' O ' HG13 ' D' ' 58' ' ' VAL . 76.5 Cg_endo -90.45 -178.26 11.17 Favored 'Cis proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.493 -1.461 . . . . 0.0 112.268 -0.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 88' ' ' TYR . . . . . 0.728 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 1.7 m-85 7.71 92.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 125.32 1.448 . . . . 0.0 113.773 -177.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.839 HG12 HG22 ' D' ' 58' ' ' VAL . 71.6 mt -110.95 136.62 46.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.211 0.529 . . . . 0.0 112.24 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.629 ' O ' ' HD2' ' D' ' 57' ' ' PHE . 39.3 tt0 -128.36 95.81 4.26 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.846 175.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 91' ' ' ILE . . . . . 1.02 HG22 ' HZ3' ' D' ' 54' ' ' TRP . 6.5 mt -96.37 108.82 21.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -177.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 92' ' ' LYS . . . . . 0.662 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -161.0 169.97 21.48 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 177.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.682 ' HB3' ' NE1' ' D' ' 54' ' ' TRP . 17.4 pt20 -85.24 163.36 18.7 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.399 177.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . 0.662 HG22 ' HE2' ' D' ' 92' ' ' LYS . 9.3 pt . . . . . 0 C--N 1.31 -1.145 0 CA-C-N 114.197 -1.365 . . . . 0.0 111.311 -167.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 39.2 t70 . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 120.688 0.28 . . . . 0.0 110.77 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' D' D ' 2' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 58.27 61.53 2.27 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.311 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -79.02 -15.78 57.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.011 0.434 . . . . 0.0 110.483 176.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -103.55 -36.83 7.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.649 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 5' ' ' ALA . . . . . . . . . . . . . . . 75.61 -45.33 0.54 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.512 0.725 . . . . 0.0 111.659 -177.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . 0.424 HD12 ' N ' ' D' ' 6' ' ' LEU . 5.8 mp -75.07 9.9 1.75 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.769 0.319 . . . . 0.0 111.338 177.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -73.83 -11.24 60.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.169 0.509 . . . . 0.0 110.749 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 1.082 ' HG3' HE21 ' D' ' 9' ' ' GLN . 18.2 pt-20 -72.74 -15.8 61.66 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.806 176.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . 1.082 HE21 ' HG3' ' D' ' 8' ' ' GLU . 77.1 mm-40 -97.65 4.96 49.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.001 -177.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 10' ' ' MET . . . . . . . . . . . . . 27.9 ttt -105.21 -79.64 0.55 Allowed 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 119.455 -0.898 . . . . 0.0 112.173 -172.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -104.59 -33.54 8.49 Favored 'General case' 0 C--O 1.203 -1.365 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 12' ' ' SER . . . . . 0.556 ' CB ' ' HA ' ' D' ' 8' ' ' GLU . 46.4 t -23.08 -68.47 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 -170.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.404 ' O ' HG12 ' D' ' 16' ' ' VAL . 64.2 mt -73.4 -7.8 10.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 122.103 0.954 . . . . 0.0 111.463 -173.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -95.93 -45.65 6.85 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.656 -1.157 . . . . 0.0 110.053 172.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 15' ' ' SER . . . . . 0.529 ' O ' ' HB2' ' D' ' 18' ' ' ASP . 39.4 m -66.17 -25.44 66.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.794 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 16' ' ' VAL . . . . . 0.698 ' HA ' ' HE2' ' D' ' 19' ' ' LYS . 7.1 p -58.93 -33.72 50.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.057 0.456 . . . . 0.0 110.532 179.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 17' ' ' ASN . . . . . 0.556 ' O ' ' HB2' ' D' ' 21' ' ' ASN . 5.4 m120 -66.42 -41.46 89.18 Favored 'General case' 0 C--O 1.209 -1.043 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 176.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 18' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' D' ' 15' ' ' SER . 1.2 m-20 -59.72 -14.03 12.54 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 175.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.698 ' HE2' ' HA ' ' D' ' 16' ' ' VAL . 1.7 mppt? -90.55 -44.93 9.25 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.933 0.873 . . . . 0.0 109.881 175.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 20' ' ' LEU . . . . . 1.008 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 69.8 mt -85.89 -19.02 31.18 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 112.762 -2.017 . . . . 0.0 111.812 -169.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 21' ' ' ASN . . . . . 0.556 ' HB2' ' O ' ' D' ' 17' ' ' ASN . 1.4 t-20 -106.24 98.58 8.24 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.351 -0.84 . . . . 0.0 108.891 -169.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 22' ' ' LYS . . . . . 0.633 ' CE ' ' HA ' ' D' ' 47' ' ' ILE . 2.3 mppt? -119.94 -42.95 2.57 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 118.619 -1.232 . . . . 0.0 113.112 -168.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.19 -75.94 0.16 Allowed Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.147 -1.025 . . . . 0.0 112.598 -175.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . 0.785 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 53.0 tptt -52.13 -61.16 2.44 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 25' ' ' GLY . . . . . 0.548 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -137.97 157.67 24.39 Favored Glycine 0 N--CA 1.43 -1.712 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.93 174.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 26' ' ' LYS . . . . . 0.67 ' HA ' ' O ' ' D' ' 20' ' ' LEU . 9.1 ptpt -149.25 162.13 40.63 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.378 -0.911 . . . . 0.0 110.818 -167.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 27' ' ' LEU . . . . . 1.008 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 58.3 tp -136.51 136.83 39.7 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.24 0.543 . . . . 0.0 111.448 -177.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 28' ' ' SER . . . . . 0.629 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 53.9 m -124.44 142.18 51.51 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.334 -175.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 29' ' ' LEU . . . . . 0.843 HD11 HD12 ' D' ' 20' ' ' LEU . 0.1 OUTLIER -141.49 148.11 38.9 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 119.49 -0.884 . . . . 0.0 112.097 -176.233 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 50.4 m -154.33 -173.81 4.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.968 176.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 24.6 ptm -145.66 162.91 36.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.289 0.566 . . . . 0.0 111.197 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 32' ' ' ASN . . . . . 0.475 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 26.4 t-20 -141.8 88.58 2.13 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.057 178.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.59 -98.45 0.53 Allowed Glycine 0 CA--C 1.516 0.146 0 C-N-CA 120.256 -0.973 . . . . 0.0 111.853 -176.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -104.77 2.89 30.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.783 0.325 . . . . 0.0 110.346 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 35' ' ' GLN . . . . . 0.475 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 3.6 tp-100 -91.32 155.9 18.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.127 -174.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.737 HD11 HG22 ' D' ' 79' ' ' ILE . 1.9 tm? -124.38 137.65 54.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.366 173.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 37' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 12.8 mmmm -131.04 115.81 16.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.774 -169.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 38' ' ' ALA . . . . . 0.533 ' HB1' HD11 ' D' ' 27' ' ' LEU . . . -123.01 155.02 37.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.156 0.503 . . . . 0.0 111.559 177.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 39' ' ' THR . . . . . 0.629 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 2.4 p -150.77 139.4 20.64 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.903 -178.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . 0.676 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 53.3 p -109.0 133.97 52.27 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 173.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 41' ' ' SER . . . . . 0.647 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 35.4 t -96.01 148.05 23.06 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.905 -1.118 . . . . 0.0 109.199 176.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 42' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' D' ' 41' ' ' SER . 75.1 m-80 80.09 -0.57 2.04 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.95 -168.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.17 60.54 3.36 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 170.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 44' ' ' GLY . . . . . 0.684 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 110.15 35.95 2.06 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.317 -1.42 . . . . 0.0 114.706 169.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 45' ' ' TYR . . . . . 0.785 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 1.3 m-85 -112.97 152.75 29.02 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 173.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -88.77 -153.81 27.59 Favored Glycine 0 C--O 1.219 -0.782 0 C-N-CA 121.124 -0.56 . . . . 0.0 111.991 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 47' ' ' ILE . . . . . 1.058 HG13 ' HB3' ' D' ' 68' ' ' GLU . 1.0 OUTLIER -57.38 -57.08 11.56 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 CA-C-O 122.338 1.066 . . . . 0.0 108.184 -179.479 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' D' ' 47' ' ' ILE . 23.1 t 169.56 -63.47 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 111.893 -2.412 . . . . 0.0 106.836 -178.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 49' ' ' TYR . . . . . 0.437 ' O ' ' HD1' ' D' ' 49' ' ' TYR . 0.2 OUTLIER -165.07 74.74 0.24 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 113.746 -1.57 . . . . 0.0 109.667 168.569 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' D' ' 69' ' ' LYS . 72.3 mm-40 -139.99 -158.92 0.9 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.049 -175.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 51' ' ' ASP . . . . . 0.51 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 1.1 t70 -152.39 124.37 8.01 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.615 173.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 52' ' ' LYS . . . . . 0.572 ' HB2' ' CG ' ' D' ' 68' ' ' GLU . 0.2 OUTLIER -141.15 120.01 12.66 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.528 178.672 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -93.4 129.06 39.68 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 174.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 54' ' ' TRP . . . . . 0.701 ' NE1' ' HB3' ' D' ' 93' ' ' GLN . 0.1 OUTLIER -114.87 153.18 30.94 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -171.267 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -132.57 156.16 21.93 Favored Glycine 0 N--CA 1.431 -1.685 0 C-N-CA 120.157 -1.021 . . . . 0.0 114.524 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 56' ' ' ILE . . . . . 0.814 HD13 HG12 ' D' ' 84' ' ' ILE . 65.4 mt -146.28 108.27 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 113.66 -1.27 . . . . 0.0 107.652 177.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 57' ' ' PHE . . . . . 0.869 ' HB2' ' HB3' ' D' ' 90' ' ' GLU . 7.4 m-30 -117.72 107.92 14.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.97 -169.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.767 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 53.2 t -97.04 117.15 41.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.684 173.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 59' ' ' ASN . . . . . 0.673 HD21 ' HG2' ' D' ' 87' ' ' PRO . 3.6 m120 62.37 43.46 8.13 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.258 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.4 -33.87 4.19 Favored Glycine 0 CA--C 1.508 -0.361 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.905 173.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 61' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 23.5 pt-20 -90.99 155.84 18.41 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.247 0.546 . . . . 0.0 111.479 -175.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . 0.501 ' HD2' ' OG1' ' D' ' 65' ' ' THR . 6.2 ttpm? -85.55 125.2 32.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.561 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.43 HG22 ' O ' ' D' ' 56' ' ' ILE . 25.6 m -104.57 -29.79 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -177.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 64' ' ' TYR . . . . . 0.433 ' HB3' HD12 ' D' ' 56' ' ' ILE . 17.4 t80 -153.21 147.33 25.59 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.863 0.363 . . . . 0.0 111.384 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.501 ' OG1' ' HD2' ' D' ' 62' ' ' LYS . 86.8 m -132.29 126.75 34.12 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.016 175.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 66' ' ' PHE . . . . . 0.566 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 14.0 p90 -130.44 155.08 47.01 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 175.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 67' ' ' ASN . . . . . 0.557 ' O ' HD11 ' D' ' 75' ' ' ILE . 72.7 m-20 -117.57 138.23 52.06 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -177.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 68' ' ' GLU . . . . . 1.058 ' HB3' HG13 ' D' ' 47' ' ' ILE . 38.5 mm-40 -61.19 -22.82 65.1 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.885 0.374 . . . . 0.0 111.144 177.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' D' ' 50' ' ' GLU . 46.3 mtmt -65.02 -39.07 92.84 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 70' ' ' SER . . . . . 0.47 ' HB3' ' O ' ' D' ' 67' ' ' ASN . 23.2 t -64.79 121.32 14.29 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 113.744 -1.571 . . . . 0.0 106.817 166.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 54.0 p -52.33 120.36 5.45 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.045 -177.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 72' ' ' VAL . . . . . 0.656 ' HA ' HD12 ' D' ' 75' ' ' ILE . 0.0 OUTLIER -55.3 -11.62 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.368 0 CA-C-O 120.984 0.421 . . . . 0.0 111.395 -175.279 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 73' ' ' GLY . . . . . 0.684 ' HA3' ' HA2' ' D' ' 44' ' ' GLY . . . -67.49 -64.73 3.05 Favored Glycine 0 N--CA 1.434 -1.434 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.884 169.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -65.54 -18.05 65.03 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.987 -0.285 . . . . 0.0 111.332 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 75' ' ' ILE . . . . . 0.684 ' O ' HG13 ' D' ' 79' ' ' ILE . 76.2 mt -70.02 -41.98 79.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 172.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 38.3 t -73.3 -26.16 60.96 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.086 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -59.73 -24.55 64.1 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.367 168.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 78' ' ' ASP . . . . . 0.988 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 76.8 m-20 -90.75 -38.76 12.82 Favored 'General case' 0 C--O 1.225 -0.225 0 O-C-N 123.849 0.718 . . . . 0.0 112.333 176.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . 0.737 HG22 HD11 ' D' ' 36' ' ' LEU . 42.8 mt -64.88 -24.4 35.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 O-C-N 121.719 -0.613 . . . . 0.0 111.106 -172.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -70.77 -25.19 62.79 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 177.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . 0.988 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -90.32 -46.68 8.24 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 120.081 -0.648 . . . . 0.0 111.829 175.174 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 82' ' ' LEU . . . . . 0.637 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.9 mm? -51.33 -25.93 6.74 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 49.71 69.36 0.61 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.038 0.535 . . . . 0.0 110.8 175.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 84' ' ' ILE . . . . . 0.814 HG12 HD13 ' D' ' 56' ' ' ILE . 2.2 mp -74.0 107.33 4.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.007 -178.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 85' ' ' LYS . . . . . 0.552 ' O ' ' HE3' ' D' ' 85' ' ' LYS . 0.0 OUTLIER -150.44 179.23 8.32 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 178.317 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 86' ' ' GLY . . . . . 0.712 ' HA2' HD11 ' D' ' 89' ' ' ILE . . . -57.48 168.3 4.6 Favored Glycine 0 CA--C 1.509 -0.299 0 CA-C-N 115.266 -0.879 . . . . 0.0 114.923 -173.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 87' ' ' PRO . . . . . 0.729 ' O ' HG13 ' D' ' 58' ' ' VAL . 46.7 Cg_endo -91.84 178.25 13.87 Favored 'Cis proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.736 -1.777 . . . . 0.0 114.165 0.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 88' ' ' TYR . . . . . 0.767 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 11.7 m-85 31.34 93.19 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.853 1.261 . . . . 0.0 113.121 -178.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.855 HG22 HG13 ' D' ' 91' ' ' ILE . 3.2 mp -110.19 117.55 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 CA-C-O 121.714 0.768 . . . . 0.0 110.896 -178.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.869 ' HB3' ' HB2' ' D' ' 57' ' ' PHE . 5.0 tp10 -100.93 87.4 3.28 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.126 174.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 91' ' ' ILE . . . . . 0.855 HG13 HG22 ' D' ' 89' ' ' ILE . 18.8 mt -98.68 101.76 12.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.751 177.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 92' ' ' LYS . . . . . 0.669 ' HE3' ' CG2' ' D' ' 94' ' ' ILE . 0.0 OUTLIER -161.4 168.62 23.49 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.469 -179.405 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.701 ' HB3' ' NE1' ' D' ' 54' ' ' TRP . 26.3 pt20 -93.17 160.91 14.64 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 119.474 -0.89 . . . . 0.0 111.413 174.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . 0.669 ' CG2' ' HE3' ' D' ' 92' ' ' LYS . 4.7 pt . . . . . 0 C--N 1.314 -0.978 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.587 -172.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 7.7 t70 . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.974 0.416 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' D' D ' 2' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -120.47 17.26 12.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.73 0.776 . . . . 0.0 109.518 -178.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -93.9 -22.89 18.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.555 -177.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 4' ' ' LYS . . . . . 0.639 ' HA ' ' HB2' ' D' ' 7' ' ' GLU . 39.1 ttmt -109.27 10.33 25.7 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.726 0.774 . . . . 0.0 109.009 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 5' ' ' ALA . . . . . . . . . . . . . . . -67.7 -55.77 11.88 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.733 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 91.0 mt -109.9 19.5 19.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.178 0.514 . . . . 0.0 110.649 178.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . 0.639 ' HB2' ' HA ' ' D' ' 4' ' ' LYS . 5.5 tm-20 -65.4 -36.22 83.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.53 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.722 ' HA ' ' CB ' ' D' ' 12' ' ' SER . 84.3 mt-10 -61.69 -28.24 69.27 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.994 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . 0.582 HE21 ' HB2' ' D' ' 8' ' ' GLU . 62.0 mm-40 -93.73 6.47 48.24 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.259 -176.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 10' ' ' MET . . . . . . . . . . . . . 15.7 tpt -106.36 -78.38 0.58 Allowed 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.269 -0.573 . . . . 0.0 111.366 -175.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -103.64 -38.52 7.07 Favored 'General case' 0 CA--C 1.494 -1.192 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.817 175.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 12' ' ' SER . . . . . 0.722 ' CB ' ' HA ' ' D' ' 8' ' ' GLU . 37.9 t -35.87 -69.04 0.11 Allowed 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 113.731 -1.577 . . . . 0.0 113.816 -167.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.437 ' C ' HG12 ' D' ' 16' ' ' VAL . 60.5 mt -81.73 -8.24 11.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.341 -171.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -95.12 -62.3 1.33 Allowed 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.897 175.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 15' ' ' SER . . . . . 0.518 ' HA ' ' OD1' ' D' ' 18' ' ' ASP . 88.6 p -68.24 -15.94 63.77 Favored 'General case' 0 C--O 1.223 -0.307 0 O-C-N 122.193 -0.317 . . . . 0.0 111.343 -178.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 16' ' ' VAL . . . . . 0.789 HG11 HD11 ' D' ' 29' ' ' LEU . 7.4 p -52.49 -39.8 30.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.127 0.489 . . . . 0.0 109.711 173.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 17' ' ' ASN . . . . . 0.664 ' OD1' ' HA ' ' D' ' 28' ' ' SER . 79.9 m-20 -75.75 -25.88 56.9 Favored 'General case' 0 C--O 1.212 -0.891 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.32 -178.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 18' ' ' ASP . . . . . 0.518 ' OD1' ' HA ' ' D' ' 15' ' ' SER . 1.5 m-20 -66.74 -16.41 64.23 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 177.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.628 ' HE2' ' HA ' ' D' ' 16' ' ' VAL . 0.0 OUTLIER -92.2 -36.78 13.08 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-O 122.044 0.926 . . . . 0.0 108.742 174.087 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 20' ' ' LEU . . . . . 0.92 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 76.4 mt -71.93 -41.16 68.17 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 113.329 -1.76 . . . . 0.0 109.482 -175.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 21' ' ' ASN . . . . . 0.632 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 62.3 m-20 -81.24 94.69 6.75 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.026 -1.443 . . . . 0.0 111.55 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 22' ' ' LYS . . . . . 0.497 ' HB2' HG23 ' D' ' 47' ' ' ILE . 55.8 mtpt -123.01 -42.11 2.3 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -177.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . 0.538 ' O ' ' HE3' ' D' ' 26' ' ' LYS . . . 177.92 -94.03 0.09 OUTLIER Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 119.614 -1.279 . . . . 0.0 113.555 -178.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . 0.849 ' HE3' ' HA ' ' D' ' 48' ' ' SER . 25.7 ttpp -54.73 -43.31 72.51 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 122.072 0.939 . . . . 0.0 110.192 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -139.6 141.16 11.42 Favored Glycine 0 N--CA 1.427 -1.941 0 CA-C-N 114.193 -1.367 . . . . 0.0 111.98 178.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 26' ' ' LYS . . . . . 0.753 ' HA ' ' O ' ' D' ' 20' ' ' LEU . 9.7 ptpt -148.13 159.84 43.52 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 114.213 -0.994 . . . . 0.0 110.09 -170.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 27' ' ' LEU . . . . . 0.92 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 41.1 tp -139.52 148.46 42.66 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 120.864 0.364 . . . . 0.0 111.37 -177.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 28' ' ' SER . . . . . 0.664 ' HA ' ' OD1' ' D' ' 17' ' ' ASN . 21.1 t -140.47 148.47 41.18 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 29' ' ' LEU . . . . . 0.789 HD11 HG11 ' D' ' 16' ' ' VAL . 0.5 OUTLIER -141.88 144.89 34.05 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 175.61 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 50.1 m -148.07 -170.64 3.64 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.33 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -147.21 166.56 26.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.214 0.53 . . . . 0.0 112.028 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 32' ' ' ASN . . . . . 0.572 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 0.8 OUTLIER -146.96 88.74 1.76 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.788 179.839 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.75 -101.52 0.72 Allowed Glycine 0 CA--C 1.516 0.14 0 C-N-CA 120.327 -0.94 . . . . 0.0 111.568 -174.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -107.78 16.66 23.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.926 0.394 . . . . 0.0 110.615 176.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 35' ' ' GLN . . . . . 0.572 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 68.1 tp60 -99.39 156.76 16.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.627 -176.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.866 ' HB2' ' HG2' ' D' ' 85' ' ' LYS . 2.3 tm? -120.62 140.12 52.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.667 174.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 37' ' ' LYS . . . . . 0.54 ' H ' HD22 ' D' ' 36' ' ' LEU . 73.0 mmtt -132.02 123.76 27.94 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.169 -171.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 38' ' ' ALA . . . . . 0.502 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -130.83 138.69 49.98 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.46 175.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 39' ' ' THR . . . . . 0.553 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 19.9 p -133.51 122.0 22.99 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.373 0.606 . . . . 0.0 111.36 178.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . 0.693 ' HB2' ' HA2' ' D' ' 73' ' ' GLY . 40.7 m -109.99 129.58 55.65 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 175.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 41' ' ' SER . . . . . 0.656 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 37.2 t -95.74 154.82 17.03 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.617 -173.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 42' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' D' ' 41' ' ' SER . 73.6 m-80 80.38 11.86 1.01 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 114.053 -1.431 . . . . 0.0 110.079 -171.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 45.15 55.47 6.27 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 114.445 -1.252 . . . . 0.0 113.693 170.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 44' ' ' GLY . . . . . 0.614 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 108.79 35.54 2.38 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 119.754 -1.213 . . . . 0.0 114.126 171.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 45' ' ' TYR . . . . . 0.681 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 1.7 m-85 -116.04 157.67 24.31 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 171.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . 0.543 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -97.74 174.77 29.54 Favored Glycine 0 CA--C 1.501 -0.843 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 177.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 47' ' ' ILE . . . . . 0.689 ' CG1' ' HB3' ' D' ' 68' ' ' GLU . 46.3 mm -46.4 -60.37 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-O 121.614 0.721 . . . . 0.0 111.659 -177.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.849 ' HA ' ' HE3' ' D' ' 24' ' ' LYS . 22.1 t 172.93 -151.02 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 113.391 -1.731 . . . . 0.0 108.214 -177.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -80.69 77.0 7.57 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 120.9 0.381 . . . . 0.0 110.541 172.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . 0.642 ' HB2' ' HZ3' ' D' ' 52' ' ' LYS . 97.2 mt-10 -150.46 155.58 39.8 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.469 176.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 51' ' ' ASP . . . . . 0.608 ' HB3' ' HD3' ' D' ' 69' ' ' LYS . 18.6 m-20 -118.96 127.65 53.67 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.869 176.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 52' ' ' LYS . . . . . 0.714 ' HE2' ' CB ' ' D' ' 68' ' ' GLU . 3.5 mppt? -142.63 128.74 19.73 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.879 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -104.11 129.71 51.81 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.746 175.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 54' ' ' TRP . . . . . 1.035 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 1.0 OUTLIER -115.69 160.8 19.58 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -174.498 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 55' ' ' GLY . . . . . 0.448 ' HA3' ' HE2' ' D' ' 62' ' ' LYS . . . -143.81 158.82 27.49 Favored Glycine 0 N--CA 1.434 -1.498 0 CA-C-N 114.848 -1.069 . . . . 0.0 113.371 176.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 56' ' ' ILE . . . . . 1.073 HG12 HG23 ' D' ' 91' ' ' ILE . 91.2 mt -140.92 115.09 5.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 N-CA-C 106.363 -1.718 . . . . 0.0 106.363 178.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 57' ' ' PHE . . . . . 0.739 ' CE1' ' HE2' ' D' ' 92' ' ' LYS . 5.6 m-85 -115.37 123.03 47.65 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 119.589 -0.844 . . . . 0.0 110.466 -171.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.643 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 85.3 t -101.01 112.59 34.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.954 173.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 59' ' ' ASN . . . . . 0.611 ' OD1' ' HG2' ' D' ' 87' ' ' PRO . 6.8 m120 60.78 35.95 19.39 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.322 -176.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.04 -33.05 6.6 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.374 -0.917 . . . . 0.0 113.998 174.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 61' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 24.5 pt-20 -90.08 148.64 22.9 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.914 0.388 . . . . 0.0 111.183 -174.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . 0.448 ' HE2' ' HA3' ' D' ' 55' ' ' GLY . 5.5 tppp? -65.66 126.56 28.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.766 175.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.543 HG11 HG23 ' D' ' 58' ' ' VAL . 12.4 p -109.48 -29.44 2.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.663 178.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 64' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -151.5 135.22 16.35 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.758 175.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.409 HG23 ' O ' ' D' ' 54' ' ' TRP . 70.6 m -117.06 125.66 51.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.133 175.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 66' ' ' PHE . . . . . 0.461 ' HB2' HG21 ' D' ' 75' ' ' ILE . 16.6 p90 -126.8 161.02 29.19 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 121.153 0.501 . . . . 0.0 110.064 173.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 67' ' ' ASN . . . . . 0.535 ' O ' ' HB2' ' D' ' 70' ' ' SER . 73.1 m-20 -126.1 147.46 49.59 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -177.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 68' ' ' GLU . . . . . 0.714 ' CB ' ' HE2' ' D' ' 52' ' ' LYS . 39.0 mm-40 -80.98 -14.68 57.73 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.438 0.637 . . . . 0.0 109.592 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.608 ' HD3' ' HB3' ' D' ' 51' ' ' ASP . 47.6 mtmt -65.97 -48.96 69.55 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-N 113.808 -1.542 . . . . 0.0 107.27 169.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 70' ' ' SER . . . . . 0.535 ' HB2' ' O ' ' D' ' 67' ' ' ASN . 51.0 m -61.32 129.57 41.87 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 111.615 -2.539 . . . . 0.0 108.775 169.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 68.4 p -58.61 112.03 1.46 Allowed 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -178.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 72' ' ' VAL . . . . . 0.608 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -49.84 -24.36 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 121.06 0.457 . . . . 0.0 110.269 -176.557 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 73' ' ' GLY . . . . . 0.693 ' HA2' ' HB2' ' D' ' 40' ' ' SER . . . -60.77 -67.46 2.12 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.208 -0.905 . . . . 0.0 114.671 175.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -62.49 -19.48 63.61 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.057 0.456 . . . . 0.0 110.965 -177.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 75' ' ' ILE . . . . . 0.584 ' O ' HG13 ' D' ' 79' ' ' ILE . 34.8 mm -76.05 -39.48 36.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.017 174.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 76' ' ' SER . . . . . 0.471 ' HA ' HG13 ' D' ' 79' ' ' ILE . 40.4 t -75.01 -21.05 59.35 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.535 177.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -61.72 -30.67 70.91 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 168.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 78' ' ' ASP . . . . . 1.001 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 1.0 OUTLIER -83.65 -30.8 26.57 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.606 174.84 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . 0.717 HG22 HD11 ' D' ' 36' ' ' LEU . 35.8 mt -69.81 -18.0 21.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.29 -177.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -66.41 -41.41 89.32 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.06 174.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . 1.001 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -80.23 -47.05 15.22 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 179.44 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 82' ' ' LEU . . . . . 0.699 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.4 mm? -50.34 -27.81 6.86 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -178.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 83' ' ' ASN . . . . . 0.533 ' HA ' ' HB3' ' D' ' 36' ' ' LEU . 0.7 OUTLIER 46.16 62.6 2.2 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.553 0.533 . . . . 0.0 110.678 176.403 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 84' ' ' ILE . . . . . 0.583 HG22 HD13 ' D' ' 89' ' ' ILE . 44.8 mm -86.32 97.36 5.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.535 -175.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 85' ' ' LYS . . . . . 0.866 ' HG2' ' HB2' ' D' ' 36' ' ' LEU . 28.3 mmmt -147.13 95.55 2.58 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.816 175.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 86' ' ' GLY . . . . . 0.724 ' H ' HD11 ' D' ' 89' ' ' ILE . . . 73.97 151.72 2.23 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.648 -0.706 . . . . 0.0 113.746 173.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 87' ' ' PRO . . . . . 0.611 ' HG2' ' OD1' ' D' ' 59' ' ' ASN . 62.5 Cg_endo -90.19 179.61 14.38 Favored 'Cis proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.17 -1.596 . . . . 0.0 112.773 -0.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 88' ' ' TYR . . . . . 0.643 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 5.8 m-85 15.54 94.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 125.43 1.492 . . . . 0.0 114.217 -178.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.724 HD11 ' H ' ' D' ' 86' ' ' GLY . 70.5 mt -110.52 133.31 56.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.223 0.535 . . . . 0.0 112.357 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.481 ' O ' ' HD1' ' D' ' 57' ' ' PHE . 46.3 mt-10 -118.97 96.75 5.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.536 174.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 91' ' ' ILE . . . . . 1.073 HG23 HG12 ' D' ' 56' ' ' ILE . 4.0 mt -101.11 110.92 29.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 92' ' ' LYS . . . . . 0.739 ' HE2' ' CE1' ' D' ' 57' ' ' PHE . 0.0 OUTLIER -163.55 172.76 13.93 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.023 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.587 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 23.9 pt20 -81.6 169.34 17.17 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 119.091 -1.043 . . . . 0.0 111.185 175.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . 0.519 ' CG2' ' HE3' ' D' ' 92' ' ' LYS . 6.7 pt . . . . . 0 C--N 1.317 -0.837 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.971 -173.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 53.5 p-10 . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 120.59 0.233 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' D' D ' 2' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -109.91 -3.62 16.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.065 0.46 . . . . 0.0 110.708 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -76.67 -3.83 39.95 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.219 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -85.55 -21.62 28.48 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 175.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 5' ' ' ALA . . . . . . . . . . . . . . . 54.99 63.25 2.19 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.192 -175.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 28.4 tp -110.45 17.27 20.97 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.059 -174.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -56.94 -47.71 80.01 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -175.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.747 ' HA ' ' CB ' ' D' ' 12' ' ' SER . 20.9 pt-20 -70.2 -21.84 62.99 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.518 -178.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . 0.466 ' H ' ' NE2' ' D' ' 9' ' ' GLN . 0.0 OUTLIER -96.59 12.07 32.98 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.142 -0.223 . . . . 0.0 110.758 174.69 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 10' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -105.05 -75.29 0.63 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -175.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -103.14 -37.43 7.73 Favored 'General case' 0 CA--C 1.495 -1.171 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.58 173.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 12' ' ' SER . . . . . 0.747 ' CB ' ' HA ' ' D' ' 8' ' ' GLU . 47.6 t -44.06 -61.69 1.39 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 113.925 -1.489 . . . . 0.0 111.956 -166.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.573 ' O ' HG12 ' D' ' 16' ' ' VAL . 12.2 tt -86.69 -22.57 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-O 120.85 0.357 . . . . 0.0 111.932 -178.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -82.13 -58.88 2.76 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -178.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 15' ' ' SER . . . . . 0.573 ' O ' ' HE2' ' D' ' 19' ' ' LYS . 97.9 p -69.97 -15.46 63.04 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.701 -178.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 16' ' ' VAL . . . . . 0.695 ' HB ' ' O ' ' D' ' 12' ' ' SER . 1.7 p -61.3 -26.56 39.68 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -78.3 -38.05 43.37 Favored 'General case' 0 C--O 1.212 -0.891 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.545 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.99 -16.36 17.72 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.644 ' O ' ' HE2' ' D' ' 22' ' ' LYS . 35.0 mttm -91.12 -39.29 12.24 Favored 'General case' 0 CA--C 1.492 -1.28 0 CA-C-O 122.487 1.137 . . . . 0.0 109.397 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 20' ' ' LEU . . . . . 0.63 HD12 HD12 ' D' ' 27' ' ' LEU . 61.0 mt -82.26 -32.82 29.44 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 112.887 -1.961 . . . . 0.0 109.581 -174.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 21' ' ' ASN . . . . . 0.774 ' OD1' ' HB2' ' D' ' 26' ' ' LYS . 57.4 m-20 -71.95 92.33 1.27 Allowed 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.449 -1.25 . . . . 0.0 109.708 172.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 22' ' ' LYS . . . . . 0.644 ' HE2' ' O ' ' D' ' 19' ' ' LYS . 61.0 mttm -121.75 -41.45 2.47 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -174.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . 0.407 ' O ' ' HE2' ' D' ' 26' ' ' LYS . . . 176.93 -92.64 0.09 OUTLIER Glycine 0 N--CA 1.437 -1.283 0 C-N-CA 119.658 -1.258 . . . . 0.0 112.857 -177.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . 0.742 ' HG2' ' HB3' ' D' ' 45' ' ' TYR . 76.0 tttt -47.44 -55.83 8.22 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.584 0.707 . . . . 0.0 109.786 179.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 25' ' ' GLY . . . . . 0.644 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -133.99 156.21 22.22 Favored Glycine 0 N--CA 1.432 -1.573 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.906 174.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 26' ' ' LYS . . . . . 0.774 ' HB2' ' OD1' ' D' ' 21' ' ' ASN . 0.1 OUTLIER -150.3 162.48 40.44 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.301 -0.949 . . . . 0.0 110.556 -168.516 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 27' ' ' LEU . . . . . 0.746 ' HB2' HG11 ' D' ' 72' ' ' VAL . 3.4 tm? -132.46 143.23 49.64 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.762 -171.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 28' ' ' SER . . . . . 0.689 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 50.0 m -137.05 145.64 44.25 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.924 178.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 29' ' ' LEU . . . . . 0.525 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 18.3 mt -138.75 157.91 45.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.157 0.503 . . . . 0.0 110.871 177.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 39.3 t -160.3 -175.49 5.07 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 175.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 31' ' ' MET . . . . . 0.687 ' HA ' ' O ' ' D' ' 35' ' ' GLN . 26.6 ptt? -150.28 127.1 11.03 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.659 0.743 . . . . 0.0 111.06 175.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.52 89.01 7.01 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.022 176.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.51 -104.1 2.02 Favored Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -169.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -120.71 31.78 6.28 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.164 0.507 . . . . 0.0 109.938 172.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 35' ' ' GLN . . . . . 0.687 ' O ' ' HA ' ' D' ' 31' ' ' MET . 32.9 tt0 -108.11 115.95 31.07 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.579 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.672 ' HB2' ' HB2' ' D' ' 85' ' ' LYS . 1.1 tm? -77.76 134.95 37.95 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.225 0.536 . . . . 0.0 111.536 -177.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 37' ' ' LYS . . . . . 0.588 ' HB3' ' NZ ' ' D' ' 37' ' ' LYS . 0.7 OUTLIER -133.79 116.71 16.03 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.491 -169.313 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 38' ' ' ALA . . . . . 0.41 ' HA ' HD23 ' D' ' 29' ' ' LEU . . . -115.09 152.88 31.75 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.408 0.623 . . . . 0.0 112.401 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 39' ' ' THR . . . . . 0.689 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 5.2 p -150.87 134.49 16.43 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.53 177.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . 0.544 ' HB3' ' HA2' ' D' ' 73' ' ' GLY . 40.1 t -108.11 136.12 48.32 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 172.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 41' ' ' SER . . . . . 0.744 ' HB3' ' HG3' ' D' ' 26' ' ' LYS . 47.6 t -96.17 151.78 19.17 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 118.963 -1.095 . . . . 0.0 109.748 -179.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 42' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' D' ' 41' ' ' SER . 77.1 m-20 80.66 6.75 1.45 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.693 -167.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 53.94 60.13 3.82 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 114.713 -1.13 . . . . 0.0 113.455 171.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 44' ' ' GLY . . . . . 0.61 ' HA2' ' HA3' ' D' ' 73' ' ' GLY . . . 104.72 37.92 2.67 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.122 -1.513 . . . . 0.0 114.989 168.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 45' ' ' TYR . . . . . 0.742 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 2.3 m-85 -116.11 154.4 30.04 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 117.856 0.828 . . . . 0.0 109.944 173.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . 0.628 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -93.78 -173.58 39.56 Favored Glycine 0 C--O 1.22 -0.744 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 178.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 47' ' ' ILE . . . . . 0.812 HG12 ' HB3' ' D' ' 68' ' ' GLU . 26.9 mm -48.55 -54.81 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-O 122.025 0.917 . . . . 0.0 108.775 175.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.589 ' HA ' ' HD3' ' D' ' 24' ' ' LYS . 93.4 p 178.76 -146.22 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 112.832 -1.985 . . . . 0.0 107.561 178.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -82.54 75.9 9.43 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.462 166.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . 0.677 ' HB3' ' HE2' ' D' ' 52' ' ' LYS . 95.6 mt-10 -146.84 163.37 36.28 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.646 -176.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 51' ' ' ASP . . . . . 0.678 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 1.4 m-20 -124.1 132.7 53.68 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.804 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 52' ' ' LYS . . . . . 0.678 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 3.5 mptp? -142.93 120.7 11.89 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.453 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 53' ' ' ASN . . . . . 0.615 ' HA ' ' OD1' ' D' ' 67' ' ' ASN . 3.0 m120 -90.83 131.46 36.47 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 176.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 54' ' ' TRP . . . . . 0.617 ' HB2' ' O ' ' D' ' 66' ' ' PHE . 0.1 OUTLIER -122.93 155.0 37.63 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -172.161 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -144.81 161.14 28.07 Favored Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.254 -0.974 . . . . 0.0 113.97 174.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 56' ' ' ILE . . . . . 0.857 HD13 HG12 ' D' ' 84' ' ' ILE . 74.0 mt -137.03 111.79 10.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 57' ' ' PHE . . . . . 0.882 ' HB2' ' HB3' ' D' ' 90' ' ' GLU . 15.8 m-85 -105.59 97.8 7.58 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.894 -167.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.867 HG22 HG12 ' D' ' 89' ' ' ILE . 99.4 t -98.2 120.64 47.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.475 176.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 67.64 34.98 4.25 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 123.438 0.461 . . . . 0.0 110.539 -175.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.35 42.54 97.68 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.625 -0.716 . . . . 0.0 113.54 177.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 61' ' ' GLU . . . . . 0.634 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 24.9 pt-20 -155.41 141.63 18.46 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 176.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . 0.476 ' HB2' ' CE2' ' D' ' 57' ' ' PHE . 27.9 ttpp -73.01 99.72 2.81 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -178.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.491 HG12 ' O ' ' D' ' 56' ' ' ILE . 9.1 p -84.29 -32.43 8.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.657 -172.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 64' ' ' TYR . . . . . 0.43 ' HB3' HD12 ' D' ' 56' ' ' ILE . 17.2 t80 -134.39 132.0 38.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.746 0.307 . . . . 0.0 110.797 176.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 35.0 m -116.4 112.46 21.51 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.124 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 66' ' ' PHE . . . . . 0.617 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 9.3 p90 -118.66 158.51 25.37 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 173.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 67' ' ' ASN . . . . . 0.615 ' OD1' ' HA ' ' D' ' 53' ' ' ASN . 73.7 m-80 -129.81 142.09 50.74 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.349 -175.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 68' ' ' GLU . . . . . 0.812 ' HB3' HG12 ' D' ' 47' ' ' ILE . 42.1 mm-40 -69.07 -8.41 44.96 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 123.574 0.546 . . . . 0.0 110.415 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.432 ' HE2' ' CB ' ' D' ' 67' ' ' ASN . 44.1 mtmt -60.62 -46.66 89.44 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 167.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 70' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' D' ' 67' ' ' ASN . 35.1 t -69.78 129.78 40.51 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 113.179 -1.828 . . . . 0.0 108.355 168.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 71' ' ' THR . . . . . 0.461 ' O ' HG13 ' D' ' 75' ' ' ILE . 74.1 p -57.86 128.86 39.19 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 178.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 72' ' ' VAL . . . . . 0.746 HG11 ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -54.57 -16.84 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-O 121.294 0.568 . . . . 0.0 110.44 -175.655 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 73' ' ' GLY . . . . . 0.61 ' HA3' ' HA2' ' D' ' 44' ' ' GLY . . . -72.92 -58.58 4.72 Favored Glycine 0 N--CA 1.435 -1.39 0 CA-C-N 114.911 -1.041 . . . . 0.0 112.841 173.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -64.25 -20.25 65.93 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 120.885 0.374 . . . . 0.0 110.305 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 75' ' ' ILE . . . . . 0.645 ' O ' HG13 ' D' ' 79' ' ' ILE . 74.7 mt -73.34 -41.12 57.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.462 171.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 41.5 t -71.03 -26.8 63.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.048 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -56.12 -30.92 62.78 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 167.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 78' ' ' ASP . . . . . 1.084 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 1.1 m-20 -90.35 -33.28 16.13 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 177.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . 0.645 HG13 ' O ' ' D' ' 75' ' ' ILE . 41.5 mt -68.3 -27.81 38.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 O-C-N 121.689 -0.632 . . . . 0.0 110.595 -175.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -73.92 -20.02 60.51 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . 1.084 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -89.92 -52.38 5.0 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.601 171.416 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 82' ' ' LEU . . . . . 0.57 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.7 mm? -48.67 -31.44 6.78 Favored 'General case' 0 C--O 1.231 0.086 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 176.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 83' ' ' ASN . . . . . 0.496 ' HA ' HD12 ' D' ' 36' ' ' LEU . 22.2 t-20 40.6 77.77 0.05 Allowed 'General case' 0 N--CA 1.469 0.506 0 O-C-N 124.639 1.212 . . . . 0.0 111.134 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 84' ' ' ILE . . . . . 0.857 HG12 HD13 ' D' ' 56' ' ' ILE . 2.6 mp -77.97 97.05 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.362 -176.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 85' ' ' LYS . . . . . 0.672 ' HB2' ' HB2' ' D' ' 36' ' ' LEU . 0.0 OUTLIER -158.28 93.07 1.2 Allowed 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 121.431 0.634 . . . . 0.0 110.505 -177.424 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 86' ' ' GLY . . . . . 0.659 ' H ' HD11 ' D' ' 89' ' ' ILE . . . 68.54 148.56 0.21 Allowed Glycine 0 N--CA 1.453 -0.193 0 CA-C-N 114.59 -1.187 . . . . 0.0 113.929 178.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 87' ' ' PRO . . . . . 0.6 ' O ' HG13 ' D' ' 58' ' ' VAL . 60.8 Cg_endo -90.6 -177.53 10.12 Favored 'Cis proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.533 -1.445 . . . . 0.0 112.508 -0.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 88' ' ' TYR . . . . . 0.721 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 13.0 m-85 4.89 94.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 125.527 1.531 . . . . 0.0 114.214 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.867 HG12 HG22 ' D' ' 58' ' ' VAL . 66.5 mt -108.35 148.81 12.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.192 0.52 . . . . 0.0 111.883 -177.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.882 ' HB3' ' HB2' ' D' ' 57' ' ' PHE . 39.7 tt0 -132.13 91.41 2.95 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.281 173.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 91' ' ' ILE . . . . . 0.582 HG13 HG22 ' D' ' 89' ' ' ILE . 37.0 mt -94.14 99.84 10.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.89 -176.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 92' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' D' ' 93' ' ' GLN . 0.0 OUTLIER -160.74 164.47 31.55 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 177.379 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.625 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 24.3 pt20 -80.6 162.73 24.12 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.537 176.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . 0.406 HG22 ' HE2' ' D' ' 92' ' ' LYS . 10.6 pt . . . . . 0 C--N 1.305 -1.357 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.366 -171.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 9.4 t70 . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' D' D ' 2' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -172.48 -27.32 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 177.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 3' ' ' GLN . . . . . 0.473 ' CD ' ' H ' ' D' ' 3' ' ' GLN . 15.1 mp0 -55.93 -70.73 0.1 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.084 0.469 . . . . 0.0 110.785 -175.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -111.46 -26.01 9.3 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.71 174.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 5' ' ' ALA . . . . . 0.523 ' O ' ' HG2' ' D' ' 9' ' ' GLN . . . 61.59 31.06 18.85 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.001 -177.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 57.2 tp -70.24 -34.43 72.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.654 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -69.27 -26.21 64.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.339 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.81 ' HA ' ' CB ' ' D' ' 12' ' ' SER . 93.8 mt-10 -73.61 -21.13 60.4 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.34 176.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . 0.523 ' HG2' ' O ' ' D' ' 5' ' ' ALA . 72.0 mm-40 -89.05 11.74 17.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.833 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 10' ' ' MET . . . . . . . . . . . . . 62.6 mtt -106.05 -77.91 0.58 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.015 0.436 . . . . 0.0 111.042 -178.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -104.52 -38.5 6.75 Favored 'General case' 0 CA--C 1.493 -1.249 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.709 174.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 12' ' ' SER . . . . . 0.81 ' CB ' ' HA ' ' D' ' 8' ' ' GLU . 47.2 t -41.58 -66.03 0.38 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 113.667 -1.606 . . . . 0.0 112.83 -164.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.488 ' C ' HG12 ' D' ' 16' ' ' VAL . 57.5 mt -87.9 -7.18 10.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.623 -174.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -88.54 -57.36 2.94 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.334 176.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 15' ' ' SER . . . . . 0.513 ' O ' ' HE2' ' D' ' 19' ' ' LYS . 92.6 p -68.11 -17.74 64.45 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.673 -0.239 . . . . 0.0 111.457 -178.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 16' ' ' VAL . . . . . 0.645 HG13 ' ND2' ' D' ' 17' ' ' ASN . 9.6 p -59.97 -30.06 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-O 121.945 0.879 . . . . 0.0 109.562 176.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 17' ' ' ASN . . . . . 0.645 ' ND2' HG13 ' D' ' 16' ' ' VAL . 3.8 m120 -78.26 -33.96 49.29 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.256 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.31 -15.71 49.64 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.331 177.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.513 ' HE2' ' O ' ' D' ' 15' ' ' SER . 40.3 mttm -89.56 -39.52 13.22 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 122.726 1.25 . . . . 0.0 109.255 -179.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 20' ' ' LEU . . . . . 0.805 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 73.0 mt -77.19 -37.29 53.88 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 111.935 -2.393 . . . . 0.0 110.127 -176.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 21' ' ' ASN . . . . . 0.627 ' OD1' ' HB2' ' D' ' 26' ' ' LYS . 57.5 m-20 -75.33 95.92 3.29 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.678 177.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 22' ' ' LYS . . . . . 0.805 ' HD3' HG23 ' D' ' 47' ' ' ILE . 23.0 mtpp -120.89 -43.62 2.45 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 118.594 -1.242 . . . . 0.0 114.064 -168.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.27 -69.9 0.25 Allowed Glycine 0 N--CA 1.436 -1.315 0 C-N-CA 119.746 -1.216 . . . . 0.0 112.509 -174.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . 0.819 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 22.2 tptm -55.27 -67.07 0.31 Allowed 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 176.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 25' ' ' GLY . . . . . 1.061 ' HA2' HD21 ' D' ' 42' ' ' ASN . . . -139.38 156.49 24.61 Favored Glycine 0 CA--C 1.493 -1.337 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.279 172.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 26' ' ' LYS . . . . . 0.691 ' CD ' ' HB3' ' D' ' 41' ' ' SER . 0.4 OUTLIER -140.5 160.12 40.69 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -168.53 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 27' ' ' LEU . . . . . 0.805 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 45.1 tp -139.44 144.38 38.02 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.463 0.649 . . . . 0.0 112.392 -177.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 28' ' ' SER . . . . . 0.715 ' HB2' ' OG1' ' D' ' 39' ' ' THR . 49.2 m -135.34 151.91 50.96 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.505 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 29' ' ' LEU . . . . . . . . . . . . . 16.4 mt -141.02 138.01 33.38 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 56.3 m -148.06 -179.04 6.62 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 31' ' ' MET . . . . . 0.813 ' HA ' ' O ' ' D' ' 35' ' ' GLN . 20.2 ptp -137.23 126.62 24.92 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.67 0.747 . . . . 0.0 111.057 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -90.84 88.34 7.02 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 175.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.64 -100.97 1.99 Allowed Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -165.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -120.16 12.5 11.86 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.999 0.428 . . . . 0.0 109.987 171.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 35' ' ' GLN . . . . . 0.813 ' O ' ' HA ' ' D' ' 31' ' ' MET . 25.6 mt-30 -88.63 125.94 35.06 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.471 -175.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.686 HD11 HG22 ' D' ' 79' ' ' ILE . 2.8 tm? -78.08 124.38 27.98 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.204 0.526 . . . . 0.0 111.436 -178.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 37' ' ' LYS . . . . . 0.642 ' HE2' ' HB3' ' D' ' 35' ' ' GLN . 74.9 mmtt -135.53 103.49 5.48 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.794 -173.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.28 152.64 18.38 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.322 0.582 . . . . 0.0 111.581 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 39' ' ' THR . . . . . 0.715 ' OG1' ' HB2' ' D' ' 28' ' ' SER . 7.1 p -141.01 124.79 16.98 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.118 176.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . 0.654 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 19.1 p -107.88 128.87 55.0 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 172.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 41' ' ' SER . . . . . 0.691 ' HB3' ' CD ' ' D' ' 26' ' ' LYS . 44.3 t -96.3 168.75 10.39 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 42' ' ' ASN . . . . . 1.061 HD21 ' HA2' ' D' ' 25' ' ' GLY . 21.3 p30 60.8 7.44 1.45 Allowed 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.975 1.422 . . . . 0.0 112.499 -174.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 41.41 60.29 2.14 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 168.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.87 35.86 0.81 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 118.873 -1.632 . . . . 0.0 114.931 168.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 45' ' ' TYR . . . . . 0.819 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 0.7 OUTLIER -122.83 154.26 38.48 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 170.504 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . 0.562 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -99.81 -163.63 29.02 Favored Glycine 0 C--O 1.216 -1.013 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.414 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 47' ' ' ILE . . . . . 0.805 HG23 ' HD3' ' D' ' 22' ' ' LYS . 41.9 mm -55.04 -59.53 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 CA-C-O 122.088 0.947 . . . . 0.0 109.675 176.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 83.5 p 175.0 -164.61 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 112.327 -2.215 . . . . 0.0 108.789 -172.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -78.27 77.96 4.75 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.924 0.869 . . . . 0.0 111.632 173.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -145.56 -167.8 2.8 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.957 177.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 51' ' ' ASP . . . . . 0.691 ' C ' ' HD3' ' D' ' 52' ' ' LYS . 9.6 p-10 -136.34 135.18 38.65 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.359 168.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 52' ' ' LYS . . . . . 0.732 ' CE ' ' HB2' ' D' ' 68' ' ' GLU . 2.7 mppt? -139.79 128.1 22.64 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.263 -167.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 53' ' ' ASN . . . . . 0.448 HD22 ' C ' ' D' ' 52' ' ' LYS . 2.8 m120 -116.65 138.8 51.17 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 173.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 54' ' ' TRP . . . . . 0.651 ' HZ3' HG23 ' D' ' 91' ' ' ILE . 0.1 OUTLIER -125.76 160.38 29.93 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -173.077 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -140.43 156.2 25.07 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.042 -1.075 . . . . 0.0 113.908 175.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 56' ' ' ILE . . . . . 0.628 HD13 HG12 ' D' ' 84' ' ' ILE . 62.8 mt -140.24 108.75 3.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 176.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 57' ' ' PHE . . . . . 0.738 ' CE2' ' HE2' ' D' ' 92' ' ' LYS . 7.0 m-85 -108.25 102.91 12.0 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.637 -168.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.713 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 78.2 t -91.97 110.17 22.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.814 170.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 59' ' ' ASN . . . . . 0.44 ' OD1' ' HG2' ' D' ' 87' ' ' PRO . 5.2 m120 63.74 44.51 4.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.436 -176.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.3 -33.91 4.7 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.793 -0.718 . . . . 0.0 114.511 172.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 61' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 12.5 pt-20 -94.81 154.06 17.44 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.966 -0.293 . . . . 0.0 111.072 -175.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -73.92 106.94 5.86 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 173.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 9.9 p -76.52 -27.9 17.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.522 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 64' ' ' TYR . . . . . 0.551 ' HB3' HD12 ' D' ' 56' ' ' ILE . 14.2 t80 -148.13 135.57 20.59 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.545 173.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.422 HG23 ' O ' ' D' ' 54' ' ' TRP . 65.3 m -119.87 123.04 42.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.514 174.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 66' ' ' PHE . . . . . 0.632 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 11.3 p90 -129.62 143.11 50.67 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 121.477 0.656 . . . . 0.0 110.679 178.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 67' ' ' ASN . . . . . 0.803 HD22 ' HB2' ' D' ' 69' ' ' LYS . 15.1 p-10 -110.31 130.28 55.58 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.271 -175.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 68' ' ' GLU . . . . . 0.804 ' HB3' HG12 ' D' ' 47' ' ' ILE . 35.1 mm-40 -67.62 -8.45 34.67 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.831 -177.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.803 ' HB2' HD22 ' D' ' 67' ' ' ASN . 53.3 mtpt -62.28 -40.79 97.4 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 169.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 70' ' ' SER . . . . . 0.489 ' HB3' ' O ' ' D' ' 67' ' ' ASN . 32.5 t -68.51 124.52 23.79 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 113.051 -1.886 . . . . 0.0 107.353 164.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 71' ' ' THR . . . . . 0.422 ' O ' HG13 ' D' ' 75' ' ' ILE . 67.3 p -55.17 130.98 44.17 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 72' ' ' VAL . . . . . 0.66 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -57.3 -14.99 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-O 120.722 0.296 . . . . 0.0 111.011 -178.582 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 73' ' ' GLY . . . . . 0.654 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -63.98 -65.45 3.02 Favored Glycine 0 N--CA 1.433 -1.562 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.156 168.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -62.62 -20.55 64.88 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.523 0.201 . . . . 0.0 111.428 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 75' ' ' ILE . . . . . 0.592 ' O ' HG13 ' D' ' 79' ' ' ILE . 69.7 mt -73.26 -40.61 57.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.148 174.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 35.9 t -75.83 -21.32 57.4 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.817 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 77' ' ' ASN . . . . . 0.605 ' O ' ' HD3' ' D' ' 81' ' ' LYS . 5.7 m120 -61.69 -23.97 66.46 Favored 'General case' 0 C--O 1.216 -0.66 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 166.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 78' ' ' ASP . . . . . 0.627 ' O ' HD23 ' D' ' 82' ' ' LEU . 1.0 OUTLIER -93.23 -41.56 9.83 Favored 'General case' 0 C--O 1.225 -0.237 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 175.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . 0.686 HG22 HD11 ' D' ' 36' ' ' LEU . 56.0 mt -65.78 -34.35 69.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 O-C-N 121.449 -0.782 . . . . 0.0 111.645 -169.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -66.86 -14.05 62.29 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.126 176.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . 0.605 ' HD3' ' O ' ' D' ' 77' ' ' ASN . 0.0 OUTLIER -89.77 -57.39 2.88 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.207 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 82' ' ' LEU . . . . . 0.627 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.4 mm? -53.86 -23.74 13.5 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 113.88 -1.509 . . . . 0.0 112.343 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 83' ' ' ASN . . . . . 0.409 HD22 ' HB3' ' D' ' 36' ' ' LEU . 0.7 OUTLIER 50.69 69.75 0.6 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.647 174.093 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 84' ' ' ILE . . . . . 0.628 HG12 HD13 ' D' ' 56' ' ' ILE . 2.2 mp -74.68 99.09 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.377 0.608 . . . . 0.0 111.175 -176.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 85' ' ' LYS . . . . . 0.62 ' C ' HD11 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -131.99 179.07 6.31 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.165 174.722 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . -48.38 165.15 0.24 Allowed Glycine 0 C--N 1.334 0.463 0 O-C-N 123.696 0.623 . . . . 0.0 113.928 -174.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 87' ' ' PRO . . . . . 0.534 ' O ' HG13 ' D' ' 58' ' ' VAL . 60.5 Cg_endo -93.82 -177.09 7.26 Favored 'Cis proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.898 -1.293 . . . . 0.0 114.758 -0.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 88' ' ' TYR . . . . . 0.713 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 41.5 m-85 23.04 93.06 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.504 1.521 . . . . 0.0 113.57 179.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.62 HD11 ' C ' ' D' ' 85' ' ' LYS . 72.7 mt -112.36 139.27 37.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 178.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.704 ' HG2' ' HD2' ' D' ' 92' ' ' LYS . 88.9 tt0 -127.59 94.75 4.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.032 171.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 91' ' ' ILE . . . . . 0.651 HG23 ' HZ3' ' D' ' 54' ' ' TRP . 27.4 mt -95.68 99.82 9.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.088 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 92' ' ' LYS . . . . . 0.738 ' HE2' ' CE2' ' D' ' 57' ' ' PHE . 0.0 OUTLIER -161.99 169.29 21.34 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.373 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.664 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 3.0 pt20 -79.56 157.54 27.35 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.283 173.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . 0.429 HG22 ' HE3' ' D' ' 92' ' ' LYS . 9.9 pt . . . . . 0 C--N 1.308 -1.236 0 CA-C-N 114.902 -1.044 . . . . 0.0 112.186 -170.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' D' D ' 2' ' ' ASN . . . . . . . . . . . . . 6.0 m120 52.78 58.08 5.72 Favored 'General case' 0 N--CA 1.462 0.165 0 O-C-N 123.567 0.542 . . . . 0.0 111.001 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.08 21.93 0.32 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -88.67 -19.56 26.02 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 5' ' ' ALA . . . . . . . . . . . . . . . 59.84 64.55 1.27 Allowed 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.919 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 58.4 tp -110.03 -31.55 7.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.231 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . 0.414 ' HA ' ' SD ' ' D' ' 10' ' ' MET . 87.5 tt0 -66.68 -16.09 63.96 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.44 177.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.698 ' HA ' ' CB ' ' D' ' 12' ' ' SER . 43.7 mm-40 -64.76 -32.7 74.51 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.147 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . 0.562 ' OE1' ' HB2' ' D' ' 8' ' ' GLU . 1.3 mp0 -86.29 5.05 36.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.353 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 10' ' ' MET . . . . . 0.414 ' SD ' ' HA ' ' D' ' 7' ' ' GLU . 66.1 mtt -100.98 -77.45 0.54 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.348 -174.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -103.25 -36.79 7.95 Favored 'General case' 0 CA--C 1.488 -1.415 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.288 172.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 12' ' ' SER . . . . . 0.698 ' CB ' ' HA ' ' D' ' 8' ' ' GLU . 48.1 t -44.22 -70.45 0.1 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 113.994 -1.457 . . . . 0.0 113.235 -164.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.636 ' O ' HG12 ' D' ' 16' ' ' VAL . 57.0 mt -83.45 -8.36 11.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.902 -173.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -88.19 -41.86 12.7 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.095 175.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 15' ' ' SER . . . . . 0.559 ' HA ' ' OD2' ' D' ' 18' ' ' ASP . 88.2 p -72.01 -23.52 61.41 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 122.045 -0.409 . . . . 0.0 109.907 175.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 16' ' ' VAL . . . . . 0.636 HG12 ' O ' ' D' ' 13' ' ' ILE . 0.5 OUTLIER -56.84 -24.05 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 121.515 0.674 . . . . 0.0 109.41 178.927 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -74.65 -43.75 53.81 Favored 'General case' 0 C--O 1.209 -1.071 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.771 176.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 18' ' ' ASP . . . . . 0.559 ' OD2' ' HA ' ' D' ' 15' ' ' SER . 51.4 m-20 -55.3 -16.2 3.19 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -177.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.588 ' HD2' ' N ' ' D' ' 19' ' ' LYS . 0.0 OUTLIER -91.18 -43.16 10.03 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-O 122.306 1.051 . . . . 0.0 108.691 175.533 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 20' ' ' LEU . . . . . 0.927 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 70.7 mt -69.36 -37.74 77.76 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 113.168 -1.833 . . . . 0.0 110.258 -177.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 21' ' ' ASN . . . . . 0.443 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 3.3 m120 -79.7 94.08 5.66 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.705 -178.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 22' ' ' LYS . . . . . 0.701 ' HD2' HD12 ' D' ' 47' ' ' ILE . 95.8 mttt -122.32 -41.95 2.38 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -176.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 165.87 -84.0 0.1 Allowed Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 119.32 -1.419 . . . . 0.0 113.231 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . 0.807 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 27.2 tptp -44.89 -57.76 3.57 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 25' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -139.86 163.95 26.16 Favored Glycine 0 N--CA 1.431 -1.685 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.967 171.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 26' ' ' LYS . . . . . 0.679 ' HD2' ' HB3' ' D' ' 41' ' ' SER . 0.3 OUTLIER -149.29 159.59 44.14 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.933 -0.634 . . . . 0.0 109.986 -171.743 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 27' ' ' LEU . . . . . 0.927 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 39.8 tp -136.16 134.49 38.29 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.436 0.636 . . . . 0.0 111.806 -178.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 28' ' ' SER . . . . . 0.637 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 26.5 t -121.36 145.96 47.36 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 29' ' ' LEU . . . . . . . . . . . . . 20.9 mt -131.43 134.96 46.75 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.754 -0.779 . . . . 0.0 110.745 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 32.1 t -137.01 -171.04 2.84 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 31' ' ' MET . . . . . 0.502 ' HB2' ' O ' ' D' ' 35' ' ' GLN . 26.3 ptt? -150.08 166.59 29.29 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.81 0.338 . . . . 0.0 110.618 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 32' ' ' ASN . . . . . 0.637 ' O ' ' HB2' ' D' ' 35' ' ' GLN . 25.9 t-20 -141.82 87.28 2.04 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 176.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.48 -113.81 4.82 Favored Glycine 0 CA--C 1.516 0.142 0 C-N-CA 119.898 -1.144 . . . . 0.0 111.121 -172.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -95.7 31.0 2.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.776 0.798 . . . . 0.0 109.92 173.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 35' ' ' GLN . . . . . 0.637 ' HB2' ' O ' ' D' ' 32' ' ' ASN . 52.5 mm-40 -110.24 164.94 12.17 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 114.928 -1.033 . . . . 0.0 112.367 -178.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.586 HD11 HG22 ' D' ' 79' ' ' ILE . 2.7 tm? -130.72 128.95 41.88 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 175.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 37' ' ' LYS . . . . . 0.401 ' N ' HD13 ' D' ' 36' ' ' LEU . 35.7 mmtp -132.4 100.6 5.04 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.145 0.498 . . . . 0.0 110.842 -176.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.72 149.95 21.24 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.856 -177.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 39' ' ' THR . . . . . 0.637 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 29.8 p -137.32 126.72 24.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.916 174.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . 0.761 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 60.6 p -109.89 135.73 50.31 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 175.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 41' ' ' SER . . . . . 0.679 ' HB3' ' HD2' ' D' ' 26' ' ' LYS . 43.9 t -104.0 156.42 17.87 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.814 -176.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 42' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' D' ' 41' ' ' SER . 74.0 m-80 78.79 9.34 1.89 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.423 -172.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 43.74 59.02 3.27 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 114.73 -1.123 . . . . 0.0 113.648 170.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.84 34.96 2.1 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 119.732 -1.223 . . . . 0.0 113.872 172.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 45' ' ' TYR . . . . . 0.807 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 2.8 m-30 -112.89 146.72 38.45 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 170.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . 0.597 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -93.93 -162.97 35.99 Favored Glycine 0 C--O 1.218 -0.876 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 175.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 47' ' ' ILE . . . . . 0.832 HG12 ' HB3' ' D' ' 68' ' ' GLU . 38.5 mm -56.27 -57.1 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.886 0 CA-C-O 122.14 0.971 . . . . 0.0 109.514 174.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -178.97 -123.05 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 112.796 -2.002 . . . . 0.0 108.906 -177.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -114.47 76.79 1.01 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.119 0.485 . . . . 0.0 109.916 169.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . 0.563 ' CB ' ' HD3' ' D' ' 52' ' ' LYS . 51.5 mt-10 -140.16 168.73 19.13 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.53 177.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 51' ' ' ASP . . . . . 0.634 ' CB ' ' HD2' ' D' ' 69' ' ' LYS . 1.6 m-20 -114.69 122.06 45.29 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.763 175.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 52' ' ' LYS . . . . . 0.823 ' HG3' ' HB2' ' D' ' 68' ' ' GLU . 0.0 OUTLIER -131.84 107.44 8.74 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.858 -166.354 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -94.33 129.35 41.04 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.466 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 54' ' ' TRP . . . . . 0.61 ' HZ3' HG23 ' D' ' 91' ' ' ILE . 0.1 OUTLIER -121.93 153.78 38.03 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -174.827 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -141.06 158.78 26.45 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.153 -1.022 . . . . 0.0 113.607 175.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 56' ' ' ILE . . . . . 0.681 HD13 HD13 ' D' ' 84' ' ' ILE . 62.8 mt -142.97 106.51 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 -178.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 57' ' ' PHE . . . . . 0.536 ' HD2' ' HB2' ' D' ' 90' ' ' GLU . 11.8 m-85 -108.6 106.87 17.13 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.59 -168.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.71 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 49.9 t -95.79 118.36 41.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.63 173.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 58.91 34.34 23.59 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.033 -178.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.91 -32.77 6.88 Favored Glycine 0 CA--C 1.505 -0.537 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.706 174.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 61' ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 25.4 pt-20 -90.19 146.91 23.9 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.078 0.466 . . . . 0.0 110.818 -175.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -79.36 101.75 8.29 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 177.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.518 HG12 ' O ' ' D' ' 56' ' ' ILE . 10.5 p -76.87 -30.32 18.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.695 -172.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 64' ' ' TYR . . . . . 0.529 ' HB3' HD12 ' D' ' 56' ' ' ILE . 20.5 t80 -147.16 142.57 27.45 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.757 0.313 . . . . 0.0 110.979 178.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 30.5 m -124.8 125.65 44.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.587 175.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 66' ' ' PHE . . . . . 0.561 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 17.5 p90 -133.83 157.49 45.79 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 121.441 0.639 . . . . 0.0 110.43 173.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 67' ' ' ASN . . . . . 0.589 ' HA ' ' O ' ' D' ' 52' ' ' LYS . 5.2 m120 -116.92 141.61 48.01 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 68' ' ' GLU . . . . . 0.832 ' HB3' HG12 ' D' ' 47' ' ' ILE . 55.6 mm-40 -70.83 -16.75 62.74 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 175.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.634 ' HD2' ' CB ' ' D' ' 51' ' ' ASP . 25.0 mtpp -60.21 -44.31 95.24 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 114.102 -1.408 . . . . 0.0 108.159 169.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 18.8 t -76.1 90.72 3.08 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 113.633 -1.621 . . . . 0.0 107.898 171.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 65.6 p -24.39 120.67 0.05 Allowed 'General case' 0 C--N 1.32 -0.695 0 O-C-N 124.815 1.322 . . . . 0.0 112.811 -175.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 72' ' ' VAL . . . . . 0.535 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -50.96 -15.3 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 O-C-N 123.356 0.41 . . . . 0.0 111.922 179.615 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 73' ' ' GLY . . . . . 0.761 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -65.3 -66.86 2.25 Favored Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 115.805 -0.634 . . . . 0.0 113.183 171.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -62.07 -27.24 68.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.229 -0.485 . . . . 0.0 110.332 -177.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 75' ' ' ILE . . . . . 0.629 ' O ' HG13 ' D' ' 79' ' ' ILE . 29.9 mm -78.24 -41.48 26.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.217 178.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 76' ' ' SER . . . . . 0.566 ' HB2' HD13 ' D' ' 27' ' ' LEU . 29.3 t -72.37 -21.33 61.31 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.449 -178.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 77' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -64.89 -34.01 77.38 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 167.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 78' ' ' ASP . . . . . 1.047 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 0.9 OUTLIER -77.89 -31.99 51.57 Favored 'General case' 0 C--O 1.224 -0.272 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 175.005 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . 0.629 HG13 ' O ' ' D' ' 75' ' ' ILE . 60.2 mt -65.49 -21.21 28.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 O-C-N 121.543 -0.723 . . . . 0.0 111.294 -174.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -73.25 -43.48 61.08 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 176.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . 1.047 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -68.79 -44.47 73.53 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.468 177.269 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 82' ' ' LEU . . . . . 0.659 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.8 mm? -55.53 -22.15 20.2 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 177.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 45.57 73.2 0.17 Allowed 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.778 0.674 . . . . 0.0 110.984 175.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 84' ' ' ILE . . . . . 0.865 HG21 HD11 ' D' ' 91' ' ' ILE . 35.0 mt -70.71 99.8 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.315 -177.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 85' ' ' LYS . . . . . 0.594 ' HD3' ' O ' ' D' ' 35' ' ' GLN . 30.5 mmmt -139.19 177.87 7.59 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.719 176.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 86' ' ' GLY . . . . . 0.716 ' HA2' HD11 ' D' ' 89' ' ' ILE . . . -59.67 175.89 3.44 Favored Glycine 0 CA--C 1.506 -0.481 0 N-CA-C 115.008 0.763 . . . . 0.0 115.008 -174.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 87' ' ' PRO . . . . . 0.603 ' O ' HG13 ' D' ' 58' ' ' VAL . 33.0 Cg_endo -91.67 175.73 17.48 Favored 'Cis proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.158 -2.017 . . . . 0.0 114.53 0.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 88' ' ' TYR . . . . . 0.71 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 33.4 m-85 31.52 92.47 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.32 1.448 . . . . 0.0 112.614 -179.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.716 HD11 ' HA2' ' D' ' 86' ' ' GLY . 3.1 mp -109.5 143.1 20.28 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.402 -177.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.656 ' O ' ' HA ' ' D' ' 56' ' ' ILE . 37.3 mt-10 -129.24 89.19 2.81 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.385 172.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 91' ' ' ILE . . . . . 0.865 HD11 HG21 ' D' ' 84' ' ' ILE . 21.0 mt -94.44 99.8 10.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.912 178.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 92' ' ' LYS . . . . . 0.844 ' HE3' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -161.8 169.2 21.81 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.125 -177.434 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.716 ' O ' ' HD3' ' D' ' 92' ' ' LYS . 2.5 pp0? -85.78 147.17 26.44 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.054 170.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . 0.844 HG22 ' HE3' ' D' ' 92' ' ' LYS . 8.9 pt . . . . . 0 C--N 1.304 -1.389 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.979 -169.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.483 1.183 0 CA-C-O 120.476 0.179 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' D' D ' 2' ' ' ASN . . . . . . . . . . . . . 45.4 t30 63.43 88.67 0.1 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.589 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -84.4 -71.04 0.53 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 174.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -110.85 -53.37 2.71 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 170.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 5' ' ' ALA . . . . . 0.722 ' HA ' ' HB2' ' D' ' 8' ' ' GLU . . . 30.16 53.81 0.14 Allowed 'General case' 0 N--CA 1.469 0.49 0 O-C-N 124.683 1.239 . . . . 0.0 113.8 175.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . 0.41 HD23 ' C ' ' D' ' 6' ' ' LEU . 5.8 tt -84.59 -70.6 0.57 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -93.03 -10.16 37.18 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 174.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.722 ' HB2' ' HA ' ' D' ' 5' ' ' ALA . 50.4 mt-10 -59.62 -52.55 65.06 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.025 -174.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . 0.502 ' HG3' ' HB1' ' D' ' 5' ' ' ALA . 2.1 pp0? -89.05 14.19 11.24 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.41 176.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 10' ' ' MET . . . . . . . . . . . . . 48.3 ttm -104.3 -77.96 0.57 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.132 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -103.03 -54.61 2.58 Favored 'General case' 0 CA--C 1.492 -1.25 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.907 172.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 12' ' ' SER . . . . . 0.715 ' HB3' ' HA ' ' D' ' 8' ' ' GLU . 42.7 t -25.53 -69.28 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 113.663 -1.608 . . . . 0.0 113.899 -170.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.449 ' C ' HG12 ' D' ' 16' ' ' VAL . 55.8 mt -91.69 -8.6 10.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.672 -172.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -95.06 -61.16 1.53 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.678 175.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 15' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' D' ' 18' ' ' ASP . 88.5 p -60.45 -21.78 62.71 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 116.906 -0.134 . . . . 0.0 111.238 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 16' ' ' VAL . . . . . 0.687 ' HA ' ' HE2' ' D' ' 19' ' ' LYS . 9.7 p -54.51 -38.48 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 120.761 0.315 . . . . 0.0 110.647 177.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 17' ' ' ASN . . . . . 0.562 ' ND2' HG13 ' D' ' 16' ' ' VAL . 2.7 m120 -68.61 -35.79 77.81 Favored 'General case' 0 C--O 1.214 -0.793 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.7 178.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 18' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' D' ' 15' ' ' SER . 1.2 m-20 -64.42 -17.29 63.65 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -176.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.687 ' HE2' ' HA ' ' D' ' 16' ' ' VAL . 0.0 OUTLIER -90.78 -44.43 9.45 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-O 122.031 0.919 . . . . 0.0 108.563 173.778 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 20' ' ' LEU . . . . . 1.014 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 75.6 mt -61.76 -39.08 90.36 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 113.515 -1.675 . . . . 0.0 109.937 -178.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 21' ' ' ASN . . . . . 0.437 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 3.2 m120 -77.99 97.21 5.28 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.558 178.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 22' ' ' LYS . . . . . 0.781 ' HD2' HD12 ' D' ' 47' ' ' ILE . 67.5 mttm -123.12 -43.37 2.22 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -177.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.4 -96.22 0.1 Allowed Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 119.403 -1.379 . . . . 0.0 113.721 -176.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . 0.799 ' HE2' ' HA ' ' D' ' 48' ' ' SER . 35.0 ttpt -53.81 -47.36 70.92 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.737 0.78 . . . . 0.0 109.404 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 25' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -135.96 153.71 21.55 Favored Glycine 0 N--CA 1.431 -1.642 0 CA-C-N 114.232 -1.349 . . . . 0.0 112.006 176.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 26' ' ' LYS . . . . . 0.723 ' CD ' ' HB2' ' D' ' 41' ' ' SER . 0.1 OUTLIER -150.44 160.48 43.73 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.05 -1.075 . . . . 0.0 110.213 -170.192 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 27' ' ' LEU . . . . . 1.014 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 41.8 tp -135.43 130.1 34.28 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.302 0.572 . . . . 0.0 112.023 -177.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 28' ' ' SER . . . . . 0.547 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 8.1 t -117.46 125.16 50.44 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 29' ' ' LEU . . . . . 0.62 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 1.0 OUTLIER -141.14 148.48 40.12 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 176.584 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 62.5 p -157.8 179.07 9.56 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.205 -179.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 31' ' ' MET . . . . . 0.416 ' SD ' ' N ' ' D' ' 31' ' ' MET . 0.0 OUTLIER -117.95 166.17 12.83 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.396 0.617 . . . . 0.0 110.608 179.795 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 32' ' ' ASN . . . . . 0.653 ' HB3' ' HB2' ' D' ' 35' ' ' GLN . 26.1 t-20 -144.16 87.13 1.87 Allowed 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 176.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.74 -98.65 0.7 Allowed Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.187 -1.006 . . . . 0.0 111.281 -171.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 34' ' ' ASN . . . . . 0.417 ' O ' ' HG2' ' D' ' 85' ' ' LYS . 4.8 m120 -110.66 10.36 22.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.029 0.442 . . . . 0.0 110.395 175.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 35' ' ' GLN . . . . . 0.653 ' HB2' ' HB3' ' D' ' 32' ' ' ASN . 3.8 mm100 -91.35 165.28 13.5 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 121.533 0.682 . . . . 0.0 112.222 -177.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.947 HD11 HG22 ' D' ' 79' ' ' ILE . 1.8 tm? -132.82 135.03 45.41 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.693 172.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 37' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 34.9 mmtp -132.1 106.36 7.95 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.698 -171.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 38' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -118.52 148.46 42.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.857 0.361 . . . . 0.0 111.911 -177.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 39' ' ' THR . . . . . 0.547 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 57.2 p -145.43 148.5 33.37 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.265 178.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' D' ' 26' ' ' LYS . 41.9 p -109.28 131.87 54.66 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 168.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 41' ' ' SER . . . . . 0.723 ' HB2' ' CD ' ' D' ' 26' ' ' LYS . 43.7 m -94.44 147.76 22.91 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 118.915 -1.114 . . . . 0.0 108.882 177.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 42' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' D' ' 41' ' ' SER . 75.1 m-80 80.67 2.5 1.79 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.942 -165.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.19 62.08 2.13 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 168.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 44' ' ' GLY . . . . . 0.479 ' O ' ' HB ' ' D' ' 71' ' ' THR . . . 119.19 -6.48 13.05 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 118.405 -1.855 . . . . 0.0 115.072 168.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 45' ' ' TYR . . . . . 0.766 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 1.3 m-85 -86.17 155.84 20.58 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.98 0.39 . . . . 0.0 111.784 -174.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . 0.6 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -94.84 178.95 36.63 Favored Glycine 0 C--O 1.222 -0.654 0 CA-C-O 118.812 -0.993 . . . . 0.0 110.642 174.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 47' ' ' ILE . . . . . 0.781 HD12 ' HD2' ' D' ' 22' ' ' LYS . 33.4 mm -47.65 -57.22 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 CA-C-N 118.109 0.955 . . . . 0.0 110.652 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.799 ' HA ' ' HE2' ' D' ' 24' ' ' LYS . 22.1 t 178.83 -135.24 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.02 -1.446 . . . . 0.0 107.923 -178.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -95.03 76.93 3.53 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 165.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . 0.853 ' HB3' ' HE3' ' D' ' 52' ' ' LYS . 50.6 mt-10 -144.58 164.63 30.36 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.95 -173.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 51' ' ' ASP . . . . . 0.686 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 10.7 p-10 -132.61 135.49 45.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.231 0.539 . . . . 0.0 111.337 177.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 52' ' ' LYS . . . . . 0.853 ' HE3' ' HB3' ' D' ' 50' ' ' GLU . 0.2 OUTLIER -146.97 142.35 27.44 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.392 -174.261 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 53' ' ' ASN . . . . . 0.46 HD22 ' C ' ' D' ' 52' ' ' LYS . 3.3 m120 -118.25 135.99 53.94 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 172.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 54' ' ' TRP . . . . . 1.065 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 0.9 OUTLIER -126.29 162.49 25.35 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -170.89 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -148.69 163.46 29.03 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.204 174.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 56' ' ' ILE . . . . . 1.064 HG12 HG23 ' D' ' 91' ' ' ILE . 93.6 mt -135.97 108.99 8.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 C-N-CA 124.853 1.261 . . . . 0.0 107.689 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 57' ' ' PHE . . . . . 0.726 ' CE1' ' HE2' ' D' ' 92' ' ' LYS . 14.6 m-85 -107.63 101.55 10.86 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.898 -168.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.806 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 84.0 t -83.24 106.48 13.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.927 171.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 64.4 45.24 3.84 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.51 0.506 . . . . 0.0 110.692 -177.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.76 41.94 99.68 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.313 -178.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 61' ' ' GLU . . . . . 0.515 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 42.8 tt0 -142.97 112.64 6.9 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.264 -0.468 . . . . 0.0 110.059 178.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . 0.524 ' HB2' ' CE2' ' D' ' 57' ' ' PHE . 37.8 ttpt -70.36 105.65 3.1 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.446 -177.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 27.6 m -89.14 -24.48 5.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.708 -175.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 64' ' ' TYR . . . . . 0.451 ' HB3' HD12 ' D' ' 56' ' ' ILE . 16.4 t80 -141.36 135.45 30.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.766 0.317 . . . . 0.0 111.035 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 79.6 m -117.66 118.89 33.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.308 175.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 66' ' ' PHE . . . . . 0.456 ' CZ ' ' CE3' ' D' ' 54' ' ' TRP . 9.4 p90 -125.61 159.36 32.35 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 174.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 67' ' ' ASN . . . . . 0.713 ' ND2' ' HB2' ' D' ' 69' ' ' LYS . 16.0 p-10 -130.2 136.1 48.87 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -174.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 68' ' ' GLU . . . . . 0.778 ' HB3' HG12 ' D' ' 47' ' ' ILE . 51.9 mm-40 -68.31 -8.37 39.12 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.368 -175.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.713 ' HB2' ' ND2' ' D' ' 67' ' ' ASN . 6.0 mtpm? -64.74 -44.4 90.24 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 169.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 70' ' ' SER . . . . . 0.475 ' HB3' ' O ' ' D' ' 67' ' ' ASN . 35.0 t -64.61 125.43 24.71 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 113.32 -1.763 . . . . 0.0 107.847 168.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 71' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' D' ' 44' ' ' GLY . 72.3 p -56.03 126.57 26.5 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 72' ' ' VAL . . . . . 0.618 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -57.56 -11.47 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-O 121.04 0.448 . . . . 0.0 111.341 -176.292 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 73' ' ' GLY . . . . . 0.47 ' HA3' ' HA2' ' D' ' 44' ' ' GLY . . . -73.49 -57.34 5.09 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.568 170.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -63.84 -23.84 67.51 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 177.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 75' ' ' ILE . . . . . 0.65 ' O ' HG13 ' D' ' 79' ' ' ILE . 72.0 mt -71.33 -44.8 72.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.216 174.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 76' ' ' SER . . . . . 0.469 ' HA ' HG13 ' D' ' 79' ' ' ILE . 31.8 t -71.55 -25.89 62.41 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 121.116 -0.233 . . . . 0.0 111.037 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 77' ' ' ASN . . . . . 0.423 ' O ' ' HD2' ' D' ' 81' ' ' LYS . 4.4 m120 -60.71 -26.36 67.1 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 169.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 78' ' ' ASP . . . . . 1.023 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 80.7 m-20 -86.3 -37.54 18.42 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.196 174.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . 0.947 HG22 HD11 ' D' ' 36' ' ' LEU . 24.2 mt -64.85 -27.96 43.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 O-C-N 121.897 -0.502 . . . . 0.0 110.803 -175.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -69.11 -29.49 67.57 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.293 178.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . 1.023 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -85.04 -49.45 8.28 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 119.677 -0.809 . . . . 0.0 111.323 175.116 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 82' ' ' LEU . . . . . 0.642 HD23 ' O ' ' D' ' 78' ' ' ASP . 4.1 mm? -50.43 -26.57 5.18 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 52.89 66.91 1.09 Allowed 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.617 0.573 . . . . 0.0 110.153 178.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 84' ' ' ILE . . . . . 0.53 HG23 HG21 ' D' ' 56' ' ' ILE . 50.3 mm -73.66 99.94 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.601 -175.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 85' ' ' LYS . . . . . 0.54 ' C ' ' HE3' ' D' ' 85' ' ' LYS . 0.0 OUTLIER -142.39 -171.57 3.43 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 179.7 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 86' ' ' GLY . . . . . 0.694 ' HA2' HD11 ' D' ' 89' ' ' ILE . . . -61.22 168.12 11.54 Favored Glycine 0 CA--C 1.507 -0.45 0 CA-C-N 115.316 -0.856 . . . . 0.0 114.543 -174.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 87' ' ' PRO . . . . . 0.671 ' O ' HG13 ' D' ' 58' ' ' VAL . 45.2 Cg_endo -91.38 178.4 14.33 Favored 'Cis proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.868 -1.722 . . . . 0.0 114.171 0.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 88' ' ' TYR . . . . . 0.806 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 1.4 m-85 36.67 91.39 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 O-C-N 124.483 1.115 . . . . 0.0 112.435 178.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.694 HD11 ' HA2' ' D' ' 86' ' ' GLY . 3.5 mp -111.09 121.88 64.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.507 0.67 . . . . 0.0 111.03 -176.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.638 ' HB2' ' HB2' ' D' ' 57' ' ' PHE . 54.3 mt-10 -124.15 88.99 3.0 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.916 177.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 91' ' ' ILE . . . . . 1.065 HG22 ' HZ3' ' D' ' 54' ' ' TRP . 4.1 mt -100.06 111.05 28.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 92' ' ' LYS . . . . . 0.726 ' HE2' ' CE1' ' D' ' 57' ' ' PHE . 0.0 OUTLIER -162.57 172.47 15.37 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.651 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 17.2 pt20 -81.33 158.45 24.72 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.807 173.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 7.6 pt . . . . . 0 C--N 1.305 -1.364 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.631 -172.394 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 53.3 p30 . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 120.906 0.384 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' D' D ' 2' ' ' ASN . . . . . 0.463 ' HB3' ' HD2' ' D' ' 4' ' ' LYS . 4.5 m120 -107.9 128.76 54.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.953 -179.424 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -87.55 9.26 21.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.474 179.137 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' D' D ' 4' ' ' LYS . . . . . 0.715 ' H ' ' HD2' ' D' ' 4' ' ' LYS . 0.0 OUTLIER -108.78 15.6 23.46 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 172.485 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' D' D ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.23 133.94 55.1 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.89 -179.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . 0.463 HD22 ' N ' ' D' ' 6' ' ' LEU . 2.5 mm? -83.46 -0.13 48.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.306 -177.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . 0.67 ' HA ' ' HB2' ' D' ' 10' ' ' MET . 94.5 mt-10 -75.73 -0.83 22.23 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -176.53 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' D' ' 12' ' ' SER . 10.4 pt-20 -53.57 -51.2 63.73 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -172.34 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . 0.414 ' H ' ' CD ' ' D' ' 9' ' ' GLN . 3.1 pm0 -97.19 13.96 27.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.886 0.374 . . . . 0.0 110.667 174.17 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 10' ' ' MET . . . . . 0.67 ' HB2' ' HA ' ' D' ' 7' ' ' GLU . 24.3 mmt -106.03 -72.35 0.72 Allowed 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.264 -174.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -103.54 -45.08 4.94 Favored 'General case' 0 CA--C 1.495 -1.15 0 CA-C-O 120.94 0.4 . . . . 0.0 110.742 174.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' D' D ' 12' ' ' SER . . . . . 0.647 ' O ' ' HB ' ' D' ' 16' ' ' VAL . 41.3 t -35.29 -71.71 0.06 Allowed 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 113.722 -1.581 . . . . 0.0 112.872 -168.266 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.567 ' O ' HG12 ' D' ' 16' ' ' VAL . 48.4 mt -93.18 -9.45 9.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.649 -177.558 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 14' ' ' ASN . . . . . 0.598 ' HB2' ' O ' ' D' ' 10' ' ' MET . 5.2 m120 -93.87 -57.07 2.66 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.604 -176.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 15' ' ' SER . . . . . 0.688 ' HA ' ' OD2' ' D' ' 18' ' ' ASP . 97.5 p -69.65 -16.16 63.32 Favored 'General case' 0 C--O 1.218 -0.59 0 C-N-CA 120.156 -0.618 . . . . 0.0 110.199 175.23 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 16' ' ' VAL . . . . . 0.647 ' HB ' ' O ' ' D' ' 12' ' ' SER . 1.5 p -56.08 -23.9 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 121.974 0.892 . . . . 0.0 109.138 174.336 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 17' ' ' ASN . . . . . 0.63 ' HB3' ' ND2' ' D' ' 21' ' ' ASN . 5.4 m120 -84.71 -32.38 23.57 Favored 'General case' 0 C--O 1.206 -1.232 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.204 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 18' ' ' ASP . . . . . 0.688 ' OD2' ' HA ' ' D' ' 15' ' ' SER . 63.0 m-20 -61.61 -14.91 34.66 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 177.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.862 ' N ' ' HE2' ' D' ' 19' ' ' LYS . 0.3 OUTLIER -86.4 -48.54 8.36 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 174.334 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' D' D ' 20' ' ' LEU . . . . . 0.98 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 71.9 mt -64.92 -40.79 95.6 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 112.299 -2.228 . . . . 0.0 110.497 -176.122 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 21' ' ' ASN . . . . . 0.734 ' OD1' ' HB2' ' D' ' 26' ' ' LYS . 75.1 m-20 -85.33 97.74 10.14 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.434 -179.598 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 22' ' ' LYS . . . . . 0.607 ' NZ ' ' HB3' ' D' ' 22' ' ' LYS . 7.5 mtpm? -123.03 -41.67 2.32 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 118.767 -1.173 . . . . 0.0 114.125 -178.018 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 173.38 -82.52 0.08 OUTLIER Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 119.901 -1.143 . . . . 0.0 112.527 -177.473 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . 0.866 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 27.2 tptp -48.18 -60.94 2.26 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.675 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -134.73 160.14 24.15 Favored Glycine 0 N--CA 1.433 -1.542 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.451 174.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' D' D ' 26' ' ' LYS . . . . . 0.734 ' HB2' ' OD1' ' D' ' 21' ' ' ASN . 0.1 OUTLIER -149.63 159.74 44.08 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.57 -0.815 . . . . 0.0 111.099 -168.611 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' D' D ' 27' ' ' LEU . . . . . 0.98 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 44.9 tp -143.73 139.15 29.3 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.96 0.409 . . . . 0.0 111.942 -178.621 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 28' ' ' SER . . . . . 0.599 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 8.7 t -127.7 153.77 46.11 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 174.834 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 29' ' ' LEU . . . . . . . . . . . . . 18.4 mt -133.96 140.52 46.8 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.886 178.717 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 49.8 m -152.44 -176.28 5.64 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.731 178.065 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 66.8 mtm -136.24 166.39 23.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.056 0.455 . . . . 0.0 110.546 -179.849 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' D' D ' 32' ' ' ASN . . . . . 0.556 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 24.4 t-20 -146.06 88.38 1.81 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.39 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.15 -105.32 1.81 Allowed Glycine 0 N--CA 1.454 -0.144 0 C-N-CA 119.998 -1.096 . . . . 0.0 110.749 -170.344 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -114.16 29.89 7.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.177 0.513 . . . . 0.0 109.952 171.462 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' D' D ' 35' ' ' GLN . . . . . 0.556 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 65.0 tp60 -102.31 155.75 18.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.241 -178.146 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.636 HD11 HG22 ' D' ' 79' ' ' ILE . 2.5 tm? -113.43 129.16 56.61 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 175.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 37' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -136.14 99.01 4.01 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.967 -169.393 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' D' D ' 38' ' ' ALA . . . . . 0.681 ' HB1' HD11 ' D' ' 27' ' ' LEU . . . -98.21 150.76 21.16 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.017 176.115 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 39' ' ' THR . . . . . 0.599 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 74.4 p -133.67 123.01 24.26 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 174.394 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' D' ' 26' ' ' LYS . 18.7 m -115.7 128.89 56.23 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.233 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 41' ' ' SER . . . . . 0.62 ' HB2' ' CD ' ' D' ' 26' ' ' LYS . 31.9 m -104.87 162.05 13.66 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.42 -173.066 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 42' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' D' ' 41' ' ' SER . 74.7 m-80 77.35 9.9 2.51 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 114.197 -1.365 . . . . 0.0 110.52 -171.68 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 49.04 60.5 3.7 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 114.799 -1.092 . . . . 0.0 113.753 169.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' D' D ' 44' ' ' GLY . . . . . 0.455 ' C ' ' HD2' ' D' ' 45' ' ' TYR . . . 106.72 37.11 2.45 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 119.216 -1.469 . . . . 0.0 114.043 171.193 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 45' ' ' TYR . . . . . 0.866 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 3.9 m-30 -114.59 153.33 30.31 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 117.376 0.588 . . . . 0.0 110.037 176.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -97.82 -155.77 29.9 Favored Glycine 0 C--O 1.217 -0.909 0 CA-C-O 119.459 -0.634 . . . . 0.0 111.598 178.014 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 47' ' ' ILE . . . . . 0.963 HG13 ' HB3' ' D' ' 68' ' ' GLU . 0.4 OUTLIER -54.62 -56.53 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-O 122.118 0.961 . . . . 0.0 108.659 -179.994 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' D' ' 47' ' ' ILE . 26.3 t 162.33 -60.3 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 111.922 -2.399 . . . . 0.0 106.909 -174.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -169.89 76.27 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.546 172.683 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . 0.661 ' O ' ' HG2' ' D' ' 69' ' ' LYS . 49.0 mt-10 -149.27 -177.94 6.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.881 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 51' ' ' ASP . . . . . 0.592 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 1.0 OUTLIER -129.07 130.15 46.17 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.457 0.646 . . . . 0.0 111.316 172.553 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' D' D ' 52' ' ' LYS . . . . . 0.592 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 0.4 OUTLIER -141.77 100.92 3.85 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.861 -179.833 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' D' D ' 53' ' ' ASN . . . . . 0.618 ' HA ' ' OD1' ' D' ' 67' ' ' ASN . 2.7 m120 -78.16 125.7 29.74 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 176.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 54' ' ' TRP . . . . . 0.572 ' HB2' ' O ' ' D' ' 66' ' ' PHE . 0.1 OUTLIER -118.21 155.86 29.78 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.385 -171.948 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -148.13 161.79 28.66 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 119.833 -1.175 . . . . 0.0 114.297 175.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' D' D ' 56' ' ' ILE . . . . . 0.506 HG23 HG12 ' D' ' 91' ' ' ILE . 71.9 mt -135.09 111.25 13.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 57' ' ' PHE . . . . . 0.65 ' HZ ' HG21 ' D' ' 94' ' ' ILE . 9.2 m-85 -111.83 114.16 26.95 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.654 -166.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.938 HG22 HG12 ' D' ' 89' ' ' ILE . 59.6 t -96.28 105.92 17.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.903 174.661 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 7.0 m120 56.42 51.74 10.99 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.155 -176.374 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.04 48.08 68.4 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.823 178.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' D' D ' 61' ' ' GLU . . . . . 0.619 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 86.9 tt0 -150.29 116.87 5.79 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 177.631 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . 0.447 ' HB2' ' CE1' ' D' ' 57' ' ' PHE . 27.3 ttpp -75.86 99.91 4.63 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.971 0.415 . . . . 0.0 110.282 179.086 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 30.3 m -84.96 -27.2 6.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.051 -175.205 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' D' D ' 64' ' ' TYR . . . . . 0.449 ' HB3' HD12 ' D' ' 56' ' ' ILE . 14.4 t80 -136.75 131.46 33.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.736 0.303 . . . . 0.0 110.373 178.367 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 19.4 m -117.98 104.6 11.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.94 177.816 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' D' D ' 66' ' ' PHE . . . . . 0.572 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 12.2 p90 -114.64 164.68 13.69 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 175.515 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 67' ' ' ASN . . . . . 0.618 ' OD1' ' HA ' ' D' ' 53' ' ' ASN . 74.8 m-20 -130.88 152.0 50.68 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.289 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 68' ' ' GLU . . . . . 0.963 ' HB3' HG13 ' D' ' 47' ' ' ILE . 84.0 mt-10 -68.78 -18.94 64.28 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.689 -0.804 . . . . 0.0 109.774 174.257 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.661 ' HG2' ' O ' ' D' ' 50' ' ' GLU . 45.4 mtmt -61.38 -42.46 98.75 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 172.61 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 70' ' ' SER . . . . . 0.403 ' HB3' ' O ' ' D' ' 67' ' ' ASN . 27.7 t -67.87 125.41 26.19 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 113.669 -1.605 . . . . 0.0 107.405 170.503 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 76.6 p -58.19 116.33 3.5 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -176.539 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' D' D ' 72' ' ' VAL . . . . . 0.745 ' HA ' HD12 ' D' ' 75' ' ' ILE . 0.0 OUTLIER -51.41 -20.56 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-O 120.674 0.273 . . . . 0.0 111.472 -173.654 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' D' D ' 73' ' ' GLY . . . . . 0.533 ' HA2' ' HB2' ' D' ' 40' ' ' SER . . . -63.39 -59.91 8.22 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.709 -0.678 . . . . 0.0 113.081 172.422 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 74' ' ' ASN . . . . . 0.828 ' HA ' HD22 ' D' ' 77' ' ' ASN . 4.3 m120 -66.61 -18.75 65.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.444 0.164 . . . . 0.0 110.902 178.62 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 75' ' ' ILE . . . . . 0.745 HD12 ' HA ' ' D' ' 72' ' ' VAL . 77.7 mt -71.6 -42.39 71.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.021 173.752 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 76' ' ' SER . . . . . 0.444 ' HA ' HG13 ' D' ' 79' ' ' ILE . 47.1 t -74.1 -22.68 59.39 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.008 -177.439 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 77' ' ' ASN . . . . . 0.828 HD22 ' HA ' ' D' ' 74' ' ' ASN . 78.0 m-20 -63.93 -27.29 69.05 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 168.32 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 78' ' ' ASP . . . . . 1.035 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 51.6 m-20 -83.6 -36.14 24.13 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.943 173.187 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . 0.687 HG13 ' O ' ' D' ' 75' ' ' ILE . 22.2 mt -67.05 -16.04 20.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.266 -175.6 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -69.85 -48.83 57.37 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.108 174.127 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . 1.035 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -69.39 -47.82 63.03 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.645 178.427 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' D' D ' 82' ' ' LEU . . . . . 0.618 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.5 mm? -54.26 -23.97 16.98 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 178.195 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 83' ' ' ASN . . . . . 0.474 ' O ' ' HE2' ' D' ' 85' ' ' LYS . 0.7 OUTLIER 39.25 69.29 0.29 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.916 0.886 . . . . 0.0 111.159 176.008 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' D' D ' 84' ' ' ILE . . . . . 0.597 HG23 HD13 ' D' ' 89' ' ' ILE . 47.8 mm -75.17 99.28 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.166 -172.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 85' ' ' LYS . . . . . 0.542 ' O ' ' HE3' ' D' ' 85' ' ' LYS . 0.0 OUTLIER -158.19 91.44 1.1 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 173.972 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' D' D ' 86' ' ' GLY . . . . . 0.549 ' H ' HD12 ' D' ' 89' ' ' ILE . . . 69.63 154.51 0.97 Allowed Glycine 0 C--N 1.329 0.175 0 CA-C-N 115.127 -0.942 . . . . 0.0 114.106 173.163 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 87' ' ' PRO . . . . . 0.619 ' O ' HG13 ' D' ' 58' ' ' VAL . 68.8 Cg_endo -87.33 178.96 19.74 Favored 'Cis proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.681 -1.8 . . . . 0.0 112.09 -0.301 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 88' ' ' TYR . . . . . 0.648 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 2.3 m-85 4.67 91.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 125.253 1.421 . . . . 0.0 113.942 -175.45 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.938 HG12 HG22 ' D' ' 58' ' ' VAL . 66.2 mt -111.38 129.19 67.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.999 -179.803 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.542 ' O ' ' HD2' ' D' ' 57' ' ' PHE . 49.2 mm-40 -112.33 100.36 8.73 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.879 175.266 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 91' ' ' ILE . . . . . 0.582 HG13 HG22 ' D' ' 89' ' ' ILE . 35.0 mt -94.38 101.19 12.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.05 -178.744 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 92' ' ' LYS . . . . . 0.627 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -160.5 163.64 32.73 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.107 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.609 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 19.7 pt20 -79.53 167.4 20.81 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 119.764 -0.774 . . . . 0.0 110.807 176.818 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . 0.65 HG21 ' HZ ' ' D' ' 57' ' ' PHE . 10.9 pt . . . . . 0 C--N 1.313 -1.006 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.572 -170.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 58.6 t0 . . . . . 0 N--CA 1.483 1.178 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' D' D ' 2' ' ' ASN . . . . . 0.711 ' HB3' ' HB2' ' D' ' 5' ' ' ALA . 0.8 OUTLIER -75.02 120.49 20.63 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.545 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -64.5 -25.12 67.85 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -175.472 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -111.18 22.36 15.31 Favored 'General case' 0 CA--C 1.518 -0.27 0 O-C-N 122.189 -0.32 . . . . 0.0 111.32 179.123 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' D' D ' 5' ' ' ALA . . . . . 0.711 ' HB2' ' HB3' ' D' ' 2' ' ' ASN . . . -59.01 -34.1 71.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.914 0.387 . . . . 0.0 111.545 -177.145 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 88.4 mt -104.76 -22.72 13.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.555 -178.527 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -90.16 -0.72 57.75 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -177.35 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.559 ' O ' ' HB3' ' D' ' 12' ' ' SER . 10.4 pt-20 -58.3 -50.51 73.34 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -174.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . 0.442 ' NE2' ' HG2' ' D' ' 10' ' ' MET . 1.9 pp0? -93.06 15.03 16.06 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.841 0.353 . . . . 0.0 111.526 177.196 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 10' ' ' MET . . . . . 0.442 ' HG2' ' NE2' ' D' ' 9' ' ' GLN . 95.2 mmm -103.16 -77.12 0.57 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.097 179.698 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -104.6 -38.05 6.89 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.159 173.601 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' D' D ' 12' ' ' SER . . . . . 0.696 ' O ' ' HB ' ' D' ' 16' ' ' VAL . 42.8 t -40.06 -68.29 0.18 Allowed 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.329 -1.305 . . . . 0.0 112.741 -166.618 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.645 ' O ' HG12 ' D' ' 16' ' ' VAL . 51.6 mt -90.84 -8.62 10.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.544 -175.547 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -85.25 -59.19 2.4 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.291 176.137 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' D' D ' 15' ' ' SER . . . . . 0.476 ' O ' ' HE2' ' D' ' 19' ' ' LYS . 88.7 p -68.22 -13.88 62.57 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 175.603 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 16' ' ' VAL . . . . . 0.696 ' HB ' ' O ' ' D' ' 12' ' ' SER . 0.9 OUTLIER -62.18 -25.68 38.18 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.92 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' D' D ' 17' ' ' ASN . . . . . 0.469 ' ND2' ' H ' ' D' ' 29' ' ' LEU . 2.2 m120 -73.56 -42.24 61.9 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 114.383 -1.281 . . . . 0.0 108.592 177.122 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 18' ' ' ASP . . . . . 0.401 ' OD1' ' HA ' ' D' ' 15' ' ' SER . 1.6 m-20 -59.25 -14.85 12.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.864 -178.387 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.498 ' CE ' ' HA ' ' D' ' 16' ' ' VAL . 34.9 mttm -91.1 -45.77 8.5 Favored 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 123.198 1.475 . . . . 0.0 108.803 -179.743 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 20' ' ' LEU . . . . . 0.841 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 59.1 mt -66.53 -36.53 82.92 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 111.986 -2.37 . . . . 0.0 109.795 -179.87 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 21' ' ' ASN . . . . . 0.657 ' HA ' ' HB2' ' D' ' 26' ' ' LYS . 3.0 m120 -74.91 94.4 2.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.399 178.837 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 22' ' ' LYS . . . . . 0.467 ' HD2' HD12 ' D' ' 47' ' ' ILE . 43.3 mttp -122.46 -43.29 2.3 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -176.681 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 171.68 -87.98 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 119.125 -1.512 . . . . 0.0 113.63 -177.13 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . 0.637 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 0.0 OUTLIER -48.02 -53.42 16.35 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.943 0.877 . . . . 0.0 109.172 179.166 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' D' D ' 25' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -149.32 156.11 26.64 Favored Glycine 0 N--CA 1.43 -1.761 0 CA-C-N 113.928 -1.487 . . . . 0.0 110.918 177.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 26' ' ' LYS . . . . . 0.717 ' HD2' ' HB3' ' D' ' 41' ' ' SER . 8.7 ptpt -151.15 160.4 43.88 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 114.331 -0.934 . . . . 0.0 110.52 -167.128 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 27' ' ' LEU . . . . . 0.841 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 49.7 tp -134.61 147.35 50.19 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.402 0.62 . . . . 0.0 111.937 -176.645 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 28' ' ' SER . . . . . 0.582 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 33.5 t -132.5 128.65 37.8 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.437 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 29' ' ' LEU . . . . . 0.561 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 9.3 mt -126.94 144.9 50.87 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.796 177.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 73.1 p -160.32 176.89 11.18 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.977 177.7 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' D' D ' 31' ' ' MET . . . . . 0.515 ' HA ' ' O ' ' D' ' 35' ' ' GLN . 0.0 OUTLIER -129.65 116.89 19.5 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.377 0.608 . . . . 0.0 110.417 177.076 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -90.36 89.36 7.58 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.395 -0.821 . . . . 0.0 108.97 179.329 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.68 -103.31 2.07 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.275 -0.964 . . . . 0.0 111.064 -171.083 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -120.4 31.14 6.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.381 0.61 . . . . 0.0 109.883 174.674 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' D' D ' 35' ' ' GLN . . . . . 0.515 ' O ' ' HA ' ' D' ' 31' ' ' MET . 8.1 tt0 -108.36 158.69 17.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.308 -174.674 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.673 ' HB3' HD22 ' D' ' 83' ' ' ASN . 2.5 tm? -112.77 126.96 55.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.668 0.271 . . . . 0.0 110.346 178.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 37' ' ' LYS . . . . . 0.567 ' HB3' ' NZ ' ' D' ' 37' ' ' LYS . 1.6 mmmp? -132.58 115.7 15.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.973 -168.113 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 38' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -119.91 142.54 48.62 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.925 174.617 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 39' ' ' THR . . . . . 0.582 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 15.1 p -145.76 132.46 19.96 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.057 177.73 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . 0.809 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 78.8 p -112.28 145.38 40.08 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.326 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 41' ' ' SER . . . . . 0.717 ' HB3' ' HD2' ' D' ' 26' ' ' LYS . 44.3 t -104.39 149.8 25.08 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 118.949 -1.101 . . . . 0.0 109.821 177.176 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 42' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' D' ' 41' ' ' SER . 75.2 m-80 80.31 1.42 1.96 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.891 -171.731 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 44.58 57.76 4.27 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 170.927 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.91 35.77 0.71 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 119.419 -1.372 . . . . 0.0 113.857 173.313 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' D' D ' 45' ' ' TYR . . . . . 0.637 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 18.2 m-85 -126.31 148.37 49.55 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 172.1 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . 0.473 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -88.2 -168.94 44.74 Favored Glycine 0 CA--C 1.497 -1.062 0 N-CA-C 110.579 -1.009 . . . . 0.0 110.579 175.782 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 47' ' ' ILE . . . . . 0.818 HG12 ' HB3' ' D' ' 68' ' ' GLU . 50.4 mm -45.41 -56.71 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 CA-C-O 121.53 0.681 . . . . 0.0 110.001 178.714 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.414 ' HA ' ' CB ' ' D' ' 24' ' ' LYS . 40.8 t 173.41 -103.18 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 112.552 -2.113 . . . . 0.0 109.258 173.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -119.54 74.55 1.01 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.223 0.535 . . . . 0.0 111.705 175.129 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . 0.499 ' HA ' ' OE1' ' D' ' 50' ' ' GLU . 3.7 mm-40 -155.74 -170.35 3.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.946 173.12 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 51' ' ' ASP . . . . . 0.615 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 1.8 m-20 -133.45 138.98 46.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.928 175.458 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 52' ' ' LYS . . . . . 0.615 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 0.1 OUTLIER -144.24 144.12 31.36 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 177.926 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -114.6 142.77 46.01 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 176.672 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' D' D ' 54' ' ' TRP . . . . . 0.71 ' HZ3' HG23 ' D' ' 91' ' ' ILE . 0.7 OUTLIER -126.71 153.84 44.92 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -173.919 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -142.31 159.76 27.16 Favored Glycine 0 N--CA 1.44 -1.091 0 CA-C-N 114.832 -1.076 . . . . 0.0 113.266 174.074 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' D' D ' 56' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' D' ' 90' ' ' GLU . 72.3 mt -137.85 105.78 3.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 179.461 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 57' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' D' ' 61' ' ' GLU . 8.9 m-85 -106.47 109.87 21.91 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.676 -0.809 . . . . 0.0 111.353 -170.032 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 94.7 t -88.69 110.6 21.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.957 173.837 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 59' ' ' ASN . . . . . 0.417 ' OD1' ' HG2' ' D' ' 87' ' ' PRO . 6.0 m120 53.39 53.83 11.09 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.191 -176.926 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.9 48.71 78.62 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.941 178.594 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' D' D ' 61' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 89.1 tt0 -156.73 116.43 3.5 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.686 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . 0.488 ' HB2' ' CE2' ' D' ' 57' ' ' PHE . 5.5 ttpm? -73.67 101.46 3.65 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -177.864 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 32.5 m -85.74 -25.53 6.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.998 -175.508 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' D' D ' 64' ' ' TYR . . . . . 0.405 ' HB3' HD12 ' D' ' 56' ' ' ILE . 15.1 t80 -140.28 137.94 34.59 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.222 178.822 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.487 ' OG1' ' HE2' ' D' ' 62' ' ' LYS . 38.5 m -120.13 119.03 32.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.102 174.531 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 66' ' ' PHE . . . . . 0.594 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 9.3 p90 -126.75 158.91 35.28 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 170.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 67' ' ' ASN . . . . . 0.674 ' O ' HD11 ' D' ' 75' ' ' ILE . 72.4 m-80 -128.51 142.24 51.14 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.505 -173.21 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 68' ' ' GLU . . . . . 0.818 ' HB3' HG12 ' D' ' 47' ' ' ILE . 5.0 mm-40 -67.14 -10.32 48.97 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 174.586 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.573 ' HE3' ' OD2' ' D' ' 51' ' ' ASP . 48.2 mtpt -63.19 -47.44 82.57 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 114.196 -1.365 . . . . 0.0 107.597 169.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t -67.3 138.04 56.54 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 113.505 -1.68 . . . . 0.0 107.961 170.249 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' D' D ' 71' ' ' THR . . . . . 0.448 ' O ' HG13 ' D' ' 75' ' ' ILE . 79.4 p -62.51 122.33 15.5 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.294 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 72' ' ' VAL . . . . . 0.687 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.0 OUTLIER -56.57 -12.93 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 120.966 0.412 . . . . 0.0 111.243 -176.228 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' D' D ' 73' ' ' GLY . . . . . 0.809 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -69.38 -59.95 5.42 Favored Glycine 0 N--CA 1.435 -1.375 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.743 170.169 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 74' ' ' ASN . . . . . 0.721 ' HA ' HD22 ' D' ' 77' ' ' ASN . 46.7 t30 -62.72 -27.34 69.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.965 0.412 . . . . 0.0 109.97 177.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 75' ' ' ILE . . . . . 0.674 HD11 ' O ' ' D' ' 67' ' ' ASN . 77.7 mt -68.15 -45.28 83.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.899 176.328 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 76' ' ' SER . . . . . . . . . . . . . 29.1 t -75.78 -19.43 58.99 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.216 -176.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' D' D ' 77' ' ' ASN . . . . . 0.721 HD22 ' HA ' ' D' ' 74' ' ' ASN . 73.4 m-20 -64.48 -31.5 72.74 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 166.198 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 78' ' ' ASP . . . . . 1.091 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 58.4 m-20 -78.52 -39.89 36.75 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.567 175.304 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . 0.644 HG22 HD11 ' D' ' 36' ' ' LEU . 22.2 mt -67.29 -17.15 22.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.349 -174.401 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -71.29 -42.92 68.1 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.375 175.65 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . 1.091 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -73.26 -51.9 15.96 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.161 176.914 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' D' D ' 82' ' ' LEU . . . . . 0.611 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.7 mm? -48.05 -32.09 6.26 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 178.226 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 83' ' ' ASN . . . . . 0.673 HD22 ' HB3' ' D' ' 36' ' ' LEU . 0.7 OUTLIER 34.41 65.24 0.34 Allowed 'General case' 0 N--CA 1.477 0.914 0 O-C-N 124.18 0.925 . . . . 0.0 111.602 175.756 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' D' D ' 84' ' ' ILE . . . . . 0.474 HG22 HD13 ' D' ' 89' ' ' ILE . 44.1 mt -92.84 99.89 10.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.003 0.43 . . . . 0.0 111.974 -172.839 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.96 94.27 3.68 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.616 0.722 . . . . 0.0 112.065 177.726 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 86' ' ' GLY . . . . . 0.655 ' H ' HD11 ' D' ' 89' ' ' ILE . . . 71.46 155.99 2.23 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.356 177.795 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 87' ' ' PRO . . . . . 0.493 ' O ' HG13 ' D' ' 58' ' ' VAL . 60.7 Cg_endo -89.31 179.99 15.09 Favored 'Cis proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.141 -1.608 . . . . 0.0 113.045 0.112 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 88' ' ' TYR . . . . . 0.578 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 10.2 m-85 8.27 93.8 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 125.48 1.512 . . . . 0.0 113.875 -176.366 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.655 HD11 ' H ' ' D' ' 86' ' ' GLY . 72.4 mt -108.71 137.74 39.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -177.885 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.443 ' HB2' ' HD1' ' D' ' 57' ' ' PHE . 55.2 mm-40 -113.48 93.04 4.21 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.084 170.161 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 91' ' ' ILE . . . . . 0.71 HG23 ' HZ3' ' D' ' 54' ' ' TRP . 23.7 mt -93.68 100.7 11.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.563 178.155 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 92' ' ' LYS . . . . . 0.841 ' HE3' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -162.82 169.45 19.83 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.177 -178.223 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.707 ' O ' ' HD3' ' D' ' 92' ' ' LYS . 25.7 pt20 -87.28 151.76 22.86 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.634 172.177 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . 0.841 HG22 ' HE3' ' D' ' 92' ' ' LYS . 9.1 pt . . . . . 0 C--N 1.307 -1.249 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.933 -170.539 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 2.2 p30 . . . . . 0 N--CA 1.485 1.299 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' D' D ' 2' ' ' ASN . . . . . 0.472 ' ND2' ' HB2' ' D' ' 7' ' ' GLU . 25.3 t-20 -85.61 88.02 7.48 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -179.391 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -102.05 -11.65 18.73 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -177.288 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' D' D ' 4' ' ' LYS . . . . . 0.425 ' HB3' ' NZ ' ' D' ' 4' ' ' LYS . 3.1 mmmp? -98.06 -10.97 23.46 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 121.104 -0.238 . . . . 0.0 110.702 -177.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 5' ' ' ALA . . . . . . . . . . . . . . . 59.8 34.92 21.98 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.972 179.366 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . 0.476 ' O ' HD23 ' D' ' 6' ' ' LEU . 6.2 tt -110.63 -42.05 4.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.076 0.465 . . . . 0.0 109.76 179.212 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . 0.472 ' HB2' ' ND2' ' D' ' 2' ' ' ASN . 52.8 mp0 -67.98 -7.73 31.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.086 -176.479 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.848 ' HG3' ' NE2' ' D' ' 9' ' ' GLN . 14.0 pt-20 -79.69 -18.14 52.03 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.9 -179.006 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . 0.848 ' NE2' ' HG3' ' D' ' 8' ' ' GLU . 14.6 mp0 -90.19 6.96 40.48 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.814 170.35 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 10' ' ' MET . . . . . . . . . . . . . 26.0 mmt -107.71 -76.06 0.62 Allowed 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -175.752 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -102.1 -37.47 8.14 Favored 'General case' 0 CA--C 1.495 -1.145 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.252 178.397 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' D' D ' 12' ' ' SER . . . . . 0.81 ' CB ' ' HA ' ' D' ' 8' ' ' GLU . 36.0 t -43.54 -59.28 2.23 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.596 -1.184 . . . . 0.0 112.504 -169.124 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.434 ' C ' HG12 ' D' ' 16' ' ' VAL . 59.1 mt -90.12 -7.5 10.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 114.506 -1.224 . . . . 0.0 110.907 -174.173 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -94.41 -60.84 1.63 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.843 175.754 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' D' D ' 15' ' ' SER . . . . . . . . . . . . . 92.8 p -65.87 -18.51 65.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.822 -0.172 . . . . 0.0 111.152 -179.088 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' D' D ' 16' ' ' VAL . . . . . 0.792 ' HA ' ' HE2' ' D' ' 19' ' ' LYS . 14.5 p -54.77 -36.27 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 175.02 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 17' ' ' ASN . . . . . 0.591 ' OD1' ' HA ' ' D' ' 28' ' ' SER . 78.8 m-20 -76.23 -27.7 56.9 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.675 -178.682 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.92 -16.14 64.13 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 179.509 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.792 ' HE2' ' HA ' ' D' ' 16' ' ' VAL . 0.0 OUTLIER -90.92 -28.99 17.72 Favored 'General case' 0 CA--C 1.494 -1.199 0 CA-C-O 121.68 0.752 . . . . 0.0 109.046 173.486 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' D' D ' 20' ' ' LEU . . . . . 0.902 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 79.5 mt -82.98 -40.09 20.48 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 113.98 -1.464 . . . . 0.0 109.715 -173.14 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 21' ' ' ASN . . . . . 0.643 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 53.0 m-20 -78.3 92.25 4.5 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.032 -1.44 . . . . 0.0 110.694 178.69 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 22' ' ' LYS . . . . . 0.549 ' HD3' HG23 ' D' ' 47' ' ' ILE . 7.3 mtpm? -123.96 -43.58 2.1 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -172.262 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 172.1 -71.63 0.11 Allowed Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 119.195 -1.478 . . . . 0.0 113.805 -175.209 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . 0.828 ' HB3' ' O ' ' D' ' 46' ' ' GLY . 17.4 tptp -56.99 -66.02 0.52 Allowed 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 179.449 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -137.19 172.32 22.73 Favored Glycine 0 N--CA 1.426 -1.975 0 CA-C-N 113.656 -1.611 . . . . 0.0 110.256 171.578 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' D' D ' 26' ' ' LYS . . . . . 0.643 ' CB ' ' HA ' ' D' ' 21' ' ' ASN . 10.5 ptpt -148.1 161.64 41.01 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.502 -0.349 . . . . 0.0 111.629 -170.294 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 27' ' ' LEU . . . . . 0.902 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 37.4 tp -134.84 145.48 48.36 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.152 0.501 . . . . 0.0 112.007 179.486 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 28' ' ' SER . . . . . 0.647 ' H ' HD12 ' D' ' 27' ' ' LEU . 29.5 t -134.04 139.23 45.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.582 -178.503 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 29' ' ' LEU . . . . . . . . . . . . . 15.2 mt -130.94 130.4 43.4 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.059 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 49.3 m -134.35 174.2 10.79 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 178.789 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' D' D ' 31' ' ' MET . . . . . 0.769 ' HA ' ' O ' ' D' ' 35' ' ' GLN . 25.8 ptt? -137.72 121.94 18.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.815 0.817 . . . . 0.0 111.681 176.681 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -92.2 88.32 6.44 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.025 173.531 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.69 -102.35 1.75 Allowed Glycine 0 N--CA 1.454 -0.141 0 C-N-CA 120.155 -1.021 . . . . 0.0 110.879 -170.431 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -120.21 31.25 6.58 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.179 0.514 . . . . 0.0 109.845 174.02 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' D' D ' 35' ' ' GLN . . . . . 0.769 ' O ' ' HA ' ' D' ' 31' ' ' MET . 8.1 tt0 -111.43 118.08 34.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.598 -175.519 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.547 HD11 HG22 ' D' ' 79' ' ' ILE . 2.8 tm? -79.04 135.68 36.95 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.902 0.382 . . . . 0.0 110.655 178.62 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 37' ' ' LYS . . . . . 0.417 ' N ' HD13 ' D' ' 36' ' ' LEU . 13.3 mmmm -135.01 99.65 4.34 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.24 -172.754 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 38' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -97.73 141.42 30.77 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.486 0.66 . . . . 0.0 111.817 -177.701 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 39' ' ' THR . . . . . 0.545 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 11.5 p -143.93 132.36 22.13 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.645 177.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . 0.599 ' HA ' ' O ' ' D' ' 26' ' ' LYS . 36.8 t -106.03 128.05 53.58 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 169.38 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 41' ' ' SER . . . . . 0.642 ' O ' ' HB3' ' D' ' 42' ' ' ASN . 46.8 t -93.09 142.9 26.78 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -177.13 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 42' ' ' ASN . . . . . 0.642 ' HB3' ' O ' ' D' ' 41' ' ' SER . 5.0 t30 80.16 -15.83 0.71 Allowed 'General case' 0 CA--C 1.537 0.477 0 O-C-N 124.116 0.885 . . . . 0.0 110.705 -167.816 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 60.91 62.24 1.49 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 165.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' D' D ' 44' ' ' GLY . . . . . 0.514 ' C ' ' HD2' ' D' ' 45' ' ' TYR . . . 123.74 35.21 0.7 Allowed Glycine 0 CA--C 1.507 -0.42 0 C-N-CA 118.481 -1.818 . . . . 0.0 115.142 167.365 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 45' ' ' TYR . . . . . 0.716 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 3.1 m-30 -122.23 162.67 20.97 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 172.465 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . 0.828 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -100.13 -149.31 23.63 Favored Glycine 0 C--O 1.218 -0.87 0 C-N-CA 121.421 -0.419 . . . . 0.0 113.219 -175.319 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 47' ' ' ILE . . . . . 1.038 HG13 ' HB2' ' D' ' 68' ' ' GLU . 1.3 mp -63.48 -59.57 4.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -176.144 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.421 ' HA ' ' HB2' ' D' ' 24' ' ' LYS . 31.0 m 167.83 -111.96 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 111.448 -2.615 . . . . 0.0 106.477 -178.517 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -110.99 75.99 0.95 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.458 163.424 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . 0.565 ' HB3' ' HE2' ' D' ' 52' ' ' LYS . 51.4 mt-10 -148.1 177.17 9.6 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.115 -179.122 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 51' ' ' ASP . . . . . 0.751 ' HB2' ' HD2' ' D' ' 69' ' ' LYS . 2.7 p30 -143.41 129.47 19.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.338 0.59 . . . . 0.0 111.851 176.625 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 52' ' ' LYS . . . . . 0.708 ' HD3' HG12 ' D' ' 47' ' ' ILE . 4.1 mptp? -138.73 136.05 35.37 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.203 -168.55 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 53' ' ' ASN . . . . . 0.462 HD22 ' C ' ' D' ' 52' ' ' LYS . 2.6 m120 -111.98 132.54 54.71 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 172.319 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 54' ' ' TRP . . . . . 1.101 ' HZ3' HG22 ' D' ' 91' ' ' ILE . 1.4 m95 -119.04 155.27 31.75 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -173.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -142.64 157.9 26.85 Favored Glycine 0 N--CA 1.436 -1.333 0 CA-C-N 114.524 -1.216 . . . . 0.0 113.034 171.536 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' D' D ' 56' ' ' ILE . . . . . 1.061 HG12 HG23 ' D' ' 91' ' ' ILE . 95.1 mt -127.11 104.63 12.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-N 113.081 -1.56 . . . . 0.0 106.96 178.826 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 57' ' ' PHE . . . . . 0.671 ' HD1' ' O ' ' D' ' 90' ' ' GLU . 16.2 m-85 -103.71 106.35 16.83 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.413 -166.123 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.878 HG22 HG12 ' D' ' 89' ' ' ILE . 77.2 t -90.44 111.47 23.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.996 174.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 5.3 m120 53.99 45.88 26.71 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.152 -178.323 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.23 49.06 35.04 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.868 179.152 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' D' D ' 61' ' ' GLU . . . . . 0.578 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 89.0 tt0 -154.23 119.68 5.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.659 0.266 . . . . 0.0 110.548 178.386 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -73.88 107.99 6.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.08 179.407 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 23.5 m -91.77 -30.1 4.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.031 -174.742 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' D' D ' 64' ' ' TYR . . . . . 0.525 ' HB3' HD12 ' D' ' 56' ' ' ILE . 13.4 t80 -140.22 134.76 31.57 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.399 179.677 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' D' ' 54' ' ' TRP . 32.4 m -117.64 105.68 12.29 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.412 178.005 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 66' ' ' PHE . . . . . 0.72 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 10.8 p90 -112.94 153.08 28.57 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 174.517 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -109.86 145.13 37.3 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 176.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' D' D ' 68' ' ' GLU . . . . . 1.038 ' HB2' HG13 ' D' ' 47' ' ' ILE . 35.7 mt-10 -70.66 -17.79 62.85 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 177.746 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.751 ' HD2' ' HB2' ' D' ' 51' ' ' ASP . 5.7 mtpm? -58.84 -43.95 90.86 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.375 171.095 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 18.6 t -72.12 99.95 2.43 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.665 -1.607 . . . . 0.0 107.298 171.296 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 75.9 p -31.53 121.56 0.26 Allowed 'General case' 0 C--N 1.317 -0.833 0 O-C-N 124.731 1.27 . . . . 0.0 111.95 -173.246 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' D' D ' 72' ' ' VAL . . . . . 0.56 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.1 OUTLIER -54.38 -11.71 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -178.816 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' D' D ' 73' ' ' GLY . . . . . 0.448 ' HA3' ' HA2' ' D' ' 44' ' ' GLY . . . -69.52 -67.0 2.06 Favored Glycine 0 N--CA 1.435 -1.374 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.689 172.193 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 74' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -62.71 -21.0 65.45 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.727 0.299 . . . . 0.0 111.131 -177.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' D' D ' 75' ' ' ILE . . . . . 0.456 ' O ' HG12 ' D' ' 79' ' ' ILE . 28.7 mm -80.46 -35.96 15.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.464 176.757 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 76' ' ' SER . . . . . 0.735 ' HB2' HD13 ' D' ' 27' ' ' LEU . 30.2 t -74.37 -21.66 59.56 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.916 177.21 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 77' ' ' ASN . . . . . 0.426 ' O ' ' HD2' ' D' ' 81' ' ' LYS . 4.8 m120 -64.09 -31.33 72.48 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 166.08 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 78' ' ' ASP . . . . . 1.006 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 79.5 m-20 -78.0 -30.52 50.12 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.177 174.252 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . 0.565 HG12 ' HA ' ' D' ' 76' ' ' SER . 28.7 mm -69.72 -19.98 23.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.006 -0.678 . . . . 0.0 109.642 179.732 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -64.66 -41.44 96.1 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.854 174.182 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . 1.006 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -81.66 -56.02 4.27 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 177.832 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' D' D ' 82' ' ' LEU . . . . . 0.563 HD23 ' O ' ' D' ' 78' ' ' ASP . 4.0 mm? -48.0 -30.63 4.51 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 83' ' ' ASN . . . . . 0.564 ' O ' ' HE2' ' D' ' 85' ' ' LYS . 0.7 OUTLIER 51.34 81.95 0.07 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.227 0.611 . . . . 0.0 111.21 173.36 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' D' D ' 84' ' ' ILE . . . . . 0.509 ' HB ' ' HG ' ' D' ' 36' ' ' LEU . 48.3 mt -77.08 99.8 2.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -176.367 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 85' ' ' LYS . . . . . 0.564 ' HE2' ' O ' ' D' ' 83' ' ' ASN . 0.0 OUTLIER -160.03 91.24 0.94 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 171.973 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.2 155.88 0.51 Allowed Glycine 0 N--CA 1.454 -0.133 0 CA-C-N 114.85 -1.068 . . . . 0.0 114.915 169.506 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' D' D ' 87' ' ' PRO . . . . . 0.566 ' O ' HG13 ' D' ' 58' ' ' VAL . 67.2 Cg_endo -86.8 177.61 23.5 Favored 'Cis proline' 0 CA--C 1.532 0.403 0 C-N-CA 122.467 -1.889 . . . . 0.0 112.364 -0.399 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 88' ' ' TYR . . . . . 0.597 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 3.8 m-85 6.67 92.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 125.369 1.468 . . . . 0.0 114.173 -176.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.878 HG12 HG22 ' D' ' 58' ' ' VAL . 70.3 mt -112.02 133.05 58.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.671 ' O ' ' HD1' ' D' ' 57' ' ' PHE . 69.7 mm-40 -119.9 101.87 8.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.084 172.26 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 91' ' ' ILE . . . . . 1.101 HG22 ' HZ3' ' D' ' 54' ' ' TRP . 2.7 mt -98.11 110.54 25.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -178.316 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 92' ' ' LYS . . . . . 0.77 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -162.36 170.59 18.59 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.986 -0.446 . . . . 0.0 110.038 178.337 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.612 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 21.7 pt20 -81.31 158.25 24.81 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.093 175.066 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . 0.77 HG22 ' HE2' ' D' ' 92' ' ' LYS . 8.0 pt . . . . . 0 C--N 1.311 -1.08 0 CA-C-N 114.11 -1.405 . . . . 0.0 111.451 -167.128 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 120.697 0.284 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' D' D ' 2' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 -70.33 103.82 2.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.847 178.472 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' D' D ' 3' ' ' GLN . . . . . 0.438 ' HB3' ' OE2' ' D' ' 7' ' ' GLU . 53.3 tt0 -79.16 -52.67 7.86 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.66 177.66 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 4' ' ' LYS . . . . . 0.652 ' HB3' ' HB3' ' D' ' 7' ' ' GLU . 62.7 tttm -110.07 -8.68 14.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.248 177.39 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 5' ' ' ALA . . . . . . . . . . . . . . . 70.81 -61.44 0.48 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.576 0.75 . . . . 0.0 112.014 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 89.4 mt -75.13 8.71 2.42 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.298 0.57 . . . . 0.0 110.676 176.567 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . 0.652 ' HB3' ' HB3' ' D' ' 4' ' ' LYS . 23.1 pt-20 -70.93 -22.59 62.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.627 -179.333 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.763 ' HA ' ' CB ' ' D' ' 12' ' ' SER . 62.7 mm-40 -69.09 -20.0 64.07 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.776 -178.183 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . 0.469 HE22 ' HB2' ' D' ' 8' ' ' GLU . 15.1 mp0 -96.92 -4.22 40.44 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -177.472 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 10' ' ' MET . . . . . 0.679 ' HG3' ' H ' ' D' ' 11' ' ' ASN . 25.9 ptt? -107.82 -69.53 0.84 Allowed 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 119.763 -0.775 . . . . 0.0 112.887 -175.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 11' ' ' ASN . . . . . 0.679 ' H ' ' HG3' ' D' ' 10' ' ' MET . 60.9 m-80 -94.27 -45.73 7.37 Favored 'General case' 0 CA--C 1.484 -1.571 0 CA-C-O 120.815 0.34 . . . . 0.0 110.42 178.104 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 12' ' ' SER . . . . . 0.763 ' CB ' ' HA ' ' D' ' 8' ' ' GLU . 30.8 t -38.11 -49.22 1.3 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 113.456 -1.702 . . . . 0.0 113.591 -170.059 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.545 ' O ' HG12 ' D' ' 16' ' ' VAL . 7.1 tp -73.93 -16.42 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 121.215 0.531 . . . . 0.0 112.373 -174.865 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 14' ' ' ASN . . . . . 0.5 ' O ' ' HB2' ' D' ' 17' ' ' ASN . 3.9 m120 -95.69 -36.42 11.21 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.532 173.647 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 15' ' ' SER . . . . . 0.528 ' O ' ' HB2' ' D' ' 18' ' ' ASP . 80.3 p -75.89 -23.71 55.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.894 0.378 . . . . 0.0 110.224 178.142 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 16' ' ' VAL . . . . . 0.545 HG12 ' O ' ' D' ' 13' ' ' ILE . 5.6 p -61.27 -22.4 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 CA-C-O 122.196 0.998 . . . . 0.0 108.85 176.264 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 17' ' ' ASN . . . . . 0.5 ' HB2' ' O ' ' D' ' 14' ' ' ASN . 4.3 m120 -74.02 -39.73 63.37 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 113.578 -1.646 . . . . 0.0 109.271 176.476 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 18' ' ' ASP . . . . . 0.528 ' HB2' ' O ' ' D' ' 15' ' ' SER . 74.9 m-20 -57.34 -17.19 11.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.4 -0.818 . . . . 0.0 113.007 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.607 ' HD2' ' H ' ' D' ' 19' ' ' LYS . 0.0 OUTLIER -90.69 -40.72 11.7 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 121.957 0.884 . . . . 0.0 108.723 174.77 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' D' D ' 20' ' ' LEU . . . . . 0.708 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 81.5 mt -68.31 -34.83 76.85 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 113.327 -1.76 . . . . 0.0 110.523 -177.54 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 21' ' ' ASN . . . . . 0.682 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 63.6 m-20 -78.61 100.55 7.03 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.203 -179.356 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 22' ' ' LYS . . . . . 0.493 ' HD3' HD12 ' D' ' 47' ' ' ILE . 38.3 mtpt -122.07 -42.55 2.38 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 119.066 -1.054 . . . . 0.0 113.263 -170.398 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 158.11 -74.28 0.22 Allowed Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.144 -1.026 . . . . 0.0 112.719 -176.821 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . 0.837 ' HG3' ' HB3' ' D' ' 45' ' ' TYR . 21.9 tptm -53.06 -54.84 29.45 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.239 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 25' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' D' ' 45' ' ' TYR . . . -150.44 154.52 25.69 Favored Glycine 0 N--CA 1.429 -1.803 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.772 175.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 26' ' ' LYS . . . . . 0.733 ' CG ' ' HB3' ' D' ' 41' ' ' SER . 10.0 ptpt -149.67 159.61 44.2 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.707 -0.747 . . . . 0.0 110.897 -166.618 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 27' ' ' LEU . . . . . 0.708 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 42.7 tp -136.97 138.34 40.45 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.446 0.641 . . . . 0.0 111.904 -176.451 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 28' ' ' SER . . . . . 0.543 ' HB3' ' OG1' ' D' ' 39' ' ' THR . 18.0 t -128.41 153.94 46.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.061 -178.188 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 29' ' ' LEU . . . . . 0.44 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 22.7 mt -138.22 152.47 48.64 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.987 0.422 . . . . 0.0 110.262 177.465 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . 0.501 ' HB3' ' HB2' ' D' ' 37' ' ' LYS . 36.7 t -145.4 -171.25 3.63 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.411 178.787 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 31' ' ' MET . . . . . . . . . . . . . 23.5 ptp -145.85 166.57 25.56 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.84 0.352 . . . . 0.0 110.187 -179.854 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' D' D ' 32' ' ' ASN . . . . . 0.657 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 48.9 t30 -150.4 87.24 1.44 Allowed 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 174.769 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.83 -98.64 0.79 Allowed Glycine 0 N--CA 1.454 -0.166 0 C-N-CA 120.004 -1.093 . . . . 0.0 111.14 -171.366 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' D' D ' 34' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -112.6 14.46 20.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.853 0.359 . . . . 0.0 110.135 174.185 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' D' D ' 35' ' ' GLN . . . . . 0.657 ' HB3' ' HB3' ' D' ' 32' ' ' ASN . 3.5 tp-100 -89.21 159.13 17.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.601 -174.791 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.998 ' HB2' ' HB2' ' D' ' 85' ' ' LYS . 0.8 OUTLIER -121.24 135.79 55.07 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.299 179.352 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' D' D ' 37' ' ' LYS . . . . . 0.501 ' HB2' ' HB3' ' D' ' 30' ' ' SER . 74.5 mmtt -133.62 139.84 46.74 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.472 -171.511 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 38' ' ' ALA . . . . . 0.409 ' HB3' ' HB ' ' D' ' 79' ' ' ILE . . . -138.6 147.6 43.16 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.861 0.362 . . . . 0.0 111.074 177.184 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 39' ' ' THR . . . . . 0.543 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 17.7 p -147.1 131.94 18.04 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.369 175.731 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . 0.622 ' OG ' ' HA2' ' D' ' 73' ' ' GLY . 80.2 p -108.82 170.66 7.9 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 175.456 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 41' ' ' SER . . . . . 0.733 ' HB3' ' CG ' ' D' ' 26' ' ' LYS . 38.1 t -134.46 153.61 51.84 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.378 -0.929 . . . . 0.0 111.356 177.662 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 42' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' D' ' 41' ' ' SER . 75.3 m-80 79.57 9.41 1.57 Allowed 'General case' 0 N--CA 1.467 0.409 0 O-C-N 124.863 1.352 . . . . 0.0 110.462 -174.279 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 42.82 59.62 2.76 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 114.692 -1.14 . . . . 0.0 113.683 171.247 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' D' D ' 44' ' ' GLY . . . . . 0.435 ' O ' HG21 ' D' ' 71' ' ' THR . . . 112.94 35.96 1.59 Allowed Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 119.576 -1.297 . . . . 0.0 114.087 172.534 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 45' ' ' TYR . . . . . 0.837 ' HB3' ' HG3' ' D' ' 24' ' ' LYS . 1.2 m-85 -121.42 149.6 42.77 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 170.986 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . 0.57 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -100.11 -153.25 27.1 Favored Glycine 0 C--O 1.221 -0.703 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 -178.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 47' ' ' ILE . . . . . 0.899 HD11 ' HG3' ' D' ' 68' ' ' GLU . 40.3 mm -52.26 -57.82 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 CA-C-O 121.773 0.797 . . . . 0.0 109.618 175.418 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 78.7 p 179.37 -78.0 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 113.035 -1.893 . . . . 0.0 109.206 -174.569 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' D' D ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.52 74.59 0.76 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.811 171.662 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -147.12 148.51 31.65 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.588 -178.131 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' D' D ' 51' ' ' ASP . . . . . 0.689 ' HA ' ' HD3' ' D' ' 69' ' ' LYS . 7.7 p-10 -89.59 119.39 29.97 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.214 177.04 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 52' ' ' LYS . . . . . 0.641 ' O ' ' HA ' ' D' ' 67' ' ' ASN . 11.6 mmmm -128.48 101.28 6.12 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.387 -166.127 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 53' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -88.99 127.01 35.66 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.07 176.765 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' D' D ' 54' ' ' TRP . . . . . 0.486 ' HZ3' HG23 ' D' ' 91' ' ' ILE . 0.0 OUTLIER -124.97 164.97 18.97 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.062 -173.421 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -154.55 164.34 31.56 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.543 -1.313 . . . . 0.0 114.688 177.279 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' D' D ' 56' ' ' ILE . . . . . 0.497 HG21 HG21 ' D' ' 84' ' ' ILE . 72.7 mt -140.14 107.16 2.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 125.6 1.56 . . . . 0.0 107.02 -179.156 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 57' ' ' PHE . . . . . 0.517 ' HD2' ' O ' ' D' ' 90' ' ' GLU . 4.7 m-85 -114.3 109.25 18.07 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.318 -167.725 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.75 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 0.2 OUTLIER -101.29 118.71 48.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.216 0.531 . . . . 0.0 111.567 171.611 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 5.6 m120 50.57 54.14 11.7 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.845 179.082 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.16 47.89 80.56 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.73 177.846 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -157.01 114.52 3.14 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.4 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -80.99 99.59 8.5 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.143 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 27.5 m -82.76 -18.24 10.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.471 -173.826 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' D' D ' 64' ' ' TYR . . . . . 0.471 ' HB3' HD12 ' D' ' 56' ' ' ILE . 24.4 t80 -147.82 130.37 15.87 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.414 -0.514 . . . . 0.0 111.01 176.922 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 57.9 m -115.63 125.61 53.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.368 174.491 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' D' D ' 66' ' ' PHE . . . . . 0.429 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 15.7 p90 -132.1 163.36 28.65 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.743 177.159 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 67' ' ' ASN . . . . . 0.641 ' HA ' ' O ' ' D' ' 52' ' ' LYS . 74.5 m-80 -129.76 143.02 50.61 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.296 -176.189 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 68' ' ' GLU . . . . . 0.899 ' HG3' HD11 ' D' ' 47' ' ' ILE . 3.9 mm-40 -75.37 -17.93 60.1 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 176.835 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.689 ' HD3' ' HA ' ' D' ' 51' ' ' ASP . 44.1 mtmt -60.03 -48.73 80.49 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 168.532 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 19.7 m -78.17 61.44 2.68 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 111.857 -2.428 . . . . 0.0 109.236 171.596 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' D' D ' 71' ' ' THR . . . . . 0.435 HG21 ' O ' ' D' ' 44' ' ' GLY . 74.3 p -1.62 121.84 0.0 OUTLIER 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.873 1.669 . . . . 0.0 114.992 -179.338 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 72' ' ' VAL . . . . . 0.475 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.1 OUTLIER -44.58 -21.31 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 123.436 0.694 . . . . 0.0 112.613 171.207 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' D' D ' 73' ' ' GLY . . . . . 0.622 ' HA2' ' OG ' ' D' ' 40' ' ' SER . . . -60.69 -65.87 3.06 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.819 -0.628 . . . . 0.0 113.712 175.275 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 74' ' ' ASN . . . . . 0.503 ' HA ' HD22 ' D' ' 77' ' ' ASN . 4.5 m120 -71.47 -20.2 62.11 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 120.971 0.415 . . . . 0.0 110.82 -175.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 75' ' ' ILE . . . . . 0.621 ' O ' HG13 ' D' ' 79' ' ' ILE . 27.1 mm -79.34 -40.1 21.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.882 179.472 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 76' ' ' SER . . . . . 0.494 ' HA ' HG13 ' D' ' 79' ' ' ILE . 31.0 t -74.49 -19.98 60.17 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.223 -179.738 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 77' ' ' ASN . . . . . 0.503 HD22 ' HA ' ' D' ' 74' ' ' ASN . 79.4 m-20 -64.97 -32.42 74.14 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 119.368 -0.933 . . . . 0.0 108.586 166.651 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 78' ' ' ASP . . . . . 1.042 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 60.0 m-20 -79.31 -25.1 42.42 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 176.7 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . 0.621 HG13 ' O ' ' D' ' 75' ' ' ILE . 48.6 mt -72.0 -20.62 20.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 O-C-N 121.514 -0.741 . . . . 0.0 111.129 -175.37 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -71.15 -40.19 71.5 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.426 175.777 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . 1.042 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -73.78 -54.21 8.55 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.642 176.322 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' D' D ' 82' ' ' LEU . . . . . 0.623 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.9 mm? -47.29 -33.35 5.53 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 177.532 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 83' ' ' ASN . . . . . 0.684 HD22 ' HB3' ' D' ' 36' ' ' LEU . 0.7 OUTLIER 42.07 67.08 0.62 Allowed 'General case' 0 N--CA 1.468 0.438 0 O-C-N 124.002 0.814 . . . . 0.0 110.864 174.774 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' D' D ' 84' ' ' ILE . . . . . 0.574 ' O ' ' HG ' ' D' ' 36' ' ' LEU . 44.1 mm -94.94 98.81 8.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.165 -175.084 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 85' ' ' LYS . . . . . 0.998 ' HB2' ' HB2' ' D' ' 36' ' ' LEU . 46.4 tptt -139.97 94.47 2.76 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.171 0.51 . . . . 0.0 110.812 -178.63 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 86' ' ' GLY . . . . . 0.597 ' H ' ' CD1' ' D' ' 89' ' ' ILE . . . 69.54 161.98 3.11 Favored Glycine 0 CA--C 1.5 -0.845 0 CA-C-N 115.231 -0.895 . . . . 0.0 114.357 177.42 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 87' ' ' PRO . . . . . 0.697 ' HD2' HG21 ' D' ' 58' ' ' VAL . 61.7 Cg_endo -77.03 -172.1 10.77 Favored 'Cis proline' 0 CA--C 1.545 1.055 0 C-N-CA 122.195 -2.002 . . . . 0.0 114.128 0.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 88' ' ' TYR . . . . . 0.75 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 2.2 m-85 -9.38 94.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 125.485 1.514 . . . . 0.0 114.668 -174.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.597 ' CD1' ' H ' ' D' ' 86' ' ' GLY . 70.1 mt -102.19 142.1 17.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.517 ' O ' ' HD2' ' D' ' 57' ' ' PHE . 46.3 mt-10 -116.32 98.58 6.67 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.528 170.557 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 91' ' ' ILE . . . . . 0.543 HG13 HG22 ' D' ' 89' ' ' ILE . 33.0 mt -94.34 100.25 10.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.024 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 92' ' ' LYS . . . . . 0.661 ' HG2' ' O ' ' D' ' 93' ' ' GLN . 0.0 OUTLIER -159.68 166.68 30.08 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.416 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.661 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 3.8 pm0 -80.41 162.95 24.2 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 121.533 0.682 . . . . 0.0 110.696 175.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . 0.575 HG22 ' HE2' ' D' ' 92' ' ' LYS . 9.8 pt . . . . . 0 C--N 1.307 -1.26 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.585 -171.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' D' D ' 1' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 120.757 0.313 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' D' D ' 2' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -118.55 54.24 0.95 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.633 178.655 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -82.56 -14.69 54.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.297 0.57 . . . . 0.0 109.59 173.032 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' D' D ' 4' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -107.63 -13.26 15.09 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.731 177.099 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' D' D ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.24 60.9 0.75 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.161 -174.734 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . 0.658 ' O ' HD23 ' D' ' 6' ' ' LEU . 6.3 tt -74.06 -26.79 60.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.169 -175.356 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . 0.637 ' HA ' ' HB2' ' D' ' 10' ' ' MET . 94.9 mt-10 -63.25 1.22 0.52 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.758 ' O ' ' HB3' ' D' ' 12' ' ' SER . 10.9 pt-20 -54.83 -50.91 67.46 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -176.037 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . 0.425 ' H ' ' CD ' ' D' ' 9' ' ' GLN . 3.0 pm0 -97.14 14.51 25.56 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 121.715 -0.616 . . . . 0.0 110.444 175.257 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 10' ' ' MET . . . . . 0.637 ' HB2' ' HA ' ' D' ' 7' ' ' GLU . 95.4 mmm -102.46 -72.69 0.68 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.279 -176.954 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 11' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -100.52 -42.25 6.65 Favored 'General case' 0 CA--C 1.489 -1.388 0 CA-C-O 121.098 0.475 . . . . 0.0 110.252 176.097 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' D' D ' 12' ' ' SER . . . . . 0.758 ' HB3' ' O ' ' D' ' 8' ' ' GLU . 46.1 t -42.04 -55.1 3.3 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.137 -1.392 . . . . 0.0 112.265 -170.194 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.465 HG13 ' O ' ' D' ' 8' ' ' GLU . 64.0 mt -91.37 -8.89 10.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.365 -174.668 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 14' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -93.53 -59.12 2.08 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.395 175.183 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' D' D ' 15' ' ' SER . . . . . 0.481 ' O ' ' HE2' ' D' ' 19' ' ' LYS . 84.6 p -64.79 -15.19 61.36 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.644 0.239 . . . . 0.0 111.644 179.592 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 16' ' ' VAL . . . . . 0.586 ' HA ' ' HE2' ' D' ' 19' ' ' LYS . 11.8 p -60.64 -30.68 47.39 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.085 0 CA-C-O 121.527 0.679 . . . . 0.0 109.478 175.64 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 17' ' ' ASN . . . . . 0.517 HD22 HG13 ' D' ' 16' ' ' VAL . 2.6 m120 -71.95 -39.59 69.28 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.044 177.079 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 18' ' ' ASP . . . . . 0.465 ' OD1' ' HA ' ' D' ' 15' ' ' SER . 1.2 m-20 -58.95 -15.55 13.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.691 -179.367 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.604 ' O ' ' HE3' ' D' ' 22' ' ' LYS . 31.9 mttm -91.03 -52.71 4.7 Favored 'General case' 0 CA--C 1.492 -1.259 0 CA-C-O 122.525 1.155 . . . . 0.0 108.765 179.131 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 20' ' ' LEU . . . . . 0.958 ' HB3' ' HB3' ' D' ' 27' ' ' LEU . 55.7 mt -57.1 -40.34 76.84 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 112.381 -2.19 . . . . 0.0 110.734 178.266 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 21' ' ' ASN . . . . . 0.547 ' HA ' ' CB ' ' D' ' 26' ' ' LYS . 53.3 m-20 -76.04 94.15 3.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.153 179.054 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 22' ' ' LYS . . . . . 0.772 ' HD2' HD12 ' D' ' 47' ' ' ILE . 95.7 mttt -121.81 -42.19 2.42 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -175.397 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 172.02 -92.38 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 119.589 -1.291 . . . . 0.0 113.337 -178.742 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . 0.735 ' HG2' ' HB3' ' D' ' 45' ' ' TYR . 80.4 tttt -47.22 -50.05 21.84 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.654 0.74 . . . . 0.0 109.628 178.195 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -141.54 158.08 26.42 Favored Glycine 0 N--CA 1.432 -1.626 0 CA-C-N 114.383 -1.281 . . . . 0.0 111.524 175.884 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' D' D ' 26' ' ' LYS . . . . . 0.688 ' CD ' ' HB2' ' D' ' 41' ' ' SER . 0.2 OUTLIER -150.47 161.3 42.79 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.672 -0.764 . . . . 0.0 110.24 -170.448 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' D' D ' 27' ' ' LEU . . . . . 0.958 ' HB3' ' HB3' ' D' ' 20' ' ' LEU . 35.5 tp -140.19 143.67 36.2 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.129 0.49 . . . . 0.0 111.116 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 28' ' ' SER . . . . . 0.575 ' H ' HD12 ' D' ' 27' ' ' LEU . 13.0 t -140.6 109.78 6.17 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.703 -176.217 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 29' ' ' LEU . . . . . 0.524 ' HA ' ' O ' ' D' ' 37' ' ' LYS . 0.9 OUTLIER -131.61 145.75 51.85 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -179.767 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 72.8 p -160.18 -171.71 3.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.513 -177.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' D' D ' 31' ' ' MET . . . . . 0.798 ' HA ' ' O ' ' D' ' 35' ' ' GLN . 69.9 mtm -125.73 131.23 52.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.173 0.511 . . . . 0.0 111.005 176.127 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 32' ' ' ASN . . . . . 0.407 ' HB3' ' HB3' ' D' ' 35' ' ' GLN . 49.2 t30 -90.78 88.87 7.24 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 172.612 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.53 -99.86 1.64 Allowed Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -164.439 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' D' D ' 34' ' ' ASN . . . . . 0.686 ' O ' ' HE3' ' D' ' 85' ' ' LYS . 75.4 m-80 -120.99 13.45 11.35 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.672 -0.311 . . . . 0.0 110.569 171.879 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 35' ' ' GLN . . . . . 0.798 ' O ' ' HA ' ' D' ' 31' ' ' MET . 52.2 tt0 -88.52 126.39 35.23 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.041 -175.102 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.778 HD12 ' HA ' ' D' ' 83' ' ' ASN . 3.0 tm? -79.08 124.67 28.51 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.278 0.561 . . . . 0.0 111.13 -179.311 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 37' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' D' ' 29' ' ' LEU . 30.9 mmmt -135.91 117.09 14.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.523 -170.756 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 38' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' D' ' 28' ' ' SER . . . -126.91 148.46 50.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.215 0.531 . . . . 0.0 112.068 -177.374 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 39' ' ' THR . . . . . 0.468 ' OG1' ' HB3' ' D' ' 28' ' ' SER . 15.5 p -146.87 124.85 12.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.797 177.581 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . 0.544 ' HB2' ' HA2' ' D' ' 73' ' ' GLY . 69.2 m -110.7 128.86 55.89 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 173.378 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 41' ' ' SER . . . . . 0.688 ' HB2' ' CD ' ' D' ' 26' ' ' LYS . 50.2 m -97.59 161.71 13.64 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.987 -174.217 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 42' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' D' ' 41' ' ' SER . 71.9 m-80 79.69 10.88 1.33 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.901 -172.006 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . 39.74 61.85 1.34 Allowed 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 169.355 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.54 -5.53 7.58 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 118.745 -1.693 . . . . 0.0 115.315 172.111 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' D' D ' 45' ' ' TYR . . . . . 0.735 ' HB3' ' HG2' ' D' ' 24' ' ' LYS . 1.6 m-85 -96.6 155.84 16.6 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 117.454 0.627 . . . . 0.0 111.882 -178.738 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . 0.607 ' O ' ' HB3' ' D' ' 24' ' ' LYS . . . -101.82 -177.13 28.2 Favored Glycine 0 C--O 1.214 -1.115 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 173.088 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 47' ' ' ILE . . . . . 0.938 HG12 ' HB3' ' D' ' 68' ' ' GLU . 34.9 mm -48.09 -55.28 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.836 0 CA-C-N 118.391 1.095 . . . . 0.0 110.239 178.376 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.512 ' HA ' ' HD3' ' D' ' 24' ' ' LYS . 23.2 t 179.44 -156.67 0.02 OUTLIER 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 113.026 -1.897 . . . . 0.0 107.154 -177.268 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 49' ' ' TYR . . . . . 0.473 ' O ' ' HD1' ' D' ' 49' ' ' TYR . 0.3 OUTLIER -81.13 76.81 8.07 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.795 0.807 . . . . 0.0 109.794 167.969 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . 0.654 ' O ' ' HG2' ' D' ' 69' ' ' LYS . 71.2 mm-40 -119.24 -163.04 0.94 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.993 -171.964 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 51' ' ' ASP . . . . . 0.71 ' C ' ' HD2' ' D' ' 52' ' ' LYS . 11.6 t70 -162.76 107.44 1.13 Allowed 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.631 170.633 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 52' ' ' LYS . . . . . 0.71 ' HD2' ' C ' ' D' ' 51' ' ' ASP . 4.2 mptp? -138.67 109.1 6.51 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 113.755 -1.566 . . . . 0.0 109.447 -172.812 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 53' ' ' ASN . . . . . 0.459 ' HA ' ' OD1' ' D' ' 67' ' ' ASN . 2.9 m120 -83.66 131.41 34.95 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.297 177.764 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 54' ' ' TRP . . . . . 0.607 ' HZ3' HG23 ' D' ' 91' ' ' ILE . 0.3 OUTLIER -120.55 153.52 36.62 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.82 -173.139 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -144.87 159.54 27.86 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 120.019 -1.086 . . . . 0.0 113.578 174.313 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' D' D ' 56' ' ' ILE . . . . . 0.652 HG23 HG12 ' D' ' 91' ' ' ILE . 61.8 mt -134.31 111.94 15.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 176.557 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 57' ' ' PHE . . . . . 0.65 ' HZ ' HG21 ' D' ' 94' ' ' ILE . 3.6 m-85 -110.77 105.04 13.75 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 119.214 -0.994 . . . . 0.0 111.122 -166.633 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.714 ' HA ' ' O ' ' D' ' 88' ' ' TYR . 94.3 t -89.04 108.47 19.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.977 173.647 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 59' ' ' ASN . . . . . 0.719 HD21 ' HG2' ' D' ' 87' ' ' PRO . 77.8 m-20 60.89 52.18 4.33 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.344 -177.525 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 57.82 47.44 88.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.291 -179.5 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' D' D ' 61' ' ' GLU . . . . . 0.582 ' O ' ' HA ' ' D' ' 57' ' ' PHE . 5.3 tp10 -151.82 125.41 8.93 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.252 -0.474 . . . . 0.0 109.904 -177.398 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -67.77 105.82 2.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.093 0.473 . . . . 0.0 109.954 177.103 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.443 HG12 ' O ' ' D' ' 56' ' ' ILE . 14.6 p -86.69 -21.98 7.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.193 -178.044 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 64' ' ' TYR . . . . . 0.505 ' HB3' HD12 ' D' ' 56' ' ' ILE . 31.6 t80 -156.92 135.14 11.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.324 176.429 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.406 HG23 ' O ' ' D' ' 54' ' ' TRP . 74.9 m -120.28 120.48 36.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.721 0.296 . . . . 0.0 110.757 176.77 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 66' ' ' PHE . . . . . 0.531 ' O ' ' HB2' ' D' ' 54' ' ' TRP . 21.2 p90 -126.76 171.12 11.47 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 173.317 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 67' ' ' ASN . . . . . 0.459 ' OD1' ' HA ' ' D' ' 53' ' ' ASN . 75.4 m-20 -129.88 152.76 49.01 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 68' ' ' GLU . . . . . 0.938 ' HB3' HG12 ' D' ' 47' ' ' ILE . 33.5 mt-10 -76.66 -8.36 57.1 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.044 178.473 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.654 ' HG2' ' O ' ' D' ' 50' ' ' GLU . 48.6 mtpt -69.63 -50.36 45.03 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 168.759 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 13.8 t -61.93 120.46 10.81 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 113.569 -1.65 . . . . 0.0 107.685 172.621 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' D' D ' 71' ' ' THR . . . . . . . . . . . . . 81.0 p -54.17 114.06 1.48 Allowed 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.929 -172.676 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' D' D ' 72' ' ' VAL . . . . . 0.532 ' CG1' ' HB2' ' D' ' 27' ' ' LEU . 0.1 OUTLIER -50.63 -23.29 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.727 -179.483 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' D' D ' 73' ' ' GLY . . . . . 0.544 ' HA2' ' HB2' ' D' ' 40' ' ' SER . . . -58.4 -66.77 2.58 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.733 -0.667 . . . . 0.0 113.62 173.231 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 74' ' ' ASN . . . . . 0.651 ' HA ' HD22 ' D' ' 77' ' ' ASN . 4.3 m120 -63.79 -24.28 67.7 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 120.796 0.331 . . . . 0.0 110.801 -178.003 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 75' ' ' ILE . . . . . 0.435 ' O ' HG12 ' D' ' 79' ' ' ILE . 36.6 mm -78.39 -38.8 23.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.606 178.348 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 76' ' ' SER . . . . . 0.922 ' HA ' HG12 ' D' ' 79' ' ' ILE . 36.9 t -76.2 -19.93 57.95 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.479 -0.489 . . . . 0.0 111.002 179.544 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 77' ' ' ASN . . . . . 0.651 HD22 ' HA ' ' D' ' 74' ' ' ASN . 75.3 m-20 -63.35 -32.39 73.8 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 166.073 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 78' ' ' ASP . . . . . 1.106 ' HA ' ' HD3' ' D' ' 81' ' ' LYS . 1.1 m-20 -79.27 -25.03 42.56 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.94 174.033 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . 0.922 HG12 ' HA ' ' D' ' 76' ' ' SER . 22.2 mm -69.03 -25.32 29.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.235 -177.729 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -73.01 -33.31 65.69 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.855 179.331 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . 1.106 ' HD3' ' HA ' ' D' ' 78' ' ' ASP . 0.0 OUTLIER -77.82 -61.18 2.08 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.97 174.197 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' D' D ' 82' ' ' LEU . . . . . 0.525 HD23 ' O ' ' D' ' 78' ' ' ASP . 3.8 mm? -48.53 -31.81 7.02 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 176.314 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 83' ' ' ASN . . . . . 0.778 ' HA ' HD12 ' D' ' 36' ' ' LEU . 22.3 t-20 25.01 80.86 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 O-C-N 124.973 1.42 . . . . 0.0 112.533 177.0 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 84' ' ' ILE . . . . . 0.543 ' N ' ' HG ' ' D' ' 36' ' ' LEU . 2.7 mp -81.56 99.25 4.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.612 -175.174 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 85' ' ' LYS . . . . . 0.686 ' HE3' ' O ' ' D' ' 34' ' ' ASN . 21.5 ptmt -126.76 92.08 3.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.284 0.564 . . . . 0.0 111.318 179.664 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 86' ' ' GLY . . . . . 0.863 ' H ' HD11 ' D' ' 89' ' ' ILE . . . 65.2 154.26 0.16 Allowed Glycine 0 CA--C 1.516 0.11 0 CA-C-N 115.911 -0.586 . . . . 0.0 113.433 177.261 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 87' ' ' PRO . . . . . 0.719 ' HG2' HD21 ' D' ' 59' ' ' ASN . 56.8 Cg_endo -90.85 -179.65 12.44 Favored 'Cis proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.515 -1.452 . . . . 0.0 112.797 -0.429 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 88' ' ' TYR . . . . . 0.714 ' O ' ' HA ' ' D' ' 58' ' ' VAL . 0.9 OUTLIER 18.65 93.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.081 1.353 . . . . 0.0 113.531 179.637 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.863 HD11 ' H ' ' D' ' 86' ' ' GLY . 74.2 mt -111.02 136.78 46.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.097 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.55 ' O ' ' HD1' ' D' ' 57' ' ' PHE . 35.9 mm-40 -123.55 93.47 3.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.678 172.438 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 91' ' ' ILE . . . . . 0.652 HG12 HG23 ' D' ' 56' ' ' ILE . 32.2 mt -94.25 99.38 9.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.822 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 92' ' ' LYS . . . . . 0.695 ' HE2' HG22 ' D' ' 94' ' ' ILE . 0.0 OUTLIER -162.65 167.34 23.32 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.198 178.432 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.615 ' O ' ' HG2' ' D' ' 92' ' ' LYS . 23.6 pt20 -81.18 164.45 22.32 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.067 175.116 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . 0.695 HG22 ' HE2' ' D' ' 92' ' ' LYS . 6.3 pt . . . . . 0 C--O 1.245 0.85 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.8 -169.667 . . . . . . . . 1 1 . 1 stop_ save_